PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ba, XQ; Gupta, S; Davidson, M; Garg, NJ				Ba, Xueqing; Gupta, Shivali; Davidson, Mercy; Garg, Nisha Jain			Trypanosoma cruzi Induces the Reactive Oxygen Species-PARP-1-RelA Pathway for Up-regulation of Cytokine Expression in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; POLY(ADP-RIBOSE) POLYMERASE-1; CHAGASIC CARDIOMYOPATHY; OXIDATIVE STRESS; DNA-BINDING; IFN-GAMMA; INFECTION; PARP-1; ALPHA	In this study, we demonstrate that human cardiomyocytes (AC16) produce reactive oxygen species (ROS) and inflammatory cytokines in response to Trypanosoma cruzi. ROS were primarily produced by mitochondria, some of which diffused to cytosol of infected cardiomyocytes. These ROS resulted in an increase in 8-hydroxyguanine lesions and DNA fragmentation that signaled PARP-1 activation evidenced by poly(ADP-ribose) ( PAR) modification of PARP-1 and other proteins in infected cardiomyocytes. Phenyl-alpha-tert-butylnitrone blocked the mitochondrial ROS (mtROS) formation, DNA damage, and PARP-1 activation in infected cardiomyocytes. Further inhibition studies demonstrated that ROS and PARP-1 signaled TNF-alpha and IL-1 beta expression in infected cardiomyocytes. ROS directly signaled the nuclear translocation of RelA (p65), NF-kappa B activation, and cytokine gene expression. PARP-1 exhibited no direct interaction with p65 and did not signal its translocation to nuclei in infected cardiomyocytes. Instead, PARP-1 contributed to PAR modification of p65-interacting nuclear proteins and assembly of the NF-kappa B transcription complex. PJ34 (PARP-1 inhibitor) also prevented mitochondrial poly(ADP-ribosyl)ation (PARylation) and ROS formation. We conclude that T. cruzimediated mtROS provide primary stimulus for PARP-1-NF-kappa B activation and cytokine gene expression in infected cardiomyocytes. PAR modification of mitochondrial membranes then results in a feedback cycle of mtROS formation and DNA damage/PARP-1 activation. ROS, either through direct modulation of cytosolic NF-kappa B, or via PARP-1-dependent PAR modification of p65-interacting nuclear proteins, contributes to cytokine gene expression. Our results demonstrate a link between ROS and inflammatory responses in cardiomyocytes infected by T. cruzi and provide a clue to the pathomechanism of sustained inflammation in Chagas disease.	[Ba, Xueqing; Gupta, Shivali; Garg, Nisha Jain] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Davidson, Mercy] Columbia Univ, Dept Neurol, New York, NY 10032 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Columbia University	Garg, NJ (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, 3-142C Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	nigarg@utmb.edu		Ba, Xueqing/0000-0002-1075-5496	National Institutes of Health [RO1-HL094802]; NHLBI; NIAID [RO1-AI054578]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL094802 from NHLBI and RO1-AI054578 from NIAID (to N. J. G.).	Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; de Oliveira TB, 2007, INT J CARDIOL, V116, P357, DOI 10.1016/j.ijcard.2006.04.046; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Cardoni RL, 1999, MEDICINA-BUENOS AIRE, V59, P84; CARDONI RL, 1990, CELL IMMUNOL, V128, P11, DOI 10.1016/0008-8749(90)90002-9; Cardoni RL, 1997, AM J TROP MED HYG, V56, P329, DOI 10.4269/ajtmh.1997.56.329; Chandrasekar B, 1998, AM J PATHOL, V152, P925; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Druzhyna N, 2000, DIABETES, V49, P1849, DOI 10.2337/diabetes.49.11.1849; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; DYER RB, 1995, BIOTECHNIQUES, V19, P192; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; Gupta S, 2009, FREE RADICAL BIO MED, V47, P1414, DOI 10.1016/j.freeradbiomed.2009.08.008; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Liaudet L, 2002, AM J RESP CRIT CARE, V165, P372, DOI 10.1164/ajrccm.165.3.2106050; Lima ECS, 1997, INFECT IMMUN, V65, P457, DOI 10.1128/IAI.65.2.457-465.1997; Mabley JG, 2001, INFLAMM RES, V50, P561, DOI 10.1007/PL00000234; Machado FS, 2008, MICROBES INFECT, V10, P1558, DOI 10.1016/j.micinf.2008.09.009; Machado FS, 2000, CIRCULATION, V102, P3003, DOI 10.1161/01.CIR.102.24.3003; MUNOZFERNANDEZ MA, 1992, IMMUNOL LETT, V33, P35, DOI 10.1016/0165-2478(92)90090-B; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Pankotai E, 2009, MITOCHONDRION, V9, P159, DOI 10.1016/j.mito.2009.01.013; Perez-Fuentes R, 2003, INT J PARASITOL, V33, P293, DOI 10.1016/S0020-7519(02)00283-7; ROSSI MA, 2003, FRONT BIOSCI, V8, P94; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Sheeran FL, 2006, BBA-BIOENERGETICS, V1757, P543, DOI 10.1016/j.bbabio.2006.03.008; Talvani A, 2000, MICROBES INFECT, V2, P851, DOI 10.1016/S1286-4579(00)00388-9; Talvani A, 2004, CLIN INFECT DIS, V38, P943, DOI 10.1086/381892; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; Wen JJ, 2006, AM J PATHOL, V169, P1953, DOI 10.2353/ajpath.2006.060475; Wen JJ, 2006, FREE RADICAL BIO MED, V41, P270, DOI 10.1016/j.freeradbiomed.2006.04.009; Wen JJ, 2010, ANTIOXID REDOX SIGN, V12, P27, DOI [10.1089/ars.2008.2418, 10.1089/ARS.2008.2418]; Wen JJ, 2008, J BIOENERG BIOMEMBR, V40, P587, DOI 10.1007/s10863-008-9184-4; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; World Health Organization (WHO), 2006, REP SCI WORK GROUP C; Zacks MA, 2005, AN ACAD BRAS CIENC, V77, P695, DOI 10.1590/S0001-37652005000400009	44	97	100	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11596	11606		10.1074/jbc.M109.076984	http://dx.doi.org/10.1074/jbc.M109.076984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145242	hybrid, Green Published			2022-12-25	WOS:000276286200065
J	Hilton, T; Gross, MK; Kioussi, C				Hilton, Traci; Gross, Michael K.; Kioussi, Chrissa			Pitx2-dependent Occupancy by Histone Deacetylases Is Associated with T-box Gene Regulation in Mammalian Abdominal Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL BODY-WALL; TRANSCRIPTION FACTOR; HEART DEVELOPMENT; BETA-CATENIN; TOOTH MORPHOGENESIS; PATTERN-FORMATION; RIEGER-SYNDROME; EXPRESSION; PITX2; TBX5	The homeodomain transcription factor Pitx2 and the T-box transcription factors are essential for organogenesis. Pitx2 and T-box genes are induced by growth factors and function as transcriptional activators or repressors. Gene expression analyses on abdominal tissue were used to identify seven of the T-box genes of the genome as Pitx2 target genes in the abdomen at embryonic day. 10.5. Pitx2 activated Tbx4, Tbx15, and Mga and repressed Tbx1, Tbx2, Tbx5, and Tbx6 expression. As expected, activated genes showed reduced expression patterns, and repressed T-box genes showed increased expression patterns in the abdomen of Pitx2 mutants. Pitx2 occupied chromatin sites near all of these T-box genes. Co-occupancy by coactivators, corepressors, and histone acetylation at these sites was frequently Pitx2-dependent. Genes repressed by Pitx2 generally showed increased histone acetylation and decreased histone deacetylase (HDAC)/corepressor occupancy in Pitx2 mutants. The lower N-CoR, HDAC1, and HDAC3 occupancy observed at multiple sites along Tbx1 chromatin in mutants is consistent with the model that increased histone acetylation and gene expression of Tbx1 may result from a loss of recruitment of corepressors by Pitx2. Genes activated by Pitx2 showed less consistent patterns in chromatin analyses. Reduced H4 acetylation and increased HDAC1/nuclear receptor corepressor (N-CoR) occupancy at some Tbx4 sites were accompanied by increased H3 acetylation and reduced HDAC3 occupancy at the same or other more distal chromatin sites in mutants. Pitx2-dependent occupancy by corepressors resulted in alteration of the acetylation levels of several T-box genes, whereas Pitx2-dependent occupancy by coactivators was more site-localized. These studies will provide the basic scientific underpinning to understand abdominal wall syndromes.	[Hilton, Traci; Gross, Michael K.; Kioussi, Chrissa] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	Oregon State University	Gross, MK (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	grossm@onid.orst.edu; chrissa.kioussi@oregonstate.edu		Kioussi, Chrissa/0000-0001-8226-9908	National Institutes of Health [AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR054406 (to C. K.).	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Arnold JS, 2006, DEVELOPMENT, V133, P977, DOI 10.1242/dev.02264; Behesti H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-62; Brewer S, 2004, BIOESSAYS, V26, P1307, DOI 10.1002/bies.20137; Brewer S, 2004, DEV BIOL, V267, P399, DOI 10.1016/j.ydbio.2003.11.021; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Choi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000395; DeLaurier A, 2006, DEV BIOL, V299, P22, DOI 10.1016/j.ydbio.2006.06.055; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Jepsen K, 2002, J CELL SCI, V115, P689; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kioussi C, 2006, P NATL ACAD SCI USA, V103, P18621, DOI 10.1073/pnas.0609055103; Kioussi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002179; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus F, 2001, MECH DEVELOP, V100, P87, DOI 10.1016/S0925-4773(00)00499-8; Krause A, 2004, DEV BIOL, V273, P106, DOI 10.1016/j.ydbio.2004.05.024; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu JX, 2001, P NATL ACAD SCI USA, V98, P8674, DOI 10.1073/pnas.141234898; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Maira M, 2003, J BIOL CHEM, V278, P46523, DOI 10.1074/jbc.M305626200; MENGUS G, 1995, EMBO J, V14, P1520, DOI 10.1002/j.1460-2075.1995.tb07138.x; Mitsiadis TA, 2008, DEV BIOL, V320, P39, DOI 10.1016/j.ydbio.2008.04.006; Naiche LA, 2007, DEVELOPMENT, V134, P93, DOI 10.1242/dev.02712; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; OREILLY MAJ, 1995, DEVELOPMENT, V121, P1351; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; Shima Y, 2008, MOL ENDOCRINOL, V22, P1633, DOI 10.1210/me.2007-0444; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Singh R, 2009, CIRC RES, V105, P442, DOI 10.1161/CIRCRESAHA.109.196063; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Tada M, 2001, DEV GROWTH DIFFER, V43, P1; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wardle FC, 2006, SEMIN CELL DEV BIOL, V17, P99, DOI 10.1016/j.semcdb.2005.11.008; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; White JA, 2008, J EXP ZOOL PART B, V310B, P73, DOI 10.1002/jez.b.21153; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Yang Y, 2007, J MOL BIOL, V369, P917, DOI 10.1016/j.jmb.2007.04.004	64	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11129	11142		10.1074/jbc.M109.087429	http://dx.doi.org/10.1074/jbc.M109.087429			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20129917	hybrid, Green Published			2022-12-25	WOS:000276286200018
J	Manna, SK; Babajan, B; Raghavendra, PB; Raviprakash, N; Sureshkumar, C				Manna, Sunil K.; Babajan, Banaganapalli; Raghavendra, Pongali B.; Raviprakash, Nune; Sureshkumar, Chitta			Inhibiting TRAF2-mediated Activation of NF-kappa B Facilitates Induction of AP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; POTENTIATES APOPTOSIS; RELA PHOSPHORYLATION; PROTEIN; MECHANISM; CELLS; TRADD-TRAF2; PROGRESSION; EXPRESSION; ANTITUMOR	The compound 5-(4-methoxyarylimino)-2-N-(3,4-dichlorophenyl)3-oxo-1,2,4-thiadiazolidine (P-3-25) is known to possess anti-bacterial, anti-fungal, and anti-tubercular activities. In this report, we provide evidence that P-3-25 inhibits NF-kappa B, known to induce inflammatory and tumorigenic responses. It activates AP-1, another transcription factor. It inhibits TRAF2-mediated NF-kappa B activation but not TRAF6-mediated NF-kappa B DNA binding by preventing its association with TANK ( TRAF for NF-kappa B). It facilitates binding of MEKK1 with TRAF2 and thereby activates JNK and AP-1. We provide evidence, for the first time, that suggests that the interaction of P3-25 with TRAF2 leads to inhibition of the NF-kappa B pathway and activation of AP-1 pathway. These results suggest novel approaches to design of P3-25 as an anti-cancer/inflammatory drug for therapy through regulation of the TRAF2 pathway.	[Manna, Sunil K.; Raghavendra, Pongali B.; Raviprakash, Nune] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India; [Babajan, Banaganapalli; Raghavendra, Pongali B.; Sureshkumar, Chitta] Sri Krishnadevaraya Univ, Dept Biochem, Anantapur 515003, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Sri Krishnadevaraya University	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India.	manna@cdfd.org.in	Banaganapalli, Babajan/A-6282-2013	Banaganapalli, Babajan/0000-0001-8089-2210	Department of Biotechnology, Government of India; University Grants Commission, India; Council for Scientific and Industrial Research, New Delhi	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission, India(University Grants Commission, India); Council for Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Government of India. This work was also supported by a University Grants Commission, India, Major Research Project (to B. B.) and a Council for Scientific and Industrial Research, New Delhi, Senior Research Fellowship (to P. B. R.).	Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BERNSTEIN FC, 1977, J MOL BIOL, V112, P542; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Chadee DN, 2002, MOL CELL BIOL, V22, P737, DOI 10.1128/MCB.22.3.737-749.2002; Chin AID, 1999, MOL CELL BIOL, V19, P6665; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Duffey DC, 1999, CANCER RES, V59, P3468; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim JW, 2001, J BIOL CHEM, V276, P27064, DOI 10.1074/jbc.M009364200; Kriehuber E, 2005, BLOOD, V106, P175, DOI 10.1182/blood-2004-08-3072; Manna P, 2005, INT J CANCER, V113, P549, DOI 10.1002/ijc.20590; Manna P, 2004, INDIAN J HETEROCY CH, V13, P249; Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Manna SK, 1999, J IMMUNOL, V162, P1510; Manna SK, 2009, MOL IMMUNOL, V46, P1340, DOI 10.1016/j.molimm.2008.11.014; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sarkar A, 2004, J BIOL CHEM, V279, P33768, DOI 10.1074/jbc.M403424200; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sreenivasan Y, 2003, ONCOGENE, V22, P4356, DOI 10.1038/sj.onc.1206486; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	33	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11617	11627		10.1074/jbc.M109.094961	http://dx.doi.org/10.1074/jbc.M109.094961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20133937	Green Published, hybrid			2022-12-25	WOS:000276286200067
J	Sun, XL; Jones, WT; Harvey, D; Edwards, PJB; Pascal, SM; Kirk, C; Considine, T; Sheerin, DJ; Rakonjac, J; Oldfield, CJ; Xue, B; Dunker, AK; Uversky, VN				Sun, Xiaolin; Jones, William T.; Harvey, Dawn; Edwards, Patrick J. B.; Pascal, Steven M.; Kirk, Christopher; Considine, Therese; Sheerin, David J.; Rakonjac, Jasna; Oldfield, Christopher J.; Xue, Bin; Dunker, A. Keith; Uversky, Vladimir N.			N-terminal Domains of DELLA Proteins Are Intrinsically Unstructured in the Absence of Interaction with GID1/Gibberellic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR RECOGNITION FEATURES; NATIVELY UNFOLDED PROTEINS; LONG DISORDERED REGIONS; FUNCTIONAL ANTHOLOGY; FLORAL DEVELOPMENT; GIBBERELLIN RESPONSES; SECONDARY STRUCTURE; SEED-GERMINATION; ARABIDOPSIS; BINDING	The plant growth-repressing DELLA proteins (DELLAs) are known to represent a convergence point in integration of multiple developmental and environmental signals in planta, one of which is hormone gibberellic acid (GA). Binding of the liganded GA receptor (GID1/GA) to the N-terminal domain of DELLAs is required for GA-induced degradation of DELLAs via the ubiquitin-proteasome pathway, thus derepressing plant growth. However, the conformational changes of DELLAs upon binding to GID1/GA, which are the key to understanding the precise mechanism of GID1/GA-mediated degradation of DELLAs, remain unclear. Using biophysical, biochemical, and bioinformatics approaches, we demonstrated for the first time that the unbound N-terminal domains of DELLAs are intrinsically unstructured proteins under physiological conditions. Within the intrinsically disordered N-terminal domain of DELLAs, we have identified several molecular recognition features, sequences known to undergo disorder-to-order transitions upon binding to interacting proteins in intrinsically unstructured proteins. In accordance with the molecular recognition feature analyses, we have observed the binding-induced folding of N-terminal domains of DELLAs upon interaction with AtGID1/GA. Our results also indicate that DELLA proteins can be divided into two subgroups in terms of their molecular compactness and their interactions with monoclonal antibodies.	[Sun, Xiaolin; Jones, William T.; Harvey, Dawn; Kirk, Christopher] New Zealand Inst Plant & Food Res, Palmerston North, New Zealand; [Edwards, Patrick J. B.; Pascal, Steven M.] Massey Univ, Struct Biol Ctr, Inst Fundamental Sci, Palmerston North, New Zealand; [Kirk, Christopher; Sheerin, David J.; Rakonjac, Jasna] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; [Considine, Therese] Fonterra Res Ctr, Palmerston North, New Zealand; [Oldfield, Christopher J.; Xue, Bin; Dunker, A. Keith; Uversky, Vladimir N.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia	New Zealand Institute for Plant & Food Research Ltd; Massey University; Massey University; Fonterra; Indiana University System; Indiana University-Purdue University Indianapolis; Russian Academy of Sciences	Sun, XL (corresponding author), New Zealand Inst Plant & Food Res, Private Bag 11 030, Palmerston North, New Zealand.	Xiaolin.Sun@plantandfood.co.nz; William.Jones@plantandfood.co.nz	Uversky, Vladimir N./F-4515-2011; Pascal, Steven/AAP-5684-2021; Rakonjac, Jasna V/E-6836-2011; Edwards, P/E-2804-2018; xue, bin/E-5617-2011; Sun, Xiaolin/P-4882-2016; Harvey, Dawn/R-2697-2016	Uversky, Vladimir N./0000-0002-4037-5857; Rakonjac, Jasna V/0000-0002-6756-4682; Edwards, P/0000-0003-3776-7582; xue, bin/0000-0002-6344-0623; Sun, Xiaolin/0000-0001-7538-1301; Harvey, Dawn/0000-0001-7457-9703	National Institutes of Health [R01 LM007688-01A1, GM071714-01A2]; New Zealand Foundation for Research, Science, and Technology [C06X0207]; Russian Academy of Sciences for "Molecular and Cellular Biology"; Indiana University Purdue University Indianapolis Signature Centers Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071714] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Zealand Foundation for Research, Science, and Technology(New Zealand Foundation for Research, Science and Technology); Russian Academy of Sciences for "Molecular and Cellular Biology"; Indiana University Purdue University Indianapolis Signature Centers Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 LM007688-01A1 and GM071714-01A2. This work was also supported by New Zealand Foundation for Research, Science, and Technology Grant C06X0207 and the Program of the Russian Academy of Sciences for "Molecular and Cellular Biology." This work was also supported by the Indiana University Purdue University Indianapolis Signature Centers Initiative.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Chen AA, 2007, J PHYS CHEM B, V111, P11884, DOI 10.1021/jp0765392; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hou XL, 2008, PLANT PHYSIOL, V147, P1126, DOI 10.1104/pp.108.121301; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; Hussain A, 2005, PLANT J, V44, P88, DOI 10.1111/j.1365-313X.2005.02512.x; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schwechheimer C, 2008, CURR OPIN PLANT BIOL, V11, P9, DOI 10.1016/j.pbi.2007.10.011; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Silverstone AL, 2007, PLANT PHYSIOL, V143, P987, DOI 10.1104/pp.106.091025; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Sun XL, 2008, PROTEIN EXPRES PURIF, V58, P168, DOI 10.1016/j.pep.2007.09.003; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u	63	52	60	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11557	11571		10.1074/jbc.M109.027011	http://dx.doi.org/10.1074/jbc.M109.027011			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20103592	hybrid, Green Published			2022-12-25	WOS:000276286200062
J	Kim, YM; Geiger, TR; Egan, DI; Sharma, N; Nyborg, JK				Kim, Y-M; Geiger, T. R.; Egan, D. I.; Sharma, N.; Nyborg, J. K.			The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription	ONCOGENE			English	Article						CRE; cell cycle; transducer of regulated CREB; CREB-regulated transcription co-activator; CRTC	LEUKEMIA-VIRUS TYPE-1; NF-KAPPA-B; ELEMENT-BINDING PROTEIN; CAMP-RESPONSIVE ELEMENT; I TAX; COACTIVATOR CBP; GENE-EXPRESSION; T-CELLS; MOLECULAR CHARACTERIZATION; TRANSACTIVATOR TAX	Adult T-cell leukemia/lymphoma is a fatal malignancy etiologically linked to infection with the human T-cell leukemia virus (HTLV-1). The virally encoded oncoprotein Tax activates the transcription of HTLV-1 and cellular genes by cooperating with cellular transcription factors. Cyclin D1 is a pivotal regulator of cell cycle progression, and increased expression strongly correlates with malignant transformation. Here, we characterize the mechanism of Tax transactivation of cyclin D1. We find that cyclin D1 transcript levels are elevated in HTLV-1 infected cells and that Tax physically associates with the cyclin D1 gene in vivo. Tax binds the cyclin D1 promoter-proximal cyclic AMP response element (CRE) in the presence of phosphorylated CREB (pCREB) in vitro, and together the Tax-pCREB complex recruits the cellular co-activator p300 to the promoter through this unconventional Tax-responsive element. We further show that the transducer of regulated CREB 2 (TORC2) cooperates with Tax to further enhance p300 recruitment to the cyclin D1 promoter in vitro. Tax and TORC2 in combination stimulate cyclin D1 expression in vivo, demonstrating the functional outcome of the binding interactions. Together, our findings support a model in which Tax-induced accumulation of cyclin D1 shortens the G1 phase of the cell cycle, promotes mitotic replication of the virus, and drives selection and expansion of malignant T-cells. Oncogene (2010) 29, 2142-2152; doi: 10.1038/onc.2009.498; published online 25 January 2010	[Kim, Y-M; Geiger, T. R.; Egan, D. I.; Sharma, N.; Nyborg, J. K.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Nyborg, JK (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Campus Box 1870, Ft Collins, CO 80523 USA.	Jennifer.Nyborg@ColoState.Edu			National Institutes of Health [CA055035]; NATIONAL CANCER INSTITUTE [R55CA055035, R01CA055035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs R Pestell (Thomas Jefferson University, Philadelphia, PA, USA) and A Baldwin (University of North Carolina, Chapel Hill, NC, USA) for the cyclin D1 luciferase constructs, and DY Jin (University of Hong Kong, Pokfulam, Hong Kong) for the TORC expression plasmids. We also thank Sarah Horstmann for helping with TORC2 cloning and expression and Holli Giebler for critical reading of the manuscript. This work was supported by a grant from the National Institutes of Health (CA055035).	Afonso PV, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-27; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Castellone MD, 2009, CANCER RES, V69, P1867, DOI 10.1158/0008-5472.CAN-08-1982; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; de la Fuente C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-43; Fox KE, 2008, J BIOL CHEM, V283, P35096, DOI 10.1074/jbc.M806423200; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Geiger TR, 2008, MOL CELL BIOL, V28, P1383, DOI 10.1128/MCB.01657-07; Georges SA, 2003, MOL CELL BIOL, V23, P3392, DOI 10.1128/MCB.23.10.3392-3404.2003; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hiraiwa N, 2003, BLOOD, V101, P3615, DOI 10.1182/blood-2002-07-2301; Huang YP, 2001, ONCOGENE, V20, P1094, DOI 10.1038/sj.onc.1204198; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Iwai K, 2001, VIROLOGY, V279, P38, DOI 10.1006/viro.2000.0669; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kashanchi F, 1998, J BIOL CHEM, V273, P34646, DOI 10.1074/jbc.273.51.34646; Kim YM, 2007, J BIOL CHEM, V282, P18750, DOI 10.1074/jbc.M700391200; Kimzey AL, 1998, J BIOL CHEM, V273, P13768, DOI 10.1074/jbc.273.22.13768; Koga H, 2004, J BIOL CHEM, V279, P52978, DOI 10.1074/jbc.M409021200; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Lemasson I, 2006, J BIOL CHEM, V281, P13075, DOI 10.1074/jbc.M512193200; Lemasson I, 2004, MOL CELL BIOL, V24, P6117, DOI 10.1128/MCB.24.14.6117-6126.2004; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Lemoine FJ, 2001, J BIOL CHEM, V276, P31851, DOI 10.1074/jbc.M105195200; Lenzmeier BA, 1998, MOL CELL BIOL, V18, P721, DOI 10.1128/MCB.18.2.721; Lopez DI, 2007, PROTEIN EXPRES PURIF, V55, P406, DOI 10.1016/j.pep.2007.06.011; Lu HX, 2002, MOL CELL BIOL, V22, P4450, DOI 10.1128/MCB.22.13.4450-4462.2002; Lundblad JR, 1998, J BIOL CHEM, V273, P19251, DOI 10.1074/jbc.273.30.19251; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mori N, 2002, INT J CANCER, V99, P378, DOI 10.1002/ijc.10388; Nelsen CJ, 2005, J BIOL CHEM, V280, P768, DOI 10.1074/jbc.M407105200; Ramirez JA, 2007, J MOL BIOL, V372, P958, DOI 10.1016/j.jmb.2007.06.062; Rousset R, 1996, NATURE, V381, P328, DOI 10.1038/381328a0; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sharma N, 2008, P NATL ACAD SCI USA, V105, P7959, DOI 10.1073/pnas.0800534105; Siu YT, 2006, J VIROL, V80, P7052, DOI 10.1128/JVI.00103-06; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; SUZUKI T, 1994, ONCOGENE, V9, P3099; Tanaka Y, 1996, J VIROL, V70, P8508, DOI 10.1128/JVI.70.12.8508-8517.1996; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; Terme JM, 2008, J VIROL, V82, P7913, DOI 10.1128/JVI.02414-07; Trevisan R, 2006, EXP CELL RES, V312, P1390, DOI 10.1016/j.yexcr.2006.01.009; Trevisan R, 2004, EXP CELL RES, V299, P57, DOI 10.1016/j.yexcr.2004.05.024; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang D, 2008, J BIOL CHEM, V283, P16299, DOI 10.1074/jbc.M706426200; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Yan JP, 1998, J MOL BIOL, V281, P395, DOI 10.1006/jmbi.1998.1951; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445	56	29	31	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 8	2010	29	14					2142	2152		10.1038/onc.2009.498	http://dx.doi.org/10.1038/onc.2009.498			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101207	Green Accepted			2022-12-25	WOS:000276402800012
J	Cheung, LWT; Leung, PCK; Wong, AST				Cheung, L. W. T.; Leung, P. C. K.; Wong, A. S. T.			Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer	ONCOGENE			English	Article						ovarian cancer; GnRH; cadherin; p120(ctn); motility	RHO-FAMILY GTPASES; BREAST-CANCER; N-CADHERIN; P-CADHERIN; EXPRESSION; RECEPTOR; ADHESION; GROWTH; PROGRESSION; PATHWAY	Gonadotropin-releasing hormone (GnRH) receptor expression is often elevated in ovarian cancer, but its potential role in ovarian cancer metastasis has just begun to be revealed. Cadherin switching is a crucial step during tumorigenesis, particularly in metastasis. Here, we showed that GnRH is an inducer of E-to P-cadherin switching, which is reminiscent of that seen during ovarian tumor progression. Overexpression of P-cadherin significantly enhanced, whereas knockdown of P-cadherin reduced migration and invasion regardless of E-cadherin expression, suggesting that inappropriate expression of P-cadherin contributes to the invasive phenotype. These effects of P-cadherin were mediated by activation of the Rho GTPases, Rac1, and Cdc42, through accumulation of p120 catenin (p120(ctn)) in the cytoplasm. The use of p120(ctn) small interfering RNA or chimeric cadherin construct to inhibit p120(ctn) expression and cytoplasmic localization, respectively, resulted in significant inhibition of cell migration and invasion, with a concomitant reduction in Rac1 and Cdc42 activation, confirming that the effect was p120(ctn) specific. Similarly, the migratory/invasive phenotype could be reversed by expression of dominant-negative Rac1 and Cdc42. These results identify for the first time cadherin switching and p120(ctn) signaling as important targets of GnRH function and as novel mediators of invasiveness and tumor progression in ovarian cancer. Oncogene (2010) 29, 2427-2440; doi:10.1038/onc.2009.523; published online 1 February 2010	[Cheung, L. W. T.; Wong, A. S. T.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Leung, P. C. K.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	University of Hong Kong; University of British Columbia	Wong, AST (corresponding author), Univ Hong Kong, Sch Biol Sci, 4S-14 Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	awong1@hku.hk	Wong, Alice/AFJ-4595-2022	Wong, Alice/0000-0002-0676-6475; Cheung, Lydia Wai Ting/0000-0003-1137-3200; Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health; Hong Kong Research Grant Council [778108]; HKU	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Hong Kong Research Grant Council(Hong Kong Research Grants Council); HKU(University of Hong Kong)	We thank Drs N Auersperg, A Hall, and C Gottardi for cell lines and plasmids. This work was supported by Canadian Institutes of Health Research grant (PCK Leung), and by Hong Kong Research Grant Council Grant 778108 and HKU Outstanding Young Researcher Award (AST Wong).	Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Chen CL, 2007, ENDOCRINE, V31, P311, DOI 10.1007/s12020-007-0041-8; Chen GTC, 2002, MOL REPROD DEV, V62, P289, DOI 10.1002/mrd.10121; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; Cheung LWT, 2008, FEBS J, V275, P5479, DOI 10.1111/j.1742-4658.2008.06677.x; Cheung LWT, 2006, CANCER RES, V66, P10902, DOI 10.1158/0008-5472.CAN-06-2217; Choi JH, 2008, CANCER RES, V68, P5716, DOI 10.1158/0008-5472.CAN-08-0001; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; EMONS G, 1989, EUR J CANCER CLIN ON, V25, P215, DOI 10.1016/0277-5379(89)90011-4; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Feltes CM, 2002, CANCER RES, V62, P6688; IRMER G, 1995, CANCER RES, V55, P817; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kang SK, 2000, ENDOCRINE, V13, P297, DOI 10.1385/ENDO:13:3:297; Kim KY, 2006, ENDOCR-RELAT CANCER, V13, P211, DOI 10.1677/erc.1.01033; LI SL, 1994, ENDOCRINOLOGY, V135, P45, DOI 10.1210/en.135.1.45; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Paredes J, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1774; Patel IS, 2003, INT J CANCER, V106, P172, DOI 10.1002/ijc.11086; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; SOMMERS CL, 1994, CANCER RES, V54, P3544; Soubry A, 2005, CANCER RES, V65, P2224, DOI 10.1158/0008-5472.CAN-04-2020; Spentzos D, 2007, ENDOCR-RELAT CANCER, V14, P781, DOI 10.1677/ERC-06-0073; Sundfeldt K, 2003, MOL CELL ENDOCRINOL, V202, P89, DOI 10.1016/S0303-7207(03)00068-6; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Taniuchi K, 2005, CANCER RES, V65, P3092, DOI 10.1158/0008.5472.CAN-04-3646; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wong AST, 1999, INT J CANCER, V81, P180	35	59	60	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	16					2427	2440		10.1038/onc.2009.523	http://dx.doi.org/10.1038/onc.2009.523			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20118984				2022-12-25	WOS:000276951500011
J	Yahi, N; Aulas, A; Fantini, J				Yahi, Nouara; Aulas, Anais; Fantini, Jacques			How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's beta Amyloid Peptide (A beta(1-40))	PLOS ONE			English	Article							SPHINGOLIPID-BINDING DOMAIN; HELICOBACTER-PYLORI; PRECURSOR PROTEIN; LIPID MONOLAYERS; DISEASE; MEMBRANES; FIBRILLOGENESIS; CEREBROSIDE; FORM; GM1	Membrane lipids play a pivotal role in the pathogenesis of Alzheimer's disease, which is associated with conformational changes, oligomerization and/or aggregation of Alzheimer's beta-amyloid (A beta) peptides. Yet conflicting data have been reported on the respective effect of cholesterol and glycosphingolipids (GSLs) on the supramolecular assembly of A beta peptides. The aim of the present study was to unravel the molecular mechanisms by which cholesterol modulates the interaction between A beta(1-40) and chemically defined GSLs (GalCer, LacCer, GM1, GM3). Using the Langmuir monolayer technique, we show that A beta(1-40) selectively binds to GSLs containing a 2-OH group in the acyl chain of the ceramide backbone (HFA-GSLs). In contrast, A beta(1-40) did not interact with GSLs containing a nonhydroxylated fatty acid (NFA-GSLs). Cholesterol inhibited the interaction of A beta(1-40) with HFA-GSLs, through dilution of the GSL in the monolayer, but rendered the initially inactive NFA-GSLs competent for A beta(1-40) binding. Both crystallographic data and molecular dynamics simulations suggested that the active conformation of HFA-GSL involves a H-bond network that restricts the orientation of the sugar group of GSLs in a parallel orientation with respect to the membrane. This particular conformation is stabilized by the 2-OH group of the GSL. Correspondingly, the interaction of A beta(1-40) with HFA-GSLs is strongly inhibited by NaF, an efficient competitor of H-bond formation. For NFA-GSLs, this is the OH group of cholesterol that constrains the glycolipid to adopt the active L-shape conformation compatible with sugar-aromatic CH-pi stacking interactions involving residue Y10 of A beta(1-40). We conclude that cholesterol can either inhibit or facilitate membrane-A beta interactions through fine tuning of glycosphingolipid conformation. These data shed some light on the complex molecular interplay between cell surface GSLs, cholesterol and A beta peptides, and on the influence of this molecular ballet on A beta-membrane interactions.	[Yahi, Nouara; Aulas, Anais; Fantini, Jacques] Univ Aix Marseille 2, Univ Paul Cezanne Aix Marseille 3, Ctr Rech Neurobiol & Neurophysiol Marseille, CNRS UMR 6231,INRA USC 2027,Fac Sci St Jerome, Marseille, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Aix-Marseille Universite	Yahi, N (corresponding author), Univ Aix Marseille 2, Univ Paul Cezanne Aix Marseille 3, Ctr Rech Neurobiol & Neurophysiol Marseille, CNRS UMR 6231,INRA USC 2027,Fac Sci St Jerome, Marseille, France.	jacques.fantini@univ-cezanne.fr	Aulas, Anaïs/AAA-8813-2020	Aulas, Anais/0000-0003-4865-724X; Fantini, Jacques/0000-0001-8653-5521	Centre National de la Recherche Scienctifique (CNRS)	Centre National de la Recherche Scienctifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work has been entirely supported by institutional funds from the Centre National de la Recherche Scienctifique (CNRS) and the Universities of Aix-Marseille 2 and Aix-Marseille 3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Milh M, 2001, GLYCOCONJUGATE J, V18, P253, DOI 10.1023/A:1012460824913; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; BARRIER L, 2008, NEUROBIOL A IN PRESS; BOGGS JM, 1987, BIOCHIM BIOPHYS ACTA, V906, P353, DOI 10.1016/0304-4157(87)90017-7; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Fantini J, 2006, BIOCHEMISTRY-US, V45, P10957, DOI 10.1021/bi060762s; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fantini J, 2009, BBA-BIOMEMBRANES, V1788, P2345, DOI 10.1016/j.bbamem.2009.08.016; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harris JR, 2008, MICRON, V39, P1192, DOI 10.1016/j.micron.2008.05.001; Harris JR, 2002, MICRON, V33, P609, DOI 10.1016/S0968-4328(02)00029-X; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; Ikeda K, 2008, BIOCHEM BIOPH RES CO, V370, P525, DOI 10.1016/j.bbrc.2008.03.130; JOHNSTON DS, 1988, BIOCHIM BIOPHYS ACTA, V937, P10, DOI 10.1016/0005-2736(88)90222-2; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kakio A, 2003, BIOCHEM BIOPH RES CO, V303, P514, DOI 10.1016/S0006-291X(03)00386-3; KANNAGI R, 1983, CANCER RES, V43, P4997; Lahdo R, 2004, BIOCHEM J, V382, P987, DOI 10.1042/BJ20040777; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; Mahfoud R, 2002, J AGR FOOD CHEM, V50, P327, DOI 10.1021/jf010874k; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; Maresca M, 2008, PHYS CHEM CHEM PHYS, V10, P2792, DOI 10.1039/b802594k; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; NISHIO M, 1995, TETRAHEDRON, V51, P8665, DOI 10.1016/0040-4020(94)01066-9; NYHOLM PG, 1990, CHEM PHYS LIPIDS, V52, P1, DOI 10.1016/0009-3084(90)90002-9; OBRIEN JS, 1964, J LIPID RES, V5, P339; Okada T, 2007, J MOL BIOL, V371, P481, DOI 10.1016/j.jmb.2007.05.069; PASCHER I, 1977, CHEM PHYS LIPIDS, V20, P175, DOI 10.1016/0009-3084(77)90033-0; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SLOTTE JP, 1993, BIOCHEMISTRY-US, V32, P7886, DOI 10.1021/bi00082a008; Smaby JM, 1996, BIOCHEMISTRY-US, V35, P5696, DOI 10.1021/bi953057k; Thakur G, 2009, COLLOID SURFACE B, V74, P436, DOI 10.1016/j.colsurfb.2009.07.043; Valdes-Gonzalez T, 2001, PEPTIDES, V22, P1099, DOI 10.1016/S0196-9781(01)00432-6; van der Bijl P, 1996, BIOCHEM J, V317, P589, DOI 10.1042/bj3170589; Yanagisawa K, 2005, SUB CELL BIOCHEM, V38, P179; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881	48	81	83	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9079	10.1371/journal.pone.0009079	http://dx.doi.org/10.1371/journal.pone.0009079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140095	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442400016
J	Larzabal, M; Mercado, EC; Vilte, DA; Salazar-Gonzalez, H; Cataldi, A; Navarro-Garcia, F				Larzabal, Mariano; Mercado, Elsa C.; Vilte, Daniel A.; Salazar-Gonzalez, Hector; Cataldi, Angel; Navarro-Garcia, Fernando			Designed Coiled-Coil Peptides Inhibit the Type Three Secretion System of Enteropathogenic Escherichia coli	PLOS ONE			English	Article							PROTEIN TRANSLOCATION SYSTEM; SMALL-MOLECULE INHIBITOR; III SECRETION; ENTEROCYTE EFFACEMENT; VIRULENCE FACTORS; BACTERIAL VIRULENCE; HEMOLYTIC-ACTIVITY; POTENT INHIBITORS; ESPA; DOMAIN	Background: Enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC) are two categories of E. coli strains associated with human disease. A major virulence factor of both pathotypes is the expression of a type three secretion system (TTSS), responsible for their ability to adhere to gut mucosa causing a characteristic attaching and effacing lesion (A/E). The TTSS translocates effector proteins directly into the host cell that subvert mammalian cell biochemistry. Methods/Principal Findings: We examined synthetic peptides designed to inhibit the TTSS. CoilA and CoilB peptides, both representing coiled-coil regions of the translocator protein EspA, and CoilD peptide, corresponding to a coiled-coil region of the needle protein EscF, were effective in inhibiting the TTSS dependent hemolysis of red blood cells by the EPEC E2348/69 strain. CoilA and CoilB peptides also reduced the formation of actin pedestals by the same strain in HEp-2 cells and impaired the TTSS-mediated protein translocation into the epithelial cell. Interestingly, CoilA and CoilB were able to block EspA assembly, destabilizing the TTSS and thereby Tir translocation. This blockage of EspA polymerization by CoilA or CoilB peptides, also inhibited the correct delivery of EspB and EspD as detected by immunoblotting. Interestingly, electron microscopy of bacteria incubated with the CoilA peptide showed a reduction of the length of EspA filaments. Conclusions: Our data indicate that coiled-coil peptides can prevent the assembly and thus the functionality of the TTSS apparatus and suggest that these peptides could provide an attractive tool to block EPEC and EHEC pathogenesis.	[Larzabal, Mariano; Cataldi, Angel] INTA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Mercado, Elsa C.; Vilte, Daniel A.] INTA, Inst Patobiol, Buenos Aires, DF, Argentina; [Salazar-Gonzalez, Hector; Navarro-Garcia, Fernando] CINVESTAV, Dept Biol Celular, Mexico City 14000, DF, Mexico	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Larzabal, M (corresponding author), INTA, Inst Biotecnol, Buenos Aires, DF, Argentina.	acataldi@cnia.inta.gov.ar; fnavarro@cell.cinvestav.mx	Navarro-Garcia, Fernando/A-3980-2011	Larzabal, Mariano/0000-0002-1358-6982	Agencia Nacional de Promocion Cientifica y Tecnologica [PICTO 2002 12923]; Consejo Nacional de Ciencia y Tecnologica (CONACYT), Mexico [44660-M, 60714]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Ciencia y Tecnologica (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants PICTO 2002 12923 from the Agencia Nacional de Promocion Cientifica y Tecnologica and 44660-M and 60714 from Consejo Nacional de Ciencia y Tecnologica (CONACYT), Mexico to FN-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; Burbaum JJ, 1997, CURR OPIN CHEM BIOL, V1, P72, DOI 10.1016/S1367-5931(97)80111-1; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Dahlgren MK, 2007, J MED CHEM, V50, P6177, DOI 10.1021/jm070741b; Daniell SJ, 2001, INFECT IMMUN, V69, P4055, DOI 10.1128/IAI.69.6.4055-4064.2001; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Delahay RM, 1999, J BIOL CHEM, V274, P35969, DOI 10.1074/jbc.274.50.35969; DeVinney R, 1999, CELL MOL LIFE SCI, V55, P961, DOI 10.1007/s000180050347; DONNENBERG MS, 1993, J BACTERIOL, V175, P4670, DOI 10.1128/JB.175.15.4670-4680.1993; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Gioffre A, 2002, VET MICROBIOL, V87, P301, DOI 10.1016/S0378-1135(02)00079-2; Goldschmidt RM, 1997, CURR PHARM DESIGN, V3, P125; Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Kauppi AM, 2003, ADV EXP MED BIOL, V529, P97; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kenny B, 1996, MOL MICROBIOL, V20, P313, DOI 10.1111/j.1365-2958.1996.tb02619.x; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; LEVINE MM, 1978, LANCET, V1, P1119; Liu H, 2002, MOL MICROBIOL, V45, P1557, DOI 10.1046/j.1365-2958.2002.03137.x; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mercado EC, 2004, J VET MED B, V51, P82, DOI 10.1111/j.1439-0450.2004.00729.x; Miliwebsky E., 2007, Rev. argent. microbiol., V39, P90; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Vallance BA, 2000, P NATL ACAD SCI USA, V97, P8799, DOI 10.1073/pnas.97.16.8799; Vilte DA, 2008, CLIN VACCINE IMMUNOL, V15, P1208, DOI 10.1128/CVI.00027-08; Wachter C, 1999, MOL MICROBIOL, V31, P1695, DOI 10.1046/j.1365-2958.1999.01303.x; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999; Wieler LH, 1997, FEMS MICROBIOL LETT, V156, P49, DOI 10.1016/S0378-1097(97)00403-5; Wilson RK, 2001, CELL MICROBIOL, V3, P753, DOI 10.1046/j.1462-5822.2001.00159.x; Wolff C, 1998, MOL MICROBIOL, V28, P143, DOI 10.1046/j.1365-2958.1998.00782.x	46	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9046	10.1371/journal.pone.0009046	http://dx.doi.org/10.1371/journal.pone.0009046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140230	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474400005
J	Miller, M; Donat, S; Rakette, S; Stehle, T; Kouwen, TRHM; Diks, SH; Dreisbach, A; Reilman, E; Gronau, K; Becher, D; Peppelenbosch, MP; van Dijl, JM; Ohlsen, K				Miller, Malgorzata; Donat, Stefanie; Rakette, Sonja; Stehle, Thilo; Kouwen, Thijs R. H. M.; Diks, Sander H.; Dreisbach, Annette; Reilman, Ewoud; Gronau, Katrin; Becher, Doerte; Peppelenbosch, Maikel P.; van Dijl, Jan Maarten; Ohlsen, Knut			Staphylococcal PknB as the First Prokaryotic Representative of the Proline-Directed Kinases	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-2; SERINE/THREONINE PROTEIN-KINASE; FIBRONECTIN-BINDING PROTEINS; YERSINIA YOPE CYTOTOXIN; BAX-DEPENDENT APOPTOSIS; STREPTOCOCCUS-PNEUMONIAE; EPITHELIAL-CELLS; MAMMALIAN-CELLS; PSEUDOMONAS-AERUGINOSA; ALVEOLAR MACROPHAGES	In eukaryotic cell types, virtually all cellular processes are under control of proline-directed kinases and especially MAP kinases. Serine/threonine kinases in general were originally considered as a eukaryote-specific enzyme family. However, recent studies have revealed that orthologues of eukaryotic serine/threonine kinases exist in bacteria. Moreover, various pathogenic species, such as Yersinia and Mycobacterium, require serine/threonine kinases for successful invasion of human host cells. The substrates targeted by bacterial serine/threonine kinases have remained largely unknown. Here we report that the serine/threonine kinase PknB from the important pathogen Staphylococcus aureus is released into the external milieu, which opens up the possibility that PknB does not only phosphorylate bacterial proteins but also proteins of the human host. To identify possible human targets of purified PknB, we studied in vitro phosphorylation of peptide microarrays and detected 68 possible human targets for phosphorylation. These results show that PknB is a proline-directed kinase with MAP kinase-like enzymatic activity. As the potential cellular targets for PknB are involved in apoptosis, immune responses, transport, and metabolism, PknB secretion may help the bacterium to evade intracellular killing and facilitate its growth. In apparent agreement with this notion, phosphorylation of the host-cell response coordinating transcription factor ATF-2 by PknB was confirmed by mass spectrometry. Taken together, our results identify PknB as the first prokaryotic representative of the proline-directed kinase/MAP kinase family of enzymes.	[Miller, Malgorzata; Kouwen, Thijs R. H. M.; Dreisbach, Annette; Reilman, Ewoud; van Dijl, Jan Maarten] Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands; [Miller, Malgorzata; Kouwen, Thijs R. H. M.; Diks, Sander H.; Dreisbach, Annette; Reilman, Ewoud; Peppelenbosch, Maikel P.; van Dijl, Jan Maarten] Univ Groningen, Groningen, Netherlands; [Donat, Stefanie; Ohlsen, Knut] Univ Wurzburg, Inst Mol Infekt Biol, Wurzburg, Germany; [Diks, Sander H.; Peppelenbosch, Maikel P.] Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Rakette, Sonja; Stehle, Thilo] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany; [Gronau, Katrin; Becher, Doerte] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	University of Groningen; University of Groningen; University of Wurzburg; University of Groningen; Eberhard Karls University of Tubingen; Ernst Moritz Arndt Universitat Greifswald; Vanderbilt University	Miller, M (corresponding author), Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands.	j.m.van.dijl@med.umcg.nl	van Dijl, Jan Maarten/G-1205-2013; Becher, Doerte/B-4454-2015	Becher, Doerte/0000-0002-9630-5735; Peppelenbosch, Maikel/0000-0001-9112-6028	EU [LSHM-CT-2006-019064, LSHG-CT-2006-037469]; transnational SysMO initiative; European Science Foundation; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research [04-EScope 01-011]; Top Institute [T4-213]; Deutsche Forschungsgemeinschaft [TR34]	EU(European Commission); transnational SysMO initiative; European Science Foundation(European Science Foundation (ESF)European Commission); Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Top Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding for this work was received from the EU (CEU projects LSHM-CT-2006-019064 and LSHG-CT-2006-037469), the transnational SysMO initiative through project BACELL SysMO, the European Science Foundation under the EUROCORES Programme EuroSCOPE, grant 04-EScope 01-011 from the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research, the Top Institute Pharma project T4-213, and the Deutsche Forschungsgemeinschaft (TR34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; BAUGHN RE, 1975, MED MICROBIOL IMMUN, V161, P243, DOI 10.1007/BF02122712; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Beier F, 2000, J BIOL CHEM, V275, P12948, DOI 10.1074/jbc.275.17.12948; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; Carrillo-Marquez MA, 2009, PEDIATR INFECT DIS J, V28, P1076, DOI 10.1097/INF.0b013e3181adbcfe; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Deftereos Savas P, 2009, Cases J, V2, P8293, DOI 10.4076/1757-1626-2-8293; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; ELLIOTT GR, 1982, ANTIMICROB AGENTS CH, V22, P781, DOI 10.1128/AAC.22.5.781; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Geipel U, 2009, INT J MED SCI, V6, P234; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Hebert A, 2000, FEMS MICROBIOL LETT, V193, P57, DOI 10.1016/S0378-1097(00)00455-9; JAKAB GJ, 1976, J CLIN INVEST, V57, P1533, DOI 10.1172/JCI108423; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; KAPRAL FA, 1965, ANN NY ACAD SCI, V128, P285, DOI 10.1111/j.1749-6632.1965.tb11645.x; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; Lammers A, 1999, FEMS MICROBIOL LETT, V180, P103, DOI 10.1111/j.1574-6968.1999.tb08783.x; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lomas-Lopez R, 2007, FEMS MICROBIOL LETT, V272, P35, DOI 10.1111/j.1574-6968.2007.00742.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lu KP, 2003, BIOESSAYS, V25, P174, DOI 10.1002/bies.10223; Ma Q, 2007, J CELL BIOCHEM, V101, P477, DOI 10.1002/jcb.21198; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; MELLY MA, 1960, J EXP MED, V112, P1121, DOI 10.1084/jem.112.6.1121; Michailova L, 2000, INT J MED MICROBIOL, V290, P259; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Motley ST, 1999, INFECT IMMUN, V67, P5386, DOI 10.1128/IAI.67.10.5386-5394.1999; MUNOZDORADO J, 1993, J CELL BIOCHEM, V51, P29, DOI 10.1002/jcb.240510107; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilsdotter-Augustinsson A, 2004, APMIS, V112, P109, DOI 10.1111/j.1600-0463.2004.apm1120205.x; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Novakova L, 2005, FEBS J, V272, P1243, DOI 10.1111/j.1742-4658.2005.04560.x; Pallova P, 2007, BIOCHEM BIOPH RES CO, V355, P526, DOI 10.1016/j.bbrc.2007.01.184; Park H, 2007, J IMMUNOL, V178, P6426, DOI 10.4049/jimmunol.178.10.6426; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROGERS DE, 1952, J EXP MED, V95, P209, DOI 10.1084/jem.95.2.209; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; ROSQVIST R, 1991, BIOCHEM SOC T, V19, P1131, DOI 10.1042/bst0191131; Sambrook J., 2002, MOL CLONING LAB MANU; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; TREUSCH AH, 2009, ISME J; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wang JY, 1998, J BACTERIOL, V180, P6764, DOI 10.1128/JB.180.24.6764-6768.1998; Weglarczyk K, 2004, INFECT IMMUN, V72, P2590, DOI 10.1128/IAI.72.5.2590-2597.2004; Westers L, 2008, PROTEOMICS, V8, P2704, DOI 10.1002/pmic.200800009; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Wiley DJ, 2009, J BIOL CHEM, V284, P24744, DOI 10.1074/jbc.M109.010140; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	83	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9057	10.1371/journal.pone.0009057	http://dx.doi.org/10.1371/journal.pone.0009057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140229	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474400015
J	Suits, MDL; Zhu, YP; Taylor, EJ; Walton, J; Zechel, DL; Gilbert, HJ; Davies, GJ				Suits, Michael D. L.; Zhu, Yanping; Taylor, Edward J.; Walton, Julia; Zechel, David L.; Gilbert, Harry J.; Davies, Gideon J.			Structure and Kinetic Investigation of Streptococcus pyogenes Family GH38 alpha-Mannosidase	PLOS ONE			English	Article							II INHIBITORS; PROTEIN; GLYCOSIDASE; MECHANISM; BINDING; CRYSTALLIZATION; OLIGOSACCHARIDES; PATHOGENESIS; SWAINSONINE; METASTASIS	Background: The enzymatic hydrolysis of alpha-mannosides is catalyzed by glycoside hydrolases (GH), termed alpha-mannosidases. These enzymes are found in different GH sequence-based families. Considerable research has probed the role of higher eukaryotic "GH38'' alpha-mannosides that play a key role in the modification and diversification of hybrid N-glycans; processes with strong cellular links to cancer and autoimmune disease. The most extensively studied of these enzymes is the Drosophila GH38 alpha-mannosidase II, which has been shown to be a retaining alpha-mannosidase that targets both alpha-1,3 and alpha-1,6 mannosyl linkages, an activity that enables the enzyme to process GlcNAc(Man)(5)(GlcNAc)(2) hybrid N-glycans to GlcNAc(Man)(3)(GlcNAc)(2). Far less well understood is the observation that many bacterial species, predominantly but not exclusively pathogens and symbionts, also possess putative GH38 alpha-mannosidases whose activity and specificity is unknown. Methodology/Principal Findings: Here we show that the Streptococcus pyogenes (M1 GAS SF370) GH38 enzyme (Spy1604; hereafter SpGH38) is an alpha-mannosidase with specificity for alpha-1,3 mannosidic linkages. The 3D X-ray structure of SpGH38, obtained in native form at 1.9 angstrom resolution and in complex with the inhibitor swainsonine (K-i 18 mu M) at 2.6 angstrom, reveals a canonical GH38 five-domain structure in which the catalytic "-1'' subsite shows high similarity with the Drosophila enzyme, including the catalytic Zn2+ ion. In contrast, the "leaving group'' subsites of SpGH38 display considerable differences to the higher eukaryotic GH38s; features that contribute to their apparent specificity. Conclusions/Significance: Although the in vivo function of this streptococcal GH38 alpha-mannosidase remains unknown, it is shown to be an alpha-mannosidase active on N-glycans. SpGH38 lies on an operon that also contains the GH84 hexosaminidase (Spy1600) and an additional putative glycosidase. The activity of SpGH38, together with its genomic context, strongly hints at a function in the degradation of host N- or possibly O-glycans. The absence of any classical signal peptide further suggests that SpGH38 may be intracellular, perhaps functioning in the subsequent degradation of extracellular host glycans following their initial digestion by secreted glycosidases.	[Suits, Michael D. L.; Taylor, Edward J.; Walton, Julia; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Zhu, Yanping; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zechel, David L.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Zhu, Yanping; Gilbert, Harry J.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England	University of York - UK; University System of Georgia; University of Georgia; Queens University - Canada; Newcastle University - UK	Suits, MDL (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	davies@ysbl.york.ac.uk	Davies, Gideon J/A-9042-2011	Davies, Gideon J/0000-0002-7343-776X; Zechel, David/0000-0002-1570-599X; Taylor, Edward/0000-0003-4024-0976	Biotechnology and Biological Sciences Research Council [BB/G016127/1]; European Molecular Biology Organization; BBSRC [BB/G016127/1, BB/E000568/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000568/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Biotechnology and Biological Sciences Research Council grant BB/G016127/1, by the European Molecular Biology Organization. M. D. L. S. is an European Molecular Biology Laboratory long-term fellowship holder, and G. J. D. is a Royal Society/Wolfson Research Merit Award recipient. Y. Z. is supported by the Department for Innovation, Universities and Skills, United Kingdom; Newcastle University; and the Chinese Scholarship Council. D. Z. is supported by and Early Researcher Award from the province of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alzari PM, 2006, ACTA CRYSTALLOGR D, V62, P1103, DOI 10.1107/S0907444906029775; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Crich D, 2004, ANGEW CHEM INT EDIT, V43, P5386, DOI 10.1002/anie.200453688; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies G.J., 2008, BIOCHEM J, DOI [10.1042/BJ20080382, DOI 10.1042/BJ20080382]; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; DAVIS BG, 2000, HAND GLOVE INVESTIGA, P134; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englebienne P, 2007, PROTEINS, V69, P160, DOI 10.1002/prot.21479; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fiaux H, 2008, BIOORGAN MED CHEM, V16, P7337, DOI 10.1016/j.bmc.2008.06.021; Fogg MJ, 2008, BIOCHEM SOC T, V36, P771, DOI 10.1042/BST0360771; Goss PE, 1997, CLIN CANCER RES, V3, P1077; Granovsky M, 2000, NAT MED, V6, P306; Gridley JJ, 2000, J CHEM SOC PERK T 1, P1471, DOI 10.1039/a909165c; Guo HB, 2003, GLYCOBIOLOGY, V13, P867; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo J, 2006, ANGEW CHEM INT EDIT, V45, P5345, DOI 10.1002/anie.200600808; Handerson T, 2003, CANCER RES, V63, P5363; Heikinheimo P, 2003, J MOL BIOL, V327, P631, DOI 10.1016/S0022-2836(03)00172-4; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; ITO Y, 1994, ANGEW CHEM INT EDIT, V33, P1765, DOI 10.1002/anie.199417651; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Kawatkar SP, 2006, J AM CHEM SOC, V128, P8310, DOI 10.1021/ja061216p; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar NS, 2008, PROTEINS, V71, P1484, DOI 10.1002/prot.21850; Kuntz DA, 2005, TETRAHEDRON-ASYMMETR, V16, P25, DOI 10.1016/j.tetasy.2004.11.057; Kuntz DA, 2008, BIOCHEMISTRY-US, V47, P10058, DOI 10.1021/bi8010785; Kuntz DA, 2009, CHEMBIOCHEM, V10, P268, DOI 10.1002/cbic.200800538; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2006, ACTA CRYSTALLOGR F, V62, P104, DOI 10.1107/S1744309105042508; Nerinckx W, 2006, ARKIVOC, P90, DOI 10.3998/ark.5550190.0007.d10; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabouille C, 1999, J CELL SCI, V112, P3319; Sampaio MM, 2004, J BIOL CHEM, V279, P5537, DOI 10.1074/jbc.M310980200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Sheldon WL, 2006, BIOCHEM J, V399, P241, DOI 10.1042/BJ20060307; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Tarelli E, 1998, CARBOHYD RES, V312, P159, DOI 10.1016/S0008-6215(98)00246-8; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Watanabe Y, 2009, ACTA CRYSTALLOGR F, V65, P571, DOI 10.1107/S1744309109015826; Wen X, 2005, BIOCHEMISTRY-US, V44, P6729, DOI 10.1021/bi0500426; Zhong W, 2008, J AM CHEM SOC, V130, P8975, DOI 10.1021/ja711248y; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	63	35	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9006	10.1371/journal.pone.0009006	http://dx.doi.org/10.1371/journal.pone.0009006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140249	Green Published, Green Accepted, gold			2022-12-25	WOS:000274474200007
J	Hussenet, T; Dali, S; Exinger, J; Monga, B; Jost, B; Dembele, D; Martinet, N; Thibault, C; Huelsken, J; Brambilla, E; du Manoir, S				Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; Jost, Bernard; Dembele, Doulaye; Martinet, Nadine; Thibault, Christelle; Huelsken, Joerg; Brambilla, Elisabeth; du Manoir, Stanislas			SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION PROFILES; RESPIRATORY EPITHELIUM; CULLIN NEDDYLATION; GENOME BROWSER; BREAST-CANCER; SCCRO DCUN1D1; SOLID TUMORS; MODULE MAP; DIFFERENTIATION	Squamous cell carcinoma (SCC) of the lung is a frequent and aggressive cancer type. Gene amplifications, a known activating mechanism of oncogenes, target the 3q26-qter region as one of the most frequently gained/amplified genomic sites in SCC of various types. Here, we used array comparative genomic hybridization to delineate the consensus region of 3q26.3 amplifications in lung SCC. Recurrent amplifications occur in 20% of lung SCC (136 tumors in total) and map to a core region of 2 Mb (Megabases) that encompasses SOX2, a transcription factor gene. Intense SOX2 immunostaining is frequent in nuclei of lung SCC, indicating potential active transcriptional regulation by SOX2. Analyses of the transcriptome of lung SCC, SOX2-overexpressing lung epithelial cells and embryonic stem cells (ESCs) reveal that SOX2 contributes to activate ESC-like phenotypes and provide clues pertaining to the deregulated genes involved in the malignant phenotype. In cell culture experiments, overexpression of SOX2 stimulates cellular migration and anchorage-independent growth while SOX2 knockdown impairs cell growth. Finally, SOX2 over-expression in non-tumorigenic human lung bronchial epithelial cells is tumorigenic in immunocompromised mice. These results indicate that the SOX2 transcription factor, a major regulator of stem cell function, is also an oncogene and a driver gene for the recurrent 3q26.33 amplifications in lung SCC.	[Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; du Manoir, Stanislas] INSERM, U964, IGBMC, Dept Canc Biol, Illkirch Graffenstaden, France; [Jost, Bernard; Dembele, Doulaye; Thibault, Christelle; du Manoir, Stanislas] INSERM, U964, IGBMC, Dept Biochip, Illkirch Graffenstaden, France; [Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; Jost, Bernard; Dembele, Doulaye; Thibault, Christelle; du Manoir, Stanislas] CNRS, UMR 7104, Illkirch Graffenstaden, France; [Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; Jost, Bernard; Dembele, Doulaye; Thibault, Christelle; du Manoir, Stanislas] Univ Strasbourg, Strasbourg, France; [Martinet, Nadine] Hop St Louis, INSERM, U728, Paris, France; [Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; du Manoir, Stanislas] Coll France, Chaire Genet, Illkirch Graffenstaden, France; [Huelsken, Joerg] EPFL SV ISREC CDTSO, Lausanne, Switzerland; [Brambilla, Elisabeth] INSERM, Inst Albert Bonniot, Dept Oncogenese & Biotechnol, U578, La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Swiss Institute Experimental Cancer Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Hussenet, T (corresponding author), INSERM, U964, IGBMC, Dept Canc Biol, Illkirch Graffenstaden, France.	hussenet@igbmc.fr; dumanoir@igbmc.fr	Brambilla, Elisabeth MP/L-8796-2013; Huelsken, Joerg/AAC-9581-2021; Dembélé, Doulaye/O-6513-2017; du manoir, stan p/O-8677-2017	Huelsken, Joerg/0000-0003-3105-9606; Dembélé, Doulaye/0000-0003-3879-6940; du manoir, stan p/0000-0002-2200-2651; Thibault-Carpentier, Christelle/0000-0003-1562-1451	Comitee Regional du Haut-Rhin de la Ligue Contre le Cancer; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Institut National du Cancer; Ligue Nationale Contre le Cancer; Association pour la Recherche sur le Cancer (ARC)	Comitee Regional du Haut-Rhin de la Ligue Contre le Cancer; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	Funding: This study was supported by funds from the Comitee Regional du Haut-Rhin de la Ligue Contre le Cancer, from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS) and the Institut National du Cancer (axe IV canceropole Grand-Est) as well as the Carte d'Identite des Tumeurs program (CIT) from the Ligue Nationale Contre le Cancer. Equipment necessary for array-CGH was funded by the Association pour la Recherche sur le Cancer (ARC). We are grateful to the Ligue Nationale Contre le Cancer for the "Allocation post-doctorale pour Jeune Chercheur Confirme'' attributed to Thomas Hussenet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Feng J, 2004, NEOPLASIA, V6, P623, DOI 10.1593/neo.04142; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gebhart E, 2000, INT J ONCOL, V16, P383; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; HOGARTY MD, 2001, METABOLIC MOL BASES, P597; Hollander MC, 2005, P NATL ACAD SCI USA, V102, P13200, DOI 10.1073/pnas.0503133102; Hussenet T, 2006, CANCER GENET CYTOGEN, V169, P102, DOI 10.1016/j.cancergencyto.2006.03.009; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lantuejoul S, 2005, CLIN CANCER RES, V11, P2074, DOI 10.1158/1078-0432.CCR-04-1376; Maeno K, 2006, ONCOGENE, V25, P271, DOI 10.1038/sj.onc.1209018; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Massion PP, 2002, CANCER RES, V62, P3636; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moro-Sibilot D, 2008, EUR RESPIR J, V31, P854, DOI 10.1183/09031936.00058507; Muller D, 2006, BRIT J CANCER, V94, P1041, DOI 10.1038/sj.bjc.6603036; O-charoenrat P, 2008, CLIN CANCER RES, V14, P6780, DOI 10.1158/1078-0432.CCR-08-0719; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Perl AKT, 2005, GENESIS, V41, P23, DOI 10.1002/gene.20093; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Redon R, 2002, CANCER RES, V62, P6211; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Wilting SM, 2009, CANCER RES, V69, P647, DOI 10.1158/0008-5472.CAN-08-2478; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009	67	226	234	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8960	10.1371/journal.pone.0008960	http://dx.doi.org/10.1371/journal.pone.0008960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126410	Green Published, gold, Green Submitted			2022-12-25	WOS:000274139100009
J	Sanz, AB; Sanchez-Nino, MD; Izquierdo, MC; Jakubowski, A; Justo, P; Blanco-Colio, LM; Ruiz-Ortega, M; Selgas, R; Egido, J; Ortiz, A				Sanz, Ana B.; Sanchez-Nino, Maria D.; Izquierdo, Maria C.; Jakubowski, Aniela; Justo, Pilar; Blanco-Colio, Luis M.; Ruiz-Ortega, Marta; Selgas, Rafael; Egido, Jesus; Ortiz, Alberto			TWEAK Activates the Non-Canonical NF kappa B Pathway in Murine Renal Tubular Cells: Modulation of CCL21	PLOS ONE			English	Article							EPITHELIAL-CELLS; NF-KAPPA-B2 P100; HUMAN KIDNEY; EXPRESSION; APOPTOSIS; INJURY; ALPHA; MICE; PROLIFERATION; INFLAMMATION	TWEAK is a member of the TNF superfamily of cytokines that contribute to kidney tubulointerstitial injury. It has previously been reported that TWEAK induces transient nuclear translocation of RelA and expression of RelA-dependent cytokines in renal tubular cells. Additionally, TWEAK induced long-lasting NF kappa B activation suggestive of engagement of the non-canonical NF kappa B pathway. We now explore TWEAK-induced activation of NF kappa B2 and RelB, as well as expression of CCL21, a T-cell chemotactic factor, in cultured murine tubular epithelial cells and in healthy kidneys in vivo. In cultured tubular cells, TWEAK and TNF alpha activated different DNA-binding NF kappa B complexes. TWEAK-induced sustained NF kappa B activation was associated with NF kappa B2 p100 processing to p52 via proteasome and nuclear translocation and DNA-binding of p52 and RelB. TWEAK, but not TNF alpha used as control), induced a delayed increase in CCL21a mRNA (3.5 +/- 1.22-fold over control) and CCL21 protein (2.5 +/- 0.8-fold over control), which was prevented by inhibition of the proteasome, or siRNA targeting of NIK or RelB, but not by RelA inhibition with parthenolide. A second NF kappa B2-dependent chemokine, CCL19, was upregulates by TWEAK, but not by TNF alpha. However, both cytokines promoted chemokine RANTES expression (3-fold mRNA at 24 h). In vivo, TWEAK induced nuclear NF kappa B2 and RelB translocation and CCL21a mRNA (1.5 +/- 0.3-fold over control) and CCL21 protein (1.6 +/- 0.5-fold over control) expression in normal kidney. Increased tubular nuclear RelB and tubular CCL21 expression in acute kidney injury were decreased by neutralization (2 +/- 0.9 vs 1.3 +/- 0.6-fold over healthy control) or deficiency of TWEAK (2 +/- 0.9 vs 0.8 +/- 0.6-fold over healthy control). Moreover, anti-TWEAK treatment prevented the recruitment of T cells to the kidney in this model (4.1 +/- 1.4 vs 1.8 +/- 1-fold over healthy control). Our results thus identify TWEAK as a regulator of non-canonical NF kappa B activation and CCL21 expression in tubular cells thus promoting lymphocyte recruitment to the kidney during acute injury.	[Sanchez-Nino, Maria D.; Izquierdo, Maria C.; Justo, Pilar; Blanco-Colio, Luis M.; Ruiz-Ortega, Marta; Egido, Jesus; Ortiz, Alberto] Univ Autonoma Madrid, Fdn Jimenez Diaz, Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain; [Sanz, Ana B.; Selgas, Rafael] Hosp Univ La Paz, Serv Nefrol, Fdn Invest Biomed, Madrid, Spain; [Jakubowski, Aniela] Biogen Idec Inc, Dept Immunobiol, Cambridge, MA USA	Autonomous University of Madrid; Hospital Universitario La Paz; Biogen	Sanz, AB (corresponding author), Hosp Univ La Paz, Serv Nefrol, Fdn Invest Biomed, Madrid, Spain.	aortiz@fjd.es	ortiz, alberto/Y-7582-2018; IZQUIERDO, M CONCEPCIÓN/A-8164-2013; Sanchez-Niño, Maria Dolores/B-7350-2019; Sanz, Ana Belen/C-9489-2013; Blanco-Colio, Luis M./Z-2390-2019; Ruiz-Ortega, Marta/D-3584-2012; Ortega, Marta Ruiz/AAN-2136-2020; ruiz-ortega, marta/D-3584-2012	ortiz, alberto/0000-0002-9805-9523; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Sanz, Ana Belen/0000-0002-0255-5689; Ruiz-Ortega, Marta/0000-0002-1495-6535; Ortega, Marta Ruiz/0000-0002-1495-6535; ruiz-ortega, marta/0000-0002-1403-2690; IZQUIERDO, MARIA CONCEPCION/0000-0002-8690-0151; Blanco-Colio, Luis Miguel/0000-0002-1560-6609	FIS [CP04/00060, 06/0046]; EU [QLG1-CT-2002-01215]; Sociedad Espanola de Nefrologia; ISCIII-RETIC [REDinREN/RD06/0016]; Comunidad de Madrid [Madrid/FRACM/S-BIO0283/2006];  [SAF03/884];  [SAF2005-03378];  [SAF 2007-60896];  [PS09/00447]	FIS(Instituto de Salud Carlos III); EU(European Commission); Sociedad Espanola de Nefrologia; ISCIII-RETIC(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); ; ; ; 	Funding: Grant support: FIS CP04/00060, 06/0046, SAF03/884, SAF2005-03378, SAF 2007-60896, PS09/00447, EU QLG1-CT-2002-01215, Sociedad Espanola de Nefrologia, ISCIII-RETIC REDinREN/RD06/0016, Comunidad de Madrid/FRACM/S-BIO0283/2006. Salary support: FIS to PJ and to MCI and FIS and CAM to ABS, and to MDSN, Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas B, 2002, J IMMUNOL, V168, P4301, DOI 10.4049/jimmunol.168.9.4301; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Boonstra JG, 1997, J AM SOC NEPHROL, V8, P1517; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Campbell S, 2004, FRONT BIOSCI-LANDMRK, V9, P2273, DOI 10.2741/1395; Carragher D, 2004, J IMMUNOL, V173, P2271, DOI 10.4049/jimmunol.173.4.2271; Chen SC, 2002, J IMMUNOL, V168, P1001, DOI 10.4049/jimmunol.168.3.1001; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Cuenca J, 2007, AM J PATHOL, V171, P820, DOI 10.2353/ajpath.2007.061076; de Haij S, 2004, KIDNEY INT, V65, P1577, DOI 10.1111/j.1523-1755.2004.00553.x; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; GAO HX, 2009, CYTOKINE GROWTH F R, V20, P251; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; Justo P, 2003, KIDNEY INT, V64, pS52, DOI 10.1046/j.1523-1755.64.s86.10.x; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lorz C, 2000, J AM SOC NEPHROL, V11, P1266, DOI 10.1681/ASN.V1171266; Loverre A, 2004, J AM SOC NEPHROL, V15, P2675, DOI 10.1097/01.ASN.0000139932.00971.E4; Morrissey JJ, 1997, KIDNEY INT, V52, P926, DOI 10.1038/ki.1997.414; Navarro JF, 2006, CYTOKINE GROWTH F R, V17, P441, DOI 10.1016/j.cytogfr.2006.09.011; Nemeth ZH, 2004, MOL PHARMACOL, V65, P342, DOI 10.1124/mol.65.2.342; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Ortega A, 2006, J AM SOC NEPHROL, V17, P1594, DOI 10.1681/ASN.2005070690; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; Remuzzi G, 1997, KIDNEY INT, V51, P2, DOI 10.1038/ki.1997.2; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; SANZ AB, 2009, J CELL MOL MED  0501; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Starkey JM, 2006, DIABETES, V55, P1252, DOI 10.2337/db05-1554; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; van Kooten C, 1999, EXP NEPHROL, V7, P429; Zhao Z, 2007, J IMMUNOL, V179, P7949, DOI 10.4049/jimmunol.179.11.7949	44	83	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8955	10.1371/journal.pone.0008955	http://dx.doi.org/10.1371/journal.pone.0008955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126461	Green Submitted, Green Published, gold			2022-12-25	WOS:000274139100006
J	Hu, JF; Qi, Q; August, A				Hu, Jianfang; Qi, Qian; August, Avery			Itk Derived Signals Regulate the Expression of Th-POK and Controls the Development of CD4(+) T Cells	PLOS ONE			English	Article							TEC FAMILY KINASES; LINEAGE DIFFERENTIATION; TRANSCRIPTION FACTORS; CD8 LINEAGE; TCR SIGNALS; COMMITMENT; THPOK; MICE; REQUIREMENTS; DISTINCT	T cell development is critically dependent on both the environment and signals delivered by the T cell Receptor (TCR). The Tec family kinase Itk has been suggested to be an amplifier of signals emanating from the TCR and the loss of Itk partially affects most stages of thymopoiesis. Loss of Itk also differentially affects the development of conventional vs. non-conventional or innate memory phenotype T cells. Here, we examine whether these lineage choices are affected by a combination of TCR affinity and Itk by analyzing mice lacking Itk and carrying two TCR transgenes with differing affinities, OT-II and DO11.10. Our results show that developing thymocytes receive a gradient of signals, DO11.10 > OT-II > DO11.10/Itk(-/-) > OT-II/Itk(-/-). We also show that the development of CD4(+) T cells is controlled by TCR signaling via Itk, which regulates the expression of the transcription factor, Th-POK, an enforcement factor for CD4 commitment. This results in a reduction in CD4(+) T cell development, and an increase in the development of MHC class II restricted TCR transgenic CD8(+) T cells that resemble non-conventional or innate memory phenotype CD8 T cells. This alteration accompanies increased expression of Runx3 and its target genes Eomesodermin, Granzyme B and Perforin in Itk null OT-II CD4(+) thymocytes. All together, these data suggest that Itk plays an important role in CD4/CD8 commitment by regulating signal thresholds for the lineage commitment. Our data also suggest that the lower level of TCR signaling that occurs with a low affinity TCR in the absence of Itk can redirect some MHC class II restricted CD4(+) T cell to class II-restricted CD8(+) innate memory phenotype T cells.	[Hu, Jianfang; Qi, Qian; August, Avery] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Hu, Jianfang; Qi, Qian] Penn State Univ, Immunol & Infect Dis Grad Program, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hu, JF (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.	axa45@psu.edu	Qi, Qian/E-7454-2012		National Institutes of Health (NIH) [AI051626, AI065566]; Huck Institutes for Life Sciences; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051626, R01AI065566, R56AI065566] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huck Institutes for Life Sciences; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI051626 and AI065566 (NIH.gov) to AA. JH and QQ were Graduate Fellows of the Huck Institutes for Life Sciences. The Center for Molecular Immunology and Infectious Disease (supported in part under a grant from the Pennsylvania Department of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliahmad P, 2004, J EXP MED, V199, P1089, DOI 10.1084/jem.20040051; August A, 2002, INT J BIOCHEM CELL B, V34, P1184, DOI 10.1016/S1357-2725(02)00068-7; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; Dubois S, 2006, P NATL ACAD SCI USA, V103, P12075, DOI 10.1073/pnas.0605212103; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; GRATIOTDEANS J, 1994, P NATL ACAD SCI USA, V91, P10685, DOI 10.1073/pnas.91.22.10685; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; Hayashi K, 2001, J IMMUNOL, V167, P4957, DOI 10.4049/jimmunol.167.9.4957; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; HU J, 2007, EUR J IMMUNOL; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Laky K, 2006, IMMUNOL REV, V209, P274, DOI 10.1111/j.0105-2896.2006.00358.x; Laky K, 2005, CURR OPIN IMMUNOL, V17, P116, DOI 10.1016/j.coi.2005.02.004; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; Lucas JA, 2003, IMMUNOL REV, V191, P119, DOI 10.1034/j.1600-065X.2003.00029.x; Lucas JA, 2007, J IMMUNOL, V179, P7561, DOI 10.4049/jimmunol.179.11.7561; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Prince Amanda L, 2009, Immunol Rev, V228, P115, DOI 10.1111/j.1600-065X.2008.00746.x; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rothenberg EV, 2009, IMMUNOL CELL BIOL, V87, P109, DOI 10.1038/icb.2008.100; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Sharp LL, 1999, J IMMUNOL, V163, P6598; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8891	10.1371/journal.pone.0008891	http://dx.doi.org/10.1371/journal.pone.0008891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126642	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500014
J	Meier, ID; Bernreuther, C; Tilling, T; Neidhardt, J; Wong, YW; Schulze, C; Streichert, T; Schachner, M				Meier, Ingo D.; Bernreuther, Christian; Tilling, Thomas; Neidhardt, John; Wong, Yong Wee; Schulze, Christian; Streichert, Thomas; Schachner, Melitta			Short DNA sequences inserted for gene targeting can accidentally interfere with off-target gene expression	FASEB JOURNAL			English	Article						loxP sites; conditional knockout mice; genomic positional effects	EXTRACELLULAR-MATRIX; REGULATORY ELEMENTS; TENASCIN-R; DISRUPTION; NCAM; MICE; INACTIVATION; MECHANISMS; DELETION; REVEALS	Targeting of genes in mice, a key approach to study development and disease, often leaves a neo cassette, loxP, or FRT sites inserted in the mouse genome. Insertion of neo can influence the expression of neighboring genes, but similar effects have not been reported for loxP sites. We therefore performed microarray analyses of mice in which the Ncam or the Tnr gene were targeted either by insertion of neo or loxP/FRT sites. In the case of Ncam, neo, but not loxP/FRT insertion, led to a 2-fold reduction in mRNA levels of 3 genes located at distances between 0.2 and 3.1 Mb from the target. In contrast, after introduction of loxP/FRT sites into introns of Tnr, we observed a 2.5- to 4-fold reduction in the transcript level of the Gas5 gene, 1.1 Mb away from Tnr, most probably due to disruption of a conserved regulatory element in Tnr. Insertion of short DNA sequences such as loxP/FRT can thus influence off-target mRNA levels if these sites are accidentally placed into regulatory elements. Our results imply that conditional knockout mice should be analyzed for genomic positional side effects that may influence the animals' phenotypes.-Meier, I. D., Bernreuther, C., Tilling, T., Neidhardt, J., Wong, Y. W., Schulze, C., Streichert, T., Schachner, M. Short DNA sequences inserted for gene targeting can accidentally interfere with off-target gene expression. FASEB J. 24, 1714-1724 (2010). www.fasebj.org	[Meier, Ingo D.; Bernreuther, Christian; Tilling, Thomas; Neidhardt, John; Wong, Yong Wee; Schulze, Christian; Schachner, Melitta] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Hamburg, Germany; [Bernreuther, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, Hamburg, Germany; [Neidhardt, John] Univ Zurich, Inst Med Genet, Div Med Mol Genet & Gene Diagnost, CH-8603 Schwerzenbach, Switzerland; [Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Shantou Med Coll, Ctr Neurosci, Shantou, Peoples R China	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Neidhardt, John/J-4310-2017; Schulze, Christian/AGJ-7744-2022	Schulze, Christian/0000-0001-9442-7141; Neidhardt, John/0000-0002-9205-8394; Schulze, Christian/0000-0002-1442-1987	Alexander von Humboldt Foundation; German Federal Ministry for Research (Nationales Genomforschungsnetz); New Jersey Professorship of Spinal Cord Research	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Federal Ministry for Research (Nationales Genomforschungsnetz); New Jersey Professorship of Spinal Cord Research	The authors thank Fabio Morellini and Edgar Kramer for helpful discussions and comments on the manuscript. The authors also thank Achim Dahlmann and Peggy Putthoff for expert technical assistance, Michael Bosl for blastocyst injection, Eva Kronberg for animal care, Kristin Reeck for help with microarray analysis, Sabine Wuttke for help with the design of Supplemental Fig. S2, and Kavita Praveen for proofreading of the manuscript. This work was supported by a research fellowship awarded by the Alexander von Humboldt Foundation (to Y.W.W.); the German Federal Ministry for Research (Nationales Genomforschungsnetz; NGFN2 to M. S.); and a New Jersey Professorship of Spinal Cord Research (to M. S.).	Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Dityatev A, 2006, CELL TISSUE RES, V326, P647, DOI 10.1007/s00441-006-0217-1; FIERING S, 1993, P NATL ACAD SCI USA, V90, P8469, DOI 10.1073/pnas.90.18.8469; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Hinsby AM, 2004, FRONT BIOSCI-LANDMRK, V9, P2227, DOI 10.2741/1393; Hirose T, 2006, MOL CELL, V23, P673, DOI 10.1016/j.molcel.2006.07.011; Kaufman RM, 2001, BLOOD, V98, P65, DOI 10.1182/blood.V98.1.65; Kawaji H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040022; KIM CG, 1992, GENE DEV, V6, P928, DOI 10.1101/gad.6.6.928; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Pesheva P, 2000, PROG NEUROBIOL, V61, P465, DOI 10.1016/S0301-0082(99)00061-1; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Ren SY, 2002, DEV DYNAM, V225, P305, DOI 10.1002/dvdy.10171; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; RIJLI FM, 1994, DEV DYNAM, V201, P366, DOI 10.1002/aja.1002010408; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stork O, 2000, EUR J NEUROSCI, V12, P3291, DOI 10.1046/j.1460-9568.2000.00197.x; TORRES PM, 1997, LAB PROTOCOLS CONDIT; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; vanderNeut R, 1997, J NEUROSCI METH, V71, P19, DOI 10.1016/S0165-0270(96)00123-9; Weber P, 1999, J NEUROSCI, V19, P4245, DOI 10.1523/jneurosci.19-11-04245.1999; Ying SY, 2008, MOL BIOTECHNOL, V38, P257, DOI 10.1007/s12033-007-9013-8; Zekri L, 2005, MOL CELL BIOL, V25, P8703, DOI 10.1128/MCB.25.19.8703-8716.2005	40	57	68	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1714	1724		10.1096/fj.09-140749	http://dx.doi.org/10.1096/fj.09-140749			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20110269				2022-12-25	WOS:000278200000009
J	Miriyala, S; Subramanian, T; Panchatcharam, M; Ren, HM; McDermott, MI; Sunkara, M; Drennan, T; Smyth, SS; Spielmann, HP; Morris, AJ				Miriyala, Sumitra; Subramanian, Thangaiah; Panchatcharam, Manikandan; Ren, Hongmei; McDermott, Mark I.; Sunkara, Manjula; Drennan, Tracy; Smyth, Susan S.; Spielmann, H. Peter; Morris, Andrew J.			Functional Characterization of the Atypical Integral Membrane Lipid Phosphatase PDP1/PPAPDC2 Identifies a Pathway for Interconversion of Isoprenols and Isoprenoid Phosphates in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESQUALENE DIPHOSPHATE PHOSPHATASE; LYSOPHOSPHATIDIC ACID; RHO GTPASES; PROTEIN; FARNESYL; BIOSYNTHESIS; CHOLESTEROL; ACTIVATION; MECHANISMS; INHIBITOR	The polyisoprenoid diphosphates farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP) are intermediates in the synthesis of cholesterol and related sterols by the mevalonate pathway and precursors for the addition of isoprenyl anchors to many membrane proteins. We developed tandem mass spectrometry assays to evaluate polyisoprenoid diphosphate phosphatase activity of an unusual integral membrane lipid enzyme: type 1 polyisoprenoid diphosphate phosphatase encoded by the PPAPDC2 gene (PDP1/PPAPDC2). In vitro, recombinant PDP1/PPAPDC2 preferentially hydrolyzed polyisoprenoid diphosphates, including FPP and GGPP over a variety of glycerol-and sphingo-phospholipid substrates. Overexpression of mammalian PDP1/PPAPDC2 in budding yeast depletes cellular pools of FPP leading to growth defects and sterol auxotrophy. In mammalian cells, PDP1/PPAPDC2 localizes to the endoplasmic reticulum and nuclear envelope and, unlike the structurally related lipid phosphate phosphatases, is predicted to be oriented with key residues of its catalytic domain facing the cytoplasmic face of the membrane. Studies using synthetic isoprenols with chemical properties that facilitate detection by mass spectrometry identify a pathway for interconversion of isoprenols and isoprenoid diphosphates in intact mammalian cells and demonstrate a role for PDP1/PPAPDC2 in this process. Overexpression of PDP1/PPAPDC2 in mammalian cells substantially decreases protein isoprenylation and results in defects in cell growth and cytoskeletal organization that are associated with dysregulation of Rho family GTPases. Taken together, these results focus attention on integral membrane lipid phosphatases as regulators of isoprenoid phosphate metabolism and suggest that PDP1/PPAPDC2 is a functional isoprenoid diphosphate phosphatase.	[Miriyala, Sumitra; Panchatcharam, Manikandan; Ren, Hongmei; Sunkara, Manjula; Drennan, Tracy; Smyth, Susan S.; Spielmann, H. Peter; Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, Lexington, KY 40536 USA; [Subramanian, Thangaiah; Morris, Andrew J.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Spielmann, H. Peter] Univ Kentucky, Dept Chem, Lexington, KY 40536 USA; [Spielmann, H. Peter] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA; [Smyth, Susan S.] Dept Vet Affairs Med Ctr, Lexington, KY 40511 USA; [McDermott, Mark I.] NHLBI, NIH, Bethesda, MD 20892 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Morris, AJ (corresponding author), Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, 900 S Limestone St,326 CTW Bldg, Lexington, KY 40536 USA.	a.j.morris@uky.edu	Thangaiah, Subramanian/H-3824-2011; Morris, Andrew/B-7869-2010; sunkara, Manjula/H-7944-2016	sunkara, Manjula/0000-0001-6151-1929; Miriyala, Sumitra/0000-0001-7158-9295; Panchatcharam, Manikandan/0000-0002-7691-8948	National Institutes of Health [5R01GM050388, P20RR001954, 5R01GM066152]; Lexington VA Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066152, R01GM050388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lexington VA Medical Center(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM050388, P20RR001954, and 5R01GM066152 (to A.J.M., H. P. S., and S. S. S.). This study is the result of work supported with resources and the use of facilities at the Lexington VA Medical Center.	BANSAL VS, 1994, ARCH BIOCHEM BIOPHYS, V315, P393, DOI 10.1006/abbi.1994.1516; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Carlo T, 2009, BIOCHEMISTRY-US, V48, P2997, DOI 10.1021/bi8020636; CHRISTOPHE J, 1961, J LIPID RES, V2, P244; Coffinier C, 2008, J BIOL CHEM, V283, P9797, DOI 10.1074/jbc.M709629200; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Crick D C, 1996, SAAS Bull Biochem Biotechnol, V9, P37; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Fukunaga K, 2006, J BIOL CHEM, V281, P9490, DOI 10.1074/jbc.M512970200; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grkovich A, 2009, BBA-MOL CELL BIOL L, V1791, P975, DOI 10.1016/j.bbalip.2009.02.002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JENNINGS SM, 1991, P NATL ACAD SCI USA, V88, P6038, DOI 10.1073/pnas.88.14.6038; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; Levy BD, 2005, BRIT J PHARMACOL, V146, P344, DOI 10.1038/sj.bjp.0706338; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu GH, 2009, MOL CELL BIOL, V29, P5800, DOI 10.1128/MCB.00684-09; Long JS, 2006, BIOCHEM J, V394, P495, DOI 10.1042/BJ20051674; McDermot MI, 2006, METHODS, V39, P169, DOI 10.1016/j.ymeth.2006.05.010; McDermott MI, 2004, NAT NEUROSCI, V7, P789, DOI 10.1038/nn0804-789a; Meredith D, 2009, ARTERIOSCL THROM VAS, V29, P465, DOI 10.1161/ATVBAHA.109.184234; Morris KE, 2006, J BIOL CHEM, V281, P9297, DOI 10.1074/jbc.M511710200; Munck A, 2005, FEBS J, V272, P1718, DOI 10.1111/j.1742-4658.2005.04601.x; Pamuklar Z, 2008, ARTERIOSCL THROM VAS, V28, P555, DOI 10.1161/ATVBAHA.107.151837; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Roberts RZ, 2000, BBA-MOL CELL BIOL L, V1487, P33, DOI 10.1016/S1388-1981(00)00081-0; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; Schirmer EC, 2005, TRENDS BIOCHEM SCI, V30, P551, DOI 10.1016/j.tibs.2005.08.003; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Sigal YJ, 2007, J CELL SCI, V120, P340, DOI 10.1242/jcs.03335; Sturley SL, 1998, CURR OPIN LIPIDOL, V9, P85, DOI 10.1097/00041433-199804000-00002; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Subramanian T, 2005, ORG LETT, V7, P2109, DOI 10.1021/ol050386o; Tanyi JL, 2003, CANCER RES, V63, P1073; Thai L, 1999, P NATL ACAD SCI USA, V96, P13080, DOI 10.1073/pnas.96.23.13080; Theofilopoulos S, 2008, BBA-MOL CELL BIOL L, V1781, P731, DOI 10.1016/j.bbalip.2008.09.001; Tong H, 2008, ANAL BIOCHEM, V378, P138, DOI 10.1016/j.ab.2008.04.021; Troutman JM, 2005, BIOCONJUGATE CHEM, V16, P1209, DOI 10.1021/bc050068+; Vaidya S, 1998, ARCH BIOCHEM BIOPHYS, V355, P84, DOI 10.1006/abbi.1998.0704; Yang SH, 2008, J CLIN INVEST, V118, P3291, DOI 10.1172/JCI35876; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	45	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13918	13929		10.1074/jbc.M109.083931	http://dx.doi.org/10.1074/jbc.M109.083931			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20110354	Green Published, hybrid			2022-12-25	WOS:000276987700066
J	Kim, SH; Richardson, M; Chinnakannu, K; Bai, VU; Menon, M; Barrack, ER; Reddy, GPV				Kim, Sahn-Ho; Richardson, Michelle; Chinnakannu, Kannagi; Bai, V. Uma; Menon, Mani; Barrack, Evelyn R.; Reddy, G. Prem-Veer			Androgen Receptor Interacts with Telomeric Proteins in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRF2; TIN2; EXPRESSION; DNA; LOCALIZATION; MAINTENANCE; DYSFUNCTION; REGULATOR; PHENOTYPE; COMPLEX	The telomeric complex, shelterin, plays a critical role in protecting chromosome ends from erosion, and disruption of these complexes can lead to chromosomal instability culminating in cell death or malignant transformation. We reported previously that dominant-negative mutants of one of the telomeric proteins called TIN2 cause death of androgen receptor (AR)-negative but not AR-positive prostate cancer cells, raising the question of a possible role of AR in the structural stability of telomeric complexes. Consistent with this possibility, in the present study, we observed that the AR antagonist Casodex (bicalutamide) disrupted telomeric complexes in AR-positive LNCaP cells but not in AR-negative PC-3 cells. Immunofluorescent studies revealed colocalization of TIN2 and AR. Reciprocal immunoprecipitation studies showed association of AR with telomeric proteins. Furthermore, telomeric proteins were overexpressed in prostate cancer cells compared with normal prostate epithelial cells, and sucrose density gradient analysis showed co-sedimentation of AR with telomeric proteins in a shelterin-like mega complex. Together, these observations suggest an allosteric role of AR in telomere complex stability in prostate cancer cells and suggest that AR-antagonist Casodex-mediated cell death may be due to telomere complex disruption.	[Kim, Sahn-Ho; Richardson, Michelle; Chinnakannu, Kannagi; Bai, V. Uma; Menon, Mani; Barrack, Evelyn R.; Reddy, G. Prem-Veer] Henry Ford Hosp, Vattikuti Urol Inst, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Kim, SH (corresponding author), Henry Ford Hlth Syst, 1 Ford Pl, Detroit, MI 48202 USA.	skim3@hfhs.org			Henry Ford Health System	Henry Ford Health System	This work was funded by Institutional Research Support from the Henry Ford Health System (to S. K.).	Bai VU, 2007, P NATL ACAD SCI USA, V104, P2343, DOI 10.1073/pnas.0610504104; Cifuentes E, 2004, P NATL ACAD SCI USA, V101, P464, DOI 10.1073/pnas.0307161101; Cifuentes E, 2003, J CELL PHYSIOL, V195, P337, DOI 10.1002/jcp.10317; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Else T, 2009, CANCER CELL, V15, P465, DOI 10.1016/j.ccr.2009.04.011; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 2008, J CELL BIOL, V181, P447, DOI 10.1083/jcb.200710028; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Legrier ME, 2009, INT J CANCER, V124, P1103, DOI 10.1002/ijc.24073; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Murthy S, 2006, J CELL PHYSIOL, V209, P711, DOI 10.1002/jcp.20842; Nakanishi K, 2003, CLIN CANCER RES, V9, P1105; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; REDDY GPV, 1983, NATURE, V304, P86; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; ROSEN S, 2004, IVD TECH, V10, P39; Schoeftner S, 2009, P NATL ACAD SCI USA, V106, P19387, DOI 10.1073/pnas.0909265106; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Song K, 2000, FEBS LETT, V481, P81, DOI 10.1016/S0014-5793(00)01958-X; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; Waller AS, 2000, J MOL ENDOCRINOL, V24, P339, DOI 10.1677/jme.0.0240339; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhan P, 2002, J STEROID BIOCHEM, V83, P101, DOI 10.1016/S0960-0760(02)00275-3; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	32	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10472	10476		10.1074/jbc.M109.098798	http://dx.doi.org/10.1074/jbc.M109.098798			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110352	Green Published, hybrid			2022-12-25	WOS:000276264600033
J	Kthiri, F; Le, HT; Gautier, V; Caldas, T; Malki, A; Landoulsi, A; Bohn, C; Bouloc, P; Richarme, G				Kthiri, Fatoum; Le, Hai-Tuong; Gautier, Valerie; Caldas, Teresa; Malki, Abderrahim; Landoulsi, Ahmed; Bohn, Chantal; Bouloc, Philippe; Richarme, Gilbert			Protein Aggregation in a Mutant Deficient in YajL, the Bacterial Homolog of the Parkinsonism-associated Protein DJ-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RIBOSOME BIOGENESIS; CHAPERONE ACTIVITY; HYDROGEN-PEROXIDE; GENE-EXPRESSION; ALPHA-SYNUCLEIN; ATP; HSP31; DNAK	YajL is the closest prokaryotic homolog of the parkinsonism-associated protein DJ-1 (40% sequence identity and similar three-dimensional structure), a protein of unknown function involved in the cellular response to oxidative stress. We report here that a yajL mutant of Escherichia coli displays an increased sensitivity to oxidative stress. It also exhibits a protein aggregation phenotype in aerobiosis, but not in anaerobiosis or in aerobic cells overexpressing superoxide dismutase, suggesting that protein aggregation depends on the presence of reactive oxygen species produced by respiratory chains. The protein aggregation phenotype of the yajL mutant, which can be rescued by the wildtype yajL gene, but not by the corresponding cysteine 106 mutant allele, is similar to that of multiple mutants deficient in superoxide dismutases and catalases, although intracellular hydrogen peroxide levels were not increased in the yajL mutant, suggesting that protein aggregation in this strain does not result from a hydrogen peroxide detoxification defect. Aggregation-prone proteins included 17 ribosomal proteins, the ATP synthase beta subunit, flagellin, and the outer membrane proteins OmpA and PAL; all of them are part of multiprotein complexes, suggesting that YajL might be involved in optimal expression of these complexes, especially during oxidative stress. YajL stimulated the renaturation of urea-unfolded citrate synthase and the solubilization of the urea-unfolded ribosomal proteins S1 and L3 and was more efficient as a chaperone in its oxidized form than in its reduced form. The mRNA levels of several aggregated proteins of the yajL mutant were severely affected, suggesting that YajL also acts at the level of gene expression. These two functions of YajL might explain the protein aggregation phenotype of the yajL mutant.	[Kthiri, Fatoum; Le, Hai-Tuong; Gautier, Valerie; Caldas, Teresa; Malki, Abderrahim; Richarme, Gilbert] Univ Paris 07, Inst Jacques Monod, F-75013 Paris, France; [Kthiri, Fatoum; Landoulsi, Ahmed] Fac Sci Bizerte, Lab Biochim & Biol Mol, Zarzouna 7021, Bizerte, Tunisia; [Bohn, Chantal; Bouloc, Philippe] Univ Paris 11, Lab Signalisat & Reseaux Regulat Bacteriens, CNRS, Inst Genet & Microbiol,UMR8621, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Cite; Universite de Carthage; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Richarme, G (corresponding author), Univ Paris 07, Inst Jacques Monod, 15 Rue Helene Brion, F-75013 Paris, France.	richarme@paris7.jussieu.fr	Bouloc, Philippe/ABA-5732-2021	Bouloc, Philippe/0000-0003-4601-3387; Landoulsi, Ahmed/0000-0002-5101-7641; Bohn, Chantal/0000-0003-1569-9072				Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Al Refaii A, 2009, MOL MICROBIOL, V71, P748, DOI 10.1111/j.1365-2958.2008.06561.x; Aldridge P, 2006, J BACTERIOL, V188, P4487, DOI 10.1128/JB.00094-06; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bisaglia M, 2003, J BIOL CHEM, V278, P15261, DOI 10.1074/jbc.M212731200; Blackinton J, 2009, NEUROSCI LETT, V452, P8, DOI 10.1016/j.neulet.2008.12.053; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Campbell BCV, 2000, NEUROBIOL DIS, V7, P192, DOI 10.1006/nbdi.2000.0286; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Collier J, 2004, J BIOL CHEM, V279, P54193, DOI 10.1074/jbc.M314012200; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; ElYaagoubi A, 1996, MICROBIOL-SGM, V142, P2595; Ferrer I, 2007, NEUROSCI LETT, V415, P205, DOI 10.1016/j.neulet.2007.01.026; Fredriksson A, 2006, MOL MICROBIOL, V59, P350, DOI 10.1111/j.1365-2958.2005.04947.x; Fredriksson A, 2005, J BACTERIOL, V187, P4207, DOI 10.1128/JB.187.12.4207-4213.2005; GEORGELLIS D, 1995, MOL MICROBIOL, V16, P1259, DOI 10.1111/j.1365-2958.1995.tb02347.x; GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; LAGONI OR, 1993, J BACTERIOL, V175, P5791, DOI 10.1128/JB.175.18.5791-5797.1993; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Sambrook J, 2001, MOL CLONING LAB MANU; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Semrad K, 2004, RNA, V10, P1855, DOI 10.1261/rna.7121704; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Wang X, 2008, PRION, V2, P57, DOI 10.4161/pri.2.2.6746; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P279, DOI 10.1271/bbb.60647; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Yoon H, 2008, J MICROBIOL BIOTECHN, V18, P228; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	52	30	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10328	10336		10.1074/jbc.M109.077529	http://dx.doi.org/10.1074/jbc.M109.077529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20124404	Green Published, hybrid			2022-12-25	WOS:000276264600017
J	Gehrau, RC; D'Astolfo, DS; Dumur, CI; Bocco, JL; Koritschoner, NP				Gehrau, Ricardo C.; D'Astolfo, Diego S.; Dumur, Catherine I.; Bocco, Jose L.; Koritschoner, Nicolas P.			Nuclear Expression of KLF6 Tumor Suppressor Factor Is Highly Associated with Overexpression of ERBB2 Oncoprotein in Ductal Breast Carcinomas	PLOS ONE			English	Article							TRANSCRIPTION FACTOR KLF6; PREDICTIVE MARKERS; GENE KLF6; IN-VIVO; CANCER; PROTEIN; ABSENCE; MUTATIONS; HETEROZYGOSITY; INACTIVATION	Background: Kruppel-like factor 6 (KLF6) is an evolutionarily conserved and ubiquitously expressed protein that belongs to the mammalian Sp1/KLF family of transcriptional regulators. Though KLF6 is a transcription factor and harbors a nuclear localization signal it is not systematically located in the nucleus but it was detected in the cytoplasm of several tissues and cell lines. Hence, it is still not fully settled whether the tumor suppressor function of KLF6 is directly associated with its ability to regulate target genes. Methodology/Principal Findings: In this study we analyzed KLF6 expression and sub-cellular distribution by immunohistochemistry in several normal and tumor tissues in a microarray format representing fifteen human organs. Results indicate that while both nuclear and cytoplasmic distribution of KLF6 is detected in normal breast tissues, breast carcinomas express KLF6 mainly detected in the cytoplasm. Expression of KLF6 was further analyzed in breast cancer tissues overexpressing ERBB2 oncoprotein, which is associated with poor disease prognosis and patient's survival. The analysis of 48 ductal carcinomas revealed a significant population expressing KLF6 predominantly in the nuclear compartment (X-2 p = 0.005; Fisher p = 0.003). Moreover, this expression pattern correlates directly with early stage and small ductal breast tumors and linked to metastatic events in lymph nodes. Conclusions/Significance: Data are consistent with a preferential localization of KLF6 in the nuclear compartment of early stage and small HER2-ERBB2 overexpressing ductal breast tumor cells, also presenting lymph node metastatic events. Thus, KLF6 tumor suppressor could represent a new molecular marker candidate for tumor prognosis and/or a potential target for therapy strategies.	[Gehrau, Ricardo C.; Bocco, Jose L.; Koritschoner, Nicolas P.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina; [D'Astolfo, Diego S.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC CONICET, RA-5000 Cordoba, Argentina; [Dumur, Catherine I.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Virginia Commonwealth University	Gehrau, RC (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina.	jbocco@fcq.unc.edu.ar	Dumur, Catherine/AAH-9489-2020	Bocco, Jose Luis/0000-0002-9682-1270; Dumur, Catherine/0000-0003-3975-9332	Fundacion Antorchas; Beca Carrillo-onativia (Ministerio de Salud de la Nacion Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina; Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT) [PICT 15-20279, PICT 8321]; Third World Academy of Sciences (TWAS); Secretaria de Ciencia y Tecnologia; Universidad Nacional de Cordoba, Argentina	Fundacion Antorchas; Beca Carrillo-onativia (Ministerio de Salud de la Nacion Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT)(ANPCyTFONCyT); Third World Academy of Sciences (TWAS); Secretaria de Ciencia y Tecnologia(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad Nacional de Cordoba, Argentina	Fundacion Antorchas. - Beca Carrillo-onativia (Ministerio de Salud de la Nacion Argentina). - Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. - Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT: PICT 15-20279 to JLB; PICT 2000-2001 No 8321). - Third World Academy of Sciences (TWAS). - Secretaria de Ciencia y Tecnologia - Universidad Nacional de Cordoba, Argentina. D. S. D. and R. C. G. were supported by a CONICET and FONCyT fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell L, 2008, MODERN PATHOL, V21, P1470, DOI 10.1038/modpathol.2008.145; Azim H, 2008, ONCOLOGY-BASEL, V74, P150, DOI 10.1159/000151362; Benson JR, 2003, LANCET ONCOL, V4, P56, DOI 10.1016/S1470-2045(03)00961-6; Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; Blanchon L, 2001, MECH DEVELOP, V105, P185, DOI 10.1016/S0925-4773(01)00391-4; Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Boyault S, 2005, HEPATOLOGY, V41, P681, DOI 10.1002/hep.20588; Bureau C, 2008, J GASTROEN HEPATOL, V23, P78, DOI 10.1111/j.1440-1746.2007.05234.x; Camacho-Vanegas O, 2007, INT J CANCER, V121, P1390, DOI 10.1002/ijc.22809; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; D'Astolfo DS, 2008, CELL DEATH DIFFER, V15, P613, DOI 10.1038/sj.cdd.4402299; Faratian D, 2008, HISTOPATHOLOGY, V52, P91, DOI 10.1111/j.1365-2559.2007.02896.x; Foster KW, 2000, CANCER RES, V60, P6488; Gehrau RC, 2005, BBA-GENE STRUCT EXPR, V1730, P137, DOI 10.1016/j.bbaexp.2005.06.006; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Grizzle William E., 1998, V14, P143; Grizzle William E., 1998, V14, P161; Guo HS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-110; Irvine T, 2007, EXPERT REV ANTICANC, V7, P135, DOI 10.1586/14737140.7.2.135; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kohler B, 2004, INT J CANCER, V111, P644, DOI 10.1002/ijc.20302; Koivisto PA, 2004, INT J CANCER, V111, P642, DOI 10.1002/ijc.20301; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Lievre A, 2005, ONCOGENE, V24, P7253, DOI 10.1038/sj.onc.1208867; LIU J, 2009, MOL CELL BIOCH; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Miyaki M, 2006, ONCOLOGY-BASEL, V71, P131, DOI 10.1159/000100523; Montanini L, 2004, INT J CANCER, V111, P640, DOI 10.1002/ijc.20303; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Narla G, 2008, J CLIN INVEST, V118, P2711, DOI 10.1172/JCI34780; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Payne SJL, 2008, HISTOPATHOLOGY, V52, P82, DOI 10.1111/j.1365-2559.2007.02897.x; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Sangodkar J, 2009, EUR J CANCER, V45, P666, DOI 10.1016/j.ejca.2008.11.009; Sirach E, 2007, CELL DEATH DIFFER, V14, P1202, DOI 10.1038/sj.cdd.4402114; Slavin D, 1999, BIOL REPROD, V61, P1586, DOI 10.1095/biolreprod61.6.1586; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; Sun Ming, 2006, Zhonghua Nan Ke Xue, V12, P502; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; TAHARA E, 2009, CANC BIOL THER, V8; Tang P, 2007, CURR OPIN OBSTET GYN, V19, P63, DOI 10.1097/GCO.0b013e3280114a3a; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wiechmann L, 2008, CANCER-AM CANCER SOC, V112, P2130, DOI 10.1002/cncr.23430; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yea S, 2008, GASTROENTEROLOGY, V134, P1521, DOI 10.1053/j.gastro.2008.02.015	52	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8929	10.1371/journal.pone.0008929	http://dx.doi.org/10.1371/journal.pone.0008929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126619	gold, Green Published, Green Submitted			2022-12-25	WOS:000274138000008
J	Pethica, R; Barker, G; Kovacs, T; Gough, J				Pethica, Ralph; Barker, Gary; Kovacs, Tim; Gough, Julian			TreeVector: Scalable, Interactive, Phylogenetic Trees for the Web	PLOS ONE			English	Article							PROTEIN SEQUENCES; MANIPULATION; DISPLAY	Background: Phylogenetic trees are complex data forms that need to be graphically displayed to be human-readable. Traditional techniques of plotting phylogenetic trees focus on rendering a single static image, but increases in the production of biological data and large-scale analyses demand scalable, browsable, and interactive trees. Methodology/Principal Findings: We introduce TreeVector, a Scalable Vector Graphics-and Java-based method that allows trees to be integrated and viewed seamlessly in standard web browsers with no extra software required, and can be modified and linked using standard web technologies. There are now many bioinformatics servers and databases with a range of dynamic processes and updates to cope with the increasing volume of data. TreeVector is designed as a framework to integrate with these processes and produce user-customized phylogenies automatically. We also address the strengths of phylogenetic trees as part of a linked-in browsing process rather than an end graphic for print. Conclusions/Significance: TreeVector is fast and easy to use and is available to download precompiled, but is also open source. It can also be run from the web server listed below or the user's own web server. It has already been deployed on two recognized and widely used database Web sites.	[Pethica, Ralph; Kovacs, Tim; Gough, Julian] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Barker, Gary] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol; University of Bristol	Pethica, R (corresponding author), Univ Bristol, Dept Comp Sci, Bristol, Avon, England.	pethica@cs.bris.ac.uk		Barker, Gary/0000-0002-9018-9526	Engineering and Physical Sciences Research Council Departmental Grant; Biotechnology and Biological Sciences Research Council [BB/G022771/1] Funding Source: researchfish; BBSRC [BB/G022771/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council Departmental Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Engineering and Physical Sciences Research Council Departmental Grant (http://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker G, 2003, BIOINFORMATICS, V19, P421, DOI 10.1093/bioinformatics/btf881; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fredslund J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-315; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; MADDISON WP, 1992, MCCLADE ANAL PHYLOGE; Makarenkov U, 2001, BIOINFORMATICS, V17, P664, DOI 10.1093/bioinformatics/17.7.664; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palidwor G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-79; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383; [No title captured]	13	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8934	10.1371/journal.pone.0008934	http://dx.doi.org/10.1371/journal.pone.0008934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126613	gold, Green Published, Green Submitted			2022-12-25	WOS:000274138000012
J	Hyams, C; Tam, JCH; Brown, JS; Gordon, SB				Hyams, Catherine; Tam, Jerry C. H.; Brown, Jeremy S.; Gordon, Stephen B.			C3b/iC3b Deposition on Streptococcus pneumoniae Is Not Affected by HIV Infection	PLOS ONE			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCOCCAL DISEASE; COMPLEMENT PATHWAY; MALAWIAN ADULTS; IMMUNITY; DEFICIENCY; RESPONSES; VACCINE; MICE	Streptococcus pneumoniae is a common cause of infection in both HIV positive patients and those with complement deficiencies. We hypothesised that HIV positive individuals might exhibit reduced opsonisation of pneumococcus with complement due to reduced levels of S. pneumoniae specific IgG. We discovered no difference in C3 deposition on S. pneumoniae between HIV positive or negative individuals, and furthermore C3 deposition remained unchanged as HIV progressed towards AIDS. We found no correlation between C3 deposition on S. pneumoniae and CD4 cell count in HIV infected individuals. Hence we have demonstrated no failure of complement immunity in HIV positive patients.	[Hyams, Catherine; Brown, Jeremy S.] UCL, Rayne Inst, Sch Med, Ctr Resp Res,Dept Med, London, England; [Tam, Jerry C. H.; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of London; King's College London; University College London; UCL Medical School; Liverpool School of Tropical Medicine; University of Liverpool	Hyams, C (corresponding author), UCL, Rayne Inst, Sch Med, Ctr Resp Res,Dept Med, London, England.	sbgordon@liv.ac.uk	Hyams, Catherine/AAH-1721-2019; Tam, Jerry/P-1995-2014	Hyams, Catherine/0000-0003-3923-1773; Brown, Jeremy/0000-0002-5650-5361; Tam, Jerry/0000-0001-7991-1568; Gordon, Stephen/0000-0001-6576-1116	Astor Foundation; Glaxo Smith Kline; Wellcome Trust [061231]	Astor Foundation; Glaxo Smith Kline(GlaxoSmithKline); Wellcome Trust(Wellcome TrustEuropean Commission)	CH is supported by the Astor Foundation and Glaxo Smith Kline through the University College London MB PhD programme. SGB is supported by the Wellcome Trust ( grant 061231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTRIAN R, 1979, AM J MED, V67, P547, DOI 10.1016/0002-9343(79)90222-5; BERNSTEIN LJ, 1985, J PEDIATR-US, V107, P352, DOI 10.1016/S0022-3476(85)80505-9; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; CARSON PJ, 1995, J INFECT DIS, V172, P340, DOI 10.1093/infdis/172.2.340; Chang BG, 1999, AM J KIDNEY DIS, V33, P441, DOI 10.1016/S0272-6386(99)70180-0; CROSS AS, 1990, CURR TOP MICROBIOL, V150, P87; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; French N, 1998, AIDS, V12, P1683, DOI 10.1097/00002030-199813000-00017; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gordon SB, 2003, J INFECT DIS, V188, P666, DOI 10.1086/377480; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; LEVO Y, 1974, International Urology and Nephrology, V6, P233, DOI 10.1007/BF02089270; MAYERSIUTA R, 1988, MED MICROBIOL IMMUN, V177, P189, DOI 10.1007/BF00211218; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; MUSHER DM, 1990, INFECT IMMUN, V58, P3871, DOI 10.1128/IAI.58.12.3871-3876.1990; Scamurra RW, 2000, J IMMUNOL, V164, P5482, DOI 10.4049/jimmunol.164.10.5482; Takahashi H, 2003, CLIN INFECT DIS, V37, P1534, DOI 10.1086/379511; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WINKELSTEIN JA, 1968, NEW ENGL J MED, V279, P459, DOI 10.1056/NEJM196808292790904; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8902	10.1371/journal.pone.0008902	http://dx.doi.org/10.1371/journal.pone.0008902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126656	gold, Green Published, Green Accepted			2022-12-25	WOS:000273896500021
J	Kaczmarczyk, SJ; Sitaraman, K; Hill, T; Hartley, JL; Chatterjee, DK				Kaczmarczyk, Stanislaw J.; Sitaraman, Kalavathy; Hill, Thomas; Hartley, James L.; Chatterjee, Deb K.			Tus, an E. coli Protein, Contains Mammalian Nuclear Targeting and Exporting Signals	PLOS ONE			English	Article							ESCHERICHIA-COLI; TER COMPLEX; DNA-REPLICATION; SEQUENCE; TRANSLOCATION; TERMINATION; BINDING; DOMAIN; LOCALIZATION; RECOMBINASE	Shuttling of proteins between nucleus and cytoplasm in mammalian cells is facilitated by the presence of nuclear localization signals (NLS) and nuclear export signals (NES), respectively. However, we have found that Tus, an E. coli replication fork arresting protein, contains separate sequences that function efficiently as NLS and NES in mammalian cell lines, as judged by cellular location of GFP-fusion proteins. The NLS was localized to a short stretch of 9 amino acids in the carboxy-terminus of Tus protein. Alterations of any of these basic amino acids almost completely abolished the nuclear targeting. The NES comprises a cluster of leucine/hydrophobic residues located within 21 amino acids at the amino terminus of Tus. Finally, we have shown that purified GFP-Tus fusion protein or GFP-Tus NLS fusion protein, when added to the culture media, was internalized very efficiently into mammalian cells. Thus, Tus is perhaps the first reported bacterial protein to possess both NLS and NES, and has the capability to transduce protein into mammalian cells.	[Kaczmarczyk, Stanislaw J.; Sitaraman, Kalavathy; Hartley, James L.; Chatterjee, Deb K.] NCI, Prot Express Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Hill, Thomas] Univ N Dakota, Sch Med & Hlth Sci, Dept Microbiol & Immunol, Grand Forks, ND 58201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of North Dakota Grand Forks	Kaczmarczyk, SJ (corresponding author), NCI, Prot Express Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA.	dchatterjee@mail.nih.gov			National Cancer Institute, National Institutes of Health [NO1-CO-12400]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. NO1-CO-12400. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Chatterjee DK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003265; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; DWORETZKY SI, 1988, J CELL BIOL, V106, P575, DOI 10.1083/jcb.106.3.575; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; GANGETEN S, 1997, NUCLEIC ACIDS RES, V25, P3326; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GOTTLIEB PA, 1992, J BIOL CHEM, V267, P7434; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kamada K, 1996, NATURE, V383, P598, DOI 10.1038/383598a0; KUEMPEL PL, 1973, MOL GEN GENET, V125, P1, DOI 10.1007/BF00292981; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Le YZ, 1999, NUCLEIC ACIDS RES, V27, P4703, DOI 10.1093/nar/27.24.4703; MASTERS M, 1971, NATURE-NEW BIOL, V232, P137, DOI 10.1038/newbio232137a0; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Murriel Christopher L, 2006, Expert Opin Drug Deliv, V3, P739, DOI 10.1517/17425247.3.6.739; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pelczar P, 2004, EMBO REP, V5, P632, DOI 10.1038/sj.embor.7400165; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Skokotas A, 1995, J BIOL CHEM, V270, P30941, DOI 10.1074/jbc.270.52.30941	33	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8889	10.1371/journal.pone.0008889	http://dx.doi.org/10.1371/journal.pone.0008889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126275	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896500012
J	Silvagno, F; De Vivo, E; Attanasio, A; Gallo, V; Mazzucco, G; Pescarmona, G				Silvagno, Francesca; De Vivo, Enrico; Attanasio, Angelo; Gallo, Valentina; Mazzucco, Gianna; Pescarmona, Gianpiero			Mitochondrial Localization of Vitamin D Receptor in Human Platelets and Differentiated Megakaryocytes	PLOS ONE			English	Article							LEUKEMIA-CELL LINE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; EXPRESSION; IDENTIFICATION; INVOLVEMENT; ACTIVATION; MEMBRANE; PROTEINS	Background: Like other steroid hormones, vitamin D elicits both transcriptional events and rapid non genomic effects. Vitamin D receptor (VDR) localization and mechanisms of VDR-triggered non genomic responses are still controversial. Although anticoagulant effects of vitamin D have been reported and VDR signalling has been characterized in monocytes and vascular cells, nothing is known about VDR expression and functions in human platelets, anucleated fragments of megakaryocytes which are known targets of other steroids. Methodology/Principal Findings: In this study we characterized the expression and cellular localization of VDR in human platelets and in a megakaryocyte lineage. Human platelets and their TPA-differentiated precursors expressed a classical 50 kDa VDR protein, which increased with megakaryocytes maturation. By biochemical fractionation studies we demonstrated the presence of the receptor in the soluble and mitochondrial compartment of human platelets, and the observation was confirmed by immunoelectron microscopy analysis. Similar localization was found in mature megakaryocytes, where besides its classical nuclear localization the receptor was evident as soluble and mitochondria resident protein. Conclusions: The results reported here suggest that megakaryocytopoiesis and platelet activation, which are calcium-dependent events, might be modulated by a mitochondrial non genomic activity of VDR. These data open challenging future studies on VDR physiological role in platelets and more generally in mitochondria.	[Silvagno, Francesca; De Vivo, Enrico; Gallo, Valentina; Pescarmona, Gianpiero] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Silvagno, Francesca; Pescarmona, Gianpiero] S Giovanni Battista Hosp, CERMS, Turin, Italy; [Attanasio, Angelo; Mazzucco, Gianna] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Silvagno, F (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	francesca.silvagno@unito.it	Gallo, Valentina/E-1132-2011	Gallo, Valentina/0000-0002-1621-5829; PESCARMONA, GIAN PIERO/0000-0003-2143-8901	MIUR (Ministero dell'Istruzione Universita e Ricerca)	MIUR (Ministero dell'Istruzione Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR))	Funding: This work was supported by MIUR (Ministero dell'Istruzione Universita e Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; BAATONT S, 1993, HEMATOL CELL THER, V10, P33; Barsony J, 1997, J BIOL CHEM, V272, P5774, DOI 10.1074/jbc.272.9.5774; BORD S, 2001, J CELL BIOCHEM, V92, P219; Bouillon R, 2003, J CELL BIOCHEM, V88, P332, DOI 10.1002/jcb.10360; BRETONGORIUS J, 1986, SEMIN HEMATOL, V23, P43; BROEKMAN MJ, 1974, J CELL BIOL, V60, P507, DOI 10.1083/jcb.60.2.507; Casas F, 2003, FASEB J, V17, P426, DOI 10.1096/fj.02-0732com; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; CONKERO JB, 2002, J BIOL CHEM, V277, P39665; DENDEKKER E, 2003, BIOCHIM BIOPHYS ACTA, V16, P85; DUSSO AS, 2005, AM J PHYSIOL-RENAL, V289, P3; GAVR, 2007, SCUAN REPROD MED, V25, P134; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; KAUSHANSKY K, 2003, BLOOD, V111, P931; KHET, 2000, BLOOD, V95, P2239; Koyama T, 1998, BLOOD, V92, P160, DOI 10.1182/blood.V92.1.160.413k16_160_167; LAJDOVA I, 2003, EUR J PHARMACOL, V586, P11; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Leytin V, 2003, TRANSFUS APHER SCI, V28, P285, DOI 10.1016/S1473-0502(03)00048-X; Li YC, 2003, J CELL BIOCHEM, V88, P327, DOI 10.1002/jcb.10343; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097; Moraes LA, 2005, BLOOD, V106, P4167, DOI 10.1182/blood-2005-04-1723; MTOSKE G, 2000, EXP HEMATOL, V28, P111; NEMERE I, 1994, J BIOL CHEM, V269, P23750; NORM, 2006, ENDOCRINOLOGY, V147, P5542; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; O'Kelly J, 2002, J CLIN INVEST, V109, P1091, DOI 10.1172/JCI200212392; OGURA M, 1988, BLOOD, V72, P49; Ohsawa M, 2000, CIRCULATION, V102, P2867; PAMELA DK, 2004, J BIOL CHEM, V279, P16751; Pardo VG, 2008, BIOGERONTOLOGY, V9, P109, DOI 10.1007/s10522-007-9118-2; PILO R, 1981, THROMB HAEMOSTASIS, V46, P538; Psarra AMG, 2005, INT J BIOCHEM CELL B, V37, P2544, DOI 10.1016/j.biocel.2005.06.015; QUESADA JM, 1990, NEPHROL DIAL TRANSPL, V5, P1013, DOI 10.1093/ndt/5.12.1013; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Rebsamen MC, 2002, CIRC RES, V91, P17, DOI 10.1161/01.RES.0000025269.60668.0F; Reineri S, 2007, BBA-MOL CELL RES, V1773, P273, DOI 10.1016/j.bbamcr.2006.12.001; SATTAK T, 2003, LEUKOT ESSCUT FATTY, V69, P299; SELV, 1996, J INVEST DERMATOL, V1, P23; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song LN, 1996, J STEROID BIOCHEM, V57, P265, DOI 10.1016/0960-0760(95)00266-9; SONG LN, 1993, STEM CELLS, V11, P312, DOI 10.1002/stem.5530110409; TABI, 1924, LEUKEMIA RES, V3, P769; Zanello LP, 1996, BIOCHEM BIOPH RES CO, V225, P551, DOI 10.1006/bbrc.1996.1210	49	99	103	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8670	10.1371/journal.pone.0008670	http://dx.doi.org/10.1371/journal.pone.0008670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XC	20107497	gold, Green Published, Green Submitted			2022-12-25	WOS:000278099300001
J	Kroviarski, Y; Debbabi, M; Bachoual, R; Perianin, A; Gougerot-Pocidalo, MA; El-Benna, J; Dang, PMC				Kroviarski, Yolande; Debbabi, Maya; Bachoual, Rafik; Perianin, Axel; Gougerot-Pocidalo, Marie-Anne; El-Benna, Jamel; Dang, Pham My-Chan			Phosphorylation of NADPH oxidase activator 1 (NOXA1) on serine 282 by MAP kinases and on serine 172 by protein kinase C and protein kinase A prevents NOX1 hyperactivation	FASEB JOURNAL			English	Article						reactive oxygen species; innate immunity; inflammation	RESPIRATORY BURST OXIDASE; COLON EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; SUPEROXIDE-PRODUCTION; CYCLIC-AMP; NEUTROPHIL ACTIVATION; COMPONENT P47(PHOX); NAD(P)H OXIDASE-1; CYTOCHROME B(558); TISSUE EXPRESSION	NADPH oxidase activator 1 (NOXA1) together with NADPH oxidase organizer 1 (NOXO1) are key regulatory subunits of the NADPH oxidase NOX1. NOX1 is expressed mainly in colon epithelial cells and could be involved in mucosal innate immunity by producing reactive oxygen species (ROS). Contrary to its phagocyte counterpart NOX2, the mechanisms involved in NOX1 activation and regulation remain unclear. Here we report that NOX1 activity is regulated through MAP kinase (MAPK), protein kinase C (PKC), and protein kinase A (PKA)-dependent phosphorylation of NOXA1. We identified Ser-282 as target of MAPK and Ser-172 as target of PKC and PKA in vitro and in a transfected human embryonic kidney 293 (HEK293) cell model using site directed mutagenesis and phosphopeptide mapping analysis. In HEK293 cells, phosphorylation of these sites occurred at a basal level and down-regulated constitutive NOX1 activity. Indeed, S172A and S282A single mutants of NOXA1 significantly up-regulated constitutive NOX1-derived ROS production, and S172A/S282A double mutant further increased it, as compared to wild-type NOXA1. Furthermore, phosphorylation of NOXA1 on Ser-282 and Ser-172 decreased its binding to NOX1 and Rac1. These results demonstrated a critical role of NOXA1 phosphorylation on Ser-282 and Ser-172 in preventing NOX1 hyperactivation through the decrease of NOXA1 interaction to NOX1 and Rac1.-Kroviarski, Y., Debbabi, M., Bachoual, R., Perianin, A., Gougerot-Pocidalo, M.-A., El-Benna, J., Dang, P. M. Phosphorylation of NADPH oxidase activator 1 (NOXA1) on serine 282 by MAP kinases and on serine 172 by protein kinase C and protein kinase A prevents NOX1 hyperactivation. FASEB J. 24, 2077-2092 (2010). www.fasebj.org	[Dang, Pham My-Chan] Univ Paris 07, INSERM, U773, Ctr Rech Biomed Bichat Beaujon CRB3, F-75018 Paris, France; [Kroviarski, Yolande; Debbabi, Maya; Gougerot-Pocidalo, Marie-Anne; El-Benna, Jamel; Dang, Pham My-Chan] Univ Paris 07, Paris, France; [Kroviarski, Yolande; Gougerot-Pocidalo, Marie-Anne] CHU Xavier Bichat, AP HP, Ctr Invest Biomed Phenogen, Paris, France; [Perianin, Axel] CNRS, Inst Cochin, INSERM, U567,UMR 8104, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dang, PMC (corresponding author), Univ Paris 07, INSERM, U773, Ctr Rech Biomed Bichat Beaujon CRB3, 16 Rue Henri Huchard, F-75018 Paris, France.	my-chan.dang@inserm.fr		BACHOUAL, Rafik/0000-0003-2195-4068	French Research Ministry	French Research Ministry(Ministry of Research, France)	The authors thank Dr. Yun Soo Bae (Ewha Womans University, Seoul, Korea) for the PGEX-4T-1-NOX1(217-550) plasmid, Dr. Alan Hall (University College, London, UK) for the pGEX-4T-3-Rac1 plasmid, and Dr. Anne Brunet and Dr. Jacques Pouyssegur (Universite de Nice, CNRS UMR 6543, Nice, France) for the constitutively active MEK1-mutant plasmid. The authors are grateful to Dr. Tom Leto (NIH, Bethesda, MD, USA) for providing pcDNA3.1 plamids encoding NOX1, NOXO1, and NOXA1 and for comments on the manuscript. M. D. is a recipient of fellowships from the French Research Ministry.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Cheng GJ, 2005, GENE, V356, P118, DOI 10.1016/j.gene.2005.03.008; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; Crawford MA, 2006, J IMMUNOL, V176, P7557, DOI 10.4049/jimmunol.176.12.7557; CROSS AR, 1982, BIOCHEM J, V204, P479, DOI 10.1042/bj2040479; Dang PMC, 2003, BIOCHEMISTRY-US, V42, P4520, DOI 10.1021/bi0205754; Dang PMC, 2001, P NATL ACAD SCI USA, V98, P3001, DOI 10.1073/pnas.061029698; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; ElBenna J, 1997, J BIOL CHEM, V272, P17204, DOI 10.1074/jbc.272.27.17204; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Jacob C, 2004, BRIT J PHARMACOL, V143, P257, DOI 10.1038/sj.bjp.0705927; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim JS, 2007, J BIOL CHEM, V282, P34787, DOI 10.1074/jbc.M704754200; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Koshkin V, 1996, J BIOL CHEM, V271, P30326, DOI 10.1074/jbc.271.48.30326; Kuwano Y, 2008, FREE RADICAL BIO MED, V45, P1642, DOI 10.1016/j.freeradbiomed.2008.08.033; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; Lin P, 2005, J IMMUNOL, V174, P2981, DOI 10.4049/jimmunol.174.5.2981; Mizrahi A, 2006, J LEUKOCYTE BIOL, V79, P881, DOI 10.1189/jlb.1005553; Nakano Y, 2007, BIOCHEM J, V403, P97, DOI 10.1042/BJ20060819; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; OTTONELLO L, 1995, BRIT J HAEMATOL, V91, P566, DOI 10.1111/j.1365-2141.1995.tb05348.x; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Park HS, 2006, BIOCHEM BIOPH RES CO, V339, P985, DOI 10.1016/j.bbrc.2005.11.108; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Rokutan K, 2006, ANTIOXID REDOX SIGN, V8, P1573, DOI 10.1089/ars.2006.8.1573; Saha S, 2008, CAN J PHYSIOL PHARM, V86, P190, DOI 10.1139/Y08-012; SAVITHA G, 1993, CELL SIGNAL, V5, P107, DOI 10.1016/0898-6568(93)90063-R; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Yasunari K, 2000, CIRCULATION, V101, P2302, DOI 10.1161/01.CIR.101.19.2302	54	50	50	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2077	2092		10.1096/fj.09-147629	http://dx.doi.org/10.1096/fj.09-147629			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20110267				2022-12-25	WOS:000278200000041
J	Rana, S; Gupta, K; Gomez, J; Matsuyama, S; Chakrabarti, A; Agarwal, ML; Agarwal, A; Agarwal, MK; Wald, DN				Rana, Sonia; Gupta, Kalpana; Gomez, Jose; Matsuyama, Shigemi; Chakrabarti, Amitabha; Agarwal, Munna L.; Agarwal, Anju; Agarwal, Mukesh K.; Wald, David N.			Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells	FASEB JOURNAL			English	Article						cell death; drug development; signaling	P53 TUMOR-SUPPRESSOR; DNA-DAMAGE; WILD-TYPE; C-ABL; P73; EXPRESSION; INHIBITOR; GROWTH	The identification of agents that preferentially kill cancer cells while protecting normal cells offers the potential to overcome toxicities found in many existing chemotherapeutic agents. Because p53 is frequently inactivated in cancer, agents that preferentially kill p53-null cells and protect wild-type p53-expressing cells are highly desirable chemotherapeutic agents. By using pairs of isogenic colon cancer cell lines that differ only in p53 expression (RKO and HCT116), securinine was found to exhibit these properties. Securinine (30 mu M) induces apoptosis in 73% of p53-null HCT116 cells (LD50 17.5 mu M) as opposed to 17.6% of HCT116 parental cells (LD50 50 mu M) at 72 h after treatment. The mechanism of securinine-mediated death in p53-deficient cells involves the induction of the p53 family member, p73. Interestingly, the proapoptotic protein p73 is down-regulated in colon cancer cells expressing p53. This differential regulation of p73 in a p53-dependent fashion reveals a novel pathway for preferentially targeting cancer cells. In contrast to p53-deficient cells, cells expressing p53 are protected from cell death through the p53-mediated up-regulation of p21. These studies reveal a novel approach to specifically target colon cancer cells lacking p53 as well as identify a novel clinically relevant pathway to selectively induce p73 in p53-null cells.-Rana, S., Gupta, K., Gomez, J., Matsuyama, S., Chakrabarti, A., Agarwal, M. L., Agarwal, A., Agarwal, M. K., Wald, D. N. Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells. FASEB J. 24, 2126- 2134 (2010). www.fasebj.org	[Wald, David N.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Gomez, Jose; Matsuyama, Shigemi] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Agarwal, Munna L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Rana, Sonia; Chakrabarti, Amitabha; Agarwal, Anju; Agarwal, Mukesh K.] Invenio Therapeut, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Wald, David N.] Case Med Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University	Wald, DN (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, WRB3-530,2103 Cornell Rd, Cleveland, OH 44106 USA.	mukeshagarwal@inveniotherapeutics.com; dnw@case.edu						Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Amin ARMR, 2007, CANCER RES, V67, P5617, DOI 10.1158/0008-5472.CAN-07-0655; BURAVTSEVA G R, 1958, Farmakol Toksikol, V21, P7; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Copperman R, 1973, Pa Med, V76, P36; COPPERMAN R, 1974, JAMA-J AM MED ASSOC, V228, P288, DOI 10.1001/jama.1974.03230280016013; DeFrank JS, 1996, CANCER RES, V56, P5365; Dong NZ, 1999, ACTA PHARMACOL SIN, V20, P267; Duke J. A., 1985, REFERENCE PUBLICATIO, pS219; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; FAN SJ, 1995, CANCER RES, V55, P1649; Ferreira CG, 1999, ANN ONCOL, V10, P1011, DOI 10.1023/A:1008361818480; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Harris CC, 1996, JNCI-J NATL CANCER I, V88, P1442, DOI 10.1093/jnci/88.20.1442; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Lokshin M, 2005, COLD SH Q B, V70, P121, DOI 10.1101/sqb.2005.70.046; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Mueller S, 2000, CANCER RES, V60, P156; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SMITH ML, 1995, ONCOGENE, V10, P1053; Thottassery JV, 2006, MOL CANCER THER, V5, P400, DOI 10.1158/1535-7163.MCT-05-0409; Tomkova K, 2008, NEOPLASMA, V55, P177; Tsai-Turton M, 2007, TOXICOL SCI, V98, P216, DOI 10.1093/toxsci/kfm087; Yu T, 2006, DNA REPAIR, V5, P935, DOI 10.1016/j.dnarep.2006.05.040; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; ZHIVOTOSKY B, 2001, CURR PROTOC CELL BIO	32	34	35	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2126	2134		10.1096/fj.09-148999	http://dx.doi.org/10.1096/fj.09-148999			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20133503				2022-12-25	WOS:000278200000045
J	West, NR; Watson, PH				West, N. R.; Watson, P. H.			S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer	ONCOGENE			English	Article						breast cancer; S100A7; cytokines; inflammation	CARCINOMA IN-SITU; GENE-EXPRESSION; RECEPTOR; CELLS; IL-6; BINDING; STAT3; FEATURES; JAB1; DIFFERENTIATION	S100A7 promotes aggressive features in breast cancer, although regulation of its expression is poorly understood. As S100A7 associates with inflammation in skin and breast tissue, we hypothesized that inflammatory cytokines may regulate S100A7 in breast cancer. We therefore examined the effects of several cytokines, among which oncostatin-M (OSM) and the related cytokine, interleukin (IL)-6, showed the most significant effects on S100A7 expression in breast tumor cells in vitro. Both cytokines consistently induced S100A7 expression in three cell lines (MCF7, T47D and MDA-MB-468) in a dose- and time-dependent manner. Induction of S100A7 was inhibited by blockade of STAT3, phosphatidylinositol 3 kinase (PI3K) and ERK1/2 signaling and small interference RNA (siRNA)-mediated knockdown of S100A7 eliminated the promigratory effects of OSM treatment. S100A7 mRNA levels in a case-control cohort of breast tumors (n = 20) were significantly associated with expression of the OSM receptor beta (OSMR beta) chain (P = 0.0098). This association was confirmed using publicly available microarray data from an independent breast tumor cohort (n = 201, P = 0.0005) and a correlation between S100A7 and poor patient survival was observed specifically in cases with high OSMRb expression (HR = 2.35; P = 0.0396; n = 85). We conclude that inflammatory cytokines can regulate S100A7 expression and that S100A7 may mediate some of their effects in breast cancer. Oncogene (2010) 29, 2083-2092; doi: 10.1038/onc.2009.488; published online 18 January 2010	[West, N. R.; Watson, P. H.] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC V8R 6V5, Canada; [West, N. R.; Watson, P. H.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Watson, P. H.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of Victoria; University of British Columbia	Watson, PH (corresponding author), British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, 2410 Lee Ave, Victoria, BC V8R 6V5, Canada.	pwatson@bccancer.bc.ca		West, Nathaniel/0000-0001-9991-0503; Watson, Peter/0000-0002-1642-0638	Canadian Institutes of Health Research (CIHR) [MOP-64349, PRG80155]; Manitoba Breast Tumor Bank; US DOD	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Breast Tumor Bank; US DOD(United States Department of Defense)	We thank Rebecca Barnes for editorial and Melanie Olson for technical assistance, Dr Robert Burke for assistance with microscopy, and Dr Jiaxu Wang, Dr Julian Lum, Eric Tran and Darin Wick for helpful discussion. We also wish to thank the investigators responsible for making the UNC microarray data set publically available. PHW holds an operating grant from the Canadian Institutes of Health Research (CIHR, grant # MOP-64349). This study was supported by the Manitoba Breast Tumor Bank (supported by CIHR grant # PRG80155), a member of the Canadian Tumor Repository Network. NRW is supported by a US DOD Breast Cancer Research Program predoctoral traineeship award.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Badache A, 2001, CANCER RES, V61, P383; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bando M, 2007, IMMUNOL CELL BIOL, V85, P532, DOI 10.1038/sj.icb.7100078; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Conze D, 2001, CANCER RES, V61, P8851; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Di Nuzzo S, 2000, PHOTOCHEM PHOTOBIOL, V72, P374; Emberley ED, 2005, CANCER RES, V65, P5696, DOI 10.1158/0008-5472.CAN-04-3927; Emberley ED, 2004, BREAST CANCER RES, V6, pR308, DOI 10.1186/bcr791; Emberley ED, 2004, BREAST CANCER RES, V6, P153, DOI 10.1186/bcr816; Emberley ED, 2003, CLIN CANCER RES, V9, P2627; Emberley ED, 2003, CANCER RES, V63, P1954; Enerback C, 2002, CANCER RES, V62, P43; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Grant SL, 2002, ONCOGENE, V21, P460, DOI 10.1038/sj.onc.1205100; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Holzer RG, 2004, CLIN EXP METASTAS, V21, P167, DOI 10.1023/B:CLIN.0000024760.02667.db; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Jorcyk CL, 2006, CYTOKINE, V33, P323, DOI 10.1016/j.cyto.2006.03.004; Kennedy RD, 2005, CANCER RES, V65, P10265, DOI 10.1158/0008-5472.CAN-05-1841; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu JW, 1998, CYTOKINE, V10, P295, DOI 10.1006/cyto.1997.0283; Modur V, 1997, J CLIN INVEST, V100, P158, DOI 10.1172/JCI119508; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Paruchuri V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001741; Perrier S, 2009, FEBS LETT, V583, P259, DOI 10.1016/j.febslet.2008.12.030; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Petersson S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-205; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; Royuela M, 2004, J PATHOL, V202, P41, DOI 10.1002/path.1476; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Skliris GP, 2007, BREAST CANCER RES TR, V104, P75, DOI 10.1007/s10549-006-9390-x; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2105; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	53	56	58	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2010	29	14					2083	2092		10.1038/onc.2009.488	http://dx.doi.org/10.1038/onc.2009.488			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101226				2022-12-25	WOS:000276402800007
J	Yamamoto, H; Oue, N; Sato, A; Hasegawa, Y; Yamamoto, H; Matsubara, A; Yasui, W; Kikuchi, A				Yamamoto, H.; Oue, N.; Sato, A.; Hasegawa, Y.; Yamamoto, H.; Matsubara, A.; Yasui, W.; Kikuchi, A.			Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase	ONCOGENE			English	Article						Wnt5a; prostate cancer; Gleason score; invasion; MMP-1	RADICAL PROSTATECTOMY; ACTIVATOR PROTEIN-1; TUMOR-FORMATION; CELL-MIGRATION; GASTRIC-CANCER; GROWTH-FACTOR; IN-VITRO; INVASION; PATHWAY; WNT-5A	Wnt5a is a representative ligand that activates the beta-catenin-independent pathway in Wnt signaling. Although it has been reported that abnormal activation of the Wnt/beta-catenin-dependent pathway is often observed in human prostate cancer, the involvement of the b-catenin-independent pathway in this cancer is unclear. Abnormal expression of Wnt5a and beta-catenin was observed in 27 (28%) and 49 (50%) of 98 prostate cancer cases, respectively, by immunohistochemical analyses. Simultaneous expression of Wnt5a and b-catenin was observed in only five cases, suggesting their exclusive expression. The positive detection of Wnt5a was correlated with high Gleason scores and biochemical relapse of prostate cancer, but that of b-catenin was not. Knockdown and overexpression of Wnt5a in human prostate cancer cell lines reduced and stimulated, respectively, their invasion activities, and the invasion activity required Frizzled2 and Ror2 as Wnt receptors. Wnt5a activated Jun-N-terminal kinase through protein kinase D (PKD) and the inhibition of PKD suppressed Wnt5a-dependent cell migration and invasion. In addition, Wnt5a induced the expression of metalloproteinase-1 through the recruitment of JunD to its promoter region. These results suggest that Wnt5a promotes the aggressiveness of prostate cancer and that its expression is involved in relapse after prostatectomy. Oncogene (2010) 29, 2036-2046; doi: 10.1038/onc.2009.496; published online 18 January 2010	[Sato, A.; Yamamoto, H.; Kikuchi, A.] Osaka Univ, Grad Sch Med, Fac Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan; [Yamamoto, H.] Hiroshima Univ, Dept Biochem, Grad Sch Biomed Sci, Hiroshima, Japan; [Yamamoto, H.] Hiroshima Univ, Dept Surg, Grad Sch Biomed Sci, Hiroshima, Japan; [Oue, N.; Yasui, W.] Hiroshima Univ, Dept Mol Pathol, Grad Sch Biomed Sci, Hiroshima, Japan; [Hasegawa, Y.; Matsubara, A.] Hiroshima Univ, Dept Urol, Grad Sch Biomed Sci, Hiroshima, Japan	Osaka University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Kikuchi, A (corresponding author), Osaka Univ, Grad Sch Med, Fac Med, Dept Mol Biol & Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	akikuchi@molbiobc.med.osaka-u.ac.jp		Yamamoto, Hideki/0000-0003-4919-3483	Ministry of Education, Science, and Culture of Japan (2007, 2008, 2009); The YASUDA Medical Foundation (2006); Uehara Memorial Foundation (2008)	Ministry of Education, Science, and Culture of Japan (2007, 2008, 2009)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The YASUDA Medical Foundation (2006); Uehara Memorial Foundation (2008)(Uehara Memorial Foundation)	This work was supported by Grants-in-Aid for Scientific Research and for Scientific Research on Priority Areas from the Ministry of Education, Science, and Culture of Japan (2007, 2008, 2009), The YASUDA Medical Foundation (2006) and Uehara Memorial Foundation (2008).	ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; D'Amico AV, 2000, J CLIN ONCOL, V18, P1164, DOI 10.1200/JCO.2000.18.6.1164; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Doyle GAR, 1997, J BIOL CHEM, V272, P11840, DOI 10.1074/jbc.272.18.11840; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Hart CA, 2002, BRIT J CANCER, V86, P1136, DOI 10.1038/sj/bjc/6600207; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kikuchi A, 2003, CANCER SCI, V94, P225, DOI 10.1111/j.1349-7006.2003.tb01424.x; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445; Polakis P, 2000, GENE DEV, V14, P1837; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sobin, 2009, UICC TNM CLASSIFICAT; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wu JY, 2006, CANCER RES, V66, P5111, DOI 10.1158/0008-5472.CAN-06-0383; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003; Yardy GW, 2005, PROSTATE CANCER P D, V8, P119, DOI 10.1038/sj.pcan.4500794; Zeng ZZ, 2006, CANCER RES, V66, P8091, DOI 10.1158/0008-5472.CAN-05-4400	44	175	189	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2010	29	14					2036	2046		10.1038/onc.2009.496	http://dx.doi.org/10.1038/onc.2009.496			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101234				2022-12-25	WOS:000276402800003
J	Teoh, SSY; Whisstock, JC; Bird, PI				Teoh, Sonia S. Y.; Whisstock, James C.; Bird, Phillip I.			Maspin (SERPINB5) Is an Obligate Intracellular Serpin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR; PLASMINOGEN-ACTIVATOR; BREAST-CANCER; EXTRACELLULAR-MATRIX; OVALBUMIN FAMILY; SIGNAL SEQUENCES; MAMMALIAN-CELLS; EXPRESSION; PROTEIN	Maspin (SERPINB5) is a tumor suppressor lost in breast and prostate cancer whose molecular function is unknown. It is a non-inhibitory member of the clade B serpins suggested to play a role in a plethora of intracellular and extracellular settings, yet its normal cellular distribution has never been clarified. Here we investigate the distribution of maspin in non-transformed human epithelial cells. By indirect immunofluorescence, maspin has a nucleocytoplasmic distribution in breast (MCF10A) and prostate (RWPE-1) cells and, by immunoblotting and pulse-chase analyses, is neither glycosylated nor secreted. Cell surface biotinylation studies also show that maspin is not present at the cell surface. Differentiation of MCF10A cells into three-dimensional acini results in the redistribution of maspin from the nucleus to the cytoplasm but does not result in secretion. Addition of an efficient conventional signal peptide to maspin directs it into the secretory pathway and results in glycosylation but not secretion. We further show that maspin in the cytoplasm of MCF10A cells is a soluble monomeric protein that is not detectably associated with the cytoskeleton or other extractable components. Taken together, these results suggest that maspin is restricted to an intracellular, possibly nuclear, role in which it influences cell-matrix interactions indirectly. It is probably released only as a consequence of cell damage or necrosis.	[Teoh, Sonia S. Y.; Whisstock, James C.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Sch Biomed Sci, Clayton, Vic 3800, Australia	Monash University; Monash University	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia.	phil.bird@med.monash.edu.au		Whisstock, James/0000-0003-4200-5611; Bird, Phillip/0000-0002-6695-606X	National Health and Medical Research Council of Australia [490900]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Program Grant 490900.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Belin D, 2004, J MOL BIOL, V335, P437, DOI 10.1016/j.jmb.2003.10.076; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bettstetter M, 2005, J PATHOL, V205, P606, DOI 10.1002/path.1732; Biliran H, 2001, CANCER RES, V61, P8676; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; BIRD P, 1987, J CELL BIOL, V105, P2905, DOI 10.1083/jcb.105.6.2905; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; BROCK TG, 1994, J BIOL CHEM, V269, P22059; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; CHAO CCK, 1987, MOL CELL BIOL, V7, P3842, DOI 10.1128/MCB.7.10.3842; Chu M, 1998, THROMB HAEMOSTASIS, V80, P119, DOI 10.1055/s-0037-1615150; Chua I, 2009, J AM ACAD DERMATOL, V60, P758, DOI 10.1016/j.jaad.2009.01.018; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kulasingam V, 2007, MOL CELL PROTEOMICS, V6, P1997, DOI 10.1074/mcp.M600465-MCP200; Latha K, 2005, MOL CELL BIOL, V25, P1737, DOI 10.1128/MCB.25.5.1737-1748.2005; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Liu JY, 2004, CANCER RES, V64, P1703, DOI 10.1158/0008-5472.CAN-03-2568; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lonardo F, 2006, LUNG CANCER, V51, P31, DOI 10.1016/j.lungcan.2005.07.011; Maass N, 2001, CLIN CANCER RES, V7, P812; Machtens S, 2001, INT J CANCER, V95, P337, DOI 10.1002/1097-0215(20010920)95:5<337::AID-IJC1059>3.0.CO;2-1; MADISON EL, 1992, GENE, V121, P179, DOI 10.1016/0378-1119(92)90179-S; Martin DB, 2004, CANCER RES, V64, P347, DOI 10.1158/0008-5472.CAN-03-2062; McGowen R, 2000, CANCER RES, V60, P4771; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mikus P, 1996, J BIOL CHEM, V271, P10048, DOI 10.1074/jbc.271.17.10048; Mohsin SK, 2003, J PATHOL, V199, P432, DOI 10.1002/path.1319; Murai S, 2006, CANCER SCI, V97, P883, DOI 10.1111/j.1349-7006.2006.00266.x; Ngamkitidechakul C, 2001, INVEST OPHTH VIS SCI, V42, P3135; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Petrich BG, 2009, THROMB HAEMOSTASIS, V101, P1020, DOI 10.1160/TH08-08-0553; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Romani AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-255; Scott FL, 1996, J BIOL CHEM, V271, P1605, DOI 10.1074/jbc.271.3.1605; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Sternlicht MD, 1997, CLIN CANCER RES, V3, P1949; Uemura Y, 2000, INT J CANCER, V89, P368, DOI 10.1002/1097-0215(20000720)89:4<368::AID-IJC9>3.0.CO;2-6; Ulmasov B, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-8; WIRTH DF, 1979, J CELL BIOL, V81, P154, DOI 10.1083/jcb.81.1.154; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Yu M, 2007, HUM PATHOL, V38, P1248, DOI 10.1016/j.humpath.2006.11.025; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Zhang WG, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-50; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	55	35	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10862	10869		10.1074/jbc.M109.073171	http://dx.doi.org/10.1074/jbc.M109.073171			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123984	hybrid, Green Published			2022-12-25	WOS:000276264600071
J	Borgdorff, V; Lleonart, ME; Bishop, CL; Fessart, D; Bergin, AH; Overhoff, MG; Beach, DH				Borgdorff, V.; Lleonart, M. E.; Bishop, C. L.; Fessart, D.; Bergin, A. H.; Overhoff, M. G.; Beach, D. H.			Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1)	ONCOGENE			English	Article						oncogene-induced senescence; Ras; siRNA; miRNA; p21(Waf1/Cip1)	ONCOGENE-INDUCED SENESCENCE; ANCHORAGE-INDEPENDENT GROWTH; MAMMARY EPITHELIAL-CELLS; HUMAN-BREAST; CANCER; PROLIFERATION; FIBROBLASTS; P16(INK4A); P53	Overexpression of Ras(G12V) in primary cells induces a permanent growth arrest called oncogene-induced senescence (OIS) that serves as a fail-safe mechanism against malignant transformation. We have performed a genome-wide small interfering RNA (siRNA) screen and a microRNA (miRNA) screen to identify mediators of OIS and show that siRNA-mediated knockdown of p21(Waf1/Cip1) rescues from Ras(G12V)-induced senescence in human mammary epithelial cells (HMECs). Moreover, we isolated a total of 28 miRNAs that prevented Ras(G12V)-induced growth arrest, among which all of the miR-106b family members were present. In addition, we obtained a number of hits, miR-130b, miR-302a, miR-302b, miR302c, miR-302d, miR-512-3p and miR-515-3p with seed sequences very similar to miR-106b family members. We show that overexpression of all these miRNAs rescues HMECs from Ras(G12V)-induced senescence by prevention of Ras(G12V)-induced upregulation of p21(Waf1/Cip1). Our results establish an important role for the cell cycle inhibitor p21(Waf1/Cip1) in growth control of HMECs and extend the repertoire of miRNAs that modulate the activity of this tumour suppressor. Oncogene (2010) 29, 2262-2271; doi: 10.1038/onc.2009.497; published online 25 January 2010	[Borgdorff, V.; Bishop, C. L.; Fessart, D.; Bergin, A. H.; Overhoff, M. G.; Beach, D. H.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, London E1 2AT, England; [Lleonart, M. E.] Hosp Gen Valle Hebron, Inst Recerca, Dept Pathol, Barcelona, Spain	University of London; Queen Mary University London; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Beach, DH (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, London E1 2AT, England.	dhbeach@btinternet.com	FESSART, Delphine/J-2784-2014; LLeonart, Matilde E./Q-2662-2019	FESSART, Delphine/0000-0001-7566-5670; LLeonart, Matilde E./0000-0002-6196-7405; Bishop, Cleo/0000-0002-6189-8163	Wellcome Programme [DERG1C3R]; Marato TV3 Grant [052130-TV3]; AGAUR [2007 BE-1 00296]; MRC [DERB1A4R]; CRUK [DERG1F2R]; Medical Research Council [G0500357] Funding Source: researchfish; MRC [G0500357] Funding Source: UKRI	Wellcome Programme; Marato TV3 Grant; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Wellcome Programme Grant DERG1C3R (Viola Borgdorff, Marita G Overhoff); Marato TV3 Grant 052130-TV3 (Matilde E Lleonart); AGAUR fellowship 2007 BE-1 00296 (Matilde E Lleonart); MRC Project Grant DERB1A4R (Cleo L Bishop, Ann-Marie H Bergin); CRUK Project Grant DERG1F2R (Delphine Fessart). MELL is a FIS (Fondo de Investigacion Sanitario) investigator (CP03/00101).	Adnane J, 2000, ONCOGENE, V19, P5338, DOI 10.1038/sj.onc.1203956; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carbone CJ, 2007, CANCER RES, V67, P4130, DOI 10.1158/0008-5472.CAN-07-0499; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Gohring UJ, 2001, J CLIN PATHOL, V54, P866, DOI 10.1136/jcp.54.11.866; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Li YZ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-7; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wei WY, 2003, MOL CELL BIOL, V23, P2859, DOI 10.1128/MCB.23.8.2859-2870.2003; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666	24	119	122	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2262	2271		10.1038/onc.2009.497	http://dx.doi.org/10.1038/onc.2009.497			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101223				2022-12-25	WOS:000276685200011
J	Mishra, PJ; Ha, L; Rieker, J; Sviderskaya, EV; Bennett, DC; Oberst, MD; Kelly, K; Merlino, G				Mishra, P. J.; Ha, L.; Rieker, J.; Sviderskaya, E. V.; Bennett, D. C.; Oberst, M. D.; Kelly, K.; Merlino, G.			Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation	ONCOGENE			English	Article						anchorage-independent growth; BRaf; melanoma; NRas; PI3K; RalGEF	CELLULAR-TRANSFORMATION; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; SIGNALING PATHWAYS; BRAF MUTATIONS; CANCER; GTPASES; CELLS; ACTIVATION; MIGRATION	Cutaneous malignant melanoma is considered one of the most deadly human cancers, based on both its penchant for metastatic spread and its typical resistance to currently available therapy. Long known to harbor oncogenic NRAS mutations, melanomas were more recently reported to be frequent bearers of activating mutations in BRAF, one of the effectors situated downstream of wild-type NRAS. NRAS and BRAF mutations are rarely found in the same melanoma, suggesting that they may possess important overlapping oncogenic activities. Here, we compare and contrast the oncogenic roles of the three major NRas downstream effectors, Raf, phosphatidylinositol 3-kinase (PI3K) and Ral guanine exchange factor (RalGEF), using genetically engineered Arf-deficient immortalized mouse melanocytes as a model system. Although no single downstream pathway could recapitulate all of the consequences of oncogenic NRas expression, our data indicate a prominent role for BRaf and PI3K in melanocyte senescence and invasiveness, respectively. More surprisingly, we discovered that constitutive RalGEF activation had a major impact on several malignant phenotypes, particularly anchorage-independent growth, indicating that this often overlooked pathway should be more carefully evaluated as a possible therapeutic target. Oncogene (2010) 29, 2449-2456; doi:10.1038/onc.2009.521; published online 1 February 2010	[Mishra, P. J.; Ha, L.; Rieker, J.; Merlino, G.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Ha, L.] US FDA, Div Monoclonal Antibody, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [Sviderskaya, E. V.; Bennett, D. C.] Univ London, Div Basic Med Sci, London, England; [Oberst, M. D.; Kelly, K.] NCI, Cell & Canc Biol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); University of London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bldg 37,Room 5002,37 Convent Dr, Bethesda, MD 20892 USA.	gmerlino@helix.nih.gov	Bennett, Dorothy C/C-2418-2008; Sviderskaya, Elena V/D-2419-2009	Bennett, Dorothy C/0000-0002-3639-7527; 	NCI [N01-CO-12400]; National Institutes of Health; Wellcome Trust [078327]; NATIONAL CANCER INSTITUTE [ZIABC010607, ZIABC008756] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Christopher Counter (Duke University) for useful discussions, and for communicating data before publication. We acknowledge Dr Paul Khavari (Stanford University) for gifting the NRas, PI3K and BRaf retroviral vectors, and Drs Frederique Zindy and Charles Sherr (St Jude Children's Research Hospital) for the Arf-deficient mouse skins from which the immortalized melanocytes were generated. The PEP7 and PEP8H antibodies were a gift from Dr Vince Hearing (NCI). The pEF-CAAX-Raf-1 vector was a gift from Dr Silvio J Gutkind (NIH/NIDCR). This work was supported in part by the Intramural Research Program of the NCI, National Institutes of Health, in part by NCI Contract N01-CO-12400, and in part by Wellcome Trust Program Grant 078327 (to EVS).	ALBINI A, 1987, CANCER RES, V47, P3239; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Brose MS, 2002, CANCER RES, V62, P6997; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dahl C, 2007, APMIS, V115, P1161, DOI 10.1111/j.1600-0463.2007.apm_855.xml.x; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Gorter DJJ, 2008, BLOOD, V111, P3364, DOI 10.1182/blood-2007-08-106583; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Freedberg DE, 2008, JNCI-J NATL CANCER I, V100, P784, DOI 10.1093/jnci/djn157; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Omholt K, 2007, MELANOMA RES, V17, P410, DOI 10.1097/CMR.0b013e3282ef4178; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pollock PM, 2002, CANCER CELL, V2, P5, DOI 10.1016/S1535-6108(02)00089-2; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Recio JA, 2002, CANCER RES, V62, P6724; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Stiles BL, 2009, INT J BIOCHEM CELL B, V41, P757, DOI 10.1016/j.biocel.2008.09.022; Tsao HS, 1998, ONCOGENE, V16, P3397, DOI 10.1038/sj.onc.1201881; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Virador VM, 1999, ANAL BIOCHEM, V270, P207, DOI 10.1006/abio.1999.4090; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07	41	48	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	16					2449	2456		10.1038/onc.2009.521	http://dx.doi.org/10.1038/onc.2009.521			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20118982	Green Accepted			2022-12-25	WOS:000276951500013
J	Elbein, AD; Pastuszak, I; Tackett, AJ; Wilson, T; Pan, YT				Elbein, Alan D.; Pastuszak, Irena; Tackett, Alan J.; Wilson, Tyler; Pan, Yuan T.			Last Step in the Conversion of Trehalose to Glycogen A MYCOBACTERIAL ENZYME THAT TRANSFERS MALTOSE FROM MALTOSE 1-PHOSPHATE TO GLYCOGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-SMEGMATIS; 3 PATHWAYS; BIOSYNTHESIS; CLONING; TREHALOSE-6-PHOSPHATE; PURIFICATION; SYNTHASE; METABOLISM; INHIBITORS; EXPRESSION	We show that Mycobacterium smegmatis has an enzyme catalyzing transfer of maltose from [C-14] maltose 1-phosphate to glycogen. This enzyme was purified 90-fold from crude extracts and characterized. Maltose transfer required addition of an acceptor. Liver, oyster, or mycobacterial glycogens were the best acceptors, whereas amylopectin had good activity, but amylose was a poor acceptor. Maltosaccharides inhibited the transfer of maltose from [C-14]maltose-1-P to glycogen because they were also acceptors of maltose, and they caused production of larger sized radioactive maltosaccharides. When maltotetraose was the acceptor, over 90% of the C-14-labeled product was maltohexaose, and no radioactivity was in maltopentaose, demonstrating that maltose was transferred intact. Stoichiometry showed that 0.89 mu mol of inorganic phosphate was produced for each micromole of maltose transferred to glycogen, and 56% of the added maltose-1-P was transferred to glycogen. This enzyme has been named alpha 1,4-glucan:maltose-1-P maltosyltransferase (GMPMT). Transfer of maltose to glycogen was inhibited by micromolar amounts of inorganic phosphate or arsenate but was only slightly inhibited by millimolar concentrations of glucose-1-P, glucose-6-P, or inorganic pyrophosphate. GMPMT was compared with glycogen phosphorylase (GP). GMPMT catalyzed transfer of [C-14] maltose-1-P, but not [C-14] glucose-1-P, to glycogen, whereas GP transferred radioactivity from glucose-1-P but not maltose-1-P. GMPMT and GP were both inhibited by 1,4-dideoxy-1,4-imino-D-arabinitol, but only GP was inhibited by isofagomine. Because mycobacteria that contain trehalose synthase accumulate large amounts of glycogen when grown in high concentrations of trehalose, we propose that trehalose synthase, maltokinase, and GMPMT represent a new pathway of glycogen synthesis using trehalose as the source of glucose.	[Elbein, Alan D.; Pastuszak, Irena; Tackett, Alan J.; Wilson, Tyler; Pan, Yuan T.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Tackett, AJ (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ajtackett@uams.edu						BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Carroll JD, 2007, FEBS J, V274, P1701, DOI 10.1111/j.1742-4658.2007.05715.x; CHRISTENSEN HN, 1974, ENZYME KINETICS, P75; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199; Elbein A D, 1974, Adv Carbohydr Chem Biochem, V30, P227, DOI 10.1016/S0065-2318(08)60266-8; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; HOTTIGER T, 1987, FEBS LETT, V220, P113, DOI 10.1016/0014-5793(87)80886-4; Jakobsen P, 2001, BIOORGAN MED CHEM, V9, P733, DOI 10.1016/S0968-0896(00)00291-1; Jarling M, 2004, J BASIC MICROB, V44, P360, DOI 10.1002/jobm.200410403; Klutts S, 2003, J BIOL CHEM, V278, P2093, DOI 10.1074/jbc.M209937200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latsis T, 2002, BIOCHEM J, V368, P309, DOI 10.1042/BJ20021070; LOEWUS FA, 1952, ANAL CHEM, V24, P219, DOI 10.1021/ac60061a050; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Maruta K, 1996, BIOSCI BIOTECH BIOCH, V60, P717, DOI 10.1271/bbb.60.717; Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200; Niehues B, 2003, ARCH MICROBIOL, V180, P233, DOI 10.1007/s00203-003-0575-y; Nwaka S, 1998, PROG NUCLEIC ACID RE, V58, P197; Pan YT, 2004, EUR J BIOCHEM, V271, P4259, DOI 10.1111/j.1432-1033.2004.04365.x; Pan YT, 2008, FEBS J, V275, P3408, DOI 10.1111/j.1742-4658.2008.06491.x; RATH VL, 1987, PROTEINS, V2, P225, DOI 10.1002/prot.340020307; TAKAYAMA K, 1976, BIOCHEMISTRY-US, V15, P441, DOI 10.1021/bi00647a032; TREVELYAN WE, 1950, NATURE, V166, P444, DOI 10.1038/166444b0; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Vogel G, 1998, PLANT J, V13, P673, DOI 10.1046/j.1365-313X.1998.00064.x; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x	30	48	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9803	9812		10.1074/jbc.M109.033944	http://dx.doi.org/10.1074/jbc.M109.033944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118231	Green Published, hybrid			2022-12-25	WOS:000276165900052
J	Untersmayr, E; Bises, G; Starkl, P; Bevins, CL; Scheiner, O; Boltz-Nitulescu, G; Wrba, F; Jensen-Jarolim, E				Untersmayr, Eva; Bises, Giovanna; Starkl, Philipp; Bevins, Charles L.; Scheiner, Otto; Boltz-Nitulescu, George; Wrba, Fritz; Jensen-Jarolim, Erika			The High Affinity IgE Receptor Fc epsilon RI Is Expressed by Human Intestinal Epithelial Cells	PLOS ONE			English	Article							TRANSEPITHELIAL ANTIGEN TRANSPORT; TRICHINELLA-SPIRALIS; BINDING-PROTEIN; COLORECTAL-CANCER; HUMAN EOSINOPHILS; CROHNS-DISEASE; MESSENGER-RNA; PANETH CELLS; HUMAN COLON; ALPHA	Background: IgE antibodies play a paramount role in the pathogenesis of various intestinal disorders. To gain insights in IgE-mediated pathophysiology of the gut, we investigated the expression of the high affinity IgE receptor Fc epsilon RI in human intestinal epithelium. Methodology/Principal Findings: Fc epsilon RI alpha-chain, as detected by immunohistochemistry, was positive in epithelial cells for eight of eleven (8/11) specimens from colon cancer patients and 5/11 patients with inflammation of the enteric mucosa. The Fc epsilon RI alpha positive epithelial cells co-expressed Fc epsilon RI gamma, whereas with one exception, none of the samples was positive for the beta-chain in the epithelial layer. The functionality of Fc epsilon RI was confirmed in situ by human IgE binding. In experiments with human intestinal tumor cell lines, subconfluent Caco-2/TC7 and HCT-8 cells were found to express the alpha- and gamma-chains of Fc epsilon RI and to bind IgE, whereas confluent cells were negative for gamma-chains. Conclusions/Significance: Our data provide the first evidence that the components of a functional Fc epsilon RI are in vitro expressed by the human intestinal epithelial cells depending on differentiation and, more importantly, in situ in epithelia of patients with colon cancer or gastrointestinal inflammations. Thus, a contribution of Fc epsilon RI either to immunosurveillance or pathophysiology of the intestinal epithelium is suggested.	[Untersmayr, Eva; Bises, Giovanna; Starkl, Philipp; Scheiner, Otto; Boltz-Nitulescu, George; Jensen-Jarolim, Erika] Med Univ Vienna, Dept Pathophysiol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Wrba, Fritz] Med Univ Vienna, Dept Pathol, Vienna, Austria	Medical University of Vienna; University of California System; University of California Davis; Medical University of Vienna	Untersmayr, E (corresponding author), Med Univ Vienna, Dept Pathophysiol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	eva.untersmayr@meduniwien.ac.at	Jensen-Jarolim, Erika/C-5120-2018; Untersmayr, Eva/GRY-4470-2022; Bevins, Charles L/P-4438-2015	Jensen-Jarolim, Erika/0000-0003-4019-5765; Bevins, Charles L/0000-0003-2725-2622; Untersmayr, Eva/0000-0002-1963-499X; Starkl, Philipp/0000-0001-7521-129X	OeNB Jubilaumsfond [11375]; Blanca Moser Fund [P21577-B11, APW0105FW, PA-18238-B13, SFB F 1808-B13]; Austrian Science funds FWF; Hochschuljubilaumsstiftung of the city of Vienna [H-02325/2007]; Austrian Science Fund (FWF) [P 21577] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738] Funding Source: NIH RePORTER	OeNB Jubilaumsfond; Blanca Moser Fund; Austrian Science funds FWF(Austrian Science Fund (FWF)); Hochschuljubilaumsstiftung of the city of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by OeNB Jubilaumsfond 11375 (http://www.oenb.at/de/ueber_die_oenb/foerderung/jubilaeumsfonds/jubilaeumsfonds.jsp), a Hans and Blanca Moser Fund project, P21577-B11, APW0105FW, PA-18238-B13 and SFB F 1808-B13 of the Austrian Science funds FWF (www.fwf.ac.at), and by the Hochschuljubilaumsstiftung of the city of Vienna H-02325/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bevilacqua C, 2004, INT ARCH ALLERGY IMM, V135, P108, DOI 10.1159/000080653; Bises G, 2004, J HISTOCHEM CYTOCHEM, V52, P985, DOI 10.1369/jhc.4B6271.2004; Blumberg RS, 1999, IMMUNOL LETT, V69, P7, DOI 10.1016/S0165-2478(99)00093-0; BOLTZNITULESCU G, 1981, J EXP MED, V154, P374, DOI 10.1084/jem.154.2.374; Borkowski TA, 2001, J IMMUNOL, V167, P1290, DOI 10.4049/jimmunol.167.3.1290; Brandtzaeg P, 1996, ANN NY ACAD SCI, V778, P1, DOI 10.1111/j.1749-6632.1996.tb21110.x; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; CASTRONOVO V, 1992, JNCI-J NATL CANCER I, V84, P1161, DOI 10.1093/jnci/84.15.1161; CONRAD DH, 1990, ANNU REV IMMUNOL, V8, P623, DOI 10.1146/annurev.immunol.8.1.623; Cross HS, 2005, J STEROID BIOCHEM, V97, P121, DOI 10.1016/j.jsbmb.2005.06.005; DELAZZARI F, 1994, ITAL J GASTROENTEROL, V26, P7; DELESPESSE G, 1992, IMMUNOL REV, V125, P77, DOI 10.1111/j.1600-065X.1992.tb00626.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; GONZALEZMOLINA A, 1976, J IMMUNOL, V117, P1838; Gould HJ, 1999, EUR J IMMUNOL, V29, P3527, DOI 10.1002/(SICI)1521-4141(199911)29:11<3527::AID-IMMU3527>3.3.CO;2-X; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; GRANGETTE C, 1989, J IMMUNOL, V143, P3580; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; GSCHEIDLINGER R, 1998, THESIS U VIENNA; Gurish MF, 2004, J IMMUNOL, V172, P1139, DOI 10.4049/jimmunol.172.2.1139; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Huber A, 1998, INT ARCH ALLERGY IMM, V115, P67, DOI 10.1159/000023832; Jensen-Jarolim E, 2002, EUR J GASTROEN HEPAT, V14, P145, DOI 10.1097/00042737-200202000-00008; JENSENJAROLIM E, 2008, ALLERGY; KAISERLIAN D, 1993, IMMUNOLOGY, V80, P90; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; KUSTER H, 1992, J BIOL CHEM, V267, P12782; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; LIU FT, 1985, P NATL ACAD SCI USA, V82, P4100, DOI 10.1073/pnas.82.12.4100; Maurer D, 1996, J IMMUNOL, V157, P607; Maurer D, 1998, J IMMUNOL, V161, P2731; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; MOUTSATSOS IK, 1987, P NATL ACAD SCI USA, V84, P6452, DOI 10.1073/pnas.84.18.6452; NegraoCorrea D, 1996, J IMMUNOL, V157, P4037; RAMASWAMY K, 1994, PARASITE IMMUNOL, V16, P435, DOI 10.1111/j.1365-3024.1994.tb00371.x; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Riemer AB, 2007, CANCER RES, V67, P3406, DOI 10.1158/0008-5472.CAN-06-3758; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; Seminario MC, 1999, J IMMUNOL, V162, P6893; Shen B, 2005, J CLIN PATHOL, V58, P687, DOI 10.1136/jcp.2004.022426; Stokes AJ, 2006, CELL SIGNAL, V18, P640, DOI 10.1016/j.cellsig.2005.06.003; VANSPREEUWEL JP, 1984, J CLIN PATHOL, V37, P601, DOI 10.1136/jcp.37.6.601; Wada Ryo, 2005, J Carcinog, V4, P5, DOI 10.1186/1477-3163-4-5; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wehkamp J, 2006, CURR OPIN GASTROEN, V22, P644, DOI 10.1097/01.mog.0000245541.95408.86; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Yu LCH, 2001, GASTROENTEROLOGY, V121, P370, DOI 10.1053/gast.2001.26470	52	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9023	10.1371/journal.pone.0009023	http://dx.doi.org/10.1371/journal.pone.0009023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126404	Green Published, gold, Green Submitted			2022-12-25	WOS:000274207200018
J	Braun, DA; Waldert, S; Aertsen, A; Wolpert, DM; Mehring, C				Braun, Daniel A.; Waldert, Stephan; Aertsen, Ad; Wolpert, Daniel M.; Mehring, Carsten			Structure Learning in a Sensorimotor Association Task	PLOS ONE			English	Article							STIMULUS-RESPONSE THEORIES; EXTRADIMENSIONAL SHIFTS; NETWORK; MODELS	Learning is often understood as an organism's gradual acquisition of the association between a given sensory stimulus and the correct motor response. Mathematically, this corresponds to regressing a mapping between the set of observations and the set of actions. Recently, however, it has been shown both in cognitive and motor neuroscience that humans are not only able to learn particular stimulus-response mappings, but are also able to extract abstract structural invariants that facilitate generalization to novel tasks. Here we show how such structure learning can enhance facilitation in a sensorimotor association task performed by human subjects. Using regression and reinforcement learning models we show that the observed facilitation cannot be explained by these basic models of learning stimulus-response associations. We show, however, that the observed data can be explained by a hierarchical Bayesian model that performs structure learning. In line with previous results from cognitive tasks, this suggests that hierarchical Bayesian inference might provide a common framework to explain both the learning of specific stimulus-response associations and the learning of abstract structures that are shared by different task environments.	[Braun, Daniel A.; Waldert, Stephan; Aertsen, Ad; Mehring, Carsten] Bernstein Ctr Computat Neurosci, Freiburg, Germany; [Braun, Daniel A.; Waldert, Stephan; Aertsen, Ad; Mehring, Carsten] Univ Freiburg, Fac Biol, Freiburg, Germany; [Braun, Daniel A.; Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Cambridge CB2 1TN, England	University of Freiburg; University of Cambridge	Braun, DA (corresponding author), Bernstein Ctr Computat Neurosci, Freiburg, Germany.	dab54@cam.ac.uk	Mehring, Carsten/R-8986-2019; Braun, Daniel Alexander/B-7696-2015	Mehring, Carsten/0000-0001-8125-5205; Braun, Daniel Alexander/0000-0002-8637-6652; Wolpert, Daniel/0000-0003-2011-2790	German Federal Ministry of Education and Research [01GQ0420]; Bohringer-Ingelheim Fonds; SENSOPAC [IST-2005-028056]; Wellcome Trust	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Bohringer-Ingelheim Fonds; SENSOPAC; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: This study was supported in part by the German Federal Ministry of Education and Research (Grant 01GQ0420 to the Bernstein Center for Computational Neuroscience Freiburg), the Bohringer-Ingelheim Fonds, the European project SENSOPAC IST-2005-028056, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; BLACK AH, 1972, CLASSICAL CONDITION, V2, pR12; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Braun DA, 2009, J NEUROSCI, V29, P6472, DOI 10.1523/JNEUROSCI.3075-08.2009; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Broomhead D. S., 1988, Complex Systems, V2, P321; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Dayan P, 2001, THEORETICAL NEUROSCI, pxv; Garner JP, 2006, BEHAV BRAIN RES, V173, P53, DOI 10.1016/j.bbr.2006.06.002; GLUCK MA, 1988, J EXP PSYCHOL GEN, V117, P227, DOI 10.1037/0096-3445.117.3.227; Goodman ND, 2008, COGNITIVE SCI, V32, P108, DOI 10.1080/03640210701802071; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Holland PC, 2008, LEARN BEHAV, V36, P227, DOI 10.3758/LB.36.3.227; KANDEL ER, 2000, PRINCIPLES NEURAL SC, pR41; KEMP C, 2009, COGNITIONP IN PRESS; Kemp C, 2008, P NATL ACAD SCI USA, V105, P10687, DOI 10.1073/pnas.0802631105; Kemp C, 2007, DEVELOPMENTAL SCI, V10, P307, DOI 10.1111/j.1467-7687.2007.00585.x; Kemp C, 2009, PSYCHOL REV, V116, P20, DOI 10.1037/a0014282; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kohler W., 1925, MENTALITY APES; Kruschke JK, 2008, LEARN BEHAV, V36, P210, DOI 10.3758/LB.36.3.210; LUCAS CG, 2009, COGNITIONP IN PRESS; MACKINTO.NJ, 1969, PSYCHON SCI, V14, P5, DOI 10.3758/BF03336395; PAVLOV I. P., 1927; Perfors A., 2009, P 31 ANN C COGN SCI; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; REZNIKOVA ZI, 2007, ANIMAL INTELLIGENCE, pR14; ROBERTS AC, 1988, Q J EXP PSYCHOL-B, V40, P321; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SKINNER B. F., 1938; SPENCE KW, 1950, PSYCHOL REV, V57, P159, DOI 10.1037/h0058250; Sutton R. S., 1998, REINFORCEMENT LEARNI, pXVIII; TENENBAUM JB, 2001, ADV NEURAL INFORM PR; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Trobalon JB, 2003, J EXP PSYCHOL ANIM B, V29, P143, DOI 10.1037/0097-7403.29.2.143; WIDROFF G, 1960, I RAD ENG W EL SHO 4; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	38	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8973	10.1371/journal.pone.0008973	http://dx.doi.org/10.1371/journal.pone.0008973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	550PA	20126409	gold, Green Published			2022-12-25	WOS:000274139100021
J	Garavaglia, BS; Thomas, L; Gottig, N; Dunger, G; Garofalo, CG; Daurelio, LD; Ndimba, B; Orellano, EG; Gehring, C; Ottado, J				Garavaglia, Betiana S.; Thomas, Ludivine; Gottig, Natalia; Dunger, German; Garofalo, Cecilia G.; Daurelio, Lucas D.; Ndimba, Bongani; Orellano, Elena G.; Gehring, Chris; Ottado, Jorgelina			A Eukaryotic-Acquired Gene by a Biotrophic Phytopathogen Allows Prolonged Survival on the Host by Counteracting the Shut-Down of Plant Photosynthesis	PLOS ONE			English	Article							AXONOPODIS PV. CITRI; XANTHOMONAS-AXONOPODIS; B RADIATION; PROTEIN; DEHYDROGENASE; CANKER; RESISTANCE; EXPRESSION; METABOLISM; EFFECTOR	Xanthomonas citri pv. citri, the bacteria responsible for citrus canker posses a biological active plant natriuretic peptide (PNP)-like protein, not present in any other bacteria. PNPs are a class of extracellular, systemically mobile peptides that elicit a number of plant responses important in homeostasis and growth. Previously, we showed that a Xanthomonas citri pv. citri mutant lacking the PNP-like protein XacPNP produced more necrotic lesions in citrus leaves than wild type infections and suggested a role for XacPNP in the regulation of host homeostasis. Here we have analyzed the proteome modifications observed in citrus leaves infected with the wild type and XacPNP deletion mutant bacteria. While both of them cause down-regulation of enzymes related to photosynthesis as well as chloroplastic ribosomal proteins, proteins related to defense responses are up-regulated. However, leaves infiltrated with the XacPNP deletion mutant show a more pronounced decrease in photosynthetic proteins while no reduction in defense related proteins as compared to the wild-type pathogen. This suggests that XacPNP serves the pathogen to maintain host photosynthetic efficiency during pathogenesis. The results from the proteomics analyses are consistent with our chlorophyll fluorescence data and transcript analyses of defense genes that show a more marked reduction in photosynthesis in the mutant but no difference in the induction of genes diagnostic for biotic-stress responses. We therefore conclude that XacPNP counteracts the shut-down of host photosynthesis during infection and in that way maintains the tissue in better conditions, suggesting that the pathogen has adapted a host gene to modify its natural host and render it a better reservoir for prolonged bacterial survival and thus for further colonization.	[Garavaglia, Betiana S.; Gottig, Natalia; Dunger, German; Garofalo, Cecilia G.; Daurelio, Lucas D.; Orellano, Elena G.; Ottado, Jorgelina] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Mol Biol Div,Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Argentina; [Garavaglia, Betiana S.] Univ Nacl Rosario, Consejo Invest, RA-2000 Rosario, Argentina; [Thomas, Ludivine; Ndimba, Bongani; Gehring, Chris] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa; [Gehring, Chris] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of the Western Cape; King Abdullah University of Science & Technology	Garavaglia, BS (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Mol Biol Div,Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Argentina.	ottado@ibr.gov.ar	Thomas, Ludivine/A-5062-2013; Dunger, German/AAT-6743-2021; Daurelio, Lucas/AAT-6969-2020	Thomas, Ludivine/0000-0003-0857-1775; Dunger, German/0000-0001-7307-6792; Gottig, Natalia/0000-0002-8730-8248; Daurelio, Lucas Damian/0000-0002-1156-2266; Gehring, Christoph/0000-0003-4355-4591	Argentine Federal Government (ANPCyT) [PICT2006-01073, PICT2006-00678]; South African National Research Foundation; King Abdullah University of Science and Technology (KAUST)	Argentine Federal Government (ANPCyT)(ANPCyT); South African National Research Foundation(National Research Foundation - South Africa); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This work was supported by grants from Argentine Federal Government (ANPCyT PICT2006-01073 to N.G. and PICT2006-00678 to J.O.), the South African National Research Foundation and King Abdullah University of Science and Technology (KAUST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena-Gonzalez E, 2003, PLANT J, V35, P704, DOI 10.1046/j.1365-313X.2003.01842.x; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Brill EM, 1999, PLANT MOL BIOL, V41, P279, DOI 10.1023/A:1006381630494; Brosche M, 2003, PHYSIOL PLANTARUM, V117, P1, DOI 10.1034/j.1399-3054.2003.1170101.x; Casano LM, 2000, J BIOL CHEM, V275, P942, DOI 10.1074/jbc.275.2.942; Cernadas RA, 2008, MOL PLANT PATHOL, V9, P609, DOI 10.1111/J.1364-3703.2008.00486.X; De Gara L, 2003, PLANT PHYSIOL BIOCH, V41, P863, DOI 10.1016/S0981-9428(03)00135-9; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Gottig Natalia, 2009, Commun Integr Biol, V2, P89; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Holley SR, 2003, PLANT PHYSIOL, V132, P1728, DOI 10.1104/pp.103.024414; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jansen MAK, 1998, TRENDS PLANT SCI, V3, P131, DOI 10.1016/S1360-1385(98)01215-1; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kunz BA, 2008, PLANT PHYSIOL, V148, P1021, DOI 10.1104/pp.108.125435; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Manning VA, 2009, MOL PLANT MICROBE IN, V22, P665, DOI 10.1094/MPMI-22-6-0665; Moiseyev GP, 1997, FEBS LETT, V407, P207, DOI 10.1016/S0014-5793(97)00337-2; Montesano M, 2003, PLANT MOL BIOL, V52, P177, DOI 10.1023/A:1023981631596; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; Nembaware V, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-10; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Ramagli LS, 1999, METH MOL B, V112, P99; Sheveleva EV, 1998, PLANT PHYSIOL, V117, P831, DOI 10.1104/pp.117.3.831; Somssich IE, 1996, P NATL ACAD SCI USA, V93, P14199, DOI 10.1073/pnas.93.24.14199; Speth EB, 2007, CURR OPIN PLANT BIOL, V10, P580, DOI 10.1016/j.pbi.2007.08.003; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; Walters DR, 2006, TRENDS PLANT SCI, V11, P581, DOI 10.1016/j.tplants.2006.10.003; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	45	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8950	10.1371/journal.pone.0008950	http://dx.doi.org/10.1371/journal.pone.0008950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126632	Green Published, gold, Green Submitted			2022-12-25	WOS:000274138000025
J	Gonen-Gross, T; Goldman-Wohl, D; Huppertz, B; Lankry, D; Greenfield, C; Natanson-Yaron, S; Hamani, Y; Gilad, R; Yagel, S; Mandelboim, O				Gonen-Gross, Tsufit; Goldman-Wohl, Debra; Huppertz, Berthold; Lankry, Dikla; Greenfield, Caryn; Natanson-Yaron, Shira; Hamani, Yaron; Gilad, Ronit; Yagel, Simcha; Mandelboim, Ofer			Inhibitory NK Receptor Recognition of HLA-G: Regulation by Contact Residues and by Cell Specific Expression at the Fetal-Maternal Interface	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTOR; CLASS-I MOLECULES; CRYSTAL-STRUCTURE; HUMAN-REPRODUCTION; G PROTEIN; PREGNANCY; COMPLEX; SURFACE; ANTIGEN	The non-classical HLA-G protein is distinguished from the classical MHC class I molecules by its expression pattern, low polymorphism and its ability to form complexes on the cell surface. The special role of HLA-G in the maternal-fetal interface has been attributed to its ability to interact with specific receptors found on maternal immune cells. However this interaction is restricted to a limited number of receptors. In this study we elucidate the reason for this phenomenon by comparing the specific contact residues responsible for MHC-KIR interactions. This alignment revealed a marked difference between the HLA-G molecule and other MHC class I molecules. By mutating these residues to the equivalent classical MHC residues, the HLA-G molecule regained an ability of interacting with KIR inhibitory receptors found on NK cells derived either from peripheral blood or from the decidua. Functional NK killing assays further substantiated the binding results. Furthermore, double immunofluorescent staining of placental sections revealed that while the conformed form of HLA-G was expressed in all extravillous trophoblasts, the free heavy chain form of HLA-G was expressed in more distal cells of the column, the invasion front. Overall we suggest that HLA-G protein evolved to interact with only some of the NK inhibitory receptors thus allowing a control of inhibition, while permitting appropriate NK cell cytokine and growth factor production necessary for a viable maternal fetal interface.	[Gonen-Gross, Tsufit; Lankry, Dikla; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel; [Goldman-Wohl, Debra; Greenfield, Caryn; Natanson-Yaron, Shira; Hamani, Yaron; Gilad, Ronit; Yagel, Simcha] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; [Huppertz, Berthold] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Medical University of Graz	Gonen-Gross, T (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel.	oferm@ekmd.huji.ac.il	Huppertz, Berthold/I-2331-2019	Huppertz, Berthold/0000-0003-4814-2158; Mandelboim, Ofer/0000-0002-9354-1855	Israeli Cancer Research Foundation; Israeli Science Foundation; Israel Scientific Foundation (ISF) (Morasha); Rosenkratz Foundation; Israel-Croatia research; DKFZ-MOST; Association for International Cancer Research (AICR)	Israeli Cancer Research Foundation; Israeli Science Foundation(Israel Science Foundation); Israel Scientific Foundation (ISF) (Morasha)(Israel Science Foundation); Rosenkratz Foundation; Israel-Croatia research; DKFZ-MOST; Association for International Cancer Research (AICR)	This study was supported by grants from the Israeli Cancer Research Foundation, the Israeli Science Foundation, the Israel Scientific Foundation (ISF) (Morasha), the Rosenkratz Foundation, the Israel-Croatia research grant, the DKFZ-MOST and the Association for International Cancer Research (AICR) (all to O.M.). O.M. is a Crown professor of Molecular Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2001, IMMUNOGENETICS, V53, P200, DOI 10.1007/s002510100318; Allan DSJ, 2000, IMMUNOBIOLOGY, V202, P34, DOI 10.1016/S0171-2985(00)80050-9; APPS R, 2007, EUR J IMMUNOL; Arnaiz-Villena A, 2007, TISSUE ANTIGENS, V69, P156, DOI 10.1111/j.1399-0039.2006.763_8.x; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Bellon T, 2002, J IMMUNOL, V168, P3351, DOI 10.4049/jimmunol.168.7.3351; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Boyson JE, 1996, J IMMUNOL, V157, P5428; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Drake PM, 2001, J EXP MED, V193, P1199, DOI 10.1084/jem.193.10.1199; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Favier B, 2007, TISSUE ANTIGENS, V69, P150, DOI 10.1111/j.1399-0039.2006.763_6.x; Gazit R, 2004, BLOOD, V103, P1965, DOI 10.1182/blood-2003-11-3796; Gomez-Lozano N, 2003, EUR J IMMUNOL, V33, P639, DOI 10.1002/eji.200323741; Gonen-Gross T, 2003, HUM IMMUNOL, V64, P1011, DOI 10.1016/j.humimm.2003.08.355; Gonen-Gross T, 2005, J IMMUNOL, V175, P4866, DOI 10.4049/jimmunol.175.8.4866; Gonen-Gross T, 2003, J IMMUNOL, V171, P1343, DOI 10.4049/jimmunol.171.3.1343; Gonen-Gross T, 2007, HUM IMMUNOL, V68, P227, DOI 10.1016/j.humimm.2006.10.013; Goodridge JP, 2003, J IMMUNOL, V171, P1768, DOI 10.4049/jimmunol.171.4.1768; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; Katz G, 2001, J IMMUNOL, V166, P7260, DOI 10.4049/jimmunol.166.12.7260; King A, 1996, AM J REPROD IMMUNOL, V35, P258; King A, 2000, PLACENTA, V21, P376, DOI 10.1053/plac.1999.0496; King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; MCMASTER MT, 1995, J IMMUNOL, V154, P3771; Moesta AK, 2009, J IMMUNOL, V182, P3628, DOI 10.4049/jimmunol.0803401; Park B, 2001, IMMUNITY, V15, P213, DOI 10.1016/S1074-7613(01)00179-0; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; Ponte M, 1999, P NATL ACAD SCI USA, V96, P5674, DOI 10.1073/pnas.96.10.5674; Rajagopalan S, 2006, PLOS BIOL, V4, P70, DOI 10.1371/journal.pbio.0040009; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Rizzo R, 2007, HUM IMMUNOL, V68, P244, DOI 10.1016/j.humimm.2006.10.012; Sawicki MW, 2001, IMMUNOL REV, V181, P52, DOI 10.1034/j.1600-065X.2001.1810104.x; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; STARKEY PM, 1988, IMMUNOLOGY, V65, P129; Tabiasco J, 2006, PLACENTA, V27, pS34, DOI 10.1016/j.placenta.2006.01.009; Vales-Gomez M, 1998, P NATL ACAD SCI USA, V95, P14326, DOI 10.1073/pnas.95.24.14326; van den Heuvel M, 2005, J REPROD IMMUNOL, V67, P21, DOI 10.1016/j.jri.2005.03.004; van der Meer A, 2007, MOL HUM REPROD, V13, P123, DOI 10.1093/molehr/gal100; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Winter CC, 1998, J IMMUNOL, V161, P571	53	54	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8941	10.1371/journal.pone.0008941	http://dx.doi.org/10.1371/journal.pone.0008941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126612	Green Submitted, gold, Green Published			2022-12-25	WOS:000274138000018
J	Peifer, M; Weiss, J; Sos, ML; Koker, M; Heynck, S; Netzer, C; Fischer, S; Rode, H; Rauh, D; Rahnenfuhrer, J; Thomas, RK				Peifer, Martin; Weiss, Jonathan; Sos, Martin L.; Koker, Mirjam; Heynck, Stefanie; Netzer, Christian; Fischer, Stefanie; Rode, Haridas; Rauh, Daniel; Rahnenfuehrer, Joerg; Thomas, Roman K.			Analysis of Compound Synergy in High-Throughput Cellular Screens by Population-Based Lifetime Modeling	PLOS ONE			English	Article							LUNG-CANCER; COMBINATION THERAPY; ACQUIRED-RESISTANCE; TYROSINE KINASE; GEFITINIB; EGFR; MUTATIONS; ERLOTINIB; INHIBITION; TUMORS	Despite the successful introduction of potent anti-cancer therapeutics, most of these drugs lead to only modest tumor-shrinkage or transient responses, followed by re-growth of tumors. Combining different compounds has resulted in enhanced tumor control and prolonged survival. However, methods querying the efficacy of such combinations have been hampered by limited scalability, analytical resolution, statistical feasibility, or a combination thereof. We have developed a theoretical framework modeling cellular viability as a stochastic lifetime process to determine synergistic compound combinations from high-throughput cellular screens. We apply our method to data derived from chemical perturbations of 65 cancer cell lines with two inhibitors. Our analysis revealed synergy for the combination of both compounds in subsets of cell lines. By contrast, in cell lines in which inhibition of one of both targets was sufficient to induce cell death, no synergy was detected, compatible with the topology of the oncogenically activated signaling network. In summary, we provide a tool for the measurement of synergy strength for combination perturbation experiments that might help define pathway topologies and direct clinical trials.	[Peifer, Martin; Weiss, Jonathan; Sos, Martin L.; Koker, Mirjam; Heynck, Stefanie; Fischer, Stefanie; Thomas, Roman K.] Univ Cologne, Max Planck Soc, Klaus Joachim Zulch Labs, Max Planck Inst Neurol Res, Cologne, Germany; [Peifer, Martin; Weiss, Jonathan; Sos, Martin L.; Koker, Mirjam; Heynck, Stefanie; Fischer, Stefanie; Thomas, Roman K.] Univ Cologne, Max Planck Soc, Fac Med, Cologne, Germany; [Netzer, Christian; Rahnenfuehrer, Joerg] Tech Univ Dortmund, Dept Stat, Dortmund, Germany; [Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Rode, Haridas; Rauh, Daniel; Thomas, Roman K.] Max Planck Soc, Chem Genom Ctr, Dortmund, Germany	Max Planck Society; University of Cologne; Max Planck Society; University of Cologne; Dortmund University of Technology; University of Cologne; University of Cologne; Max Planck Society	Peifer, M (corresponding author), Univ Cologne, Max Planck Soc, Klaus Joachim Zulch Labs, Max Planck Inst Neurol Res, Cologne, Germany.	peifer@nf.mpg.de; nini@nf.mpg.de	Rauh, Daniel/G-1595-2013; Sos, Martin L/I-1852-2014	Peifer, Martin/0000-0002-5243-5503; Rahnenfuhrer, Jorg/0000-0002-8947-440X; Rauh, Daniel/0000-0002-1970-7642	Deutsche Krebshilfe [107954]; German Ministry of Science and Education (BMBF) [01GS08100]; Fritz-Thyssen Stiftung [10.08.2.175]; Deutsche Forschungsgemeinschaft [SFB832]	Deutsche Krebshilfe(Deutsche Krebshilfe); German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Fritz-Thyssen Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	1. Deutsche Krebshilfe (grant 107954) http://www.krebshilfe.de/ 2. German Ministry of Science and Education (BMBF) as part of the German National Genome Research Network (NGFNplus) program (grant 01GS08100) http://www.bmbf.de/en/ 3. Fritz-Thyssen Stiftung (grant 10.08.2.175) http://www.fritz-thyssen-stiftung.de/ 4. Deutsche Forschungsgemeinschaft through SFB832 http://www.dfg.de/en/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; BLISS CI, 1956, BACTERIOL REV, V20, P243, DOI 10.1128/MMBR.20.4.243-258.1956; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; CHOU TC, 1976, J THEOR BIOL, V59, P253, DOI 10.1016/0022-5193(76)90169-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Diehl V, 2004, LANCET ONCOL, V5, P19, DOI 10.1016/S1470-2045(03)01320-2; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P441; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Press W. H., 1992, ART SCI COMPUTING; REGALES L, 2009, J CLIN INVE IN PRESS; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; SOS ML, 2009, P NATL ACAD IN PRESS; SOS ML, 2009, INSIGHTS LTD A UNPUB; Uphoff Cord C, 2005, Methods Mol Biol, V290, P25	41	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8919	10.1371/journal.pone.0008919	http://dx.doi.org/10.1371/journal.pone.0008919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111714	Green Submitted, gold, Green Published			2022-12-25	WOS:000274114800021
J	Hewitt, FC; Samulski, RJ				Hewitt, F. Curtis; Samulski, R. Jude			Creating a Novel Origin of Replication through Modulating DNA-Protein Interfaces	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS AAV; ADENO-ASSOCIATED VIRUS; IN-VITRO; HELICASE ACTIVITY; TERMINAL REPEATS; NUCLEASE DOMAIN; REP PROTEIN; SEQUENCE; BINDING; NICKING	Background: While the molecular mechanisms of DNA-protein specificity at the origin of replication have been determined in many model organisms, these interactions remain unknown in the majority of higher eukaryotes and numerous vertebrate viruses. Similar to many viral origins of replication, adeno-associated virus (AAV) utilizes a cis-acting origin of replication and a virus specific Replication protein (Rep) to faithfully carry out self-priming replication. The mechanisms of AAV DNA replication are generally well understood. However, the molecular basis of specificity between the Rep protein and the viral origin of replication between different AAV serotypes remains uncharacterized. Methodology/Principal Findings: By generating a panel of chimeric and mutant origins between two AAV serotypes, we have mapped two independent DNA-Protein interfaces involved in replicative specificity. In vivo replication assays and structural modeling demonstrated that three residues in the AAV2 Rep active site are necessary to cleave its cognate origin. An analogous origin (AAV5) possesses a unique interaction between an extended Rep binding element and a 49 aa region of Rep containing two DNA binding interfaces. Conclusions/Significance: The elucidation of these structure-function relationships at the AAV origin led to the creation of a unique recombinant origin and compatible Rep protein with properties independent of either parent serotype. This novel origin may impact the safety and efficacy of AAV as a gene delivery tool. This work may also explain the unique ability of certain AAV serotypes to achieve site-directed integration into the human chromosome. Finally, this result impacts the study of conserved DNA viruses which employ rolling circle mechanisms of replication.	[Hewitt, F. Curtis; Samulski, R. Jude] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA; [Hewitt, F. Curtis; Samulski, R. Jude] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hewitt, FC (corresponding author), Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA.	rjs@med.unc.edu			National Institutes of Health [GM0529299, HL066973, HL051818, AI072176]; National Institute of Allergy and Infectious Diseases [AI007419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072176, T32AI007419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants GM0529299, HL066973, HL051818, AI072176 awarded to Dr. Jude Samulski and National Institute of Allergy and Infectious Diseases grant AI007419 awarded to Curtis Hewitt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brister JR, 2000, J VIROL, V74, P7762, DOI 10.1128/JVI.74.17.7762-7771.2000; Brister JR, 1999, J VIROL, V73, P9325, DOI 10.1128/JVI.73.11.9325-9336.1999; Chiorini JA, 1999, J VIROL, V73, P4293, DOI 10.1128/JVI.73.5.4293-4298.1999; Chiorini JA, 1999, J VIROL, V73, P1309, DOI 10.1128/JVI.73.2.1309-1319.1999; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; DEISS V, 1990, VIROLOGY, V175, P247, DOI 10.1016/0042-6822(90)90205-6; Farkas SL, 2004, J GEN VIROL, V85, P555, DOI 10.1099/vir.0.19616-0; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; HAUSWIRTH WW, 1977, VIROLOGY, V78, P488, DOI 10.1016/0042-6822(77)90125-8; HERMONAT PL, 1997, FEBS LETT, V20, P180; Hewitt FC, 2009, J VIROL, V83, P3919, DOI 10.1128/JVI.02466-08; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; Hickman AB, 2004, MOL CELL, V13, P403, DOI 10.1016/S1097-2765(04)00023-1; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; ILYINA TV, 1992, CELL, V84, P791; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; Prasad KMR, 1995, VIROLOGY, V214, P360, DOI 10.1006/viro.1995.0045; Ryan JH, 1996, J VIROL, V70, P1542, DOI 10.1128/JVI.70.3.1542-1553.1996; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; SAMULSKI RJ, 1983, CELL, V33, P135, DOI 10.1016/0092-8674(83)90342-2; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; VOS JC, 1993, GENE DEV, V7, P1244, DOI 10.1101/gad.7.7a.1244; Wu JW, 2001, ARCH BIOCHEM BIOPHYS, V389, P271, DOI 10.1006/abbi.2001.2348; Xiao X, 1997, J VIROL, V71, P941, DOI 10.1128/JVI.71.2.941-948.1997; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yoon M, 2001, J VIROL, V75, P3230, DOI 10.1128/JVI.75.7.3230-3239.2001; Young SM, 2000, J VIROL, V74, P3953, DOI 10.1128/JVI.74.9.3953-3966.2000; Young SM, 2000, METH MOL B, V133, P111; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	11	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8850	10.1371/journal.pone.0008850	http://dx.doi.org/10.1371/journal.pone.0008850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107513	gold, Green Published, Green Submitted			2022-12-25	WOS:000273896100015
J	Hasegawa, K; Wakino, S; Yoshioka, K; Tatematsu, S; Hara, Y; Minakuchi, H; Sueyasu, K; Washida, N; Tokuyama, H; Tzukerman, M; Skorecki, K; Hayashi, K; Itoh, H				Hasegawa, Kazuhiro; Wakino, Shu; Yoshioka, Kyoko; Tatematsu, Satoru; Hara, Yoshikazu; Minakuchi, Hitoshi; Sueyasu, Keiko; Washida, Naoki; Tokuyama, Hirobumi; Tzukerman, Maty; Skorecki, Karl; Hayashi, Koichi; Itoh, Hiroshi			Kidney-specific Overexpression of Sirt1 Protects against Acute Kidney Injury by Retaining Peroxisome Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED NEPHROTOXICITY; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; CALORIE RESTRICTION; TRANSGENIC MICE; RAT-KIDNEY; MITOCHONDRIAL BIOGENESIS; CELLS; METABOLISM; APOPTOSIS	Sirt1, a NAD-dependent protein deacetylase, is reported to regulate intracellular metabolism and attenuate reactive oxidative species (ROS)-induced apoptosis leading to longevity and acute stress resistance. We created transgenic (TG) mice with kidney-specific overexpression of Sirt1 using the promoter sodium-phosphate cotransporter IIa (Npt2) driven specifically in proximal tubules and investigated the kidney-specific role of Sirt1 in the protection against acute kidney injury (AKI). We also elucidated the role of number or function of peroxisome and mitochondria in mediating the mechanisms for renal protective effects of Sirt1 in AKI. Cisplatin-induced AKI decreased the number and function of peroxisomes as well as mitochondria and led to increased local levels of ROS production and renal tubular apoptotic cells. TG mice treated with cisplatin mitigated AKI, local ROS, and renal tubular apoptotic tubular cells. Consistent with these results, TG mice treated with cisplatin also exhibited recovery of peroxisome number and function, as well as rescued mitochondrial function; however, mitochondrial number was not recovered. Immunoelectron microscopic findings consistently demonstrated that the decrease in peroxisome number by cisplatin in wild type mice was restored in transgenic mice. In HK-2 cells, a cultured proximal tubule cell line, overexpression of Sirt1 rescued the cisplatin-induced cell apoptosis through the restoration of peroxisome number, although the mitochondria number was not restored. These results indicate that Sirt1 overexpression in proximal tubules rescues cisplatin-induced AKI by maintaining peroxisomes number and function, concomitant up-regulation of catalase, and elimination of renal ROS levels. Renal Sirt1 can be a potential therapeutic target for the treatment of AKI.	[Tzukerman, Maty; Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Wakino, Shu] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Tzukerman, Maty; Skorecki, Karl] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Keio University; Technion Israel Institute of Technology	Wakino, S (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	swakino@sc.itc.keio.ac.jp						Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Do Amaral CL, 2008, ARCH TOXICOL, V82, P363, DOI 10.1007/s00204-007-0262-x; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Giovannini L, 2001, J CARDIOVASC PHARM, V37, P262, DOI 10.1097/00005344-200103000-00004; Guarente L, 2000, GENE DEV, V14, P1021; GULATI S, 1992, ARCH BIOCHEM BIOPHYS, V295, P90, DOI 10.1016/0003-9861(92)90492-F; Hasegawa K, 2002, FEBS LETT, V520, P47, DOI 10.1016/S0014-5793(02)02761-8; Hasegawa K, 2008, BIOCHEM BIOPH RES CO, V372, P51, DOI 10.1016/j.bbrc.2008.04.176; Hashiguchi N, 2002, MOL BIOL CELL, V13, P711, DOI 10.1091/mbc.01-10-0479; Kim J, 2006, J BIOL CHEM, V281, P20349, DOI 10.1074/jbc.M512740200; LAWRENCE JW, 1995, BIOCHEM PHARMACOL, V49, P915, DOI 10.1016/0006-2952(95)00002-H; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Negishi K, 2007, KIDNEY INT, V72, P348, DOI 10.1038/sj.ki.5002304; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Plotnikov EY, 2007, KIDNEY INT, V72, P1493, DOI 10.1038/sj.ki.5002568; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Rosenberg T, 2007, AM J PHYSIOL-RENAL, V292, pF1617, DOI 10.1152/ajprenal.00412.2006; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Tenorio-Velazquez Veronica M, 2005, BMC Nephrol, V6, P12, DOI 10.1186/1471-2369-6-12; Van Hoek AN, 2000, AM J PHYSIOL-RENAL, V278, pF310, DOI 10.1152/ajprenal.2000.278.2.F310; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Wakino S, 2001, J BIOL CHEM, V276, P47650, DOI 10.1074/jbc.M108719200; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhou ZX, 2000, J HISTOCHEM CYTOCHEM, V48, P585, DOI 10.1177/002215540004800502	35	169	183	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13045	13056		10.1074/jbc.M109.067728	http://dx.doi.org/10.1074/jbc.M109.067728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20139070	Green Published, hybrid			2022-12-25	WOS:000276787800062
J	Fu, JJ; Lv, XY; Lin, HY; Wu, L; Wang, R; Zhou, Z; Zhang, BH; Wang, YL; Tsang, BK; Zhu, C; Wang, HM				Fu, Jiejun; Lv, Xiaoyin; Lin, Haiyan; Wu, Liang; Wang, Rui; Zhou, Zhi; Zhang, Baohua; Wang, Yan-Ling; Tsang, Benjamin K.; Zhu, Cheng; Wang, Hongmei			Ubiquitin Ligase Cullin 7 Induces Epithelial-Mesenchymal Transition in Human Choriocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR-TRANSFORMATION; TROPHOBLAST INVASION; GROWTH-RETARDATION; CYCLIN-E; CUL7; EXPRESSION; COMPLEX; TUMOR; PREECLAMPSIA; METASTASIS	Germ line mutations of the ubiquitin ligase cullin 7 (CUL7) are linked to 3-M syndrome and Yakuts short stature syndrome, both of which are characterized by pre- and post-natal growth retardation. CUL7 knock-out mice show placental and embryonic defects similar to intrauterine growth retardation, suggesting a role of CUL7 in placentation. CUL7 was found in this study to be highly expressed in first trimester invasive human placental villi as well as in HTR8/SVneo and B6Tert cells, two cell lines derived from human first trimester trophoblast cells. However, CUL7 levels in term trophoblast cells or JEG-3 cells, which are derived from human choriocarcinoma but exhibit weak invasion capacity, were low or undetectable. Forced expression of CUL7 in JEG-3 cells induced cell morphological changes characteristic of epithelial-mesenchymal transition, which was accompanied by a complete loss of the epithelial markers E-cadherin and P-cadherin and a significant elevation of mesenchymal markers Vimentin and N-cadherin. JEG-3 cells expressing CUL7 exhibited enhanced cell migration and invasion. Conversely, CUL7-specific RNA interference in HTR8/SVneo cells resulted in increased E-cadherin expression and reduced cell migration and invasion. Furthermore, CUL7 expression downregulated E-cadherin mRNA expression by up-regulating ZEB1 and Slug, two transcriptional repressors of E-cadherin. Finally, CUL7-induced loss of E-cadherin expression was partially reversed by treatment of CUL7-expressing cells with the proteasome inhibitor MG-132. These results suggest that the CUL7 E3 ligase is a key regulator in trophoblast cell epithelial-mesenchymal transition and placental development.	[Zhu, Cheng; Wang, Hongmei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Fu, Jiejun; Lv, Xiaoyin; Wu, Liang; Wang, Rui; Zhou, Zhi; Zhang, Baohua] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Tsang, Benjamin K.] Univ Ottawa, Chron Dis Program, Ottawa Hosp Res Inst, Dept Obstet & Gynecol, Ottawa, ON K1Y 4E9, Canada; [Tsang, Benjamin K.] Univ Ottawa, Chron Dis Program, Ottawa Hosp Res Inst, Dept Cellular & Mol Med, Ottawa, ON K1Y 4E9, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Wang, HM (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	wanghm@ioz.ac.cn	Lu, Xiaoyin/AAO-5561-2021	Lu, Xiaoyin/0000-0002-9244-325X; Tsang, Benjamin K./0000-0003-1213-3946	Ministry of Science and Technology of the People's Republic of China [2006CB504006, 2006CB944008]; Chinese Academy of Sciences [KSCX2-YW-R-080]; National Natural Science Foundation of China [30971088, 30770323]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program Grants 2006CB504006 and 2006CB944008 from the Ministry of Science and Technology of the People's Republic of China (to H. W.), Chinese Academy of Sciences Knowledge Innovation Program Grant KSCX2-YW-R-080 (to H. W.), and National Natural Science Foundation of China Grants 30971088 and 30770323 (to H. W. and H. Lin).	Ali SH, 2004, J VIROL, V78, P2749, DOI 10.1128/JVI.78.6.2749-2757.2004; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Blechschmidt K, 2007, VIRCHOWS ARCH, V450, P195, DOI 10.1007/s00428-006-0343-x; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Fu JJ, 2009, PLACENTA, V30, P305, DOI 10.1016/j.placenta.2009.01.005; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Huber C, 2005, NAT GENET, V37, P1119, DOI 10.1038/ng1628; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Karmakar S, 2004, J BIOL CHEM, V279, P55297, DOI 10.1074/jbc.M407013200; Kasper JS, 2005, J VIROL, V79, P11685, DOI 10.1128/JVI.79.18.11685-11692.2005; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Knoeller S, 2003, AM J REPROD IMMUNOL, V50, P41, DOI 10.1034/j.1600-0897.2003.00046.x; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Maksimova N, 2007, J MED GENET, V44, P772, DOI 10.1136/jmg.2007.051979; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Palmieri C, 2005, LANCET, V366, P688, DOI 10.1016/S0140-6736(05)67143-7; Sarikas A, 2008, CELL CYCLE, V7, P3154, DOI 10.4161/cc.7.20.6922; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skaar JR, 2005, MOL CELL BIOL, V25, P5579, DOI 10.1128/mcb.25.13.5579-5589.2005; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsunematsu R, 2006, MOL CELL BIOL, V26, P6157, DOI 10.1128/MCB.00595-06; Tsutsumi T, 2008, MOL CELL BIOL, V28, P743, DOI 10.1128/MCB.01665-07; Vicovac L, 1996, ACTA ANAT, V156, P202; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	30	60	66	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10870	10879		10.1074/jbc.M109.004200	http://dx.doi.org/10.1074/jbc.M109.004200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139075	Green Published, hybrid			2022-12-25	WOS:000276264600072
J	Wen, J; Chiang, YJ; Gao, C; Xue, H; Xu, JY; Ning, YH; Hodes, RJ; Gao, X; Chen, YG				Wen, Jun; Chiang, Y. Jeffrey; Gao, Chan; Xue, Hua; Xu, Jingyue; Ning, Yuanheng; Hodes, Richard J.; Gao, Xiang; Chen, Ye-Guang			Loss of Dact1 Disrupts Planar Cell Polarity Signaling by Altering Dishevelled Activity and Leads to Posterior Malformation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERGENT EXTENSION; MESODERM INDUCTION; WNT; CATENIN; PATHWAY; REGULATOR; INHIBITOR; DAPPER1; PROTEIN; INVOLVEMENT	Wnt signaling plays a key role in embryogenesis and cancer development. Dvl (Dishevelled) is a central mediator for both the canonical and noncanonical Wnt pathways. Dact1 (Dapper1, Dpr1), a Dvl interactor, has been shown to negatively modulate Wnt signaling by promoting lysosomal degradation of Dvl. Here we report that Dact1-deficient mice have multiple physiological defects that resemble the human neonate disease congenital caudal regression syndrome, including caudal vertebrae agenesis, anorectal malformation, renal agenesis/dysplasia, fused kidneys, and loss of bladder. These urogenital defects can be traced to impaired hindgut formation starting at embryonic day 8.25. Examination of morphological changes and Wnt target gene expression revealed that the planar cell polarity (PCP) signaling is deregulated, whereas the canonical Wnt/beta-catenin pathway is largely unaffected in mutant embryos. Consistently, the activity of the PCP signal mediators Rho GTPase and c-Jun N-terminal kinase is altered in Dact1(-/-) mouse embryonic fibroblasts. We further observed alterations in the protein level and the cellular distribution of Dvl in the primitive streak of mutant embryos. An increased amount of Dvl2 tends to be accumulated in the cortical regions of the cells, especially at the primitive streak ectoderm close to the posterior endoderm that lately forms the hindgut diverticulum. Together, these data suggest that Dact1 may regulate vertebrate PCP by controlling the level and the cellular localization of Dvl protein.	[Wen, Jun; Gao, Chan; Xue, Hua; Ning, Yuanheng; Chen, Ye-Guang] Tsinghua Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Chiang, Y. Jeffrey; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Hodes, Richard J.] NIA, NIH, Bethesda, MD 20892 USA; [Xu, Jingyue; Gao, Xiang] Nanjing Univ, MOE, Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China; [Xu, Jingyue; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China	Tsinghua University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Nanjing University; Nanjing University	Chen, YG (corresponding author), Tsinghua Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Gao, Chan/D-7964-2013		National Natural Science Foundation of China [30930050, 30921004]; 973 Program [2006CB943401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported, in whole or in part, by a National Institutes of Health Intramural Research Program grant ( to Y.J.C.). This work was also supported by National Natural Science Foundation of China Grants 30930050 and 30921004 and 973 Program Grant 2006CB943401 ( to Y.-G.C.).	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Behringer R, 2003, MANIPULATING MOUSE E, P371; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Brott BK, 2005, DEV CELL, V8, P703, DOI 10.1016/j.devcel.2005.02.012; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Katoh M, 2003, INT J ONCOL, V22, P907; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; KUCZUK MH, 1984, TERATOLOGY, V29, P427, DOI 10.1002/tera.1420290314; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Merei JM, 2004, PEDIATR SURG INT, V20, P439, DOI 10.1007/s00383-004-1172-0; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Michos O, 2009, CURR OPIN GENET DEV, V19, P484, DOI 10.1016/j.gde.2009.09.003; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Philips MF, 1997, PEDIATR NEUROSURG, V26, P130, DOI 10.1159/000121178; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Saburi S, 2005, CURR OPIN CELL BIOL, V17, P482, DOI 10.1016/j.ceb.2005.08.011; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sikandar Rozina, 2009, JPMA Journal of the Pakistan Medical Association, V59, P721; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Singh SK, 2005, PEDIATR SURG INT, V21, P578, DOI 10.1007/s00383-005-1451-4; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tessarollo L, 2000, METH MOL B, V158, P47; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; WU D, 2010, TRENDS BIOC IN PRESS; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yau TO, 2005, ONCOGENE, V24, P1607, DOI 10.1038/sj.onc.1208340; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Yi HF, 2009, BLOOD, V113, P5819, DOI 10.1182/blood-2008-11-190033; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250	64	46	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					11023	11030		10.1074/jbc.M109.085381	http://dx.doi.org/10.1074/jbc.M109.085381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145239	hybrid, Green Published			2022-12-25	WOS:000276264600086
J	Barone, I; Iacopetta, D; Covington, KR; Cui, Y; Tsimelzon, A; Beyer, A; Ando, S; Fuqua, SAW				Barone, I.; Iacopetta, D.; Covington, K. R.; Cui, Y.; Tsimelzon, A.; Beyer, A.; Ando, S.; Fuqua, S. A. W.			Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity	ONCOGENE			English	Article						breast cancer; estrogen receptor; K303R mutant ER alpha; aromatase inhibitors resistance; s305 ER alpha phosphorylation; IGF-1-signaling pathway	HUMAN-BREAST-CANCER; GROWTH-FACTOR-I; TAMOXIFEN RESISTANCE; DEOXYRIBONUCLEIC-ACID; HINGE REGION; MUTATION; KINASE; CELLS; ACTIVATION; BINDING	We earlier identified a lysine to arginine transition at residue 303 (K303R) in estrogen receptor alpha (ER alpha) in invasive breast cancers, which confers resistance to the aromatase inhibitor (AI) anastrozole (Ana) when expressed in MCF-7 breast cancer cells. Here, we show that AI resistance arises through an enhanced cross talk of the insulin-like growth factor receptor-1 (IGF-1R)/insulin receptor substrate (IRS)-1/Akt pathway with ER alpha, and the serine (S) residue 305 adjacent to the K303R mutation has a key function in mediating this cross talk. The ERa S305 residue is an important site that modifies response to tamoxifen; thus, we questioned whether this site could also influence AI response. We generated stable transfectants-expressing wild-type, K303R ER alpha or a double K303R/S305A mutant receptor, and found that the AI-resistant phenotype associated with expression of the K303R mutation was dependent on activation of S305 within the receptor. Ana significantly reduced growth in K303R/S305A-expressing cells. Preventing S305 phosphorylation with a blocking peptide inhibited IGF-1R/IRS-1/Akt activation and also restored AI sensitivity. Our data suggest that the K303R mutation and the S305 ER alpha residue may be a novel determinant of AI response in breast cancer, and blockade of S305 phosphorylation represents a new therapeutic strategy for treating tumors resistant to hormone therapy. Oncogene (2010) 29, 2404-2414; doi:10.1038/onc.2009.520; published online 25 January 2010	[Fuqua, S. A. W.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Breast Ctr, Houston, TX 77030 USA; [Barone, I.; Iacopetta, D.; Covington, K. R.; Cui, Y.; Tsimelzon, A.; Beyer, A.; Fuqua, S. A. W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Barone, I.; Ando, S.] Univ Calabria, Ctr Sanit, I-87036 Cosenza, Italy; [Ando, S.] Univ Calabria, Dept Cellular Biol, I-87036 Cosenza, Italy	Baylor College of Medicine; Baylor College of Medicine; University of Calabria; University of Calabria	Fuqua, SAW (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, Breast Ctr, BCM 600,1 Baylor Plaza, Houston, TX 77030 USA.	sfuqua@bcm.edu	Iacopetta, Domenico/H-4242-2014	Iacopetta, Domenico/0000-0001-5179-7118; BARONE, Ines/0000-0002-9769-1615	NCI [RO1 CA72038]; NATIONAL CANCER INSTITUTE [R01CA072038] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI RO1 CA72038 to SAWF. We thank Mrs. Robin Sample for excellent administrative assistance.	Agoulnik IU, 2004, J CLIN ENDOCR METAB, V89, P6340, DOI 10.1210/jc.2004-0114; ARTEAGA CL, 1989, CANCER RES, V49, P6237; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Barone I, 2009, CANCER RES, V69, P4724, DOI 10.1158/0008-5472.CAN-08-4194; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Burtrum D, 2003, CANCER RES, V63, P8912; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Conway K, 2005, BREAST CANCER RES, V7, pR871, DOI 10.1186/bcr1315; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Deeb A, 2008, J CLIN ENDOCR METAB, V93, P3691, DOI 10.1210/jc.2008-0737; ENCARNACION CA, 1993, BREAST CANCER RES TR, V26, P237, DOI 10.1007/BF00665801; EVAN GI, 1995, CURR OPIN CELL BIOL, V7, P825, DOI 10.1016/0955-0674(95)80066-2; Faus H, 2006, BIOMED PHARMACOTHER, V60, P520, DOI 10.1016/j.biopha.2006.07.082; Fontenot DR, 2007, BIOCHEM BIOPH RES CO, V363, P901, DOI 10.1016/j.bbrc.2007.09.046; Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712; Fuqua SAW, 2000, CANCER RES, V60, P4026; Giordano C, 2010, BREAST CANCER RES TR, V119, P71, DOI 10.1007/s10549-009-0334-0; Haelens A, 2007, CANCER RES, V67, P4514, DOI 10.1158/0008-5472.CAN-06-1701; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Herynk MH, 2007, CLIN CANCER RES, V13, P3235, DOI 10.1158/1078-0432.CCR-06-2608; Herynk MH, 2006, MOL CANCER THER, V5, P3023, DOI 10.1158/1535-7163.MCT-06-0394; Holm C, 2009, J PATHOL, V217, P372, DOI 10.1002/path.2455; Jelovac D, 2005, CANCER RES, V65, P5380, DOI 10.1158/0008-5472.CAN-04-4502; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Ksiezak-Reding H, 2003, BBA-MOL BASIS DIS, V1639, P159, DOI 10.1016/j.bbadis.2003.09.001; Lee AV, 1999, MOL ENDOCRINOL, V13, P787, DOI 10.1210/me.13.5.787; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; MANNING BD, 2002, SCI STKE, pPE49; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; MCGUIRE WL, 1992, J NATL CANCER I, V84, P1336, DOI 10.1093/jnci/84.17.1336; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Nakajima H, 2008, BREAST CANCER-TOKYO, V15, P65, DOI 10.1007/s12282-007-0018-8; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Rayala SK, 2007, BIOMED PHARMACOTHER, V61, P408, DOI 10.1016/j.biopha.2007.05.006; Romano A, 2006, GYNECOL ONCOL, V101, P287, DOI 10.1016/j.ygyno.2005.10.040; Sabnis GJ, 2005, CANCER RES, V65, P3903, DOI 10.1158/0008-5472.CAN-04-4092; Sachdev D, 2004, J BIOL CHEM, V279, P5017, DOI 10.1074/jbc.M305403200; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Salerno M, 1999, INT J CANCER, V81, P299; Santen RJ, 2005, J STEROID BIOCHEM, V95, P155, DOI 10.1016/j.jsbmb.2005.04.025; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Staka CM, 2005, ENDOCR-RELAT CANCER, V12, pS85, DOI 10.1677/erc.1.01006; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tharakan R, 2008, MOL CELL ENDOCRINOL, V295, P70, DOI 10.1016/j.mce.2008.07.018; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; WISEMAN LR, 1993, EUR J CANCER, V29A, P2256, DOI 10.1016/0959-8049(93)90218-5	50	48	50	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	16					2404	2414		10.1038/onc.2009.520	http://dx.doi.org/10.1038/onc.2009.520			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20101208	Green Accepted			2022-12-25	WOS:000276951500009
J	Huang, J; Dorsey, J; Chuikov, S; Zhang, XY; Jenuwein, T; Reinberg, D; Berger, SL				Huang, Jing; Dorsey, Jean; Chuikov, Sergei; Zhang, Xinyue; Jenuwein, Thomas; Reinberg, Danny; Berger, Shelley L.			G9a and Glp Methylate Lysine 373 in the Tumor Suppressor p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHWAY; H3-K9	The tumor suppressor p53 is regulated by numerous post-translational modifications. Lysine methylation has recently emerged as a key post-translational modification that alters the activity of p53. Here, we describe a novel lysine methylation site in p53 that is carried out by two homologous histone methyltransferases, G9a and Glp. G9a and Glp specifically methylate p53 at Lys(373), resulting mainly in dimethylation. During DNA damage, the overall level of p53 modified at Lys(373)me2 does not increase, despite the dramatic increase in total p53, indicating that Lys(373)me2 correlates with inactive p53. Further, reduction of G9a and/or Glp levels leads to a larger population of apoptotic cells. Examination of the Oncomine data base shows that G9a and Glp are overexpressed in various cancers compared with corresponding normal tissues, suggesting that they are putative oncogenes. These data reveal a new methylation site within p53 mediated by the methylases G9a and Glp and indicate that G9a is a potential inhibitory target for cancer treatment.	[Huang, Jing; Zhang, Xinyue] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Huang, Jing; Dorsey, Jean; Berger, Shelley L.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Jenuwein, Thomas] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Jenuwein, Thomas] Max Planck Inst Immunobiol, D-076151080 Freiburg, Germany; [Chuikov, Sergei; Reinberg, Danny] NYU, Sch Med, Smilow Res Ctr, New York, NY 10016 USA; [Reinberg, Danny] Univ Med & Dent New Jersey, Piscataway, NJ 08854 USA; [Berger, Shelley L.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); The Wistar Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Huang, J (corresponding author), NCI, Lab Canc Biol & Genet, NIH, 37 Convent Dr,MSC 4258,Bldg 37,Rm 3140, Bethesda, MD 20892 USA.	huangj3@mail.nih.gov	Huang, Jing/A-2566-2009	Huang, Jing/0000-0002-7163-5156; Berger, Shelley/0000-0001-5398-4400; Reinberg, Danny/0000-0003-4288-2016	NCI, National Institutes of Health Intramural Research Program and Center for Cancer Research [CA 078831]; NATIONAL CANCER INSTITUTE [ZIABC011158, R01CA078831, ZIABC011260, R55CA078831] Funding Source: NIH RePORTER	NCI, National Institutes of Health Intramural Research Program and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the NCI, National Institutes of Health Intramural Research Program and Center for Cancer Research (J. H.). This work was also supported by NCI, National Institutes of Health Grant CA 078831 (to S. L. B.).	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; LYSACHIRSKAIA I, 2008, J BIOL CHEM, V283, P34660; LYSAHL P, 2006, CANCER RES, V66, P11341; LYSRUMMEL L, 2005, P NATL ACAD SCI USA, V102, P10188; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012	18	282	297	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9636	9641		10.1074/jbc.M109.062588	http://dx.doi.org/10.1074/jbc.M109.062588			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118233	Green Published, hybrid			2022-12-25	WOS:000276165900036
J	Jensen, AA; Bergmann, ML; Sander, T; Balle, T				Jensen, Anders A.; Bergmann, Marianne L.; Sander, Tommy; Balle, Thomas			Ginkgolide X Is a Potent Antagonist of Anionic Cys-loop Receptors with a Unique Selectivity Profile at Glycine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; BETA-SUBUNIT; FUNCTIONAL-CHARACTERIZATION; TERPENE TRILACTONES; EXTRACELLULAR HALF; 5-HT3 RECEPTOR; LIGAND-BINDING; M2 REGION; CHANNEL; FLUORESCENCE	The novel ginkgolide analog ginkgolide X was characterized functionally at human glycine and gamma-aminobutyric acid type A receptors (GlyRs and GABA(A)Rs, respectively) in the fluorescence-based FLIPR (TM) Membrane Potential assay. The compound inhibited the signaling of all GABA(A)R subtypes included in the study with high nanomolar/low micromolar IC50 values, except the rho 1 receptor at which it was a significantly weaker antagonist. Ginkgolide X also displayed high nanomolar/low micromolar IC50 values at the homomeric alpha 1 and alpha 2 GlyRs, whereas it was inactive at the heteromeric alpha 1 beta and alpha 2 beta subtypes at concentrations up to 300 mu M. Thus, the functional properties of the compound were significantly different from those of the naturally occurring ginkgolides A, B, C, J, and M but similar to those of picrotoxin. In a mutagenesis study the 6' M2 residues in the GlyR ion channel were identified as the primary molecular determinant of the selectivity profile of ginkgolide X, and a 6' M2 ring consisting of five Thr residues was found to be of key importance for its activity at the GABAAR. Conformational analysis and docking of low-energy conformations of the native ginkgolide A and ginkgolide X into a alpha 1 GlyR homology model revealed two distinct putative binding sites formed by the 6' M2 residues together with the 2' residues and the 10' and 13' residues, respectively. Thus, we propose that the distinct functionalities of ginkgolide X compared with the other ginkgolides could arise from different flexibility and thus different binding modes to the ion channel of the anionic Cys-loop receptor.	[Jensen, Anders A.; Bergmann, Marianne L.; Sander, Tommy; Balle, Thomas] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark	University of Copenhagen	Jensen, AA (corresponding author), Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, Univ Parken 2, DK-2100 Copenhagen, Denmark.	aaj@farma.ku.dk	Jensen, Anders/AAJ-3335-2020	Jensen, Anders/0000-0002-7927-5052; Balle, Thomas/0000-0002-0233-8350	The Lundbeck Foundation; The Carlsberg Foundation; Direktor Ib Henriksen Foundation; Danish Medical Research Council; Lundbeck Foundation [R9-2007-928] Funding Source: researchfish	The Lundbeck Foundation(Lundbeckfonden); The Carlsberg Foundation(Carlsberg Foundation); Direktor Ib Henriksen Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Lundbeck Foundation, The Carlsberg Foundation, Direktor Ib Henriksen Foundation, and the Danish Medical Research Council. Part of this work was presented at the Society of Neuroscience conference, November 15-19, 2008, in Washington D. C.	[Anonymous], 2008, GLID VERS 5 0; [Anonymous], 2008, MAESTR VERS 8 5; [Anonymous], 2008, MACROMODEL VERS 9 6; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Chatterjee SS, 2002, N-S ARCH PHARMACOL, V365, pR79; Chen LG, 2006, J BIOL CHEM, V281, P38871, DOI 10.1074/jbc.M608301200; Da Settimo F, 2007, CURR MED CHEM, V14, P2680, DOI 10.2174/092986707782023190; Dalziel JE, 1999, EUR J PHARMACOL, V370, P345, DOI 10.1016/S0014-2999(99)00138-7; Dang H, 2000, MOL PHARMACOL, V57, P1114; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEVILLERSTHIERY A, 1992, NEUROREPORT, V3, P1001, DOI 10.1097/00001756-199211000-00014; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Francis MM, 2000, MOL PHARMACOL, V58, P109, DOI 10.1124/mol.58.1.109; Goren EN, 2004, J BIOL CHEM, V279, P11198, DOI 10.1074/jbc.M314050200; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; GURLEY D, 1995, RECEPTOR CHANNEL, V3, P13; Hawthorne R, 2006, J NEUROCHEM, V98, P395, DOI 10.1111/j.1471-4159.2006.03875.x; Heads JA, 2008, J NEUROCHEM, V105, P1418, DOI 10.1111/j.1471-4159.2008.05244.x; Huang SH, 2004, EUR J PHARMACOL, V494, P131, DOI 10.1016/j.ejphar.2004.04.051; Ivic L, 2003, J BIOL CHEM, V278, P49279, DOI 10.1074/jbc.M304034200; Jaracz S, 2004, CHEM-EUR J, V10, P1507, DOI 10.1002/chem.200305473; Jensen AA, 2005, EUR J PHARMACOL, V521, P39, DOI 10.1016/j.ejphar.2005.08.002; Jensen AA, 2004, BIOCHEM PHARMACOL, V67, P1789, DOI 10.1016/j.bcp.2003.12.037; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jensen AA, 2007, J MED CHEM, V50, P4616, DOI 10.1021/jm070574f; Jensen AA, 2007, J MED CHEM, V50, P1610, DOI 10.1021/jm070003n; Joesch C, 2008, J BIOMOL SCREEN, V13, P218, DOI 10.1177/1087057108315036; Karadsheh MS, 2004, J NEUROCHEM, V91, P1138, DOI 10.1111/j.1471-4159.2004.02801.x; Kirsch J, 2006, CELL TISSUE RES, V326, P535, DOI 10.1007/s00441-006-0261-x; Kondratskaya EL, 2005, NEUROPHARMACOLOGY, V49, P945, DOI 10.1016/j.neuropharm.2005.07.001; Kondratskaya EL, 2004, BRAIN RES BULL, V63, P309, DOI 10.1016/j.brainresbull.2004.03.007; Korpi ER, 2006, PHARMACOL THERAPEUT, V109, P12, DOI 10.1016/j.pharmthera.2005.05.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nakanishi K, 2005, BIOORGAN MED CHEM, V13, P4987, DOI 10.1016/j.bmc.2005.06.014; Nemeroff Charles B, 2003, Psychopharmacol Bull, V37, P133; Orser Beverley A, 2002, Curr Opin Anaesthesiol, V15, P427, DOI 10.1097/00001503-200208000-00004; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Price KL, 2005, J NEUROSCI METH, V149, P172, DOI 10.1016/j.jneumeth.2005.05.014; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; *SCHROD LLC, 2008, SCHROD SUIT 2008 IND; *SCHROD LLC, 2005, PRIM VERS 1 7; *SCHROD LLC, 2008, IMP VERS 5 0; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sinkkonen ST, 2000, J NEUROSCI, V20, P3588, DOI 10.1523/JNEUROSCI.20-10-03588.2000; Stromgaard K, 2004, ANGEW CHEM INT EDIT, V43, P1640, DOI 10.1002/anie.200300601; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tierney ML, 1997, RECEPTOR CHANNEL, V5, P113; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wenningmann I, 2001, MOL PHARMACOL, V60, P584; Whiting PJ, 2003, CURR OPIN DRUG DISC, V6, P648; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x	63	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10141	10153		10.1074/jbc.M109.079319	http://dx.doi.org/10.1074/jbc.M109.079319			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106969	Green Published, hybrid			2022-12-25	WOS:000276165900081
J	Lu, L; Wang, L; Li, T; Wang, J				Lu, Luo; Wang, Ling; Li, Tie; Wang, Jie			NF-kappa B Subtypes Regulate CCCTC Binding Factor Affecting Corneal Epithelial Cell Fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR CTCF; K+ CHANNEL; SIGNALING PATHWAY; EGFR ACTIVATION; DOWN-REGULATION; IN-VIVO; APOPTOSIS; PAX6; EXPRESSION; STRESS	CCCTC binding factor (CTCF) controls DNA imprinting, insulates important gene expression, and mediates growth factor and stress-induced cell fate. However, regulatory mechanisms involved in intracellular CTCF activity are largely unknown. In this study, we show that epidermal growth factor (EGF)-induced increase and UV stress-induced decrease in CTCF activities mediate human corneal epithelial cell proliferation and apoptosis, respectively. CTCF is regulated by activation of different NF-kappa B subtypes via stimulation by EGF and UV stress. EGF-induced formation of a p65/p50 heterodimer activated CTCF transcription to promote cellular proliferation. This was accomplished by the heterodimer binding to a kappa B site in the promoter region of CTCF gene. In contrast, UV stress induced formation of a p50/p50 homodimer, which suppressed CTCF expression leading to apoptosis. Thus, CTCF by itself plays a central role in mediating the dichotomous effects of growth factor- and stress-stimulated NF-kappa B activation on cell survival and death. These results suggest that CTCF is a downstream component of the NF-kappa B pathway involved in the core transcriptional network of cell fate.	[Lu, Luo; Wang, Ling; Li, Tie; Wang, Jie] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lu, L (corresponding author), Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu			National Institutes of Health [R01-EY015282]; NATIONAL EYE INSTITUTE [R01EY015281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-EY015282 (to L.L.).	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Belandia B, 1998, J BIOL CHEM, V273, P30366, DOI 10.1074/jbc.273.46.30366; Bell KD, 2000, CORNEA, V19, P40, DOI 10.1097/00003226-200001000-00009; BUSCHER M, 1988, ONCOGENE, V3, P301; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chi ZL, 2007, EXP EYE RES, V84, P254, DOI 10.1016/j.exer.2006.09.016; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; DeBiasi RL, 2003, J VIROL, V77, P8934, DOI 10.1128/JVI.77.16.8934-8947.2003; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HERRLICH P, 1992, REV PHYSIOL BIOCH P, V119, P187; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Holbrook N J, 1996, EXS, V77, P273; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Kumala W, 2006, HELICOBACTER, V11, P21; Kumar A, 2007, BIOCHEM BIOPH RES CO, V354, P955, DOI 10.1016/j.bbrc.2007.01.072; Lee DH, 2005, OPHTHAL RES, V37, P83, DOI 10.1159/000084249; Li H, 2006, IMMUNOLOGY, V117, P167, DOI 10.1111/j.1365-2567.2005.02275.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Li T, 2002, J BIOL CHEM, V277, P32668, DOI 10.1074/jbc.M203519200; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Li T, 2006, INVEST OPHTH VIS SCI, V47, P5218, DOI 10.1167/iovs.06-0254; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Liu JJ, 1999, EXP EYE RES, V68, P295, DOI 10.1006/exer.1998.0593; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Lu L, 2006, PROG RETIN EYE RES, V25, P515, DOI 10.1016/j.preteyeres.2006.07.004; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Miyamoto T, 2006, J CATARACT REFR SURG, V32, P1736, DOI 10.1016/j.jcrs.2006.05.005; Nishi M, 2005, DIABETIC MED, V22, P641, DOI 10.1111/j.1464-5491.2005.01469.x; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Qi CF, 2003, P NATL ACAD SCI USA, V100, P633, DOI 10.1073/pnas.0237127100; Rajala MS, 2005, J VIROL, V79, P12332, DOI 10.1128/JVI.79.19.12332-12341.2005; Rasko JEJ, 2001, CANCER RES, V61, P6002; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shiraishi A, 1998, INVEST OPHTH VIS SCI, V39, P2554; Wang L, 2005, EXP CELL RES, V311, P39, DOI 10.1016/j.yexcr.2005.08.020; Wang L, 2005, ONCOGENE, V24, P3020, DOI 10.1038/sj.onc.1208547; Wu D, 2006, INVEST OPHTH VIS SCI, V47, P2422, DOI 10.1167/iovs.05-0536; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P813, DOI 10.1167/iovs.03-0851; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Zaragoza C, 2006, P NATL ACAD SCI USA, V103, P19051, DOI 10.1073/pnas.0606019103; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005; Zhang MC, 2006, OCUL IMMUNOL INFLAMM, V14, P359, DOI 10.1080/09273940601001322; Zhou H, 2007, CELL PROLIFERAT, V40, P431, DOI 10.1111/j.1365-2184.2007.00444.x	54	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9373	9382		10.1074/jbc.M109.094425	http://dx.doi.org/10.1074/jbc.M109.094425			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110362	Green Published, hybrid			2022-12-25	WOS:000276165900009
J	Li, GL; Ma, J; Zhang, LX				Li, Guoliang; Ma, Jian; Zhang, Louxin			Greedy Selection of Species for Ancestral State Reconstruction on Phylogenies: Elimination Is Better than Insertion	PLOS ONE			English	Article							GENOMIC SEQUENCES; MAXIMUM PARSIMONY; CHARACTER STATES; EVOLUTION; INFERENCE; ACCURACY	Accurate reconstruction of ancestral character states on a phylogeny is crucial in many genomics studies. We study how to select species to achieve the best reconstruction of ancestral character states on a phylogeny. We first show that the marginal maximum likelihood has the monotonicity property that more taxa give better reconstruction, but the Fitch method does not have it even on an ultrametric phylogeny. We further validate a greedy approach for species selection using simulation. The validation tests indicate that backward greedy selection outperforms forward greedy selection. In addition, by applying our selection strategy, we obtain a set of the ten most informative species for the reconstruction of the genomic sequence of the so-called boreoeutherian ancestor of placental mammals. This study has broad relevance in comparative genomics and paleogenomics since limited research resources do not allow researchers to sequence the large number of descendant species required to reconstruct an ancestral sequence.	[Li, Guoliang] Genome Inst Singapore, Singapore, Singapore; [Ma, Jian] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Zhang, Louxin] Natl Univ Singapore, Dept Math, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore	Li, GL (corresponding author), Genome Inst Singapore, Singapore, Singapore.	matzlx@nus.edu.sg	Zhang, Louxin/M-4865-2016; Ma, Jian/A-9838-2008; Li, Guoliang/D-8014-2012	Zhang, Louxin/0000-0003-0260-824X; Ma, Jian/0000-0002-4202-5834; Li, Guoliang/0000-0003-1601-6640	ARF [R146-000-109-112]	ARF	The research was partially supported by the ARF grant R146-000-109-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA ML, 1984, MOL BIOL EVOL, V1, P442; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Chindelevitch Leonid, 2006, Journal of Bioinformatics and Computational Biology, V4, P721, DOI 10.1142/S0219720006002168; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Crisp MD, 2005, TRENDS ECOL EVOL, V20, P122, DOI 10.1016/j.tree.2004.11.010; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Elias I, 2007, J COMPUT BIOL, V14, P216, DOI 10.1089/cmb.2006.0101; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Fischer M, 2009, J THEOR BIOL, V260, P290, DOI 10.1016/j.jtbi.2009.06.010; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Hall BG, 2006, P NATL ACAD SCI USA, V103, P5431, DOI 10.1073/pnas.0508991103; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim JH, 1996, SYST BIOL, V45, P363, DOI 10.2307/2413570; Koshi JM, 1996, J MOL EVOL, V42, P313, DOI 10.1007/BF02198858; Kuang DH, 2006, P NATL ACAD SCI USA, V103, P14050, DOI 10.1073/pnas.0604717103; Li GL, 2008, SYST BIOL, V57, P647, DOI 10.1080/10635150802203898; Liberles DA., 2007, ANCESTRAL SEQUENCE R; Lucena B, 2005, SYST BIOL, V54, P693, DOI 10.1080/10635150590950344; MAAULIFFE JD, 2005, P NATL AM SCI US, V102, P7900; Maddison WP, 1995, SYST BIOL, V44, P474, DOI 10.2307/2413655; Mooers AO, 2004, SYST BIOL, V53, P809, DOI 10.1080/10635150490502595; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pardi F, 2005, PLOS GENET, V1, P672, DOI 10.1371/journal.pgen.0010071; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; PAULING L, 1963, ACTA CHEM SCAND, V17, P9, DOI 10.3891/acta.chem.scand.17s-0009; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Rivas E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000172; Salisbury BA, 2001, SYST BIOL, V50, P557, DOI 10.1080/106351501750435103; SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004; Schultz TR, 1996, EVOLUTION, V50, P504, DOI 10.1111/j.1558-5646.1996.tb03863.x; Steel M.A., 1999, ANN COMB, V3, P103; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tuller T, 2009, LECT N BIOINFORMAT, V5817, P164, DOI 10.1007/978-3-642-04744-2_14; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; YANG ZH, 1995, GENETICS, V141, P1641; Zhang JZ, 2002, P NATL ACAD SCI USA, V99, P5486, DOI 10.1073/pnas.072626199; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067	45	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e8985	10.1371/journal.pone.0008985	http://dx.doi.org/10.1371/journal.pone.0008985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140213	gold, Green Published, Green Submitted			2022-12-25	WOS:000274474400002
J	Grohmann, M; Hammer, P; Walther, M; Paulmann, N; Buttner, A; Eisenmenger, W; Baghai, TC; Schule, C; Rupprecht, R; Bader, M; Bondy, B; Zill, P; Priller, J; Walther, DJ				Grohmann, Maik; Hammer, Paul; Walther, Maria; Paulmann, Nils; Buettner, Andreas; Eisenmenger, Wolfgang; Baghai, Thomas C.; Schuele, Cornelius; Rupprecht, Rainer; Bader, Michael; Bondy, Brigitta; Zill, Peter; Priller, Josef; Walther, Diego J.			Alternative Splicing and Extensive RNA Editing of Human TPH2 Transcripts	PLOS ONE			English	Article							SEROTONIN 2C RECEPTOR; TRYPTOPHAN HYDROXYLASE-2 GENE; OF-FUNCTION MUTATION; PRE-MESSENGER-RNA; HUMAN TRYPTOPHAN-HYDROXYLASE-2 GENE; MEDIAN RAPHE NUCLEI; MAJOR DEPRESSION; HAPLOTYPE ANALYSIS; EXPRESSION; BRAIN	Brain serotonin (5-HT) neurotransmission plays a key role in the regulation of mood and has been implicated in a variety of neuropsychiatric conditions. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the biosynthesis of 5-HT. Recently, we discovered a second TPH isoform (TPH2) in vertebrates, including man, which is predominantly expressed in brain, while the previously known TPH isoform (TPH1) is primarly a non-neuronal enzyme. Overwhelming evidence now points to TPH2 as a candidate gene for 5-HT-related psychiatric disorders. To assess the role of TPH2 gene variability in the etiology of psychiatric diseases we performed cDNA sequence analysis of TPH2 transcripts from human post mortem amygdala samples obtained from individuals with psychiatric disorders (drug abuse, schizophrenia, suicide) and controls. Here we show that TPH2 exists in two alternatively spliced variants in the coding region, denoted TPH2a and TPH2b. Moreover, we found evidence that the pre-mRNAs of both splice variants are dynamically RNA-edited in a mutually exclusive manner. Kinetic studies with cell lines expressing recombinant TPH2 variants revealed a higher activity of the novel TPH2B protein compared with the previously known TPH2A, whereas RNA editing was shown to inhibit the enzymatic activity of both TPH2 splice variants. Therefore, our results strongly suggest a complex fine-tuning of central nervous system 5-HT biosynthesis by TPH2 alternative splicing and RNA editing. Finally, we present molecular and large-scale linkage data evidencing that deregulated alternative splicing and RNA editing is involved in the etiology of psychiatric diseases, such as suicidal behaviour.	[Grohmann, Maik; Hammer, Paul; Walther, Maria; Paulmann, Nils; Walther, Diego J.] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Grohmann, Maik; Paulmann, Nils] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Grohmann, Maik; Priller, Josef] Charite, Neuropsychiat & Lab Mol Psychiat, D-13353 Berlin, Germany; [Buettner, Andreas; Eisenmenger, Wolfgang] Univ Munich, Inst Legal Med, Munich, Germany; [Bader, Michael] Max Delbruck Ctr Mol Med, Lab Mol Biol Peptide Hormones, Berlin, Germany; [Baghai, Thomas C.; Schuele, Cornelius; Rupprecht, Rainer; Bondy, Brigitta; Zill, Peter] Univ Munich, Dept Psychiat, D-8000 Munich, Germany	Max Planck Society; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich	Grohmann, M (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany.	dwalther@molgen.mpg.de	Priller, Josef/ABW-3835-2022; Bader, Michael/K-2124-2013; Büttner, Andreas/I-5974-2014	Büttner, Andreas/0000-0002-6676-4957; Priller, Josef/0000-0001-7596-0979; Baghai, Thomas C/0000-0002-7873-4130; Bader, Michael/0000-0003-4780-4164	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funding: The study was funded in part by grants of the Deutsche Forschungsgemeinschaft, the Bundesministerium fur Bildung und Forschung and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaria N, 2008, CELL MOL NEUROBIOL, V28, P331, DOI 10.1007/s10571-007-9259-5; Bach-Mizrachi H, 2008, MOL PSYCHIATR, V13, P507, DOI 10.1038/sj.mp.4002143; Bach-Mizrachi H, 2006, NEUROPSYCHOPHARMACOL, V31, P814, DOI 10.1038/sj.npp.1300897; Barlati S, 2005, ACTA NEUROCHIR SUPPL, V93, P53; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Bicalho MA, 2006, MOL PSYCHIATR, V11, P799, DOI 10.1038/sj.mp.4001861; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Bourara K, 2000, SCIENCE, V289, P1564, DOI 10.1126/science.289.5484.1564; Brown SM, 2005, MOL PSYCHIATR, V10, P884, DOI 10.1038/sj.mp.4001716; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Buznikov GA, 2005, NEUROCHEM RES, V30, P825, DOI 10.1007/s11064-005-6876-6; Canli T, 2005, J NEURAL TRANSM, V112, P1479, DOI 10.1007/s00702-005-0391-4; Carkaci-Salli N, 2006, J BIOL CHEM, V281, P28105, DOI 10.1074/jbc.M602817200; CATTANEO MG, 1993, CANCER RES, V53, P5566; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Cichon S, 2008, HUM MOL GENET, V17, P87, DOI 10.1093/hmg/ddm286; De Luca V, 2006, INT J NEUROPSYCHOPH, V9, P21, DOI 10.1017/S1461145705005572; De Luca V, 2005, PSYCHOPHARMACOLOGY, V183, P378, DOI 10.1007/s00213-005-0191-4; Englander MT, 2005, J NEUROSCI, V25, P648, DOI 10.1523/JNEUROSCI.3895-04.2005; Farrer T, 2002, NUCLEIC ACIDS RES, V30, P3360, DOI 10.1093/nar/gkf465; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Garriock HA, 2005, MOL PSYCHIATR, V10, P976, DOI 10.1038/sj.mp.4001712; Glatt C.E., 2005, NEURON, V45, P11; Glatt CE, 2005, NEURON, V48, P704, DOI 10.1016/j.neuron.2005.11.019; Gurevich I, 2002, J NEUROSCI, V22, P10529; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Haghighi F, 2008, MOL PSYCHIATR, V13, P813, DOI 10.1038/sj.mp.4002127; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Iwamoto K, 2005, NEUROSCI RES, V53, P69, DOI 10.1016/j.neures.2005.06.001; Iwamoto K, 2003, NEUROSCI LETT, V346, P169, DOI 10.1016/S0304-3940(03)00608-6; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kulikov AV, 2005, GENES BRAIN BEHAV, V4, P482, DOI 10.1111/j.1601-183X.2005.00145.x; Lauder J M, 1981, Adv Exp Med Biol, V133, P477; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Maas Stefan, 2006, RNA Biol, V3, P1; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; McKinney J, 2008, MOL PSYCHIATR, V13, P365, DOI 10.1038/sj.mp.4002152; McKinney J, 2005, J NEUROCHEM, V92, P311, DOI 10.1111/j.1471-4159.2004.02850.x; Meier JC, 2005, NAT NEUROSCI, V8, P736, DOI 10.1038/nn1467; Morecroft I, 2007, HYPERTENSION, V49, P232, DOI 10.1161/01.HYP.0000252210.58849.78; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Niswender CM, 2001, NEUROPSYCHOPHARMACOL, V24, P478, DOI 10.1016/S0893-133X(00)00223-2; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rosen JB, 2006, BIOL PSYCHOL, V73, P49, DOI 10.1016/j.biopsycho.2006.01.007; Sakowski SA, 2006, BRAIN RES, V1085, P11, DOI 10.1016/j.brainres.2006.02.047; Scheuch K, 2007, BIOL PSYCHIAT, V62, P1288, DOI 10.1016/j.biopsych.2007.01.015; Schonn JS, 2003, J NEUROCHEM, V84, P669, DOI 10.1046/j.1471-4159.2003.01561.x; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; Steele EJ, 2006, DNA REPAIR, V5, P1346, DOI 10.1016/j.dnarep.2006.06.002; Talarovicova Alzbeta, 2007, Endocr Regul, V41, P155; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; Van den Bogaert A, 2005, NEURON, V48, P704, DOI 10.1016/j.neuron.2005.11.017; Walitza S, 2005, MOL PSYCHIATR, V10, P1126, DOI 10.1038/sj.mp.4001734; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 1999, MOL BRAIN RES, V68, P55, DOI 10.1016/S0169-328X(99)00046-7; Walther DJ, 2002, CANCER-AM CANCER SOC, V94, P3135, DOI 10.1002/cncr.10592; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zhou Z., 2005, NEURON, V48, P702; Zhou ZF, 2005, NEURON, V48, P702, DOI 10.1016/j.neuron.2005.11.018; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525; Zill P, 2004, BIOL PSYCHIAT, V56, P581, DOI 10.1016/j.biopsych.2004.07.015; Zill P, 2007, J PSYCHIATR RES, V41, P168, DOI 10.1016/j.jpsychires.2005.05.004	73	56	59	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8956	10.1371/journal.pone.0008956	http://dx.doi.org/10.1371/journal.pone.0008956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126463	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000274139100007
J	Lapucci, A; Lulli, M; Amedei, A; Papucci, L; Witort, E; Di Gesualdo, F; Bertolini, F; Brewer, G; Nicolin, A; Bevilacqua, A; Schiavone, N; Morello, D; Donnini, M; Capaccioli, S				Lapucci, Andrea; Lulli, Matteo; Amedei, Amedeo; Papucci, Laura; Witort, Ewa; Di Gesualdo, Federico; Bertolini, Francesco; Brewer, Gary; Nicolin, Angelo; Bevilacqua, Annamaria; Schiavone, Nicola; Morello, Dominique; Donnini, Martino; Capaccioli, Sergio			zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia	FASEB JOURNAL			English	Article						post-transcriptional control; cancer; ARE-binding protein	ACUTE LYMPHOBLASTIC-LEUKEMIA; GUINEA-PIG LENS; GENE-EXPRESSION; QUINONE REDUCTASE; UP-REGULATION; ELEMENT; IDENTIFICATION; APOPTOSIS; STABILIZATION; PURIFICATION	The human antiapoptotic bcl-2 gene has been discovered in t(14; 18) B-cell leukemias/lymphomas because of its overexpression caused at a transcriptional control level by the bcl-2/IgH fusion gene. We were the first to disclose the post-transcriptional control of bcl-2 expression mediated by interactions of an adenine + uracil (AU)-rich element (ARE) in the 3'-UTR of bcl-2 mRNA with AU-binding proteins (AUBPs). Here, we identify and characterize zeta-crystallin as a new bcl-2 AUBP, whose silencing or overexpression has impact on bcl-2 mRNA stability. An increased Bcl-2 level observed in normal phytohemagglutinin (PHA)-activated T lymphocytes, acute lymphatic leukemia (ALL) T-cell lines, and T cells of patients with leukemia in comparison with normal non-PHA-activated T lymphocytes was concomitant with an increase in zeta-crystallin level. The specific association of zeta-crystallin with the bcl-2 ARE was significantly enhanced in T cells of patients with ALL, which accounts for the higher stability of bcl-2 mRNA and suggests a possible contribution of zeta-crystallin to bcl-2 overexpression occurring in this leukemia.-Lapucci, A., Lulli, M., Amedei, A., Papucci, L., Witort, E., Di Gesualdo, F., Bertolini, F., Brewer, G., Nicolin, A., Bevilacqua, A., Schiavone, N., Morello, D., Donnini, M., Capaccioli, S. zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia. FASEB J. 24, 1852-1865 (2010). www.fasebj.org	[Lapucci, Andrea; Lulli, Matteo; Papucci, Laura; Witort, Ewa; Di Gesualdo, Federico; Schiavone, Nicola; Donnini, Martino; Capaccioli, Sergio] Univ Florence, Dept Expt Pathol & Oncol, I-50134 Florence, Italy; [Amedei, Amedeo] Univ Florence, Immunol Sect, Dept Internal Med, I-50134 Florence, Italy; [Lapucci, Andrea; Lulli, Matteo; Papucci, Laura; Witort, Ewa; Di Gesualdo, Federico; Donnini, Martino; Capaccioli, Sergio] Unit Ist Toscano Tumori, Florence, Italy; [Lapucci, Andrea; Lulli, Matteo; Amedei, Amedeo; Di Gesualdo, Federico; Brewer, Gary; Morello, Dominique; Donnini, Martino; Capaccioli, Sergio] Phoenix Stem Cell Fdn Human Life, Florence, Italy; [Bertolini, Francesco] European Inst Oncol, Div Clin Hematooncol, Milan, Italy; [Brewer, Gary] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA; [Nicolin, Angelo; Bevilacqua, Annamaria] Univ Milan, Dept Pharmacol, Milan, Italy; [Morello, Dominique] Univ Toulouse 3, Ctr Dev Biol, F-31062 Toulouse, France	University of Florence; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; IRCCS European Institute of Oncology (IEO); Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Milan; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Donnini, M (corresponding author), Univ Florence, Dept Expt Pathol & Oncol, Viale GB Morgagni 50, I-50134 Florence, Italy.	martinod@unifi.it; sergio@unifi.it	Bevilacqua, Annamaria/C-6357-2008; Amedei, Amedeo/G-5378-2011; Lapucci, Andrea/AAA-6645-2019; Lulli, Matteo/M-5377-2019; Lulli, Matteo/J-8623-2016; bertolini, francesco/AAC-9780-2019	Bevilacqua, Annamaria/0000-0002-3136-3424; Amedei, Amedeo/0000-0002-6797-9343; Lulli, Matteo/0000-0002-8528-4094; Lulli, Matteo/0000-0002-8528-4094; bertolini, francesco/0000-0001-5660-3255; LAPUCCI, Andrea/0000-0001-9613-7164; Papucci, Laura/0000-0002-8450-7428; Schiavone, Nicola/0000-0002-1592-4244	Programmi di Ricerca di Interesse Nazionale; Associazione Italiana per la Ricerca sul Cancro; Ente Cassa di Risparmio di Firenze; Fondazione Cassa di Risparmio di Lucca; U.S. National Institutes of Health [R01 CA052443]; NATIONAL CANCER INSTITUTE [R01CA052443] Funding Source: NIH RePORTER	Programmi di Ricerca di Interesse Nazionale; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Fondazione Cassa di Risparmio di Lucca; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Professors Vieri Boddi and Riccardo Caldini for help with the statistical analysis, Dr. J. Samuel Zigler, Jr. (National Eye Institute, Bethesda, MD, USA) for the contribution of the anti-zeta-crystallin antibody, and Professor Mary Forrest and Dr. Carolyn Demsey for accurate editing of the article. This work was supported by grants from Programmi di Ricerca di Interesse Nazionale (to S. C. and A. N.), the Associazione Italiana per la Ricerca sul Cancro (to S. C.), the Ente Cassa di Risparmio di Firenze (to S. C.), the Fondazione Cassa di Risparmio di Lucca (to S. C.), and the U.S. National Institutes of Health (R01 CA052443 to G. B.).	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Amedei A, 2001, EUR J IMMUNOL, V31, P1927, DOI 10.1002/1521-4141(200106)31:6<1927::AID-IMMU1927>3.0.CO;2-D; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bevilacqua A, 2003, J BIOL CHEM, V278, P23451, DOI 10.1074/jbc.M210620200; Bevilacqua A, 2007, MOL PHARMACOL, V71, P531, DOI 10.1124/mol.106.029041; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Borgmann A, 2003, BLOOD, V101, P3835, DOI 10.1182/blood.V101.10.3835; Bose SK, 2006, BIOCHEM J, V396, P99, DOI 10.1042/BJ20051548; Capaccioli S, 1996, ONCOGENE, V13, P105; CHESSELLS JM, BR J HAEMATOL, V102, P423; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cok SJ, 2004, J BIOL CHEM, V279, P8196, DOI 10.1074/jbc.M308475200; Donnini M, 2004, J BIOL CHEM, V279, P20154, DOI 10.1074/jbc.M314071200; Donnini M, 2001, BIOCHEM BIOPH RES CO, V287, P1063, DOI 10.1006/bbrc.2001.5700; DUHAIMAN AS, 1995, BIOCHEM BIOPH RES CO, V215, P632, DOI 10.1006/bbrc.1995.2511; Fernandez MR, 2007, CELL MOL LIFE SCI, V64, P1419, DOI 10.1007/s00018-007-7091-1; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fujii Y, 2001, J BIOL CHEM, V276, P28134, DOI 10.1074/jbc.M102880200; GALA JL, 1994, ANN HEMATOL, V69, P17, DOI 10.1007/BF01757343; GARLAND D, 1991, ARCH BIOCHEM BIOPHYS, V285, P134, DOI 10.1016/0003-9861(91)90339-K; Gaynon PS, 1998, CANCER, V82, P1387, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1; Ghisolfi L, 2009, J BIOL CHEM, V284, P20946, DOI 10.1074/jbc.M109.023721; GONZALEZ P, 1993, BIOCHEM BIOPH RES CO, V191, P902, DOI 10.1006/bbrc.1993.1302; GRANINGER WB, 1987, J CLIN INVEST, V80, P1512, DOI 10.1172/JCI113235; Graux C, 2006, LEUKEMIA, V20, P1496, DOI 10.1038/sj.leu.2404302; Harrison Christine J, 2002, Rev Clin Exp Hematol, V6, P91, DOI 10.1046/j.1468-0734.2002.00069.x; HUANG QL, 1987, CURR EYE RES, V6, P725, DOI 10.3109/02713688709034836; Ibrahim H, 2008, KIDNEY INT, V73, P11, DOI 10.1038/sj.ki.5002581; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Karawajew L, 2000, BLOOD, V96, P297, DOI 10.1182/blood.V96.1.297.013k24_297_306; Kranthi BV, 2006, NUCLEIC ACIDS RES, V34, P4060, DOI 10.1093/nar/gkl577; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; Mano J, 2000, BBA-PROTEIN STRUCT M, V1480, P374, DOI 10.1016/S0167-4838(00)00073-X; Morelli S, 1997, P NATL ACAD SCI USA, V94, P8150, DOI 10.1073/pnas.94.15.8150; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Porte S, 2009, CHEM-BIOL INTERACT, V178, P288, DOI 10.1016/j.cbi.2008.10.018; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; RAO PV, 1992, BIOCHIM BIOPHYS ACTA, V1117, P315; RAO PV, 1992, J BIOL CHEM, V267, P96; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Robertson LE, 1996, LEUKEMIA, V10, P456; RODOKANAKI A, 1989, GENE, V78, P215, DOI 10.1016/0378-1119(89)90224-2; Schiavone N, 2000, FASEB J, V14, P174, DOI 10.1096/fasebj.14.1.174; Schroeder JM, 2003, AM J PHYSIOL-RENAL, V285, pF258, DOI 10.1152/ajprenal.00422.2002; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; STEUBE KG, 1995, LEUKEMIA, V9, P1841; Tang A, 2001, J BIOL CHEM, V276, P21375, DOI 10.1074/jbc.M101941200; VALERIE I, 2008, IMMUNOL RES, V42, P84	54	17	18	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1852	1865		10.1096/fj.09-140459	http://dx.doi.org/10.1096/fj.09-140459			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20103721	Green Published, Green Submitted			2022-12-25	WOS:000278200000021
J	Shumilina, E; Xuan, NT; Matzner, N; Bhandaru, M; Zemtsova, IM; Lang, F				Shumilina, Ekaterina; Xuan, Nguyen Thi; Matzner, Nicole; Bhandaru, Madhuri; Zemtsova, Irina M.; Lang, Florian			Regulation of calcium signaling in dendritic cells by 1,25-dihydroxyvitamin D-3	FASEB JOURNAL			English	Article						Na+/Ca2+ exchanger; CD86; lipopolysaccharide; 3 ',4 '-dichlorobenzamyl	VITAMIN-D-RECEPTOR; DEPENDENT NA+/CA2+ EXCHANGERS; NA/CA EXCHANGE; CO-STIMULATION; CA2+; MODULATION; PATHWAYS; ENTRY; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; ENCEPHALOMYELITIS	Dendritic cells (DCs) are antigen- presenting cells that provide a link between innate and adaptive immunity. Ca2+-dependent signaling plays a central regulatory role in DC responses to diverse antigens. DCs are a primary target of 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3], a secosteroid hormone, that, in addition to its well-established action on Ca2+ homeostasis, possesses immunomodulatory properties. Surprisingly, nothing is known about its effects on DC cytosolic Ca2+ activity. The present study explored whether 1,25(OH)(2)D-3 modifies the intracellular Ca2+ concentration ([Ca2+](i)) in DCs. Here we show that mouse DCs expressed K+-independent (NCX1-3) and K+-dependent (NCKX1, 3, 4, and 5) Na+/Ca2+ exchangers. Acute application of LPS (100 ng/ml) to DCs increased [Ca2+](i), an effect significantly blunted by prior incubation with 1,25(OH)(2)D-3. 1,25(OH)(2)D-3 increased the membrane abundance of the NCKX1 protein, up-regulated the K+- and Na+-dependent Ca2+ entry and enhanced the K+-dependent Na+/Ca2+ exchanger currents. The NCKX blocker 3',4'-dichlorobenzamyl (DBZ) reversed the inhibitory effect of 1,25(OH)(2)D-3 on the LPS-induced increase of [Ca2+](i). Expression of the costimulatory molecule CD86 was down-regulated by 1,25(OH)(2)D-3, an effect reversed by DBZ. In summary, 1,25(OH)(2)D-3 blunts the LPS-induced increase in [Ca2+](i) by stimulation of Na+/Ca2+ exchanger-dependent Ca2+ extrusion, an effect that contributes to 1,25(OH)(2)D-3-mediated immunosuppression. The results disclose completely novel mechanisms in the regulation of DC maturation and function.-Shumilina, E., Xuan, N. T., Matzner, N., Bhandaru, M., Zemtsova, I. M., Lang, F. Regulation of calcium signaling in dendritic cells by 1,25-dihydroxyvitamin D-3. FASEB J. 24, 1989-1996 (2010). www.fasebj.org	[Shumilina, Ekaterina; Xuan, Nguyen Thi; Matzner, Nicole; Bhandaru, Madhuri; Zemtsova, Irina M.; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de		Xuan, Nguyen Thi/0000-0003-3494-5136	Deutsche Forschungsgemeinschaft [SFB 766, GRK 1302/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors gratefully acknowledge the technical assistance of E. Faber and the meticulous preparation of the manuscript by Lejla Subasic and Tanja Loch. This work was supported by the Deutsche Forschungsgemeinschaft (SFB 766; GRK 1302/1).	Adorini L, 2004, J STEROID BIOCHEM, V89-90, P437, DOI 10.1016/j.jsbmb.2004.03.013; Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Aneiros E, 2005, J IMMUNOL, V174, P119, DOI 10.4049/jimmunol.174.1.119; BALASUBRAMANYAM M, 1994, J CLIN INVEST, V94, P2002, DOI 10.1172/JCI117553; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; BECKLUND BR, 2009, P NATL ACAD SCI US; Bellou A, 2005, CURR ALLERGY ASTHM R, V5, P149, DOI 10.1007/s11882-005-0089-6; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Canitano A, 2002, ANN NY ACAD SCI, V976, P394; Cantorna MT, 1999, J NUTR, V129, P1966, DOI 10.1093/jn/129.11.1966; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Choy EH, 2009, CLIN EXP RHEUMATOL, V27, P510; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Connolly SF, 2007, IMMUNOL RES, V39, P115, DOI 10.1007/s12026-007-0076-1; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; den Haan JMM, 2000, P NATL ACAD SCI USA, V97, P12950, DOI 10.1073/pnas.97.24.12950; Fritsche J, 2003, BLOOD, V102, P3314, DOI 10.1182/blood-2002-11-3521; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Griffin MD, 2007, ARCH BIOCHEM BIOPHYS, V460, P218, DOI 10.1016/j.abb.2007.01.034; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Herchuelz A, 2007, ANN NY ACAD SCI, V1099, P456, DOI 10.1196/annals.1387.048; Herrmann TL, 2007, J LEUKOCYTE BIOL, V82, P686, DOI 10.1189/jlb.0107045; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; Hewison M, 2003, J BONE MINER RES, V18, P579, DOI 10.1359/jbmr.2003.18.3.579; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Imazeki I, 2006, BIOMED RES-TOKYO, V27, P1, DOI 10.2220/biomedres.27.1; Kimura M, 1999, AM J PHYSIOL-HEART C, V277, pH911, DOI 10.1152/ajpheart.1999.277.3.H911; Korhonen R, 2009, BASIC CLIN PHARMACOL, V104, P276, DOI 10.1111/j.1742-7843.2009.00375.x; Koski GK, 1999, J IMMUNOL, V163, P82; Lagana B, 2009, CLIN DRUG INVEST, V29, P185, DOI 10.2165/00044011-200929030-00005; Lambers TT, 2006, KIDNEY INT, V69, P650, DOI 10.1038/sj.ki.5000169; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Lyakh LA, 2005, J IMMUNOL, V174, P2061, DOI 10.4049/jimmunol.174.4.2061; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Penna G, 2007, J IMMUNOL, V178, P145, DOI 10.4049/jimmunol.178.1.145; Ramasamy I, 2006, CLIN CHEM LAB MED, V44, P237, DOI 10.1515/CCLM.2006.046; Reppel M, 2007, ANN NY ACAD SCI, V1099, P361, DOI 10.1196/annals.1387.065; Rogister F, 2001, EUR J MED CHEM, V36, P597, DOI 10.1016/S0223-5234(01)01247-8; Rumpel E, 2000, BIOPHYS J, V79, P2975, DOI 10.1016/S0006-3495(00)76534-9; Schmitt R, 1999, AM J PHYSIOL-RENAL, V276, pF367, DOI 10.1152/ajprenal.1999.276.3.F367; Sipido KR, 2007, ANN NY ACAD SCI, V1099, P339, DOI 10.1196/annals.1387.066; Staiano RL, 2009, EUR J IMMUNOL, V39, P1405, DOI 10.1002/eji.200838792; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Szeles L, 2009, J IMMUNOL, V182, P2074, DOI 10.4049/jimmunol.0803345; Tintinger GR, 2004, BIOCHEM PHARMACOL, V67, P2263, DOI 10.1016/j.bcp.2004.02.029; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Venetucci LA, 2007, ANN NY ACAD SCI, V1099, P315, DOI 10.1196/annals.1387.033; Visser F, 2007, PHYSIOLOGY, V22, P185, DOI 10.1152/physiol.00001.2007; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Vukcevic M, 2008, J BIOL CHEM, V283, P34913, DOI 10.1074/jbc.M804472200; Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001; Yu SH, 2008, P NATL ACAD SCI USA, V105, P5207, DOI 10.1073/pnas.0711558105; Zehnder D, 1999, MOL CELL ENDOCRINOL, V151, P213, DOI 10.1016/S0303-7207(99)00039-8	60	25	26	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1989	1996		10.1096/fj.09-142265	http://dx.doi.org/10.1096/fj.09-142265			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20124438				2022-12-25	WOS:000278200000033
J	Sun, DW; Nakao, S; Xie, F; Zandi, S; Schering, A; Hafezi-Moghadam, A				Sun, Dawei; Nakao, Shintaro; Xie, Fang; Zandi, Souska; Schering, Alexander; Hafezi-Moghadam, Ali			Superior sensitivity of novel molecular imaging probe: simultaneously targeting two types of endothelial injury markers	FASEB JOURNAL			English	Article						early diagnosis; ocular inflammation; leukocyte-endothelial interaction; adhesion molecules	ENDOTOXIN-INDUCED UVEITIS; SELECTIN GLYCOPROTEIN LIGAND-1; ROLLING IN-VIVO; P-SELECTIN; UP-REGULATION; CELLS; ADHESION; ICAM-1; LFA-1; DISEASE	The need remains great for early diagnosis of diseases. The special structure of the eye provides a unique opportunity for noninvasive light-based imaging of fundus vasculature. To detect endothelial injury at the early and reversible stage of adhesion molecule up-regulation, we generated novel imaging agents that target two distinct types of endothelial molecules, a mediator of rolling, P-selectin, and one that mediates firm adhesion, ICAM-1. Interactions of these double-conjugated fluorescent microspheres (MSs) in retinal or choroidal microvasculature were visualized in live animals by scanning laser ophthalmoscopy. The new imaging agents showed significantly higher sensitivity for detection of endothelial injury than singly conjugated MSs (rPSGL-1- or alpha-ICAM-1-conjugated), both in terms of rolling (P<0.01) and firm adhesion (P<0.01). The rolling flux of alpha-ICAM-1-conjugated MSs did not differ in EIU animals, whereas double-conjugated MSs showed significantly higher rolling flux (P<0.01), revealing that ICAM-1 in vivo supports rolling, once MS interaction with the endothelium is initiated. Double-conjugated MSs specifically detected firmly adhering leukocytes (P<0.01), allowing in vivo quantification of immune response. Antiinflammatory treatment with dexamethasone led to reduced leukocyte accumulation (P<0.01) as well as MS interaction (P<0.01), which suggests that treatment success and resolution of inflammation is quantitatively reflected with this molecular imaging approach. This work introduces novel imaging agents for noninvasive detection of endothelial injury in vivo. Our approach may be developed further to diagnose human disease at a much earlier stage than currently possible.-Sun, D., Nakao, S., Xie, F., Zandi, S., Schering, A., Hafezi-Moghadam, A. Superior sensitivity of novel molecular imaging probe: simultaneously targeting two types of endothelial injury markers. FASEB J. 24, 1532-1540 (2010). www.fasebj.org	[Sun, Dawei; Nakao, Shintaro; Xie, Fang; Zandi, Souska; Schering, Alexander; Hafezi-Moghadam, Ali] Harvard Univ, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Sch Med,Angiogenesis Lab, Boston, MA 02114 USA; [Sun, Dawei] Harbin Med Coll, Dept Ophthalmol, Affiliated Hosp 2, Harbin, Peoples R China	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harbin Medical University	Hafezi-Moghadam, A (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Sch Med,Angiogenesis Lab, 325 Cambridge St,3rd Floor, Boston, MA 02114 USA.	ali_hafezi-moghadam@hms.harvard.edu		Hafezi-Moghadam, Ali/0000-0002-5336-0697; Zandi, Souska/0000-0001-9351-4278	U.S. National Institute of Health (NIH) [AI050775, HL086933]; Science and Technology project of Heilongjiang Province, China [GB06C40104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050775] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science and Technology project of Heilongjiang Province, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Recombinant PSGL-1 (Y's PSGL) was a generous gift of Y's Therapeutics, Inc. (San Bruno, CA, USA). The authors thank Mark I. Melhorn and Rebecca C. Garland for their help in the preparation of this manuscript. This work was supported by U.S. National Institute of Health (NIH) grants AI050775 (A.H.-M.) and HL086933 (Alan Cross, University of Maryland, College Park, MD, USA), the American Health Assistance Foundation (A.H.-M.), and a Science and Technology project of Heilongjiang Province, China (GB06C40104 to D. S.). The authors thank the Massachusetts Lions Eye Research Fund Inc., Research to Prevent Blindness, and the Marion W. and Edward F. Knight AMD Fund. Author contributions: A.H.-M. designed research; D.S., S.N., F.X., and S.Z. performed research; D.S., A.S., and A.H.-M. analyzed data; D. S. and A.H.-M. wrote the paper.	Becker MD, 2001, INVEST OPHTH VIS SCI, V42, P2563; BISCHOFF PM, 1995, RETINA-J RET VIT DIS, V15, P91, DOI 10.1097/00006982-199515020-00002; CRONSTEIN BN, 1992, P NATL ACAD SCI USA, V89, P9991, DOI 10.1073/pnas.89.21.9991; Devine L, 1996, IMMUNOLOGY, V88, P456, DOI 10.1046/j.1365-2567.1996.d01-666.x; Durrani OM, 2004, OPHTHALMOLOGICA, V218, P223, DOI 10.1159/000078612; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Hafezi-Moghadam A, 2007, FASEB J, V21, P464, DOI 10.1096/fj.06-6390com; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Hafezi-Moghadam A, 1999, J EXP MED, V189, P939, DOI 10.1084/jem.189.6.939; Hirata Y, 2006, PROG RETIN EYE RES, V25, P129, DOI 10.1016/j.preteyeres.2005.08.001; Jin XH, 2006, INVEST OPHTH VIS SCI, V47, P2562, DOI 10.1167/iovs.05-1429; Kanagawa T, 1996, JPN J OPHTHALMOL, V40, P174; Khoobehi B, 1997, OPHTHALMIC SURG LAS, V28, P937; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Miyahara S, 2008, FASEB J, V22, P1973, DOI 10.1096/fj.07-096891; Miyamoto K, 1996, INVEST OPHTH VIS SCI, V37, P2708; Moore KL, 1998, LEUKEMIA LYMPHOMA, V29, P1, DOI 10.3109/10428199809058377; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Suzuma K, 1997, INVEST OPHTH VIS SCI, V38, P1610; Xu HP, 2003, INVEST OPHTH VIS SCI, V44, P226, DOI 10.1167/iovs.01-1202	23	25	25	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2010	24	5					1532	1540		10.1096/fj.09-148981	http://dx.doi.org/10.1096/fj.09-148981			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	589OD	20103715	Green Published			2022-12-25	WOS:000277158900026
J	Wolthers, KR; Levy, C; Scrutton, NS; Leys, D				Wolthers, Kirsten R.; Levy, Colin; Scrutton, Nigel S.; Leys, David			Large-scale Domain Dynamics and Adenosylcobalamin Reorientation Orchestrate Radical Catalysis in Ornithine 4,5-Aminomutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; ELECTRON-PARAMAGNETIC-RESONANCE; METHYLMALONYL-COA MUTASE; GLUTAMATE MUTASE; COENZYME B-12; PROTEIN; SUBSTRATE; INTERMEDIATE; MECHANISM	D-Ornithine 4,5-aminomutase (OAM) from Clostridium sticklandii converts D-ornithine to 2,4-diaminopentanoic acid by way of radical propagation from an adenosylcobalamin (AdoCbl) to a pyridoxal 5'-phosphate (PLP) cofactor. We have solved OAM crystal structures in different catalytic states that together demonstrate unusual stability of the AdoCbl Co-C bond and that radical catalysis is coupled to large-scale domain motion. The 2.0-angstrom substrate-free enzyme crystal structure reveals the Rossmann domain, harboring the intact AdoCbl cofactor, is tilted toward the edge of the PLP binding triosephosphate isomerase barrel domain. The PLP forms an internal aldimine link to the Rossmann domain through Lys(629), effectively locking the enzyme in this "open" pre-catalytic conformation. The distance between PLP and 5'-deoxyadenosyl group is 23 angstrom, and large-scale domain movement is thus required prior to radical catalysis. The OAM crystals contain two Rossmann domains within the asymmetric unit that are unconstrained by the crystal lattice. Surprisingly, the binding of various ligands to OAM crystals (in an oxygen-free environment) leads to transimination in the absence of significant reorientation of the Rossmann domains. In contrast, when performed under aerobic conditions, this leads to extreme disorder in the latter domains correlated with the loss of the 5'-deoxyadenosyl group. Our data indicate turnover and hence formation of the "closed" conformation is occurring within OAM crystals, but that the equilibrium is poised toward the open conformation. We propose that substrate binding induces large-scale domain motion concomitant with a reconfiguration of the 5'-deoxyadenosyl group, triggering radical catalysis in OAM.	[Wolthers, Kirsten R.; Levy, Colin; Scrutton, Nigel S.; Leys, David] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Manchester	Wolthers, KR (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	kirsten.wolthers@manchester.ac.uk; nigel.scrutton@manchester.ac.uk; david.leys@manchester.ac.uk	Wolthers, Kirsten/M-6833-2019	Levy, Colin/0000-0002-9724-310X	Biotechnology and Biological Sciences Research Council [BB/D01963X/1, BB/G001383/1, BB/H000577/1] Funding Source: Medline; BBSRC [BB/H000577/1, BB/D01963X/1, BB/G001383/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; Berkovitch F, 2004, P NATL ACAD SCI USA, V101, P15870, DOI 10.1073/pnas.0407074101; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bothe H, 1998, BIOCHEMISTRY-US, V37, P4105, DOI 10.1021/bi971393q; Brown KL, 1998, POLYHEDRON, V17, P2213, DOI 10.1016/S0277-5387(98)00053-9; Chang CH, 1996, BIOCHEMISTRY-US, V35, P11081, DOI 10.1021/bi960850k; Chen HP, 2001, J BIOL CHEM, V276, P44744, DOI 10.1074/jbc.M108365200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gruber K, 2001, ANGEW CHEM INT EDIT, V40, P3377, DOI 10.1002/1521-3773(20010917)40:18<3377::AID-ANIE3377>3.0.CO;2-8; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LENHERT PG, 1961, NATURE, V192, P937, DOI 10.1038/192937a0; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Mansoorabadi SO, 2005, BIOCHEMISTRY-US, V44, P3153, DOI 10.1021/bi0482102; Masuda J, 2000, STRUCTURE, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ouyang LZ, 2004, INORG CHEM, V43, P1235, DOI 10.1021/ic0348446; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; SCHEPLER KL, 1975, BIOCHIM BIOPHYS ACTA, V397, P510, DOI 10.1016/0005-2744(75)90141-2; SUMMERS MF, 1986, J AM CHEM SOC, V108, P4285, DOI 10.1021/ja00275a008; Toraya T, 2003, CHEM REV, V103, P2095, DOI 10.1021/cr020428b; Wetmore SD, 2001, J AM CHEM SOC, V123, P8678, DOI 10.1021/ja010211j; Wolthers KR, 2008, J BIOL CHEM, V283, P34615, DOI 10.1074/jbc.M807911200; Yoon M, 2006, BIOCHEMISTRY-US, V45, P11650, DOI 10.1021/bi061067n; ZHAO Y, 1994, EUR J BIOCHEM, V225, P891, DOI 10.1111/j.1432-1033.1994.0891b.x	33	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13942	13950		10.1074/jbc.M109.068908	http://dx.doi.org/10.1074/jbc.M109.068908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20106986	hybrid, Green Published			2022-12-25	WOS:000276987700068
J	Odyniec, AN; Barral, DC; Garg, S; Tatituri, RV; Besra, GS; Brenner, MB				Odyniec, Artur N.; Barral, Duarte C.; Garg, Salil; Tatituri, Raju V.; Besra, Gurdyal S.; Brenner, Michael B.			Regulation of CD1 Antigen-presenting Complex Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; T-CELLS; CYTOPLASMIC TAIL; LIPID ANTIGENS; MONOCLONAL-ANTIBODIES; B-CELLS; RECOGNITION; TRAFFICKING; EXPRESSION; BINDING	For major histocompatibility complex class I and II molecules, the binding of specific peptide antigens is essential for assembly and trafficking and is at the center of their quality control mechanism. However, the role of lipid antigen binding in stabilization and quality control of CD1 heavy chain (HC).beta(2)-microglobulin (beta(2)m) complexes is unclear. Furthermore, the distinct trafficking and loading routes of CD1 proteins take them from mildly acidic pH in early endososmal compartments (pH 6.0) to markedly acidic pH in lysosomes (pH 5.0) and back to neutral pH of the cell surface (pH 7.4). Here, we present evidence that the stability of each CD1 HC.beta(2)m complex is determined by the distinct pH optima identical to that of the intracellular compartments in which each CD1 isoform resides. Although stable at acidic endosomal pH, complexes are only stable at cell surface pH 7.4 when bound to specific lipid antigens. The proposed model outlines a quality control program that allows lipid exchange at low endosomal pH without dissociation of the CD1 HC.beta(2)m complex and then stabilizes the antigen-loaded complex at neutral pH at the cell surface.	[Odyniec, Artur N.; Barral, Duarte C.; Garg, Salil; Tatituri, Raju V.; Brenner, Michael B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Birmingham	Brenner, MB (corresponding author), Smith Bldg,Rm 552,1 Jimmy Fund Way, Boston, MA 02115 USA.	mbrenner@rics.bwh.harvard.edu	Garg, Salil/GXH-2201-2022; Barral, Duarte/E-7548-2013	Garg, Salil/0000-0002-7198-1833; Barral, Duarte/0000-0001-8867-2407; Besra, Gurdyal/0000-0002-5605-0395; Odyniec, Artur/0000-0001-7593-0809; Wojcik-Odyniec, Joanna/0000-0002-8495-4316	National Institutes of Health [R01 AI 028973, R01 AI 063428]; Royal Society; Medical Council; Wellcome Trust [084923/B/08/7]; Medical Research Council [G0400421] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063428, R01AI028973, R56AI063428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; MRC [G0400421] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Medical Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI 028973 and AI 063428 (to M. B. B.). This work was also supported by a personal research chair from Mr. James Badrick, Royal Society Wolfson Research Merit Award, as a former Lister Institute-Jenner Research Fellow, the Medical Council, and the Wellcome Trust (084923/B/08/7) (to G. S. B.).	BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Barral DC, 2008, TRAFFIC, V9, P1446, DOI 10.1111/j.1600-0854.2008.00781.x; Beckman EM, 1996, J IMMUNOL, V157, P2795; BEHAR SM, 1995, J EXP MED, V182, P2007, DOI 10.1084/jem.182.6.2007; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Kaser A, 2008, EUR J IMMUNOL, V38, P2351, DOI 10.1002/eji.200738102; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Lawton AP, 2005, J IMMUNOL, V174, P3179, DOI 10.4049/jimmunol.174.6.3179; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Manolova V, 2006, EUR J IMMUNOL, V36, P1083, DOI 10.1002/eji.200535544; MCMICHAEL AJ, 1979, EUR J IMMUNOL, V9, P205, DOI 10.1002/eji.1830090307; Melian A, 2000, J IMMUNOL, V165, P4494, DOI 10.4049/jimmunol.165.8.4494; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P2007; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; OLIVE D, 1984, IMMUNOGENETICS, V20, P253, DOI 10.1007/BF00364207; Paulsson KM, 2004, FASEB J, V18, P31, DOI 10.1096/fj.03-0846rev; Relloso M, 2008, IMMUNITY, V28, P774, DOI 10.1016/j.immuni.2008.04.017; Roark JH, 1998, J IMMUNOL, V160, P3121; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SMITH LM, 1982, P NATL ACAD SCI-BIOL, V79, P608, DOI 10.1073/pnas.79.2.608; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C; Sugita M, 2000, P NATL ACAD SCI USA, V97, P8445, DOI 10.1073/pnas.150236797; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Wubbolts R, 1999, IMMUNOL REV, V172, P189, DOI 10.1111/j.1600-065X.1999.tb01366.x; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104	43	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11937	11947		10.1074/jbc.M109.077933	http://dx.doi.org/10.1074/jbc.M109.077933			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20133943	Green Published, hybrid			2022-12-25	WOS:000276787100022
J	Tronconi, MA; Maurino, VG; Andreo, CS; Drincovich, MF				Tronconi, Marcos A.; Maurino, Veronica G.; Andreo, Carlos S.; Drincovich, Maria F.			Three Different and Tissue-specific NAD-Malic Enzymes Generated by Alternative Subunit Association in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; PHYSIOLOGICAL-FUNCTION; REGULATORY MECHANISM; EXPRESSION ANALYSIS; KINETIC-BEHAVIOR; PLANT DEFENSE; METABOLISM; MALATE; PURIFICATION; MAIZE	The Arabidopsis thaliana genome contains two genes encoding the mitochondrial NAD-malic enzyme (NAD-ME), NAD-ME1 (At2g13560) and NAD-ME2 (At4g00570). The characterization of recombinant NAD-ME1 and -2 indicated that both enzymes assemble as active homodimers; however, a heterodimeric enzyme (NAD-MEH) can also be detected by electrophoretic studies. To analyze the metabolic contribution of each enzymatic entity, NAD-MEH was obtained by a co-expression-based recombinant approach, and its kinetic and regulatory properties were analyzed. The three NAD-MEs show similar kinetic properties, although they differ in the regulation by several metabolic effectors. In this regard, whereas fumarate activates NAD-ME1 and CoA activates NAD-ME2, both compounds act synergistically on NAD-MEH activity. The characterization of two chimeric enzymes between NAD-ME1 and -2 allowed specific domains of the primary structure, which are involved in the differential allosteric regulation, to be identified. NAD-ME1 and -2 subunits showed a distinct pattern of accumulation in the separate components of the floral organ. In sepals, the NAD-ME1 subunit is present at a slightly higher proportion than the NAD-ME2 subunit, and thus, NAD-MEH and NAD-ME1 act in concert in this tissue. On the other hand, NAD-ME2 is the only isoform present in anthers. In view of the different properties of NAD-ME1, -2, and -H, we suggest that mitochondrial NAD-ME activity may be regulated by varying native association in vivo, rendering enzymatic entities with distinct allosteric regulation to fulfill specific roles. The presence of three different NAD-ME entities, which originate by alternative associations of two subunits, is suggested to be a novel phenomenon unique to plant mitochondria.	[Tronconi, Marcos A.; Andreo, Carlos S.; Drincovich, Maria F.] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, RA-2000 Rosario, Santa Fe, Argentina; [Maurino, Veronica G.] Univ Cologne, Inst Bot, D-50674 Cologne, Germany	National University of Rosario; University of Cologne	Andreo, CS (corresponding author), Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, Suipacha 531, RA-2000 Rosario, Santa Fe, Argentina.	candreo@fbioyf.unr.edu.ar	Drincovich, Maria F/F-3902-2017; Drincovich, Maria F/Q-4195-2019	Drincovich, Maria F/0000-0003-4897-3285; Drincovich, Maria F/0000-0003-4897-3285; Tronconi, Marcos/0000-0001-9568-7818	Agencia de Promocion Cientifica y Tecnologica [32233]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); Deutsche Forschungsgemeinschaft (Germany)	Agencia de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG))	This work was supported by the Agencia de Promocion Cientifica y Tecnologica (PICT Grant 32233) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) and the Deutsche Forschungsgemeinschaft (Germany).	Andre C, 2007, PLANT CELL, V19, P2006, DOI 10.1105/tpc.106.048629; Brown NJ, 2010, PLANT J, V61, P122, DOI 10.1111/j.1365-313X.2009.04040.x; CANELLAS PF, 1984, ARCH BIOCHEM BIOPHYS, V229, P414, DOI 10.1016/0003-9861(84)90171-1; Casati P, 1999, PHOTOSYNTH RES, V61, P99, DOI 10.1023/A:1006209003096; Casati P, 1997, PLANT CELL PHYSIOL, V38, P928, DOI 10.1093/oxfordjournals.pcp.a029253; DAVISSON VJ, 1985, BIOCHEM J, V225, P335, DOI 10.1042/bj2250335; de Bari L, 2007, BBA-BIOENERGETICS, V1767, P281, DOI 10.1016/j.bbabio.2007.02.010; Detarsio E, 2004, BIOCHEM J, V382, P1025, DOI 10.1042/BJ20040594; Drincovich MF, 2001, FEBS LETT, V490, P1, DOI 10.1016/S0014-5793(00)02331-0; Eastmond PJ, 1997, PLANT PHYSIOL, V114, P851, DOI 10.1104/pp.114.3.851; Fahnenstich H, 2007, PLANT PHYSIOL, V145, P640, DOI 10.1104/pp.107.104455; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; GROVER SD, 1982, PLANT PHYSIOL, V70, P1169, DOI 10.1104/pp.70.4.1169; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kapri R., 2000, ACTA HORTIC, V535, P113; Karsten WE, 2003, BIOCHEMISTRY-US, V42, P9712, DOI 10.1021/bi034101w; Kurimoto K, 2004, PLANT CELL PHYSIOL, V45, P1015, DOI 10.1093/pcp/pch116; LAEMMLI UK, 1970, NATURE, V227, P685; Lemaitre T, 2006, PLANT CELL PHYSIOL, V47, P634, DOI 10.1093/pcp/pcj030; Liu SK, 2007, PLANT MOL BIOL, V64, P49, DOI 10.1007/s11103-007-9133-3; LONG JJ, 1994, J BIOL CHEM, V269, P2827; MARTINOIA E, 1994, ANNU REV PLANT PHYS, V45, P447, DOI 10.1146/annurev.pp.45.060194.002311; Maurino VG, 2001, PLANT MOL BIOL, V45, P409, DOI 10.1023/A:1010665910095; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Muller GL, 2008, PLANT CELL PHYSIOL, V49, P469, DOI 10.1093/pcp/pcn022; MURATA T, 1989, PLANT PHYSIOL, V89, P316, DOI 10.1104/pp.89.1.316; NAGEL WO, 1982, J BIOL CHEM, V257, P2405; O'Leary B, 2009, J BIOL CHEM, V284, P24797, DOI 10.1074/jbc.M109.022863; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; Rontein D, 2002, J BIOL CHEM, V277, P43948, DOI 10.1074/jbc.M206366200; Saigo M, 2004, PLANT MOL BIOL, V55, P97, DOI 10.1007/s11103-004-0472-z; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SMITH RG, 1992, PLANT PHYSIOL, V98, P1233, DOI 10.1104/pp.98.4.1233; Suzuki J., 2003, Genetics and Molecular Research, V2, P376; Tronconi MA, 2008, PLANT PHYSIOL, V146, P1540, DOI 10.1104/pp.107.114975; WEDDING RT, 1989, PLANT PHYSIOL, V90, P367, DOI 10.1104/pp.90.2.367; Wheeler MCG, 2005, PLANT PHYSIOL, V139, P39, DOI 10.1104/pp.105.065953; WILLEFORD KO, 1987, J BIOL CHEM, V262, P8423; WINNING BM, 1994, J BIOL CHEM, V269, P4780; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	42	32	35	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11870	11879		10.1074/jbc.M109.097477	http://dx.doi.org/10.1074/jbc.M109.097477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20133948	Green Published, hybrid			2022-12-25	WOS:000276787100015
J	Fernandez, IS; Cuevas, P; Angulo, J; Lopez-Navajas, P; Canales-Mayordomo, A; Gonzalez-Corrochano, R; Lozano, RM; Valverde, S; Jimenez-Barbero, J; Romero, A; Gimenez-Gallego, G				Fernandez, Israel S.; Cuevas, Pedro; Angulo, Javier; Lopez-Navajas, Pilar; Canales-Mayordomo, Angeles; Gonzalez-Corrochano, Rocio; Lozano, Rosa M.; Valverde, Serafin; Jimenez-Barbero, Jesus; Romero, Antonio; Gimenez-Gallego, Guillermo			Gentisic Acid, a Compound Associated with Plant Defense and a Metabolite of Aspirin, Heads a New Class of in Vivo Fibroblast Growth Factor Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FACTOR RECEPTOR; HEPARIN-BINDING; TUMOR-GROWTH; FACTOR FGF; C6 GLIOMA; ANGIOGENESIS; AFFINITY; CELLS; RESISTANCE	Fibroblast growth factors are key proteins in many intercellular signaling networks. They normally remain attached to the extracellular matrix, which confers on them a considerable stability. The unrestrained accumulation of fibroblast growth factors in the extracellular milieu, either due to uncontrolled synthesis or enzymatic release, contributes to the pathology of many diseases. Consequently, the neutralization of improperly mobilized fibroblast growth factors is of clear therapeutic interest. In pursuing described rules to identify potential inhibitors of these proteins, gentisic acid, a plant pest-controlling compound, an aspirin and vegetarian diet common catabolite, and a component of many traditional liquors and herbal remedies, was singled out as a powerful inhibitor of fibroblast growth factors. Gentisic acid was used as a lead to identify additional compounds with better inhibitory characteristics generating a new chemical class of fibroblast growth factor inhibitors that includes the agent responsible for alkaptonuria. Through low and high resolution approaches, using representative members of the fibroblast growth factor family and their cell receptors, it was shown that this class of inhibitors may employ two different mechanisms to interfere with the assembly of the signaling complexes that trigger fibroblast growth factor-driven mitogenesis. In addition, we obtained evidence from in vivo disease models that this group of inhibitors may be of interest to treat cancer and angiogenesis-dependent diseases.	[Fernandez, Israel S.; Lopez-Navajas, Pilar; Canales-Mayordomo, Angeles; Gonzalez-Corrochano, Rocio; Lozano, Rosa M.; Jimenez-Barbero, Jesus; Romero, Antonio; Gimenez-Gallego, Guillermo] CSIC, Ctr Invest Biol, Dept Biol Fis Quim, Madrid 28040, Spain; [Cuevas, Pedro; Angulo, Javier; Gonzalez-Corrochano, Rocio] Hosp Univ Ramon y Cajal, Dept Invest, Serv Histol, Madrid 28034, Spain; [Valverde, Serafin] CSIC, Inst Quim Organ Gen, Dept Nat Prod, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario Ramon y Cajal; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Organica General (IQOG)	Gimenez-Gallego, G (corresponding author), Ramiro de Maeztu 9, Madrid 28040, Spain.	gimenez_gallego@cib.csic.es	Canales, Angeles/K-7499-2015; Romero, Antonio/K-5754-2014; JIMENEZ-BARBERO, JESUS/D-4431-2014	Canales, Angeles/0000-0003-0542-3080; Romero, Antonio/0000-0002-6990-6973; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Lozano, Rosa Maria/0000-0003-2762-6938	Ministerio de Educacion y Ciencia (Spain) [BFU2008-02595]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by BFU2008-02595 from the Ministerio de Educacion y Ciencia (Spain).	Abuharbeid S, 2006, INT J BIOCHEM CELL B, V38, P1463, DOI 10.1016/j.biocel.2005.10.017; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Aoki T, 2002, INT J ONCOL, V21, P629; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAIRD A, 1990, HDB EXPT PHARM, V95, P369; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; CAMPBEL WF, 1964, J RANGE MANAGE, V37, P365; Canales A, 2006, FEBS J, V273, P4716, DOI 10.1111/j.1742-4658.2006.05474.x; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cuevas P, 2005, NEUROL RES, V27, P797, DOI 10.1179/016164105X63665; Cuevas P, 2004, NEUROL RES, V26, P273, DOI 10.1179/016164104225013941; Cuevas P, 1997, GROWTH FACTORS, V15, P29, DOI 10.3109/08977199709002110; CUEVAS P, 1994, NEUROL RES, V16, P310; Cuevas P, 1996, NEUROSCI LETT, V221, P25, DOI 10.1016/S0304-3940(96)13277-8; Cuevas P, 1996, P NATL ACAD SCI USA, V93, P11996, DOI 10.1073/pnas.93.21.11996; CUEVAS P, 1994, CELL SIGNAL TRANSDUCTION, SECOND MESSENGERS, AND PROTEIN PHOSPHORYLATION IN HEALTH AND DISEASE, P161; Cuevas P, 1999, NEUROL RES, V21, P191, DOI 10.1080/01616412.1999.11740917; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Dirix LY, 1997, BRIT J CANCER, V76, P238, DOI 10.1038/bjc.1997.368; Dvorak P, 2006, FEBS LETT, V580, P2869, DOI 10.1016/j.febslet.2006.01.095; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON AE, 1993, PROTEIN SCI, V2, P1274, DOI 10.1002/pro.5560020810; ESCH F, 1985, P NATL ACAD SCI USA, V82, P6507, DOI 10.1073/pnas.82.19.6507; Fernandez-Tornero C, 2005, J BIOL CHEM, V280, P19948, DOI 10.1074/jbc.M501236200; Fernandez-Tornero C, 2003, J BIOL CHEM, V278, P21774, DOI 10.1074/jbc.M212833200; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; FISCHER DC, 1990, J ENTOMOL SCI, V25, P230, DOI 10.18474/0749-8004-25.2.230; Gerstner ER, 2007, EXPERT OPIN INV DRUG, V16, P1895, DOI 10.1517/13543784.16.12.1895; GIMENEZGALLEGO G, 1986, BIOCHEM BIOPH RES CO, V135, P541, DOI 10.1016/0006-291X(86)90028-8; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; GRIFFITHS LA, 1958, NATURE, V182, P733, DOI 10.1038/182733a0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; HARPER JW, 1988, BIOCHEMISTRY-US, V27, P671, DOI 10.1021/bi00402a027; HOUSSAINT E, 1990, P NATL ACAD SCI USA, V87, P8180, DOI 10.1073/pnas.87.20.8180; Indraccolo S, 2006, P NATL ACAD SCI USA, V103, P4216, DOI 10.1073/pnas.0506200103; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jeffers Michael, 2002, Expert Opin Ther Targets, V6, P469, DOI 10.1517/14728222.6.4.469; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805; Lee JT, 2007, J CELL PHYSIOL, V213, P603, DOI 10.1002/jcp.21252; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Lozano RM, 1998, J MOL BIOL, V281, P899, DOI 10.1006/jmbi.1998.1977; Lozano RM, 2001, J BIOL CHEM, V276, P35723, DOI 10.1074/jbc.M101565200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McKeehan WL, 1997, IN VITRO CELL DEV-AN, V33, P727, DOI 10.1007/s11626-997-0146-7; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; OKUMURA N, 1989, J BIOCHEM-TOKYO, V106, P904, DOI 10.1093/oxfordjournals.jbchem.a122950; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; ORTEGA S, 1992, BIO-TECHNOL, V10, P795, DOI 10.1038/nbt0792-795; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; PESENTI E, 1992, BRIT J CANCER, V66, P367, DOI 10.1038/bjc.1992.272; PinedaLucena A, 1996, J MOL BIOL, V264, P162, DOI 10.1006/jmbi.1996.0631; PINEDALUCENA A, 1994, J MOL BIOL, V242, P81, DOI 10.1006/jmbi.1994.1558; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RODTS GE, 1994, NEUROL RES, V16, P184; Romero A, 1996, EUR J BIOCHEM, V241, P453, DOI 10.1111/j.1432-1033.1996.00453.x; Santiago R, 2005, J ECON ENTOMOL, V98, P1349, DOI 10.1603/0022-0493-98.4.1349; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Scrutton NS, 1996, BIOCHEM J, V319, P1; Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; STEFANIK DF, 1991, CANCER RES, V51, P5760; Szebenyi G, 1999, INT REV CYTOL, V185, P45; THOMAS KA, 1985, P NATL ACAD SCI USA, V82, P6409, DOI 10.1073/pnas.82.19.6409; THOMAS KA, 1986, TRENDS BIOCHEM SCI, V11, P81, DOI 10.1016/0968-0004(86)90271-9; TODD GW, 1971, ANN ENTOMOL SOC AM, V64, P718, DOI 10.1093/aesa/64.3.718; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208; Wang HM, 1997, BIOCHEM BIOPH RES CO, V235, P369, DOI 10.1006/bbrc.1997.6789; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	90	53	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11714	11729		10.1074/jbc.M109.064618	http://dx.doi.org/10.1074/jbc.M109.064618			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145243	hybrid, Green Published			2022-12-25	WOS:000276286200075
J	Takeuchi, Y; Yahagi, N; Izumida, Y; Nishi, M; Kubota, M; Teraoka, Y; Yamamoto, T; Matsuzaka, T; Nakagawa, Y; Sekiya, M; Iizuka, Y; Ohashi, K; Osuga, J; Gotoda, T; Ishibashi, S; Itaka, K; Kataoka, K; Nagai, R; Yamada, N; Kadowaki, T; Shimano, H				Takeuchi, Yoshinori; Yahagi, Naoya; Izumida, Yoshihiko; Nishi, Makiko; Kubota, Midori; Teraoka, Yuji; Yamamoto, Takashi; Matsuzaka, Takashi; Nakagawa, Yoshimi; Sekiya, Motohiro; Iizuka, Yoko; Ohashi, Ken; Osuga, Jun-ichi; Gotoda, Takanari; Ishibashi, Shun; Itaka, Keiji; Kataoka, Kazunori; Nagai, Ryozo; Yamada, Nobuhiro; Kadowaki, Takashi; Shimano, Hitoshi			Polyunsaturated Fatty Acids Selectively Suppress Sterol Regulatory Element-binding Protein-1 through Proteolytic Processing and Autoloop Regulatory Circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GENE-TRANSCRIPTION; PROMOTER ANALYSIS; TRANSGENIC MICE; CULTURED-CELLS; MESSENGER-RNAS; MOUSE-LIVER; X-RECEPTOR; EXPRESSION; SREBP-1	Sterol regulatory element-binding protein (SREBP)-1 is a key transcription factor for the regulation of lipogenic enzyme genes in the liver. Polyunsaturated fatty acids (PUFA) selectively suppress hepatic SREBP-1, but molecular mechanisms remain largely unknown. To gain insight into this regulation, we established in vivo reporter assays to assess the activities of Srebf1c transcription and proteolytic processing. Using these in vivo reporter assays, we showed that the primary mechanism for PUFA suppression of SREBP-1 is at the proteolytic processing level and that this suppression in turn decreases the mRNA transcription through lowering SREBP-1 binding to the SREBP-binding element on the promoter ("autoloop regulatory circuit"), although liver X receptor, an activator for Srebf1c transcription, is not involved in this regulation by PUFA. The mechanisms for PUFA suppression of SREBP-1 confirm that the autoloop regulation for transcription is crucial for the nutritional regulation of triglyceride synthesis.	[Takeuchi, Yoshinori; Yahagi, Naoya; Izumida, Yoshihiko; Nishi, Makiko; Kubota, Midori; Teraoka, Yuji; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Lab Mol Physiol Energy Metab, Tokyo 1138655, Japan; [Takeuchi, Yoshinori; Yahagi, Naoya; Izumida, Yoshihiko; Nishi, Makiko; Kubota, Midori; Teraoka, Yuji; Yamamoto, Takashi; Sekiya, Motohiro; Iizuka, Yoko; Ohashi, Ken; Osuga, Jun-ichi; Gotoda, Takanari; Ishibashi, Shun; Nagai, Ryozo; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan; [Itaka, Keiji; Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Tokyo 1138655, Japan; [Takeuchi, Yoshinori; Matsuzaka, Takashi; Nakagawa, Yoshimi; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tsukuba	Yahagi, N (corresponding author), 7-3-1 Hongo,Bunkyoku, Tokyo 1138655, Japan.	nyahagi-tky@umin.ac.jp; shimano-tky@umin.ac.jp	Yahagi, Naoya/D-2360-2014; Shimano, Hitoshi/V-1761-2019; Shimano, Hitoshi/AAI-5648-2020	Yahagi, Naoya/0000-0002-1823-1865; Shimano, Hitoshi/0000-0002-5562-5572; Kataoka, Kazunori/0000-0002-8591-413X	Ministry of Science, Education, Culture and Technology of Japan; The Uehara Memorial Foundation; ONO Medical Research Foundation; Takeda Science Foundation; Suzuken Memorial Foundation; Japan Heart Foundation; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Japan Foundation for Applied Enzymology; Okinaka Memorial Institute for Medical Research; Grants-in-Aid for Scientific Research [21591123] Funding Source: KAKEN	Ministry of Science, Education, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Uehara Memorial Foundation(Uehara Memorial Foundation); ONO Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Japan Heart Foundation; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Japan Foundation for Applied Enzymology; Okinaka Memorial Institute for Medical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Science, Education, Culture and Technology of Japan (to N.Y. and H. S.) and research grants from The Uehara Memorial Foundation, ONO Medical Research Foundation, Takeda Science Foundation, Suzuken Memorial Foundation, Japan Heart Foundation, Kanae Foundation for the Promotion of Medical Science, Senri Life Science Foundation, Japan Foundation for Applied Enzymology, and Okinaka Memorial Institute for Medical Research (to N.Y.).	ALLMANN DW, 1965, J LIPID RES, V6, P51; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CLARKE SD, 1994, ANNU REV NUTR, V14, P83, DOI 10.1146/annurev.nu.14.070194.000503; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOODRIDGE AG, 1991, BIOCH LIPIDS LIPOPRO, P111; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005; Irisawa M, 2009, J BIOL CHEM, V284, P28995, DOI 10.1074/jbc.M109.041376; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Nakatani T, 2003, J LIPID RES, V44, P369, DOI 10.1194/jlr.M200289-JLR200; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; SATTLER W, 1991, ANAL BIOCHEM, V198, P184, DOI 10.1016/0003-2697(91)90526-Y; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Takeuchi Y, 2007, BIOCHEM BIOPH RES CO, V363, P329, DOI 10.1016/j.bbrc.2007.08.165; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	37	101	104	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11681	11691		10.1074/jbc.M109.096107	http://dx.doi.org/10.1074/jbc.M109.096107			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145241	Green Published, hybrid			2022-12-25	WOS:000276286200072
J	Aktary, Z; Chapman, K; Lam, L; Lo, A; Ji, C; Graham, K; Cook, L; Li, L; Mackey, JR; Pasdar, M				Aktary, Z.; Chapman, K.; Lam, L.; Lo, A.; Ji, C.; Graham, K.; Cook, L.; Li, L.; Mackey, J. R.; Pasdar, M.			Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1	ONCOGENE			English	Article						plakoglobin; tumor suppressor; Nm23; cadherin; alpha-catenin	GAMMA-CATENIN EXPRESSION; SQUAMOUS CARCINOMA-CELLS; KIDNEY EPITHELIAL-CELLS; BETA-CATENIN; E-CADHERIN; ALPHA-CATENIN; C-MYC; SUBCELLULAR-LOCALIZATION; DESMOPLAKIN ORGANIZATION; SPATIAL REGULATION	Plakoglobin (gamma-catenin) is a homolog of beta-catenin with similar dual adhesive and signaling functions. The adhesive function of these proteins is mediated by their interactions with cadherins, whereas their signaling activity is regulated by association with various intracellular partners. In this respect, beta-catenin has a well-defined oncogenic activity through its role in the Wnt signaling pathway, whereas plakoglobin acts as a tumor/metastasis suppressor through mechanisms that remain unclear. We previously expressed plakoglobin in SCC9 squamous carcinoma cells (SCC9-P) and observed a mesenchymal-to-epidermoid transition. Comparison of the protein and RNA profiles of parental SCC9 cells and SCC9-P transfectants identified various differentially expressed proteins and transcripts, including the nonmetastatic protein 23 (Nm23). In this study, we show that Nm23-H1 mRNA and Nm23-H2 protein are increased after plakoglobin expression. Coimmunoprecipitation and confocal microscopy studies using SCC9-P and various epithelial cell lines with endogenous plakoglobin expression revealed that Nm23 interacts with plakoglobin, cadherins and alpha-catenin. Furthermore, Nm23-H2 is the primary isoform involved in these interactions, which occur prominently in the cytoskeleton-associated pool of cellular proteins. In addition, we show that plakoglobin-Nm23 interaction requires the N-terminal (alpha-catenin interacting) domain of plakoglobin. Our data suggest that by increasing the expression and stability of Nm23, plakoglobin has a role in regulating the metastasis suppressor activity of Nm23, which may further provide a potential mechanism for the tumor/metastasis suppressor function of plakoglobin itself. Oncogene (2010) 29, 2118-2129; doi: 10.1038/onc.2009.495; published online 25 January 2010	[Aktary, Z.; Chapman, K.; Lam, L.; Pasdar, M.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Lo, A.; Ji, C.; Li, L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2H7, Canada; [Graham, K.; Cook, L.; Mackey, J. R.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta	Pasdar, M (corresponding author), Univ Alberta, Dept Cell Biol, 6-24 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	mpasdar@ualberta.ca	Li, Liang/D-1822-2011	Aktary, Zackie/0000-0002-7238-3245	Alberta Cancer Research Institute; Canadian Breast Cancer Foundation-Prairies/NWT Chapter; Canadian Institutes of Health Research Frederick Banting; Charles Best Canada Graduate Scholarships; Canadian Research Chairs Program; Alberta Cancer Foundation; Killam Doctoral Award	Alberta Cancer Research Institute; Canadian Breast Cancer Foundation-Prairies/NWT Chapter; Canadian Institutes of Health Research Frederick Banting(Canadian Institutes of Health Research (CIHR)); Charles Best Canada Graduate Scholarships; Canadian Research Chairs Program(Canada Research Chairs); Alberta Cancer Foundation; Killam Doctoral Award	This work is supported by the Alberta Cancer Research Institute and the Canadian Breast Cancer Foundation-Prairies/NWT Chapter (MP) and Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarships award (ZA). LL is supported by the Canadian Research Chairs Program. JM is supported by the Alberta Cancer Research Institute and Alberta Cancer Foundation. ZA currently holds a Killam Doctoral Award.	Arnaud-Dabernat S, 2004, EXP CELL RES, V301, P293, DOI 10.1016/j.yexcr.2004.07.026; Ayabe Takanori, 2004, Ann Thorac Cardiovasc Surg, V10, P152; Bago R, 2009, MOL CARCINOGEN, V48, P779, DOI 10.1002/mc.20536; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Bosnar MH, 2009, MOL CELL BIOCHEM, V329, P63, DOI 10.1007/s11010-009-0107-4; Bosnar MH, 2004, EXP CELL RES, V298, P275, DOI 10.1016/j.yexcr.2004.04.018; Che G, 2006, NEOPLASMA, V53, P530; Chen XF, 2005, LUNG CANCER, V48, P69, DOI 10.1016/j.lungcan.2004.09.009; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Garrod D, 2008, BIOCHEM SOC T, V36, P195, DOI 10.1042/BST0360195; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Holthofer B, 2007, INT REV CYTOL, V264, P65, DOI 10.1016/S0074-7696(07)64003-0; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huber O, 2008, CELL CYCLE, V7, P1326, DOI 10.4161/cc.7.10.5926; IGAWA M, 1994, CANCER RES, V54, P1313; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Ji CJ, 2005, J PROTEOME RES, V4, P1419, DOI 10.1021/pr050094h; Jin L, 2009, LIFE SCI, V84, P458, DOI 10.1016/j.lfs.2009.01.010; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Jung S, 2006, ANTICANCER RES, V26, P249; Kanazawa Y, 2008, ANTICANCER RES, V28, P655; Khan MH, 2001, AM J PATHOL, V158, P1785, DOI 10.1016/S0002-9440(10)64134-X; Kim HD, 2009, MOL CELL BIOCHEM, V329, P167, DOI 10.1007/s11010-009-0109-2; Kolligs FT, 2000, GENE DEV, V14, P1319; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lam L, 2009, BREAST CANCER RES TR, V118, P605, DOI 10.1007/s10549-008-0231-y; Lee HY, 1999, CANCER LETT, V145, P93, DOI 10.1016/S0304-3835(99)00236-0; Lee MY, 2009, CANCER LETT, V275, P221, DOI 10.1016/j.canlet.2008.10.018; Li LJ, 2007, MOL CARCINOGEN, V46, P824, DOI 10.1002/mc.20310; Li Z, 1998, J CELL SCI, V111, P1005; MACDONALD NJ, 1993, J BIOL CHEM, V268, P25780; McDermott WG, 2008, CLIN EXP METASTAS, V25, P131, DOI 10.1007/s10585-007-9128-0; Miyazaki H, 1999, CLIN CANCER RES, V5, P4301; MORTON RA, 1993, CANCER RES, V53, P3585; Nakanishi K, 2006, ARCH PATHOL LAB MED, V130, P1330; Narkio-Makela M, 2009, ARCH OTOLARYNGOL, V135, P1035, DOI 10.1001/archoto.2009.132; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Pantel K, 1998, J CLIN ONCOL, V16, P1407, DOI 10.1200/JCO.1998.16.4.1407; Parker HR, 1998, CELL MOTIL CYTOSKEL, V40, P87, DOI 10.1002/(SICI)1097-0169(1998)40:1<87::AID-CM8>3.0.CO;2-C; PASDAR M, 1988, J CELL BIOL, V106, P677, DOI 10.1083/jcb.106.3.677; PASDAR M, 1988, J CELL BIOL, V106, P687, DOI 10.1083/jcb.106.3.687; PASDAR M, 1995, CELL MOTIL CYTOSKEL, V32, P258, DOI 10.1002/cm.970320403; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; SACCO PA, 1995, J BIOL CHEM, V270, P20201, DOI 10.1074/jbc.270.34.20201; Schuldiner O, 2002, GENE, V292, P91, DOI 10.1016/S0378-1119(02)00668-6; Simcha I, 1996, J CELL BIOL, V133, P199, DOI 10.1083/jcb.133.1.199; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; STEEG PS, 1988, CANCER RES, V48, P6550; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Suzuki E, 2004, INT J CANCER, V108, P207, DOI 10.1002/ijc.11546; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Tee Yi-Torng, 2006, Taiwan J Obstet Gynecol, V45, P107; Torlakovic E, 2002, HUM PATHOL, V33, P646, DOI 10.1053/hupa.2002.124033; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wagner PD, 1997, P NATL ACAD SCI USA, V94, P9000, DOI 10.1073/pnas.94.17.9000; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhurinsky J, 2000, J CELL SCI, V113, P3127; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	74	44	45	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2010	29	14					2118	2129		10.1038/onc.2009.495	http://dx.doi.org/10.1038/onc.2009.495			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101217				2022-12-25	WOS:000276402800010
J	Bruscoli, S; Donato, V; Velardi, E; Di Sante, M; Migliorati, G; Donato, R; Riccardi, C				Bruscoli, Stefano; Donato, Valerio; Velardi, Enrico; Di Sante, Moises; Migliorati, Graziella; Donato, Rosario; Riccardi, Carlo			Glucocorticoid-induced Leucine Zipper (GILZ) and Long GILZ Inhibit Myogenic Differentiation and Mediate Anti-myogenic Effects of Glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MUSCLE; MYOD; PROTEIN; APOPTOSIS; PATHWAY; ACETYLATION; MACROPHAGES; RECRUITMENT; ACTIVATION	Myogenesis is a process whereby myoblasts differentiate and fuse into multinucleated myotubes, the precursors of myofibers. Various signals and factors modulate this process, and glucocorticoids (GCs) are important regulators of skeletal muscle metabolism. We show that glucocorticoid-induced leucine zipper (GILZ), a GC-induced gene, and the newly identified isoform long GILZ (L-GILZ) are expressed in skeletal muscle tissue and in C2C12 myoblasts where GILZ/L-GILZ maximum expression occurs during the first few days in differentiation medium. Moreover, we observed that GC treatment of myoblasts, which increased GILZ/L-GILZ expression, resulted in reduced myotube formation, whereas GILZ and L-GILZ silencing dampened GC effects. Inhibition of differentiation caused by GILZ/L-GILZ overexpression correlated with inhibition of MyoD function and reduced expression of myogenin. Notably, results indicate that GILZ and L-GILZ bind and regulate MyoD/HDAC1 transcriptional activity, thus mediating the anti-myogenic effect of GCs.	[Bruscoli, Stefano; Donato, Valerio; Velardi, Enrico; Di Sante, Moises; Migliorati, Graziella; Riccardi, Carlo] Univ Perugia, Dipartimento Med Clin & Sperimentale, Sez Farmacol Tossicol & Chemioterapia, I-06122 Perugia, Italy; [Donato, Rosario] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, Sez Anat, I-06122 Perugia, Italy	University of Perugia; University of Perugia	Riccardi, C (corresponding author), Via Giochetto, I-06122 Perugia, Italy.	riccardi@unipg.it	Donato, Rosario/I-3943-2019; Velardi, Enrico/AAB-7443-2019; Riccardi, Carlo/N-4610-2014; di sante, moises/AAZ-4936-2020; velardi, Enrico/AAC-5440-2022	Velardi, Enrico/0000-0001-8383-0453; Riccardi, Carlo/0000-0001-9257-3997; bruscoli, stefano/0000-0003-0313-1615; MIGLIORATI, Graziella/0000-0002-9475-6399; Di Sante, Moises/0000-0002-4174-1257	Associazione Italiana per la Ricerca sul Cancro Milan; Ministero Istruzione Universita della Ricerca; Fondo per gli Investimenti della Ricerca di Base [RBPR05NWWC CHEM-PROFARMA-NET]	Associazione Italiana per la Ricerca sul Cancro Milan(Fondazione AIRC per la ricerca sul cancro); Ministero Istruzione Universita della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was been supported by grants from Associazione Italiana per la Ricerca sul Cancro Milan (to C. R.) and by Ministero Istruzione Universita della Ricerca, Fondo per gli Investimenti della Ricerca di Base Grant RBPR05NWWC CHEM-PROFARMA-NET.	Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Betters JL, 2008, MUSCLE NERVE, V37, P203, DOI 10.1002/mus.20915; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Bruscoli S, 2006, EUR J PHARMACOL, V529, P63, DOI 10.1016/j.ejphar.2005.10.053; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Dekelbab BH, 2007, STEROIDS, V72, P705, DOI 10.1016/j.steroids.2007.05.007; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hopkins RL, 2005, ENDOCRIN METAB CLIN, V34, P371, DOI 10.1016/j.ecl.2005.01.013; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; KHAN MA, 1993, J NEUROL SCI, V120, P8, DOI 10.1016/0022-510X(93)90017-S; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Lovett FA, 2006, J CELL SCI, V119, P4828, DOI 10.1242/jcs.03278; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lundberg I, 2000, ARTHRITIS RHEUM, V43, P336, DOI 10.1002/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Mastaglia FL, 2003, MUSCLE NERVE, V27, P407, DOI 10.1002/mus.10313; Menconi M, 2007, CRIT CARE MED, V35, pS602, DOI 10.1097/01.CCM.0000279194.11328.77; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Muller OG, 2003, J AM SOC NEPHROL, V14, P1107, DOI 10.1097/01.ASN.0000061777.67332.77; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Pujols L, 2002, AM J PHYSIOL-CELL PH, V283, pC1324, DOI 10.1152/ajpcell.00363.2001; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200	57	49	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10385	10396		10.1074/jbc.M109.070136	http://dx.doi.org/10.1074/jbc.M109.070136			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20124407	Green Published, hybrid			2022-12-25	WOS:000276264600024
J	Cailotto, F; Sebillaud, S; Netter, P; Jouzeau, JY; Bianchi, A				Cailotto, Frederic; Sebillaud, Sylvie; Netter, Patrick; Jouzeau, Jean-Yves; Bianchi, Arnaud			The Inorganic Pyrophosphate Transporter ANK Preserves the Differentiated Phenotype of Articular Chondrocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAY; GENE-EXPRESSION; MESSENGER-RNA; WNT PATHWAY; CARTILAGE; MECHANISMS; JOINT; CELLS	The differentiated phenotype of chondrocyte is lost in pathological situations and after interleukin (IL)-1 beta challenge. Wnt proteins and the inorganic pyrophosphate (PPi) transporter Ank regulate the differentiation process in many cell types. We investigated the possible contribution of Ank and/or PPi to the maintenance of the differentiated chondrocyte phenotype with special care to Wnt signaling. Primary articular chondrocytes lost their phenotype upon IL-1 beta challenge, with cessation of type II collagen and Sox-9 expression. Ank expression and PPi transport were strongly reduced by IL-1 beta, whereas Wnt-5a was the only Wnt protein increased. Transient overexpression of Ank counteracted most of IL-1 beta effects on Type II collagen, Sox-9, and Wnt-5a expression. When resting chondrocytes were transfected with a siRNA against Ank, this reproduced the phenotype induced by IL-1 beta. In both cases, no markers for hypertrophic chondrocytes were detected. The conditioned supernatant from chondrocytes knocked-down for Ank contained Wnt-5a, which activated Tcf/Lef reporter plasmids and promoted translocation of beta-catenin into the nucleus without activating the c-Jun N-terminal kinase (JNK) pathway. Supplementation with PPi compensated for most effects of Ank deficiency on Type II collagen, Sox-9, and Wnt-5 expression, both in IL-1 beta and Ank knock-down conditions. Phenotype changes induced by IL-1 beta were also supported by activation of the JNK pathway, but this latter was not sensitive to PPi supplementation. Altogether our data demonstrate that the transport of PPi by ANK contributed to the maintenance of the differentiated phenotype of chondrocyte by controlling the canonical Wnt pathway in a Wnt-5a-dependent manner.	[Cailotto, Frederic; Sebillaud, Sylvie; Netter, Patrick; Jouzeau, Jean-Yves; Bianchi, Arnaud] Nancy Univ, LPPIA, UMR 7561, Fac Med,CNRS, F-54505 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Cailotto, F (corresponding author), Nancy Univ, LPPIA, UMR 7561, Fac Med,CNRS, Ave Foret de Haye,BP184, F-54505 Vandoeuvre Les Nancy, France.	frederic.cailotto@hotmail.fr; arnaud.bianchi@medecine.uhp-nancy	bianchi, arnaud/AAY-7059-2021	bianchi, arnaud/0000-0003-4925-5269; Cailotto, Frederic/0000-0002-4941-9238	Fondation pour la Recherche Medicale (FRM); University Hospital of Nancy (CPRC/PHRC); Region Lorraine; Conseil General 54; Communaute Urbaine du Grand Nancy	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); University Hospital of Nancy (CPRC/PHRC); Region Lorraine(Region Grand-Est); Conseil General 54; Communaute Urbaine du Grand Nancy(Region Grand-Est)	This work was supported by grants from the Fondation pour la Recherche Medicale ( FRM) and from the University Hospital of Nancy ( CPRC/PHRC), the Region Lorraine, the Conseil General 54, and the Communaute Urbaine du Grand Nancy.	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Badger AM, 2000, OSTEOARTHR CARTILAGE, V8, P434, DOI 10.1053/joca.1999.0319; Bergwitz C, 2001, BBA-MOL CELL RES, V1538, P129, DOI 10.1016/S0167-4889(00)00123-3; Bianchi A, 2005, ARTHRITIS RES THER, V7, pR1325, DOI 10.1186/ar1830; Cailotto F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2330; Cheung HS, 2005, FRONT BIOSCI-LANDMRK, V10, P1336, DOI 10.2741/1623; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Church VL, 2002, INT J DEV BIOL, V46, P927; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Dell'Accio F, 2008, ARTHRITIS RHEUM-US, V58, P1410, DOI 10.1002/art.23444; Denison TA, 2009, J CELL BIOCHEM, V107, P155, DOI 10.1002/jcb.22111; Foster BL, 2006, CALCIFIED TISSUE INT, V78, P103, DOI 10.1007/s00223-005-0184-7; Ge XP, 2009, ARTHRITIS RHEUM-US, V60, P2714, DOI 10.1002/art.24779; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Hwang SG, 2005, FEBS LETT, V579, P4837, DOI 10.1016/j.febslet.2005.07.067; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Johnson K, 2004, OSTEOARTHR CARTILAGE, V12, P321, DOI 10.1016/j.joca.2003.12.004; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; Katoh M, 2005, INT J MOL MED, V15, P749; Katoh M, 2007, INT J MOL MED, V19, P273; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743; LOTZ M, 1995, P NATL ACAD SCI USA, V92, P10364, DOI 10.1073/pnas.92.22.10364; Martel-Pelletier Johanne, 1999, Frontiers in Bioscience, V4, pd694, DOI 10.2741/Martel; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Nakamura Y, 2005, AM J PATHOL, V167, P97, DOI 10.1016/S0002-9440(10)62957-4; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Robbins JR, 2000, ARTHRITIS RHEUM, V43, P2189, DOI 10.1002/1529-0131(200010)43:10<2189::AID-ANR6>3.0.CO;2-S; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sohn P, 2002, OSTEOARTHR CARTILAGE, V10, P482, DOI 10.1053/joca.2002.0810; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; Tew SR, 2006, J BIOL CHEM, V281, P39471, DOI 10.1074/jbc.M604322200; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; VANDERSTRAETEN EF, 1995, DIS COLON RECTUM, V38, P172, DOI 10.1007/BF02052446; Wang W, 2005, MOL CELL BIOL, V25, P312, DOI 10.1128/MCB.25.1.312-323.2005; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yang Yingzi, 2003, Birth Defects Research, V69, P305, DOI 10.1002/bdrc.10026; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zaka R, 2009, J BONE MINER RES, V24, P1869, DOI [10.1359/JBMR.090512, 10.1359/jbmr.090512]; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	56	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10572	10582		10.1074/jbc.M109.050534	http://dx.doi.org/10.1074/jbc.M109.050534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133941	Green Published, hybrid			2022-12-25	WOS:000276264600044
J	Cheng, GJ; Sun, J; Fridlender, ZG; Wang, LCS; Ching, LM; Albelda, SM				Cheng, Guanjun; Sun, Jing; Fridlender, Zvi G.; Wang, Liang-Chuan S.; Ching, Lai-Ming; Albelda, Steven M.			Activation of the Nucleotide Oligomerization Domain Signaling Pathway by the Non-bacterially Derived Xanthone Drug 5 ' 6-Dimethylxanthenone-4-acetic Acid (Vadimezan)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR-DISRUPTING AGENT; FLAVONE ACETIC-ACID; P38 MAP KINASE; KAPPA-B; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; MURAMYL DIPEPTIDE; HOST RECOGNITION; PHASE-II; NOD1; INHIBITION	The cytosolic nucleotide-binding oligomerization domain 1 (NOD1)/CARD4 and NOD2/CARD15 proteins are members of NOD-like receptors recognizing specific motifs within peptidoglycans of both Gram-negative and Gram-positive bacteria. NOD1 and NOD2 signal via the downstream adaptor serine/threonine kinase RIP2/CARDIAK/RICK to initiate NF-kappa B activation and the release of inflammatory cytokines/chemokines. In this report, we show that 5,6-dimethylxanthenone-4-aceticacid(DMXAA), a cell-permeable, small molecule that has anti-tumor activity, can also activate NOD1 and NOD2. This was demonstrated: 1) by using human embryonic kidney epithelial (HEK) 293 cells transfected with a NF-kappa B reporter plasmid in combination with NOD1 or NOD2 expression plasmids; 2) by inhibiting DMXAA-induced chemokine (CXCL10) mRNA and protein production in the AB12 mesothelioma cell line using a pharmacological inhibitor of RICK kinase, SB20358; and 3) by using small interfering RNA to knock down NOD2 and lentiviral short hairpin RNA to knock down RICK. These findings expand the potential ligands for the NOD-like receptors, suggesting that other xanthone compounds may act similarly and could be developed as anti-tumor agents. This information also expands our knowledge on the mechanisms of action of the anti-tumor agent DMXAA (currently in clinical trials) and may be important for its biological activity.	[Cheng, Guanjun] Univ Penn, Thorac Oncol Res Lab, ARC 1016B, Philadelphia, PA 19104 USA; [Ching, Lai-Ming] Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc, Res Ctr, Auckland 1023, New Zealand	University of Pennsylvania; University of Auckland	Cheng, GJ (corresponding author), Univ Penn, Thorac Oncol Res Lab, ARC 1016B, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	guanjun@mail.med.upenn.edu			NCI [PO1 CA 66726]; NATIONAL CANCER INSTITUTE [P01CA066726] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 CA 66726 from NCI.	ATASSI G, 1985, EUR J MED CHEM, V20, P393; Barbera M, 2009, INT J ONCOL, V34, P273, DOI 10.3892/ijo_00000149; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; CORBETT TH, 1986, INVEST NEW DRUG, V4, P207; Fidler I J, 1994, Adv Pharmacol, V30, P271, DOI 10.1016/S1054-3589(08)60177-5; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; HAVLIN KA, 1991, J NATL CANCER I, V83, P124; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Jassar AS, 2005, CANCER RES, V65, P11752, DOI 10.1158/0008-5472.CAN-05-1658; KERR DJ, 1989, BRIT J CANCER, V60, P104, DOI 10.1038/bjc.1989.230; KERR DJ, 1987, CANCER RES, V47, P6776; Kim S, 2008, CANCER RES, V68, P10247, DOI 10.1158/0008-5472.CAN-08-1494; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Li J, 2008, CLIN CANCER RES, V14, P2102, DOI 10.1158/1078-0432.CCR-07-1475; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Meyers PA, 2008, J CLIN ONCOL, V26, P633, DOI 10.1200/JCO.2008.14.0095; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Odaka M, 2001, CANCER RES, V61, P6201; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pinto MMM, 2005, CURR MED CHEM, V12, P2517, DOI 10.2174/092986705774370691; REWCASTLE GW, 1989, J MED CHEM, V32, P793, DOI 10.1021/jm00124a012; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Wallace A, 2007, CANCER RES, V67, P7011, DOI 10.1158/0008-5472.CAN-06-3757; Wang LCS, 2006, ONCOL RES, V16, P1; Wang LCS, 2009, NEOPLASIA, V11, P793, DOI 10.1593/neo.09506; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Wolfert MA, 2002, J BIOL CHEM, V277, P39179, DOI 10.1074/jbc.M204885200; Woon ST, 2001, ONCOL RES, V13, P95; Zhao L, 2007, J BIOL CHEM, V282, P11618, DOI 10.1074/jbc.M608644200	39	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10553	10562		10.1074/jbc.M109.065631	http://dx.doi.org/10.1074/jbc.M109.065631			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118240	Green Published, hybrid			2022-12-25	WOS:000276264600042
J	Cook, A; Hippensteel, R; Shimizu, S; Nicolai, J; Fatatis, A; Meucci, O				Cook, Anna; Hippensteel, Randi; Shimizu, Saori; Nicolai, Jaclyn; Fatatis, Alessandro; Meucci, Olimpia			Interactions between Chemokines REGULATION OF FRACTALKINE/CX(3)CL1 HOMEOSTASIS BY SDF/CXCL12 IN CORTICAL NEURONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; RAT HIPPOCAMPAL-NEURONS; CENTRAL-NERVOUS-SYSTEM; METHYL-D-ASPARTATE; TRANSMEMBRANE CHEMOKINES; MEDIATED EXCITOTOXICITY; ALPHA-SECRETASE; CXCR4; NEUROTOXICITY; SURVIVAL	The soluble form of the chemokine fractalkine/CX(3)CL1 regulates microglia activation in the central nervous system (CNS), ultimately affecting neuronal survival. This study aims to determine whether CXCL12, another chemokine constitutively expressed in the CNS (known as stromal cell-derived factor 1; SDF-1), regulates cleavage of fractalkine from neurons. To this end, ELISA was used to measure protein levels of soluble fractalkine in the medium of rat neuronal cultures exposed to SDF-1. Gene arrays, quantitative RT-PCR, and Western blot were used to measure overall fractalkine expression in neurons. The data show that the rate of fractalkine shedding in healthy cultures positively correlates with in vitro differentiation and survival. In analogy to non-neuronal cells, metalloproteinases (ADAM10/17) are involved in cleavage of neuronal fractalkine as indicated by studies with pharmacologic inhibitors. Moreover, treatment of the neuronal cultures with SDF-1 stimulates expression of the inducible metalloproteinase ADAM17 and increases soluble fractalkine content in culture medium. The effect of SDF-1 is blocked by an inhibitor of both ADAM10 and -17, but only partially affected by a more specific inhibitor of ADAM10. In addition, SDF-1 also up-regulates expression of the fractalkine gene. Conversely, exposure of neurons to an excitotoxic stimulus (i.e. NMDA) inhibits alpha-secretase activity and markedly diminishes soluble fractalkine levels, leading to cell death. These results, along with previous findings on the neuroprotective role of both SDF-1 and fractalkine, suggest that this novel interaction between the two chemokines may contribute to in vivo regulation of neuronal survival by modulating microglial neurotoxic properties.	[Cook, Anna; Hippensteel, Randi; Shimizu, Saori; Nicolai, Jaclyn; Fatatis, Alessandro; Meucci, Olimpia] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Meucci, Olimpia] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19102 USA	Drexel University; Drexel University	Meucci, O (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, 245 N 15th St,NCB Rm 8804, Philadelphia, PA 19102 USA.	omeucci@drexelmed.edu			National Institutes of Health [DA15014, DA19808, GM067892]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015014, R01DA019808, R01DA015014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA15014 and DA19808 (to O.M.) and GM067892 (to A. F.).	BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bardi G, 2006, J NEUROVIROL, V12, P211, DOI 10.1080/13550280600848373; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bruno V, 2000, EUR J PHARMACOL, V399, P117, DOI 10.1016/S0014-2999(00)00367-8; Bruno V, 2000, J NEUROSCI, V20, P6413, DOI 10.1523/JNEUROSCI.20-17-06413.2000; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chalasani SH, 2003, J NEUROSCI, V23, P4601; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Corti C, 2007, J NEUROSCI, V27, P8297, DOI 10.1523/JNEUROSCI.1889-07.2007; Deiva K, 2004, EUR J NEUROSCI, V20, P3222, DOI 10.1111/j.1460-9568.2004.03800.x; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Jamieson WL, 2008, CANCER RES, V68, P1715, DOI 10.1158/0008-5472.CAN-07-1315; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Khan MZ, 2005, MOL CELL NEUROSCI, V30, P58, DOI 10.1016/j.mcn.2005.05.007; Khan MZ, 2004, AIDS RES HUM RETROV, V20, P1063, DOI 10.1089/aid.2004.20.1063; Klein RS, 2004, TRENDS IMMUNOL, V25, P306, DOI 10.1016/j.it.2004.04.002; Lafon-Cazal M, 1999, EUR J NEUROSCI, V11, P663, DOI 10.1046/j.1460-9568.1999.00475.x; Lauro C, 2006, J IMMUNOL, V177, P7599, DOI 10.4049/jimmunol.177.11.7599; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Ludwig A, 2008, J NEUROIMMUNOL, V198, P92, DOI 10.1016/j.jneuroim.2008.04.024; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Meucci O, 1996, J NEUROSCI, V16, P4080; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Patel JP, 2006, J NEUROVIROL, V12, P492, DOI 10.1080/13550280601064798; Ragozzino D, 2006, J NEUROSCI, V26, P10488, DOI 10.1523/JNEUROSCI.3192-06.2006; Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009; Shiraishi K, 2000, CANCER RES, V60, P3722; Tong N, 2000, J IMMUNOL, V164, P1333, DOI 10.4049/jimmunol.164.3.1333; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	51	45	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10563	10571		10.1074/jbc.M109.035477	http://dx.doi.org/10.1074/jbc.M109.035477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20124406	hybrid, Green Published			2022-12-25	WOS:000276264600043
J	Athineos, D; Sansom, OJ				Athineos, D.; Sansom, O. J.			Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine	ONCOGENE			English	Article						APC; Myc; colorectal cancer	C-MYC; COLORECTAL-CANCER; IN-VIVO; ADENOMA FORMATION; IDENTIFICATION; PROLIFERATION; INHIBITION; ACTIVATION; RS6983267; TARGET	The adenomatous polyposis coli (APC) gene encodes APC tumour suppressor protein, germline mutation of which causes familial adenomatous polyposis, an autosomal intestinal cancer syndrome. We have previously demonstrated that the proto-oncogene c-Myc is essential for all the phenotypes that occur after APC loss in the murine small intestine. One caveat to this study is that it was performed in the complete absence of c-Myc. In this study, we show that heterozygosity for Myc reduces the phenotypes of APC loss and Wnt target gene expression and slows tumourigenesis. Crucially, the levels of Myc are twofold higher than wild-type levels showing that the level of Myc induced by Wnt signalling is absolutely vital for the fate of APC-deficient cells. Taken together, this suggests that c-Myc inhibition may be a viable chemoprevention strategy for colorectal cancer. Oncogene (2010) 29, 2585-2590; doi:10.1038/onc.2010.5; published online 8 February 2010	[Athineos, D.; Sansom, O. J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk		Sansom, Owen J./0000-0001-9540-3010; Athineos, Dimitris/0000-0001-5298-7941	Cancer Research UK [12481] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Baena E, 2005, P NATL ACAD SCI USA, V102, P7286, DOI 10.1073/pnas.0409260102; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bommer GT, 2007, CANCER CELL, V11, P391, DOI 10.1016/j.ccr.2007.04.015; Ciznadija D, 2009, CELL DEATH DIFFER, V16, P1530, DOI 10.1038/cdd.2009.94; Finch AJ, 2009, MOL CELL BIOL, V29, P5306, DOI 10.1128/MCB.01745-08; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ignatenko NA, 2006, CANCER BIOL THER, V5, P1658, DOI 10.4161/cbt.5.12.3376; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wilkins JA, 2008, CANCER RES, V68, P4963, DOI 10.1158/0008-5472.CAN-07-5558; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232	24	34	35	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	17					2585	2590		10.1038/onc.2010.5	http://dx.doi.org/10.1038/onc.2010.5			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20140021				2022-12-25	WOS:000277169400013
J	Boidot, R; Vegran, F; Jacob, D; Chevrier, S; Cadouot, M; Feron, O; Solary, E; Lizard-Nacol, S				Boidot, R.; Vegran, F.; Jacob, D.; Chevrier, S.; Cadouot, M.; Feron, O.; Solary, E.; Lizard-Nacol, S.			The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism	ONCOGENE			English	Article						GATA-1; survivin promoter polymorphism; breast carcinoma	SPLICE VARIANTS; GENE-EXPRESSION; CANCER; ERYTHROPOIETIN; PHOSPHORYLATION; DIFFERENTIATION; REQUIREMENTS; ACTIVATION; APOPTOSIS; CLEAVAGE	Expression of survivin, a member of the inhibitor of apoptosis protein family, is elevated in human cancers and considered as a new therapeutic target. Mechanism upregulating survivin expression in tumour cells is poorly understood. In this study, we show that breast cancer patients harbouring a polymorphism G235A in the survivin promoter present a higher level of survivin expression. This polymorphism creates a binding site for the transcription factor GATA-1 inducing a second GATA-1-binding site in survivin promoter. At the mRNA level, GATA-1 was present in breast carcinomas and adjacent normal tissues, whereas the protein was only detected in carcinomas by western blot and immunohistochemistry. Transfection of wild-type and different constitutively active GATA-1 mutants (serine 26, 178 or 310) showed that only phospho-serine 26 GATA-1 was able to increase survivin expression. This increase was higher in G235A than in G235G cell lines. Phospho-serine 26 GATA-1 bound directly survivin promoter, with a stronger interaction in G235A than in G235G polymorphism indicating that both GATA-1-binding sites are functional. These data identify GATA-1 as a key feature in tumour aggressiveness by enhancing survivin expression and delineate its targeting as a possible new therapeutic strategy in breast carcinomas. Oncogene (2010) 29, 2577-2584; doi:10.1038/onc.2009.525; published online 25 January 2010	[Boidot, R.; Vegran, F.; Jacob, D.; Chevrier, S.; Cadouot, M.; Lizard-Nacol, S.] Ctr Georges Francois Leclerc, Mol Genet Lab, F-21034 Dijon, France; [Solary, E.] UMR INSERM, U866, IFR 100, Dijon, France	UNICANCER; Centre Georges-Francois Leclerc; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Lizard-Nacol, S (corresponding author), Ctr Georges Francois Leclerc, Mol Genet Lab, 1 Rue Prof Marion, F-21034 Dijon, France.	SLizard@dijon.fnclcc.fr	VEGRAN, Frederique/O-9986-2018; VEGRAN, Frédérique/H-4792-2017; FERON, Olivier/AAM-6395-2020	VEGRAN, Frederique/0000-0002-4377-1441; FERON, Olivier/0000-0001-5360-0286; Solary, Eric/0000-0002-8629-1341	Conseil Regional de Bourgogne; Association pour la Recherche contre le Cancer	Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the Conseil Regional de Bourgogne and the Association pour la Recherche contre le Cancer. We thank Dr Laurent Arnould (as Pathologist) for the validation of GATA-1 immunohistochemical staining.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri Dario C, 2003, Prog Cell Cycle Res, V5, P447; Altieri DC, 2005, IMMUNITY, V22, P534, DOI 10.1016/j.immuni.2005.05.001; Altieri DC, 1999, LAB INVEST, V79, P1327; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Boidot R, 2008, GENE CHROMOSOME CANC, V47, P299, DOI 10.1002/gcc.20533; Boidot R, 2009, INT J MOL MED, V23, P285, DOI 10.3892/ijmm_00000129; CHIBA T, 1991, NUCLEIC ACIDS RES, V19, P3843, DOI 10.1093/nar/19.14.3843; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Connell CM, 2008, CANCER RES, V68, P7923, DOI 10.1158/0008-5472.CAN-08-0817; CROSSLEY M, 1994, J BIOL CHEM, V269, P16589; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; Kadri Z, 2005, MOL CELL BIOL, V25, P7412, DOI 10.1128/MCB.25.17.7412-7422.2005; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li FZ, 1999, CANCER RES, V59, P3143; Nasu S, 2002, ANTICANCER RES, V22, P1839; O'Driscoll L, 2003, CURR CANCER DRUG TAR, V3, P131, DOI 10.2174/1568009033482038; Obexer P, 2009, MOL BIOL CELL, V20, P2041, DOI 10.1091/mbc.E08-07-0699; Perez-Stable CM, 2000, MOL CELL ENDOCRINOL, V167, P43, DOI 10.1016/S0303-7207(00)00300-2; Phillips TM, 2007, NEOPLASIA, V9, P1122, DOI 10.1593/neo.07694; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Richter M, 2003, AM J PHYSIOL-LUNG C, V285, pL719, DOI 10.1152/ajplung.00406.2002; Ryan B, 2005, BRIT J CANCER, V92, P120, DOI 10.1038/sj.bjc.6602314; Sebastian S, 2002, MOL ENDOCRINOL, V16, P2243, DOI 10.1210/me.2002-0123; Towatari M, 2004, HEMATOL J, V5, P262, DOI 10.1038/sj.thj.6200345; Vegran F, 2007, ONCOGENE, V26, P290, DOI 10.1038/sj.onc.1209784; Vegran F, 2005, INT J ONCOL, V27, P1151; Wu YH, 2008, ACTA BIOCHIM POL, V55, P673; Xia F, 2006, CANCER RES, V66, P3392, DOI 10.1158/0008-5472.CAN-05-4537; Xu Y, 2004, DNA CELL BIOL, V23, P527, DOI 10.1089/dna.2004.23.527; Yu YL, 2005, J BIOL CHEM, V280, P29533, DOI 10.1074/jbc.M506514200; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516; Zhen HN, 2007, INT J ONCOL, V31, P1111; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	38	37	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	17					2577	2584		10.1038/onc.2009.525	http://dx.doi.org/10.1038/onc.2009.525			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20101202				2022-12-25	WOS:000277169400012
J	Mimura, S; Yamaguchi, T; Ishii, S; Noro, E; Katsura, T; Obuse, C; Kamura, T				Mimura, Satoru; Yamaguchi, Tsuyoshi; Ishii, Satoru; Noro, Emiko; Katsura, Tomoya; Obuse, Chikashi; Kamura, Takumi			Cul8/Rtt101 Forms a Variety of Protein Complexes That Regulate DNA Damage Response and Transcriptional Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; UBIQUITIN LIGASE; REPLICATION FORKS; BUDDING YEAST; PROMOTES REPLICATION; HISTONE H3; S-PHASE; RECOMBINATION; DEGRADATION	The budding yeast, Saccharomyces cerevisiae, has three cullin proteins, which act as platforms for Cullin-based E3 ubiquitin ligases. Genetic evidence indicates that Cul8, together with Mms1, Mms22, and Esc4, is involved in the repair of DNA damage that can occur during DNA replication. Cul8 is thought to form a complex with these proteins, but the composition and the function of Cul8-based E3 ubiquitin ligases remain largely uncharacterized. Herein, we report a comprehensive biochemical analysis of Cul8 complexes. Cul8 was found to form a Cul8-Mms1-Mms22-Esc4 complex under physiological conditions, with Mms1 bridging Cul8 and Mms22 and Mms22 bridging Mms1 and Esc4. Domain analysis demonstrated that the N-terminal region of Mms1 and the C-terminal region of Mms22 are required for the Mms1-Mms22 interaction, whereas the N-terminal region of Mms22 is required for the Mms22-Esc4 interaction. We also found other Cul8-Mms1-binding proteins Ctf4, Esc2, and Orc5 using yeast two-hybrid screening. Esc4 and Ctf4 bound to Mms22 directly and bound to Cul8-Mms1 in the presence of Mms22, whereas Esc2 and Orc5 interacted with both Cul8 and Mms1, independently. We found that Cul8, Mms1, and Mms22 participated in the regulation of transcriptional silencing of yeast telomeres. These results suggest that Cul8-Mms1, as part of various protein complexes, is involved in the regulation of chromatin metabolism.	[Mimura, Satoru; Yamaguchi, Tsuyoshi; Ishii, Satoru; Katsura, Tomoya; Kamura, Takumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Noro, Emiko; Obuse, Chikashi] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0010021, Japan	Nagoya University; Hokkaido University	Kamura, T (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	z47617a@nucc.cc.nagoya-u.ac.jp	Obuse, Chikashi/F-5273-2011	Yamaguchi, Tsuyoshi/0000-0001-5341-4184	Ministry of Education, Science, Sports, and Culture of Japan; Sumitomo Foundation; Uehara Foundation; Saibou Kagaku Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Uehara Foundation(Uehara Memorial Foundation); Saibou Kagaku Foundation	This work was supported in part by grants from the Ministry of Education, Science, Sports, and Culture of Japan, the Sumitomo Foundation, the Uehara Foundation, and the Saibou Kagaku Foundation.	Andrulis ED, 2004, GENETICS, V166, P631, DOI 10.1534/genetics.166.1.631; Baldwin EL, 2005, NUCLEIC ACIDS RES, V33, P1021, DOI 10.1093/nar/gki246; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cuperus G, 2002, GENETICS, V162, P633; Dovey CL, 2007, GENETICS, V177, P47, DOI 10.1534/genetics.107.077255; Dula ML, 2000, GENETICS, V156, P933; Duro E, 2008, DNA REPAIR, V7, P811, DOI 10.1016/j.dnarep.2008.01.007; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kishi T, 2008, P NATL ACAD SCI USA, V105, P14497, DOI 10.1073/pnas.0806253105; Kishi T, 2007, P NATL ACAD SCI USA, V104, P17418, DOI 10.1073/pnas.0704951104; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Luke B, 2006, CURR BIOL, V16, P786, DOI 10.1016/j.cub.2006.02.071; Mankouri HW, 2009, MOL BIOL CELL, V20, P1683, DOI 10.1091/mbc.E08-08-0877; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Mimura S, 2009, EMBO J, V28, P3693, DOI 10.1038/emboj.2009.320; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Novatchkova M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-22; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ogiwara H, 2007, BIOCHEM BIOPH RES CO, V354, P222, DOI 10.1016/j.bbrc.2006.12.185; Ohya T, 2008, GENETICS, V180, P41, DOI 10.1534/genetics.107.086249; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Scholes DT, 2001, GENETICS, V159, P1449; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155	40	31	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9858	9867		10.1074/jbc.M109.082107	http://dx.doi.org/10.1074/jbc.M109.082107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20139071	Green Published, hybrid			2022-12-25	WOS:000276165900057
J	Song, WF; Wei, SP; Zhou, YJ; Lazrak, A; Liu, G; Londino, JD; Squadrito, GL; Matalon, S				Song, Weifeng; Wei, Shipeng; Zhou, Yongjian; Lazrak, Ahmed; Liu, Gang; Londino, James D.; Squadrito, Giuseppe L.; Matalon, Sadis			Inhibition of Lung Fluid Clearance and Epithelial Na+ Channels by Chlorine, Hypochlorous Acid, and Chloramines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNELS; LONGITUDINAL DISTRIBUTION; HISTIDINE-RESIDUES; HUMAN-NEUTROPHILS; HUMAN AIRWAYS; IN-VITRO; TRANSPORT; MYELOPEROXIDASE; OXIDATION; ACTIVATION	We investigated the mechanisms by which chlorine (Cl-2) and its reactive byproducts inhibit Na+-dependent alveolar fluid clearance (AFC) in vivo and the activity of amiloride-sensitive epithelial Na+ channels (ENaC) by measuring AFC in mice exposed to Cl-2 (0-500 ppm for 30 min) and Na+ and amiloride-sensitive currents (I-Na and I-amil, respectively) across Xenopus oocytes expressing human alpha-, beta-, and gamma-ENaC incubated with HOCl (1-2000 mu M). Both Cl-2 and HOCl-derived products decreased AFC in mice and whole cell and single channel I-Na in a dose-dependent manner; these effects were counteracted by serine proteases. Mass spectrometry analysis of the oocyte recording medium identified organic chloramines formed by the interaction of HOCl with HEPES (used as an extracellular buffer). In addition, chloramines formed by the interaction of HOCl with taurine or glycine decreased I-Na in a similar fashion. Preincubation of oocytes with serine proteases prevented the decrease of I-Na by HOCl, whereas perfusion of oocytes with a synthetic 51-mer peptide corresponding to the putative furin and plasmin cleaving segment in the gamma-ENaC subunit restored the ability of HOCl to inhibit I-Na. Finally, I-Na of oocytes expressing wild type alpha- and gamma-ENaC and a mutant form of beta ENaC (S520K), known to result in ENaC channels locked in the open position, were not altered by HOCl. We concluded that HOCl and its reactive intermediates (such as organic chloramines) inhibit ENaC by affecting channel gating, which could be relieved by proteases cleavage.	[Song, Weifeng; Wei, Shipeng; Zhou, Yongjian; Lazrak, Ahmed; Londino, James D.; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol, Birmingham, AL 35205 USA; [Liu, Gang; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35205 USA; [Squadrito, Giuseppe L.] Univ Alabama Birmingham, Sch Med, Dept Environm Hlth Sci, Birmingham, AL 35205 USA; [Squadrito, Giuseppe L.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35205 USA; [Song, Weifeng; Wei, Shipeng; Lazrak, Ahmed; Liu, Gang; Londino, James D.; Squadrito, Giuseppe L.; Matalon, Sadis] Univ Alabama Birmingham, Ctr Pulm Injury & Repair, Birmingham, AL 35205 USA; [Squadrito, Giuseppe L.; Matalon, Sadis] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35205 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Matalon, S (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Anesthesiol, 224 BMR II,901 19th St S, Birmingham, AL 35205 USA.	sadis@uab.edu	Londino, James/GXH-4404-2022	Londino, James/0000-0001-7647-6927; , Gang/0000-0002-6999-7633; Lazrak, Ahmed/0000-0002-4127-1937; Liu, Gang/0000-0003-2615-131X	United States Public Health Service [HL-31197, HL-51173, U01ES015676, 1U54ES017218]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051173, R01HL031197, R37HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES017218, U01ES015676] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by United States Public Health Service Grants HL-31197, HL-51173, U01ES015676, and 1U54ES017218.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Batchinsky AL, 2006, J TRAUMA, V60, P944, DOI 10.1097/01.ta.0000205862.57701.48; Bell D.P., 2008, AM J RESP CRIT CARE, V176, pA314; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Chen L, 2004, AM J PHYSIOL-RENAL, V286, pF1202, DOI 10.1152/ajprenal.00352.2003; Chen L, 2008, AM J RESP CELL MOL, V39, P150, DOI 10.1165/rcmb.2008-0005OC; Cho HY, 2007, FREE RADICAL BIO MED, V42, P433, DOI 10.1016/j.freeradbiomed.2006.11.021; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Crow JP, 1999, METHOD ENZYMOL, V301, P151; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Davis IC, 2007, AM J RESP CELL MOL, V37, P379, DOI 10.1165/rcmb.2007-0142OC; Davis IC, 2006, AM J RESP CRIT CARE, V173, P673, DOI 10.1164/rccm.200508-1200OC; Davis IC, 2002, FREE RADICAL BIO MED, V33, P1703, DOI 10.1016/S0891-5849(02)01170-X; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; den Hartog GJM, 2002, BIOL CHEM, V383, P709; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; DuVall MD, 1998, AM J PHYSIOL-CELL PH, V274, pC1417, DOI 10.1152/ajpcell.1998.274.5.C1417; Eiserich JP, 1996, J BIOL CHEM, V271, P19199, DOI 10.1074/jbc.271.32.19199; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Guo Y, 1998, AM J PHYSIOL-LUNG C, V274, pL369, DOI 10.1152/ajplung.1998.274.3.L369; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; HEINECKE JW, 1994, BIOCHEMISTRY-US, V33, P10127, DOI 10.1021/bi00199a041; Hickman-Davis JM, 2006, AM J RESP CRIT CARE, V173, P334, DOI 10.1164/rccm.200501-155OC; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; IWASE H, 1995, BIOCHEM BIOPH RES CO, V215, P945, DOI 10.1006/bbrc.1995.2555; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kleyman TR, 2006, KIDNEY INT, V70, P1391, DOI 10.1038/sj.ki.5001860; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; LANG JDJ, 2006, OXIDATIVE NITROSATIV, P359; Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590; Lazrak A, 2009, AM J RESP CELL MOL, V41, P261, DOI 10.1165/rcmb.2008-0384OC; Leduc-Nadeau A, 2007, AM J PHYSIOL-CELL PH, V292, pC1132, DOI 10.1152/ajpcell.00136.2006; Lentner C., 1984, GEIGY SCI TABLES, V3, P92; Leustik M, 2008, AM J PHYSIOL-LUNG C, V295, pL733, DOI 10.1152/ajplung.90240.2008; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Martin JG, 2003, AM J RESP CRIT CARE, V168, P568, DOI 10.1164/rccm.200201-021OC; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Midwinter RG, 2006, BIOCHEM J, V396, P71, DOI 10.1042/BJ20052026; Nielsen VG, 1998, AM J PHYSIOL-LUNG C, V275, pL1127, DOI 10.1152/ajplung.1998.275.6.L1127; NIELSON DW, 1986, J APPL PHYSIOL, V60, P972, DOI 10.1152/jappl.1986.60.3.972; Nodelman V, 1999, J APPL PHYSIOL, V86, P1984, DOI 10.1152/jappl.1999.86.6.1984; Nodelman V, 1999, J APPL PHYSIOL, V87, P2073, DOI 10.1152/jappl.1999.87.6.2073; Pattison DI, 2007, BIOCHEMISTRY-US, V46, P9853, DOI 10.1021/bi7008294; Peskin AV, 2004, FREE RADICAL BIO MED, V37, P1622, DOI 10.1016/j.freeradbiomed.2004.08.010; Pittet JF, 2001, J IMMUNOL, V166, P6301, DOI 10.4049/jimmunol.166.10.6301; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Prutz WA, 1996, ARCH BIOCHEM BIOPHYS, V332, P110, DOI 10.1006/abbi.1996.0322; Prutz WA, 1998, ARCH BIOCHEM BIOPHYS, V349, P183, DOI 10.1006/abbi.1997.0440; Prutz WA, 1998, ARCH BIOCHEM BIOPHYS, V357, P265, DOI 10.1006/abbi.1998.0822; Pullar JM, 1999, AM J PHYSIOL-HEART C, V277, pH1505, DOI 10.1152/ajpheart.1999.277.4.H1505; Rahman I, 1996, THORAX, V51, P348, DOI 10.1136/thx.51.4.348; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Sartori C, 2001, ADV EXP MED BIOL, V502, P315; Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Song WF, 2007, AM J PHYSIOL-LUNG C, V293, pL855, DOI 10.1152/ajplung.00305.2007; Spalteholz H, 2006, ARCH BIOCHEM BIOPHYS, V445, P225, DOI 10.1016/j.abb.2005.06.025; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Winterton N, 1997, MUTAT RES-FUND MOL M, V373, P293, DOI 10.1016/S0027-5107(96)00239-4; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200	75	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9716	9728		10.1074/jbc.M109.073981	http://dx.doi.org/10.1074/jbc.M109.073981			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106988	Green Published, hybrid			2022-12-25	WOS:000276165900044
J	Wakamatsu, T; Kitamura, Y; Kotera, Y; Nakagawa, N; Kuramitsu, S; Masui, R				Wakamatsu, Taisuke; Kitamura, Yoshiaki; Kotera, Yutaro; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji			Structure of RecJ Exonuclease Defines Its Specificity for Single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED MISMATCH REPAIR; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; RNASE-II; OB-FOLD; IN-VIVO; PROTEIN; BINDING; IDENTIFICATION	RecJ is a single-stranded DNA (ssDNA)-specific 5'-3' exonuclease that plays an important role in DNA repair and recombination. To elucidate how RecJ achieves its high specificity for ssDNA, we determined the entire structures of RecJ both in a ligand-free form and in a complex with Mn2+ or Mg2+ by x-ray crystallography. The entire RecJ consists of four domains that form a molecule with an O-like structure. One of two newly identified domains had structural similarities to an oligonucleotide/oligosaccharide-binding (OB) fold. The OB fold domain alone could bind to DNA, indicating that this domain is a novel member of the OB fold superfamily. The truncated RecJ containing only the core domain exhibited much lower affinity for the ssDNA substrate compared with intact RecJ. These results support the hypothesis that these structural features allow specific binding of RecJ to ssDNA. In addition, the structure of the RecJ-Mn2+ complex suggests that the hydrolysis reaction catalyzed by RecJ proceeds through a two-metal ion mechanism.	[Kotera, Yutaro; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; [Wakamatsu, Taisuke; Kuramitsu, Seiki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Kitamura, Yoshiaki; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji] RIKEN, SPring Ctr 8, Harima Inst, Sayo, Hyogo 6795148, Japan	Osaka University; Osaka University; RIKEN	Masui, R (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol, 1-1 Machikaneyama Cho, Osaka 5600043, Japan.	rmasui@bio.sci.osaka-u.ac.jp	Wakamatsu, Taisuke/AAD-8007-2022		Ministry of Education, Science, Sports and Culture of Japan [20570131, 19770083]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research 20570131 (to R. M.) and 19770083 (to N. N.) from the Ministry of Education, Science, Sports and Culture of Japan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DIANOV G, 1994, NUCLEIC ACIDS RES, V22, P993, DOI 10.1093/nar/22.6.993; Han ES, 2006, NUCLEIC ACIDS RES, V34, P1084, DOI 10.1093/nar/gkj503; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kovall RA, 1999, CURR OPIN CHEM BIOL, V3, P578, DOI 10.1016/S1367-5931(99)00012-5; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; LOVETT ST, 1984, J BACTERIOL, V157, P190, DOI 10.1128/JB.157.1.190-196.1984; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meier B, 2009, EMBO J, V28, P3549, DOI 10.1038/emboj.2009.278; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rajman LA, 2000, J BACTERIOL, V182, P607, DOI 10.1128/JB.182.3.607-612.2000; Schubert M, 2004, J MOL BIOL, V341, P37, DOI 10.1016/j.jmb.2004.05.061; Sharma R, 2009, J MOL BIOL, V385, P1375, DOI 10.1016/j.jmb.2008.11.041; Sutera VA, 1999, J BACTERIOL, V181, P6098, DOI 10.1128/JB.181.19.6098-6102.1999; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Ugochukwu E, 2007, J MOL BIOL, V371, P1007, DOI 10.1016/j.jmb.2007.05.066; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Viswanathan M, 2001, J BIOL CHEM, V276, P31053, DOI 10.1074/jbc.M105481200; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yamagata A, 2001, NUCLEIC ACIDS RES, V29, P4617, DOI 10.1093/nar/29.22.4617; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	34	48	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9762	9769		10.1074/jbc.M109.096487	http://dx.doi.org/10.1074/jbc.M109.096487			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20129927	Green Published, hybrid			2022-12-25	WOS:000276165900048
J	Dhami, P; Bruce, AW; Jim, JH; Dillon, SC; Hall, A; Cooper, JL; Bonhoure, N; Chiang, K; Ellis, PD; Langford, C; Andrews, RM; Vetrie, D				Dhami, Pawandeep; Bruce, Alexander W.; Jim, Johanna H.; Dillon, Shane C.; Hall, Amanda; Cooper, Jonathan L.; Bonhoure, Nicolas; Chiang, Kelly; Ellis, Peter D.; Langford, Cordelia; Andrews, Robert M.; Vetrie, David			Genomic Approaches Uncover Increasing Complexities in the Regulatory Landscape at the Human SCL (TAL1) Locus	PLOS ONE			English	Article							STEM-CELL ENHANCER; TRANSCRIPTION FACTOR-BINDING; RNA-POLYMERASE-II; HEMATOPOIETIC PROGENITORS; HISTONE MODIFICATIONS; HYPERSENSITIVE SITES; CHROMATIN OCCUPANCY; NONCODING RNAS; PROTEIN CTCF; GENE	The SCL (TAL1) transcription factor is a critical regulator of haematopoiesis and its expression is tightly controlled by multiple cis-acting regulatory elements. To elaborate further the DNA elements which control its regulation, we used genomic tiling microarrays covering 256 kb of the human SCL locus to perform a concerted analysis of chromatin structure and binding of regulatory proteins in human haematopoietic cell lines. This approach allowed us to characterise further or redefine known human SCL regulatory elements and led to the identification of six novel elements with putative regulatory function both up and downstream of the SCL gene. They bind a number of haematopoietic transcription factors (GATA1, E2A LMO2, SCL, LDB1), CTCF or components of the transcriptional machinery and are associated with relevant histone modifications, accessible chromatin and low nucleosomal density. Functional characterisation shows that these novel elements are able to enhance or repress SCL promoter activity, have endogenous promoter function or enhancer-blocking insulator function. Our analysis opens up several areas for further investigation and adds new layers of complexity to our understanding of the regulation of SCL expression.	[Dhami, Pawandeep; Bruce, Alexander W.; Jim, Johanna H.; Dillon, Shane C.; Hall, Amanda; Cooper, Jonathan L.; Ellis, Peter D.; Langford, Cordelia; Andrews, Robert M.; Vetrie, David] Wellcome Trust Sanger Inst, Hinxton, England; [Bonhoure, Nicolas; Chiang, Kelly; Vetrie, David] Univ Glasgow, Sect Pathol & Gene Regulat, Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland	Wellcome Trust Sanger Institute; University of Glasgow	Dhami, P (corresponding author), UCL, Inst Canc, London, England.	dlv1q@clinmed.gla.ac.uk	cheng, yong/I-4270-2012; Dillon, Shane/A-2280-2011; Bruce, Alexander W/H-4235-2014	Bruce, Alexander W/0000-0003-4297-4412; Vetrie, David/0000-0003-2075-4662; Andrews, Robert/0000-0002-3491-2361	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y., 1998, TFSEARCH SEARCHING T; Anguita E, 2001, P NATL ACAD SCI USA, V98, P12114, DOI 10.1073/pnas.201413098; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Begley CG, 1999, BLOOD, V93, P2760; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; Chapman MA, 2004, GENOME RES, V14, P313, DOI 10.1101/gr.1759004; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Courtes C, 2000, J BIOL CHEM, V275, P949, DOI 10.1074/jbc.275.2.949; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; De Gobbi M, 2007, BLOOD, V110, P4503, DOI 10.1182/blood-2007-06-097964; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; Endoh M, 2002, EMBO J, V21, P6700, DOI 10.1093/emboj/cdf674; Follows GA, 2006, GENOME RES, V16, P1310, DOI 10.1101/gr.5373606; Fordham JL, 1999, LEUKEMIA, V13, P750, DOI 10.1038/sj.leu.2401420; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Gottgens B, 2004, MOL CELL BIOL, V24, P1870, DOI 10.1128/MCB.24.5.1870-1883.2004; Gottgens B, 1997, ONCOGENE, V15, P2419, DOI 10.1038/sj.onc.1201426; Gottgens B, 2002, GENOME RES, V12, P749, DOI 10.1101/gr.45502; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Gu XS, 2001, J BIOL CHEM, V276, P9421, DOI 10.1074/jbc.M010070200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LEROYVIARD K, 1994, BLOOD, V84, P3819, DOI 10.1182/blood.V84.11.3819.bloodjournal84113819; Lozzio B B, 1977, Int J Cancer, V19, P136, DOI 10.1002/ijc.2910190119; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Ogilvy S, 2007, MOL CELL BIOL, V27, P7206, DOI 10.1128/MCB.00931-07; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Robertson SM, 2000, DEVELOPMENT, V127, P2447; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sanchez MJ, 1999, DEVELOPMENT, V126, P3891; Sanchez MJ, 2001, DEVELOPMENT, V128, P4815; SCHUG J, 1997, CBILT19971001V00 U P; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Sinclair AM, 1999, DEV BIOL, V209, P128, DOI 10.1006/dbio.1999.9236; Smith AM, 2008, GENOME RES, V18, P1422, DOI 10.1101/gr.077008.108; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	77	15	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9059	10.1371/journal.pone.0009059	http://dx.doi.org/10.1371/journal.pone.0009059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140202	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000274442400003
J	Do, T; Gilbert, SC; Clark, D; Ali, F; Parolo, CCF; Maltz, M; Russell, RR; Holbrook, P; Wade, WG; Beighton, D				Do, Thuy; Gilbert, Steven C.; Clark, Douglas; Ali, Farida; Parolo, Clarissa C. Fatturi; Maltz, Marisa; Russell, Roy R.; Holbrook, Peter; Wade, William G.; Beighton, David			Generation of Diversity in Streptococcus mutans Genes Demonstrated by MLST	PLOS ONE			English	Article							CLONAL POPULATION-STRUCTURE; POLYMERASE-CHAIN-REACTION; SEQUENCE TYPING SCHEME; ORAL STREPTOCOCCI; RAPID IDENTIFICATION; MOLECULAR EVOLUTION; DNA; RECOMBINATION; SEROTYPE; STRAINS	Streptococcus mutans, consisting of serotypes c, e, f and k, is an oral aciduric organism associated with the initiation and progression of dental caries. A total of 135 independent Streptococcus mutans strains from caries-free and caries-active subjects isolated from various geographical locations were examined in two versions of an MLST scheme consisting of either 6 housekeeping genes [accC (acetyl-CoA carboxylase biotin carboxylase subunit), gki (glucokinase), lepA (GTP-binding protein), recP (transketolase), sodA (superoxide dismutase), and tyrS (tyrosyl-tRNA synthetase)] or the housekeeping genes supplemented with 2 extracellular putative virulence genes [gtfB (glucosyltransferase B) and spaP (surface protein antigen I/II)] to increase sequence type diversity. The number of alleles found varied between 20 (lepA) and 37 (spaP). Overall, 121 sequence types (STs) were defined using the housekeeping genes alone and 122 with all genes. However pi, nucleotide diversity per site, was low for all loci being in the range 0.019-0.007. The virulence genes exhibited the greatest nucleotide diversity and the recombination/mutation ratio was 0.67 [95% confidence interval 0.3-1.15] compared to 8.3 [95% confidence interval 5.0-14.5] for the 6 concatenated housekeeping genes alone. The ML trees generated for individual MLST loci were significantly incongruent and not significantly different from random trees. Analysis using ClonalFrame indicated that the majority of isolates were singletons and no evidence for a clonal structure or evidence to support serotype c strains as the ancestral S. mutans strain was apparent. There was also no evidence of a geographical distribution of individual isolates or that particular isolate clusters were associated with caries. The overall low sequence diversity suggests that S. mutans is a newly emerged species which has not accumulated large numbers of mutations but those that have occurred have been shuffled as a consequence of intra-species recombination generating genotypes which can be readily distinguished by sequence analysis.	[Do, Thuy; Gilbert, Steven C.; Clark, Douglas; Ali, Farida; Wade, William G.; Beighton, David] Kings Coll London, Inst Dent, Infect Res Grp, London WC2R 2LS, England; [Parolo, Clarissa C. Fatturi; Maltz, Marisa] Univ Fed Rio Grande do Sul, Fac Dent, Dept Social & Prevent Med, Porto Alegre, RS, Brazil; [Russell, Roy R.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Holbrook, Peter] Univ Iceland, Fac Odontol, Reykjavik, Iceland	University of London; King's College London; Universidade Federal do Rio Grande do Sul; Newcastle University - UK; University of Iceland	Do, T (corresponding author), Kings Coll London, Inst Dent, Infect Res Grp, London WC2R 2LS, England.	david.beighton@kcl.ac.uk	Russell, Roy/A-1685-2008	Parolo, Clarissa/0000-0001-6477-4521; Wade, William/0000-0003-2685-826X	Wellcome Trust [076381]; Department of Health via the National Institute for Health Research (NIHR); Comprehensive Biomedical Research Centre; NHS Foundation Trust; Brazilian Ministry of Science and Technology [480841/2007-1]; Brazilian Federal Agency; Evaluation of Graduate Education (CAPES)	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Comprehensive Biomedical Research Centre; NHS Foundation Trust; Brazilian Ministry of Science and Technology; Brazilian Federal Agency; Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The project was supported by the Wellcome Trust [Supported Grant 076381], the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's National Health Service (NHS) Foundation Trust in partnership with King's College Hospital NHS Foundation Trust, the Brazilian Ministry of Science and Technology, through its National Council of Research (CNPq) agency (grant 480841/2007-1) and the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; BEIGHTON D, 1991, CARIES RES, V25, P174, DOI 10.1159/000261363; BERKOWITZ RJ, 1985, ARCH ORAL BIOL, V30, P377, DOI 10.1016/0003-9969(85)90014-7; Bratthall D, 1972, Odontol Revy Suppl, V23, P1; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Caufield PW, 2007, J BACTERIOL, V189, P1238, DOI 10.1128/JB.01183-06; CAUFIELD PW, 1989, J CLIN MICROBIOL, V27, P1918; CAUFIELD PW, 1989, J CLIN MICROBIOL, V27, P274, DOI 10.1128/JCM.27.2.274-278.1989; Chen Z, 2007, FEMS MICROBIOL LETT, V272, P154, DOI 10.1111/j.1574-6968.2007.00756.x; Coffey TJ, 2006, APPL ENVIRON MICROB, V72, P1420, DOI 10.1128/AEM.72.2.1420-1428.2006; DAVEY AL, 1984, ARCH ORAL BIOL, V29, P453, DOI 10.1016/0003-9969(84)90026-8; de las Rivas B, 2006, MICROBIOL-SGM, V152, P85, DOI 10.1099/mic.0.28482-0; Delorme C, 2007, J BACTERIOL, V189, P1330, DOI 10.1128/JB.01058-06; Diancourt L, 2007, APPL ENVIRON MICROB, V73, P6601, DOI 10.1128/AEM.01095-07; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Do T, 2009, MICROBIOL-SGM, V155, P2593, DOI 10.1099/mic.0.027284-0; Edwards MT, 2008, MICROBIOL-SGM, V154, P852, DOI 10.1099/mic.0.2007/012336-0; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Gronroos L, 2000, CARIES RES, V34, P474, DOI 10.1159/000016626; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Igarashi T, 1996, MICROBIOL IMMUNOL, V40, P867, DOI 10.1111/j.1348-0421.1996.tb01152.x; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lachenauer CS, 2000, P NATL ACAD SCI USA, V97, P9630, DOI 10.1073/pnas.97.17.9630; Li Y, 1998, ORAL MICROBIOL IMMUN, V13, P17, DOI 10.1111/j.1399-302X.1998.tb00745.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MA JKC, 1991, INFECT IMMUN, V59, P2686, DOI 10.1128/IAI.59.8.2686-2694.1991; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marsh P D, 1994, Adv Dent Res, V8, P263; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Maruyama F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-358; McGraw EA, 1999, MOL BIOL EVOL, V16, P12, DOI 10.1093/oxfordjournals.molbev.a026032; Mineyama R, 2007, MICROBIOL RES, V162, P244, DOI 10.1016/j.micres.2006.06.014; Nakano K, 2004, J CLIN MICROBIOL, V42, P4925, DOI 10.1128/JCM.42.11.4925-4930.2004; Nakano K, 2004, J CLIN MICROBIOL, V42, P198, DOI 10.1128/JCM.42.1.198-202.2004; Nakano K, 2007, J CLIN MICROBIOL, V45, P2616, DOI 10.1128/JCM.02343-06; Oha T, 2000, ORAL MICROBIOL IMMUN, V15, P258, DOI 10.1034/j.1399-302x.2000.150408.x; PERCH B, 1974, ACTA PATH MICRO IM B, VB 82, P357; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; SAARELA M, 1993, J CLIN MICROBIOL, V31, P584, DOI 10.1128/JCM.31.3.584-587.1993; Saarela M, 1996, ARCH ORAL BIOL, V41, P821, DOI 10.1016/S0003-9969(96)00049-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shibata Y, 2003, J CLIN MICROBIOL, V41, P4107, DOI 10.1128/JCM.41.9.4107-4112.2003; SMITH JM, 1994, J MOL EVOL, V39, P123; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Toi CS, 2005, ANTON LEEUW INT J G, V88, P75, DOI 10.1007/s10482-005-1674-3; Truong TL, 2000, J MED MICROBIOL, V49, P63, DOI 10.1099/0022-1317-49-1-63; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wan AKL, 2001, J DENT RES, V80, P2060, DOI 10.1177/00220345010800120701; Waterhouse JC, 2007, ORAL MICROBIOL IMMUN, V22, P216, DOI 10.1111/j.1399-302X.2007.00330.x; Waterhouse JC, 2006, MICROBIOL-SGM, V152, P1777, DOI 10.1099/mic.0.28647-0; Whiley RA, 1998, ORAL MICROBIOL IMMUN, V13, P195, DOI 10.1111/j.1399-302X.1998.tb00698.x	63	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9073	10.1371/journal.pone.0009073	http://dx.doi.org/10.1371/journal.pone.0009073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140210	gold, Green Published			2022-12-25	WOS:000274442400012
J	Kim, CX; Bailey, KR; Klee, GG; Ellington, AA; Liu, GH; Mosley, TH; Rehman, H; Kullo, IJ				Kim, Charles X.; Bailey, Kent R.; Klee, George G.; Ellington, Allison A.; Liu, Guanghui; Mosley, Thomas H., Jr.; Rehman, Hamid; Kullo, Iftikhar J.			Sex and Ethnic Differences in 47 Candidate Proteomic Markers of Cardiovascular Disease: The Mayo Clinic Proteomic Markers of Arteriosclerosis Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; IMMUNOLUMINOMETRIC ASSAY; AFRICAN-AMERICAN; RISK-FACTORS; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; NATRIURETIC PEPTIDES; PROGNOSTIC VALUE; QUALITY-CONTROL	Background: Cardiovascular disease (CVD) susceptibility differs between men and women and varies with ethnicity. This variability is not entirely explained by conventional CVD risk factors. We examined differences in circulating levels of 47 novel protein markers of CVD in 2561 men and women of African-American (AA) and non-Hispanic White (NHW) ethnicity, enrolled at geographically distinct sites. Methodology/Principal Findings: Participants (1,324 AAs, mean age 63.5 y, 71% women; 1,237 NHWs, mean age 58.9 y, 57% women) belonged to sibships ascertained on the basis of hypertension. Solid-phase immunoassays and immunoturbidometric, clot-based, chromogenic, and electrophoretic assays were used to measure the 47 protein markers in plasma or serum. Marker levels were log transformed and outliers were adjusted to within 4 SD. To identify markers independently associated with sex or ethnicity, we employed multivariable regression analyses that adjusted for conventional risk factors, prior history of CVD, medication use and lifestyle factors (physical activity, alcohol consumption and education). Generalized estimating equations were used to correct for intrafamilial correlations. After adjustment for the above covariates, female sex was associated with higher levels of 29 markers and lower levels of 6 markers. Female sex was independently associated with higher levels of several inflammatory markers as well as lipoproteins, adipokines, natriuretic peptides, vasoconstrictor peptides and markers of calcification and thrombosis. AA ethnicity was associated with higher levels of 19 markers and lower levels of 6 markers, including higher levels of several inflammatory makers, higher leptin and lower adiponectin levels, lower levels of vasodilator-natriuretic peptides, higher levels of vasoconstrictor-antidiuretic peptides and markers of calcification and thrombosis. Conclusions/Significance: Plasma levels of several novel protein markers of CVD differ significantly in the context of sex and ethnicity. These results have implications for individualized CVD risk assessment.	[Kim, Charles X.; Bailey, Kent R.; Klee, George G.; Ellington, Allison A.; Liu, Guanghui; Mosley, Thomas H., Jr.; Rehman, Hamid; Kullo, Iftikhar J.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Kim, CX (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	kullo.iftikhar@mayo.edu			National Institutes of Health [HL-81331, M01 RR00585]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL081331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL-81331 and M01 RR00585 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Michelle A, 2004, Rev Cardiovasc Med, V5 Suppl 3, pS22; [Anonymous], 1989, AM J EPIDEMIOL, V129, P687; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bakris G, 1997, J HYPERTENS, V15, P545, DOI 10.1097/00004872-199715050-00011; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brilakis ES, 2008, ATHEROSCLEROSIS, V199, P110, DOI 10.1016/j.atherosclerosis.2007.10.010; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Cavusoglu E, 2007, AM J CARDIOL, V99, P1364, DOI 10.1016/j.amjcard.2006.12.060; Chang AY, 2007, J AM COLL CARDIOL, V49, P109, DOI 10.1016/j.jacc.2006.10.040; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Considine RV, 2008, OBESITY, V16, P428, DOI 10.1038/oby.2007.80; Davis CL, 2005, ETHNIC DIS, V15, P568; de Bold MLK, 1999, CARDIOVASC RES, V41, P524; Degawa-Yamauchi M, 2003, OBES RES, V11, P1384, DOI 10.1038/oby.2003.187; Ellington AA, 2009, CLIN CHEM, V55, P1092, DOI 10.1373/clinchem.2008.120717; Fan Amy Z, 2007, Atherosclerosis, V195, pe191, DOI 10.1016/j.atherosclerosis.2007.03.045; Fink E, 2000, OSTEOPOROSIS INT, V11, P295, DOI 10.1007/PL00004183; GERBES AL, 1994, J CLIN ENDOCR METAB, V78, P1307, DOI 10.1210/jc.78.6.1307; Gerszten RE, 2008, AM J PHYSIOL-LUNG C, V295, pL16, DOI 10.1152/ajplung.00044.2008; Granger CB, 2004, CIRCULATION, V109, P1697, DOI 10.1161/01.CIR.0000121563.47232.2A; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Gundberg CM, 2002, BONE, V31, P703, DOI 10.1016/S8756-3282(02)00902-X; Ho RH, 2007, PHARMACOGENET GENOM, V17, P647, DOI 10.1097/FPC.0b013e3280ef698f; Hoffmann B, 2009, ENVIRON HEALTH PERSP, V117, P1302, DOI 10.1289/ehp.0800362; Ikonomidis I, 2008, ATHEROSCLEROSIS, V199, P3, DOI 10.1016/j.atherosclerosis.2008.02.019; JNEID H, 2008, CIRCULATION; Kaplan Robert C, 2008, J Stroke Cerebrovasc Dis, V17, P344, DOI 10.1016/j.jstrokecerebrovasdis.2008.04.006; Kelley-Hedgepeth A, 2008, CLIN CHEM, V54, P1027, DOI 10.1373/clinchem.2007.098996; Khawaja FJ, 2007, MAYO CLIN PROC, V82, P709; Klos KLE, 2005, ANN HUM GENET, V69, P157, DOI 10.1046/j.1529-8817.2004.00148.x; Knopp Robert H, 2005, Curr Atheroscler Rep, V7, P472, DOI 10.1007/s11883-005-0065-6; Laughlin GA, 2007, AM J EPIDEMIOL, V165, P164, DOI 10.1093/aje/kwk001; Leder BZ, 2007, J CLIN ENDOCR METAB, V92, P3453, DOI 10.1210/jc.2006-2695; Lee JH, 2003, J CLIN ENDOCR METAB, V88, P4848, DOI 10.1210/jc.2003-030519; LIEB W, 2008, DIABETES CARE; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1957, DOI 10.1161/01.ATV.0000141842.27810.a9; Lukacs JL, 2006, MENOPAUSE, V13, P799, DOI 10.1097/01.gme.0000227023.89062.43; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; Okosun IS, 2001, J HUM HYPERTENS, V15, P299, DOI 10.1038/sj.jhh.1001181; Omland T, 2008, J AM COLL CARDIOL, V51, P627, DOI 10.1016/j.jacc.2007.09.058; Palmas W, 2008, ETHNIC DIS, V18, P324; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Romero-Corral A, 2008, NAT CLIN PRACT CARD, V5, P418, DOI 10.1038/ncpcardio1218; Rothenbacher D, 2005, EUR HEART J, V26, P1640, DOI 10.1093/eurheartj/ehi340; Schellings MWM, 2004, CARDIOVASC RES, V64, P24, DOI 10.1016/j.cardiores.2004.06.006; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Sladek CD, 2008, FRONT NEUROENDOCRIN, V29, P114, DOI 10.1016/j.yfrne.2007.08.005; Sowers James R, 2008, Clin Cornerstone, V9, P32, DOI 10.1016/S1098-3597(08)60026-5; Steinvil A, 2008, ENVIRON RES, V106, P51, DOI 10.1016/j.envres.2007.08.006; Stumvoll M, 2002, OBES RES, V10, P1197, DOI 10.1038/oby.2002.162; Sukhu K, 2003, CLIN LAB HAEMATOL, V25, P247, DOI 10.1046/j.1365-2257.2003.00523.x; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Ueland T, 2004, J AM COLL CARDIOL, V44, P1970, DOI 10.1016/j.jacc.2004.06.076; Vaidya D, 2008, METABOLISM, V57, P782, DOI 10.1016/j.metabol.2008.01.019; Verma S, 2003, CIRCULATION, V108, P736, DOI 10.1161/01.CIR.0000084503.91330.49; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; WESTGARD JO, 1981, CLIN CHEM, V27, P493; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; 2002, HEART, V88, P222; 2002, HYPERTENSION, V39, P3	70	73	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9065	10.1371/journal.pone.0009065	http://dx.doi.org/10.1371/journal.pone.0009065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140090	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442400005
J	Tanzer, M; Balluff, B; Distler, J; Hale, K; Leodolter, A; Rocken, C; Molnar, B; Schmid, R; Lofton-Day, C; Schuster, T; Ebert, MPA				Taenzer, Marc; Balluff, Benjamin; Distler, Juergen; Hale, Kari; Leodolter, Andreas; Roecken, Christoph; Molnar, Bela; Schmid, Roland; Lofton-Day, Catherine; Schuster, Tibor; Ebert, Matthias P. A.			Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions	PLOS ONE			English	Article							FECAL OCCULT BLOOD; DNA-METHYLATION; CANCER; COLITIS	Background: Screening for colorectal cancer (CRC) has shown to reduce cancer-related mortality, however, acceptance and compliance to current programmes are poor. Developing new, more acceptable non-invasive tests for the detection of cancerous and precancerous colorectal lesions would not only allow preselection of individuals for colonoscopy, but may also prevent cancer by removal of precancerous lesions. Methods: Plasma from 128 individuals (cohort I - exploratory study: 73 cases / 55 controls) was used to test the performance of a single marker, SEPT9, using a real-time quantitative PCR assay. To validate performance of SEPT9, plasma of 76 individuals (cohort II - validation study: 54 cases / 22 controls) was assessed. Additionally, improvement of predictive capability considering SEPT9 and additionally ALX4 methylation was investigated within these patients. Results: In both cohorts combined, methylation of SEPT9 was observed in 9% of controls (3/33), 29% of patients with colorectal precancerous lesions (27/94) and 73% of colorectal cancer patients (24/33). The presence of both SEPT9 and ALX4 markers was analysed in cohort II and was observed in 5% of controls (1/22) and 37% of patients with polyps (18/49). Interestingly, also 3/5 (60%) patients with colorectal cancer were tested positive by the two marker panel in plasma. Conclusions: While these data confirm the detection rate of SEPT9 as a biomarker for colorectal cancer, they also show that methylated DNA from advanced precancerous colorectal lesions can be detected using a panel of two DNA methylation markers, ALX4 and SEPT9. If confirmed in larger studies these data indicate that screening for colorectal precancerous lesions with a blood-based test may be as feasible as screening for invasive cancer.	[Taenzer, Marc; Balluff, Benjamin; Schmid, Roland; Ebert, Matthias P. A.] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany; [Distler, Juergen; Hale, Kari; Lofton-Day, Catherine] Epigenomics Inc, Seattle, WA USA; [Leodolter, Andreas] Jung Stilling Krankenhaus, Dept Med, Siegen, Germany; [Roecken, Christoph] Univ Kiel, Inst Pathol, D-2300 Kiel, Germany; [Molnar, Bela] Semmelweis Univ, Dept Med 2, H-1085 Budapest, Hungary; [Schuster, Tibor] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, D-8000 Munich, Germany	Technical University of Munich; University of Kiel; Semmelweis University; Technical University of Munich	Tanzer, M (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany.	Matthias.Ebert@lrz.tum.de	Röcken, Christoph/A-9239-2010	Röcken, Christoph/0000-0002-6989-8002	Deutsche Krebshilfe [107885]; Deutsche Forschungsgemeinschaft [SFB 824, TP B1]; Else Kroner Stiftung [P14/07//A104/06]; Bundesministerium fur Bildung und Forschung - German Federal Ministry for Education and Research (BMBF) [Mobimed 01EZ0802]; BMBF [0315116B]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Stiftung; Bundesministerium fur Bildung und Forschung - German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF))	M. Ebert is supported by grants from the Deutsche Krebshilfe (107885), the Deutsche Forschungsgemeinschaft (SFB 824, TP B1), the Else Kroner Stiftung (Nr P14/07//A104/06) and the Bundesministerium fur Bildung und Forschung - German Federal Ministry for Education and Research (BMBF) (Mobimed 01EZ0802). This study was also supported by a grant from the KMU-innovativ Initiative of the BMBF (No 0315116B) awarded to M. Ebert and J. Distler. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. J. Distler, C. Lofton-Day and K. Hale are employees of Epigenomics. Epigenomics did not provide funding for conduct of the experiments within this project. However, Epigenomcis provided information on the assays for methylation analysis which were developed by its employees. Analysis of the samples and interpretation of the data was performed independent of Epigenomics by the first and senior author. Epigenomics had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cottrell SE, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh008; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; Eads CA, 2001, CANCER RES, V61, P3410; Eads CA, 2000, CANCER RES, V60, P5021; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Ebert MPA, 2003, J CLIN ONCOL, V21, P1708, DOI 10.1200/JCO.2003.10.017; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Howarth GF, 2002, AM J GASTROENTEROL, V97, P690; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Okamoto M, 2005, AM J TROP MED HYG, V73, P934; Petko Z, 2005, CLIN CANCER RES, V11, P1203; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Sobin, 2009, UICC TNM CLASSIFICAT; Song K, 2004, GASTROENTEROLOGY, V126, P1270, DOI 10.1053/j.gastro.2004.02.016; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1297, DOI 10.1001/jama.289.10.1297	22	129	145	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9061	10.1371/journal.pone.0009061	http://dx.doi.org/10.1371/journal.pone.0009061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140221	gold, Green Published			2022-12-25	WOS:000274474400017
J	Spiegelhalter, C; Tosch, V; Hentsch, D; Koch, M; Kessler, P; Schwab, Y; Laporte, J				Spiegelhalter, Coralie; Tosch, Valerie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick; Laporte, Jocelyn			From Dynamic Live Cell Imaging to 3D Ultrastructure: Novel Integrated Methods for High Pressure Freezing and Correlative Light-Electron Microscopy	PLOS ONE			English	Article							CRYOELECTRON TOMOGRAPHY; AMPHIPHYSIN-2 BIN1; FLUORESCENCE; SUSPENSIONS; IMMUNOCYTOCHEMISTRY; PHOTOOXIDATION; CRYOSECTIONS; RESOLUTION; SUBSTRATE; APPARATUS	Background: In cell biology, the study of proteins and organelles requires the combination of different imaging approaches, from live recordings with light microscopy (LM) to electron microscopy (EM). Methodology: To correlate dynamic events in adherent cells with both ultrastructural and 3D information, we developed a method for cultured cells that combines confocal time-lapse images of GFP-tagged proteins with electron microscopy. With laser micro-patterned culture substrate, we created coordinates that were conserved at every step of the sample preparation and visualization processes. Specifically designed for cryo-fixation, this method allowed a fast freezing of dynamic events within seconds and their ultrastructural characterization. We provide examples of the dynamic oligomerization of GFP-tagged myotubularin (MTM1) phosphoinositides phosphatase induced by osmotic stress, and of the ultrastructure of membrane tubules dependent on amphiphysin 2 (BIN1) expression. Conclusion: Accessible and versatile, we show that this approach is efficient to routinely correlate functional and dynamic LM with high resolution morphology by EM, with immuno-EM labeling, with 3D reconstruction using serial immuno-EM or tomography, and with scanning-EM.	[Spiegelhalter, Coralie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick] IGBMC, Imaging Ctr, Illkirch Graffenstaden, France; [Tosch, Valerie; Laporte, Jocelyn] IGBMC, Dept Neurobiol & Genet, Illkirch Graffenstaden, France; [Spiegelhalter, Coralie; Tosch, Valerie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick; Laporte, Jocelyn] INSERM, U964, Illkirch Graffenstaden, France; [Spiegelhalter, Coralie; Tosch, Valerie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick; Laporte, Jocelyn] CNRS, UMR7104, Illkirch Graffenstaden, France; [Spiegelhalter, Coralie; Tosch, Valerie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick; Laporte, Jocelyn] Univ Strasbourg, Illkirch Graffenstaden, France; [Tosch, Valerie; Laporte, Jocelyn] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France	Spiegelhalter, C (corresponding author), IGBMC, Imaging Ctr, Illkirch Graffenstaden, France.	yschwab@igbmc.fr; jocelyn@igbmc.fr	Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019; laporte, jocelyn/J-7008-2012; Kessler, Pascal/ABF-6615-2021	Schwab, Yannick/0000-0001-8027-1836; Spiegelhalter, Coralie/0000-0001-6372-1647; Koch, Marc/0000-0002-2678-235X	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University of Strasbourg (UdS); College de France; Association Francaise contre les Myopathies (AFM); Fondation Recherche Medicale [FRM DEQ20071210538]; Agence Nationale de la Recherche [ANR-07-BLAN-0065-03, ANR-08-GENOPAT-005]; E-rare program	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg (UdS)(European Commission); College de France; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Recherche Medicale; Agence Nationale de la Recherche(French National Research Agency (ANR)); E-rare program	This study was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), the University of Strasbourg (UdS), the College de France, the Association Francaise contre les Myopathies (AFM), Fondation Recherche Medicale (FRM DEQ20071210538), Agence Nationale de la Recherche (ANR-07-BLAN-0065-03, ANR-08-GENOPAT-005) and the E-rare program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRONSKAIA AV, 2008, J STRUCT BIOL; Auinger S, 2008, METHOD CELL BIOL, V88, P257, DOI 10.1016/S0091-679X(08)00414-7; Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Colombelli Julien, 2008, V457, P203, DOI 10.1007/978-1-59745-261-8_15; Darcy KJ, 2006, NAT PROTOC, V1, P988, DOI 10.1038/nprot.2006.146; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Gruska M, 2008, J STRUCT BIOL, V161, P384, DOI 10.1016/j.jsb.2007.10.008; Hess MW, 2000, J STRUCT BIOL, V130, P63, DOI 10.1006/jsbi.2000.4230; HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x; Jimenez N, 2006, J MICROSC-OXFORD, V221, P216, DOI 10.1111/j.1365-2818.2006.01558.x; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lucic V, 2007, J STRUCT BIOL, V160, P146, DOI 10.1016/j.jsb.2007.08.014; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Meisslitzer-Ruppitsch C, 2009, J MICROSC-OXFORD, V235, P322, DOI 10.1111/j.1365-2818.2009.03220.x; Mironov AA, 2009, J MICROSC-OXFORD, V235, P308, DOI 10.1111/j.1365-2818.2009.03222.x; Mironov AA, 2000, TRENDS CELL BIOL, V10, P349, DOI 10.1016/S0962-8924(00)01787-6; Monaghan P, 1998, J MICROSC-OXFORD, V192, P248, DOI 10.1046/j.1365-2818.1998.00387.x; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Murk JLAN, 2003, J MICROSC-OXFORD, V212, P81, DOI 10.1046/j.1365-2818.2003.01238.x; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Prendergast GC, 2009, BBA-REV CANCER, V1795, P25, DOI 10.1016/j.bbcan.2008.09.001; Sartori A, 2007, J STRUCT BIOL, V160, P135, DOI 10.1016/j.jsb.2007.07.011; Sawaguchi A, 2003, J MICROSC-OXFORD, V212, P13, DOI 10.1046/j.1365-2818.2003.01225.x; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Schwarz Heinz, 2007, Methods Mol Biol, V369, P229; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; van Rijnsoever C, 2008, NAT METHODS, V5, P973, DOI 10.1038/nmeth.1263; Verkade P, 2008, J MICROSC-OXFORD, V230, P317, DOI 10.1111/j.1365-2818.2008.01989.x; Vicidomini G, 2008, TRAFFIC, V9, P1828, DOI 10.1111/j.1600-0854.2008.00815.x	37	57	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9014	10.1371/journal.pone.0009014	http://dx.doi.org/10.1371/journal.pone.0009014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140253	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474200010
J	Lin, SL; Yan, LY; Zhang, XT; Yuan, J; Li, M; Qiao, J; Wang, ZY; Sun, QY				Lin, Sheng-Li; Yan, Li-Ying; Zhang, Xin-Tian; Yuan, Ju; Li, Mo; Qiao, Jie; Wang, Zhao-Yi; Sun, Qing-Yuan			ER-alpha 36, a Variant of ER-alpha, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; ACTIVATED PROTEIN-KINASE; ESTROGEN-RECEPTOR-ALPHA; SURGICAL ADJUVANT BREAST; GROWTH-FACTOR; ANTIESTROGEN RESISTANCE; MOLECULAR-MECHANISMS; C-MYC; EXPRESSION; ESTRADIOL	Background: Recently, a novel variant of ER-alpha, ER-alpha 36 was identified and cloned. ER-alpha 36 lacks intrinsic transcription activity and mainly mediates nongenomic estrogen signaling. Here, we studied the role of nongenomic estrogen signaling pathways mediated by ER-alpha 36 in tamoxifen resistance and agonist action. Methodology: The cellular localization of ER-alpha 36 was examined by immunofluorescence in MCF-7 cells and Hec1A cells. MCF-7 breast cancer cells, MCF-7 cells expressing recombinant ER-alpha 36 (MCF-7/ER36), Hec1A endometrial cancer cells and Hec1A cells with siRNA knockdown of ER-alpha 36 (Hec1A/RNAiER36) were treated with 17 beta-estradial (E2) and tamoxifen (TAM) in the absence and presence of kinase inhibitor U0126 and LY294002. We examined phosphorylation of signaling molecules and the expression of c-Myc by immunoblotting, and tumor cell growth by MTT assay. Conclusions: ER variant ER-alpha 36 enhances TAM agonist activity through activation of the membrane-initiated signaling pathways in endometrial cancer, and that ER-alpha 36 is involved in de novo and acquired TAM resistance in breast cancer.	[Lin, Sheng-Li; Yuan, Ju; Li, Mo; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Lin, Sheng-Li; Yuan, Ju; Li, Mo; Sun, Qing-Yuan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Yan, Li-Ying; Qiao, Jie] Peking Univ Third Hosp, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing 100871, Peoples R China; [Zhang, Xin-Tian; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Creighton University	Lin, SL (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	jie.qiao@263.net; zywang@creighton.edu; sunqy@ioz.ac.cn			National Basic Research Program of China [2006CB504004, 2006CB944005]	National Basic Research Program of China(National Basic Research Program of China)	This study was supported by National Basic Research Program of China (2006CB504004, 2006CB944005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; COLE MP, 1971, BRIT J CANCER, V25, P270, DOI 10.1038/bjc.1971.33; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; Dutertre M, 2000, J PHARMACOL EXP THER, V295, P431; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; FRIEDL A, 1989, CANCER RES, V49, P4758; Frogne T, 2005, ENDOCR-RELAT CANCER, V12, P599, DOI 10.1677/erc.1.00946; Gao J, 2005, INT J ONCOL, V26, P737; Glaros S, 2006, MOL ENDOCRINOL, V20, P996, DOI 10.1210/me.2005-0285; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Jordan NJ, 2004, BREAST CANCER RES TR, V87, P167, DOI 10.1023/B:BREA.0000041623.21338.47; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Levin ER, 2008, BREAST CANCER RES TR, V108, P351, DOI 10.1007/s10549-007-9618-4; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; LOVE RR, 1989, J CLIN ONCOL, V7, P803, DOI 10.1200/JCO.1989.7.6.803; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Mueller H, 2000, INT J CANCER, V89, P384, DOI 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R; NEVEN P, 1990, BRIT J OBSTET GYNAEC, V97, P551, DOI 10.1111/j.1471-0528.1990.tb02536.x; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; REDDEL RR, 1983, CANCER RES, V43, P4618; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shibutani S, 2000, CARCINOGENESIS, V21, P1461, DOI 10.1093/carcin/21.8.1461; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Sotgia F, 2006, CANCER RES, V66, P10647, DOI 10.1158/0008-5472.CAN-06-2805; Stoica GE, 2003, MOL ENDOCRINOL, V17, P818, DOI 10.1210/me.2002-0330; Tokunaga E, 2006, EUR J CANCER, V42, P629, DOI 10.1016/j.ejca.2005.11.025; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; WATSON PH, 1991, CANCER RES, V51, P3996; Werf H. M. G. van der, 1995, Journal of the International Hemp Association, V2, P14; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003	47	101	120	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9013	10.1371/journal.pone.0009013	http://dx.doi.org/10.1371/journal.pone.0009013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126312	Green Published, Green Submitted, gold			2022-12-25	WOS:000274207200011
J	Ortega, FJ; Moreno-Navarrete, JM; Pardo, G; Sabater, M; Hummel, M; Ferrer, A; Rodriguez-Hermosa, JI; Ruiz, B; Ricart, W; Peral, B; Fernandez-Real, JM				Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Pardo, Gerard; Sabater, Monica; Hummel, Manuela; Ferrer, Anna; Rodriguez-Hermosa, Jose I.; Ruiz, Bartomeu; Ricart, Wifredo; Peral, Belen; Fernandez-Real, Jose M.			MiRNA Expression Profile of Human Subcutaneous Adipose and during Adipocyte Differentiation	PLOS ONE			English	Article							MICRORNA EXPRESSION; TISSUE CELLULARITY; CELL; ADIPOGENESIS; NUMBER; TUMORIGENESIS; GENES; IDENTIFICATION; CHILDREN; OBESITY	Background: Potential regulators of adipogenesis include microRNAs (miRNAs), small non-coding RNAs that have been recently shown related to adiposity and differentially expressed in fat depots. However, to date no study is available, to our knowledge, regarding miRNAs expression profile during human adipogenesis. Thereby, the aim of this study was to investigate whether miRNA pattern in human fat cells and subcutaneous adipose tissue is associated to obesity and co-morbidities and whether miRNA expression profile in adipocytes is linked to adipogenesis. Methodology/Principal Findings: We performed a global miRNA expression microarray of 723 human and 76 viral mature miRNAs in human adipocytes during differentiation and in subcutaneous fat samples from non-obese (n=6) and obese with (n=9) and without (n=13) Type-2 Diabetes Mellitus (DM-2) women. Changes in adipogenesis-related miRNAs were then validated by RT-PCR. Fifty of 799 miRNAs (6.2%) significantly differed between fat cells from lean and obese subjects. Seventy miRNAs (8.8%) were highly and significantly up or down-regulated in mature adipocytes as compared to pre-adipocytes. Otherwise, 17 of these 799 miRNAs (2.1%) were correlated with anthropometrical (BMI) and/or metabolic (fasting glucose and/or triglycerides) parameters. We identified 11 miRNAs (1.4%) significantly deregulated in subcutaneous fat from obese subjects with and without DM-2. Interestingly, most of these changes were associated with miRNAs also significantly deregulated during adipocyte differentiation. Conclusions/Significance: The remarkable inverse miRNA profile revealed for human pre-adipocytes and mature adipocytes hints at a closely crosstalk between miRNAs and adipogenesis. Such candidates may represent biomarkers and therapeutic targets for obesity and obesity-related complications.	[Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Pardo, Gerard; Sabater, Monica; Ricart, Wifredo; Fernandez-Real, Jose M.] CIBEROBN CB06 03 0010, Serv Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, Girona, Spain; [Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Pardo, Gerard; Sabater, Monica; Ricart, Wifredo; Fernandez-Real, Jose M.] Inst Salud Carlos III, Girona, Spain; [Hummel, Manuela; Ferrer, Anna] UPF, Microarray Unit, CRG, Barcelona, Spain; [Peral, Belen] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Peral, Belen] Univ Autonoma Madrid, Madrid, Spain; [Rodriguez-Hermosa, Jose I.; Ruiz, Bartomeu] Inst Invest Biomed Girona IdIBGi, Dept Surg, Girona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI)	Ortega, FJ (corresponding author), CIBEROBN CB06 03 0010, Serv Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, Girona, Spain.	jmfernandezreal.girona.ics@gencat.cat	Moreno-Navarrete, José María/H-9772-2015; Xie, Huangming/B-2260-2012; Moreno-Navarrete, José María/ABG-5548-2021; Sabater-Masdeu, Mònica/G-1168-2016; Duarte, Graziela Biude Silva/Q-7728-2016; Ortega, Francisco José J/F-3883-2016; Fernández-Real, Jose Manuel/AGH-3599-2022; Ferrer-Salvador, Anna/K-6001-2015; PERAL, BELEN/F-4562-2015	Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Sabater-Masdeu, Mònica/0000-0001-9636-0921; Ortega, Francisco José J/0000-0003-2111-769X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Ferrer-Salvador, Anna/0000-0001-5507-0733; Ricart, Wifredo/0000-0002-3452-9098; PERAL, BELEN/0000-0003-4984-4020	Ministerio de Educacion y Ciencia (MEC) [SAF2008-02073]; Instituto de Salud Carlos III [CB06/03/0010]	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by research grants from the Ministerio de Educacion y Ciencia (MEC) (SAF2008-02073), the Instituto de Salud Carlos III (CIBERObN, CB06/03/0010), and the Hospital Dr. Josep Trueta de Girona. The funders had no role in study design, data collection nor analysis, decision to publish, or preparation of the manuscript.	Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BROOK CGD, 1972, BMJ-BRIT MED J, V2, P25, DOI 10.1136/bmj.2.5804.25; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; GINSBERGFELLNER F, 1981, PEDIATR RES, V15, P1381, DOI 10.1203/00006450-198110000-00016; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hauner H, 1988, Horm Metab Res Suppl, V19, P35; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hernando E, 2007, CLIN TRANSL ONCOL, V9, P155, DOI 10.1007/s12094-007-0029-0; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Joglekar MV, 2007, TRENDS ENDOCRIN MET, V18, P393, DOI 10.1016/j.tem.2007.10.001; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Obregon MJ, 2008, THYROID, V18, P185, DOI 10.1089/thy.2007.0254; Pasarica M, 2009, DIABETES CARE, V32, P900, DOI 10.2337/dc08-2240; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; RONCARI DAK, 1981, METABOLISM, V30, P425, DOI 10.1016/0026-0495(81)90174-8; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; SALANS LB, 1973, J CLIN INVEST, V52, P929, DOI 10.1172/JCI107258; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	43	287	299	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9022	10.1371/journal.pone.0009022	http://dx.doi.org/10.1371/journal.pone.0009022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126310	gold, Green Published			2022-12-25	WOS:000274207200017
J	Pombert, JF; Keeling, PJ				Pombert, Jean-Francois; Keeling, Patrick J.			The Mitochondrial Genome of the Entomoparasitic Green Alga Helicosporidium	PLOS ONE			English	Article							GROUP-I INTRON; SEQUENCE; GENES; DNA; TREBOUXIOPHYCEAE; CHLOROPHYTA; SELECTION	Background: Helicosporidia are achlorophyllous, non-photosynthetic protists that are obligate parasites of invertebrates. Highly specialized, these pathogens feature an unusual cyst stage that dehisces inside the infected organism and releases a filamentous cell displaying surface projections, which will penetrate the host gut wall and eventually reproduce in the hemolymph. Long classified as incertae sedis or as relatives of other parasites such as Apicomplexa or Microsporidia, the Helicosporidia were surprisingly identified through molecular phylogeny as belonging to the Chlorophyta, a phylum of green algae. Most phylogenetic analyses involving Helicosporidia have placed them within the subgroup Trebouxiophyceae and further suggested a close affiliation between the Helicosporidia and the genus Prototheca. Prototheca species are also achlorophyllous and pathogenic, but they infect vertebrate hosts, inducing protothecosis in humans. The complete plastid genome of an Helicosporidium species was recently described and is a model of compaction and reduction. Here we describe the complete mitochondrial genome sequence of the same strain, Helicosporidium sp. ATCC 50920 isolated from the black fly Simulium jonesi. Methodology/Principal Findings: The circular mapping 49343 bp mitochondrial genome of Helicosporidium closely resembles that of the vertebrate parasite Prototheca wickerhamii. The two genomes share an almost identical gene complement and display a level of synteny that is higher than any other sequenced chlorophyte mitochondrial DNAs. Interestingly, the Helicosporidium mtDNA feature a trans-spliced group I intron, and a second group I intron that contains two open reading frames that appear to be degenerate maturase/endonuclease genes, both rare characteristics for this type of intron. Conclusions/Significance: The architecture, genome content, and phylogeny of the Helicosporidium mitochondrial genome are all congruent with its close relationship to Prototheca within the Trebouxiophyceae. The Helicosporidium mitochondrial genome does, however, contain a number of novel features, particularly relating to its introns.	[Pombert, Jean-Francois; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Pombert, JF (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	jpombert@interchange.ubc.ca		Keeling, Patrick/0000-0002-7644-0745; Pombert, Jean-Francois/0000-0002-3449-8375	Natural Sciences and Engineering Research Council (NSERC); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)/Genome Quebec Louis-Berlinguet Postdoctoral Fellowship; Canadian Institute for Advanced Research (CIFAR); Michael Smith Foundation for Health Research (MSFHR)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)/Genome Quebec Louis-Berlinguet Postdoctoral Fellowship(FQRNT); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	Funding: This work was supported by a Natural Sciences and Engineering Research Council (NSERC) operating grant to PJK. JFP is the recipient of the Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)/Genome Quebec Louis-Berlinguet Postdoctoral Fellowship. PJK is a Fellow of the Canadian Institute for Advanced Research (CIFAR), and a Senior Scholar of the Michael Smith Foundation for Health Research (MSFHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blaske-Lietze VU, 2006, J EUKARYOT MICROBIOL, V53, P165, DOI 10.1111/j.1550-7408.2006.00090.x; Blaske-Lietze VU, 2005, J INVERTEBR PATHOL, V90, P161, DOI 10.1016/j.jip.2005.09.002; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Boucias DG, 2001, J EUKARYOT MICROBIOL, V48, P460, DOI 10.1111/j.1550-7408.2001.tb00180.x; Burger G, 2009, TRENDS GENET, V25, P381, DOI 10.1016/j.tig.2009.07.003; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Conklin T, 2005, FLA ENTOMOL, V88, P431, DOI 10.1653/0015-4040(2005)88[431:IOTIOH]2.0.CO;2; de Koning AP, 2005, PROTIST, V156, P181, DOI 10.1016/j.protis.2005.02.005; de Koning AP, 2004, EUKARYOT CELL, V3, P1198, DOI 10.1128/EC.3.5.1198-1205.2004; de Koning AP, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-12; Dotson PP, 2008, NUCLEIC ACIDS RES, V36, P5281, DOI 10.1093/nar/gkn507; Dotson PP, 2008, BIOCHEMISTRY-US, V47, P4780, DOI 10.1021/bi7020525; Einvik Christer, 2004, Methods Mol Biol, V252, P359; GORDON D, 2004, CURRENT PROTOCOLS BI; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; Keilin D., 1921, Parasitology Cambridge, V13, P97, DOI 10.1017/S003118200001235X; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lass-Florl C, 2007, CLIN MICROBIOL REV, V20, P230, DOI 10.1128/CMR.00032-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pombert JF, 2006, CURR GENET, V50, P137, DOI 10.1007/s00294-006-0076-z; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Silva GH, 2006, J MOL BIOL, V361, P744, DOI 10.1016/j.jmb.2006.06.063; Tartar A, 2004, FEMS MICROBIOL LETT, V233, P153, DOI 10.1016/j.femsle.2004.02.006; Tartar A, 2003, INT J SYST EVOL MICR, V53, P1719, DOI 10.1099/ijs.0.02559-0; Tartar A, 2002, INT J SYST EVOL MICR, V52, P273, DOI 10.1099/00207713-52-1-273; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; WOLFF G, 1994, J MOL BIOL, V237, P75, DOI 10.1006/jmbi.1994.1210	37	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8954	10.1371/journal.pone.0008954	http://dx.doi.org/10.1371/journal.pone.0008954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126458	Green Published, gold, Green Submitted			2022-12-25	WOS:000274139100005
J	Stabentheiner, A; Kovac, H; Brodschneider, R				Stabentheiner, Anton; Kovac, Helmut; Brodschneider, Robert			Honeybee Colony Thermoregulation - Regulatory Mechanisms and Contribution of Individuals in Dependence on Age, Location and Thermal Stress	PLOS ONE			English	Article							APIS-MELLIFERA-CARNICA; FLIGHT MUSCLE DEVELOPMENT; DIVISION-OF-LABOR; OXYGEN-CONSUMPTION; CALORIMETRIC INVESTIGATIONS; AMBIENT-TEMPERATURE; RESTING HONEYBEES; BROOD-TEMPERATURE; PUPAL DEVELOPMENT; METABOLIC RATES	Honeybee larvae and pupae are extremely stenothermic, i.e. they strongly depend on accurate regulation of brood nest temperature for proper development (33-36 degrees C). Here we study the mechanisms of social thermoregulation of honeybee colonies under changing environmental temperatures concerning the contribution of individuals to colony temperature homeostasis. Beside migration activity within the nest, the main active process is "endothermy on demand" of adults. An increase of cold stress (cooling of the colony) increases the intensity of heat production with thoracic flight muscles and the number of endothermic individuals, especially in the brood nest. As endothermy means hard work for bees, this eases much burden of nestmates which can stay ectothermic. Concerning the active reaction to cold stress by endothermy, age polyethism is reduced to only two physiologically predetermined task divisions, 0 to similar to 2 days and older. Endothermic heat production is the job of bees older than about two days. They are all similarly engaged in active heat production both in intensity and frequency. Their active heat production has an important reinforcement effect on passive heat production of the many ectothermic bees and of the brood. Ectothermy is most frequent in young bees (<similar to 2 days) both outside and inside of brood nest cells. We suggest young bees visit warm brood nest cells not only to clean them but also to speed up flight muscle development for proper endothermy and foraging later in their life. Young bees inside brood nest cells mostly receive heat from the surrounding cell wall during cold stress, whereas older bees predominantly transfer heat from the thorax to the cell wall. Endothermic bees regulate brood comb temperature more accurately than local air temperature. They apply the heat as close to the brood as possible: workers heating cells from within have a higher probability of endothermy than those on the comb surface. The findings show that thermal homeostasis of honeybee colonies is achieved by a combination of active and passive processes. The differential individual endothermic and behavioral reactions sum up to an integrated action of the honeybee colony as a superorganism.	[Stabentheiner, Anton; Kovac, Helmut; Brodschneider, Robert] Karl Franzens Univ Graz, Inst Zool, Graz, Austria	University of Graz	Stabentheiner, A (corresponding author), Karl Franzens Univ Graz, Inst Zool, Graz, Austria.	anton.stabentheiner@uni-graz.at; he.kovac@uni-graz.at			Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) [P13916, P16584]	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF))	Funding: Supported by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (FWF, P13916, P16584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile R, 2008, ZOOLOGY, V111, P433, DOI 10.1016/j.zool.2007.11.002; Becher MA, 2009, J COMP PHYSIOL A, V195, P673, DOI 10.1007/s00359-009-0442-7; BUDEL A, 1960, BIENE BIENENZUCHT; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; CAHILL K, 1976, COMP BIOCHEM PHYS A, V55, P355, DOI 10.1016/0300-9629(76)90060-8; Crailsheim K, 1999, ENTOMOL GEN, V24, P01; ESCH H, 1960, Z VERGL PHYSIOL, V43, P305, DOI 10.1007/BF00298066; FAHRENHOLZ L, 1992, J COMP PHYSIOL B, V162, P119, DOI 10.1007/BF00398337; Fehler M, 2007, NATURWISSENSCHAFTEN, V94, P675, DOI 10.1007/s00114-007-0240-4; GATES V, 1914, B USDA, V96, P1; Graham S, 2006, INSECT SOC, V53, P226, DOI 10.1007/s00040-005-0862-5; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; HARRISON JM, 1987, J EXP BIOL, V129, P53; Heinrich B., 1993, HOT BLOODED INSECTS; HERAN H, 1952, Z VERGL PHYSIOL, V34, P179; HEROLD RC, 1965, DEV BIOL, V12, P269, DOI 10.1016/0012-1606(65)90031-X; HEROLD RC, 1963, DEV BIOL, V8, P67, DOI 10.1016/0012-1606(63)90026-5; HERSCH MI, 1978, COMP BIOCHEM PHYS B, V61, P427, DOI 10.1016/0305-0491(78)90149-9; HESS W. R., 1926, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V4, P465, DOI 10.1007/BF00340746; Himmer A, 1932, BIOL REV BIOL P CAMB, V7, P224; Johnson BR, 2002, BEHAV ECOL SOCIOBIOL, V51, P188, DOI 10.1007/s00265-001-0419-1; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Klein BA, 2008, J EXP BIOL, V211, P3028, DOI 10.1242/jeb.017426; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; KOENIGER N, 1978, APIDOLOGIE, V9, P305, DOI 10.1051/apido:19780404; Kovac H, 2007, J INSECT PHYSIOL, V53, P1250, DOI 10.1016/j.jinsphys.2007.06.019; Kovac H, 2009, APIDOLOGIE, V40, P82, DOI 10.1051/apido/2008069; KRONENBERG F, 1982, J COMP PHYSIOL, V148, P65, DOI 10.1007/BF00688889; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; LINDAUER M, 1954, Z VERGL PHYSIOL, V36, P391, DOI 10.1007/BF00345028; Mackasmiel LAM, 2000, J APICULT RES, V39, P125, DOI 10.1080/00218839.2000.11101032; Mandl M., 2004, P 1 EUR C AP EURBEE; MANDL M, 2005, THESIS K FRANZENS U, P227; MELAMPY R. M., 1939, PHYSIOL ZOOL, V12, P302; Moritz R.F.A., 1988, Biona Report, V6, P51; Moritz R.F.A., 1992, BEES SUPERORGANISMS; PAGE RE, 1991, ADV INSECT PHYSIOL, V23, P117, DOI 10.1016/S0065-2806(08)60093-4; Petz M, 2004, J COMP PHYSIOL B, V174, P511, DOI 10.1007/s00360-004-0439-z; RITTER W, 1982, APIDOLOGIE, V13, P169, DOI 10.1051/apido:19820205; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROTHE U, 1989, J COMP PHYSIOL B, V158, P739, DOI 10.1007/BF00693012; Sachs L., 1997, ANGEW STAT, P11, DOI [10.1007/978-3-662-05746-9_2, DOI 10.1007/978-3-662-05746-9_2, 10.1007/978-3-662-05746-9]; SAKAGAMI SF, 1956, Z VERGL PHYSIOL, V39, P21; Schmolz E, 2002, THERMOCHIM ACTA, V382, P221, DOI 10.1016/S0040-6031(01)00740-7; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1991, ETHOLOGY, V87, P284; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; SEELEY TD, 1994, BEHAV ECOL SOCIOBIOL, V34, P51, DOI 10.1007/BF00175458; SEELEY TD, 1992, BEHAV ECOL SOCIOBIOL, V31, P375, DOI 10.1007/BF00170604; SIMPSON J, 1961, SCIENCE, V133, P1327, DOI 10.1126/science.133.3461.1327; SOUTHWICK EE, 1987, J INSECT PHYSIOL, V33, P623, DOI 10.1016/0022-1910(87)90130-2; SOUTHWICK EE, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P28; SOUTHWICK EE, 1985, J COMP PHYSIOL B, V156, P143, DOI 10.1007/BF00692937; Stabentheiner A, 1996, ETHOLOGY, V102, P360, DOI 10.1111/j.1439-0310.1996.tb01132.x; Stabentheiner A., 1987, Thermology, V2, P563; Stabentheiner A, 1995, J COMP PHYSIOL B, V165, P433, DOI 10.1007/BF00261297; STABENTHEINER A, 1991, NATURWISSENSCHAFTEN, V78, P471, DOI 10.1007/BF01134389; Stabentheiner A, 2003, J INSECT PHYSIOL, V49, P881, DOI 10.1016/S0022-1910(03)00148-3; Stabentheiner A, 2003, J EXP BIOL, V206, P353, DOI 10.1242/jeb.00082; Stabentheiner A, 2002, J EXP BIOL, V205, P2637; Stabentheiner A, 1999, ENTOMOL GEN, V24, P13; Stabentheiner A, 2001, J INSECT PHYSIOL, V47, P385, DOI 10.1016/S0022-1910(00)00132-3; STABENTHEINER A, 2002, APIDOLOGIE, V33, P499; Stabentheiner A, 2007, ETHOLOGY, V113, P995, DOI 10.1111/j.1439-0310.2007.01403.x; Starks PT, 2005, BEHAV ECOL, V16, P128, DOI 10.1093/beheco/arh124; Starks PT, 1999, NATURWISSENSCHAFTEN, V86, P438, DOI 10.1007/s001140050648; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Vollmann J., 2004, Mitteilungen der Deutschen Gesellschaft fur allgemeine und angewandte Entomologie, V14, P467; [No title captured]	71	143	149	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8967	10.1371/journal.pone.0008967	http://dx.doi.org/10.1371/journal.pone.0008967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126462	Green Published, Green Submitted, gold			2022-12-25	WOS:000274139100015
J	Wallace, WHB; Kelsey, TW				Wallace, W. Hamish B.; Kelsey, Thomas W.			Human Ovarian Reserve from Conception to the Menopause	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; ADULT MAMMALIAN OVARIES; GERMLINE STEM-CELLS; AGE; WOMEN; FOLLICLES; FAILURE; DECLINE; OOCYTE; NUMBER	The human ovary contains a fixed number of non-growing follicles (NGFs) established before birth that decline with increasing age culminating in the menopause at 50-51 years. The objective of this study is to model the age-related population of NGFs in the human ovary from conception to menopause. Data were taken from eight separate quantitative histological studies (n = 325) in which NGF populations at known ages from seven weeks post conception to 51 years ( median 32 years) were calculated. The data set was fitted to 20 peak function models, with the results ranked by obtained r(2) correlation coefficient. The highest ranked model was chosen. Our model matches the log-adjusted NGF population from conception to menopause to a five-parameter asymmetric double Gaussian cumulative (ADC) curve (r(2) = 0.81). When restricted to ages up to 25 years, the ADC curve has r(2) = 0.95. We estimate that for 95% of women by the age of 30 years only 12% of their maximum pre-birth NGF population is present and by the age of 40 years only 3% remains. Furthermore, we found that the rate of NGF recruitment towards maturation for most women increases from birth until approximately age 14 years then decreases towards the menopause. To our knowledge, this is the first model of ovarian reserve from conception to menopause. This model allows us to estimate the number of NGFs present in the ovary at any given age, suggests that 81% of the variance in NGF populations is due to age alone, and shows for the first time, to our knowledge, that the rate of NGF recruitment increases from birth to age 14 years then declines with age until menopause. An increased understanding of the dynamics of human ovarian reserve will provide a more scientific basis for fertility counselling for both healthy women and those who have survived gonadotoxic cancer treatments.	[Wallace, W. Hamish B.] Univ Edinburgh, Dept Reprod & Dev Sci, Div Child Life & Hlth, Edinburgh, Midlothian, Scotland; [Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland	University of Edinburgh; University of St Andrews	Wallace, WHB (corresponding author), Univ Edinburgh, Dept Reprod & Dev Sci, Div Child Life & Hlth, Edinburgh, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458; wallace, william, hamish/0000-0001-8080-5674	United Kingdom Engineering and Physical Sciences Research Council (EPSRC) [EP/CS23229/1, EP/H004092/1]; EPSRC [EP/H004092/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H004092/1, EP/C523229/1] Funding Source: researchfish	United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TWK is supported by United Kingdom Engineering and Physical Sciences Research Council (EPSRC) grants EP/CS23229/1 and EP/H004092/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; BLOCK E, 1953, ACTA ANAT, V17, P201; BLOCK E, 1952, ACTA ANAT, V14, P108; BRETHERICK KL, 2009, FERTILITY S IN PRESS; Brett S, 2009, REPROD BIOMED ONLINE, V18, P348, DOI 10.1016/S1472-6483(10)60092-2; Broekmans FJ, 2008, TRENDS ENDOCRIN MET, V19, P340, DOI 10.1016/j.tem.2008.08.002; Faddy MJ, 1996, HUM REPROD, V11, P1484; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Forabosco A, 2007, FERTIL STERIL, V88, P675, DOI 10.1016/j.fertnstert.2006.11.191; GOUGEON A, 1987, J REPROD FERTIL, V81, P433; Guibourdenche J, 2003, MOL CELL ENDOCRINOL, V211, P55, DOI 10.1016/j.mce.2003.09.011; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; JOSSO N, 1993, EARLY HUM DEV, V33, P91, DOI 10.1016/0378-3782(93)90204-8; Knauff EAH, 2009, J CLIN ENDOCR METAB, V94, P786, DOI 10.1210/jc.2008-1818; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Telfer EE, 2005, CELL, V122, P821, DOI 10.1016/j.cell.2005.09.004; Tilly JL, 2009, MOL HUM REPROD, V15, P393, DOI 10.1093/molehr/gap036; Wallace WH, 2004, HUM REPROD, V19, P1612, DOI 10.1093/humrep/deh285; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Wallace WHB, 2003, HUM REPROD, V18, P117, DOI 10.1093/humrep/deg016; YOUNIS JS, 2009, FERTILITY S IN PRESS; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	28	421	442	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8772	10.1371/journal.pone.0008772	http://dx.doi.org/10.1371/journal.pone.0008772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111701	Green Published, gold, Green Submitted			2022-12-25	WOS:000274114800003
J	Fumagalli, M; Vergari, M; Pasqualetti, P; Marceglia, S; Mameli, F; Ferrucci, R; Mrakic-Sposta, S; Zago, S; Sartori, G; Pravettoni, G; Barbieri, S; Cappa, S; Priori, A				Fumagalli, Manuela; Vergari, Maurizio; Pasqualetti, Patrizio; Marceglia, Sara; Mameli, Francesca; Ferrucci, Roberta; Mrakic-Sposta, Simona; Zago, Stefano; Sartori, Giuseppe; Pravettoni, Gabriella; Barbieri, Sergio; Cappa, Stefano; Priori, Alberto			Brain Switches Utilitarian Behavior: Does Gender Make the Difference?	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; HUMAN MOTOR CORTEX; SEX-DIFFERENCES; ELECTRICAL-STIMULATION; EXCITABILITY CHANGES; HEALTHY-INDIVIDUALS; MODULATION; DAMAGE	Decision often implies a utilitarian choice based on personal gain, even at the expense of damaging others. Despite the social implications of utilitarian behavior, its neurophysiological bases remain largely unknown. To assess how the human brain controls utilitarian behavior, we delivered transcranial direct current stimulation (tDCS) over the ventral prefrontal cortex (VPC) and over the occipital cortex (OC) in 78 healthy subjects. Utilitarian judgment was assessed with the moral judgment task before and after tDCS. At baseline, females provided fewer utilitarian answers than males for personal moral dilemmas (p = .007). In males, VPC-tDCS failed to induce changes and in both genders OC-tDCS left utilitarian judgments unchanged. In females, cathodal VPC-tDCS tended to decrease whereas anodal VPC-tDCS significantly increased utilitarian responses (p = .005). In males and females, reaction times for utilitarian responses significantly decreased after cathodal (p,. 001) but not after anodal (p = .735) VPC-tDCS. We conclude that ventral prefrontal tDCS interferes with utilitarian decisions, influencing the evaluation of the advantages and disadvantages of each option in both sexes, but does so more strongly in females. Whereas cathodal tDCS alters the time for utilitarian reasoning in both sexes, anodal stimulation interferes more incisively in women, modifying utilitarian reasoning and the possible consequent actions. The gender-related tDCS-induced changes suggest that the VPC differentially controls utilitarian reasoning in females and in males. The gender-specific functional organization of the brain areas involved in utilitarian behavior could be a correlate of the moral and social behavioral differences between the two sexes.	[Fumagalli, Manuela; Marceglia, Sara; Mameli, Francesca; Ferrucci, Roberta; Mrakic-Sposta, Simona; Zago, Stefano; Priori, Alberto] Univ Milan, Dipartimento Sci Neurol, Milan, Italy; [Fumagalli, Manuela; Vergari, Maurizio; Marceglia, Sara; Mameli, Francesca; Ferrucci, Roberta; Mrakic-Sposta, Simona; Priori, Alberto] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ctr Clin Neuronanotecnol & Neurostimolaz, Milan, Italy; [Vergari, Maurizio; Barbieri, Sergio] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Unita Operat Neurofisiopatol Clin, Milan, Italy; [Fumagalli, Manuela; Marceglia, Sara; Mameli, Francesca; Ferrucci, Roberta; Mrakic-Sposta, Simona; Zago, Stefano; Priori, Alberto] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Unita Operat Neurol, Milan, Italy; [Pasqualetti, Patrizio] Osped San Giovanni Calibita Fatebenefratelli Isol, AFaR, Rome, Italy; [Sartori, Giuseppe] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Pravettoni, Gabriella] Univ Milan, Dipartimento Sci Sociali & Polit, Milan, Italy; [Cappa, Stefano] Univ Vita Salute San Raffaele, Ctr Neurosci Cognit, Milan, Italy; [Cappa, Stefano] Ist Sci San Raffaele, Dipartimento Neurosci, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Padua; University of Milan; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Fumagalli, M (corresponding author), Univ Milan, Dipartimento Sci Neurol, Milan, Italy.	alberto.priori@unimi.it	Pravettoni, Gabriella/AAC-3500-2022; Pravettoni, Gabriella/C-6915-2011; Pasqualetti, Patrizio/D-4496-2013; Sartori, Giuseppe/B-8140-2008; Priori, Alberto/K-9603-2016; Mrakic-Sposta, Simona/AAA-2991-2019; Ferrucci, Roberta/K-6081-2016; Cappa, Stefano/B-1874-2014; Marceglia, Sara/N-6999-2019; Pravettoni, Gabriella/E-6055-2012; Zago, Stefano/I-5838-2015; Zago, Stefano/AAW-8595-2021; Vergari, Maurizio/K-6513-2016	Pravettoni, Gabriella/0000-0002-4843-4663; Pasqualetti, Patrizio/0000-0001-5560-1979; Priori, Alberto/0000-0002-1549-3851; Mrakic-Sposta, Simona/0000-0001-7359-2690; Ferrucci, Roberta/0000-0001-5109-9483; Cappa, Stefano/0000-0003-1003-3925; Marceglia, Sara/0000-0002-0456-866X; Zago, Stefano/0000-0001-6578-4385; Zago, Stefano/0000-0001-6578-4385; Sartori, Giuseppe/0000-0002-6026-0133; Mameli, Francesca/0000-0003-4774-582X; Pravettoni, Gabriella/0000-0002-9135-2938; Vergari, Maurizio/0000-0002-5350-8014				Accornero N, 2007, EXP BRAIN RES, V178, P261, DOI 10.1007/s00221-006-0733-y; AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Ardolino G, 2005, J PHYSIOL-LONDON, V568, P653, DOI 10.1113/jphysiol.2005.088310; Australian Government National Health and Medical Research Council, 2007, AUSTR ASS PRESS 0426, P1; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Boggio PS, 2008, NEUROSCI LETT, V447, P101, DOI 10.1016/j.neulet.2008.10.009; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; CAMUS M, 2009, EUR J NEUROSCI; Cedzich C, 1998, NEUROSURGERY, V42, P527, DOI 10.1097/00006123-199803000-00018; Chaieb L, 2008, VISUAL NEUROSCI, V25, P77, DOI 10.1017/S0952523808080097; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; DAMASIO AR, 1994, DESCARTES ERROR; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Eisenberg N, 2005, NEBR SYM MOTIV, V51, P73; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Ferrucci R, 2008, J COGNITIVE NEUROSCI, V20, P1687, DOI 10.1162/jocn.2008.20112; Ferrucci R, 2009, J AFFECT DISORDERS, V118, P215, DOI 10.1016/j.jad.2009.02.015; Fumagalli M, 2010, COGN PROCESS, V11, P219, DOI 10.1007/s10339-009-0335-2; Gilligan Carol., 1982, DIFFERENT VOICE; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; GREENFELD L, 1999, WOMEN OFFENDERS, P1; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; Holdefer RN, 2006, CLIN NEUROPHYSIOL, V117, P1388, DOI 10.1016/j.clinph.2006.02.020; HOLLIS V, 2003, PRISON POPULATION BR, P1; Jaffee S, 2000, PSYCHOL BULL, V126, P703, DOI 10.1037//0033-2909.126.5.703; Kaasinen V, 2001, AM J PSYCHIAT, V158, P308, DOI 10.1176/appi.ajp.158.2.308; KARIM AA, 2009, CEREB CORTEX; Kimura Doreen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P67; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; KNOCH D, 2007, CEREB CORTEX; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; KOENIGS M, 2008, CLIN NEUROPHYSIOL; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kuo MF, 2008, CEREB CORTEX, V18, P648, DOI 10.1093/cercor/bhm098; Kuo MF, 2006, NEUROREPORT, V17, P1703, DOI 10.1097/01.wnr.0000239955.68319.c2; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Liebetanz D, 2009, CLIN NEUROPHYSIOL, V120, P1161, DOI 10.1016/j.clinph.2009.01.022; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Moll J, 2007, TRENDS COGN SCI, V11, P319, DOI 10.1016/j.tics.2007.06.001; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; NATHAN SS, 1993, ELECTROEN CLIN NEURO, V86, P183, DOI 10.1016/0013-4694(93)90006-H; Nitsche MA, 2006, EUR J NEUROSCI, V23, P1651, DOI 10.1111/j.1460-9568.2006.04676.x; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Pagonabarraga J, 2007, MOVEMENT DISORD, V22, P1430, DOI 10.1002/mds.21457; Paulus Walter, 2004, Suppl Clin Neurophysiol, V57, P708; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; Priori A, 2003, CLIN NEUROPHYSIOL, V114, P589, DOI 10.1016/S1388-2457(02)00437-6; Priori A, 2009, BRAIN STIMUL, V2, P241, DOI 10.1016/j.brs.2009.02.004; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; RANGO M, 2008, MAGN RESON IN PRESS, V59; Riccardi P, 2006, AM J PSYCHIAT, V163, P1639, DOI 10.1176/appi.ajp.163.9.1639; Sabol WJ., 2007, PRISONERS 2007; SCHLAEPFER TE, 1995, PSYCHIAT RES-NEUROIM, V61, P129, DOI 10.1016/0925-4927(95)02634-A; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Walsh V, 2003, BRADFORD BOOKS, P1; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254	72	73	76	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8865	10.1371/journal.pone.0008865	http://dx.doi.org/10.1371/journal.pone.0008865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111608	gold, Green Published, Green Submitted			2022-12-25	WOS:000273896300014
J	Marinach-Patrice, C; Fekkar, A; Atanasova, R; Gomes, J; Djamdjian, L; Brossas, JY; Meyer, I; Buffet, P; Snounou, G; Datry, A; Hennequin, C; Golmard, JL; Mazier, D				Marinach-Patrice, Carine; Fekkar, Arnaud; Atanasova, Ralitsa; Gomes, Johanna; Djamdjian, Laura; Brossas, Jean-Yves; Meyer, Isabelle; Buffet, Pierre; Snounou, Georges; Datry, Annick; Hennequin, Christophe; Golmard, Jean-Louis; Mazier, Dominique			Rapid Species Diagnosis for Invasive Candidiasis Using Mass Spectrometry	PLOS ONE			English	Article							IDENTIFICATION; CANDIDEMIA; REVOLUTION; PATHOGENS	Background: Matrix-assisted laser desorption ionisation time of flight mass spectrometry (MALDI TOF-MS) allows the identification of most bacteria and an increasing number of fungi. The potential for the highest clinical benefit of such methods would be in severe acute infections that require prompt treatment adapted to the infecting species. Our objective was to determine whether yeasts could be identified directly from a positive blood culture, avoiding the 1-3 days subculture step currently required before any therapeutic adjustments can be made. Methodology/Principal Findings: Using human blood spiked with Candida albicans to simulate blood cultures, we optimized protocols to obtain MALDI TOF-MS fingerprints where signals from blood proteins are reduced. Simulated cultures elaborated using a set of 12 strains belonging to 6 different species were then tested. Quantifiable spectral differences in the 5000-7400 Da mass range allowed to discriminate between these species and to build a reference database. The validation of the method and the statistical approach to spectral analysis were conducted using individual simulated blood cultures of 36 additional strains (six for each species). Correct identification of the species of these strains was obtained. Conclusions/Significance: Direct MALDI TOF-MS analysis of aliquots from positive blood cultures allowed rapid and accurate identification of the main Candida species, thus obviating the need for sub-culturing on specific media. Subsequent to this proof-of-principle demonstration, the method can be extended to other clinically relevant yeast species, and applied to an adequate number of clinical samples in order to establish its potential to improve antimicrobial management of patients with fungemia.	[Marinach-Patrice, Carine; Fekkar, Arnaud; Atanasova, Ralitsa; Gomes, Johanna; Brossas, Jean-Yves; Buffet, Pierre; Snounou, Georges; Datry, Annick; Hennequin, Christophe; Mazier, Dominique] INSERM, U945, Paris, France; [Marinach-Patrice, Carine; Fekkar, Arnaud; Atanasova, Ralitsa; Gomes, Johanna; Brossas, Jean-Yves; Buffet, Pierre; Snounou, Georges; Datry, Annick; Hennequin, Christophe; Mazier, Dominique] Univ Paris 06, UMR S945, Paris, France; [Fekkar, Arnaud; Djamdjian, Laura; Meyer, Isabelle; Buffet, Pierre; Datry, Annick; Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France; [Brossas, Jean-Yves] Grp Hosp Pitie Salpetriere, Ctr Invest Biomed, F-75634 Paris, France; [Snounou, Georges] Natl Univ Singapore, Fac Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117548, Singapore; [Hennequin, Christophe] Hop St Antoine, AP HP, Serv Parasitol Mycol, F-75571 Paris, France; [Golmard, Jean-Louis] Univ Paris 06, EA 3974, ER4, Modelisat Rech Clin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; National University of Singapore; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Marinach-Patrice, C (corresponding author), INSERM, U945, Paris, France.	dominique.mazier@upmc.fr	Snounou, Georges/F-3352-2011; Fekkar, Arnaud/P-2803-2017; Buffet, Pierre A/O-6189-2017; Hennequin, Christophe/AAF-2755-2021	Snounou, Georges/0000-0002-6133-6398; Buffet, Pierre A/0000-0003-4010-929X; Hennequin, Christophe/0000-0002-4528-927X	INSERM; UPMC, France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC, France	The study was supported by the INSERM and UPMC, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Fernandez J, 2009, DIAGN MICR INFEC DIS, V64, P402, DOI 10.1016/j.diagmicrobio.2009.04.002; Gherna M, 2009, J CLIN MICROBIOL, V47, P247, DOI 10.1128/JCM.01241-08; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Lau A, 2008, J CLIN MICROBIOL, V46, P3021, DOI 10.1128/JCM.00689-08; Marinach C, 2009, PROTEOMICS, V9, P4627, DOI 10.1002/pmic.200900152; MARINACHPATRICE C, 2009, CLIN MICROBIOL INFEC; MARKLEIN G, 2009, J CLIN MICROBIOL; Nassif X, 2009, CLIN INFECT DIS, V49, P552, DOI 10.1086/600886; Pappas PG, 2007, CLIN INFECT DIS, V45, P883, DOI 10.1086/520980; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Petersen Catherine E., 2009, V492, P367, DOI 10.1007/978-1-59745-493-3_22; Qian J, 2008, ANAL BIOANAL CHEM, V392, P439, DOI 10.1007/s00216-008-2288-1; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y	15	71	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8862	10.1371/journal.pone.0008862	http://dx.doi.org/10.1371/journal.pone.0008862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111603	Green Submitted, gold, Green Published			2022-12-25	WOS:000273896300012
J	Hemond, EM; Vollmer, SV				Hemond, Elizabeth M.; Vollmer, Steven V.			Genetic Diversity and Connectivity in the Threatened Staghorn Coral (Acropora cervicornis) in Florida	PLOS ONE			English	Article							CARIBBEAN CORAL; POPULATION-STRUCTURE; GENOTYPIC DIVERSITY; CLIMATE-CHANGE; REEF; FLOW; PHYLOGEOGRAPHY; REPRODUCTION; VARIABILITY; EXTINCTION	Over the past three decades, populations of the dominant shallow water Caribbean corals, Acropora cervicornis and A. palmata, have been devastated by white-band disease (WBD), resulting in the listing of both species as threatened under the U.S. Endangered Species Act. A key to conserving these threatened corals is understanding how their populations are genetically interconnected throughout the greater Caribbean. Genetic research has demonstrated that gene flow is regionally restricted across the Caribbean in both species. Yet, despite being an important site of coral reef research, little genetic data has been available for the Florida Acropora, especially for the staghorn coral, A. cervicornis. In this study, we present new mitochondrial DNA sequence data from 52 A. cervicornis individuals from 22 sites spread across the upper and lower Florida Keys, which suggest that Florida's A. cervicornis populations are highly genetically interconnected (F-ST=-0.081). Comparison between Florida and existing mtDNA data from six regional Caribbean populations indicates that Florida possesses high levels of standing genetic diversity (h = 0.824) relative to the rest of the greater Caribbean (h = 0.701 +/- 0.043). We find that the contemporary level of gene flow across the greater Caribbean, including Florida, is restricted (Phi(CT) = 0.117), but evidence from shared haplotypes suggests the Western Caribbean has historically been a source of genetic variation for Florida. Despite the current patchiness of A. cervicornis in Florida, the relatively high genetic diversity and connectivity within Florida suggest that this population may have sufficient genetic variation to be viable and resilient to environmental perturbation and disease. Limited genetic exchange across regional populations of the greater Caribbean, including Florida, indicates that conservation efforts for A. cervicornis should focus on maintaining and managing populations locally rather than relying on larval inputs from elsewhere.	[Hemond, Elizabeth M.; Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University	Hemond, EM (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	hemond.e@husky.neu.edu			National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Florida Keys National Marine Sanctuary; National Science Foundation [OCE-0751666]; Northeastern University Excellence Fellowship	National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Florida Keys National Marine Sanctuary; National Science Foundation(National Science Foundation (NSF)); Northeastern University Excellence Fellowship	Fieldwork support was provided through the National Oceanic and Atmospheric Administration's Coral Reef Conservation Program and the Florida Keys National Marine Sanctuary. Research funding was also provided by National Science Foundation grant OCE-0751666 to S.V.V. and a Northeastern University Excellence Fellowship to E.M.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AROUSON RB, 2001, HYDROBIOLOGIA, V460, P25; Avise John C., 1994, pi; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; BOTSFORD L, 2009, CORAL REEFS; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; EXCOFFIER L, 1992, GENETICS, V131, P479; FU YX, 1993, GENETICS, V133, P693; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLENENT M, 2000, MOL ECOL, V9, P1657; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Grober-Dunsmore R, 2006, MAR ECOL PROG SER, V321, P123, DOI 10.3354/meps321123; Gutierrez-Rodriguez C, 2004, MOL ECOL, V13, P2211, DOI 10.1111/j.1365-294X.2004.02247.x; Gutierrez-Rodriguez C, 2009, MOL PHYLOGENET EVOL, V50, P1, DOI 10.1016/j.ympev.2008.09.019; Hard D. L, 1997, PRINCIPLES POPULATIO; HARE JA, 2007, CAN J FISH AQUAT SCI, V1234, P1217; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hedrick P, 2005, EVOLUTION, V59, P1596; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hogarth W.T., 2006, FED REGISTER, V71, P26852; LACSON JM, 1991, MAR BIOL, V110, P353, DOI 10.1007/BF01344354; LEE TN, 1992, CONT SHELF RES, V12, P971, DOI 10.1016/0278-4343(92)90055-O; Lessios HA, 2001, P ROY SOC B-BIOL SCI, V268, P2347, DOI 10.1098/rspb.2001.1806; Mackenzie JB, 2004, MOL ECOL, V13, P9, DOI 10.1046/j.1365-294X.2003.02019.x; MARUYAMA T, 1980, P NATL ACAD SCI-BIOL, V77, P6710, DOI 10.1073/pnas.77.11.6710; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; MITTON JB, 1989, BIOL BULL-US, V177, P356, DOI 10.2307/1541595; MULLER S, 2008, POPULATION STATUS AE; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Murdoch TJT, 1999, CORAL REEFS, V18, P341, DOI 10.1007/s003380050210; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; PREEHT WE, 2004, FRONT ECOL ENVIRON, V2, P307; Purcell JFH, 2009, J FISH BIOL, V74, P403, DOI 10.1111/j.1095-8649.2008.02078.x; RAMOSOUSIUS SE, 2002, MOL BIOL EVOL, V19, P2002; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; ROZAS J, 2003, DNA POLYMORPHISM ANA, P2496; SCHNEIDER S., 2000, ARLEQUIN VERSION 2 0; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Sokal R. R., 2012, BIOMETRY; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; TUNNICLIFFE V, 1981, P NATL ACAD SCI-BIOL, V78, P2427, DOI 10.1073/pnas.78.4.2427; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; van Oppen MJH, 1999, MOL BIOL EVOL, V16, P1812, DOI 10.1093/oxfordjournals.molbev.a026094; Vargas-Angel B, 2002, CORAL REEFS, V21, P25, DOI 10.1007/s00338-001-0208-3; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Wellington GM, 2003, MAR BIOL, V143, P1185, DOI 10.1007/s00227-003-1150-4; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIL E, 2004, CORAL RREF DIS WIDER, P35; Zubillaga AL, 2008, CORAL REEFS, V27, P63, DOI 10.1007/s00338-007-0291-1; 2005, FED REG, V70, P21359	65	33	33	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8652	10.1371/journal.pone.0008652	http://dx.doi.org/10.1371/journal.pone.0008652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XB	20111583	gold, Green Submitted, Green Published			2022-12-25	WOS:000278099200003
J	Baek, K; Knodler, A; Lee, SH; Zhang, XY; Orlando, K; Zhang, J; Foskett, TJ; Guo, W; Dominguez, R				Baek, Kyuwon; Knoedler, Andreas; Lee, Sung Haeng; Zhang, Xiaoyu; Orlando, Kelly; Zhang, Jian; Foskett, Trevor J.; Guo, Wei; Dominguez, Roberto			Structure-Function Study of the N-terminal Domain of Exocyst Subunit Sec3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; BRUTONS TYROSINE KINASE; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; PH DOMAIN; POLARIZED SECRETION; PLASMA-MEMBRANE; COMPLEX; EXOCYTOSIS; PROTEIN	The exocyst is an evolutionarily conserved octameric complex involved in polarized exocytosis from yeast to humans. The Sec3 subunit of the exocyst acts as a spatial landmark for exocytosis through its ability to bind phospholipids and small GTPases. The structure of the N-terminal domain of Sec3 (Sec3N) was determined ab initio and defines a new subclass of pleckstrin homology (PH) domains along with a new family of proteins carrying this domain. Respectively, N- and C-terminal to the PH domain Sec3N presents an additional alpha-helix and two beta-strands that mediate dimerization through domain swapping. The structure identifies residues responsible for phospholipid binding, which when mutated in cells impair the localization of exocyst components at the plasma membrane and lead to defects in exocytosis. Through its ability to bind the small GTPase Cdc42 and phospholipids, the PH domain of Sec3 functions as a coincidence detector at the plasma membrane.	[Knoedler, Andreas; Zhang, Xiaoyu; Orlando, Kelly; Zhang, Jian; Guo, Wei] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Baek, Kyuwon; Lee, Sung Haeng; Foskett, Trevor J.; Dominguez, Roberto] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Guo, W (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	guowei@sas.upenn.edu; droberto@mail.med.upenn.edu	Zhang, xiaoyu/GXA-3206-2022		Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064690, R01GM073791] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a fellowship from the Deutsche Forschungsgemeinschaft.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Constable JRL, 2005, J BIOL CHEM, V280, P31615, DOI 10.1074/jbc.M505858200; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Croteau NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004443; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; DINITTO JP, 2003, SCI STKE 2003; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Hutagalung AH, 2009, MOL BIOL CELL, V20, P153, DOI 10.1091/mbc.E08-02-0157; Jackson SG, 2006, ACTA CRYSTALLOGR D, V62, P324, DOI 10.1107/S0907444905043179; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; LO CL, 1999, J MOL BIOL, V285, P2177; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Murayama K, 2008, BIOCHEM BIOPH RES CO, V377, P23, DOI 10.1016/j.bbrc.2008.09.055; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Scales SJ, 2002, J BIOL CHEM, V277, P28271, DOI 10.1074/jbc.M204929200; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128; Zhang XY, 2005, J BIOL CHEM, V280, P20356, DOI 10.1074/jbc.M500511200; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	57	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10424	10433		10.1074/jbc.M109.096966	http://dx.doi.org/10.1074/jbc.M109.096966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139078	Green Published, hybrid			2022-12-25	WOS:000276264600028
J	Emara, MM; Ivanov, P; Hickman, T; Dawra, N; Tisdale, S; Kedersha, N; Hu, GF; Anderson, P				Emara, Mohamed M.; Ivanov, Pavel; Hickman, Tyler; Dawra, Nemisha; Tisdale, Sarah; Kedersha, Nancy; Hu, Guo-Fu; Anderson, Paul			Angiogenin-induced tRNA-derived Stress-induced RNAs Promote Stress-induced Stress Granule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC TRANSLATION INITIATION; INHIBITS TRANSLATION; SURVIVAL; PHOSPHORYLATION; EXPRESSION; TRANSCRIPTION; RECRUITMENT; APOPTOSIS; PROTEINS; PATHWAY	Angiogenin (ANG) is a secreted ribonuclease that cleaves tRNA to initiate a stress-response program in mammalian cells. Here we show that ANG inhibits protein synthesis and promotes arsenite-and pateamine A-induced assembly of stress granules (SGs). These effects are abrogated in cells transfected with the ANG inhibitor RNH1. Transfection of natural or synthetic 5'-but not 3'-tRNA fragments (tRNA-derived stress-induced RNAs; tiRNAs) induces the phospho-eukaryotic translation initiation factor 2 alpha-independent assembly of SGs. Natural 5'-tiRNAs but not 3'-tiRNAs are capped with a 5'-monophosphate that is required for optimal SG assembly. These findings reveal that SG assembly is a component of the ANG- and tiRNA-induced stress response program.	[Anderson, Paul] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hu, Guo-Fu] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Emara, Mohamed M.] Cairo Univ, Sch Vet Med, Dept Virol, Giza 12211, Egypt	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Egyptian Knowledge Bank (EKB); Cairo University	Anderson, P (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Smith Bldg 652,1 Jimmy Fund Way, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu	Ivanov, Pavel/F-3339-2016; Ivanov, Pavel/AAZ-9197-2021	Ivanov, Pavel/0000-0002-7986-7760; Ivanov, Pavel/0000-0002-7986-7760; Hickman, Tyler/0000-0003-2623-3251	National Institutes of Health [AI065858, AI033600, AR0514732]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065858, R01AI033600, R56AI033600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI065858, AI033600, and AR0514732.	Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Blazquez M, 1996, J BIOL CHEM, V271, P18638, DOI 10.1074/jbc.271.31.18638; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Hatzi E, 1999, EUR J BIOCHEM, V260, P825, DOI 10.1046/j.1432-1327.1999.00222.x; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hu GF, 1997, P NATL ACAD SCI USA, V94, P2204, DOI 10.1073/pnas.94.6.2204; Ibaragi S, 2009, MOL CANCER RES, V7, P415, DOI 10.1158/1541-7786.MCR-08-0137; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Low WK, 2007, CHEM BIOL, V14, P715, DOI 10.1016/j.chembiol.2007.05.012; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Monti DM, 2007, FEBS LETT, V581, P930, DOI 10.1016/j.febslet.2007.01.072; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Scadden ADJ, 2007, MOL CELL, V28, P491, DOI 10.1016/j.molcel.2007.09.005; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yuan Y, 2009, LUNG CANCER, V66, P28, DOI 10.1016/j.lungcan.2008.12.027	43	318	336	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10959	10968		10.1074/jbc.M109.077560	http://dx.doi.org/10.1074/jbc.M109.077560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20129916	Green Published, hybrid			2022-12-25	WOS:000276264600080
J	Hagiwara, S; Murakumo, Y; Mii, S; Shigetomi, T; Yamamoto, N; Furue, H; Ueda, M; Takahashi, M				Hagiwara, S.; Murakumo, Y.; Mii, S.; Shigetomi, T.; Yamamoto, N.; Furue, H.; Ueda, M.; Takahashi, M.			Processing of CD109 by furin and its role in the regulation of TGF-beta signaling	ONCOGENE			English	Article						CD109; furin; processing; TGF-beta; cell proliferation	GROWTH-FACTOR-BETA; SQUAMOUS-CELL CARCINOMA; TRANSFORMING GROWTH-FACTOR-BETA-1; PROPROTEIN CONVERTASES; HUMAN KERATINOCYTES; TUMOR-SUPPRESSOR; HUMAN CANCER; EXPRESSION; PROTEINS; MECHANISMS	CD109 is a glycosylphosphatidylinositol (GPI)-anchored glycoprotein, whose expression is upregulated in squamous cell carcinomas of the lung, esophagus, uterus and oral cavity. CD109 negatively regulates transforming growth factor (TGF)-beta signaling in keratinocytes by directly modulating receptor activity. In this study, we further characterized CD109 regulation of TGF-beta signaling and cell proliferation. We found that CD109 is produced as a 205 kDa glycoprotein, which is then processed in the Golgi apparatus into 180 kDa and 25 kDa proteins by furin (furinase). 180 kDa CD109 associated with GPI-anchored 25 kDa CD109 on the cell surface and was also secreted into the culture medium. To investigate whether furinase cleavage of CD109 is necessary for its biological activity, we mutated arginine 1273 in the CD109 furinase cleavage motif (amino acid 1270-RRRR-1273) to serine (R1273S). Interestingly, CD109 R1273S neither significantly impaired TGF-beta signaling nor affected TGF-beta-mediated suppression of cell growth, although it was expressed on the cell surface as a 205 kDa protein. Consistent with this finding, the 180 kDa and 25 kDa CD109 complex, but not CD109 R1273S, associated with the type I TGF-beta receptor. These findings indicate that processing of CD109 into 180 kDa and 25kDa proteins by furin, followed by complex formation with the type I TGF-beta receptor is required for the regulation of TGF-beta signaling in cancer cells and keratinocytes. Oncogene (2010) 29, 2181-2191; doi: 10.1038/onc.2009.506; published online 25 January 2010	[Hagiwara, S.; Murakumo, Y.; Mii, S.; Takahashi, M.] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan; [Hagiwara, S.; Shigetomi, T.; Yamamoto, N.; Furue, H.; Ueda, M.] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4648601, Japan; [Takahashi, M.] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Pathol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University	Takahashi, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, 65 Tsurumai Cho, Aichi 4668550, Japan.	mtakaha@med.nagoya-u.ac.jp	TAKAHASHI, Masahide/I-7244-2014; Takahashi, Masahide/AAN-4770-2020; Mii, Shinji/I-7480-2014	Takahashi, Masahide/0000-0002-2803-2683; Mii, Shinji/0000-0001-8266-3235	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Global Center of Excellence (GCOE) research, Scientific Research (A) and Scientific Research on Priority Area 'Cancer' commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to MT).	Arnold JN, 2006, J BIOL CHEM, V281, P6955, DOI 10.1074/jbc.M511432200; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; GARCIA M, 1993, J CELL SCI, V104, P1281; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; Giesert C, 2003, ANN NY ACAD SCI, V996, P227, DOI 10.1111/j.1749-6632.2003.tb03250.x; GUARNACCIA SP, 1983, P NATL ACAD SCI-BIOL, V80, P1551, DOI 10.1073/pnas.80.6.1551; Hagiwara S, 2008, CANCER SCI, V99, P1916, DOI 10.1111/j.1349-7006.2008.00949.x; HAREGEWOIN A, 1994, CELL IMMUNOL, V156, P357, DOI 10.1006/cimm.1994.1181; Hasegawa M, 2008, PATHOL INT, V58, P288, DOI 10.1111/j.1440-1827.2008.02225.x; Hasegawa M, 2007, PATHOL INT, V57, P245, DOI 10.1111/j.1440-1827.2007.02097.x; Hashimoto M, 2004, ONCOGENE, V23, P3716, DOI 10.1038/sj.onc.1207418; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; KELTON JG, 1990, BLOOD, V75, P2172; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Murray LJ, 1999, EXP HEMATOL, V27, P1282, DOI 10.1016/S0301-472X(99)00071-5; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; OUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; Sato T, 2007, PATHOL INT, V57, P719, DOI 10.1111/j.1440-1827.2007.02168.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STRUCK DK, 1977, J BIOL CHEM, V252, P1007; SUTHERLAND DR, 1991, BLOOD, V77, P84; TAKATSUKI A, 1971, J ANTIBIOT, V24, P215, DOI 10.7164/antibiotics.24.215; Tam BYY, 2003, J BIOL CHEM, V278, P49610, DOI 10.1074/jbc.M308492200; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; WAECHTER CJ, 1977, ARCH BIOCHEM BIOPHYS, V181, P185, DOI 10.1016/0003-9861(77)90497-0; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang XM, 2009, MOL BIOL REP, V36, P861, DOI 10.1007/s11033-008-9256-x; Xu XL, 2000, ONCOGENE, V19, P1868, DOI 10.1038/sj.onc.1203504; Zhang JM, 2005, PATHOL INT, V55, P165, DOI 10.1111/j.1440-1827.2005.01807.x	40	58	60	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2181	2191		10.1038/onc.2009.506	http://dx.doi.org/10.1038/onc.2009.506			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101215				2022-12-25	WOS:000276685200004
J	He, X; Zheng, Z; Song, T; Wei, C; Ma, H; Ma, Q; Zhang, Y; Xu, Y; Shi, W; Ye, Q; Zhong, H				He, X.; Zheng, Z.; Song, T.; Wei, C.; Ma, H.; Ma, Q.; Zhang, Y.; Xu, Y.; Shi, W.; Ye, Q.; Zhong, H.			c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation	ONCOGENE			English	Article						c-Abl nonreceptor tyrosine kinases; estrogen receptor alpha; transcriptional activity	BREAST-CANCER CELLS; ESTRADIOL-INDUCED PHOSPHORYLATION; LIGAND-INDEPENDENT ACTIVATION; TYROSINE KINASE; DNA-DAMAGE; APOPTOTIC RESPONSE; PROTEIN-KINASE; IN-VIVO; HORMONE RECEPTORS; FAMILY KINASES	Estrogen receptors are members of the steroid hormone superfamily of nuclear receptors that act as ligand-activated transcription factors. Similar to other steroid hormone receptors, estrogen receptor alpha (ER alpha) is a substrate for protein kinases, and phosphorylation has profound effects on the function of this receptor. In this study, we show that ER alpha associates with c-Abl nonreceptor tyrosine kinase. The direct interaction is mediated by two PXXP motifs of ER alpha and the c-Abl SH3 domain. Mutational analysis and in vitro kinase assays show that ER alpha can be phosphorylated on two sites, tyrosine 52 (Y-52) and tyrosine 219 (Y-219). ER alpha phosphorylation by c-Abl stabilizes ER alpha, resulting in enhanced ER alpha transcriptional activity and increased expression of endogenous ER alpha target genes. Furthermore, ER alpha phosphorylation at the Y-219 site affects DNA binding and dimerization by ER alpha. Both the c-Abl inhibitor and the c-Abl kinase dead mutation abolish the c-Abl-induced accumulation of ER alpha and enhancement of ER alpha transcriptional activity, indicating that c-Abl kinase activity is required for regulation of the ER alpha function. Moreover, the ER alpha (Y52,219F) mutant shows reduced breast cancer cell growth and invasion. Taken together, these results show that c-Abl is a novel kinase that upregulates ER alpha expression and promotes breast cancer cell proliferation, suggesting a great potential for this kinase to function as a therapeutic target for breast cancer. Oncogene (2010) 29, 2238-2251; doi: 10.1038/onc.2009.513; published online 25 January 2010	[He, X.; Zheng, Z.; Song, T.; Wei, C.; Ma, H.; Ma, Q.; Ye, Q.; Zhong, H.] Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing 100850, Peoples R China; [Xu, Y.; Shi, W.] Jilin Univ, Key Lab Mol Enzymol, Changchun 130023, Peoples R China; [He, X.] Inst Dis Control & Prevent, Beijing, Peoples R China	Jilin University	Zhong, H (corresponding author), Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, 841 E Dist Bldg,27 Taipinglu, Beijing 100850, Peoples R China.	yeqn66@yahoo.com; towall@yahoo.com			National Natural Science Foundation [30772605, 30700413, 30870500, 30871276, 30530320]; Beijing Natural Science Foundation [7092081]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported in part by the National Natural Science Foundation (30772605, 30700413, 30870500, 30871276 and 30530320) and by the Beijing Natural Science Foundation (7092081).	Acconcia F, 2006, CANCER RES, V66, P11030, DOI 10.1158/0008-5472.CAN-06-2676; Agami R, 1999, NATURE, V399, P809; Alen P, 1999, MOL ENDOCRINOL, V13, P117, DOI 10.1210/me.13.1.117; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Arnold SF, 1997, MOL ENDOCRINOL, V11, P48, DOI 10.1210/me.11.1.48; ARNOLD SF, 1994, MOL ENDOCRINOL, V8, P1208, DOI 10.1210/me.8.9.1208; ARNOLD SF, 1995, MOL ENDOCRINOL, V9, P24, DOI 10.1210/me.9.1.24; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Castano E, 1997, BIOCHEM J, V326, P149, DOI 10.1042/bj3260149; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Clarkl DE, 2001, EMBO J, V20, P3484, DOI 10.1093/emboj/20.13.3484; DEBORAH AL, 2003, STEROIDS, V68, P1; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Frech MS, 2005, CANCER RES, V65, P681; Han JQ, 2006, NUCLEIC ACIDS RES, V34, P3095, DOI 10.1093/nar/gkl389; He X, 2009, APOPTOSIS, V14, P268, DOI 10.1007/s10495-009-0313-2; HIROKO Y, 2005, BREAST CANCER RES, V7, P753; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; JOEL PB, 1995, MOL ENDOCRINOL, V9, P1041, DOI 10.1210/me.9.8.1041; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Katzenellenbogen BS, 1997, BREAST CANCER RES TR, V44, P23, DOI 10.1023/A:1005835428423; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Katzenellenbogen BS, 1996, BIOL REPROD, V54, P287, DOI 10.1095/biolreprod54.2.287; Kim HJ, 2004, AM J HEMATOL, V76, P360, DOI 10.1002/ajh.20117; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Liu X, 2006, MOL CELL, V22, P317, DOI 10.1016/j.molcel.2006.04.007; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Nagano K, 2006, ONCOGENE, V25, P493, DOI 10.1038/sj.onc.1208996; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pace P, 1997, J BIOL CHEM, V272, P25832, DOI 10.1074/jbc.272.41.25832; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; PENDERGAST AM, 2001, CHRONIC MYELOID LEUK, P19; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; SENAD M, 2005, J BIOL CHEM, V280, P33006; Singer CF, 2004, ENDOCR-RELAT CANCER, V11, P861, DOI 10.1677/erc.1.00801; Skorski T, 1998, BLOOD, V91, P406, DOI 10.1182/blood.V91.2.406.406_406_418; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Tsai KKC, 2003, CANCER RES, V63, P3418; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704	61	42	43	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2238	2251		10.1038/onc.2009.513	http://dx.doi.org/10.1038/onc.2009.513			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101225				2022-12-25	WOS:000276685200009
J	Maltsev, AS; Oswald, RE				Maltsev, Alexander S.; Oswald, Robert E.			Hydrophobic Side Chain Dynamics of a Glutamate Receptor Ligand Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-SCALE DYNAMICS; GLUR2 AMPA RECEPTOR; CRYSTAL-STRUCTURES; NMR-SPECTROSCOPY; CONFORMATIONAL-CHANGES; PARTIAL AGONISTS; PEPTIDE COMPLEX; CAVITY MUTANT; ION CHANNELS; T4 LYSOZYME	Ionotropic glutamate receptors are ligand-gated ion channels that mediate much of the fast excitatory neurotransmission in the central nervous system. The extracellular ligand binding core (S1S2) of the GluR2 subtype of ionotropic glutamate receptors can be produced as a soluble protein with properties essentially identical to the corresponding domain in the intact, membrane-bound protein. Using a variety of biophysical techniques, much has been learned about the structure and dynamics of S1S2 and the relationship between its ligand-induced conformational changes and the function of the receptor. It is clear that dynamic processes are essential to the function of ionotropic glutamate receptors. We have isotopically labeled side chain methyls of GluR2 S1S2 and used NMR spectroscopy to study their dynamics on the ps-ns and mu s-ms time scales. Increased disorder is seen in regions that are part of the key dimer interface in the intact protein. When glutamate is bound, the degree of ps-ns motion is less than that observed with other ligands, suggesting that the physiological agonist binds to a preformed binding site. At the slower time scales, the degree of S1S2 flexibility induced by ligand binding is greatest for willardiine partial agonists, least for antagonists, and intermediate for full agonists. Notable differences among bound ligands are in the region of the protein that forms a hinge between two lobes that close upon agonist binding, and along the beta-sheet in Lobe 2. These motions provide clues as to the functional properties of partial agonists and to the conformational changes associated with lobe closure and channel activation.	[Maltsev, Alexander S.; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	reo1@cornell.edu	Maltsev, Alexander/A-8175-2012		National Institutes of Health [R01-GM068935]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant R01-GM068935 from the National Institutes of Health.	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Asztely F, 1996, MOL NEUROBIOL, V12, P1, DOI 10.1007/BF02740744; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Cheng Q, 2002, BIOCHEMISTRY-US, V41, P1602, DOI 10.1021/bi015729e; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingledine R, 1999, PHARMACOL REV, V51, P7; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; Gill A, 2008, BIOCHEMISTRY-US, V47, P13831, DOI 10.1021/bi8013196; Gizachew D, 2001, BIOCHEMISTRY-US, V40, P14368, DOI 10.1021/bi010989h; Goddard T. D., SPARKY3; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ishima R, 1999, J AM CHEM SOC, V121, P11589, DOI 10.1021/ja992836b; Jayaraman V, 2000, BIOCHEMISTRY-US, V39, P8693, DOI 10.1021/bi000892f; Jayaraman V, 2000, FEBS LETT, V475, P278, DOI 10.1016/S0014-5793(00)01690-2; Kasper C, 2006, J MOL BIOL, V357, P1184, DOI 10.1016/j.jmb.2006.01.024; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Madden DR, 2000, EUR J BIOCHEM, V267, P4281; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; McFeeters RL, 2002, J BIOMOL NMR, V22, P297, DOI 10.1023/A:1014954931635; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Skrynnikov NR, 2001, J AM CHEM SOC, V123, P4556, DOI 10.1021/ja004179p; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tugarinov V, 2005, BIOCHEMISTRY-US, V44, P15970, DOI 10.1021/bi0519809; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Valentine ER, 2005, BIOCHEMISTRY-US, V44, P3410, DOI 10.1021/bi047984f; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581	51	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10154	10162		10.1074/jbc.M109.088641	http://dx.doi.org/10.1074/jbc.M109.088641			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110365	Green Published, hybrid			2022-12-25	WOS:000276165900082
J	Romito, A; Lonardo, E; Roma, G; Minchiotti, G; Ballabio, A; Cobellis, G				Romito, Antonio; Lonardo, Enza; Roma, Guglielmo; Minchiotti, Gabriella; Ballabio, Andrea; Cobellis, Gilda			Lack of Sik1 in Mouse Embryonic Stem Cells Impairs Cardiomyogenesis by Down-Regulating the Cyclin-Dependent Kinase Inhibitor p57(kip2)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROTEIN-KINASE; DIFFERENTIATION; HEART; EXIT; SPECIFICATION; DISEASE; GATA-4; ROLES	Sik1 (salt inducible kinase 1) is a serine/threonine kinase that belongs to the stress-and energy-sensing AMP-activated protein kinase family. During murine embryogenesis, sik1 marks the monolayer of future myocardial cells that will populate first the primitive ventricle, and later the primitive atrium suggesting its involvement in cardiac cell differentiation and/or heart development. Despite that observation, the involvement of sik1 in cardiac differentiation is still unknown. We examined the sik1 function during cardiomyocyte differentiation using the ES-derived embryoid bodies. We produced a null embryonic stem cell using a gene-trap cell line carrying an insertion in the sik1 locus. In absence of the sik1 protein, the temporal appearance of cardiomyocytes is delayed. Expression profile analysis revealed sik1 as part of a genetic network that controls the cell cycle, where the cyclin-dependent kinase inhibitor p57(Kip2) is directly involved. Collectively, we provided evidence that sik1-mediated effects are specific for cardiomyogenesis regulating cardiomyoblast cell cycle exit toward terminal differentiation.	[Romito, Antonio; Ballabio, Andrea; Cobellis, Gilda] Telethon Inst Genet & Med, Naples, Italy; [Lonardo, Enza; Minchiotti, Gabriella] CNR, Stem Cell Fate Lab, Inst Genet & Biophys, I-80125 Naples, Italy; [Roma, Guglielmo] Pompeu Fabra Univ UPF, Ctr Genom Regulat, Barcelona, Spain; [Cobellis, Gilda] Univ Naples 2, Dipartimento Patol Gen, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universita della Campania Vanvitelli	Romito, A (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	cobellis@tigem.it	BALLABIO, Andrea/AAL-2672-2020; Lonardo, Enza/A-8786-2011; lonardo, enza/AAI-5726-2020	BALLABIO, Andrea/0000-0003-1381-4604; Minchiotti, Gabriella/0000-0003-0225-9043; Lonardo, Enza/0000-0001-6654-1043; Cobellis, Gilda/0000-0003-2687-2272	EU [037627]; Italian Association for Cancer Research (AIRC); Telethon Foundation	EU(European Commission); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon Foundation(Fondazione Telethon)	Project was supported by the grant from 6th Framework of EU Commission, Contract no.: 037627 to A. B., A. R. and G. C. and the Italian Association for Cancer Research (AIRC) and Telethon Foundation grant to G. M. and E. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; ASAKURA A, 1995, DEV BIOL, V171, P386, DOI 10.1006/dbio.1995.1290; Barlow GM, 2001, GENET MED, V3, P91, DOI 10.1097/00125817-200103000-00002; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Brennan J, 1999, METH MOL B, V97, P123, DOI 10.1385/1-59259-270-8:123; Brooks Gavin, 2004, V296, P291; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cobellis G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni045; Grepin C, 1997, DEVELOPMENT, V124, P2387; Griffin KJP, 2000, DEV BIOL, V218, P235, DOI 10.1006/dbio.1999.9571; Gui HX, 2007, DEV BIOL, V301, P14, DOI 10.1016/j.ydbio.2006.10.035; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kochilas LK, 1999, PEDIATR RES, V45, P635, DOI 10.1203/00006450-199905010-00004; LINTS TJ, 1993, DEVELOPMENT, V119, P969; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Politis PK, 2008, CELL CYCLE, V7, P691, DOI 10.4161/cc.7.6.5550; RUIZ JC, 1994, MECH DEVELOP, V48, P153, DOI 10.1016/0925-4773(94)90056-6; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stephenson A, 2004, GENOMICS, V83, P1105, DOI 10.1016/j.ygeno.2003.12.007; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Wobus A M, 2002, Methods Mol Biol, V185, P127; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	35	19	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9029	10.1371/journal.pone.0009029	http://dx.doi.org/10.1371/journal.pone.0009029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140255	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474200015
J	Tondeur, S; Pangault, C; Le Carrour, T; Lannay, Y; Benmahdi, R; Cubizolle, A; Assou, S; Pantesco, V; Klein, B; Hamamah, S; Schved, JF; Fest, T; De Vos, J				Tondeur, Sylvie; Pangault, Celine; Le Carrour, Tanguy; Lannay, Yoann; Benmahdi, Rima; Cubizolle, Aurelie; Assou, Said; Pantesco, Veronique; Klein, Bernard; Hamamah, Samir; Schved, Jean-Francois; Fest, Thierry; De Vos, John			Expression Map of the Human Exome in CD34+Cells and Blood Cells: Increased Alternative Splicing in Cell Motility and Immune Response Genes	PLOS ONE			English	Article							HUMAN GENOME; RNA; CANCER; TRANSCRIPTION; MICROARRAYS; ANNOTATION; PROMOTERS; VARIANTS; REVEALS; DISEASE	Background: Hematopoietic cells are endowed with very specific biological functions, including cell motility and immune response. These specific functions are dramatically altered during hematopoietic cell differentiation, whereby undifferentiated hematopoietic stem and progenitor cells (HSPC) residing in bone marrow differentiate into platelets, red blood cells and immune cells that exit into the blood stream and eventually move into lymphoid organs or inflamed tissues. The contribution of alternative splicing (AS) to these functions has long been minimized due to incomplete knowledge on AS events in hematopoietic cells. Principal Findings: Using Human Exon ST 1.0 microarrays, the entire exome expression profile of immature CD34+ HSPC and mature whole blood cells was mapped, compared to a collection of solid tissues and made freely available as an online exome expression atlas (Amazonia Exon! : http://amazonia.transcriptome.eu/exon.php). At a whole transcript level, HSPC strongly expressed EREG and the pluripotency marker DPPA4. Using a differential splicing index scheme (dsi), a list of 849 transcripts differentially expressed between hematopoietic cells and solid tissues was computed, that included NEDD9 and CD74. Some of these genes also underwent alternative splicing events during hematopoietic differentiation, such as INPP4B, PTPLA or COMMD6, with varied contribution of CD3+ T cells, CD19+ B cells, CD14+ or CD15+ myelomonocytic populations. Strikingly, these genes were significantly enriched for genes involved in cell motility, cell adhesion, response to wounding and immune processes. Conclusion: The relevance and the precision provided by this exon expression map highlights the contribution of alternative splicing to key feature of blood cells differentiation and function.	[Tondeur, Sylvie; Le Carrour, Tanguy; Assou, Said; Klein, Bernard; Hamamah, Samir; De Vos, John] CHU Montpellier, Hop St Eloi, Inst Res Biotherapy, Montpellier, France; [Tondeur, Sylvie; Le Carrour, Tanguy; Benmahdi, Rima; Cubizolle, Aurelie; Assou, Said; Pantesco, Veronique; Klein, Bernard; Hamamah, Samir; De Vos, John] INSERM, U847, Montpellier, France; [Tondeur, Sylvie; Klein, Bernard; Hamamah, Samir; Schved, Jean-Francois; De Vos, John] Univ Montpellier 1, UFR Med, Montpellier, France; [Pangault, Celine; Fest, Thierry] CHU Rennes, Hematol Lab, Rennes, France; [Pangault, Celine; Fest, Thierry] Univ Rennes 1, INSERM, U917, UFR Med, Rennes, France; [Lannay, Yoann; Hamamah, Samir] CHU Montpellier, Unite Biol Clin AMP DPI, Hop Arnaud Villeneuve, Montpellier, France; [Schved, Jean-Francois] CHU Montpellier, Hematol Lab, Hop St Eloi, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Tondeur, S (corresponding author), CHU Montpellier, Hop St Eloi, Inst Res Biotherapy, Montpellier, France.	john.devos@inserm.fr	De Vos, John/A-5703-2010; Pangault, Celine/C-3254-2017	De Vos, John/0000-0003-1880-4130; Pangault, Celine/0000-0003-3978-2209; Schved, Jean-Francois/0000-0003-0332-3254; fest, thierry/0000-0002-6437-4189; assou, said/0000-0001-6448-7995	Groupe Ouest Est des Leucemies et Autres Maladies du Sang (GOELAMS); Societe Francaise d'Hematologie (SFH)	Groupe Ouest Est des Leucemies et Autres Maladies du Sang (GOELAMS); Societe Francaise d'Hematologie (SFH)	This work was supported by Roche, the Groupe Ouest Est des Leucemies et Autres Maladies du Sang (GOELAMS) group and the Societe Francaise d'Hematologie (SFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Bonafoux B, 2004, HAEMATOLOGICA, V89, P1434; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; de Bie P, 2006, BIOCHEM J, V398, P63, DOI 10.1042/BJ20051664; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gooding C, 2008, ADV EXP MED BIOL, V644, P27; Inamoto S, 2007, ONCOGENE, V26, P893, DOI 10.1038/sj.onc.1209848; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Li DX, 2000, GENE, V256, P237, DOI 10.1016/S0378-1119(00)00347-4; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; Okoniewski MJ, 2007, BIOTECHNIQUES, V42, P181, DOI 10.2144/000112315; Pangoult C, 2007, M S-MED SCI, V23, P13, DOI 10.1051/medsci/2007231s13; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yates T, 2008, NUCLEIC ACIDS RES, V36, pD780, DOI 10.1093/nar/gkm779	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8990	10.1371/journal.pone.0008990	http://dx.doi.org/10.1371/journal.pone.0008990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126548	Green Published, Green Submitted, gold			2022-12-25	WOS:000274209700016
J	Gilani, SR; Vuga, LJ; Lindell, KO; Gibson, KF; Xue, JM; Kaminski, N; Valentine, VG; Lindsay, EK; George, MP; Steele, C; Duncan, SR				Gilani, Syed R.; Vuga, Louis J.; Lindell, Kathleen O.; Gibson, Kevin F.; Xue, Jianmin; Kaminski, Naftali; Valentine, Vincent G.; Lindsay, Emily K.; George, M. Patricia; Steele, Chad; Duncan, Steven R.			CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; IDENTIFICATION; COSTIMULATION; PROLIFERATION; AUTOANTIGEN; LYMPHOCYTES; EXPANSIONS; SENESCENCE; EXPRESSION	Background: Although the etiology of idiopathic pulmonary fibrosis (IPF) remains perplexing, adaptive immune activation is evident among many afflicted patients. Repeated cycles of antigen-induced proliferation cause T-cells to lose surface expression of CD28, and we hypothesized this process might also occur in IPF. Methodology/Principal Findings: Peripheral blood CD4 T-cells from 89 IPF patients were analyzed by flow cytometry and cytokine multiplex assays, and correlated with clinical events. In comparison to autologous CD4(+) CD28(+) cells, the unusual CD4(+) CD28(null) lymphocytes seen in many IPF patients had discordant expressions of activation markers, more frequently produced cytotoxic mediators perforin (2.4 +/- 0.8% vs. 60.0 +/- 7.4%, p<0.0001) and granzyme B (4.5 +/- 2.8% vs. 74.9 +/- 6.5%, p<0.0001), produced greater amounts of many pro-inflammatory cytokines, and less frequently expressed the regulatory T-cell marker FoxP3 (12.9 +/- 1.1% vs. 3.3 +/- 0.6% p<0.0001). Infiltration of CD4(+) CD28(null) T-cells in IPF lungs was confirmed by confocal microscopy. Interval changes of CD28 expression among subjects who had replicate studies were correlated with conterminous changes of their forced vital capacities (r(s) = 0.49, p = 0.012). Most importantly, one-year freedom from major adverse clinical events (either death or lung transplantation) was 56 +/- 6% among 78 IPF patients with CD4(+) CD28(+)/CD4(total)>= 82%, compared to 9 +/- 9% among those with more extensive CD28 down-regulation (CD4(+) CD28(+)/CD4(total)<82%) (p = 0.0004). The odds ratio for major adverse events among those with the most extensive CD28 down-regulation was 13.0, with 95% confidence intervals 1.6-111.1. Conclusions/Significance: Marked down-regulation of CD28 on circulating CD4 T-cells, a result of repeated antigen-driven proliferations, is associated with poor outcomes in IPF patients. The CD4(+) CD28(null) cells of these patients have potentially enhanced pathogenic characteristics, including increased productions of cytotoxic mediators and pro-inflammatory cytokines. These findings show proliferative T-cell responses to antigen(s) resulting in CD28 down-regulation are associated with progression and manifestations of IPF, and suggest assays of circulating CD4 T-cells may identify patients at greatest risk for clinical deterioration.	[Gilani, Syed R.; Vuga, Louis J.; Lindell, Kathleen O.; Gibson, Kevin F.; Xue, Jianmin; Kaminski, Naftali; Lindsay, Emily K.; George, M. Patricia; Duncan, Steven R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Valentine, Vincent G.] Univ Texas Med Branch, Dept Med, Galveston, TX USA; [Steele, Chad] Univ Alabama, Dept Med, Birmingham, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Medical Branch Galveston; University of Alabama System; University of Alabama Birmingham	Gilani, SR (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	duncsr@upmc.edu	Lindell, Kathleen Oare/GQQ-6372-2022; Lindsay, Emily/AAF-7246-2021	Lindsay, Emily/0000-0002-5314-9517; Kaminski, Naftali/0000-0001-5917-4601; George, Marjorie Patricia/0000-0002-6534-1020	U.S. National Institutes of Health [1RO1HL073241, 1P50 HL084932, 5T32 HL007563]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073241, P50HL084932, T32HL007563] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This research was supported in part by U. S. National Institutes of Health grants 1RO1HL073241, 1P50 HL084932, and 5T32 HL007563. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Atamas SP, 2002, J IMMUNOL, V168, P1139, DOI 10.4049/jimmunol.168.3.1139; Barbas-Filho JV, 2001, J CLIN PATHOL, V54, P132, DOI 10.1136/jcp.54.2.132; Collard HR, 2004, AM J RESP CRIT CARE, V169, P1076; Colombatti A, 1998, CLIN IMMUNOL IMMUNOP, V89, P61, DOI 10.1006/clin.1998.4580; Conti P, 2003, IMMUNOL LETT, V86, P123, DOI 10.1016/S0165-2478(03)00002-6; Dobashi N, 2000, LUNG, V178, P171, DOI 10.1007/s004080000020; DUFFNER C, 2005, ARTERIOSCLER THROMB, V25, P1347; Duncan SR, 2002, AM J RESP CRIT CARE, V165, P1439, DOI 10.1164/rccm.2107009; Fasth AER, 2009, J IMMUNOL, V183, P4792, DOI 10.4049/jimmunol.0803688; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Fontenot AP, 2003, J CLIN INVEST, V112, P776, DOI 10.1172/JCI200318317; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Goronzy JJ, 2004, ARTHRITIS RHEUM-US, V50, P43, DOI 10.1002/art.11445; Hirokawa M, 2001, BONE MARROW TRANSPL, V27, P1095, DOI 10.1038/sj.bmt.1703045; Homolka J, 2003, RESPIRATION, V70, P262, DOI 10.1159/000072007; JENDRO MC, 1995, ARTHRITIS RHEUM, V38, P1242, DOI 10.1002/art.1780380912; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Komocsi A, 2002, AM J PATHOL, V160, P1717, DOI 10.1016/S0002-9440(10)61118-2; Kotsianidis I, 2009, AM J RESP CRIT CARE, V179, P1121, DOI 10.1164/rccm.200812-1936OC; KRENSKY AM, 1990, NEW ENGL J MED, V322, P510, DOI 10.1056/NEJM199002223220805; Kurosu K, 2008, J IMMUNOL, V181, P756, DOI 10.4049/jimmunol.181.1.756; Lambers C, 2009, CLIN EXP IMMUNOL, V155, P466, DOI 10.1111/j.1365-2249.2008.03835.x; Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883; Magro CM, 2006, HUM IMMUNOL, V67, P284, DOI 10.1016/j.humimm.2006.02.026; Marchal-Somme J, 2006, J IMMUNOL, V176, P5735, DOI 10.4049/jimmunol.176.10.5735; Martens PB, 1997, ARTHRITIS RHEUM, V40, P1106, DOI 10.1002/art.1780400615; Mason DP, 2007, ANN THORAC SURG, V84, P1121, DOI 10.1016/j.athoracsur.2007.04.096; Miyazaki H, 2004, J CLIN PATHOL, V57, P1292, DOI 10.1136/jcp.2003.015495; Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881; Nakajima T, 2002, CIRCULATION, V105, P570, DOI 10.1161/hc0502.103348; Papiris Spyros A, 2007, J Inflamm (Lond), V4, P14, DOI 10.1186/1476-9255-4-14; Pignatti P, 2006, AM J RESP CRIT CARE, V173, P310, DOI 10.1164/rccm.200502-244OC; Rosas IO, 2007, AM J RESP CRIT CARE, V176, P698, DOI 10.1164/rccm.200702-254OC; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Scheibenbogen C, 2000, J IMMUNOL METHODS, V244, P81, DOI 10.1016/S0022-1759(00)00257-X; Schirmer M, 1998, J IMMUNOL, V161, P1018; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Selman MS, 2004, DRUGS, V64, P405, DOI 10.2165/00003495-200464040-00005; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shimizudani N, 2002, CLIN EXP IMMUNOL, V129, P140, DOI 10.1046/j.1365-2249.2002.01871.x; Studer SM, 2008, AM J RESP CRIT CARE, V178, P765, DOI 10.1164/rccm.200701-013OC; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takahashi T, 2007, RESPIROLOGY, V12, P642, DOI 10.1111/j.1440-1843.2007.01140.x; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; WALLACE WAH, 1994, THORAX, V49, P1139, DOI 10.1136/thx.49.11.1139; WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539; Zal B, 2004, CIRCULATION, V109, P1230, DOI 10.1161/01.CIR.0000118476.29352.2A; Zhu XH, 2009, J IMMUNOL, V182, P3270, DOI 10.4049/jimmunol.0802622	52	137	145	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8959	10.1371/journal.pone.0008959	http://dx.doi.org/10.1371/journal.pone.0008959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126467	Green Published, Green Accepted, gold			2022-12-25	WOS:000274139100008
J	Spurney, CF; Cha, HJ; Sali, A; Pandey, GS; Pistilli, E; Guerron, AD; Gordish-Dressman, H; Hoffman, EP; Nagaraju, K				Spurney, Christopher F.; Cha, Hee-Jae; Sali, Arpana; Pandey, Gouri S.; Pistilli, Emidio; Guerron, Alfredo D.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina			Evaluation of Skeletal and Cardiac Muscle Function after Chronic Administration of Thymosin beta-4 in the Dystrophin Deficient Mouse	PLOS ONE			English	Article							ACTIN-SEQUESTERING PEPTIDE; NF-KAPPA-B; MDX MOUSE; GENE-EXPRESSION; MUSCULAR-DYSTROPHY; REGENERATION; CARDIOMYOPATHY; EVOLUTION; DIAPHRAGM; BETA(4)	Thymosin beta-4 (T beta 4) is a ubiquitous protein with many properties relating to cell proliferation and differentiation that promotes wound healing and modulates inflammatory mediators. We studied the effects of chronic administration of T beta 4 on the skeletal and cardiac muscle of dystrophin deficient mdx mice, the mouse model of Duchenne muscular dystrophy. Female wild type (C57BL10/ScSnJ) and mdx mice, 8-10 weeks old, were treated with 150 mu g of T beta 4 twice a week for 6 months. To promote muscle pathology, mice were exercised for 30 minutes twice a week. Skeletal and cardiac muscle function were assessed via grip strength and high frequency echocardiography. Localization of T beta 4 and amount of fibrosis were quantified using immunohistochemistry and Gomori's tri-chrome staining, respectively. Mdx mice treated with T beta 4 showed a significant increase in skeletal muscle regenerating fibers compared to untreated mdx mice. T beta 4 stained exclusively in the regenerating fibers of mdx mice. Although untreated mdx mice had significantly decreased skeletal muscle strength compared to untreated wild type, there were no significant improvements in mdx mice after treatment. Systolic cardiac function, measured as percent shortening fraction, was decreased in untreated mdx mice compared to untreated wild type and there was no significant difference after treatment in mdx mice. Skeletal and cardiac muscle fibrosis were also significantly increased in untreated mdx mice compared to wild type, but there was no significant improvement in treated mdx mice. In exercised dystrophin deficient mice, chronic administration of T beta 4 increased the number of regenerating fibers in skeletal muscle and could have a potential role in treatment of skeletal muscle disease in Duchenne muscular dystrophy.	[Spurney, Christopher F.] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA; [Cha, Hee-Jae] Kosin Univ, Coll Med, Dept Parasitol & Genet, Pusan, South Korea; [Sali, Arpana; Pandey, Gouri S.; Guerron, Alfredo D.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DE USA; [Pistilli, Emidio] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA	Children's National Health System; University of Pennsylvania	Spurney, CF (corresponding author), Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA.	knagaraju@cnmcresearch.org	Nagaraju, Kanneboyina/AAV-7684-2021; Cha, Hee-Jae/AFO-8772-2022; Nagaraju, Kanneboyina/ABA-6525-2021; Cruz, Alfredo Daniel Guerron/V-5188-2019	Cruz, Alfredo Daniel Guerron/0000-0002-4632-1681; Hoffman, Eric/0000-0001-6470-5139	National Institutes of Health (NIH)/National Institute of Child Health and Human Development/Child Health Research Career Development Award [K12HD001399-04, 1U54HD053177-01A1, R01-AR050478]; Department of Defense United States Army Medical Research Acquisition Activity [W81XWH-05-1-0616]; Foundation to Eradicate Duchenne, Inc.; Muscular Dystrophy Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Child Health and Human Development/Child Health Research Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Defense United States Army Medical Research Acquisition Activity(United States Department of Defense); Foundation to Eradicate Duchenne, Inc.; Muscular Dystrophy Association(Muscular Dystrophy Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding: This work was supported by funding provided by the following: National Institutes of Health (NIH)/National Institute of Child Health and Human Development/Child Health Research Career Development Award K12HD001399-04 (PI: Spurney); Department of Defense United States Army Medical Research Acquisition Activity grant W81XWH-05-1-0616 (Mouse Drug Screening Core to K. Nagaraju and E. Hoffman), Foundation to Eradicate Duchenne, Inc. (www.duchennemd.org), Muscular Dystrophy Association (www.mda.org), Charley's Fund (K. Nagaraju)(www. charleysfund. com), NIH grant 1U54HD053177-01A1 (Wellstone Muscular Dystrophy Center to E. Hoffman and K. Nagaraju), and NIH grant R01-AR050478 (K. Nagaraju). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boer JM, 2002, NEUROMUSCULAR DISORD, V12, pS118, DOI 10.1016/S0960-8966(02)00092-5; Cavasin MA, 2007, HYPERTENSION, V50, P130, DOI 10.1161/HYPERTENSIONAHA.106.084103; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; Hannappel E, 2003, VITAM HORM, V66, P257, DOI 10.1016/S0083-6729(03)01007-0; Hara Takahiko, 2005, Rinsho Shinkeigaku, V45, P880; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Marotta M, 2009, PHYSIOL GENOMICS, V37, P119, DOI 10.1152/physiolgenomics.90370.2008; Mora CA, 1997, INT J IMMUNOPHARMACO, V19, P1, DOI 10.1016/S0192-0561(97)00005-2; Nakayama Y, 2004, AM J PATHOL, V164, P1773, DOI 10.1016/S0002-9440(10)63735-2; OATES KK, 1995, BIOL THERAPY CANC, P841; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Pokharel S, 2004, CIRCULATION, V110, P3129, DOI 10.1161/01.CIR.0000147180.87553.79; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Porter JD, 2003, HUM MOL GENET, V12, P1813, DOI 10.1093/hmg/ddg197; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Reti R, 2008, EUR J ORAL SCI, V116, P424, DOI 10.1111/j.1600-0722.2008.00569.x; Rouger K, 2002, AM J PHYSIOL-CELL PH, V283, pC773, DOI 10.1152/ajpcell.00112.2002; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; SAFER D, 1991, J BIOL CHEM, V266, P4029; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; SANDERS MC, 1992, P NATL ACAD SCI USA, V89, P4678, DOI 10.1073/pnas.89.10.4678; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Sosne G, 2001, EXP EYE RES, V72, P605, DOI 10.1006/exer.2000.0985; Sosne G, 2007, EXP EYE RES, V84, P663, DOI 10.1016/j.exer.2006.12.004; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; TIETZ N, 1982, FUNDAMENTALS CLIN CH, P682; Tseng BS, 2002, J APPL PHYSIOL, V93, P537, DOI 10.1152/japplphysiol.00202.2002; Turk R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-98; WEBER A, 1992, BIOCHEMISTRY-US, V31, P6179, DOI 10.1021/bi00142a002; Zhang YQ, 2008, CANCER BIOL THER, V7, P419, DOI 10.4161/cbt.7.3.5415	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8976	10.1371/journal.pone.0008976	http://dx.doi.org/10.1371/journal.pone.0008976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126456	Green Submitted, Green Published, gold			2022-12-25	WOS:000274139100022
J	Clarke, ND; Bourque, G				Clarke, Neil D.; Bourque, Guillaume			Success in the DREAM3 Signaling Response Challenge Using Simple Weighted-Average Imputation: Lessons for Community-Wide Experiments in Systems Biology	PLOS ONE			English	Article							CASP7 PREDICTIONS; TARGETS	Our group produced the best predictions overall in the DREAM3 signaling response challenge, being tops by a substantial margin in the cytokine sub-challenge and nearly tied for best in the phosphoprotein sub-challenge. We achieved this success using a simple interpolation strategy. For each combination of a stimulus and inhibitor for which predictions were required, we had noted there were six other datasets using the same stimulus (but different inhibitor treatments) and six other datasets using the same inhibitor (but different stimuli). Therefore, for each treatment combination for which values were to be predicted, we calculated rank correlations for the data that were in common between the treatment combination and each of the 12 related combinations. The data from the 12 related combinations were then used to calculate missing values, weighting the contributions from each experiment based on the rank correlation coefficients. The success of this simple method suggests that the missing data were largely over-determined by similarities in the treatments. We offer some thoughts on the current state and future development of DREAM that are based on our success in this challenge, our success in the earlier DREAM2 transcription factor target challenge, and our experience as the data provider for the gene expression challenge in DREAM3.	[Clarke, Neil D.; Bourque, Guillaume] Genome Inst Singapore, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Clarke, ND (corresponding author), Genome Inst Singapore, Singapore, Singapore.	clarken@gis.a-star.edu.sg	Bourque, Guillaume/AFR-2927-2022; Clarke, Neil/D-9613-2014	Bourque, Guillaume/0000-0002-3933-9656; 	Agency for Science, Technology and Research (Singapore)	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR))	This work was funded by the Agency for Science, Technology and Research (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753; Read RJ, 2007, PROTEINS, V69, P27, DOI 10.1002/prot.21662; Vega VB, 2009, ANN NY ACAD SCI, V1158, P215, DOI 10.1111/j.1749-6632.2008.03759.x; 2009, PLOS ONE, P1	4	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8417	10.1371/journal.pone.0008417	http://dx.doi.org/10.1371/journal.pone.0008417			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126276	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500002
J	Gonzalez-Cabo, P; Ros, S; Palau, F				Gonzalez-Cabo, Pilar; Ros, Sheila; Palau, Francesc			Flavin Adenine Dinucleotide Rescues the Phenotype of Frataxin Deficiency	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; PLACEBO-CONTROLLED TRIAL; FRIEDREICHS-ATAXIA; SACCHAROMYCES-CEREVISIAE; IDEBENONE TREATMENT; OXIDATIVE-PHOSPHORYLATION; DEHYDROGENASE DEFICIENCY; MITOCHONDRIAL IRON; RESPIRATORY-CHAIN; BETA-OXIDATION	Background: Friedreich ataxia is a neurodegenerative disease caused by the lack of frataxin, a mitochondrial protein. We previously demonstrated that frataxin interacts with complex II subunits of the electronic transport chain (ETC) and putative electronic transfer flavoproteins, suggesting that frataxin could participate in the oxidative phosphorylation. Methods and Findings: Here we have investigated the effect of riboflavin and its cofactors flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) in Saccharomyces cerevisiae and Caenorhabditis elegans models of frataxin deficiency. We used a S. cerevisiae strain deleted for the yfh1 gene obtained by homologous recombination and we assessed growth in fermentable and non-fermentable cultures supplemented with either riboflavin or its derivates. Experiments with C. elegans were performed in transient knock-down worms (frh-1[RNAi]) generated by microinjection of dsRNA frh-1 into the gonads of young worms. We observed that FAD rescues the phenotype of both defective organisms. We show that cell growth and enzymatic activities of the ETC complexes and ATP production of yfh1 Delta cells were improved by FAD supplementation. Moreover, FAD also improved lifespan and other physiological parameters in the C. elegans knock-down model for frataxin. Conclusions/Significance: We propose that rescue of frataxin deficiency by FAD supplementation could be explained by an improvement in mitochondrial respiration. We suggest that riboflavin may be useful in the treatment of Friedreich ataxia.	[Gonzalez-Cabo, Pilar; Ros, Sheila; Palau, Francesc] CSIC, Inst Biomed, Lab Genet & Mol Med, Valencia, Spain; [Gonzalez-Cabo, Pilar; Ros, Sheila; Palau, Francesc] CIBERER, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gonzalez-Cabo, P (corresponding author), CSIC, Inst Biomed, Lab Genet & Mol Med, Valencia, Spain.	fpalau@ibv.csic.es	González-Cabo, Pilar/ABG-5080-2020; Gonzalez-Cabo, Pilar/H-1862-2015; Palau, Francesc/A-9391-2014	González-Cabo, Pilar/0000-0003-3131-6334; Gonzalez-Cabo, Pilar/0000-0003-3131-6334; Palau, Francesc/0000-0002-8635-5421	Spanish Ministry of Science and Innovation [SAF2006-01047, SAF2009-07063]; Generalitat Valenciana [Prometeo/2009/051]; Instituto de Salud Carlos III; Plan Nacional I+D+I	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Plan Nacional I+D+I	This work has been supported by the Spanish Ministry of Science and Innovation (grants SAF2006-01047 and SAF2009-07063) and the Generalitat Valenciana (grant Prometeo/2009/051). The CIBERER is funded by the Instituto de Salud Carlos III and the Plan Nacional I+D+I 2008-2011, and is an initiative of Ingenio 2010, Consolider Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOZZI C, 1994, NEUROLOGY, V44, P2153, DOI 10.1212/WNL.44.11.2153; AVERY L, 1997, C ELEGANS, V2, P679, DOI [10.1101/087969532.33.679, DOI 10.1101/087969532.33.679]; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; BELL RB, 1990, NEUROLOGY, V40, P1779, DOI 10.1212/WNL.40.11.1779; BENTLAGE H, 1995, EUR J BIOCHEM, V227, P909, DOI 10.1111/j.1432-1033.1995.tb20218.x; BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; BRENNER S, 1974, GENETICS, V77, P71; Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Buyse G, 2003, NEUROLOGY, V60, P1679, DOI 10.1212/01.WNL.0000068549.52812.0F; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; De Castro M, 2000, HUM GENET, V106, P86, DOI 10.1007/s004399900201; Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Festenstein R, 2006, NAT CHEM BIOL, V2, P512, DOI 10.1038/nchembio1006-512; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; Grant L, 2006, FEBS LETT, V580, P5399, DOI 10.1016/j.febslet.2006.09.006; GREGERSEN N, 1985, J INHERIT METAB DIS, V8, P65, DOI 10.1007/BF01800662; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; KMOCH S, 1995, J INHERIT METAB DIS, V18, P227, DOI 10.1007/BF00711774; Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492; Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC; Murphy MP, 2001, EXPERT OPIN BIOL TH, V1, P753, DOI 10.1517/14712598.1.5.753; Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8; PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147; Pinard JM, 1999, ARCH PEDIATRIE, V6, P421, DOI 10.1016/S0929-693X(99)80224-3; Pineda M, 2008, EUR J PAEDIATR NEURO, V12, P470, DOI 10.1016/j.ejpn.2007.11.006; Priller J, 1997, ANN NEUROL, V42, P265, DOI 10.1002/ana.410420222; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Reihl P, 2005, J BIOL CHEM, V280, P39809, DOI 10.1074/jbc.M505002200; Richardson DR, 2001, BBA-MOL BASIS DIS, V1536, P133, DOI 10.1016/S0925-4439(01)00041-2; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; Rustin P, 2002, FREE RADICAL RES, V36, P467, DOI 10.1080/10715760290021333; Schols L, 2001, NEUROSCI LETT, V306, P169, DOI 10.1016/S0304-3940(01)01892-4; SCHOLTE HR, 1995, BBA-MOL BASIS DIS, V1271, P75, DOI 10.1016/0925-4439(95)00013-T; SCHOLTE HR, 1992, J INHERIT METAB DIS, V15, P331, DOI 10.1007/BF02435969; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401; Waldvogel D, 1999, ANN NEUROL, V46, P123, DOI 10.1002/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H; YILMAZ K, 2008, EUR J PAEDIAT NEUROL; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	55	32	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8872	10.1371/journal.pone.0008872	http://dx.doi.org/10.1371/journal.pone.0008872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111601	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896300021
J	Wilson, SP; Law, JS; Mitchinson, B; Prescott, TJ; Bednar, JA				Wilson, Stuart P.; Law, Judith S.; Mitchinson, Ben; Prescott, Tony J.; Bednar, James A.			Modeling the Emergence of Whisker Direction Maps in Rat Barrel Cortex	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; THALAMOCORTICAL RESPONSE TRANSFORMATIONS; SOMATOSENSORY CORTEX; SELF-ORGANIZATION; RECEPTIVE-FIELDS; IN-VIVO; SPATIOTEMPORAL DYNAMICS; FEEDFORWARD INHIBITION; HORIZONTAL CONNECTIONS; THALAMIC BARRELOIDS	Based on measuring responses to rat whiskers as they are mechanically stimulated, one recent study suggests that barrel-related areas in layer 2/3 rat primary somatosensory cortex (S1) contain a pinwheel map of whisker motion directions. Because this map is reminiscent of topographic organization for visual direction in primary visual cortex (V1) of higher mammals, we asked whether the S1 pinwheels could be explained by an input-driven developmental process as is often suggested for V1. We developed a computational model to capture how whisker stimuli are conveyed to supragranular S1, and simulate lateral cortical interactions using an established self-organizing algorithm. Inputs to the model each represent the deflection of a subset of 25 whiskers as they are contacted by a moving stimulus object. The subset of deflected whiskers corresponds with the shape of the stimulus, and the deflection direction corresponds with the movement direction of the stimulus. If these two features of the inputs are correlated during the training of the model, a somatotopically aligned map of direction emerges for each whisker in S1. Predictions of the model that are immediately testable include (1) that somatotopic pinwheel maps of whisker direction exist in adult layer 2/3 barrel cortex for every large whisker on the rat's face, even peripheral whiskers; and (2) in the adult, neurons with similar directional tuning are interconnected by a network of horizontal connections, spanning distances of many whisker representations. We also propose specific experiments for testing the predictions of the model by manipulating patterns of whisker inputs experienced during early development. The results suggest that similar intracortical mechanisms guide the development of primate V1 and rat S1.	[Wilson, Stuart P.; Law, Judith S.; Bednar, James A.] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Wilson, Stuart P.; Mitchinson, Ben; Prescott, Tony J.] Univ Sheffield, Act Touch Lab, Sheffield, S Yorkshire, England	University of Edinburgh; University of Sheffield	Wilson, SP (corresponding author), Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland.	S.P.Wilson@Sheffield.ac.uk	Prescott, Tony J/A-7574-2008	Prescott, Tony J/0000-0003-4927-5390; Wilson, Stuart/0000-0001-8125-5133	European Union [215910]; Engineering and Physical Sciences Research Council [EP/P504759/1]	European Union(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by European Union Framework 7 ICT Project 215910 (BIOTACT, www.biotact.org), and Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) grant EP/P504759/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajima A, 2006, CEREB CORTEX, V16, P1202, DOI 10.1093/cercor/bhj061; Andermann ML, 2006, NAT NEUROSCI, V9, P543, DOI 10.1038/nn1671; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Bale MR, 2009, J NEUROPHYSIOL, V102, P2771, DOI 10.1152/jn.00636.2009; Bednar JA, 2004, NEUROCOMPUTING, V58, P1129, DOI 10.1016/j.neucom.2004.01.177; Bednar JA, 2003, NEUROCOMPUTING, V52-4, P473, DOI 10.1016/SO925-2312(02)00735-X; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brecht M, 2002, J PHYSIOL-LONDON, V538, P495, DOI 10.1113/jphysiol.2001.012334; Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130, DOI 10.1152/jn.1996.76.1.130; Bruno RM, 2009, J NEUROSCI, V29, P3172, DOI 10.1523/JNEUROSCI.5911-08.2009; Bruno RM, 2003, J NEUROSCI, V23, P9565; Bruno RM, 2002, J NEUROSCI, V22, P10966; Burger T, 2001, Z NATURFORSCH C, V56, P464; Derdikman D, 2003, J NEUROSCI, V23, P3100; Drew PJ, 2007, J NEUROPHYSIOL, V98, P1566, DOI 10.1152/jn.00056.2007; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fox C, 2009, AUTON ROBOT, V26, P223, DOI 10.1007/s10514-009-9109-z; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Furuta T, 2006, J NEUROSCI, V26, P10548, DOI 10.1523/JNEUROSCI.1746-06.2006; Ghazanfar AA, 1999, CEREB CORTEX, V9, P348, DOI 10.1093/cercor/9.4.348; Golomb D, 2006, J NEUROPHYSIOL, V95, P1735, DOI 10.1152/jn.00734.2005; Grant RA, 2009, J NEUROPHYSIOL, V101, P862, DOI 10.1152/jn.90783.2008; Hartings JA, 2000, J NEUROPHYSIOL, V83, P2791, DOI 10.1152/jn.2000.83.5.2791; Helmstaedter M, 2009, CEREB CORTEX, V19, P951, DOI 10.1093/cercor/bhn130; Higley MJ, 2007, J NEUROPHYSIOL, V97, P647, DOI 10.1152/jn.00777.2006; Jacob V, 2008, NEURON, V60, P1112, DOI 10.1016/j.neuron.2008.10.017; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Khatri V, 2007, CEREB CORTEX, V17, P599, DOI 10.1093/cercor/bhk006; Kida H, 2005, J NEUROPHYSIOL, V94, P2004, DOI 10.1152/jn.00113.2004; Krupa DJ, 2001, J NEUROSCI METH, V104, P199, DOI 10.1016/S0165-0270(00)00345-9; KYRIAZI HT, 1993, J NEUROSCI, V13, P1601; Kyriazi HT, 1996, J NEUROPHYSIOL, V75, P547, DOI 10.1152/jn.1996.75.2.547; Lavallee P, 2004, J NEUROSCI, V24, P6098, DOI 10.1523/JNEUROSCI.0973-04.2004; Lee SH, 2004, J NEUROPHYSIOL, V91, P223, DOI 10.1152/jn.00541.2003; Li L, 2007, J NEUROSCI, V27, P167, DOI 10.1523/JNEUROSCI.4165-06.2007; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Miikkulainen R, 2005, COMPUTATIONAL MAPS V; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Mitchinson B, 2004, P ROY SOC B-BIOL SCI, V271, P2509, DOI 10.1098/rspb.2004.2882; Mitchinson B, 2008, BIOL CYBERN, V98, P185, DOI 10.1007/s00422-007-0208-7; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Neimark MA, 2003, J NEUROSCI, V23, P6499; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Pinto DJ, 1996, J COMPUT NEUROSCI, V3, P247, DOI 10.1007/BF00161134; Polley DB, 2005, NEUROBIOL LEARN MEM, V83, P134, DOI 10.1016/j.nlm.2004.10.005; Puccini GD, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000137; Ren M, 2007, SCIENCE, V316, P758, DOI 10.1126/science.1135468; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Sachdev RNS, 2001, SOMATOSENS MOT RES, V18, P91; Sarid L, 2007, P NATL ACAD SCI USA, V104, P16353, DOI 10.1073/pnas.0707853104; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Shimegi S, 1999, J NEUROSCI, V19, P10164; Shoykhet M, 2008, J NEUROPHYSIOL, V99, P356, DOI 10.1152/jn.01063.2007; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Sirosh J, 1997, NEURAL COMPUT, V9, P577, DOI 10.1162/neco.1997.9.3.577; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Stafford T, 2007, NEUROCOMPUTING, V70, P1932, DOI 10.1016/j.neucom.2006.10.134; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Temereanca S, 2004, NEURON, V41, P639, DOI 10.1016/S0896-6273(04)00046-7; Timofeeva E, 2003, J NEUROSCI, V23, P10717; Wallace H, 1999, SOMATOSENS MOT RES, V16, P122; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wirth C, 2004, J NEUROPHYSIOL, V91, P1635, DOI 10.1152/jn.00950.2003	78	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8778	10.1371/journal.pone.0008778	http://dx.doi.org/10.1371/journal.pone.0008778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107500	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000273896100003
J	Liu, X; Zhao, YP				Liu, Xin; Zhao, Ya-Pu			Switch Region for Pathogenic Structural Change in Conformational Disease and Its Prediction	PLOS ONE			English	Article							VIRUS NUCLEOPROTEIN GENE; AMYLOID FIBRILS; INFLUENZA-VIRUS; PARKINSONS-DISEASE; SYNTHETIC PEPTIDES; ALPHA-SYNUCLEIN; PRION PROTEIN; IN-VITRO; MUTATIONS; VARIANT	Many diseases are believed to be related to abnormal protein folding. In the first step of such pathogenic structural changes, misfolding occurs in regions important for the stability of the native structure. This destabilizes the normal protein conformation, while exposing the previously hidden aggregation-prone regions, leading to subsequent errors in the folding pathway. Sites involved in this first stage can be deemed switch regions of the protein, and can represent perfect binding targets for drugs to block the abnormal folding pathway and prevent pathogenic conformational changes. In this study, a prediction algorithm for the switch regions responsible for the start of pathogenic structural changes is introduced. With an accuracy of 94%, this algorithm can successfully find short segments covering sites significant in triggering conformational diseases (CDs) and is the first that can predict switch regions for various CDs. To illustrate its effectiveness in dealing with urgent public health problems, the reason of the increased pathogenicity of H5N1 influenza virus is analyzed; the mechanisms of the pandemic swine-origin 2009 A(H1N1) influenza virus in overcoming species barriers and in infecting large number of potential patients are also suggested. It is shown that the algorithm is a potential tool useful in the study of the pathology of CDs because: (1) it can identify the origin of pathogenic structural conversion with high sensitivity and specificity, and (2) it provides an ideal target for clinical treatment.	[Liu, Xin; Zhao, Ya-Pu] Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS	Liu, X (corresponding author), Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech, Beijing 100080, Peoples R China.	liuxin@lnm.imech.ac.cn; yzhao@imech.ac.cn			National High-Tech R&D Program of China (863 Program) [2007AA021803]; National Basic Research Program of China (973 Program) [200703310500]; National Natural Science Foundation of China [10704077]	National High-Tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was jointly supported by the National High-Tech R&D Program of China (863 Program, Grant No. 2007AA021803), National Basic Research Program of China (973 Program, Grant No. 200703310500), and National Natural Science Foundation of China, No. 10704077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson M, 1996, SCAND J CLIN LAB INV, V56, P47; Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREOTTI G, DESIGNING A IN PRESS; Berkhoff EGM, 2005, J VIROL, V79, P11239, DOI 10.1128/JVI.79.17.11239-11246.2005; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Collod-Beroud G, 1998, NUCLEIC ACIDS RES, V26, P229, DOI 10.1093/nar/26.1.229; DEBELLEROCHE J, 1995, J MED GENET, V32, P841, DOI 10.1136/jmg.32.11.841; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Frank PG, 2000, J LIPID RES, V41, P853; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hasegawa K, 2003, BIOCHEM BIOPH RES CO, V304, P101, DOI 10.1016/S0006-291X(03)00543-6; Haspel N, 2005, J MOL BIOL, V345, P1213, DOI 10.1016/j.jmb.2004.11.002; Henneke Marco, 2003, Hum Mutat, V22, P417, DOI 10.1002/humu.9187; Hiramatsu H, 2005, J AM CHEM SOC, V127, P7988, DOI 10.1021/ja050844o; Hiramatsu H, 2004, J AM CHEM SOC, V126, P3008, DOI 10.1021/ja0383017; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; JACOBSON DR, 1992, HUM GENET, V89, P353; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Johnson DJD, 2004, J BIOL CHEM, V279, P4913, DOI 10.1074/jbc.M311644200; Johnson RJK, 2005, J MOL BIOL, V352, P823, DOI 10.1016/j.jmb.2005.07.040; JUNG J, BIOCHEMISTRY, V48, P2597; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kazantzis A, 2002, EUR J BIOCHEM, V269, P780, DOI 10.1046/j.0014-2956.2001.02689.x; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Liu X, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051927; Liu XK, 2008, PROCEEDINGS OF THE 27TH CHINESE CONTROL CONFERENCE, VOL 2, P91, DOI 10.1109/CHICC.2008.4605378; Liu X, 2009, J THEOR BIOL, V261, P593, DOI 10.1016/j.jtbi.2009.08.028; Liu X, 2009, J THEOR BIOL, V258, P294, DOI 10.1016/j.jtbi.2009.02.009; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Olafsson I, 2000, AMYLOID, V7, P70, DOI 10.3109/13506120009146827; Page LJ, 2005, EMBO J, V24, P4124, DOI 10.1038/sj.emboj.7600872; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; SCHOLTISSEK C, 1993, ARCH VIROL, V131, P237, DOI 10.1007/BF01378629; Sebastiao MP, 1998, J BIOL CHEM, V273, P24715, DOI 10.1074/jbc.273.38.24715; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	55	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8441	10.1371/journal.pone.0008441	http://dx.doi.org/10.1371/journal.pone.0008441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XB	20111584	Green Published, gold, Green Submitted			2022-12-25	WOS:000278099200002
J	Toribio, RE; Brown, HA; Novince, CM; Marlow, B; Hernon, K; Lanigan, LG; Hildreth, BE; Werbeck, JL; Shu, ST; Lorch, G; Carlton, M; Foley, J; Boyaka, P; McCauley, LK; Rosol, TJ				Toribio, Ramiro E.; Brown, Holly A.; Novince, Chad M.; Marlow, Brandlyn; Hernon, Krista; Lanigan, Lisa G.; Hildreth, Blake E., III; Werbeck, Jillian L.; Shu, Sherry T.; Lorch, Gwendolen; Carlton, Michelle; Foley, John; Boyaka, Prosper; McCauley, Laurie K.; Rosol, Thomas J.			The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice	FASEB JOURNAL			English	Article						parathyroid; osteoblast; craniofacial; lethality	HORMONE-RELATED PROTEIN; PARATHYROID-HORMONE; PTH/PTHRP RECEPTOR; HUMORAL HYPERCALCEMIA; CALCIUM-TRANSPORT; TARGETING SIGNAL; LINK PROTEIN; CELL-DEATH; IN-VITRO; PEPTIDE	The functions of parathyroid hormone-related protein (PTHrP) on morphogenesis, cell proliferation, apoptosis, and calcium homeostasis have been attributed to its N terminus. Evidence suggests that many of these effects are not mediated by the N terminus but by the midregion, a nuclear localization sequence (NLS), and C terminus of the protein. A knock-in mouse lacking the midregion, NLS, and C terminus of PTHrP (Pthrp(Delta/Delta)) was developed. Pthrp(Delta/Delta) mice had craniofacial dysplasia, chondrodysplasia, and kyphosis, with most mice dying by d 5 of age. In bone, there were fewer chondrocytes and osteoblasts per area, bone mass was decreased, and the marrow was less cellular, with erythroid hypoplasia. Cellular proliferation was impaired, and apoptosis was increased. Runx2, Ocn, Sox9, Crtl1, beta-catenin, Runx1, ephrin B2, cyclin D1, and Gata1 were underexpressed while P16/Ink4a, P21, GSK-3 beta, Il-6, Ffg3, and Ihh were overexpressed. Mammary gland development was aberrant, and energy metabolism was deregulated. These results establish that the midregion, NLS, and C terminus of PTHrP are crucial for the commitment of osteogenic and hematopoietic precursors to their lineages, and for survival, and many of the effects of PTHrP on development are not mediated by its N terminus. The down-regulation of Runx1, Runx2, and Sox9 indicates that PTHrP is a modulator of transcriptional activation during stem cell commitment. Toribio, R. E., Brown, H. A., Novince, C. M., Marlow, B. Hernon, K., Lanigan, L. G., Hildreth III, B. E., Werbeck, J. L., Shu, S. T., Lorch, G., Carlton, M., Foley, J., Boyaka, P., McCauley, L. K., Rosol, T. J. The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice. FASEB J. 24, 1947-1957 (2010). www.fasebj.org	[Toribio, Ramiro E.; Brown, Holly A.; Marlow, Brandlyn; Hernon, Krista] Ohio State Univ, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Lanigan, Lisa G.; Hildreth, Blake E., III; Werbeck, Jillian L.; Shu, Sherry T.; Lorch, Gwendolen; Boyaka, Prosper; Rosol, Thomas J.] Ohio State Univ, Dept Vet Biosci, Coll Vet Med, Columbus, OH 43210 USA; [Carlton, Michelle] Ohio State Univ, Wright Ctr Innovat Biomed Imaging, Columbus, OH 43210 USA; [Novince, Chad M.; McCauley, Laurie K.] Univ Michigan, Sch Med, Dept Periodont & Oral Med, Ann Arbor, MI USA; [McCauley, Laurie K.] Univ Michigan, Dept Psychol, Sch Med, Ann Arbor, MI USA; [Foley, John] Indiana Univ, Sch Med, Med Sci Program, Bloomington, IN 47405 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington	Toribio, RE (corresponding author), Ohio State Univ, Dept Vet Clin Sci, 601 Vernon Tharp St, Columbus, OH 43210 USA.	toribio.1@osu.edu	McCauley, Laurie/G-4041-2012; Rosol, Thomas/G-9585-2011; Toribio, Ramiro/H-7838-2013; Hildreth, Eason/W-8186-2019	Rosol, Thomas/0000-0003-3737-1190; Toribio, Ramiro/0000-0002-9063-540X; Hildreth, Eason/0000-0002-4631-1117; Boyaka, Prosper/0000-0001-6857-9088; Lanigan, Lisa/0000-0001-8969-7411	Ohio State University, Columbus, OH, USA; National Institutes of Health [K01 RR018924, S10 RR020888, DE014073, CA09390]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020888, K01RR018924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014073] Funding Source: NIH RePORTER	Ohio State University, Columbus, OH, USA(Ohio State University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank laboratory members for their support; Hui Wang and Gustavo Leone (Human Cancer Genetics Program, The Ohio State University, Columbus, OH, USA) for their assistance with embryonic stem cell work and for providing the EIIa-Cre mice; Sanjay Singh and Girish Rajgolikar for technical assistance; Jan Hu for consultation regarding tooth morphology; and Alan Flechtner and Florinda Jaynes for histological specimen processing. The pPNT plasmid was a kind gift from Dr. Michael Weinstein (Human Cancer Genetics Program, The Ohio State University). The authors thank Dr. T.J. Martin for the constructive comments on this manuscript. This study was possible with funding from the National Institutes of Health to R.E.T. (K01 RR018924; S10 RR020888) and L.K.M. (DE014073 and CA09390). The authors declare no competing financial interests.	Aarts MM, 1999, J BONE MINER RES, V14, P1493, DOI 10.1359/jbmr.1999.14.9.1493; Aarts MM, 2001, J BIOL CHEM, V276, P37934; Aarts MM, 1999, J BIOL CHEM, V274, P4832, DOI 10.1074/jbc.274.8.4832; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; BURTIS WJ, 1994, J CLIN ENDOCR METAB, V78, P317, DOI 10.1210/jc.78.2.317; BURTIS WJ, 1992, J CLIN ENDOCR METAB, V75, P1110, DOI 10.1210/jc.75.4.1110; CARE AD, 1990, EXP PHYSIOL, V75, P605, DOI 10.1113/expphysiol.1990.sp003437; Cebrian A, 2002, DIABETES, V51, P3003, DOI 10.2337/diabetes.51.10.3003; Chatterjee O, 2002, BRAIN RES, V930, P58, DOI 10.1016/S0006-8993(01)03407-2; Chen L, 1999, J CLIN INVEST, V104, P1517, DOI 10.1172/JCI6690; de Gortazar AR, 2006, CALCIFIED TISSUE INT, V79, P360, DOI 10.1007/s00223-006-0099-y; De Miguel F, 2001, ENDOCRINOLOGY, V142, P4096, DOI 10.1210/en.142.9.4096; FENTON AJ, 1991, ENDOCRINOLOGY, V129, P3424, DOI 10.1210/endo-129-6-3424; Fuentes J, 2006, AM J PHYSIOL-REG I, V291, pR1499, DOI 10.1152/ajpregu.00892.2005; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Kovacs CS, 1996, P NATL ACAD SCI USA, V93, P15233, DOI 10.1073/pnas.93.26.15233; Kuznetsov SA, 2004, J CELL BIOL, V167, P1113, DOI 10.1083/jcb.200408079; Lam MHC, 2001, BIOCHEM BIOPH RES CO, V282, P629, DOI 10.1006/bbrc.2001.4607; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lee K, 1996, ENDOCRINOLOGY, V137, P5109, DOI 10.1210/en.137.11.5109; LOPEZHILKER S, 1992, J LAB CLIN MED, V119, P738; MARTIN TJ, 1988, AUST NZ J MED, V18, P287, DOI 10.1111/j.1445-5994.1988.tb02039.x; Miao DS, 2008, P NATL ACAD SCI USA, V105, P20309, DOI 10.1073/pnas.0805690105; MOSELEY JM, 1987, P NATL ACAD SCI USA, V84, P5048, DOI 10.1073/pnas.84.14.5048; Onda K, 2006, J VET MED SCI, V68, P709, DOI 10.1292/jvms.68.709; Orloff JJ, 1996, ENDOCRINOLOGY, V137, P5376, DOI 10.1210/en.137.12.5376; Pache JC, 2006, ENDOCRINOLOGY, V147, P990, DOI 10.1210/en.2005-0663; Pannier S, 2009, BBA-MOL BASIS DIS, V1792, P140, DOI 10.1016/j.bbadis.2008.11.010; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; Sawada Y, 2001, MOL CELL ENDOCRINOL, V182, P265, DOI 10.1016/S0303-7207(01)00482-8; Schipani Ernestina, 2003, Birth Defects Research, V69, P352, DOI 10.1002/bdrc.10028; SEITZ PK, 1995, MINER ELECTROL METAB, V21, P180; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Uemura H, 1997, J ENDOCRINOL, V153, P445, DOI 10.1677/joe.0.1530445; Valin A, 2001, ENDOCRINOLOGY, V142, P2752, DOI 10.1210/en.142.7.2752; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanHouten JN, 2003, J CLIN INVEST, V112, P1429, DOI 10.1172/JCI200319504; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Wu TL, 1996, J BIOL CHEM, V271, P24371, DOI 10.1074/jbc.271.40.24371; Wysolmerski JJ, 1998, ANNU REV PHYSIOL, V60, P431, DOI 10.1146/annurev.physiol.60.1.431; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; Wysolmerski JJ, 2001, J CLIN ENDOCR METAB, V86, P1788, DOI 10.1210/jc.86.4.1788	49	52	55	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1947	1957		10.1096/fj.09-147033	http://dx.doi.org/10.1096/fj.09-147033			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20145205	Green Published, Green Submitted			2022-12-25	WOS:000278200000029
J	Matsushita, K; Morello, F; Wu, YJ; Zhang, LN; Iwanaga, S; Pratt, RE; Dzau, VJ				Matsushita, Kenichi; Morello, Fulvio; Wu, Yaojiong; Zhang, Lunan; Iwanaga, Shiro; Pratt, Richard E.; Dzau, Victor J.			Mesenchymal Stem Cells Differentiate into Renin-producing Juxtaglomerular (JG)-like Cells under the Control of Liver X Receptor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; LXR-ALPHA; REGULATORY ELEMENTS; ADHERENT CELLS; MOUSE; CAMP; PROMOTER; KIDNEY; MICE; IDENTIFICATION	Renin is a key enzyme for cardiovascular and renal homeostasis and is produced by highly specialized endocrine cells in the kidney, known as juxtaglomerular (JG) cells. The nature and origin of these cells remain as mysteries. Previously, we have shown that the nuclear hormone receptor liver X receptor-alpha (LXR alpha) is a major transcriptional regulator of the expression of renin, c-myc, and other genes involved with growth/differentiation. In this study we test the hypothesis that LXR alpha plays an important role not only in renin expression but also in renin-containing cell differentiation, specifically from the mesenchymal stem cell (MSC), which may be the origin of the JG cell. Indeed, our data demonstrated that LXR alpha activation by its ligands or cAMP stimulated renin gene expression in both murine and human MSCs. Furthermore, sustained cAMP stimulation of murine MSCs overexpressing LXR alpha led to their differentiation into JG-like cells expressing renin and alpha-smooth muscle actin. These MSC-derived JG-like cells contained renin in secretory granules and released active renin in response to cAMP. In conclusion, the activation of LXR alpha stimulates renin expression and induces MSCs differentiation into renin-secreting, JG-like cells. Our results suggest that the MSC may be the origin of the juxtaglomerular cell and provide insight into novel understanding of pathophysiology of the renin-angiotensin system.	[Dzau, Victor J.] Duke Univ, Off Chancellor, Med Ctr, Mandel Ctr Hypertens & Atherosclerosis Res, Durham, NC 27710 USA; [Matsushita, Kenichi; Morello, Fulvio; Wu, Yaojiong; Zhang, Lunan; Pratt, Richard E.; Dzau, Victor J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Matsushita, Kenichi; Iwanaga, Shiro] Keio Univ, Div Cardiol, Dept Med, Sch Med, Tokyo 1608582, Japan	Duke University; Duke University; Keio University	Dzau, VJ (corresponding author), Duke Univ, Off Chancellor, Med Ctr, Mandel Ctr Hypertens & Atherosclerosis Res, DUMC Box 3178, Durham, NC 27710 USA.	victor.dzau@duke.edu	Matsushita, Kenichi/R-1902-2018; Morello, Fulvio/G-8519-2011	Matsushita, Kenichi/0000-0001-7668-3117; Morello, Fulvio/0000-0002-7833-9632	National Institutes of Health, NHLBI [RO1 HL35610, HL58516, HL72010, HL73219]; Edna Mandel Foundation; Leducq Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 21790745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058516, R01HL073219, R01HL072010, R01HL035610] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Edna Mandel Foundation; Leducq Foundation(Leducq Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL35610, HL58516, HL72010, and HL73219 from NHLBI (to V.J.D.). This work was also supported by the Edna Mandel Foundation and the Leducq Foundation (to V.J.D.) and in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI 21790745, to K. M.).	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Al-Awqati Q, 2002, KIDNEY INT, V61, P387, DOI 10.1046/j.1523-1755.2002.00164.x; Anderson LM, 2003, J BIOL CHEM, V278, P15252, DOI 10.1074/jbc.M208644200; Anglani F, 2004, J CELL MOL MED, V8, P474, DOI 10.1111/j.1582-4934.2004.tb00472.x; Bader M, 2000, J MOL MED, V78, P130, DOI 10.1007/s001090000089; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; BURT DW, 1989, J BIOL CHEM, V264, P7357; CATANZARO DF, 1994, KIDNEY INT, V46, P1513, DOI 10.1038/ki.1994.433; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Fujino T, 2004, J CLIN INVEST, V114, P805, DOI 10.1172/JCI200421382; Germain S, 1996, BIOCHEM J, V316, P107, DOI 10.1042/bj3160107; HORIUCHI M, 1993, J CLIN INVEST, V92, P1805, DOI 10.1172/JCI116770; HORIUCHI M, 1991, J BIOL CHEM, V266, P16247; ICE KS, 1988, CLIN EXP HYPERTENS A, V10, P1169, DOI 10.1080/07300077.1988.11878809; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; KON Y, 1992, ACTA ANAT, V144, P354; LANG JA, 1995, HYPERTENSION, V25, P704, DOI 10.1161/01.HYP.25.4.704; Lantelme P, 2002, HYPERTENSION, V39, P1007, DOI 10.1161/01.HYP.0000016177.20565.A0; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MLSS, 2004, DEV CELL, V6, P719; Lopez MLSS, 2001, AM J PHYSIOL-RENAL, V281, pF345, DOI 10.1152/ajprenal.2001.281.2.F345; Mackins CJ, 2006, J CLIN INVEST, V116, P1063, DOI 10.1172/JCI25713; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Matsushita K, 2006, HYPERTENSION, V48, P1095, DOI 10.1161/01.HYP.0000248211.82232.a7; Matsushita K, 2007, J AM SOC HYPERTENS, V1, P164, DOI 10.1016/j.jash.2007.02.004; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Morello F, 2005, J CLIN INVEST, V115, P1913, DOI 10.1172/JCI24594; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; NAKAMURA N, 1989, P NATL ACAD SCI USA, V86, P56, DOI 10.1073/pnas.86.1.56; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; OWEN RA, 1995, TOXICOL PATHOL, V23, P606, DOI 10.1177/019262339502300319; Pan L, 2005, HYPERTENSION, V45, P3, DOI 10.1161/01.HYP.0000149717.55920.45; Pan L, 2001, J BIOL CHEM, V276, P45530, DOI 10.1074/jbc.M103010200; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Schoof E, 2001, J CLIN ENDOCR METAB, V86, P1313, DOI 10.1210/jc.86.3.1313; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916; TAMURA K, 1994, J CLIN INVEST, V94, P1959, DOI 10.1172/JCI117547; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Tamura K, 2004, MOL CELL ENDOCRINOL, V224, P11, DOI 10.1016/j.mce.2004.07.005; Watorek E, 2006, ARCH IMMUNOL THER EX, V54, P45, DOI 10.1007/s00005-006-0004-4; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Zhang ZP, 2007, HYPERTENSION, V50, pE100	51	26	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11974	11982		10.1074/jbc.M109.099671	http://dx.doi.org/10.1074/jbc.M109.099671			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20118482	hybrid, Green Published			2022-12-25	WOS:000276787100026
J	Rangarajan, ES; Park, H; Fortin, E; Sygusch, J; Izard, T				Rangarajan, Erumbi S.; Park, HaJeung; Fortin, Emanuelle; Sygusch, Jurgen; Izard, Tina			Mechanism of Aldolase Control of Sorting Nexin 9 Function in Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ALDRICH-SYNDROME PROTEIN; MAXIMUM-LIKELIHOOD; ANONYMOUS PROTEIN; BINDING-SITE; F-ACTIN; MEMBRANE; DYNAMIN; TRAFFICKING; REFINEMENT	Sorting nexin 9 (SNX9) functions in a complex with the GTPase dynamin-2 at clathrin-coated pits, where it provokes fission of vesicles to complete endocytosis. Here the SNX9.dynamin-2 complex binds to clathrin and adapter protein complex 2 (AP-2) that line these pits, and this occurs through interactions of the low complexity domain (LC4) of SNX9 with AP-2. Intriguingly, localization of the SNX9.dynamin-2 complex to clathrin-coated pits is blocked by interactions with the abundant glycolytic enzyme aldolase, which also binds to the LC4 domain of SNX9. The crystal structure of the LC4 motif of human SNX9 in complex with aldolase explains the biochemistry and biology of this interaction, where SNX9 binds near the active site of aldolase via residues 165-171 that are also required for the interactions of SNX9 with AP-2. Accordingly, SNX9 binding to aldolase is structurally precluded by the binding of substrate to the active site. Interactions of SNX9 with aldolase are far more extensive and differ from those of the actin-nucleating factor WASP with aldolase, indicating considerable plasticity in mechanisms that direct the functions of the aldolase as a scaffold protein.	[Sygusch, Jurgen] Univ Montreal, Stn Ctr Ville, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Rangarajan, Erumbi S.; Park, HaJeung; Izard, Tina] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	Universite de Montreal; Scripps Research Institute	Sygusch, J (corresponding author), Univ Montreal, Stn Ctr Ville, Dept Biochem, CP 6128, Montreal, PQ H3C 3J7, Canada.	Jurgen.Sygusch@UMontreal.CA		Sygusch, Jurgen/0000-0002-6629-2128	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health grant (to T.I.). This is Publication Number 20157 from The Scripps Research Institute.	Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Bricogne G, 1997, METHOD ENZYMOL, V276, P361, DOI 10.1016/S0076-6879(97)76069-5; Buscaglia CA, 2006, J BIOL CHEM, V281, P1324, DOI 10.1074/jbc.M506346200; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kusakabe T, 1997, ARCH BIOCHEM BIOPHYS, V344, P184, DOI 10.1006/abbi.1997.0204; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leatherbarrow R J, 2007, GRAFIT VERSION 6; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; MATHEWS CK, 2000, BIOCHEMISTRY-US, P383; Mayer BJ, 2001, J CELL SCI, V114, P1253; MIDELFORT CF, 1976, BIOCHEMISTRY-US, V15, P2178, DOI 10.1021/bi00655a023; MORRIS AJ, 1993, J BIOL CHEM, V268, P1095; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENHOET E, 1967, BIOCHEMISTRY-US, V6, P2940, DOI 10.1021/bi00861a039; RACKER E, 1947, J BIOL CHEM, V167, P843; Raikar LS, 2006, J CELL BIOCHEM, V98, P861, DOI 10.1002/jcb.20732; Schindler R, 2001, BIOCHEM CELL BIOL, V79, P719, DOI 10.1139/bcb-79-6-719; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SMART OS, 2008, ANN M AM CRYST ASS K; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; St-Jean M, 2007, J BIOL CHEM, V282, P14309, DOI 10.1074/jbc.M611505200; STECK TL, 1978, J SUPRAMOL STR CELL, V8, P311, DOI 10.1002/jss.400080309; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volker KW, 1997, ARCH BIOCHEM BIOPHYS, V338, P237, DOI 10.1006/abbi.1996.9819; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200	41	26	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11983	11990		10.1074/jbc.M109.092049	http://dx.doi.org/10.1074/jbc.M109.092049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20129922	Green Published, hybrid			2022-12-25	WOS:000276787100027
J	Mauris, J; Evans, TC				Mauris, Jerome; Evans, Thomas C., Jr.			A Human PMS2 Homologue from Aquifex aeolicus Stimulates an ATP-dependent DNA Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH REPAIR; ESCHERICHIA-COLI; MUTL-ALPHA; UVRD HELICASE; ENDONUCLEASE ACTIVITY; PROTEIN; MECHANISMS; REPLICATION; HYDROLYSIS; BINDING	Mismatch repair in Escherichia coli involves a number of proteins including MutL and UvrD. Eukaryotes also possess MutL homologues; however, no UvrD helicase homologues have been identified. The hyperthermophilic bacterium Aquifex aeolicus has a MutL protein (Aae MutL) that possesses a latent endonuclease activity similar to eukaryotic, but different from E. coli, MutL proteins. By sequence homology Aq793 is a member of the PcrA/UvrD/Rep helicase subfamily. We expressed Aae MutL and the putative A. aeolicus DNA helicase (Aq793) proteins in E. coli. Using synthetic oligonucleotide substrates, we observed that lower concentrations of Aq793 were required to unwind double-stranded DNA that had a 3'-poly(dT) overhang as compared with double-stranded DNA with a 5'-poly(dT) or lacking a poly(dT) tail. This unwinding activity was stimulated by adding Aae MutL with maximal stimulation observed at an similar to 1.5:1 (MutL: Aq793) stoichiometric ratio. The enhancement of Aq793 helicase activity did not require the Aae MutL protein to retain endonuclease activity. Furthermore, the C-terminal 123 amino acid residues of Aae MutL were sufficient to stimulate Aq793 helicase activity, albeit at a significantly reduced efficacy. To the best of our knowledge this is the first time a human PMS2 homologue has been demonstrated to stimulate a PcrA/UvrD/Rep subfamily helicase, and this finding may further our understanding of the evolution of the mismatch repair pathway.	[Mauris, Jerome; Evans, Thomas C., Jr.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Evans, TC (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	evans@neb.com						An LX, 2005, J BIOL CHEM, V280, P28952, DOI 10.1074/jbc.M503096200; Atkinson J, 2009, J BIOL CHEM, V284, P9612, DOI 10.1074/jbc.M808030200; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Evans TC, 1999, BIOPOLYMERS, V51, P333, DOI 10.1002/(SICI)1097-0282(1999)51:5<333::AID-BIP3>3.3.CO;2-R; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Horiike T, 2009, GENE, V429, P59, DOI 10.1016/j.gene.2008.10.006; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, CELL, V126, P239, DOI 10.1016/j.cell.2006.07.003; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LAHUE RS, 1988, MUTAT RES, V198, P37, DOI 10.1016/0027-5107(88)90037-1; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; MATSON SW, 1986, J BIOL CHEM, V261, P169; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Robertson AB, 2006, J BIOL CHEM, V281, P19949, DOI 10.1074/jbc.M601604200; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658	31	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11087	11092		10.1074/jbc.M109.050955	http://dx.doi.org/10.1074/jbc.M109.050955			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20129926	Green Published, hybrid			2022-12-25	WOS:000276286200012
J	Dong, F; Soubeyrand, S; Hache, RJG				Dong, F.; Soubeyrand, S.; Hache, R. J. G.			Activation of PARP-1 in response to bleomycin depends on the Ku antigen and protein phosphatase 5	ONCOGENE			English	Article						Ku antigen; PARP-1; protein phosphatase 5; DNA repair; bleomycin	DOUBLE-STRAND BREAKS; DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE-1; SERINE/THREONINE PHOSPHATASE; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; KINASE-C; IN-VITRO; PHOSPHORYLATION; IDENTIFICATION	Poly (ADP-ribose) polymerase-1 (PARP-1) has an important role in the cellular response to a broad spectrum of DNA lesions. PARP-1 is strongly activated in response to double-stranded DNA breaks (DSBs), yet its contribution to the DSB response is poorly understood. Here we used bleomycin, a radiomimetic that generates DSBs with high specificity to focus on the response of PARP-1 to DSBs. We report that the induction of PARP-1 activity by bleomycin depends on the Ku antigen, a nonhomologous-DNA-End-Joining factor and protein phosphatase 5 (PP5). PARP-1 activation in response to bleomycin was reduced over 10-fold in Ku-deficient cells, whereas its activation in response to U. V. was unaffected. PARP-1 activation was rescued by reexpression of Ku, but was refractory to manipulation of DNA-dependent protein kinase or ATM. Similarly, PARP-1 activation subsequent to bleomycin was reduced 2-fold on ablation of PP5 and was increased 5-fold when PP5 was overexpressed. PP5 seemed to act directly on PARP-1, as its basal phosphorylation was reduced on overexpression of PP5, and PP5 dephosphorylated PARP-1 in vitro. These results highlight the functional importance of Ku antigen and PP5 for PARP-1 activity subsequent to DSBs. Oncogene (2010) 29, 2093-2103; doi: 10.1038/onc.2009.492; published online 25 January 2010	[Dong, F.; Soubeyrand, S.; Hache, R. J. G.] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Hache, R. J. G.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Hache, R. J. G.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Hache, RJG (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr, Calgary, AB T2N 1N4, Canada.	rjhache@ucalgary.ca		soubeyrand, sebastien/0000-0002-9317-301X	Canadian Institutes of Health Research [CIHR MT 13412]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are very grateful to Dr V Schreiber and Dr G de Murcia for providing the PARP-deficient and control mouse fibroblasts. We would also like to thank Dr Y Shiloh for providing us with the ATM-restored and AT fibroblast cell lines (PEBS-YZ5 and PEBS, respectively). Finally, we are grateful to L Pope for her logistical support. This work was funded by an operating grant from the Canadian Institutes of Health Research (CIHR MT 13412) to RJGH. RJGH was a University of Ottawa Health Research Chair.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Ariumi Y, 1999, ONCOGENE, V18, P4616, DOI 10.1038/sj.onc.1202823; Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; BAUER PI, 1992, BIOCHEM BIOPH RES CO, V187, P730, DOI 10.1016/0006-291X(92)91256-P; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; CANTONI O, 1986, BIOCHIM BIOPHYS ACTA, V867, P135, DOI 10.1016/0167-4781(86)90073-4; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Cole A, 1975, Basic Life Sci, V5B, P665; Douglas P, 2005, DNA REPAIR, V4, P1006, DOI 10.1016/j.dnarep.2005.05.003; Errami A, 1996, MOL CELL BIOL, V16, P1519; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Giffin W, 1995, DNA CELL BIOL, V14, P1025, DOI 10.1089/dna.1995.14.1025; Golden TA, 2003, METHOD ENZYMOL, V366, P372; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grote J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-48; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Hossain MB, 2009, J BIOL CHEM, V284, P8612, DOI 10.1074/jbc.M807198200; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Idogawa M, 2007, CANCER RES, V67, P911, DOI 10.1158/0008-5472.CAN-06-2360; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kang Y, 2009, J BIOL CHEM, V284, P9845, DOI 10.1074/jbc.M809272200; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Li BM, 2004, J BIOL CHEM, V279, P13659, DOI 10.1074/jbc.M311606200; Lis JT, 2006, CELL, V125, P1225, DOI 10.1016/j.cell.2006.06.016; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Meyer-Ficca ML, 2005, INT J BIOCHEM CELL B, V37, P920, DOI 10.1016/j.biocel.2004.09.011; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; OGATA N, 1981, J BIOL CHEM, V256, P4135; OKAYAMA H, 1977, J BIOL CHEM, V252, P7000; Perrault R, 2004, J CELL BIOCHEM, V92, P781, DOI 10.1002/jcb.20104; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Postow L, 2008, J CELL BIOL, V182, P467, DOI 10.1083/jcb.200802146; POVIRK LF, 1989, BIOCHEMISTRY-US, V28, P5808, DOI 10.1021/bi00440a016; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Rivera-Calzada A, 2007, EMBO REP, V8, P56, DOI 10.1038/sj.embor.7400847; Ruscetti T, 1998, J BIOL CHEM, V273, P14461, DOI 10.1074/jbc.273.23.14461; Schild-Poulter C, 2003, CANCER RES, V63, P7197; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Skinner J, 1997, J BIOL CHEM, V272, P22464, DOI 10.1074/jbc.272.36.22464; TANAKA Y, 1987, BIOCHEM BIOPH RES CO, V148, P709, DOI 10.1016/0006-291X(87)90934-X; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Yin H, 2006, J BIOL CHEM, V281, P11496, DOI 10.1074/jbc.M511138200; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	55	13	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2010	29	14					2093	2103		10.1038/onc.2009.492	http://dx.doi.org/10.1038/onc.2009.492			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101203				2022-12-25	WOS:000276402800008
J	Bolz, DD; Tenor, JL; Aballay, A				Bolz, Devin D.; Tenor, Jennifer L.; Aballay, Alejandro			A Conserved PMK-1/p38 MAPK Is Required in Caenorhabditis elegans Tissue-specific Immune Response to Yersinia pestis Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATA TRANSCRIPTION FACTOR; C-ELEGANS; INNATE IMMUNITY; VIRULENCE FACTORS; OUTER PROTEINS; EXPRESSION; BACTERIAL; DEFENSE; ANTIGEN; SYSTEM	Yersinia pestis has acquired a variety of complex strategies that enable the bacterium to overcome defenses in different hosts and ensure its survival and successful transmission. A full-genome microarray analysis on Caenorhabditis elegans infected with Y. pestis shows enrichment in genes that are markers of innate immune responses and regulated by a conserved PMK-1/p38 MAPK. Consistent with a role in regulating expression of immune effectors, inhibition of PMK-1/p38 by mutation or RNA interference enhances susceptibility to Y. pestis. Further studies of mosaic animals where PMK-1/p38 is exclusively inhibited or overexpressed in a tissue-specific manner indicate that PMK-1/p38 controls expression of a CUB-like family of immune genes at the cell-autonomous level. Given the conserved nature of PMK-1/p38 MAPK-mediated signaling and innate immune responses, PMK-1/p38 MAPK may play a role in the immune response against Y. pestis in natural hosts.	[Bolz, Devin D.; Tenor, Jennifer L.; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 268 Jones,Box 3054 DUMC, Durham, NC 27710 USA.	a.aballay@duke.edu			National Institutes of Health [GM070977, AI075844]; National Institutes of Health National Center for Research Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI075844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM070977 (to A. A.) and AI075844 (to D. D. B.).; We thank the Duke Microarray Facility, Dr. Timothy Hammond (Durham Veterans Affairs Medical Center), for use of the COPAS Biosort instrument, and members of the Aballay laboratory for helpful discussions. Some strains used in this work were provided by the Caenorhabditis Genetics Center (University of Minnesota), which is funded by the National Institutes of Health National Center for Research Resources. Strain VP303 was kindly provided by Kevin Strange (Vanderbilt University).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Ajees AA, 2006, NATURE, V444, P221, DOI 10.1038/nature05258; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Anisimov AP, 2005, INFECT IMMUN, V73, P7324, DOI 10.1128/IAI.73.11.7324-7331.2005; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; BRENNER S, 1974, GENETICS, V77, P71; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Huang XZ, 2004, INFECT IMMUN, V72, P7212, DOI 10.1128/IAI.72.12.7212-7219.2004; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Mollenhauer J, 2000, CANCER RES, V60, P1704; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Pulak Rock, 2006, V351, P275; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Styer KL, 2005, EMBO REP, V6, P992, DOI 10.1038/sj.embor.7400516; Titball RW, 2003, BIOCHEM SOC T, V31, P104, DOI 10.1042/BST0310104; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wang JJ, 2002, DEVELOPMENT, V129, P4989; Welkos S, 1998, MICROB PATHOGENESIS, V24, P185, DOI 10.1006/mpat.1997.0188; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	45	82	88	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10832	10840		10.1074/jbc.M109.091629	http://dx.doi.org/10.1074/jbc.M109.091629			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133945	Green Published, hybrid			2022-12-25	WOS:000276264600068
J	Hofstetter, G; Berger, A; Fiegl, H; Slade, N; Zoric, A; Holzer, B; Schuster, E; Mobus, VJ; Reimer, D; Daxenbichler, G; Marth, C; Zeimet, AG; Concin, N; Zeillinger, R				Hofstetter, G.; Berger, A.; Fiegl, H.; Slade, N.; Zoric, A.; Holzer, B.; Schuster, E.; Mobus, V. J.; Reimer, D.; Daxenbichler, G.; Marth, C.; Zeimet, A. G.; Concin, N.; Zeillinger, R.			Alternative splicing of p53 and p73: the novel p53 splice variant p53 delta is an independent prognostic marker in ovarian cancer	ONCOGENE			English	Article						ovarian cancer; p53; p73; splice variants	SITE MUTATION; EXPRESSION; ISOFORMS; CARCINOMA; DELTA-NP73; GENE	Similar to p73, the tumor suppressor gene p53 is subject to alternative splicing. Besides p53 Delta E6 and p53 beta, we identified p53 zeta, p53 delta and p53 epsilon, arising from alternative splicing of exon 6 and intron 9, respectively. p53 splice variants were present in 18 of 34 ovarian cancer cell lines (52.9%) and 134 of 245 primary ovarian cancers (54.7%). p53 delta expression was associated with impaired response to primary platinum-based chemotherapy (P = 0.032). Also, p53 delta expression constituted an independent prognostic marker for recurrence-free and overall survival (hazard ratio 1.854, 95% confidence interval 1.121-3.065, P = 0.016; and hazard ratio 1.937, 95% confidence interval 1.177-3.186, P = 0.009, respectively). p53 beta expression was associated with adverse clinicopathologic markers, that is, serous and poorly differentiated cancers (P = 0.002 and P = 0.008, respectively), and correlated with worse recurrence-free survival in patients exhibiting functionally active p53 (P = 0.049). Delta N'p73 constituted the main N-terminally truncated p73 isoform and was preferentially found in ovarian cancer cell lines showing functionally active p53, supporting our hypothesis that N-terminally truncated p73 isoforms can alleviate the selection pressure for p53 mutations by the inhibition of p53 protein function. Oncogene (2010) 29, 1997-2004; doi:10.1038/onc.2009.482; published online 18 January 2010	[Holzer, B.; Schuster, E.; Zeillinger, R.] Med Univ Vienna, Dept Obstet & Gynecol, Mol Oncol Grp, A-1090 Vienna, Austria; [Hofstetter, G.; Berger, A.; Fiegl, H.; Reimer, D.; Daxenbichler, G.; Marth, C.; Zeimet, A. G.; Concin, N.] Innsbruck Med Univ, Dept Gynecol & Obstet, Innsbruck, Austria; [Slade, N.; Zoric, A.] Rudjer Boskovic Inst, Dept Mol Med, Mol Oncol Lab, Zagreb, Croatia; [Mobus, V. J.] Staedt Kliniken, Dept Obstet & Gynecol, Frankfurt, Germany; [Zeillinger, R.] Ludwig Boltzmann Gesell, Cluster Translat Oncol, Vienna, Austria	Medical University of Vienna; Medical University of Innsbruck; Rudjer Boskovic Institute; Ludwig Boltzmann Institute	Zeillinger, R (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Mol Oncol Grp, Waehringer Guertel 18-20,5Q, A-1090 Vienna, Austria.	robert.zeillinger@meduniwien.ac.at	Zeillinger, Robert/AAI-6164-2020; Fiegl, Heidi/K-4445-2017	Zeillinger, Robert/0000-0001-6771-4591; Concin, Nicole/0000-0002-9795-2643; Hofstetter, Gerda/0000-0001-8912-3725; Fiegl, Heidi/0000-0002-1236-6806				Anczukow O, 2008, HUM MUTAT, V29, P65, DOI 10.1002/humu.20590; Avery-Kiejda KA, 2008, CLIN CANCER RES, V14, P1659, DOI 10.1158/1078-0432.CCR-07-1422; Boldrup L, 2007, EUR J CANCER, V43, P617, DOI 10.1016/j.ejca.2006.10.019; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Casciano I, 2002, CELL DEATH DIFFER, V9, P343, DOI 10.1038/sj.cdd.4400992; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; CHOW VTK, 1993, CANCER LETT, V73, P141, DOI 10.1016/0304-3835(93)90256-9; Concin N, 2004, CANCER RES, V64, P2449, DOI 10.1158/0008-5472.CAN-03-1060; Concin N, 2005, CLIN CANCER RES, V11, P8372, DOI 10.1158/1078-0432.CCR-05-0899; Concin N, 2003, INT J ONCOL, V22, P51; Cui Rutao, 2005, Biochem Biophys Res Commun, V336, P339; Duddy PM, 2000, J MOL DIAGN, V2, P139, DOI 10.1016/S1525-1578(10)60629-0; Ebrahimi M, 2008, ORAL ONCOL, V44, P156, DOI 10.1016/j.oraloncology.2007.01.014; Fischer DC, 2004, ONCOL REP, V11, P1085; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; Graupner V, 2009, CELL CYCLE, V8, P1238, DOI 10.4161/cc.8.8.8251; Guan M, 2005, J CLIN PATHOL, V58, P1175, DOI 10.1136/jcp.2005.026955; Holmila R, 2003, Hum Mutat, V21, P101, DOI 10.1002/humu.9104; Janicke RU, 2009, BIOL CHEM, V390, P951, DOI 10.1515/BC.2009.093; JOLLY KW, 1994, ONCOGENE, V9, P97; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Magnusson KP, 2000, GENE, V246, P247, DOI 10.1016/S0378-1119(00)00068-8; Marabese M, 2008, EUR J CANCER, V44, P131, DOI 10.1016/j.ejca.2007.10.011; MOBUS V, 1992, INT J CANCER, V52, P76, DOI 10.1002/ijc.2910520115; Oswald C, 2008, CELL CYCLE, V7, P1726, DOI 10.4161/cc.7.12.6148; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Slade N, 2004, CELL DEATH DIFFER, V11, P357, DOI 10.1038/sj.cdd.4401335; Stiewe T, 2004, CLIN CANCER RES, V10, P626, DOI 10.1158/1078-0432.CCR-0153-03; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029	31	54	56	4	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	13					1997	2004		10.1038/onc.2009.482	http://dx.doi.org/10.1038/onc.2009.482			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20101229				2022-12-25	WOS:000276199600012
J	Lam, S; Lodder, K; Teunisse, AFAS; Rabelink, MJWE; Schutte, M; Jochemsen, AG				Lam, S.; Lodder, K.; Teunisse, A. F. A. S.; Rabelink, M. J. W. E.; Schutte, M.; Jochemsen, A. G.			Role of Mdm4 in drug sensitivity of breast cancer cells	ONCOGENE			English	Article						Mdm4; p53; cancer; Nutlin; doxorubicin	P53 ACTIVATION; TUMOR-CELLS; POLY(ADP-RIBOSE) POLYMERASE; P53-BINDING PROTEIN; MALIGNANT GLIOMAS; DNA-DAMAGE; HDMX; AMPLIFICATION; INHIBITION; EXPRESSION	The p53 tumor suppressor protein is frequently mutated in human tumors. It is thought that the p53 pathway is indirectly impaired in the remaining tumors, for example by overexpression of its important regulators Mdm2 and Mdm4, making them attractive targets for the development of anti-cancer agents. Recent studies have suggested that Mdm4 levels determine the sensitivity of tumor cells for anti-cancer therapy. To investigate this possibility, we studied the drug sensitivity of several breast cancer cell lines containing wild-type p53, but expressing different Mdm4 levels. We show that endogenous Mdm4 levels can affect the sensitivity of breast cancer cells to anti-cancer agents, but in a cell line-dependent manner and depending on an intact apoptotic response. Furthermore, treatment with the non-genotoxic agent Nutlin-3 sensitizes cells for doxorubicin, showing that activation of p53 by targeting its regulators is an efficient strategy to decrease cell viability of breast cancer cells. These results confirm a function of Mdm4 in determining the efficacy of chemotherapeutic agents to induce apoptosis of cancer cells in a p53-dependent manner, although additional undetermined factors also influence the drug response. Targeting Mdm4 to sensitize tumor cells for chemotherapeutic drugs might be a strategy to effectively treat tumors harboring wild-type p53. Oncogene (2010) 29, 2415-2426; doi:10.1038/onc.2009.522; published online 8 February 2010	[Lam, S.; Lodder, K.; Teunisse, A. F. A. S.; Rabelink, M. J. W. E.; Jochemsen, A. G.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Schutte, M.] Erasmus Univ, Dept Med Oncol, Josephine Nefkens Inst, Med Ctr, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Jochemsen, AG (corresponding author), Leiden Univ, Dept Mol Cell Biol, Med Ctr, POB 9600,Postal Zone S1-P, NL-2300 RC Leiden, Netherlands.	A.G.Jochemsen@lumc.nl		Rabelink, Martijn/0000-0002-3274-7825	Association for International Cancer [05-273]; EC [503576]	Association for International Cancer; EC(European CommissionEuropean Commission Joint Research Centre)	We thank Dr G Selivanova for providing RITA, Dr A Levine and Dr G Peters for providing anti-Mdm2 and anti-p16 antibodies, respectively. This study was supported by grants from the Association for International Cancer Research (grant 05-273) and by EC FP6 funding (contract 503576) to AG Jochemsen. This publication reflects the authors' views and not necessarily those of the European Community. The EC is not liable for any use that may be made of the information contained.	Barbieri E, 2006, MOL CANCER THER, V5, P2358, DOI 10.1158/1535-7163.MCT-06-0305; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cao C, 2006, MOL CANCER THER, V5, P411, DOI 10.1158/1535-7163.MCT-05-0356; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLESTELLE A, 2009, BREAST CANC IN PRESS; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kitagawa M, 2008, ONCOGENE, V27, P5303, DOI 10.1038/onc.2008.164; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Ramos YFM, 2001, CANCER RES, V61, P1839; Riemenschneider MJ, 2003, INT J CANCER, V104, P752, DOI 10.1002/ijc.11023; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shapiro CL, 2001, NEW ENGL J MED, V344, P1997, DOI 10.1056/NEJM200106283442607; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Stad R, 2000, J BIOL CHEM, V275, P28039; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2008, CELL CYCLE, V7, P1973, DOI 10.4161/cc.7.13.6072; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Wasielewski M, 2006, BREAST CANCER RES TR, V99, P97, DOI 10.1007/s10549-006-9186-z	42	42	42	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	16					2415	2426		10.1038/onc.2009.522	http://dx.doi.org/10.1038/onc.2009.522			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20140020				2022-12-25	WOS:000276951500010
J	Thalappilly, S; Soubeyran, P; Iovanna, JL; Dusetti, NJ				Thalappilly, S.; Soubeyran, P.; Iovanna, J. L.; Dusetti, N. J.			VAV2 regulates epidermal growth factor receptor endocytosis and degradation	ONCOGENE			English	Article						VAV2; EGFR; endosome; receptor internalization	NUCLEOTIDE EXCHANGE FACTOR; EGF RECEPTOR; C-CBL; PANCREATIC-CANCER; TRAFFICKING; ACTIVATION; PROTEIN; RAC1; FAMILY; CDC42	Vav proteins are guanine nucleotide exchange factors for Rho GTPases that regulate cell adhesion, motility, spreading and proliferation in response to growth factor signalling. In this work, we show that Vav2 expression delayed epidermal growth factor receptor (EGFR) internalization and degradation, and enhanced EGFR, ERK and Akt phosphorylations. This effect of Vav2 on EGFR degradation is dependent on its guanine nucleotide exchange function. Knockdown of Vav2 in HeLa cells enhanced EGFR degradation and reduced cell proliferation. epidermal growth factor stimulation led to colocalization of Vav2 with EGFR and Rab5 in endosomes. We further show that the effect of Vav2 on EGFR stability is modulated by its interaction with two endosome-associated proteins and require RhoA function. Thus, in this work, we report for the first time that Vav2 can regulate growth factors receptor signalling by slowing receptor internalization and degradation through its interaction with endosome-associated proteins. Oncogene (2010) 29, 2528-2539; doi:10.1038/onc.2010.1; published online 8 February 2010	[Thalappilly, S.; Soubeyran, P.; Iovanna, J. L.; Dusetti, N. J.] INSERM, U624, F-13288 Marseille, France; [Thalappilly, S.; Soubeyran, P.; Iovanna, J. L.; Dusetti, N. J.] Aix Marseille Univ, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Dusetti, NJ (corresponding author), INSERM, U624, Parc Sci Luminy,Case 915, F-13288 Marseille, France.	nelson.dusetti@inserm.fr	Iovanna, Juan/M-9805-2017; Soubeyran, Philippe/P-1758-2018; Dusetti, Nelson/O-7919-2017	Iovanna, Juan/0000-0003-1822-2237; Dusetti, Nelson/0000-0002-6161-8483; Thalappilly, Subhash/0000-0003-1766-3057; Soubeyran, Philippe/0000-0002-5876-3217	INSERM; Ligue Contre le Cancer; ARC (Association pour la Recherche sur le Cancer)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Contre le Cancer(Ligue nationale contre le cancer); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer)	We gratefully acknowledge M Seux for help throughout the work and P Spotto for technical help. Dr Alan Saltiel (University of Michigan, Ann Arbor, MI, USA) kindly provided Gapvd1 constructs and Dr Laszlo Buday (Semmelweis University, Budapest, Hungary) Vav2-GFP plasmids. This work was supported in part by INSERM and grants from the Ligue Contre le Cancer. ST was supported by a postdoctoral fellowship from ARC (Association pour la Recherche sur le Cancer).	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; BUSTELO XR, 1994, ONCOGENE, V9, P2405; Bustelo XR, 2002, FRONT BIOSCI, V7, pD24, DOI 10.2741/bustelo; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Ceresa BP, 2006, HISTOL HISTOPATHOL, V21, P987, DOI 10.14670/HH-21.987; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; de Melker AA, 2001, J CELL SCI, V114, P2167; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Doody GM, 2000, EMBO J, V19, P6173, DOI 10.1093/emboj/19.22.6173; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Franco M, 2006, MOL CELL BIOL, V26, P1932, DOI 10.1128/MCB.26.5.1932-1947.2006; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Goel S, 2007, J EXP THER ONCOL, V6, P305; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Houlard M, 2002, J EXP MED, V195, P1115, DOI 10.1084/jem.20011701; Hunker CM, 2006, BIOCHEM BIOPH RES CO, V340, P967, DOI 10.1016/j.bbrc.2005.12.099; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Patel V, 2007, CARCINOGENESIS, V28, P1145, DOI 10.1093/carcin/bgm008; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Puertollano R, 2005, J BIOL CHEM, V280, P9258, DOI 10.1074/jbc.M412481200; Romero F, 1996, CELL SIGNAL, V8, P545, DOI 10.1016/S0898-6568(96)00118-0; Schuebel KE, 1996, ONCOGENE, V13, P363; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Seye CI, 2004, J BIOL CHEM, V279, P35679, DOI 10.1074/jbc.M401799200; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stuffers S, 2009, EXP CELL RES, V315, P1619, DOI 10.1016/j.yexcr.2008.10.013; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tamas P, 2001, CELL SIGNAL, V13, P475, DOI 10.1016/S0898-6568(01)00172-3; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Ung CY, 2008, FEBS LETT, V582, P2283, DOI 10.1016/j.febslet.2008.05.026; Wadsworth P, 2005, CURR BIOL, V15, pR871, DOI 10.1016/j.cub.2005.10.021; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yamazaki T, 2002, J CELL SCI, V115, P1791; Yanagida-Ishizaki Y, 2008, CELL STRUCT FUNCT, V33, P91, DOI 10.1247/csf.07037; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000	57	33	34	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	17					2528	2539		10.1038/onc.2010.1	http://dx.doi.org/10.1038/onc.2010.1			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20140013				2022-12-25	WOS:000277169400008
J	Chang, YW; Chuang, YC; Ho, YC; Cheng, MY; Sun, YJ; Hsiao, CD; Wang, C				Chang, Yi-Wei; Chuang, Yi-Chien; Ho, Yu-Chi; Cheng, Ming-Yuan; Sun, Yuh-Ju; Hsiao, Chwan-Deng; Wang, Chung			Crystal Structure of Get4-Get5 Complex and Its Interactions with Sgt2, Get3, and Ydj1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; DATA QUALITY; YEAST; IDENTIFICATION; ACTIVATOR; DENSITY; GENES; HSP70	Get3, Get4, and Get5 in Saccharomyces cerevisiae participate in the insertion of tail-anchored proteins into the endoplasmic reticulum membrane. We elucidated the interaction between Get4 and Get5 and investigated their interaction with Get3 and a tetratricopeptide repeat-containing protein, Sgt2. Based on co-immunoprecipitation and crystallographic studies, Get4 and Get5 formed a tight complex, suggesting that they constitute subunits of a larger complex. In contrast, although Get3 interacted physically with the Get4-Get5 complex, low amounts of Get3 co-precipitated with Get5, implying a transient interaction between Get3 and Get4-Get5. Sgt2 also interacted with Get5, although the amount of Sgt2 that co-precipitated with Get5 varied. Moreover, GET3, GET4, and GET5 interacted genetically with molecular chaperone YDJ1, suggesting that chaperones might also be involved in the insertion of tail-anchored proteins.	[Chang, Yi-Wei; Chuang, Yi-Chien; Ho, Yu-Chi; Hsiao, Chwan-Deng; Wang, Chung] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Chang, Yi-Wei; Sun, Yuh-Ju] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 300, Taiwan; [Cheng, Ming-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Yang Ming Chiao Tung University	Hsiao, CD (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	hsiao@gate.sinica.edu.tw; mbcw@gate.sinica.edu.tw	Chang, Yi-Wei/ABH-1418-2020; Hsiao, Chwan-Deng/D-7327-2013; Hsiao, Chwan-Deng/AAZ-8869-2021	Chang, Yi-Wei/0000-0003-2391-473X; Hsiao, Chwan-Deng/0000-0002-7012-1532	National Science Council [NSC96-2311-B-001-035-MY3, NSC-95-2311-B-001-064]; Academia Sinica Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica Taiwan, ROC(Academia Sinica - Taiwan)	This work was supported by National Science Council Grants NSC96-2311-B-001-035-MY3 (to C. W.) and NSC-95-2311-B-001-064 (to C.-D.H.) and grants from the Academia Sinica Taiwan, ROC.	Amberg DC., 2005, METHODS YEAST GENETI; Becker J, 1996, MOL CELL BIOL, V16, P4378; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandes JMO, 2008, GENOMICS, V91, P315, DOI 10.1016/j.ygeno.2007.10.017; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hainzl O, 2004, J BIOL CHEM, V279, P23267, DOI 10.1074/jbc.M402189200; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hu Z, 2006, J CELL SCI, V119, P326, DOI 10.1242/jcs.02754; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kordes E, 1998, GENOMICS, V52, P90, DOI 10.1006/geno.1998.5385; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	34	65	67	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9962	9970		10.1074/jbc.M109.087098	http://dx.doi.org/10.1074/jbc.M109.087098			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106980	Green Published, hybrid			2022-12-25	WOS:000276165900065
J	He, JZ; Ho, JJD; Gingerich, S; Courtman, DW; Marsden, PA; Ward, ME				He, Jeff Z.; Ho, J. J. David; Gingerich, Sheena; Courtman, David W.; Marsden, Philip A.; Ward, Michael E.			Enhanced Translation of Heme Oxygenase-2 Preserves Human Endothelial Cell Viability during Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PROLONGED HYPOXIA; OXIDATIVE STRESS; GENE-EXPRESSION; CARBON-MONOXIDE; RAT-BRAIN; APOPTOSIS; HO-2; MECHANISMS; MUSCLE	Heme oxygenases (HOs) -1 and -2 catalyze the breakdown of heme to release carbon monoxide, biliverdin, and ferrous iron, which may preserve cell function during oxidative stress. HO-1 levels decrease in endothelial cells exposed to hypoxia, whereas the effect of hypoxia on HO-2 expression is unknown. The current study was carried out to determine if hypoxia alters HO-2 protein levels in human endothelial cells and whether this enzyme plays a role in preserving their viability during hypoxic stress. Human umbilical vein endothelial cells (HUVECs), human aortic endothelial cells (HAECs), and human blood outgrowth endothelial cells were exposed to 21% or 1% O-2 for 48 or 16 h in the presence or absence of tumor necrosis factor-alpha (10 ng/ml) or H2O2 (100 mu M). In all three endothelial cell types HO-1 mRNA and protein levels were decreased following hypoxic incubation, whereas HO-2 protein levels were unaltered. In HUVECs HO-2 levels were maintained during hypoxia despite a 57% reduction in steady-state HO-2 mRNA level and a 43% reduction in total protein synthesis. Polysome profiling revealed increased HO-2 transcript association with polysomes during hypoxia consistent with enhanced translation of these transcripts. Importantly, inhibition of HO-2 expression by small interference RNA increased oxidative stress, exacerbated mitochondrial membrane depolarization, and enhanced caspase activation and apoptotic cell death in cells incubated under hypoxic but not normoxic conditions. These data indicate that HO-2 is important in maintaining endothelial viability and may preserve local regulation of vascular tone, thrombosis, and inflammatory responses during reductions in systemic oxygen delivery.	[Marsden, Philip A.] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON M5S 1A8, Canada; [He, Jeff Z.; Courtman, David W.; Ward, Michael E.] St Michaels Hosp, Terrence Donnelly Labs, Toronto, ON M5B 1W8, Canada; [He, Jeff Z.; Courtman, David W.; Marsden, Philip A.; Ward, Michael E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [He, Jeff Z.; Ward, Michael E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Ho, J. J. David] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Ward, Michael E.] Univ Toronto, Dept Med, Div Respirol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Marsden, PA (corresponding author), Univ Toronto, Dept Med, Div Nephrol, Rm 7358,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	p.marsden@utoronto.ca	Marsden, Philip A/B-1441-2012		Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation [T-5834]; Peterborough K. M. Hunter Graduate Studentship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Peterborough K. M. Hunter Graduate Studentship	This work was supported in part by the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation (Grant T-5834).; Recipient of a Peterborough K. M. Hunter Graduate Studentship.; Recipient of a CIHR Molecular Collaborative Graduate Training Studentship.	Adachi T, 2004, BIOCHEM BIOPH RES CO, V320, P514, DOI 10.1016/j.bbrc.2004.05.195; Auer G, 1998, J APPL PHYSIOL, V85, P411, DOI 10.1152/jappl.1998.85.2.411; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; Bitzan MM, 1998, J CLIN INVEST, V101, P372, DOI 10.1172/JCI522; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Chen J, 2004, BIOCHEM BIOPH RES CO, V318, P88, DOI 10.1016/j.bbrc.2004.03.187; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Dennery PA, 2003, FREE RADICAL BIO MED, V34, P124, DOI 10.1016/S0891-5849(02)01295-9; Dennery PA, 1998, J CLIN INVEST, V101, P1001, DOI 10.1172/JCI448; Di Filippo C, 2006, CARDIOVASC DRUG REV, V24, P77; EWING JF, 1995, ENDOCRINOLOGY, V136, P2294, DOI 10.1210/en.136.5.2294; Fish JE, 2007, J BIOL CHEM, V282, P15652, DOI 10.1074/jbc.M608318200; Foltz WD, 2008, BIOMATERIALS, V29, P1844, DOI 10.1016/j.biomaterials.2007.12.012; Goodman AI, 2006, J AM SOC NEPHROL, V17, P1073, DOI 10.1681/ASN.2004121082; Govindaraju V, 2005, AM J PHYSIOL-HEART C, V288, pH962, DOI 10.1152/ajpheart.01218.2003; Hartsfield C, 1999, AM J PHYSIOL-LUNG C, V277, pL1133, DOI 10.1152/ajplung.1999.277.6.L1133; Kim JY, 2003, FEBS LETT, V549, P94, DOI 10.1016/S0014-5793(03)00795-6; Kim YM, 2008, BMB REP, V41, P164, DOI 10.5483/BMBRep.2008.41.2.164; Kim YS, 2005, FREE RADICAL BIO MED, V38, P85, DOI 10.1016/j.freeradbiomed.2004.09.031; Kim YS, 2005, FREE RADICAL BIO MED, V39, P558, DOI 10.1016/j.freeradbiomed.2005.04.009; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; MCCOUBREY WK, 1992, ARCH BIOCHEM BIOPHYS, V295, P13, DOI 10.1016/0003-9861(92)90481-B; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; MCCOUBREY WK, 1995, BIOL REPROD, V53, P1330, DOI 10.1095/biolreprod53.6.1330; MORITA T, 1995, P NATL ACAD SCI USA, V92, P1475, DOI 10.1073/pnas.92.5.1475; Motterlini R, 2000, J BIOL CHEM, V275, P13613, DOI 10.1074/jbc.275.18.13613; Nakayama M, 2000, BIOCHEM BIOPH RES CO, V271, P665, DOI 10.1006/bbrc.2000.2683; Newby D, 2005, PLACENTA, V26, P201, DOI 10.1016/j.placenta.2004.05.002; Panchenko MV, 2000, AM J PHYSIOL-CELL PH, V278, pC92, DOI 10.1152/ajpcell.2000.278.1.C92; Parfenova H, 2006, AM J PHYSIOL-CELL PH, V290, pC1399, DOI 10.1152/ajpcell.00386.2005; Park EH, 2005, J BIOL CHEM, V280, P20945, DOI 10.1074/jbc.M412744200; Raju VS, 1997, BBA-GENE STRUCT EXPR, V1351, P89, DOI 10.1016/S0167-4781(96)00183-2; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Stempien-Otero A, 1999, J BIOL CHEM, V274, P8039, DOI 10.1074/jbc.274.12.8039; SUN Y, 1990, J BIOL CHEM, V265, P8212; Ward ME, 2005, J CLIN INVEST, V115, P3128, DOI 10.1172/JCI20806; Ward ME, 1999, J APPL PHYSIOL, V86, P1644, DOI 10.1152/jappl.1999.86.5.1644; Yang ZZ, 2001, AM J PHYSIOL-RENAL, V281, pF900, DOI 10.1152/ajprenal.2001.281.5.F900; Zacour ME, 1998, PULM PHARMACOL THER, V11, P197, DOI 10.1006/pupt.1998.0137; Zapelini PH, 2008, MITOCHONDRION, V8, P211, DOI 10.1016/j.mito.2008.03.002; Zhang YZ, 2006, FEBS J, V273, P3136, DOI 10.1111/j.1742-4658.2006.05319.x	45	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9452	9461		10.1074/jbc.M109.077230	http://dx.doi.org/10.1074/jbc.M109.077230			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118244	Green Published, hybrid			2022-12-25	WOS:000276165900018
J	Ryckman, KK; Morken, NH; White, MJ; Velez, DR; Menon, R; Fortunato, SJ; Magnus, P; Williams, SM; Jacobsson, B				Ryckman, Kelli K.; Morken, Nils-Halvdan; White, Marquitta J.; Velez, Digna R.; Menon, Ramkumar; Fortunato, Stephen J.; Magnus, Per; Williams, Scott M.; Jacobsson, Bo			Maternal and Fetal Genetic Associations of PTGER3 and PON1 with Preterm Birth	PLOS ONE			English	Article							NORWEGIAN MOTHER; GESTATIONAL-AGE; CHILD COHORT; WEIGHT; RISK; PATTERNS; ALPHA	Objective: The purpose of this study was to identify associations between maternal and fetal genetic variants in candidate genes and spontaneous preterm birth (PTB) in a Norwegian population and to determine the effect size of those associations that corroborate a previous study of PTB. Methods: DNA from 434 mother-baby dyads (214 cases and 220 controls) collected from the Norwegian Mother and Child Cohort (MoBa) was examined for association between 1,430 single nucleotide polymorphisms in 143 genes and PTB. These results were compared to a previous study on European Americans (EA) from Centennial Women's Hospital in Nashville, TN, USA. Odds ratios for SNPs that corroborated the Cenntennial study were determined on the combined MoBa and Centennial studies. Results: In maternal samples the strongest results that corroborated the Centennial study were in the prostaglandin E receptor 3 gene (PTGER3; rs977214) (combined genotype p = 3x10(-4)). The best model for rs977214 was the AG/GG genotypes relative to the AA genotype and resulted in an OR of 0.55 (95% CI = 0.37-0.82, p = 0.003), indicating a protective effect. In fetal samples the most significant association in the combined data was rs854552 in the paraoxonase 1 gene (PON1) (combined allele p = 8x10(-4)). The best model was the TT genotype relative to the CC/CT genotypes, and resulted in an OR of 1.32 (95% CI = 1.13-1.53, p = 4x10(-4)). Conclusions: These studies identify single locus associations with preterm birth for both maternal and fetal genotypes in two populations of European ancestry.	[Ryckman, Kelli K.; White, Marquitta J.; Williams, Scott M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ryckman, Kelli K.; White, Marquitta J.; Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Morken, Nils-Halvdan] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Morken, Nils-Halvdan; Magnus, Per] Norwegian Inst Publ Hlth, Oslo, Norway; [Velez, Digna R.] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Velez, Digna R.] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33136 USA; [Menon, Ramkumar; Fortunato, Stephen J.] Perinatal Res Ctr, Nashville, TN USA; [Menon, Ramkumar; Fortunato, Stephen J.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Jacobsson, Bo] Univ Oslo, Rikshosp, Dept Obstet & Gynecol, N-0027 Oslo, Norway; [Jacobsson, Bo] Sahlgrens Acad, Inst Clin Sci, Dept Obstet & Gynecol, Perinatal Ctr, Gothenburg, Sweden	Vanderbilt University; Vanderbilt University; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH); University of Miami; University of Miami; Emory University; University of Oslo; National Hospital Norway; University of Gothenburg	Ryckman, KK (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	smwilliams@chgr.mc.vanderbilt.edu	Velez Edwards, Digna/C-1090-2012; Williams, Scott/Q-4812-2019; Fortunato, Stephen J/L-7545-2013; Williams, Scott/B-9491-2012; Jacobsson, Bo/O-8007-2014	Williams, Scott/0000-0002-4835-9544; Jacobsson, Bo/0000-0001-5079-2374; Ryckman, Kelli/0000-0002-9496-4147	Norwegian Research Council [FRIMEDKLI-05 ES236011]; Norwegian Research Council FUGE -Functional Genomics at Norwegian Research Counsile [183220/S10]; Telemark Hospital Research Foundation; Southern Health Region in Norway [ALFGBG-5173, ALFGBG-11522]; Norwegian Ministry of Health, NIH/NIEHS [N01-ES-85433]; NIH/NINDS [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [N01ES085433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Research Council FUGE -Functional Genomics at Norwegian Research Counsile; Telemark Hospital Research Foundation; Southern Health Region in Norway; Norwegian Ministry of Health, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the Norwegian Research Council (FRIMEDKLI-05 ES236011), Norwegian Research Council FUGE -Functional Genomics at Norwegian Research Counsile (183220/S10), Telemark Hospital Research Foundation, The Southern Health Region in Norway, Swedish government grants to researchers in public health service (ALFGBG-5173 and ALFGBG-11522). The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health, NIH/NIEHS (grant no N01-ES-85433), NIH/NINDS (grant no. 1 UO1 NS 047537-01), and the Norwegian Research Council/FUGE (grant no. 151918/S10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKETEIG LS, 1979, AM J OBSTET GYNECOL, V135, P1086, DOI 10.1016/0002-9378(79)90742-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basso O, 1999, INT J EPIDEMIOL, V28, P695, DOI 10.1093/ije/28.4.695; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CARRHILL RA, 1985, BRIT J OBSTET GYNAEC, V92, P921, DOI 10.1111/j.1471-0528.1985.tb03071.x; Chang CJ, 2009, BIOCHEM BIOPH RES CO, V385, P241, DOI 10.1016/j.bbrc.2009.05.049; Chen DF, 2004, EPIDEMIOLOGY, V15, P466, DOI 10.1097/01.ede.0000129509.59912.b2; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Girling J, 1998, CURR OPIN OBSTET GYN, V10, P135, DOI 10.1097/00001703-199804000-00010; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Koga S, 1991, ANN NY ACAD SCI, V622, P315; Koo BH, 2009, J BIOL CHEM, V284, P23375, DOI 10.1074/jbc.M109.036848; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lockwood CJ, 2001, PAEDIATR PERINAT EP, V15, P78, DOI 10.1046/j.1365-3016.2001.00010.x; MACDORMAN M, 2008, TRENDS PRETERM RELAT; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Menon R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.071; Menon R, 2007, REPROD SCI, V14, P253, DOI 10.1177/1933719107301336; Menon R, 2006, J SOC GYNECOL INVEST, V13, P531, DOI 10.1016/j.jsgi.2006.09.006; Menon R, 2006, AM J OBSTET GYNECOL, V195, P1240, DOI 10.1016/j.ajog.2006.05.037; Menon R, 2006, HUM HERED, V62, P107, DOI 10.1159/000096301; MITCHELL MD, 1990, PROSTAG LEUKOTR ESS, V41, P35, DOI 10.1016/0952-3278(90)90128-8; Morken NH, 2005, ACTA OBSTET GYN SCAN, V84, P558, DOI 10.1111/j.0001-6349.2005.00765.x; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Orbe J, 2009, ARTERIOSCL THROM VAS, V29, P2109, DOI 10.1161/ATVBAHA.109.194589; Pennell CE, 2007, AM J OBSTET GYNECOL, V196, P107, DOI 10.1016/j.ajog.2006.03.109; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Ryckman KK, 2008, GENET EPIDEMIOL, V32, P600, DOI 10.1002/gepi.20342; Stephenson CD, 2005, J MATERN-FETAL NEO M, V18, P17, DOI 10.1080/14767050500123632; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Varner MW, 2005, BJOG-INT J OBSTET GY, V112, P28, DOI 10.1111/j.1471-0528.2005.00581.x; Velez DR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003283; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; 2006, PRETERM BIRTH CAUSES	43	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9040	10.1371/journal.pone.0009040	http://dx.doi.org/10.1371/journal.pone.0009040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140262	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474200022
J	Ghosh, Z; Wilson, KD; Wu, Y; Hu, SJ; Quertermous, T; Wu, JC				Ghosh, Zhumur; Wilson, Kitchener D.; Wu, Yi; Hu, Shijun; Quertermous, Thomas; Wu, Joseph C.			Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells	PLOS ONE			English	Article							ADIPOSE-TISSUE; HUMAN FIBROBLASTS; GENERATION; ADIPOCYTES; DERIVATION; REJECTION; PROFILES; THERAPY; DISPLAY; MEMORY	Human induced pluripotent stem cells (hiPSCs) generated by de-differentiation of adult somatic cells offer potential solutions for the ethical issues surrounding human embryonic stem cells (hESCs), as well as their immunologic rejection after cellular transplantation. However, although hiPSCs have been described as "embryonic stem cell-like'', these cells have a distinct gene expression pattern compared to hESCs, making incomplete reprogramming a potential pitfall. It is unclear to what degree the difference in tissue of origin may contribute to these gene expression differences. To answer these important questions, a careful transcriptional profiling analysis is necessary to investigate the exact reprogramming state of hiPSCs, as well as analysis of the impression, if any, of the tissue of origin on the resulting hiPSCs. In this study, we compare the gene profiles of hiPSCs derived from fetal fibroblasts, neonatal fibroblasts, adipose stem cells, and keratinocytes to their corresponding donor cells and hESCs. Our analysis elucidates the overall degree of reprogramming within each hiPSC line, as well as the "distance'' between each hiPSC line and its donor cell. We further identify genes that have a similar mode of regulation in hiPSCs and their corresponding donor cells compared to hESCs, allowing us to specify core sets of donor genes that continue to be expressed in each hiPSC line. We report that residual gene expression of the donor cell type contributes significantly to the differences among hiPSCs and hESCs, and adds to the incompleteness in reprogramming. Specifically, our analysis reveals that fetal fibroblast-derived hiPSCs are closer to hESCs, followed by adipose, neonatal fibroblast, and keratinocyte-derived hiPSCs.	[Ghosh, Zhumur; Wilson, Kitchener D.; Wu, Yi; Hu, Shijun; Quertermous, Thomas; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Ghosh, Zhumur; Wilson, Kitchener D.; Hu, Shijun; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Wilson, Kitchener D.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Ghosh, Z (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	joewu@stanford.edu	Hu, Shijun/I-5818-2012; Wilson, Kitchener/A-7146-2016; Wu, Joseph/H-1067-2013	Ghosh, Zhumur/0000-0002-4877-7551; Wu, Joseph/0000-0002-6068-8041; Quertermous, Thomas/0000-0002-7645-9067; Hu, Shijun/0000-0002-0068-8429	Edward Mallinckrodt Foundation; NIH [R01AI085575, DP2OD004437]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL065585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085575] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	Edward Mallinckrodt Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank funding support from Edward Mallinckrodt Foundation, AHA Innovative Research Grant, NIH R01AI085575, and NIH DP2OD004437 (JCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gazel A, 2003, J INVEST DERMATOL, V121, P1459, DOI 10.1111/j.1523-1747.2003.12611.x; Gibbons FD, 2002, GENOME RES, V12, P1574, DOI 10.1101/gr.397002; Gosiewska A, 2001, WOUND REPAIR REGEN, V9, P213, DOI 10.1046/j.1524-475x.2001.00213.x; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sipp D, 2009, CELL STEM CELL, V5, P360, DOI 10.1016/j.stem.2009.09.005; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Stojkovic M, 2004, REPRODUCTION, V128, P259, DOI 10.1530/rep.1.00243; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; SUN NLM, 2010, CELL CYCLE IN PRESS; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Swijnenburg RJ, 2008, STEM CELLS DEV, V17, P1023, DOI 10.1089/scd.2008.0091; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Waddington C H, 1957, STRATEGY GENES DISCU; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yih LH, 2002, CARCINOGENESIS, V23, P867, DOI 10.1093/carcin/23.5.867; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	47	214	225	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8975	10.1371/journal.pone.0008975	http://dx.doi.org/10.1371/journal.pone.0008975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126639	Green Published, Green Submitted, gold			2022-12-25	WOS:000274209700007
J	Nunez-Iglesias, J; Liu, CC; Morgan, TE; Finch, CE; Zhou, XJ				Nunez-Iglesias, Juan; Liu, Chun-Chi; Morgan, Todd E.; Finch, Caleb E.; Zhou, Xianghong Jasmine			Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA Regulation	PLOS ONE			English	Article							MICRORNA; MICROARRAY; IDENTIFICATION; OLIGOMERS; NETWORKS; MIRBASE; TARGETS; GENES; BRAIN	Although microRNAs are being extensively studied for their involvement in cancer and development, little is known about their roles in Alzheimer's disease (AD). In this study, we used microarrays for the first joint profiling and analysis of miRNAs and mRNAs expression in brain cortex from AD and age-matched control subjects. These data provided the unique opportunity to study the relationship between miRNA and mRNA expression in normal and AD brains. Using a non-parametric analysis, we showed that the levels of many miRNAs can be either positively or negatively correlated with those of their target mRNAs. Comparative analysis with independent cancer datasets showed that such miRNA-mRNA expression correlations are not static, but rather context-dependent. Subsequently, we identified a large set of miRNA-mRNA associations that are changed in AD versus control, highlighting AD-specific changes in the miRNA regulatory system. Our results demonstrate a robust relationship between the levels of miRNAs and those of their targets in the brain. This has implications in the study of the molecular pathology of AD, as well as miRNA biology in general.	[Nunez-Iglesias, Juan; Liu, Chun-Chi; Zhou, Xianghong Jasmine] Univ So Calif, Los Angeles, CA 90089 USA; [Morgan, Todd E.; Finch, Caleb E.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA	University of Southern California; University of Southern California	Nunez-Iglesias, J (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	cefinch@usc.edu; xjzhou@usc.edu	Finch, Caleb/AAA-7250-2022	Nunez-Iglesias, Juan/0000-0002-7239-5828	National Institutes of Health [R01GM074163, P50HG002790, U54CA112952]; National Science Foundation [0515936, 0747475]; NATIONAL CANCER INSTITUTE [U54CA112952] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants [R01GM074163, P50HG002790, U54CA112952], and National Science Foundation grants [0515936, 0747475]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffen TD, 2004, J INDO-EUR STUD, V32, P11; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lonnstedt I, 2002, STAT SINICA, V12, P31; LU Y, 2007, NUCL ACIDS RES; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218	39	266	280	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8898	10.1371/journal.pone.0008898	http://dx.doi.org/10.1371/journal.pone.0008898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126538	Green Published, gold, Green Submitted			2022-12-25	WOS:000274209700001
J	Shah, S; Sanford, UR; Vargas, JC; Xu, HM; Groen, A; Paulusma, CC; Grenert, JP; Pawlikowska, L; Sen, S; Elferink, RPJO; Bull, LN				Shah, Sohela; Sanford, Ukina R.; Vargas, Julie C.; Xu, Hongmei; Groen, Annamiek; Paulusma, Coen C.; Grenert, James P.; Pawlikowska, Ludmila; Sen, Saunak; Elferink, Ronald P. J. Oude; Bull, Laura N.			Strain Background Modifies Phenotypes in the ATP8B1-Deficient Mouse	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; HEREDITARY CHOLESTASIS; CANALICULAR MEMBRANE; BILE-SALTS; MICE; LIPOPROTEIN; DISEASE; PROTEIN; GENE; DEFICIENCY	Background: Mutations in ATP8B1 (FIC1) underlie cases of cholestatic disease, ranging from chronic and progressive (progressive familial intrahepatic cholestasis) to intermittent (benign recurrent intrahepatic cholestasis). The ATP8B1-deficient mouse serves as an animal model of human ATP8B1 deficiency. Methodology/Principal Findings: We investigated the effect of genetic background on phenotypes of ATP8B1-deficient and wild-type mice, using C57Bl/6 (B6), 129, and (B6-129) F1 strain backgrounds. B6 background resulted in greater abnormalities in ATP8B1-deficient mice than did 129 and/or F1 background. ATP8B1-deficient pups of B6 background gained less weight. In adult ATP8B1-deficient mice at baseline, those of B6 background had lower serum cholesterol levels, higher serum alkaline phosphatase levels, and larger livers. After challenge with cholate-supplemented diet, these mice exhibited higher serum alkaline phosphatase and bilirubin levels, greater weight loss and larger livers. ATP8B1-deficient phenotypes in mice of F1 and 129 backgrounds are usually similar, suggesting that susceptibility to manifestations of ATP8B1 deficiency may be recessive. We also detected differences in hepatobiliary phenotypes between wild-type mice of differing strains. Conclusions/Significance: Our results indicate that the ATP8B1-deficient mouse in a B6 background may be a better model of human ATP8B1 deficiency and highlight the importance of informed background strain selection for mouse models of liver disease.	[Shah, Sohela; Sanford, Ukina R.; Vargas, Julie C.; Xu, Hongmei; Grenert, James P.; Sen, Saunak; Bull, Laura N.] Univ Calif San Francisco, UCSF Liver Ctr, San Francisco, CA 94143 USA; [Shah, Sohela; Sanford, Ukina R.; Vargas, Julie C.; Xu, Hongmei; Bull, Laura N.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Groen, Annamiek; Paulusma, Coen C.; Elferink, Ronald P. J. Oude] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Grenert, James P.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Pawlikowska, Ludmila] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Pawlikowska, Ludmila; Bull, Laura N.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Sen, Saunak] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shah, S (corresponding author), Univ Calif San Francisco, UCSF Liver Ctr, San Francisco, CA 94143 USA.	lbull@medsfgh.ucsf.edu	Shah, Sohela/B-3137-2013; xu, hong/GSD-8903-2022; Paulusma, Coen/AAR-7943-2021	Paulusma, Coen/0000-0001-7284-1974	U.S. National Institutes of Health [R01 DK50697, R01 GM078338, R01 DK072187]; NIH [P30 DK026743]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072187, R01DK050697, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078338] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants from the U.S. National Institutes of Health: R01 DK50697 to L. N. Bull, R01 GM078338 to S. Sen, and R01 DK072187 to S. Erickson, and the UCSF Liver Center (NIH P30 DK026743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cai SY, 2009, GASTROENTEROLOGY, V136, P1060, DOI 10.1053/j.gastro.2008.10.025; Claudel T, 2002, J CLIN INVEST, V109, P961; CLAYTON RJ, 1969, AM J DIS CHILD, V117, P112, DOI 10.1001/archpedi.1969.02100030114014; COX DR, 2000, THEORY DESIGN EXPT; Elferink RPJO, 1998, J CLIN INVEST, V102, P1749, DOI 10.1172/JCI3597; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; GROEN AK, 1995, GASTROENTEROLOGY, V109, P1997, DOI 10.1016/0016-5085(95)90768-8; Groen A, 2008, GASTROENTEROLOGY, V134, P2091, DOI 10.1053/j.gastro.2008.02.097; Groen A, 2007, J HEPATOL, V47, P114, DOI 10.1016/j.jhep.2007.02.011; Groen A, 2006, MOL PHARMACEUT, V3, P756, DOI 10.1021/mp060009t; HAMILTON RL, 1971, SCIENCE, V172, P475, DOI 10.1126/science.172.3982.475; Kimmings N, 2001, SURGERY, V129, P282, DOI 10.1067/msy.2001.110855; Klomp LWJ, 2000, HEPATOLOGY, V32, P1337, DOI 10.1053/jhep.2000.20520; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; LINARELLI LG, 1972, J PEDIATR-US, V81, P484, DOI 10.1016/S0022-3476(72)80174-4; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Nagasaka H, 2005, J PEDIATR-US, V146, P329, DOI 10.1016/j.jpeds.2004.10.047; Nagasaka H, 2004, J PEDIATR GASTR NUTR, V39, P404, DOI 10.1097/00005176-200410000-00018; Nagasaka H, 2007, J PEDIATR GASTR NUTR, V45, P96, DOI 10.1097/MPG.0b013e3180331df9; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Paulusma CC, 2009, J BIOL CHEM, V284, P9947, DOI 10.1074/jbc.M808667200; Pawlikowska L, 2004, HUM MOL GENET, V13, P881, DOI 10.1093/hmg/ddh100; PAWLIKOWSKA L, J HEPAT IN PRESS; R Development Core Team, 2005, R LANG ENV STAT COMP; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Ujhazy P, 2001, HEPATOLOGY, V34, P768, DOI 10.1053/jhep.2001.27663	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8984	10.1371/journal.pone.0008984	http://dx.doi.org/10.1371/journal.pone.0008984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126555	gold, Green Published, Green Submitted			2022-12-25	WOS:000274209700012
J	Striegl, H; Andrade-Navarro, MA; Heinemann, U				Striegl, Harald; Andrade-Navarro, Miguel A.; Heinemann, Udo			Armadillo Motifs Involved in Vesicular Transport	PLOS ONE			English	Article							PROTEIN; P115; COMPLEX; CANCER	Armadillo (ARM) repeat proteins function in various cellular processes including vesicular transport and membrane tethering. They contain an imperfect repeating sequence motif that forms a conserved three-dimensional structure. Recently, structural and functional insight into tethering mediated by the ARM-repeat protein p115 has been provided. Here we describe the p115 ARM-motifs for reasons of clarity and nomenclature and show that both sequence and structure are highly conserved among ARM-repeat proteins. We argue that there is no need to invoke repeat types other than ARM repeats for a proper description of the structure of the p115 globular head region. Additionally, we propose to define a new subfamily of ARM-like proteins and show lack of evidence that the ARM motifs found in p115 are present in other long coiled-coil tethering factors of the golgin family.	[Striegl, Harald; Andrade-Navarro, Miguel A.; Heinemann, Udo] Max Delbruck Ctr Mol Med, Berlin, Germany; [Striegl, Harald; Heinemann, Udo] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin	Striegl, H (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	heinemann@mdc-berlin.de	Heinemann, Udo/S-3379-2016; Andrade, Miguel A/B-6565-2008; Heinemann, Udo/AAH-4766-2019	Heinemann, Udo/0000-0002-8191-3850; Andrade, Miguel A/0000-0001-6650-1711; Heinemann, Udo/0000-0002-8191-3850	Deutsche Forschungsgemeinschaft [740]; Helmholtz foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz foundation(Helmholtz Association)	work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) through SFB 740. M.A.A-N. acknowledges support from the Helmholtz foundation (www.helmholtz.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An Y, 2009, J MOL BIOL, V391, P26, DOI 10.1016/j.jmb.2009.04.062; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CHAN EKL, 1998, ELECTRON J BIOTECHN, V1, P1; Delano W. L., 2003, PYMOL MOL GENETICS G; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; HARTZFELD M, 1996, J CELL SCI, V109, P2767; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Huska MR, 2007, BIOINFORMATICS, V23, P3093, DOI 10.1093/bioinformatics/btm489; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Palidwor GA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000304; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Satoh A, 2008, TRAFFIC, V9, P1522, DOI 10.1111/j.1600-0854.2008.00783.x; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Striegl H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004656; Yamakawa H, 1996, J STRUCT BIOL, V116, P356, DOI 10.1006/jsbi.1996.0053	33	17	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8991	10.1371/journal.pone.0008991	http://dx.doi.org/10.1371/journal.pone.0008991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126549	Green Published, Green Accepted, gold			2022-12-25	WOS:000274209700017
J	Becirovic, E; Nakova, K; Hammelmann, V; Hennel, R; Biel, M; Michalakis, S				Becirovic, Elvir; Nakova, Kostadinka; Hammelmann, Verena; Hennel, Roman; Biel, Martin; Michalakis, Stylianos			The Retinitis Pigmentosa Mutation c.3444+1G > A in CNGB1 Results in Skipping of Exon 32	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; BETA-SUBUNIT	Retinitis pigmentosa (RP) is a severe hereditary eye disorder characterized by progressive degeneration of photoreceptors and subsequent loss of vision. Two of the RP associated mutations were found in the CNGB1 gene that encodes the B subunit of the rod cyclic nucleotide-gated channel (CNGB1a). One of them (c.3444+1G>A) is located at the donor site of exon 32 and has been proposed to result in a frameshift and truncation of the last 28 aa of the corresponding protein. However, this ambiguous conclusion was not verified by experimental data. Recently, another study reported that the last 28 aa of CNGB1a harbor a motif required for the proper targeting of this subunit to rod photoreceptor outer segments. This suggests that defective targeting is the major cause for the RP phenotype in affected patients. Here, we investigated the splicing of c.3444+1G>A by exon trapping experiments and could demonstrate that instead of the proposed truncation of the last 28 aa this mutation leads to replacement of the last 170 aa of CNGB1a by 68 unrelated amino acids. The 170 aa deletion covers the complete distal C-terminus including the last 10 aa of an important alpha (alpha C) helix within the ligand-binding domain of CNGB1a. When expressed in a heterologous expression system the corresponding mutant full-length CNGB1a subunit was more susceptible to proteosomal degradation compared to the wild-type counterpart. In conclusion, our experimental data do not support the hypothesis proposed by the original study on the c.3444+1G>A mutation. Based on this, we suggest that apart from the defective targeting other mechanisms may be responsible for the RP phenotype in affected individuals.	[Becirovic, Elvir] Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Munich, Germany; Univ Munich, Dept Pharm, Ctr Drug Res, Munich, Germany	University of Munich; University of Munich	Becirovic, E (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Munich, Germany.	michalakis@lmu.de	Biel, Martin/G-1175-2014; Becirovic, Elvir/GWC-9928-2022; Michalakis, Stylianos/M-4677-2019; Michalakis, Stylianos/W-2094-2018; Becirovic, Elvir/ABE-6710-2020	Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Becirovic, Elvir/0000-0001-8801-0649	Deutsche Forschungsgemeinschaft [Mi1238/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by the Deutsche Forschungsgemeinschaft (Mi1238/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Colville CA, 1996, J BIOL CHEM, V271, P32968, DOI 10.1074/jbc.271.51.32968; Kizhatil K, 2009, SCIENCE, V323, P1614, DOI 10.1126/science.1169789; Kondo H, 2004, INVEST OPHTH VIS SCI, V45, P4433, DOI 10.1167/iovs.04-0544; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Mazzolini M, 2002, BIOPHYS J, V83, P3283, DOI 10.1016/S0006-3495(02)75329-0; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Pages F, 2000, BIOPHYS J, V78, P1227, DOI 10.1016/S0006-3495(00)76680-X; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347	10	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8969	10.1371/journal.pone.0008969	http://dx.doi.org/10.1371/journal.pone.0008969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126465	gold, Green Published, Green Submitted			2022-12-25	WOS:000274139100017
J	Boesch, C; Bole, C; Eckhardt, N; Boesch, H				Boesch, Christophe; Bole, Camille; Eckhardt, Nadin; Boesch, Hedwige			Altruism in Forest Chimpanzees: The Case of Adoption	PLOS ONE			English	Article							WILD CHIMPANZEES; KIN SELECTION; EVOLUTION; COMPETITION; PUNISHMENT; PATERNITY; BEHAVIOR; KINSHIP; HUMANS	In recent years, extended altruism towards unrelated group members has been proposed to be a unique characteristic of human societies. Support for this proposal seemingly came from experimental studies on captive chimpanzees that showed that individuals were limited in the ways they shared or cooperated with others. This dichotomy between humans and chimpanzees was proposed to indicate an important difference between the two species, and one study concluded that "chimpanzees are indifferent to the welfare of unrelated group members''. In strong contrast with these captive studies, consistent observations of potentially altruistic behaviors in different populations of wild chimpanzees have been reported in such different domains as food sharing, regular use of coalitions, cooperative hunting and border patrolling. This begs the question of what socio-ecological factors favor the evolution of altruism. Here we report 18 cases of adoption, a highly costly behavior, of orphaned youngsters by group members in Tai forest chimpanzees. Half of the adoptions were done by males and remarkably only one of these proved to be the father. Such adoptions by adults can last for years and thus imply extensive care towards the orphans. These observations reveal that, under the appropriate socio-ecologic conditions, chimpanzees do care for the welfare of other unrelated group members and that altruism is more extensive in wild populations than was suggested by captive studies.	[Boesch, Christophe; Eckhardt, Nadin; Boesch, Hedwige] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Bole, Camille; Eckhardt, Nadin] Ctr Suisse Rech Sci, Abidjan, Cote Ivoire	Max Planck Society	Boesch, C (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	boesch@eva.mpg.de			Swiss Science Foundation; Max Planck Society	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	For year-long faithful financial support, the authors are very grateful to the Swiss Science Foundation and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boesch C., 2008, AM J PRIMATOL, V70, P1; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P139, DOI 10.1007/3-540-28277-7_8; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Chapais B, 2001, BEHAV ECOL SOCIOBIOL, V49, P493, DOI 10.1007/s002650100335; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gomes CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005116; Goodall J., 1986, CHIMPANZEES GOMBE PA; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kuehl HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002440; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Lehmann J, 2006, BEHAVIOUR, V143, P931, DOI 10.1163/156853906778623635; Lehmann L, 2008, TRENDS ECOL EVOL, V23, P664, DOI 10.1016/j.tree.2008.07.012; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; Povinelli DJ, 2003, TRENDS COGN SCI, V7, P157, DOI 10.1016/S1364-6613(03)00053-6; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Silk JB., 1987, CULTURAL ANTHR, V2, P39, DOI [10.1525/can.1987.2.1.02a00050, DOI 10.1525/CAN.1987.2.1.02A00050]; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513	36	75	76	9	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8901	10.1371/journal.pone.0008901	http://dx.doi.org/10.1371/journal.pone.0008901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111704	gold, Green Published			2022-12-25	WOS:000274114800011
J	Funk, SM; Fa, JE				Funk, Stephan M.; Fa, John E.			Ecoregion Prioritization Suggests an Armoury Not a Silver Bullet for Conservation Planning	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; PRIORITY ECOREGIONS; SPECIES RICHNESS; AREAS; MAMMALS; LIFE; RARE	In the face of accelerating species extinctions, map-based prioritization systems are increasingly useful to decide where to pursue conservation action most effectively. However, a number of seemingly inconsistent schemes have emerged, mostly focussing on endemism. Here we use global vertebrate distributions in terrestrial ecoregions to evaluate how continuous and categorical ranking schemes target and accumulate endangered taxa within the IUCN Red List, Alliance for Zero Extinction (AZE), and EDGE of Existence programme. We employed total, endemic and threatened species richness and an estimator for richness-adjusted endemism as metrics in continuous prioritization, and WWF's Global200 and Conservation International's (CI) Hotspots in categorical prioritization. Our results demonstrate that all metrics target endangerment more efficiently than by chance, but each selects unique sets of top-ranking ecoregions, which overlap only partially, and include different sets of threatened species. Using the top 100 ecoregions as defined by continuous prioritization metrics, we develop an inclusive map for global vertebrate conservation that incorporates important areas for endemism, richness, and threat. Finally, we assess human footprint and protection levels within these areas to reveal that endemism sites are more impacted but have more protection, in contrast to high richness and threat ones. Given such contrasts, major efforts to protect global biodiversity must involve complementary conservation approaches in areas of unique species as well as those with highest diversity and threat.	[Funk, Stephan M.; Fa, John E.] Durrell Wildlife Conservat Trust, Trinity, NJ USA		Funk, SM (corresponding author), Durrell Wildlife Conservat Trust, Trinity, NJ USA.	jfa@durrell.org		FA, Julia Elizabeth/0000-0002-1572-9828	Institutional funding through Durrell Wildlife	Institutional funding through Durrell Wildlife	Institutional funding through Durrell Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonn A, 2002, ECOL LETT, V5, P733, DOI 10.1046/j.1461-0248.2002.00376.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cabeza M, 2008, J APPL ECOL, V45, P976, DOI 10.1111/j.1365-2664.2007.01364.x; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Fa JE, 2004, ORYX, V38, P91, DOI 10.1017/S0030605304000146; Fa John E., 2007, Endangered Species Research, V3, P31, DOI 10.3354/esr003031; Fjeldsa J, 2000, ENVIRON CONSERV, V27, P67, DOI 10.1017/S0376892900000084; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Jepson P, 2001, GLOBAL ECOL BIOGEOGR, V10, P225, DOI 10.1046/j.1466-822X.2001.00255.x; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lamoreux JF, 2007, CONSERV BIOL, V21, P269, DOI 10.1111/j.1523-1739.2006.00629.x; Lawler JJ, 2008, ANIM CONSERV, V11, P270, DOI 10.1111/j.1469-1795.2008.00176.x; Lee TM, 2008, P ROY SOC B-BIOL SCI, V275, P1261, DOI 10.1098/rspb.2007.1732; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Mace GM, 2000, NATURE, V405, P393, DOI 10.1038/35013247; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McBride MF, 2007, CONSERV BIOL, V21, P1463, DOI 10.1111/j.1523-1739.2007.00832.x; McDonald RI, 2009, P NATL ACAD SCI USA, V106, P15101, DOI 10.1073/pnas.0908125106; Mittermeier RA., 2005, HOTSPOTS REVISITED E; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pearce D, 2007, ENVIRON RESOUR ECON, V37, P313, DOI 10.1007/s10640-007-9118-3; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Ulrich W, 2005, BIODIVERS CONSERV, V14, P1977, DOI 10.1007/s10531-004-2526-6; *UNESCO WORLD HER, 2007, GAL NIOK KOB NAT PAR; *US GEOL SURV, 2000, ESRI ARCVIEW EXT POI; *WWF, 2008, DAT DOWNL; 2006, IUCN; [No title captured]	43	29	30	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8923	10.1371/journal.pone.0008923	http://dx.doi.org/10.1371/journal.pone.0008923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111722	Green Published, gold			2022-12-25	WOS:000274114800024
J	Jha, UM; Satyanarayana, S; Dewan, PK; Chadha, S; Wares, F; Sahu, S; Gupta, D; Chauhan, LS				Jha, Ugra Mohan; Satyanarayana, Srinath; Dewan, Puneet K.; Chadha, Sarabjit; Wares, Fraser; Sahu, Suvanand; Gupta, Devesh; Chauhan, L. S.			Risk Factors for Treatment Default among Re-Treatment Tuberculosis Patients in India, 2006	PLOS ONE			English	Article							SOUTH-INDIA; DOTS PROGRAM; BARRIERS	Setting: Under India's Revised National Tuberculosis Control Programme (RNTCP), >15% of previously-treated patients in the reported 2006 patient cohort defaulted from anti-tuberculosis treatment. Objective: To assess the timing, characteristics, and risk factors for default amongst re-treatment TB patients. Methodology: For this case-control study, in 90 randomly-selected programme units treatment records were abstracted from all 2006 defaulters from the RNTCP re-treatment regimen (cases), with one consecutively-selected non-defaulter per case. Patients who interrupted anti-tuberculosis treatment for >2 months were classified as defaulters. Results: 1,141 defaulters and 1,189 non-defaulters were included. The median duration of treatment prior to default was 81 days (25%-75% interquartile range 44-117 days) and documented retrieval efforts after treatment interruption were inadequate. Defaulters were more likely to have been male (adjusted odds ratio [aOR] 1.4, 95% confidence interval [CI] 1.2-1.7), have previously defaulted anti-tuberculosis treatment (aOR 1.3 95% CI 1.1-1.6], have previous treatment from non-RNTCP providers (AOR 1.3, 95% CI 1.0-1.6], or have public health facility-based treatment observation (aOR 1.3, 95% CI 1.1-1.6). Conclusions: Amongst the large number of re-treatment patients in India, default occurs early and often. Improved pretreatment counseling and community-based treatment provision may reduce default rates. Efforts to retrieve treatment interrupters prior to default require strengthening.	[Jha, Ugra Mohan; Gupta, Devesh; Chauhan, L. S.] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Satyanarayana, Srinath] The Union, Ctr Operat Res, Int Union TB & Lung Dis, New Delhi, India; [Dewan, Puneet K.; Chadha, Sarabjit; Wares, Fraser; Sahu, Suvanand] Off WHO Representat India, New Delhi, India	World Health Organization	Jha, UM (corresponding author), Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India.	srinaths@rntcp.org		Satyanarayana, Srinath/0000-0002-5420-2551				Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Bam TS, 2006, INT J TUBERC LUNG D, V10, P270; Chandrasekaran V, 2007, Indian J Tuberc, V54, P12; Chang KC, 2004, INT J TUBERC LUNG D, V8, P1492; Dandona R, 2004, NATL MED J INDIA, V17, P292; Dodor EA, 2004, INT J TUBERC LUNG D, V8, P1337; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Gopi PG, 2006, INDIAN J MED RES, V124, P71; Gopi P G, 2007, Indian J Tuberc, V54, P66; *GOV IND MIN HLTH, 2008, TB IND 2008 RNTCP ST; *GOV IND MIN HLTH, 2009, TB IND 2009 RNTCP ST; *GOV IND MIN HLTH, 2005, TECHN OP GUID TUB CO; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Jaggarajamma K, 2007, Indian J Tuberc, V54, P130; JAKUBOWIAK W, 2008, INT J INFECT DIS; Kolappan C, 2008, INT J TUBERC LUNG D, V12, P81; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; *MIN HLTH FAM WELF, 2002, MAN REV NAT TUB CONT; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Sisodia RS, 2006, INT J TUBERC LUNG D, V10, P1373; WHO, 2008, GLOBAL TUBERCULOSIS; WHO, 2009, WHOHTMTB2009411	23	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8873	10.1371/journal.pone.0008873	http://dx.doi.org/10.1371/journal.pone.0008873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111727	gold, Green Published			2022-12-25	WOS:000273896300022
J	Palmer, CV; Bythell, JC; Willis, BL				Palmer, Caroline V.; Bythell, John C.; Willis, Bette L.			Levels of immunity parameters underpin bleaching and disease susceptibility of reef corals	FASEB JOURNAL			English	Article						melanin; phenoloxidase; fluorescent protein; climate change; reef resilience	GREAT-BARRIER-REEF; PROPHENOLOXIDASE-ACTIVATING SYSTEM; CAUSE OXIDATIVE STRESS; PHENOLOXIDASE ACTIVITY; SCLERACTINIAN CORAL; FLUORESCENT PROTEINS; SPATIAL VARIABILITY; MARINE ECOLOGY; CLIMATE-CHANGE; HOST PIGMENTS	Immunity is a key life history trait that may explain hierarchies in the susceptibility of corals to disease and thermal bleaching, two of the greatest current threats to coral health and the persistence of tropical reefs. Despite their ongoing and rapid global decline, there have been few investigations into the immunity mechanisms of reef-building corals. Variables commonly associated with invertebrate immunity, including the presence of melanin, size of melanin-containing granular cells, and phenoloxidase (PO) activity, as well as concentrations of fluorescent proteins (FPs), were investigated in hard (Scleractinia) and soft (Alcyonacea) corals spanning 10 families from the Great Barrier Reef. Detectable levels of these indicators were present in all corals investigated, although relative investment differed among coral taxa. Overall levels of investment were inversely correlated to thermal bleaching and disease susceptibility. In addition, PO activity, melanin-containing granular cell size, and FP concentration were each found to be significant predictors of susceptibility and thus may play key roles in coral immunity. Correlative evidence that taxonomic (family-level) variation in the levels of these constituent immunity parameters underpins susceptibility to both thermal bleaching and disease indicates that baseline immunity underlies the vulnerability of corals to these two threats. This reinforces the necessity of a holistic approach to understanding bleaching and disease in order to accurately determine the resilience of coral reefs.-Palmer, C. V., Bythell, J. C., Willis. B. L. Levels of immunity parameters underpin bleaching and disease susceptibility of reef corals. FASEB J. 24, 1935-1946 (2010). www.fasebj.org	[Palmer, Caroline V.; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Palmer, Caroline V.; Willis, Bette L.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Palmer, Caroline V.; Bythell, John C.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	James Cook University; James Cook University; Newcastle University - UK	Palmer, CV (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	caroline.palmer@jcu.edu.au	Bythell, John C/E-7962-2010; Bythell, John/ABE-6138-2021; Palmer, Caroline/B-6498-2011	Bythell, John C/0000-0003-2416-9786; Bythell, John/0000-0003-2416-9786; Palmer, Caroline/0000-0002-5903-995X	Natural Environmental Research Council UK; Australian Research Council; Natural Environment Research Council [NE/E006949/1] Funding Source: researchfish; NERC [NE/E006949/1] Funding Source: UKRI	Natural Environmental Research Council UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors thank David Abrego and Patricia Warner for assistance with sample collection, Sue Reilly and Karen Chong-Seng for assistance with histological processing, Laura D. Mydlarz for comments on manuscript drafts, and Scan Connolly for valuable suggestions. Research funding was provided by a Natural Environmental Research Council UK grant to J.B. and an Australian Research Council Discovery Project grant to B.W.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Adamo SA, 2004, J INSECT PHYSIOL, V50, P209, DOI 10.1016/j.jinsphys.2003.11.011; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; Aronson RB, 2004, ECOLOGY, V85, P1876, DOI 10.1890/03-0108; Aronson RB, 2003, SCIENCE, V302, P1502; Asokan R, 1997, DEV COMP IMMUNOL, V21, P1, DOI 10.1016/S0145-305X(97)00004-9; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 2000, NATURE, V404, P142, DOI 10.1038/35004657; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; BULL AT, 1970, ARCH BIOCHEM BIOPHYS, V137, P345, DOI 10.1016/0003-9861(70)90448-0; Burkhart CG, 2005, INT J DERMATOL, V44, P340, DOI 10.1111/j.1365-4632.2004.02556.x; Butt D, 2008, DEV COMP IMMUNOL, V32, P299, DOI 10.1016/j.dci.2007.06.006; Bythell J.C., 1988, P535; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cooper Edwin L., 2008, V15, P1, DOI 10.1159/000135680; COOPER MD, 2002, INTERFACE INNATE ACQ; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Cox G, 2007, MICROSC RES TECHNIQ, V70, P243, DOI 10.1002/jemt.20410; Crabbe MJC, 2009, MAR ENVIRON RES, V67, P189, DOI 10.1016/j.marenvres.2009.01.003; Domart-Coulon IJ, 2006, CORAL REEFS, V25, P531, DOI 10.1007/s00338-006-0133-6; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Dove S, 2004, MAR ECOL PROG SER, V272, P99, DOI 10.3354/meps272099; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Dove SG, 2008, PLANT CELL ENVIRON, V31, P1523, DOI 10.1111/j.1365-3040.2008.01852.x; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Harvell C. D., 2007, OCEANOGRAPHY, V20, P58; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hawkridge JM, 2000, MAR BIOL, V137, P1, DOI 10.1007/s002270000324; HILDEMANN WH, 1977, IMMUNOGENETICS, V5, P193, DOI 10.1007/BF01570476; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Hosken DJ, 2001, CURR BIOL, V11, pR379, DOI 10.1016/S0960-9822(01)00211-1; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; Hutton DMC, 1996, BIOL BULL-US, V191, P441, DOI 10.2307/1543017; JACKSON JBC, 1979, BIOL SYSTEMATICS COL, P499; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; KramarskyWinter E, 1996, MAR ECOL PROG SER, V134, P179, DOI 10.3354/meps134179; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Lang J.C., 1990, P209; Laufer Z, 2006, ANN BOT-LONDON, V98, P1035, DOI 10.1093/aob/mcl184; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Leutenegger A, 2007, J EXP MAR BIOL ECOL, V353, P221, DOI 10.1016/j.jembe.2007.09.013; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Meredith P, 2006, SOFT MATTER, V2, P37, DOI 10.1039/b511922g; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; Metchnikoff E, 1892, LECONS PATHOLOGIE CO; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mucklow PT, 2004, P ROY SOC B-BIOL SCI, V271, P1175, DOI 10.1098/rspb.2004.2707; Munoz P, 2006, FISH SHELLFISH IMMUN, V20, P12, DOI 10.1016/j.fsi.2005.02.002; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Mydlarz LD, 2007, COMP BIOCHEM PHYS A, V146, P54, DOI 10.1016/j.cbpa.2006.09.005; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Newton K, 2004, DEV COMP IMMUNOL, V28, P565, DOI 10.1016/j.dci.2003.10.004; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Olano CT, 2000, J INVERTEBR PATHOL, V76, P176, DOI 10.1006/jipa.2000.4974; Page CA, 2008, CORAL REEFS, V27, P257, DOI 10.1007/s00338-007-0317-8; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Palmer CV, 2009, BIOL BULL-US, V216, P68, DOI 10.1086/BBLv216n1p68; Raymundo LJ, 2005, DIS AQUAT ORGAN, V64, P181, DOI 10.3354/dao064181; Rinkevich B, 2004, IMMUNOL REV, V198, P25, DOI 10.1111/j.0105-2896.2004.0114.x; Rinkevich B, 1996, MAR ECOL PROG SER, V143, P297, DOI 10.3354/meps143297; RINKEVICH B, 1996, INVERTEBRATE IMMUNOL; Roff G, 2006, CORAL REEFS, V25, P255, DOI 10.1007/s00338-006-0099-4; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Rowley AF, 1996, MEDIAT INFLAMM, V5, P3, DOI 10.1155/S0962935196000014; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Salih A., 2001, Photosynthesis Research, V69, P221; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Salih A, 1998, P AUSTR COR REEF SOC, P217; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; Schwarzenbach GA, 2007, J EVOLUTION BIOL, V20, P2192, DOI 10.1111/j.1420-9101.2007.01430.x; Selig ER., 2006, ANALYZING RELATIONSH, P111; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; SODERHALL K, 1982, DEV COMP IMMUNOL, V6, P601; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; SOONG K, 1991, B MAR SCI, V49, P832; SOONG KY, 1992, BIOL BULL, V183, P418, DOI 10.2307/1542018; Stearns S.C., 1992, pi; Stearns S.C., 1993, EVOLUTION LIFE HIST; Stedman T.L., 2000, STEDMANS MED DICT, V27th ed.; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Veron J.E.N., 2000, CORALS WORLD, V1-3; Ward JR, 2006, DIS AQUAT ORGAN, V69, P23, DOI 10.3354/dao069023; Weil E, 2009, DIS AQUAT ORGAN, V83, P195, DOI 10.3354/dao02011; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P249, DOI 10.1016/S1050-4648(02)00164-X; [No title captured]	126	98	100	1	96	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1935	1946		10.1096/fj.09-152447	http://dx.doi.org/10.1096/fj.09-152447			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20124432				2022-12-25	WOS:000278200000028
J	Kwon, SK; Woo, J; Kim, SY; Kim, H; Kim, E				Kwon, Seok-Kyu; Woo, Jooyeon; Kim, Soo-Young; Kim, Hyun; Kim, Eunjoon			Trans-synaptic Adhesions between Netrin-G Ligand-3 (NGL-3) and Receptor Tyrosine Phosphatases LAR, Protein-tyrosine Phosphatase delta (PTP delta), and PTP sigma via Specific Domains Regulate Excitatory Synapse Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; HIPPOCAMPAL CHOLINERGIC INNERVATION; CENTRAL-NERVOUS-SYSTEM; LIPRIN-ALPHA; MICE LACKING; SYNAPTOGENIC PROTEINS; SULFATE PROTEOGLYCAN; DEFICIENT MICE; ACTIVE ZONE; RPTP-DELTA	Synaptic cell adhesion molecules regulate various steps of synapse formation. The trans-synaptic adhesion between postsynaptic NGL-3 (for netrin-G ligand-3) and presynaptic LAR (for leukocyte antigen-related) regulates excitatory synapse formation in a bidirectional manner. However, little is known about the molecular details of the NGL-3-LAR adhesion and whether two additional LAR family proteins, protein-tyrosine phosphatase delta (PTP delta), and PTP sigma, also interact with NGL-3 and are involved in synapse formation. We report here that the leucine-rich repeat (LRR) domain of NGL-3, containing nine LRRs, interacts with the first two fibronectin III (FNIII) domains of LAR to induce bidirectional synapse formation. Moreover, Gln-96 in the first LRR motif of NGL-3 is critical for LAR binding and induction of presynaptic differentiation. PTP delta and PTP sigma also interact with NGL-3 via their first two FNIII domains. These two interactions promote synapse formation in a different manner; the PTP sigma-NGL-3 interaction promotes synapse formation in a bidirectional manner, whereas the PTP delta-NGL-3 interaction instructs only presynaptic differentiation in a unidirectional manner. mRNAs encoding LAR family proteins display overlapping and differential expression patterns in various brain regions. These results suggest that trans-synaptic adhesion between NGL-3 and the three LAR family proteins regulates excitatory synapse formation in shared and distinct neural circuits.	[Kwon, Seok-Kyu; Woo, Jooyeon; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Dept Biol Sci, Taejon 305701, South Korea; [Kwon, Seok-Kyu; Woo, Jooyeon; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Nanosci & Technol, Taejon 305701, South Korea; [Kim, Soo-Young; Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Kim, Soo-Young; Kim, Hyun] Korea Univ, Coll Med, Div Brain Korea Biomed Sci 21, Seoul 136705, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 205701, South Korea.	kime@kaist.ac.kr	Kim, Eunjoon/C-1566-2011; Kim, SooYoung/AAS-7899-2021; kim, soo-young/G-2365-2014	Kim, SooYoung/0000-0003-3632-8246; kim, soo-young/0000-0003-3632-8246; Kim, Hyun/0000-0002-7210-5798; Kwon, Seok-Kyu/0000-0002-7280-9867	Korean Ministry of Education, Science and Technology; Brain Research Center	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Research Center	This work was supported by the National Creative Research Initiative Program of the Korean Ministry of Education, Science and Technology (to E. K.).; We thank the In Situ Hybridization facility at Korea University supported by the Brain Research Center under the 21st Century Frontier Research Program.	Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Alete DE, 2006, FEBS J, V273, P4668, DOI 10.1111/j.1742-4658.2006.05471.x; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Apperson ML, 1996, J NEUROSCI, V16, P6839; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Brose N, 2009, NEURON, V61, P650, DOI 10.1016/j.neuron.2009.02.014; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Gonzalez-Brito MR, 2006, INT J DEV NEUROSCI, V24, P425, DOI 10.1016/j.ijdevneu.2006.08.006; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko J, 2007, J NEUROSCI RES, V85, P2824, DOI 10.1002/jnr.21306; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krasnoperov V, 2002, J BIOL CHEM, V277, P35887, DOI 10.1074/jbc.M205478200; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McLean J, 2002, J NEUROSCI, V22, P5481; Meathrel K, 2002, J NEUROSCI RES, V70, P24, DOI 10.1002/jnr.10382; MIZUNO K, 1993, MOL CELL BIOL, V13, P5513, DOI 10.1128/MCB.13.9.5513; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Rashid-Doubell F, 2002, J NEUROSCI, V22, P5024, DOI 10.1523/JNEUROSCI.22-12-05024.2002; Sajnani G, 2005, J NEUROBIOL, V65, P59, DOI 10.1002/neu.20175; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Schaapveld RQJ, 1998, MECH DEVELOP, V77, P59, DOI 10.1016/S0925-4773(98)00119-1; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sommer L, 1997, DEV DYNAM, V208, P48, DOI 10.1002/(SICI)1097-0177(199701)208:1<48::AID-AJA5>3.0.CO;2-1; Stepanek L, 2005, J NEUROSCI, V25, P3813, DOI 10.1523/JNEUROSCI.4531-04.2005; Stryker E, 2007, J CELL SCI, V120, P3723, DOI 10.1242/jcs.03491; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun QL, 2000, MOL CELL NEUROSCI, V16, P686, DOI 10.1006/mcne.2000.0893; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Van Lieshout EMM, 2001, NEUROSCIENCE, V102, P833, DOI 10.1016/S0306-4522(00)00526-1; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Wang J, 1999, MOL CELL NEUROSCI, V14, P370, DOI 10.1006/mcne.1999.0789; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Woo J, 2009, MOL CELL NEUROSCI, V42, P1, DOI 10.1016/j.mcn.2009.05.008; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; YAN H, 1993, J BIOL CHEM, V268, P24880; Yeo TT, 1997, J NEUROSCI RES, V47, P348, DOI 10.1002/(SICI)1097-4547(19970201)47:3<348::AID-JNR13>3.0.CO;2-Y; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; Zhang JS, 1998, MOL CELL NEUROSCI, V10, P271, DOI 10.1006/mcne.1998.0663; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	75	108	110	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13966	13978		10.1074/jbc.M109.061127	http://dx.doi.org/10.1074/jbc.M109.061127			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20139422	Green Published, hybrid			2022-12-25	WOS:000276987700071
J	Fenwick, MK; Oswald, RE				Fenwick, Michael K.; Oswald, Robert E.			On the Mechanisms of alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid (AMPA) Receptor Binding to Glutamate and Kainate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP HYDROGEN-EXCHANGE; CONFORMATIONAL-CHANGES; IONOTROPIC GLUTAMATE-RECEPTOR-2; SYNAPTIC-TRANSMISSION; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; PARTIAL AGONISTS; STRUCTURAL BASIS; ION CHANNELS	The alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) subtype of ionotropic glutamate receptors mediates much of the fast excitatory neurotransmission in the central nervous system. The ability of these receptors to shape such responses appears to be due in part to dynamic processes induced by agonists in the ligand-binding domain. Previous studies employing fluorescence spectroscopy and whole cell recording suggest that agonist binding is followed by sequential transitions to one or more distinct conformational states. Here, we used hydrogen-deuterium exchange to determine the mechanisms of binding of glutamate and kainate (full and partial agonists, respectively) to a soluble ligand-binding domain of GluR2. Our results provide a structural basis for sequential state models of agonist binding and the free energy changes of the associated state-to-state transitions. For glutamate, a multi-equilibrium binding reaction was discerned involving distinct ligand docking, domain isomerization, and lobe-locking steps. In contrast, kainate binding involves a simpler dock-isomerization process in which the isomerization equilibrium is shifted dramatically toward open domain conformations. In light of increasing evidence that the stability, in addition to the extent, of domain closure is a critical component of the channel activation mechanism, the differences in domain opening and closing equilibria detected for glutamate and kainate should be useful structural measures for interpreting the markedly different current responses evoked by these agonists.	[Fenwick, Michael K.; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	reo1@cornell.edu			National Institutes of Health [T32CA09682, GM068935]; NATIONAL CANCER INSTITUTE [T32CA009682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32CA09682 (M. K. F.) and GM068935 (to R. E. O.).	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Anderson JS, 2008, BIOCHEMISTRY-US, V47, P6178, DOI 10.1021/bi800284y; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Arvola M, 1996, J BIOL CHEM, V271, P15527, DOI 10.1074/jbc.271.26.15527; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BERGER ARIEH, 1957, ARCH BIOCHEM AND BIOPHYS, V69, P106, DOI 10.1016/0003-9861(57)90478-2; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dempsey CE, 2001, PROG NUCL MAG RES SP, V39, P135, DOI 10.1016/S0079-6565(01)00032-2; DINGLEDINE R, 1999, PHARMACOL REV, V7, P61; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fenwick MK, 2007, BIOMOL NMR ASSIGN, V1, P241, DOI 10.1007/s12104-007-9067-3; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; HOLLMANN M, 1994, ANNU REV NEUROSCI, V108, P17; Holm MM, 2005, J BIOL CHEM, V280, P35469, DOI 10.1074/jbc.M507800200; Holm MM, 2005, P NATL ACAD SCI USA, V102, P12053, DOI 10.1073/pnas.0505522102; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Kessler M, 2008, NEUROCHEM INT, V52, P1383, DOI 10.1016/j.neuint.2008.02.009; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Madden DR, 2005, J BIOL CHEM, V280, P23637, DOI 10.1074/jbc.M414523200; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Maity H, 2003, PROTEIN SCI, V12, P153, DOI 10.1110/ps.0225803; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mamonova T, 2008, BIOCHEMISTRY-US, V47, P11077, DOI 10.1021/bi801367d; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; McFeeters RL, 2002, J BIOMOL NMR, V22, P297, DOI 10.1023/A:1014954931635; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; Milne JS, 1998, PROTEIN SCI, V7, P739, DOI 10.1002/pro.5560070323; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; Oswald RE, 2004, ADV PROTEIN CHEM, V68, P313; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; ROBERTSON AD, 1991, BIOCHEMISTRY-US, V30, P9907, DOI 10.1021/bi00105a014; RODER H, 1985, BIOCHEMISTRY-US, V24, P7407, DOI 10.1021/bi00346a056; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; Valentine ER, 2005, BIOCHEMISTRY-US, V44, P3410, DOI 10.1021/bi047984f; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Zhang W, 2006, BIOPHYS J, V91, P1336, DOI 10.1529/biophysj.106.084426	56	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12334	12343		10.1074/jbc.M109.086371	http://dx.doi.org/10.1074/jbc.M109.086371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20110361	hybrid, Green Published			2022-12-25	WOS:000276787100062
J	Mayers, CM; Wadell, J; McLean, K; Venere, M; Malik, M; Shibata, T; Driggers, PH; Kino, T; Guo, XC; Koide, H; Gorivodsky, M; Grinberg, A; Mukhopadhyay, M; Abu-Asab, M; Westphal, H; Segars, JH				Mayers, Chantal M.; Wadell, Jennifer; McLean, Kate; Venere, Monica; Malik, Minnie; Shibata, Takahisa; Driggers, Paul H.; Kino, Tomoshige; Guo, X. Catherine; Koide, Hisashi; Gorivodsky, Marat; Grinberg, Alex; Mukhopadhyay, Mahua; Abu-Asab, Mones; Westphal, Heiner; Segars, James H.			Rho Guanine Nucleotide Exchange Factor AKAP13 (BRX) Is Essential for Cardiac Development in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; PROTEIN-KINASE-A; MOUSE EMBRYOGENESIS; GENE-EXPRESSION; ACTIVATION; HEART; LBC; CARDIOMYOCYTES; MORPHOGENESIS; RAS	A fundamental biologic principle is that diverse biologic signals are channeled through shared signaling cascades to regulate development. Large scaffold proteins that bind multiple proteins are capable of coordinating shared signaling pathways to provide specificity to activation of key developmental genes. Although much is known about transcription factors and target genes that regulate cardiomyocyte differentiation, less is known about scaffold proteins that couple signals at the cell surface to differentiation factors in developing heart cells. Here we show that AKAP13( also known as Brx-1, AKAP-Lbc, andproto-Lbc), a unique protein kinase A-anchoring protein (AKAP) guanine nucleotide exchange region belonging to the Dbl family of oncogenes, is essential for cardiac development. Cardiomyocytes of Akap13-null mice had deficient sarcomere formation, and developing hearts were thin-walled and mice died at embryonic day 10.5-11.0. Disruption of Akap13 was accompanied by reduced expression of Mef2C. Consistent with a role of AKAP13 upstream of MEF2C, Akap13 siRNA led to a reduction in Mef2C mRNA, and overexpression of AKAP13 augmented MEF2C-dependent reporter activity. The results suggest that AKAP13 coordinates G alpha(12) and Rho signaling to an essential transcription program in developing cardiomyocytes.	[Driggers, Paul H.; Kino, Tomoshige; Guo, X. Catherine; Koide, Hisashi] NICHD, Program Reprod & Adult Endocrinol, Bethesda, MD 20892 USA; [Gorivodsky, Marat; Grinberg, Alex; Mukhopadhyay, Mahua; Westphal, Heiner] NICHD, Lab Mammalian Genes & Dev, Bethesda, MD 20892 USA; [Abu-Asab, Mones] NIH, Pathol Lab, Bethesda, MD 20892 USA; [Malik, Minnie] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; Uniformed Services University of the Health Sciences - USA	Segars, JH (corresponding author), Clin Res Ctr, Bldg 10,Rm 1E-3140,10 Ctr Dr,MSC1109, Bethesda, MD 20892 USA.	segarsj@mail.nih.gov		Koide, Hisashi/0000-0002-8545-7530; Abu-Asab, Mones/0000-0002-4047-1232; Malik, Minnie/0000-0003-1129-6575	NICHD, National Institutes of Health [ZO1-HD-008737-07-URE]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000071, ZIAHD008732] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008737, Z01HD008737] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the Intramural Research Program of NICHD, National Institutes of Health, Grant ZO1-HD-008737-07-URE.	Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Driggers PH, 2001, J BIOL CHEM, V276, P46792, DOI 10.1074/jbc.M106927200; Dutt P, 2002, FEBS LETT, V531, P565, DOI 10.1016/S0014-5793(02)03625-6; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; Kino T, 2006, J BIOL CHEM, V281, P9118, DOI 10.1074/jbc.M509339200; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miller BT, 2000, AM J OBSTET GYNECOL, V182, P286, DOI 10.1016/S0002-9378(00)70213-4; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Teramoto H, 2003, ONCOGENE, V22, P2689, DOI 10.1038/sj.onc.1206364; TOKSOZ D, 1994, ONCOGENE, V9, P621; Uhlen P, 2006, P NATL ACAD SCI USA, V103, P2160, DOI 10.1073/pnas.0510876103; Wei L, 2001, FASEB J, V15, P785, DOI 10.1096/fj.00-026com; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zakhary DR, 2000, CIRCULATION, V101, P1459, DOI 10.1161/01.CIR.101.12.1459; Zakhary DR, 2000, J BIOL CHEM, V275, P41389, DOI 10.1074/jbc.M004212200	45	43	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12344	12354		10.1074/jbc.M110.106856	http://dx.doi.org/10.1074/jbc.M110.106856			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20139090	Green Published, hybrid			2022-12-25	WOS:000276787100063
J	Cremers, CM; Reichmann, D; Hausmann, J; Ilbert, M; Jakob, U				Cremers, Claudia M.; Reichmann, Dana; Hausmann, Jens; Ilbert, Marianne; Jakob, Ursula			Unfolding of Metastable Linker Region Is at the Core of Hsp33 Activation as a Redox-regulated Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CRYSTAL-STRUCTURE; MOLECULAR CHAPERONES; STRUCTURAL DISORDER; SUBSTRATE-BINDING; ESCHERICHIA-COLI; IN-VIVO; STRESS; MECHANISM; DOMAIN	Hsp33, a molecular chaperone specifically activated by oxidative stress conditions that lead to protein unfolding, protects cells against oxidative protein aggregation. Stress sensing in Hsp33 occurs via its C-terminal redox switch domain, which consists of a zinc center that responds to the presence of oxidants and an adjacent metastable linker region, which responds to unfolding conditions. Here we show that single mutations in the N terminus of Hsp33 are sufficient to either partially (Hsp33-M172S) or completely (Hsp33-Y12E) abolish this post-translational regulation of Hsp33 chaperone function. Both mutations appear to work predominantly via the destabilization of the Hsp33 linker region without affecting zinc coordination, redox sensitivity, or substrate binding of Hsp33. We found that the M172S substitution causes moderate destabilization of the Hsp33 linker region, which seems sufficient to convert the redox-regulated Hsp33 into a temperature-controlled chaperone. The Y12E mutation leads to the constitutive unfolding of the Hsp33 linker region thereby turning Hsp33 into a constitutively active chaperone. These results demonstrate that the redox-controlled unfolding of the Hsp33 linker region plays the central role in the activation process of Hsp33. The zinc center of Hsp33 appears to act as the redox-sensitive toggle that adjusts the thermostability of the linker region to the cell redox status. In vivo studies confirmed that even mild overexpression of the Hsp33-Y12E mutant protein inhibits bacterial growth, providing important evidence that the tight functional regulation of Hsp33 chaperone activity plays a vital role in bacterial survival.	[Cremers, Claudia M.; Reichmann, Dana; Hausmann, Jens; Ilbert, Marianne; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	ujakob@umich.edu	Reichmann, Dana/J-4999-2019; Ilbert, marianne/ABG-5015-2021	Reichmann, Dana/0000-0003-0315-5334; ilbert, marianne/0000-0002-9070-2334; Hausmann, Jens/0000-0001-8960-6225	National Institutes of Health [GM065318]; Human Frontiers; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health Grant GM065318 (to U.J.) and a Human Frontiers postdoctoral fellowship (to D. R.).	Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; BARRETTE WC, 1989, BIOCHEMISTRY-US, V28, P9172, DOI 10.1021/bi00449a032; Beissinger M, 1998, BIOL CHEM, V379, P245; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Graf PCF, 2002, CELL MOL LIFE SCI, V59, P1624, DOI 10.1007/PL00012489; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Janda I, 2004, STRUCTURE, V12, P1901, DOI 10.1016/j.str.2004.08.003; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kang HJ, 2007, BIOCHEM BIOPH RES CO, V358, P743, DOI 10.1016/j.bbrc.2007.04.184; Kim SJ, 2001, NAT STRUCT BIOL, V8, P459, DOI 10.1038/87639; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Raman B, 2001, FEBS LETT, V489, P19, DOI 10.1016/S0014-5793(01)02074-9; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Reichmann D, 2008, BIOCHEMISTRY-US, V47, P1051, DOI 10.1021/bi7019639; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2009, FEBS J, V276, P5406, DOI 10.1111/j.1742-4658.2009.07250.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vijayalakshmi J, 2001, STRUCTURE, V9, P367, DOI 10.1016/S0969-2126(01)00597-4; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Winter J, 2004, CRIT REV BIOCHEM MOL, V39, P297, DOI 10.1080/10409230490900658; Wu YE, 2008, BIOCHEM J, V412, P389, DOI 10.1042/BJ20071682; Yang HM, 1999, PROTEIN SCI, V8, P174; Zhou ZHS, 1999, BIOCHEMISTRY-US, V38, P15915, DOI 10.1021/bi992062b	36	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11243	11251		10.1074/jbc.M109.084350	http://dx.doi.org/10.1074/jbc.M109.084350			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139072	hybrid, Green Published			2022-12-25	WOS:000276286200030
J	Li, K; Bethea, HN; Liu, J				Li, Kai; Bethea, Heather N.; Liu, Jian			Using Engineered 2-O-Sulfotransferase to Determine the Activity of Heparan Sulfate C-5-epimerase and Its Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-IDURONIC ACID; GLUCURONYL C5-EPIMERASE; HEPARIN/HEPARAN SULFATE; STRUCTURAL SPECIFICITY; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; ENTRY RECEPTOR; HEPARINASE-II; BIOSYNTHESIS; ANTITHROMBIN	Heparan sulfate (HS) is involved in essential physiological and pathophysiological functions. HS is a highly sulfated polysaccharide consisting of glucuronic acid (or iduronic acid) linked to glucosamine carrying various sulfo groups. Biosynthesis of HS involves sulfotransferases and an epimerase. The HS C-5-epimerase converts glucuronic acid to iduronic acid. The method for determining the activity has been cumbersome due to the use of a site-specifically H-3-labeled polysaccharide substrate. Here, we report a two-enzyme coupling assay to determine the activity of C-5-epimerase. HS 2-O-sulfotransferase (2OST) transfers the sulfo group to the 2-OH-position of glucuronic or iduronic acid. Unlike the wild type protein, 2-O-sulfotransferase mutant (2OST Y94I) transfers sulfate to the iduronic acid but not to the glucuronic acid. Thus, 2OST Y94I cannot sulfate N-sulfated heparosan, a polysaccharide containing glucuronic acid. Incubating N-sulfated heparosan with C-5-epimerase converts some of the glucuronic acid to iduronic acid, thus becoming a substrate for 2OST Y94I. The susceptibility of the C-5-epimerase-treated N-sulfated heparosan to 2OST Y94I modification directly correlates to the amount of the activity of C-5-epimerase, proving that this two-enzyme coupling system can be used to assay for C-5-epimerase. The method was further used to determine the activities of various C-5-epimerase mutants. Our approach will significantly reduce the complexity for assaying the activity of C-5-epimerase and facilitate the structural and functional analysis of C-5-epimerase.	[Li, Kai; Bethea, Heather N.; Liu, Jian] Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Rm 303A,Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu			National Institutes of Health [AI50050, HL094463]; American Heart Association; MidAtlantic Affiliate [0855424E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); MidAtlantic Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI50050 and HL094463. This work is also supported by American Heart Association, MidAtlantic Affiliate, Grant-in-aid 0855424E.	Bethea HN, 2008, P NATL ACAD SCI USA, V105, P18724, DOI 10.1073/pnas.0806975105; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chen JH, 2005, BBA-GEN SUBJECTS, V1725, P190, DOI 10.1016/j.bbagen.2005.06.012; Chen JH, 2003, GLYCOBIOLOGY, V13, P785, DOI 10.1093/glycob/cwg101; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Das SK, 2001, CHEM-EUR J, V7, P4821; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Edavettal SC, 2004, J BIOL CHEM, V279, P25789, DOI 10.1074/jbc.M401089200; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Kakuta Y, 2003, BIOCHEM SOC T, V31, P331, DOI 10.1042/BST0310331; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; Lindahl U, 2005, J MED CHEM, V48, P349, DOI 10.1021/jm049812m; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Munoz E, 2006, BIOCHEM BIOPH RES CO, V339, P597, DOI 10.1016/j.bbrc.2005.11.051; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shriver Z, 1998, J BIOL CHEM, V273, P22904, DOI 10.1074/jbc.273.36.22904; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66	35	19	23	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11106	11113		10.1074/jbc.M109.081059	http://dx.doi.org/10.1074/jbc.M109.081059			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20118238	Green Published, hybrid			2022-12-25	WOS:000276286200015
J	Schaefer, JS; Sabherwal, Y; Shi, HY; Sriraman, V; Richards, J; Minella, A; Turner, DP; Watson, DK; Zhang, M				Schaefer, Jeremy S.; Sabherwal, Yamini; Shi, Heidi Y.; Sriraman, Venkataraman; Richards, JoAnne; Minella, Alex; Turner, David P.; Watson, Dennis K.; Zhang, Ming			Transcriptional Regulation of p21/CIP1 Cell Cycle Inhibitor by PDEF Controls Cell Proliferation and Mammary Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; HUMAN BREAST-CANCER; ETS FACTOR; FUNCTIONAL-ANALYSIS; ANDROGEN RECEPTOR; EPITHELIAL-CELLS; GENE-EXPRESSION; TARGET GENES; DNA-DAMAGE; IN-VIVO	The Ets family of transcription factors control a myriad of cellular processes and contribute to the underlying genetic loss of cellular homeostasis resulting in cancer. PDEF (prostate-derived Ets factor) has been under investigation for its role in tumor development and progression. However, the role of PDEF in cancer development has been controversial. Some reports link PDEF to tumor promoter, and others show tumor-suppressing functions in various systems under different conditions. So far, there has been no conclusive evidence from in vivo experiments to prove the role of PDEF. We have used both in vitro and in vivo systems to provide a conclusive role of PDEF in the progression process. PDEF-expressing cells block the cell growth rate, and this retardation was reversible when PDEF expression was silenced with PDEF-specific small interfering RNA. When these PDEF-expressing cells were orthotopically implanted into the mouse mammary gland, tumor incidence and growth rate were significantly retarded. Cell cycle analysis revealed that PDEF expression partially blocked cell cycle progression at G(1)/S without an effect on apoptosis. PDEF overexpression resulted in an increase in p21/CIP1 at both the mRNA and protein levels, resulting in decreased Cdk2 activity. Promoter deletion analysis, electrophoresis mobility shift assays, and chromatin immunoprecipitation studies identified the functional Ets DNA binding site at -2118 bp of the p21/CIP1 gene promoter. This site is capable of binding and responding to PDEF. Furthermore, we silenced p21/CIP1 expression in PDEF-overexpressing cells by small interfering RNA. p21-silenced PDEF cells exhibited significantly increased cell growth in vitro and in vivo, demonstrating the p21 regulation by PDEF as a key player. These experiments identified PDEF as a new transcription factor that directly regulates p21/CIP1 expression under non-stressed conditions. This study conclusively proves that PDEF is a breast tumor suppressor for the first time using both in vitro and in vivo systems. PDEF can be further developed as a target for designing therapeutic intervention of breast cancer.	[Sabherwal, Yamini; Shi, Heidi Y.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Sabherwal, Yamini; Shi, Heidi Y.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA; [Minella, Alex] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol & Oncol, Chicago, IL 60611 USA; [Schaefer, Jeremy S.; Sriraman, Venkataraman; Richards, JoAnne] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Turner, David P.; Watson, Dennis K.] Med Univ S Carolina, Coll Med, Dept Pathol & Lab Med, Charleston, SC 29425 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Baylor College of Medicine; Medical University of South Carolina	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.	m-zhang@northwestern.edu		Minella, Alex/0000-0001-6693-3362	National Institutes of Health, NCI [CA79736]; Susan Komen Breast Cancer Foundation; IPDH; Northwestern University Zell; NATIONAL CANCER INSTITUTE [R01CA079736, K22CA130984] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); IPDH; Northwestern University Zell; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA79736. This work was also supported by a Susan Komen Breast Cancer Foundation fellowship (to J.S.S.) and by the IPDH fund and the Northwestern University Zell fund (to M.Z.).	Altieri Dario C, 2003, Prog Cell Cycle Res, V5, P447; Altieri Dario C, 2003, Methods Mol Biol, V223, P533; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Altieri DC, 2003, ADV CANCER RES, V88, P31, DOI 10.1016/S0065-230X(03)88303-3; Anderson GR, 2001, CANCER RES, V61, P8274; Chen H, 2005, J CELL BIOCHEM, V94, P168, DOI 10.1002/jcb.20297; Chen H, 2002, CANCER RES, V62, P338; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dowell SP, 1996, CYTOPATHOLOGY, V7, P340, DOI 10.1111/j.1365-2303.1996.tb00313.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Falender AE, 2003, ENDOCRINOLOGY, V144, P3598, DOI 10.1210/en.2002-0137; Feldman RJ, 2003, CANCER RES, V63, P4626; Feldman RJ, 2003, ANTICANCER RES, V23, P2125; Findlay VJ, 2008, CANCER RES, V68, P8499, DOI 10.1158/0008-5472.CAN-08-0907; Fowler M, 2006, J CELL BIOCHEM, V97, P1, DOI 10.1002/jcb.20664; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Ghadersohi A, 2001, CLIN CANCER RES, V7, P2731; Ghadersohi A, 2007, BREAST CANCER RES TR, V102, P19, DOI 10.1007/s10549-006-9314-9; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Hill R, 2008, CELL CYCLE, V7, P2535; HOFFMAN BD, 1991, CYTOMETRY, V12, P26, DOI 10.1002/cyto.990120105; Hsouna A, 2004, GENE EXPR PATTERNS, V5, P285, DOI 10.1016/j.modgep.2004.07.002; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Kong G, 2002, ONCOGENE, V21, P7214, DOI 10.1038/sj.onc.1205895; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Nozawa M, 2000, CANCER RES, V60, P1348; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; PAPAS TS, 1990, PROG CLIN BIOL RES, V360, P137; PAPAS TS, 1989, CURR TOP MICROBIOL, V149, P143; Russell DL, 1996, BIOL REPROD, V55, P1029, DOI 10.1095/biolreprod55.5.1029; SAID TK, 1995, CARCINOGENESIS, V16, P823, DOI 10.1093/carcin/16.4.823; Said TK, 2004, J MAMMARY GLAND BIOL, V9, P81, DOI 10.1023/B:JOMG.0000023590.63974.f8; Said TK, 2001, CELL GROWTH DIFFER, V12, P285; Salz W, 2005, CANCER RES, V65, P3531, DOI 10.1158/0008-5472.CAN-04-4284; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sood AK, 2007, HUM PATHOL, V38, P1628, DOI 10.1016/j.humpath.2007.03.010; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Tsujimoto Y, 2002, INT J UROL, V9, P167, DOI 10.1046/j.1442-2042.2002.00444.x; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; WATSON D K, 1990, Critical Reviews in Oncogenesis, V1, P409; WATSON PA, 1991, CYTOMETRY, V12, P242, DOI 10.1002/cyto.990120306; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Yamada N, 2000, GENE, V241, P267, DOI 10.1016/S0378-1119(99)00484-9; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179	54	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11258	11269		10.1074/jbc.M109.073932	http://dx.doi.org/10.1074/jbc.M109.073932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139077	Green Published, hybrid			2022-12-25	WOS:000276286200032
J	Girija, UV; Furze, C; Toth, J; Schwaeble, WJ; Mitchell, DA; Keeble, AH; Wallis, R				Girija, Umakhanth Venkatraman; Furze, Christopher; Toth, Julia; Schwaeble, Wilhelm J.; Mitchell, Daniel A.; Keeble, Anthony H.; Wallis, Russell			Engineering Novel Complement Activity into a Pulmonary Surfactant Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING PROTEIN; COLLAGEN-LIKE DOMAIN; 1ST COMPONENT; ELECTRON-MICROSCOPY; SERINE PROTEASES; STRUCTURAL BASIS; LECTIN; LOCALIZATION; RECOGNITION; ACTIVATION	Complement neutralizes invading pathogens, stimulates inflammatory and adaptive immune responses, and targets no-nor altered-self structures for clearance. In the classical and lectin activation pathways, it is initiated when complexes composed of separate recognition and activation subcomponents bind to a pathogen surface. Despite its apparent complexity, recognition-mediated activation has evolved independently in three separate protein families, C1q, mannose-binding lectins (MBLs), and serum ficolins. Although unrelated, all have bouquet-like architectures and associate with complement-specific serine proteases: MBLs and ficolins with MBL-associated serine protease-2 (MASP-2) and C1q with C1r and C1s. To examine the structural requirements for complement activation, we have created a number of novel recombinant rat MBLs in which the position and orientation of the MASP-binding sites have been changed. We have also engineered MASP binding into a pulmonary surfactant protein (SP-A), which has the same domain structure and architecture as MBL but lacks any intrinsic complement activity. The data reveal that complement activity is remarkably tolerant to changes in the size and orientation of the collagenous stalks of MBL, implying considerable rotational and conformational flexibility in unbound MBL. Furthermore, novel complement activity is introduced concurrently with MASP binding in SP-A but is uncontrolled and occurs even in the absence of a carbohydrate target. Thus, the active rather than the zymogen state is default in lectin.MASP complexes and must be inhibited through additional regions in circulating MBLs until triggered by pathogen recognition.	[Girija, Umakhanth Venkatraman; Furze, Christopher; Toth, Julia; Schwaeble, Wilhelm J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England	University of Leicester		rw73@le.ac.uk	Mitchell, Daniel A/A-6580-2009	Mitchell, Daniel A/0000-0003-0936-6212; VENKATRAMAN GIRIJA, UMAKHANTH/0000-0002-0761-5994; Schwaeble, Wilhelm/0000-0001-8927-0864; Furze, Christopher/0000-0002-2785-4618; Keeble, Anthony/0000-0002-4873-6960; Wallis, Russell/0000-0002-8705-5295	Medical Research Council [G0501425]; Wellcome Trust [077400]; MRC [G0501425] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grant G0501425 from the Medical Research Council and Grant 077400 from The Wellcome Trust.	BRODSKYDOYLE B, 1976, BIOCHEM J, V159, P279, DOI 10.1042/bj1590279; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Doliana R, 1999, J BIOL CHEM, V274, P16773, DOI 10.1074/jbc.274.24.16773; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; HAURUM JS, 1993, BIOCHEM J, V293, P873, DOI 10.1042/bj2930873; Heise CT, 2000, J IMMUNOL, V165, P1403, DOI 10.4049/jimmunol.165.3.1403; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; HOPPE HJ, 1994, PROTEIN SCI, V3, P1143, DOI 10.1002/pro.5560030801; Jensenius H, 2009, J MOL BIOL, V391, P246, DOI 10.1016/j.jmb.2009.05.083; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KURATA H, 1993, BIOCHEM BIOPH RES CO, V191, P1204, DOI 10.1006/bbrc.1993.1345; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; PORTER RR, 1978, NATURE, V275, P699, DOI 10.1038/275699a0; REID KBM, 1977, BIOCHEM J, V161, P239, DOI 10.1042/bj1610239; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Reid KBM, 1998, IMMUNOL TODAY, V19, P56, DOI 10.1016/S0167-5699(97)01207-3; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; STRANG CJ, 1982, P NATL ACAD SCI-BIOL, V79, P586, DOI 10.1073/pnas.79.2.586; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Uemura T, 2006, BIOCHEMISTRY-US, V45, P14543, DOI 10.1021/bi061338u; Wallis R, 1999, J BIOL CHEM, V274, P3580, DOI 10.1074/jbc.274.6.3580; Wallis R, 1999, J IMMUNOL, V163, P4953; Wallis R, 2004, J BIOL CHEM, V279, P14065, DOI 10.1074/jbc.M400171200; Wallis R, 1997, BIOCHEM J, V325, P391, DOI 10.1042/bj3250391; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006	32	6	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10546	10552		10.1074/jbc.M109.097493	http://dx.doi.org/10.1074/jbc.M109.097493			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118239	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000276264600041
J	Labriola, JM; daCosta, CJB; Wang, SZ; Figeys, D; Smith, JC; Sturgeon, RM; Baenziger, JE				Labriola, Jonathan M.; daCosta, Corrie J. B.; Wang, Shuzhi; Figeys, Daniel; Smith, Jeffrey C.; Sturgeon, R. Michel; Baenziger, John E.			Phospholipase C Activity Affinity Purifies with the Torpedo Nicotinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PROTEIN INTERACTIONS; PHOSPHATE PHOSPHOHYDROLASES; NONCOMPETITIVE INHIBITORS; RAPID METHOD; MEMBRANES; ACID; CONFORMATION; INFLAMMATION; CALIFORNICA; ACTIVATION	Nicotinic acetylcholine receptors mediate fast synaptic transmission by fluxing ions across the membrane in response to neurotransmitter binding. We show here that during affinity purification of the nicotinic acetylcholine receptor from Torpedo, phosphatidic acid, but not other anionic or zwitterionic phospholipids, is hydrolyzed to diacylglycerol. The phospholipase C activity elutes with the acetylcholine receptor and is inhibited by a lipid phosphate phosphohydrolase inhibitor, sodium vanadate, but not a phosphatidate phosphohydrolase inhibitor, N-ethylmaleimide. Further, the hydrolysis product of phosphatidic acid, diacylglycerol, enhances the functional capabilities of the acetylcholine receptor in the presence of anionic lipids. We conclude that a phospholipase C activity, which appears to be specific for phosphatidic acid, is associated with the nicotinic acetylcholine receptor. The acetylcholine receptor may directly or indirectly influence lipid metabolism in a manner that enhances its own function.	[Labriola, Jonathan M.; daCosta, Corrie J. B.; Wang, Shuzhi; Sturgeon, R. Michel; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Figeys, Daniel; Smith, Jeffrey C.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Labriola, JM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca		Baenziger, John/0000-0002-2888-5328; Sturgeon, Raymond/0000-0002-0043-0241; Figeys, Daniel/0000-0002-5373-7546	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to J. E. B.).	Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Blanchet MR, 2006, AM J PHYSIOL-LUNG C, V291, pL757, DOI 10.1152/ajplung.00409.2005; BLEASDALE JE, 1976, BIOCHEM J, V158, P557, DOI 10.1042/bj1580557; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2004, J BIOL CHEM, V279, P14967, DOI 10.1074/jbc.M310037200; daCosta CJB, 2003, ACTA CRYSTALLOGR D, V59, P77, DOI 10.1107/S0907444902019236; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Goetz T, 2007, PROG BRAIN RES, V160, P21, DOI 10.1016/S0079-6123(06)60003-4; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HERZ JM, 1991, J BIOL CHEM, V266, P16691; HERZ JM, 1987, J BIOL CHEM, V262, P7238; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; MCCARTHY MP, 1992, J BIOL CHEM, V267, P7655; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Simon MF, 2002, J BIOL CHEM, V277, P23131, DOI 10.1074/jbc.M201530200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sturgeon RM, 2010, BIOPHYS J, V98, P989, DOI 10.1016/j.bpj.2009.11.030; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029	30	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10337	10343		10.1074/jbc.M109.071993	http://dx.doi.org/10.1074/jbc.M109.071993			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133947	Green Published, hybrid			2022-12-25	WOS:000276264600018
J	Albano, F; Anelli, L; Zagaria, A; Coccaro, N; D'Addabbo, P; Liso, V; Rocchi, M; Specchia, G				Albano, F.; Anelli, L.; Zagaria, A.; Coccaro, N.; D'Addabbo, P.; Liso, V.; Rocchi, M.; Specchia, G.			Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia	ONCOGENE			English	Article						segmental duplications; chronic myeloid leukemia; microdeletions	DERIVATIVE CHROMOSOME-9 DELETIONS; BREAKPOINT; REGION; TRANSLOCATION; HYBRIDIZATION; ARCHITECTURE; COMMON; GENE	A crucial role of segmental duplications (SDs) of the human genome has been shown in chromosomal rearrangements associated with several genomic disorders. Limited knowledge is yet available on the molecular processes resulting in chromosomal rearrangements in tumors. The t(9;22)(q34;q11) rearrangement causing the 5'BCR/3'ABL gene formation has been detected in more than 90% of cases with chronic myeloid leukemia (CML). In 10-18% of patients with CML, genomic deletions were detected on der(9) chromosome next to translocation breakpoints. The molecular mechanism triggering the t(9; 22) and deletions on der(9) is still speculative. Here we report a molecular cytogenetic analysis of a large series of patients with CML with der(9) deletions, revealing an evident breakpoint clustering in two regions located proximally to ABL and distally to BCR, containing an interchromosomal duplication block (SD_9/22). The deletions breakpoints distribution appeared to be strictly related to the distance from the SD_9/22. Moreover, bioinformatic analyses of the regions surrounding the SD_9/22 revealed a high Alu frequency and a poor gene density, reflecting genomic instability and susceptibility to rearrangements. On the basis of our results, we propose a three-step model for t(9; 22) formation consisting of alignment of chromosomes 9 and 22 mediated by SD_9/22, spontaneous chromosome breakages and misjoining of DNA broken ends. Oncogene (2010) 29, 2509-2516; doi:10.1038/onc.2009.524; published online 25 January 2010	[Albano, F.; Anelli, L.; Zagaria, A.; Coccaro, N.; Liso, V.; Specchia, G.] Univ Bari, Dept Hematol, I-70124 Bari, Italy; [D'Addabbo, P.; Rocchi, M.] Univ Bari, Dept Genet & Microbiol, I-70124 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Albano, F (corresponding author), Univ Bari, Azienda Osped Univ Policlin, Dept Hematol, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	f.albano@ematba.uniba.it	Albano, Francesco/J-2352-2016; D'Addabbo, Pietro/AAC-7731-2020; D'Addabbo, Pietro/D-8551-2016; Anelli, Luisa/K-2661-2016; Zagaria, Antonella/K-2995-2016; Specchia, Giorgina/K-3084-2016	Albano, Francesco/0000-0001-7926-6052; D'Addabbo, Pietro/0000-0003-3325-4931; Anelli, Luisa/0000-0002-9185-724X; Coccaro, Nicoletta/0000-0003-1327-8186; Zagaria, Antonella/0000-0002-0135-6661; Specchia, Giorgina/0000-0002-2479-9529; Rocchi, Mariano/0000-0002-9451-5616	Associazione Italiana contro le Leucemie (AIL)-BARI	Associazione Italiana contro le Leucemie (AIL)-BARI	We thank Ms MVC Pragnell for language revision of the paper. The financial support of Associazione Italiana contro le Leucemie (AIL)-BARI is gratefully acknowledged.	Albano F, 2007, CANCER GENET CYTOGEN, V174, P121, DOI 10.1016/j.cancergencyto.2006.09.025; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Barbouti A, 2004, AM J HUM GENET, V74, P1, DOI 10.1086/380648; Darai-Ramqvist E, 2008, GENOME RES, V18, P370, DOI 10.1101/gr.7010208; de Campos MGV, 2007, CANCER GENET CYTOGEN, V178, P49, DOI 10.1016/j.cancergencyto.2007.06.013; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Fourouclas N, 2006, HAEMATOL-HEMATOL J, V91, P952; Gibcus JH, 2007, HUM GENET, V121, P187, DOI 10.1007/s00439-006-0299-6; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Huntly BJP, 2001, BLOOD, V98, P1732, DOI 10.1182/blood.V98.6.1732; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Kolomietz E, 2003, LEUKEMIA, V17, P1313, DOI 10.1038/sj.leu.2402969; Kolomietz E, 2001, BLOOD, V97, P3581, DOI 10.1182/blood.V97.11.3581; Kreil S, 2007, BLOOD, V110, P1283, DOI 10.1182/blood-2007-02-074252; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LITZ CE, 1993, BLOOD, V81, P1567; Lomiento M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r173; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Saglio G, 2002, P NATL ACAD SCI USA, V99, P9882, DOI 10.1073/pnas.152171299; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Sinclair PB, 2000, BLOOD, V95, P738, DOI 10.1182/blood.V95.3.738.003k21_738_743; Specchia G, 2004, LEUKEMIA LYMPHOMA, V45, P689, DOI 10.1080/10428190310001623900; Storlazzi CT, 2002, GENE CHROMOSOME CANC, V35, P271, DOI 10.1002/gcc.10116; Yatsenko SA, 2009, HUM MOL GENET, V18, P1924, DOI 10.1093/hmg/ddp114	24	24	24	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	17					2509	2516		10.1038/onc.2009.524	http://dx.doi.org/10.1038/onc.2009.524			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20101201				2022-12-25	WOS:000277169400006
J	Chung, H; Lopez, CG; Young, DJ; Lai, JF; Holmstrom, J; Ream-Robinson, D; Cabrera, BL; Carethers, JM				Chung, H.; Lopez, C. G.; Young, D. J.; Lai, J. F.; Holmstrom, J.; Ream-Robinson, D.; Cabrera, B. L.; Carethers, J. M.			Flanking sequence specificity determines coding microsatellite heteroduplex and mutation rates with defective DNA mismatch repair (MMR)	ONCOGENE			English	Article							NONPOLYPOSIS COLON-CANCER; COLORECTAL-CANCER; INSTABILITY; GENE; RECEPTOR; INACTIVATION; ACTIVIN; BETA; HOMOLOG; GROWTH	The activin type II receptor (ACVR2) contains two identical microsatellites in exons 3 and 10, but only the exon 10 microsatellite is frameshifted in mismatch repair (MMR)-defective colonic tumors. The reason for this selectivity is not known. We hypothesized that ACVR2 frameshifts were influenced by DNA sequences surrounding the microsatellite. We constructed plasmids in which exons 3 or 10 of ACVR2 were cloned vertical bar 1 bp out of frame of enhanced green fluorescent protein (EGFP), allowing -1 bp frameshift to express EGFP. Plasmids were stably transfected into MMR-deficient cells, and subsequent non-fluorescent cells were sorted, cultured and harvested for mutation analysis. We swapped DNA sequences flanking the exon 3 and 10 microsatellites to test our hypothesis. Native ACVR2 exon 3 and 10 microsatellites underwent heteroduplex formation (A7/T8) in hMLH1(-/-) cells, but only exon 10 microsatellites fully mutated (A7/T7) in both hMLH1(-/-) and hMSH6(-/-) backgrounds, showing selectivity for exon 10 frameshifts and inability of exon 3 heteroduplexes to fully mutate. Substituting nucleotides flanking the exon 3 microsatellite for nucleotides flanking the exon 10 microsatellite significantly reduced heteroduplex and full mutation in hMLH1(-/-) cells. When the exon 3 microsatellite was flanked by nucleotides normally surrounding the exon 10 microsatellite, fully mutant exon 3 frameshifts appeared. Mutation selectivity for ACVR2 lies partly with flanking nucleotides surrounding each microsatellite. Oncogene (2010) 29, 2172-2180; doi: 10.1038/onc.2009.508; published online 8 February 2010	[Chung, H.; Lopez, C. G.; Lai, J. F.; Holmstrom, J.; Ream-Robinson, D.; Cabrera, B. L.; Carethers, J. M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Young, D. J.; Carethers, J. M.] Univ Calif San Diego, Rebecca & John Moores Comprehens Canc Ctr, San Diego, CA 92103 USA; [Carethers, J. M.] VA San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Carethers, JM (corresponding author), Univ Michigan, Dept Internal Med, 3100A Taubman Ctr,1500 E Med Ctr Dr,SPC 5368, Ann Arbor, MI 48109 USA.	jcarethe@umich.edu			United States Public Health Service [DK067287]; UCSD Digestive Diseases Research Development Center [DK080506]; VA Research Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287, R24DK080506] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); UCSD Digestive Diseases Research Development Center; VA Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the United States Public Health Service (DK067287 to JMC), the UCSD Digestive Diseases Research Development Center (DK080506), and the VA Research Service (Merit Review Award to JMC). We thank the support of Moores UCSD Cancer Center Flow Cytometry and DNA Sequencing Shared Resources.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Akiyama Y, 1997, CANCER RES, V57, P3920; Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Hempen PM, 2003, CANCER RES, V63, P994; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Jung BH, 2007, GASTROENTEROLOGY, V132, P633, DOI 10.1053/j.gastro.2006.11.018; Luria SE, 1943, GENETICS, V28, P491; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1995, CANCER RES, V55, P5548; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Woerner SM, 2005, ONCOGENE, V24, P2525, DOI 10.1038/sj.onc.1208456	23	10	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	15					2172	2180		10.1038/onc.2009.508	http://dx.doi.org/10.1038/onc.2009.508			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20140012	Green Accepted			2022-12-25	WOS:000276685200003
J	Yao, Z; Duan, S; Hou, D; Wang, W; Wang, G; Liu, Y; Wen, L; Wu, M				Yao, Z.; Duan, S.; Hou, D.; Wang, W.; Wang, G.; Liu, Y.; Wen, L.; Wu, M.			B23 acts as a nucleolar stress sensor and promotes cell survival through its dynamic interaction with hnRNPU and hnRNPA1	ONCOGENE			English	Article						B23/NPM; hnRNPs; nucleolar stress; cell survival; apoptosis	MESSENGER-RNA; PROTEIN; NUCLEOPHOSMIN; A1; ACTINOMYCIN; P53	The nucleolus is one of the functional nuclear compartments in which the ribosome biogenesis takes place. Proteomic analysis revealed a large number of nucleolar proteins that are involved in diverse cellular processes, including biogenesis of ribonucleoprotein particles, stress responses, cell proliferation and cell cycle progression. Here, we report that in response to transcription repression-induced nucleolar segregation, B23, a nucleolar protein required for rRNA processing, is localized to the cytoplasm and forms a complex with the mRNA-binding proteins hnRNPU and hnRNPA1 in a sequential manner. In addition, RNA Polymerase I, but not RNA Polymerase II inhibition, was found to account for the translocation-dependent assembly of B23/hnRNPU/hnRNPA1. We also showed that interactions among these proteins are regulated by hnRNPU-bound mRNAs such as the 30-untranslated region (UTR) of Bcl-xL mRNA. Ectopically expressed 30-UTR of Bcl-xL mRNA, which disrupted the interactions among B23, hnRNPU and hnRNPA1, led to enhanced cell apoptosis induced by either actinomycin D treatment or mitotic arrest. Overall, these data highlight a novel function of B23 as a stress sensor in the assembly of B23/hnRNPU/hnRNPA1 complex to promote cell survival. Oncogene (2010) 29, 1821-1834; doi:10.1038/onc.2009.473; published online 18 January 2010	[Yao, Z.; Duan, S.; Hou, D.; Wang, W.; Wang, G.; Wen, L.; Wu, M.] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Liu, Y.] Univ Sci & Technol China, Sch Life Sci, Ctr Tech Serv Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, M (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, 96 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	wumian@ustc.edu.cn	Yao, Zhan/AAK-6756-2020; Wu, Mian/H-2494-2018; Yao, Zhan/K-1839-2013	Wen, Longping/0000-0003-0384-4578; YAO, ZHAN/0000-0001-5391-5691; Wu, Mian/0000-0002-2714-0500; WANG, Wenyu/0000-0001-8947-4867	National Natural Science Foundation of China [30530200, 30871290, 30728003]; Ministry of Science and Technology of China [2006CB933300, 2006CB910300]; Chinese Academy of Sciences [KSCX1-YW-R-57]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We are grateful to Dr Yinon Ben-Neriah (The Hebrew University-Hadassah Medical School, Israel) for kindly providing the pFLAG-CMV-2-hnRNPU plasmid. This research was supported by grants from the National Natural Science Foundation of China (30530200, 30871290 and 30728003), the Ministry of Science and Technology of China (2006CB933300 and 2006CB910300) and the Chinese Academy of Sciences (KSCX1-YW-R-57).	Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Duan SS, 2007, EMBO J, V26, P3062, DOI 10.1038/sj.emboj.7601749; FREI E, 1974, CANCER CHEMOTH REP 1, V58, P49; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; Johnson RF, 2006, J VIROL, V80, P5135, DOI 10.1128/JVI.01857-05; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wu MH, 2002, INT J CANCER, V97, P297, DOI 10.1002/ijc.1606; Yugami M, 2007, FEBS LETT, V581, P1, DOI 10.1016/j.febslet.2006.11.062; YUNG BYM, 1985, BIOCHIM BIOPHYS ACTA, V826, P167, DOI 10.1016/0167-4781(85)90002-8	22	41	43	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	12					1821	1834		10.1038/onc.2009.473	http://dx.doi.org/10.1038/onc.2009.473			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	574VR	20101230				2022-12-25	WOS:000276022800011
J	Chan, SH; Opitz, L; Higgins, L; O'Ioane, D; Xu, SY				Chan, Siu-hong; Opitz, Lars; Higgins, Lauren; O'Ioane, Diana; Xu, Shuang-yong			Cofactor Requirement of HpyAV Restriction Endonuclease	PLOS ONE			English	Article							YIG NUCLEASE SUPERFAMILY; MYCOIDES SUBSP MYCOIDES; DOUBLE-STRANDED DNA; N-H ENDONUCLEASES; II RESTRICTION; HELICOBACTER-PYLORI; HOMING ENDONUCLEASE; METAL-ION; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE	Background: Helicobacter pylori is the etiologic agent of common gastritis and a risk factor for gastric cancer. It is also one of the richest sources of Type II restriction-modification (R-M) systems in microorganisms. Principal/Findings: We have cloned, expressed and purified a new restriction endonuclease HpyAV from H. pylori strain 26695. We determined the HpyAV DNA recognition sequence and cleavage site as CCTTC 6/5. In addition, we found that HpyAV has a unique metal ion requirement: its cleavage activity is higher with transition metal ions than in Mg++. The special metal ion requirement of HpyAV can be attributed to the presence of a HNH catalytic site similar to ColE9 nuclease instead of the canonical PD-X-D/EXK catalytic site found in many other REases. Site-directed mutagenesis was carried out to verify the catalytic residues of HpyAV. Mutation of the conserved metal-binding Asn311 and His320 to alanine eliminated cleavage activity. HpyAV variant H295A displayed approximately 1% of wt activity. Conclusions/Significance: Some HNH-type endonucleases have unique metal ion cofactor requirement for optimal activities. Homology modeling and site-directed mutagenesis confirmed that HpyAV is a member of the HNH nuclease family. The identification of catalytic residues in HpyAV paved the way for further engineering of the metal binding site. A survey of sequenced microbial genomes uncovered 10 putative R-M systems that show high sequence similarity to the HpyAV system, suggesting lateral transfer of a prototypic HpyAV-like R-M system among these microorganisms.	[Chan, Siu-hong; Opitz, Lars; Higgins, Lauren; O'Ioane, Diana; Xu, Shuang-yong] New England Biolabs Inc, Res Dept, Ipswich, MA USA	New England Biolabs	Chan, SH (corresponding author), New England Biolabs Inc, Res Dept, Ipswich, MA USA.	xus@neb.com		Chan, Siu-Hong/0000-0002-9554-7273	New England Biolabs, Inc	New England Biolabs, Inc	The project was funded by New England Biolabs, Inc. The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Allingham JS, 2002, J MOL BIOL, V319, P53, DOI 10.1016/S0022-2836(02)00297-8; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azarinskas A, 2006, J BIOTECHNOL, V123, P288, DOI 10.1016/j.jbiotec.2005.12.016; Baltrus DA, 2008, EVOLUTION, V62, P39, DOI 10.1111/j.1558-5646.2007.00271.x; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Bujnicki JM, 2001, TRENDS BIOCHEM SCI, V26, P9, DOI 10.1016/S0968-0004(00)01690-X; Caner V, 2007, WORLD J GASTROENTERO, V13, P2581, DOI 10.3748/wjg.v13.i18.2581; Chan SH, 2004, NUCLEIC ACIDS RES, V32, P6187, DOI 10.1093/nar/gkh958; Chandrashekaran S, 2004, J BIOL CHEM, V279, P49736, DOI 10.1074/jbc.M409483200; Cheng YS, 2002, J MOL BIOL, V324, P227, DOI 10.1016/S0022-2836(02)01092-6; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; CIRINO NM, 1995, BIOCHEMISTRY-US, V34, P9936, DOI 10.1021/bi00031a016; Cymerman IA, 2006, PROTEINS, V65, P867, DOI 10.1002/prot.21156; Derbyshire V, 1997, J MOL BIOL, V265, P494, DOI 10.1006/jmbi.1996.0754; Dunten PW, 2008, NUCLEIC ACIDS RES, V36, P5405, DOI 10.1093/nar/gkn510; Eklund JL, 2007, NUCLEIC ACIDS RES, V35, P5839, DOI 10.1093/nar/gkm624; Friedhoff P, 1996, NUCLEIC ACIDS RES, V24, P2632, DOI 10.1093/nar/24.14.2632; Galburt EA, 1999, NAT STRUCT BIOL, V6, P1096, DOI 10.1038/70027; Galburt EA, 2002, BIOCHEMISTRY-US, V41, P13851, DOI 10.1021/bi020467h; Gasiunas G, 2008, NUCLEIC ACIDS RES, V36, P938, DOI 10.1093/nar/gkm1090; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Harrington DJ, 2002, MICROBES INFECT, V4, P501, DOI 10.1016/S1286-4579(02)01565-4; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Horton J.R., 2004, RESTRICTION ENDONUCL, P316; HSU MT, 1978, BIOCHEMISTRY-US, V17, P131, DOI 10.1021/bi00594a019; Ibryashkina EM, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-48; Ibryashkina EM, 2009, J MOL BIOL, V387, P10, DOI 10.1016/j.jmb.2009.01.048; Israel DA, 2000, FEMS MICROBIOL LETT, V186, P275, DOI 10.1016/S0378-1097(00)00156-7; IZSVAK Z, 1989, BIOCHEM J, V258, P301, DOI 10.1042/bj2580301; Jakubauskas A, 2008, BIOCHEMISTRY-US, V47, P8546, DOI 10.1021/bi800660u; Jakubauskas A, 2007, J MOL BIOL, V370, P157, DOI 10.1016/j.jmb.2007.04.049; Kahng LS, 2001, J BACTERIOL, V183, P3065, DOI 10.1128/JB.183.10.3065-3075.2001; Kaminska KH, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-48; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kovall RA, 1999, CURR OPIN CHEM BIOL, V3, P578, DOI 10.1016/S1367-5931(99)00012-5; Kriukiene E, 2005, BBA-PROTEINS PROTEOM, V1751, P194, DOI 10.1016/j.bbapap.2005.06.006; Kriukiene E, 2006, FEBS LETT, V580, P6115, DOI 10.1016/j.febslet.2006.09.075; Ku WY, 2002, NUCLEIC ACIDS RES, V30, P1670, DOI 10.1093/nar/30.7.1670; Lin LF, 2001, P NATL ACAD SCI USA, V98, P2740, DOI 10.1073/pnas.051612298; Mannino SJ, 1999, BIOCHEMISTRY-US, V38, P16178, DOI 10.1021/bi991452v; Mate MJ, 2004, J BIOL CHEM, V279, P34763, DOI 10.1074/jbc.M403719200; Miller MD, 1996, PROTEIN SCI, V5, P24; MILLER MD, 1994, NAT STRUCT BIOL, V1, P461, DOI 10.1038/nsb0794-461; Morgan RD, 2008, NUCLEIC ACIDS RES, V36, P6558, DOI 10.1093/nar/gkn711; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5208, DOI 10.1093/nar/gkp534; Nobusato A, 2000, GENE, V259, P89, DOI 10.1016/S0378-1119(00)00455-8; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; Orlowski J, 2008, NUCLEIC ACIDS RES, V36, P3552, DOI 10.1093/nar/gkn175; Phillips ND, 2009, VET MICROBIOL, V134, P294, DOI 10.1016/j.vetmic.2008.08.006; Pilo P, 2007, VET J, V174, P513, DOI 10.1016/j.tvjl.2006.10.016; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Pingoud V, 2009, J MOL BIOL, V393, P140, DOI 10.1016/j.jmb.2009.08.011; Platt R, 2000, PLASMID, V43, P12, DOI 10.1006/plas.1999.1433; Pommer AJ, 1999, J BIOL CHEM, V274, P27153, DOI 10.1074/jbc.274.38.27153; Pommer AJ, 2001, J MOL BIOL, V314, P735, DOI 10.1006/jmbi.2001.5189; Pommer AJ, 1998, BIOCHEM J, V334, P387, DOI 10.1042/bj3340387; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; SAMUELSON J, 2008, WO2008073746 WIPO; Saravanan M, 2004, NUCLEIC ACIDS RES, V32, P6129, DOI 10.1093/nar/gkh951; Saravanan M, 2007, NUCLEIC ACIDS RES, V35, P2777, DOI 10.1093/nar/gkm114; Shen BW, 2004, J MOL BIOL, V342, P43, DOI 10.1016/j.jmb.2004.07.032; Skoglund A, 2007, J BACTERIOL, V189, P8914, DOI 10.1128/JB.00108-07; Sokolowska M, 2009, NUCLEIC ACIDS RES, V37, P3799, DOI 10.1093/nar/gkp228; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; TAYLOR JD, 1989, BIOCHEMISTRY-US, V28, P6198, DOI 10.1021/bi00441a011; THIGPEN JE, 1983, J CLIN MICROBIOL, V18, P956, DOI 10.1128/JCM.18.4.956-960.1983; Truglio JJ, 2005, EMBO J, V24, P885, DOI 10.1038/sj.emboj.7600568; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Van Roey P, 2002, NAT STRUCT BIOL, V9, P806, DOI 10.1038/nsb853; VERMOTE CLM, 1992, BIOCHEMISTRY-US, V31, P6082, DOI 10.1021/bi00141a018; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; Walker DC, 2002, NUCLEIC ACIDS RES, V30, P3225, DOI 10.1093/nar/gkf420; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; Wittmayer PK, 1996, BIOCHEMISTRY-US, V35, P1076, DOI 10.1021/bi952363v; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3839, DOI 10.1093/nar/gkf504; Xu Q, 2000, P NATL ACAD SCI USA, V97, P9671, DOI 10.1073/pnas.97.17.9671; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2008, NAT STRUCT MOL BIOL, V15, P1228, DOI 10.1038/nsmb.1502; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	80	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9071	10.1371/journal.pone.0009071	http://dx.doi.org/10.1371/journal.pone.0009071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140205	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442400010
J	Gupta, PK; Liu, SH; Leppla, SH				Gupta, Pradeep K.; Liu, Shihui; Leppla, Stephen H.			Characterization of a Chinese Hamster Ovary Cell Mutant Having a Mutation in Elongation Factor-2	PLOS ONE			English	Article							PSEUDOMONAS EXOTOXIN-A; RECEPTOR-RELATED PROTEIN; ADP-RIBOSYLATING TOXINS; ANTHRAX LETHAL FACTOR; DIPHTHERIA-TOXIN; FACTOR-II; MAMMALIAN-CELLS; TRANSLATION ELONGATION-FACTOR-2; AMINO-ACID; DIPHTHAMIDE	Retroviral insertional mutagenesis provides an effective forward genetic method for identifying genes involved in essential cellular pathways. A Chinese hamster ovary cell line mutant resistant to several bacterial ADP-ribosylating was obtained by this approach. The toxins used catalyze ADP-ribosylation of eukaryotic elongation factor 2 (eEF-2), block protein synthesis, and cause cell death. Strikingly, in the CHO PR328 mutant cells, the eEF-2 substrate of these ADP-ribosylating toxins was found to be modified, but the cells remained viable. A systematic study of these cells revealed the presence of a structural mutation in one allele of the eEF-2 gene. This mutation, Gly717Arg, is close to His715, the residue that is modified to become diphthamide. This Arg substitution prevents diphthamide biosynthesis at His715, rendering the mutated eEF-2 non-responsive to ADP-ribosylating toxins, while having no apparent effect on protein synthesis. Thus, CHO PR328 cells are heterozygous, having wild type and mutant eEF-2 alleles, with the latter allowing the cells to survive even in the presence of ADP-ribosylating toxins. Here, we report the comprehensive characterization of these cells.	[Gupta, Pradeep K.; Liu, Shihui; Leppla, Stephen H.] NIAID, Lab Bacterial Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gupta, PK (corresponding author), NIAID, Lab Bacterial Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov		Liu, Shihui/0000-0003-3444-1069	National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000929] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA N, 1993, J BIOL CHEM, V268, P3334; ARORA N, 1992, J BIOL CHEM, V267, P15542; BODLEY JW, 1984, METHOD ENZYMOL, V106, P378; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; FOLEY BT, 1995, J BIOL CHEM, V270, P23218, DOI 10.1074/jbc.270.39.23218; FOLEY BT, 1992, SOMAT CELL MOLEC GEN, V18, P227, DOI 10.1007/BF01233859; Gupta PK, 2008, CELL MICROBIOL, V10, P1687, DOI 10.1111/j.1462-5822.2008.01159.x; Gupta PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003130; Hobson JP, 2006, NAT METHODS, V3, P259, DOI 10.1038/NMETH862; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; KOHNO K, 1987, J BIOL CHEM, V262, P12298; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; LEPPLA SH, 1976, INFECT IMMUN, V14, P1077, DOI 10.1128/IAI.14.4.1077-1086.1976; LEPPLA SH, 2006, COMPREHENSIVE SOURCE, P323; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; MOEHRING JM, 1980, P NATL ACAD SCI-BIOL, V77, P1010, DOI 10.1073/pnas.77.2.1010; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; PERENTESIS JP, 1992, BIOFACTORS, V3, P173; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; VANNESS BG, 1980, J BIOL CHEM, V255, P717; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zhu PJ, 2009, BIOORGAN MED CHEM, V17, P5139, DOI 10.1016/j.bmc.2009.05.054	28	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9078	10.1371/journal.pone.0009078	http://dx.doi.org/10.1371/journal.pone.0009078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140093	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442400015
J	Guo, XM; Ernst, NL; Carnes, J; Stuart, KD				Guo, Xuemin; Ernst, Nancy Lewis; Carnes, Jason; Stuart, Kenneth D.			The Zinc-Fingers of KREPA3 Are Essential for the Complete Editing of Mitochondrial mRNAs in Trypanosoma brucei	PLOS ONE			English	Article							BINDING PROTEIN; EDITOSOME INTEGRITY; GUIDE RNA; IN-VITRO; OB-FOLD; AFRICAN TRYPANOSOMES; CYTOCHROME-OXIDASE; B TRANSCRIPTS; DELETION; LEISHMANIA	Most mitochondrial mRNAs in trypanosomes undergo uridine insertion/deletion editing that is catalyzed by similar to 20S editosomes. The editosome component KREPA3 is essential for editosome structural integrity and its two zinc finger (ZF) motifs are essential for editing in vivo but not in vitro. KREPA3 function was further explored by examining the consequence of mutation of its N- and C-terminal ZFs (ZF1 and ZF2, respectively). Exclusively expressed myc-tagged KREPA3 with ZF2 mutation resulted in lower KREPA3 abundance and a relative increase in KREPA2 and KREL1 proteins. Detailed analysis of edited RNA products revealed the accumulation of partially edited mRNAs with less insertion editing compared to the partially edited mRNAs found in the cells with wild type KREPA3 expression. Mutation of ZF1 in TAP-tagged KREPA3 also resulted in accumulation of partially edited mRNAs that were shorter and only edited in the 39-terminal editing region. Mutation of both ZFs essentially eliminated partially edited mRNA. The mutations did not affect gRNA abundance. These data indicate that both ZFs are essential for the progression of editing and perhaps its accuracy, which suggests that KREPA3 plays roles in the editing process via its ZFs interaction with editosome proteins and/or RNA substrates.	[Guo, Xuemin; Ernst, Nancy Lewis; Carnes, Jason; Stuart, Kenneth D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	Center for Infectious Disease Research	Guo, XM (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	ken.stuart@sbri.org		Carnes, Jason/0000-0001-7302-1935	National Institutes of Health (NIH) [AI014012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014102] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI014012 to K. Stuart (http://www.nih.gov/). Research was conducted using equipment made possible by the Economic Development Administration - United States Department of Commerce (http://www.eda.gov/) and the M.J. Murdock Charitable Trust (http://www.murdock-trust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; Agrawal V, 2003, CURR PROTEIN PEPT SC, V4, P195, DOI 10.2174/1389203033487207; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2005, CELL MOL LIFE SCI, V62, P2194, DOI 10.1007/s00018-005-5198-9; Aphasizhev R, 2003, P NATL ACAD SCI USA, V100, P10617, DOI 10.1073/pnas.1833120100; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Babbarwal VK, 2007, RNA, V13, P737, DOI 10.1261/rna.327707; BENNE R, 1994, EUR J BIOCHEM, V221, P9, DOI 10.1111/j.1432-1033.1994.tb18710.x; BENNE R, 1992, MOL BIOL REP, V16, P217, DOI 10.1007/BF00419661; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BHAT GJ, 1990, CELL, V61, P885, DOI 10.1016/0092-8674(90)90199-O; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Clement SL, 2004, EUKARYOT CELL, V3, P862, DOI 10.1128/EC.3.4.862-869.2004; Cruz-Reyes J, 2002, MOL CELL BIOL, V22, P4652, DOI 10.1128/MCB.22.13.4652-4660.2002; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; Domingo GJ, 2003, EUKARYOT CELL, V2, P569, DOI 10.1128/EC.2.3.569-577.2003; Ernst NL, 2009, RNA, V15, P947, DOI 10.1261/rna.1373009; Ernst NL, 2003, MOL CELL, V11, P1525, DOI 10.1016/S1097-2765(03)00185-0; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Fisk JC, 2009, MOL CELL BIOL, V29, P5214, DOI 10.1128/MCB.00520-09; Golden DE, 2005, RNA, V11, P29, DOI 10.1261/rna.7170705; Grams J, 2000, EMBO J, V19, P5525, DOI 10.1093/emboj/19.20.5525; Guo XM, 2008, MOL CELL BIOL, V28, P6939, DOI 10.1128/MCB.01115-08; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; Kang XD, 2006, P NATL ACAD SCI USA, V103, P13944, DOI 10.1073/pnas.0604476103; Koller J, 1997, J BIOL CHEM, V272, P3749, DOI 10.1074/jbc.272.6.3749; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Lambert L, 1999, NUCLEIC ACIDS RES, V27, P1429, DOI 10.1093/nar/27.6.1429; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; Law JA, 2007, MOL CELL BIOL, V27, P777, DOI 10.1128/MCB.01460-06; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lukes J, 2002, EUKARYOT CELL, V1, P495, DOI 10.1128/EC.1.4.495-502.2002; Madison-Antenucci S, 2002, CELL, V108, P435, DOI 10.1016/S0092-8674(02)00653-0; Madison-Antenucci S, 2001, MOL CELL, V7, P879, DOI 10.1016/S1097-2765(01)00231-3; MASLOV DA, 1992, CELL, V70, P459, DOI 10.1016/0092-8674(92)90170-H; Miller MM, 2006, RNA, V12, P1292, DOI 10.1261/rna.2331506; OCHSENREITER T, 2008, MOL CELL BIOL; Ochsenreiter T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001566; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; Osato D, 2009, RNA, V15, P1338, DOI 10.1261/rna.1642809; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; READ LK, 1992, J BIOL CHEM, V267, P1123; Salavati R, 2006, RNA, V12, P819, DOI 10.1261/rna.2244106; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; SCHNAUFER A, 2009, J BIOL CHEM; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; STURM NR, 1990, CELL, V61, P871, DOI 10.1016/0092-8674(90)90197-M; Tarun SZ, 2008, RNA, V14, P347, DOI 10.1261/rna.763308; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; VANDERSPEK H, 1991, EMBO J, V10, P1217, DOI 10.1002/j.1460-2075.1991.tb08063.x; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wang BB, 2003, EUKARYOT CELL, V2, P578, DOI 10.1128/EC.2.3.578-587.2003; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P6392, DOI 10.1093/nar/gkg870	71	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8913	10.1371/journal.pone.0008913	http://dx.doi.org/10.1371/journal.pone.0008913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111718	Green Published, Green Submitted, gold			2022-12-25	WOS:000274114800016
J	Metzner, M; Schuh, W; Roth, E; Jack, HM; Wabl, M				Metzner, Mirjam; Schuh, Wolfgang; Roth, Edith; Jaeck, Hans-Martin; Wabl, Matthias			Two Forms of Activation-Induced Cytidine Deaminase Differing in Their Ability to Bind Agarose	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; DIVERSIFICATION ENZYME; EXPRESSION LEVELS; B-CELLS; AID; PHOSPHORYLATION	Background: Activation-induced cytidine deaminase ( AID) is a B-cell-specific DNA mutator that plays a key role in the formation of the secondary antibody repertoire in germinal center B cells. In the search for binding partners, protein coimmunoprecipitation assays are often performed, generally with agarose beads. Methodology/Principal Findings: We found that, regardless of whether cell lysates containing exogenous or endogenous AID were examined, one of two mouse AID forms bound to agarose alone. Conclusions/Significance: These binding characteristics may be due to the known post-translational modifications of AID; they may also need to be considered in coimmunoprecipitation experiments to avoid false-positive results.	[Metzner, Mirjam; Schuh, Wolfgang; Roth, Edith; Jaeck, Hans-Martin] Univ Erlangen Nurnberg, Dept Internal Med 3, Nikolaus Fiebiger Ctr, Div Mol Immunol, Erlangen, Germany; [Metzner, Mirjam; Wabl, Matthias] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Erlangen Nuremberg; University of California System; University of California San Francisco	Metzner, M (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, Nikolaus Fiebiger Ctr, Div Mol Immunol, Erlangen, Germany.	mirjam.metzner@ucsf.edu		Jack, Hans-Martin/0000-0002-6332-8463	National Institutes of Health [R01AI041570]; Deutsche Forschungsgemeinschaft [JA968/5, FOR832]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01AI041570 to Matthias Wabl and by the Research Grant JA968/5 through FOR832 from the Deutsche Forschungsgemeinschaft to Hans-Martin Jack. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri S, 2004, IEEE T KNOWL DATA EN, V16, P992, DOI 10.1109/TKDE.2004.30; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Imai K, 2005, CLIN IMMUNOL, V115, P277, DOI 10.1016/j.clim.2005.02.003; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Krueger C, 2006, J GENE MED, V8, P1037, DOI 10.1002/jgm.932; Lorens JB, 2000, VIROLOGY, V272, P7, DOI 10.1006/viro.2000.0353; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8883	10.1371/journal.pone.0008883	http://dx.doi.org/10.1371/journal.pone.0008883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111710	Green Published, gold, Green Submitted			2022-12-25	WOS:000274114800008
J	le Feber, J; Stegenga, J; Rutten, WLC				le Feber, Joost; Stegenga, Jan; Rutten, Wim L. C.			The Effect of Slow Electrical Stimuli to Achieve Learning in Cultured Networks of Rat Cortical Neurons	PLOS ONE			English	Article							DYNAMICS; PLASTICITY; CALCIUM; BURSTS	Learning, or more generally, plasticity may be studied using cultured networks of rat cortical neurons on multi electrode arrays. Several protocols have been proposed to affect connectivity in such networks. One of these protocols, proposed by Shahaf and Marom, aimed to train the input-output relationship of a selected connection in a network using slow electrical stimuli. Although the results were quite promising, the experiments appeared difficult to repeat and the training protocol did not serve as a basis for wider investigation yet. Here, we repeated their protocol, and compared our 'learning curves' to the original results. Although in some experiments the protocol did not seem to work, we found that on average, the protocol showed a significantly improved stimulus response indeed. Furthermore, the protocol always induced functional connectivity changes that were much larger than changes that occurred after a comparable period of random or no stimulation. Finally, our data shows that stimulation at a fixed electrode induces functional connectivity changes of similar magnitude as stimulation through randomly varied sites; both larger than spontaneous connectivity fluctuations. We concluded that slow electrical stimulation always induced functional connectivity changes, although uncontrolled. The magnitude of change increased when we applied the adaptive (closed-loop) training protocol. We hypothesize that networks develop an equilibrium between connectivity and activity. Induced connectivity changes depend on the combination of applied stimulus and initial connectivity. Plain stimuli may drive networks to the nearest equilibrium that accommodates this input, whereas adaptive stimulation may direct the space for exploration and force networks to a new balance, at a larger distance from the initial state.	[le Feber, Joost; Stegenga, Jan; Rutten, Wim L. C.] Univ Twente, MIRA, Inst Biomed Engn, Dept Elect Engn Math & Comp Sci, NL-7500 AE Enschede, Netherlands	University of Twente	le Feber, J (corresponding author), Univ Twente, MIRA, Inst Biomed Engn, Dept Elect Engn Math & Comp Sci, POB 217, NL-7500 AE Enschede, Netherlands.	j.lefeber@utwente.nl			University of Twente	University of Twente	This work was funded by an internal grant (spearhead program) from the University of Twente. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkum DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002088; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Chiappalone M, 2008, EUR J NEUROSCI, V28, P221, DOI 10.1111/j.1460-9568.2008.06259.x; Eytan D, 2003, J NEUROSCI, V23, P9349; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; GROSS GW, 1995, BIOSENS BIOELECTRON, V10, P553, DOI 10.1016/0956-5663(95)96931-N; Jimbo Y, 1998, IEEE T BIO-MED ENG, V45, P1297, DOI 10.1109/10.725326; JIMBO Y, 1993, IEEE T BIO-MED ENG, V40, P804, DOI 10.1109/10.238465; Jimbo Y, 2000, BIOL CYBERN, V83, P1, DOI 10.1007/PL00007970; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; le Feber J, 2009, BIOPHYS J, V96, P3443, DOI 10.1016/j.bpj.2009.01.013; Li YL, 2007, BIOSENS BIOELECTRON, V22, P2976, DOI 10.1016/j.bios.2006.12.018; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; MELSSEN WJ, 1987, BIOL CYBERN, V57, P403, DOI 10.1007/BF00354985; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; ROMIJN HJ, 1984, NEUROSCI BIOBEHAV R, V8, P301, DOI 10.1016/0149-7634(84)90055-1; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stegenga J, 2008, IEEE T BIO-MED ENG, V55, P1382, DOI 10.1109/TBME.2007.913987; Stegenga J, 2009, IEEE T BIO-MED ENG, V56, P1220, DOI 10.1109/TBME.2008.2006856; Vajda I, 2008, BIOPHYS J, V94, P5028, DOI 10.1529/biophysj.107.112730; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; van Staveren GW, 2005, I IEEE EMBS C NEUR E, P328; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Wagenaar DA, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-16; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	29	56	57	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8871	10.1371/journal.pone.0008871	http://dx.doi.org/10.1371/journal.pone.0008871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111726	Green Published, gold			2022-12-25	WOS:000273896300020
J	Yokoyama, M; Mori, H; Sato, H				Yokoyama, Masaru; Mori, Hiromi; Sato, Hironori			Allosteric Regulation of HIV-1 Reverse Transcriptase by ATP for Nucleotide Selection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-REPLICATION FIDELITY; T7 RNA-POLYMERASE; DRUG-RESISTANCE; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURES; 3'-AZIDO-3'-DEOXYTHYMIDINE; TRANSLOCATION; INHIBITION; AZT	Background: Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) is a DNA polymerase that converts viral RNA genomes into proviral DNAs. How HIV-1 RT regulates nucleotide selectivity is a central issue for genetics and the nucleoside analog RT inhibitor (NRTI) resistance of HIV-1. Methodology/Principal Findings: Here we show that an ATP molecule at physiological concentrations acts as an allosteric regulator of HIV-1 RT to decrease the K-m value of the substrate, decrease the k(cat) value, and increase the K-i value of NRTIs for RT. Computer-assisted structural analyses and mutagenesis studies suggested the positions of the ATP molecule and NRTI-resistance mutations during a catalytic reaction, which immediately predict possible influences on nucleotide insertion into the catalytic site, the DNA polymerization, and the excision reaction. Conclusions/Significance: These data imply that the ATP molecule and NRTI mutations can modulate nucleotide selectivity by altering the fidelity of the geometric selection of nucleotides and the probability of an excision reaction.	[Yokoyama, Masaru; Mori, Hiromi; Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Musashimurayama, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Yokoyama, M (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Musashimurayama, Tokyo, Japan.	yokoyama@nih.go.jp			Ministry of Health, Labor and Welfare, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Chen RX, 2005, J VIROL, V79, P12045, DOI 10.1128/JVI.79.18.12045-12057.2005; Das K, 2007, J MOL BIOL, V365, P77, DOI 10.1016/j.jmb.2006.08.097; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Sato H, 2001, J VIROL, V75, P5604, DOI 10.1128/JVI.75.12.5604-5613.2001; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; STARNES MC, 1989, J BIOL CHEM, V264, P7073; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VRANG L, 1987, ANTIVIR RES, V7, P139, DOI 10.1016/0166-3542(87)90002-7; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	34	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8867	10.1371/journal.pone.0008867	http://dx.doi.org/10.1371/journal.pone.0008867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111609	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896300016
J	Bilbo, SD; Tsang, V				Bilbo, Staci D.; Tsang, Verne			Enduring consequences of maternal obesity for brain inflammation and behavior of offspring	FASEB JOURNAL			English	Article						cytokines; hippocampus; cognition; microglia; perinatal programming	DIET-INDUCED OBESITY; FATTY-ACIDS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DUAL ROLE; INTERLEUKIN-1; TRANS; CONSUMPTION; RESTRICTION; MICROGLIA	Obesity is well characterized as a systemic inflammatory condition, and is also associated with cognitive disruption, suggesting a link between the two. We assessed whether peripheral inflammation in maternal obesity may be transferred to the offspring brain, in particular, the hippocampus, and thereby result in cognitive dysfunction. Rat dams were fed a high-saturated-fat diet (SFD), a high-trans-fat diet (TFD), or a low-fat diet (LFD) for 4 wk prior to mating, and remained on the diet throughout pregnancy and lactation. SFD/TFD exposure significantly increased body weight in both dams and pups compared to controls. Microglial activation markers were increased in the hippocampus of SFD/TFD pups at birth. At weaning and in adulthood, proinflammatory cytokine expression was strikingly increased in the periphery and hippocampus following a bacterial challenge [lipo-polysaccharide (LPS)] in the SFD/TFD groups compared to controls. Microglial activation within the hippocampus was also increased basally in SFD rats, suggesting a chronic priming of the cells. Finally, there were marked changes in anxiety and spatial learning in SFD/TFD groups. These effects were all observed in adulthood, even after the pups were placed on standard chow at weaning, suggesting these outcomes were programmed early in life.-Bilbo, S. D., Tsang, V. Enduring consequences of maternal obesity for brain inflammation and behavior of offspring. FASEB J. 24, 2104-2115 (2010). www.fasebj.org	[Bilbo, Staci D.; Tsang, Verne] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA	Duke University	Bilbo, SD (corresponding author), Duke Univ, Dept Psychol & Neurosci, 572 Res Dr,Box 91050,3016 GSRB 2, Durham, NC 27708 USA.	staci.bilbo@duke.edu	Bilbo, Staci D/L-5076-2016	Bilbo, Staci D/0000-0001-6736-7841; Bilbo, Staci/0000-0001-7395-5033				Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Bilbo SD, 2010, PSYCHONEUROENDOCRINO, V35, P369, DOI 10.1016/j.psyneuen.2009.07.014; Bland ST, 2010, BRAIN BEHAV IMMUN, V24, P329, DOI 10.1016/j.bbi.2009.09.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Craig-Schmidt MC, 2001, LIPIDS, V36, P997, DOI 10.1007/s11745-001-0811-8; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Duffield JA, 2009, PEDIATR RES, V66, P59, DOI 10.1203/PDR.0b013e3181a7c121; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Elias SL, 2001, AM J CLIN NUTR, V73, P807; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Freeman DJ, 2010, SEMIN FETAL NEONAT M, V15, P113, DOI 10.1016/j.siny.2009.09.001; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; GRANDGIRARD A, 1994, LIPIDS, V29, P251, DOI 10.1007/BF02536329; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Grattan DR, 2008, ENDOCRINOLOGY, V149, P5345, DOI 10.1210/en.2008-1106; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Lafrance V, 2010, BRAIN BEHAV IMMUN, V24, P358, DOI 10.1016/j.bbi.2009.11.003; Legendre A, 2007, AM J PHYSIOL-REG I, V293, pR1076, DOI 10.1152/ajpregu.00592.2006; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luvisetto S, 2008, NEUROSCIENCE, V155, P585, DOI 10.1016/j.neuroscience.2008.06.030; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; McGuire W, 2010, SEMIN FETAL NEONAT M, V15, P108, DOI 10.1016/j.siny.2009.09.005; McNaull BBA, 2010, GERONTOLOGY, V56, P3, DOI 10.1159/000237873; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Murray AJ, 2009, FASEB J, V23, P4353, DOI 10.1096/fj.09-139691; Padilla ND, 2003, IMMUNOLOGY, V109, P564, DOI 10.1046/j.1365-2567.2003.01681.x; Pasinetti GM, 2008, J NEUROCHEM, V106, P1503, DOI 10.1111/j.1471-4159.2008.05454.x; PETTERSEN J, 1988, LIPIDS, V23, P720, DOI 10.1007/BF02535675; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinteaux E, 2007, J NEUROCHEM, V102, P826, DOI 10.1111/j.1471-4159.2007.04559.x; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schmatz M, 2010, J PERINATOL, V30, P441, DOI 10.1038/jp.2009.182; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Simmons R, 2008, SEMIN PERINATOL, V32, P371, DOI 10.1053/j.semperi.2008.08.004; Souza CG, 2007, LIFE SCI, V81, P198, DOI 10.1016/j.lfs.2007.05.001; Spulber S, 2009, J NEUROIMMUNOL, V208, P46, DOI 10.1016/j.jneuroim.2009.01.010; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Wolff RL, 2003, LIPIDS, V38, P1143, DOI 10.1007/s11745-003-1172-z; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003	55	339	346	1	45	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2104	2115		10.1096/fj.09-144014	http://dx.doi.org/10.1096/fj.09-144014			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20124437				2022-12-25	WOS:000278200000043
J	Nagai, Y; Nishimura, A; Tago, K; Mizuno, N; Itoh, H				Nagai, Yusuke; Nishimura, Akiyuki; Tago, Kenji; Mizuno, Norikazu; Itoh, Hiroshi			Ric-8B Stabilizes the alpha Subunit of Stimulatory G Protein by Inhibiting Its Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC DIVISION; SIGNAL-TRANSDUCTION; DROSOPHILA RIC-8; PLASMA-MEMBRANE; SYNEMBRYN; DEGRADATION; EXPRESSION; INTERACTS; RECEPTOR; GTP	The alpha subunit of stimulatory G protein (G alpha(s)) activates adenylyl cyclase, which catalyzes cAMP production, and regulates many physiological aspects, such as cardiac regulation and endocrine systems. Ric-8B (resistance to inhibitors of cholinesterase 8B) has been identified as the G alpha(s)-binding protein; however, its role in G(s) signaling remains obscure. In this study, we present evidence that Ric-8B specifically and positively regulates G(s) signaling by stabilizing the G alpha(s) protein. An in vitro biochemical study suggested that Ric-8B does not possess guanine nucleotide exchange factor activity. However, knockdown of Ric-8B attenuated beta-adrenergic agonist-induced cAMP accumulation, indicating that Ric-8B positively regulates G(s) signaling. Interestingly, overexpression and knockdown of Ric-8B resulted in an increase and a decrease in the G alpha(s) protein, respectively, without affecting the G alpha(s) mRNA level. We found that the G alpha(s) protein is ubiquitinated and that this ubiquitination is inhibited by Ric-8B. This Ric-8B-mediated inhibition of G alpha(s) ubiquitination requires interaction between Ric-8B and G alpha(s) because Ric-8B splicing variants, which are defective for G alpha(s) binding, failed to inhibit the ubiquitination. Taken together, these results suggest that Ric-8B plays a critical and specific role in the control of G alpha(s) protein levels by modulating G alpha(s) ubiquitination and positively regulates G(s) signaling.	[Nagai, Yusuke; Nishimura, Akiyuki; Tago, Kenji; Mizuno, Norikazu; Itoh, Hiroshi] Nara Inst Sci & Technol, Dept Cell Biol, Grad Sch Biol Sci, Nara 6300192, Japan	Nara Institute of Science & Technology	Itoh, H (corresponding author), Nara Inst Sci & Technol, Dept Cell Biol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	hitoh@bs.naist.jp			Ministry of Education, Culture, Sports, Science, and Technology [17079006]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research on Priority Areas 17079006 from the Ministry of Education, Culture, Sports, Science, and Technology.	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; CHANG FH, 1989, J BIOL CHEM, V264, P5352; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; ITOH H, 1991, J BIOL CHEM, V266, P16226; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Klattenhoff C, 2003, J CELL PHYSIOL, V195, P151, DOI 10.1002/jcp.10300; Kozasa Tohru, 2003, V237, P21; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Nagayoshi S, 2008, DEVELOPMENT, V135, P159, DOI 10.1242/dev.009050; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Perez-Oliva AB, 2009, J BIOL CHEM, V284, P31714, DOI 10.1074/jbc.M109.028100; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	35	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11114	11120		10.1074/jbc.M109.063313	http://dx.doi.org/10.1074/jbc.M109.063313			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20133939	Green Published, hybrid			2022-12-25	WOS:000276286200016
J	Welman, A; Serrels, A; Brunton, VG; Ditzel, M; Frame, MC				Welman, Arkadiusz; Serrels, Alan; Brunton, Valerie G.; Ditzel, Mark; Frame, Margaret C.			Two-color Photoactivatable Probe for Selective Tracking of Proteins and Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED FLUORESCENT PROTEIN; MONOMERIC RED; DROSOPHILA; EXPRESSION; CONVERSION; MIGRATION; DYNAMICS; SYSTEM; GENES	We report the development and application of photoactivatable Green Cherry (G(PA)C), the first genetically encoded "continuously red-photoactivatable green" two-color probe for live cell imaging. G(PA)C is unique in that it enables real-time tracking of selected subpopulations of proteins and organelles in the cell or of cells within tissues and whole organisms, with constant reference to the entire population of the probe. Using G(PA)C-zyxin as proof of utility, we obtained new insights into the dynamic movement of the cytoskeletal protein zyxin. We show that zyxin is continuously and rapidly recruited from the cytosol into established focal adhesions. It can also move rapidly within a given focal adhesion and "hop" between adjacent focal adhesions, emphasizing the dynamic nature of proteins within these structures. The in vivo utility of G(PA)C is exemplified by tracking hemocyte movements using a versatile transgenic Drosophila model engineered to express G(PA)C in tissues and cells of interest under the control of the GAL4-inducible promoter.	[Welman, Arkadiusz; Serrels, Alan; Brunton, Valerie G.; Ditzel, Mark; Frame, Margaret C.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland	University of Edinburgh	Welman, A (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	a.welman@ed.ac.uk		Frame, Margaret/0000-0001-5882-1942	Cancer Research UK [C157/A9148]	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK Grant C157/A9148.	Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Giebel B, 1997, MECH DEVELOP, V63, P75, DOI 10.1016/S0925-4773(97)00029-4; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Lindberg U, 2008, SEMIN CANCER BIOL, V18, P2, DOI 10.1016/j.semcancer.2007.10.002; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Matsuda T, 2008, NAT METHODS, V5, P339, DOI [10.1038/nmeth.1193, 10.1038/NMETH.1193]; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Thomas SM, 1999, J CELL SCI, V112, P181; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Verkhusha VV, 2005, CHEM BIOL, V12, P279, DOI 10.1016/j.chembiol.2005.01.005; Welman A, 2000, ONCOGENE, V19, P4582, DOI 10.1038/sj.onc.1203818; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Worth DC, 2008, INT J BIOCHEM CELL B, V40, P2397, DOI 10.1016/j.biocel.2008.04.008; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	36	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11607	11616		10.1074/jbc.M110.102392	http://dx.doi.org/10.1074/jbc.M110.102392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139076	Green Published, hybrid			2022-12-25	WOS:000276286200066
J	Trong-Tue, N; Thao, DTP; Yamaguchi, M				Trong-Tue, N.; Thao, D. T. P.; Yamaguchi, M.			Role of DREF in transcriptional regulation of the Drosophila p53 gene	ONCOGENE			English	Article						Drosophila; DREF; p53; transcriptional regulation	REPLICATION-RELATED ELEMENT; DNA-REPLICATION; BINDING-FACTOR; CELL-PROLIFERATION; P53 HOMOLOG; IDENTIFICATION; MELANOGASTER; EXPRESSION; PROMOTER; SYSTEM	The tumor suppressor protein p53 has a critical role in safeguarding the integrity of the genome. Its functions are well understood but factors responsible for the transcriptional regulation of the p53 gene are almost entirely unknown. The DNA replication-related element (DRE)/DNA replication-related element-binding factor (DREF) transcriptional regulatory system is established as a master key to cell proliferation in Drosophila. DREF binds specifically to DRE sequences in the Drosophila p53 (dmp53) gene promoter as shown using anti-DREF antibodies in chromatin immunoprecipitation assays. Furthermore, a rough eye phenotype because of overexpression of DREF in Drosophila eye imaginal disks could be suppressed by half dose reduction of the dmp53 gene. In addition, the level of mRNA of dmp53 was decreased in DREF-knockdown cells and transient expression of the luciferase gene under control of the wild-type dmp53 gene promoter showed strong promoter activity in S2 cells, but this was almost completely abrogated with a DRE-mutated promoter. Requirement of DREs for dmp53 promoter activity was further confirmed by anti-beta-galactosidase antibody-staining of various tissues from transgenic flies carrying dmp53 promoter-lacZ fusion genes. These results indicate that DREF is necessary for dmp53 gene promoter activity. Oncogene (2010) 29, 2060-2069; doi: 10.1038/onc.2009.483; published online 18 January 2010	[Trong-Tue, N.; Thao, D. T. P.; Yamaguchi, M.] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Yamaguchi, M.] Kyoto Inst Technol, Sakyo Ku, Insect Biomed Res Ctr, Kyoto 6068585, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology	Yamaguchi, M (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.	myamaguc@kit.ac.jp	Dang, Thao/AFC-0112-2022	Yamaguchi, Masamitsu/0000-0002-6321-9750; Dang, Thao/0000-0002-5713-323X	KIT	KIT	We are grateful to Dr M Abrams for dmp53 mutant stock, Dr Dean P Smith for kindly providing the casper-nls-LacZ plasmid, Dr Fumiko Hirose for the anti-DREF monoclonal antibodies and Dr Malcolm Moore for comments on the English language in the paper. This study was partially supported by a scholarship and grants from the KIT.	Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Burns TF, 1999, J CELL PHYSIOL, V181, P231, DOI 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO;2-L; Choi TY, 2000, FEBS LETT, V483, P71, DOI 10.1016/S0014-5793(00)02085-8; Galindo K, 2001, GENETICS, V159, P1059; Harris CC, 1996, JNCI-J NATL CANCER I, V88, P1442, DOI 10.1093/jnci/88.20.1442; Hayashi Y, 2006, BBA-GENE STRUCT EXPR, V1759, P359, DOI 10.1016/j.bbaexp.2006.07.002; Hirose F, 1996, J BIOL CHEM, V271, P3930; Hirose F, 2001, MOL CELL BIOL, V21, P7231, DOI 10.1128/MCB.21.21.7231-7242.2001; HIROSE F, 1993, J BIOL CHEM, V268, P2092; Hirose F, 1999, MOL CELL BIOL, V19, P6020; Hyun JY, 2005, MOL CELL BIOL, V25, P5590, DOI 10.1128/MCB.25.13.5590-5598.2005; Ida H, 2007, EXP CELL RES, V313, P4208, DOI 10.1016/j.yexcr.2007.08.016; Ida H, 2009, NUCLEIC ACIDS RES, V37, P1423, DOI 10.1093/nar/gkn1068; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Kim YS, 2007, GENES CELLS, V12, P569, DOI 10.1111/j.1365-2443.2007.01075.x; Matsukage A, 2008, BBA-GENE REGUL MECH, V1779, P81, DOI 10.1016/j.bbagrm.2007.11.011; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nakamura K, 2008, NUCLEIC ACIDS RES, V36, P3905, DOI 10.1093/nar/gkn291; Ohno K, 1996, NUCLEIC ACIDS RES, V24, P3942, DOI 10.1093/nar/24.20.3942; Ohshima N, 2003, J BIOL CHEM, V278, P22928, DOI 10.1074/jbc.M303109200; Okudaira K, 2005, BBA-GENE STRUCT EXPR, V1732, P23, DOI 10.1016/j.bbaexp.2005.10.009; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Rebollar E, 2006, FEBS LETT, V580, P642, DOI 10.1016/j.febslet.2005.12.083; ROBERTSON HM, 1988, GENETICS, V118, P461; Ryu JR, 1997, NUCLEIC ACIDS RES, V25, P794, DOI 10.1093/nar/25.4.794; Sawado T, 1998, J BIOL CHEM, V273, P26042, DOI 10.1074/jbc.273.40.26042; Seto H, 2006, GENES CELLS, V11, P499, DOI 10.1111/j.1365-2443.2006.00956.x; Sharpless NE, 2002, CANCER RES, V62, P2761; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Somasundaram K, 2000, FRONT BIOSCI, V5, pD424, DOI 10.2741/Somasund; Spradling A. C, 1986, DROSOPHILA PRACTICAL; Suyari O, 2009, EXP CELL RES, V315, P1403, DOI 10.1016/j.yexcr.2008.12.017; Takahashi Y, 1996, J BIOL CHEM, V271, P14541, DOI 10.1074/jbc.271.24.14541; Takahashi Y, 1999, NUCLEIC ACIDS RES, V27, P510, DOI 10.1093/nar/27.2.510; Thao DTP, 2006, EXP CELL RES, V312, P3641, DOI DOI 10.1016/J.YEXCR.2006.08.005; Tsuchiya A, 2007, FEBS J, V274, P1818, DOI 10.1111/j.1742-4658.2007.05730.x; YAMAGUCHI M, 1995, J BIOL CHEM, V270, P15808, DOI 10.1074/jbc.270.26.15808; Yamaguchi M, 1996, GENES CELLS, V1, P47, DOI 10.1046/j.1365-2443.1996.03003.x; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113; Yamashita D, 2007, MOL CELL BIOL, V27, P2003, DOI 10.1128/MCB.01462-06; Yoshida H, 2004, GENES CELLS, V9, P935, DOI 10.1111/j.1365-2443.2004.00775.x; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	45	15	15	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2010	29	14					2060	2069		10.1038/onc.2009.483	http://dx.doi.org/10.1038/onc.2009.483			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101238				2022-12-25	WOS:000276402800005
J	Chen, RL; Chou, YC; Lan, YJ; Huang, TS; Shen, CKJ				Chen, Ruei-Lin; Chou, Yu-Chi; Lan, Yii-Jenq; Huang, Ting-Shuo; Shen, C. -K. James			Developmental Silencing of Human zeta-Globin Gene Expression Is Mediated by the Transcriptional Repressor RREB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; LEUKEMIC CELL-LINE; ERYTHROID-DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; REGULATORY ELEMENT; PROMOTER; BINDING; LOCUS; ALPHA; MOUSE	The mammalian embryonic zeta-globin genes, including that of humans, are expressed at the early embryonic stage and then switched off during erythroid development. This autonomous silencing of the zeta-globin gene transcription is probably regulated by the cooperative work of various protein-DNA and protein-protein complexes formed at the zeta-globin promoter and its upstream enhancer (HS-40). We present data here indicating that a protein-binding motif, ZF2, contributes to the repression of the HS-40-regulated human zeta-promoter activity in erythroid cell lines and in transgenic mice. Combined site-directed mutagenesis and EMSA suggest that repression of the human zeta-globin promoter is mediated through binding of the zinc finger factor RREB1 to ZF2. This model is further supported by the observation that human zeta-globin gene transcription is elevated in the human erythroid K562 cell line or the primary erythroid culture upon RNA interference (RNAi)(2) knockdown of RREB1 expression. These data together suggest that RREB1 is a putative repressor for the silencing of the mammalian zeta-globin genes during erythroid development. Because zeta-globin is a powerful inhibitor of HbS polymerization, our experiments have provided a foundation for therapeutic up-regulation of zeta-globin gene expression in patients with severe hemoglobinopathies.	[Chen, Ruei-Lin; Chou, Yu-Chi; Shen, C. -K. James] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Chen, Ruei-Lin; Shen, C. -K. James] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Chen, Ruei-Lin; Shen, C. -K. James] Natl Yang Ming Univ, Inst Genome Sci, Taipei 11221, Taiwan; [Lan, Yii-Jenq; Huang, Ting-Shuo] Chang Gung Univ, Sch Med, Tao Yuan 333, Taiwan; [Lan, Yii-Jenq] Chang Gung Mem Hosp, Dept Internal Med, Div Hematooncol, Keelung Branch, Chilung 204, Taiwan; [Huang, Ting-Shuo] Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Keelung Branch, Chilung 204, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Shen, CKJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	ckshen@imb.sinica.edu.tw	Huang, Ting-Shuo/ABD-3205-2021; shen, Che-Kun James/L-1343-2015	Huang, Ting-Shuo/0000-0002-2932-6878; 	National Health Research Institute [NHRI-EX99- 9514SI]; Academia Sinica (AS)	National Health Research Institute(National Health Research Institutes - Taiwan); Academia Sinica (AS)(Academia Sinica - Taiwan)	This work was supported in part by National Health Research Institute Grant NHRI-EX99- 9514SI and by Academia Sinica (AS).	BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; Bieker JJ, 2005, MT SINAI J MED, V72, P333; BROWN BA, 1982, P NATL ACAD SCI-BIOL, V79, P2753, DOI 10.1073/pnas.79.9.2753; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; Chen ZY, 2009, BLOOD CELL MOL DIS, V42, P144, DOI 10.1016/j.bcmd.2008.12.003; FRASER PJ, 1987, GENE DEV, V1, P855, DOI 10.1101/gad.1.8.855; GONG QH, 1991, MOL CELL BIOL, V11, P2558, DOI 10.1128/MCB.11.5.2558; Higgs DR, 2008, ADV GENET, V61, P143, DOI 10.1016/S0065-2660(07)00005-3; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; Huang BL, 1998, P NATL ACAD SCI USA, V95, P14669, DOI 10.1073/pnas.95.25.14669; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Kobayashi M, 2007, J BIOCHEM, V142, P1, DOI 10.1093/jb/mvm122; LEDER A, 1992, DEVELOPMENT, V116, P1041; Li QL, 1997, P NATL ACAD SCI USA, V94, P2444, DOI 10.1073/pnas.94.6.2444; MACLEOD K, 1991, MOL CELL BIOL, V11, P4324, DOI 10.1128/MCB.11.9.4324; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mukhopadhyay NK, 2007, MOL ENDOCRINOL, V21, P2056, DOI 10.1210/me.2006-0503; ORKIN SH, 1992, BLOOD, V80, P575; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; RAICH N, 1995, EMBO J, V14, P801, DOI 10.1002/j.1460-2075.1995.tb07058.x; RUTHERFORD T, 1981, P NATL ACAD SCI-BIOL, V78, P348, DOI 10.1073/pnas.78.1.348; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shyu YC, 2005, MOL CELL BIOL, V25, P10365, DOI 10.1128/MCB.25.23.10365-10378.2005; Shyu YC, 2007, MOL CELL BIOL, V27, P2309, DOI 10.1128/MCB.01875-06; Stamatoyannopoulos G, 2001, MOL BASIS BLOOD DIS; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; STRAUSS EC, 1992, MOL CELL BIOL, V12, P2135, DOI 10.1128/MCB.12.5.2135; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Tanimoto K, 2000, TRENDS CARDIOVAS MED, V10, P15, DOI 10.1016/S1050-1738(00)00035-9; Thiagalingam A, 1996, MOL CELL BIOL, V16, P5335; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; Wen SC, 2000, MOL CELL BIOL, V20, P1993, DOI 10.1128/MCB.20.6.1993-2003.2000; YU CY, 1990, MOL CELL BIOL, V10, P282, DOI 10.1128/MCB.10.1.282; ZHANG Q, 1995, MOL BIOL HEMOGLOBIN; ZHANG QY, 1993, MOL CELL BIOL, V13, P2298, DOI 10.1128/MCB.13.4.2298; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257; Zhao Q, 2006, BLOOD, V107, P2138, DOI 10.1182/blood-2005-06-2497; Zhou WL, 2000, MOL CELL BIOL, V20, P7662, DOI 10.1128/MCB.20.20.7662-7672.2000	42	12	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10189	10197		10.1074/jbc.M109.049130	http://dx.doi.org/10.1074/jbc.M109.049130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133935	Green Published, hybrid			2022-12-25	WOS:000276264600003
J	Czymai, T; Viemann, D; Sticht, C; Molema, G; Goebeler, M; Schmidt, M				Czymai, Tobias; Viemann, Dorothee; Sticht, Carsten; Molema, Grietje; Goebeler, Matthias; Schmidt, Marc			FOXO3 Modulates Endothelial Gene Expression and Function by Classical and Alternative Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTORS; NF-KAPPA-B; CELL-SURVIVAL; ANGIOGENESIS; CANCER; INHIBITION; APOPTOSIS; COMPLEX; PROTEIN; ACTIVATION	FOXO transcription factors represent targets of the phosphatidylinositol 3-kinase/protein kinase B survival pathway controlling important biological processes, such as cell cycle progression, apoptosis, vascular remodeling, stress responses, and metabolism. Recent studies suggested the existence of alternative mechanisms of FOXO-dependent gene expression beyond classical binding to a FOXO-responsive DNA-binding element (FRE). Here we analyzed the relative contribution of those mechanisms to vascular function by comparing the transcriptional and cellular responses to conditional activation of FOXO3 and a corresponding FRE-binding mutant in human primary endothelial cells. We demonstrate that FOXO3 controls expression of vascular remodeling genes in an FRE-dependent manner. In contrast, FOXO3-induced cell cycle arrest and apoptosis occurs independently of FRE binding, albeit FRE-dependent gene expression augments the proapoptotic response. These findings are supported by bioinformatical analysis, which revealed a statistical overrepresentation of cell cycle regulators and apoptosis-related genes in the group of co-regulated genes. Molecular analysis of FOXO3-induced endothelial apoptosis excluded modulators of the extrinsic death receptor pathway and demonstrated important roles for the BCL-2 family members BIM and NOXA in this process. Although NOXA essentially contributed to FRE-dependent apoptosis, BIM was effectively induced in the absence of FRE-binding, and small interfering RNA-mediated BIM depletion could rescue apoptosis induced by both FOXO3 mutants. These data suggest BIM as a critical cell type-specific mediator of FOXO3-induced endothelial apoptosis, whereas NOXA functions as an amplifying factor. Our study provides the first comprehensive analysis of alternatively regulated FOXO3 targets in relevant primary cells and underscores the importance of such genes for endothelial function and integrity.	[Sticht, Carsten] Heidelberg Univ, Univ Med Ctr Mannheim, Med Res Ctr, D-68167 Mannheim, Germany; [Czymai, Tobias; Goebeler, Matthias; Schmidt, Marc] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, D-68167 Mannheim, Germany; [Viemann, Dorothee] Univ Munster, Dept Immunol, D-48149 Munster, Germany; [Viemann, Dorothee] Univ Munster, Dept Pediat, D-48149 Munster, Germany; [Molema, Grietje] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands; [Goebeler, Matthias; Schmidt, Marc] Univ Giessen, Univ Hosp Giessen, Dept Dermatol, D-35392 Giessen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Munster; University of Munster; University of Groningen; Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Schmidt, M (corresponding author), Univ Hosp Giessen, Dept Dermatol, Gaffkystr 14, D-35392 Giessen, Germany.	schmidt.marc@gmx.de	Schmidt, Marc/E-8821-2010; Goebeler, Matthias/P-3612-2019; Goebeler, Matthias/F-7118-2013	Schmidt, Marc/0000-0002-8643-1615; Viemann, Dorothee/0000-0002-9009-3559; Molema, Grietje/0000-0002-4147-6676	Deutsche Forschungsgemeinschaft [880/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft "International Research Training Group Vascular Medicine" (Graduiertenkolleg 880/2) (to M. S. and M. G.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bernard DJ, 2001, RECENT PROG HORM RES, V56, P417, DOI 10.1210/rp.56.1.417; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buitenhuis M, 2005, BLOOD, V105, P4272, DOI 10.1182/blood-2004-12-4883; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hsieh WP, 2003, GENETICS, V165, P747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ji M, 2008, BLOOD, V112, P1068, DOI 10.1182/blood-2008-01-133504; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lucerna M, 2006, CANCER RES, V66, P6708, DOI 10.1158/0008-5472.CAN-05-2732; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Schmidt M, 2010, J CELL MOL MED, V14, P1760, DOI 10.1111/j.1582-4934.2009.00823.x; Shav-Tal Y, 2002, STEM CELLS, V20, P493, DOI 10.1634/stemcells.20-6-493; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Stassi G, 2000, NAT IMMUNOL, V1, P483, DOI 10.1038/82725; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	57	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10163	10178		10.1074/jbc.M109.056663	http://dx.doi.org/10.1074/jbc.M109.056663			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123982	hybrid, Green Published			2022-12-25	WOS:000276264600001
J	Girard, V; Cote, JP; Charbonneau, ME; Campos, M; Berthiaume, F; Hancock, MA; Siddiqui, N; Mourez, M				Girard, Victoria; Cote, Jean-Philippe; Charbonneau, Marie-Eve; Campos, Manuel; Berthiaume, Frederic; Hancock, Mark A.; Siddiqui, Nadeem; Mourez, Michael			Conformation Change in a Self-recognizing Autotransporter Modulates Bacterial Cell-Cell Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; OUTER-MEMBRANE PROTEIN; BIOFILM FORMATION; DIFFUSE ADHERENCE; AIDA-I; POSTWEANING DIARRHEA; EDEMA DISEASE; ADHESIN; PIGS; AUTOAGGREGATION	Bacteria mostly live as multicellular communities, although they are unicellular organisms, yet the mechanisms that tie individual bacteria together are often poorly understood. The adhesin involved in diffuse adherence (AIDA-I) is an adhesin of diarrheagenic Escherichia coli strains. AIDA-I also mediates bacterial auto-aggregation and biofilm formation and thus could be important for the organization of communities of pathogens. Using purified protein and whole bacteria, we provide direct evidence that AIDA-I promotes auto-aggregation by interacting with itself. Using various biophysical and biochemical techniques, we observed a conformational change in the protein during AIDA-AIDA interactions, strengthening the notion that this is a highly specific interaction. The self-association of AIDA-I is of high affinity but can be modulated by sodium chloride. We observe that a bile salt, sodium deoxycholate, also prevents AIDA-I oligomerization and bacterial auto-aggregation. Thus, we propose that AIDA-I, and most likely other similar autotransporters such as antigen 43 (Ag43) and TibA, organize bacterial communities of pathogens through a self-recognition mechanism that is sensitive to the environment. This could permit bacteria to switch between multicellular and unicellular lifestyles to complete their infection.	[Girard, Victoria; Cote, Jean-Philippe; Charbonneau, Marie-Eve; Campos, Manuel; Berthiaume, Frederic; Mourez, Michael] Univ Montreal, Fac Med Vet, Canada Res Chair Bacterial Anim Dis, St Hyacinthe, PQ J2S 7C6, Canada; [Siddiqui, Nadeem] Univ Montreal, Inst Rech Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Hancock, Mark A.] McGill Univ, Sheldon Biotechnol Ctr, Montreal, PQ H3A 2B4, Canada	Universite de Montreal; Universite de Montreal; McGill University	Mourez, M (corresponding author), Univ Montreal, Fac Med Vet, Canada Res Chair Bacterial Anim Dis, 3200 Sicotte, St Hyacinthe, PQ J2S 7C6, Canada.	m.mourez@umontreal.ca			Canadian Institutes for Health Research [84578]; Groupe de Recherche et d'Etudes sur les Maladies Infectieuses du Porc; Canada Research Chair; Canada Foundation for Innovation [201414]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Groupe de Recherche et d'Etudes sur les Maladies Infectieuses du Porc; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by Canadian Institutes for Health Research Grant 84578, funds from the Groupe de Recherche et d'Etudes sur les Maladies Infectieuses du Porc, Canada Research Chair and Canada Foundation for Innovation Grant 201414, and a research resource grant from Canadian Institutes for Health Research.	Alamuri P, 2008, MOL MICROBIOL, V68, P997, DOI 10.1111/j.1365-2958.2008.06199.x; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; BENZ I, 1989, INFECT IMMUN, V57, P1506, DOI 10.1128/IAI.57.5.1506-1511.1989; Berge A, 1997, J BIOL CHEM, V272, P20774, DOI 10.1074/jbc.272.33.20774; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Charbonneau ME, 2007, J BACTERIOL, V189, P9020, DOI 10.1128/JB.01238-07; Charbonneau ME, 2006, J BACTERIOL, V188, P8504, DOI 10.1128/JB.00864-06; Charbonneau ME, 2009, J BIOL CHEM, V284, P17340, DOI 10.1074/jbc.M109.010108; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; ELSINGHORST EA, 1994, INFECT IMMUN, V62, P3463, DOI 10.1128/IAI.62.8.3463-3471.1994; Felek S, 2008, MICROBIOL-SGM, V154, P1802, DOI 10.1099/mic.0.2007/010918-0; Frick IM, 2000, MOL MICROBIOL, V37, P1232, DOI 10.1046/j.1365-2958.2000.02084.x; Girard V, 2006, RES MICROBIOL, V157, P407, DOI 10.1016/j.resmic.2006.02.001; Ha SK, 2003, J VET DIAGN INVEST, V15, P378, DOI 10.1177/104063870301500414; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 1997, FEMS MICROBIOL LETT, V149, P115, DOI 10.1016/S0378-1097(97)00065-7; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kajava AV, 2006, J STRUCT BIOL, V155, P306, DOI 10.1016/j.jsb.2006.01.015; Klemm P, 2004, MOL MICROBIOL, V51, P283, DOI 10.1046/j.1365-2958.2003.03833.x; Klemm P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/j.ijmm.2005.10.002; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Mainil JG, 2002, VET MICROBIOL, V86, P303, DOI 10.1016/S0378-1135(02)00019-6; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; MENOZZI FD, 1994, INFECT IMMUN, V62, P4261, DOI 10.1128/IAI.62.10.4261-4269.1994; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; Ngeleka M, 2003, J VET DIAGN INVEST, V15, P242, DOI 10.1177/104063870301500305; Niewerth U, 2001, CLIN DIAGN LAB IMMUN, V8, P143, DOI 10.1128/CDLI.8.1.143-149.2001; OCHIAI K, 1993, J MED MICROBIOL, V39, P183, DOI 10.1099/00222615-39-3-183; Ravi M, 2007, VET MICROBIOL, V120, P308, DOI 10.1016/j.vetmic.2006.10.035; Schembri MA, 2001, MOL MICROBIOL, V41, P1419, DOI 10.1046/j.1365-2958.2001.02613.x; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Sherlock O, 2004, J BACTERIOL, V186, P8058, DOI 10.1128/JB.186.23.8058-8065.2004; Sherlock O, 2006, J BACTERIOL, V188, P1798, DOI 10.1128/JB.188.5.1798-1807.2006; Suhr M, 1996, MOL MICROBIOL, V22, P31, DOI 10.1111/j.1365-2958.1996.tb02653.x; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018	41	20	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10616	10626		10.1074/jbc.M109.069070	http://dx.doi.org/10.1074/jbc.M109.069070			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123991	Green Published, hybrid			2022-12-25	WOS:000276264600049
J	Wu, YT; Tan, HL; Shui, GH; Bauvy, C; Huang, Q; Wenk, MR; Ong, CN; Codogno, P; Shen, HM				Wu, You-Tong; Tan, Hui-Ling; Shui, Guanghou; Bauvy, Chantal; Huang, Qing; Wenk, Markus R.; Ong, Choon-Nam; Codogno, Patrice; Shen, Han-Ming			Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONITORING AUTOPHAGY; DEPENDENT REGULATION; MAMMALIAN TARGET; PROTEIN; COMPLEX; MTOR; LC3; MACROAUTOPHAGY; DEGRADATION; RAPAMYCIN	A group of phosphoinositide 3-kinase (PI3K) inhibitors, such as 3-methyladenine (3-MA) and wortmannin, have been widely used as autophagy inhibitors based on their inhibitory effect on class III PI3K activity, which is known to be essential for induction of autophagy. In this study, we systematically examined and compared the effects of these two inhibitors on autophagy under both nutrient-rich and deprivation conditions. To our surprise, 3-MA is found to promote autophagy flux when treated under nutrient-rich conditions with a prolonged period of treatment, whereas it is still capable of suppressing starvation-induced autophagy. We first observed that there are marked increases of the autophagic markers in cells treated with 3-MA in full medium for a prolonged period of time (up to 9 h). Second, we provide convincing evidence that the increase of autophagic markers is the result of enhanced autophagic flux, not due to suppression of maturation of autophagosomes or lysosomal function. More importantly, we found that the autophagy promotion activity of 3-MA is due to its differential temporal effects on class I and class III PI3K; 3-MA blocks class I PI3K persistently, whereas its suppressive effect on class III PI3K is transient. Because 3-MA has been widely used as an autophagy inhibitor in the literature, understanding the dual role of 3-MA in autophagy thus suggests that caution should be exercised in the application of 3-MA in autophagy study.	[Wu, You-Tong; Tan, Hui-Ling; Huang, Qing; Ong, Choon-Nam; Shen, Han-Ming] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117597, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Wenk, Markus R.; Shen, Han-Ming] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; [Bauvy, Chantal; Codogno, Patrice] Univ Paris 11, INSERM, U756, F-92290 Chatenay Malabry, France	National University of Singapore; National University of Singapore; National University of Singapore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Shen, HM (corresponding author), Level 4,16 Med Dr, Singapore 117597, Singapore.	ephshm@nus.edu.sg	Wenk, Markus Rene/D-1441-2014; SHEN, Han-Ming/B-5942-2011; Ong, Choon Nam/E-8638-2010; Codogno, Patrice/G-1384-2013	SHEN, Han-Ming/0000-0001-7369-5227; Codogno, Patrice/0000-0002-5492-3180; Ong, Choon Nam/0000-0002-4002-1725; Shui, Guanghou/0000-0002-1621-9643	National University of Singapore (NUS) University Research Council; Singapore Biomedical Research Council; Life Science Institute, NUS	National University of Singapore (NUS) University Research Council(National University of Singapore); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Life Science Institute, NUS(National University of Singapore)	The work was supported in part by research grants from the National University of Singapore (NUS) University Research Council and Singapore Biomedical Research Council and the Toxicology Program of the Life Science Institute, NUS.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bains M, 2009, METHOD ENZYMOL, V453, P145, DOI 10.1016/S0076-6879(08)04007-X; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Ito H, 2005, INT J ONCOL, V26, P1401; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; POWIS G, 1994, CANCER RES, V54, P2419; PUNNONEN EL, 1994, EUR J CELL BIOL, V65, P14; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Wu YT, 2009, AUTOPHAGY, V5, P824, DOI 10.4161/auto.9099; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xiong HY, 2010, CANCER LETT, V288, P68, DOI 10.1016/j.canlet.2009.06.039; Xue LZ, 2002, BIOCHEM PHARMACOL, V64, P441, DOI 10.1016/S0006-2952(02)01181-4; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	70	812	845	8	107	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10850	10861		10.1074/jbc.M109.080796	http://dx.doi.org/10.1074/jbc.M109.080796			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123989	hybrid, Green Published			2022-12-25	WOS:000276264600070
J	Goh, YM; Cinghu, S; Hong, ETH; Lee, YS; Kim, JH; Jang, JW; Li, YH; Chi, XZ; Lee, KS; Wee, H; Ito, Y; Oh, BC; Bae, SC				Goh, Yun-Mi; Cinghu, Senthilkumar; Hong, Eileen Tan Hwee; Lee, You-Soub; Kim, Jang-Hyun; Jang, Ju-Won; Li, Ying-Hui; Chi, Xin-Zi; Lee, Kyeong-Sook; Wee, Heejun; Ito, Yoshiaki; Oh, Byung-Chul; Bae, Suk-Chul			Src Kinase Phosphorylates RUNX3 at Tyrosine Residues and Localizes the Protein in the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPG ISLAND HYPERMETHYLATION; TUMOR-RELATED GENES; RING-FINGER DOMAIN; CANCER CELL-LINES; PROMOTER HYPERMETHYLATION; NUCLEAR EXPORT; CLEIDOCRANIAL DYSPLASIA; GASTRIC-CARCINOMA; FREQUENT LOSS; C-SRC	RUNX3 is a transcription factor that functions as a tumor suppressor. In some cancers, RUNX3 expression is down-regulated, usually due to promoter hypermethylation. Recently, it was found that RUNX3 can also be inactivated by the mislocalization of the protein in the cytoplasm. The molecular mechanisms controlling this mislocalization are poorly understood. In this study, we found that the overexpression of Src results in the tyrosine phosphorylation and cytoplasmic localization of RUNX3. We also found that the tyrosine residues of endogenous RUNX3 are phosphorylated and that the protein is localized in the cytoplasm in Src-activated cancer cell lines. We further showed that the knockdown of Src by small interfering RNA, or the inhibition of Src kinase activity by a chemical inhibitor, causes the re-localization of RUNX3 to the nucleus. Collectively, our results demonstrate that the tyrosine phosphorylation of RUNX3 by activated Src is associated with the cytoplasmic localization of RUNX3 in gastric and breast cancers.	[Oh, Byung-Chul] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Goh, Yun-Mi; Cinghu, Senthilkumar; Lee, You-Soub; Kim, Jang-Hyun; Jang, Ju-Won; Chi, Xin-Zi; Lee, Kyeong-Sook; Wee, Heejun; Bae, Suk-Chul] Chungbuk Natl Univ, Inst Tumor Res, Dept Biochem, Sch Med, Cheongju 361763, South Korea; [Hong, Eileen Tan Hwee; Ito, Yoshiaki] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 138673, Singapore; [Hong, Eileen Tan Hwee; Ito, Yoshiaki] Inst Mol & Cell Biol, Singapore 138673, Singapore	Gachon University; Chungbuk National University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Oh, BC (corresponding author), Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, 7-45 Songdo Dong, Inchon 406840, South Korea.	bcoh@gachon.ac.kr; scbae@chungbuk.ac.kr		Oh, Byung-Chul/0000-0002-4277-7083	Korean Science and Engineering Foundation [R16-2003-002-01001-02006]	Korean Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Research Grant R16-2003-002-01001-02006 (to S.-C.B.) from the Korean Science and Engineering Foundation.	Balmain A, 2002, NATURE, V417, P235, DOI 10.1038/417235a; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Blain SW, 2002, NAT MED, V8, P1076, DOI 10.1038/nm1002-1076; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Goel A, 2004, INT J CANCER, V112, P754, DOI 10.1002/ijc.20472; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Kang GH, 2004, J PATHOL, V202, P233, DOI 10.1002/path.1503; Kang S, 2005, GYNECOL ONCOL, V96, P173, DOI 10.1016/j.ygyno.2004.09.031; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Kastan MB, 2003, CELL, V112, P1, DOI 10.1016/S0092-8674(02)01281-3; Kato N, 2003, AM J PATHOL, V163, P387, DOI 10.1016/S0002-9440(10)63668-1; Kim HP, 2004, BIOCHEM J, V379, P141, DOI 10.1042/BJ20031408; Kim HR, 2008, J CELL BIOCHEM, V105, P1048, DOI 10.1002/jcb.21906; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kopetz S, 2007, CLIN CANCER RES, V13, P7232, DOI 10.1158/1078-0432.CCR-07-1902; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mori T, 2005, LIVER INT, V25, P380, DOI 10.1111/j.1478-3231.2005.1059.x; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakase Y, 2005, BRIT J CANCER, V92, P562, DOI 10.1038/sj.bjc.6602372; Osaki M, 2004, EUR J CLIN INVEST, V34, P605, DOI 10.1111/j.1365-2362.2004.01401.x; Oshimo Y, 2004, PATHOBIOLOGY, V71, P137, DOI 10.1159/000076468; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pande S, 2009, J CELL PHYSIOL, V218, P473, DOI 10.1002/jcp.21630; Pockwinse SM, 2006, J CELL PHYSIOL, V206, P354, DOI 10.1002/jcp.20469; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Sakakura C, 2005, INT J CANCER, V113, P221, DOI 10.1002/ijc.20551; Schulmann K, 2005, ONCOGENE, V24, P4138, DOI 10.1038/sj.onc.1208598; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tamura G, 2004, HISTOL HISTOPATHOL, V19, P221, DOI 10.14670/HH-19.221; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wada M, 2004, ONCOGENE, V23, P2401, DOI 10.1038/sj.onc.1207395; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Xiao WH, 2004, WORLD J GASTROENTERO, V10, P376; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yanagawa N, 2003, CANCER SCI, V94, P589, DOI 10.1111/j.1349-7006.2003.tb01487.x; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	51	39	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10122	10129		10.1074/jbc.M109.071381	http://dx.doi.org/10.1074/jbc.M109.071381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100835	Green Published, hybrid			2022-12-25	WOS:000276165900079
J	Jeong, HS; Kim, SM; Lim, MS; Kim, KS; Choi, SH				Jeong, Hye Sook; Kim, Seung Min; Lim, Moon Sub; Kim, Kun Soo; Choi, Sang Ho			Direct Interaction between Quorum-sensing Regulator SmcR and RNA Polymerase Is Mediated by Integration Host Factor to Activate vvpE Encoding Elastase in Vibrio vulnificus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; HARVEYI-LUXR; ESCHERICHIA-COLI; BACTERIAL PROMOTERS; FUNCTIONAL-ANALYSIS; CONSENSUS SEQUENCE; RECEPTOR PROTEIN; IDENTIFICATION; CHOLERAE; HOMOLOG	It has been suggested that quorum sensing is an important signal transduction system regulating the expression of numerous virulence genes in bacterial pathogens. We previously revealed that SmcR, a LuxR homologue of Vibrio vulnificus, activates promoter S, an RpoS-dependent promoter of vvpE encoding a potential virulence factor elastase and binds in vitro to a binding site centered at -196.5. In this study, chromatin immunoprecipitation assays and promoter deletion analyses demonstrated that SmcR binds to the vvpE regulatory region in vivo and directly interacts with RNAP for activation of the vvpE expression. A search for regulatory genes involved in the regulation of elastase production singled out ihfA, which encodes for a subunit of integration host factor (IHF). Levels of both elastase activity and vvpE transcript decreased significantly as a result of inactivation of ihfA, and primer extension analyses demonstrated that IHF regulates the vvpE transcription by activating PS. Direct binding of IHF to the two distinct binding sites centered at -174 and -131, respectively, was determined using an electrophoretic mobility shift assay and a DNase I protection assay. Chromatin immunoprecipitation assays revealed that the interaction of SmcR with RNAP in vivo was mediated by IHF. Collectively, the results proposed a model whereby IHF positions SmcR to contact RNAP by looping the vvpE regulatory DNA, thus allowing precise control of the expression level of VvpE during the pathogenesis of V. vulnificus.	[Jeong, Hye Sook; Kim, Seung Min; Lim, Moon Sub; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Ctr Agr Biomat, Seoul 151921, South Korea; [Jeong, Hye Sook; Kim, Seung Min; Lim, Moon Sub; Choi, Sang Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kim, Kun Soo] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Kim, Kun Soo] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul 121742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sogang University; Sogang University	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Ctr Agr Biomat, Seoul 151921, South Korea.	choish@snu.ac.kr		KIM, KUN-SOO/0000-0002-5433-4175; Choi, Sang Ho/0000-0003-3865-1039	World Class University [R32-2008-000-10183-0]; 21C Frontier Microbial Genomics and Applications Center Program; National Research Laboratory [R0A-2007-00020039-0]; Ministry of Education, Science and Technology of the Republic of Korea	World Class University; 21C Frontier Microbial Genomics and Applications Center Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Laboratory(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology of the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by World Class University Program Grant R32-2008-000-10183-0, a 21C Frontier Microbial Genomics and Applications Center Program grant, National Research Laboratory Grant R0A-2007-00020039-0, and funds from the Ministry of Education, Science and Technology of the Republic of Korea (to S. H. C.).	Arfin SM, 2000, J BIOL CHEM, V275, P29672, DOI 10.1074/jbc.M002247200; Barnard A, 2004, CURR OPIN MICROBIOL, V7, P102, DOI 10.1016/j.mib.2004.02.011; Beyhan S, 2007, J BACTERIOL, V189, P388, DOI 10.1128/JB.00981-06; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Choi HK, 2002, J BIOL CHEM, V277, P47292, DOI 10.1074/jbc.M206893200; CRAIG NL, 1984, CELL, V39, P707, DOI 10.1016/0092-8674(84)90478-1; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim HJ, 2002, J MICROBIOL BIOTECHN, V12, P318; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Lee BC, 2008, INFECT IMMUN, V76, P1509, DOI 10.1128/IAI.01503-07; Lee DH, 2008, J BIOL CHEM, V283, P23610, DOI 10.1074/jbc.M801480200; Lee JH, 2007, J MICROBIOL, V45, P146; Lee JH, 2007, J MICROBIOL BIOTECHN, V17, P325; Lee JH, 2006, MOL MICROBIOL, V60, P513, DOI 10.1111/j.1365-2958.2006.05115.x; Lin W, 2007, MOL MICROBIOL, V64, P953, DOI 10.1111/j.1365-2958.2007.05693.x; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; McDougald D, 2001, J BACTERIOL, V183, P758, DOI 10.1128/JB.183.2.758-762.2001; McDougald D, 2000, GENE, V248, P213, DOI 10.1016/S0378-1119(00)00117-7; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MIYAMOTO CM, 1994, MOL MICROBIOL, V14, P255, DOI 10.1111/j.1365-2958.1994.tb01286.x; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Rhee JE, 2005, J BACTERIOL, V187, P7870, DOI 10.1128/JB.187.22.7870-7875.2005; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; Sambrook J, 2001, MOL CLONING LAB MANU; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	43	31	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9357	9366		10.1074/jbc.M109.089987	http://dx.doi.org/10.1074/jbc.M109.089987			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110369	hybrid, Green Published			2022-12-25	WOS:000276165900007
J	Guillemin, Y; Lopez, J; Gimenez, D; Fuertes, G; Valero, JG; Blum, L; Gonzalo, P; Salgado, J; Girard-Egrot, A; Aouacheria, A				Guillemin, Yannis; Lopez, Jonathan; Gimenez, Diana; Fuertes, Gustavo; Valero, Juan Garcia; Blum, Loic; Gonzalo, Philippe; Salgado, Jesus; Girard-Egrot, Agnes; Aouacheria, Abdel			Active Fragments from Pro- and Antiapoptotic BCL-2 Proteins Have Distinct Membrane Behavior Reflecting Their Functional Divergence	PLOS ONE			English	Article							BREWSTER-ANGLE MICROSCOPY; CYTOCHROME-C RELEASE; BAX-DERIVED PEPTIDE; MITOCHONDRIAL-MEMBRANE; LIPID-MEMBRANES; LANGMUIR-MONOLAYER; PORE FORMATION; X-L; ANTIMICROBIAL PEPTIDES; INDEPENDENT MECHANISMS	Background: The BCL-2 family of proteins includes pro-and antiapoptotic members acting by controlling the permeabilization of mitochondria. Although the association of these proteins with the outer mitochondrial membrane is crucial for their function, little is known about the characteristics of this interaction. Methodology/Principal Findings: Here, we followed a reductionist approach to clarify to what extent membrane-active regions of homologous BCL-2 family proteins contribute to their functional divergence. Using isolated mitochondria as well as model lipid Langmuir monolayers coupled with Brewster Angle Microscopy, we explored systematically and comparatively the membrane activity and membrane-peptide interactions of fragments derived from the central helical hairpin of BAX, BCL-xL and BID. The results show a connection between the differing abilities of the assayed peptide fragments to contact, insert, destabilize and porate membranes and the activity of their cognate proteins in programmed cell death. Conclusion/Significance: BCL-2 family-derived pore-forming helices thus represent structurally analogous, but functionally dissimilar membrane domains.	[Guillemin, Yannis; Lopez, Jonathan; Valero, Juan Garcia; Gonzalo, Philippe; Aouacheria, Abdel] Univ Lyon, IBCP, CNRS, UMR5086, Lyon, France; [Gimenez, Diana; Fuertes, Gustavo; Salgado, Jesus] Univ Valencia, ICMol, Valencia, Spain; [Blum, Loic; Girard-Egrot, Agnes] Univ Lyon, CNRS, ICBMS, UMR5246, Villeurbanne, France; [Salgado, Jesus] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Valencia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; University of Valencia	Guillemin, Y (corresponding author), Univ Lyon, IBCP, CNRS, UMR5086, Lyon, France.	a.aouacheria@ibcp.fr	Salgado, Jesús/A-7759-2013; GONZALO, Philippe/P-1313-2019; GIRARD-EGROT, Agnès/AAP-5586-2020; Vives, Gustavo Fuertes/S-8618-2016	Salgado, Jesús/0000-0002-8537-1550; GONZALO, Philippe/0000-0002-9763-0150; GIRARD-EGROT, Agnès/0000-0003-2612-3124; Vives, Gustavo Fuertes/0000-0002-8564-8644; LOPEZ, Jonathan/0000-0003-3768-2378; Valero, Juan Garcia/0000-0003-3193-9099; Gimenez, Diana/0000-0003-2842-6989	La Ligue Contre le Cancer (Comites de la Drome et du Rhone); Fondation d'Entreprise SILAB -Jean PAUFIQUE; Spanish MEC [BFU2007-67097]; EGIDE PHC PICASSO [17092SM]; MEC [HF2007-0090]; MRT; La Region Rhone-Alpes	La Ligue Contre le Cancer (Comites de la Drome et du Rhone); Fondation d'Entreprise SILAB -Jean PAUFIQUE; Spanish MEC(Spanish Government); EGIDE PHC PICASSO; MEC(European Commission); MRT; La Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by grants from La Ligue Contre le Cancer (Comites de la Drome et du Rhone), La Fondation d'Entreprise SILAB -Jean PAUFIQUE, the Spanish MEC (BFU2007-67097) and a collaborative French/Spanish project (EGIDE PHC PICASSO 17092SM; MEC, HF2007-0090). YG is a recipient of an MRT (Ministere de la Recherche des Sciences et Techniques) fellowship. JL is supported by Hospices Civils de Lyon. JGV is recipient of doctoral fellowship from La Region Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Aisenbrey C, 2007, EUR BIOPHYS J BIOPHY, V37, P71, DOI 10.1007/s00249-007-0165-z; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; Capano M, 2002, BIOCHEM J, V367, P169, DOI 10.1042/BJ20020805; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; de Mul MNG, 1998, LANGMUIR, V14, P2455, DOI 10.1021/la9713154; Denisov AY, 2003, J BIOL CHEM, V278, P21124, DOI 10.1074/jbc.M301798200; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Epand RF, 2002, BIOCHEM BIOPH RES CO, V298, P744, DOI 10.1016/S0006-291X(02)02544-5; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Franzin CM, 2004, MAGN RESON CHEM, V42, P172, DOI 10.1002/mrc.1322; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; GIORGI FD, 2002, FASEB J, V16, P607; Glomm WR, 2009, ANAL CHEM, V81, P3042, DOI 10.1021/ac8027257; Gong XM, 2004, J BIOL CHEM, V279, P28954, DOI 10.1074/jbc.M403490200; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Heimlich G, 2004, BIOCHEM J, V378, P247, DOI 10.1042/BJ20031152; HENDRICKSON HS, 1983, ARCH BIOCHEM BIOPHYS, V227, P242, DOI 10.1016/0003-9861(83)90367-3; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hu X, 2003, APOPTOSIS, V8, P277, DOI 10.1023/A:1023676906857; Ishitsuka Y, 2006, BBA-BIOMEMBRANES, V1758, P1450, DOI 10.1016/j.bbamem.2006.08.001; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; KERTESZ Z, 1995, BIOCHEM J, V310, P315, DOI 10.1042/bj3100315; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kiss E, 2008, J COLLOID INTERF SCI, V325, P337, DOI 10.1016/j.jcis.2008.05.057; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Liang Y, 2002, MOL PHARMACOL, V61, P142, DOI 10.1124/mol.61.1.142; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P484, DOI 10.1038/sj.cdd.4402280; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; MAGGIO B, 1994, BBA-BIOMEMBRANES, V1190, P137, DOI 10.1016/0005-2736(94)90043-4; Malhotra R, 1996, BIOCHEM J, V314, P297, DOI 10.1042/bj3140297; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Matsuyama S, 1998, J BIOL CHEM, V273, P30995, DOI 10.1074/jbc.273.47.30995; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Nouraini S, 2000, MOL CELL BIOL, V20, P1604, DOI 10.1128/MCB.20.5.1604-1615.2000; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Roucou X, 2002, BIOCHEM J, V363, P547, DOI 10.1042/0264-6021:3630547; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Thuduppathy GR, 2006, J MOL BIOL, V359, P1045, DOI 10.1016/j.jmb.2006.03.052; Upton JP, 2007, CELL DEATH DIFFER, V14, P932, DOI 10.1038/sj.cdd.4402092; Valentijn AJ, 2008, CELL DEATH DIFFER, V15, P1243, DOI 10.1038/cdd.2008.39; Van Mau N, 2005, J MEMBRANE BIOL, V207, P1, DOI 10.1007/s00232-005-0799-7; Vernoux N, 2007, J COLLOID INTERF SCI, V310, P436, DOI 10.1016/j.jcis.2007.01.093; Volinsky R, 2006, BBA-BIOMEMBRANES, V1758, P1393, DOI 10.1016/j.bbamem.2006.03.002; Vollhardt D, 1996, ADV COLLOID INTERFAC, V64, P143, DOI 10.1016/0001-8686(95)00285-5; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wieckowski MR, 2001, FEBS LETT, V505, P453, DOI 10.1016/S0014-5793(01)02858-7; Winsel K, 2003, EUR BIOPHYS J BIOPHY, V32, P544, DOI 10.1007/s00249-003-0290-2; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zemel A, 2004, BIOPHYS J, V86, P3607, DOI 10.1529/biophysj.103.033605; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	91	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9066	10.1371/journal.pone.0009066	http://dx.doi.org/10.1371/journal.pone.0009066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140092	Green Submitted, gold, Green Published			2022-12-25	WOS:000274442400006
J	Busch, CR; DiRuggiero, J				Busch, Courtney R.; DiRuggiero, Jocelyne			MutS and MutL Are Dispensable for Maintenance of the Genomic Mutation Rate in the Halophilic Archaeon Halobacterium salinarum NRC-1	PLOS ONE			English	Article							DNA MISMATCH REPAIR; ESCHERICHIA-COLI MUTS; SP STRAIN NRC-1; LACI GENE; SULFOLOBUS-ACIDOCALDARIUS; PYROCOCCUS-FURIOSUS; URACIL RECOGNITION; FIDELITY; REPLICATION; POLYMERASES	Background: The genome of the halophilic archaeon Halobacterium salinarum NRC-1 encodes for homologs of MutS and MutL, which are key proteins of a DNA mismatch repair pathway conserved in Bacteria and Eukarya. Mismatch repair is essential for retaining the fidelity of genetic information and defects in this pathway result in the deleterious accumulation of mutations and in hereditary diseases in humans. Methodology/Principal Findings: We calculated the spontaneous genomic mutation rate of H. salinarum NRC-1 using fluctuation tests targeting genes of the uracil monophosphate biosynthesis pathway. We found that H. salinarum NRC-1 has a low incidence of mutation suggesting the presence of active mechanisms to control spontaneous mutations during replication. The spectrum of mutational changes found in H. salinarum NRC-1, and in other archaea, appears to be unique to this domain of life and might be a consequence of their adaption to extreme environmental conditions. In-frame targeted gene deletions of H. salinarum NRC-1 mismatch repair genes and phenotypic characterization of the mutants demonstrated that the mutS and mutL genes are not required for maintenance of the observed mutation rate. Conclusions/Significance: We established that H. salinarum NRC-1 mutS and mutL genes are redundant to an alternative system that limits spontaneous mutation in this organism. This finding leads to the puzzling question of what mechanism is responsible for maintenance of the low genomic mutation rates observed in the Archaea, which for the most part do not have MutS and MutL homologs.	[Busch, Courtney R.; DiRuggiero, Jocelyne] Univ Maryland, Dept Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Busch, CR (corresponding author), Univ Maryland, Dept Biol & Mol Genet, College Pk, MD 20742 USA.	jdiruggiero@jhu.edu			NASA [EXB04-0000-0055]; NSF [MCB-0425825]; AFOSR [FA95500710158]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by grants from NASA (EXB04-0000-0055), NSF (MCB-0425825), and AFOSR ((FA95500710158) to J.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bawa S, 1997, CANCER RES, V57, P2715; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Berkner S, 2008, EXTREMOPHILES, V12, P263, DOI 10.1007/s00792-007-0125-7; Bjornson KP, 2003, J BIOL CHEM, V278, P34667, DOI 10.1074/jbc.M305513200; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Connolly BA, 2003, BIOCHEM SOC T, V31, P699, DOI 10.1042/bst0310699; Crowley David J, 2006, Saline Syst, V2, P11, DOI 10.1186/1746-1448-2-11; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Engel MB, 2005, CELL BIOL INT, V29, P616, DOI 10.1016/j.cellbi.2005.03.024; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Grogan DW, 2000, TRENDS MICROBIOL, V8, P180, DOI 10.1016/S0966-842X(00)01729-7; Grogan DW, 2001, P NATL ACAD SCI USA, V98, P7928, DOI 10.1073/pnas.141113098; HALLIDAY JA, 1991, MUTAT RES, V250, P55, DOI 10.1016/0027-5107(91)90162-H; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs KL, 1997, J BACTERIOL, V179, P3298, DOI 10.1128/jb.179.10.3298-3303.1997; Kish A, 2008, J BACTERIOL, V190, P5210, DOI 10.1128/JB.00292-08; Kottemann M, 2005, EXTREMOPHILES, V9, P219, DOI 10.1007/s00792-005-0437-4; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; Lasken RS, 1996, J BIOL CHEM, V271, P17692, DOI 10.1074/jbc.271.30.17692; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Lin Z, 2007, NUCLEIC ACIDS RES, V35, P7591, DOI 10.1093/nar/gkm921; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Mackwan RR, 2008, GENETICS, V180, P17, DOI 10.1534/genetics.108.089086; Mackwan RR, 2007, GENETICS, V176, P697, DOI 10.1534/genetics.106.069666; Martin EL, 2000, CAN J MICROBIOL, V46, P180, DOI 10.1139/cjm-46-2-180; MATTILA P, 1991, NUCLEIC ACIDS RES, V19, P4967, DOI 10.1093/nar/19.18.4967; McCready Shirley, 2005, Saline Syst, V1, P3, DOI 10.1186/1746-1448-1-3; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; RIPLEY LS, 1990, ANNU REV GENET, V24, P189, DOI 10.1146/annurev.ge.24.120190.001201; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; SCHAAPER RM, 1991, GENETICS, V129, P317; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Vijayvargia R, 2002, CURR MICROBIOL, V44, P224, DOI 10.1007/s00284-001-0025-5; Wang GJ, 2004, J BACTERIOL, V186, P3187, DOI 10.1128/JB.186.10.3187-3194.2004; Whitehead K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100091; XIAO W, 1995, CARCINOGENESIS, V16, P1933, DOI 10.1093/carcin/16.8.1933; YANG H, 2002, J BIOL CHEM; Yang HJ, 2000, J BACTERIOL, V182, P1272, DOI 10.1128/JB.182.5.1272-1279.2000; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	57	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9045	10.1371/journal.pone.0009045	http://dx.doi.org/10.1371/journal.pone.0009045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140215	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474400004
J	Huang, HC; Jupiter, D; VanBuren, V				Huang, Hung-Chung; Jupiter, Daniel; VanBuren, Vincent			Classification of Genes and Putative Biomarker Identification Using Distribution Metrics on Expression Profiles	PLOS ONE			English	Article							ESSENTIAL FATTY-ACIDS; HEDGEHOG PATHWAY; CEREBROSPINAL-FLUID; AXON GUIDANCE; NCBI GEO; MECHANISMS; RECEPTORS; DEMENTIA; INFLAMMATION; ACTIVATION	Background: Identification of genes with switch-like properties will facilitate discovery of regulatory mechanisms that underlie these properties, and will provide knowledge for the appropriate application of Boolean networks in gene regulatory models. As switch-like behavior is likely associated with tissue-specific expression, these gene products are expected to be plausible candidates as tissue-specific biomarkers. Methodology/Principal Findings: In a systematic classification of genes and search for biomarkers, gene expression profiles (GEPs) of more than 16,000 genes from 2,145 mouse array samples were analyzed. Four distribution metrics (mean, standard deviation, kurtosis and skewness) were used to classify GEPs into four categories: predominantly-off, predominantly-on, graded (rheostatic), and switch-like genes. The arrays under study were also grouped and examined by tissue type. For example, arrays were categorized as 'brain group' and 'non-brain group'; the Kolmogorov-Smirnov distance and Pearson correlation coefficient were then used to compare GEPs between brain and non-brain for each gene. We were thus able to identify tissue-specific biomarker candidate genes. Conclusions/Significance: The methodology employed here may be used to facilitate disease-specific biomarker discovery.	[Huang, Hung-Chung; Jupiter, Daniel; VanBuren, Vincent] Texas A&M Hlth Sci Ctr, Coll Med, Dept Syst Biol & Translat Med, Temple, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Huang, HC (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Syst Biol & Translat Med, Temple, TX USA.	vanburen@tamu.edu			Department of Systems Biology and Translational Medicine; Dean of the Texas A&M Health Science Center College of Medicine; AHA [SDG 0630263N]	Department of Systems Biology and Translational Medicine; Dean of the Texas A&M Health Science Center College of Medicine; AHA(American Heart Association)	This work was supported by start-up funds to VV from the Department of Systems Biology and Translational Medicine and the Dean of the Texas A&M Health Science Center College of Medicine. Identification of candidate biomarkers for heart (supplied in Table S3) was supported by AHA SDG 0630263N (PI: VV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akabas M H, 1990, Int Rev Neurobiol, V32, P241; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Barginear MF, 2009, BREAST CANCER RES TR, V116, P239, DOI 10.1007/s10549-009-0423-0; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bernet A, 2008, EXPERT OPIN THER TAR, V12, P995, DOI [10.1517/14728222.12.8.995, 10.1517/14728222.12.8.995 ]; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; BISCOE TJ, 1990, AM J PHYSIOL, V258, pL271, DOI 10.1152/ajplung.1990.258.6.L271; Bolstad B, 2005, BIOINFORMATICS COMPU; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Bourque CW, 2007, EXP PHYSIOL, V92, P499, DOI 10.1113/expphysiol.2006.035634; Boyce JA, 2008, CURR MOL MED, V8, P335, DOI 10.2174/156652408785160989; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; CHAKRAVARTI IM, 1967, HDB METHODS APPL STA, V1, P160; Chen L, 2009, PROTEIN PEPTIDE LETT, V16, P467, DOI 10.2174/092986609788167851; Choolani M, 2009, EXPERT REV PROTEOMIC, V6, P87, DOI 10.1586/14789450.6.1.87; Cohen J., 2002, APPL MULTIPLE REGRES, P736; Creaney J, 2009, CURR OPIN PULM MED, V15, P366, DOI 10.1097/MCP.0b013e32832b98eb; Cunnane SC, 1997, J LIPID RES, V38, P805; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Davies NWS, 2005, J NEUROL NEUROSUR PS, V76, P82, DOI 10.1136/jnnp.2004.045336; DESIMONE JA, 1993, CIBA F SYMP, V179, P218; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Badry AM, 2007, J HEPATOL, V47, P718, DOI 10.1016/j.jhep.2007.08.005; Ertel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-3; Ertel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-628; Frankfort SV, 2008, CURR CLIN PHARMACOL, V3, P123, DOI 10.2174/157488408784293723; Giles PJ, 2003, BIOINFORMATICS, V19, P2254, DOI 10.1093/bioinformatics/btg311; Graeber MB, 2009, EXP NEUROL, V216, P249, DOI 10.1016/j.expneurol.2008.12.017; Heidelberger R, 2007, J PHYSIOL-LONDON, V585, P663, DOI 10.1113/jphysiol.2007.137927; Huang ZJ, 2006, NEURON, V50, P521, DOI 10.1016/j.neuron.2006.05.005; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jamjute P, 2009, J MATERN-FETAL NEO M, V22, P274, DOI 10.1080/14767050802211929; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Jupiter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001717; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kaznessis YN, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-47; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kotake Shigeru, 2009, Clin Calcium, V19, P362; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Lennon S, 2009, J CLIN ONCOL, V27, P1685, DOI 10.1200/JCO.2008.16.8351; Lewczuk P, 2008, PROTEOMICS, V8, P1292, DOI 10.1002/pmic.200700703; Lo R, 2009, CURR MED CHEM, V16, P1442, DOI 10.2174/092986709787909622; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Ma BY, 2009, P NATL ACAD SCI USA, V106, P6887, DOI 10.1073/pnas.0903024106; Mann F, 2004, INT J DEV BIOL, V48, P957, DOI 10.1387/ijdb.041899fm; Massoumi R, 2007, THESCIENTIFICWORLDJO, V7, P1413, DOI 10.1100/tsw.2007.200; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Medina V, 2009, CLIN TRANSL ONCOL, V11, P199, DOI 10.1007/s12094-009-0341-y; Meyers B, 2008, J FOOD SCI, V73, pR81, DOI 10.1111/j.1750-3841.2008.00832.x; Mody I, 2008, NEUROCHEM INT, V52, P60, DOI 10.1016/j.neuint.2007.07.010; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; NINFA AJ, 2004, SCI STKE, pPE20, DOI DOI 10.1126/STKE.2322004PE2; Palmada Monica, 1998, Frontiers in Bioscience, V3, pD701; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; Reid RC, 2005, CURR MED CHEM, V12, P3011, DOI 10.2174/092986705774462860; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schlitt T, 2006, PHILOS T R SOC B, V361, P483, DOI 10.1098/rstb.2005.1806; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Simpson F, 2009, MECH DEVELOP, V126, P279, DOI 10.1016/j.mod.2009.01.007; Singer JH, 2007, J PHYSIOL-LONDON, V580, P23, DOI 10.1113/jphysiol.2006.125302; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Sugita M, 2006, CELL MOL LIFE SCI, V63, P2000, DOI 10.1007/s00018-006-6100-0; Tang FR, 2009, CURR MED CHEM, V16, P2189, DOI 10.2174/092986709788612710; Van den Veyver IB, 2009, PRENATAL DIAG, V29, P29, DOI 10.1002/pd.2127; Veleiro AS, 2009, CURR MED CHEM, V16, P455, DOI 10.2174/092986709787315522; Wiltfang J, 2005, WORLD J BIOL PSYCHIA, V6, P69, DOI 10.1080/15622970510029786; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Yasuo T, 2008, BIOL PHARM BULL, V31, P1833, DOI 10.1248/bpb.31.1833; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	87	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9056	10.1371/journal.pone.0009056	http://dx.doi.org/10.1371/journal.pone.0009056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140228	Green Submitted, gold, Green Published			2022-12-25	WOS:000274474400014
J	Ruan, JH				Ruan, Jianhua			A Top-Performing Algorithm for the DREAM3 Gene Expression Prediction Challenge	PLOS ONE			English	Article							NETWORKS	A wealth of computational methods has been developed to address problems in systems biology, such as modeling gene expression. However, to objectively evaluate and compare such methods is notoriously difficult. The DREAM (Dialogue on Reverse Engineering Assessments and Methods) project is a community-wide effort to assess the relative strengths and weaknesses of different computational methods for a set of core problems in systems biology. This article presents a top-performing algorithm for one of the challenge problems in the third annual DREAM (DREAM3), namely the gene expression prediction challenge. In this challenge, participants are asked to predict the expression levels of a small set of genes in a yeast deletion strain, given the expression levels of all other genes in the same strain and complete gene expression data for several other yeast strains. I propose a simple k-nearest-neighbor (KNN) method to solve this problem. Despite its simplicity, this method works well for this challenge, sharing the "top performer'' honor with a much more sophisticated method. I also describe several alternative, simple strategies, including a modified KNN algorithm that further improves the performance of the standard KNN method. The success of these methods suggests that complex methods attempting to integrate multiple data sets do not necessarily lead to better performance than simple yet robust methods. Furthermore, none of these top-performing methods, including the one by a different team, are based on gene regulatory networks, which seems to suggest that accurately modeling gene expression using gene regulatory networks is unfortunately still a difficult task.	Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA)	Ruan, JH (corresponding author), Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX USA.	jruan@cs.utsa.edu	Ruan, Jianhua/I-2529-2012	Ruan, Jianhua/0000-0002-5622-3137	University of Texas; National Institutes of Health [1SC3GM086305-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM086305] Funding Source: NIH RePORTER	University of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by a University of Texas at San Antonio Faculty Research Award and National Institutes of Health grant 1SC3GM086305-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brito MR, 1997, STAT PROBABIL LETT, V35, P33, DOI 10.1016/S0167-7152(96)00213-1; Burrage K, 2006, BRIEF BIOINFORM, V7, P390, DOI 10.1093/bib/bbl033; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Dwight SS, 2004, BRIEF BIOINFORM, V5, P9, DOI 10.1093/bib/5.1.9; Frazier Zach, 2009, V541, P535, DOI 10.1007/978-1-59745-243-4_23; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gilbert D, 2006, BRIEF BIOINFORM, V7, P339, DOI 10.1093/bib/bbl043; Gustafsson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009134; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim Sun Yong, 2003, Briefings in Bioinformatics, V4, P228, DOI 10.1093/bib/4.3.228; Lilburn TG, 2006, BRIEF BIOINFORM, V7, P186, DOI 10.1093/bib/bbl005; Middendorf M, 2004, BIOINFORMATICS, V20, P232, DOI 10.1093/bioinformatics/bth923; Ruan JH, 2006, BIOINFORMATICS, V22, P332, DOI 10.1093/bioinformatics/bti792; Ruan JH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S8; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199	25	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e8944	10.1371/journal.pone.0008944	http://dx.doi.org/10.1371/journal.pone.0008944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140212	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474400001
J	Jourdain, E; Gunnarsson, G; Wahlgren, J; Latorre-Margalef, N; Brojer, C; Sahlin, S; Svensson, L; Waldenstrom, J; Lundkvist, A; Olsen, B				Jourdain, Elsa; Gunnarsson, Gunnar; Wahlgren, John; Latorre-Margalef, Neus; Brojer, Caroline; Sahlin, Sofie; Svensson, Lovisa; Waldenstrom, Jonas; Lundkvist, Ake; Olsen, Bjorn			Influenza Virus in a Natural Host, the Mallard: Experimental Infection Data	PLOS ONE			English	Article							A VIRUS; ANAS-PLATYRHYNCHOS; FEBRILE RESPONSE; IMMUNE-RESPONSE; NORTHERN EUROPE; WILD BIRDS; HEART-RATE; DUCKS; H5N1; REPLICATION	Wild waterfowl, particularly dabbling ducks such as mallards (Anas platyrhynchos), are considered the main reservoir of low-pathogenic avian influenza viruses (LPAIVs). They carry viruses that may evolve and become highly pathogenic for poultry or zoonotic. Understanding the ecology of LPAIVs in these natural hosts is therefore essential. We assessed the clinical response, viral shedding and antibody production of juvenile mallards after intra-esophageal inoculation of two LPAIV subtypes previously isolated from wild congeners. Six ducks, equipped with data loggers that continually monitored body temperature, heart rate and activity, were successively inoculated with an H7N7 LPAI isolate (day 0), the same H7N7 isolate again (day 21) and an H5N2 LPAI isolate (day 35). After the first H7N7 inoculation, the ducks remained alert with no modification of heart rate or activity. However, body temperature transiently increased in four individuals, suggesting that LPAIV strains may have minor clinical effects on their natural hosts. The excretion patterns observed after both reinoculations differed strongly from those observed after the primary H7N7 inoculation, suggesting that not only homosubtypic but also heterosubtypic immunity exist. Our study suggests that LPAI infection has minor clinically measurable effects on mallards and that mallard ducks are able to mount immunological responses protective against heterologous infections. Because the transmission dynamics of LPAIVs in wild populations is greatly influenced by individual susceptibility and herd immunity, these findings are of high importance. Our study also shows the relevance of using telemetry to monitor disease in animals.	[Jourdain, Elsa; Gunnarsson, Gunnar; Latorre-Margalef, Neus; Svensson, Lovisa; Waldenstrom, Jonas; Olsen, Bjorn] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Jourdain, Elsa] INRA, UR 346, F-63122 St Genes Champanelle, France; [Gunnarsson, Gunnar] Kristianstad Univ, Aquat Biol & Chem Grp, Kristianstad, Sweden; [Wahlgren, John; Sahlin, Sofie] Karolinska Inst, Microbiol & Tumor Biol Ctr MTC, Stockholm, Sweden; [Wahlgren, John; Sahlin, Sofie; Lundkvist, Ake] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Brojer, Caroline] Natl Vet Inst, S-75007 Uppsala, Sweden; [Brojer, Caroline] Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	Linnaeus University; INRAE; Kristianstad University; Karolinska Institutet; Swedish Institute for Infectious Disease Control; National Veterinary Institute SVA; Swedish University of Agricultural Sciences; Uppsala University	Jourdain, E (corresponding author), Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden.	elsa.jourdain@clermont.inra.fr	Gunnarsson, Gunnar/G-8458-2014; Waldenström, Jonas/E-4460-2013	Gunnarsson, Gunnar/0000-0003-2345-3953; Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council; La Fondation pour La Recherche Medicale (FRM) [SPE20070709608]; Formas [2008-614]; Crafoordska Stiftelsen; Magnus Bergvalls Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); La Fondation pour La Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Formas(Swedish Research Council Formas); Crafoordska Stiftelsen; Magnus Bergvalls Stiftelse	This study was funded by the Swedish Research Council for Spatial Planning and Agriculture (Formas, http://www.formas.se/) and the Swedish Research Council (VR, http://www.vr.se/). EJ had a grant from La Fondation pour La Recherche Medicale (FRM SPE20070709608, http://www.frm.org/) and GG from Formas (2008-614), Crafoordska Stiftelsen (http://www.crafoord.se/) and Magnus Bergvalls Stiftelse (http://www.magnbergvallsstiftelse.nu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHL AK, 1977, J WILDLIFE DIS, V13, P420, DOI 10.7589/0090-3558-13.4.420; Brojer C, 2009, J VET DIAGN INVEST, V21, P579, DOI 10.1177/104063870902100501; Caron A, 2009, INFECT GENET EVOL, V9, P298, DOI 10.1016/j.meegid.2008.12.001; COOLEY AJ, 1989, VET PATHOL, V26, P1, DOI 10.1177/030098588902600101; DALECY LG, 1975, J PHYSIOL-LONDON, V253, P223, DOI 10.1113/jphysiol.1975.sp011188; Davidson AJ, 2003, J BIOL RHYTHM, V18, P430, DOI 10.1177/0748730403256066; Ellstrom P, 2008, VACCINE, V26, P4414, DOI 10.1016/j.vaccine.2008.06.027; Fallacara DM, 2001, AVIAN DIS, V45, P128, DOI 10.2307/1593019; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Foni E, 2005, MICROBIOLOGICA, V28, P31; Harms CA, 1997, CONDOR, V99, P231, DOI 10.2307/1370247; HIGGINS DA, 1987, IMMUNOLOGY, V62, P499; HOMME PJ, 1970, AVIAN DIS, V14, P285, DOI 10.2307/1588473; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Jansson DS, 2004, J MED MICROBIOL, V53, P293, DOI 10.1099/jmm.0.05488-0; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Laroucau K, 2009, VET MICROBIOL, V135, P82, DOI 10.1016/j.vetmic.2008.09.048; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; LAUDERT E, 1993, AVIAN DIS, V37, P845, DOI 10.2307/1592040; LAUDERT EA, 1993, J WILDLIFE DIS, V29, P523, DOI 10.7589/0090-3558-29.4.523; MA W, 2009, ZOONOSES PUBLIC HLTH, V3, P158; Machida N, 2001, J ZOO WILDLIFE MED, V32, P47, DOI 10.1638/1042-7260(2001)032[0047:EHRAHW]2.0.CO;2; Maloney SK, 1998, J COMP PHYSIOL B, V168, P177, DOI 10.1007/s003600050134; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; PHILPOTT MS, 1989, J WILDLIFE DIS, V25, P507, DOI 10.7589/0090-3558-25.4.507; REED LJ, 1938, AM J HYG, V27; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Savory CJ, 1997, PHYSIOL BEHAV, V61, P963, DOI 10.1016/S0031-9384(97)00016-4; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; SLEMONS RD, 1978, AVIAN DIS, V22, P367, DOI 10.2307/1589291; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; TOURE M, 1979, AVIAN DIS, V23, P335, DOI 10.2307/1589563; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; *VET LAB AG, 2008, PCR PROT DET AV INFL; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	46	109	112	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8935	10.1371/journal.pone.0008935	http://dx.doi.org/10.1371/journal.pone.0008935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126617	gold, Green Submitted, Green Published			2022-12-25	WOS:000274138000013
J	Yang, ZS; Zhang, BA; Li, DP; Lv, M; Huang, CM; Shen, GX; Huang, B				Yang, Zhuoshun; Zhang, Biao; Li, Dapeng; Lv, Meng; Huang, Chunmei; Shen, Guan-Xin; Huang, Bo			Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarcinoma Model	PLOS ONE			English	Article							REGULATORY T-CELLS; HUMAN AIRWAY EPITHELIUM; IMMUNE-RESPONSES; BEARING HOST; CANCER; INFLAMMATION; INTERLEUKIN-17; MACROPHAGES; EXPRESSION; GROWTH	Tumor immunosuppression is commonly braided with chronic inflammation during tumor development. However, the relationship between immunosuppression and inflammation in tumor microenvironment is still unclear. We have demonstrated that mast cells are accumulated and exacerbate the inflammation and immunosuppression in tumor microenvironment via SCF/c-kit signaling pathway. Here, we further elucidate the underlying mechanism, which involves both myeloid-derived suppressor cells (MDSCs) and regulatory T (Treg) cells. Our data showed that mast cells mobilized the infiltration of MDSCs to tumor and induced the production of IL-17 by MDSCs; MDSCs-derived IL-17 indirectly attracted Treg cells, enhanced their suppressor function, and induced the IL-9 production by Treg cells; in turn, IL-9 strengthened the survival and protumor effect of mast cells in tumor microenvironment. Our findings disclose a closed loop among mast cells, MDSCs and Treg cells in tumor microenvironment, which provides a new insight into the paralleled developments of inflammation and immunosuppression in tumor microenvironment. Based on these findings, we propose that targeting tumor inflammation might be a potential strategy to reverse the immunosuppression of tumor microenvironment, thus facilitating cancer immunotherapy.	[Yang, Zhuoshun; Zhang, Biao; Li, Dapeng; Lv, Meng; Huang, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China; [Huang, Chunmei; Shen, Guan-Xin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, ZS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China.	tjhuangbo@hotmail.com	Lv, Meng/I-5203-2014	Lv, Meng/0000-0001-6625-9523	Program for New Century Excellent Talents in University [NCET-08-0219]; National Natural Science Foundation of China [30871020]; Special Research Foundation [Z2009005]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Foundation	This work was supported by the Program for New Century Excellent Talents in University (NCET-08-0219) to BH, National Natural Science Foundation of China (30871020) to BH, Special Research Foundation for Universities affiliated with Ministry of Education of China to BH (Z2009005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Cao YC, 2008, J IMMUNOL, V180, P7681, DOI 10.4049/jimmunol.180.11.7681; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Fossiez F, 1998, Int Rev Immunol, V16, P541, DOI 10.3109/08830189809043008; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmielau J, 2001, CANCER RES, V61, P4756; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Sylvester J, 2004, CELL SIGNAL, V16, P469, DOI 10.1016/j.cellsig.2003.09.008; Tartour E, 1999, CANCER RES, V59, P3698; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xiao MJ, 2009, CANCER RES, V69, P2010, DOI 10.1158/0008-5472.CAN-08-3479; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	50	113	128	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8922	10.1371/journal.pone.0008922	http://dx.doi.org/10.1371/journal.pone.0008922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111717	Green Published, gold, Green Submitted			2022-12-25	WOS:000274114800023
J	Xiao, ZJ; Lv, CJ; Gao, C; Qin, JY; Ma, CQ; Liu, Z; Liu, PH; Li, LX; Xu, P				Xiao, Zijun; Lv, Chuanjuan; Gao, Chao; Qin, Jiayang; Ma, Cuiqing; Liu, Zhen; Liu, Peihai; Li, Lixiang; Xu, Ping			A Novel Whole-Cell Biocatalyst with NAD(+) Regeneration for Production of Chiral Chemicals	PLOS ONE			English	Article							NADH OXIDASE; COFACTOR REGENERATION; LACTOBACILLUS-BREVIS; ESCHERICHIA-COLI; REDUCTASE/2,3-BUTANEDIOL DEHYDROGENASE; GENE; 2,3-BUTANEDIOL; ACETOIN; CATALYST; SCALE	Background: The high costs of pyridine nucleotide cofactors have limited the applications of NAD(P)-dependent oxidoreductases on an industrial scale. Although NAD(P) H regeneration systems have been widely studied, NAD(P)(+) regeneration, which is required in reactions where the oxidized form of the cofactor is used, has been less well explored, particularly in whole-cell biocatalytic processes. Methodology/Principal Findings: Simultaneous overexpression of an NAD(+) dependent enzyme and an NAD(+) regenerating enzyme (H2O producing NADH oxidase from Lactobacillus brevis) in a whole-cell biocatalyst was studied for application in the NAD(+)-dependent oxidation system. The whole-cell biocatalyst with (2R,3R)-2,3-butanediol dehydrogenase as the catalyzing enzyme was used to produce (3R)-acetoin, (3S)-acetoin and (2S,3S)-2,3-butanediol. Conclusions/Significance: A recombinant strain, in which an NAD(+) regeneration enzyme was coexpressed, displayed significantly higher biocatalytic efficiency in terms of the production of chiral acetoin and (2S,3S)-2,3-butanediol. The application of this coexpression system to the production of other chiral chemicals could be extended by using different NAD(P)-dependent dehydrogenases that require NAD(P)(+) for catalysis.	[Xiao, Zijun; Lv, Chuanjuan; Gao, Chao; Qin, Jiayang; Ma, Cuiqing; Liu, Zhen; Liu, Peihai; Li, Lixiang; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xiao, ZJ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn; pingxu@sjtu.edu.cn		Gao, Chao/0000-0002-5205-0670; Ma, Cuiqing/0000-0002-7468-1027	National Natural Science Foundation of China [30770064, 30821005]; Chinese National Programs for High Technology Research and Development [2006AA02Z244]; National Basic Research Program of China [2007CB707803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Programs for High Technology Research and Development(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This study was partly supported by the National Natural Science Foundation of China (30770064 and 30821005), Chinese National Programs for High Technology Research and Development (2006AA02Z244) and National Basic Research Program of China (2007CB707803). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranat I, 2002, NAT REV DRUG DISCOV, V1, P753, DOI 10.1038/nrd915; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENAULT HK, 1987, APPL BIOCHEM BIOTECH, V14, P147, DOI 10.1007/BF02798431; Endo T, 2001, ADV SYNTH CATAL, V343, P521, DOI 10.1002/1615-4169(200108)343:6/7<521::AID-ADSC521>3.0.CO;2-5; Findrik Z, 2007, J BIOSCI BIOENG, V104, P275, DOI 10.1263/jbb.104.275; Galkin A, 1997, APPL ENVIRON MICROB, V63, P4651, DOI 10.1128/AEM.63.12.4651-4656.1997; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; Geueke B, 2003, ENZYME MICROB TECH, V32, P205, DOI 10.1016/S0141-0229(02)00290-9; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; HOHNBENTZ H, 1978, ARCH MICROBIOL, V116, P197, DOI 10.1007/BF00406037; Hosaka T, 2001, J BIOSCI BIOENG, V91, P539, DOI 10.1263/jbb.91.539; Hummel W, 2003, BIOTECHNOL LETT, V25, P51, DOI 10.1023/A:1021730131633; Hummel W, 1999, TRENDS BIOTECHNOL, V17, P487, DOI 10.1016/S0167-7799(98)01207-4; Ishige T, 2005, CURR OPIN CHEM BIOL, V9, P174, DOI 10.1016/j.cbpa.2005.02.001; KIM MJ, 1988, J AM CHEM SOC, V110, P2959, DOI 10.1021/ja00217a044; Nicholson WL, 2008, APPL ENVIRON MICROB, V74, P6832, DOI 10.1128/AEM.00881-08; Riebel BR, 2003, ADV SYNTH CATAL, V345, P707, DOI 10.1002/adsc.200303039; Saito S., 1992, US Patent, Patent No. 5164112; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; Ui S, 1998, LETT APPL MICROBIOL, V26, P275; van der Donk WA, 2003, CURR OPIN BIOTECH, V14, P421, DOI 10.1016/S0958-1669(03)00094-6; Wichmann R, 2005, ADV BIOCHEM ENG BIOT, V92, P225, DOI 10.1007/b98911; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5; Yamada-Onodera K, 2002, ACTA BIOTECHNOL, V22, P355, DOI 10.1002/1521-3846(200207)22:3/4<355::AID-ABIO355>3.0.CO;2-6	26	120	125	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8860	10.1371/journal.pone.0008860	http://dx.doi.org/10.1371/journal.pone.0008860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126645	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500004
J	Popp, D; Iwasa, M; Erickson, HP; Narita, A; Maeda, Y; Robinson, RC				Popp, David; Iwasa, Mitsusada; Erickson, Harold P.; Narita, Akihiro; Maeda, Yuichiro; Robinson, Robert C.			Suprastructures and Dynamic Properties of Mycobacterium tuberculosis FtsZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL-DIVISION; COUNTERION CONDENSATION; ACTIN BUNDLE; Z-RING; HYDROLYSIS; NUCLEATION; MECHANISM; GROWTH; MODEL; SIZE	Tuberculosis causes the most death in humans by any bacterium. Drug targeting of bacterial cytoskeletal proteins requires detailed knowledge of the various filamentous suprastructures and dynamic properties. Here, we have investigated by high resolution electron microscopy the assembly of cell division protein and microtubule homolog FtsZ from Mycobacterium tuberculosis (MtbFtsZ) in vitro in the presence of various monovalent salts, crowding agents and polycations. Supramolecular structures, including two-dimensional rings, three-dimensional toroids, and multistranded helices formed in the presence of molecular crowding, were similar to those observed by fluorescence microscopy in bacteria in vivo. Dynamic properties of MtbFtsZ filaments were visualized by light scattering and real time total internal reflection fluorescence microscopy. Interestingly, MtbFtsZ revealed a form of dynamic instability at steady state. Cation-induced condensation phenomena of bacterial cytomotive polymers have not been investigated in any detail, although it is known that many bacteria can contain high amounts of polycations, which may modulate the prokaryotic cytoskeleton. We find that above a threshold concentration of polycations which varied with the valence of the cation, ionic strength, and pH, MtbFtsZ mainly formed sheets. The general features of these cation-induced condensation phenomena could be explained in the framework of the Manning condensation theory. Chirality and packing defects limited the dimensions of sheets and toroids at steady state as predicted by theoretical models. In first approximation simple physical principles seem to govern the formation of MtbFtsZ suprastructures.	[Popp, David; Robinson, Robert C.] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Popp, David; Iwasa, Mitsusada; Narita, Akihiro; Maeda, Yuichiro] RIKEN, Harima Inst Spring 8, Japan Sci & Technol Corp, ERATO Actin Filament Dynam Project, Sayo, Hyogo 6795148, Japan; [Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Japan Science & Technology Agency (JST); RIKEN; Duke University; Nagoya University; Nagoya University	Popp, D (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Proteos 138673, Singapore.	dpopp@imcb.a-star.edu.sg	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903	Agency for Science, Technology, and Research (A*STAR), Singapore	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research (A*STAR), Singapore (R.C.R.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Borukhov L, 2005, P NATL ACAD SCI USA, V102, P3673, DOI 10.1073/pnas.0404140102; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Flyvbjerg H, 1996, PHYS REV E, V54, P5538, DOI 10.1103/PhysRevE.54.5538; Gov NS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011916; Grason GM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098101; Ha BY, 1999, EUROPHYS LETT, V46, P624, DOI 10.1209/epl/i1999-00311-6; Henle ML, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.060801; Hud NV, 2005, ANNU REV BIOPH BIOM, V34, P295, DOI 10.1146/annurev.biophys.34.040204.144500; KRULWICH TA, 1985, J BACTERIOL, V162, P768, DOI 10.1128/JB.162.2.768-772.1985; Kwon HJ, 2006, BIOCHEMISTRY-US, V45, P10313, DOI 10.1021/bi060721w; Lai GH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.187802; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Manning GS, 1998, J BIOMOL STRUCT DYN, V16, P461, DOI 10.1080/07391102.1998.10508261; MANNING GS, 1978, BIOPHYS CHEM, V9, P65, DOI 10.1016/0301-4622(78)87016-1; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Oosawa F., 1975, THERMODYNAMICS POLYM; Park SY, 1998, BIOPHYS J, V75, P714, DOI 10.1016/S0006-3495(98)77561-7; Peters PC, 2007, MOL MICROBIOL, V64, P487, DOI 10.1111/j.1365-2958.2007.05673.x; Popp D, 2008, BIOPOLYMERS, V89, P711, DOI 10.1002/bip.20999; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; SHINDLER DB, 1977, J BACTERIOL, V130, P698, DOI 10.1128/JB.130.2.698-703.1977; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; VIOTTI A, 1971, BIOCHIM BIOPHYS ACTA, V244, P329, DOI 10.1016/0304-4165(71)90234-0; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025	34	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11281	11289		10.1074/jbc.M109.084079	http://dx.doi.org/10.1074/jbc.M109.084079			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139085	Green Published, hybrid			2022-12-25	WOS:000276286200034
J	Ritchie, MF; Yue, CY; Zhou, YD; Houghton, PJ; Soboloff, J				Ritchie, Michael F.; Yue, Chanyu; Zhou, Yandong; Houghton, Peter J.; Soboloff, Jonathan			Wilms Tumor Suppressor 1 (WT1) and Early Growth Response 1 (EGR1) Are Regulators of STIM1 Expression*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE WT1; CALCIUM INFLUX; RHABDOID TUMOR; IN-VITRO; CELL; ORAI1; CRAC; DIFFERENTIATION; ACTIVATION; INHIBITION	Store-operated calcium entry (SOCE) is a key evolutionarily conserved process whereby decreases in endoplasmic reticulum Ca2+ content lead to the influx of Ca2+ across the plasma membrane. How this process is regulated in specific tumor cell types is poorly understood. In an effort to address this concern, we obtained and tested primary Wilms tumor cells, finding no detectable SOCE in this cell type. Analysis of the expression levels of STIM1 and ORAI1 (the molecular mediators of SOC) revealed poor STIM1 expression. Analysis of the STIM1 promoter using the TESS search system (University of Pennsylvania) revealed four putative response elements to the zinc-finger proteins WT1 (Wilms tumor suppressor 1) and EGR1 (early growth response 1). Either overexpression of WT1 or knockdown of EGR1 resulted in loss of STIM1 expression and a resultant decrease in SOCE. Furthermore, examination of Egr1 knock-out animals revealed loss of STIM1 expression in multiple tissues. Finally, using chromatin immunoprecipitation, we reveal direct binding of both WT1 and EGR1 to putative response elements located within 500 bp of the transcriptional start site of STIM1. Considering that WT1 and EGR1 are well described oncogenes and tumor suppressors, these observations may reveal new mechanisms responsible for distinct Ca2+ signals in cancer cells.	[Ritchie, Michael F.; Yue, Chanyu; Zhou, Yandong; Soboloff, Jonathan] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Houghton, Peter J.] Nationwide Childrens Hosp, Childrens Canc Ctr, Columbus, OH 43205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Soboloff, J (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3400 N Broad St, Philadelphia, PA 19140 USA.	soboloff@temple.edu	Yue, Chanyu/H-1792-2015; Soboloff, Jonathan/I-6995-2012	Soboloff, Jonathan/0000-0001-5192-1297	Pennsylvania Department of Health; American Heart Association [0730184N]	Pennsylvania Department of Health; American Heart Association(American Heart Association)	This work was supported by a grant from the Pennsylvania Department of Health (to J.S.) and by Grant 0730184N from the American Heart Association (to J.S.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Ahn BH, 2007, FEBS LETT, V581, P5940, DOI 10.1016/j.febslet.2007.11.077; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; COLE K, 1994, CANCER METAST REV, V13, P31, DOI 10.1007/BF00690417; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; DEY BR, 1994, MOL ENDOCRINOL, V8, P595, DOI 10.1210/me.8.5.595; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GARVIN AJ, 1993, AM J PATHOL, V142, P375; Ghanem MA, 2000, CLIN CANCER RES, V6, P4265; Graham C, 2006, CLIN CANCER RES, V12, P223, DOI 10.1158/1078-0432.CCR-05-1225; GRUBB GR, 1994, LAB INVEST, V71, P472; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hamilton TB, 1998, BIOCHEMISTRY-US, V37, P2051, DOI 10.1021/bi9717993; HARRINGTON MA, 1993, J BIOL CHEM, V268, P21271; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; Loeb DM, 2001, CANCER RES, V61, P921; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MIWA H, 1992, LEUKEMIA, V6, P405; Morton CL, 2007, INVEST NEW DRUG, V25, P285, DOI 10.1007/s10637-007-9042-y; Oji Y, 2004, CANCER SCI, V95, P822, DOI 10.1111/j.1349-7006.2004.tb02188.x; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; POWIS G, 1994, CANCER CHEMOTH PHARM, V34, P344, DOI 10.1007/BF00686043; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sabbioni S, 1999, CYTOGENET CELL GENET, V86, P214, DOI 10.1159/000015341; Sabbioni S, 1997, CANCER RES, V57, P4493; Sarfstein R, 2006, J NEUROCHEM, V99, P818, DOI 10.1111/j.1471-4159.2006.04119.x; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2002, EXP HEMATOL, V30, P1219, DOI 10.1016/S0301-472X(02)00893-7; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; WANG ZY, 1992, J BIOL CHEM, V267, P21999; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	45	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10591	10596		10.1074/jbc.M109.083493	http://dx.doi.org/10.1074/jbc.M109.083493			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123987	hybrid, Green Published			2022-12-25	WOS:000276264600046
J	Wang, Y; Fu, Y; Gao, L; Zhu, GX; Liang, J; Gao, C; Huang, BL; Fenger, U; Niehrs, C; Chen, YG; Wu, W				Wang, Ying; Fu, Yu; Gao, Lei; Zhu, Guixin; Liang, Juan; Gao, Chan; Huang, Binlu; Fenger, Ursula; Niehrs, Christof; Chen, Ye-Guang; Wu, Wei			Xenopus Skip Modulates Wnt/beta-Catenin Signaling and Functions in Neural Crest Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED TRANSCRIPTION; BETA-CATENIN; INTERACTING PROTEIN; WNT PATHWAY; SNW DOMAIN; ACTIVATION; GENE; TRANSDUCTION; EXPRESSION; CANCER	The beta-catenin-lymphoid enhancer factor (LEF) protein complex is the key mediator of canonical Wnt signaling and initiates target gene transcription upon ligand stimulation. In addition to beta-catenin and LEF themselves, many other proteins have been identified as necessary cofactors. Here we report that the evolutionally conserved splicing factor and transcriptional co-regulator, SKIP/SNW/NcoA62, forms a ternary complex with LEF1 and HDAC1 and mediates the repression of target genes. Loss-of-function studies showed that SKIP is obligatory for Wnt signaling-induced target gene transactivation, suggesting an important role of SKIP in the canonical Wnt signaling. Consistent with its involvement in beta-catenin signaling, the C-terminally truncated forms of SKIP are able to stabilize beta-catenin and enhance Wnt signaling. In Xenopus embryos, both overexpression and knockdown of Skip lead to reduced neural crest induction, consistent with down-regulated Wnt signaling in both cases. Our results indicate that SKIP is a novel component of the beta-catenin transcriptional complex.	[Chen, Ye-Guang; Wu, Wei] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Ying; Fu, Yu; Gao, Lei; Zhu, Guixin; Liang, Juan; Huang, Binlu; Wu, Wei] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China; [Gao, Chan; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Fenger, Ursula; Niehrs, Christof] German Canc Res Ctr, Div Mol Embryol, D-69120 Heidelberg, Germany	Tsinghua University; Tsinghua University; Tsinghua University; Helmholtz Association; German Cancer Research Center (DKFZ)	Wu, W (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	wwu@mail.tsinghua.edu.cn	Gao, Chan/D-7964-2013; Chen, Ye-Guang/L-6998-2019		Major Science Programs of China [2006CB943401, 2006CB943402]	Major Science Programs of China	This work was supported by Grants 2006CB943401 (to Y. G. C.) and 2006CB943402 (to W. W.) from The Major Science Programs of China.	Abu-Elmagd M, 2006, DEV BIOL, V298, P285, DOI 10.1016/j.ydbio.2006.06.037; Agius E, 2000, DEVELOPMENT, V127, P1173; Albers M, 2003, RNA, V9, P138, DOI 10.1261/rna.2119903; Ambrozkova M, 2001, BIOCHEM BIOPH RES CO, V284, P1148, DOI 10.1006/bbrc.2001.5108; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; BLITZ IL, 1995, DEVELOPMENT, V121, P993; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Heeg-Truesdell E, 2006, DEV BIOL, V298, P71, DOI 10.1016/j.ydbio.2006.06.015; Hong CS, 2008, DEVELOPMENT, V135, P3903, DOI 10.1242/dev.026229; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; Knochel S, 2001, MECH DEVELOP, V109, P79, DOI 10.1016/S0925-4773(01)00506-8; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kostrouchova M, 2002, P NATL ACAD SCI USA, V99, P9254, DOI 10.1073/pnas.112213799; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Leong GM, 2001, J BIOL CHEM, V276, P18243, DOI 10.1074/jbc.M010815200; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Martinkova K, 2002, J BIOCHEM, V132, P557, DOI 10.1093/oxfordjournals.jbchem.a003257; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Negeri D, 2002, MECH DEVELOP, V117, P151, DOI 10.1016/S0925-4773(02)00193-4; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Prathapam T, 2002, NUCLEIC ACIDS RES, V30, P5261, DOI 10.1093/nar/gkf658; Prathapam T, 2001, ONCOGENE, V20, P7677, DOI 10.1038/sj.onc.1204960; Prathapam T, 2001, NUCLEIC ACIDS RES, V29, P3469, DOI 10.1093/nar/29.17.3469; Raible DW, 2006, CURR OPIN CELL BIOL, V18, P698, DOI 10.1016/j.ceb.2006.09.003; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sakai D, 2005, DEV GROWTH DIFFER, V47, P471, DOI 10.1111/j.1440-169X.2005.00821.x; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu JL, 2005, DEV BIOL, V279, P220, DOI 10.1016/j.ydbio.2004.12.016; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000; Zhou SF, 2000, J VIROL, V74, P1939, DOI 10.1128/JVI.74.4.1939-1947.2000	66	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10890	10901		10.1074/jbc.M109.058347	http://dx.doi.org/10.1074/jbc.M109.058347			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20103590	Green Published, hybrid			2022-12-25	WOS:000276264600074
J	Oakley, AJ; Coggan, M; Board, PG				Oakley, Aaron J.; Coggan, Marjorie; Board, Philip G.			Identification and Characterization of gamma-Glutamylamine Cyclotransferase, an Enzyme Responsible for gamma-Glutamyl-epsilon-lysine Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GLUTAMYLCYCLOTRANSFERASE; ERYTHROCYTES; PURIFICATION; SPECIFICITY; ALIGNMENT; CYCLASE; SYSTEM	gamma-Glutamylamine cyclotransferase (GGACT) is an enzyme that converts gamma-glutamylamines to free amines and 5-oxoproline. GGACT shows high activity toward gamma-glutamyl-epsilon-lysine, derived from the breakdown of fibrin and other proteins crosslinked by transglutaminases. The enzyme adopts the newly identified cyclotransferase fold, observed in gamma-glutamylcyclotransferase (GGCT), an enzyme with activity toward gamma-glutamyl-alpha-amino acids (Oakley, A. J., Yamada, T., Liu, D., Coggan, M., Clark, A. G., and Board, P. G. (2008) J. Biol. Chem. 283, 22031-22042). Despite the absence of significant sequence identity, several residues are conserved in the active sites of GGCT and GGACT, including a putative catalytic acid/base residue (GGACT Glu(82)). The structure of GGACT in complex with the reaction product 5-oxoproline provides evidence for a common catalytic mechanism in both enzymes. The proposed mechanism, combined with the three-dimensional structures, also explains the different substrate specificities of these enzymes. Despite significant sequence divergence, there are at least three subfamilies in prokaryotes and eukaryotes that have conserved the GGCT fold and GGCT enzymatic activity.	[Coggan, Marjorie; Board, Philip G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Oakley, Aaron J.] CSIRO, Div Mol & Hlth Technol, Parkville, Vic 3052, Australia	Australian National University; John Curtin School of Medical Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Board, PG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Philip.Board@anu.edu.au	Oakley, Aaron/A-9464-2013	Oakley, Aaron/0000-0002-4764-014X	Australian Research Council [DP0880027]; National Health and Medical Research Council [525458]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Discovery Grant DP0880027 and National Health and Medical Research Council Project Grant 525458.	BOARD PG, 1978, J LAB CLIN MED, V91, P127; BOARD PG, 1978, BIOCHEM J, V173, P427, DOI 10.1042/bj1730427; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FINK ML, 1980, P NATL ACAD SCI-BIOL, V77, P4564, DOI 10.1073/pnas.77.8.4564; FINK ML, 1981, MOL CELL BIOCHEM, V38, P59, DOI 10.1007/BF00235688; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Klock HE, 2005, PROTEINS, V61, P1132, DOI 10.1002/prot.20610; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Llewellyn NM, 2007, CHEM BIOL, V14, P379, DOI 10.1016/j.chembiol.2007.02.005; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; ORLOWSKI M, 1969, BIOCHEMISTRY-US, V8, P1048, DOI 10.1021/bi00831a036; ORLOWSKI M, 1973, J BIOL CHEM, V248, P2836; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; PISANO JJ, 1968, SCIENCE, V160, P892, DOI 10.1126/science.160.3830.892; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; STEINKAMP R, 1987, PHYSIOL PLANTARUM, V69, P499, DOI 10.1111/j.1399-3054.1987.tb09231.x; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029	23	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9642	9648		10.1074/jbc.M109.082099	http://dx.doi.org/10.1074/jbc.M109.082099			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110353	Green Published, hybrid			2022-12-25	WOS:000276165900037
J	Wen, H; Li, JZ; Song, TJ; Lu, M; Kan, PY; Lee, MG; Sha, BD; Shi, XB				Wen, Hong; Li, Jingzhi; Song, Tanjing; Lu, Ming; Kan, Pu-Yeh; Lee, Min Gyu; Sha, Bingdong; Shi, Xiaobing			Recognition of Histone H3K4 Trimethylation by the Plant Homeodomain of PHF2 Modulates Histone Demethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; LYSINE-4 TRIMETHYLATION; CHROMATIN MODIFICATIONS; GENE-EXPRESSION; METHYLATION; TRANSCRIPTION; DOMAIN; COMPLEX; NURF; CODE	Distinct lysine methylation marks on histones create dynamic signatures deciphered by the "effector" modules, although the underlying mechanisms remain unclear. We identified the plant homeodomain-and Jumonji C domain-containing protein PHF2 as a novel histone H3K9 demethylase. We show in biochemical and crystallographic analyses that PHF2 recognizes histone H3K4 trimethylation through its plant homeodomain finger and that this interaction is essential for PHF2 occupancy and H3K9 demethylation at rDNA promoters. Our study provides molecular insights into the mechanism by which distinct effector domains within a protein cooperatively modulate the "cross-talk" of histone modifications.	[Wen, Hong; Song, Tanjing; Lu, Ming; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kan, Pu-Yeh; Lee, Min Gyu] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wen, Hong; Song, Tanjing; Kan, Pu-Yeh; Lee, Min Gyu; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Wen, Hong; Song, Tanjing; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Genes & Dev Grad Program, Houston, TX 77030 USA; [Li, Jingzhi; Sha, Bingdong] Univ Alabama, Dept Cell Biol, Birmingham, AL 35205 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Alabama System; University of Alabama Birmingham	Shi, XB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xbshi@mdanderson.org	song, tanjing/N-7539-2013	Shi, Xiaobing/0000-0001-5242-8189; Wen, Hong/0000-0001-8739-4572	Welch Foundation [G1719]; American Cancer Society; University of Texas M. D. Anderson Cancer Center	Welch Foundation(The Welch Foundation); American Cancer Society(American Cancer Society); University of Texas M. D. Anderson Cancer Center	This work was supported by Welch Foundation Grant G1719 and institutional research grants from the American Cancer Society and The University of Texas M. D. Anderson Cancer Center.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wen H, 2008, GENE DEV, V22, P601, DOI 10.1101/gad.1626308; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	26	110	113	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9322	9326		10.1074/jbc.C109.097667	http://dx.doi.org/10.1074/jbc.C109.097667			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20129925	Green Published, hybrid			2022-12-25	WOS:000276165900003
J	Guillen-Ahlers, H; Suckow, MA; Castellino, FJ; Ploplis, VA				Guillen-Ahlers, Hector; Suckow, Mark A.; Castellino, Francis J.; Ploplis, Victoria A.			Fas/CD95 Deficiency in Apc(Min/+) Mice Increases Intestinal Tumor Burden	PLOS ONE			English	Article							FAS LIGAND EXPRESSION; COLON-CANCER; COLORECTAL-CANCER; MEDIATED APOPTOSIS; CELL-SURVIVAL; CD95 LIGAND; AKT; GENE; RESISTANCE; REJECTION	Background: Fas, a member of the tumor necrosis family, is responsible for initiating the apoptotic pathway when bound to its ligand, Fas-L. Defects in the Fas-mediated apoptotic pathway have been reported in colorectal cancer. Methodology/Principal Findings: In the present study, a variant of the Apc(Min/+) mouse, a model for the human condition, Familial Adenomatous Polyposis (FAP), was generated with an additional deficiency of Fas (Apc(Min/+)/Fas(lpr)) by crossbreeding Apc(Min/+) mice with Fas deficient (Fas(lpr)) mice. One of the main limitations of the Apc(Min/+) mouse model is that it only develops benign polyps. However, Apc(Min/+)/Fas(lpr) mice presented with a dramatic increase in tumor burden relative to Apc(Min/+) mice and invasive lesions at advanced ages. Proliferation and apoptosis markers revealed an increase in cellular proliferation, but negligible changes in apoptosis, while p53 increased at early ages. Fas-L was lower in Apc(Min/+)/Fas(lpr) mice relative to Apc(Min/+) cohorts, which resulted in enhanced inflammation. Conclusions/Significance: This study demonstrated that imposition of a Fas deletion in an Apc(Min/+) background results in a more aggressive phenotype of the Apc(Min/+) mouse model, with more rapid development of invasive intestinal tumors and a decrease in Fas-L levels.	[Guillen-Ahlers, Hector; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Guillen-Ahlers, Hector; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA; [Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; Walther Cancer Institute; University of Notre Dame	Guillen-Ahlers, H (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	vploplis@nd.edu	Suckow, Mark/C-2696-2014	Guillen Ahlers, Hector/0000-0001-6077-3425; Suckow, Mark/0000-0001-7317-697X	NIH (NHLBI) [HL 73750]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073750] Funding Source: NIH RePORTER	NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (NHLBI) grant HL 73750 (FJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTOMARE DA, PERTURBATIONS AKT SI, V24, P7455; Arai H, 1997, P NATL ACAD SCI USA, V94, P13862, DOI 10.1073/pnas.94.25.13862; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; BEDI A, 1995, CANCER RES, V55, P1811; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chappell DB, 1999, CANCER RES, V59, P59; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fingleton B, 2007, CANCER RES, V67, P4800, DOI 10.1158/0008-5472.CAN-06-4473; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fuchs EJ, 1997, CANCER RES, V57, P2550; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Guillen-Ahlers H, 2008, CARCINOGENESIS, V29, P1421, DOI 10.1093/carcin/bgn123; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; Hohlbaum AM, 2000, J EXP MED, V191, P1209, DOI 10.1084/jem.191.7.1209; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kang SM, 1998, TRANSPLANT P, V30, P538, DOI 10.1016/S0041-1345(97)01396-1; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kita H, 2006, J GASTROENTEROL, V41, P1053, DOI 10.1007/s00535-006-1894-y; Lee SJ, 2000, J IMMUNOL, V164, P1277, DOI 10.4049/jimmunol.164.3.1277; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mahidhara RS, 2005, J SURG RES, V123, P302, DOI 10.1016/j.jss.2004.08.016; Mann B, 1999, BRIT J CANCER, V79, P1262, DOI 10.1038/sj.bjc.6690202; Matloff ET, 2004, CANCER J, V10, P280, DOI 10.1097/00130404-200409000-00002; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; O'Connell J, 1998, J PATHOL, V186, P240; O'Connell J, 2000, ANN NY ACAD SCI, V910, P178; O'Connor L, 2000, CANCER RES, V60, P1217; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Restifo NP, 2000, NAT MED, V6, P493, DOI 10.1038/74955; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Seino KI, 1997, NAT MED, V3, P165, DOI 10.1038/nm0297-165; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; VAUX DL, 1995, NATURE, V377, P576, DOI 10.1038/377576a0; WOFSY D, 1981, J EXP MED, V154, P1671, DOI 10.1084/jem.154.5.1671; Yagita H, 1996, NATURE, V379, P682, DOI 10.1038/379682a0; Yao H, 2004, BRIT J CANCER, V91, P1718, DOI 10.1038/sj.bjc.6602136; Zhou BHP, 2002, SEMIN ONCOL, V29, P62, DOI 10.1053/sonc.2002.34057	48	24	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9070	10.1371/journal.pone.0009070	http://dx.doi.org/10.1371/journal.pone.0009070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140201	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442400009
J	Angeli, S; Shao, J; Diamond, MI				Angeli, Suzanne; Shao, Jieya; Diamond, Marc I.			F-Actin Binding Regions on the Androgen Receptor and Huntingtin Increase Aggregation and Alter Aggregate Characteristics	PLOS ONE			English	Article							BULBAR MUSCULAR-ATROPHY; POLYGLUTAMINE AGGREGATION; IN-VITRO; TOXICITY; PROTEINS; EXPRESSION; PROFILIN; CLEAVAGE; DISEASE; PHOSPHORYLATION	Protein aggregation is associated with neurodegeneration. Polyglutamine expansion diseases such as spinobulbar muscular atrophy and Huntington disease feature proteins that are destabilized by an expanded polyglutamine tract in their N-termini. It has previously been reported that intracellular aggregation of these target proteins, the androgen receptor (AR) and huntingtin (Htt), is modulated by actin-regulatory pathways. Sequences that flank the polyglutamine tract of AR and Htt might influence protein aggregation and toxicity through protein-protein interactions, but this has not been studied in detail. Here we have evaluated an N-terminal 127 amino acid fragment of AR and Htt exon 1. The first 50 amino acids of ARN127 and the first 14 amino acids of Htt exon 1 mediate binding to filamentous actin in vitro. Deletion of these actin-binding regions renders the polyglutamine-expanded forms of ARN127 and Htt exon 1 less aggregation-prone, and increases the SDS-solubility of aggregates that do form. These regions thus appear to alter the aggregation frequency and type of polyglutamine-induced aggregation. These findings highlight the importance of flanking sequences in determining the propensity of unstable proteins to misfold.	[Angeli, Suzanne] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Shao, Jieya; Diamond, Marc I.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University of California System; University of California San Francisco; Washington University (WUSTL)	Angeli, S (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	diamondm@neuro.wustl.edu		Angeli, Suzanne/0000-0002-6229-9648	NIH/NINDS [1 R01 NS50284, 5F31NS054604]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054604, R01NS050284] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Muscular Dystrophy Association: www.mda.org, NIH/NINDS: 1 R01 NS50284, NIH/NINDS: 5F31NS054604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; [Anonymous], CELL, V72, P971; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Burnett BG, 2008, NEUROBIOL DIS, V30, P365, DOI 10.1016/j.nbd.2008.02.007; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; LI M, 2009, NEUROBIOL DIS; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; THOMPSON LM, 2009, J CELL BIOL; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003	38	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9053	10.1371/journal.pone.0009053	http://dx.doi.org/10.1371/journal.pone.0009053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140226	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474400012
J	Weisser, H; Altmann, A; Sierra, S; Incardona, F; Struck, D; Sonnerborg, A; Kaiser, R; Zazzi, M; Tschochner, M; Walter, H; Lengauer, T				Weisser, Hendrik; Altmann, Andre; Sierra, Saleta; Incardona, Francesca; Struck, Daniel; Sonnerborg, Anders; Kaiser, Rolf; Zazzi, Maurizio; Tschochner, Monika; Walter, Hauke; Lengauer, Thomas			Only Slight Impact of Predicted Replicative Capacity for Therapy Response Prediction	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-INFECTED PATIENTS; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; TREATMENT FAILURE; INHIBITORS; PROTEASE; FITNESS; REGRESSION; MUTATION	Background: Replication capacity (RC) of specific HIV isolates is occasionally blamed for unexpected treatment responses. However, the role of viral RC in response to antiretroviral therapy is not yet fully understood. Materials and Methods: We developed a method for predicting RC from genotype using support vector machines (SVMs) trained on about 300 genotype-RC pairs. Next, we studied the impact of predicted viral RC (pRC) on the change of viral load (VL) and CD4(+) T-cell count (CD4) during the course of therapy on about 3,000 treatment change episodes (TCEs) extracted from the EuResist integrated database. Specifically, linear regression models using either treatment activity scores (TAS), the drug combination, or pRC or any combination of these covariates were trained to predict change in VL and CD4, respectively. Results: The SVM models achieved a Spearman correlation (rho) of 0.54 between measured RC and pRC. The prediction of change in VL (CD4) was best at 180 (360) days, reaching a correlation of rho = 0.45 (rho = 0.27). In general, pRC was inversely correlated to drug resistance at treatment start (on average rho = 20.38). Inclusion of pRC in the linear regression models significantly improved prediction of virological response to treatment based either on the drug combination or on the TAS (t-test; p-values range from 0.0247 to 4 10(-6)) but not for the model using both TAS and drug combination. For predicting the change in CD4 the improvement derived from inclusion of pRC was not significant. Conclusion: Viral RC could be predicted from genotype with moderate accuracy and could slightly improve prediction of virological treatment response. However, the observed improvement could simply be a consequence of the significant correlation between pRC and drug resistance.	[Weisser, Hendrik; Altmann, Andre; Lengauer, Thomas] Max Planck Inst Informat, Saarbrucken, Germany; [Sierra, Saleta; Kaiser, Rolf] Univ Cologne, Inst Virol, Cologne, Germany; [Incardona, Francesca] Informa SRL, Rome, Italy; [Struck, Daniel] CRP Sante, Retrovirol Lab, Strassen, Luxembourg; [Sonnerborg, Anders] Karolinska Inst, Div Infect Dis, Dept Med, Stockholm, Sweden; [Zazzi, Maurizio] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Tschochner, Monika; Walter, Hauke] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany	Max Planck Society; University of Cologne; Luxembourg Institute of Health; Karolinska Institutet; University of Siena; University of Erlangen Nuremberg	Weisser, H (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	altmann@mpi-inf.mpg.de	Altmann, Andre/ABF-1675-2020; Sönnerborg, Anders/W-2011-2019; Zazzi, Maurizio/K-3422-2018	Altmann, Andre/0000-0002-9265-2393; Sönnerborg, Anders/0000-0001-8928-3374; Zazzi, Maurizio/0000-0002-0344-6281	EU [IST-2004-027173-STP]	EU(European Commission)	The work at Max Planck Institute for Informatics was supported by the EuResist project (EU grant IST-2004-027173-STP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2007, ANTIVIR THER, V12, P169; Altmann A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003470; Balduin M, 2005, J CLIN VIROL, V34, P277, DOI 10.1016/j.jcv.2005.08.007; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Birkner MD, 2005, STAT APPL GENET MOL, V4; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; De Luca A, 2003, J INFECT DIS, V187, P1934, DOI 10.1086/375355; De Luca A, 2007, JAIDS-J ACQ IMM DEF, V45, P411, DOI 10.1097/QAI.0b013e318074f008; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; DIMITRIADOU E, 2007, E1071 MISC FUNCTIONS; Dykes C, 2007, CLIN MICROBIOL REV, V20, P550, DOI 10.1128/CMR.00017-07; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Grant P, 2009, CLIN INFECT DIS, V48, P680, DOI 10.1086/597008; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Larder B, 2007, ANTIVIR THER, V12, P15; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Nijhuis M., 2009, V189, P299, DOI 10.1007/978-3-540-79086-0_11; Oette M, 2006, JAIDS-J ACQ IMM DEF, V41, P573, DOI 10.1097/01.qai.0000214805.52723.c1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PERES Y, 2007, EUR J MED RES, P11; Perrin L, 1998, SCIENCE, V280, P1871, DOI 10.1126/science.280.5371.1871; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Quinones-Mateu ME, 2002, DRUG RESIST UPDATE, V5, P224, DOI 10.1016/S1368-7646(02)00123-1; R Development Core Team, 2007, R LANG ENV STAT COMP; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Sagir A, 2007, J ANTIMICROB CHEMOTH, V60, P843, DOI 10.1093/jac/dkm274; Segal M.R., 2004, STAT APPL GENET MOL, V3; Segal M.R., 2004, STAT APPL GENET MOL, V3; Segal MR., 2004, STAT APPL GENET MOL, V3, P2, DOI [10.2202/1544-6115.1031, DOI 10.2202/1544-6115.1031]; Shafer RW, 2008, AIDS REV, V10, P67; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Van Laethem K, 2002, ANTIVIR THER, V7, P123; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Walter H, 1999, J CLIN VIROL, V13, P71, DOI 10.1016/S1386-6532(99)00010-4	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9044	10.1371/journal.pone.0009044	http://dx.doi.org/10.1371/journal.pone.0009044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140263	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474200024
J	Xin, HQ; Li, Y; Shen, LH; Liu, XS; Wang, XL; Zhang, J; Pourabdollah-Nejad, S; Zhang, CL; Zhang, L; Jiang, H; Zhang, ZG; Chopp, M				Xin, Hongqi; Li, Yi; Shen, Li Hong; Liu, Xianshuang; Wang, Xinli; Zhang, Jing; Pourabdollah-Nejad, Siamak; Zhang, Chunling; Zhang, Li; Jiang, Hao; Zhang, Zheng Gang; Chopp, Michael			Increasing tPA Activity in Astrocytes Induced by Multipotent Mesenchymal Stromal Cells Facilitate Neurite Outgrowth after Stroke in the Mouse	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR PRODUCTION; ARTERY OCCLUSION MODEL; BONE-MARROW; FUNCTIONAL RECOVERY; AXONAL REGENERATION; REACTIVE ASTROCYTES; MATRIX-METALLOPROTEINASE	We demonstrate that tissue plasminogen activator (tPA) and its inhibitors contribute to neurite outgrowth in the central nervous system (CNS) after treatment of stroke with multipotent mesenchymal stromal cells (MSCs). In vivo, administration of MSCs to mice subjected to middle cerebral artery occlusion (MCAo) significantly increased activation of tPA and downregulated PAI-1 levels in the ischemic boundary zone (IBZ) compared with control PBS treated mice, concurrently with increases of myelinated axons and synaptophysin. In vitro, MSCs significantly increased tPA levels and concomitantly reduced plasminogen activator inhibitor 1 (PAI-1) expression in astrocytes under normal and oxygen and glucose deprivation (OGD) conditions. ELISA analysis of conditioned medium revealed that MSCs stimulated astrocytes to secrete tPA. When primary cortical neurons were cultured in the conditioned medium from MSC co-cultured astrocytes, these neurons exhibited a significant increase in neurite outgrowth compared to conditioned medium from astrocytes alone. Blockage of tPA with a neutralizing antibody or knock-down of tPA with siRNA significantly attenuated the effect of the conditioned medium on neurite outgrowth. Addition of recombinant human tPA into cortical neuronal cultures also substantially enhanced neurite outgrowth. Collectively, these in vivo and in vitro data suggest that the MSC mediated increased activation of tPA in astrocytes promotes neurite outgrowth after stroke.	[Xin, Hongqi; Li, Yi; Shen, Li Hong; Liu, Xianshuang; Wang, Xinli; Zhang, Jing; Pourabdollah-Nejad, Siamak; Zhang, Chunling; Zhang, Li; Jiang, Hao; Zhang, Zheng Gang; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Xin, HQ (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA.	chopp@neuro.hfh.edu	zhang, zheng/HCH-9684-2022	Xin, Hongqi/0000-0003-3172-416X; Nejad-Davarani, Siamak/0000-0002-2415-6689	National Institute of Neurological Disorders and Stroke (NINDS) [PO1 NS042345]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066041, P01NS042345] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/)grants PO1 NS042345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; An J, 2008, BLOOD, V112, P2787, DOI 10.1182/blood-2008-02-141630; Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Aoki C, 1998, PROG BRAIN RES, V118, P83; Barker PA, 2009, NAT NEUROSCI, V12, P105, DOI 10.1038/nn0209-105; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Braungart E, 2001, J INVEST DERMATOL, V116, P778, DOI 10.1046/j.1523-1747.2001.01310.x; Buisson A, 2003, CELL MOL NEUROBIOL, V23, P539, DOI 10.1023/A:1025072013107; Buisson A, 1998, FASEB J, V12, P1683, DOI 10.1096/fasebj.12.15.1683; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; CHOPP M, 2008, EUROPEAN NE IN PRESS; CHOPP M, 2006, ACUTE STROKE BENCH B, P473; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; CRUTCHER KA, 1986, CRIT REV NEUROBIOL, V2, P297; Cui X, 2008, NEUROSCIENCE, V156, P155, DOI 10.1016/j.neuroscience.2008.07.019; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; EDGAR D, 1985, J CELL SCI, P107; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fok-Seang J, 1998, EUR J NEUROSCI, V10, P2400, DOI 10.1046/j.1460-9568.1998.00251.x; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Gabriel C, 2002, FASEB J, V16, P277, DOI 10.1096/fj.02-0403fje; Gao Q, 2008, NEUROSCIENCE, V152, P646, DOI 10.1016/j.neuroscience.2007.10.069; Gravanis I, 2005, GLIA, V49, P177, DOI 10.1002/glia.20115; Hardy SA, 2008, CURR STEM CELL RES T, V3, P43; Hino H, 2001, NEUROSCI LETT, V297, P105, DOI 10.1016/S0304-3940(00)01679-7; Hua Y, 2002, J CEREBR BLOOD F MET, V22, P55, DOI 10.1097/00004647-200201000-00007; Ikeda N, 2005, STROKE, V36, P2725, DOI 10.1161/01.STR.0000190006.88896.d3; Kahles T, 2005, VASC PHARMACOL, V43, P254, DOI 10.1016/j.vph.2005.07.008; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Kucharewicz I, 2003, THROMB RES, V112, P1, DOI 10.1016/j.thromres.2003.10.011; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; LAWRENCE DA, 1990, J BIOL CHEM, V265, P20293; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Lee SR, 2007, NEUROSCIENCE, V150, P50, DOI 10.1016/j.neuroscience.2007.06.029; Lee SR, 2007, NEUROSCI LETT, V417, P1, DOI 10.1016/j.neulet.2007.01.017; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Lu WQ, 2002, DEVELOPMENT, V129, P2043; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Matsui Fumiko, 2004, Congenital Anomalies, V44, P181, DOI 10.1111/j.1741-4520.2004.00038.x; MISKIN R, 1981, ANAL BIOCHEM, V118, P252, DOI 10.1016/0003-2697(81)90187-1; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Nolin WB, 2008, GLIA, V56, P177, DOI 10.1002/glia.20603; Oikawa K, 2000, XENOBIOTICA, V30, P993, DOI 10.1080/00498250050200140; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Peltonen S, 1996, THROMB RES, V82, P369, DOI 10.1016/0049-3848(96)00086-2; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Ribotta MG, 2004, ACTA NEUROCHIR SUPPL, V89, P87; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; SALTHOUSE TN, 1964, STAIN TECHNOL, V39, P123; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; SHICHINOHE H, 2009, NEUROPATHOLOGY; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Siao CJ, 2002, CELL MOL BIOL, V48, P151; SIDDIQUI S, 2009, GLIA; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Teesalu T, 2001, AM J PATHOL, V159, P2227, DOI 10.1016/S0002-9440(10)63073-8; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; TOSHNIWAL PK, 1987, J NEUROL SCI, V80, P277, DOI 10.1016/0022-510X(87)90162-6; Tsirka SE, 2002, BIOCHEM SOC T, V30, P222, DOI 10.1042/BST0300222; Tzarfaty-Majar V, 2001, J BIOL CHEM, V276, P28233, DOI 10.1074/jbc.M102585200; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Vivien D, 2000, J CEREBR BLOOD F MET, V20, P755, DOI 10.1097/00004647-200005000-00001; von Bohlen und Halbach O, 1998, J NEUROSCI METH, V81, P169, DOI 10.1016/S0165-0270(98)00026-0; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wang YF, 1997, EXP EYE RES, V65, P105, DOI 10.1006/exer.1997.0314; Wozniak W, 1993, Folia Morphol (Warsz), V52, P173; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Xin HQ, 2006, J NEUROSCI RES, V83, P1485, DOI 10.1002/jnr.20834; Yamada K, 2008, BIOL PHARM BULL, V31, P1635, DOI 10.1248/bpb.31.1635; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Yepes M, 2004, TRENDS CARDIOVAS MED, V14, P173, DOI 10.1016/j.tcm.2004.03.004; Yepes M, 2004, THROMB HAEMOSTASIS, V91, P457, DOI 10.1160/TH03-12-0766; Yepes M, 2000, BLOOD, V96, P569; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang J, 2004, BRAIN RES, V1030, P19, DOI 10.1016/j.brainres.2004.09.061; Zhang N, 2005, J NEUROSCI, V25, P2761, DOI 10.1523/JNEUROSCI.3195-04.2005; Zhang Y, 2009, POLYM COMPOSITE, V30, P38, DOI 10.1002/pc.20526; Zheng S, 2008, MOL VIS, V14, P975	102	66	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9027	10.1371/journal.pone.0009027	http://dx.doi.org/10.1371/journal.pone.0009027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140248	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474200013
J	Sharma, A; Callahan, LM; Sul, JY; Kim, TK; Barrett, L; Kim, M; Powers, JM; Federoff, H; Eberwine, J				Sharma, Anup; Callahan, Linda M.; Sul, Jai-Yoon; Kim, Tae Kyung; Barrett, Lindy; Kim, Minsun; Powers, James M.; Federoff, Howard; Eberwine, James			A Neurotoxic Phosphoform of Elk-1 Associates with Inclusions from Multiple Neurodegenerative Diseases	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; COMPLEX FACTOR ELK-1; TRANSCRIPTION FACTOR; PARKINSONS-DISEASE; HUNTINGTON DISEASE; ALPHA-SYNUCLEIN; LEWY BODIES; ACTIVATION; DOMAIN; MECHANISM	Neurodegenerative diseases are characterized by a number of features including the formation of inclusions, early synaptic degeneration and the selective loss of neurons. Molecules serving as links between these shared features have yet to be identified. Identifying candidates within the diseased microenvironment will open up novel avenues for therapeutic intervention. The transcription factor Elk-1 resides within multiple brain areas both in nuclear and extranuclear neuronal compartments. Interestingly, its de novo expression within a single dendrite initiates neuronal death. Given this novel regionalized function, we assessed whether extranuclear Elk-1 and/or phospho-Elk-1 (pElk-1) protein might be associated with a spectrum of human neurodegenerative disease cases including Lewy body Disease (e. g. Parkinson's), Alzheimer's disease, and Huntington's Disease. We first determined the importance of Elk-1 post-translational modifications on its ability to initiate regionalized cell death. We next screened human cases from three major neurodegenerative diseases to look for remarkable levels of Elk-1 and/or pElk-1 protein as well as their association with inclusions characteristic of these diseases. We compared our findings to age-matched control cases. We find that the ability of Elk-1 to initiate regionalized neuronal death depends on a specific phosphosite, T417. Furthermore, we find that T417(+) Elk-1 uniquely associates with several types of inclusions present in cases of human Lewy body Disease, Alzheimer's disease, and Huntington's Disease. These results suggest a molecular link between the presence of inclusions and neuronal loss that is shared across a spectrum of neurodegenerative disease.	[Sharma, Anup; Eberwine, James] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Callahan, Linda M.; Powers, James M.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Sul, Jai-Yoon; Kim, Tae Kyung; Eberwine, James] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Barrett, Lindy] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Kim, Minsun] Wonkwang Univ, Sch Med, Dept Physiol, Iksan, South Korea; [Federoff, Howard] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Eberwine, James] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Rochester; University of Pennsylvania; Memorial Sloan Kettering Cancer Center; Wonkwang University; Georgetown University; University of Pennsylvania	Sharma, A (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	eberwine@upenn.edu	Eberwine, James/B-2247-2010		National Institutes of Health (NIH); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078136] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Baba M, 1998, AM J PATHOL, V152, P879; Barrett LE, 2006, P NATL ACAD SCI USA, V103, P5155, DOI 10.1073/pnas.0510477103; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chai YL, 2001, ONCOGENE, V20, P1357, DOI 10.1038/sj.onc.1204256; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; GALLOWAY PG, 1992, AM J PATHOL, V140, P809; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; Greenamyre JT, 2007, NEW ENGL J MED, V356, P518, DOI 10.1056/NEJMcibr067022; Herndon ES, 2009, J NEUROPATH EXP NEUR, V68, P250, DOI 10.1097/NEN.0b013e318198d320; INCE PG, 2008, GREENFIELDS NEUROPAT, P897; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; LOWE J, 2008, GREENFIELDS NEUROPAT, P1041; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sgambato V, 1998, J NEUROSCI, V18, P214; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036	27	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9002	10.1371/journal.pone.0009002	http://dx.doi.org/10.1371/journal.pone.0009002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126313	Green Published, gold			2022-12-25	WOS:000274207200005
J	Mangla, K; Dill, DL; Horowitz, MA				Mangla, Karan; Dill, David L.; Horowitz, Mark A.			Timing Robustness in the Budding and Fission Yeast Cell Cycles	PLOS ONE			English	Article							NETWORK; TRANSCRIPTION; MODEL; GENE	Robustness of biological models has emerged as an important principle in systems biology. Many past analyses of Boolean models update all pending changes in signals simultaneously (i.e., synchronously), making it impossible to consider robustness to variations in timing that result from noise and different environmental conditions. We checked previously published mathematical models of the cell cycles of budding and fission yeast for robustness to timing variations by constructing Boolean models and analyzing them using model-checking software for the property of speed independence. Surprisingly, the models are nearly, but not totally, speed-independent. In some cases, examination of timing problems discovered in the analysis exposes apparent inaccuracies in the model. Biologically justified revisions to the model eliminate the timing problems. Furthermore, in silico random mutations in the regulatory interactions of a speed-independent Boolean model are shown to be unlikely to preserve speed independence, even in models that are otherwise functional, providing evidence for selection pressure to maintain timing robustness. Multiple cell cycle models exhibit strong robustness to timing variation, apparently due to evolutionary pressure. Thus, timing robustness can be a basis for generating testable hypotheses and can focus attention on aspects of a model that may need refinement.	[Mangla, Karan; Dill, David L.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Horowitz, Mark A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Mangla, K (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	dill@cs.stanford.edu			King Abdullah University of Science and Technology (KAUST); Stanford University Department of Computer Science	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Stanford University Department of Computer Science	This research has been funded in part by a King Abdullah University of Science and Technology (KAUST) research grant under the KAUST-Stanford Academic Excellence Alliance program, and by a seed grant from the Stanford University Department of Computer Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this paper are those of the authors and do not necessarily reflect the views of any of the funders.	ALUR R, 1994, THEORETICAL COMPUTER, V126, P235; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; Cimatti, 2002, LECT NOTES COMPUTER, P359, DOI DOI 10.1007/3-540-45657-0_29; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Fages Francois, 2004, Journal of Biological Physics and Chemistry, V4, P64, DOI 10.4024/2040402.jbpc.04.02; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Fisher J, 2008, LECT N BIOINFORMAT, V5054, P17, DOI 10.1007/978-3-540-68413-8_2; Fisher J, 2007, PLOS COMPUT BIOL, V3, P862, DOI 10.1371/journal.pcbi.0030092; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007; Irons DJ, 2009, J THEOR BIOL, V257, P543, DOI 10.1016/j.jtbi.2008.12.028; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; MAHER M, 1995, MOL CELL BIOL, V15, P3129; Novak B, 2001, CHAOS, V11, P277, DOI 10.1063/1.1345725; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pfleger CM, 2000, GENE DEV, V14, P655; Shen XL, 2008, P NATL ACAD SCI USA, V105, P11340, DOI 10.1073/pnas.0805258105; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Sveiczer Akos, 2004, Briefings in Functional Genomics & Proteomics, V2, P298, DOI 10.1093/bfgp/2.4.298; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063	27	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8906	10.1371/journal.pone.0008906	http://dx.doi.org/10.1371/journal.pone.0008906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126540	gold, Green Submitted, Green Published			2022-12-25	WOS:000274209700002
J	Potter, WB; O'Riordan, KJ; Barnett, D; Osting, SMK; Wagoner, M; Burger, C; Roopra, A				Potter, Wyatt B.; O'Riordan, Kenneth J.; Barnett, David; Osting, Susan M. K.; Wagoner, Matthew; Burger, Corinna; Roopra, Avtar			Metabolic Regulation of Neuronal Plasticity by the Energy Sensor AMPK	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; TUBEROUS SCLEROSIS GENE; RAT HIPPOCAMPAL SLICES; SYNAPTIC PLASTICITY; MAMMALIAN TARGET; LATE-PHASE; SIGNALING PATHWAY; GLUCOSE-CONCENTRATION; RAPAMYCIN PATHWAY	Long Term Potentiation (LTP) is a leading candidate mechanism for learning and memory and is also thought to play a role in the progression of seizures to intractable epilepsy. Maintenance of LTP requires RNA transcription, protein translation and signaling through the mammalian Target of Rapamycin (mTOR) pathway. In peripheral tissue, the energy sensor AMP-activated Protein Kinase (AMPK) negatively regulates the mTOR cascade upon glycolytic inhibition and cellular energy stress. We recently demonstrated that the glycolytic inhibitor 2-deoxy-D-glucose (2DG) alters plasticity to retard epileptogenesis in the kindling model of epilepsy. Reduced kindling progression was associated with increased recruitment of the nuclear metabolic sensor CtBP to NRSF at the BDNF promoter. Given that energy metabolism controls mTOR through AMPK in peripheral tissue and the role of mTOR in LTP in neurons, we asked whether energy metabolism and AMPK control LTP. Using a combination of biochemical approaches and field-recordings in mouse hippocampal slices, we show that the master regulator of energy homeostasis, AMPK couples energy metabolism to LTP expression. Administration of the glycolytic inhibitor 2-deoxy-D-glucose (2DG) or the mitochondrial toxin and anti-Type II Diabetes drug, metformin, or AMP mimetic AICAR results in activation of AMPK, repression of the mTOR pathway and prevents maintenance of Late-Phase LTP (L-LTP). Inhibition of AMPK by either compound-C or the ATP mimetic ara-A rescues the suppression of L-LTP by energy stress. We also show that enhanced LTP via AMPK inhibition requires mTOR signaling. These results directly link energy metabolism to plasticity in the mammalian brain and demonstrate that AMPK is a modulator of LTP. Our work opens up the possibility of using modulators of energy metabolism to control neuronal plasticity in diseases and conditions of aberrant plasticity such as epilepsy.	[Potter, Wyatt B.; O'Riordan, Kenneth J.; Barnett, David; Osting, Susan M. K.; Wagoner, Matthew; Burger, Corinna; Roopra, Avtar] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Potter, WB (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.	roopra@neurology.wisc.edu	O'Riordan, Kenneth J./H-6467-2019	O'Riordan, Kenneth J./0000-0003-0081-6010; Burger, Corinna/0000-0002-9432-0114	Department of Neurology, Graduate School and Medical School; University of Wisconsin-Madison and Citizens United for Research in Epilepsy (CURE); Neuroscience Training Program; University of Wisconsin-Madison; Molecular and Cellular Pharmacology program, University of Wisconsin-Madison	Department of Neurology, Graduate School and Medical School; University of Wisconsin-Madison and Citizens United for Research in Epilepsy (CURE); Neuroscience Training Program; University of Wisconsin-Madison; Molecular and Cellular Pharmacology program, University of Wisconsin-Madison	This work was supported by funds from the Department of Neurology, Graduate School and Medical School, University of Wisconsin-Madison and Citizens United for Research in Epilepsy (CURE) to A.R. and C.B., and Lilly's Fund to A.R. W.B.P. is supported by the Neuroscience Training Program, University of Wisconsin-Madison. M. P. W. is supported by the Molecular and Cellular Pharmacology program, University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JL, 2006, EXP BRAIN RES, V169, P126, DOI 10.1007/s00221-005-0314-5; Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; AZARI NP, 1991, PSYCHOPHARMACOLOGY, V105, P521, DOI 10.1007/BF02244373; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Godfraind Jean-Marie, 2006, Critical Reviews in Neurobiology, V18, P37; GOLD PE, 1986, BEHAV NEURAL BIOL, V45, P342, DOI 10.1016/S0163-1047(86)80022-X; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Henin N, 1996, BBA-GEN SUBJECTS, V1290, P197, DOI 10.1016/0304-4165(96)00021-9; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamal A, 1999, BRAIN RES, V824, P238, DOI 10.1016/S0006-8993(99)01215-9; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Kopf SR, 1996, NEUROBIOL LEARN MEM, V65, P189, DOI 10.1006/nlme.1996.0020; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; NELLIST M, 1993, CELL, V75, P1305; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Roopra A, 2001, Mol Interv, V1, P219; Rubin LJ, 2005, J APPL PHYSIOL, V98, P296, DOI 10.1152/japplphysiol.00075.2004; Sadgrove MP, 2007, BRAIN RES, V1165, P30, DOI 10.1016/j.brainres.2007.06.052; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schroeder JP, 2003, EUR J NEUROSCI, V17, P1482, DOI 10.1046/j.1460-9568.2003.02578.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tekkok S, 1996, J NEUROPHYSIOL, V76, P2343, DOI 10.1152/jn.1996.76.4.2343; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Vickers CA, 2005, J PHYSIOL-LONDON, V568, P803, DOI 10.1113/jphysiol.2005.092924; Xu YZ, 2001, BRAIN RES, V895, P250, DOI 10.1016/S0006-8993(01)02077-7; Zhao YT, 1997, CAN J PHYSIOL PHARM, V75, P368, DOI 10.1139/cjpp-75-5-368; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	59	133	138	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8996	10.1371/journal.pone.0008996	http://dx.doi.org/10.1371/journal.pone.0008996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126541	Green Published, Green Submitted, gold			2022-12-25	WOS:000274209700021
J	Nabe-Nielsen, J; Sibly, RM; Forchhammer, MC; Forbes, VE; Topping, CJ				Nabe-Nielsen, Jacob; Sibly, Richard M.; Forchhammer, Mads C.; Forbes, Valery E.; Topping, Christopher J.			The Effects of Landscape Modifications on the Long-Term Persistence of Animal Populations	PLOS ONE			English	Article							LIFE-HISTORY; METAPOPULATION DYNAMICS; HABITAT FRAGMENTATION; PATCH SIZE; PATTERN; CONNECTIVITY; MODEL; CORRIDORS; ABUNDANCE; LESSONS	Background: The effects of landscape modifications on the long-term persistence of wild animal populations is of crucial importance to wildlife managers and conservation biologists, but obtaining experimental evidence using real landscapes is usually impossible. To circumvent this problem we used individual-based models (IBMs) of interacting animals in experimental modifications of a real Danish landscape. The models incorporate as much as possible of the behaviour and ecology of four species with contrasting life-history characteristics: skylark (Alauda arvensis), vole (Microtus agrestis), a ground beetle (Bembidion lampros) and a linyphiid spider (Erigone atra). This allows us to quantify the population implications of experimental modifications of landscape configuration and composition. Methodology/Principal Findings: Starting with a real agricultural landscape, we progressively reduced landscape complexity by (i) homogenizing habitat patch shapes, (ii) randomizing the locations of the patches, and (iii) randomizing the size of the patches. The first two steps increased landscape fragmentation. We assessed the effects of these manipulations on the long-term persistence of animal populations by measuring equilibrium population sizes and time to recovery after disturbance. Patch rearrangement and the presence of corridors had a large effect on the population dynamics of species whose local success depends on the surrounding terrain. Landscape modifications that reduced population sizes increased recovery times in the short-dispersing species, making small populations vulnerable to increasing disturbance. The species that were most strongly affected by large disturbances fluctuated little in population sizes in years when no perturbations took place. Significance: Traditional approaches to the management and conservation of populations use either classical methods of population analysis, which fail to adequately account for the spatial configurations of landscapes, or landscape ecology, which accounts for landscape structure but has difficulty predicting the dynamics of populations living in them. Here we show how realistic and replicable individual-based models can bridge the gap between non-spatial population theory and non-dynamic landscape ecology. A major strength of the approach is its ability to identify population vulnerabilities not detected by standard population viability analyses.	[Nabe-Nielsen, Jacob; Forchhammer, Mads C.] Univ Aarhus, Natl Environm Res Inst, Dept Arctic Environm, Roskilde, Denmark; [Nabe-Nielsen, Jacob; Sibly, Richard M.; Forchhammer, Mads C.; Forbes, Valery E.; Topping, Christopher J.] Roskilde Univ, Dept Environm Social & Spatial Change, CIPE, Roskilde, Denmark; [Sibly, Richard M.] Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AJ, Berks, England; [Topping, Christopher J.] Univ Aarhus, Natl Environm Res Inst, Dept Wildlife Ecol & Biodivers, Ronde, Denmark	Aarhus University; Roskilde University; University of Reading; Aarhus University	Nabe-Nielsen, J (corresponding author), Univ Aarhus, Natl Environm Res Inst, Dept Arctic Environm, Roskilde, Denmark.	nabe@dmu.dk	Forchhammer, Mads/I-7474-2013; Forbes, Valery E/K-6763-2012; marcos, filipa/G-7133-2011; Topping, Christopher J/A-9167-2009; Nabe-Nielsen, Jacob/A-5891-2010; Forbes, Valery/P-9360-2019	Topping, Christopher J/0000-0003-0874-7603; Nabe-Nielsen, Jacob/0000-0002-0716-9525; Forbes, Valery/0000-0001-9819-9385; Sibly, Richard/0000-0001-6828-3543	Centre for Integrated Population Ecology (CIPE); Danish Natural Sciences Research Council	Centre for Integrated Population Ecology (CIPE); Danish Natural Sciences Research Council(Danish Natural Science Research Council)	The research was financed by The Centre for Integrated Population Ecology (CIPE). CIPE is an international centre of excellence supported by the Danish Natural Sciences Research Council (http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research/scientific-research-councils/natural-sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Bender DJ, 2005, ECOLOGY, V86, P1023, DOI 10.1890/03-0769; Bilde T, 2004, ECOSCIENCE, V11, P64, DOI 10.1080/11956860.2004.11682810; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Costanza R, 2002, ECOL MONOGR, V72, P203, DOI 10.1890/0012-9615(2002)072[0203:IEEMOT]2.0.CO;2; Dalkvist T, 2009, ECOTOX ENVIRON SAFE, V72, P1663, DOI 10.1016/j.ecoenv.2008.10.002; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Duncan RP, 2007, ECOLOGY, V88, P324, DOI 10.1890/0012-9658(2007)88[324:TTMTOE]2.0.CO;2; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Fahrig L, 2005, ECOSYSTEM FUNCTION IN HETEROGENEOUS LANDSCAPES, P95, DOI 10.1007/0-387-24091-8_6; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falcy MR, 2007, CONSERV BIOL, V21, P1341, DOI 10.1111/j.1523-1739.2007.00766.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; Fujiwara M, 2007, ECOLOGY, V88, P2345, DOI 10.1890/06-1405.1; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Goodwin BJ, 2002, OIKOS, V99, P552, DOI 10.1034/j.1600-0706.2002.11824.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Hiebeler D, 2000, ECOLOGY, V81, P1629, DOI 10.1890/0012-9658(2000)081[1629:POFLWS]2.0.CO;2; Jepsen JU, 2005, AGR ECOSYST ENVIRON, V105, P581, DOI 10.1016/j.agee.2004.08.007; KAREIVA P, 1990, PHILOS T R SOC B, V330, P175, DOI 10.1098/rstb.1990.0191; King AW, 2002, ECOL MODEL, V147, P23, DOI 10.1016/S0304-3800(01)00400-8; Lande R, 2006, AM NAT, V168, P76, DOI 10.1086/504851; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lindenmayer DB, 2003, ECOL LETT, V6, P41, DOI 10.1046/j.1461-0248.2003.00391.x; MAY RM, 1975, J THEOR BIOL, V51, P511, DOI 10.1016/0022-5193(75)90078-8; Mccoy ED, 2007, ECOLOGY, V88, P1401, DOI 10.1890/06-1188; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McIntire EJB, 2007, J APPL ECOL, V44, P725, DOI 10.1111/j.1365-2664.2007.01326.x; MOLLER AP, 1989, OIKOS, V56, P240, DOI 10.2307/3565342; Pinheiro JC, 2004, MIXED EFFECTS MODELS; R Core Team, 2022, R LANG ENV STAT COMP; Ritchie LE, 2009, FOREST ECOL MANAG, V257, P1920, DOI 10.1016/j.foreco.2009.01.028; Saether BE, 2002, PHILOS T ROY SOC B, V357, P1185, DOI 10.1098/rstb.2002.1119; Sibly RM, 2007, ECOL LETT, V10, P970, DOI 10.1111/j.1461-0248.2007.01092.x; Sibly Richard M., 2009, BMC Ecology, V9, P18, DOI 10.1186/1472-6785-9-18; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Thorbek P, 2005, BIOCONTROL, V50, P1, DOI 10.1007/s10526-004-1114-8; Topping CJ, 2010, ECOL MODEL, V221, P245, DOI 10.1016/j.ecolmodel.2009.09.014; Topping CJ, 2005, ECOTOXICOLOGY, V14, P925, DOI 10.1007/s10646-005-0027-3; Topping CJ, 2004, ENVIRON TOXICOL CHEM, V23, P509, DOI 10.1897/02-524a; Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X; Topping CJ, 1999, J ARACHNOL, V27, P378; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; Vos CC, 2001, AM NAT, V157, P24, DOI 10.1086/317004; Wiegand T, 2005, CONSERV BIOL, V19, P108, DOI 10.1111/j.1523-1739.2005.00208.x; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811	58	29	29	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8932	10.1371/journal.pone.0008932	http://dx.doi.org/10.1371/journal.pone.0008932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126614	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000274138000010
J	Hutson, CL; Abel, JA; Carroll, DS; Olson, VA; Braden, ZH; Hughes, CM; Dillon, M; Hopkins, C; Karem, KL; Damon, IK; Osorio, JE				Hutson, Christina L.; Abel, Jason A.; Carroll, Darin S.; Olson, Victoria A.; Braden, Zachary H.; Hughes, Christine M.; Dillon, Michael; Hopkins, Consuelo; Karem, Kevin L.; Damon, Inger K.; Osorio, Jorge E.			Comparison of West African and Congo Basin Monkeypox Viruses in BALB/c and C57BL/6 Mice	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; SQUIRRELS	Although monkeypox virus (MPXV) studies in wild rodents and non-human primates have generated important knowledge regarding MPXV pathogenesis and inferences about disease transmission, it might be easier to dissect the importance of virulence factors and correlates of protection to MPXV in an inbred mouse model. Herein, we compared the two clades of MPXV via two routes of infection in the BALB/c and C57BL/6 inbred mice strains. Our studies show that similar to previous animal studies, the Congo Basin strain of MPXV was more virulent than West African MPXV in both mouse strains as evidenced by clinical signs. Although animals did not develop lesions as seen in human MPX infections, localized signs were apparent with the foot pad route of inoculation, primarily in the form of edema at the site of inoculation; while the Congo Basin intranasal route of infection led to generalized symptoms, primarily weight loss. We have determined that future studies with MPXV and laboratory mice would be very beneficial in understanding the pathogenesis of MPXV, in particular if used in in vivo imaging studies. Although this mouse model may not suffice as a model of human MPX disease, with an appropriate inbred mouse model, we can unravel many unknown aspects of MPX pathogenesis, including virulence factors, disease progression in rodent hosts, and viral shedding from infected animals. In addition, such a model can be utilized to test antivirals and the next generation of orthopoxvirus vaccines for their ability to alter the course of disease.	[Hutson, Christina L.; Abel, Jason A.; Carroll, Darin S.; Olson, Victoria A.; Braden, Zachary H.; Hughes, Christine M.; Dillon, Michael; Hopkins, Consuelo; Karem, Kevin L.; Damon, Inger K.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Osorio, Jorge E.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	Centers for Disease Control & Prevention - USA; University of Wisconsin System; University of Wisconsin Madison	Hutson, CL (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	zuu6@cdc.gov			NIH [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to acknowledge membership within and support from the Region V 'Great Lakes' RCE (NIH award 1-U54-AI-057153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P56; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Osorio JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006592; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; Schultz DA, 2009, VIROLOGY, V383, P86, DOI 10.1016/j.virol.2008.09.025; Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039; SHCHELUKHINA EM, 1975, VOP VIRUSOL+, P703; Tesh RB, 2004, EMERG INFECT DIS, V10, P1563, DOI 10.3201/eid1009.040310; VONMAGNUS P, 1959, POX LIKE DIS CYNOMOL, P156; Xiao SY, 2005, EMERG INFECT DIS, V11, P539, DOI 10.3201/eid1104.040907; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	20	26	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8912	10.1371/journal.pone.0008912	http://dx.doi.org/10.1371/journal.pone.0008912			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111702	Green Published, gold			2022-12-25	WOS:000274114800015
J	MacKellar, J; Cushman, SW; Periwal, V				MacKellar, Jennifer; Cushman, Samuel W.; Periwal, Vipul			Waves of Adipose Tissue Growth in the Genetically Obese Zucker Fatty Rat	PLOS ONE			English	Article							CELL-SIZE; ADIPOCYTE SIZE; INSULIN-RESISTANCE; CELLULARITY; HYPERPHAGIA; DEPOTS	Background: In mammals, calories ingested in excess of those used are stored primarily as fat in adipose tissue; consistent ingestion of excess calories requires an enlargement of the adipose tissue mass. Thus, a dysfunction in adipose tissue growth may be a key factor in insulin resistance due to imbalanced fat storage and disrupted insulin action. Adipose tissue growth requires the recruitment and then the development of adipose precursor cells, but little is known about these processes in vivo. Methodology: In this study, adipose cell-size probability distributions were measured in two Zucker fa/fa rats over a period of 151 and 163 days, from four weeks of age, using micro-biopsies to obtain subcutaneous (inguinal) fat tissue from the animals. These longitudinal probability distributions were analyzed to assess the probability of periodic phenomena. Conclusions: Adipose tissue growth in this strain of rat exhibits a striking temporal periodicity of approximately 55 days. A simple model is proposed for the periodicity, with PPAR signaling driven by a deficit in lipid uptake capacity leading to the periodic recruitment of new adipocytes. This model predicts that the observed period will be diet-dependent.	[MacKellar, Jennifer; Cushman, Samuel W.] NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA; [Periwal, Vipul] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	MacKellar, J (corresponding author), NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA.	vipulp@mail.nih.gov	Periwal, Vipul/I-1728-2012	MacKellar, Jennifer/0000-0003-0162-7430	National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013035, ZIADK075014] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Farkas K, 1996, LIPIDS, V31, P313, DOI 10.1007/BF02529878; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Gregory P., 2005, BAYESIAN LOGICAL DAT; Hausman DB, 2004, EXP BIOL MED, V229, P512, DOI 10.1177/153537020422900609; Hausman DB, 2003, OBES RES, V11, P674, DOI 10.1038/oby.2003.96; HIRSCH J, 1968, J LIPID RES, V9, P110; HIRSCH J, 1970, FED PROC, V29, P1516; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; JOHNSON PR, 1971, J LIPID RES, V12, P706; KAPLAN ML, 1980, METABOLISM, V29, P333, DOI 10.1016/0026-0495(80)90006-2; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Marques BG, 1998, AM J PHYSIOL-REG I, V275, pR1898, DOI 10.1152/ajpregu.1998.275.6.R1898; Marti A, 2008, P NUTR SOC, V67, P1, DOI 10.1017/S002966510800596X; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; REYNE Y, 1985, J LIPID RES, V26, P1036; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; SMITH U, 1971, J LIPID RES, V12, P65; SMITH U, 1971, ANAT REC, V169, P97, DOI 10.1002/ar.1091690109; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tierney L., 1990, LISP STAT OBJECT ORI; VASSELLI JR, 1985, BRAIN RES BULL, V14, P633, DOI 10.1016/0361-9230(85)90113-3; VASSELLI JR, 1992, AM J PHYSIOL, V262, pR33, DOI 10.1152/ajpregu.1992.262.1.R33	28	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8197	10.1371/journal.pone.0008197	http://dx.doi.org/10.1371/journal.pone.0008197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107501	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896100001
J	Ramot, Y; Biro, T; Tiede, S; Toth, BI; Langan, EA; Sugawara, K; Foitzik, K; Ingber, A; Goffin, V; Langbein, L; Paus, R				Ramot, Yuval; Biro, Tamas; Tiede, Stephan; Toth, Balazs I.; Langan, Ewan A.; Sugawara, Koji; Foitzik, Kerstin; Ingber, Arieh; Goffin, Vincent; Langbein, Lutz; Paus, Ralf			Prolactin-a novel neuroendocrine regulator of human keratin expression in situ	FASEB JOURNAL			English	Article						human hair follicle; stem cells; keratinocytes; gene regulation; prolactin receptor antagonist	HUMAN HAIR FOLLICLE; CORTICOTROPIN-RELEASING HORMONE; EPITHELIAL STEM-CELLS; TERMINAL DIFFERENTIATION; THYROID-HORMONES; GENE-EXPRESSION; ROOT SHEATH; HUMAN SKIN; HPA AXIS; RECEPTOR	The controls of human keratin expression in situ remain to be fully elucidated. Here, we have investigated the effects of the neurohormone prolactin ( PRL) on keratin expression in a physiologically and clinically relevant test system: organ-cultured normal human hair follicles (HFs). Not only do HFs express a wide range of keratins, but they are also a source and target of PRL. Microarray analysis revealed that PRL differentially regulated a defined subset of keratins and keratin-associated proteins. Quantitative immunohistomorphometry and quantitative PCR confirmed that PRL up-regulated expression of keratins K5 and K14 and the epithelial stem cell-associated keratins K15 and K19 in organ-cultured HFs and/or isolated HF keratinocytes. PRL also up-regulated K15 promoter activity and K15 protein expression in situ, whereas it inhibited K6 and K31 expression. These regulatory effects were reversed by a pure competitive PRL receptor antagonist. Antagonist alone also modulated keratin expression, suggesting that "tonic stimulation" by endogenous PRL is required for normal expression levels of selected keratins. Therefore, our study identifies PRL as a major, clinically relevant, novel neuroendocrine regulator of both human keratin expression and human epithelial stem cell biology in situ.-Ramot, Y., Biro, T., Tiede, S. Toth, B. I., Langan, E. A., Sugawara, K., Foitzik, K., Ingber, A., Goffin, V., Langbein, L., Paus, R. Prolactin-a novel neuroendocrine regulator of human keratin expression in situ. FASEB J. 24, 1768-1779 (2010). www.fasebj.org	[Ramot, Yuval; Tiede, Stephan; Sugawara, Koji; Paus, Ralf] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Ramot, Yuval; Ingber, Arieh] Hadassah Hebrew Univ, Med Ctr, Dept Dermatol, Jerusalem, Israel; [Biro, Tamas; Toth, Balazs I.] Univ Debrecen, Med & Hlth Sci Ctr, Res Ctr Mol Med, Dept Physiol, H-4012 Debrecen, Hungary; [Langan, Ewan A.; Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester, Lancs, England; [Foitzik, Kerstin] Childrens Hosp Wilhelmstift, Dept Dermatol, Hamburg, Germany; [Goffin, Vincent] INSERM, Res Ctr Growth & Signaling, U845, Paris, France; [Goffin, Vincent] Univ Paris 05, Fac Med, Paris, France; [Langbein, Lutz] German Canc Res Ctr, D-6900 Heidelberg, Germany	University of Lubeck; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Debrecen; University of Manchester; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; German Cancer Research Center (DKFZ)	Paus, R (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	ralf.paus@uk-sh.de	Tóth, Balázs István/K-1214-2013; Paus, Ralf/F-6243-2011; GOFFIN, Vincent/G-3322-2013; Paus, Ralf/B-5279-2015	Tóth, Balázs István/0000-0002-4103-4333; GOFFIN, Vincent/0000-0002-8021-3086; Paus, Ralf/0000-0002-3492-9358; Tiede, Stephan/0000-0002-6045-3736; Sugawara, Koji/0000-0003-1662-3272	Minerva Fellowship; German Federal Ministry of Education and Research [01GN0517]; Deutsche Forschungsgemeinschaft; Manchester National Health Research System Biomedical Research Center; Wilhelm Sander Stiftung [2007.133.1]	Minerva Fellowship; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Manchester National Health Research System Biomedical Research Center; Wilhelm Sander Stiftung	The excellent technical assistance of Astrid Becker and Nadine Dorwald for these studies is gratefully acknowledged. The authors also thank Sophie Bernichtein for her help with PRLR antagonist preparation. This study was supported in part by a Minerva Fellowship (for Y.R.) and by grants from the German Federal Ministry of Education and Research (01GN0517), the Deutsche Forschungsgemeinschaft, the Manchester National Health Research System Biomedical Research Center (to R. P.), and the Wilhelm Sander Stiftung (2007.133.1 to L. L.).	Arin MJ, 2009, HUM GENET, V125, P355, DOI 10.1007/s00439-009-0646-5; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; BLUM I, 1980, NEW ENGL J MED, V303, P1418; Bodo E, 2007, FASEB J, V21, P3346, DOI 10.1096/fj.07-8628com; Bodo E, 2009, J INVEST DERMATOL, V129, P1126, DOI 10.1038/jid.2008.361; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bowden PE, 2009, EXP DERMATOL, V18, P650, DOI 10.1111/j.1600-0625.2008.00820.x; Cai J, 2009, DEV BIOL, V326, P420, DOI 10.1016/j.ydbio.2008.11.021; Chahal J, 2008, PITUITARY, V11, P141, DOI 10.1007/s11102-008-0107-5; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Craven AJ, 2001, ENDOCRINOLOGY, V142, P2533, DOI 10.1210/en.142.6.2533; DICKS P, 1994, J ENDOCRINOL, V143, P441, DOI 10.1677/joe.0.1430441; DUNCAN MJ, 1984, J EXP ZOOL, V230, P97, DOI 10.1002/jez.1402300113; FABRE N, 1993, CLIN NEUROPHARMACOL, V16, P266, DOI 10.1097/00002826-199306000-00012; Foitzik K, 2006, AM J PATHOL, V168, P748, DOI 10.2353/ajpath.2006.050468; Foitzik K, 2003, AM J PATHOL, V162, P1611, DOI 10.1016/S0002-9440(10)64295-2; Foitzik K, 2009, J INVEST DERMATOL, V129, P1071, DOI 10.1038/jid.2008.348; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; GASPAR E, 2009, FASEB J, DOI DOI 10.1096/FJ.08-126417V1; Goffin V, 2005, ENDOCR REV, V26, P400, DOI 10.1210/er.2004-0016; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Goffin V, 2006, NAT CLIN PRACT ENDOC, V2, P571, DOI 10.1038/ncpendmet0270; Goldhar AS, 2005, MOL CELL ENDOCRINOL, V232, P9, DOI 10.1016/j.mce.2005.01.005; Gootwine E, 2004, ANIM REPROD SCI, V82-3, P551, DOI 10.1016/j.anireprosci.2004.04.008; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Havlickova B, 2009, J INVEST DERMATOL, V129, P972, DOI 10.1038/jid.2008.315; HU L, 1994, J BIOL CHEM, V269, P183; IBRAHEEM M, 1994, J ANAT, V185, P135; Ichikawa E, 1997, ARCH DERMATOL RES, V289, P519, DOI 10.1007/s004030050233; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Jave-Suarez LF, 2004, J INVEST DERMATOL, V122, P555, DOI 10.1111/j.0022-202X.2004.22336.x; Kallergi G, 2007, MOL MED, V13, P79, DOI 10.2119/2006-00083.Kallergi; Kauser S, 2004, J INVEST DERMATOL, V123, P184, DOI 10.1111/j.0022-202X.2004.22724.x; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Langan EA, 2010, J INVEST DERMATOL, V130, P886, DOI 10.1038/jid.2009.340; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Langbein L, 2005, J INVEST DERMATOL, V125, P428, DOI 10.1111/j.0022-202X.2005.23860.x; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; Langbein L, 2006, J INVEST DERMATOL, V126, P2377, DOI 10.1038/sj.jid.5700494; Larouche D, 2008, FASEB J, V22, P1404, DOI 10.1096/fj.07-8109com; Limat A, 2003, J AM ACAD DERMATOL, V48, P207, DOI 10.1067/mjd.2003.69; LIMAT A, 1989, J INVEST DERMATOL, V92, P758, DOI 10.1111/1523-1747.ep12722530; LIMAT A, 1986, J INVEST DERMATOL, V87, P485, DOI 10.1111/1523-1747.ep12455548; LUPULESCU A, 1985, J NATL CANCER I, V74, P1335; Lyle S, 1998, J CELL SCI, V111, P3179; Ma L, 2003, DEVELOPMENT, V130, P379, DOI 10.1242/dev.00201; Ma SH, 1997, GENE EXPRESSION, V6, P361; MARTINET L, 1984, J ENDOCRINOL, V103, P9, DOI 10.1677/joe.0.1030009; Michalczyk A, 2001, DIFFERENTIATION, V67, P41, DOI 10.1046/j.1432-0436.2001.067001041.x; Michel M, 1996, J CELL SCI, V109, P1017; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nixon AJ, 2002, J ENDOCRINOL, V172, P605, DOI 10.1677/joe.0.1720605; Ohnemus U, 2006, ENDOCR REV, V27, P677, DOI 10.1210/er.2006-0020; Ormandy CJ, 2003, RECENT PROG HORM RES, V58, P297, DOI 10.1210/rp.58.1.297; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Paus R, 2008, MOL CELL ENDOCRINOL, V288, P38, DOI 10.1016/j.mce.2008.02.023; Pearson AJ, 1996, J ENDOCRINOL, V148, P157, DOI 10.1677/joe.0.1480157; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Radoja N, 2004, MOL CELL BIOL, V24, P3168, DOI 10.1128/MCB.24.8.3168-3179.2004; Ramot Y, 2009, BRIT J DERMATOL, V161, P933, DOI 10.1111/j.1365-2133.2009.09294.x; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; SCHMIDT JB, 1994, SKIN PHARMACOL, V7, P61; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; SCHOFIELD JK, 1995, HISTOPATHOLOGY, V26, P153, DOI 10.1111/j.1365-2559.1995.tb00645.x; Schweizer J, 2007, EXP CELL RES, V313, P2010, DOI 10.1016/j.yexcr.2007.02.032; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2003, Minerva Endocrinol, V28, P135; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Soares Michael J, 2004, Reprod Biol Endocrinol, V2, P51, DOI 10.1186/1477-7827-2-51; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; THEWES M, 1991, ARCH DERMATOL RES, V283, P465, DOI 10.1007/BF00371784; Tiede S, 2009, STEM CELLS, V27, P2793, DOI 10.1002/stem.213; Tiede S, 2009, J INVEST DERMATOL, V129, P2711, DOI 10.1038/jid.2009.148; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Weatherhead S, 2007, BRIT MED J, V334, P1218, DOI 10.1136/bmj.39202.518484.80; Xue ML, 2008, J INVEST DERMATOL, V128, P2676, DOI 10.1038/jid.2008.136; Zouboulis CC, 2000, HORM RES, V54, P230, DOI 10.1159/000053265; Zouboulis Christos C, 2004, Hormones (Athens), V3, P9	87	50	53	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1768	1779		10.1096/fj.09-146415	http://dx.doi.org/10.1096/fj.09-146415			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20103718				2022-12-25	WOS:000278200000014
J	Soto-Reyes, E; Recillas-Targa, F				Soto-Reyes, E.; Recillas-Targa, F.			Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines	ONCOGENE			English	Article						tumor suppressor gene; CTCF; epigenetics; DNA methylation; p53 human promoter and histone covalent modifications	TUMOR-SUPPRESSOR; DNA METHYLATION; HUMAN GENOME; PROTEIN CTCF; CANCER; BINDING; EXPRESSION; INSULATOR; REGION; DOMAIN	Epigenetic silencing of tumor suppressor gene promoters has become a more frequent phenomenon in cancer than previously anticipated. In this study we addressed the mechanisms involved in the protection of the p53 tumor suppressor gene against epigenetic silencing in human transformed cell lines. We characterized a binding site for the CCCTC-binding factor (CTCF) in the human p53 gene promoter that contributes to its transcriptional expression, and has the ability to maintain this regulatory element in a local open chromatin configuration. In the absence of CTCF we observe the incorporation of repressive histone marks, such as H3K9me3, H3K27me3 and H4K20me3, in different sub-domains of the upstream regulatory sequence. This evidence suggests that CTCF protects the p53 gene promoter against repressive histone marks. Notably, no apparent direct correlation between repression and DNA hypermethylation has been detected. Together, we present evidence supporting the relevant role of CTCF in the epigenetic regulation of tumor suppressor genes and cancer. We propose that CTCF is a strategic component responsible for the maintenance and segregation of epigenetic traits. Oncogene (2010) 29, 2217-2227; doi: 10.1038/onc.2009.509; published online 25 January 2010	[Soto-Reyes, E.; Recillas-Targa, F.] Univ Nacl Autonoma Mexico, Dept Mol Genet, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Recillas-Targa, F (corresponding author), Univ Nacl Autonoma Mexico, Dept Mol Genet, Inst Fisiol Celular, Apartado Postal 70-242, Mexico City 04510, DF, Mexico.	frecilla@ifc.unam.mx	Xie, Huangming/B-2260-2012	Soto-Reyes, Ernesto/0000-0002-4219-6406	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico [IN209403, IN214407]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [42653-Q, 58767, 181389]; Fundacion Miguel Aleman, AC; Direccion General de estudios de Posgrado-Universidad Nacional Autonoma de Mexico (DGEP); Doctorado en Ciencias Biomedicas	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Miguel Aleman, AC; Direccion General de estudios de Posgrado-Universidad Nacional Autonoma de Mexico (DGEP)(Universidad Nacional Autonoma de Mexico); Doctorado en Ciencias Biomedicas	We thank Inti Alberto de la Rosa-Velazquez, Catherine Farrell, Mayra Furlan-Magaril, Francisco Antequera, Abrahan Hernandez-Hernandez, Martin Escamilla-del-Arenal and Hector Rincon-Arano for suggestions and constant scientific discussions. We are particularly indebted with the excellent technical assistance of Georgina Guerrero Avendano, members of the Felix Recillas-Targa laboratory, Dr JA Garcia-Sainz and the Instituto de Fisiologia Celular, UNAM. We thank L Ongay, G Codiz and M Mora from the Unidad de Biologia Molecular, IFC-UNAM, for DNA sequencing. This work was supported by the Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico (IN209403 and IN214407), Consejo Nacional de Ciencia y Tecnologia (CONACyT: 42653-Q and 58767) and Fundacion Miguel Aleman, AC. E Soto-Reyes is supported by a PhD fellowship from CONACyT (181389) and Direccion General de estudios de Posgrado-Universidad Nacional Autonoma de Mexico (DGEP). Additional support was provided by the PhD Graduate Program of Doctorado en Ciencias Biomedicas.	Amatya VJ, 2005, ACTA NEUROPATHOL, V110, P178, DOI 10.1007/s00401-005-1041-5; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Butcher DT, 2007, EUR J CANCER, V43, P210, DOI 10.1016/j.ejca.2006.09.002; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Docquier F, 2009, CLIN CANCER RES, V15, P5762, DOI 10.1158/1078-0432.CCR-09-0329; El-Kady A, 2005, FEBS LETT, V579, P1424, DOI 10.1016/j.febslet.2005.01.044; Escamilla-Del-Arenal M, 2008, MOL CELL BIOL, V28, P575, DOI 10.1128/MCB.00943-07; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kang JH, 2001, LAB INVEST, V81, P573, DOI 10.1038/labinvest.3780266; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Pogribny IP, 2000, CANCER RES, V60, P588; Recillas-Targa F, 2006, J CELL MOL MED, V10, P554, DOI 10.1111/j.1582-4934.2006.tb00420.x; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Su CH, 2009, MOL CELL BIOL, V29, P93, DOI 10.1128/MCB.00704-08; Sun LC, 2008, CANCER RES, V68, P2726, DOI 10.1158/0008-5472.CAN-07-6654; Valadez-Graham V, 2004, NUCLEIC ACIDS RES, V32, P1354, DOI 10.1093/nar/gkh301; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426	41	76	77	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2217	2227		10.1038/onc.2009.509	http://dx.doi.org/10.1038/onc.2009.509			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101205				2022-12-25	WOS:000276685200007
J	Yang, YW; Hua, QX; Liu, J; Shimizu, EH; Choquette, MH; Mackin, RB; Weiss, MA				Yang, Yanwu; Hua, Qing-xin; Liu, Jin; Shimizu, Eri H.; Choquette, Meredith H.; Mackin, Robert B.; Weiss, Michael A.			Solution Structure of Proinsulin CONNECTING DOMAIN FLEXIBILITY AND PROHORMONE PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE DETERMINATION; RECEPTOR-BINDING SURFACE; NMR-SPECTROSCOPY; SECONDARY STRUCTURE; DIABETES-MELLITUS; BACKBONE DYNAMICS; XPLOR-NIH; PROTEIN; INSULIN; DESIGN	The folding of proinsulin, the single-chain precursor of insulin, ensures native disulfide pairing in pancreatic beta-cells. Mutations that impair folding cause neonatal diabetes mellitus. Although the classical structure of insulin is well established, proinsulin is refractory to crystallization. Here, we employ heteronuclear NMR spectroscopy to characterize a monomeric analogue. Proinsulin contains a native-like insulin moiety (A- and B-domains); the tethered connecting (C) domain (as probed by {H-1}-(15)Nnuclear Overhauser enhancements) is progressively less ordered. Although the BC junction is flexible, residues near the CA junction exhibit alpha-helical-like features. Relative to canonical alpha-helices, however, segmental C-13(alpha/beta) chemical shifts are attenuated, suggesting that this junction and contiguous A-chain residues are molten. We propose that flexibility at each C-domain junction facilitates prohormone processing. Studies of protease SPC3 (PC1/3) suggest that C-domain sequences contribute to cleavage site selection. The structure of proinsulin provides a foundation for studies of insulin biosynthesis and its impairment in monogenic forms of diabetes mellitus.	[Yang, Yanwu; Hua, Qing-xin; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Liu, Jin; Shimizu, Eri H.; Choquette, Meredith H.; Mackin, Robert B.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Case Western Reserve University; Creighton University	Yang, YW (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	yanwu.yang@ase.edu; maw21@case.edu	liu, jin/A-9012-2010		National Institutes of Health [DK052085]; National Institutes of Health and American Diabetes Association [DK040949, DK0697604]; American Heart Association [0530067N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK074176, R01DK052085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health and American Diabetes Association; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK052085 (to R.B.M.) and Grants DK040949 and DK0697604 from the National Institutes of Health and American Diabetes Association (to M.A.W.). This work was also supported by American Heart Association Grant 0530067N (to Y.Y.).	BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Lipkind G, 1999, BIOCHEMISTRY-US, V38, P890, DOI 10.1021/bi981556q; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; Mackin RB, 2003, PROTEIN EXPRES PURIF, V27, P210, DOI 10.1016/S1046-5928(02)00643-5; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TAYLOR NA, 1992, BIOCHEM J, V286, P619, DOI 10.1042/bj2860619; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850	35	52	55	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7847	7851		10.1074/jbc.C109.084921	http://dx.doi.org/10.1074/jbc.C109.084921			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20106974	Green Published, hybrid			2022-12-25	WOS:000275413800001
J	Larsen, N; Vogensen, FK; van den Berg, FWJ; Nielsen, DS; Andreasen, AS; Pedersen, BK; Abu Al-Soud, W; Sorensen, SJ; Hansen, LH; Jakobsen, M				Larsen, Nadja; Vogensen, Finn K.; van den Berg, Frans W. J.; Nielsen, Dennis Sandris; Andreasen, Anne Sofie; Pedersen, Bente K.; Abu Al-Soud, Waleed; Sorensen, Soren J.; Hansen, Lars H.; Jakobsen, Mogens			Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults	PLOS ONE			English	Article							REAL-TIME PCR; LACTIC-ACID BACTERIA; RIBOSOMAL-RNA; WEIGHT-LOSS; ANTIBIOTIC-TREATMENT; FECAL MICROBIOTA; HUMAN FECES; OBESITY; LACTOBACILLUS; INFLAMMATION	Background: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. Methods and Findings: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). Conclusions: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.	[Larsen, Nadja; Vogensen, Finn K.; van den Berg, Frans W. J.; Nielsen, Dennis Sandris; Jakobsen, Mogens] Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark; [Andreasen, Anne Sofie; Pedersen, Bente K.] Rigshosp, Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Andreasen, Anne Sofie; Pedersen, Bente K.] Rigshosp, Univ Hosp, CMRC, DK-2100 Copenhagen, Denmark; [Abu Al-Soud, Waleed; Sorensen, Soren J.; Hansen, Lars H.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Larsen, N (corresponding author), Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark.	nf@life.ku.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Nielsen, Dennis/A-9769-2015; Abu Al-Soud, Waleed/AAH-3477-2021; van den Berg, Frans W.J./N-2899-2014; Sørensen, Søren J/J-5015-2014; Vogensen, Finn/E-1245-2015; Abu Al-Soud, Waleed/K-4408-2014; Sørensen, Søren Johannes/N-2120-2019; Larsen, Nadja/F-2692-2015; Berg, Frans/ABB-5814-2021; Abu Al-Soud, Waleed/K-4408-2014	Pedersen, Bente Klarlund/0000-0001-6508-6288; Nielsen, Dennis/0000-0001-8121-1114; Abu Al-Soud, Waleed/0000-0002-1143-9233; van den Berg, Frans W.J./0000-0002-9170-9052; Sørensen, Søren J/0000-0001-6227-9906; Vogensen, Finn/0000-0003-2151-7802; Abu Al-Soud, Waleed/0000-0002-1143-9233; Sørensen, Søren Johannes/0000-0001-6227-9906; Larsen, Nadja/0000-0002-5899-4883; Abu Al-Soud, Waleed/0000-0002-1488-4826; Andreasen, Anne Sofie/0000-0002-8759-3405	Danish Ministry of Food, Agriculture and Fisheries; Danish Food Industry Agency [3304-FSE-06-0501-1]	Danish Ministry of Food, Agriculture and Fisheries; Danish Food Industry Agency	This study was supported by the Danish Ministry of Food, Agriculture and Fisheries, The Danish Food Industry Agency (J. nr. 3304-FSE-06-0501-1; www. dffe. dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock GH, 2001, CLIN EXP IMMUNOL, V123, P62, DOI 10.1046/j.1365-2249.2001.01370.x; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Cani PD, 2008, DIABETOLOGIA, V51, pS34; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Nielsen DS, 2003, APPL ENVIRON MICROB, V69, P7545, DOI 10.1128/AEM.69.12.7545-7548.2003; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; SCHWIERTZ A, 2009, OBESITY; Tilg H, 2009, GASTROENTEROLOGY, V136, P1476, DOI 10.1053/j.gastro.2009.03.030; Tsukumo DM, 2009, ARQ BRAS ENDOCRINOL, V53, P139, DOI 10.1590/S0004-27302009000200004; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	36	1769	1985	10	485	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9085	10.1371/journal.pone.0009085	http://dx.doi.org/10.1371/journal.pone.0009085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140211	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442400021
J	Larsen, AP; Olesen, SP				Larsen, Anders Peter; Olesen, Soren-Peter			Differential Expression of hERG1 Channel Isoforms Reproduces Properties of Native I-Kr and Modulates Cardiac Action Potential Characteristics	PLOS ONE			English	Article							RECTIFIER K+ CURRENT; LONG-QT SYNDROME; VENTRICULAR MYOCYTES; GUINEA-PIG; ELECTRICAL RESTITUTION; POTASSIUM CHANNEL; M CELLS; CANINE; REPOLARIZATION; DURATION	Background: The repolarizing cardiac rapid delayed rectifier current, I-Kr, is composed of ERG1 channels. It has been suggested that two isoforms of the ERG1 protein, ERG1a and ERG1b, both contribute to I-Kr. Marked heterogeneity in the kinetic properties of native I-Kr has been described. We hypothesized that the heterogeneity of native I-Kr can be reproduced by differential expression of ERG1a and ERG1b isoforms. Furthermore, the functional consequences of differential expression of ERG1 isoforms were explored as a potential mechanism underlying native heterogeneity of action potential duration (APD) and restitution. Methodology/Principal Findings: The results show that the heterogeneity of native I-Kr can be reproduced in heterologous expression systems by differential expression of ERG1a and ERG1b isoforms. Characterization of the macroscopic kinetics of ERG1 currents demonstrated that these were dependent on the relative abundance of ERG1a and ERG1b. Furthermore, we used a computational model of the ventricular cardiomyocyte to show that both APD and the slope of the restitution curve may be modulated by varying the relative abundance of ERG1a and ERG1b. As the relative abundance of ERG1b was increased, APD was gradually shortened and the slope of the restitution curve was decreased. Conclusions/Significance: Our results show that differential expression of ERG1 isoforms may explain regional heterogeneity of I-Kr kinetics. The data demonstrate that subunit dependent changes in channel kinetics are important for the functional properties of ERG1 currents and hence I-Kr. Importantly, our results suggest that regional differences in the relative abundance of ERG1 isoforms may represent a potential mechanism underlying the heterogeneity of both APD and APD restitution observed in mammalian hearts.	[Larsen, Anders Peter; Olesen, Soren-Peter] Univ Copenhagen, Dept Biomed Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Larsen, AP (corresponding author), Univ Copenhagen, Dept Biomed Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark.	spo@mfi.ku.dk	Olesen, Søren P/H-4206-2011; Olesen, Søren-Peter/B-9621-2012	Olesen, Søren P/0000-0002-4381-5192; 	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Danish National Research Foundation (http://www.dg.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balati B, 1998, ACTA PHYSIOL SCAND, V164, P181; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Bryant SM, 1998, CARDIOVASC RES, V40, P322, DOI 10.1016/S0008-6363(98)00133-3; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; Garny A, 2009, PHILOS T R SOC A, V367, P1885, DOI 10.1098/rsta.2008.0289; Gintant GA, 2000, AM J PHYSIOL-HEART C, V278, pH806, DOI 10.1152/ajpheart.2000.278.3.H806; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Karma A, 1994, CHAOS, V4, P461, DOI 10.1063/1.166024; Kirchberger NM, 2006, J PHYSIOL-LONDON, V571, P27, DOI 10.1113/jphysiol.2005.101667; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Laurita KR, 1996, CIRC RES, V79, P493, DOI 10.1161/01.RES.79.3.493; LeesMiller JP, 1997, CIRC RES, V81, P719; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; London B, 1997, CIRC RES, V81, P870; Luo XB, 2008, AM J PHYSIOL-HEART C, V294, pH1371, DOI 10.1152/ajpheart.01026.2007; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Riccio ML, 1999, CIRC RES, V84, P955; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Szabo G, 2005, PFLUG ARCH EUR J PHY, V450, P307, DOI 10.1007/s00424-005-1445-z; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2001, J MOL CELL CARDIOL, V33, P835, DOI 10.1006/jmcc.2000.1317; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Weiss JN, 1999, CIRCULATION, V99, P2819, DOI 10.1161/01.CIR.99.21.2819; Yan GX, 1998, CIRCULATION, V98, P1921, DOI 10.1161/01.CIR.98.18.1921; Yue AM, 2005, J AM COLL CARDIOL, V46, P1067, DOI 10.1016/j.jacc.2005.05.074; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	32	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9021	10.1371/journal.pone.0009021	http://dx.doi.org/10.1371/journal.pone.0009021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126398	Green Published, gold, Green Submitted			2022-12-25	WOS:000274207200016
J	Shindo, A; Hara, Y; Yamamoto, TS; Ohkura, M; Nakai, J; Ueno, N				Shindo, Asako; Hara, Yusuke; Yamamoto, Takamasa S.; Ohkura, Masamichi; Nakai, Junichi; Ueno, Naoto			Tissue-Tissue Interaction-Triggered Calcium Elevation Is Required for Cell Polarization during Xenopus Gastrulation	PLOS ONE			English	Article							MECHANICAL-STRESS; EPITHELIAL-CELLS; ATP; COMMUNICATION; POLARITY; RECEPTOR; RELEASE; PATHWAY; INTERCALATION; ORGANIZATION	The establishment of cell polarity is crucial for embryonic cells to acquire their proper morphologies and functions, because cell alignment and intracellular events are coordinated in tissues during embryogenesis according to the cell polarity. Although much is known about the molecules involved in cell polarization, the direct trigger of the process remains largely obscure. We previously demonstrated that the tissue boundary between the chordamesoderm and lateral mesoderm of Xenopus laevis is important for chordamesodermal cell polarity. Here, we examined the intracellular calcium dynamics during boundary formation between two different tissues. In a combination culture of nodal-induced chordamesodermal explants and a heterogeneous tissue, such as ectoderm or lateral mesoderm, the chordamesodermal cells near the boundary frequently displayed intracellular calcium elevation; this frequency was significantly less when homogeneous explants were used. Inhibition of the intracellular calcium elevation blocked cell polarization in the chordamesodermal explants. We also observed frequent calcium waves near the boundary of the dorsal marginal zone ( DMZ) dissected from an early gastrula-stage embryo. Optical sectioning revealed that where heterogeneous explants touched, the chordamesodermal surface formed a wedge with the narrow end tucked under the heterogeneous explant. No such configuration was seen between homogeneous explants. When physical force was exerted against a chordamesodermal explant with a glass needle at an angle similar to that created in the explant, or migrating chordamesodermal cells crawled beneath a silicone block, intracellular calcium elevation was frequent and cell polarization was induced. Finally, we demonstrated that a purinergic receptor, which is implicated in mechano-sensing, is required for such frequent calcium elevation in chordamesoderm and for cell polarization. This study raises the possibility that tissue-tissue interaction generates mechanical forces through cell-cell contact that initiates coordinated cell polarization through a transient increase in intracellular calcium.	[Shindo, Asako; Hara, Yusuke; Yamamoto, Takamasa S.; Ueno, Naoto] Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Japan; [Ohkura, Masamichi; Nakai, Junichi] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan; [Hara, Yusuke; Ueno, Naoto] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Saitama University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Shindo, A (corresponding author), Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Japan.	ueno@nibb.ac.jp	Hara, Yusuke/B-7916-2010; Nakai, Junichi/GQZ-6415-2022; Hara, Yusuke/AAQ-1000-2021; Ohkura, Masamichi/J-6976-2012	Hara, Yusuke/0000-0002-2005-7704; Hara, Yusuke/0000-0002-2005-7704; Ueno, Naoto/0000-0002-8375-2317; Shindo, Asako/0000-0002-3314-7151; Ohkura, Masamichi/0000-0002-3659-7780	Ministry of Education, Culture, Sport, Science and Technology, Japan; Human Frontier Science Program; Grants-in-Aid for Scientific Research [21500379] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by a grant from the Ministry of Education, Culture, Sport, Science and Technology, Japan to N.U. and M.O. and Human Frontier Science Program to J.N.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; Devader C, 2007, FEBS LETT, V581, P5332, DOI 10.1016/j.febslet.2007.10.024; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Formigli L, 2007, J CELL PHYSIOL, V211, P296, DOI 10.1002/jcp.20936; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; KELLER R, 1989, J EXP ZOOL, V251, P134, DOI 10.1002/jez.1402510204; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Millward-Sadler SJ, 2004, BIORHEOLOGY, V41, P567; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ninomiya H, 2008, NAT CELL BIOL, V10, P61, DOI 10.1038/ncb1669; Pedersen S, 1999, BBA-BIOMEMBRANES, V1416, P271, DOI 10.1016/S0005-2736(98)00228-4; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; Sauer H, 2000, AM J PHYSIOL-CELL PH, V279, pC295, DOI 10.1152/ajpcell.2000.279.2.C295; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shindo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001600; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Strong CF, 2000, DEV BIOL, V222, P405, DOI 10.1006/dbio.2000.9710; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2001, CURR BIOL, V11, P652, DOI 10.1016/S0960-9822(01)00201-9; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861; Yamamoto TS, 2001, DEVELOPMENT, V128, P2769; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211	33	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e8897	10.1371/journal.pone.0008897	http://dx.doi.org/10.1371/journal.pone.0008897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126393	Green Submitted, Green Published, gold			2022-12-25	WOS:000274207200001
J	Burkepile, DE; Hay, ME				Burkepile, Deron E.; Hay, Mark E.			Impact of Herbivore Identity on Algal Succession and Coral Growth on a Caribbean Reef	PLOS ONE			English	Article							PARROTFISH SCARUS-VETULA; FUNCTIONAL REDUNDANCY; ECOSYSTEM FUNCTION; GRAZING INTENSITY; PHASE-SHIFTS; HABITAT USE; COMMUNITY; COMPETITION; MACROALGAE; DIVERSITY	Background: Herbivory is an important top-down force on coral reefs that regulates macroalgal abundance, mediates competitive interactions between macroalgae and corals, and provides resilience following disturbances such as hurricanes and coral bleaching. However, reductions in herbivore diversity and abundance via disease or over-fishing may harm corals directly and may indirectly increase coral susceptibility to other disturbances. Methodology and Principal Findings: In two experiments over two years, we enclosed equivalent densities and masses of either single-species or mixed-species of herbivorous fishes in replicate, 4 m 2 cages at a depth of 17 m on a reef in the Florida Keys, USA to evaluate the effects of herbivore identity and species richness on colonization and development of macroalgal communities and the cascading effects of algae on coral growth. In Year 1, we used the redband parrotfish (Sparisoma aurofrenatum) and the ocean surgeonfish (Acanthurus bahianus); in Year 2, we used the redband parrotfish and the princess parrotfish (Scarus taeniopterus). On new substrates, rapid grazing by ocean surgeonfish and princess parrotfish kept communities in an early successional stage dominated by short, filamentous algae and crustose coralline algae that did not suppress coral growth. In contrast, feeding by redband parrotfish allowed an accumulation of tall filaments and later successional macroalgae that suppressed coral growth. These patterns contrast with patterns from established communities not undergoing primary succession; on established substrates redband parrotfish significantly reduced upright macroalgal cover while ocean surgeonfish and princess parrotfish allowed significant increases in late successional macroalgae. Significance: This study further highlights the importance of biodiversity in affecting ecosystem function in that different species of herbivorous fishes had very different impacts on reef communities depending on the developmental stage of the community. The species-specific effects of herbivorous fishes suggest that a species-rich herbivore fauna can be critical in providing the resilience that reefs need for recovery from common disturbances such as coral bleaching and storm damage.	[Burkepile, Deron E.; Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Burkepile, Deron E.] Florida Int Univ, Dept Biol Sci, Marine Sci Program, N Miami, FL USA	University System of Georgia; Georgia Institute of Technology; State University System of Florida; Florida International University	Burkepile, DE (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	deron.burkepile@fiu.edu	Burkepile, Deron/F-2368-2013; Hay, Mark E/D-9752-2011	Hay, Mark E/0000-0002-6130-9349	National Undersea Research Center [SEGM-2003-19A]; National Science Foundation Integrative Graduate Education and Research Traineeship; National Science Foundation; Teasley Endowment to Georgia Tech.	National Undersea Research Center; National Science Foundation Integrative Graduate Education and Research Traineeship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Teasley Endowment to Georgia Tech.	Funding: Support was provided by National Undersea Research Center Project # SEGM-2003-19A to M. E. H., National Science Foundation Integrative Graduate Education and Research Traineeship and National Science Foundation Graduate Fellowship to D. E. B., and the Teasley Endowment to Georgia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V112, P51, DOI 10.3354/meps112051; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; Bruno JF, 2008, ECOLOGY, V89, P2518, DOI 10.1890/07-1345.1; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2007, OECOLOGIA, V154, P167, DOI 10.1007/s00442-007-0801-4; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Burkepile DE, 2009, MAR ECOL PROG SER, V389, P71, DOI 10.3354/meps08142; CARPENTER RC, 1988, P NATL ACAD SCI USA, V85, P511, DOI 10.1073/pnas.85.2.511; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; CARPENTER RC, 1985, LIMNOL OCEANOGR, V30, P784, DOI 10.4319/lo.1985.30.4.0784; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Duffy JE, 2003, ECOL LETT, V6, P637; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; HAY ME, 1981, AQUAT BOT, V11, P97, DOI 10.1016/0304-3770(81)90051-6; Hillebrand H, 2004, ECOL LETT, V7, P192, DOI 10.1111/j.1461-0248.2004.00570.x; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; LEWIS SM, 1985, OECOLOGIA, V65, P370, DOI 10.1007/BF00378911; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; MARKS KW, 2007, AGRRA SUMMARY PRODUC; McAfee ST, 1996, MAR BIOL, V125, P427; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V218, P77, DOI 10.1016/S0022-0981(97)00069-5; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Menge BA, 1997, AM NAT, V149, P801, DOI 10.1086/286025; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Miller MW, 1998, OECOLOGIA, V113, P231, DOI 10.1007/s004420050373; Miller MW, 1999, LIMNOL OCEANOGR, V44, P1847, DOI 10.4319/lo.1999.44.8.1847; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; MORRISON D, 1988, ECOLOGY, V69, P1367, DOI 10.2307/1941634; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Williams ID, 2001, MAR ECOL PROG SER, V222, P187, DOI 10.3354/meps222187; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	59	120	129	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8963	10.1371/journal.pone.0008963	http://dx.doi.org/10.1371/journal.pone.0008963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126450	Green Submitted, gold, Green Published			2022-12-25	WOS:000274139100011
J	Aitken, S; Robert, MC; Alexander, RD; Goryanin, I; Bertrand, E; Beggs, JD				Aitken, Stuart; Robert, Marie-Cecile; Alexander, Ross D.; Goryanin, Igor; Bertrand, Edouard; Beggs, Jean D.			Processivity and Coupling in Messenger RNA Transcription	PLOS ONE			English	Article							POLYMERASE-II; GENE-EXPRESSION; PROTEIN EXPRESSION; REAL-TIME; NOISE; DYNAMICS; MOLECULE; FLUCTUATIONS; REVEALS; BIOLOGY	Background: The complexity of messenger RNA processing is now being uncovered by experimental techniques that are capable of detecting individual copies of mRNA in cells, and by quantitative real-time observations that reveal the kinetics. This processing is commonly modelled by permitting mRNA to be transcribed only when the promoter is in the on state. In this simple on/off model, the many processes involved in active transcription are represented by a single reaction. These processes include elongation, which has a minimum time for completion and processing that is not captured in the model. Methodology: In this paper, we explore the impact on the mRNA distribution of representing the elongation process in more detail. Consideration of the mechanisms of elongation leads to two alternative models of the coupling between the elongating polymerase and the state of the promoter: Processivity allows polymerases to complete elongation irrespective of the promoter state, whereas coupling requires the promoter to be active to produce a full-length transcript. We demonstrate that these alternatives have a significant impact on the predicted distributions. Models are simulated by the Gillespie algorithm, and the third and fourth moments of the resulting distribution are computed in order to characterise the length of the tail, and sharpness of the peak. By this methodology, we show that the moments provide a concise summary of the distribution, showing statistically-significant differences across much of the feasible parameter range. Conclusions: We conclude that processivity is not fully consistent with the on/off model unless the probability of successfully completing elongation is low-as has been observed. The results also suggest that some form of coupling between the promoter and a rate-limiting step in transcription may explain the cell's inability to maintain high mRNA levels at low noise-a prediction of the on/off model that has no supporting evidence.	[Aitken, Stuart; Alexander, Ross D.; Goryanin, Igor; Beggs, Jean D.] Univ Edinburgh, Ctr Syst Biol, Edinburgh, Midlothian, Scotland; [Robert, Marie-Cecile; Bertrand, Edouard] CNRS, Inst Genet Mol Montpellier, UMR5535, Montpellier, France; [Alexander, Ross D.; Beggs, Jean D.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Edinburgh	Aitken, S (corresponding author), Univ Edinburgh, Ctr Syst Biol, Edinburgh, Midlothian, Scotland.	s.aitken@ed.ac.uk	Beggs, Jean/H-4861-2011; , jbeggs/N-9551-2019; Goryanin, Igor/AAB-1400-2022; Goryanin, Igor/J-1913-2015	Beggs, Jean/0000-0002-8179-6519; Goryanin, Igor/0000-0002-8293-774X; bertrand, edouard/0000-0002-9642-7994	Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council [BB/D019621/1]; European Union [518280]; eDIKT; BBSRC [BB/D019621/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); eDIKT; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Centre for Systems Biology at Edinburgh is a Centre for Integrative Systems Biology (CISB) funded by the Biotechnology and Biological Sciences Research Council and by the Engineering and Physical Sciences Research Council, reference BB/D019621/1. This work was also supported by the European Union funded RiboSys project no. 518280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has made use of the resources provided by the Edinburgh Compute and Data Facility (ECDF). The ECDF is partially supported by the eDIKT initiative (http://www.edikt.org.uk).	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hastie T., 2003, ELEMENTS STAT LEARNI; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Romano MC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198104; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Voliotis M, 2008, BIOPHYS J, V94, P334, DOI 10.1529/biophysj.107.105767; Voliotis M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258101; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	33	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8845	10.1371/journal.pone.0008845	http://dx.doi.org/10.1371/journal.pone.0008845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126621	gold, Green Published, Green Submitted			2022-12-25	WOS:000274138000001
J	Frykman, S; Hur, JY; Franberg, J; Aoki, M; Winblad, B; Nahalkova, J; Behbahani, H; Tjernberg, LO				Frykman, Susanne; Hur, Ji-Yeun; Franberg, Jenny; Aoki, Mikio; Winblad, Bengt; Nahalkova, Jarmila; Behbahani, Homira; Tjernberg, Lars O.			Synaptic and Endosomal Localization of Active gamma-Secretase in Rat Brain	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; GOLGI NETWORK; LIPID RAFTS; PRESENILIN-1; ASSOCIATION; NICASTRIN; PEPTIDES	Background: A key player in the development of Alzheimer's disease (AD) is the gamma-secretase complex consisting of at least four components: presenilin, nicastrin, Aph-1 and Pen-2. gamma-Secretase is crucial for the generation of the neurotoxic amyloid beta-peptide (A beta) but also takes part in the processing of many other substrates. In cell lines, active gamma-secretase has been found to localize primarily to the Golgi apparatus, endosomes and plasma membranes. However, no thorough studies have been performed to show the subcellular localization of the active gamma-secretase in the affected organ of AD, namely the brain. Principal Findings: We show by subcellular fractionation of rat brain that high gamma-secretase activity, as assessed by production of A beta 40, is present in an endosome-and plasma membrane-enriched fraction of an iodixanol gradient. We also prepared crude synaptic vesicles as well as synaptic membranes and both fractions showed high A beta 40 production and contained high amounts of the gamma-secretase components. Further purification of the synaptic vesicles verified the presence of the gamma-secretase components in these compartments. The localization of an active gamma-secretase in synapses and endosomes was confirmed in rat brain sections and neuronal cultures by using a biotinylated gamma-secretase inhibitor together with confocal microscopy. Significance: The information about the subcellular localization of gamma-secretase in brain is important for the understanding of the molecular mechanisms of AD. Furthermore, the identified fractions can be used as sources for highly active gamma-secretase.	[Frykman, Susanne; Hur, Ji-Yeun; Aoki, Mikio; Winblad, Bengt; Nahalkova, Jarmila; Behbahani, Homira; Tjernberg, Lars O.] Karolinska Inst, Dainippon Sumitomo Pharma Alzheimer Ctr KASPAC, Dept Neurobiol Care Sci & Soc NVS, Huddinge, Sweden; [Franberg, Jenny] Karolinska Inst, Alzheimers Dis Res Ctr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Frykman, S (corresponding author), Karolinska Inst, Dainippon Sumitomo Pharma Alzheimer Ctr KASPAC, Dept Neurobiol Care Sci & Soc NVS, Huddinge, Sweden.	susanne.frykman@ki.se	Nahálková, Jarmila/E-9931-2016	Nahálková, Jarmila/0000-0001-9918-6105; Hur, Ji Yeun/0000-0002-9895-3090	Dainippon Sumitomo Pharma (DSP); Foundation for Alzheimer's Disease and Dementia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039287, R01NS038752] Funding Source: NIH RePORTER	Dainippon Sumitomo Pharma (DSP); Foundation for Alzheimer's Disease and Dementia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by Dainippon Sumitomo Pharma (DSP) and DSP had a role in reading the manuscript and decision to publish. Apart from that DSP had no role in study design, data collection and analysis and have no financial interest in the manuscript. JF was supported by The Foundation for Alzheimer's Disease and Dementia and this funder had no role in study design, data colection and analysis, decision to publish or preparation of the manuscript.	Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Behbahani H, 2005, J NEUROSCI RES, V82, P432, DOI 10.1002/jnr.20634; Beher D, 1999, J NEUROCHEM, V72, P1564, DOI 10.1046/j.1471-4159.1999.721564.x; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chun J, 2004, J ORG CHEM, V69, P7344, DOI 10.1021/jo0486948; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Efthimiopoulos S, 1998, J NEUROCHEM, V71, P2365; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Franberg J, 2007, BIOCHEMISTRY-US, V46, P7647, DOI 10.1021/bi0621258; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; KOO EH, 1994, J BIOL CHEM, V269, P17386; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lah JJ, 1997, J NEUROSCI, V17, P1971; MCCARTHY JV, 2009, CELL MOL LIFE SCI; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ribaut-Barassin C, 2003, NEUROSCIENCE, V120, P405, DOI 10.1016/S0306-4522(03)00332-4; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Shupliakov O, 2009, NEUROSCIENCE, V158, P204, DOI 10.1016/j.neuroscience.2008.03.035; Siman R, 2003, J NEUROCHEM, V84, P1143, DOI 10.1046/j.1471-4159.2003.01616.x; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Teranishi Y., 2009, J CELL MOL MED; Torp R, 2003, NEUROSCIENCE, V120, P291, DOI 10.1016/S0306-4522(03)00320-8; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	38	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8948	10.1371/journal.pone.0008948	http://dx.doi.org/10.1371/journal.pone.0008948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126630	Green Published, Green Submitted, gold			2022-12-25	WOS:000274138000023
J	Steptoe, A; Hamer, M; O'Donnell, K; Venuraju, S; Marmot, MG; Lahiri, A				Steptoe, Andrew; Hamer, Mark; O'Donnell, Katie; Venuraju, Shreenidhi; Marmot, Michael G.; Lahiri, Avijit			Socioeconomic Status and Subclinical Coronary Disease in the Whitehall II Epidemiological Study	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; INTIMA-MEDIA THICKNESS; HEART-DISEASE; CARDIOVASCULAR-DISEASE; YOUNG-ADULTS; PSYCHOSOCIAL FACTORS; SOCIAL INEQUALITIES; CALCIFICATION; ATHEROSCLEROSIS; PROGRESSION	Background: There are pronounced socioeconomic disparities in coronary heart disease, but the extent to which these primarily reflect gradients in underlying coronary artery disease severity or in the clinical manifestation of advanced disease is uncertain. We measured the relationship between socioeconomic status (SES) as indexed by grade of employment and coronary artery calcification (CAC) in the Whitehall II epidemiological cohort, and tested the contribution of lifestyle, biological and psychosocial factors in accounting for this association. Methods and Findings: CAC was assessed in 528 asymptomatic men and women aged 53-76 years, stratified into higher, intermediate and lower by grade of employment groups. Lifestyle (smoking, body mass index, alcohol consumption, physical activity), biological (blood pressure, lipids, fasting glucose, inflammatory markers) and psychosocial factors (work stress, financial strain, social support, depression, hostility, optimism) were also measured. Detectable CAC was present in 293 participants (55.5%). The presence of calcification was related to lifestyle and biological risk factors, but not to grade of employment. But among individuals with detectable calcification, the severity of CAC was inversely associated with grade of employment (p = 0.010), and this relationship remained after controlling for demographic, lifestyle, biological and psychosocial factors. Compared with the higher grade group, there was a mean increase in log Agatston scores of 0.783 (95% C. I. 0.265-1.302, p = 0.003) in the intermediate and 0.941 (C. I. 0.226-1.657, p = 0.010) in the lower grade of employment groups, after adjustment for demographic, lifestyle, biological and psychosocial factors. Conclusions: Low grade of employment did not predict the presence of calcification in this cohort, but was related to the severity of CAC. These findings suggest that lower SES may be particularly relevant at advanced stages of subclinical coronary artery disease, when calcification has developed.	[Steptoe, Andrew; Hamer, Mark; O'Donnell, Katie; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Venuraju, Shreenidhi; Lahiri, Avijit] Wellington Hosp, Cardiac Imaging & Res Ctr, London, England	University of London; University College London; Wellington Hospital	Steptoe, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	a.steptoe@ucl.ac.uk	Hamer, Mark/C-1602-2008; Marmot, M G/Y-3920-2019; Hamer, Mark/AAJ-6814-2021; Steptoe, Andrew/Y-2440-2019	Hamer, Mark/0000-0002-8726-7992; Marmot, M G/0000-0002-2431-6419; Hamer, Mark/0000-0002-8726-7992; Steptoe, Andrew/0000-0001-7808-4943	British Heart Foundation [RG/05/006]; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G8802774, G19/35, G0100222, G0902037] Funding Source: researchfish; MRC [G0902037] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the British Heart Foundation (RG/05/006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand DV, 2007, J AM COLL CARDIOL, V50, P2218, DOI 10.1016/j.jacc.2007.08.032; Bild DE, 2001, ARTERIOSCL THROM VAS, V21, P852, DOI 10.1161/01.ATV.21.5.852; Brydon L, 2004, BRAIN BEHAV IMMUN, V18, P281, DOI 10.1016/j.bbi.2003.09.011; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Cohen Sheldon, 1997, JAMA (Journal of the American Medical Association), V277, P1940, DOI 10.1001/jama.277.24.1940; Colhoun HM, 2000, BMJ-BRIT MED J, V321, P1262, DOI 10.1136/bmj.321.7271.1262; Dragano N, 2007, EUR J CARDIOV PREV R, V14, P568, DOI 10.1097/HJR.0b013e32804955c4; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Gibson PH, 2009, HEART, V95, P793, DOI 10.1136/hrt.2008.149849; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Kivimaki M, 2005, ARTERIOSCL THROM VAS, V25, P2197, DOI 10.1161/01.ATV.0000183729.91449.6e; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Kop WJ, 2005, PSYCHOSOM MED, V67, P343, DOI 10.1097/01.psy.0000161201.45643.8d; LYNCH J, 1995, CIRCULATION, V92, P1786, DOI 10.1161/01.CIR.92.7.1786; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot MG, 2008, DIABETOLOGIA, V51, P1980, DOI 10.1007/s00125-008-1144-3; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1986, LANCET, V2, P274; Mittleman MA, 1997, ARCH INTERN MED, V157, P769, DOI 10.1001/archinte.157.7.769; Moser DK, 2006, CIRCULATION, V114, P168, DOI 10.1161/CIRCULATIONAHA.106.176040; O'Malley PG, 2000, NEW ENGL J MED, V343, P1298, DOI 10.1056/NEJM200011023431803; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ranjit N, 2006, ARTERIOSCL THROM VAS, V26, P411, DOI 10.1161/01.ATV.0000198245.16342.3d; Roux AVD, 2006, ANN INTERN MED, V144, P822, DOI 10.7326/0003-4819-144-11-200606060-00008; Roux AVD, 2005, CIRCULATION, V112, P1557, DOI 10.1161/CIRCULATIONAHA.104.530147; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; STANSFELD S, 1992, SOC SCI MED, V35, P1027, DOI 10.1016/0277-9536(92)90242-I; Steptoe A, 2002, EUR HEART J, V23, P1757, DOI 10.1053/euhj.2001.3233; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P1793, DOI 10.1001/jama.295.15.1793	32	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8874	10.1371/journal.pone.0008874	http://dx.doi.org/10.1371/journal.pone.0008874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	547NM	20111604	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896300023
J	Pust, S; Dyve, AB; Torgersen, ML; van Deurs, B; Sandvig, K				Pust, Sascha; Dyve, Anne Berit; Torgersen, Maria L.; van Deurs, Bo; Sandvig, Kirsten			Interplay between Toxin Transport and Flotillin Localization	PLOS ONE			English	Article							SHIGA TOXIN; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; MEMBRANE MICRODOMAINS; PLASMA-MEMBRANE; GOLGI TRANSPORT; REGGIE/FLOTILLIN PROTEINS; TYROSINE SULFATION; RAFT ASSOCIATION; CHOLERA-TOXIN	The flotillin proteins are localized in lipid domains at the plasma membrane as well as in intracellular compartments. In the present study, we examined the importance of flotillin-1 and flotillin-2 for the uptake and transport of the bacterial Shiga toxin (Stx) and the plant toxin ricin and we investigated whether toxin binding and uptake were associated with flotillin relocalization. We observed a toxin-induced redistribution of the flotillins, which seemed to be regulated in a p38-dependent manner. Our experiments provide no evidence for a changed endocytic uptake of Stx or ricin in cells silenced for flotillin-1 or -2. However, the Golgi-dependent sulfation of both toxins was significantly reduced in flotillin knockdown cells. Interestingly, when the transport of ricin to the ER was investigated, we obtained an increased mannosylation of ricin in flotillin-1 and flotillin-2 knockdown cells. The toxicity of both toxins was twofold increased in flotillin-depleted cells. Since BFA (Brefeldin A) inhibits the toxicity even in flotillin knockdown cells, the retrograde toxin transport is apparently still Golgi-dependent. Thus, flotillin proteins regulate and facilitate the retrograde transport of Stx and ricin.	[Pust, Sascha; Dyve, Anne Berit; Torgersen, Maria L.; Sandvig, Kirsten] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Pust, Sascha; Dyve, Anne Berit; Torgersen, Maria L.; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [van Deurs, Bo] Univ Copenhagen, Panum Inst, Struct Cell Biol Unit, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark	University of Oslo; University of Oslo; University of Copenhagen	Pust, S (corresponding author), Univ Oslo, Ctr Canc Biomed, Oslo, Norway.	ksandvig@radium.uio.no	Torgersen, Maria Lyngaas L/F-3492-2017; Torgersen, Maria Lyngaas/O-6240-2019; Pust, Sascha/M-3201-2013	Torgersen, Maria Lyngaas L/0000-0003-2616-7194; Torgersen, Maria Lyngaas/0000-0003-2616-7194; Pust, Sascha/0000-0002-0178-2206	Norwegian Cancer Society; Norwegian Research Council for Science and Humanities; Helse Sor-Ost	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council for Science and Humanities; Helse Sor-Ost	This work was supported by The Norwegian Cancer Society, The Norwegian Research Council for Science and Humanities, and Helse Sor-Ost. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MA, 1996, ARCH BIOCHEM BIOPHYS, V326, P64, DOI 10.1006/abbi.1996.0047; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Fernow I, 2007, EUR J CELL BIOL, V86, P345, DOI 10.1016/j.ejcb.2007.03.004; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GRIFFITHS GD, 1987, J PATHOL, V151, P221, DOI 10.1002/path.1711510310; Grimmer S, 2000, MOL BIOL CELL, V11, P4205, DOI 10.1091/mbc.11.12.4205; Grimmer S, 2006, TRAFFIC, V7, P1243, DOI 10.1111/j.1600-0854.2006.00456.x; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; IWANAGA T, 2009, PROG LIPID RES; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; LEITINGER B, 1994, J BIOL CHEM, V269, P8115; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Lingwood CA, 1999, BBA-MOL BASIS DIS, V1455, P375, DOI 10.1016/S0925-4439(99)00062-9; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Llorente A, 2003, J BIOL CHEM, V278, P35850, DOI 10.1074/jbc.M303425200; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Planey SL, 2009, MOL MEMBR BIOL, V26, P14, DOI 10.1080/09687680802646703; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; SANDVIG K, 1979, EXP CELL RES, V121, P15, DOI 10.1016/0014-4827(79)90439-7; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Sandvig K, 2001, TOXICON, V39, P1629, DOI 10.1016/S0041-0101(01)00150-7; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schulte T, 1997, DEVELOPMENT, V124, P577; SKANLAND SS, 2009, CELL MICROBIOL; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; Walchli S, 2009, CELL SIGNAL, V21, P1161, DOI 10.1016/j.cellsig.2009.03.005; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Ying M, 2003, TRAFFIC, V4, P772, DOI 10.1034/j.1600-0854.2003.00134.x	55	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8844	10.1371/journal.pone.0008844	http://dx.doi.org/10.1371/journal.pone.0008844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107503	gold, Green Published, Green Submitted			2022-12-25	WOS:000273896100010
J	Murholm, M; Dixen, K; Qvortrup, K; Hansen, LHL; Amri, EZ; Madsen, L; Barbatelli, G; Quistorff, B; Hansen, JB				Murholm, Maria; Dixen, Karen; Qvortrup, Klaus; Hansen, Lillian H. L.; Amri, Ez-Zoubir; Madsen, Lise; Barbatelli, Giorgio; Quistorff, Bjorn; Hansen, Jacob B.			Dynamic Regulation of Genes Involved in Mitochondrial DNA Replication and Transcription during Mouse Brown Fat Cell Differentiation and Recruitment	PLOS ONE			English	Article							ADIPOSE-TISSUE; RECEPTOR-ALPHA; RETINOBLASTOMA PROTEIN; INDUCIBLE COACTIVATOR; COREPRESSOR RIP140; RNA-POLYMERASE; WHITE FAT; FACTOR-A; BIOGENESIS; EXPRESSION	Background: Brown adipocytes are specialised in dissipating energy through adaptive thermogenesis, whereas white adipocytes are specialised in energy storage. These essentially opposite functions are possible for two reasons relating to mitochondria, namely expression of uncoupling protein 1 (UCP1) and a remarkably higher mitochondrial abundance in brown adipocytes. Methodology/Principal Findings: Here we report a comprehensive characterisation of gene expression linked to mitochondrial DNA replication, transcription and function during white and brown fat cell differentiation in vitro as well as in white and brown fat, brown adipose tissue fractions and in selected adipose tissues during cold exposure. We find a massive induction of the majority of such genes during brown adipocyte differentiation and recruitment, e. g. of the mitochondrial transcription factors A (Tfam) and B2 (Tfb2m), whereas only a subset of the same genes were induced during white adipose conversion. In addition, PR domain containing 16 (PRDM16) was found to be expressed at substantially higher levels in brown compared to white pre-adipocytes and adipocytes. We demonstrate that forced expression of Tfam but not Tfb2m in brown adipocyte precursor cells promotes mitochondrial DNA replication, and that silencing of PRDM16 expression during brown fat cell differentiation blunts mitochondrial biogenesis and expression of brown fat cell markers. Conclusions/Significance: Using both in vitro and in vivo model systems of white and brown fat cell differentiation, we report a detailed characterisation of gene expression linked to mitochondrial biogenesis and function. We find significant differences in differentiating white and brown adipocytes, which might explain the notable increase in mitochondrial content observed during brown adipose conversion. In addition, our data support a key role of PRDM16 in triggering brown adipocyte differentiation, including mitochondrial biogenesis and expression of UCP1.	[Murholm, Maria; Dixen, Karen; Qvortrup, Klaus; Hansen, Lillian H. L.; Quistorff, Bjorn; Hansen, Jacob B.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Amri, Ez-Zoubir] Univ Nice Sophia Antipolis, CNRS, IBDC, UMR 6543, Nice, France; [Madsen, Lise] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Barbatelli, Giorgio] Univ Ancona, Sch Med, Dept Mol Pathol & Innovat Therapies, Ancona, Italy	University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Copenhagen; Marche Polytechnic University	Murholm, M (corresponding author), Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark.	jbhansen@sund.ku.dk	Madsen, Lise/C-6246-2012; Hansen, Jacob B/F-3775-2010	Madsen, Lise/0000-0003-4468-1947; Hansen, Jacob B/0000-0001-5249-2586; amri, Ez-Zoubir/0000-0001-8426-5396; Qvortrup, Klaus/0000-0001-8811-0260	Danish Medical Research Council; Novo Nordisk Foundation; Carlsberg Foundation; Aase & Ejnar Danielsen Foundation; Augustinus Foundation; Beckett Foundation; Grosserer Ernst Fischers Mindelegat; Novo Scholarship Program	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Aase & Ejnar Danielsen Foundation; Augustinus Foundation; Beckett Foundation; Grosserer Ernst Fischers Mindelegat; Novo Scholarship Program	This work was supported by grants to J.B.H. from the Danish Medical Research Council, the Novo Nordisk Foundation, the Carlsberg Foundation, the Aase & Ejnar Danielsen Foundation, the Augustinus Foundation, the Beckett Foundation and Grosserer Ernst Fischers Mindelegat. M. M. was supported by the Novo Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2000, METH MOL B, V155, P213; Chen Y, 2005, BIOCHEM BIOPH RES CO, V337, P1112, DOI 10.1016/j.bbrc.2005.09.164; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GOGLIA F, 1992, AM J PHYSIOL, V262, pC1018, DOI 10.1152/ajpcell.1992.262.4.C1018; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Murano I., 2005, ADIPOCYTES, V1, P121; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; REHNMARK S, 1989, EXP CELL RES, V180, P574, DOI 10.1016/0014-4827(89)90086-4; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang XJ, 2005, MOL CELL ENDOCRINOL, V238, P1, DOI 10.1016/j.mce.2005.04.009; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	66	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8458	10.1371/journal.pone.0008458	http://dx.doi.org/10.1371/journal.pone.0008458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20107496	Green Published, gold, Green Submitted			2022-12-25	WOS:000273104000019
J	Whibley, C; Odell, AF; Nedelko, T; Balaburski, G; Murphy, M; Liu, ZP; Stevens, L; Walker, JH; Routledge, M; Hollstein, M				Whibley, Catherine; Odell, Adam F.; Nedelko, Tatiana; Balaburski, Gregor; Murphy, Maureen; Liu, Zhipei; Stevens, Louisa; Walker, John H.; Routledge, Michael; Hollstein, Monica			Wild-type and Hupki (Human p53 Knock-in) Murine Embryonic Fibroblasts p53/ARF PATHWAY DISRUPTION IN SPONTANEOUS ESCAPE FROM SENESCENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENES; CELLULAR SENESCENCE; HUMAN CANCER; LUNG-TUMORS; CELLS; MUTATIONS; MOUSE; DNA; IMMORTALIZATION; MICE	Research on cell senescence and immortalization of murine embryonic fibroblasts (MEFs) has revealed important clues about genetic control of senescence in humans. To investigate senescence and genetic alterations in the p53 pathway that lead to senescence bypass in culture, we compared the behavior of MEFs from wild-type mice with MEFs from Hupki mice, which harbor a humanized p53 gene. We found that humanizing the p53 gene in mice preserved major features of the MEF senescence/immortalization process. In both genotypes, a significant proportion of spontaneously arising cell lines had sustained either a p53 point mutation or p19/ARF biallelic deletion. The p53 mutations selected for during Hupki MEF immortalization have been found in human tumors and are classified in the yeast transactivation assay as transcriptionally defunct, suggesting that disabling this component of p53 activity is crucial in senescence bypass. Surprisingly, in spontaneously immortalized cell lines from both wild-type and Hupki MEFs, the predominant type of p53 mutation was a G to C transversion, rather than the G to T substitutions expected from the raised oxygen levels characteristic of standard culture conditions. Over half of the cell lines did not reveal evidence of p53 mutation or loss of p19/ARF and retained a robust wild-type p53 response to DNA damage, supporting the inference from senescence bypass screens that alternative genetic routes to immortalization occur.	[Whibley, Catherine; Stevens, Louisa; Routledge, Michael; Hollstein, Monica] Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Odell, Adam F.; Walker, John H.] Univ Leeds, LIGHT Labs, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Balaburski, Gregor; Murphy, Maureen] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Nedelko, Tatiana; Hollstein, Monica] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Liu, Zhipei] Max Planck Inst Heart & Lung Dis, D-61231 Bad Nauheim, Germany	University of Leeds; University of Leeds; Fox Chase Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Hollstein, M (corresponding author), Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England.	m.hollstein@leeds.ac.uk	Odell, Adam/J-1386-2012; Routledge, Michael N/N-7413-2017	Routledge, Michael N/0000-0001-9139-2182; Murphy, Maureen/0000-0001-7644-7296	Cancer Research UK; Yorkshire Cancer Research; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: researchfish; BBSRC [BB/D524875/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA102184] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Yorkshire Cancer Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancer Research UK and by Yorkshire Cancer Research.	Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; BOND JA, 1995, CANCER RES, V55, P2404; BROSH R, 2010, NAT REV CANCER, V6, P17; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; COLLINS AR, 1993, CARCINOGENESIS, V14, P1733, DOI 10.1093/carcin/14.9.1733; Cook WD, 2000, ONCOGENE, V19, P3434, DOI 10.1038/sj.onc.1203653; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Esteller M, 2000, CANCER RES, V60, P129; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Hainaut P, 2000, ADV CANCER RES, V77, P81; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hergenhahn M, 2004, CELL CYCLE, V3, P738; HERMAN JG, 1995, CANCER RES, V55, P4525; HIRABAYASHI Y, 1985, J IMMUNOL METHODS, V82, P253, DOI 10.1016/0022-1759(85)90357-6; Jaworski M, 2005, CARCINOGENESIS, V26, P1829, DOI 10.1093/carcin/bgi142; Johnson TM, 2008, P NATL ACAD SCI USA, V105, P1215, DOI 10.1073/pnas.0706764105; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liu ZP, 2005, CANCER RES, V65, P2583, DOI 10.1158/0008-5472.CAN-04-3675; Liu ZP, 2004, P NATL ACAD SCI USA, V101, P2963, DOI 10.1073/pnas.0308607101; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nedelko T, 2009, INT J CANCER, V124, P987, DOI 10.1002/ijc.24006; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Randle DH, 2001, P NATL ACAD SCI USA, V98, P9654, DOI 10.1073/pnas.171217498; Reinbold M, 2008, ONCOGENE, V27, P2788, DOI 10.1038/sj.onc.1210932; RITTLING SR, 1992, ONCOGENE, V7, P935; Roussel MF, 2002, CANCER CELL, V2, P434, DOI 10.1016/S1535-6108(02)00216-7; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Tam AS, 2003, CARCINOGENESIS, V24, P121, DOI 10.1093/carcin/24.1.121; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; vom Brocke J, 2009, MUTAGENESIS, V24, P17, DOI 10.1093/mutage/gen049; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; WynfordThomas D, 1996, J PATHOL, V180, P118, DOI 10.1002/(SICI)1096-9896(199610)180:2<118::AID-PATH673>3.0.CO;2-I; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	55	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11326	11335		10.1074/jbc.M109.064444	http://dx.doi.org/10.1074/jbc.M109.064444			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20118236	hybrid, Green Published			2022-12-25	WOS:000276286200039
J	Li, LT; Murdock, G; Bagley, D; Jia, XA; Ward, DM; Kaplan, J				Li, Liangtao; Murdock, Grace; Bagley, Dustin; Jia, Xuan; Ward, Diane McVey; Kaplan, Jerry			Genetic Dissection of a Mitochondria-Vacuole Signaling Pathway in Yeast Reveals a Link between Chronic Oxidative Stress and Vacuolar Iron Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; AFT1; IDENTIFICATION; DEFICIENCY; REGULON; STORAGE	Deletion of two homologous genes, MRS3 and MRS4, that encode mitochondrial iron transporters affects the activity of the vacuolar iron importer Ccc1. Ccc1 levels are decreased in Delta mrs3 Delta mrs4 cells, but the activity of the transporter is increased, resulting is reduced cytosolic iron. Overexpression of CCC1 in Delta mrs3 Delta mrs4 cells results in a severe growth defect due to decreased cytosolic iron, referred to as the mitochondria-vacuole signaling (MVS) phenotype. Mutants were identified that suppress the MVS growth defect, and FRA1 was identified as a gene that suppresses the MVS phenotype. Overexpression of FRA1 suppresses altered transition metal metabolism in Delta mrs3 Delta mrs4 cells, whereas deletion of FRA1 is synthetically lethal with Delta mrs3 Delta mrs4. Fra1 binds to Tsa1, which encodes a thioredoxin-dependent peroxidase. Deletion of TSA1 or TRR1 is synthetically lethal in Delta mrs3 Delta mrs4 cells, suggesting that Delta mrs3 Delta mrs4 cells generate reactive oxygen metabolites. The generation of reactive oxygen metabolites in Delta mrs3 Delta mrs4 cells was confirmed by use of the reporter molecule 2',7'-dichlorodihydrofluorescein diacetate. These results suggest that mitochondria-induced oxidant damage is responsible for activating Ccc1 and that Fra1 and Tsa1 can reduce oxidant damage.	[Li, Liangtao; Murdock, Grace; Bagley, Dustin; Jia, Xuan; Ward, Diane McVey; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu			National Institutes of Health [DK052380, DK035034]; Center of Excellence in Molecular Hematology [5P30DK72437]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072437, R01DK052380, R01DK030534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Molecular Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052380 and DK035034 (to J. K.). This work was also supported by Center of Excellence in Molecular Hematology Grant 5P30DK72437.	AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Lesuisse E, 2005, GENETICS, V169, P107, DOI 10.1534/genetics.104.035873; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Tuttle MS, 2003, J BIOL CHEM, V278, P1273, DOI 10.1074/jbc.M209631200; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x	22	27	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10232	10242		10.1074/jbc.M109.096859	http://dx.doi.org/10.1074/jbc.M109.096859			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139087	hybrid, Green Published			2022-12-25	WOS:000276264600007
J	Tang, GM; Perng, MD; Wilk, S; Quinlan, R; Goldman, JE				Tang, Guomei; Perng, Ming D.; Wilk, Sherwin; Quinlan, Roy; Goldman, James E.			Oligomers of Mutant Glial Fibrillary Acidic Protein (GFAP) Inhibit the Proteasome System in Alexander Disease Astrocytes, and the Small Heat Shock Protein alpha B-Crystallin Reverses the Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT; STRESS-RESPONSE; 26S PROTEASOME; RAT-BRAIN; MUTATIONS; TRANSCRIPTION; ACCUMULATION; DEGRADATION; ACTIVATION; EXPRESSION	The accumulation of the intermediate filament protein, glial fibrillary acidic protein (GFAP), in astrocytes of Alexander disease (AxD) impairs proteasome function in astrocytes. We have explored the molecular mechanism that underlies the proteasome inhibition. We find that both assembled and unassembled wild type (wt) and R239C mutant GFAP protein interacts with the 20 S proteasome complex and that the R239C AxD mutation does not interfere with this interaction. However, the R239C GFAP accumulates to higher levels and forms more protein aggregates than wt protein. These aggregates bind components of the ubiquitin-proteasome system and, thus, may deplete the cytosolic stores of these proteins. We also find that the R239C GFAP has a greater inhibitory effect on proteasome system than wt GFAP. Using a ubiquitin-independent degradation assay in vitro, we observed that the proteasome cannot efficiently degrade unassembled R239C GFAP, and the interaction of R239C GFAP with proteasomes actually inhibits proteasomal protease activity. The small heat shock protein, alpha B-crystallin, which accumulates massively in AxD astrocytes, reverses the inhibitory effects of R239C GFAP on proteasome activity and promotes degradation of the mutant GFAP, apparently by shifting the size of the mutant protein from larger oligomers to smaller oligomers and monomers. These observations suggest that oligomeric forms of GFAP are particularly effective at inhibiting proteasome activity.	[Tang, Guomei; Goldman, James E.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Perng, Ming D.; Quinlan, Roy] Univ Durham, Sch Biol & Med Sci, Durham DH1 3LE, England; [Wilk, Sherwin] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Columbia University; Durham University; Icahn School of Medicine at Mount Sinai	Goldman, JE (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, 630 W 168th St,P&S Rm 15-420, New York, NY 10032 USA.	jeg5@columbia.edu	Quinlan, Roy/A-1348-2012	Quinlan, Roy/0000-0003-0644-4123	National Institutes of Health [PO1NS42803, P30-HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1NS42803 and P30-HD03352.	Alvarez-Castelao B, 2005, FEBS LETT, V579, P4797, DOI 10.1016/j.febslet.2005.07.060; Arcangeletti C, 1997, J STRUCT BIOL, V119, P35, DOI 10.1006/jsbi.1997.3871; BANAYSCHWARTZ M, 1992, AGE, V15, P51, DOI 10.1007/BF02435024; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Dachsel JC, 2005, FEBS LETT, V579, P3913, DOI 10.1016/j.febslet.2005.06.003; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; DESA MFG, 1988, J CELL BIOL, V107, P1517, DOI 10.1083/jcb.107.4.1517; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Gregori L, 1997, J BIOL CHEM, V272, P58; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Koyama Y, 1999, AM J PATHOL, V154, P1563, DOI 10.1016/S0002-9440(10)65409-0; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Li R, 2005, ANN NEUROL, V57, P310, DOI 10.1002/ana.20406; MALLOCH GDA, 1987, J NEUROCHEM, V48, P299, DOI 10.1111/j.1471-4159.1987.tb13162.x; Middeldorp J, 2009, FASEB J, V23, P2710, DOI 10.1096/fj.08-127696; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; OLINKCOUX M, 1994, J CELL SCI, V107, P353; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Wilk S., 2001, CURR PROTOC PROTEIN; Wolburg H, 2005, NEUROGLIA, V2, P19, DOI [10.1093/acprof:oso/9780195152227.001.0001/acprof-9780195152227-chapter-2, DOI 10.1093/ACPROF:OSO/9780195152227.003]; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001	33	67	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10527	10537		10.1074/jbc.M109.067975	http://dx.doi.org/10.1074/jbc.M109.067975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110364	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000276264600039
J	Jiang, SX; Whitehead, S; Aylsworth, A; Slinn, J; Zurakowski, B; Chan, K; Li, JJ; Hou, ST				Jiang, Susan X.; Whitehead, Shawn; Aylsworth, Amy; Slinn, Jacqueline; Zurakowski, Bogdan; Chan, Kenneth; Li, Jianjun; Hou, Sheng T.			Neuropilin 1 Directly Interacts with Fer Kinase to Mediate Semaphorin 3A-induced Death of Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR E2F1; CEREBRAL-ISCHEMIA; SYMPATHETIC NEURONS; GLUTAMATE TOXICITY; SIGNALING PATHWAY; MASS-SPECTROMETRY; TISSUE-SECTIONS; AXON RETRACTION; FOCAL ISCHEMIA; SPINAL-CORD	Neuropilins (NRPs) are receptors for the major chemorepulsive axonal guidance cue semaphorins (Sema). The interaction of Sema3A/NRP1 during development leads to the collapse of growth cones. Here we show that Sema3A also induces death of cultured cortical neurons through NRP1. A specific NRP1 inhibitory peptide ameliorated Sema3A-evoked cortical axonal retraction and neuronal death. Moreover, Sema3A was also involved in cerebral ischemia-induced neuronal death. Expression levels of Sema3A and NRP1, but not NRP2, were significantly increased early during brain reperfusion following transient focal cerebral ischemia. NRP1 inhibitory peptide delivered to the ischemic brain was potently neuroprotective and prevented the loss of motor functions in mice. The integrity of the injected NRP1 inhibitory peptide into the brain remained unchanged, and the intact peptide permeated the ischemic hemisphere of the brain as determined using MALDI-MS-based imaging. Mechanistically, NRP1-mediated axonal collapse and neuronal death is through direct and selective interaction with the cytoplasmic tyrosine kinase Fer. Fer RNA interference effectively attenuated Sema 3A-induced neurite retraction and neuronal death in cortical neurons. More importantly, down-regulation of Fer expression using Fer-specific RNA interference attenuated cerebral ischemia-induced brain damage. Together, these studies revealed a previously unknown function of NRP1 in signaling Sema3A-evoked neuronal death through Fer in cortical neurons.	[Jiang, Susan X.; Whitehead, Shawn; Aylsworth, Amy; Slinn, Jacqueline; Zurakowski, Bogdan; Hou, Sheng T.] Natl Res Council Canada, Inst Biol Sci, Expt NeuroTherapeut Lab, Ottawa, ON K1A 0R6, Canada; [Chan, Kenneth; Li, Jianjun] Natl Res Council Canada, Inst Biol Sci, Mass Spectrometry Glycoanal Lab, Ottawa, ON K1A 0R6, Canada; [Aylsworth, Amy; Hou, Sheng T.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	National Research Council Canada; National Research Council Canada; University of Ottawa	Hou, ST (corresponding author), Natl Res Council Canada, Inst Biol Sci, Expt NeuroTherapeut Lab, Bldg M54,1200 Montreal Rd, Ottawa, ON K1A 0R6, Canada.	sheng.hou@nrc-cnrc.gc.ca	Hou, Sheng Tao/O-3202-2018; Whitehead, Shawn/E-3772-2016; Hou, Sheng Tao/AAM-7756-2020	Whitehead, Shawn/0000-0003-4728-8067; Hou, Sheng Tao/0000-0001-9736-342X	Heart and Stroke Foundation of Ontario [NA5393, T5760]; Canadian Institutes of Health Research [CCI85680]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Heart and Stroke Foundation of Ontario Grants NA5393 and T5760 and by Canadian Institutes of Health Research Grant CCI85680 (to S.T.H.).	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Beck H, 2002, J NEUROPATH EXP NEUR, V61, P339, DOI 10.1093/jnen/61.4.339; Ben-Zvi A, 2008, J NEUROSCI, V28, P12427, DOI 10.1523/JNEUROSCI.3573-08.2008; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; De Winter F, 2002, ADV EXP MED BIOL, V515, P115; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Ding S, 2007, BIOCHEM BIOPH RES CO, V356, P857, DOI 10.1016/j.bbrc.2007.03.073; Fujita H, 2001, BRAIN RES, V914, P1, DOI 10.1016/S0006-8993(01)02765-2; Gagliardini V, 1999, MOL CELL NEUROSCI, V14, P301, DOI 10.1006/mcne.1999.0787; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Giger RJ, 1998, PROG BRAIN RES, V117, P133; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Hou ST, 2008, INT REV CEL MOL BIO, V267, P125, DOI 10.1016/S1937-6448(08)00603-5; Hou ST, 2008, BIOCHEM BIOPH RES CO, V367, P109, DOI 10.1016/j.bbrc.2007.12.103; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hou ST, 2000, J NEUROCHEM, V75, P91, DOI 10.1046/j.1471-4159.2000.0750091.x; Jiang SX, 2007, MOL CELL BIOL, V27, P1696, DOI 10.1128/MCB.01760-06; Jiang SX, 2005, J BIOL CHEM, V280, P33811, DOI 10.1074/jbc.M503113200; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; MacManus JP, 1999, NEUROREPORT, V10, P2711, DOI 10.1097/00001756-199909090-00004; MacManus JP, 2003, J CEREBR BLOOD F MET, V23, P1020, DOI 10.1097/01.WCB.0000084249.20114.FA; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Pasterkamp RJ, 1998, EXP NEUROL, V153, P313, DOI 10.1006/exnr.1998.6886; Pasterkamp RJ, 2001, BRAIN RES REV, V35, P36, DOI 10.1016/S0165-0173(00)00050-3; Pasterkamp RJ, 1998, PROG BRAIN RES, V117, P151; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Rohner TC, 2005, MECH AGEING DEV, V126, P177, DOI 10.1016/j.mad.2004.09.032; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; Shapovalova Z, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-133; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; Shirvan A, 2002, J BIOL CHEM, V277, P49799, DOI 10.1074/jbc.M204793200; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Trim PJ, 2008, ANAL CHEM, V80, P8628, DOI 10.1021/ac8015467; WAKADE TD, 1995, J PHYSIOL-LONDON, V488, P123, DOI 10.1113/jphysiol.1995.sp020951; Weaver JGR, 2005, J CLIN INVEST, V115, P1828, DOI 10.1172/JCI22954; Williams G, 2005, J NEUROCHEM, V92, P1180, DOI 10.1111/j.1471-4159.2004.02950.x; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	49	36	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9908	9918		10.1074/jbc.M109.080689	http://dx.doi.org/10.1074/jbc.M109.080689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20133938	Green Published, hybrid			2022-12-25	WOS:000276165900061
J	Qian, C; Liu, JN; Tang, FY; Yuan, DW; Guo, ZG; Zhang, J				Qian, Chen; Liu, Jian-Ning; Tang, Fengyuan; Yuan, Dawen; Guo, Zhigang; Zhang, Jing			A Novel Strategy for Proteome-wide Ligand Screening Using Cross-linked Phage Matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY LIGANDS; PEPTIDE LIGAND; SELECTION; ANTIBODY; LIBRARIES; DISPLAY; TECHNOLOGY; FRAGMENTS	To find a suitable ligand from a complex antigen system is still a mission to be accomplished. Here we have explored a novel "library against proteome" panning strategy for ligand screening and antigen purification from a complex system using phage-displayed antibody technology. Human plasma proteome was targeted for phage library panning. During the process, the panning was carried out in solution, using a biotin/streptavidin beads separation system, for three rounds. Nine monoclonal phages, bound tightly to a number of unknown plasma proteins, were selected from the last round, six of which were directly employed as cross-linked matrices to purify their corresponding antigens from the plasma. The proteins isolated by G5 and E1 matrices were identified as amyloid protein and apolipoprotein A-I precursor, respectively. The results demonstrated that it was feasible to simultaneously obtain a number of ligand phages for various antigens, including low abundant proteins in a non-comparative proteome-wide system.	[Qian, Chen; Liu, Jian-Ning; Tang, Fengyuan; Yuan, Dawen; Zhang, Jing] Nanjing Univ, Inst Mol Med, Nanjing 210093, Peoples R China; [Qian, Chen; Liu, Jian-Ning; Tang, Fengyuan; Yuan, Dawen; Zhang, Jing] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; [Liu, Jian-Ning; Guo, Zhigang; Zhang, Jing] E China Normal Univ, Inst Mol & Expt Therapeut, Shanghai 200062, Peoples R China	Nanjing University; Nanjing University; East China Normal University	Zhang, J (corresponding author), Nanjing Univ, Inst Mol Med, 22 Hankou Rd, Nanjing 210093, Peoples R China.	jingzhang2001@gmail.com			Ministry of Education, China [20060284042, 20060284045]	Ministry of Education, China(Ministry of Education, China)	The work was supported by the Ministry of Education, China (Grants 20060284042 and 20060284045).	Adamson SR, 1998, DEV BIOL STAND, V93, P89; Amatschek K, 2000, HRC-J HIGH RES CHROM, V23, P47; Bowley DR, 2009, P NATL ACAD SCI USA, V106, P1380, DOI 10.1073/pnas.0812291106; Breccia JD, 2003, ENZYME MICROB TECH, V33, P244, DOI 10.1016/S0141-0229(03)00118-2; Furuta M, 2002, J BIOCHEM, V132, P245, DOI 10.1093/oxfordjournals.jbchem.a003217; GIROT P, 1990, J CHROMATOGR, V510, P213, DOI 10.1016/S0021-9673(01)93755-0; Goletz S, 2002, J MOL BIOL, V315, P1087, DOI 10.1006/jmbi.2001.5314; Hage DS, 1999, CLIN CHEM, V45, P593; Hammond DJ, 1998, CHROMATOGRAPHIA, V47, P475, DOI 10.1007/BF02466484; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hoogenboom HR, 1999, EUR J BIOCHEM, V260, P774, DOI 10.1046/j.1432-1327.1999.00214.x; Hortin GL, 2006, CLIN CHEM, V52, P1223, DOI 10.1373/clinchem.2006.069252; Huang PY, 1999, BIOTECHNOL BIOENG, V63, P633, DOI 10.1002/(SICI)1097-0290(19990620)63:6<633::AID-BIT1>3.0.CO;2-C; Hust M, 2004, TRENDS BIOTECHNOL, V22, P8, DOI 10.1016/j.tibtech.2003.10.011; Kay B. K, 1996, PHAGE DISPLAY PEPTID; Kelley BD, 2004, J CHROMATOGR A, V1038, P121, DOI 10.1016/j.chroma.2004.03.041; Kouzmitcheva GA, 2001, CLIN DIAGN LAB IMMUN, V8, P150, DOI 10.1128/CDLI.8.1.150-160.2001; KRETZSCHMAR T, 1995, ANAL BIOCHEM, V224, P413, DOI 10.1006/abio.1995.1059; LABROU N, 1994, J BIOTECHNOL, V36, P95, DOI 10.1016/0168-1656(94)90047-7; Labrou NE, 2003, J CHROMATOGR B, V790, P67, DOI 10.1016/S1570-0232(03)00098-9; Liu B, 2002, J MOL BIOL, V315, P1063, DOI 10.1006/jmbi.2001.5276; McConnell SJ, 1999, BIOTECHNIQUES, V26, P208, DOI 10.2144/99262bm06; Nord K, 2001, EUR J BIOCHEM, V268, P4269, DOI 10.1046/j.1432-1327.2001.02344.x; Samoylova TI, 2004, BIOTECHNIQUES, V37, P254, DOI 10.2144/04372RR02; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith GP, 1998, J IMMUNOL METHODS, V215, P151, DOI 10.1016/S0022-1759(98)00087-8; StausbolGron B, 1996, FEBS LETT, V391, P71, DOI 10.1016/0014-5793(96)00703-X; Su Z G, 1991, Chin J Biotechnol, V7, P161	29	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9367	9372		10.1074/jbc.M109.059857	http://dx.doi.org/10.1074/jbc.M109.059857			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118230	hybrid, Green Published			2022-12-25	WOS:000276165900008
J	Kieken, F; Sharma, M; Jovic, M; Giridharan, SSP; Naslavsky, N; Caplan, S; Sorgen, PL				Kieken, Fabien; Sharma, Mahak; Jovic, Marko; Giridharan, Sai Srinivas Panapakkam; Naslavsky, Naava; Caplan, Steve; Sorgen, Paul L.			Mechanism for the Selective Interaction of C-terminal Eps15 Homology Domain Proteins with Specific Asn-Pro-Phe-containing Partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SUBSTRATE; EARLY ENDOSOMAL TRANSPORT; EH-DOMAIN; PLASMA-MEMBRANE; MAMMALIAN-CELLS; ENDOCYTOSIS; RME-1; IDENTIFICATION; RECOGNITION; COMPARTMENT	Epidermal growth factor receptor tyrosine kinase substrate 15 (Eps15) homology (EH)-domain proteins can be divided into two classes: those with an N-terminal EH-domain(s), and the C-terminal Eps15 homology domain-containing proteins (EHDs). Whereas many N-terminal EH-domain proteins regulate internalization events, the best characterized C-terminal EHD, EHD1, regulates endocytic recycling. Because EH-domains interact with the tripeptide Asn-Pro-Phe (NPF), it is of critical importance to elucidate the molecular mechanisms that allow EHD1 and its paralogs to interact selectively with a subset of the hundreds of NPF-containing proteins expressed in mammalian cells. Here, we capitalize on our findings that C-terminal EH-domains possess highly positively charged interaction surfaces and that many NPF-containing proteins that interact with C-terminal (but not N-terminal) EH-domains are followed by acidic residues. Using the recently identified EHD1 interaction partner molecule interacting with CasL (MICAL)-Like 1 (MICAL-L1) as a model, we have demonstrated that only the first of its two NPF motifs is required for EHD1 binding. Because only this first NPF is followed by acidic residues, we have utilized glutathione S-transferase pulldowns, two-hybrid analysis, and NMR to demonstrate that the flanking acidic residues "fine tune" the binding affinity to EHD1. Indeed, our NMR solution structure of the EHD1 EH-domain in complex with the MICAL-L1 NPFEEEEED peptide indicates that the first two flanking Glu residues lie in a position favorable to form salt bridges with Lys residues within the EH-domain. Our data provide a novel explanation for the selective interaction of C-terminal EH-domains with specific NPF-containing proteins and allow for the prediction of new interaction partners with C-terminal EHDs.	[Caplan, Steve] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Caplan, S (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	scaplan@unmc.edu; psorgen@unmc.edu	giridharan, sai srinivas panapakkam/X-9083-2019	Jovic, Marko/0000-0002-0310-7730; Sharma, Mahak/0000-0002-4117-4790	National Institutes of Health [GM072631, GM074876, P20RR018759]; University of Nebraska Medical Center Eppley Cancer Center; Nebraska Health and Human Services [LB506, 2009-38, 2010-05]; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631, R01GM074876, R01GM087455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Medical Center Eppley Cancer Center; Nebraska Health and Human Services; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072631 (to P. L. S.), GM074876 (to S. C.), and P20RR018759 (to M.J. and N.N.). This work was also supported by the University of Nebraska Medical Center Eppley Cancer Center (P. L. S. and S. C.), Nebraska Health and Human Services Grants LB506 and 2009-38 (to P. L. S.) and LB506 and 2010-05 (to S. C.), and by an American Heart Association predoctoral fellowship (to M.	Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Gao GH, 2006, BIOCHEMISTRY-US, V45, P1785, DOI 10.1021/bi051856p; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Miliaras NB, 2004, CELL BIOCHEM BIOPHYS, V41, P295, DOI 10.1385/CBB:41:2:295; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nishimura N, 2008, J MED INVESTIG, V55, P9, DOI 10.2152/jmi.55.9; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; Zhang XY, 2005, J BIOL CHEM, V280, P20356, DOI 10.1074/jbc.M500511200	36	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8687	8694		10.1074/jbc.M109.045666	http://dx.doi.org/10.1074/jbc.M109.045666			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20106972	Green Published, hybrid			2022-12-25	WOS:000275553700021
J	Waldenstrom, J; Axelsson-Olsson, D; Olsen, B; Hasselquist, D; Griekspoor, P; Jansson, L; Teneberg, S; Svensson, L; Ellstrom, P				Waldenstrom, Jonas; Axelsson-Olsson, Diana; Olsen, Bjorn; Hasselquist, Dennis; Griekspoor, Petra; Jansson, Lena; Teneberg, Susann; Svensson, Lovisa; Ellstrom, Patrik			Campylobacter jejuni Colonization in Wild Birds: Results from an Infection Experiment	PLOS ONE			English	Article							GENETIC DIVERSITY; SUBSP JEJUNI; PREVALENCE; RESISTANCE; GENOTYPES; RESERVOIR; CHICKENS; ANIMALS; POULTRY	Campylobacter jejuni is a common cause of bacterial gastroenteritis in most parts of the world. The bacterium has a broad host range and has been isolated from many animals and environments. To investigate shedding patterns and putative effects on an avian host, we developed a colonization model in which a wild bird species, the European Robin Erithacus rubecula, was inoculated orally with C. jejuni from either a human patient or from another wild bird species, the Song Thrush Turdus philomelos. These two isolates were genetically distinct from each other and provoked very different host responses. The Song Thrush isolate colonized all challenged birds and colonization lasted 6.8 days on average. Birds infected with this isolate also showed a transient but significant decrease in body mass. The human isolate did not colonize the birds and could be detected only in the feces of the birds shortly after inoculation. European Robins infected with the wild bird isolate generated a specific antibody response to C. jejuni membrane proteins from the avian isolate, which also was cross-reactive to membrane proteins of the human isolate. In contrast, European Robins infected with the human isolate did not mount a significant response to bacterial membrane proteins from either of the two isolates. The difference in colonization ability could indicate host adaptations.	[Waldenstrom, Jonas; Axelsson-Olsson, Diana; Olsen, Bjorn; Griekspoor, Petra; Svensson, Lovisa; Ellstrom, Patrik] Linnaeus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Waldenstrom, Jonas; Hasselquist, Dennis] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Olsen, Bjorn] Uppsala Univ, Dept Infect Dis, Uppsala, Sweden; [Jansson, Lena; Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Ellstrom, Patrik] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Ellstrom, Patrik] Univ Uppsala Hosp, Uppsala, Sweden	Linnaeus University; Lund University; Uppsala University; University of Gothenburg; Uppsala University; Uppsala University; Uppsala University Hospital	Waldenstrom, J (corresponding author), Linnaeus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden.	jonas.waldenstrom@lnu.se	Hasselquist, Dennis/M-5223-2014; Waldenström, Jonas/E-4460-2013	Hasselquist, Dennis/0000-0002-0056-6616; Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X; Axelsson Olsson, Diana/0000-0003-4474-8531	Swedish Research Council; Swedish Research Council for Environment; Agricultural Science and Spatial Planning (FORMAS) [2008-10]; Carl Tryggers Stiftelse; Swedish Medical Research Council [12628]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment(Swedish Research Council Formas); Agricultural Science and Spatial Planning (FORMAS)(Swedish Research Council Formas); Carl Tryggers Stiftelse; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	Funding for this project came from the Swedish Research Council (VR), the Swedish Research Council for Environment, Agricultural Science and Spatial Planning (FORMAS, grant no. 2008-10), Carl Tryggers Stiftelse, and the Swedish Medical Research Council (grant no. 12628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1983, INFECT IMMUN, V42, P276, DOI 10.1128/IAI.42.1.276-284.1983; Broman T, 2004, J APPL MICROBIOL, V96, P834, DOI 10.1111/j.1365-2672.2004.02232.x; Broman T, 2002, J CLIN MICROBIOL, V40, P4594, DOI 10.1128/JCM.40.12.4594-4602.2002; Broman T, 2000, APPL ENVIRON MICROB, V66, P449, DOI 10.1128/AEM.66.1.449-452.2000; CABRITA J, 1992, J APPL BACTERIOL, V73, P279, DOI 10.1111/j.1365-2672.1992.tb04978.x; Cawthraw SA, 1996, EPIDEMIOL INFECT, V117, P213, DOI 10.1017/S0950268800001333; Colles FM, 2008, APPL ENVIRON MICROB, V74, P3583, DOI 10.1128/AEM.02491-07; Colles FM, 2009, ENVIRON MICROBIOL, V11, P258, DOI 10.1111/j.1462-2920.2008.01773.x; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Colles FM, 2008, ENVIRON MICROBIOL, V10, P2042, DOI 10.1111/j.1462-2920.2008.01623.x; Dingle KE, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P43; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; FRIEDMAN CR, 2000, CAMPYLOBACTER, V121, P138; Friis LM, 2005, J MICROBIOL METH, V61, P145, DOI 10.1016/j.mimet.2004.12.003; Grindstaff JL, 2006, P ROY SOC B-BIOL SCI, V273, P2551, DOI 10.1098/rspb.2006.3608; Hald B, 2004, EMERG INFECT DIS, V10, P1490, DOI 10.3201/eid1008.040129; HASSELQUIST D, 1985, RINGING MIGRATION, V6, P66; Hickey TE, 1999, INFECT IMMUN, V67, P88, DOI 10.1128/IAI.67.1.88-93.1999; Ilmonen P, 2000, P ROY SOC B-BIOL SCI, V267, P665, DOI 10.1098/rspb.2000.1053; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jones K, 2001, J APPL MICROBIOL, V90, p68S, DOI 10.1046/j.1365-2672.2001.01355.x; KAPPERUD G, 1983, APPL ENVIRON MICROB, V45, P375, DOI 10.1128/AEM.45.2.375-380.1983; Kinana AD, 2006, APPL ENVIRON MICROB, V72, P3309, DOI 10.1128/AEM.72.5.3309-3313.2006; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; Miller WG, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P101; Newell D. G., 2001, Society for Applied Microbiology Symposium Series, p57S; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; Petersen L, 2001, APPL ENVIRON MICROB, V67, P3115, DOI 10.1128/AEM.67.7.3115-3121.2001; ROSEF O, 1983, APPL ENVIRON MICROB, V45, P381, DOI 10.1128/AEM.45.2.381-383.1983; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; Strother KO, 2005, J MED ENTOMOL, V42, P42, DOI 10.1603/0022-2585(2005)042[0042:RCOLMC]2.0.CO;2; Waldenstrom J, 2002, APPL ENVIRON MICROB, V68, P5911, DOI 10.1128/AEM.68.12.5911-5917.2002; WHELAN CD, 1988, EPIDEMIOL INFECT, V101, P259, DOI 10.1017/S0950268800054170	37	36	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9082	10.1371/journal.pone.0009082	http://dx.doi.org/10.1371/journal.pone.0009082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140204	gold, Green Submitted, Green Published			2022-12-25	WOS:000274442400018
J	Leahy, SC; Kelly, WJ; Altermann, E; Ronimus, RS; Yeoman, CJ; Pacheco, DM; Li, D; Kong, ZH; McTavish, S; Sang, C; Lambie, SC; Janssen, PH; Dey, D; Attwood, GT				Leahy, Sinead C.; Kelly, William J.; Altermann, Eric; Ronimus, Ron S.; Yeoman, Carl J.; Pacheco, Diana M.; Li, Dong; Kong, Zhanhao; McTavish, Sharla; Sang, Carrie; Lambie, Suzanne C.; Janssen, Peter H.; Dey, Debjit; Attwood, Graeme T.			The Genome Sequence of the Rumen Methanogen Methanobrevibacter ruminantium Reveals New Possibilities for Controlling Ruminant Methane Emissions	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE; METHANOBACTERIUM-RUMINANTIUM; KYOTO ENCYCLOPEDIA; FATTY-ACIDS; DATABASE; GENES; ARCHAEA; IDENTIFICATION; PREDICTION; PROTEINS	Background: Methane (CH4) is a potent greenhouse gas (GHG), having a global warming potential 21 times that of carbon dioxide (CO2). Methane emissions from agriculture represent around 40% of the emissions produced by human-related activities, the single largest source being enteric fermentation, mainly in ruminant livestock. Technologies to reduce these emissions are lacking. Ruminant methane is formed by the action of methanogenic archaea typified by Methanobrevibacter ruminantium, which is present in ruminants fed a wide variety of diets worldwide. To gain more insight into the lifestyle of a rumen methanogen, and to identify genes and proteins that can be targeted to reduce methane production, we have sequenced the 2.93 Mb genome of M. ruminantium M1, the first rumen methanogen genome to be completed. Methodology/Principal Findings: The M1 genome was sequenced, annotated and subjected to comparative genomic and metabolic pathway analyses. Conserved and methanogen-specific gene sets suitable as targets for vaccine development or chemogenomic-based inhibition of rumen methanogens were identified. The feasibility of using a synthetic peptide-directed vaccinology approach to target epitopes of methanogen surface proteins was demonstrated. A prophage genome was described and its lytic enzyme, endoisopeptidase PeiR, was shown to lyse M1 cells in pure culture. A predicted stimulation of M1 growth by alcohols was demonstrated and microarray analyses indicated up-regulation of methanogenesis genes during co-culture with a hydrogen (H-2) producing rumen bacterium. We also report the discovery of non-ribosomal peptide synthetases in M. ruminantium M1, the first reported in archaeal species. Conclusions/Significance: The M1 genome sequence provides new insights into the lifestyle and cellular processes of this important rumen methanogen. It also defines vaccine and chemogenomic targets for broad inhibition of rumen methanogens and represents a significant contribution to worldwide efforts to mitigate ruminant methane emissions and reduce production of anthropogenic greenhouse gases.	[Leahy, Sinead C.; Kelly, William J.; Altermann, Eric; Ronimus, Ron S.; Yeoman, Carl J.; Pacheco, Diana M.; Li, Dong; Kong, Zhanhao; McTavish, Sharla; Sang, Carrie; Lambie, Suzanne C.; Janssen, Peter H.; Dey, Debjit; Attwood, Graeme T.] AgResearch Ltd, Grasslands Res Ctr, Food & Text Grp, Rumen Microbial Genom Food Metab & Microbiol Sect, Palmerston North, New Zealand	AgResearch - New Zealand	Leahy, SC (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Food & Text Grp, Rumen Microbial Genom Food Metab & Microbiol Sect, Palmerston North, New Zealand.	graeme.attwood@agresearch.co.nz	Chen, Tianren/AAS-6018-2021; Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Janssen, Peter/0000-0002-1022-3502; Attwood, Graeme Trevor/0000-0002-6443-8760; Leahy, Sinead/0000-0002-5461-6738; McTavish, Sharla/0000-0002-8794-4981; Sang, Carrie/0000-0003-4368-1558; Ronimus, Ron/0000-0001-8669-5840; Altermann, Eric/0000-0003-1376-1549	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Foundation for Research, Science and Technology (FRST) [METH0201, METH0701]	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Foundation for Research, Science and Technology (FRST)(New Zealand Foundation for Research, Science and Technology)	Authors acknowledge the financial support of the Pastoral Greenhouse Gas Research Consortium (PGgRc), an industry led partnership co-funded by the New Zealand Foundation for Research, Science and Technology (FRST), http://www.pggrc.co.nz/ (Grant No.s METH0201 A genomics approach to identify targets for methanogen inhibition; METH0201 Reducing ruminant methane emission: a consortium approach; METH0701 Pastoral Greenhouse Gas Research Consortium). All authors are current or past employees of AgResearch Limited (www.agresearch.co.nz), a New Zealand Crown Research Institute. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Authors required PGgRc approval to publish.	Abken HJ, 1998, J BACTERIOL, V180, P2027, DOI 10.1128/JB.180.8.2027-2032.1998; Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; ALTERMANN E, 2009, PHAGE PHI MRU POLYNU; Altermann Eric, 2003, OMICS A Journal of Integrative Biology, V7, P161, DOI 10.1089/153623103322246557; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amoutzias GD, 2008, FUTURE MICROBIOL, V3, P361, DOI 10.2217/17460913.3.3.361; Asanuma N, 2005, CURR MICROBIOL, V51, P91, DOI 10.1007/s00284-005-4477-x; Attwood GT, 2008, AUST J EXP AGR, V48, P83, DOI 10.1071/EA07269; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berk H, 1997, ARCH MICROBIOL, V168, P396, DOI 10.1007/s002030050514; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; BRYANT MP, 1971, ADV CHEM SER, P23; Bryant MP, 1965, PHYSL DIGESTION RUMI; Caron PR, 2001, CURR OPIN CHEM BIOL, V5, P464, DOI 10.1016/S1367-5931(00)00229-5; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GOLDBERG SM, P NATL ACAD SCI US, V103, P11240; Graham DE, 2002, J BIOL CHEM, V277, P13421, DOI 10.1074/jbc.M201011200; GRAHAM LL, 1994, J BACTERIOL, V176, P1413, DOI 10.1128/jb.176.5.1413-1421.1994; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; JARRELL KF, 1992, CAN J MICROBIOL, V38, P65, DOI 10.1139/m92-010; Jensen LJ, 1999, RES MICROBIOL, V150, P773, DOI 10.1016/S0923-2508(99)00116-3; JOBLIN KN, 1990, APPL ENVIRON MICROB, V56, P2287, DOI 10.1128/AEM.56.8.2287-2295.1990; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; KANDLER O, 1978, ARCH MICROBIOL, V118, P141, DOI 10.1007/BF00415722; Kandler O, 1998, CELL MOL LIFE SCI, V54, P305, DOI 10.1007/s000180050156; KANDLER O, BACTERIA, V8, P413; Klieve AV, 1999, AUST J AGR RES, V50, P1315, DOI 10.1071/AR99006; KONIG H, 1994, SYST APPL MICROBIOL, V16, P510; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leslie M, 2008, AUST J EXP AGR, V48, P1, DOI 10.1071/EA07306; Lienard T, 1996, EUR J BIOCHEM, V239, P857, DOI 10.1111/j.1432-1033.1996.0857u.x; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAKAROVA KS, 2007, BIOL DIRECT, V27, P2; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; McAllister TA, 2008, AUST J EXP AGR, V48, P7, DOI 10.1071/EA07218; MCINERNEY MJ, 1979, ARCH MICROBIOL, V122, P129, DOI 10.1007/BF00411351; MILLER TL, 2001, BERGEYS MANUAL SYSTE, V1, P218; *MIN ENV, 2007, NZ GREENH GAS INV 19; Moon CD, 2008, INT J SYST EVOL MICR, V58, P2041, DOI 10.1099/ijs.0.65845-0; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Podell S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r16; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reeve JN, 1997, J BACTERIOL, V179, P5975, DOI 10.1128/jb.179.19.5975-5986.1997; Reymond N, 2004, BIOINFORMATICS, V20, P271, DOI 10.1093/bioinformatics/btg401; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROBINSON IM, 1969, J BACTERIOL, V97, P1220, DOI 10.1128/JB.97.3.1220-1226.1969; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; SCHEEHLE EA, 2006, ENERGY J, V3, P33; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; SMITH PH, 1958, J BACTERIOL, V75, P713, DOI 10.1128/JB.75.6.713-718.1958; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Staden R, 2000, Methods Mol Biol, V132, P115; *STAT NZ, 2008, GLOB NZ INT TRAD INV; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Tokura M, 1999, J GEN APPL MICROBIOL, V45, P43, DOI 10.2323/jgam.45.43; TSCHECH A, 1984, ARCH MICROBIOL, V137, P163, DOI 10.1007/BF00414460; *UN, 1997, UNEPIUC9910; USA-Department of Agriculture, 2008, RIS FOOD PRIC INT FO; Vivona S, 2008, TRENDS BIOTECHNOL, V26, P190, DOI 10.1016/j.tibtech.2007.12.006; Volfovsky N., 2001, GENOME BIOL, V2, DOI [DOI 10.1186/GB-2001-2-8-RESEARCH0027, 10.1186/gb-2001-2-8-research0027]; WEDLOCK DN, 2009, NZ VET J IN PRESS; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804; Yurist-Doutsch S, 2008, MOL MICROBIOL, V68, P1079, DOI 10.1111/j.1365-2958.2008.06224.x; ZEIKUS JG, 1975, CAN J MICROBIOL, V21, P121, DOI 10.1139/m75-019	91	196	223	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8926	10.1371/journal.pone.0008926	http://dx.doi.org/10.1371/journal.pone.0008926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126622	Green Published, gold, Green Submitted			2022-12-25	WOS:000274138000005
J	Cainarca, S; Fenu, S; Ferri, C; Nucci, C; Arioli, P; Menegon, A; Piemonti, L; Lohmer, S; Wrabetz, L; Corazza, S				Cainarca, Silvia; Fenu, Simone; Ferri, Cinzia; Nucci, Cinzia; Arioli, Patrizia; Menegon, Andrea; Piemonti, Lorenzo; Lohmer, Stefan; Wrabetz, Lawrence; Corazza, Sabrina			A Photoprotein in Mouse Embryonic Stem Cells Measures Ca2+ Mobilization in Cells and in Animals	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; DIFFERENTIATION; EXPRESSION; AEQUORIN; PROLIFERATION; PHIALIDIN; INDICATOR; SEQUENCE	Exogenous expression of pharmacological targets in transformed cell lines has been the traditional platform for high throughput screening of small molecules. However, exogenous expression in these cells is limited by aberrant dosage, or its toxicity, the potential lack of interaction partners, and alterations to physiology due to transformation itself. Instead, primary cells or cells differentiated from precursors are more physiological, but less amenable to exogenous expression of reporter systems. To overcome this challenge, we stably expressed c-Photina, a Ca2+- sensitive photoprotein, driven by a ubiquitous promoter in a mouse embryonic stem (mES) cell line. The same embryonic stem cell line was also used to generate a transgenic mouse that expresses c-Photina in most tissues. We show here that these cells and mice provide an efficient source of primary cells, cells differentiated from mES cells, including cardiomyocytes, neurons, astrocytes, macrophages, endothelial cells, pancreatic islet cells, stably and robustly expressing c-Photina, and may be exploited for miniaturized high throughput screening. Moreover, we provide evidence that the transgenic mice may be suitable for ex-vivo bioimaging studies in both cells and tissues.	[Cainarca, Silvia; Fenu, Simone; Nucci, Cinzia; Arioli, Patrizia; Lohmer, Stefan; Corazza, Sabrina] Axxam SpA, Milan, Italy; [Ferri, Cinzia; Wrabetz, Lawrence] DIBIT, San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy; [Menegon, Andrea] Ist Sci San Raffaele, ALEMBIC, I-20132 Milan, Italy; [Piemonti, Lorenzo] Ist Sci San Raffaele, San Raffaele Diabet Res Inst HSR DRI, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Cainarca, S (corresponding author), Axxam SpA, Milan, Italy.	silvia.cainarca.sc@axxam.com	Piemonti, Lorenzo/P-7605-2017; Ferri, Cinzia/ABG-8426-2020; menegon, andrea/AAN-3736-2020	Piemonti, Lorenzo/0000-0002-2172-2198; Ferri, Cinzia/0000-0003-1800-4993; menegon, andrea/0000-0002-2396-756X; Cainarca, Silvia/0000-0002-4590-4420	Regione Lombardia (Italy); Telethon (Italy); National Institutes of Health; Axxam SpA	Regione Lombardia (Italy)(Regione Lombardia); Telethon (Italy)(Fondazione Telethon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Axxam SpA	This work was supported in part by a Metadistretti grant from Regione Lombardia (Italy) to Axxam and LW, and grants from Telethon (Italy) and the National Institutes of Health to LW. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was also supported by Axxam SpA, which paid for the employment of 6 (SC, SF, CN, PA, SL, SC) out of 10 authors.	Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; BLOEMERS SM, 1993, BIOCHEM BIOPH RES CO, V191, P118, DOI 10.1006/bbrc.1993.1192; Boheler KR, 2003, METHOD ENZYMOL, V365, P228; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Bovolenta S, 2007, J BIOMOL SCREEN, V12, P694, DOI 10.1177/1087057107301497; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; CAMPBELL AK, 1981, BIOLUMINESCENCE CHEM, P601; Chiesa A, 2001, BIOCHEM J, V355, P1, DOI 10.1042/0264-6021:3550001; DAVIES JQ, 2005, METH MOL BIOL BASIC, P91; DeGiorgi F, 1996, GENE, V173, P113, DOI 10.1016/0378-1119(95)00687-7; Fedirko N, 2006, J NEUROPHYSIOL, V96, P919, DOI 10.1152/jn.00258.2006; Fico A, 2008, STEM CELLS DEV, V17, P573, DOI 10.1089/scd.2007.0130; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heo JS, 2006, STEM CELLS, V24, P2637, DOI 10.1634/stemcells.2005-0588; INOUYE S, 1985, P NATL ACAD SCI USA, V82, P3154, DOI 10.1073/pnas.82.10.3154; Johnson F.H., 1978, Methods in Enzymology, V57, P271; Kendall JM, 1998, TRENDS BIOTECHNOL, V16, P216, DOI 10.1016/S0167-7799(98)01184-6; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; LEE K, 2008, NEUROSCI B, V24, P195; LEVINE LD, 1982, COMP BIOCHEM PHYS B, V72, P77, DOI 10.1016/0305-0491(82)90013-X; MATTHEAKIS LC, 2000, DRUG DISCOV TODAY S, V1, P18; McNeish J, 2004, NAT REV DRUG DISCOV, V3, P70, DOI 10.1038/nrd1281; Melzi R, 2008, CELL TRANSPLANT, V17, P1361, DOI 10.3727/096368908787648146; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Molina-Hernandez A, 2008, J NEUROCHEM, V106, P706, DOI 10.1111/j.1471-4159.2008.05424.x; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RINK TJ, 1990, FEBS LETT, V268, P381, DOI 10.1016/0014-5793(90)81290-5; Rizzuto R, 1999, CELL CALCIUM, V26, P193, DOI 10.1054/ceca.1999.0076; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Rogers KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000974; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Sambrook J, 2001, MOL CLONING LAB MANU; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SHIMOMURA O, 1985, BIOCHEM J, V228, P745, DOI 10.1042/bj2280745; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stewart MH, 2008, J MOL MED, V86, P875, DOI 10.1007/s00109-008-0356-9; Suh SH, 1999, PFLUG ARCH EUR J PHY, V438, P612, DOI 10.1007/s004240051084; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; WOBUS AM, 1984, EXP CELL RES, V152, P212, DOI 10.1016/0014-4827(84)90246-5; Yanagida E, 2004, CELL CALCIUM, V36, P135, DOI 10.1016/j.ceca.2004.01.022	44	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8882	10.1371/journal.pone.0008882	http://dx.doi.org/10.1371/journal.pone.0008882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111708	Green Submitted, gold, Green Published			2022-12-25	WOS:000274114800007
J	Ashktorab, H; Schaffer, AA; Daremipouran, M; Smoot, DT; Lee, E; Brim, H				Ashktorab, Hassan; Schaeffer, Alejandro A.; Daremipouran, Mohammad; Smoot, Duane T.; Lee, Edward; Brim, Hassan			Distinct Genetic Alterations in Colorectal Cancer	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; HUMAN BREAST; CHROMOSOMAL INSTABILITY; MLL3 MUTATIONS; CARCINOMA; ABNORMALITIES; EXPRESSION; SEQUENCES; ADENOMAS; PROFILES	Background: Colon cancer (CRC) development often includes chromosomal instability (CIN) leading to amplifications and deletions of large DNA segments. Epidemiological, clinical, and cytogenetic studies showed that there are considerable differences between CRC tumors from African Americans (AAs) and Caucasian patients. In this study, we determined genomic copy number aberrations in sporadic CRC tumors from AAs, in order to investigate possible explanations for the observed disparities. Methodology/Principal Findings: We applied genome-wide array comparative genome hybridization (aCGH) using a 105k chip to identify copy number aberrations in samples from 15 AAs. In addition, we did a population comparative analysis with aCGH data in Caucasians as well as with a widely publicized list of colon cancer genes (CAN genes). There was an average of 20 aberrations per patient with more amplifications than deletions. Analysis of DNA copy number of frequently altered chromosomes revealed that deletions occurred primarily in chromosomes 4, 8 and 18. Chromosomal duplications occurred in more than 50% of cases on chromosomes 7, 8, 13, 20 and X. The CIN profile showed some differences when compared to Caucasian alterations. Conclusions/Significance: Chromosome X amplification in male patients and chromosomes 4, 8 and 18 deletions were prominent aberrations in AAs. Some CAN genes were altered at high frequencies in AAs with EXOC4, EPHB6, GNAS, MLL3 and TBX22 as the most frequently deleted genes and HAPLN1, ADAM29, SMAD2 and SMAD4 as the most frequently amplified genes. The observed CIN may play a distinctive role in CRC in AAs.	[Ashktorab, Hassan] Howard Univ, Dept Med, Coll Med, Washington, DC 20059 USA; [Ashktorab, Hassan] Howard Univ, Ctr Canc, Coll Med, Washington, DC 20059 USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, DHHS, Bethesda, MD 20892 USA; [Daremipouran, Mohammad; Smoot, Duane T.; Lee, Edward; Brim, Hassan] Howard Univ, Coll Med, Dept Pathol, Washington, DC USA	Howard University; Howard University; National Institutes of Health (NIH) - USA; Howard University	Ashktorab, H (corresponding author), Howard Univ, Dept Med, Coll Med, Washington, DC 20059 USA.	hashktorab@howard.edu	Ashktorab, hassan/AAJ-2908-2020; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012		National Institutes of Health [CA102681]; NIH; NLM; Howard University; NATIONAL CANCER INSTITUTE [R01CA102681] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Howard University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by PHS grant from the National Institutes of Health CA102681, the Intramural Research Program of the NIH, NLM and GCRC award from Howard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Ahn CH, 2007, APMIS, V115, P859, DOI 10.1111/j.1600-0463.2007.apm_696.x; Andreou AM, 2007, AM J HUM GENET, V81, P700, DOI 10.1086/521033; Ashktorab H, 2005, INT J CANCER, V116, P914, DOI 10.1002/ijc.21062; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; BARDI G, 1995, GENE CHROMOSOME CANC, V12, P97, DOI 10.1002/gcc.2870120204; BOMME L, 1994, GENE CHROMOSOME CANC, V10, P190, DOI 10.1002/gcc.2870100307; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; CLARKE DC, 2009, MOL CELL BIOL; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Georgiades IB, 1999, ONCOGENE, V18, P7933, DOI 10.1038/sj.onc.1203368; Goel A, 2003, CANCER RES, V63, P1608; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; James MR, 2001, ENDOCRINOLOGY, V142, P1497, DOI 10.1210/en.142.4.1497; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Laramie JM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-46; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lehnerdt GF, 2008, LARYNGOSCOPE, V118, P2172, DOI 10.1097/MLG.0b013e318185793ds; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Markowitz S, 2000, J CLIN ONCOL, V18, p75S; Martinez-Gimeno M, 2003, INVEST OPHTH VIS SCI, V44, P2171, DOI 10.1167/iovs.02-0871; MULERIS M, 1995, GENE CHROMOSOME CANC, V14, P223, DOI 10.1002/gcc.2870140312; Naishiro Y, 2005, ONCOGENE, V24, P3141, DOI 10.1038/sj.onc.1208517; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shin SK, 2007, GASTROENTEROLOGY, V133, P1849, DOI 10.1053/j.gastro.2007.08.074; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tang RP, 2004, CARCINOGENESIS, V25, P841, DOI 10.1093/carcin/bgh074; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Unotoro J, 2006, J INT MED RES, V34, P397, DOI 10.1177/147323000603400409; Vakoc CR, 2009, CANCER GENET CYTOGEN, V189, P140, DOI 10.1016/j.cancergencyto.2008.10.014; Vik-Mo EO, 2003, NEUROSCIENCE, V119, P73, DOI 10.1016/S0306-4522(03)00065-4; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weizman N, 2003, J BIOL CHEM, V278, P6741, DOI 10.1074/jbc.M211168200; Wirrig EE, 2007, DEV BIOL, V310, P291, DOI 10.1016/j.ydbio.2007.07.041; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	45	87	89	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8879	10.1371/journal.pone.0008879	http://dx.doi.org/10.1371/journal.pone.0008879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126641	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500008
J	Meier, S; Ruzvidzo, O; Morse, M; Donaldson, L; Kwezi, L; Gehring, C				Meier, Stuart; Ruzvidzo, Oziniel; Morse, Monique; Donaldson, Lara; Kwezi, Lusisizwe; Gehring, Chris			The Arabidopsis Wall Associated Kinase-Like 10 Gene Encodes a Functional Guanylyl Cyclase and Is Co-Expressed with Pathogen Defense Related Genes	PLOS ONE			English	Article							WALL-ASSOCIATED KINASES; CELL-WALL; SALICYLIC-ACID; NITRIC-OXIDE; PROTEIN-KINASE; DISEASE RESISTANCE; RECEPTOR KINASE; TRIGGERED IMMUNITY; CHITIN ELICITOR; INNATE IMMUNITY	Background: Second messengers have a key role in linking environmental stimuli to physiological responses. One such messenger, guanosine 39,59-cyclic monophosphate (cGMP), has long been known to be an essential signaling molecule in many different physiological processes in higher plants, including biotic stress responses. To date, however, the guanylyl cyclase (GC) enzymes that catalyze the formation of cGMP from GTP have largely remained elusive in higher plants. Principal Findings: We have identified an Arabidopsis receptor type wall associated kinase-like molecule (AtWAKL10) as a candidate GC and provide experimental evidence to show that the intracellular domain of AtWAKL10431-700 can generate cGMP in vitro. Further, we also demonstrate that the molecule has kinase activity indicating that AtWAKL10 is a twin-domain catalytic protein. A co-expression and stimulus-specific expression analysis revealed that AtWAKL10 is consistently co-expressed with well characterized pathogen defense related genes and along with these genes is induced early and sharply in response to a range of pathogens and their elicitors. Conclusions: We demonstrate that AtWAKL10 is a twin-domain, kinase-GC signaling molecule that may function in biotic stress responses that are critically dependent on the second messenger cGMP.	[Meier, Stuart; Gehring, Chris] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Ruzvidzo, Oziniel; Morse, Monique; Donaldson, Lara; Kwezi, Lusisizwe; Gehring, Chris] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa	King Abdullah University of Science & Technology; University of the Western Cape	Meier, S (corresponding author), King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia.	christoph.gehring@KAUST.edu.sa		Donaldson, Lara/0000-0001-5727-3155; Gehring, Christoph/0000-0003-4355-4591	South African National Research Foundation	South African National Research Foundation(National Research Foundation - South Africa)	The project was supported by a grant from the South African National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BOWLER C, 1994, GENE DEV, V8, P2188, DOI 10.1101/gad.8.18.2188; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Clarke A, 2000, PLANT J, V24, P667, DOI 10.1046/j.1365-313x.2000.00911.x; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Decreux A, 2005, PLANT CELL PHYSIOL, V46, P268, DOI 10.1093/pcp/pci026; Decreux A, 2006, PHYTOCHEMISTRY, V67, P1068, DOI 10.1016/j.phytochem.2006.03.009; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Donaldson L, 2004, FEBS LETT, V569, P317, DOI 10.1016/j.febslet.2004.06.016; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Felle HH, 2004, MOL PLANT MICROBE IN, V17, P118, DOI 10.1094/MPMI.2004.17.1.118; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; He ZH, 1996, J BIOL CHEM, V271, P19789, DOI 10.1074/jbc.271.33.19789; He ZH, 1998, PLANT J, V14, P55, DOI 10.1046/j.1365-313X.1998.00092.x; He ZH, 1999, PLANT MOL BIOL, V39, P1189, DOI 10.1023/A:1006197318246; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hoefle C, 2008, CELL MICROBIOL, V10, P2400, DOI 10.1111/j.1462-5822.2008.01238.x; Hu XY, 2005, PLANT PHYSIOL, V137, P663, DOI 10.1104/pp.104.054494; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kankainen M, 2004, NUCLEIC ACIDS RES, V32, pW222, DOI 10.1093/nar/gkh463; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; KING EO, 1954, J LAB CLIN MED, V44, P301; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kohorn BD, 2001, CURR OPIN CELL BIOL, V13, P529, DOI 10.1016/S0955-0674(00)00247-7; KOSHIBA T, 1995, J MOL BIOL, V253, P396, DOI 10.1006/jmbi.1995.0562; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kwezi L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000449; Lally D, 2001, PLANT CELL, V13, P1317, DOI 10.1105/tpc.13.6.1317; Lecourieux D, 2002, PLANT CELL, V14, P2627, DOI 10.1105/tpc.005579; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Ludidi N, 2003, J BIOL CHEM, V278, P6490, DOI 10.1074/jbc.M210983200; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Manfield IW, 2006, NUCLEIC ACIDS RES, V34, pW504, DOI 10.1093/nar/gkl204; Meier Stuart, 2008, Biotechnology Journal, V3, P1375, DOI 10.1002/biot.200800142; Meier S, 2009, PLANT SIGNAL BEHAV, V4, P307, DOI 10.4161/psb.4.4.8066; Meier S, 2007, PLANT SIGNAL BEHAV, V2, P536, DOI 10.4161/psb.2.6.4788; Meier S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-24; Michel K, 2006, PLANT MOL BIOL, V62, P561, DOI 10.1007/s11103-006-9045-7; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mollet JC, 2000, PLANT CELL, V12, P1737, DOI 10.1105/tpc.12.9.1737; Murray SL, 2002, MOL PLANT MICROBE IN, V15, P557, DOI 10.1094/MPMI.2002.15.6.557; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Newton RP, 2004, PHYTOCHEMISTRY, V65, P2423, DOI 10.1016/j.phytochem.2004.07.026; Nishiuchi T, 2002, PLANT MOL BIOL, V49, P473, DOI 10.1023/A:1015553232309; Nuhse TS, 2003, J BIOL CHEM, V278, P45248, DOI 10.1074/jbc.M307443200; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Onate-Sanchez L, 2002, PLANT PHYSIOL, V128, P1313, DOI 10.1104/pp.010862; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Pasqualini S, 2009, NEW PHYTOL, V181, P860, DOI 10.1111/j.1469-8137.2008.02711.x; Penson SP, 1996, PLANT CELL, V8, P2325, DOI 10.1105/tpc.8.12.2325; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Peumans WJ, 2003, BIOCHEM J, V376, P717, DOI 10.1042/BJ20031069; Pharmawati M, 2001, PLANT PHYSIOL BIOCH, V39, P385, DOI 10.1016/S0981-9428(01)01252-9; Pilz RB, 2003, CIRC RES, V93, P1034, DOI 10.1161/01.RES.0000103311.52853.48; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Schuhegger R, 2007, J PLANT PHYSIOL, V164, P636, DOI 10.1016/j.jplph.2006.04.012; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; SHRIDHAR S, 2009, NUCL ACIDS RES; Shults MD, 2003, J AM CHEM SOC, V125, P14248, DOI 10.1021/ja0380502; Shults MD, 2006, ANAL BIOCHEM, V352, P198, DOI 10.1016/j.ab.2006.03.003; Sweetlove LJ, 2005, NEW PHYTOL, V168, P9, DOI 10.1111/j.1469-8137.2005.01513.x; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; THORPE DS, 1990, J BIOL CHEM, V265, P14717; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Tsutsui T, 2006, BIOSCI BIOTECH BIOCH, V70, P2042, DOI 10.1271/bbb.50700; Van Damme EJM, 2004, TRENDS PLANT SCI, V9, P484, DOI 10.1016/j.tplants.2004.08.003; Verica JA, 2003, PLANT PHYSIOL, V133, P1732, DOI 10.1104/pp.103.028530; Verica JA, 2002, PLANT PHYSIOL, V129, P455, DOI 10.1104/pp.011028; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004	104	92	97	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8904	10.1371/journal.pone.0008904	http://dx.doi.org/10.1371/journal.pone.0008904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126659	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896500023
J	Zohar, A; Dekel, N; Rubinsky, B; Parnas, H				Zohar, Assaf; Dekel, Noa; Rubinsky, Boris; Parnas, Hanna			New Mechanism for Voltage Induced Charge Movement Revealed in GPCRs - Theory and Experiments	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; SHAKER K+ CHANNELS; GATING-CURRENTS; POTASSIUM CHANNELS; XENOPUS-OOCYTES; IONIC LOCK; ACTIVATION; INACTIVATION; RHODOPSIN; RELEASE	Depolarization induced charge movement associated currents, analogous to gating currents in channels, were recently demonstrated in G-protein coupled receptors (GPCRs), and were found to affect the receptor's Agonist binding Affinity, hence denoted AA-currents. Here we study, employing a combined theoretical-experimental approach, the properties of the AA-currents using the m2-muscarinic receptor (m2R) as a case study. We found that the AA-currents are characterized by a "bump'', a distinct rise followed by a slow decline, which appears both in the On and the Off responses. The cumulative features implied a directional behavior of the AA-currents. This forced us to abandon the classical chemical reaction type of models and develop instead a model that includes anisotropic processes, thus producing directionality. This model fitted well the experimental data. Our main findings are that the AA-currents include two components. One is extremely fast, similar to 0.2ms, at all voltages. The other is slow, 2-3ms at all voltages. Surprisingly, the slow component includes a process which strongly depends on voltage and can be as fast as 0.3ms at + 40mV. The reason that it does not affect the overall time constant of the slow component is that it carries very little charge. The two fast processes are suitable candidates to link between charge movement and agonist binding affinity under physiological conditions.	[Zohar, Assaf; Dekel, Noa; Parnas, Hanna] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel; [Rubinsky, Boris] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Ctr Bioengn, Serv Humanity & Soc, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Zohar, A (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel.	hannap@savion.huji.ac.il	Rubinsky, Boris/B-4439-2010	Rubinsky, Boris/0000-0002-2794-1543	Hebrew University of Jerusalem, Israel	Hebrew University of Jerusalem, Israel	This work was not supported by any grant. The experiments were performed and supported by the resources of the Hebrew University of Jerusalem, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; BEZANILLA F, 1982, ABNORMAL NERVES MUSC, P62; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; Friedman MH, 1986, PRINCIPLES MODELS BI, P74; KOWDLEY GC, 1994, J GEN PHYSIOL, V103, P217, DOI 10.1085/jgp.103.2.217; Kupchik YM, 2008, P NATL ACAD SCI USA, V105, P4435, DOI 10.1073/pnas.0708540105; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; LU L, 1990, BIOPHYS J, V57, P1117, DOI 10.1016/S0006-3495(90)82632-1; Ohana L, 2006, J BIOL CHEM, V281, P24204, DOI 10.1074/jbc.M513447200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parnas H, 2005, J NEUROPHYSIOL, V93, P3257, DOI 10.1152/jn.01131.2004; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Sigg D, 2003, BIOPHYS J, V84, P3703, DOI 10.1016/S0006-3495(03)75099-1; SPIRES S, 1989, J GEN PHYSIOL, V93, P263, DOI 10.1085/jgp.93.2.263; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8752	10.1371/journal.pone.0008752	http://dx.doi.org/10.1371/journal.pone.0008752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107506	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896100002
J	Leibowitch, J; Mathez, D; de Truchis, P; Perronne, C; Melchior, JC				Leibowitch, Jacques; Mathez, Dominique; de Truchis, Pierre; Perronne, Christian; Melchior, Jean-Claude			Short cycles of antiretroviral drugs provide intermittent yet effective therapy: a pilot study in 48 patients with chronic HIV infection	FASEB JOURNAL			English	Article						intermittent HIV treatment; HIV genotype; cost of treatment; observance; antiviral regimen	STRUCTURED TREATMENT INTERRUPTION; ADHERENCE; PROTEASE; RNA; TOXICITY; REGIMEN; TRIAL	The present study evaluated the efficacy of intermittent antiviral treatment administered to HIV-infected patients under stepwise reductions in weekly medication. Forty-eight patients were invited to reduce their antiviral medication to 5 consecutive days per week; after control over HIV activity was ascertained, antiviral drugs were cut to 4 consecutive days per week. Of the 48, 39 then reduced medicines further to 3 d, and 12 of those eventually undertook a 2 d/wk schedule. Clinical and immunological status and plasma HIV load were repeatedly monitored. HIV was unremittingly maintained below detection levels in all patients under either 5- or 4-d/wk treatment regimens, for a mean 56 +/- 40 wk/patient (5-d regimen) and 84 +/- 46 wk/patient (4-d regimen). Of the 39 patients under 3-d regimens, 35 maintained optimal control over HIV activity for a mean 50 +/- 32 wk, as did 10 of the 12 under 2-d regimens, for 24 +/- 10.5 wk. Summing up treatment <= 5 d/wk, plasma HIV remained below detection levels for a cumulative 8895 wk (170 patient-yr). No major HIV-related clinical event was reported. and CD4(+) T-cell counts and percentages readily increased over the last value noted under the 7-d treatment course. Viral failure was documented in 6 of the 48 patients: 4 under a 3-d/wk regimen, 2 under a 2-d/wk regimen. All 6 patients had their treatment swiftly set back to a 7-d/wk regimen, resulting in rapid control over HIV replication. In summary, intermittent antiretroviral regimens optimally suppressed HIV in patients taking antiviral medicines 5 and 4 d/wk, as well as in a substantial proportion of patients under 3- or 2-d/wk antiviral regimens, reducing both expenses and, possibly, drug toxicity. Controlled prospective clinical trials are warranted before considering short weekly cycles of antiretroviral medicines an alternative in the management of chronically HIV-infected patients.-Leibowitch, J., Mathez, D., de Truchis, P., Perronne, C., Melchior, J. C. Short cycles of antiretroviral drugs provide intermittent yet effective therapy: a pilot study in 48 patients with chronic HIV infection. FASEB J. 24, 1649-1655 (2010). www.fasebj.org	[Leibowitch, Jacques; Mathez, Dominique] Hop Raymond Poincare, AP HP, Immunol & Virol Unit, F-92380 Garches, France; [de Truchis, Pierre; Perronne, Christian] Hop Raymond Poincare, AP HP, Clin Infect Dis Unit, F-92380 Garches, France; [Melchior, Jean-Claude] Hop Raymond Poincare, AP HP, Dept Internal Med & Infect Dis, Clin Nutr & Infect Dis Unit, F-92380 Garches, France; [Leibowitch, Jacques; Perronne, Christian; Melchior, Jean-Claude] Univ & Med Sch, Versailles, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Leibowitch, J (corresponding author), Hop Raymond Poincare, AP HP, Immunol & Virol Unit, 104 Bd Raymond Poincare, F-92380 Garches, France.	jacques.leibowitch@rpc.aphp.fr						Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; Ananworanich J, 2003, CLIN INFECT DIS, V37, P723, DOI 10.1086/376989; Ananworanich J, 2008, J ANTIMICROB CHEMOTH, V61, P1340, DOI 10.1093/jac/dkn097; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Cardiello PG, 2005, CLIN INFECT DIS, V40, P594, DOI 10.1086/427695; Cohen CJ, 2007, HIV CLIN TRIALS, V8, P19, DOI 10.1310/hct0801-19; Dybul M, 2004, J INFECT DIS, V189, P1974, DOI 10.1086/386344; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Ferry JA, 2009, MODERN PATHOL, V22, P618, DOI 10.1038/modpathol.2009.36; Fischer M, 2004, J INFECT DIS, V190, P1979, DOI 10.1086/425983; Fischer M, 2003, AIDS, V17, P195, DOI 10.1097/00002030-200301240-00009; Hirschel B, 2009, AIDS, V23, P757, DOI 10.1097/QAD.0b013e328321b791; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Magalhaes MG, 2007, J AM DENT ASSOC, V138, P1468, DOI 10.14219/jada.archive.2007.0083; Marsden MD, 2009, J ANTIMICROB CHEMOTH, V63, P7, DOI 10.1093/jac/dkn455; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Strenger V, 2009, CLIN INFECT DIS, V48, P91, DOI 10.1086/595004; Vergis EN, 2001, INT J STD AIDS, V12, P463, DOI 10.1258/0956462011923507; 2009, TREATMENTUPDATE, V21, P7	23	8	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1649	1655		10.1096/fj.09-148676	http://dx.doi.org/10.1096/fj.09-148676			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20103716				2022-12-25	WOS:000278200000003
J	Smith, MA; Mack, V; Ebneth, A; Moraes, I; Felicetti, B; Wood, M; Schonfeld, D; Mather, O; Cesura, A; Barker, J				Smith, Myron A.; Mack, Volker; Ebneth, Andreas; Moraes, Isabel; Felicetti, Brunella; Wood, Michael; Schonfeld, Dorian; Mather, Owen; Cesura, Andrea; Barker, John			The Structure of Mammalian Serine Racemase EVIDENCE FOR CONFORMATIONAL CHANGES UPON INHIBITOR BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; NMDA-RECEPTORS; GLYCINE; BRAIN; ACTIVATION; DEHYDRATASE; COMPLEX; PROTEIN	Serine racemase is responsible for the synthesis of D-serine, an endogenous co-agonist for N-methyl-D-aspartate receptor-type glutamate receptors (NMDARs). This pyridoxal 5'-phosphate-dependent enzyme is involved both in the reversible conversion of L- to D-serine and serine catabolism by alpha,beta-elimination of water, thereby regulating D-serine levels. Because D-serine affects NMDAR signaling throughout the brain, serine racemase is a promising target for the treatment of disorders related to NMDAR dysfunction. To provide a molecular basis for rational drug design the x-ray crystal structures of human and rat serine racemase were determined at 1.5- and 2.1-angstrom resolution, respectively, and in the presence and absence of the orthosteric inhibitor malonate. The structures revealed a fold typical of beta-family pyridoxal 5'-phosphate enzymes, with both a large domain and a flexible small domain associated into a symmetric dimer, and indicated a ligand-induced rearrangement of the small domain that organizes the active site for specific turnover of the substrate.	[Smith, Myron A.; Mack, Volker; Ebneth, Andreas; Moraes, Isabel; Felicetti, Brunella; Wood, Michael; Schonfeld, Dorian; Mather, Owen; Cesura, Andrea; Barker, John] Evotec, Dept Struct Biol & Biol, Abingdon OX14 4SA, Oxon, England	Evotec	Smith, MA (corresponding author), Evotec, Dept Struct Biol & Biol, 114 Milton Pk, Abingdon OX14 4SA, Oxon, England.	myron.smith@evotec.com	Moraes, Isabel/AAK-7872-2021	Moraes, Isabel/0000-0002-7427-5467				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Brown DG, 2006, CURR TOP MED CHEM, V6, P749, DOI 10.2174/156802606777057571; Chaffey H, 2008, CURR ANAESTHES CRIT, V19, P183, DOI [DOI 10.1016/J.CACC.2008.05.004, DOI 10.1016/j.cacc.2008.05.004]; Chen HJ, 2009, STRUCTURE, V17, P517, DOI 10.1016/j.str.2009.02.013; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; DeLano W.L., 2003, PYMOL REFERENCE MANU; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; Goto M, 2009, J BIOL CHEM, V284, P25944, DOI 10.1074/jbc.M109.010470; Hoffman HE, 2009, PROTEIN EXPRES PURIF, V63, P62, DOI 10.1016/j.pep.2008.09.003; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; MATSUI T, 1995, J NEUROCHEM, V65, P454; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGATA Y, 1992, EXPERIENTIA, V48, P753, DOI 10.1007/BF02124295; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schell MJ, 1997, J NEUROSCI, V17, P1604; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Strisovsky K, 2005, BIOCHEMISTRY-US, V44, P13091, DOI 10.1021/bi051201o; Sun L, 2005, PROTEIN SCI, V14, P791, DOI 10.1110/ps.041179105; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yoshimura T, 2008, FEBS J, V275, P3527, DOI 10.1111/j.1742-4658.2008.06516.x	35	68	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12873	12881		10.1074/jbc.M109.050062	http://dx.doi.org/10.1074/jbc.M109.050062			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20106978	hybrid, Green Published			2022-12-25	WOS:000276787800045
J	Filosto, S; Fry, W; Knowlton, AA; Goldkorn, T				Filosto, Simone; Fry, William; Knowlton, Anne A.; Goldkorn, Tzipora			Neutral Sphingomyelinase 2 (nSMase2) Is a Phosphoprotein Regulated by Calcineurin (PP2B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG EPITHELIAL-CELLS; KINASE-C-DELTA; NECROSIS-FACTOR-ALPHA; ACID SPHINGOMYELINASE; CIGARETTE-SMOKE; CYCLOSPORINE-A; UP-REGULATION; P38 MAPK; MEDIATED PHOSPHORYLATION	We previously reported that exposure of human airway epithelial cells to oxidative stress increased ceramide generation via specific activation of neutral sphingomyelinase2 (nSMase2). Here we show that nSMase2 is a phosphoprotein exclusively phosphorylated at serine residues. The level of nSMase2 phosphorylation can be modulated by treatment with anisomycin or phorbol 12-myristate 13-acetate (PMA/12-O-tetradecanoylphorbol-13-acetate), suggesting that p38 mitogen-activated protein kinase (MAPK) and protein kinases Cs are upstream of nSMase2 phosphorylation. Oxidative stress enhances both the activity and phosphorylation of nSMase2. Strikingly, we show here that nSMase2 is bound directly by the phosphatase calcineurin (CaN), which acts as an on/off switch for nSMase2 phosphorylation in the presence or absence of oxidative stress. Specifically, CaN is being inhibited/degraded and therefore does not bind nSMase2 under oxidative stress, and a mutant nSMase2 that lacks the CaN binding site exhibits constitutively elevated phosphorylation and increased activity relative to wild type nSMase2. Importantly, the phosphorylation and activity of the mutant no longer responds to oxidative stress, confirming that CaN is the critical link that allows oxidative stress to modulate nSMase2 phosphorylation and function.	[Filosto, Simone; Fry, William; Knowlton, Anne A.; Goldkorn, Tzipora] Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis	Goldkorn, T (corresponding author), Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Dept Internal Med, Rm 6321,451 E Hlth Sci Dr, Davis, CA 95616 USA.	ttgoldkorn@ucdavis.edu		Filosto, Simone/0000-0002-7854-998X	National Institutes of Health [HL-71871, HL-66189]; Tobacco-related Disease Research Program [17RT-0131]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071871, R01HL066189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-71871 and HL-66189 (to T. G.) and Tobacco-related Disease Research Program Grant 17RT-0131 (to T. G.).	Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Bezombes C, 1998, FASEB J, V12, P101, DOI 10.1096/fasebj.12.1.101; Bogumil R, 2000, EUR J BIOCHEM, V267, P1407, DOI 10.1046/j.1432-1327.2000.01133.x; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Castillo SS, 2007, EXP CELL RES, V313, P2680, DOI 10.1016/j.yexcr.2007.04.002; Castillo SS, 2007, EXP CELL RES, V313, P816, DOI 10.1016/j.yexcr.2006.12.001; Chan C, 2000, AM J RESP CELL MOL, V22, P460, DOI 10.1165/ajrcmb.22.4.3376; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Dave V, 2004, J BIOL CHEM, V279, P34578, DOI 10.1074/jbc.M404296200; Eckstein LA, 2005, INVEST OPHTH VIS SCI, V46, P782, DOI 10.1167/iovs.04-1022; Elias JA, 2005, NAT MED, V11, P471, DOI 10.1038/nm0505-471; Elias Jack A, 2006, Proc Am Thorac Soc, V3, P494, DOI 10.1513/pats.200603-068MS; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Goldkorn T, 2005, ANTIOXID REDOX SIGN, V7, P119, DOI 10.1089/ars.2005.7.119; Goldkorn T, 1998, J CELL SCI, V111, P3209; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; Hamai H, 2009, J LIPID RES, V50, P1101, DOI 10.1194/jlr.M800427-JLR200; Hardin SC, 1998, BIOTECHNIQUES, V24, P344, DOI 10.2144/98243bm01; Heit I, 2001, ONCOGENE, V20, P5143, DOI 10.1038/sj.onc.1204657; Henson PM, 2008, AM J PHYSIOL-LUNG C, V294, pL601, DOI 10.1152/ajplung.00320.2007; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P713, DOI 10.1513/pats.200605-104SF; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Ikeda T, 2009, IUBMB LIFE, V61, P644, DOI 10.1002/iub.193; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Jung JY, 2008, ARCH ORAL BIOL, V53, P1042, DOI 10.1016/j.archoralbio.2008.03.008; Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Lavrentiadou SN, 2001, AM J RESP CELL MOL, V25, P676, DOI 10.1165/ajrcmb.25.6.4321; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Lee JE, 2007, J NEUROCHEM, V100, P1703, DOI 10.1111/j.1471-4159.2006.04340.x; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Magnasco A, 2008, CURR CLIN PHARMACOL, V3, P166, DOI 10.2174/157488408785747674; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Melgert BN, 2007, CLIN EXP ALLERGY, V37, P1798, DOI 10.1111/j.1365-2222.2007.02843.x; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Park JS, 2007, TISSUE ENG REGEN MED, V4, P347; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Rahman I, 2005, MUTAT RES-FUND MOL M, V579, P58, DOI 10.1016/j.mrfmmm.2005.02.025; Rahman Irfan, 2008, Ther Adv Respir Dis, V2, P351, DOI 10.1177/1753465808098224; Ravid T, 2003, AM J PHYSIOL-LUNG C, V284, pL1082, DOI 10.1152/ajplung.00172.2002; Rennard Stephen I, 2006, Proc Am Thorac Soc, V3, P703, DOI 10.1513/pats.200605-121SF; ROBINSON CB, 1991, J TISSUE CULTURE MET, V13, P95; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Spurzem JR, 2005, SEMIN RESP CRIT CARE, V26, P142, DOI 10.1055/s-2005-869535; Szijgyarto Z, 2007, INT J MOL MED, V20, P359; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Xiong W, 2006, BRAIN RES, V1085, P68, DOI 10.1016/j.brainres.2006.02.015; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zimmerman GA, 2004, TRENDS MOL MED, V10, P245, DOI 10.1016/j.molmed.2004.03.009	67	45	47	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10213	10222		10.1074/jbc.M109.069963	http://dx.doi.org/10.1074/jbc.M109.069963			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20106976	Green Published, hybrid			2022-12-25	WOS:000276264600005
J	Pewzner-Jung, Y; Brenner, O; Braun, S; Laviad, EL; Ben-Dor, S; Feldmesser, E; Horn-Saban, S; Amann-Zalcenstein, D; Raanan, C; Berkutzki, T; Erez-Roman, R; Ben-David, O; Levy, M; Holzman, D; Park, H; Nyska, A; Merrill, AH; Futerman, AH				Pewzner-Jung, Yael; Brenner, Ori; Braun, Svantje; Laviad, Elad L.; Ben-Dor, Shifra; Feldmesser, Ester; Horn-Saban, Shirley; Amann-Zalcenstein, Daniela; Raanan, Calanit; Berkutzki, Tamara; Erez-Roman, Racheli; Ben-David, Oshrit; Levy, Michal; Holzman, Dorin; Park, Hyejung; Nyska, Abraham; Merrill, Alfred H., Jr.; Futerman, Anthony H.			A Critical Role for Ceramide Synthase 2 in Liver Homeostasis II. INSIGHTS INTO MOLECULAR CHANGES LEADING TO HEPATOPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGEVITY ASSURANCE GENE-1; FUMONISIN B-1; HUMAN HEAD; EXPRESSION; INHIBITOR; APOPTOSIS; TOXICITY; SPHINGOLIPIDS; ACCUMULATION; SENSITIVITY	We have generated a mouse that cannot synthesize very long acyl chain (C22-C24) ceramides (Pewzner-Jung, Y., Park, H., Laviad, E. L., Silva, L. C., Lahiri, S., Stiban, J., Erez-Roman, R., Brugger, B., Sachsenheimer, T., Wieland, F. T., Prieto, M., Merrill, A. H., and Futerman, A. H. (2010) J. Biol. Chem. 285, 10902-10910) due to ablation of ceramide synthase 2 (CerS2). As a result, significant changes were observed in the sphingolipid profile of livers from these mice, including elevated C16-ceramide and sphinganine levels. We now examine the functional consequences of these changes. CerS2 null mice develop severe nonzonal hepatopathy from about 30 days of age, the age at which CerS2 expression peaks in wild type mice, and display increased rates of hepatocyte apoptosis and proliferation. In older mice there is extensive and pronounced hepatocellular anisocytosis with widespread formation of nodules of regenerative hepatocellular hyperplasia. Progressive hepatomegaly and noninvasive hepatocellular carcinoma are also seen from similar to 10 months of age. Even though CerS2 is found at equally high mRNA levels in kidney and liver, there are no changes in renal function and no pathological changes in the kidney. High throughput analysis of RNA expression in liver revealed up-regulation of genes associated with cell cycle regulation, protein transport, cell-cell interactions and apoptosis, and down-regulation of genes associated with intermediary metabolism, such as lipid and steroid metabolism, adipocyte signaling, and amino acid metabolism. In addition, levels of the cell cycle regulator, the cyclin dependent-kinase inhibitor p21(WAF1/CIP1), were highly elevated, which occurs by at least two mechanisms, one of which may involve p53. We propose a functional rationale for the synthesis of sphingolipids with very long acyl chains in liver homeostasis and in cell physiology.	[Pewzner-Jung, Yael; Braun, Svantje; Laviad, Elad L.; Erez-Roman, Racheli; Ben-David, Oshrit; Levy, Michal; Holzman, Dorin; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Brenner, Ori; Raanan, Calanit; Berkutzki, Tamara] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Ben-Dor, Shifra; Feldmesser, Ester; Horn-Saban, Shirley; Amann-Zalcenstein, Daniela] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Nyska, Abraham] Tel Aviv Univ, Timrat & Sackler Sch Med, IL-69978 Ramat Aviv, Israel; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	BEN-DOR, SHIFRA/M-6718-2019; Pewzner, Faivish/I-6225-2017	BEN-DOR, SHIFRA/0000-0001-9604-1939; Pewzner, Faivish/0000-0002-7490-8121; Merrill, Alfred/0000-0002-6673-968X; Stiban, Johnny/0000-0002-3748-9976; Futerman, Anthony/0000-0003-0013-0115	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by Israel Science Foundation Grant 1404/07 and by The Minerva Foundation.	Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; Amacher DE, 1998, FOOD CHEM TOXICOL, V36, P831, DOI 10.1016/S0278-6915(98)00066-0; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bannasch P, 2003, TOXICOL PATHOL, V31, P566, DOI 10.1080/01926230390224700; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bondy GS, 1997, FOOD CHEM TOXICOL, V35, P981, DOI 10.1016/S0278-6915(97)87267-5; Ciacci-Zanella JR, 1998, FOOD CHEM TOXICOL, V36, P791, DOI 10.1016/S0278-6915(98)00034-9; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DESCHL U, 2001, INT CLASSIFICATION R; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dragan YP, 2001, TOXICOL SCI, V61, P6, DOI 10.1093/toxsci/61.1.6; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Goodman DG., 1994, GUIDES TOXICOLOGIC P; GREAVES P, 2000, HISTOPATHOLOGY PRECL, P448; Hailey JR, 2005, TOXICOL PATHOL, V33, P165, DOI 10.1080/01926230590888324; HARADA T, 1999, PATHOLOGY MOUSE; HARADA T, 1999, LIVER GALLBLADDER; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HOWARD PC, 2001, TOXICOLOGY CARCINOGE; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Merrill AH, 1996, TRENDS CELL BIOL, V6, P218, DOI 10.1016/0962-8924(96)10021-0; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Riley RT, 2006, TOXICOL SCI, V92, P335, DOI 10.1093/toxsci/kfj198; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Sonnino S, 2009, GLYCOCONJUGATE J, V26, P615, DOI 10.1007/s10719-008-9215-8; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; SULLARDS MC, 2001, SCI STKE, V86; Tennant B.C., 1999, CLIN CHEM LAB ANIMAL; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Voss KA, 2001, ENVIRON HEALTH PERSP, V109, P259, DOI 10.2307/3435017; Walker T, 2009, MOL PHARMACOL, V76, P342, DOI 10.1124/mol.109.056523; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; [No title captured]	62	169	170	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10911	10923		10.1074/jbc.M109.077610	http://dx.doi.org/10.1074/jbc.M109.077610			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110366	Green Published, hybrid			2022-12-25	WOS:000276264600076
J	Yu, WF; Kong, TQ; Beaudry, S; Tran, M; Negoro, H; Yanamadala, V; Denker, BM				Yu, Wanfeng; Kong, Tianqing; Beaudry, Sarah; Tran, Mei; Negoro, Hideyuki; Yanamadala, Vijay; Denker, Bradley M.			Polycystin-1 Protein Level Determines Activity of the G alpha(12)/JNK Apoptosis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; EPITHELIAL-CELLS; ALPHA-SUBUNITS; E-CADHERIN; PKD1; PROLIFERATION; ACTIVATION; RESISTANCE; MIGRATION; JUNCTION	Mutations in PKD1 are the most common cause of autosomal dominant polycystic kidney disease (ADPKD). The protein product of PKD1 (polycystin-1 (PC1)) is a large transmembrane protein with a short intracellular C terminus that interacts with numerous signaling molecules, including G alpha(12). Cyst formation in ADPKD results from numerous cellular defects, including abnormal cilia, changes in polarity, and dysregulated apoptosis and proliferation. Recently, we reported increased apoptosis in Madin-Darby canine kidney (MDCK) cells through G alpha(12) stimulation of JNK and degradation of the anti-apoptotic protein Bcl-2 (Yanamadala, V., Negoro, H., Gunaratnam, L., Kong, T., and Denker, B. M. (2007) J. Biol. Chem. 282, 24352-24363). Herein, we confirm this pathway in G alpha(12)-silenced MDCK cells and utilize MDCK cell lines harboring either overexpressed or silenced PC1 to demonstrate that PC1 expression levels determine activity of the JNK/Bcl-2 apoptosis pathway. PC1-overexpressing MDCK cells were resistant to thrombin/alpha(12)-stimulated apoptosis, JNK activation, and Bcl-2 degradation. In contrast, PC1-silenced MDCK cells displayed enhanced thrombin-induced apoptosis, JNK activity, and Bcl-2 degradation. In pulldown experiments, PC1 bound to G alpha(12), but not the related G alpha(13) subunit, and thrombin-stimulated MDCK cells led to increased interaction of G alpha(12) with the PC1 C terminus. In transient transfection assays, a PC1 C-terminal mutant lacking the G protein-binding domain was uncoupled from PC1-inhibited apoptosis. PC1 expression levels may be increased or decreased in ADPKD, and these findings suggest a mechanism in which levels of PC1 expression modulate G alpha(12)/JNK-stimulated apoptosis. Taken together, these findings are consistent with a set point model in which PC1 expression levels regulate specific G protein signaling pathways important to cyst development.	[Yu, Wanfeng; Kong, Tianqing; Beaudry, Sarah; Tran, Mei; Negoro, Hideyuki; Yanamadala, Vijay; Denker, Bradley M.] Brigham & Womens Hosp, Harvard Inst Med, Div Renal, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Denker, BM (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Div Renal, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	bdenker@rics.bwh.harvard.edu	yu, wanfeng/G-2915-2013		National Institutes of Health [P50 DK074030, GM55223]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK074030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055223, R29GM055223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 DK074030 (Polycystic Kidney Center; Project 1) and GM55223 (to B. M. D.).	Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T; Basavanna U, 2007, BIOCHEM BIOPH RES CO, V359, P367, DOI 10.1016/j.bbrc.2007.05.114; Battini L, 2006, J AM SOC NEPHROL, V17, P3049, DOI 10.1681/ASN.2006030234; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; Boca M, 2006, J AM SOC NEPHROL, V17, P637, DOI 10.1681/ASN.2005050534; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; DENKER BM, 1995, BIOCHEMISTRY-US, V34, P5544, DOI 10.1021/bi00016a028; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kim E, 1999, P NATL ACAD SCI USA, V96, P6371, DOI 10.1073/pnas.96.11.6371; Kong TQ, 2009, MOL BIOL CELL, V20, P4596, DOI 10.1091/mbc.E09-03-0220; Landry Y, 2006, CURR MED CHEM, V13, P51, DOI 10.2174/092986706775197953; Lanoix J, 1996, ONCOGENE, V13, P1153; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Meyer TN, 2003, AM J PHYSIOL-CELL PH, V285, pC1281, DOI 10.1152/ajpcell.00548.2002; Meyer TN, 2002, J BIOL CHEM, V277, P24855, DOI 10.1074/jbc.C200240200; NEER EJ, 1994, PROTEIN SCI, V3, P3; Nishio S, 2005, J CLIN INVEST, V115, P910, DOI 10.1172/JCI200522850; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; QUICK MW, 1994, J BIOL CHEM, V269, P30164; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; Streets AJ, 2009, J CELL SCI, V122, P1410, DOI 10.1242/jcs.045021; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Yanamadala V, 2007, J BIOL CHEM, V282, P24352, DOI 10.1074/jbc.M702804200; Yanamadala V, 2009, CURR MOL MED, V9, P527, DOI 10.2174/156652409788488784; Yuasa T, 2004, GENOMICS, V84, P126, DOI 10.1016/j.ygeno.2004.02.008; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	35	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10243	10251		10.1074/jbc.M109.070821	http://dx.doi.org/10.1074/jbc.M109.070821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20106977	Green Published, hybrid			2022-12-25	WOS:000276264600008
J	Sarrabayrouse, G; Pich, C; Moriez, R; Armand-Labit, V; Rochaix, P; Favre, G; Tilkin-Mariame, AF				Sarrabayrouse, Guillaume; Pich, Christine; Moriez, Raphael; Armand-Labit, Virginie; Rochaix, Philippe; Favre, Gilles; Tilkin-Mariame, Anne-Francoise			Melanoma Cells Treated with GGTI and IFN-gamma Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells	PLOS ONE			English	Article							GERANYLGERANYLTRANSFERASE-I; ANTITUMOR IMMUNITY; TUMOR-CELLS; EXPRESSION; CANCER; PEPTIDE; INHIBITION; IMMUNOTHERAPY; LYMPHOCYTES; INDUCTION	Background: Suboptimal activation of T lymphocytes by melanoma cells is often due to the defective expression of class I major histocompatibility antigens (MHC-I) and costimulatory molecules. We have previously shown that geranylgeranyl transferase inhibition (done with GGTI-298) stimulates anti-melanoma immune response through MHC-I and costimulatory molecule expression in the B16F10 murine model [1]. Methodology/Principal Findings: In this study, it is shown that vaccination with mIFN-gamma and GGTI-298 pretreated B16F10 cells induces a protection against untreated tumor growth and pulmonary metastases implantation. Furthermore, using a human melanoma model (LB1319-MEL), we demonstrated that in vitro treatment with hIFN-gamma and GGTI-298 led to the up regulation of MHC-I and a costimulatory molecule CD86 and down regulation of an inhibitory molecule PD-1L. Co-culture experiments with peripheral blood mononuclear cells (PBMC) revealed that modifications induced by hIFN-gamma and GGTI-298 on the selected melanoma cells, enables the stimulation of lymphocytes from HLA compatible healthy donors. Indeed, as compared with untreated melanoma cells, pretreatment with hIFN-gamma and GGTI-298 together rendered the melanoma cells more efficient at inducing the: i) activation of CD8 T lymphocytes (CD8+/CD69+); ii) proliferation of tumor-specific CD8 T cells (MelanA-MART1/TCR+); iii) secretion of hIFN-gamma; and iv) anti-melanoma specific cytotoxic cells. Conclusions/Significance: These data indicate that pharmacological treatment of melanoma cell lines with IFN-gamma and GGTI-298 stimulates their immunogenicity and could be a novel approach to produce tumor cells suitable for vaccination and for stimulation of anti-melanoma effector cells.	[Sarrabayrouse, Guillaume; Pich, Christine; Armand-Labit, Virginie; Favre, Gilles; Tilkin-Mariame, Anne-Francoise] Fac Med Toulouse, INSERM, U563, Dept Innovat Therapeut & Oncol Mol,CPTP, F-31073 Toulouse, France; [Sarrabayrouse, Guillaume; Pich, Christine; Armand-Labit, Virginie; Rochaix, Philippe; Favre, Gilles; Tilkin-Mariame, Anne-Francoise] Inst Claudius Regaud, Toulouse, France; [Sarrabayrouse, Guillaume; Pich, Christine; Armand-Labit, Virginie; Favre, Gilles] Univ Toulouse 3, F-31062 Toulouse, France; [Moriez, Raphael] INRA, Neurogastroenterol & Nutr Unit, F-31931 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE	Sarrabayrouse, G (corresponding author), Fac Med Toulouse, INSERM, U563, Dept Innovat Therapeut & Oncol Mol,CPTP, U317, F-31073 Toulouse, France.	tilkin.anne@claudiusregaud.fr	GLADIEFF, Laurence/O-5129-2014; FAVRE, Gilles/K-9189-2014; ARMAND-LABIT, Virginie/P-5807-2014; Rochaix, Philippe/O-4710-2014; Moriez, Raphael/M-1773-2014	GLADIEFF, Laurence/0000-0002-6980-9719; FAVRE, Gilles/0000-0002-2344-1883; ARMAND-LABIT, Virginie/0000-0003-4643-5344; Rochaix, Philippe/0000-0001-6238-1599; Pich-Bavastro, Christine/0000-0002-6526-749X; Moriez, Raphael/0000-0002-0569-2558	Institut National de la Sante et de la Recherche Medicale; La Ligue contre le Cancer, Region Midi Pyrenees; Institut Claudius Regaud	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Ligue contre le Cancer, Region Midi Pyrenees(Region Occitanie); Institut Claudius Regaud	This work was supported by the "Institut National de la Sante et de la Recherche Medicale'' and by grants from "La Ligue contre le Cancer, Region Midi Pyrenees'' and from the "Institut Claudius Regaud''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2004, ANTICANCER RES, V24, P571; Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Allal C, 2002, CELL CYCLE, V1, P430, DOI 10.4161/cc.1.6.272; Benlalam H, 2007, CANCER IMMUNOL IMMUN, V56, P515, DOI 10.1007/s00262-006-0204-0; Blank C, 2006, INT J CANCER, V119, P317, DOI 10.1002/ijc.21775; Botella-Estrada R, 2005, EUR CYTOKINE NETW, V16, P47; Bredel M, 1998, NEUROSURGERY, V43, P124, DOI 10.1097/00006123-199807000-00081; Coral S, 2002, CLIN CANCER RES, V8, P2690; Cormary C, 2005, CANCER GENE THER, V12, P963, DOI 10.1038/sj.cgt.7700861; Cormary C, 2004, CANCER GENE THER, V11, P497, DOI 10.1038/sj.cgt.7700708; Coulie PG, 2001, P NATL ACAD SCI USA, V98, P10290, DOI 10.1073/pnas.161260098; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Godelaine D, 2003, J IMMUNOL, V171, P4893, DOI 10.4049/jimmunol.171.9.4893; HERSEY P, 1994, INT J CANCER, V58, P527, DOI 10.1002/ijc.2910580413; HORI Y, 1991, ONCOGENE, V6, P515; Kusama T, 2003, CLIN EXP METASTAS, V20, P561, DOI 10.1023/A:1025898316728; Lu J, 2009, MOL CANCER THER, V8, P1218, DOI 10.1158/1535-7163.MCT-08-1122; Luo W, 2006, J IMMUNOL, V176, P6046, DOI 10.4049/jimmunol.176.10.6046; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Reinke S, 2005, AM J DERMATOPATH, V27, P401, DOI 10.1097/01.dad.0000180076.17932.ee; Sarrabayrouse G, 2007, NEOPLASIA, V9, P1078, DOI 10.1593/neo.07727; Seliger B, 2001, CANCER RES, V61, P1095; Shu S, 2006, CANCER METAST REV, V25, P233, DOI 10.1007/s10555-006-8503-7; Sojka DK, 2000, J IMMUNOL, V164, P6230, DOI 10.4049/jimmunol.164.12.6230; Tilkin-Mariame AF, 2005, FASEB J, V19, P1513, DOI 10.1096/fj.04-3482fje; YOKOYAMA WM, 1989, IMMUNOL REV, V109, P153, DOI 10.1111/j.1600-065X.1989.tb00024.x	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9043	10.1371/journal.pone.0009043	http://dx.doi.org/10.1371/journal.pone.0009043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140259	Green Published, gold			2022-12-25	WOS:000274474200023
J	Tan, YHC; Krishnaswamy, S; Nandi, S; Kanteti, R; Vora, S; Onel, K; Hasina, R; Lo, FY; El-Hashani, E; Cervantes, G; Robinson, M; Kales, SC; Lipkowitz, S; Karrison, T; Sattler, M; Vokes, EE; Wang, YC; Salgia, R				Tan, Yi-Hung Carol; Krishnaswamy, Soundararajan; Nandi, Suvobroto; Kanteti, Rajani; Vora, Sapana; Onel, Kenan; Hasina, Rifat; Lo, Fang-Yi; El-Hashani, Essam; Cervantes, Gustavo; Robinson, Matthew; Kales, Stephen C.; Lipkowitz, Stanley; Karrison, Theodore; Sattler, Martin; Vokes, Everett E.; Wang, Yi-Ching; Salgia, Ravi			CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ACQUIRED UNIPARENTAL DISOMY; C-CBL; UBIQUITIN LIGASE; BINDING-SITE; OF-FUNCTION; PROTEIN; DOMAIN; AMPLIFICATION; PHOSPHORYLATION	Background: Non-small cell lung cancer (NSCLC) is a heterogeneous group of disorders with a number of genetic and proteomic alterations. c-CBL is an E3 ubiquitin ligase and adaptor molecule important in normal homeostasis and cancer. We determined the genetic variations of c-CBL, relationship to receptor tyrosine kinases (EGFR and MET), and functionality in NSCLC. Methods and Findings: Using archival formalin-fixed paraffin embedded (FFPE) extracted genomic DNA, we show that c-CBL mutations occur in somatic fashion for lung cancers. c-CBL mutations were not mutually exclusive of MET or EGFR mutations; however they were independent of p53 and KRAS mutations. In normal/tumor pairwise analysis, there was significant loss of heterozygosity (LOH) for the c-CBL locus (22%, n = 8/37) and none of these samples revealed any mutation in the remaining copy of c-CBL. The c-CBL LOH also positively correlated with EGFR and MET mutations observed in the same samples. Using select c-CBL somatic mutations such as S80N/H94Y, Q249E and W802* (obtained from Caucasian, Taiwanese and African-American samples, respectively) transfected in NSCLC cell lines, there was increased cell viability and cell motility. Conclusions: Taking the overall mutation rate of c-CBL to be a combination as somatic missense mutation and LOH, it is clear that c-CBL is highly mutated in lung cancers and may play an essential role in lung tumorigenesis and metastasis.	[Tan, Yi-Hung Carol; Lo, Fang-Yi] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Krishnaswamy, Soundararajan; Nandi, Suvobroto; Kanteti, Rajani; Hasina, Rifat; El-Hashani, Essam; Cervantes, Gustavo; Robinson, Matthew; Vokes, Everett E.; Salgia, Ravi] Univ Chicago, Pritzker Sch Med, Med Ctr, Canc Res Ctr,Dept Med, Chicago, IL 60637 USA; [Vora, Sapana; Onel, Kenan] Univ Chicago, Pritzker Sch Med, Med Ctr, Canc Res Ctr,Dept Pediat, Chicago, IL 60637 USA; [Kales, Stephen C.; Lipkowitz, Stanley] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Natl Inst Hlth, Bethesda, MD 20892 USA; [Karrison, Theodore] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Sattler, Martin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sattler, Martin] Harvard Univ, Sch Med, Boston, MA USA; [Wang, Yi-Ching] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan	National Taiwan Normal University; University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; National Cheng Kung University	Tan, YHC (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	rsalgia@medicine.bsd.uchicago.edu	Wang, Yi-Ching/J-8702-2019; Vokes, Everett/Q-2146-2019	Wang, Yi-Ching/0000-0002-7694-2067; Tan, Yi-Hung Carol/0000-0001-7541-007X	National Institutes of Health (NIH)/National Cancer Institute (NCI) [5RO1CA125541-03, 3RO1CA125541-03S109, 5RO1CA129501-02, 3RO1CA129501-02S109, 1R21CA140003-01]; MARF; V-Foundation; National Science Council, Taiwan [NSC96-2628-B-006-048-MY3]; NATIONAL CANCER INSTITUTE [R01CA125541, ZIABC010977, R01CA134660, R01CA129501, R21CA140003] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MARF; V-Foundation; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: Supported by National Institutes of Health (NIH)/National Cancer Institute (NCI) Grants: 5RO1CA125541-03, 3RO1CA125541-03S109, 5RO1CA129501-02, 3RO1CA129501-02S109, 1R21CA140003-01, MARF, V-Foundation, Cancer Research Foundation and American Respiratory Health Association of America (RS) and grant NSC96-2628-B-006-048-MY3 from the National Science Council, Taiwan. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funding agenices had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidoye O, 2007, REV RECENT CLIN TRIA, V2, P143, DOI 10.2174/157488707780599357; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Caligiuri MA, 2007, BLOOD, V110, P1022, DOI 10.1182/blood-2006-12-061176; Clague MJ, 2001, J CELL SCI, V114, P3075; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Higgins RSD, 2003, ANN THORAC SURG, V76, pS1363, DOI 10.1016/S0003-4975(03)01208-6; Hirsch DS, 2006, CANCER RES, V66, P3523, DOI 10.1158/0008-5472.CAN-05-1547; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kozlov G, 2007, J BIOL CHEM, V282, P27547, DOI 10.1074/jbc.M703333200; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; LANGDON WY, 1989, J VIROL, V63, P5420, DOI 10.1128/JVI.63.12.5420-5424.1989; Lill NL, 2000, J BIOL CHEM, V275, P367, DOI 10.1074/jbc.275.1.367; MEISNER H, 1995, J BIOL CHEM, V270, P25332, DOI 10.1074/jbc.270.43.25332; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; TAN YH, 2009, BIOFORMOSA, V44, P1; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001447; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	40	84	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8972	10.1371/journal.pone.0008972	http://dx.doi.org/10.1371/journal.pone.0008972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126411	Green Submitted, Green Published, gold			2022-12-25	WOS:000274139100020
J	Simon, JC; Dickinson, MH				Simon, Jasper C.; Dickinson, Michael H.			A New Chamber for Studying the Behavior of Drosophila	PLOS ONE			English	Article							COURTSHIP; MELANOGASTER; AGGRESSION; CIRCUIT; FLY	Methods available for quickly and objectively quantifying the behavioral phenotypes of the fruit fly, Drosophila melanogaster, lag behind in sophistication the tools developed for manipulating their genotypes. We have developed a simple, easy-to-replicate, general-purpose experimental chamber for studying the ground-based behaviors of fruit flies. The major innovative feature of our design is that it restricts flies to a shallow volume of space, forcing all behavioral interactions to take place within a monolayer of individuals. The design lessens the frequency that flies occlude or obscure each other, limits the variability in their appearance, and promotes a greater number of flies to move throughout the center of the chamber, thereby increasing the frequency of their interactions. The new chamber design improves the quality of data collected by digital video and was conceived and designed to complement automated machine vision methodologies for studying behavior. Novel and improved methodologies for better quantifying the complex behavioral phenotypes of Drosophila will facilitate studies related to human disease and fundamental questions of behavioral neuroscience.	[Simon, Jasper C.; Dickinson, Michael H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Simon, JC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jasper@caltech.edu		Simon, Jasper/0000-0003-3022-258X	United States National Institutes of Health [320 R01 DA022777]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022777] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this research was provided by United States National Institutes of Health grant 320 R01 DA022777 (to MHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; GOTZ KG, 1973, J COMP PHYSIOL, V85, P235, DOI 10.1007/BF00694232; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; HOTTA Y, 1976, P NATL ACAD SCI USA, V73, P4154, DOI 10.1073/pnas.73.11.4154; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Lewis E.B., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; O'Dell KMC, 2003, BEHAV PROCESS, V64, P211, DOI 10.1016/S0376-6357(03)00136-0; Ramazani RB, 2007, J NEUROSCI METH, V162, P171, DOI 10.1016/j.jneumeth.2007.01.005; Straw AD, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-5; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Wolf FW, 2002, J NEUROSCI, V22, P11035; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	22	67	68	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8793	10.1371/journal.pone.0008793	http://dx.doi.org/10.1371/journal.pone.0008793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111707	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000274114800004
J	Hassan, SW; Doody, KM; Hardy, S; Uetani, N; Cournoyer, D; Tremblay, ML				Hassan, Syed-Wajahat; Doody, Karen M.; Hardy, Serge; Uetani, Noriko; Cournoyer, Denis; Tremblay, Michel L.			Increased Susceptibility to Dextran Sulfate Sodium Induced Colitis in the T Cell Protein Tyrosine Phosphatase Heterozygous Mouse	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; MICE; FAMILY; ASSOCIATION; REGULATOR; BLOCKADE; PATHWAY; MODEL; GENE	T cell protein tyrosine phosphatase (TC-PTP / PTPN2) is an enzyme that is essential for the proper functioning of the immune system and that participates in the control of cell proliferation, and inflammation. We previously observed that TC-PTP-/- mice display various immunodeficiencies, hypersensitivity to LPS and die within three weeks of birth due to anemia and widespread inflammation. A recent analysis of the Wellcome Trust Case Control Consortium (WTCC) genome wide scan data, reported in 2007, indicated a potential role for TC-PTP in inflammatory bowel disease (IBD). To further investigate the potential role of TC-PTP in IBD, we studied heterozygous TC-PTP mutant mice challenged with dextran sulfate sodium (DSS) in their drinking water. In comparison to control animals, we observed significant changes in the colon mucosa of DSS-treated TC-PTP+/- mice, in the ratio of colon to body weight, as well as an up-regulation of mRNA transcripts for IL-6, IL-23, 1L-12 beta, IFN-gamma, TNF-alpha. Moreover, up-regulation of serum IL-6 levels in DSS- treated TC-PTP+/- mice confirms that mice with a single copy of the TC-PTP gene display increased susceptibility to systemic inflammation due to bowel epithelial erosion resulting from DSS challenge. Our findings support the lack of modulation of Janus kinases 1 and 3 (Jak1, Jak3), and the downstream signal transducer and activator of transcription 1,3 and 5 (Stat1, Stat3, Stat 5) by PTPN2 in the development of IBD like condition. Pathological and molecular analysis reveal that the deficiency of TC-PTP results in pro-inflammatory condition in the bowel of heterozygous TC-PTP+/- mice. These novel findings in TC-PTP hemi-deficiency support the hypothesis that TC-PTP is an important regulator of inflammatory cytokine signaling and that it may be implicated in the pathophysiology of IBD.	[Hassan, Syed-Wajahat; Doody, Karen M.; Hardy, Serge; Uetani, Noriko; Cournoyer, Denis; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada; [Hassan, Syed-Wajahat; Cournoyer, Denis; Tremblay, Michel L.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Doody, Karen M.; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Cournoyer, Denis] McGill Univ, Dept Oncol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Hassan, SW (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada.	michel.tremblay@mcgill.ca			Canadian Cancer Society [NCIC 015200]	Canadian Cancer Society(Canadian Cancer Society (CCS))	This work has been supported by the Canadian Cancer Society (NCIC#015200) grant to MLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2000, J ALLERGY CLIN IMMUN, V105, pS29, DOI 10.1016/S0091-6749(00)90514-1; Balding J, 2004, MEDIAT INFLAMM, V13, P181, DOI 10.1080/09511920410001713529; BARRETT JC, 2008, NAT GENET; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; FISHER SA, 2008, NAT GENET; Fitzpatrick LR, 2000, DIGEST DIS SCI, V45, P2327, DOI 10.1023/A:1005630723111; FRANKE A, 2008, NAT GENET; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Glinsky GV, 2008, CELL CYCLE, V7, P2570, DOI 10.4161/cc.7.16.6524; Gu F, 2003, MOL CELL BIOL, V23, P3753, DOI 10.1128/MCB.23.11.3753-3762.2003; Heinonen KM, 2006, P NATL ACAD SCI USA, V103, P2776, DOI 10.1073/pnas.0508563103; Heinonen KM, 2004, BLOOD, V103, P3457, DOI 10.1182/blood-2003-09-3153; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Malago JJ, 2008, J ZHEJIANG UNIV-SC B, V9, P341, DOI 10.1631/jzus.B0720198; Masubuchi Y, 2004, DRUG METAB DISPOS, V32, P437, DOI 10.1124/dmd.32.4.437; McCaffery DM, 1999, GUT, V45, P864, DOI 10.1136/gut.45.6.864; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Nielsen OH, 2003, SCAND J GASTROENTERO, V38, P180, DOI 10.1080/00365520310000672; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Roviezzo F, 2006, FASEB J, V20, P340, DOI 10.1096/fj.05-4647fje; SAKAGUCHI AY, 1992, GENOMICS, V12, P151, DOI 10.1016/0888-7543(92)90418-R; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683	32	34	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8868	10.1371/journal.pone.0008868	http://dx.doi.org/10.1371/journal.pone.0008868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111595	gold, Green Published, Green Submitted			2022-12-25	WOS:000273896300017
J	Mohtashemi, M; Kawamura, LM				Mohtashemi, Mojdeh; Kawamura, L. Masae			Empirical Evidence for Synchrony in the Evolution of TB Cases and HIV plus Contacts among the San Francisco Homeless	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; SPATIAL HIERARCHIES; RISK-FACTORS; PREVALENCE; INFECTION; AFRICA; ADULTS; TRENDS; IMPACT; WAVES	The re-emergence of tuberculosis (TB) in the mid-1980s in many parts of the world, including the United States, is often attributed to the emergence and rapid spread of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). Although it is well established that TB transmission is particularly amplified in populations with high HIV prevalence, the epidemiology of interaction between TB and HIV is not well understood. This is partly due to the scarcity of HIV-related data, a consequence of the voluntary nature of HIV status reporting and testing, and partly due to current practices of screening high risk populations through separate surveillance programs for HIV and TB. The San Francisco Department of Public Health, TB Control Program, has been conducting active surveillance among the San Francisco high-risk populations since the early 1990s. We present extensive TB surveillance data on HIV and TB infection among the San Francisco homeless to investigate the association between the TB cases and their HIV+ contacts. We applied wavelet coherence and phase analyses to the TB surveillance data from January 1993 through December 2005, to establish and quantify statistical association and synchrony in the highly non-stationary and ostensibly non-periodic waves of TB cases and their HIV+ contacts in San Francisco. When stratified by homelessness, we found that the evolution of TB cases and their HIV+ contacts is highly coherent over time and locked in phase at a specific periodic scale among the San Francisco homeless, but no significant association was observed for the non-homeless. This study confirms the hypothesis that the dynamics of HIV and TB are significantly intertwined and that HIV is likely a key factor in the sustenance of TB transmission among the San Francisco homeless. The findings of this study underscore the importance of contact tracing in detection of HIV+ individuals that may otherwise remain undetected, and thus highlights the ever-increasing need for HIV-related data and an integrative approach to monitoring high-risk populations with respect to HIV and TB transmission.	[Mohtashemi, Mojdeh] Mitre Corp, Mclean, VA USA; [Mohtashemi, Mojdeh] MIT, Comp Sci & Ai Lab, Cambridge, MA USA; [Kawamura, L. Masae] San Francisco Dept Publ Hlth, TB Control Sect, San Francisco, CA USA	MITRE Corporation; Massachusetts Institute of Technology (MIT); San Francisco Department of Public Health	Mohtashemi, M (corresponding author), Mitre Corp, Mclean, VA USA.	mojdeh@mit.edu			MITRE Corporation; San Francisco Department of Public Health	MITRE Corporation; San Francisco Department of Public Health	M. M. was fully supported by an internal grant from the MITRE Corporation. L. M. K. was supported by the San Francisco Department of Public Health. The study sponsors did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; BERMEJO A, 1992, AIDS, V6, P1203, DOI 10.1097/00002030-199210000-00022; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chatfield J. R, 1989, ANAL TIME SERIES INT; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Daubechies I, 1992, LECT WAVELETS; de Magny GC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-20; DeRiemer K, 2007, AM J RESP CRIT CARE, V176, P936, DOI 10.1164/rccm.200603-440OC; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Efron B., 1994, INTRO BOOTSTRAP; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; *I MED EM INF, 1992, MICR THREATS HLTH US; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, AIDS, V20, P1787, DOI 10.1097/01.aids.0000242831.27990.da; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Marks S., 2007, Morbidity and Mortality Weekly Report, V56, P1103; Nason GP, 1999, PHILOS T R SOC A, V357, P2511, DOI 10.1098/rsta.1999.0445; Percival D., 2000, CA ST PR MA; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Robertson MJ, 2004, AM J PUBLIC HEALTH, V94, P1207, DOI 10.2105/AJPH.94.7.1207; *SAN FRANC DEP PUB, 2003, SAN FRANC DEP PUBL H; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; WHO, 2006, WORLD HLTH REPORT 20; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Williams B, 2007, AM J RESP CRIT CARE, V175, P6, DOI 10.1164/rccm.200609-1376ED; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2004, WORLD HLTH REP 2004; Yang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001399; Zetola NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002591; ZOLOPA AR, 1994, JAMA-J AM MED ASSOC, V272, P455, DOI 10.1001/jama.272.6.455	33	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8851	10.1371/journal.pone.0008851	http://dx.doi.org/10.1371/journal.pone.0008851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107514	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896100016
J	Roy, PH; Tetu, SG; Larouche, A; Elbourne, L; Tremblay, S; Ren, QH; Dodson, R; Harkins, D; Shay, R; Watkins, K; Mahamoud, Y; Paulsen, IT				Roy, Paul H.; Tetu, Sasha G.; Larouche, Andre; Elbourne, Liam; Tremblay, Simon; Ren, Qinghu; Dodson, Robert; Harkins, Derek; Shay, Ryan; Watkins, Kisha; Mahamoud, Yasmin; Paulsen, Ian T.			Complete Genome Sequence of the Multiresistant Taxonomic Outlier Pseudomonas aeruginosa PA7	PLOS ONE			English	Article							BETA-LACTAMASE; IV PILINS; D-ARAF; VIRULENCE; RESISTANCE; GENES; IDENTIFICATION; EVOLUTION; REVEALS; STRAIN	Pseudomonas aeruginosa PA7 is a non-respiratory human isolate from Argentina that is multiresistant to antibiotics. We first sequenced gyrA, gyrB, parC, parE, ampC, ampR, and several housekeeping genes and found that PA7 is a taxonomic outlier. We report here the complete sequence of the 6,588,339 bp genome, which has only about 95% overall identity to other strains. PA7 has multiple novel genomic islands and a total of 51 occupied regions of genomic plasticity. These islands include antibiotic resistance genes, parts of transposons, prophages, and a pKLC102-related island. Several PA7 genes not present in PAO1 or PA14 are putative orthologues of other Pseudomonas spp. and Ralstonia spp. genes. PA7 appears to be closely related to the known taxonomic outlier DSM1128 (ATCC9027). PA7 lacks several virulence factors, notably the entire TTSS region corresponding to PA1690-PA1725 of PAO1. It has neither exoS nor exoU and lacks toxA, exoT, and exoY. PA7 is serotype O12 and pyoverdin type II. Preliminary proteomic studies indicate numerous differences with PAO1, some of which are probably a consequence of a frameshift mutation in the mvfR quorum sensing regulatory gene.	[Roy, Paul H.; Larouche, Andre; Tremblay, Simon] Univ Laval, Dept Biochim & Microbiol, Quebec City, PQ, Canada; [Roy, Paul H.; Larouche, Andre; Tremblay, Simon] Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada; [Tetu, Sasha G.; Elbourne, Liam; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Ren, Qinghu; Dodson, Robert; Harkins, Derek; Shay, Ryan; Watkins, Kisha; Mahamoud, Yasmin; Paulsen, Ian T.] J Craig Venter Inst, Rockville, MD USA	Laval University; Laval University; Macquarie University; J. Craig Venter Institute	Roy, PH (corresponding author), Univ Laval, Dept Biochim & Microbiol, Quebec City, PQ, Canada.	ipaulsen@science.mq.edu.au	Paulsen, Ian T/K-3832-2012; Tetu, Sasha/C-8760-2013; Elbourne, Liam/G-6150-2011	Paulsen, Ian T/0000-0001-9015-9418; Elbourne, Liam/0000-0002-9784-0959; Tetu, Sasha/0000-0002-8943-3499	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services [N01-AI-30071]; Canadian Institutes for Health Research (CIHR) [MT-13564]; Strategic Training Initiative in Heath Reasearch (STIHR) [STP-59324]; New South Wales Office of Science and Medical Research	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Strategic Training Initiative in Heath Reasearch (STIHR); New South Wales Office of Science and Medical Research	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services, under NIAID contract N01-AI-30071, and the Canadian Institutes for Health Research (CIHR) grant MT-13564 to PHR. ST was a recipient of a fellowship from the Strategic Training Initiative in Heath Reasearch (STIHR) training grant STP-59324. ITP is supported by a Life Science Research Award, provided by the New South Wales Office of Science and Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; BODILIS J, 2009, ENV MICROBIOL; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Dotsch A, 2009, ANTIMICROB AGENTS CH, V53, P2522, DOI 10.1128/AAC.00035-09; Dong YH, 2005, MOL MICROBIOL, V58, P552, DOI 10.1111/j.1365-2958.2005.04851.x; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hanau-Bercot B, 2002, MOL MICROBIOL, V44, P119, DOI 10.1046/j.1365-2958.2002.02843.x; HUANG HJ, 1992, FEMS MICROBIOL LETT, V97, P267, DOI 10.1111/j.1574-6968.1992.tb05474.x; Jalal S, 1998, MICROB DRUG RESIST, V4, P257, DOI 10.1089/mdr.1998.4.257; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Juhas M, 2004, MICROBIOL-SGM, V150, P831, DOI 10.1099/mic.0.26906-0; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; MARTIN C, 1990, NATURE, V345, P739, DOI 10.1038/345739a0; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mifsud AJ, 1997, J HOSP INFECT, V36, P105, DOI 10.1016/S0195-6701(97)90116-X; Mikkelsen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006018; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Ramisse F, 2000, FEMS IMMUNOL MED MIC, V28, P241, DOI 10.1016/S0928-8244(00)00162-0; RATHER PN, 1992, J BACTERIOL, V174, P3196, DOI 10.1128/jb.174.10.3196-3203.1992; Raymond CK, 2002, J BACTERIOL, V184, P3614, DOI 10.1128/JB.184.13.3614-3622.2002; RECCHIA GD, 1994, NUCLEIC ACIDS RES, V22, P2071, DOI 10.1093/nar/22.11.2071; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09; Smith EE, 2005, J BACTERIOL, V187, P2138, DOI 10.1128/JB.187.6.2138-2147.2005; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Talarmin A, 1996, EUR J CLIN MICROBIOL, V15, P459, DOI 10.1007/BF01691312; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Wuerdemann D, 2007, FEMS MICROBIOL LETT, V275, P244, DOI 10.1111/j.1574-6968.2007.00891.x; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951	43	174	182	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8842	10.1371/journal.pone.0008842	http://dx.doi.org/10.1371/journal.pone.0008842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107499	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896100008
J	Moulton, VR; Tsokos, GC				Moulton, Vaishali R.; Tsokos, George C.			Alternative Splicing Factor/Splicing Factor 2 Regulates the Expression of the zeta Subunit of the Human T Cell Receptor-associated CD3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRE-MESSENGER-RNA; SR PROTEINS; 3'-UNTRANSLATED REGION; FACTOR ASF/SF2; FACTOR SF2/ASF; CHAIN; TRANSLATION; ACTIVATION; STABILITY	T cells from patients with systemic lupus erythematosus express decreased levels of the T cell receptor-associated CD3 zeta chain, a feature directly linked to their aberrant function. The decrease in CD3 zeta protein expression is in part due to decreased levels of functional wild type isoform of the 3'-untranslated region (UTR) of CD3 zeta mRNAwith concomitant increased levels of an unstable alternatively spliced isoform. In order to identify factors involved in the post-transcriptional regulation of CD3 zeta, we performed mass spectrometric analysis of Jurkat T cell nuclear proteins "pulled down" by a CD3 zeta 3'-UTR oligonucleotide, which identified the splicing protein alternative splicing factor/splicing factor 2 (ASF/SF2). We show for the first time that ASF/SF2 binds specifically to the 3'-UTR of CD3 zeta and regulates expression of CD3 zeta protein by limiting the production of the alternatively spliced isoform. During activation of human T cells, an increase in the wild type CD3 zeta mRNAis associated with increased expression of ASF/SF2. Finally, we show a significant correlation between ASF/SF2 and CD3 zeta protein levels in T cells from systemic lupus erythematosus patients. Thus, our results identify ASF/SF2 as a novel factor in the regulation of alternative splicing of the 3'-UTR of CD3 zeta and protein expression in human T cells.	[Moulton, Vaishali R.; Tsokos, George C.] Harvard Univ, Sch Med, Dept Med, Div Rheumatol,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsokos, GC (corresponding author), 3 Blackfan Circle,CLS-928, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360	National Institutes of Health [RO1 AI42269]; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI42269 (to G.C.T.) and an Arthritis Foundation grant (to V.R.M.).	Bakkour N, 2007, PLOS PATHOG, V3, P1530, DOI 10.1371/journal.ppat.0030159; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chowdhury B, 2005, J BIOL CHEM, V280, P18959, DOI 10.1074/jbc.M501048200; Chowdhury B, 2006, J IMMUNOL, V177, P8248, DOI 10.4049/jimmunol.177.11.8248; Cohen RA, 2008, CLIN IMMUNOL, V128, P1, DOI 10.1016/j.clim.2008.04.004; Dauksaite V, 2002, J BIOL CHEM, V277, P12579, DOI 10.1074/jbc.M107867200; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; JENSEN JP, 1992, J IMMUNOL, V148, P2563; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Krishnan S, 2003, J IMMUNOL, V171, P3325, DOI 10.4049/jimmunol.171.7.3325; Lemaire R, 1999, EUR J IMMUNOL, V29, P823, DOI 10.1002/(SICI)1521-4141(199903)29:03<823::AID-IMMU823>3.0.CO;2-C; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Mole S, 2009, J VIROL, V83, P357, DOI 10.1128/JVI.01414-08; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Moulton VR, 2008, J BIOL CHEM, V283, P20037, DOI 10.1074/jbc.M710434200; Nambiar MP, 2003, ARTHRITIS RHEUM, V48, P1948, DOI 10.1002/art.11072; Nambiar MP, 2003, LUPUS, V12, P46, DOI 10.1191/0961203303lu281oa; Nambiar MP, 2001, J AUTOIMMUN, V16, P133, DOI 10.1006/jaut.2000.0475; Neugebauer KM, 2000, ARTHRITIS RHEUM, V43, P1768, DOI 10.1002/1529-0131(200008)43:8<1768::AID-ANR13>3.0.CO;2-9; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Pang M, 1998, ARTHRITIS RHEUM, V41, P1456, DOI 10.1002/1529-0131(199808)41:8<1456::AID-ART16>3.0.CO;2-0; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tenbrock K, 2002, J IMMUNOL, V169, P4147, DOI 10.4049/jimmunol.169.8.4147; Tyson-Capper AJ, 2005, J BIOL CHEM, V280, P34521, DOI 10.1074/jbc.M505344200; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359	41	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12490	12496		10.1074/jbc.M109.091660	http://dx.doi.org/10.1074/jbc.M109.091660			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20118245	Green Published, hybrid			2022-12-25	WOS:000276787800005
J	Lee, GH; Yan, C; Shin, SJ; Hong, SC; Ahn, T; Moon, A; Park, SJ; Lee, YC; Yoo, WH; Kim, HT; Kim, DS; Chae, SW; Kim, HR; Chae, HJ				Lee, G-H; Yan, C.; Shin, S-J; Hong, S-C; Ahn, T.; Moon, A.; Park, S. J.; Lee, Y. C.; Yoo, W. H.; Kim, H-T; Kim, D-S; Chae, S-W; Kim, H-R; Chae, H-J			BAX inhibitor-1 enhances cancer metastasis by altering glucose metabolism and activating the sodium-hydrogen exchanger: the alteration of mitochondrial function	ONCOGENE			English	Article						BI-1; cancer; metastasis; NHE; acidic pH	INTRACELLULAR PH REGULATION; NA+/H+ EXCHANGER; EXTRACELLULAR PH; EPITHELIAL-CELLS; MATRIX-METALLOPROTEINASE; ENDOPLASMIC-RETICULUM; INCREASED EXPRESSION; PROSTATE-CANCER; SKELETAL-MUSCLE; DOWN-REGULATION	The anti-apoptotic protein, BAX inhibitor-1 (BI-1), has a role in cancer/tumor progression. BI-1-overexpressing HT1080 and B16F10 cells produced higher lung weights and tumor volumes after injection into the tail veins of mice. Transfection of BI-1 siRNA into cells before injection blocked lung metastasis. in vitro, the overexpression of BI-1 increased cell mobility and invasiveness, with highly increased glucose consumption and cytosolic accumulation of lactate and pyruvate, but decreased mitochondrial O(2) consumption and ATP production. Glucose metabolism-associated extracellular pH also decreased as cells excreted more H(+), and sodium hydrogen exchanger (NHE) activity increased, probably as a homeostatic mechanism for intracellular pH. These alterations activated MMP 2/9 and cell mobility and invasiveness, which were reversed by the NHE inhibitor, 5-(N-ethyl-N-isopropyl) amiloride (EIPA), suggesting a role for NHE in cancer metastasis. In both in vitro and in vivo experiments, C-terminal deleted (CDBI-1) cells showed similar results to control cells, suggesting that the C-terminal motif is required for BI-1-associated alterations of glucose metabolism, NHE activation and cancer metastasis. These findings strongly suggest that BI-1 reduces extracellular pH and regulates metastasis by altering glucose metabolism and activating NHE, with the C-terminal tail having a pivotal role in these processes. Oncogene (2010) 29, 2130-2141; doi: 10.1038/onc.2009.491; published online 1 February 2010	[Chae, H-J] Chonbuk Natl Univ, Dept Pharmacol & Res, Sch Med, Res Ctr Pulm Disorder, Jeonju 561181, Chonbuk, South Korea; [Lee, G-H; Yan, C.; Kim, D-S; Chae, S-W; Chae, H-J] Chonbuk Natl Univ, Dept Pharmacol & Cardiovasc Res Ctr, Jeonju 561181, Chonbuk, South Korea; [Shin, S-J; Hong, S-C] Chonbuk Natl Univ, Dept Microbiol, Sch Med, Jeonju 561181, Chonbuk, South Korea; [Ahn, T.] Chonnam Natl Univ, Coll Vet Med, Dept Biochem, Kwangju, South Korea; [Moon, A.] Duksung Womens Univ, Sch Pharm, Seoul, South Korea; [Park, S. J.; Lee, Y. C.] Chonbuk Natl Univ, Dept Internal Med, Jeonju 561181, Chonbuk, South Korea; [Park, S. J.; Lee, Y. C.] Chonbuk Natl Univ, Airway Remodeling Lab, Sch Med, Jeonju 561181, Chonbuk, South Korea; [Yoo, W. H.] Chonbuk Natl Univ, Dept Internal Med, Div Rheumatol, Jeonju 561181, Chonbuk, South Korea; [Kim, H-T] Chonbuk Natl Univ, Sch Med, Dept Anat, Jeonju 561181, Chonbuk, South Korea; [Kim, H-R] Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Iksan, Chonbuk, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Chonnam National University; Duksung Women's University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Wonkwang University	Chae, HJ (corresponding author), Chonbuk Natl Univ, Dept Pharmacol & Res, Sch Med, Res Ctr Pulm Disorder, San2-20, Jeonju 561181, Chonbuk, South Korea.	hrkimdp@wonkwang.ac.kr; hjchae@chonbuk.ac.kr		Hong, Seong-Tshool/0000-0001-8254-6581; HyoungTae, Kim/0000-0002-2482-6064	Ministry of Education, Science and Technology, South Korea; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A084144]	Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the Research Program for New Drug Target Discovery grant from the Ministry of Education, Science and Technology, South Korea and partly supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A084144).	Alrefai WA, 2001, AM J PHYSIOL-CELL PH, V281, pC1551, DOI 10.1152/ajpcell.2001.281.5.C1551; BENNETT AF, 1982, BIOCHEMISTRY-US, V21, P4407, DOI 10.1021/bi00261a033; BEREITERHAHN J, 1988, CELL MOTIL CYTOSKEL, V10, P528, DOI 10.1002/cm.970100409; Bhujwalla ZM, 2002, NMR BIOMED, V15, P114, DOI 10.1002/nbm.743; Bolduc N, 2002, FEBS LETT, V532, P111, DOI 10.1016/S0014-5793(02)03650-5; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Boyd RS, 1999, BRIT J CANCER, V80, P315, DOI 10.1038/sj.bjc.6690357; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DELCARMEN G, 2005, EUR J GYNAECOL ONCOL, V26, P501; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dohm CP, 2006, J MOL NEUROSCI, V29, P1, DOI 10.1385/JMN:29:1:1; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GILLIES RJ, 1990, P NATL ACAD SCI USA, V87, P7414, DOI 10.1073/pnas.87.19.7414; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; Harguindey S, 2005, BBA-REV CANCER, V1756, P1, DOI 10.1016/j.bbcan.2005.06.004; Harima Y, 2004, INT J RADIAT ONCOL, V60, P237, DOI 10.1016/j.ijrobp.2004.02.047; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; Hille C, 2007, J EXP BIOL, V210, P1463, DOI 10.1242/jeb.001529; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; KAPLAN DL, 1994, J BIOL CHEM, V269, P4116; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kim MS, 2003, CANCER RES, V63, P5454; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; LAGARDE AE, 1988, J CELL BIOCHEM, V36, P249, DOI 10.1002/jcb.240360306; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Provent P, 2007, CANCER RES, V67, P7638, DOI 10.1158/0008-5472.CAN-06-3459; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; ROSENGREN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1623, DOI 10.1152/ajpcell.1994.267.6.C1623; ROTIN D, 1989, CANCER RES, V49, P205; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Schornack PA, 2003, NEOPLASIA, V5, P135, DOI 10.1016/S1476-5586(03)80005-2; Stacpoole Peter W., 2003, Current Gene Therapy, V3, P239, DOI 10.2174/1566523034578320; Steffan JJ, 2009, TRAFFIC, V10, P737, DOI 10.1111/j.1600-0854.2009.00904.x; Stellingwerff T, 2003, AM J PHYSIOL-ENDOC M, V284, pE589, DOI 10.1152/ajpendo.00418.2002; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; TANNOCK IF, 1989, CANCER RES, V49, P4373; Thomas SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002103; Wahl ML, 2000, J CELL PHYSIOL, V183, P373, DOI 10.1002/(SICI)1097-4652(200006)183:3<373::AID-JCP10>3.0.CO;2-S; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9	55	51	52	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 8	2010	29	14					2130	2141		10.1038/onc.2009.491	http://dx.doi.org/10.1038/onc.2009.491			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20118983				2022-12-25	WOS:000276402800011
J	Peng, S; Maihle, NJ; Huang, Y				Peng, S.; Maihle, N. J.; Huang, Y.			Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer	ONCOGENE			English	Article						Lin28; Oct4; ovarian cancer; cancer stem cell; gene therapy; molecular diagnostics	MESSENGER-RNA; LIN-28; EXPRESSION; BIOGENESIS; SUPPRESSES; PROMOTES; MARKER	Lin28 and Oct4 are highly expressed in human embryonic stem (ES) cells and, along with two other stem cell marker proteins (Nanog and Sox2), together can convert human somatic cells to pluripotency. As an RNA-binding protein, Lin28 acts to stimulate the translation of a specific subset of mRNAs, and to inhibit the biogenesis of a group of microRNAs. Oct4 is a transcription factor essential for the maintenance of pluripotency and survival of ES cells. In this study, we report that a sub-population of epithelial ovarian cancer (EOC) cells co-expresses Lin28 and Oct4 as demonstrated in the analyses of both cell lines and patient tumor samples. We also observe that the combined expression of these proteins in tumor samples is correlated with advanced tumor grade. Intriguingly, when the expression of these two proteins is repressed in the same cells using RNA interference, there is significant reduction in cell growth and survival. We thus propose that Lin28 and Oct4 may have important roles in the initiation and/or progression of EOC, and consequently may serve as important molecular diagnostics and/or therapeutic targets for the development of novel treatment strategies in EOC patients. Oncogene (2010) 29, 2153-2159; doi: 10.1038/onc.2009.500; published online 25 January 2010	[Peng, S.; Maihle, N. J.; Huang, Y.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA; [Maihle, N. J.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Maihle, N. J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Huang, Y (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, 310 Cedar St,LSOG 205C, New Haven, CT 06510 USA.	yingqun.huang@yale.edu			Fannie E Rippel Foundation; CT Stem Cell Grant [09SCAYALE14]; Yale School of Medicine 'Senior Women in Medicine' Professorship; NIH [CA 79808]; NATIONAL CANCER INSTITUTE [R01CA079808] Funding Source: NIH RePORTER	Fannie E Rippel Foundation; CT Stem Cell Grant; Yale School of Medicine 'Senior Women in Medicine' Professorship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jianyu Jin for technical assistance, Jill Reiter for extracts from ovarian cancer cells and insightful scientific discussions, Philip Low and Gil Mor for cell lines and Jason Wilken for critical discussions and reading of this paper. This study was supported by the Fannie E Rippel Foundation and a CT Stem Cell Grant 09SCAYALE14 to YH, and a Yale School of Medicine 'Senior Women in Medicine' Professorship, and NIH CA 79808 to NJM.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; BENARD J, 1985, CANCER RES, V45, P4970; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Cheng L, 2007, J PATHOL, V211, P1, DOI 10.1002/path.2105; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Darr H, 2009, STEM CELLS, V27, P352, DOI 10.1634/stemcells.2008-0720; Fodde R, 2009, CANCER CELL, V15, P87, DOI 10.1016/j.ccr.2009.01.011; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hu TS, 2008, CANCER RES, V68, P6533, DOI 10.1158/0008-5472.CAN-07-6642; Jinawath N, 2009, ONCOGENE, V28, P1941, DOI 10.1038/onc.2009.37; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Mlarotta LLC, 2009, CURR OPIN GENET DEV, V19, P44, DOI 10.1016/j.gde.2008.12.003; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Vasey PA, 2008, ANN ONCOL, V19, P61, DOI 10.1093/annonc/mdn479; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang KX, 2008, RNA, V14, P577, DOI 10.1261/rna.739308; Zhang M, 2007, PLACENTA, V28, P779, DOI 10.1016/j.placenta.2007.01.012	34	207	219	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2010	29	14					2153	2159		10.1038/onc.2009.500	http://dx.doi.org/10.1038/onc.2009.500			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101213				2022-12-25	WOS:000276402800013
J	Saha, A; Lee, YC; Zhang, ZJ; Chandra, G; Su, SB; Mukherjee, AB				Saha, Arjun; Lee, Yi-Ching; Zhang, Zhongjian; Chandra, Goutam; Su, Shao-Bo; Mukherjee, Anil B.			Lack of an Endogenous Anti-inflammatory Protein in Mice Enhances Colonization of B16F10 Melanoma Cells in the Lungs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; CANCER-CELLS; MICROENVIRONMENTAL REGULATION; SURFACE RECEPTOR; BINDING PROTEINS; METASTASIS; INFLAMMATION; UTEROGLOBIN; EXPRESSION; DISEASE	Emerging evidence indicates a link between inflammation and cancer metastasis, but the molecular mechanism(s) remains unclear. Uteroglobin (UG), a potent anti-inflammatory protein, is constitutively expressed in the lungs of virtually all mammals. UG-knock-out (UG-KO) mice, which are susceptible to pulmonary inflammation, and B16F10 melanoma cells, which preferentially metastasize to the lungs, provide the components of a model system to determine how inflammation and metastasis are linked. We report here that B16F10 cells, injected into the tail vein of UG-KO mice, form markedly elevated numbers of tumor colonies in the lungs compared with their wild type littermates. Remarkably, UG-KO mouse lungs overexpress two calcium-binding proteins, S100A8 and S100A9, whereas B16F10 cells express the receptor for advanced glycation end products (RAGE), which is a known receptor for these proteins. Moreover, S100A8 and S100A9 are potent chemoattractants for RAGE-expressing B16F10 cells, and pretreatment of these cells with a blocking antibody to RAGE suppressed migration and invasion. Interestingly, in UG-KO mice S100A8/S100A9 concentrations in blood are lowest in tail vein and highest in the lungs, which most likely guide B16F10 cells to migrate to the lungs. Further, B16F10 cells treated with S100A8 or S100A9 overexpress matrix metalloproteinases, which are known to promote tumor invasion. Most notably, the metastasized B16F10 cells in UG-KO mouse lungs express MMP-2, MMP-9, and MMP-14 as well as furin, a pro-protein convertase that activates MMPs. Taken together, our results suggest that a lack of an anti-inflammatory protein leads to increased pulmonary colonization of melanoma cells and identify RAGE as a potential anti-metastatic drug target.	[Mukherjee, Anil B.] Eunice Kennedy Shriver NICHD, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Su, Shao-Bo] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Sun Yat Sen University	Mukherjee, AB (corresponding author), Eunice Kennedy Shriver NICHD, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.	mukherja@exchange.nih.gov	Chandra, Goutam/AAC-7319-2022; Lee, Yi-Ching/AAE-6900-2022	Chandra, Goutam/0000-0002-6485-8562; Lee, Yi-Ching/0000-0002-7734-5619	Eunice Kennedy Shriver NICHD, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000910] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; BROERS JLV, 1992, LAB INVEST, V66, P337; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Couzin J, 2003, SCIENCE, V299, P1002, DOI 10.1126/science.299.5609.1002; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1975, CANCER RES, V35, P218; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Hedley BD, 2009, ADV CANCER RES, V102, P67, DOI 10.1016/S0065-230X(09)02003-X; Heizmann C. W., 2007, V45, P93; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kundu GC, 1998, J BIOL CHEM, V273, P22819, DOI 10.1074/jbc.273.35.22819; LINNOILA RI, 1992, AM J CLIN PATHOL, V97, P233, DOI 10.1093/ajcp/97.2.233; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Liotta LA, 2003, NAT GENET, V33, P10, DOI 10.1038/ng0103-10; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marx J, 2004, SCIENCE, V306, P966, DOI 10.1126/science.306.5698.966; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; NEEPER M, 1992, J BIOL CHEM, V267, P14998; PERI A, 1993, J CLIN INVEST, V92, P2099, DOI 10.1172/JCI116810; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rafii S, 2006, NAT CELL BIOL, V8, P1321, DOI 10.1038/ncb1206-1321; RAY MK, 1993, BIOCHEM BIOPH RES CO, V197, P163, DOI 10.1006/bbrc.1993.2455; Saha A, 2008, FEBS LETT, V582, P3823, DOI 10.1016/j.febslet.2008.10.015; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; Szabo E, 1998, CELL GROWTH DIFFER, V9, P475; Warembourg M, 2000, J NEUROSCI METH, V104, P27, DOI 10.1016/S0165-0270(00)00320-4; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Yang YP, 2004, J BIOL CHEM, V279, P29336, DOI 10.1074/jbc.C400162200; Zhang ZJ, 1997, SCIENCE, V276, P1408, DOI 10.1126/science.276.5317.1408; Zhang ZJ, 1999, P NATL ACAD SCI USA, V96, P3963, DOI 10.1073/pnas.96.7.3963	48	52	56	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10822	10831		10.1074/jbc.M109.083550	http://dx.doi.org/10.1074/jbc.M109.083550			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118237	Green Published, hybrid			2022-12-25	WOS:000276264600067
J	Puhlmann, J; Puehler, F; Mumberg, D; Boukamp, P; Beier, R				Puhlmann, J.; Puehler, F.; Mumberg, D.; Boukamp, P.; Beier, R.			Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus	ONCOGENE			English	Article						Newcastle disease virus; transformation; oncolytic; Rac1; Ras; interferon	NEWCASTLE-DISEASE-VIRUS; RAS SIGNALING PATHWAY; TUMOR PROGRESSION; INTERFERON RESPONSE; ACTIVATION; INFECTION; TRANSFORMATION; EXPRESSION; GTPASE; PERMISSIVENESS	Oncolytic Newcastle disease virus (NDV) replicates selectively in most human tumor cells but not in normal cells. The relationship between tumorigenesis and the selective susceptibility of most tumor cells to oncolytic NDV replication is poorly understood. A multistage skin carcinogenesis model derived from non-tumorigenic HaCaT cells was used to systematically investigate the molecular mechanisms involved in the oncolytic NDV-sensitivity associated with tumorigenic transformation. No significant differences in interferon signaling were observed between the virus-sensitive tumor cells and the virus-resistant non-tumorigenic parental cells. Oncogenic H-Ras, which had been used for tumorigenic transformation, was shown to be necessary for virus replication but was not sufficient to render cells susceptible to NDV replication. By using an siRNA screening approach to search for virus-sensitizing genes in the tumorigenic cells, we could identify the small GTPase Rac1 as an oncogenic protein that is essential for NDV replication and anchorage-independent growth in tumorigenic cells. Furthermore, Rac1 expression was sufficient to render non-tumorigenic cells susceptible to NDV replication and to oncolytic cytotoxicity. This study establishes Rac1 as a link between tumorigenesis and oncolytic virus sensitivity in the HaCaT multistage skin carcinogenesis model. Oncogene (2010) 29, 2205-2216; doi: 10.1038/onc.2009.507; published online 25 January 2010	[Beier, R.] Bayer Schering Pharma AG, TRG Oncol, Global Drug Discovery, D-13342 Berlin, Germany; [Puhlmann, J.] FU Berlin, Inst Biol, Berlin, Germany; [Boukamp, P.] Deutsch Krebsforschungszentrum, Div Genet Skin Carcinogenesis, D-6900 Heidelberg, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Free University of Berlin; Helmholtz Association; German Cancer Research Center (DKFZ)	Beier, R (corresponding author), Bayer Schering Pharma AG, TRG Oncol, Global Drug Discovery, Mullerstr 178, D-13342 Berlin, Germany.	Rudolf.Beier@bayerhealthcare.com			Tumorzentrum Heidelberg-Mannheim	Tumorzentrum Heidelberg-Mannheim(European Commission)	The authors thank Katja Kockritz, Steve Baethge, Anica Hoegner and Andreas Jung for their excellent technical assistance and Sanna-Maria Kakonen and David Light for carefully reading this paper. This work was in part supported by a grant from the Tumorzentrum Heidelberg-Mannheim to Petra Boukamp.	Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Bergmann M, 2001, CANCER RES, V61, P8188; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; BOUKAMP P, 1990, CANCER RES, V50, P2840; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CASSEL WA, 1965, CANCER, V18, P863, DOI 10.1002/1097-0142(196507)18:7<863::AID-CNCR2820180714>3.0.CO;2-V; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Espina C, 2008, AM J PATHOL, V172, P156, DOI 10.2353/ajpath.2008.070561; Farassati F, 2001, NAT CELL BIOL, V3, P745, DOI 10.1038/35087061; Fiola C, 2006, INT J CANCER, V119, P328, DOI 10.1002/ijc.21821; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gros A, 2008, CANCER RES, V68, P8928, DOI 10.1158/0008-5472.CAN-08-1145; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hoppe S, 2006, J GEN VIROL, V87, P3483, DOI 10.1099/vir.0.82231-0; Hotte SJ, 2007, CLIN CANCER RES, V13, P977, DOI 10.1158/1078-0432.CCR-06-1817; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Kwei KA, 2006, CANCER LETT, V231, P326, DOI 10.1016/j.canlet.2005.02.031; LORENCE RM, 1994, CANCER RES, V54, P6017; Lu XB, 1996, CURR BIOL, V6, P1677, DOI 10.1016/S0960-9822(02)70792-6; Mueller MM, 2001, AM J PATHOL, V159, P1567, DOI 10.1016/S0002-9440(10)62541-2; MUNDSCHAU LJ, 1992, J BIOL CHEM, V267, P23092; Norman KL, 2004, P NATL ACAD SCI USA, V101, P11099, DOI 10.1073/pnas.0404310101; Noser JA, 2007, MOL THER, V15, P1531, DOI 10.1038/sj.mt.6300193; Pecora AL, 2002, J CLIN ONCOL, V20, P2251, DOI 10.1200/JCO.2002.08.042; Puhler F, 2008, GENE THER, V15, P371, DOI 10.1038/sj.gt.3303095; REICHARD KW, 1992, J SURG RES, V52, P448, DOI 10.1016/0022-4804(92)90310-V; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Schirrmacher Volker, 2009, V542, P565, DOI 10.1007/978-1-59745-561-9_30; Schowalter RM, 2006, VIROLOGY, V350, P323, DOI 10.1016/j.virol.2006.01.033; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sinkovics JG, 2000, J CLIN VIROL, V16, P1, DOI 10.1016/S1386-6532(99)00072-4; Smith KD, 2006, J VIROL, V80, P1110, DOI 10.1128/JVI.80.3.1110-1120.2006; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Tang Y, 1999, MOL CELL BIOL, V19, P1881; WHEELOCK EF, 1964, NEW ENGL J MED, V271, P645, DOI 10.1056/NEJM196409242711302; Wilden H, 2009, INT J ONCOL, V34, P971, DOI 10.3892/ijo_00000223	42	43	47	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2205	2216		10.1038/onc.2009.507	http://dx.doi.org/10.1038/onc.2009.507			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101224				2022-12-25	WOS:000276685200006
J	Tajima, K; Ohashi, R; Sekido, Y; Hida, T; Nara, T; Hashimoto, M; Iwakami, S; Minakata, K; Yae, T; Takahashi, F; Saya, H; Takahashi, K				Tajima, K.; Ohashi, R.; Sekido, Y.; Hida, T.; Nara, T.; Hashimoto, M.; Iwakami, S.; Minakata, K.; Yae, T.; Takahashi, F.; Saya, H.; Takahashi, K.			Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells	ONCOGENE			English	Article						osteopontin; mesothelioma; multidrug resistance; hyaluronan; CD44	MALIGNANT PLEURAL MESOTHELIOMA; RANDOMIZED PHASE-II; LUNG-CANCER CELLS; LEUKEMIA GROUP-B; EPITHELIAL-CELLS; PROGNOSTIC-FACTORS; NONSMALL CELL; TUMOR-CELLS; APOPTOSIS; LINES	Malignant pleural mesothelioma (MPM) is resistant to chemotherapy and thus shows a dismal prognosis. Osteopontin (OPN), a secreted noncollagenous and phosphoprotein, is suggested to be involved in the pathogenesis of MPM. However, the precise role of OPN, especially in the multidrug resistance of MPM, remains to be elucidated. We therefore established stable transfectants (ACC-MESO-1/OPN), which constitutively express OPN, to determine its role in the chemoresistance observed in MPM. The introduction of the OPN gene provides MPM cells with upregulated multidrug resistance through the mechanism of enhanced hyaluronate (HA) binding. The expression of CD44 variant isoforms, which inhibit HA binding, significantly decreased in ACC-MESO-1/OPN cells in comparison to control transfectants. Interestingly, the inhibition of the HA-CD44 interaction abrogated multidrug resistance in the ACC-MESO-1/OPN, thus suggesting the involvement of the surviving signal emanating from the HA-CD44 interaction. An enhanced level of the p-Akt in ACCMESO-1/OPN cells was observed, and was diminished by CD44 siRNA. Inhibition of the Akt phosphorylation increased in number of the cells underwent apoptosis induced by NVB, VP-16 and GEM. Collectively, these results indicate that OPN is strongly involved in multidrug resistance by enhancing the CD44 binding to HA. Oncogene (2010) 29, 1941-1951; doi:10.1038/onc.2009.478; published online 18 January 2010	[Tajima, K.; Ohashi, R.; Minakata, K.; Yae, T.; Takahashi, F.; Takahashi, K.] Juntendo Univ, Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo 1138421, Japan; [Tajima, K.; Ohashi, R.; Minakata, K.; Takahashi, F.; Takahashi, K.] Juntendo Univ, Sch Med, Res Inst Dis Old Ages, Bunkyo Ku, Tokyo 1138421, Japan; [Sekido, Y.; Hida, T.] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Nara, T.; Hashimoto, M.] Juntendo Univ, Sch Med, Dept Mol & Cellular Parasitol, Bunkyo Ku, Tokyo 1138421, Japan; [Iwakami, S.] Juntendo Univ, Shizuoka Hosp, Dept Resp Med, Shizuoka, Japan; [Iwakami, S.] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Tokyo, Japan	Juntendo University; Juntendo University; Aichi Cancer Center; Juntendo University; Juntendo University; Keio University	Tajima, K (corresponding author), Juntendo Univ, Sch Med, Dept Resp Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	tajiken@juntendo.ac.jp	Sekido, Yoshitaka/P-9756-2015; Hashimoto, Muneaki/L-6386-2018; Saya, Hideyuki/J-4325-2013	Hashimoto, Muneaki/0000-0001-7215-7558; Saya, Hideyuki/0000-0001-6610-1902; Sekido, Yoshitaka/0000-0002-2428-3848	Ministry of Education, Culture, Sports, Science and Technology of Japan [19590914]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grants-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (K.T. No 19590914).	Boutin C, 1998, EUR RESPIR J, V12, P972, DOI 10.1183/09031936.98.12040972; CHAHINIAN AP, 1993, J CLIN ONCOL, V11, P1559, DOI 10.1200/JCO.1993.11.8.1559; Cook AC, 2006, J BIOL CHEM, V281, P24381, DOI 10.1074/jbc.M602694200; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Elliott Tony, 2002, Expert Rev Anticancer Ther, V2, P449, DOI 10.1586/14737140.2.4.449; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Graessmann M, 2007, ONCOGENE, V26, P2840, DOI 10.1038/sj.onc.1210096; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hughes A, 2002, J CLIN ONCOL, V20, P3533, DOI 10.1200/JCO.2002.10.073; Iida N, 1997, J CELL PHYSIOL, V171, P152, DOI 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.3.CO;2-6; Jackman DM, 2008, CANCER-AM CANCER SOC, V113, P808, DOI 10.1002/cncr.23617; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Kindler HL, 2001, LUNG CANCER-J IASLC, V31, P311, DOI 10.1016/S0169-5002(00)00166-5; Kouniavsky G, 2002, CLIN EXP METASTAS, V19, P55, DOI 10.1023/A:1013880326925; Li Y, 2001, BRIT J CANCER, V85, P600, DOI 10.1054/bjoc.2001.1922; Lokeshwar VB, 1997, CANCER RES, V57, P773; MANZINI VD, 1993, CANCER-AM CANCER SOC, V72, P410, DOI 10.1002/1097-0142(19930715)72:2<410::AID-CNCR2820720216>3.0.CO;2-G; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Ohashi R, 2007, CANCER LETT, V252, P225, DOI 10.1016/j.canlet.2006.12.025; Ohashi R, 2009, ANTICANCER RES, V29, P2205; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; RUFFIE P A, 1991, Current Opinion in Oncology, V3, P328, DOI 10.1097/00001622-199104000-00014; Rusch VW, 1999, ANN THORAC SURG, V68, P1799, DOI 10.1016/S0003-4975(99)01038-3; Russo RIC, 2008, INT J CANCER, V122, P1012, DOI 10.1002/ijc.23122; SAMSON MK, 1987, J CLIN ONCOL, V5, P86, DOI 10.1200/JCO.1987.5.1.86; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Sohara Y, 2001, MOL BIOL CELL, V12, P1859, DOI 10.1091/mbc.12.6.1859; Sugarbaker DJ, 1996, ANN SURG, V224, P288, DOI 10.1097/00000658-199609000-00005; Takahashi F, 2002, INT J CANCER, V98, P707, DOI 10.1002/ijc.10261; Takahashi K, 2003, LUNG CANCER-J IASLC, V41, P145, DOI 10.1016/S0169-5002(03)00224-1; Thylen A, 1997, EUR RESPIR J, V10, P404, DOI 10.1183/09031936.97.10020404; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Uhm JH, 1999, CLIN CANCER RES, V5, P1587; Usami N, 2006, CANCER SCI, V97, P387, DOI 10.1111/j.1349-7006.2006.00184.x; White SC, 2000, ANN ONCOL, V11, P201, DOI 10.1023/A:1008328605413; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	40	38	38	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	13					1941	1951		10.1038/onc.2009.478	http://dx.doi.org/10.1038/onc.2009.478			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20101228				2022-12-25	WOS:000276199600007
J	Lu, X; Bennet, B; Mu, E; Rabinowitz, J; Kang, YB				Lu, Xin; Bennet, Bryson; Mu, Euphemia; Rabinowitz, Joshua; Kang, Yibin			Metabolomic Changes Accompanying Transformation and Acquisition of Metastatic Potential in a Syngeneic Mouse Mammary Tumor Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER METASTASIS; MASS-SPECTROMETRY; METABOLITES; CELLS; BONE; MICE	Breast cancer is the most common cancer type for women in the western world. Despite decades of research, the molecular processes associated with breast cancer progression are still inadequately defined. Here, we focus on the systematic alteration of metabolism by using the state of the art metabolomic profiling techniques to investigate the changes of 157 metabolites during the progression of normal mouse mammary epithelial cells to an isogenic series of mammary tumor cell lines with increasing metastatic potentials. Our results suggest a two-step metabolic progression hypothesis during the acquisition of tumorigenic and metastatic abilities. Metabolite changes accompanying tumor progression are identified in the intracellular and secreted forms in several pathways, including glycolysis, the tricarboxylic acid cycle, the pentose phosphate pathway, fatty acid and nucleotide biosynthesis, and the GSH-dependent antioxidative pathway. These results suggest possible biomarkers of breast cancer progression as well as opportunities of interrupting tumor progression through the targeting of metabolic pathways.	[Kang, Yibin] Princeton Univ, Dept Mol Biol, Champalimaud Metastasis Program, Princeton, NJ 08544 USA; [Bennet, Bryson; Rabinowitz, Joshua] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA; [Bennet, Bryson; Rabinowitz, Joshua] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Kang, Yibin] Canc Inst New Jersey, Breast Canc Program, New Brunswick, NJ 08903 USA	Princeton University; Princeton University; Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, Champalimaud Metastasis Program, Princeton, NJ 08544 USA.	ykang@princeton.edu	lu, xuemin/A-8741-2011; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Kang, Yibin/0000-0002-1626-6730	National Institutes of Health [R01CA134519, R21CA128620]; Brewster Foundation; Department of Defense [BC051647]; Princeton University; NATIONAL CANCER INSTITUTE [R21CA128620, R01CA134519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brewster Foundation; Department of Defense(United States Department of Defense); Princeton University(Princeton University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grant R01CA134519 (to Y.K.) and R21 Grant R21CA128620 (to J.R.). This work was also supported by the Brewster Foundation and a Department of Defense Era of Hope Scholar Award BC051647.; Recipient of a Harold W. Dodds Fellowship from Princeton University.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Filomeni G, 2002, FASEB J, V16, P64, DOI 10.1096/fj.02-0105fje; Filomeni G, 2002, BIOCHEM PHARMACOL, V64, P1057, DOI 10.1016/S0006-2952(02)01176-0; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kang YB, 2005, EXPERT REV MOL DIAGN, V5, P385, DOI 10.1586/14737159.5.3.385; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang Yibin, 2006, Breast Dis, V26, P129; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; OWENS RB, 1974, J NATL CANCER I, V53, P261, DOI 10.1093/jnci/53.1.261; Richardson AD, 2008, BREAST CANCER RES TR, V110, P297, DOI 10.1007/s10549-007-9732-3; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	26	73	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9317	9321		10.1074/jbc.C110.104448	http://dx.doi.org/10.1074/jbc.C110.104448			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20139083	Green Published, hybrid			2022-12-25	WOS:000276165900002
J	Gluschnaider, U; Hidas, G; Cojocaru, G; Yutkin, V; Ben-Neriah, Y; Pikarsky, E				Gluschnaider, Udi; Hidas, Guy; Cojocaru, Gady; Yutkin, Vladimir; Ben-Neriah, Yinon; Pikarsky, Eli			beta-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; ANDROGEN-INDEPENDENT GROWTH; NF-KAPPA-B; BOX PROTEIN BETA-TRCP1; LNCAP CELLS; DEGRADATION; CATENIN; TUMORIGENESIS; PROGRESSION; IDENTIFICATION	Background: Prostate cancer is a common and heterogeneous disease, where androgen receptor (AR) signaling plays a pivotal role in development and progression. The initial treatment for advanced prostate cancer is suppression of androgen signaling. Later on, essentially all patients develop an androgen independent stage which does not respond to anti hormonal treatment. Thus, alternative strategies targeting novel molecular mechanisms are required. beta-TrCP is an E3 ligase that targets various substrates essential for many aspects of tumorigenesis. Methodology/Principal Findings: Here we show that beta-TrCP depletion suppresses prostate cancer and identify a relevant growth control mechanism. shRNA targeted against beta-TrCP reduced prostate cancer cell growth and cooperated with androgen ablation in vitro and in vivo. We found that beta-TrCP inhibition leads to upregulation of the aryl hydrocarbon receptor (AhR) mediating the therapeutic effect. This phenomenon could be ligand independent, as the AhR ligand 2,3,7,8-Tetrachlorodibenzo- p-Dioxin (TCDD) did not alter prostate cancer cell growth. We detected high AhR expression and activation in basal cells and atrophic epithelial cells of human cancer bearing prostates. AhR expression and activation is also significantly higher in tumor cells compared to benign glandular epithelium. Conclusions/Significance: Together these observations suggest that AhR activation may be a cancer counteracting mechanism in the prostate. We maintain that combining b-TrCP inhibition with androgen ablation could benefit advanced prostate cancer patients.	[Gluschnaider, Udi; Hidas, Guy; Cojocaru, Gady; Yutkin, Vladimir; Ben-Neriah, Yinon; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel; [Gluschnaider, Udi; Hidas, Guy; Cojocaru, Gady; Yutkin, Vladimir; Ben-Neriah, Yinon; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91010 Jerusalem, Israel; [Hidas, Guy; Yutkin, Vladimir] Hadassah Hebrew Univ, Med Ctr, Dept Urol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Gluschnaider, U (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel.	peli@hadassah.org.il		pikarsky, eli/0000-0003-4186-7105	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Prostate Cancer Foundation - Israel	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Prostate Cancer Foundation - Israel	This work was supported by grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Prostate Cancer Foundation - Israel and the Prostate Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2001, SEMIN ONCOL, V28, P613, DOI 10.1053/sonc.2001.28609; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Belaidouni N, 2005, ONCOGENE, V24, P2271, DOI 10.1038/sj.onc.1208418; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Cai Y, 2009, CANCER RES, V69, P819, DOI 10.1158/0008-5472.CAN-08-2537; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chesire DR, 2004, CANCER RES, V64, P2523, DOI 10.1158/0008-5472.CAN-03-3309; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; COFFEY DS, 1981, UROLOGY, V17, P17; Deutsch E, 2004, LANCET ONCOL, V5, P303, DOI 10.1016/S1470-2045(04)01468-8; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fritz WA, 2007, CARCINOGENESIS, V28, P497, DOI 10.1093/carcin/bgl179; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gao S, 2005, MOL ENDOCRINOL, V19, P1792, DOI 10.1210/me.2004-0445; Gerstein AV, 2002, GENE CHROMOSOME CANC, V34, P9, DOI 10.1002/gcc.10037; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kizu R, 2003, ARCH TOXICOL, V77, P335, DOI 10.1007/s00204-003-0454-y; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Liang CY, 2006, CELL SIGNAL, V18, P1309, DOI 10.1016/j.cellsig.2005.10.011; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Morrow D, 2004, J STEROID BIOCHEM, V88, P27, DOI 10.1016/j.jsbmb.2003.10.005; Nadiminty N, 2008, PROSTATE, V68, P1725, DOI 10.1002/pros.20839; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Pearson HB, 2009, CANCER RES, V69, P94, DOI 10.1158/0008-5472.CAN-08-2895; Rahman M, 2004, CLIN CANCER RES, V10, P2208, DOI 10.1158/1078-0432.CCR-0746-3; Ray D, 2006, J BIOL CHEM, V281, P23060, DOI 10.1074/jbc.M604311200; Rowland JG, 2007, PROTEOMICS, V7, P47, DOI 10.1002/pmic.200600697; Sadot E, 2000, ONCOGENE, V19, P1992, DOI 10.1038/sj.onc.1203519; Setlur SR, 2005, ADV ANAT PATHOL, V12, P265, DOI 10.1097/01.pap.0000184179.50672.f7; Soldatenkov VA, 1999, CANCER RES, V59, P5085; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Tang WG, 2005, CANCER RES, V65, P1904, DOI 10.1158/0008-5472.CAN-04-2597; Yang X, 2006, ONCOGENE, V25, P3436, DOI 10.1038/sj.onc.1209366; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhang XP, 2009, INT J CANCER, V124, P1980, DOI 10.1002/ijc.24139; Zhou PB, 2005, CURR OPIN CHEM BIOL, V9, P51, DOI 10.1016/j.cbpa.2004.10.012	49	33	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9060	10.1371/journal.pone.0009060	http://dx.doi.org/10.1371/journal.pone.0009060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140206	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442400004
J	Jimenez, RH; Lee, JS; Francesconi, M; Castellani, G; Neretti, N; Sanders, JA; Sedivy, J; Gruppuso, PA				Jimenez, Rosa H.; Lee, Ju-Seog; Francesconi, Mirko; Castellani, Gastone; Neretti, Nicola; Sanders, Jennifer A.; Sedivy, John; Gruppuso, Philip A.			Regulation of Gene Expression in Hepatic Cells by the Mammalian Target of Rapamycin (mTOR)	PLOS ONE			English	Article							C-MYC; IMMUNOGLOBULIN ENHANCER; RAT-LIVER; GROWTH; TOR; TRANSCRIPTION; NUTRIENT; CYCLE; IDENTIFICATION; COMPLEXES	Background: We investigated mTOR regulation of gene expression by studying rapamycin effect in two hepatic cell lines, the non-tumorigenic WB-F344 cells and the tumorigenic WB311 cells. The latter are resistant to the growth inhibitory effects of rapamycin, thus providing us with an opportunity to study the gene expression effects of rapamycin without confounding effects on cell proliferation. Methodology/Principal Findings: The hepatic cells were exposed to rapamycin for 24 hr. Microarray analysis on total RNA preparations identified genes that were affected by rapamycin in both cell lines and, therefore, modulated independent of growth arrest. Further studies showed that the promoter regions of these genes included E-box-containing transcription factor binding sites at higher than expected rates. Based on this, we tested the hypothesis that c-Myc is involved in regulation of gene expression by mTOR by comparing genes altered by rapamycin in the hepatic cells and by c-Myc induction in fibroblasts engineered to express c-myc in an inducible manner. Results showed enrichment for c-Myc targets among rapamycin sensitive genes in both hepatic cell lines. However, microarray analyses on wild type and c-myc null fibroblasts showed similar rapamycin effect, with the set of rapamycin-sensitive genes being enriched for c-Myc targets in both cases. Conclusions/Significance: There is considerable overlap in the regulation of gene expression by mTOR and c-Myc. However, regulation of gene expression through mTOR is c-Myc-independent and cannot be attributed to the involvement of specific transcription factors regulated by the rapamycin-sensitive mTOR Complex 1.	[Jimenez, Rosa H.; Sanders, Jennifer A.; Gruppuso, Philip A.] Brown Univ, Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Francesconi, Mirko; Castellani, Gastone] Univ Bologna, Interdepartmental Ctr L Galvani, Bologna, Italy; [Neretti, Nicola] Brown Univ, Inst Brain & Neural Syst, Providence, RI 02912 USA; [Neretti, Nicola; Sedivy, John] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Neretti, Nicola; Sedivy, John] Brown Univ, Ctr Genom & Prote, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Bologna; Brown University; Brown University; Brown University	Gruppuso, PA (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA.	Philip_Gruppuso@brown.edu	Lee, Ju-Seog/X-1786-2018; francesconi, mirko/O-8080-2015; Castellani, Gastone c/L-3333-2017	Lee, Ju-Seog/0000-0002-5666-9753; francesconi, mirko/0000-0002-8702-0877; Castellani, Gastone c/0000-0003-4892-925X; Sanders, Jennifer/0000-0002-4714-5114; Neretti, Nicola/0000-0002-9552-1663	National Research Service Award (NRSA) [F31HD041893]; National Institutes of Health [R01HD024455, R01HD035831]; Ministry of Science and Technology in Korea [1R01AG035328, K25AG028753, P20RR017695]; National Institute of Nuclear Physics (INFN); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD024455] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035831, F31HD041893] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG028753, R01AG035328] Funding Source: NIH RePORTER	National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology in Korea(Ministry of Science & Technology (MOST), Republic of Korea); National Institute of Nuclear Physics (INFN)(Istituto Nazionale di Fisica Nucleare (INFN)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	R.H.J. is supported by National Research Service Award (NRSA) grant F31HD041893. Additional support was provided by National Institutes of Health grants R01HD024455 and R01HD035831 (to P. G.), 1R01AG035328 (to J. S.), K25AG028753 (to N. N.) and P20RR017695 to J. A. S. J.-S. Lee is supported by FG-4-2 of the 21C Frontier Functional Human Genome Project from the Ministry of Science and Technology in Korea. G. Castellani is supported by grants from the National Institute of Nuclear Physics (INFN) in support of the SHEILA and EXCALIBUR projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Sempere MC, 2008, CLIN TRANSL ONCOL, V10, P143, DOI 10.1007/s12094-008-0171-3; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Francesconi M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S9; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Ikezoe T, 2007, LEUKEMIA RES, V31, P673, DOI 10.1016/j.leukres.2006.08.001; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; LEE LW, 1989, AM J PATHOL, V135, P63; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Murooka TT, 2009, BIOCHEM BIOPH RES CO, V387, P381, DOI 10.1016/j.bbrc.2009.07.035; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; PROUTY SM, 1993, ONCOGENE, V8, P899; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Ravitz MJ, 2007, CANCER RES, V67, P11209, DOI 10.1158/0008-5472.CAN-06-4351; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sanders JA, 2006, AM J PHYSIOL-GASTR L, V290, pG145, DOI 10.1152/ajpgi.00545.2004; Schmidt EV, 2009, CELL CYCLE, V8, P1344, DOI 10.4161/cc.8.9.8215; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Veerla S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-384; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102	45	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9084	10.1371/journal.pone.0009084	http://dx.doi.org/10.1371/journal.pone.0009084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140209	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442400020
J	Leliveld, LMC; Scheumann, M; Zimmermann, E				Leliveld, Lisette M. C.; Scheumann, Marina; Zimmermann, Elke			Effects of Caller Characteristics on Auditory Laterality in an Early Primate (Microcebus murinus)	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; CONSPECIFIC VOCALIZATIONS; ORIENTING ASYMMETRIES; JAPANESE MACAQUES; NEURAL LATERALIZATION; SOCIAL RECOGNITION; RHESUS-MONKEYS; ADVANTAGE; CORTEX; DISCRIMINATION	Background: Auditory laterality is suggested to be characterized by a left hemisphere dominance for the processing of conspecific communication. Nevertheless, there are indications that auditory laterality can also be affected by communicative significance, emotional valence and social recognition. Methodology/Principal Findings: In order to gain insight into the effects of caller characteristics on auditory laterality in the early primate brain, 17 gray mouse lemurs were tested in a head turn paradigm. The head turn paradigm was established to examine potential functional hemispheric asymmetries on the behavioral level. Subjects were presented with playbacks of two conspecific call types (tsak calls and trill calls) from senders differing in familiarity (unfamiliar vs. familiar) and sex (same sex vs. other sex). Based on the head turn direction towards these calls, evidence was found for a right ear/left hemisphere dominance for the processing of calls of the other sex (Binomial test: p = 0.021, N = 10). Familiarity had no effect on the orientation biases. Conclusions/Significance: The findings in this study support the growing consensus that auditory laterality is not only determined by the acoustic processing of conspecific communication, but also by other factors like the sex of the sender.	[Leliveld, Lisette M. C.; Scheumann, Marina; Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Leliveld, Lisette M. C.; Zimmermann, Elke] Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Leliveld, LMC (corresponding author), Univ Vet Med Hannover, Inst Zool, Hannover, Germany.	Lisette.Maria.Charlotte.Leliveld@tiho-hannover.de		Leliveld, Lisette/0000-0002-1299-0748; Scheumann, Marina/0000-0002-4091-9500	European Commission [MEST-CT-2005-021014]; German Research Foundation [FOR 499, GK 289]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation(German Research Foundation (DFG))	This work was supported by the European Commission, Community's Sixth Framework Programme, Marie Curie Fellowship for Early Stage Research Training under contract no. MEST-CT-2005-021014, and by the German Research Foundation (DFG; FOR 499 and GK 289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenmuller E, 2002, NEUROPSYCHOLOGIA, V40, P2242, DOI 10.1016/S0028-3932(02)00107-0; Basile M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006295; Basile M, 2009, ANIM COGN, V12, P611, DOI 10.1007/s10071-009-0220-5; BEECHER MD, 1979, BRAIN BEHAV EVOLUT, V16, P443, DOI 10.1159/000121881; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Bethmann A, 2007, BRAIN RES, V1133, P145, DOI 10.1016/j.brainres.2006.11.057; Bisazza A, 1998, BEHAV BRAIN RES, V91, P157, DOI 10.1016/S0166-4328(97)00114-9; Boye M, 2005, EUR J NEUROSCI, V21, P1727, DOI 10.1111/j.1460-9568.2005.04005.x; Brudzynski SM, 2009, HDB MAMMALIAN VOCALI, P215; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1372, DOI 10.1073/pnas.89.4.1372; Deng C, 2002, ANIM BEHAV, V63, P697, DOI 10.1006/anbe.2001.1942; EcklundFlores L, 1996, DEV PSYCHOBIOL, V29, P205, DOI 10.1002/(SICI)1098-2302(199604)29:3<205::AID-DEV2>3.0.CO;2-V; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Ghazanfar AA, 1999, TRENDS COGN SCI, V3, P377, DOI 10.1016/S1364-6613(99)01379-0; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Gil-da-Costa R, 2006, P ROY SOC B-BIOL SCI, V273, P2313, DOI 10.1098/rspb.2006.3580; Hauser MD, 1998, ANIM BEHAV, V56, P41, DOI 10.1006/anbe.1998.0738; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; HEFFNER HE, 1986, J NEUROPHYSIOL, V56, P683, DOI 10.1152/jn.1986.56.3.683; LANDIS T, 1982, NEUROPSYCHOLOGIA, V20, P501, DOI 10.1016/0028-3932(82)90049-5; LELIVELD LMC, ACOUSTIC CORRE UNPUB; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; MARTIN RD, 1972, BEHAV ECOLOGY NOCTUR, P43; Palleroni A, 2003, SCIENCE, V299, P1195, DOI 10.1126/science.1078813; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; PETERSEN MR, 1984, BEHAV NEUROSCI, V98, P779, DOI 10.1037/0735-7044.98.5.779; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Rukstalis M, 2005, HORM BEHAV, V47, P1, DOI 10.1016/j.yhbeh.2004.09.004; Scheumann M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-3; Siniscalchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003349; Sproul C, 2006, ANIM BEHAV, V72, P1379, DOI 10.1016/j.anbehav.2006.04.006; Teufel C, 2007, ANIM BEHAV, V73, P249, DOI 10.1016/j.anbehav.2006.04.011; VALLORTIGARA G, 1991, ANIM BEHAV, V41, P187, DOI 10.1016/S0003-3472(05)80470-1; VANLANCKER D, 1987, NEUROPSYCHOLOGIA, V25, P829, DOI 10.1016/0028-3932(87)90120-5; Ventolini N, 2005, ANIM BEHAV, V69, P1077, DOI 10.1016/j.anbehav.2004.09.003; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; Wrogemann D, 2001, INT J PRIMATOL, V22, P91, DOI 10.1023/A:1026418132281; Yasin I, 2007, NEUROPSYCHOLOGIA, V45, P2718, DOI 10.1016/j.neuropsychologia.2007.04.009; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zucca P, 2008, CORTEX, V44, P13, DOI 10.1016/j.cortex.2006.01.002	45	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9031	10.1371/journal.pone.0009031	http://dx.doi.org/10.1371/journal.pone.0009031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140257	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474200017
J	Ali, MS; Hammonds, J; Ding, LM; Spearman, P				Ali, Mohammed S.; Hammonds, Jason; Ding, Lingmei; Spearman, Paul			CAML Does Not Modulate Tetherin-Mediated Restriction of HIV-1 Particle Release	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VPU PROTEIN; CYCLOPHILIN LIGAND; MOLECULAR-CLONING; INHIBITS HIV-1; CELL-SURFACE; DEGRADATION; CD4; MECHANISM; DOMAIN	Background: Tetherin/BST-2 is a recently-identified potent restriction factor in human cells that restricts HIV particle release following particle formation and budding at the plasma membrane. Vpu counteracts tetherin's restriction of particle release in a manner that has not yet been fully defined. We recently identified calcium-modulating cyclophilin ligand (CAML) as a Vpu-interacting protein that also restricts particle release. We hypothesized that CAML may act to enhance tetherin-mediated restriction of particle release and thereby explain how two distinct factors could be responsible for Vpu-responsive restriction. Methodology/Principal Findings: Endogenous levels of tetherin in human cells correlated well with their restriction pattern and responsiveness to Vpu, while levels of cellular CAML protein did not. Tetherin but not CAML was inducible by interferon in a wide variety of human cells. Stable depletion of human CAML in restrictive HeLa cells had no effect on cell surface levels of tetherin, and failed to relieve tetherin-mediated restriction. Stable depletion of tetherin from HeLa cells, in contrast, rendered HeLa cells permissive and Vpu-unresponsive. Tetherin but not CAML expression in permissive human cells rendered them restrictive and Vpu responsive. Depletion of CAML had no influence on cell surface levels of tetherin. Conclusions/Significance: We conclude that tetherin restricts particle release and does not require CAML for this effect. Furthermore, these results do not support a major role for CAML in restricting HIV particle release in human cells.	[Ali, Mohammed S.; Hammonds, Jason; Ding, Lingmei; Spearman, Paul] Emory Univ & Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA	Children's Healthcare of Atlanta (CHOA); Emory University	Ali, MS (corresponding author), William Beaumont Army Med Ctr, Dept Clin Invest, El Paso, TX 79920 USA.	Paul.spearman@emory.edu	Hammonds, Jason/AAC-5330-2019	Hammonds, Jason/0000-0002-1649-9008	National Institutes of Health (NIH) [R01 AI58828]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) R01 AI58828. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bego MG, 2009, J VIROL, V83, P13032, DOI 10.1128/JVI.01786-09; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Holloway MP, 1998, J BIOL CHEM, V273, P16346, DOI 10.1074/jbc.273.26.16346; Holloway MP, 1996, J BIOL CHEM, V271, P8549, DOI 10.1074/jbc.271.15.8549; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Schwartz MD, 1996, VIROLOGY, V224, P302, DOI 10.1006/viro.1996.0532; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Varthakavi V, 2008, NAT MED, V14, P641, DOI 10.1038/nm1778; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9005	10.1371/journal.pone.0009005	http://dx.doi.org/10.1371/journal.pone.0009005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126395	Green Published, Green Submitted, gold			2022-12-25	WOS:000274207200006
J	Lavasani, S; Dzhambazov, B; Nouri, M; Fak, F; Buske, S; Molin, G; Thorlacius, H; Alenfall, J; Jeppsson, B; Westrom, B				Lavasani, Shahram; Dzhambazov, Balik; Nouri, Mehrnaz; Fak, Frida; Buske, Sophia; Molin, Goran; Thorlacius, Henrik; Alenfall, Jan; Jeppsson, Bengt; Westrom, Bjorn			A Novel Probiotic Mixture Exerts a Therapeutic Effect on Experimental Autoimmune Encephalomyelitis Mediated by IL-10 Producing Regulatory T Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LACTOBACILLUS-CASEI; NATURAL RECOVERY; SUPPRESSION; MECHANISMS; DISEASE; INTERLEUKIN-10; INFLAMMATION; PROTECTION; TOLERANCE	Background: Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS). One potential therapeutic strategy for MS is to induce regulatory cells that mediate immunological tolerance. Probiotics, including lactobacilli, are known to induce immunomodulatory activity with promising effects in inflammatory diseases. We tested the potential of various strains of lactobacilli for suppression of experimental autoimmune encephalomyelitis (EAE), an animal model of MS. Methodology/Principal Findings: The preventive effects of five daily-administered strains of lactobacilli were investigated in mice developing EAE. After a primary screening, three Lactobacillus strains, L. paracasei DSM 13434, L. plantarum DSM 15312 and DSM 15313 that reduced inflammation in CNS and autoreactive T cell responses were chosen. L. paracasei and L. plantarum DSM 15312 induced CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) in mesenteric lymph nodes (MLNs) and enhanced production of serum TGF-beta 1, while L. plantarum DSM 15313 increased serum IL-27 levels. Further screening of the chosen strains showed that each monostrain probiotic failed to be therapeutic in diseased mice, while a mixture of the three lactobacilli strains suppressed the progression and reversed the clinical and histological signs of EAE. The suppressive activity correlated with attenuation of pro-inflammatory Th1 and Th17 cytokines followed by IL-10 induction in MLNs, spleen and blood. Additional adoptive transfer studies demonstrated that IL-10 producing CD4(+)CD25(+) Tregs are involved in the suppressive effect induced by the lactobacilli mixture. Conclusions/Significance: Our data provide evidence showing that the therapeutic effect of the chosen mixture of probiotic lactobacilli was associated with induction of transferable tolerogenic Tregs in MLNs, but also in the periphery and the CNS, mediated through an IL-10-dependent mechanism. Our findings indicate a therapeutic potential of oral administration of a combination of probiotics and provide a more complete understanding of the host-commensal interactions that contribute to beneficial effects in autoimmune diseases.	[Lavasani, Shahram; Fak, Frida; Buske, Sophia; Westrom, Bjorn] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Dzhambazov, Balik] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Lavasani, Shahram; Nouri, Mehrnaz; Thorlacius, Henrik; Jeppsson, Bengt] Lund Univ, Surg Res Unit, Clin Res Ctr, Dept Clin Sci, Malmo, Sweden; [Molin, Goran] Lund Univ, Ctr Chem, Dept Food Technol Engn & Nutr, Lund, Sweden; [Alenfall, Jan] Probi AB, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Lavasani, S (corresponding author), Lund Univ, Dept Cell & Organism Biol, Lund, Sweden.	Shahram.Lavasani@med.lu.se	Dzhambazov, Balik/H-1220-2015; Weström, Björn R/N-2232-2016	Dzhambazov, Balik/0000-0001-8052-5840; Weström, Björn R/0000-0001-9296-2845; Lavasani, Shahram/0000-0003-4922-9351	Royal Physiographic Society (Lund, Sweden); Knut och Alice Wallenbergs Stiftelse (Sweden)	Royal Physiographic Society (Lund, Sweden); Knut och Alice Wallenbergs Stiftelse (Sweden)(Knut & Alice Wallenberg Foundation)	This project was partially financed by grants from the Royal Physiographic Society (Lund, Sweden) and resources provided by Knut och Alice Wallenbergs Stiftelse (Sweden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 1996, APPL ENVIRON MICROB, V62, P2244, DOI 10.1128/AEM.62.7.2244-2251.1996; Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Alvarez S, 2001, J FOOD PROTECT, V64, P1768, DOI 10.4315/0362-028X-64.11.1768; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; Boyle RJ, 2006, CLIN EXP ALLERGY, V36, P568, DOI 10.1111/j.1365-2222.2006.02472.x; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Durkin HG, 2001, IMMUNOL REV, V182, P33, DOI 10.1034/j.1600-065X.2001.1820103.x; El Behi M, 2005, IMMUNOL LETT, V96, P11, DOI 10.1016/j.imlet.2004.07.017; Erickson KL, 2000, J NUTR, V130, p403S, DOI 10.1093/jn/130.2.403S; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gionchetti P, 2001, CURR OPIN GASTROEN, V17, P331, DOI 10.1097/00001574-200107000-00006; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hemmer B, 2006, NAT CLIN PRACT NEURO, V2, P201, DOI 10.1038/ncpneuro0154; Isolauri E, 2001, AM J CLIN NUTR, V73, p444S, DOI 10.1093/ajcn/73.2.444s; ISOLAURI E, 1991, PEDIATRICS, V88, P90; Isolauri E, 2002, CURR OPIN ALLERGY CL, V2, P263, DOI 10.1097/00130832-200206000-00018; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; JOHNS LD, 1991, J IMMUNOL, V147, P1792; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Maassen CBM, 2008, VACCINE, V26, P2056, DOI 10.1016/j.vaccine.2008.02.035; Madsen KL, 2001, CAN J GASTROENTEROL, V15, P817, DOI 10.1155/2001/690741; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; MOLIN G, 1993, J APPL BACTERIOL, V74, P314, DOI 10.1111/j.1365-2672.1993.tb03031.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Nicholson LB, 1997, P NATL ACAD SCI USA, V94, P9279, DOI 10.1073/pnas.94.17.9279; O'Neill EJ, 2006, J NEUROIMMUNOL, V178, P1, DOI 10.1016/j.jneuroim.2006.05.030; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; POWRIE F, 1993, EUR J IMMUNOL, V23, P3043, DOI 10.1002/eji.1830231147; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Runstrom A, 2006, J NEUROIMMUNOL, V173, P69, DOI 10.1016/j.jneuroim.2005.11.023; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Soldan SS, 2004, J NEUROIMMUNOL, V146, P209, DOI 10.1016/j.jneuroim.2003.10.033; Steinman L, 1999, NEURON, V24, P511, DOI 10.1016/S0896-6273(00)81107-1; Timmerman HM, 2007, CLIN NUTR, V26, P450, DOI 10.1016/j.clnu.2007.04.008; Timmerman HM, 2004, INT J FOOD MICROBIOL, V96, P219, DOI 10.1016/j.ijfoodmicro.2004.05.012; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zou LP, 2002, NEUROPHARMACOLOGY, V42, P731, DOI 10.1016/S0028-3908(02)00015-1	60	295	307	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9009	10.1371/journal.pone.0009009	http://dx.doi.org/10.1371/journal.pone.0009009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126401	Green Published, gold, Green Submitted			2022-12-25	WOS:000274207200008
J	Csibi, A; Cornille, K; Leibovitch, MP; Poupon, A; Tintignac, LA; Sanchez, AMJ; Leibovitch, SA				Csibi, Alfredo; Cornille, Karen; Leibovitch, Marie-Pierre; Poupon, Anne; Tintignac, Lionel A.; Sanchez, Anthony M. J.; Leibovitch, Serge A.			The Translation Regulatory Subunit eIF3f Controls the Kinase-Dependent mTOR Signaling Required for Muscle Differentiation and Hypertrophy in Mouse	PLOS ONE			English	Article							INITIATION-FACTOR 3F; MAMMALIAN TARGET; BINDING PARTNER; S6 KINASE; SKELETAL; ATROPHY; TOR; RAPTOR; GROWTH; PHOSPHORYLATION	The mTORC1 pathway is required for both the terminal muscle differentiation and hypertrophy by controlling the mammalian translational machinery via phosphorylation of S6K1 and 4E-BP1. mTOR and S6K1 are connected by interacting with the eIF3 initiation complex. The regulatory subunit eIF3f plays a major role in muscle hypertrophy and is a key target that accounts for MAFbx function during atrophy. Here we present evidence that in MAFbx-induced atrophy the degradation of eIF3f suppresses S6K1 activation by mTOR, whereas an eIF3f mutant insensitive to MAFbx polyubiquitination maintained persistent phosphorylation of S6K1 and rpS6. During terminal muscle differentiation a conserved TOS motif in eIF3f connects mTOR/raptor complex, which phosphorylates S6K1 and regulates downstream effectors of mTOR and Cap-dependent translation initiation. Thus eIF3f plays a major role for proper activity of mTORC1 to regulate skeletal muscle size.	[Csibi, Alfredo; Cornille, Karen; Leibovitch, Marie-Pierre; Tintignac, Lionel A.; Leibovitch, Serge A.] SupAgro INRA, Differenciat Cellulaire & Croissance UMR866, Lab Genom Fonct & Myogenese, Montpellier, France; [Poupon, Anne] INRA, UMR Physiol Reprod & Comportements, F-37380 Nouzilly, France; [Sanchez, Anthony M. J.] SupAgro INRA, Differenciat Cellulaire & Croissance UMR866, Equipe Remodelage Musculaire & Signalisat, Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; INRAE; INRAE; Institut Agro; Montpellier SupAgro	Csibi, A (corresponding author), Univ Montpellier Sud France, Montpellier, France.	leibovs@supagro.inra.fr	Sanchez, Anthony MJ/N-8092-2019	Sanchez, Anthony MJ/0000-0003-3054-6349; Poupon, Anne/0000-0003-0617-0935; Tintignac, Lionel/0000-0001-5902-1138	Association Francaise contre les Myopathies (AFM); Institut Nationale de la Recherche Agronomique (INRA); Institut National de la Sante et de la Recherche Medicale (INSERM)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Institut Nationale de la Recherche Agronomique (INRA); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from the Association Francaise contre les Myopathies (AFM), the department of Phyiologie Animale et Systeme d'Elevage (PHASE) from Institut Nationale de la Recherche Agronomique (INRA) and the Institut National de la Sante et de la Recherche Medicale (INSERM). Mrs A. Csibi is a graduate of an AFM and INRA fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Csibi A, 2008, CELL CYCLE, V7, P1698, DOI 10.4161/cc.7.12.6090; Csibi A, 2009, J BIOL CHEM, V284, P4413, DOI 10.1074/jbc.M807641200; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; GOLDSPINK DF, 1983, BIOCHEM J, V210, P89, DOI 10.1042/bj2100089; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Reynaud EG, 2000, J BIOL CHEM, V275, P18767, DOI 10.1074/jbc.M907412199; Richardson CJ, 2004, SEMIN CELL DEV BIOL, V15, P147, DOI 10.1016/j.semcdb.2003.12.023; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sanches M, 2007, J MOL BIOL, V370, P846, DOI 10.1016/j.jmb.2007.04.084; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Shi JQ, 2009, FEBS LETT, V583, P971, DOI 10.1016/j.febslet.2009.02.028; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Valente ST, 2009, P NATL ACAD SCI USA, V106, P4071, DOI 10.1073/pnas.0900557106; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308	54	73	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8994	10.1371/journal.pone.0008994	http://dx.doi.org/10.1371/journal.pone.0008994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126553	gold, Green Submitted, Green Published			2022-12-25	WOS:000274209700020
J	Bishop, SC; Woolliams, JA				Bishop, Stephen C.; Woolliams, John A.			On the Genetic Interpretation of Disease Data	PLOS ONE			English	Article							ATLANTIC SALMON; RESISTANCE; SUSCEPTIBILITY; TUBERCULOSIS; PARAMETERS; CATTLE; RISK	Background: The understanding of host genetic variation in disease resistance increasingly requires the use of field data to obtain sufficient numbers of phenotypes. We introduce concepts necessary for a genetic interpretation of field disease data, for diseases caused by microparasites such as bacteria or viruses. Our focus is on variance component estimation and we introduce epidemiological concepts to quantitative genetics. Methodology/Principal Findings: We have derived simple deterministic formulae to predict the impacts of incomplete exposure to infection, or imperfect diagnostic test sensitivity and specificity on heritabilities for disease resistance. We show that these factors all reduce the estimable heritabilities. The impacts of incomplete exposure depend on disease prevalence but are relatively linear with the exposure probability. For prevalences less than 0.5, imperfect diagnostic test sensitivity results in a small underestimation of heritability, whereas imperfect specificity leads to a much greater underestimation, with the impact increasing as prevalence declines. These impacts are reversed for prevalences greater than 0.5. Incomplete data recording in which infected or diseased individuals are not observed, e. g. data recording for too short a period, has impacts analogous to imperfect sensitivity. Conclusions/Significance: These results help to explain the often low disease resistance heritabilities observed under field conditions. They also demonstrate that incomplete exposure to infection, or suboptimal diagnoses, are not fatal flaws for demonstrating host genetic differences in resistance, they merely reduce the power of datasets. Lastly, they provide a tool for inferring the true extent of genetic variation in disease resistance given knowledge of the disease biology.	[Bishop, Stephen C.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Bishop, SC (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	Stephen.Bishop@roslin.ed.ac.uk	Bishop, Stephen/C-8487-2013		Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish; BBSRC [BBS/E/D/05191133] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors were funded by the Biotechnology and Biological Sciences Research Council (BBSRC), via The Roslin Institute's Institute Strategic Programme Grant (ISPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; BISHOP SC, 2005, ENCY ANIMAL SCI, P288; Clapperton M, 2008, ANIMAL, V2, P1575, DOI 10.1017/S1751731108002929; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; DETILLEUX JC, 1994, J DAIRY SCI, V77, P2640, DOI 10.3168/jds.S0022-0302(94)77205-2; Gianola D, 2006, GENETICS, V173, P2247, DOI 10.1534/genetics.105.054197; Guy DR, 2009, AQUACULTURE, V290, P229, DOI 10.1016/j.aquaculture.2009.02.015; Henryon M, 2006, ANIM SCI, V82, P597, DOI 10.1079/ASC200671; Henryon M, 2003, LIVEST PROD SCI, V83, P121, DOI 10.1016/S0301-6226(03)00053-8; Henryon M, 2001, ANIM SCI, V73, P375, DOI 10.1017/S1357729800058343; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Kjoglum S, 2008, AQUAC RES, V39, P498, DOI 10.1111/j.1365-2109.2008.01904.x; Lynch M., 1998, GENETICS ANAL QUANTI; NOORDHUIZEN JPT, 1997, APPL QUANTITATIVE ME; ROBERTSON A, 1949, GENETICS, V34, P395; Rupp R, 2003, VET RES, V34, P671, DOI 10.1051/vetres:2003020; Segal S, 2003, TRENDS MICROBIOL, V11, P445, DOI 10.1016/S0966-842X(03)00207-5; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Trammell RA, 2008, EXPERT REV MOL DIAGN, V8, P515, DOI 10.1586/14737159.8.4.515	21	79	84	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8940	10.1371/journal.pone.0008940	http://dx.doi.org/10.1371/journal.pone.0008940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126627	Green Submitted, Green Published, gold			2022-12-25	WOS:000274138000017
J	Caruso, F; Darnowski, JW; Opazo, C; Goldberg, A; Kishore, N; Agoston, ES; Rossi, M				Caruso, Francesco; Darnowski, James W.; Opazo, Cristian; Goldberg, Alexander; Kishore, Nina; Agoston, Elin S.; Rossi, Miriam			Taurolidine Antiadhesive Properties on Interaction with E. coli; Its Transformation in Biological Environment and Interaction with Bacteria Cell Wall	PLOS ONE			English	Article							FORMALDEHYDE-INDUCED MODIFICATIONS; ESCHERICHIA-COLI; IN-VITRO; ADHESION; IDENTIFICATION; PERITONEAL; MOLECULES; MODEL; APPROXIMATION; CONSERVATION	The taurine amino-acid derivative, taurolidine, bis-(1,1-dioxoperhydro-1,2,4-thiabiazinyl-4)methane, shows broad antibacterial action against gram-positive and gram-negative bacteria, mycobacteria and some clinically relevant fungi. It inhibits, in vitro, the adherence of Escherichia coli and Staphylococcus aureus to human epithelial and fibroblast cells. Taurolidine is unstable in aqueous solution and breaks down into derivatives which are thought to be responsible for the biological activity. To understand the taurolidine antibacterial mechanism of action, we provide the experimental single crystal X-ray diffraction results together with theoretical methods to characterize the hydrolysis/decomposition reactions of taurolidine. The crystal structure features two independent molecules linked through intermolecular H-bonds with one of them somewhat positively charged. Taurolidine in a biological environment exists in equilibrium with taurultam derivatives and this is described theoretically as a 2-step process without an energy barrier: formation of cationic taurolidine followed by a nucleophilic attack of O(hydroxyl) on the exocyclic C(methylene). A concerted mechanism describes the further hydrolysis of the taurolidine derivative methylol-taurultam. The interaction of methylol-taurultam with the diaminopimelic NH2 group in the E. coli bacteria cell wall (peptidoglycan) has a negative Delta G value (-38.2 kcal/mol) but a high energy barrier (45.8 kcal/mol) suggesting no reactivity. On the contrary, taurolidine docking into E. coli fimbriae protein, responsible for bacteria adhesion to the bladder epithelium, shows it has higher affinity than mannose (the natural substrate), whereas methyloltaurultam and taurultam are less tightly bound. Since taurolidine is readily available because it is administered in high doses after peritonitis surgery, it may successfully compete with mannose explaining its effectiveness against bacterial infections at laparoscopic lesions.	[Caruso, Francesco] CNR, Ist Chim Biomol, Rome, Italy; [Darnowski, James W.] Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA; [Darnowski, James W.] Brown Univ, Providence, RI 02912 USA; [Opazo, Cristian] Vassar Coll, Acad Comp Serv, Poughkeepsie, NY 12601 USA; [Goldberg, Alexander] Accelrys Inc, San Diego, CA USA; [Kishore, Nina; Agoston, Elin S.; Rossi, Miriam] Vassar Coll, Dept Chem, Poughkeepsie, NY 12601 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Vassar College; BIOVIA; Vassar College	Caruso, F (corresponding author), CNR, Ist Chim Biomol, Rome, Italy.	caruso@vassar.edu; rossi@vassar.edu		Kishore, Nina/0000-0002-8283-6201; Rossi, Miriam/0000-0001-9609-474X	Camille and Henri Dreyfus Foundation; Vassar College; Consiglio Nazionale delle Ricereche	Camille and Henri Dreyfus Foundation; Vassar College; Consiglio Nazionale delle Ricereche	This work was supported by the Camille and Henri Dreyfus Foundation Special Grant for Chemical Sciences, and the institutions where authors are employed, specifically Vassar College (Committee on Research) and Consiglio Nazionale delle Ricereche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM SN, 1987, J BACTERIOL, V169, P5530, DOI 10.1128/jb.169.12.5530-5536.1987; ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0; ABRAHAM SN, 1992, J BACTERIOL, V174, P5145, DOI 10.1128/JB.174.15.5145-5148.1992; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bobrich E, 2007, J SURG RES, V137, P75, DOI 10.1016/j.jss.2006.07.013; Braumann C, 2003, CLIN EXP METASTAS, V20, P387, DOI 10.1023/A:1025402919341; Braumann C, 2007, J SURG RES, V143, P372, DOI 10.1016/j.jss.2007.01.041; Braumann Chris, 2006, World J Surg Oncol, V4, P34, DOI 10.1186/1477-7819-4-34; BROWN SJ, 1985, J FINANC ECON, V14, P3, DOI 10.1016/0304-405X(85)90042-X; BROWNE MK, 1985, NEW CONCEPT ANTIMICR, P51; Calabresi P, 2001, CANCER RES, V61, P6816; CAMALLI M, 1994, J APPL CRYSTALLOGR, V27, P861; Da Costa ML, 2001, J SURG RES, V101, P111, DOI 10.1006/jsre.2001.6250; Darnowski JW, 2004, CANCER CHEMOTH PHARM, V54, P249, DOI 10.1007/s00280-004-0806-1; DARNOWSKI JW, 2 PATIENTS TRE UNPUB; Delley B, 1996, J PHYS CHEM-US, V100, P6107, DOI 10.1021/jp952713n; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; DUPONT L, 1995, ACTA CRYSTALLOGR C, V51, P2412, DOI 10.1107/S0108270195008006; GARDINER KR, 1994, HEPATO-GASTROENTEROL, V41, P554; GIDLEY MJ, 1981, FEBS LETT, V127, P225, DOI 10.1016/0014-5793(81)80211-6; GORMAN SP, 1987, J APPL BACTERIOL, V62, P315, DOI 10.1111/j.1365-2672.1987.tb04926.x; GORMAN SP, 1987, LETT APPL MICROBIOL, V4, P103, DOI 10.1111/j.1472-765X.1987.tb01593.x; HAGBERG L, 1981, INFECT IMMUN, V31, P564, DOI 10.1128/IAI.31.2.564-570.1981; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Jacobi CA, 1997, AM J SURG, V174, P359, DOI 10.1016/S0002-9610(97)00099-8; KEITH BR, 1986, INFECT IMMUN, V53, P693, DOI 10.1128/IAI.53.3.693-696.1986; KILLEAN RCG, 1971, ACTA CRYSTALL B-STRU, VB 27, P1707, DOI 10.1107/S0567740871004680; Koldehoff A, 2004, INT J ANTIMICROB AG, V24, P491, DOI 10.1016/j.ijantimicag.2004.06.006; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; LOWE G, 1988, J AM CHEM SOC, V110, P8512, DOI 10.1021/ja00233a030; MAIN P, 1978, SYSTEM COMPUTER PROG; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Metz B, 2006, BIOCONJUGATE CHEM, V17, P815, DOI 10.1021/bc050340f; MOSER G, 1978, SCHWEIZ RUNDSCH MED, V67, P425; NICI L, 2000, CLIN CANCER RES, V10, P7655; Oguz H, 2004, CURR EYE RES, V28, P225, DOI 10.1076/ceyr.28.4.225.27833; OROURKE N, 1993, LANCET, V342, P368, DOI 10.1016/0140-6736(93)91511-J; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; PFIRRMANN R, 1999, Patent No. 9934805; Shrayer DP, 2003, ANTI-CANCER DRUG, V14, P295, DOI 10.1097/00001813-200304000-00007; Stendel R, 2004, ANTICANCER RES, V24, P1143; Stendel R, 2002, ANTICANCER RES, V22, P809; Tarhan OR, 2008, J SURG RES, V144, P151, DOI 10.1016/j.jss.2007.09.006; Torres-Viera C, 2000, ANTIMICROB AGENTS CH, V44, P1720, DOI 10.1128/AAC.44.6.1720-1724.2000; TRAUB WH, 1993, CHEMOTHERAPY, V39, P322, DOI 10.1159/000239144; Vandemaele FJ, 2004, VET MICROBIOL, V101, P147, DOI 10.1016/j.vetmic.2004.03.013; Wenger FA, 2002, CLIN EXP METASTAS, V19, P169, DOI 10.1023/A:1014579718391; WOLD AE, 1988, INFECT IMMUN, V56, P2531, DOI 10.1128/IAI.56.10.2531-2537.1988; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306	50	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8927	10.1371/journal.pone.0008927	http://dx.doi.org/10.1371/journal.pone.0008927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126631	Green Published, gold, Green Submitted			2022-12-25	WOS:000274138000006
J	Leja, J; Nilsson, B; Yu, D; Gustafson, E; Akerstrom, G; Oberg, K; Giandomenico, V; Essand, M				Leja, Justyna; Nilsson, Berith; Yu, Di; Gustafson, Elisabet; Akerstrom, Goran; Oberg, Kjell; Giandomenico, Valeria; Essand, Magnus			Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability	PLOS ONE			English	Article							CHROMOGRANIN-A; TRANSGENE EXPRESSION; ENDOGENOUS MICRORNA	Background: We have previously developed an oncolytic serotype 5 adenovirus (Ad5) with chromogranin-A (CgA) promoter-controlled E1A expression, Ad[CgA-E1A], with the intention to treat neuroendocrine tumors, including carcinoids. Since carcinoids tend to metastasize to the liver it is important to fully repress viral replication in hepatocytes to avoid adenovirus-related liver toxicity. Herein, we explore miRNA-based regulation of E1A expression as a complementary mechanism to promoter-based transcriptional control. Methodology/Principal Findings: Ad[CgA-E1A-miR122], where E1A expression is further controlled by six tandem repeats of the target sequence for the liver-specific miR122, was constructed and compared to Ad[CgA-E1A]. We observed E1A suppression and replication arrest of the miR122-detargeted adenovirus in normal hepatocytes, while the two viruses killed carcinoid cells to the same degree. Repeated intravenous injections of Ad[CgA-E1A] induced liver toxicity in mice while Ad[CgA-E1A-miR122] injections did not. Furthermore, a miR122-detargeted adenovirus with the wild-type E1A promoter showed reduced replication in hepatic cells compared to wild-type Ad5 but not to the same extent as the miR122-detargeted adenovirus with the neuroendocrine-selective CgA promoter. Conclusions/Significance: A combination of transcriptional ( promoter) and post-transcriptional (miRNA target) regulation to control virus replication may allow for the use of higher doses of adenovirus for efficient tumors treatment without liver toxicity.	[Leja, Justyna; Nilsson, Berith; Yu, Di; Essand, Magnus] Uppsala Univ, Div Clin Immunol, Rudbeck Lab, Uppsala, Sweden; [Gustafson, Elisabet] Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Akerstrom, Goran] Univ Uppsala Hosp, Dept Surg Sci, Uppsala, Sweden; [Oberg, Kjell; Giandomenico, Valeria] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	Leja, J (corresponding author), Uppsala Univ, Div Clin Immunol, Rudbeck Lab, Uppsala, Sweden.	magnus.essand@klinimm.uu.se	Oberg, Kjell/AAG-7118-2019	Yu, Di/0000-0002-8636-0351	Swedish Cancer Society [CAN 2007/885]; Swedish Children Cancer Foundation [PROJ08/006]; Gunnar Nilsson's Cancer Foundation [E50/08]; Swedish Research Council [K2008-68X-15270-04-3]; European Community [LSHB-CT-2004-512087]	Swedish Cancer Society(Swedish Cancer Society); Swedish Children Cancer Foundation; Gunnar Nilsson's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission)	This work was supported by funding from the Swedish Cancer Society (CAN 2007/885), the Swedish Children Cancer Foundation (PROJ08/006), Gunnar Nilsson's Cancer Foundation (E50/08), the Swedish Research Council (K2008-68X-15270-04-3) and the European Community on behalf of GIANT (Grant LSHB-CT-2004-512087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bajetta E, 1999, CANCER, V86, P858, DOI 10.1002/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Cheng WS, 2004, MOL THER, V10, P355, DOI 10.1016/j.ymthe.2004.05.022; Danielsson A, 2008, CANCER GENE THER, V15, P203, DOI 10.1038/sj.cgt.7701117; Essand M, 2005, J MOL ENDOCRINOL, V35, P489, DOI 10.1677/jme.1.01875; Feldman SA, 2003, ENDOCR PATHOL, V14, P3, DOI 10.1385/EP:14:1:3; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; HITT MM, 1990, VIROLOGY, V179, P667, DOI 10.1016/0042-6822(90)90134-D; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Leja J, 2007, CLIN CANCER RES, V13, P2455, DOI 10.1158/1078-0432.CCR-06-2532; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; PRAGE L, 1970, VIROLOGY, V42, P341, DOI 10.1016/0042-6822(70)90278-3; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Suzuki T, 2008, MOL THER, V16, P1719, DOI 10.1038/mt.2008.159; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08	23	39	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8916	10.1371/journal.pone.0008916	http://dx.doi.org/10.1371/journal.pone.0008916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111709	Green Published, gold			2022-12-25	WOS:000274114800019
J	Lu, ZJ; Kipnis, J				Lu, Zhenjie; Kipnis, Jonathan			Thrombospondin 1-a key astrocyte-derived neurogenic factor	FASEB JOURNAL			English	Article						neural progenitor cells; adult neurogenesis; oligodendrogenesis; extracellular matrix proteins	OLIGODENDROCYTE PRECURSOR CELLS; GLIA-LIKE CELLS; NEURONAL MIGRATION; ADULT NEUROGENESIS; NEURITE OUTGROWTH; DENTATE GYRUS; SPINAL-CORD; STEM-CELLS; NOTCH; DIFFERENTIATION	Thrombospondin 1 (TSP1), an oligomeric matrix protein, is known for its antiangiogenic activity. Recently, TSP1 has been shown to regulate synaptogenesis in the developing brain. In this study, we examine another role of TSP1 in the CNS, namely, in proliferation and differentiation of neural progenitor cells (NPCs). We found that adult mice deficient in TSP1 exhibit reduced proliferation of NPCs in vivo [13,330 +/- 826 vs. 4914 +/- 455 (mean +/- SE wt vs. TSP1(-/-)); P<0.001, Student's t test] and impaired neuronal differentiation (1382 +/- 83 vs. 879 +/- 79; P<0.001). In vitro, NPC obtained from adult TSP1(-/-) mice display decreased proliferation in BrdU assay (48 +/- 8 vs. 24 +/- 3.5%; P<0.01) and decreased neuronal fate commitment (8 +/- 0.85 vs. 4.6 +/- 0.5%; P<0.05) in contrast to wild-type NPCs. Both proliferation and neuronal differentiation deficits are remediable in vitro by exogenous TSP1. Notably, conditioned medium from TSP1(-/-) astrocytes, unlike that from control astrocytes, fails to promote neurogenesis in wild-type NPCs, suggesting that TSP1 is one of the key molecules responsible for astrocyte-induced neurogenesis. Our data demonstrate that TSP1 is a critical participant in maintenance of the adult NPC pool and in neuronal differentiation.-Lu, Z., Kipnis, J. Thrombospondin 1-a key astrocyte-derived neurogenic factor. FASEB J. 24, 1925-1934 (2010). www.fasebj.org	[Lu, Zhenjie; Kipnis, Jonathan] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA	University of Virginia	Kipnis, J (corresponding author), Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA.	kipnis@virginia.edu	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X	University of Washington, Seattle, WA, USA; National Institute of Child Health and Human Development [R21HD056293-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034113] Funding Source: NIH RePORTER	University of Washington, Seattle, WA, USA(University of Washington); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Noel Derecki for assistance with FACS acquisition and data processing. Special thanks are extended to Dr. Bettina Winckler (Department of Neuroscience, University of Virginia) and Dr. Benjamin Purow (Department of Neurology, University of Virginia) for their critical reading and discussion of the manuscript. The authors thank Shirley Smith for editing the manuscript. Dr. Paul Bornstein (University of Washington, Seattle, WA, USA) has kindly Foundation grant and, in part, by National Institute of Child Health and Human Development award R21HD056293-01 (to J.K.).	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asakura K, 1996, J NEUROIMMUNOL, V65, P11, DOI 10.1016/0165-5728(95)00175-1; Baracskay KL, 2007, GLIA, V55, P1001, DOI 10.1002/glia.20519; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Caceres M, 2007, CEREB CORTEX, V17, P2312, DOI 10.1093/cercor/bhl140; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kyriakides TR, 2003, BLOOD, V101, P3915, DOI 10.1182/blood.V101.10.3915; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liour SS, 2003, GLIA, V42, P109, DOI 10.1002/glia.10202; Lu L, 2008, STEM CELLS, V26, P580, DOI 10.1634/stemcells.2007-0106; Medrano S, 2009, NEUROBIOL AGING, V30, P483, DOI 10.1016/j.neurobiolaging.2007.07.016; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; OSHEA KS, 1991, NEURON, V7, P231, DOI 10.1016/0896-6273(91)90261-W; OSTERHOUT DJ, 1992, DEV BIOL, V150, P256, DOI 10.1016/0012-1606(92)90240-H; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Talbott JF, 2005, EXP NEUROL, V192, P11, DOI 10.1016/j.expneurol.2004.05.038; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	40	83	83	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1925	1934		10.1096/fj.09-150573	http://dx.doi.org/10.1096/fj.09-150573			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20124433	Green Published			2022-12-25	WOS:000278200000027
J	Sarig, H; Livne, L; Held-Kuznetsov, V; Zaknoon, F; Ivankin, A; Gidalevitz, D; Mor, A				Sarig, Hadar; Livne, Liran; Held-Kuznetsov, Victoria; Zaknoon, Fadia; Ivankin, Andrey; Gidalevitz, David; Mor, Amram			A miniature mimic of host defense peptides with systemic antibacterial efficacy	FASEB JOURNAL			English	Article						antimicrobial peptide; chemical mimicry; drug design; drug resistance; mechanism of action	ACYL-LYSINE OLIGOMERS; DE-NOVO DESIGN; RESISTANT STAPHYLOCOCCUS-AUREUS; X-RAY-DIFFRACTION; IN-VIVO ACTIVITY; ANTIMICROBIAL PEPTIDES; AMINO-ACIDS; BACTERIAL-MEMBRANES; LIPID MONOLAYERS; DERIVATIVES	Oligomers of acylated lysines (OAKs) are synthetic mimics of host defense peptides (HDPs) with promising antimicrobial properties. Here we challenged the OAK concept for its ability to generate both systemically efficient and economically viable lead compounds for fighting multidrug-resistant bacteria. We describe the design and characterization of a miniature OAK composed of only 3 lysyls and 2 acyls (designated C12(omega 7)K-beta(12)) that preferentially targets gram-positive species by a bacteriostatic mode of action. To gain insight into the mechanism of action, we examined the interaction of OAK with various potential targets, including phospholipid bilayers, using surface plasmon resonance, and Langmuir monolayers, using insertion assays, epifluorescence microscopy, and grazing incidence X-ray diffraction, in a complementary manner. Collectively, the data support the notion that C12(omega 7)K-beta(12) damages the plasma-membrane architecture similarly to HDPs, that is, following a near-classic 2-step interaction including high-affinity electrostatic adhesion and a subsequent shallow insertion that was limited to the phospholipid head group region. Notably, preliminary acute toxicity and efficacy studies performed with mouse models of infection have consolidated the potential of OAK for treating bacterial infections, including systemic treatments of methicillin-resistant Staphylococcus aureus. Such simple yet robust chemicals might be useful for various antibacterial applications while circumventing potential adverse effects associated with cytolytic compounds.-Sarig, H., Livne, L., Held-Kuznetsov, V., Zaknoon, F., Ivankin, A., Gidalevitz, D., Mor, A. A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J. 24, 1904-1913 (2010). www.fasebj.org	[Sarig, Hadar; Livne, Liran; Held-Kuznetsov, Victoria; Zaknoon, Fadia; Mor, Amram] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-3200 Haifa, Israel; [Ivankin, Andrey; Gidalevitz, David] IIT, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA; [Ivankin, Andrey; Gidalevitz, David] IIT, Div Phys, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	Technion Israel Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology	Mor, A (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-3200 Haifa, Israel.	amor@tx.technion.ac.il	Gidalevitz, David/D-6717-2012		Israel Science Foundation [283/08]; U.S. National Institutes of Health [R01 AI073892]; Division Of Chemistry [0822838] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073892] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Israel Science Foundation grant 283/08 (A. M.) and U.S. National Institutes of Health grant R01 AI073892 (D. G.). The authors are indebted to Binhua Lin and Mati Meron for their help with X-ray measurements at APS. The OAK sequences described here have been submitted as part of a U.S. patent application.	Avrahami D, 2001, BIOCHEMISTRY-US, V40, P12591, DOI 10.1021/bi0105330; BERGE B, 1994, PHYS REV LETT, V73, P1652, DOI 10.1103/PhysRevLett.73.1652; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j; Choi S, 2009, P NATL ACAD SCI USA, V106, P6968, DOI 10.1073/pnas.0811818106; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Epand RF, 2009, BIOPHYS J, V97, P2250, DOI 10.1016/j.bpj.2009.08.006; Epand RF, 2001, EUR J BIOCHEM, V268, P703, DOI 10.1046/j.1432-1327.2001.01922.x; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Gaidukov L, 2003, BIOCHEMISTRY-US, V42, P12866, DOI 10.1021/bi034514x; Gidalevitz D, 2003, P NATL ACAD SCI USA, V100, P6302, DOI 10.1073/pnas.0934731100; Gottler LM, 2008, CHEMBIOCHEM, V9, P370, DOI 10.1002/cbic.200700643; Gottler LM, 2009, BBA-BIOMEMBRANES, V1788, P1680, DOI 10.1016/j.bbamem.2008.10.009; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Ilker MF, 2004, J AM CHEM SOC, V126, P15870, DOI 10.1021/ja045664d; Ishitsuka Y, 2006, J AM CHEM SOC, V128, P13123, DOI 10.1021/ja061186q; Javadpour MM, 1997, BIOCHEMISTRY-US, V36, P9540, DOI 10.1021/bi961644f; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Kamysz W, 2007, ANTIMICROB AGENTS CH, V51, P354, DOI 10.1128/AAC.00344-06; Kuroda K, 2005, J AM CHEM SOC, V127, P4128, DOI 10.1021/ja044205+; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Liu DH, 2001, J AM CHEM SOC, V123, P7553, DOI 10.1021/ja0107475; Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Mangili A, 2005, CLIN INFECT DIS, V40, P1058, DOI 10.1086/428616; MIDOUX P, 1995, BBA-BIOMEMBRANES, V1239, P249, DOI 10.1016/0005-2736(95)00163-W; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Navon-Venezia S, 2002, ANTIMICROB AGENTS CH, V46, P689, DOI 10.1128/AAC.46.3.689-694.2002; Neville F, 2006, BIOPHYS J, V90, P1275, DOI 10.1529/biophysj.105.067595; Neville F, 2008, SOFT MATTER, V4, P1665, DOI 10.1039/b718295c; Patch JA, 2003, J AM CHEM SOC, V125, P12092, DOI 10.1021/ja037320d; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Radzishevsky I, 2007, ANTIMICROB AGENTS CH, V51, P1753, DOI 10.1128/AAC.01288-06; Radzishevsky IS, 2008, CHEM BIOL, V15, P354, DOI 10.1016/j.chembiol.2008.03.006; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Rotem S., 2008, BIOCHIM BIOPHYS ACTA, V1788, P1582; Rotem S, 2008, FASEB J, V22, P2652, DOI 10.1096/fj.07-105015; Rotem S, 2006, ANTIMICROB AGENTS CH, V50, P2666, DOI 10.1128/AAC.00030-06; Sarig H, 2008, ANTIMICROB AGENTS CH, V52, P4308, DOI 10.1128/AAC.00656-08; Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1; Scott RW, 2008, CURR OPIN BIOTECH, V19, P620, DOI 10.1016/j.copbio.2008.10.013; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Tew GN, 2002, P NATL ACAD SCI USA, V99, P5110, DOI 10.1073/pnas.082046199; Thennarasu S, 2005, BBA-BIOMEMBRANES, V1711, P49, DOI 10.1016/j.bbamem.2005.02.010; VAN BF, 2008, TRENDS PHARMACOL SCI, V29, P124; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	55	37	38	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1904	1913		10.1096/fj.09-149427	http://dx.doi.org/10.1096/fj.09-149427			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20124435	Green Published			2022-12-25	WOS:000278200000025
J	Jablonska, E; Markart, P; Zakrzewicz, D; Preissner, KT; Wygrecka, M				Jablonska, Ewa; Markart, Philipp; Zakrzewicz, Dariusz; Preissner, Klaus T.; Wygrecka, Malgorzata			Transforming Growth Factor-beta 1 Induces Expression of Human Coagulation Factor XII via Smad3 and JNK Signaling Pathways in Human Lung Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; GROWTH-FACTOR-BETA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; HAGEMAN-FACTOR; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; PROTEOLYTIC ACTIVATION; PROCOLLAGEN PRODUCTION	Coagulation factor XII ( FXII) is a liver-derived serine protease involved in fibrinolysis, coagulation, and inflammation. The regulation of FXII expression is largely unknown. Transforming growth factor-beta 1 (TGF-beta 1) is a multifunctional cytokine that has been linked to several pathological processes, including tissue fibrosis by modulating procoagulant and fibrinolytic activities. This study investigated whether TGF-beta 1 may regulate FXII expression in human lung fibroblasts. Treatment of human lung fibroblasts with TGF-beta 1 resulted in a time-dependent increase in FXII production, activation of p44/42, p38, JNK, and Akt, and phosphorylation and translocation into the nucleus of Smad3. However, TGF-beta 1-induced FXII expression was repressed only by the JNK inhibitor and JNK and Smad3 antisense oligonucleotides but not by MEK, p38, or phosphoinositide 3-kinase blockers. JNK inhibition had no effect on TGF-beta 1-induced Smad3 phosphorylation, association with Smad4, and its translocation into the nucleus but strongly suppressed Smad3-DNA complex formation. FXII promoter analysis revealed that the -299/+1 region was sufficient for TGF-beta 1 to induce FXII expression. Sequence analysis of this region detected a potential Smad-binding element at position -272/-269 (SBE-(-272/-269)). Chromatin immunoprecipitation and streptavidin pulldown assays demonstrated TGF-beta 1-dependent Smad3 binding to SBE-(-272/-269). Mutation or deletion of SBE-(-272/-269) substantially reduced TGF-beta 1-mediated activation of the FXII promoter. Clinical relevance was demonstrated by elevated FXII levels and its co-localization with fibroblasts in the lungs of patients with acute respiratory distress syndrome. Our results show that JNK/Smad3 pathway plays a critical role in TGF-beta 1-induced FXII expression in human lung fibroblasts and implicate its possible involvement in pathological conditions characterized by elevated TGF-beta 1 levels.	[Jablonska, Ewa; Zakrzewicz, Dariusz; Preissner, Klaus T.; Wygrecka, Malgorzata] Univ Giessen, Dept Biochem, Fac Med, D-35392 Giessen, Germany; [Markart, Philipp] Univ Giessen, Dept Internal Med, Fac Med, D-35392 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Wygrecka, M (corresponding author), Univ Giessen, Dept Biochem, Fac Med, Friedrichstr 24, D-35392 Giessen, Germany.	malgorzata.wygrecka@innere.med.uni-giessen.de	Wygrecka, Malgorzata/AAZ-3679-2020; Jabłońska, Ewa/T-3878-2018; Jablonska, Ewa/W-2303-2018	Wygrecka, Malgorzata/0000-0002-3656-2932; Jabłońska, Ewa/0000-0001-7899-7830; Jablonska, Ewa/0000-0002-5445-4249; Zakrzewicz, Dariusz/0000-0003-3292-9706	German Research Foundation [KFO 118]; Excellence Cluster "Cardiopulmonary System"	German Research Foundation(German Research Foundation (DFG)); Excellence Cluster "Cardiopulmonary System"(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant KFO 118 and the Excellence Cluster "Cardiopulmonary System."	BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; Blanc-Brude OP, 2005, EXP CELL RES, V304, P16, DOI 10.1016/j.yexcr.2004.10.021; Bogatkevich GS, 2001, J BIOL CHEM, V276, P45184, DOI 10.1074/jbc.M106441200; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; BRISEID K, 1991, THROMB RES, V61, P123, DOI 10.1016/0049-3848(91)90239-S; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; BURKHARDT A, 1989, AM REV RESPIR DIS, V140, P513, DOI 10.1164/ajrccm/140.2.513; CAO SX, 1989, P NATL ACAD SCI USA, V86, P5306, DOI 10.1073/pnas.86.14.5306; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; Chambers RC, 2000, J BIOL CHEM, V275, P35584, DOI 10.1074/jbc.M003188200; Chesnutt AN, 1997, AM J RESP CRIT CARE, V156, P840, DOI 10.1164/ajrccm.156.3.9701124; CHIEN P, 1988, J CLIN INVEST, V82, P1554, DOI 10.1172/JCI113765; Cichon S, 2006, AM J HUM GENET, V79, P1098, DOI 10.1086/509899; Citarella F, 1997, BLOOD, V90, P1501, DOI 10.1182/blood.V90.4.1501.1501_1501_1507; Citarella F, 1996, STEROIDS, V61, P270, DOI 10.1016/0039-128X(96)00037-2; CITARELLA F, 1993, BIOCHIM BIOPHYS ACTA, V1172, P197, DOI 10.1016/0167-4781(93)90294-N; COLMAN RW, 1986, CRC CR REV ONCOL-HEM, V5, P57, DOI 10.1016/S1040-8428(86)80053-1; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Colman RW, 1999, THROMB HAEMOSTASIS, V82, P1568; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dhainaut JF, 2003, CRIT CARE MED, V31, pS258, DOI 10.1097/01.CCM.0000057901.92381.75; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; FARSETTI A, 1995, ENDOCRINOLOGY, V136, P5076, DOI 10.1210/en.136.11.5076; Farsetti A, 1998, ENDOCRINOLOGY, V139, P4581, DOI 10.1210/en.139.11.4581; Felts SJ, 1997, ONCOGENE, V14, P1679, DOI 10.1038/sj.onc.1201006; FINE A, 1987, J BIOL CHEM, V262, P3897; FUKUDA Y, 1987, AM J PATHOL, V126, P171; GARZON RJ, 1994, MOL CELL BIOL, V14, P934, DOI 10.1128/MCB.14.2.934; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; GORDON EM, 1985, BLOOD, V66, P602; GORDON EM, 1988, J LAB CLIN MED, V111, P52; GORDON EM, 1980, J LAB CLIN MED, V96, P762; GORDON EM, 1991, J LAB CLIN MED, V117, P353; Gordon EM, 1996, P NATL ACAD SCI USA, V93, P2174, DOI 10.1073/pnas.93.5.2174; Goulet S, 2007, J CELL PHYSIOL, V210, P167, DOI 10.1002/jcp.20836; GRINNEL F, 1980, EXPERIENTIA, V36, P505, DOI 10.1007/BF01965766; Gunther A, 2000, AM J RESP CRIT CARE, V161, P454; Gunther A, 2000, THROMB HAEMOSTASIS, V83, P853; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; IDELL S, 1992, AM J PHYSIOL, V263, pL487, DOI 10.1152/ajplung.1992.263.4.L487; IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240; IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217; IDELL S, 1994, AM J PHYSIOL-LUNG C, V267, pL693, DOI 10.1152/ajplung.1994.267.6.L693; Imokawa S, 1997, AM J RESP CRIT CARE, V156, P631, DOI 10.1164/ajrccm.156.2.9608094; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; KIM SJ, 1989, J BIOL CHEM, V264, P7041; KOTANI I, 1995, THROMB RES, V77, P493, DOI 10.1016/0049-3848(95)00025-9; Kutz SM, 2001, J CELL SCI, V114, P3905; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Liu QH, 2008, PERITON DIALYSIS INT, V28, pS88; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN C, 1995, CHEST, V107, P196, DOI 10.1378/chest.107.1.196; Meduri G U, 1995, Semin Respir Infect, V10, P154; Meduri GU, 1998, AM J RESP CRIT CARE, V158, P1432; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Neth P, 2001, THROMB HAEMOSTASIS, V85, P1043, DOI 10.1055/s-0037-1615961; OLMAN MA, 1995, J CLIN INVEST, V96, P1621, DOI 10.1172/JCI118201; Pelaia G, 2007, J CELL PHYSIOL, V210, P489, DOI 10.1002/jcp.20884; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; RATNOFF OD, 1991, J LAB CLIN MED, V117, P343; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; SCHMEIDLERSAPIRO KT, 1991, P NATL ACAD SCI USA, V88, P4382, DOI 10.1073/pnas.88.10.4382; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; SEEGER W, 1993, AM J RESP CELL MOL, V9, P213, DOI 10.1165/ajrcmb/9.2.213; SENIOR RM, 1986, J CLIN INVEST, V77, P1014, DOI 10.1172/JCI112353; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; TOOSSI Z, 1992, P NATL ACAD SCI USA, V89, P11969, DOI 10.1073/pnas.89.24.11969; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; Wygrecka M, 2004, THROMB HAEMOSTASIS, V92, P529, DOI 10.1160/TH04-02-0126; Wygrecka M, 2007, THORAX, V62, P880, DOI 10.1136/thx.2006.069658; Wygrecka M, 2007, J BIOL CHEM, V282, P21671, DOI 10.1074/jbc.M610748200; Yoshida K, 2005, AM J PATHOL, V166, P1029, DOI 10.1016/S0002-9440(10)62324-3; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366	84	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11638	11651		10.1074/jbc.M109.045963	http://dx.doi.org/10.1074/jbc.M109.045963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20142324	hybrid, Green Published			2022-12-25	WOS:000276286200069
J	Demma, M; Maxwell, E; Ramos, R; Liang, LZ; Li, C; Hesk, D; Rossman, R; Mallams, A; Doll, R; Liu, M; Seidel-Dugan, C; Bishop, WR; Dasmahapatra, B				Demma, Mark; Maxwell, Eugene; Ramos, Robert; Liang, Lianzhu; Li, Cheng; Hesk, David; Rossman, Randall; Mallams, Alan; Doll, Ronald; Liu, Ming; Seidel-Dugan, Cynthia; Bishop, W. Robert; Dasmahapatra, Bimalendu			SCH529074, a Small Molecule Activator of Mutant p53, Which Binds p53 DNA Binding Domain (DBD), Restores Growth-suppressive Function to Mutant p53 and Interrupts HDM2-mediated Ubiquitination of Wild Type p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE DOMAIN; TRANSCRIPTION ACTIVATION; CRYSTAL-STRUCTURE; RESCUE; MDM2; CP-31398; RESTORATION; PEPTIDE; P63; CONFORMATION	Abrogation of p53 function occurs in almost all human cancers, with more than 50% of cancers harboring inactivating mutations in p53 itself. Mutation of p53 is indicative of highly aggressive cancers and poor prognosis. The vast majority of mutations in p53 occur in its core DNA binding domain (DBD) and result in inactivation of p53 by reducing its thermodynamic stability at physiological temperature. Here, we report a small molecule, SCH529074, that binds specifically to the p53 DBD in a saturable manner with an affinity of 1-2 mu M. Binding restores wild type function to many oncogenic mutant forms of p53. This small molecule reactivates mutant p53 by acting as a chaperone, in a manner similar to that previously reported for the peptide CDB3. Binding of SCH529074 to the p53 DBD is specifically displaced by an oligonucleotide with a sequence derived from the p53-response element. In addition to reactivating mutant p53, SCH529074 binding inhibits ubiquitination of p53 by HDM2. We have also developed a novel variant of p53 by changing a single amino acid in the core domain of p53 (N268R), which abolishes binding of SCH529074. This amino acid change also inhibits HDM2-mediated ubiquitination of p53. Our novel findings indicate that through its interaction with p53 DBD, SCH529074 restores DNA binding activity to mutant p53 and inhibits HDM2-mediated ubiquitination.	[Demma, Mark; Maxwell, Eugene; Ramos, Robert; Liang, Lianzhu; Liu, Ming; Seidel-Dugan, Cynthia; Bishop, W. Robert; Dasmahapatra, Bimalendu] Schering Plough Res Inst, Dept Tumor Biol, Kenilworth, NJ 07033 USA; [Li, Cheng; Hesk, David; Rossman, Randall; Mallams, Alan; Doll, Ronald] Schering Plough Res Inst, Dept Chem, Kenilworth, NJ 07033 USA	Merck & Company; Schering-Plough Research Institute; Merck & Company; Schering-Plough Research Institute	Demma, M (corresponding author), Merck Res Labs, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	Mark.Demma@spcorp.com						ABARZUA P, 1995, CANCER RES, V55, P3490; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; Camus S, 2003, FEBS LETT, V536, P220, DOI 10.1016/S0014-5793(03)00054-1; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Demma MJ, 2004, J BIOL CHEM, V279, P45887, DOI 10.1074/jbc.M401854200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Friedler A, 2004, J MOL BIOL, V336, P187, DOI 10.1016/j.jmb.2003.12.005; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Helton ES, 2008, ONCOGENE, V27, P2843, DOI 10.1038/sj.onc.1210948; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lane DR, 2003, DRUG DISCOV TODAY, V8, P347, DOI 10.1016/S1359-6446(03)02669-2; Little NA, 2001, ONCOGENE, V20, P4576, DOI 10.1038/sj.onc.1204615; Luu Y, 2002, EXP CELL RES, V276, P214, DOI 10.1006/excr.2002.5526; Meyer-Ficca ML, 2004, ANAL BIOCHEM, V334, P9, DOI 10.1016/j.ab.2004.07.011; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Pan YP, 2006, BIOCHEMISTRY-US, V45, P3925, DOI 10.1021/bi052242n; Rehman A, 2005, BREAST CANCER RES, V7, pR765, DOI 10.1186/bcr1290; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sang MX, 2006, BIOCHEM BIOPH RES CO, V347, P327, DOI 10.1016/j.bbrc.2006.06.079; Selivanova G, 1999, MOL CELL BIOL, V19, P3395; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; SKINNER RH, 1994, ANAL BIOCHEM, V223, P259, DOI 10.1006/abio.1994.1582; Soussi T, 1996, J MOL BIOL, V260, P623, DOI 10.1006/jmbi.1996.0425; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; VOJTESEK B, 1995, ONCOGENE, V10, P389; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Willis A. C., 2002, Current Molecular Medicine (Hilversum), V2, P329, DOI 10.2174/1566524023362474; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zalcenstein A, 2006, ONCOGENE, V25, P359, DOI 10.1038/sj.onc.1209061	52	72	75	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10198	10212		10.1074/jbc.M109.083469	http://dx.doi.org/10.1074/jbc.M109.083469			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20124408	Green Published, hybrid			2022-12-25	WOS:000276264600004
J	Eby, JC; Ciesla, WP; Hamman, W; Donato, GM; Pickles, RJ; Hewlett, EL; Lencer, WI				Eby, Joshua C.; Ciesla, William P.; Hamman, Wendy; Donato, Gina M.; Pickles, Raymond J.; Hewlett, Erik L.; Lencer, Wayne I.			Selective Translocation of the Bordetella pertussis Adenylate Cyclase Toxin across the Basolateral Membranes of Polarized Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INEFFICIENT GENE-TRANSFER; PORE-FORMING TOXIN; TARGET-CELLS; HEMOLYTIC ACTIVITIES; IN-VIVO; BACILLUS-ANTHRACIS; AIRWAY EPITHELIUM; DEPENDENT MANNER; AC TOXIN; SECRETION	The catalytic domain of Bordetella pertussis adenylate cyclase toxin (ACT) translocates directly across the plasma membrane of mammalian cells to induce toxicity by the production of cAMP. Here, we use electrophysiology to examine the translocation of toxin into polarized epithelial cells that model the mucosal surfaces of the host. We find that both polarized T84 cell monolayers and human airway epithelial cultures respond to nanomolar concentrations of ACT when applied to basolateral membranes, with little or no response to toxin applied apically. The induction of toxicity is rapid and fully explained by increases in intracellular cAMP, consistent with toxin translocation directly across the basolateral membrane. Intoxication of T84 cells occurs in the absence of CD11b/CD18 or evidence of another specific membrane receptor, and it is not dependent on post-translational acylation of the toxin or on host cell membrane potential, both previously reported to be required for toxin action. Thus, elements of the basolateral membrane render epithelial cells highly sensitive to the entry of ACT in the absence of a specific receptor for toxin binding.	[Eby, Joshua C.; Donato, Gina M.; Hewlett, Erik L.] Univ Virginia, Sch Med, Div Infect Dis & Int Hlth, Dept Med, Charlottesville, VA 22908 USA; [Ciesla, William P.; Hamman, Wendy; Lencer, Wayne I.] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Ciesla, William P.; Hamman, Wendy; Lencer, Wayne I.] Harvard Univ, Sch Med, Harvard Digest Dis Ctr, Boston, MA 02115 USA; [Pickles, Raymond J.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of Virginia; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Hewlett, EL (corresponding author), Univ Virginia, Sch Med, Div Infect Dis & Int Hlth, Dept Med, Box 800419, Charlottesville, VA 22908 USA.	eh2v@virginia.edu		Lencer, Wayne/0000-0001-7346-2730	National Institutes of Health [AI18000, 5 T32 A1007046-30, DK48106, DK34854]; SCCOR [5 P50 HL084934]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI081900, R01AI018000, T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048106, R37DK048106, P30DK034854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI18000 (to E. L. H.), 5 T32 A1007046-30 (to J. C. E.), DK48106 (to W. I. L.), DK34854 (to W. I. L.), and SCCOR 5 P50 HL084934 (to R. J. P.).	Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Abrami L, 2003, INFECT IMMUN, V71, P739, DOI 10.1128/IAI.71.2.739-746.2003; Atapattu DN, 2007, INFECT IMMUN, V75, P4719, DOI 10.1128/IAI.00534-07; Barrett KE, 1997, AM J PHYSIOL-CELL PH, V272, pC1069, DOI 10.1152/ajpcell.1997.272.4.C1069; BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; Basar T, 2001, J BIOL CHEM, V276, P348, DOI 10.1074/jbc.M006463200; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Bassinet L, 2004, INFECT IMMUN, V72, P5530, DOI 10.1128/IAI.72.9.5530-5533.2004; Beauregard KE, 1999, INFECT IMMUN, V67, P3026, DOI 10.1128/IAI.67.6.3026-3030.1999; Bejerano M, 1999, MOL MICROBIOL, V31, P381, DOI 10.1046/j.1365-2958.1999.01183.x; BENZ R, 1994, J BIOL CHEM, V269, P27231; Clarke LL, 1997, AM J PHYSIOL-LUNG C, V272, pL1084, DOI 10.1152/ajplung.1997.272.6.L1084; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; DHARMSATHAPHORN K, 1990, METHOD ENZYMOL, V192, P354; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GOLDHAMMER AR, 1981, EUR J BIOCHEM, V115, P605; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Gray M, 1998, J BIOL CHEM, V273, P18260, DOI 10.1074/jbc.273.29.18260; Gray MC, 1999, INFECT IMMUN, V67, P4393, DOI 10.1128/IAI.67.9.4393-4399.1999; Gray MC, 2001, J BACTERIOL, V183, P5904, DOI 10.1128/JB.183.20.5904-5910.2001; Groathouse NA, 2003, INFECT IMMUN, V71, P7208, DOI 10.1128/IAI.71.12.7208-7210.2003; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HANSKI E, 1985, J BIOL CHEM, V260, P5526; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; HEWLETT EL, 1993, J BIOL CHEM, V268, P7842; Ingalls RR, 1997, J IMMUNOL, V159, P433; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Knapp O, 2008, BBA-BIOMEMBRANES, V1778, P260, DOI 10.1016/j.bbamem.2007.09.026; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Lee SJ, 1999, INFECT IMMUN, V67, P2090, DOI 10.1128/IAI.67.5.2090-2095.1999; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; Lovell MA, 1998, ARCH PEDIAT ADOL MED, V152, P925; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mallory, 1912, J MED RES, V27, P115; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Osicka R, 2000, INFECT IMMUN, V68, P247; OTERO AS, 1995, J BIOL CHEM, V270, P9695, DOI 10.1074/jbc.270.17.9695; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; PEARSON RD, 1987, J IMMUNOL, V139, P2749; Pickles RJ, 1998, J VIROL, V72, P6014, DOI 10.1128/JVI.72.7.6014-6023.1998; Pickles RJ, 2000, J VIROL, V74, P6050, DOI 10.1128/JVI.74.13.6050-6057.2000; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; Sawal M, 2009, PEDIATR PULM, V44, P970, DOI 10.1002/ppul.21082; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Soane MC, 2000, RESP MED, V94, P791, DOI 10.1053/rmed.2000.0823; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Stonebraker JR, 2004, J VIROL, V78, P13755, DOI 10.1128/JVI.78.24.13755-13768.2004; STROHMEIER GR, 1995, J BIOL CHEM, V270, P2387, DOI 10.1074/jbc.270.5.2387; SZABO G, 1994, J BIOL CHEM, V269, P22496; TUOMANEN EI, 1983, J INFECT DIS, V148, P125, DOI 10.1093/infdis/148.1.125; VOJLOVAVODOLANO.J, 2009, FASEB J, V23, P2831; Vojtova J, 2006, MICROSC RES TECHNIQ, V69, P119, DOI 10.1002/jemt.20277; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; WOLFF J, 1973, J BIOL CHEM, V248, P350	66	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10662	10670		10.1074/jbc.M109.089219	http://dx.doi.org/10.1074/jbc.M109.089219			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139088	Green Published, hybrid			2022-12-25	WOS:000276264600053
J	Hajji, N; Wallenborg, K; Vlachos, P; Fullgrabe, J; Hermanson, O; Joseph, B				Hajji, N.; Wallenborg, K.; Vlachos, P.; Fullgrabe, J.; Hermanson, O.; Joseph, B.			Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide	ONCOGENE			English	Article						cell death; topoisomerase inhibitor; HDAC inhibitor; hMOF; SIRT1; H4K16 acetylation	HISTONE DEACETYLASE INHIBITORS; CELL LUNG CARCINOMAS; DNA-DAMAGE; ANTICANCER AGENTS; H4 LYSINE-16; CANCER; PROTEIN; APOPTOSIS; ACETYLTRANSFERASE; RESPONSES	Various inhibitors of histone deacetylase (HDAC) activity can sensitize drug resistant cancer cells to chemotherapeutic agents. However, the mechanisms underlying such effects of distinct HDAC inhibitors (HDACi) remain poorly understood. Here we show that both the HDACi trichostatin A and valproic acid induced a sensitization of multidrug-resistant cancer cells to the topoisomerase II inhibitor etoposide/VP16. This effect was associated with increased acetylation of certain lysines on histones H3 and H4, including lysine 16 on histone H4 (H4K16). Overexpression of the histone acetyltransferase hMOF, known to target H4K16, was sufficient to mimic HDACi treatment on sensitization and H4K16 acetylation, and importantly, small-interfering RNA (siRNA)-mediated knockdown of hMOF abolished the HDACi-mediated sensitizing effects as well as the increase in H4K16 acetylation. Conversely, siRNA-mediated knockdown of the H4K16 deacetylase SIRT1 mimicked HDACi treatment whereas overexpression of SIRT1 abolished H4K16 acetylation and significantly reduced the sensitizing effects of HDACi. Interestingly, the effects of hMOF on H4K16 acetylation and sensitization to the topoisomerase II inhibitor could be directly counteracted by exogenous expression of increasing amounts of SIRT1 and vice versa. Our study results suggest that hMOF and SIRT1 activities are critical parameters in HDACi-mediated sensitization of multidrug-resistant cancer cells to topoisomerase II inhibitor and increased H4K16 acetylation. Oncogene (2010) 29, 2192-2204; doi: 10.1038/onc.2009.505; published online 1 February 2010	[Hajji, N.; Vlachos, P.; Fullgrabe, J.; Joseph, B.] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Wallenborg, K.; Hermanson, O.] Karolinska Inst, CoE Dev Biol CEDB DBRM, Dept Neurosci, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Joseph, B (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, R8 03, S-17176 Stockholm, Sweden.	bertrand.joseph@ki.se	, Ola/AAF-5126-2021; hajji, nabil/AAV-1435-2020	Fullgrabe, Jens/0000-0003-0047-4719; Hermanson, Ola/0000-0001-9320-7921; Joseph, Bertrand/0000-0001-5655-9979	Swedish Research Council; Swedish Cancer Society; Ake Wiberg Foundation; Swedish Medical Society; Karolinska Institutet Foundations (KI Cancer); Swedish Children's Cancer Foundation; Medical Research Council [G0801056B] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Ake Wiberg Foundation; Swedish Medical Society; Karolinska Institutet Foundations (KI Cancer)(Karolinska Institutet); Swedish Children's Cancer Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank RG Roeder (The Rockefeller University), L Guarente (Massachusetts Institute of Technology) and M Henriksson (Karolinska Institutet) for providing us with hMOF DNA construct, SIRT1 DNA construct and SK-N-BE(2) cell line, respectively, and S Orrenius, T Perlmann and members of Hermanson and Joseph's labs for helpful comments. This work was supported by the Swedish Research Council, the Swedish Cancer Society, the Ake Wiberg Foundation, the Swedish Medical Society, the Karolinska Institutet Foundations (KI Cancer) (BJ and OH), SSF (CEDB & OBOE) and the Swedish Children's Cancer Foundation (OH).	Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gallego MA, 2004, ONCOGENE, V23, P6282, DOI 10.1038/sj.onc.1207835; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Hajji N, 2008, ONCOGENE, V27, P3134, DOI 10.1038/sj.onc.1210976; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Joseph B, 2001, ONCOGENE, V20, P2877, DOI 10.1038/sj.onc.1204402; Karagiannis TC, 2006, ONCOGENE, V25, P3885, DOI 10.1038/sj.onc.1209417; Keshelava N, 1998, CANCER RES, V58, P5396; Kyrylenko S, 2003, CELL MOL LIFE SCI, V60, P1990, DOI 10.1007/s00018-003-3090-z; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Neal KC, 2000, BBA-GENE STRUCT EXPR, V1490, P170, DOI 10.1016/S0167-4781(99)00211-0; Nyman U, 2009, MOL CELL BIOL, V29, P1814, DOI 10.1128/MCB.00585-08; Pfister S, 2008, INT J CANCER, V122, P1207, DOI 10.1002/ijc.23283; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P555, DOI 10.1038/sj.cdd.4402286; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Villar-Garea A, 2004, INT J CANCER, V112, P171, DOI 10.1002/ijc.20372; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	42	57	62	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2192	2204		10.1038/onc.2009.505	http://dx.doi.org/10.1038/onc.2009.505			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20118981				2022-12-25	WOS:000276685200005
J	Kitzing, TM; Wang, Y; Pertz, O; Copeland, JW; Grosse, R				Kitzing, T. M.; Wang, Y.; Pertz, O.; Copeland, J. W.; Grosse, R.			Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC	ONCOGENE			English	Article						cancer cell invasion; Diaphanous formins; RhoC; FMNL2; actin	GENOMIC ANALYSIS; ACTIVATION; GTPASES; G-ALPHA(12/13); METASTASIS; TRANSITION; MECHANISM; MIGRATION; INHIBIT; LARG	Invasive cell migration is a key step for cancer metastasis and involves Rho GTPase-controlled reorganization of the actin cytoskeleton. Altered Rho GTPase expression is found in various malignancies. Particularly, the closely related GTPases RhoA and RhoC are upregulated in many aggressive tumours, but specific effectors that distinguish between these two GTPases to explain mechanistic differences have not been identified. The formins are by far the largest family of Rho GTPase effectors and are characterized by the actin-nucleating formin homology 2 domain. Using siRNA-based screening against all 15 human formins, we systematically analysed their functions in 3D cell motility using three different cancer cell lines. These results reveal distinct requirements for specific formins in amoeboid versus mesenchymal invasive cell migration. Importantly, by knocking down all Rho proteins, we identified formin-like 2 ( FMNL2) as a specific RhoC effector, showing selective interaction of FMNL2 with active RhoC, but not RhoA or RhoB. Functional analysis shows that RhoC regulates auto-inhibition of FMNL2, whereas suppression of FMNL2 inhibits RhoC-, but not RhoA-dependent, rounded invasive cell migration. Thus, our data uncover a novel regulatory and functional interaction between RhoC and FMNL2 for modulating cell shape and invasiveness and provide mechanistic insight into RhoC-specific signalling events. Oncogene (2010) 29, 2441-2448; doi:10.1038/onc.2009.515; published online 25 January 2010	[Grosse, R.] Univ Marburg, Inst Pharmacol, D-35032 Marburg, Hessen, Germany; [Kitzing, T. M.; Wang, Y.] Heidelberg Univ, Inst Pharmacol, D-6900 Heidelberg, Germany; [Wang, Y.] Heidelberg Univ, HBIGS, Heidelberg, Germany; [Pertz, O.] Univ Basel, Ctr Biomed, Basel, Switzerland; [Copeland, J. W.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	Philipps University Marburg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Basel; University of Ottawa	Grosse, R (corresponding author), Univ Marburg, Inst Pharmacol, Karl von Frisch Str 1, D-35032 Marburg, Hessen, Germany.	robert.grosse@staff.uni-marburg.de		Wang, Ying/0000-0001-8699-5974; Grosse, Robert/0000-0002-3380-5273; pertz, olivier/0000-0001-8579-4919	Deutsche Krebshilfe e. V. [108293]; C.H.S.-Foundation; Heart and Stroke Foundation of Ontario [T6317]; Krebsliga beider Basel	Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); C.H.S.-Foundation; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Krebsliga beider Basel	We thank Erik Sahai for supplying siRNAs against human Rho proteins. We thank Barbara Di Ventura for comments on the paper, Philippe Chavrier for discussions and Anke Niemann for excellent technical assistance. This work was funded by the Deutsche Krebshilfe e. V. (108293) and a group leader fellowship from the C.H.S.-Foundation to RG. JWC is supported by the Heart and Stroke Foundation of Ontario (T6317) and OP by grants from the Krebsliga beider Basel.	Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Chesarone M, 2009, DEV CELL, V16, P292, DOI 10.1016/j.devcel.2008.12.001; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Fleming YM, 2009, ONCOGENE, V28, P983, DOI 10.1038/onc.2008.449; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Goulimari P, 2008, MOL BIOL CELL, V19, P30, DOI 10.1091/mbc.E06-11-1045; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Zhu XL, 2008, INT J COLORECTAL DIS, V23, P1041, DOI 10.1007/s00384-008-0520-2	33	103	108	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	16					2441	2448		10.1038/onc.2009.515	http://dx.doi.org/10.1038/onc.2009.515			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20101212				2022-12-25	WOS:000276951500012
J	Liu, G; Xirodimas, DP				Liu, G.; Xirodimas, D. P.			NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways	ONCOGENE			English	Article						NEDDylation; ubiquitination; NUB1; p53; Mdm2; cytoplasmic localization	RING-FINGER DOMAIN; NUCLEAR; NEDDYLATION; DEGRADATION; BINDING; PROTEIN; MDM2; AUTOPHAGY	Non-covalent recognition of ubiquitin (Ub) and ubiquitin-like molecules (Ubls) by interacting proteins has an important role in the regulation of protein function and initiation of signalling events. In addition, growing evidence suggests that regulation of p53 subcellular localization contributes to the biological outcome of the p53 response. Cytoplasmic p53 is shown to promote apoptosis and inhibit the induction of autophagy. In this study we show that NEDD8 ultimate buster 1 (NUB1), a non-covalent interactor of the Ubl NEDD8 (neural precursor cell expressed, developmentally downregulated 8), controls the localization of p53. Expression of NUB1 leads to decreased modification of p53 with NEDD8 and stimulation of p53 ubiquitination. The biological outcome is the cytoplasmic localization and inhibition of the transcriptional activity of p53. Although the effects of NUB1 on p53 depend on NEDDylation and the murine double minute 2 (Mdm2) E3-ligase, the cooperation of NEDD8 with ubiquitin is required. The data identify a role for NEDD8 in controlling p53 localization and suggest that NEDD8 can control protein function through its non-covalent recognition by interacting proteins. Oncogene (2010) 29, 2252-2261; doi: 10.1038/onc.2009.494; published online 25 January 2010	[Xirodimas, D. P.] Univ Dundee, Sch Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Div Gene Regulat & Express,Coll Life Sci, Dundee DD1 5EH, Angus, Scotland	University of Dundee	Xirodimas, DP (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Div Gene Regulat & Express,Coll Life Sci, Dow St, Dundee DD1 5EH, Angus, Scotland.	d.xirodimas@dundee.ac.uk		Liu, Geng/0000-0002-9293-0461; Xirodimas, Dimitris/0000-0001-9275-1140				Abida WM, 2007, J BIOL CHEM, V282, P1797, DOI 10.1074/jbc.M609001200; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Coutts AS, 2009, DNA REPAIR, V8, P483, DOI 10.1016/j.dnarep.2009.01.008; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dohmesen C, 2008, CELL CYCLE, V7, P222, DOI 10.4161/cc.7.2.5185; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kito K, 2001, J BIOL CHEM, V276, P20603, DOI 10.1074/jbc.M100920200; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; LEE KAW, 1994, CELL BIOL LAB HDB, V1, P668; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Schmidtke G, 2006, J BIOL CHEM, V281, P20045, DOI 10.1074/jbc.M603063200; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Tanji K, 2005, BIOCHEM BIOPH RES CO, V337, P116, DOI 10.1016/j.bbrc.2005.09.014; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314	44	48	50	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	15					2252	2261		10.1038/onc.2009.494	http://dx.doi.org/10.1038/onc.2009.494			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101219				2022-12-25	WOS:000276685200010
J	Nasarre, C; Roth, M; Jacob, L; Roth, L; Koncina, E; Thien, A; Labourdette, G; Poulet, P; Hubert, P; Cremel, G; Roussel, G; Aunis, D; Bagnard, D				Nasarre, C.; Roth, M.; Jacob, L.; Roth, L.; Koncina, E.; Thien, A.; Labourdette, G.; Poulet, P.; Hubert, P.; Cremel, G.; Roussel, G.; Aunis, D.; Bagnard, D.			Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo	ONCOGENE			English	Article						neuropilin; glioma; angiogenesis; peptide; tumour growth	POINT MUTATION; BREAST-CANCER; MOUSE MODEL; CELLS; RECEPTORS; BINDING; ANGIOGENESIS; ACTIVATION; PROTEIN; PROGRESSION	Angiogenesis in glioblastoma is largely dependent on vascular endothelial growth factor (VEGF) signalling. Consistently, the VEGF coreceptor NRP1 promotes angiogenesis and tumour growth in gliomas. Here, we provide data showing that an innovative peptidic tool targeting the transmembrane domain of NRP1 efficiently blocks rat and human glioma growth in vivo. We show both in vivo and in vitro that the antitumour effect results from the anti-proliferative, anti-migratory and anti-angiogenic properties of the compound. The proposed NRP1 antagonizing peptide is therefore a promising novel class of anti-angiogenic drugs that might prolong glioma patient survival. Our results finally show for the first time that the transmembrane domain of important signalling receptors can be antagonized in vivo thereby providing a new avenue towards the development of atypical antagonists with strong therapeutic potential. Oncogene (2010) 29, 2381-2392; doi:10.1038/onc.2010.9; published online 8 February 2010	[Nasarre, C.; Roth, M.; Jacob, L.; Roth, L.; Koncina, E.; Thien, A.; Labourdette, G.; Cremel, G.; Roussel, G.; Aunis, D.; Bagnard, D.] INSERM, U575, F-67200 Strasbourg, France; [Poulet, P.] Inst Phys Biol, Lab Neuroimagerie & Neurosci Cognit, Strasbourg, France; [Hubert, P.] CNRS, LISM, UPR 9027, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Bagnard, D (corresponding author), INSERM, U682, 3 Ave Moliere, F-67200 Strasbourg, France.	dominique.bagnard@inserm.u-strasbg.fr	Hubert, Pierre/C-6678-2013; Poulet, Patrick/AAD-1438-2020; Poulet, Patrick/A-2001-2012; Poulet, Patrick/AAG-7783-2021; Dominique, Aunis/W-1419-2019; Bagnard, Dominique/I-6535-2013	Hubert, Pierre/0000-0002-7549-8910; JACOB, Laurent/0000-0003-4767-0442; Poulet, Patrick/0000-0001-7998-9672; Roth, Lise/0000-0001-7555-2916; Bagnard, Dominique/0000-0002-5261-902X	INSERM; ACI JC [5327]; ARC; ANR Emergence bio; FRC/Rotary international; Pharmaxon; La Ligue Contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ACI JC; ARC(Australian Research Council); ANR Emergence bio(French National Research Agency (ANR)); FRC/Rotary international; Pharmaxon; La Ligue Contre le Cancer(Ligue nationale contre le cancer)	We thank Dr Sophie Reibel-Foisset and Mr Nicolas Lethenet for excellent assistance with in vivo experiments and animal care. This work was supported by INSERM, ACI JC (No. 5327), ARC, ANR Emergence bio, FRC/Rotary international to Dominique Bagnard. Cecile Nasarre was supported by Pharmaxon and La Ligue Contre le Cancer.	Bagci T, 2009, ONCOGENE, V28, P3537, DOI 10.1038/onc.2009.204; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; Barr MP, 2005, BRIT J CANCER, V92, P328, DOI 10.1038/sj.bjc.6602308; Bedjeguelal K, 2006, BIOORG MED CHEM LETT, V16, P3998, DOI 10.1016/j.bmcl.2006.05.014; Bennasroune A, 2004, CRIT REV ONCOL HEMAT, V50, P23, DOI 10.1016/j.critrevonc.2003.08.004; Forbes LV, 2002, ONCOGENE, V21, P5981, DOI 10.1038/sj.onc.1205767; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Giordano RJ, 2005, CHEM BIOL, V12, P1075, DOI 10.1016/j.chembiol.2005.07.008; Goldbrunner RH, 2000, J NEURO-ONCOL, V50, P53, DOI 10.1023/A:1006462504447; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Guttmann-Raviv N, 2006, CANCER LETT, V231, P1, DOI 10.1016/j.canlet.2004.12.047; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; JOCIC Z, 1993, BRAIN COGNITION, V23, P222, DOI 10.1006/brcg.1993.1056; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; KLOSEN P, 1993, J HISTOCHEM CYTOCHEM, V41, P455, DOI 10.1177/41.3.8429209; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Marchesi VT, 2005, P NATL ACAD SCI USA, V102, P9093, DOI 10.1073/pnas.0503181102; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Nasarre C, 2009, CELL ADHES MIGR, V3, P383, DOI 10.4161/cam.3.4.9934; Nasarre P, 2005, NEOPLASIA, V7, P180, DOI 10.1593/neo.04481; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Slimani H, 2006, J DRUG TARGET, V14, P694, DOI 10.1080/10611860600947607; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tessitore A, 1999, J CLIN ENDOCR METAB, V84, P3522, DOI 10.1210/jc.84.10.3522; Tirand L, 2006, J CONTROL RELEASE, V111, P153, DOI 10.1016/j.jconrel.2005.11.017; Uitenbroek, 1997, BINOMIAL SISA; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; Wang ACC, 2001, AM J RESP CELL MOL, V24, P688, DOI 10.1165/ajrcmb.24.6.4376; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; Williams G, 2005, J NEUROCHEM, V92, P1180, DOI 10.1111/j.1471-4159.2004.02950.x; Xu L, 2009, CANCER RES, V69, P7905, DOI 10.1158/0008-5472.CAN-09-2099	42	85	90	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	16					2381	2392		10.1038/onc.2010.9	http://dx.doi.org/10.1038/onc.2010.9			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20140015				2022-12-25	WOS:000276951500007
J	Wu, Y; Wang, YY; Nakamoto, Y; Li, YY; Baba, T; Kaneko, S; Fujii, C; Mukaida, N				Wu, Y.; Wang, Y. Y.; Nakamoto, Y.; Li, Y-Y; Baba, T.; Kaneko, S.; Fujii, C.; Mukaida, N.			Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver	ONCOGENE			English	Article						serine/threonine kinase; apoptosis; cell cycle; Bad	NF-KAPPA-B; SERINE/THREONINE KINASE-ACTIVITY; BAD-MEDIATED APOPTOSIS; NECROSIS-FACTOR-ALPHA; CHEMICAL HEPATOCARCINOGENESIS; PROTEIN-KINASE; GROWTH-FACTOR; CANCER CELLS; C-MYC; ACTIVATION	Pim-3, a proto-oncogene with serine/threonine kinase activity, was enhanced in hepatocellular carcinoma (HCC) tissues. To address the roles of Pim-3 in HCC development, we prepared transgenic mice that express human Pim-3 selectively in liver. The mice were born at a Mendelian ratio, were fertile and did not exhibit any apparent pathological changes in the liver until 1 year after birth. Pim-3-transgenic mouse-derived hepatocytes exhibited accelerated cell cycle progression. The administration of a potent hepatocarcinogen, diethylnitrosamine (DEN), induced accelerated proliferation of liver cells in Pim-3 transgenic mice in the early phase, compared with that observed for wild-type mice. Treatment with DEN induced lipid droplet accumulation with increased proliferating cell numbers 6 months after the treatment. Eventually, wild-type mice developed HCC with a frequency of 40% until 10 month after the treatment. Lipid accumulation was accelerated in Pim-3 transgenic mice with higher proliferating cell numbers, compared with that observed for wild-type mice. Pim-3 transgenic mice developed HCC with a higher incidence (80%) and a heavier burden, together with enhanced intratumoral CD31-positive vascular areas, compared with that observed for wild-type mice. These observations indicate that Pim-3 alone cannot cause, but can accelerate HCC development when induced by a hepatocarcinogen, such as DEN. Oncogene (2010) 29, 2228-2237; doi: 10.1038/onc.2009.504; published online 18 January 2010	[Wu, Y.; Wang, Y. Y.; Li, Y-Y; Baba, T.; Fujii, C.; Mukaida, N.] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 9200934, Japan; [Wu, Y.] Sichuan Univ, W China Hosp, Dept Hematol, Chengdu 610064, Sichuan, Peoples R China; [Wu, Y.] Sichuan Univ, W China Hosp, Hematol Res Lab, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Wu, Y.] Sichuan Univ, W China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China; [Nakamoto, Y.; Kaneko, S.] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9200934, Japan; [Li, Y-Y] Fudan Univ, Canc Hosp, Researcher Ctr, Shanghai 200433, Peoples R China	Kanazawa University; Sichuan University; Sichuan University; Sichuan University; Kanazawa University; Fudan University	Mukaida, N (corresponding author), Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, 13-1 Takara Machi, Kanazawa, Ishikawa 9200934, Japan.	naofumim@kenroku.kanazawa-u.ac.jp	Mukaida, Naofumi/D-7623-2011	Mukaida, Naofumi/0000-0002-4193-1851; Fujii, Chifumi/0000-0001-8735-5274				Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; BRAUN L, 1989, CANCER RES, V49, P1554; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chung J, 2007, LAB INVEST, V87, P540, DOI 10.1038/labinvest.3700550; Deneen B, 2003, MOL CELL BIOL, V23, P3897, DOI 10.1128/MCB.23.11.3897-3908.2003; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Feldman JD, 1998, J BIOL CHEM, V273, P16535, DOI 10.1074/jbc.273.26.16535; Fujii C, 2005, INT J CANCER, V114, P209, DOI 10.1002/ijc.20719; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; HOSONO S, 1993, ONCOGENE, V8, P491; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Li YY, 2006, CANCER RES, V66, P6741, DOI 10.1158/0008-5472.CAN-05-4272; Ma W, 2006, ONCOGENE, V25, P4207, DOI 10.1038/sj.onc.1209450; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Manna SK, 2000, J IMMUNOL, V165, P5962, DOI 10.4049/jimmunol.165.10.5962; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; NAKATSURU Y, 1993, P NATL ACAD SCI USA, V90, P6468, DOI 10.1073/pnas.90.14.6468; Otani K, 2005, GASTROENTEROLOGY, V128, P96, DOI 10.1053/j.gastro.2004.10.045; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Popivanova BK, 2007, CANCER SCI, V98, P321, DOI 10.1111/j.1349-7006.2007.00390.x; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; ROBERTS RA, 1999, CARCINOGENESIS, V20, P1297; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; TAMURA M, 1993, J BIOL CHEM, V268, P8140; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Udalova IA, 2001, BIOCHEM BIOPH RES CO, V289, P25, DOI 10.1006/bbrc.2001.5929; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Wang Y, 2009, INT J CANCER, V124, P540, DOI 10.1002/ijc.23995; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Wu Y, 2008, J IMMUNOL, V181, P6384, DOI 10.4049/jimmunol.181.9.6384; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang XQ, 2006, INT J CANCER, V118, P1869, DOI 10.1002/ijc.21596; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zheng HC, 2008, J CANCER RES CLIN, V134, P481, DOI 10.1007/s00432-007-0310-1; Zheng YY, 2007, HEPATOLOGY, V45, P16, DOI 10.1002/hep.21445	43	50	53	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2228	2237		10.1038/onc.2009.504	http://dx.doi.org/10.1038/onc.2009.504			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101231	Green Submitted			2022-12-25	WOS:000276685200008
J	Pavlov, E; Aschar-Sobbi, R; Campanella, M; Turner, RJ; Gomez-Garcia, MR; Abramov, AY				Pavlov, Evgeny; Aschar-Sobbi, Roozbeh; Campanella, Michelangelo; Turner, Raymond J.; Gomez-Garcia, Maria R.; Abramov, Andrey Y.			Inorganic Polyphosphate and Energy Metabolism in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ESCHERICHIA-COLI; OXIDATIVE PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; RESPIRATORY ENZYMES; SENSITIVITY; EXPRESSION; MEMBRANE; DEATH; CHAIN	Inorganic polyphosphate (poly P) is a polymer made from as few as 10 to several hundred phosphate molecules linked by phosphoanhydride bonds similar to ATP. Poly P is ubiquitous in all mammalian organisms, where it plays multiple physiological roles. The metabolism of poly P in mammalian organisms is not well understood. We have examined the mechanism of poly P production and the role of this polymer in cell energy metabolism. Poly P levels in mitochondria and intact cells were estimated using a fluorescent molecular probe, 4',6-diamidino-2-phenylindole. Poly P levels were dependent on the metabolic state of the mitochondria. Poly P levels were increased by substrates of respiration and in turn reduced by mitochondrial inhibitor(rotenone) or an uncoupler(carbonyl cyanide p-trifluoromethoxyphenylhydrazone). Oligomycin, an inhibitor of mitochondrial ATP-synthase, blocked the production of poly P. Enzymatic depletion of poly P from cells significantly altered the rate of ATP metabolism. We propose the existence of a feedback mechanism where poly P production and cell energy metabolism regulate each other.	[Abramov, Andrey Y.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Pavlov, Evgeny; Aschar-Sobbi, Roozbeh] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Turner, Raymond J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 4N1, Canada; [Gomez-Garcia, Maria R.] Stanford Univ, Dept Plant Biol, Carnegie Inst Sci, Stanford, CA 94305 USA; [Campanella, Michelangelo] Univ London, Royal Vet Coll, London NW1 0TU, England; [Campanella, Michelangelo] UCL, Consortium Mitochondrial Res, London WC1E 6BT, England	University of London; University College London; University of Calgary; University of Calgary; Carnegie Institution for Science; Stanford University; University of London; University of London Royal Veterinary College; University of London; University College London	Abramov, AY (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.	a.abramov@ucl.ac.uk	Abramov, Andrey/AAC-6712-2019; Turner, Raymond J./M-3961-2015; Abramov, Andrey Y/H-9053-2012	Abramov, Andrey/0000-0002-7646-7235; Turner, Raymond J./0000-0002-9263-0776; Abramov, Andrey Y/0000-0002-7646-7235	Clinical Research and Development Committee; Heart and Stroke Foundation of Alberta	Clinical Research and Development Committee; Heart and Stroke Foundation of Alberta	This work was supported by a Clinical Research and Development Committee Research Funding grant and the Heart and Stroke Foundation of Alberta.	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Abramov AY, 2005, J NEUROSCI, V25, P9176, DOI 10.1523/JNEUROSCI.1632-05.2005; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BEAUVOIT B, 1991, BIOCHEMISTRY-US, V30, P11212, DOI 10.1021/bi00111a004; Beca S, 2009, ARCH BIOCHEM BIOPHYS, V490, P110, DOI 10.1016/j.abb.2009.08.014; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; CHANCE B, 1955, J BIOL CHEM, V217, P383; CHANCE B, 1955, J BIOL CHEM, V217, P429; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; HAROLD FM, 1966, BACTERIOL REV, V30, P772, DOI 10.1128/MMBR.30.4.772-794.1966; Hooley P, 2008, TRENDS BIOCHEM SCI, V33, P577, DOI 10.1016/j.tibs.2008.09.007; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kulaev I, 1999, J BIOSCI BIOENG, V88, P111, DOI 10.1016/S1389-1723(99)80189-3; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNN WS, 1963, BIOCHEM BIOPH RES CO, V11, P367, DOI 10.1016/0006-291X(63)90124-4; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Pavlov E, 2005, BIOPHYS J, V88, P2614, DOI 10.1529/biophysj.104.057281; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Reusch RN, 1997, FEBS LETT, V412, P592, DOI 10.1016/S0014-5793(97)00863-6; SILVERMAN HS, 1994, AM J PHYSIOL, V266, pC222, DOI 10.1152/ajpcell.1994.266.1.C222; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; TIJSSEN JPF, 1982, BIOCHIM BIOPHYS ACTA, V721, P394, DOI 10.1016/0167-4889(82)90094-5; Vagabov VM, 2000, BIOCHEMISTRY-MOSCOW+, V65, P349; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100	28	123	126	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9420	9428		10.1074/jbc.M109.013011	http://dx.doi.org/10.1074/jbc.M109.013011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20124409	hybrid, Green Published			2022-12-25	WOS:000276165900014
J	Shen, YQ; Chen, CS; Ichikawa, H; Goldberg, GS				Shen, Yongquan; Chen, Chen-Shan; Ichikawa, Hitoshi; Goldberg, Gary S.			Src Induces Podoplanin Expression to Promote Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GAP JUNCTIONAL COMMUNICATION; PLATELET-AGGREGATION; TRANSFORMED-CELLS; PHOSPHORYLATION SITES; PULMONARY METASTASIS; TUMOR INVASION; CAS; GROWTH; CANCER	Nontransformed cells can force tumor cells to assume a normal morphology and phenotype by the process of contact normalization. Transformed cells must escape this process to become invasive and malignant. However, mechanisms underlying contact normalization have not been elucidated. Here, we have identified genes that are affected by contact normalization of Src-transformed cells. Tumor cells must migrate to become invasive and malignant. Src must phosphorylate the adaptor protein Cas (Crk-associated substrate) to promote tumor cell motility. We report here that Src utilizes Cas to induce podoplanin (Pdpn) expression to promote tumor cell migration. Pdpn is a membrane-bound extracellular glycoprotein that associates with endogenous ligands to promote tumor cell migration leading to cancer invasion and metastasis. In fact, Pdpn expression accounted for a major part of the increased migration seen in Src-transformed cells. Moreover, nontransformed cells suppressed Pdpn expression in adjacent Src-transformed cells. Of > 39,000 genes, Pdpn was one of only 23 genes found to be induced by transforming Src activity and suppressed by contact normalization of Src-transformed cells. In addition, we found 16 genes suppressed by Src and induced by contact normalization. These genes encode growth factor receptors, adaptor proteins, and products that have not yet been annotated and may play important roles in tumor cell growth and migration.	[Shen, Yongquan; Chen, Chen-Shan; Goldberg, Gary S.] Univ Med & Dent New Jersey, Dept Mol Biol, Stratford, NJ 08084 USA; [Chen, Chen-Shan] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Ichikawa, Hitoshi] Natl Canc Ctr, Res Inst, Canc Transcriptome Project, Chuo Ku, Tokyo 1040045, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Cancer Center - Japan	Goldberg, GS (corresponding author), Univ Med & Dent New Jersey, Dept Mol Biol, Stratford, NJ 08084 USA.	gary.goldberg@umdnj.edu			National Institutes of Health [CA88085]; Department of Molecular Biology; Research Foundation of the University of Medicine and Dentistry of New Jersey; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CANCER INSTITUTE [R13CA088085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Molecular Biology; Research Foundation of the University of Medicine and Dentistry of New Jersey; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA88085 (to G. S. G.). This work was also supported by the Department of Molecular Biology, the Research Foundation of the University of Medicine and Dentistry of New Jersey, and by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. I.).	Alexander DB, 2004, CANCER RES, V64, P1347, DOI 10.1158/0008-5472.CAN-03-2558; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Cavanna T, 2007, J CELL SCI, V120, P606, DOI 10.1242/jcs.000273; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Durchdewald M, 2008, CANCER RES, V68, P6877, DOI 10.1158/0008-5472.CAN-08-0299; Glick AB, 2005, SEMIN CANCER BIOL, V15, P75, DOI 10.1016/j.semcancer.2004.08.008; Goldberg GS, 2003, J BIOL CHEM, V278, P46533, DOI 10.1074/jbc.M307526200; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Li X, 2009, ONCOGENE, V28, P4272, DOI 10.1038/onc.2009.278; Li X, 2008, CANCER SCI, V99, P1326, DOI 10.1111/j.1349-7006.2008.00816.x; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Nakazawa Y, 2008, BLOOD, V112, P1730, DOI 10.1182/blood-2007-11-124693; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Patwardhan P, 2006, J BIOL CHEM, V281, P20689, DOI 10.1074/jbc.M602311200; Rubin H, 2006, BIOESSAYS, V28, P515, DOI 10.1002/bies.20403; Rubin H, 2008, ADV CANCER RES, V100, P159, DOI 10.1016/S0065-230X(08)00006-7; Rubin H, 2007, ADV CANCER RES, V98, P117, DOI 10.1016/S0065-230X(06)98004-X; Schenone S, 2007, CURR MED CHEM, V14, P2495, DOI 10.2174/092986707782023622; Scholl FG, 1999, J CELL SCI, V112, P4601; Shao Q, 2005, CANCER RES, V65, P2705, DOI 10.1158/0008-5472.CAN-04-2367; Shen YQ, 2007, J BIOL CHEM, V282, P18914, DOI 10.1074/jbc.M608980200; Shen YQ, 2006, CANCER RES, V66, P1543, DOI 10.1158/0008-5472.CAN-05-3152; Watanabe T, 2005, CANCER SCI, V96, P498, DOI 10.1111/j.1349-7006.2005.00073.x; Werbowetski-Ogilvie TE, 2006, CANCER RES, V66, P1464, DOI 10.1158/0008-5472.CAN-05-1913; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	35	44	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9649	9656		10.1074/jbc.M109.047696	http://dx.doi.org/10.1074/jbc.M109.047696			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20123990	Green Published, hybrid			2022-12-25	WOS:000276165900038
J	Weis, F; Moullintraffort, L; Heichette, C; Chretien, D; Garnier, C				Weis, Felix; Moullintraffort, Laura; Heichette, Claire; Chretien, Denis; Garnier, Cyrille			The 90-kDa Heat Shock Protein Hsp90 Protects Tubulin against Thermal Denaturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE DYNAMIC INSTABILITY; IN-VITRO; MOLECULAR CHAPERONE; SIGNAL-TRANSDUCTION; SUBSTRATE-BINDING; TERMINAL DOMAIN; KINASE-ACTIVITY; CO-CHAPERONE; CELLS; OLIGOMERIZATION	Hsp90 and tubulin are among the most abundant proteins in the cytosol of eukaryotic cells. Although Hsp90 plays key roles in maintaining its client proteins in their active state, tubulin is essential for fundamental processes such as cell morphogenesis and division. Several studies have suggested a possible connection between Hsp90 and the microtubule cytoskeleton. Because tubulin is a labile protein in its soluble form, we investigated whether Hsp90 protects it against thermal denaturation. Both proteins were purified from porcine brain, and their interaction was characterized in vitro by using spectrophotometry, sedimentation assays, video-enhanced differential interference contrast light microscopy, and native polyacrylamide gel electrophoresis. Our results show that Hsp90 protects tubulin against thermal denaturation and keeps it in a state compatible with microtubule polymerization. We demonstrate that Hsp90 cannot resolve tubulin aggregates but that it likely binds early unfolding intermediates, preventing their aggregation. Protection was maximal at a stoichiometry of two molecules of Hsp90 for one of tubulin. This protection does not require ATP binding and hydrolysis by Hsp90, but it is counteracted by geldanamycin, a specific inhibitor of Hsp90.	[Weis, Felix; Moullintraffort, Laura; Heichette, Claire; Chretien, Denis; Garnier, Cyrille] Univ Rennes 1, CNRS, UMR 6026, IFR Genet Fonct Agron & Sante 140, F-35042 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Garnier, C (corresponding author), Univ Rennes 1, CNRS, UMR 6026, IFR Genet Fonct Agron & Sante 140, Campus Beaulieu Batiment 13,263 Ave Gen Leclerc, F-35042 Rennes, France.	cyrille.garnier@univ-rennes1.fr		Weis, Felix/0000-0002-8137-3532; Chretien, Denis/0000-0001-8261-4396; GARNIER, Cyrille/0000-0002-5715-8218; Le Breton, Laura/0000-0002-5599-3244	Ligue contre le Cancer; Region Bretagne; Rennes Metropole	Ligue contre le Cancer(Ligue nationale contre le cancer); Region Bretagne(Region Bretagne); Rennes Metropole(Region Bretagne)	This work was supported by a Ligue contre le Cancer grant (to C.G. awarded by the Conseil Scientifique Interregional Grand-Ouest), a Region Bretagne Ph.D. grant (to L.M.), and Rennes Metropole (to D.C.).	Andersen SSL, 1997, J CELL BIOL, V139, P975, DOI 10.1083/jcb.139.4.975; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Ashford AJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P205; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; COSS RA, 1982, CANCER RES, V42, P1059; Czar MJ, 1996, EUR J CELL BIOL, V70, P322; Day RM, 2003, CELL STRESS CHAPERON, V8, P183, DOI 10.1379/1466-1268(2003)008<0183:ASHCPF>2.0.CO;2; Debec A, 1997, BIOL CELL, V89, P67, DOI 10.1016/S0248-4900(99)80082-3; Garnier C, 1998, BIOCHEM BIOPH RES CO, V250, P414, DOI 10.1006/bbrc.1998.9319; Garnier C, 1998, BIOCHEM BIOPH RES CO, V249, P197, DOI 10.1006/bbrc.1998.9108; Garnier C, 2002, BIOCHEMISTRY-US, V41, P11770, DOI 10.1021/bi025650p; Garnier C, 2001, EUR J BIOCHEM, V268, P2402, DOI 10.1046/j.1432-1327.2001.02121.x; GASKIN F, 1982, METHOD ENZYMOL, V85, P433; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; HENEGOUWEN PMPVE, 1987, EXP CELL RES, V171, P367, DOI 10.1016/0014-4827(87)90169-8; HICKEY E, 1986, GENE, V43, P147, DOI 10.1016/0378-1119(86)90018-1; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; KIM DH, 1992, J CELL PHYSIOL, V153, P353, DOI 10.1002/jcp.1041530215; KNOX JD, 1991, EXP CELL RES, V194, P275, DOI 10.1016/0014-4827(91)90365-2; LAEMMLI UK, 1970, NATURE, V227, P685; Liang P, 1997, J CELL SCI, V110, P1431; MALAWISTA SE, 1982, J CELL BIOL, V95, P960, DOI 10.1083/jcb.95.3.960; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; MOZOVILLARIAS A, 1991, EUR BIOPHYS J, V19, P295, DOI 10.1007/BF00183318; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Nemoto TK, 2004, BIOCHEMISTRY-US, V43, P7628, DOI 10.1021/bi036235f; Nemoto TK, 2001, BIOCHEM J, V354, P663, DOI 10.1042/0264-6021:3540663; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Radanyi C, 2009, CANCER LETT, V274, P88, DOI 10.1016/j.canlet.2008.09.001; REDMOND T, 1989, EUR J CELL BIOL, V50, P66; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; SANCHEZ ER, 1988, MOL ENDOCRINOL, V2, P756, DOI 10.1210/mend-2-8-756; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Schnaider T, 2000, CELL STRESS CHAPERON, V5, P52, DOI 10.1379/1466-1268(2000)005<0052:THSIGS>2.0.CO;2; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Thorne ME, 2004, BIOCHEM BIOPH RES CO, V323, P1163, DOI 10.1016/j.bbrc.2004.08.215; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; VIDAIR CA, 1995, J CELL PHYSIOL, V163, P194, DOI 10.1002/jcp.1041630122; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Williams NE, 1997, J CELL SCI, V110, P1665; Yamada S, 2003, EUR J BIOCHEM, V270, P146, DOI 10.1046/j.1432-1033.2003.03375.x; YONEZAWA N, 1988, EUR J BIOCHEM, V177, P1, DOI 10.1111/j.1432-1033.1988.tb14337.x; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201	59	53	55	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9525	9534		10.1074/jbc.M109.096586	http://dx.doi.org/10.1074/jbc.M109.096586			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110359	Green Published, hybrid			2022-12-25	WOS:000276165900026
J	Kalua, K; Chirwa, T; Kalilani, L; Abbenyi, S; Mukaka, M; Bailey, R				Kalua, Khumbo; Chirwa, Tobias; Kalilani, Linda; Abbenyi, Sam; Mukaka, Mavuto; Bailey, Robin			Prevalence and Risk Factors for Trachoma in Central and Southern Malawi	PLOS ONE			English	Article							ACTIVE TRACHOMA; BLINDNESS; TANZANIA; GAMBIA; TRIAL; NTD	Background: Trachoma, one of the neglected tropical diseases is suspected to be endemic in Malawi. Objectives: To determine the prevalence of trachoma and associated risk factors in central and southern Malawi. Methodology/Principal Findings: A population based survey conducted in randomly selected clusters in Chikwawa district (population 438,895), southern Malawi and Mchinji district (population 456,558), central Malawi. Children aged 1-9 years and adults aged 15 and above were assessed for clinical signs of trachoma. In total, 1010 households in Chikwawa and 1016 households in Mchinji districts were enumerated within 108 clusters (54 clusters in each district). A total of 6,792 persons were examined for ocular signs of trachoma. The prevalence of trachomatous inflammation, follicular (TF) among children aged 1-9 years was 13.6% (CI 11.6-15.6) in Chikwawa and 21.7% (CI 19.5-23.9) in Mchinji districts respectively. The prevalence of trachoma trichiasis (TT) in women and men aged 15 years and above was 0.6% (CI 0.2-0.9) in Chikwawa and 0.3% (CI 0.04-0.6) in Mchinji respectively. The presence of a dirty face was significantly associated with trachoma follicular (TF) in both Chikwawa and Mchinji districts (P<0.001). Conclusion/Significance: Prevalence rates of trachoma follicles (TF) in Central and Southern Malawi exceeds the WHO guidelines for the intervention with mass antibiotic distribution (TF>10%), and warrants the trachoma SAFE control strategy to be undertaken in Chikwawa and Mchinji districts.	[Kalua, Khumbo] Univ Malawi, Coll Med, Dept Ophthalmol, Blantyre, Malawi; [Chirwa, Tobias] Univ Malawi, Chancellor Coll, Dept Math & Stat, Zomba, Malawi; [Kalilani, Linda] Univ Malawi, Coll Med, Res Support Ctr, Blantyre, Malawi; [Abbenyi, Sam] ITI, New York, NY USA; [Mukaka, Mavuto] MLWT, Coll Med, Blantyre, Malawi; [Kalua, Khumbo; Bailey, Robin] London Sch Hyg & Trop Med, London WC1, England	University of Malawi; University of Malawi; University of Malawi; University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Kalua, K (corresponding author), Univ Malawi, Coll Med, Dept Ophthalmol, Blantyre, Malawi.	khumbokalua@yahoo.com	Chirwa, Tobias/AAI-9087-2021; Kalua, Khumbo k/D-8449-2019	Kalua, Khumbo k/0000-0001-9284-9009	National Prevention of Blindness Committee; Ministry of Health, Malawi by Sight Savers International (SSI)	National Prevention of Blindness Committee; Ministry of Health, Malawi by Sight Savers International (SSI)	The study was funded through National Prevention of Blindness Committee, Ministry of Health, Malawi by Sight Savers International (SSI), a UK based charity organisation which has been supporting eye care activities in Malawi for the last 30 years. SSI Malawi country office staff helped in providing logistics for the survey (printing questionnaires and assisting with transportation) but did not take part in manuscript writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley RF, 2006, TROP MED INT HEALTH, V11, P220, DOI 10.1111/j.1365-3156.2005.01553.x; Bailey R, 2007, BRIT J OPHTHALMOL, V91, P271, DOI 10.1136/bjo.2006.105270; Bowman RJC, 2001, OPHTHALMOLOGY, V108, P2219, DOI 10.1016/S0161-6420(01)00645-5; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Burton MJ, 2007, BRIT MED BULL, V84, P99, DOI 10.1093/bmb/ldm034; Courtright P, 2003, BRIT J OPHTHALMOL, V87, P1079, DOI 10.1136/bjo.87.9.1079; Emerson PM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000197; Emerson PM, 2004, LANCET, V363, P1093, DOI 10.1016/S0140-6736(04)15891-1; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; MABEY DCW, 1987, LANCET, V2, P452; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mariotti SP, 2003, AM J TROP MED HYG, V69, P33; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; Ngondi J, 2007, AM J TROP MED HYG, V77, P126, DOI 10.4269/ajtmh.2007.77.126; Polack S, 2005, B WORLD HEALTH ORGAN, V83, P913; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; TIELSCH JM, 1988, AM J TROP MED HYG, V38, P393, DOI 10.4269/ajtmh.1988.38.393; West SK, 1996, AM J EPIDEMIOL, V143, P73, DOI 10.1093/oxfordjournals.aje.a008659; WHO, 2006, TRACH CONTR GUID PRO; WHO simplified trachoma grading system, 2004, COMMUNITY EYE HLTH, V17, P68	22	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9067	10.1371/journal.pone.0009067	http://dx.doi.org/10.1371/journal.pone.0009067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140094	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000274442400007
J	Cropley, JE; Suter, CM; Beckman, KB; Martin, DIK				Cropley, Jennifer E.; Suter, Catherine M.; Beckman, Kenneth B.; Martin, David I. K.			CpG Methylation of a Silent Controlling Element in the Murine A(vy) Allele Is Incomplete and Unresponsive to Methyl Donor Supplementation	PLOS ONE			English	Article							AGOUTI GENE-EXPRESSION; DNA METHYLATION; EPIGENETIC INHERITANCE; TRANSPOSABLE ELEMENTS; MOLECULAR-BASIS; COAT COLOR; MLH1; RETROTRANSPOSONS; PHENOTYPE; MUTATION	Background: The viable yellow allele of agouti (A(vy)) is remarkable for its unstable and partially heritable epigenetic state, which produces wide variation in phenotypes of isogenic mice. In the A(vy) allele an inserted intracisternal A particle (IAP) acts as a controlling element which deregulates expression of agouti by transcription from the LTR of the IAP; the phenotypic state has been linked to CpG methylation of the LTR. Phenotypic variation between A(vy) mice indicates that the epigenetic state of the IAP is unstable in the germline. Principal Findings: We have made a detailed examination of somatic methylation of the IAP using bisulphite allelic sequencing, and find that the promoter is incompletely methylated even when it is transcriptionally silent. In utero exposure to supplementary methyl donors, which alters the spectrum of A(vy) phenotypes, does not increase the density of CpG methylation in the silent LTR. Conclusions: Our findings suggest that, contrary to previous supposition, methyl donor supplementation acts through an indirect mechanism to silence A(vy). The incomplete cytosine methylation we observe at the somatically silent A(vy) allele may reflect its unstable germline state, and the influence of epigenetic modifications underlying CpG methylation.	[Cropley, Jennifer E.; Suter, Catherine M.; Martin, David I. K.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Suter, Catherine M.] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; [Cropley, Jennifer E.; Suter, Catherine M.; Beckman, Kenneth B.; Martin, David I. K.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Cropley, JE (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia.	dimartin@chori.org		Cropley, Jennifer/0000-0001-6078-2604	NCI [CA115768-01]; NATIONAL CANCER INSTITUTE [R01CA115768] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant CA115768-01 to DM, and by a grant from the Australian Research council to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argeson AC, 1996, GENETICS, V142, P557; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Clark SJ, 2002, METHODS, V27, P99, DOI 10.1016/S1046-2023(02)00059-2; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cooney CA, 2002, J NUTR, V132, p2393S; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; DICKIES MM, 1962, J HERED, V53, P84, DOI 10.1093/oxfordjournals.jhered.a107129; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; FINCHAM JRS, 1974, ANNU REV GENET, V8, P15, DOI 10.1146/annurev.ge.08.120174.000311; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GALBRAITH DB, 1974, J HERED, V65, P137, DOI 10.1093/oxfordjournals.jhered.a108484; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Gazzoli I, 2002, CANCER RES, V62, P3925; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; PERRY WL, 1994, BIOESSAYS, V16, P705, DOI 10.1002/bies.950161002; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rangwala SH, 2006, PLOS GENET, V2, P270, DOI 10.1371/journal.pgen.0020036; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wolff GL, 1999, PHYSIOL GENOMICS, V1, P151, DOI 10.1152/physiolgenomics.1999.1.3.151; WOLFF GL, 1978, GENETICS, V88, P529; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	39	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9055	10.1371/journal.pone.0009055	http://dx.doi.org/10.1371/journal.pone.0009055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140227	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474400013
J	Pellegrini, M; Di Siena, S; Claps, G; Di Cesare, S; Dolci, S; Rossi, P; Geremia, R; Grimaldi, P				Pellegrini, Manuela; Di Siena, Sara; Claps, Giuseppina; Di Cesare, Silvia; Dolci, Susanna; Rossi, Pellegrino; Geremia, Raffaele; Grimaldi, Paola			Microgravity Promotes Differentiation and Meiotic Entry of Postnatal Mouse Male Germ Cells	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; C-KIT; SPERMATOGONIA; SPERMATOGENESIS; PROLIFERATION; SPERMATOCYTES; ACTIVATION; EXPRESSION; OOGENESIS; AKT	A critical step of spermatogenesis is the entry of mitotic spermatogonia into meiosis. Progresses on these topics are hampered by the lack of an in vitro culture system allowing mouse spermatogonia differentiation and entry into meiosis. Previous studies have shown that mouse pachytene spermatocytes cultured in simulated microgravity (SM) undergo a spontaneous meiotic progression. Here we report that mouse mitotic spermatogonia cultured under SM with a rotary cell culture system (RCCS) enter into meiosis in the absence of any added exogenous factor or contact with somatic cells. We found that isolated Kit-positive spermatogonia under the RCCS condition enter into the prophase of the first meiotic division (leptotene stage), as monitored by chromosomal organization of the synaptonemal complex 3 protein (Scp3) and up-regulation of several promeiotic genes. SM was found to activate the phosphatidyl inositol 3 kinase (PI3K) pathway and to induce in Kit-positive spermatogonia the last round of DNA replication, typical of the preleptotene stage. A PI3K inhibitor abolished Scp3 induction and meiotic entry stimulated by RCCS conditions. A positive effect of SM on germ cell differentiation was also observed in undifferentiated (Kit-negative) spermatogonia, in which RCCS conditions stimulate the expression of Kit and Stra8. In conclusion, SM is an artificial environmental condition which promotes postnatal male germ cell differentiation and might provide a tool to study the molecular mechanisms underlying the switch from mitosis to meiosis in mammals.	[Pellegrini, Manuela; Di Siena, Sara; Claps, Giuseppina; Di Cesare, Silvia; Dolci, Susanna; Rossi, Pellegrino; Geremia, Raffaele; Grimaldi, Paola] Univ Roma Tor Vergata, Dept Publ Hlth & Cellular Biol, Rome, Italy	University of Rome Tor Vergata	Pellegrini, M (corresponding author), Univ Roma Tor Vergata, Dept Publ Hlth & Cellular Biol, Rome, Italy.	grimaldi@uniroma2.it	Rossi, Pellegrino/AAA-7072-2019; Pellegrini, manuela/AAC-1423-2022; dolci, susanna/B-8363-2013; Grimaldi, Paola/AAW-8721-2020; GRIMALDI, PAOLA/AAJ-7920-2020; DI CESARE, SILVIA/AAB-5754-2020; Claps, Giuseppina/G-6180-2018	dolci, susanna/0000-0002-6864-3673; GRIMALDI, PAOLA/0000-0001-6724-7604; DI CESARE, SILVIA/0000-0002-9912-7997; ROSSI, PELLEGRINO/0000-0003-4796-327X; GEREMIA, Raffaele/0000-0001-9056-6603; pellegrini, manuela/0000-0001-6387-5187; Claps, Giuseppina/0000-0002-3064-0063	Italian Ministry of University [200788TPYE_002]; Agenzia Spaziale Italiana (ASI)	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI))	This work was supported by the Italian Ministry of University (Grant Prin 2007 200788TPYE_002) and Agenzia Spaziale Italiana (ASI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Boehrs Jessica, 2008, J Prosthodont, V17, P517, DOI 10.1111/j.1532-849X.2008.00330.x; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chiarini-Garcia H, 2002, REPRODUCTION, V123, P567, DOI 10.1530/reprod/123.4.567; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Di Agostino S, 2004, REPRODUCTION, V128, P25, DOI 10.1530/rep.1.00184; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Li S, 2009, STEM CELLS DEV, V18, P1273, DOI 10.1089/scd.2008.0371; Lolicato F, 2008, DEV BIOL, V313, P725, DOI 10.1016/j.ydbio.2007.11.011; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Morbidelli L, 2005, BIOCHEM BIOPH RES CO, V334, P491, DOI 10.1016/j.bbrc.2005.06.124; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Ollinger R, 2005, MOL BIOL CELL, V16, P212; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Ricci G, 2008, J ENDOCRINOL INVEST, V31, P229, DOI 10.1007/BF03345595; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; ROSSI P, 1993, DEV BIOL, V155, P68, DOI 10.1006/dbio.1993.1007; Rossi P, 2008, GENE EXPR PATTERNS, V8, P58, DOI 10.1016/j.modgep.2007.10.007; Sanford GL, 2002, IN VITRO CELL DEV-AN, V38, P493; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; SORRENTINO V, 1991, ONCOGENE, V6, P149; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921	30	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9064	10.1371/journal.pone.0009064	http://dx.doi.org/10.1371/journal.pone.0009064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140225	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474400019
J	Cachaco, AS; Carvalho, T; Santos, AC; Igreja, C; Fragoso, R; Osorio, C; Ferreira, M; Serpa, J; Correia, S; Pinto-do-O, P; Dias, S				Cachaco, Ana Sofia; Carvalho, Tania; Santos, Ana Cristina; Igreja, Catia; Fragoso, Rita; Osorio, Catarina; Ferreira, Manuela; Serpa, Jacinta; Correia, Sofia; Pinto-do-O, Perpetua; Dias, Sergio			TNF-alpha Regulates the Effects of Irradiation in the Mouse Bone Marrow Microenvironment	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYELODYSPLASTIC SYNDROMES; FACTOR RECEPTOR; IN-VITRO; SIGNALING PATHWAYS; MYELOID-LEUKEMIA; PROGENITOR CELLS; APLASTIC-ANEMIA; FANCONI-ANEMIA; FUSION PROTEIN	Background: Secondary bone marrow (BM) myelodysplastic syndromes (MDS) are increasingly common, as a result of radio or chemotherapy administered to a majority of cancer patients. Patients with secondary MDS have increased BM cell apoptosis, which results in BM dysfunction (cytopenias), and an increased risk of developing fatal acute leukemias. In the present study we asked whether TNF-alpha, known to regulate cell apoptosis, could modulate the onset of secondary MDS. Principal Findings: We show that TNF-alpha is induced by irradiation and regulates BM cells apoptosis in vitro and in vivo. In contrast to irradiated wild type (WT) mice, TNF-alpha deficient (TNF-alpha KO) mice or WT mice treated with a TNF-alpha-neutralizing antibody were partially protected from the apoptotic effects of irradiation. Next we established a 3-cycle irradiation protocol, in which mice were sub-lethally irradiated once monthly over a 3 month period. In this model, irradiated WT mice presented loss of microsatellite markers on BM cells, low white blood cell (WBC) counts, reduced megakaryocyte (MK) and platelet levels (thrombocytopenia) and macrocytic anemia, phenoypes that suggest the irradiation protocol resulted in BM dysfunction with clinical features of MDS. In contrast, TNF-alpha KO mice were protected from the irradiation effects: BM cell apoptosis following irradiation was significantly reduced, concomitant with sustained BM MK numbers and absence of other cytopenias. Moreover, irradiated WT mice with long term (>= 5 months) BM dysfunction had increased BM angiogenesis, MMPs and VEGF and NFkB p65, suggestive of disease progression. Conclusion: Taken together, our data shows that TNF-alpha induction following irradiation modulates BM cell apoptosis and is a crucial event in BM dysfunction, secondary MDS onset and progression.	[Cachaco, Ana Sofia; Carvalho, Tania; Igreja, Catia; Fragoso, Rita; Osorio, Catarina; Ferreira, Manuela; Serpa, Jacinta; Dias, Sergio] Inst Portugues Oncol Francisco Gentil, CIPM, Angiogenesis Lab, Lisbon, Portugal; [Santos, Ana Cristina] Univ Lisbon, Fac Med, Dept Anat Patol, P-1699 Lisbon, Portugal; [Dias, Sergio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Correia, Sofia; Pinto-do-O, Perpetua] Univ Porto, INEB, Div Biomat, P-4100 Oporto, Portugal	Portuguese Institute of Oncology; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade do Porto	Cachaco, AS (corresponding author), Inst Portugues Oncol Francisco Gentil, CIPM, Angiogenesis Lab, Lisbon, Portugal.	sergidias@ipolisboa.min-saude.pt	Igreja, Catia/I-8902-2018; Serpa, Jacinta/AAD-1861-2020; Fragoso, Rita/ABH-3528-2020; Pinto-do-Ó, Perpetua/ABD-7205-2020; Igreja, Catia/J-3674-2017; Serpa, Jacinta/A-4772-2013; Dias, Sergio/L-1250-2014; Ferreira, Manuela/I-7904-2018; Fragoso, Rita/O-7164-2019; Serpa, Jacinta/GLV-1532-2022; Carvalho, Tânia/GNM-6203-2022; Pinto-do-Ó, Perpetua/K-3742-2012; Osorio, Catarina/G-1700-2017; Ferreira, Manuela/AAF-5299-2020; Carvalho, Tânia/X-2873-2019	Serpa, Jacinta/0000-0002-1548-5907; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Dias, Sergio/0000-0002-7603-4616; Ferreira, Manuela/0000-0001-9498-8061; Fragoso, Rita/0000-0002-9206-1964; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Ferreira, Manuela/0000-0001-9498-8061; Carvalho, Tânia/0000-0002-5283-5013; Ferreira, Manuela/0000-0002-0075-2400; Cachaco, Ana/0000-0002-4080-018X; Osorio, Catarina/0000-0002-5228-0599; Igreja, Catia/0000-0003-3563-1788; Correia, Sofia/0000-0002-9361-1999; Correia, Sofia/0000-0003-2222-6396	Associacao Portuguesa Contra a Leucemia and Liga Portuguesa Contra o Cancro, Nucleo Regional Sul; Portuguese Science Foundation Fellowships	Associacao Portuguesa Contra a Leucemia and Liga Portuguesa Contra o Cancro, Nucleo Regional Sul; Portuguese Science Foundation Fellowships	This work was supported by Associacao Portuguesa Contra a Leucemia and Liga Portuguesa Contra o Cancro, Nucleo Regional Sul. During the realization of this Project, Ana Sofia Cachaco, Tania Carvalho, Catia Igreja, Rita Fragoso, Catarina Osorio, Jacinta Serpa were recipients of Portuguese Science Foundation Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Boula A, 2006, CLIN CANCER RES, V12, P3099, DOI 10.1158/1078-0432.CCR-06-0254; Daigle JL, 2001, CANCER RES, V61, P8859; De Roos AJ, 2007, CANCER CAUSE CONTROL, V18, P1199, DOI 10.1007/s10552-007-9060-2; Deeg HJ, 2002, LEUKEMIA, V16, P162, DOI 10.1038/sj.leu.2402356; Drutskaya MS, 2005, EXP HEMATOL, V33, P1348, DOI 10.1016/j.exphem.2005.08.001; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Dy LC, 1999, J BIOL CHEM, V274, P26917, DOI 10.1074/jbc.274.38.26917; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hara T, 2004, EUR J HAEMATOL, V73, P10, DOI 10.1111/j.1600-0609.2004.00259.x; HARANGHERA N, 1992, LEUKEMIA, V6, P689; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Kerbauy DB, 2007, EXP HEMATOL, V35, P1739, DOI 10.1016/j.exphem.2007.09.007; Kuruvilla J, 2003, EUR J HAEMATOL, V71, P396, DOI 10.1034/j.1600-0609.2003.00115.x; Kuruvilla J, 2004, EUR J HAEMATOL, V72, P306; Lejeune F J, 2006, Bull Cancer, V93, pE90; Leone G, 2007, HAEMATOLOGICA, V92, P1389, DOI 10.3324/haematol.11034; Lv L, 2007, LEUKEMIA RES, V31, P1479, DOI 10.1016/j.leukres.2007.01.014; Maciejewski JP, 2002, BRIT J HAEMATOL, V117, P1002; Maciejewski JP, 2002, BRIT J HAEMATOL, V117, P119, DOI 10.1046/j.1365-2141.2002.03381.x; Malcovati Luca, 2008, Cancer Control, V15 Suppl, P4; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Muller K, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2007.01.017; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Padmanabhan A, 2008, LEUKEMIA RES, V32, P1820, DOI 10.1016/j.leukres.2008.03.032; Priestley GV, 2006, BLOOD, V107, P2959, DOI 10.1182/blood-2005-07-2670; Raza A, 2000, BLOOD, V95, P1580, DOI 10.1182/blood.V95.5.1580.005k45_1580_1587; Rebel VI, 1999, J EXP MED, V190, P1493, DOI 10.1084/jem.190.10.1493; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Reza S, 1998, J INTERF CYTOK RES, V18, P871, DOI 10.1089/jir.1998.18.871; ROSSELLI F, 1994, BLOOD, V83, P1216; Rube CE, 2002, RADIOTHER ONCOL, V64, P177, DOI 10.1016/S0167-8140(02)00077-4; SATO H, 1993, ONCOGENE, V8, P395; Scott KA, 2004, ONCOGENE, V23, P6954, DOI 10.1038/sj.onc.1207915; SEED TM, 1981, SCAN ELECTRON MICROS, P61; TOLLE DV, 1979, VET PATHOL, V16, P243, DOI 10.1177/030098587901600210; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wielockx B, 2001, NAT MED, V7, P1202, DOI 10.1038/nm1101-1202; Yang WL, 2004, CANCER RES, V64, P1534, DOI 10.1158/0008-5472.CAN-03-2928; Zhang M, 2008, CLIN CANCER RES, V14, P1868, DOI 10.1158/1078-0432.CCR-07-1894; ZHANG Y, 1995, BLOOD, V86, P2930	44	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8980	10.1371/journal.pone.0008980	http://dx.doi.org/10.1371/journal.pone.0008980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126546	Green Submitted, Green Published, gold			2022-12-25	WOS:000274209700009
J	Yang, HY; Bogner, M; Stierhof, YD; Ludewig, U				Yang, Huaiyu; Bogner, Martin; Stierhof, York-Dieter; Ludewig, Uwe			H+-Independent Glutamine Transport in Plant Root Tips	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; EXPRESSION; CELLS; NANOSENSORS; NITROGEN; GLUCOSE; EFFLUX; FAMILY; COATS; SEEDS	Background: Glutamine is one of the primary amino acids in nitrogen assimilation and often the most abundant amino acid in plant roots. To monitor this important metabolite, a novel genetically encoded fluorescent FRET-reporter was constructed and expressed in Arabidopsis thaliana. As a candidate for the glutamine fluxes, the root tip localized, putative amino acid transporter CAT8 was analyzed and heterologously expressed in yeast and oocytes. Principal Findings: Rapid and reversible in vivo fluorescence changes were observed in reporter-expressing root tips upon exposure and removal of glutamine. FRET changes were detected at acid and neutral pH and in the presence of a protonophore, suggesting that part of the glutamine fluxes were independent of the pH. The putative amino acid transporter CAT8 transported glutamine, had a half maximal activity at similar to 100 mu M and the transport was independent of external pH. CAT8 localized not only to the plasma membrane, but additionally to the tonoplast, when tagged with GFP. Ultrastructural analysis confirmed this dual localization and additionally identified CAT8 in membranes of autophagosomes. Loss-of function of CAT8 did not affect growth in various conditions, but over-expressor plants had increased sensitivity to a structural substrate analog, the glutamine synthetase inhibitor L-methionine sulfoximine. Conclusions: The combined data suggest that proton-independent glutamine facilitators exist in root tips.	[Yang, Huaiyu; Ludewig, Uwe] Tech Univ Darmstadt, Inst Bot, Darmstadt, Germany; [Yang, Huaiyu; Bogner, Martin; Stierhof, York-Dieter] Univ Tubingen, Ctr Mol Biol Plants ZMBP, Tubingen, Germany	Technical University of Darmstadt; Eberhard Karls University of Tubingen	Yang, HY (corresponding author), Tech Univ Darmstadt, Inst Bot, Darmstadt, Germany.	ludewig@bio.tu-darmstadt.de		Yang, Huaiyu/0000-0001-8258-8511	German Science Foundation (DFG)	German Science Foundation (DFG)(German Research Foundation (DFG))	German Science Foundation (DFG), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bogner M, 2007, J FLUORESC, V17, P350, DOI 10.1007/s10895-007-0192-2; BOLLARD EG, 1966, PLANT SOIL, V25, P153, DOI 10.1007/BF01347815; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Curi R, 2007, FRONT BIOSCI-LANDMRK, V12, P344, DOI 10.2741/2068; De D. N., 2000, PLANT CELL VACUOLES; deJong A, 1997, PLANT PHYSIOL, V114, P731, DOI 10.1104/pp.114.2.731; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Dundar E, 2009, PLANTA, V229, P1047, DOI 10.1007/s00425-009-0892-8; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Forsum O, 2008, NEW PHYTOL, V179, P1058, DOI 10.1111/j.1469-8137.2008.02546.x; FROMMER WB, 1993, P NATL ACAD SCI USA, V90, P5944, DOI 10.1073/pnas.90.13.5944; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hammes UZ, 2006, PLANT J, V48, P414, DOI 10.1111/j.1365-313X.2006.02880.x; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; Lee YH, 2007, PLANT J, V50, P305, DOI 10.1111/j.1365-313X.2007.03045.x; Lesuffleur F, 2007, PLANT SOIL, V294, P235, DOI 10.1007/s11104-007-9249-x; LI ZC, 1990, PLANT PHYSIOL, V94, P268, DOI 10.1104/pp.94.1.268; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Lohaus G, 1997, J EXP BOT, V48, P1779, DOI 10.1093/jexbot/48.315.1779; Offler CE, 2003, ANNU REV PLANT BIOL, V54, P431, DOI 10.1146/annurev.arplant.54.031902.134812; Okumoto S, 2008, NEW PHYTOL, V180, P271, DOI 10.1111/j.1469-8137.2008.02611.x; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; RONZIO RA, 1968, P NATL ACAD SCI USA, V59, P164, DOI 10.1073/pnas.59.1.164; Su YH, 2004, PLANT PHYSIOL, V136, P3104, DOI 10.1104/pp.104.045278; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Svennerstam H, 2008, NEW PHYTOL, V180, P620, DOI 10.1111/j.1469-8137.2008.02589.x; Svennerstam H, 2007, PLANT PHYSIOL, V143, P1853, DOI 10.1104/pp.106.092205; von der Fecht-Bartenbach J, 2007, PLANT J, V50, P466, DOI 10.1111/j.1365-313X.2007.03061.x; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; Zhou YC, 2007, PLANT J, V49, P750, DOI 10.1111/j.1365-313X.2006.03000.x	34	58	60	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8917	10.1371/journal.pone.0008917	http://dx.doi.org/10.1371/journal.pone.0008917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111724	Green Submitted, gold, Green Published			2022-12-25	WOS:000274114800020
J	Sanchez-Calderon, H; Rodriguez-de la Rosa, L; Milo, M; Pichel, JG; Holley, M; Varela-Nieto, I				Sanchez-Calderon, Hortensia; Rodriguez-de la Rosa, Lourdes; Milo, Marta; Pichel, Jose G.; Holley, Matthew; Varela-Nieto, Isabel			RNA Microarray Analysis in Prenatal Mouse Cochlea Reveals Novel IGF-I Target Genes: Implication of MEF2 and FOXM1 Transcription Factors	PLOS ONE			English	Article							GROWTH-FACTOR-I; INNER HAIR-CELLS; EXPRESSION PATTERNS; SIGNALING PATHWAYS; AUDITORY-SYSTEM; SPIRAL GANGLION; HEARING-LOSS; INSULIN; MICE; DIFFERENTIATION	Background: Insulin-like growth factor-I (IGF-I) provides pivotal cell survival and differentiation signals during inner ear development throughout evolution. Homozygous mutations of human IGF1 cause syndromic sensorineural deafness, decreased intrauterine and postnatal growth rates, and mental retardation. In the mouse, deficits in IGF-I result in profound hearing loss associated with reduced survival, differentiation and maturation of auditory neurons. Nevertheless, little is known about the molecular basis of IGF-I activity in hearing and deafness. Methodology/Principal Findings: A combination of quantitative RT-PCR, subcellular fractionation and Western blotting, along with in situ hybridization studies show IGF-I and its high affinity receptor to be strongly expressed in the embryonic and postnatal mouse cochlea. The expression of both proteins decreases after birth and in the cochlea of E18.5 embryonic Igf1(-/-) null mice, the balance of the main IGF related signalling pathways is altered, with lower activation of Akt and ERK1/2 and stronger activation of p38 kinase. By comparing the Igf1(-/-) and Igf1(+/+) transcriptomes in E18.5 mouse cochleae using RNA microchips and validating their results, we demonstrate the up-regulation of the FoxM1 transcription factor and the misexpression of the neural progenitor transcription factors Six6 and Mash1 associated with the loss of IGF-I. Parallel, in silico promoter analysis of the genes modulated in conjunction with the loss of IGF-I revealed the possible involvement of MEF2 in cochlear development. E18.5 Igf1(+/+) mouse auditory ganglion neurons showed intense MEF2A and MEF2D nuclear staining and MEF2A was also evident in the organ of Corti. At P15, MEF2A and MEF2D expression were shown in neurons and sensory cells. In the absence of IGF-I, nuclear levels of MEF2 were diminished, indicating less transcriptional MEF2 activity. By contrast, there was an increase in the nuclear accumulation of FoxM1 and a corresponding decrease in the nuclear cyclin-dependent kinase inhibitor p27(Kip1). Conclusions/Significance: We have defined the spatiotemporal expression of elements involved in IGF signalling during inner ear development and reveal novel regulatory mechanisms that are modulated by IGF-I in promoting sensory cell and neural survival and differentiation. These data will help us to understand the molecular bases of human sensorineural deafness associated to deficits in IGF-I.	[Sanchez-Calderon, Hortensia; Rodriguez-de la Rosa, Lourdes; Varela-Nieto, Isabel] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Sanchez-Calderon, Hortensia; Rodriguez-de la Rosa, Lourdes; Varela-Nieto, Isabel] Inst Salud Carlos III, CIBERER, U761, Madrid, Spain; [Milo, Marta; Holley, Matthew] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Pichel, Jose G.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Ctr Invest Canc, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Sheffield; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Sanchez-Calderon, H (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain.	hsanchez@iib.uam.es	Pichel, Jose G/AAF-2255-2019; de la Rosa, Lourdes Rodríguez/K-3037-2017; Varela-Nieto, Isabel/G-5289-2015	Pichel, Jose G/0000-0001-8580-0952; de la Rosa, Lourdes Rodríguez/0000-0002-7518-6036; Varela-Nieto, Isabel/0000-0003-3077-0500; Holley, Matthew/0000-0001-9547-1953	Royal Society; DIGNA Biotech; Ministerio de Ciencia e Innovacion [BFU2005-00084, SAF2008-00470]; Fundacion Mutua Madrilena; Consejo Superior de Investigaciones Cientifica; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER)	Royal Society(Royal Society of London); DIGNA Biotech; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Consejo Superior de Investigaciones Cientifica; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER)	This work was partially supported by the Royal Society, DIGNA Biotech, Ministerio de Ciencia e Innovacion (BFU2005-00084, SAF2008-00470) and the Fundacion Mutua Madrilena. Hortensia Sanchez Calderon and Lourdes Rodriguez-de la Rosa hold contracts from Consejo Superior de Investigaciones Cientificas-FSE I3 programme and Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CL, 2002, J COMP NEUROL, V447, P331, DOI 10.1002/cne.10244; Adesanya OO, 1999, P NATL ACAD SCI USA, V96, P3287, DOI 10.1073/pnas.96.6.3287; Al-Semari A, 2007, AM J MED GENET A, V143A, P149, DOI 10.1002/ajmg.a.31497; Bergeron AL, 2005, JARO-J ASSOC RES OTO, V6, P401, DOI 10.1007/s10162-005-0018-3; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Butts BD, 2003, HORM METAB RES, V35, P763; Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Cho YS, 2002, JARO, V3, P54, DOI 10.1007/s101620010042; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Conte I, 2005, DEV DYNAM, V234, P718, DOI 10.1002/dvdy.20463; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Fritzsch B, 2006, BRAIN RES, V1091, P151, DOI 10.1016/j.brainres.2006.02.078; Gallardo ME, 1999, GENOMICS, V61, P82, DOI 10.1006/geno.1999.5916; Gao WQ, 1999, J NEUROBIOL, V39, P142, DOI 10.1002/(SICI)1097-4695(199904)39:1<142::AID-NEU11>3.0.CO;2-H; Gong TWL, 2006, JARO-J ASSOC RES OTO, V7, P317, DOI 10.1007/s10162-006-0046-7; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Karsten SL, 2003, DEV BIOL, V261, P165, DOI 10.1016/S0012-1606(03)00274-4; Knipper M, 1998, DEVELOPMENT, V125, P3709; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; LeRoith D, 2008, ENDOCRINOLOGY, V149, P5951, DOI 10.1210/en.2008-1190; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Liberman MC, 2006, JARO-J ASSOC RES OTO, V7, P211, DOI 10.1007/s10162-006-0035-x; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; LIU Q, 2008, INVEST OPHTHALMOL VI; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Lopez-Rios J, 1999, MECH DEVELOP, V83, P155, DOI 10.1016/S0925-4773(99)00017-9; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; Montessuit C, 2004, CARDIOVASC RES, V64, P94, DOI 10.1016/j.cardiores.2004.06.005; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Parker M, 2007, J BIOETHIC INQ, V4, P29, DOI 10.1007/s11673-007-9036-7; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; ROBERTS CT, 1999, IGF SYSTEM MOL BIOL; Ruberte J, 2004, J CLIN INVEST, V113, P1149, DOI 10.1172/JCI200419478; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Sanchez-Calderon H, 2004, GENE EXPR PATTERNS, V4, P659, DOI 10.1016/j.modgep.2004.04.008; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sanchez-Calderon H, 2007, GENE EXPR PATTERNS, V7, P30, DOI 10.1016/j.modgep.2006.05.003; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teijido O, 2007, NEUROBIOL DIS, V26, P532, DOI 10.1016/j.nbd.2007.01.016; Torres-Aleman I, 2008, ENDOCRINOLOGY, V149, P5952, DOI 10.1210/en.2008-0905; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; WANG XD, 2005, J ORGAN DYSFUNCT, V1, P2; Werner Haim, 2008, Archives of Physiology and Biochemistry, V114, P17, DOI [10.1080/13813450801900694, 10.1080/13813450801900694 ]; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Zhang HJ, 2006, MOL ENDOCRINOL, V20, P1853, DOI 10.1210/me.2006-0056; Zhang Q, 2003, Anesth Prog, V50, P53; Zhao FJ, 1999, J CEREAL SCI, V30, P19, DOI 10.1006/jcrs.1998.0244; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628	71	69	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8699	10.1371/journal.pone.0008699	http://dx.doi.org/10.1371/journal.pone.0008699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111592	Green Published, Green Accepted, gold			2022-12-25	WOS:000273896300004
J	Pathi, SP; Kowalczewski, C; Tadipatri, R; Fischbach, C				Pathi, Siddharth P.; Kowalczewski, Christine; Tadipatri, Ramya; Fischbach, Claudia			A Novel 3-D Mineralized Tumor Model to Study Breast Cancer Bone Metastasis	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR; OSTEOBLAST ADHESION; CELL-PROLIFERATION; SIGNALING PATHWAY; RAW264.7 CELLS; IN-VIVO; EXPRESSION; HYDROXYAPATITE; OSTEOPONTIN	Background: Metastatic bone disease is a frequent cause of morbidity in patients with advanced breast cancer, but the role of the bone mineral hydroxyapatite (HA) in this process remains unclear. We have developed a novel mineralized 3-D tumor model and have employed this culture system to systematically investigate the pro-metastatic role of HA under physiologically relevant conditions in vitro. Methodology/Principal Findings: MDA-MB231 breast cancer cells were cultured within non-mineralized or mineralized polymeric scaffolds fabricated by a gas foaming-particulate leaching technique. Tumor cell adhesion, proliferation, and secretion of pro-osteoclastic interleukin-8 (IL-8) was increased in mineralized tumor models as compared to non-mineralized tumor models, and IL-8 secretion was more pronounced for bone-specific MDA-MB231 subpopulations relative to lung-specific breast cancer cells. These differences were pathologically significant as conditioned media collected from mineralized tumor models promoted osteoclastogenesis in an IL-8 dependent manner. Finally, drug testing and signaling studies with transforming growth factor beta (TGF beta) confirmed the clinical relevance of our culture system and revealed that breast cancer cell behavior is broadly affected by HA. Conclusions/Significance: Our results indicate that HA promotes features associated with the neoplastic and metastatic growth of breast carcinoma cells in bone and that IL-8 may play an important role in this process. The developed mineralized tumor models may help to reveal the underlying cellular and molecular mechanisms that may ultimately enable more efficacious therapy of patients with advanced breast cancer.	[Pathi, Siddharth P.; Kowalczewski, Christine; Tadipatri, Ramya; Fischbach, Claudia] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University	Pathi, SP (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	cf99@cornell.edu	Fischbach, Claudia/C-8550-2009	Fischbach, Claudia/0000-0002-9368-0150	National Science Foundation (NSF); Musculoskeletal Repair and Regeneration Core Center at the Hospital for Special Surgery in New York [AR046121]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Musculoskeletal Repair and Regeneration Core Center at the Hospital for Special Surgery in New York; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a National Science Foundation (NSF) graduate research fellowship (SPP) (nsfgrfp.org) and funding by the Musculoskeletal Repair and Regeneration Core Center at the Hospital for Special Surgery in New York (Grant AR046121) (http://www.hss.edu/repair-regeneration-center.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Bachelder RE, 2001, CANCER RES, V61, P5736; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bendre M, 2003, CLIN ORTHOP RELAT R, pS39, DOI 10.1097/01.blo.0000093844.72468.f4; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Boyan B. D., 2003, European Cells & Materials, V6, P22; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Fong YC, 2008, J BONE MINER RES, V23, P961, DOI 10.1359/JBMR.080206; Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Guise TA, 2008, CANCER TREAT REV, V34, pS19, DOI 10.1016/j.ctrv.2008.03.006; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; Hiraga T, 2001, CANCER RES, V61, P4418; Iafisco M, 2008, LANGMUIR, V24, P4924, DOI 10.1021/la703381h; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khalili P, 2006, MOL CANCER THER, V5, P2271, DOI 10.1158/1535-7163.MCT-06-0100; Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016; Kindle L, 2006, J BONE MINER RES, V21, P193, DOI 10.1359/JBMR.051027; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mitsuyama H, 2004, J BONE MINER RES, V19, P671, DOI 10.1359/JBMR.0301256; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Morgan MP, 2001, MOL CARCINOGEN, V32, P111, DOI 10.1002/mc.1070; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pezzatini S, 2007, BONE, V41, P523, DOI 10.1016/j.bone.2007.06.016; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Rao H, 2009, BONE, V44, pS141, DOI 10.1016/j.bone.2009.01.447; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Singhal H, 1997, CLIN CANCER RES, V3, P605; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Tanaka Y, 2007, CLIN CANCER RES, V13, P816, DOI 10.1158/1078-0432.CCR-06-2258; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D	61	67	69	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8849	10.1371/journal.pone.0008849	http://dx.doi.org/10.1371/journal.pone.0008849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107512	Green Submitted, gold, Green Published			2022-12-25	WOS:000273896100014
J	Nakano, H; Funasaka, T; Hashizume, C; Wong, RW				Nakano, Hiroshi; Funasaka, Tatsuyoshi; Hashizume, Chieko; Wong, Richard W.			Nucleoporin Translocated Promoter Region (Tpr) Associates with Dynein Complex, Preventing Chromosome Lagging Formation during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; SPINDLE-ASSEMBLY CHECKPOINT; COILED-COIL PROTEIN; MICROTUBULE MOTOR DYNEIN; COHESIN SUBUNIT SMC1; MESSENGER-RNA EXPORT; INTRACELLULAR-TRANSPORT; MITOTIC SPINDLES; KINETOCHORE; ENVELOPE	Gain or loss of whole chromosomes is often observed in cancer cells and is thought to be due to aberrant chromosome segregation during mitosis. Proper chromosome segregation depends on a faithful interaction between spindle microtubules and kinetochores. Several components of the nuclear pore complex/nucleoporins play critical roles in orchestrating the rapid remodeling events that occur during mitosis. Our recent studies revealed that the nucleoporin, Rae1, plays critical roles in maintaining spindle bipolarity. Here, we show association of another nucleoporin, termed Tpr (translocated promoter region), with the molecular motors dynein and dynactin, which both orchestrate with the spindle checkpoints Mad1 and Mad2 during cell division. Overexpression of Tpr enhanced multinucleated cell formation. RNA interference-mediated knockdown of Tpr caused a severe lagging chromosome phenotype and disrupted spindle checkpoint proteins expression and localization. Next, we performed a series of rescue and dominant negative experiments to confirm that Tpr orchestrates proper chromosome segregation through interaction with dynein light chain. Our data indicate that Tpr functions as a spatial and temporal regulator of spindle checkpoints, ensuring the efficient recruitment of checkpoint proteins to the molecular motor dynein to promote proper anaphase formation.	[Wong, Richard W.] Kanazawa Univ, Frontier Sci Org, Canc Res Inst 1F, Kanazawa, Ishikawa 9201192, Japan; Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Kanazawa University	Wong, RW (corresponding author), Kanazawa Univ, Frontier Sci Org, Canc Res Inst 1F, Kanazawa, Ishikawa 9201192, Japan.	rwong@staff.kanazawa-u.ac.jp	Wong, Richard W./E-9155-2011	Hashizume, Chieko/0000-0002-5937-3915	Special Coordination Funds for Promoting Science and Technology (SCF); Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Astellas Foundation; Novartis Foundation (Japan)	Special Coordination Funds for Promoting Science and Technology (SCF)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation(Astellas Pharmaceuticals); Novartis Foundation (Japan)(Novartis)	This work was supported by the Program for Improvement of Research Environment for Young Researchers from the Special Coordination Funds for Promoting Science and Technology (SCF), grants-in-aid for young scientists (B), from (Ministry of Education, Culture, Sports, Science and Technology), Japan, and by grants from the Takeda Science Foundation, the Astellas Foundation for research on metabolic disorders, and The Novartis Foundation (Japan) (to R. W. W.).	Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; BYRD DA, 1994, J CELL BIOL, V127, P1515, DOI 10.1083/jcb.127.6.1515; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cordes VC, 1998, EXP CELL RES, V245, P43, DOI 10.1006/excr.1998.4246; De Souza CP, 2009, MOL BIOL CELL, V20, P2146, DOI 10.1091/mbc.E08-08-0878; Debler EW, 2009, NAT STRUCT MOL BIOL, V16, P457, DOI 10.1038/nsmb0509-457; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Funasaka T, 2005, FASEB J, V19, P1422, DOI 10.1096/fj.05-3699com; Galy V, 2006, CURR BIOL, V16, P1748, DOI 10.1016/j.cub.2006.06.067; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hase ME, 2001, MOL BIOL CELL, V12, P2433, DOI 10.1091/mbc.12.8.2433; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kuznetsov NV, 2002, CHROMOSOMA, V111, P236, DOI 10.1007/s00412-002-0208-2; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; MITCHELL PJ, 1992, ONCOGENE, V7, P383; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nguyen CL, 2008, CANCER RES, V68, P8715, DOI 10.1158/0008-5472.CAN-08-1303; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Orjalo AV, 2006, MOL BIOL CELL, V17, P3806, DOI 10.1091/mbc.e05-11-1061; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Qi HY, 2004, MOL BIOL CELL, V15, P4854, DOI 10.1091/mbc.E04-07-0579; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALLEE R, 1993, P NATL ACAD SCI USA, V90, P8769, DOI 10.1073/pnas.90.19.8769; Wojcik E, 2001, NAT CELL BIOL, V3, P1001, DOI 10.1038/ncb1101-1001; Wong RW, 2008, P NATL ACAD SCI USA, V105, P15441, DOI 10.1073/pnas.0807660105; Wong RW, 2006, P NATL ACAD SCI USA, V103, P19783, DOI 10.1073/pnas.0609582104; Wong RW, 2010, CELL CYCLE, V9, P198, DOI 10.4161/cc.9.1.10431; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Xu SL, 2009, SEMIN CELL DEV BIOL, V20, P620, DOI 10.1016/j.semcdb.2009.03.003; Xu XM, 2007, PLANT CELL, V19, P1537, DOI 10.1105/tpc.106.049239; Yang ZY, 2005, MOL CELL BIOL, V25, P4062, DOI 10.1128/MCB.25.10.4062-4074.2005	50	65	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10841	10849		10.1074/jbc.M110.105890	http://dx.doi.org/10.1074/jbc.M110.105890			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133940	hybrid, Green Published			2022-12-25	WOS:000276264600069
J	Serrano, J; Fernandez, AP; Martinez-Murillo, R; Martinez, A				Serrano, J.; Fernandez, A. P.; Martinez-Murillo, R.; Martinez, A.			High sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease	ONCOGENE			English	Article						brain tumors; Alzheimer's disease; tumor microenvironment; inflammatory mediators; carcinogenesis	ELDERLY-PATIENTS; TUMOR MICROENVIRONMENT; INFLAMMATORY RESPONSE; CEREBRAL-CORTEX; STEM-CELLS; EXPRESSION; GLIOBLASTOMA; DEMENTIA; COMORBIDITY; CANCER	Cancer and Alzheimer's disease (AD) are commonly found among elderly patients. Chronic inflammation is the characteristic of both diseases. Amyloid-beta peptide is the main inducer of inflammation in AD. Moreover, chronic inflammation promotes cancer, suggesting that AD patients may be more prone to develop cancer than non-demented people. To test this hypothesis, we injected the carcinogen 20-methylcholanthrene in the brain of transgenic mice overexpressing the mutant forms of amyloid precursor protein (APP) and presenilin 1 (PS1), as a model of AD, and their wild-type (WT) littermates. Mutant mice developed tumors faster and with higher incidence than their WT counterparts. Expression of the inflammatory markers interleukin (IL)-1 alpha, IL-1 beta, IL-6, IP-10 and tumor necrosis factor-alpha (TNF-alpha) was measured in AD and WT mice of 3 and 12 months of age that had not been exposed to the carcinogen. These cytokines were elevated in older AD mice, indicating the existence of a highly inflammatory milieu in these animals. We also found elevated expression of a mutated form of p53 in older AD mice, suggesting an alternative mechanism for the predisposition of AD brains to develop brain tumors. Clinical studies reporting comorbidity of AD and brain cancer are needed to understand whether our observations hold true for humans. Oncogene (2010) 29, 2165-2171; doi: 10.1038/onc.2009.503; published online 25 January 2010	[Serrano, J.; Fernandez, A. P.; Martinez-Murillo, R.] CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain; [Martinez, A.] Ctr Biomed Res La Rioja CIBIR, Logrono, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Martinez-Murillo, R (corresponding author), CSIC, Inst Cajal, Dept Cellular Mol & Dev Neurobiol, Avda Doctor Arce 37, E-28002 Madrid, Spain.	r.martinez@cajal.csic.es	Fernández, Ana Patricia/K-7901-2014; Martinez, Alfredo/GQH-5998-2022; Martinez-Murillo, Ricardo/K-7596-2014	Fernández, Ana Patricia/0000-0002-3843-4715; Martinez, Alfredo/0000-0003-4882-4044; Martinez-Murillo, Ricardo/0000-0003-3657-3890	Spanish Ministry of Science and Innovation [SAF2007-60010]; Instituto de Salud Carlos III [RD06/0026/1001]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	We gratefully acknowledge Professor Ignacio Torres (Instituto Cajal, Madrid, Spain) for the breeding pairs to initiate the mouse colony. We are also grateful to Dr Josune Garcia-Sanmartin (CIBIR, Logrono, Spain) for her valuable help in statistical analysis. This work was supported by Spanish Ministry of Science and Innovation Grant SAF2007-60010, and Instituto de Salud Carlos III Grant RD06/0026/1001.	Anisimov Vladimir N, 2007, Cancer Control, V14, P23; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Beard CM, 1996, ANN EPIDEMIOL, V6, P195, DOI 10.1016/1047-2797(95)00068-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Chang CY, 2005, J CLIN NEUROSCI, V12, P930, DOI 10.1016/j.jocn.2004.11.017; Chicoine MR, 1997, J NEURO-ONCOL, V35, P249, DOI 10.1023/A:1005808315821; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Di Domenico F, 2009, NEUROCHEM RES, V34, P727, DOI 10.1007/s11064-009-9924-9; Driver JA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2467; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Formiga F, 2008, REV NEUROLOGIA, V46, P72, DOI 10.33588/rn.4602.2007490; Formiga F, 2007, REV CLIN ESP, V207, P495, DOI 10.1157/13111547; Gambassi G, 1999, NEUROLOGY, V53, P508, DOI 10.1212/WNL.53.3.508; Gasper Mason C, 2005, Am J Geriatr Pharmacother, V3, P1, DOI 10.1016/j.amjopharm.2005.02.001; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Hong SH, 2000, FASEB J, V14, P1499, DOI 10.1096/fj.99-0802com; Hoozemans JJM, 2008, CURR PHARM DESIGN, V14, P1419, DOI 10.2174/138161208784480171; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Kamer AR, 2008, J ALZHEIMERS DIS, V13, P437; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lanni C, 2008, CURR PHARM DESIGN, V14, P2665, DOI 10.2174/138161208786264133; Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Nelson JS, 2002, ARCH PATHOL LAB MED, V126, P1515; Paugh BS, 2009, J BIOL CHEM, V284, P3408, DOI 10.1074/jbc.M807170200; Peebles KA, 2007, EXPERT REV ANTICANC, V7, P1405, DOI 10.1586/14737140.7.10.1405; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Quante M, 2008, PHYSIOLOGY, V23, P350, DOI 10.1152/physiol.00031.2008; Ribatti D, 2006, CLIN EXP MED, V6, P145, DOI 10.1007/s10238-006-0117-4; Rodrigo J, 2004, NEUROSCIENCE, V128, P73, DOI 10.1016/j.neuroscience.2004.06.030; Roe CM, 2005, NEUROLOGY, V64, P895, DOI 10.1212/01.WNL.0000152889.94785.51; Rogers J, 2008, J PERIODONTOL, V79, P1535, DOI 10.1902/jop.2008.080171; Saetre P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-46; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Sanders P, 2007, BRAIN RES REV, V54, P274, DOI 10.1016/j.brainresrev.2007.03.001; Sastre M, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-25; Serrano J, 2008, BRAIN PATHOL, V18, P434, DOI 10.1111/j.1750-3639.2008.00142.x; Steinman L, 2008, J CLIN INVEST, V118, P3557, DOI 10.1172/JCI36532; Stock D, 2008, UROL CLIN N AM, V35, P117, DOI 10.1016/j.ucl.2007.09.006; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Tansey MG, 2008, FRONT BIOSCI-LANDMRK, V13, P709, DOI 10.2741/2713; Uberti D, 2008, NEURODEGENER DIS, V5, P209, DOI 10.1159/000113704; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Yamada M, 1999, J AM GERIATR SOC, V47, P189, DOI 10.1111/j.1532-5415.1999.tb04577.x; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; Zimmerman HM, 1941, CANCER RES, V1, P919	54	25	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	15					2165	2171		10.1038/onc.2009.503	http://dx.doi.org/10.1038/onc.2009.503			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101216				2022-12-25	WOS:000276685200002
J	Zhang, X; Chen, XJ; Jia, CX; Geng, X; Du, XN; Zhang, HL				Zhang, Xuan; Chen, Xingjuan; Jia, Caixia; Geng, Xian; Du, Xiaona; Zhang, Hailin			Depolarization Increases Phosphatidylinositol (PI) 4,5-Bisphosphate Level and KCNQ Currents through PI 4-Kinase Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED INHIBITION; PROTEIN-COUPLED RECEPTOR; POTASSIUM CHANNELS; SYMPATHETIC NEURONS; ION CHANNELS; MODULATION; PHOSPHOINOSITIDES; HYDROLYSIS; ACTIVATION; PATHWAYS	A growing body of evidence shows that membrane phosphatidylinositol 4,5-bisphosphates (PtdIns(4,5)P-2, PIP2) play an important role in cell signaling. The presence of PIP2 is fundamentally important for maintaining the functions of a large number of ion channels and transporters, and for other cell processes such as vesicle trafficking, mobility, and endo-and exocytosis. PIP2 levels in the membrane are dynamically modulated, which is an important signaling mechanism for modulation of PIP2-dependent cellular processes. In this study, we describe a novel mechanism of membrane PIP2 modulation. Membrane depolarization induces an elevation in membrane PIP2, and subsequently increases functions of PIP2-sensitive KCNQ potassium channels expressed in Xenopus oocytes. Further evidence suggests that the depolarization-induced elevation of membrane PIP2 occurs through increased activity of PI4 kinase. With increased recognition of the importance of PIP2 in cell function, the effect of membrane depolarization in PIP2 metabolism is destined to have important physiological implications.	[Zhang, Xuan; Chen, Xingjuan; Jia, Caixia; Geng, Xian; Du, Xiaona; Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China	Hebei Medical University	Zhang, HL (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China.	zhanghl@hebmu.edu.cn	chen, xingjuan/V-4064-2019	chen, xingjuan/0000-0002-7380-8399	National Natural Science Foundation of China [30730031, 30500112]; National Basic Research Program [2007CB512100]; National Science Fund for Distinguished Young Scholars of China [30325038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Natural Science Foundation of China (30730031, to H.Z., 30500112, to X. D.) and the National Basic Research Program (2007CB512100).; Recipient of National Science Fund for Distinguished Young Scholars of China (30325038).	Araya R, 2003, J GEN PHYSIOL, V121, P3, DOI 10.1085/jgp.20028671; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Ford CP, 2003, J NEUROSCI, V23, P4931, DOI 10.1523/jneurosci.23-12-04931.2003; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jia QZ, 2007, J NEUROSCI, V27, P2503, DOI 10.1523/JNEUROSCI.2911-06.2007; Jia ZF, 2008, J GEN PHYSIOL, V131, P575, DOI 10.1085/jgp.200709924; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wood MJ, 2000, BIOPHYS J, V79, P2535, DOI 10.1016/S0006-3495(00)76494-0; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Yamamoto M, 2006, J BIOL CHEM, V281, P32630, DOI 10.1074/jbc.M605928200; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	32	15	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9402	9409		10.1074/jbc.M109.068205	http://dx.doi.org/10.1074/jbc.M109.068205			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106968	hybrid, Green Published			2022-12-25	WOS:000276165900012
J	Rouvinen, J; Janis, J; Laukkanen, ML; Jylha, S; Niemi, M; Paivinen, T; Makinen-Kiljunen, S; Haahtela, T; Soderlund, H; Takkinen, K				Rouvinen, Juha; Janis, Janne; Laukkanen, Marja-Leena; Jylha, Sirpa; Niemi, Merja; Paivinen, Tero; Makinen-Kiljunen, Soili; Haahtela, Tari; Soderlund, Hans; Takkinen, Kristiina			Transient Dimers of Allergens	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; BET V 1; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; MAJOR ALLERGEN; MACROMOLECULAR ASSEMBLIES; PROTEIN INTERACTIONS; MASS-SPECTROMETRY; X-RAY; IGE	Background: Allergen-mediated cross-linking of IgE antibodies bound to the Fc epsilon RI receptors on the mast cell surface is the key feature of the type I allergy. If an allergen is a homodimer, its allergenicity is enhanced because it would only need one type of antibody, instead of two, for cross-linking. Methodology/Principal Findings: An analysis of 55 crystal structures of allergens showed that 80% of them exist in symmetric dimers or oligomers in crystals. The majority are transient dimers that are formed at high protein concentrations that are reached in cells by colocalization. Native mass spectrometric analysis showed that native allergens do indeed form transient dimers in solution, while hypoallergenic variants of them exist almost solely in the monomeric form. We created a monomeric Bos d 5 allergen and show that it has a reduced capability to induce histamine release. Conclusions/Significance: The results suggest that dimerization would be a very common and essential feature for allergens. Thus, the preparation of purely monomeric variants of allergens could open up novel possibilities for specific immunotherapy.	[Rouvinen, Juha; Janis, Janne; Niemi, Merja; Paivinen, Tero] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Laukkanen, Marja-Leena; Jylha, Sirpa; Soderlund, Hans; Takkinen, Kristiina] VTT Tech Res Ctr Finland, Espoo, Finland; [Makinen-Kiljunen, Soili; Haahtela, Tari] Univ Helsinki, Dept Allergy, Cent Hosp, Helsinki, Finland	University of Eastern Finland; VTT Technical Research Center Finland; University of Helsinki; Helsinki University Central Hospital	Rouvinen, J (corresponding author), Univ Eastern Finland, Dept Chem, Joensuu, Finland.	juha.rouvinen@uef.fi	Jänis, Janne/B-7326-2014	Rouvinen, Juha/0000-0003-1843-5718	Sigrid Juselius Foundation; National Graduate School in Informational and Structural Biology; Frontier Funding of VTT-Technical Research Centre of Finland,; Helsinki University Central Hospital [TYH7111]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Graduate School in Informational and Structural Biology; Frontier Funding of VTT-Technical Research Centre of Finland,; Helsinki University Central Hospital	Funding was provided by the Sigrid Juselius Foundation, the National Graduate School in Informational and Structural Biology, the Frontier Funding of VTT-Technical Research Centre of Finland, and a grant (TYH7111) from the special government subsidy for health sciences research from the Helsinki University Central Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellinghausen I, 2008, CLIN EXP ALLERGY, V38, P539, DOI 10.1111/j.1365-2222.2007.02910.x; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Fedorov AA, 1997, STRUCTURE, V5, P33, DOI 10.1016/S0969-2126(97)00164-0; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gottschalk M, 2003, J PHYS CHEM B, V107, P7914, DOI 10.1021/jp034527k; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gustchina A, 2005, J MOL BIOL, V348, P433, DOI 10.1016/j.jmb.2005.02.062; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; HOUSLEY ZM, 2003, J MOL BIOL, V325, P123; Janis J, 2008, J MASS SPECTROM, V43, P1376, DOI 10.1002/jms.1413; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Kurup VP, 2003, PEPTIDES, V24, P179, DOI 10.1016/S0196-9781(03)00024-X; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Mari A, 2006, CELL IMMUNOL, V244, P97, DOI 10.1016/j.cellimm.2007.02.012; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Pasquato N, 2006, J MOL BIOL, V356, P684, DOI 10.1016/j.jmb.2005.11.063; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Rajashankar K, 2002, ACTA CRYSTALLOGR D, V58, P1175, DOI 10.1107/S0907444902007254; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Sakurai K, 2002, J BIOL CHEM, V277, P25735, DOI 10.1074/jbc.M203659200; Schirmer T, 2005, J MOL BIOL, V351, P1101, DOI 10.1016/j.jmb.2005.06.054; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Tan YW, 2009, J BIOL CHEM, V284, P3148, DOI 10.1074/jbc.M807209200; TERWILLIGER TC, 1982, BIOPHYS J, V37, P353, DOI 10.1016/S0006-3495(82)84683-3; Thomas K, 2008, FOOD CHEM TOXICOL, V46, P3219, DOI 10.1016/j.fct.2008.06.078; Verdino P, 2008, J IMMUNOL, V180, P2313, DOI 10.4049/jimmunol.180.4.2313; Vrtala S, 2001, FASEB J, V15, P2045, DOI 10.1096/fj.00-0767fje; Wagner S, 2008, J ALLERGY CLIN IMMUN, V121, P246, DOI 10.1016/j.jaci.2007.08.006; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	36	50	50	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9037	10.1371/journal.pone.0009037	http://dx.doi.org/10.1371/journal.pone.0009037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140203	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442400001
J	Gupta, S; Chakraborti, D; Sengupta, A; Basu, D; Das, S				Gupta, Sumanti; Chakraborti, Dipankar; Sengupta, Anindita; Basu, Debabrata; Das, Sampa			Primary Metabolism of Chickpea Is the Initial Target of Wound Inducing Early Sensed Fusarium oxysporum f. sp ciceri Race I	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; PLANT-PATHOGENIC FUNGI; SALICYLIC-ACID; CALLOSE DEPOSITION; DEFENSE RESPONSES; METHYL JASMONATE; SUCROSE SYNTHASE; GENE-EXPRESSION; PROTEIN-KINASE; ARIETINUM L.	Background: Biotrophic interaction between host and pathogen induces generation of reactive oxygen species that leads to programmed cell death of the host tissue specifically encompassing the site of infection conferring resistance to the host. However, in the present study, biotrophic relationship between Fusarium oxysporum and chickpea provided some novel insights into the classical concepts of defense signaling and disease perception where ROS (reactive oxygen species) generation followed by hypersensitive responses determined the magnitude of susceptibility or resistant potentiality of the host. Methodology/Principal Findings: Microscopic observations detected wound mediated in planta pathogenic establishment and its gradual progression within the host vascular tissue. cDNA-AFLP showed differential expression of many defense responsive elements. Real time expression profiling also validated the early recognition of the wound inducing pathogen by the host. The interplay between fungus and host activated changes in primary metabolism, which generated defense signals in the form of sugar molecules for combating pathogenic encounter. Conclusions/Significance: The present study showed the limitations of hypersensitive response mediated resistance, especially when foreign encounters involved the food production as well as the translocation machinery of the host. It was also predicted from the obtained results that hypersensitivity and active species generation failed to impart host defense in compatible interaction between chickpea and Fusarium. On the contrary, the defense related gene(s) played a critical role in conferring natural resistance to the resistant host. Thus, this study suggests that natural selection is the decisive factor for selecting and segregating out the suitable type of defense mechanism to be undertaken by the host without disturbing its normal metabolism, which could deviate from the known classical defense mechanisms.	[Gupta, Sumanti; Chakraborti, Dipankar; Sengupta, Anindita; Das, Sampa] Bose Inst, Plant Mol & Cellular Genet Sect, Kolkata, India; [Basu, Debabrata] Bose Inst, Dept Bot, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Gupta, S (corresponding author), Bose Inst, Plant Mol & Cellular Genet Sect, Kolkata, India.	sampa@bic.boseinst.ernet.in			Council of Scientific and Industrial Research [10-2(5) 2003(1)-EU. 11]; Bose Institute, Department of Science and Technology, Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute, Department of Science and Technology, Government of India(Department of Science & Technology (India))	SG is thankful to the Council of Scientific and Industrial Research for providing financial assistance (F. No. 10-2(5) 2003(1)-EU. 11). AS is thankful to the Department of Biotechnology, Government of India for financial assistance. SD and DB are supported by funds from the Bose Institute, Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI T, 1997, PLANT PHYSIOL, V115, P1288; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki T, 2000, J PLANT RES, V113, P475, DOI 10.1007/PL00013958; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ashraf N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-415; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; Chakraborti D, 2006, AFR J BIOTECHNOL, V5, P585; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Chen H, 2004, J BIOL CHEM, V279, P45998, DOI 10.1074/jbc.M407151200; Cho SH, 2004, PHYSIOL MOL PLANT P, V64, P57, DOI 10.1016/j.pmpp.2004.07.003; Choi KY, 2003, GENE, V311, P13, DOI 10.1016/S0378-1119(03)00561-4; COHEN Y, 1989, PHYSIOL MOL PLANT P, V34, P27, DOI 10.1016/0885-5765(89)90014-3; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; Debarry M, 2005, PLANT SCI, V168, P1171, DOI 10.1016/j.plantsci.2004.12.016; DIA Z, 1996, PLANT MOL BIOL, V32, P1055; DIETZ KJ, 1995, PLANT J, V8, P521, DOI 10.1046/j.1365-313X.1995.8040521.x; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Flandez-Galvez H, 2003, THEOR APPL GENET, V106, P1447, DOI 10.1007/s00122-003-1199-y; Ghose K, 2008, MOL PLANT PATHOL, V9, P763, DOI [10.1111/j.1364-3703.2008.00497.x, 10.1111/J.1364-3703.2008.00497.X]; Giri AP, 1998, PLANT PATHOL, V47, P693, DOI 10.1046/j.1365-3059.1998.00299.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gols R, 2003, J CHEM ECOL, V29, P2651, DOI 10.1023/B:JOEC.0000008010.40606.b0; GORDON AJ, 1997, PLANT PHYSIOL, V120, P867; GRIFFITHS HM, 2003, PLANT PHYSIOL, V131, P419; Gupta S, 2009, PHYTOPATHOLOGY, V99, P1245, DOI 10.1094/PHYTO-99-11-1245; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; HAWARE MP, 1982, PLANT DIS, V66, P809, DOI 10.1094/PD-66-809; Ibraheem O, 2008, AFR J BIOTECHNOL, V7, P4850; Jimenez-Gasco MM, 2004, INT MICROBIOL, V7, P95; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joosten MHAJ, 1999, ANNU REV PHYTOPATHOL, V37, P335, DOI 10.1146/annurev.phyto.37.1.335; JUAN A, 2000, PHYTOPATHOLOGY, V90, P1269; KISTLER HC, 1984, J GEN MICROBIOL, V130, P2605; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; Lee A, 2002, BIOCHEMISTRY-US, V41, P8886, DOI 10.1021/bi020183x; Lee MH, 2007, PLANT BIOTECHNOL-NAR, V24, P209, DOI 10.5511/plantbiotechnology.24.209; Li HY, 2008, J EXP BOT, V59, P3997, DOI 10.1093/jxb/ern241; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Machenaud J, 2007, B INSECTOL, V60, P219; Martinez M, 2003, MOL PLANT MICROBE IN, V16, P876, DOI 10.1094/MPMI.2003.16.10.876; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; MELNTOSH KB, 2005, GENOME, V48, P443; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; Merkouropoulos G, 1999, PLANTA, V208, P212, DOI 10.1007/s004250050552; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Morimoto S, 1998, J BIOL CHEM, V273, P12606, DOI 10.1074/jbc.273.20.12606; Nimbalkar SB, 2006, PHYSIOL MOL PLANT P, V68, P176, DOI 10.1016/j.pmpp.2006.10.003; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Ohta H, 1997, PHYSIOL PLANTARUM, V100, P647, DOI 10.1034/j.1399-3054.1997.1000328.x; Padmanaban S, 2004, PLANT PHYSIOL, V134, P1514, DOI 10.1104/pp.103.034025; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Purcell PC, 1998, PLANT J, V14, P195, DOI 10.1046/j.1365-313X.1998.00108.x; Remans T, 2006, PLANT PHYSIOL, V140, P909, DOI 10.1104/pp.105.075721; Roberts MR, 2002, PLANT MOL BIOL, V50, P1031, DOI 10.1023/A:1021261614491; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Ronning CM, 2003, PLANT PHYSIOL, V131, P419, DOI 10.1104/pp.013581; Ryan CA, 2002, PLANT CELL, V14, pS251, DOI 10.1105/tpc.010484; Saikia R, 2006, CURR SCI INDIA, V91, P1543; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Schilmiller AL, 2007, PLANT PHYSIOL, V143, P812, DOI 10.1104/pp.106.092916; Senthilkumar P, 2005, CURR SCI INDIA, V89, P1386; Shalitin D, 2000, PLANT PHYSIOL, V123, P597, DOI 10.1104/pp.123.2.597; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Soares-Costa A, 2002, BIOCHEM BIOPH RES CO, V296, P1194, DOI 10.1016/S0006-291X(02)02046-6; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; STANGHELLINI ME, 1993, PHYTOPATHOLOGY, V83, P1498, DOI 10.1094/Phyto-83-1498; Steinborn K, 2002, GENE DEV, V16, P959, DOI 10.1101/gad.221702; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Summerell BA, 2003, PLANT DIS, V87, P117, DOI 10.1094/PDIS.2003.87.2.117; Takahashi H, 2006, J PHYTOPATHOL, V154, P156, DOI 10.1111/j.1439-0434.2006.01076.x; Thoungchaleun V, 2008, PLANT PATHOLOGY J, V24, P112, DOI 10.5423/PPJ.2008.24.2.112; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Toyomasu T, 2007, P NATL ACAD SCI USA, V104, P3084, DOI 10.1073/pnas.0608426104; *UN FAO, 1994, FAO PROD YB; Viehweger K, 2006, PLANT CELL, V18, P1510, DOI 10.1105/tpc.105.035121; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Wu JW, 2000, COMP BIOCHEM PHYS C, V127, P209, DOI 10.1016/S0742-8413(00)00145-6; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897	90	42	45	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9030	10.1371/journal.pone.0009030	http://dx.doi.org/10.1371/journal.pone.0009030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140256	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474200016
J	Alkhuder, K; Meibom, KL; Dubail, I; Dupuis, M; Charbit, A				Alkhuder, Khaled; Meibom, Karin L.; Dubail, Iharilalao; Dupuis, Marion; Charbit, Alain			Identification of trkH, Encoding a Potassium Uptake Protein Required for Francisella tularensis Systemic Dissemination in Mice	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; PATHOGENICITY ISLAND; SCHU S4; NOVICIDA; TRANSCRIPTION; REPLICATION; TULAREMIA; BACTERIA; MUTANTS; GROWTH	Francisella tularensis is a highly infectious bacterium causing the zoonotic disease tularaemia. During its infectious cycle, F. tularensis is not only exposed to the intracellular environment of macrophages but also resides transiently in extracellular compartments, in particular during its systemic dissemination. The screening of a bank of F. tularensis LVS transposon insertion mutants on chemically defined medium (CDM) led us to identify a gene, designated trkH, encoding a homolog of the potassium uptake permease TrkH. Inactivation of trkH impaired bacterial growth in CDM. Normal growth of the mutant was only restored when CDM was supplemented with potassium at high concentration. Strikingly, although not required for intracellular survival in cell culture models, TrkH appeared to be essential for bacterial virulence in the mouse. In vivo kinetics of bacterial dissemination revealed a severe defect of multiplication of the trkH mutant in the blood of infected animals. The trkH mutant also showed impaired growth in blood ex vivo. Genome sequence analyses suggest that the Trk system constitutes the unique functional active potassium transporter in both tularensis and holarctica subspecies. Hence, the impaired survival of the trkH mutant in vivo is likely to be due to its inability to survive in the low potassium environment (1-5 mM range) of the blood. This work unravels thus the importance of potassium acquisition in the extracellular phase of the F. tularensis infectious cycle. More generally, potassium could constitute an important mineral nutrient involved in other diseases linked to systemic dissemination of bacterial pathogens.	[Alkhuder, Khaled; Meibom, Karin L.; Dubail, Iharilalao; Dupuis, Marion; Charbit, Alain] Univ Paris 05, Fac Med Necker Enfants Malad, Paris, France; [Alkhuder, Khaled; Meibom, Karin L.; Dubail, Iharilalao; Dupuis, Marion; Charbit, Alain] INSERM, U1002, Unite Pathogenie Infect Syst, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Alkhuder, K (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malad, Paris, France.	alain.charbit@inserm.fr		charbit, alain/0000-0001-5243-4861; Alkhuder, Khaled/0000-0002-4992-586X; Meibom, Karin/0000-0002-2612-6424	INSERM; CNRS; University Rene Descartes Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Rene Descartes Paris	Funding: This study was funded by INSERM, CNRS and University Rene Descartes Paris V. K. A. was supported in part by a fellowship from the Syrian government and by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Balaji B, 2005, APPL ENVIRON MICROB, V71, P8273, DOI 10.1128/AEM.71.12.8273-8283.2005; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Barker JR, 2007, ANN NY ACAD SCI, V1105, P138, DOI 10.1196/annals.1409.010; BERRY MN, 1989, CLIN CHEM, V35, P817; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Chen YC, 2004, INFECT IMMUN, V72, P629, DOI 10.1128/IAI.72.2.629-636.2004; Dominguez-Ferreras A, 2009, J BACTERIOL, V191, P2133, DOI 10.1128/JB.01567-08; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; FRYMIER JS, J BACTERIOL, V179, P3061; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Johnson HA, 2009, J BACTERIOL, V191, P2276, DOI 10.1128/JB.01367-08; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; KEM DC, 1983, POTASIUM BIOL SIGNIF, P25; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Lombardo MJ, 2007, P NATL ACAD SCI USA, V104, P18229, DOI 10.1073/pnas.0705636104; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; Maier TM, 2006, APPL ENVIRON MICROB, V72, P1878, DOI 10.1128/AEM.72.3.1878-1885.2006; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; Meibom KL, 2009, FUTURE MICROBIOL, V4, P713, DOI 10.2217/FMB.09.37; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Stingl K, 2007, EMBO J, V26, P232, DOI 10.1038/sj.emboj.7601471; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Weiss DS, 2007, ANN NY ACAD SCI, V1105, P219, DOI 10.1196/annals.1409.005; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Youn JH, 2009, ANNU REV PHYSIOL, V71, P381, DOI 10.1146/annurev.physiol.010908.163241; Yu JJ, 2008, EUR J CLIN MICROBIOL, V27, P323, DOI 10.1007/s10096-007-0434-x	52	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8966	10.1371/journal.pone.0008966	http://dx.doi.org/10.1371/journal.pone.0008966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126460	Green Submitted, Green Published, gold			2022-12-25	WOS:000274139100014
J	Dong, JJ; Mury, SP; Drahos, KE; Moscovitch, M; Zia, RKP; Finkielstein, CV				Dong, JiaJia; Mury, Sean P.; Drahos, Karen E.; Moscovitch, Marko; Zia, Royce K. P.; Finkielstein, Carla V.			Shorter Exposures to Harder X-Rays Trigger Early Apoptotic Events in Xenopus laevis Embryos	PLOS ONE			English	Article							STRAND BREAK REPAIR; PROGRAMMED CELL-DEATH; MAJOR DEVELOPMENTAL TRANSITION; DNA-DAMAGE; SMALL-INTESTINE; IONIZING-RADIATION; HOMOLOGOUS RECOMBINATION; MIDBLASTULA TRANSITION; STRESS-RESPONSE; IN-SITU	Background: A long-standing conventional view of radiation-induced apoptosis is that increased exposure results in augmented apoptosis in a biological system, with a threshold below which radiation doses do not cause any significant increase in cell death. The consequences of this belief impact the extent to which malignant diseases and non-malignant conditions are therapeutically treated and how radiation is used in combination with other therapies. Our research challenges the current dogma of dose-dependent induction of apoptosis and establishes a new parallel paradigm to the photoelectric effect in biological systems. Methodology/Principal Findings: We explored how the energy of individual X-ray photons and exposure time, both factors that determine the total dose, influence the occurrence of cell death in early Xenopus embryo. Three different experimental scenarios were analyzed and morphological and biochemical hallmarks of apoptosis were evaluated. Initially, we examined cell death events in embryos exposed to increasing incident energies when the exposure time was preset. Then, we evaluated the embryo's response when the exposure time was augmented while the energy value remained constant. Lastly, we studied the incidence of apoptosis in embryos exposed to an equal total dose of radiation that resulted from increasing the incoming energy while lowering the exposure time. Conclusions/Significance: Overall, our data establish that the energy of the incident photon is a major contributor to the outcome of the biological system. In particular, for embryos exposed under identical conditions and delivered the same absorbed dose of radiation, the response is significantly increased when shorter bursts of more energetic photons are used. These results suggest that biological organisms display properties similar to the photoelectric effect in physical systems and provide new insights into how radiation-mediated apoptosis should be understood and utilized for therapeutic purposes.	[Mury, Sean P.; Drahos, Karen E.; Finkielstein, Carla V.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA; [Dong, JiaJia; Zia, Royce K. P.] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Moscovitch, Marko] Georgetown Univ, Med Ctr, Dept Radiat Med, Washington, DC 20007 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Georgetown University	Dong, JJ (corresponding author), Hamline Univ, Dept Phys, St Paul, MN 55104 USA.	finkielc@vt.edu	Dong, JiaJia/E-3154-2012	Dong, JiaJia/0000-0001-9908-2699; Zia, R K P/0000-0002-0489-2937; finkielstein, carla/0000-0002-8417-4643	American Heart Association [0665363U]; Institute for Critical Technology and Applied Science [ICTAS117432]; Susan G. Komen Foundation [BCTR0706931]; Division of Material Research of the National Science Foundation [DMR-0705152]	American Heart Association(American Heart Association); Institute for Critical Technology and Applied Science; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Division of Material Research of the National Science Foundation	Funding: This work was supported by the American Heart Association (0665363U, http://www.americanheart.org/), Institute for Critical Technology and Applied Science (ICTAS117432), and the Susan G. Komen Foundation (BCTR0706931, http://ww5.komen.org/) to C. V. F., and the Division of Material Research of the National Science Foundation (DMR-0705152, http://www.nsf.gov/index.jsp) to R. K. P. Z. K. E. D is a Sigma Xi Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 1997, MOL BIOL CELL, V8, P1195, DOI 10.1091/mbc.8.7.1195; Badie C, 1997, CANCER RES, V57, P4600; Delacote F, 2008, CELL CYCLE, V7, P33, DOI 10.4161/cc.7.1.5149; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Finkielstein CV, 2002, J BIOL CHEM, V277, P38476, DOI 10.1074/jbc.M206184200; Finkielstein CV, 2001, P NATL ACAD SCI USA, V98, P1006, DOI 10.1073/pnas.98.3.1006; FREDERICK DL, 1994, J EXP ZOOL, V270, P410, DOI 10.1002/jez.1402700411; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Guerci AM, 2004, CYTOGENET GENOME RES, V104, P173, DOI 10.1159/000077484; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; HENDRY JH, 1982, INT J RADIAT BIOL, V42, P611, DOI 10.1080/09553008214551591; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; IMOH H, 1986, CELL DIFFER DEV, V19, P35, DOI 10.1016/0045-6039(86)90023-0; Kegel P, 2007, DNA REPAIR, V6, P1692, DOI 10.1016/j.dnarep.2007.05.013; Kellerer AM, 2002, RADIAT RES, V158, P13, DOI 10.1667/0033-7587(2002)158[0013:ESATRO]2.0.CO;2; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Liu SZ, 1996, MUTAT RES-FUND MOL M, V358, P185, DOI 10.1016/S0027-5107(96)00119-4; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Mladenov E, 2009, RADIAT RES, V171, P397, DOI 10.1667/RR1487.1; Moscovitch M, 2006, RADIAT PROT DOSIM, V119, P248, DOI 10.1093/rpd/nci692; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Nussenzweig A, 2007, CELL CYCLE, V6, P2339, DOI 10.4161/cc.6.19.4995; Patel T, 1998, SEMIN LIVER DIS, V18, P105, DOI 10.1055/s-2007-1007147; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Pena LA, 2000, CANCER RES, V60, P321; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; Prise KM, 1998, INT J RADIAT BIOL, V74, P173, DOI 10.1080/095530098141564; Rainaldi G, 2003, ANTICANCER RES, V23, P2505; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rief N, 2002, J BIOL CHEM, V277, P20572, DOI 10.1074/jbc.M200265200; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2001, CANCER RES, V61, P3886; Rudin CM, 1997, ANNU REV MED, V48, P267; Sanders EJ, 1997, ANAT EMBRYOL, V195, P147, DOI 10.1007/s004290050033; Sible JC, 1997, DEV BIOL, V189, P335, DOI 10.1006/dbio.1997.8683; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stack JH, 1997, DEVELOPMENT, V124, P3185; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Ueno S, 2007, MUTAT RES-GEN TOX EN, V634, P135, DOI 10.1016/j.mrgentox.2007.06.011; Wang GC, 1999, MUTAT RES-DNA REPAIR, V433, P147, DOI 10.1016/S0921-8777(99)00007-5; Wroble BN, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-119; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451	58	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8970	10.1371/journal.pone.0008970	http://dx.doi.org/10.1371/journal.pone.0008970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126466	Green Published, gold			2022-12-25	WOS:000274139100018
J	Gilli, F; Lindberg, RLP; Valentino, P; Marnetto, F; Malucchi, S; Sala, A; Capobianco, M; di Sapio, A; Sperli, F; Kappos, L; Calogero, RA; Bertolotto, A				Gilli, Francesca; Lindberg, Raija L. P.; Valentino, Paola; Marnetto, Fabiana; Malucchi, Simona; Sala, Arianna; Capobianco, Marco; di Sapio, Alessia; Sperli, Francesca; Kappos, Ludwig; Calogero, Raffaele A.; Bertolotto, Antonio			Learning from Nature: Pregnancy Changes the Expression of Inflammation-Related Genes in Patients with Multiple Sclerosis	PLOS ONE			English	Article							BREAST-CANCER CELLS; REGULATORY T-CELLS; OLIGONUCLEOTIDE ARRAYS; HORMONE ESTRIOL; RECEPTOR; DISEASE; HYBRIDIZATION; NORMALIZATION; PROFILES; RELAPSE	Background: Pregnancy is associated with reduced activity of multiple sclerosis (MS). However, the biological mechanisms underlying this pregnancy-related decrease in disease activity are poorly understood. Methodology: We conducted a genome-wide transcription analysis in peripheral blood mononuclear cells (PBMCs) from 12 women (7 MS patients and 5 healthy controls) followed during their pregnancy. Samples were obtained before, during (i.e. at the third, sixth, and ninth month of gestation) and after pregnancy. A validation of the expression profiles has been conducted by using the same samples and an independent group of 25 MS patients and 11 healthy controls. Finally, considering the total group of 32 MS patients, we compared expression profiles of patients relapsing during pregnancy (n = 6) with those of relapse-free patients (n = 26). Principal Findings: Results showed an altered expression of 347 transcripts in non-pregnant MS patients with respect to non-pregnant healthy controls. Complementary changes in expression, occurring during pregnancy, reverted the previous imbalance particularly for seven inflammation-related transcripts, i.e. SOCS2, TNFAIP3, NR4A2, CXCR4, POLR2J, FAM49B, and STAG3L1. Longitudinal analysis showed that the overall deregulation of gene expression reverted to "normal" already within the third month of gestation, while in the post-partum gene expressions rebounded to pre-pregnancy levels. Six (18.7%) of the 32 MS patients had a relapse during pregnancy, mostly in the first trimester. The latter showed delayed expression profiles when compared to relapse-free patients: in these patients expression imbalance was reverted later in the pregnancy, i.e. at sixth month. Conclusions: Specific changes in expression during pregnancy were associated with a decrease in disease activity assessed by occurrence of relapses during pregnancy. Findings might help in understanding the pathogenesis of MS and may provide basis for the development of novel therapeutic strategies.	[Gilli, Francesca; Valentino, Paola; Marnetto, Fabiana; Malucchi, Simona; Sala, Arianna; Capobianco, Marco; di Sapio, Alessia; Sperli, Francesca; Bertolotto, Antonio] Azienda Osped Univ San Luigi Gonzaga, Reg Ctr Multiple Sclerosis CReSM & Clin Neurobiol, Orbassano, Italy; [Lindberg, Raija L. P.; Kappos, Ludwig] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Lindberg, Raija L. P.; Kappos, Ludwig] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Calogero, Raffaele A.] Azienda Osped Univ San Luigi Gonzaga, Genom & Bioinformat Unit, Dept Clin & Biol Sci, Orbassano, Italy	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Basel; University of Basel; Azienda Ospedaliero-Universitaria San Luigi Gonzaga	Gilli, F (corresponding author), Azienda Osped Univ San Luigi Gonzaga, Reg Ctr Multiple Sclerosis CReSM & Clin Neurobiol, Orbassano, Italy.	francesca.gilli@fastwebnet.it	Calogero, Raffaele/K-9428-2019; Valentino, Paola/K-6758-2016; sperli, francesca/AAC-2055-2022; Sala, Arianna/AAB-9966-2022; Capobianco, Marco/AAC-2215-2022; Bertolotto, Antonio/K-8346-2015; Gilli, Francesca/H-4428-2019; VALENTINO, Paola/AAA-4243-2019	Calogero, Raffaele/0000-0002-2848-628X; Valentino, Paola/0000-0003-3819-9409; Sala, Arianna/0000-0001-8940-368X; Capobianco, Marco/0000-0003-2501-2932; Bertolotto, Antonio/0000-0002-7052-1907; VALENTINO, Paola/0000-0001-7863-9195; Gilli, Francesca/0000-0002-2306-458X; Di Sapio, Alessia/0000-0002-5575-7567	Italian Multiple Sclerosis Society (Fondazione Italiana Sclerosi Multipla, FISM [2004/R/9]; Swiss Multiple Sclerosis Society; Regional Health Service of Piedmont	Italian Multiple Sclerosis Society (Fondazione Italiana Sclerosi Multipla, FISM; Swiss Multiple Sclerosis Society; Regional Health Service of Piedmont	Funding: Financial support was obtained from the Italian Multiple Sclerosis Society (Fondazione Italiana Sclerosi Multipla, FISM, grant number 2004/R/9), the Swiss Multiple Sclerosis Society, and the Regional Health Service of Piedmont. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shammri S, 2004, J NEUROL SCI, V222, P21, DOI 10.1016/j.jns.2004.03.027; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; de Saizieu A, 1998, NAT BIOTECHNOL, V16, P45, DOI 10.1038/nbt0198-45; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irony-Tur-Sinai M, 2006, EXP NEUROL, V198, P136, DOI 10.1016/j.expneurol.2005.11.012; Kira J, 1996, ANN NEUROL, V40, P569; Koklanaris N, 2006, AM J OBSTET GYNECOL, V194, P687, DOI 10.1016/j.ajog.2006.01.067; KORNLUBETZKI I, 1984, ANN NEUROL, V16, P229, DOI 10.1002/ana.410160211; Kumar A, 2004, PLACENTA, V25, P347, DOI 10.1016/j.placenta.2003.10.003; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lopez C, 2006, MULT SCLER J, V12, P421, DOI 10.1191/1352458506ms1287oa; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sanchez-Ramon S, 2005, IMMUNOL LETT, V96, P195, DOI 10.1016/j.imlet.2004.09.004; Satoh J, 2006, J NEUROIMMUNOL, V174, P108, DOI 10.1016/j.jneuroim.2006.02.004; Shuster EA, 2008, CURR TOP MICROBIOL, V318, P267; Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301; Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tsao JT, 2008, CLIN EXP MED, V8, P179, DOI 10.1007/s10238-008-0006-0; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; VONHEYDEBRECK A, 2004, BIOCONDUCTOR PROJECT; VOSKUHL R, 2003, MULTIPLE SCLEROSIS T, V32, P53; Vukusic S, 2004, BRAIN, V127, P1353, DOI 10.1093/brain/awh152; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	45	62	63	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8962	10.1371/journal.pone.0008962	http://dx.doi.org/10.1371/journal.pone.0008962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126412	gold, Green Published, Green Submitted			2022-12-25	WOS:000274139100010
J	Naeger, DM; Martin, JN; Sinclair, E; Hunt, PW; Bangsberg, DR; Hecht, F; Hsue, P; McCune, JM; Deeks, SG				Naeger, David M.; Martin, Jeffrey N.; Sinclair, Elizabeth; Hunt, Peter W.; Bangsberg, David R.; Hecht, Frederick; Hsue, Priscilla; McCune, Joseph M.; Deeks, Steven G.			Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LYMPHOCYTE SUBPOPULATIONS; HIGH-FREQUENCIES; AIDS PATIENTS; RNA LEVELS; INFECTION; CD4(+); IMMUNE; LOAD; IMMUNOSENESCENCE	Background: In healthy, HIV seronegative, CMV seropositive adults, a large proportion of T cells are CMV-specific. High-level CMV-specific T cell responses are associated with accelerated immunologic aging ("immunosenesence") in the elderly population. The impact of untreated and treated HIV infection on the frequency of these cells remains undefined. Methodology/Principal Findings: We measured the proportion of CD4+ and CD8+ T cells responding to CMV pp65 and IE proteins was measured using flow cytometry in 685 unique HIV seronegative and seropositive individuals. The proportion of CMV-specific CD8+ T cells was consistently higher in the HIV-seropositive subjects compared to the HIV-seronegative subjects. This HIV effect was observed even in patients who lacked measurable immunodeficiency. Among the HIV-seropositive subjects, CMV-specific CD8+ T cell responses were proportionately lower during recent infection, higher during chronic untreated infection and higher still during long-term antiretroviral treated infection. The CD8+ T cell response to just two CMV proteins (pp65 and IE) was approximately 6% during long-term therapy, which was over twice that seen in HIV-seronegative persons. CMV-specific CD4+ T cell responses followed the same trends, but the magnitude of the effect was smaller. Conclusions/Significance: Long-term successfully treated HIV infected patients have remarkably high levels of CMV-specific effector cells. These levels are similar to that observed in the elderly, but occur at much younger ages. Future studies should focus on defining the potential role of the CMV-specific inflammatory response in non-AIDS morbidity and mortality, including immunosenescence.	[Naeger, David M.; Martin, Jeffrey N.; Sinclair, Elizabeth; Hunt, Peter W.; Hecht, Frederick; Hsue, Priscilla; McCune, Joseph M.; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Initiat Global Hlth, Boston, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts General Hospital	Naeger, DM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	sdeeks@php.ucsf.edu	Hunt, Peter W./P-2976-2017	Hunt, Peter W./0000-0002-4571-4870; Hecht, Frederick/0000-0002-5782-1171; Naeger, David/0000-0002-1884-280X	National Institutes of Health [AI41531, AI052745, AI069994, DPI OD00329]; University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 MH59037]; UCSF Clinical and Translational Research Institute Clinical Research Center [UL1 RR024131]; Center for AIDS Prevention Studies [P30 MH62246]; Doris Duke Charitable Foundation; American Foundation for AIDS Research [106710-40-RGRL]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI069994, U01AI041531, R01AI052745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037, P30MH062246, R01MH054907] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research; UCSF Clinical and Translational Research Institute Clinical Research Center; Center for AIDS Prevention Studies; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Foundation for AIDS Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This research was supported by a grants from the National Institutes of Health (AI41531, AI052745, AI069994)), University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30 MH59037; the UCSF Clinical and Translational Research Institute Clinical Research Center (UL1 RR024131); the Center for AIDS Prevention Studies (P30 MH62246); The Doris Duke Charitable Foundation and the American Foundation for AIDS Research (106710-40-RGRL). JMM is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, through grant number DPI OD00329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, J GERONTOL A-BIOL, V63, P610, DOI 10.1093/gerona/63.6.610; Almanzar G, 2005, J VIROL, V79, P3675, DOI 10.1128/JVI.79.6.3675-3683.2005; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Bowen EF, 1996, AIDS, V10, P1515, DOI 10.1097/00002030-199611000-00009; Casazza JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000646; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Davidson R, 1993, ESTIMATION INFERENCE; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Deeks SG, 2004, J INFECT DIS, V189, P312, DOI 10.1086/380098; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; DETELS R, 1994, J INFECT DIS, V169, P766, DOI 10.1093/infdis/169.4.766; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Effros RB, 2004, MECH AGEING DEV, V125, P103, DOI 10.1016/j.mad.2003.11.003; Emery VC, 1999, J INFECT DIS, V180, P695, DOI 10.1086/314936; Franceschi C, 1999, EXP GERONTOL, V34, P911, DOI 10.1016/S0531-5565(99)00068-6; Gress RE, 2009, J CLIN INVEST, V119, P2884, DOI 10.1172/JCI40855; Griffiths PP, 2006, J CLIN VIROL, V35, P489, DOI 10.1016/j.jcv.2005.10.016; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; Hakim FT, 2007, TISSUE ANTIGENS, V70, P179, DOI 10.1111/j.1399-0039.2007.00891.x; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Jabs DA, 2005, OPHTHALMOLOGY, V112, P771, DOI 10.1016/j.ophtha.2004.10.049; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kern F, 2002, J INFECT DIS, V185, P1709, DOI 10.1086/340637; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Olsson J, 2000, MECH AGEING DEV, V121, P187; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Posnett DN, 1999, INT IMMUNOL, V11, P229, DOI 10.1093/intimm/11.2.229; Qin OY, 2004, EXP GERONTOL, V39, P607, DOI 10.1016/j.exger.2003.11.016; Qin OY, 2003, J CLIN IMMUNOL, V23, P247, DOI 10.1023/A:1024580531705; Sabin CA, 2000, J INFECT DIS, V181, P1800, DOI 10.1086/315476; Sacre K, 2005, J EXP MED, V201, P1999, DOI 10.1084/jem.20042408; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Schmaltz HN, 2005, J AM GERIATR SOC, V53, P747, DOI 10.1111/j.1532-5415.2005.53250.x; Sester M, 2002, J VIROL, V76, P3748, DOI 10.1128/JVI.76.8.3748-3755.2002; Spaulding C, 1999, EXP GERONTOL, V34, P633, DOI 10.1016/S0531-5565(99)00033-9; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; Stone SF, 2005, AIDS, V19, P555, DOI 10.1097/01.aids.0000163931.68907.7e; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Valantine HA, 1999, CIRCULATION, V100, P61, DOI 10.1161/01.CIR.100.1.61; Vasto Sonya, 2007, Immun Ageing, V4, P2, DOI 10.1186/1742-4933-4-2; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1	58	145	148	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8886	10.1371/journal.pone.0008886	http://dx.doi.org/10.1371/journal.pone.0008886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126452	Green Submitted, gold, Green Published			2022-12-25	WOS:000274139100003
J	Benoit, M; Thuny, F; Le Priol, Y; Lepidi, H; Bastonero, S; Casalta, JP; Collart, F; Capo, C; Raoult, D; Mege, JL				Benoit, Marie; Thuny, Franck; Le Priol, Yannick; Lepidi, Hubert; Bastonero, Sonia; Casalta, Jean-Paul; Collart, Frederic; Capo, Christian; Raoult, Didier; Mege, Jean-Louis			The Transcriptional Programme of Human Heart Valves Reveals the Natural History of Infective Endocarditis	PLOS ONE			English	Article							VALVULAR LESIONS; CARDIAC VALVES; MESSENGER-RNA; T-CELLS; EXPRESSION; MONOCYTES; ACTIVATION; DIAGNOSIS; LEUKOCYTES; APOPTOSIS	Infective endocarditis (IE) is an infectious disease that is mainly caused by Staphylococcus aureus and Streptococcus sp. It usually leads to valvular destruction and vegetation formation. Its pathophysiology is badly understood and likely involves immune and coagulation systems with close interactions with the microorganism. Our objective was to evaluate host response by comparing transcriptional profiles of cardiac valves from IE patients with controls. Hierarchical clustering revealed a signature of IE consisting of 146 genes. Among the 89 up-regulated genes, we identified two genes strongly associated with IE: metalloproteinase 12 (MMP-12) and aquaporin-9, a member of the aquaglyceroporin membrane channel family. The up-regulation of MMP-12 gene is strengthened by the down-modulation of the gene encoding its inhibitor TIMP3. In addition, MMP-12 was expressed in macrophages infiltrating EI valves. We also found that aquaporin-9 was expressed in endothelial cells lining neo-vessel lumen, suggesting that aquaporin-9 might be associated with neovascularization of infected valves leading to tissue oedema secondary to the inflammatory process. The Gene Ontology annotation and the resulting functional classification showed that most up-regulated genes account for recruitment of inflammatory cells in vegetations, angiogenesis and remodelling of endocardium tissue. A network analysis confirmed the involvement of molecules related to the remodelling of endocardium tissue and angiogenesis in IE. It also evidenced the role of caspases, especially that of caspase-9 and intrinsic apoptotic pathway in IE. Based on this study we propose a scenario for the natural history of IE in humans. Some parameters identified in this work could become tools for measuring the disease activity and should be tested as biomarkers for diagnosis or prognosis assessment in future studies.	[Benoit, Marie; Lepidi, Hubert; Bastonero, Sonia; Casalta, Jean-Paul; Capo, Christian; Raoult, Didier; Mege, Jean-Louis] Univ Mediterranee, CNRS,Fac Med, UMR 6236, Unite Rech Malad Infect Transmissibles & Emergent, Marseille, France; [Thuny, Franck] Hop Enfants La Timone, Serv Cardiol, Marseille, France; [Le Priol, Yannick] Inst Trop Med, Serv Sante Armees, Marseille, France; [Collart, Frederic] Hop Enfants La Timone, Serv Chirurg Cardiaque, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Benoit, M (corresponding author), Univ Mediterranee, CNRS,Fac Med, UMR 6236, Unite Rech Malad Infect Transmissibles & Emergent, Marseille, France.	jean-louis.mege@univmed.fr	MEGE, JEAN-LOUIS/O-6063-2016; Thuny, Franck/GSD-2668-2022; RAOULT, Didier/A-8434-2008; Thuny, Franck/ABC-7157-2020; Thuny, Franck/ABB-2408-2021	Thuny, Franck/0000-0002-8727-7154; RAOULT, Didier/0000-0002-0633-5974; Thuny, Franck/0000-0002-8727-7154; Le Priol, Yannick/0000-0002-5176-0857	Centre National de la Recherche Scientifique et Assistance Publique - Hopitaux de Marseille	Centre National de la Recherche Scientifique et Assistance Publique - Hopitaux de Marseille(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National de la Recherche Scientifique et Assistance Publique - Hopitaux de Marseille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bancsi MJLMF, 1998, INFECT IMMUN, V66, P448, DOI 10.1128/IAI.66.2.448-450.1998; Bastonero S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005357; Benoit M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000066; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Butler TL, 2006, AM J PHYSIOL-HEART C, V291, pH705, DOI 10.1152/ajpheart.00090.2006; Carrell TWG, 2002, CIRCULATION, V105, P477, DOI 10.1161/hc0402.102621; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Chorianopoulos E, 2009, CELL TISSUE RES, V335, P153, DOI 10.1007/s00441-008-0687-4; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; GarciaZepeda EA, 1996, J IMMUNOL, V157, P5613; Greub G, 2005, AM J MED, V118, P230, DOI 10.1016/j.amjmed.2004.12.014; Houpikian P, 2005, MEDICINE, V84, P162, DOI 10.1097/01.md.0000165658.82869.17; Kellen MR, 2003, AM J PHYSIOL-HEART C, V285, pH1303, DOI 10.1152/ajpheart.00933.2001; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kruse E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-206; Lepidi H, 2006, CLIN INFECT DIS, V42, P590, DOI 10.1086/500135; Lepidi H, 2000, AM J CLIN PATHOL, V114, P880, DOI 10.1309/R0KQ-823A-BTC7-MUUJ; Lepidi H, 2004, J INFECT DIS, V190, P935, DOI 10.1086/422845; MAHIMKAR R, 2009, CARDIOVASC IN PRESS; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rodriguez A, 2006, FEBS LETT, V580, P4771, DOI 10.1016/j.febslet.2006.07.080; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Rouzet F, 2008, CIRCULATION, V117, P781, DOI 10.1161/CIRCULATIONAHA.107.718114; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Soini Y, 2001, J PATHOL, V194, P225, DOI 10.1002/path.850; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Veltrop MHAM, 2000, INFECT IMMUN, V68, P4818, DOI 10.1128/IAI.68.8.4818-4821.2000; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Yamauchi R, 2004, ARTERIOSCL THROM VAS, V24, P282, DOI 10.1161/01.ATV.0000114565.42679.c6; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yoshioka M, 2006, NAT MED, V12, P1151, DOI 10.1038/nm1476; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	42	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8939	10.1371/journal.pone.0008939	http://dx.doi.org/10.1371/journal.pone.0008939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126625	Green Published, gold, Green Submitted			2022-12-25	WOS:000274138000016
J	Obermuller, S; Calegari, F; King, A; Lindqvist, A; Lundquist, I; Salehi, A; Francolini, M; Rosa, P; Rorsman, P; Huttner, WB; Barg, S				Obermuller, Stefanie; Calegari, Federico; King, Angus; Lindqvist, Anders; Lundquist, Ingmar; Salehi, Albert; Francolini, Maura; Rosa, Patrizia; Rorsman, Patrik; Huttner, Wieland B.; Barg, Sebastian			Defective Secretion of Islet Hormones in Chromogranin-B Deficient Mice	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN GRANULE EXOCYTOSIS; DENSE-CORE GRANULES; SECRETOGRANIN FAMILY; ENDOCRINE PANCREAS; TARGETED ABLATION; ON/OFF SWITCH; BIOGENESIS; PATHWAY; PROINSULIN	Granins are major constituents of dense-core secretory granules in neuroendocrine cells, but their function is still a matter of debate. Work in cell lines has suggested that the most abundant and ubiquitously expressed granins, chromogranin A and B (CgA and CgB), are involved in granulogenesis and protein sorting. Here we report the generation and characterization of mice lacking chromogranin B (CgB-ko), which were viable and fertile. Unlike neuroendocrine tissues, pancreatic islets of these animals lacked compensatory changes in other granins and were therefore analyzed in detail. Stimulated secretion of insulin, glucagon and somatostatin was reduced in CgB-ko islets, in parallel with somewhat impaired glucose clearance and reduced insulin release, but normal insulin sensitivity in vivo. CgB-ko islets lacked specifically the rapid initial phase of stimulated secretion, had elevated basal insulin release, and stored and released twice as much proinsulin as wildtype (wt) islets. Stimulated release of glucagon and somatostatin was reduced as well. Surprisingly, biogenesis, morphology and function of insulin granules were normal, and no differences were found with regard to beta-cell stimulus-secretion coupling. We conclude that CgB is not required for normal insulin granule biogenesis or maintenance in vivo, but is essential for adequate secretion of islet hormones. Consequentially CgB-ko animals display some, but not all, hallmarks of human type-2 diabetes. However, the molecular mechanisms underlying this defect remain to be determined.	[Obermuller, Stefanie; Lindqvist, Anders; Lundquist, Ingmar; Salehi, Albert; Barg, Sebastian] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Calegari, Federico; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Calegari, Federico; Francolini, Maura; Rosa, Patrizia] Univ Milan, Dept Med Pharmacol, Inst Neurosci, CNR, Milan, Italy; [King, Angus; Huttner, Wieland B.] Univ Heidelberg, Dept Neurobiol, D-6900 Heidelberg, Germany; [Rorsman, Patrik] Univ Oxford, Churchill Hosp, OCDEM, Oxford, England; [Barg, Sebastian] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Lund University; Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); University of Milan; Ruprecht Karls University Heidelberg; University of Oxford; Uppsala University	Obermuller, S (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	huttner@mpi-cbg.de; sebastian.barg@mcb.uu.se	Calegari, Federico/A-2422-2009; Salehi, Albert/F-7768-2018; Rorsman, Patrik/A-4331-2016; Barg, Sebastian/F-9523-2010; Huttner, Wieland B./P-4080-2018; Calegari, Federico/N-7827-2019	Salehi, Albert/0000-0001-6120-3539; Rorsman, Patrik/0000-0001-7578-0767; Barg, Sebastian/0000-0003-4661-5724; calegari, federico/0000-0002-3703-2802; FRANCOLINI, MAURA/0000-0002-3126-1575; Rosa, Patrizia/0000-0002-2590-6955	Swedish Science Council; European Foundation for the Study of Diabetes; European Molecular Biology Organization (EMBO); Knut and Alice Wallenberg Foundation; Zetterlings stiftelse; Goran Gustafsson stiftelse; Deutsche Forschungsgemeinschaft (DFG); Fonds der Chemischen Industrie	Swedish Science Council; European Foundation for the Study of Diabetes; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Zetterlings stiftelse; Goran Gustafsson stiftelse; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	S.O. was a fellow of the Diabetes Programme at Lund University (DPLU), S. B. was supported by the Swedish Science Council (Vetenskapsradet), the European Foundation for the Study of Diabetes, and long-term fellowships from European Molecular Biology Organization (EMBO), the Knut and Alice Wallenberg Foundation, Zetterlings stiftelse, and Goran Gustafsson stiftelse. W. B. H. was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARDAL S, 1993, J NEUROENDOCRINOL, V5, P405, DOI 10.1111/j.1365-2826.1993.tb00501.x; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; Borjesson A, 2007, J ENDOCRINOL, V192, P381, DOI 10.1677/joe.1.06676; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Day R, 2003, TRENDS ENDOCRIN MET, V14, P10, DOI 10.1016/S1043-2760(02)00011-5; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gayen JR, 2009, J BIOL CHEM, V284, P28498, DOI 10.1074/jbc.M109.020636; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; HEDING LG, 1966, LABELLED PROTEINS TR, P345; HELLE KB, 1990, ACTA PHYSIOL SCAND, V138, P565, DOI 10.1111/j.1748-1716.1990.tb08885.x; Helle KB, 2004, BIOL REV, V79, P769, DOI 10.1017/S146479310400644X; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Hosaka M, 2002, MOL BIOL CELL, V13, P3388, DOI 10.1091/mbc.02-03-0040; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; IACANGELO AL, 1995, REGUL PEPTIDES, V58, P65, DOI 10.1016/0167-0115(95)00069-N; Iijima Y, 2004, BIOL PSYCHIAT, V56, P10, DOI 10.1016/j.biopsych.2004.03.012; Kahn SE, 1997, DIABETES, V46, P1725, DOI 10.2337/diabetes.46.11.1725; Karlsson E, 2000, REGUL PEPTIDES, V87, P33, DOI 10.1016/S0167-0115(99)00105-6; Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; KING A, 1996, THESIS U HEIDELBERG; Kromer A, 1998, J CELL BIOL, V140, P1331, DOI 10.1083/jcb.140.6.1331; Lukinius A, 2003, PANCREAS, V27, P38, DOI 10.1097/00006676-200307000-00006; Ma L, 2004, P NATL ACAD SCI USA, V101, P9266, DOI 10.1073/pnas.0403201101; MacDonald PE, 2006, CELL METAB, V4, P283, DOI 10.1016/j.cmet.2006.08.011; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; Michael DJ, 2006, DIABETES, V55, P600, DOI 10.2337/diabetes.55.03.06.db05-1054; Molinete M, 2000, SEMIN CELL DEV BIOL, V11, P243, DOI 10.1006/scdb.2000.0173; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; NANAVATI C, 1993, SCIENCE, V259, P963, DOI 10.1126/science.8438154; Natori S, 1996, P NATL ACAD SCI USA, V93, P4431, DOI 10.1073/pnas.93.9.4431; Obermuller S, 2005, J CELL SCI, V118, P4271, DOI 10.1242/jcs.02549; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; ORCI L, 1971, J CELL BIOL, V50, P565, DOI 10.1083/jcb.50.3.565; Portela-Gomes GM, 2008, REGUL PEPTIDES, V151, P19, DOI 10.1016/j.regpep.2008.07.005; RERUP C, 1966, ACTA ENDOCRINOL-COP, V52, P357, DOI 10.1530/acta.0.0520357; RHODES CJ, 1987, J CELL BIOL, V105, P145, DOI 10.1083/jcb.105.1.145; ROSA P, 1985, J CELL BIOL, V101, P1999, DOI 10.1083/jcb.101.5.1999; ROSA P, 1994, J ENDOCRINOL INVEST, V17, P207, DOI 10.1007/BF03347721; Takahashi N, 2002, SCIENCE, V297, P1349, DOI 10.1126/science.1073806; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Westphal CH, 1999, CELL, V96, P689, DOI 10.1016/S0092-8674(00)80579-6; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; Zhang KX, 2009, CIRC-CARDIOVASC GENE, V2, P46, DOI 10.1161/CIRCGENETICS.108.785659; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10299, DOI 10.1073/pnas.162352799	55	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8936	10.1371/journal.pone.0008936	http://dx.doi.org/10.1371/journal.pone.0008936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126668	Green Published, gold			2022-12-25	WOS:000274138000014
J	Equils, O; Nambiar, P; Hobel, CJ; Smith, R; Simmons, CF; Vali, S				Equils, Ozlem; Nambiar, Priya; Hobel, Calvin J.; Smith, Roger; Simmons, Charles F.; Vali, Shireen			A Computer Simulation of Progesterone and Cox2 Inhibitor Treatment for Preterm Labor	PLOS ONE			English	Article							FACTOR-KAPPA-B; HUMAN MYOMETRIUM; RECEPTOR-A; HUMAN PARTURITION; PROTEIN-KINASE; EXPRESSION; CYCLOOXYGENASE-2; BINDING; CELLS; PROSTAGLANDINS	Background: Sufficient information from in vitro and in vivo studies has become available to permit computer modeling of the processes that occur in the myometrium during labor. This development allows the in silico investigation of pathological mechanisms and the trialing of potential treatments. Methods/Results: Based on the human literature, we developed a computer model of the immune-endocrine environment of the myometrial cell. The interactions between molecules are represented by differential equations. The model is designed to simulate the estrogen and progesterone receptor changes during pregnancy and particularly the changes in the progesterone receptor (PR) isoforms A and B that are thought to mediate functional progesterone withdrawal in the human at labor. Parturition is represented by an increase in the PRA to PRB ratio to levels seen in women in labor. Infection is shown by inducing inflammation in the system by increasing phospho-IkB kinase concentration (IKK) levels; which lead to increased NF-kappa B activation, causing an increase in the PRA/PRB ratio. We examined the effects of progesterone or cyclooxygenase 2 (Cox2) inhibitor treatments on the PRA/PRB ratio in silico. The model predicted that high doses of progesterone and Cox2 inhibition would be effective in preventing an NF-kappa B-induced PRA/PRB ratio increase to the levels found during labor. Conclusions: Our data illustrate the use of dynamic biological computer simulations to test the effectiveness of therapeutic interventions. This may allow the early rejection of ineffective therapies prior to expensive field trials.	[Equils, Ozlem; Simmons, Charles F.] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr,Burns & Allen Res Inst, Dept Pediat,Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90095 USA; [Equils, Ozlem; Simmons, Charles F.] Pfizer Inc, Div Med, New York, NY USA; [Nambiar, Priya; Vali, Shireen] Cellworks Grp Inc, Saratoga, CA USA; [Smith, Roger] John Hunter Hosp, Hunter Med Res Inst, Mothers & Babies Res Ctr, Endocrine Unit, Newcastle, NSW, Australia	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pfizer; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Equils, O (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr,Burns & Allen Res Inst, Dept Pediat,Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90095 USA.	ozlem.equils@cshs.org		Smith, Roger/0000-0003-4720-0280				Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Bartlett SR, 1999, J PHYSIOL-LONDON, V520, P399, DOI 10.1111/j.1469-7793.1999.00399.x; BERNARD A, 1988, ACTA PHYSIOL HUNG, V71, P507; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Chapman NR, 2004, J CLIN ENDOCR METAB, V89, P5683, DOI 10.1210/jc.2004-0873; Conneely OM, 2000, STEROIDS, V65, P571, DOI 10.1016/S0039-128X(00)00115-X; Erkinheimo TL, 2000, J CLIN ENDOCR METAB, V85, P3468, DOI 10.1210/jc.85.9.3468; Facchinetti F, 2008, AM J PERINAT, V25, P503, DOI 10.1055/s-0028-1085071; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Geimonen E, 1996, J BIOL CHEM, V271, P23667, DOI 10.1074/jbc.271.39.23667; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Gierse JK, 2005, J PHARMACOL EXP THER, V312, P1206, DOI 10.1124/jpet.104.076877; Groom KM, 2005, BJOG-INT J OBSTET GY, V112, P725, DOI 10.1111/j.1471-0528.2005.00539.x; Henderson D, 2001, AM J OBSTET GYNECOL, V185, P579, DOI 10.1067/mob.2001.116753; Hirsch E, 2006, AM J OBSTET GYNECOL, V194, P1334, DOI 10.1016/j.ajog.2005.11.004; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Khan AH, 2008, FRONT BIOSCI-LANDMRK, V13, P5794; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Madsen G, 2004, J CLIN ENDOCR METAB, V89, P1010, DOI 10.1210/jc.2003-031037; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Mesiano S, 2001, FRONT HORM RES, V27, P86; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Olson DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1329, DOI 10.2741/2151; Ouellet M, 2001, P NATL ACAD SCI USA, V98, P14583, DOI 10.1073/pnas.251543298; Pieber D, 2001, EUR J PHARMACOL, V427, P7, DOI 10.1016/S0014-2999(01)01189-X; Pieber D, 2001, MOL HUM REPROD, V7, P875, DOI 10.1093/molehr/7.9.875; Raichur A, 2006, NEUROSCIENCE, V142, P859, DOI 10.1016/j.neuroscience.2006.06.052; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Sawdy R J, 2004, J Obstet Gynaecol, V24, P226; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; SPEROFF L, 1989, CLIN GYNECOLOGIC END, P317; Sung MH, 2004, MOL PHARMACOL, V66, P70, DOI 10.1124/mol.66.1.70; Thornton JG, 2007, NEW ENGL J MED, V357, P499, DOI 10.1056/NEJMe078097; TUNG L, 1993, MOL ENDOCRINOL, V7, P1256, DOI 10.1210/me.7.10.1256; van der Burg B, 1996, MOL HUM REPROD, V2, P433, DOI 10.1093/molehr/2.6.433; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Wang H, 2003, BIOL REPROD, V69, P1957, DOI 10.1095/biolreprod.103.019620; Weiss G, 2000, J CLIN ENDOCR METAB, V85, P4421, DOI 10.1210/jc.85.12.4421; WEN DX, 1994, MOL CELL BIOL, V14, P8356, DOI 10.1128/MCB.14.12.8356	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8502	10.1371/journal.pone.0008502	http://dx.doi.org/10.1371/journal.pone.0008502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111699	Green Submitted, Green Published, gold			2022-12-25	WOS:000274114800001
J	Zhang, Q; Chakravarty, S; Ghersi, D; Zeng, L; Plotnikov, AN; Sanchez, R; Zhou, MM				Zhang, Qiang; Chakravarty, Suvobrata; Ghersi, Dario; Zeng, Lei; Plotnikov, Alexander N.; Sanchez, Roberto; Zhou, Ming-Ming			Biochemical Profiling of Histone Binding Selectivity of the Yeast Bromodomain Family	PLOS ONE			English	Article							STRUCTURAL BASIS; LYSINE 9; CHROMATIN; RECOGNITION; ACETYLATION; COMPLEX; H3; ATPASE; FORMS; PCAF	Background: It has been shown that molecular interactions between site-specific chemical modifications such as acetylation and methylation on DNA-packing histones and conserved structural modules present in transcriptional proteins are closely associated with chromatin structural changes and gene activation. Unlike methyl-lysine that can interact with different protein modules including chromodomains, Tudor and MBT domains, as well as PHD fingers, acetyl-lysine (Kac) is known thus far to be recognized only by bromodomains. While histone lysine acetylation plays a crucial role in regulation of chromatin-mediated gene transcription, a high degree of sequence variation of the acetyl-lysine binding site in the bromodomains has limited our understanding of histone binding selectivity of the bromodomain family. Here, we report a systematic family-wide analysis of 14 yeast bromodomains binding to 32 lysine-acetylated peptides derived from known major acetylation sites in four core histones that are conserved in eukaryotes. Methodology: The histone binding selectivity of purified recombinant yeast bromodomains was assessed by using the native core histones in an overlay assay, as well as N-terminally biotinylated lysine-acetylated histone peptides spotted on streptavidin-coated nitrocellulose membrane in a dot blot assay. NMR binding analysis further validated the interactions between histones and selected bromodomain. Structural models of all yeast bromodomains were built using comparative modeling to provide insights into the molecular basis of their histone binding selectivity. Conclusions: Our study reveals that while not all members of the bromodomain family are privileged to interact with acetylated-lysine, identifiable sequence features from those that bind histone emerge. These include an asparagine residue at the C-terminus of the third helix in the 4-helix bundle, negatively charged residues around the ZA loop, and preponderance of aromatic amino acid residues in the binding pocket. Further, while bromodomains exhibit selectivity for different sites in histones, individual interactions are of modest affinity. Finally, electrostatic interactions appear to be a primary determining factor that guides productive association between a bromodomain and a lysine-acetylated histone.	[Zhang, Qiang; Chakravarty, Suvobrata; Ghersi, Dario; Zeng, Lei; Plotnikov, Alexander N.; Sanchez, Roberto; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA	Icahn School of Medicine at Mount Sinai	Zhang, Q (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA.	Ming-Ming.Zhou@mssm.edu	Ghersi, Dario/H-4468-2019; Ghersi, Dario/E-5875-2010		National Science Foundation [MCB0517352]; National Institutes of Health [HG004508, CA87658]; NATIONAL CANCER INSTITUTE [R01CA087658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by grants from the National Science Foundation (MCB0517352 to M.-M.Z. and R. S.) and the National Institutes of Health (HG004508 and CA87658 to M.-M.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; CHUA P, 1995, MOL CELL BIOL, V15, P3685; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Du J, 1998, GENETICS, V150, P987; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Greenwald RJ, 2004, BLOOD, V103, P1475, DOI 10.1182/blood-2003-06-2116; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muchardt C, 1999, SEMIN CELL DEV BIOL, V10, P189, DOI 10.1006/scdb.1999.0300; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; Travers A, 1999, CURR BIOL, V9, pR23, DOI 10.1016/S0960-9822(99)80037-2; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010	39	29	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8903	10.1371/journal.pone.0008903	http://dx.doi.org/10.1371/journal.pone.0008903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126658	Green Submitted, Green Published, gold			2022-12-25	WOS:000273896500022
J	Esue, O; Rupprecht, L; Sun, SX; Wirtz, D				Esue, Osigwe; Rupprecht, Laura; Sun, Sean X.; Wirtz, Denis			Dynamics of the Bacterial Intermediate Filament Crescentin In Vitro and In Vivo	PLOS ONE			English	Article							BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; ESCHERICHIA-COLI; CELL-DIVISION; ALPHA-ACTININ; MECHANICAL-PROPERTIES; LIVING CELLS; VIMENTIN; NETWORKS; PROTEIN	Background: Crescentin, the recently discovered bacterial intermediate filament protein, organizes into an extended filamentous structure that spans the length of the bacterium Caulobacter crescentus and plays a critical role in defining its curvature. The mechanism by which crescentin mediates cell curvature and whether crescentin filamentous structures are dynamic and/or polar are not fully understood. Methodology/Principal Findings: Using light microscopy, electron microscopy and quantitative rheology, we investigated the mechanics and dynamics of crescentin structures. Live-cell microscopy reveals that crescentin forms structures in vivo that undergo slow remodeling. The exchange of subunits between these structures and a pool of unassembled subunits is slow during the life cycle of the cell however; in vitro assembly and gelation of C. crescentus crescentin structures are rapid. Moreover, crescentin forms filamentous structures that are elastic, solid-like, and, like other intermediate filaments, can recover a significant portion of their network elasticity after shear. The assembly efficiency of crescentin is largely unaffected by monovalent cations (K+, Na+), but is enhanced by divalent cations (Mg2+, Ca2+), suggesting that the assembly kinetics and micromechanics of crescentin depend on the valence of the ions present in solution. Conclusions/Significance: These results indicate that crescentin forms filamentous structures that are elastic, labile, and stiff, and that their low dissociation rate from established structures controls the slow remodeling of crescentin in C. crescentus.	[Esue, Osigwe] Genentech Inc, Dept Pharmaceut Dev, San Francisco, CA USA; [Esue, Osigwe; Rupprecht, Laura; Sun, Sean X.; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Esue, Osigwe; Rupprecht, Laura; Sun, Sean X.; Wirtz, Denis] Johns Hopkins Univ, Phys Sci Oncol Ctr, Baltimore, MD USA; [Rupprecht, Laura] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Sun, Sean X.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA	Roche Holding; Genentech; Johns Hopkins University; Johns Hopkins University; Boston University; Johns Hopkins University	Esue, O (corresponding author), Genentech Inc, Dept Pharmaceut Dev, San Francisco, CA USA.	esue.osigwe@gene.com	Sun, Sean/M-7208-2019; Sun, Sean X/C-6755-2009; Wirtz, Denis/A-3257-2010	Sun, Sean/0000-0002-9077-7088; Sun, Sean X/0000-0002-9077-7088; Rupprecht, Laura/0000-0002-7012-3116	National Institutes of Health [GM075305, U54CA143868]; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Genentech and grants from the National Institutes of Health (GM075305 and U54CA143868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; ANGELIDES KJ, 1989, J CELL BIOL, V108, P1495, DOI 10.1083/jcb.108.4.1495; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Bagchi S, 2008, MOL MICROBIOL, V70, P1037, DOI 10.1111/j.1365-2958.2008.06473.x; BENBASAT JA, 1984, BIOCHEMISTRY-US, V23, P3609, DOI 10.1021/bi00311a007; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bretschneider T, 2002, J MUSCLE RES CELL M, V23, P639, DOI 10.1023/A:1024455023518; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; CARY RB, 1994, J CELL SCI, V107, P1609; Charbon G, 2009, GENE DEV, V23, P1131, DOI 10.1101/gad.1795509; Coulombe PA, 2000, TRENDS CELL BIOL, V10, P420, DOI 10.1016/S0962-8924(00)01828-6; Daniels BR, 2009, J CELL BIOL, V184, P473, DOI 10.1083/jcb.200809077; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; ECKELT A, 1992, EUR J CELL BIOL, V58, P319; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Garcia-Verdugo I, 2008, BIOCHEMISTRY-US, V47, P5127, DOI 10.1021/bi800070u; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 1998, Subcell Biochem, V31, P319; HOFMANN I, 1991, EUR J CELL BIOL, V56, P328; Jaiswal R, 2009, J BIOCHEM, V146, P733, DOI 10.1093/jb/mvp120; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kim JS, 2009, BIOPHYS J, V96, pL47, DOI 10.1016/j.bpj.2009.02.010; KUCHIBHATLA A, 2009, LANGMUIR; Li Xiu-zhen, 2003, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V21, P132; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; MANNING GS, 1977, BIOPHYS CHEM, V7, P189, DOI 10.1016/0301-4622(77)87021-X; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MILLER RK, 1991, J CELL BIOL, V113, P843, DOI 10.1083/jcb.113.4.843; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2005, CURR OPIN CELL BIOL, V17, P75, DOI 10.1016/j.ceb.2004.11.002; Murthy K, 2008, J CELL SCI, V121, P2350, DOI 10.1242/jcs.027052; NAKAMURA Y, 1991, GLIA, V4, P101, DOI 10.1002/glia.440040112; NGAI J, 1990, CELL, V60, P415, DOI 10.1016/0092-8674(90)90593-4; Norlen L, 2007, EXP CELL RES, V313, P2217, DOI 10.1016/j.yexcr.2007.03.037; POINDEXTER JS, 1984, ARCH MICROBIOL, V138, P140, DOI 10.1007/BF00413014; Schirner K, 2009, MICROBIOL-SGM, V155, P3611, DOI 10.1099/mic.0.030692-0; Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005; Sivaramakrishnan S, 2009, MOL BIOL CELL, V20, P2755, DOI 10.1091/mbc.E08-10-1028; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P3692, DOI 10.1073/pnas.78.6.3692; Strelkov SV, 2004, METHOD CELL BIOL, V78, P25; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; TRONCOSO JC, 1990, J STRUCT BIOL, V103, P2, DOI 10.1016/1047-8477(90)90080-V; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; VIKSTROM KL, 1992, J CELL BIOL, V118, P121, DOI 10.1083/jcb.118.1.121; WACHI M, 1989, J BACTERIOL, V171, P3123, DOI 10.1128/jb.171.6.3123-3127.1989; WADSWORTH P, 1986, J CELL BIOL, V102, P1032, DOI 10.1083/jcb.102.3.1032; Watanabe Y, 2004, CELL STRUCT FUNCT, V29, P67, DOI 10.1247/csf.29.67; Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004; WILSON RW, 1980, BIOPHYS J, V30, P317, DOI 10.1016/S0006-3495(80)85097-1; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1; Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050	69	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8855	10.1371/journal.pone.0008855	http://dx.doi.org/10.1371/journal.pone.0008855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20140233	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896300007
J	Gamboa, D; Ho, MF; Bendezu, J; Torres, K; Chiodini, PL; Barnwell, JW; Incardona, S; Perkins, M; Bell, D; McCarthy, J; Cheng, Q				Gamboa, Dionicia; Ho, Mei-Fong; Bendezu, Jorge; Torres, Katherine; Chiodini, Peter L.; Barnwell, John W.; Incardona, Sandra; Perkins, Mark; Bell, David; McCarthy, James; Cheng, Qin			A Large Proportion of P. falciparum Isolates in the Amazon Region of Peru Lack pfhrp2 and pfhrp3: Implications for Malaria Rapid Diagnostic Tests	PLOS ONE			English	Article							HISTIDINE-RICH PROTEIN-2; PLASMODIUM-FALCIPARUM; EXPERT MICROSCOPY; PARASITES; PERFORMANCE; INFECTION; COMMUNITY; ACCURACY; DEVICES; ANTIGEN	Background: Malaria rapid diagnostic tests (RDTs) offer significant potential to improve the diagnosis of malaria, and are playing an increasing role in malaria case management, control and elimination. Peru, along with other South American countries, is moving to introduce malaria RDTs as components of malaria control programmes supported by the Global Fund for AIDS, TB and malaria. The selection of the most suitable malaria RDTs is critical to the success of the programmes. Methods: Eight of nine microscopy positive P. falciparum samples collected in Iquitos, Peru tested negative or weak positive using HRP2-detecting RDTs. These samples were tested for the presence of pfhrp2 and pfhrp3 and their flanking genes by PCR, as well as the presence of HRP proteins by ELISA. To investigate for geographic extent of HRP-deleted parasites and their temporal occurrence a retrospective study was undertaken on 148 microscopy positive P. falciparum samples collected in different areas of the Amazon region of Peru. Findings: Eight of the nine isolates lacked the pfhrp2 and/or pfhrp3 genes and one or both flanking genes, and the absence of HRP was confirmed by ELISA. The retrospective study showed that 61 (41%) and 103 (70%) of the 148 samples lacked the pfhrp2 or pfhrp3 genes respectively, with 32 (21.6%) samples lacking both hrp genes. Conclusions: This is the first documentation of P. falciparum field isolates lacking pfhrp2 and/or pfhrp3. The high frequency and wide distribution of different parasites lacking pfhrp2 and/or pfhrp3 in widely dispersed areas in the Peruvian Amazon implies that malaria RDTs targeting HRP2 will fail to detect a high proportion of P. falciparum in malaria-endemic areas of Peru and should not be used. RDTs detecting parasite LDH or aldolase and quality microscopy should be use for malaria diagnosis in this region. There is an urgent need for investigation of the abundance and geographic distribution of these parasites in Peru and neighbouring countries.	[Gamboa, Dionicia; Bendezu, Jorge; Torres, Katherine] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias, Dept Bioquim Biol Mol & Farmacol, Lima, Peru; [Ho, Mei-Fong; McCarthy, James; Cheng, Qin] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Chiodini, Peter L.] Hosp Trop Dis, London NW1 0PE, England; [Barnwell, John W.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Incardona, Sandra; Perkins, Mark; Bell, David] FIND, Geneva, Switzerland; [Bell, David] WHO, Reg Off Western Pacific, Manila, Philippines; [McCarthy, James] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Ho, Mei-Fong; Cheng, Qin] Australian Army Malaria Inst, Brisbane, Qld, Australia	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; QIMR Berghofer Medical Research Institute; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; Foundation For Innovative New Diagnostics; WHO Western Pacific Regional Office; World Health Organization; University of Queensland; QIMR Berghofer Medical Research Institute	Gamboa, D (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.	qin.cheng@defence.gov.au	Gamboa, Dionicia/CAF-2097-2022; McCarthy, James S/C-1681-2009; Bendezu, Jorge/L-6597-2019; Cheng, Qin/AAO-2198-2020	Gamboa, Dionicia/0000-0002-1420-7729; Bendezu, Jorge/0000-0001-7102-3144; Cheng, Qin/0000-0001-7776-4437; Torres, Katherine/0000-0003-0414-7547; Chiodini, Peter/0000-0003-0317-7090; Incardona, Sandra/0000-0003-4994-1736; McCarthy, James/0000-0001-6596-9718	AusAID; World Health Organisation (WHO)-Western Pacific Regional Office; WHO/TDR; Foundation for Innovative New Diagnostics (FIND); Directorate General for Development Cooperation (DGCD) of the Belgian Government [95501]; NIH/NIAID [RO1 AI067727-03]; UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme; NHMRC, Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067727] Funding Source: NIH RePORTER	AusAID(Australian Aid (AusAID)); World Health Organisation (WHO)-Western Pacific Regional Office(World Health Organization); WHO/TDR(World Health Organization); Foundation for Innovative New Diagnostics (FIND); Directorate General for Development Cooperation (DGCD) of the Belgian Government; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme; NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work is partially funded by the AusAID, the World Health Organisation (WHO)-Western Pacific Regional Office, WHO/TDR and Foundation for Innovative New Diagnostics (FIND). The retrospective sample collection was financed by the Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 02, 2003-2007), project 95501. DG is supported by DGCD and NIH/NIAID (RO1 AI067727-03). PLC is supported by the UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme and JMC is supported by the NHMRC, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, with the exception of WHO and FIND facilitating the sample collection and approving the publication of the findings.	[Anonymous], 2005, Rev. perú. med. exp. salud publica, V22, P241; [Anonymous], 2008, WORLD MAL REP 2008; ARROSPIDE N, 2001, REV PERU MED EXP SAL, V19, P76; Arróspide V Nancy, 2004, Rev. perú. med. exp. salud publica, V21, P76; Arrospide V Nancy, 2006, Rev. perú. med. exp. salud publica, V23, P81; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; Bechem NN, 1999, T ROY SOC TROP MED H, V93, P46, DOI 10.1016/S0035-9203(99)90175-X; Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; Bellia PL, 2006, IEEE SECUR PRIV, V4, P20, DOI 10.1109/MSP.2006.80; BENDEZU J, 2008, EVALUACION CAMPO PRU; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Durand V Salomón, 2005, Rev. perú. med. exp. salud publica, V22, P47; Forney JR, 2003, J CLIN MICROBIOL, V41, P2358, DOI 10.1128/JCM.41.6.2358-2366.2003; Forney JR, 2001, J CLIN MICROBIOL, V39, P2884, DOI 10.1128/JCM.39.8.2884-2890.2001; Gaye O, 1998, PARASITE, V5, P189, DOI 10.1051/parasite/1998052189; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269; Huong NM, 2002, TROP MED INT HEALTH, V7, P304, DOI 10.1046/j.1365-3156.2002.00869.x; Iqbal J, 2002, J CLIN MICROBIOL, V40, P4675, DOI 10.1128/JCM.40.12.4675-4678.2002; Jiang HY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-398; KEMP DJ, 1987, P NATL ACAD SCI USA, V84, P7672, DOI 10.1073/pnas.84.21.7672; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Llanos-Zavalaga Fernando, 2002, Rev. perú. med. exp. salud publica, V19, P39; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Ranford-Cartwright LC, 1997, T ROY SOC TROP MED H, V91, P719, DOI 10.1016/S0035-9203(97)90539-3; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183; Rubio JM, 2001, J CLIN MICROBIOL, V39, P2736, DOI 10.1128/JCM.39.7.2736-2737.2001; Singh N, 2000, ANN TROP MED PARASIT, V94, P421, DOI 10.1080/00034983.2000.11813560; Tarazona Alonso Soto, 2004, Braz J Infect Dis, V8, P151, DOI 10.1590/S1413-86702004000200005; Stow NW, 1999, T ROY SOC TROP MED H, V93, P519, DOI 10.1016/S0035-9203(99)90359-0; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Veron V, 2006, AM J TROP MED HYG, V74, P941, DOI 10.4269/ajtmh.2006.74.941; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WELLEMS TE, 1988, REV BRAS GENET, V11, P813; *WHO REG OFF W PAC, 2008, METH MAN LAB QUAL CO; Wongsrichanalai C, 1999, ACTA TROP, V73, P263, DOI 10.1016/S0001-706X(99)00040-6; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; 2009, B EPIDEMIOLOGICO 200	42	289	297	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8091	10.1371/journal.pone.0008091	http://dx.doi.org/10.1371/journal.pone.0008091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111602	gold, Green Published, Green Submitted			2022-12-25	WOS:000273896300001
J	Liu, SH; Ma, JF; Wang, W; Zhang, MX; Xin, QT; Peng, SM; Li, RX; Zhu, HZ				Liu, Shaohui; Ma, Jinfang; Wang, Wei; Zhang, Maoxiang; Xin, Qingting; Peng, Siman; Li, Rongxiu; Zhu, Huanzhang			Mutational Analysis of Highly Conserved Residues in the Phage PhiC31 Integrase Reveals Key Amino Acids Necessary for the DNA Recombination	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; NONVIRAL GENETIC CORRECTION; GAMMA-DELTA-RESOLVASE; C-TERMINAL DOMAIN; PHI-C31 INTEGRASE; GENOMIC INTEGRATION; CLOSTRIDIUM-PERFRINGENS; CENTRAL DINUCLEOTIDE; BXB1 INTEGRATION; SYNAPSIS	Background: Amino acid sequence alignment of phage phiC31 integrase with the serine recombinases family revealed highly conserved regions outside the catalytic domain. Until now, no system mutational or biochemical studies have been carried out to assess the roles of these conserved residues in the recombinaton of phiC31 integrase. Methodology/Principal Findings: To determine the functional roles of these conserved residues, a series of conserved residues were targeted by site-directed mutagenesis. Out of the 17 mutants, 11 mutants showed impaired or no recombination ability, as analyzed by recombination assay both in vivo and in vitro. Results of DNA binding activity assays showed that mutants (R18A, I141A, L143A, E153A, I432A and V571A) exhibited a great decrease in DNA binding affinity, and mutants (G182A/F183A, C374A, C376A/G377A, Y393A and V566A) had completely lost their ability to bind to the specific target DNA attB as compared with wild-type protein. Further analysis of mutants (R18A, I141A, L143A and E153A) synapse and cleavage showed that these mutants were blocked in recombination at the stage of strand cleavage. Conclusions/Significance: This data reveals that some of the highly conserved residues both in the N-terminus and C-terminus region of phiC31 integrase, play vital roles in the substrate binding and cleavage. The cysteine-rich motif and the C-tail val-rich region of phiC31 integrase may represent the major DNA binding domains of phiC31 integrase.	[Liu, Shaohui; Ma, Jinfang; Wang, Wei; Zhang, Maoxiang; Xin, Qingting; Peng, Siman; Zhu, Huanzhang] Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Li, Rongxiu] Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Li, Rongxiu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, SH (corresponding author), Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	Hzzhu@fudan.edu.cn	Zhang, Maoxiang/G-1079-2015; Rong Xiu, Li/C-9683-2010	Zhang, Maoxiang/0000-0003-2790-0431; Rong Xiu, Li/0000-0002-7491-0854; wang, Wei/0000-0002-0600-7276	National Natural Science Funding of China [30671190, 3071120569]; National Grand Program on Key Infectious Disease [2008ZX10001-006]	National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease	This work is supported by National Natural Science Funding of China (No. 30671190 No. 3071120569), and National Grand Program on Key Infectious Disease (2008ZX10001-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2006, MOL MICROBIOL, V60, P591, DOI 10.1111/j.1365-2958.2006.05120.x; Adams V, 2004, MOL MICROBIOL, V53, P1195, DOI 10.1111/j.1365-2958.2004.04198.x; Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chen JZ, 2006, NUCLEIC ACIDS RES, V34, P6298, DOI 10.1093/nar/gkl890; Crellin PK, 1997, J BACTERIOL, V179, P5148, DOI 10.1128/jb.179.16.5148-5156.1997; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; Ghosh P, 2005, J MOL BIOL, V349, P331, DOI 10.1016/j.jmb.2005.03.043; Ghosh P, 2003, MOL CELL, V12, P1101, DOI 10.1016/S1097-2765(03)00444-1; Grainge I, 2002, J MOL BIOL, V320, P515, DOI 10.1016/S0022-2836(02)00517-X; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Gupta M, 2007, NUCLEIC ACIDS RES, V35, P3407, DOI 10.1093/nar/gkm206; Haren L, 2000, J MOL BIOL, V296, P757, DOI 10.1006/jmbi.1999.3485; Held PK, 2005, MOL THER, V11, P399, DOI 10.1016/j.ymthe.2004.11.001; Hollis Roger P, 2003, Reprod Biol Endocrinol, V1, P79, DOI 10.1186/1477-7827-1-79; Kamtekar S, 2006, P NATL ACAD SCI USA, V103, P10642, DOI 10.1073/pnas.0604062103; Keravala A, 2009, MOL THER, V17, P112, DOI 10.1038/mt.2008.241; KUHSTOSS S, 1991, J MOL BIOL, V222, P897, DOI 10.1016/0022-2836(91)90584-S; Leighton PA, 2008, MOL REPROD DEV, V75, P1163, DOI 10.1002/mrd.20859; Li WK, 2005, SCIENCE, V309, P1210, DOI 10.1126/science.1112064; Lucet IS, 2005, J BIOL CHEM, V280, P2503, DOI 10.1074/jbc.M409702200; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; McEwan AR, 2009, NUCLEIC ACIDS RES, V37, P4764, DOI 10.1093/nar/gkp485; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Ortiz-Urda S, 2003, HUM GENE THER, V14, P923, DOI 10.1089/104303403765701204; Rowley PA, 2008, J BACTERIOL, V190, P6918, DOI 10.1128/JB.00612-08; Rowley PA, 2008, NUCLEIC ACIDS RES, V36, P3879, DOI 10.1093/nar/gkn269; Sclimenti CR, 2001, NUCLEIC ACIDS RES, V29, P5044, DOI 10.1093/nar/29.24.5044; Smith MCA, 2004, NUCLEIC ACIDS RES, V32, P2607, DOI 10.1093/nar/gkh538; Smith MCA, 2004, MOL MICROBIOL, V51, P1719, DOI 10.1111/j.1365-2958.2003.03942.x; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; STARK WM, 1992, TRENDS GENET, V8, P432, DOI 10.1016/0168-9525(92)90176-5; STARK WM, 1991, EMBO J, V10, P3541, DOI 10.1002/j.1460-2075.1991.tb04918.x; Thomason LC, 2001, MOL GENET GENOMICS, V265, P1031, DOI 10.1007/s004380100498; Thorpe HM, 2000, MOL MICROBIOL, V38, P232, DOI 10.1046/j.1365-2958.2000.02142.x; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Tiana G, 2004, P NATL ACAD SCI USA, V101, P2846, DOI 10.1073/pnas.0306638101; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Verkhivker GM, 2006, BIOINFORMATICS, V22, P1846, DOI 10.1093/bioinformatics/btl199; Wang HM, 2000, J BACTERIOL, V182, P6577, DOI 10.1128/JB.182.23.6577-6583.2000	48	13	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8863	10.1371/journal.pone.0008863	http://dx.doi.org/10.1371/journal.pone.0008863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111606	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896300013
J	Keller, MJ; Mesquita, PMM; Torres, NM; Cho, S; Shust, G; Madan, RP; Cohen, HW; Petrie, J; Ford, T; Soto-Torres, L; Profy, AT; Herold, BC				Keller, Marla J.; Mesquita, Pedro M. M.; Torres, N. Merna; Cho, Sylvia; Shust, Gail; Madan, Rebecca P.; Cohen, Hillel W.; Petrie, Julie; Ford, Tara; Soto-Torres, Lydia; Profy, Albert T.; Herold, Betsy C.			Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RANDOMIZED CONTROLLED-TRIAL; HIV-INFECTION; CELLULOSE SULFATE; TOPICAL MICROBICIDES; SEMINAL PLASMA; VAGINAL GEL; HERPES; TRANSMISSION; CELL	Background: The pharmacokinetics and pharmacodynamics of vaginal microbicides are typically assessed among sexually abstinent women. However, the physical act of sex may modulate gel distribution, and preclinical studies demonstrate seminal plasma interferes with the antiviral activity of several microbicides. This study compared the biological activity and concentration of PRO 2000 in cervicovaginal lavage (CVL) collected in the absence or following coitus. Methods: CVL samples were collected from ten heterosexual couples at baseline, after sex, after a single dose of 0.5% PRO 2000 gel and sex, and after gel application without sex. The impact of CVL on HIV-1 infection of TZM-bl cells and HSV-2 infection of CaSki cells was monitored by luciferase and plaque assay, respectively. PRO 2000 concentrations were measured by fluorescence. Results: CVL collected after PRO 2000 application significantly inhibited HIV-1 and HSV-2 (p = 0.01). However, the antiviral activity was reduced following sex and no significant protective effect was observed in postcoital CVL obtained in the presence compared to the absence of PRO 2000 for HIV (p = 0.45) or HSV-2 (p = 0.56). Less PRO 2000 was recovered in postcoital CVL, which, in conjunction with interference by seminal plasma, may have contributed to lower antiviral activity. Conclusions: Postcoital responses to PRO 2000 differ from precoital measures and the results obtained may provide insights into the clinical trial findings in which there was no significant protection against HIV-1 or HSV-2. Postcoital studies should be incorporated into clinical studies before embarking on large-scale efficacy trials.	[Keller, Marla J.; Petrie, Julie; Ford, Tara] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Keller, Marla J.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Mesquita, Pedro M. M.; Torres, N. Merna; Cho, Sylvia; Shust, Gail; Madan, Rebecca P.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Cohen, Hillel W.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Herold, Betsy C.] Albert Einstein Coll Med, Dept & Microbiol & Immunol, Bronx, NY 10467 USA; [Soto-Torres, Lydia] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Profy, Albert T.] Endo Pharmaceut, Chadds Ford, PA USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Endo Pharmaceuticals Inc.	Keller, MJ (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	betsy.herold@einstein.yu.edu		Mesquita, Pedro/0000-0002-6591-4896; Herold, Betsy/0000-0001-9974-0786; Cohen, Hillel/0000-0002-4524-0898	National Institutes of Health [AI077549, AI065309, UL1RR025750]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077549, R01AI065309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI077549, AI065309 and UL1RR025750). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Indevus Pharmaceuticals (now Endo) provided PRO 2000 gel and is the employer of one of the co-authors, Al Profy. Their involvement does not alter our adherence to all the PLoS ONE policies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheshenko N, 2004, ANTIMICROB AGENTS CH, V48, P2025, DOI 10.1128/AAC.48.6.2025-2036.2004; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Herold BC, 1997, ANTIMICROB AGENTS CH, V41, P2776, DOI 10.1128/AAC.41.12.2776; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; John M, 2005, J INFECT DIS, V192, P1731, DOI 10.1086/497168; Karim SA, 2009, 16 C RETR OPP INF MO; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2006, J INFECT DIS, V193, P27, DOI 10.1086/498533; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Mesquita PMM, 2008, J VIROL, V82, P6576, DOI 10.1128/JVI.00335-08; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Microbicides Development Programme, 2009, HIV PREV GEL PRO 200; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Neurath AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-150; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; SHUST G, 2009, AM J REPROD IMM 1215; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	23	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8781	10.1371/journal.pone.0008781	http://dx.doi.org/10.1371/journal.pone.0008781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107502	gold, Green Submitted, Green Published			2022-12-25	WOS:000273896100004
J	Mishchenko, Y				Mishchenko, Yuriy			On Optical Detection of Densely Labeled Synapses in Neuropil and Mapping Connectivity with Combinatorially Multiplexed Fluorescent Synaptic Markers	PLOS ONE			English	Article							SEMIAUTOMATED RECONSTRUCTION; CIRCUIT RECONSTRUCTION; POSTSYNAPTIC DENSITY; ELECTRON-MICROSCOPY; DENDRITIC SPINES; ULTRASTRUCTURE; VOLUME	We propose a new method for mapping neural connectivity optically, by utilizing Cre/Lox system Brainbow to tag synapses of different neurons with random mixtures of different fluorophores, such as GFP, YFP, etc., and then detecting patterns of fluorophores at different synapses using light microscopy (LM). Such patterns will immediately report the pre- and postsynaptic cells at each synaptic connection, without tracing neural projections from individual synapses to corresponding cell bodies. We simulate fluorescence from a population of densely labeled synapses in a block of hippocampal neuropil, completely reconstructed from electron microscopy data, and show that high-end LM is able to detect such patterns with over 95% accuracy. We conclude, therefore, that with the described approach neural connectivity in macroscopically large neural circuits can be mapped with great accuracy, in scalable manner, using fast optical tools, and straightforward image processing. Relying on an electron microscopy dataset, we also derive and explicitly enumerate the conditions that should be met to allow synaptic connectivity studies with high-resolution optical tools.	[Mishchenko, Yuriy] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Mishchenko, Yuriy] Columbia Univ, Ctr Theoret Neurosci, New York, NY USA	Columbia University; Columbia University	Mishchenko, Y (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.	yuriy.mishchenko@gmail.com			Columbia University	Columbia University	The author has no support or funding to report. The study was not specifically financially supported by Columbia University. Nonetheless, the study was performed while the author was an employee at Columbia University.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BOHLAND J, 2009, PROPOSAL COORDINATED; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Dunn NA, 2004, J COMPUT NEUROSCI, V17, P137, DOI 10.1023/B:JCNS.0000037679.42570.d5; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fiala JC, 2003, J COMP NEUROL, V465, P90, DOI 10.1002/cne.10825; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; GUSTAFSSON MGL, 2005, NONLINEAR STRUCTURED, P13081; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HELMSTAEDTER M, 2009, CURRENT OPINIONS NEU; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; JURRUS E, 2006, AXON TRACKING SERIAL; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; LICHTMAN JW, 2008, NATURE REV NEUROSCIE; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu J, 2009, PLOS BIOL, V7, P996, DOI 10.1371/journal.pbio.1000108; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005655; Macke JH, 2008, J NEUROSCI METH, V167, P349, DOI 10.1016/j.jneumeth.2007.07.021; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; MISHCHENKO Y, 2009, STRATEGIES IDENTIFYI; Mishchenko Y, 2009, J NEUROSCI METH, V176, P276, DOI 10.1016/j.jneumeth.2008.09.006; Ram S, 2006, P NATL ACAD SCI USA, V103, P4457, DOI 10.1073/pnas.0508047103; Ramon y Cajal S, 1909, HISTOLOGIE SYSTEME N; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; Smith SJ, 2007, CURR OPIN NEUROBIOL, V17, P601, DOI 10.1016/j.conb.2007.11.004; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; SVOBODA K, COMMUNICATION; Wang S, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURE, P1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	40	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8853	10.1371/journal.pone.0008853	http://dx.doi.org/10.1371/journal.pone.0008853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107507	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896100017
J	Feng, JAQ; Guo, FJ; Jiang, BC; Zhang, Y; Frenkel, S; Wang, DW; Tang, W; Xie, YX; Liu, CJ				Feng, Jian Q.; Guo, Feng-Jin; Jiang, Bai-Chun; Zhang, Yan; Frenkel, Sally; Wang, Da-Wei; Tang, Wei; Xie, Yixia; Liu, Chuan-Ju			Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis	FASEB JOURNAL			English	Article						GEP; BMP-2; chondrocyte; differentiation	OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; MESENCHYMAL STEM-CELL; IN-VITRO; GENE-EXPRESSION; FACTOR-BETA; GRANULIN/EPITHELIN PRECURSOR; CHONDROCYTE PROLIFERATION; FRONTOTEMPORAL DEMENTIA; FACTOR PCDGF	Granulin epithelin precursor (GEP) has been implicated in development, tissue regeneration, tumorigenesis, and inflammation. Herein we report that GEP stimulates chondrocyte differentiation from mesenchymal stem cells in vitro and endochondral ossification ex vivo, and GEP-knockdown mice display skeleton defects. Similar to bone morphogenic protein (BMP) 2, application of the recombinant GEP accelerates rabbit cartilage repair in vivo. GEP is a key downstream molecule of BMP2, and it is required for BMP2-mediated chondrocyte differentiation. We also show that GEP activates chondrocyte differentiation through Erk1/2 signaling and that JunB transcription factor is one of key downstream molecules of GEP in chondrocyte differentiation. Collectively, these findings reveal a novel critical role of GEP growth factor in chondrocyte differentiation and the molecular events both in vivo and in vitro.-Feng, J. Q., Guo, F.-J., Jiang, B.-C., Zhang, Y., Frenkel, S., Wang, D.-W., Tang, W., Xie, Y., Liu, C.-J. Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis. FASEB J. 24, 1879-1892 (2010). www.fasebj.org	[Guo, Feng-Jin; Zhang, Yan; Frenkel, Sally; Wang, Da-Wei; Tang, Wei; Liu, Chuan-Ju] NYU, Sch Med, Dept Orthopaed Surg, New York, NY 10003 USA; [Frenkel, Sally; Liu, Chuan-Ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10003 USA; [Feng, Jian Q.; Jiang, Bai-Chun; Xie, Yixia] Texas A&M Univ Syst, Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA	New York University; New York University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Liu, CJ (corresponding author), NYU, Sch Med, Dept Orthopaed Surg, 301 E 17th St, New York, NY 10003 USA.	chuanju.liu@med.nyu.edu	Liu, Chuan-ju/AAT-8165-2021; Tang, Wei/A-6254-2016	Tang, Wei/0000-0002-4573-3502; Wang, Dawei/0000-0002-6151-5839; Frenkel, Sally/0000-0001-9450-1946; liu, chuanju/0000-0002-7181-8032	U.S. NIH [AR053210, AR050620, AG029388, DE018486, AR51587]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051587, K01AR053210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG029388] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was aided by U.S. NIH research grants AR053210, AR050620, and AG029388 (to C. J. L.) and DE018486 and AR51587 (to J. Q. F).	ANAKWE OO, 1990, BIOL REPROD, V42, P317, DOI 10.1095/biolreprod42.2.317; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Attur M. G., 2002, Current Issues in Molecular Biology, V4, P129; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P727, DOI 10.1016/j.dci.2003.11.005; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bhandari V, 1996, BIOCHEM J, V319, P441, DOI 10.1042/bj3190441; BRIGGS MD, 1993, GENOMICS, V18, P656, DOI 10.1016/S0888-7543(05)80369-6; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chalaux E, 1998, J BIOL CHEM, V273, P537, DOI 10.1074/jbc.273.1.537; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cohn DH, 1996, ANN NY ACAD SCI, V785, P188, DOI 10.1111/j.1749-6632.1996.tb56258.x; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Davidson B, 2004, CANCER-AM CANCER SOC, V100, P2139, DOI 10.1002/cncr.20219; Di Cesare PE, 2006, J ORTHOP RES, V24, P1118, DOI 10.1002/jor.20143; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P1244, DOI 10.1002/dvdy.20718; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; He ZH, 2002, CANCER RES, V62, P5590; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Hoque M, 2005, J BIOL CHEM, V280, P13648, DOI 10.1074/jbc.M409575200; Hoque M, 2003, MOL CELL BIOL, V23, P1688, DOI 10.1128/MCB.23.5.1688-1702.2003; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Johnson KA, 2008, AM J PATHOL, V172, P440, DOI 10.2353/ajpath.2008.070753; Jones MB, 2003, GYNECOL ONCOL, V88, pS136, DOI 10.1006/gyno.2002.6704; Justen H P, 2000, Mol Cell Biol Res Commun, V3, P165, DOI 10.1006/mcbr.2000.0211; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Koseki T, 2002, CELL SIGNAL, V14, P31, DOI 10.1016/S0898-6568(01)00221-2; Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Locklin RM, 2001, J BONE MINER RES, V16, P2192, DOI 10.1359/jbmr.2001.16.12.2192; Lu RQ, 2000, P NATL ACAD SCI USA, V97, P3993, DOI 10.1073/pnas.97.8.3993; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Olney RC, 2004, BIOCHEM BIOPH RES CO, V317, P1171, DOI 10.1016/j.bbrc.2004.03.170; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4; Rowland LP, 2006, ANN NEUROL, V60, P275, DOI 10.1002/ana.20962; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Sun XJ, 2004, AM J RESP CELL MOL, V30, P510, DOI 10.1165/rcmb.2003-0266OC; Susic S, 1997, CLIN GENET, V51, P219; Suzuki M, 2002, MOL GENET METAB, V75, P31, DOI 10.1006/mgme.2001.3274; Thornburg NJ, 2004, J VIROL, V78, P12848, DOI 10.1128/JVI.78.23.12848-12856.2004; Tuan RS, 2003, J BONE JOINT SURG AM, V85A, P137, DOI 10.2106/00004623-200300002-00019; VANDERKRAAN PM, 1990, J EXP PATHOL, V71, P19; Veilleux N, 2005, OSTEOARTHR CARTILAGE, V13, P278, DOI 10.1016/j.joca.2004.12.013; Wang WG, 2003, CLIN CANCER RES, V9, P2221; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Xu SQ, 1998, J BIOL CHEM, V273, P20078, DOI 10.1074/jbc.273.32.20078; Xu XL, 1999, DEV BIOL, V208, P293, DOI 10.1006/dbio.1999.9227; Xu XL, 1999, CELL TISSUE RES, V296, P33, DOI 10.1007/s004410051264; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; Zhang Y, 2008, CELL DEATH DIFFER, V15, P1760, DOI 10.1038/cdd.2008.112; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	76	90	96	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1879	1892		10.1096/fj.09-144659	http://dx.doi.org/10.1096/fj.09-144659			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20124436	Green Published			2022-12-25	WOS:000278200000023
J	Grossmann, C; Wuttke, M; Ruhs, S; Seiferth, A; Mildenberger, S; Rabe, S; Schwerdt, G; Gekle, M				Grossmann, Claudia; Wuttke, Martin; Ruhs, Stefanie; Seiferth, Anja; Mildenberger, Sigrid; Rabe, Sindy; Schwerdt, Gerald; Gekle, Michael			Mineralocorticoid receptor inhibits CREB signaling by calcineurin activation	FASEB JOURNAL			English	Article						aldosterone; steroid hormone; cAMP; glucose-6-phosphate dehydrogenase; vascular smooth muscle cells	GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; TRANSDUCTION PATHWAYS; ESTROGEN-RECEPTOR; EPITHELIAL-CELLS; IN-VITRO; ALDOSTERONE; CAMP; TRANSCRIPTION; BLOCKER	We investigated the interaction of MR with cAMP-response element binding protein (CREB) and provide a mechanistic explanation and insights into the cellular relevance. MR -> CREB crosstalk was assessed in vascular smooth muscle cells and heterologous expression systems. Experiments were designed in a way that only one variable changed at a time and the respective vehicles served as controls. MR, but not GR, activation (aldosterone or hydrocortisone, IC50, similar to 0.3 nM) inhibits CREB transcriptional activity induced by stimulation of beta 1/2-adrenoceptors and adenylyl cyclase or addition of membrane-permeable cAMP up to 70% within 2 h after addition. The MR DNA-binding domain is not required for this inhibition. cAMP formation is virtually unchanged, whereas MR exerts a robust inhibition of CREBS133 phosphorylation via calcineurin/PP2B activation without changes in PP2B-A alpha or beta expression. In parallel, the PP2B-sensitive NFaT-pathway is activated. The inhibitory crosstalk attenuates CREB-induced glucose-6-phosphate dehydrogenase expression. Overall, transcriptional relevant MR -> CREB crosstalk occurs at the level of CREB phosphorylation by enhanced calcineurin activity, enables GRE-independent genomic signaling of MR, and is of potential pathophysiological relevance.-Grossmann, C., Wuttke, M., Ruhs, S., Seiferth, A., Mildenberger, S., Rabe, S., Schwerdt, G., Gekle, M. Mineralocorticoid receptor inhibits CREB signaling by calcineurin activation. FASEB J. 24, 2010-2019 (2010). www.fasebj.org	[Grossmann, Claudia; Wuttke, Martin; Ruhs, Stefanie; Seiferth, Anja; Mildenberger, Sigrid; Rabe, Sindy; Schwerdt, Gerald; Gekle, Michael] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, D-06112 Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Gekle, M (corresponding author), Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06112 Halle, Saale, Germany.	michael.gekle@medizin.uni-halle.de			Deutsche Forschungsgemeinschaft, DFG [Ge 905/8-1, 13-1]; Medical School, Universitat Halle-Wittenberg	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); Medical School, Universitat Halle-Wittenberg	This study was supported by the Deutsche Forschungsgemeinschaft, DFG (grants Ge 905/8-1 and 13-1) and the WilhelmRoux program of the Medical School, Universitat Halle-Wittenberg. The authors declare no conflicts of interest.	AHMAD M, 1995, STEROIDS, V60, P147, DOI 10.1016/0039-128X(94)00019-9; Alzamora R, 2000, HYPERTENSION, V35, P1099, DOI 10.1161/01.HYP.35.5.1099; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Callera GE, 2005, HYPERTENSION, V46, P1032, DOI 10.1161/01.HYP.0000176588.51027.35; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Christ M, 1999, CIRCULATION, V99, P1485, DOI 10.1161/01.CIR.99.11.1485; Christ M, 2005, MOL CELL ENDOCRINOL, V231, P23, DOI 10.1016/j.mce.2004.12.004; Colella M, 2008, P NATL ACAD SCI USA, V105, P2859, DOI 10.1073/pnas.0712316105; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Esposito C, 2000, KIDNEY INT, V58, P123, DOI 10.1046/j.1523-1755.2000.00147.x; Fuse H, 2000, MOL ENDOCRINOL, V14, P889, DOI 10.1210/me.14.6.889; Gekle M, 2002, AM J PHYSIOL-RENAL, V282, pF669, DOI 10.1152/ajprenal.00159.2001; Gekle M, 1996, P NATL ACAD SCI USA, V93, P10500, DOI 10.1073/pnas.93.19.10500; Gekle M, 2007, PFLUG ARCH EUR J PHY, V454, P403, DOI 10.1007/s00424-007-0211-9; Gonzalez-Nunez D, 2004, AM J PHYSIOL-RENAL, V286, pF936, DOI 10.1152/ajprenal.00070.2003; Goto J, 2009, AM J PHYSIOL-ENDOC M, V296, pE904, DOI 10.1152/ajpendo.90840.2008; Grossmann C, 2005, MOL ENDOCRINOL, V19, P1697, DOI 10.1210/me.2004-0469; Grossmann C, 2004, AM J PHYSIOL-RENAL, V286, pF1226, DOI 10.1152/ajprenal.00378.2003; Grossmann C, 2008, STEROIDS, V73, P973, DOI 10.1016/j.steroids.2007.12.008; Hallhuber M, 2006, CIRC RES, V99, P626, DOI 10.1161/01.RES.0000243208.59795.d8; Haseroth K, 1999, BIOCHEM BIOPH RES CO, V266, P257, DOI 10.1006/bbrc.1999.1771; Jaffe IZ, 2005, CIRC RES, V96, P643, DOI 10.1161/01.RES.0000159937.05502.d1; JAZAYERI A, 1989, J STEROID BIOCHEM, V33, P987, DOI 10.1016/0022-4731(89)90250-1; Klar J, 2004, AM J PHYSIOL-RENAL, V286, pF349, DOI 10.1152/ajprenal.00411.2002; Krug AW, 2003, J BIOL CHEM, V278, P43060, DOI 10.1074/jbc.M308134200; Leopold JA, 2000, AM J PHYSIOL-HEART C, V279, pH2477, DOI 10.1152/ajpheart.2000.279.5.H2477; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Lim-Tio SS, 1998, ENDOCRINOLOGY, V139, P1653, DOI 10.1210/en.139.4.1653; Liu XQ, 2004, AM J PHYSIOL-CELL PH, V286, pC1089, DOI 10.1152/ajpcell.00461.2003; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Mano A, 2004, CIRCULATION, V110, P317, DOI 10.1161/01.CIR.0000135599.33787.CA; Massaad C, 1999, MOL ENDOCRINOL, V13, P57, DOI 10.1210/me.13.1.57; NORDEEN SK, 1994, ENDOCRINOLOGY, V134, P1723, DOI 10.1210/en.134.4.1723; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Ouvrard-Pascaud A, 2004, AM J PHYSIOL-RENAL, V286, pF180, DOI 10.1152/ajprenal.00301.2002; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; Pedram A, 2008, ENDOCRINOLOGY, V149, P3361, DOI 10.1210/en.2008-0133; Pfau A, 2007, MOL CELL ENDOCRINOL, V264, P35, DOI 10.1016/j.mce.2006.10.002; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Rogatsky I, 1998, J BIOL CHEM, V273, P14315, DOI 10.1074/jbc.273.23.14315; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; Savoia C, 2008, HYPERTENSION, V51, P432, DOI 10.1161/HYPERTENSIONAHA.107.103267; Savoia C, 2006, HYPERTENSION, V48, P271, DOI 10.1161/01.HYP.0000230234.84356.36; Sheader EA, 2002, J ENDOCRINOL, V175, P343, DOI 10.1677/joe.0.1750343; Someren JS, 1999, BIOCHEM BIOPH RES CO, V260, P619, DOI 10.1006/bbrc.1999.0800; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Thomas W, 2007, BIOCHEM SOC T, V35, P1049, DOI 10.1042/BST0351049; Tumlin JA, 1997, J CLIN INVEST, V99, P1217, DOI 10.1172/JCI119278; Vesey DA, 2002, KIDNEY INT, V62, P31, DOI 10.1046/j.1523-1755.2002.00401.x; Wohlfarth V, 2003, KIDNEY INT, V63, pS103, DOI 10.1046/j.1523-1755.63.s84.13.x; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zhou ZH, 2001, AM J PHYSIOL-CELL PH, V281, pC1118, DOI 10.1152/ajpcell.2001.281.4.C1118; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759; ZIYADEH FN, 1990, AM J PHYSIOL, V259, pF704, DOI 10.1152/ajprenal.1990.259.4.F704	59	23	23	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2010	2019		10.1096/fj.09-146985	http://dx.doi.org/10.1096/fj.09-146985			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20103717				2022-12-25	WOS:000278200000035
J	Freire-De-Lima, L; Alisson-Silva, F; Carvalho, ST; Takiya, CM; Rodrigues, MM; DosReis, GA; Mendonca-Previato, L; Previato, JO; Todeschini, AR				Freire-de-Lima, Leonardo; Alisson-Silva, Frederico; Carvalho, Sebastiao T.; Takiya, Christina M.; Rodrigues, Mauricio M.; DosReis, George A.; Mendonca-Previato, Lucia; Previato, Jose O.; Todeschini, Adriane R.			Trypanosoma cruzi Subverts Host Cell Sialylation and May Compromise Antigen-specific CD8(+) T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-SIALIDASE; CHAGAS-DISEASE; LYMPHOCYTES; MICE; BINDING; MEMORY; ACID; CD43; GLYCOSYLATION; ACTIVATION	Upon activation, cytotoxic CD8(+) T lymphocytes are desialylated exposing beta-galactose residues in a physiological change that enhances their effector activity and that can be monitored on the basis of increased binding of the lectin peanut agglutinin. Herein, we investigated the impact of sialylation mediated by trans-sialidase, a specific and unique Trypanosoma transglycosylase for sialic acid, on CD8(+) T cell response of mice infected with T. cruzi. Our data demonstrate that T. cruzi uses its trans-sialidase enzyme to resialylate the CD8(+) T cell surface, thereby dampening antigen-specific CD8(+) T cell response that might favor its own persistence in the mammalian host. Binding of the monoclonal antibody S7, which recognizes sialic acid-containing epitopes on the 115-kDa isoform of CD43, was augmented on CD8(+) T cells from ST3Gal-I-deficient infected mice, indicating that CD43 is one sialic acid acceptor for trans-sialidase activity on the CD8(+) T cell surface. The cytotoxic activity of antigen-experienced CD8(+) T cells against the immunodominant trans-sialidase synthetic peptide IYNVGQVSI was decreased following active trans-sialidase-mediated resialylation in vitro and in vivo. Inhibition of the parasite's native trans-sialidase activity during infection strongly decreased CD8(+) T cell sialylation, reverting it to the glycosylation status expected in the absence of parasite manipulation increasing mouse survival. Taken together, these results demonstrate, for the first time, that T. cruzi subverts sialylation to attenuate CD8(+) T cell interactions with peptide-major histocompatibility complex class I complexes. CD8(+) T cell resialylation may represent a sophisticated strategy to ensure lifetime host parasitism.	[Freire-de-Lima, Leonardo; Alisson-Silva, Frederico; Carvalho, Sebastiao T.; DosReis, George A.; Mendonca-Previato, Lucia; Previato, Jose O.; Todeschini, Adriane R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ilha Fundao, BR-21949900 Rio De Janeiro, Brazil; [Takiya, Christina M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Ciencias Saude, Ilha Fundao, BR-21949900 Rio De Janeiro, Brazil; [Rodrigues, Mauricio M.] Univ Fed Sao Paulo, Ctr Interdisciplinar Terapia Gen, BR-04044010 Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP)	Todeschini, AR (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ilha Fundao, Cidade Univ, BR-21949900 Rio De Janeiro, Brazil.	adrianet@biof.ufrj.br	Todeschini, Adriane Regina/ABC-9165-2020; da Silva, Frederico/AAY-4758-2021; Todeschini, Adriane/AAG-8128-2020; Takiya, Christina/AAU-5959-2021; da Silva, Frederico/X-7822-2018; Freire-de-Lima, Leonardo/I-1894-2012; Rodrigues, Mauricio M./B-8512-2012	Todeschini, Adriane Regina/0000-0002-6049-2751; da Silva, Frederico/0000-0001-6717-2518; Takiya, Christina/0000-0002-8019-628X; da Silva, Frederico/0000-0001-6717-2518; Freire-de-Lima, Leonardo/0000-0003-3013-3173; Mendonca Previato, Lucia/0000-0003-3927-3244; DosReis, George/0000-0002-8924-4727; Previato, Jose Osvaldo/0000-0002-9233-9954	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Apoio ao Desenvolvimento Cientifico e Tecnologico (PADCT)/World Bank/CNPq; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/PRONEX); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES/Cooperacao Universitaria e Cientifica com o Brasil (Cofecub); National Institute for Science and Technology in Vaccines	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio ao Desenvolvimento Cientifico e Tecnologico (PADCT)/World Bank/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/PRONEX)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES/Cooperacao Universitaria e Cientifica com o Brasil (Cofecub)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute for Science and Technology in Vaccines	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Programa de Apoio ao Desenvolvimento Cientifico e Tecnologico (PADCT)/World Bank/CNPq, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/PRONEX), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), CAPES/Cooperacao Universitaria e Cientifica com o Brasil (Cofecub), and the National Institute for Science and Technology in Vaccines.	Akha AAS, 2006, IMMUNOLOGY, V119, P187, DOI 10.1111/j.1365-2567.2006.02420.x; Amado M, 2004, J BIOL CHEM, V279, P36689, DOI 10.1074/jbc.M405629200; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; CHERVENAK R, 1982, THYMUS, V4, P61; CHUENKOVA M, 1995, J EXP MED, V181, P1693, DOI 10.1084/jem.181.5.1693; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CREMONA ML, 1995, GENE, V160, P123, DOI 10.1016/0378-1119(95)00175-6; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Dias WB, 2008, CELL MICROBIOL, V10, P88, DOI 10.1111/j.1462-5822.2007.01017.x; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Galvan M, 1998, J IMMUNOL, V161, P641; Garcia GG, 2005, EUR J IMMUNOL, V35, P622, DOI 10.1002/eji.200425538; Garg N, 1997, J IMMUNOL, V158, P3293; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; JONES AT, 1994, J IMMUNOL, V153, P3426; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kao C, 2005, INT IMMUNOL, V17, P1607, DOI 10.1093/intimm/dxh340; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Morrot A, 2004, IMMUNOL REV, V201, P291, DOI 10.1111/j.0105-2896.2004.00175.x; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; Ostberg JR, 1998, IMMUNOL TODAY, V19, P546, DOI 10.1016/S0167-5699(98)01343-7; Pace KE, 1999, J IMMUNOL, V163, P3801; Pappu BP, 2004, J IMMUNOL, V173, P275, DOI 10.4049/jimmunol.173.1.275; PEREIRA MEA, 1976, CARBOHYD RES, V51, P107; PREVIATO J O, 1990, Memorias do Instituto Oswaldo Cruz, V85, P38; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rossi M A, 1995, Sao Paulo Med J, V113, P750; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; TARLETON RL, 1990, J IMMUNOL, V144, P717; Todeschin AR, 2002, J BIOL CHEM, V277, P45962, DOI 10.1074/jbc.M203185200; Todeschini AR, 2004, J BIOL CHEM, V279, P5323, DOI 10.1074/jbc.M310663200; Todeschini AR, 2002, J IMMUNOL, V168, P5192, DOI 10.4049/jimmunol.168.10.5192; Todeschini AR, 2000, GLYCOBIOLOGY, V10, P213, DOI 10.1093/glycob/10.2.213; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; Tzelepis F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000393; VANDEKERCKHOVE F, 1992, GLYCOBIOLOGY, V2, P541, DOI 10.1093/glycob/2.6.541; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; WANG WC, 1988, J BIOL CHEM, V263, P4576	44	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13388	13396		10.1074/jbc.M109.096305	http://dx.doi.org/10.1074/jbc.M109.096305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20106975	Green Published, hybrid			2022-12-25	WOS:000276987700010
J	Chen, XQ; Zhu, HL; Yuan, M; Fu, J; Zhou, YQ; Ma, L				Chen, Xiaoqing; Zhu, Huiling; Yuan, Man; Fu, Jie; Zhou, Yuqing; Ma, Lan			G-protein-coupled Receptor Kinase 5 Phosphorylates p53 and Inhibits DNA Damage-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINUS; OPIOID RECEPTOR; DESENSITIZATION; GRK5; EXPRESSION; LOCALIZATION; PURIFICATION; PATHWAY; GROWTH; MEMBER	G-protein-coupled receptor kinases (GRKs) are an important family of Ser/Thr kinases that specifically phosphorylate and desensitize the activated receptor in response to environmental stimulation. Here we identify p53, a key tumor suppressor, as a novel GRK substrate in vivo, revealing a previously unknown function of GRKs in regulation of genome stability. Knockdown GRK5 in osteosarcoma cells inhibits DNA damage-induced apoptosis via a p53-mediated mechanism. Furthermore, GRK5, but not GRK2 or GRK6, phosphorylates p53 at Thr-55, which promotes the degradation of p53, leading to inhibition of p53-dependent apoptotic response to genotoxic damage. Consistently, the increase of p53 and irradiation-induced apoptosis were observed in GRK5-deficient mice. These results demonstrate GRK5 as a novel kinase of p53, as well as a negative regulator of p53-mediated signal transduction.	[Ma, Lan] Fudan Univ, State Key Lab Med Neurobiol & Pharmacol, Res Ctr, Shanghai Med Coll, Shanghai 200032, Peoples R China; Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Fu, Jie] Jiao Tong Univ, Hosp 6, Dept Radiat Oncol, Shanghai 200233, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Ma, L (corresponding author), Fudan Univ, State Key Lab Med Neurobiol & Pharmacol, Res Ctr, Shanghai Med Coll, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	lanma@fudan.edu.cn	Zhou, Yu/HHN-3071-2022; Ma, Lan/B-9295-2009	Ma, Lan/0000-0001-9034-5472	Ministry of Science and Technology [2009ZX09303-006, 2009ZX09301-011, 2009CB522000]; Natural Science Foundation of China [30830042, 30821002]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants from the Ministry of Science and Technology (Grants 2009ZX09303-006, 2009ZX09301-011, and 2009CB522000) and Natural Science Foundation of China (Grants 30830042 and 30821002).	Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Barthet G, 2009, EMBO J, V28, P2706, DOI 10.1038/emboj.2009.215; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GILGOMEZ G, 2003, METH MOL B, V282, P131; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Li JL, 2003, J BIOL CHEM, V278, P30219, DOI 10.1074/jbc.M302385200; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Suo Z, 2007, NEUROBIOL AGING, V28, P1873, DOI 10.1016/j.neurobiolaging.2006.08.013; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tiberi M, 1996, J BIOL CHEM, V271, P3771; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yi XP, 2005, ANAT REC PART A, V282A, P13, DOI 10.1002/ar.a.20143; Zhao J, 1997, BIOCHEM BIOPH RES CO, V238, P71, DOI 10.1006/bbrc.1997.7242	43	63	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12823	12830		10.1074/jbc.M109.094243	http://dx.doi.org/10.1074/jbc.M109.094243			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20124405	Green Published, hybrid			2022-12-25	WOS:000276787800040
J	Stuelsatz, P; Pouzoulet, F; Lamarre, Y; Dargelos, E; Poussard, S; Leibovitch, S; Cottin, P; Veschambre, P				Stuelsatz, Pascal; Pouzoulet, Frederic; Lamarre, Yann; Dargelos, Elise; Poussard, Sylvie; Leibovitch, Serge; Cottin, Patrick; Veschambre, Philippe			Down-regulation of MyoD by Calpain 3 Promotes Generation of Reserve Cells in C2C12 Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; MUSCLE-SPECIFIC CALPAIN; ADULT SKELETAL-MUSCLE; CREATINE-KINASE GENE; KAPPA-B PATHWAY; SATELLITE CELLS; IN-VIVO; DNA-BINDING; UBIQUITIN PATHWAY; TRANSGENIC MICE	Calpain 3 is a calcium-dependent cysteine protease that is primarily expressed in skeletal muscle and is implicated in limb girdle muscular dystrophy type 2A. To date, its best characterized function is located within the sarcomere, but this protease is found in other cellular compartments, which suggests that it exerts multiple roles. Here, we present evidence that calpain 3 is involved in the myogenic differentiation process. In the course of in vitro culture of myoblasts to fully differentiated myotubes, a population of quiescent undifferentiated "reserve cells" are maintained. These reserve cells are closely related to satellite cells responsible for adult muscle regeneration. In the present work, we observe that reserve cells express higher levels of endogenous Capn3 mRNA than proliferating myoblasts. We show that calpain 3 participates in the establishment of the pool of reserve cells by decreasing the transcriptional activity of the key myogenic regulator MyoD via proteolysis independently of the ubiquitin-proteasome degradation pathway. Our results identify calpain 3 as a potential new player in the muscular regeneration process by promoting renewal of the satellite cell compartment.	[Cottin, Patrick; Veschambre, Philippe] Univ Bordeaux 1, Unite Proteolyse Croissance & Dev Musculaire, INRA, USC 2009, F-33405 Talence, France; [Leibovitch, Serge] INRA UM II, Lab Genom Fonct & Myogenese, Differenciat Cellulaire & Croissance UMR866, F-34060 Montpellier, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; Universite de Montpellier	Veschambre, P (corresponding author), Univ Bordeaux 2, CNRS, UMR 5164, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	veschambre@enscbp.fr	stuelsatz, pascal/F-5735-2015; stuelsatz, pascal/AAQ-8778-2020; Lamarre, Yann/ABC-2074-2020	stuelsatz, pascal/0000-0001-7679-6410; Philippe, Veschambre/0000-0001-6094-6795; Pouzoulet, Frederic/0000-0003-4819-2876	Institut National de la Recherche Agronomique; Region Aquitaine; Association Francaise contre les Myopathies	Institut National de la Recherche Agronomique; Region Aquitaine(Region Nouvelle-Aquitaine); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by grants from the Institut National de la Recherche Agronomique, the Region Aquitaine, and the "Association Francaise contre les Myopathies."	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; AURADE F, 1994, DIFFERENTIATION, V55, P185, DOI 10.1046/j.1432-0436.1994.5530185.x; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Baroffio A, 1995, DIFFERENTIATION, V59, P259, DOI 10.1046/j.1432-0436.1995.5940259.x; Batonnet S, 2004, J BIOL CHEM, V279, P5413, DOI 10.1074/jbc.M310315200; Batonnet-Pichon S, 2006, EXP CELL RES, V312, P3999, DOI 10.1016/j.yexcr.2006.09.001; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Benayoun B, 2008, FASEB J, V22, P1521, DOI 10.1096/fj.07-8701com; Benchaouir R, 2004, EXP CELL RES, V294, P254, DOI 10.1016/j.yexcr.2003.11.005; BRUSTIS JJ, 1994, EUR J CELL BIOL, V64, P320; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; Chae J, 2001, NEUROMUSCULAR DISORD, V11, P547, DOI 10.1016/S0960-8966(01)00197-3; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Ciechanover A, 1999, MOL BIOL REP, V26, P59, DOI 10.1023/A:1006964122190; Combaret L, 2003, INT J BIOCHEM CELL B, V35, P676, DOI 10.1016/S1357-2725(02)00357-6; Cooper RN, 1999, J CELL SCI, V112, P2895; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; Duquet A, 2006, EMBO REP, V7, P1140, DOI 10.1038/sj.embor.7400820; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Herasse M, 1999, MOL CELL BIOL, V19, P4047; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2008, FEBS LETT, V582, P691, DOI 10.1016/j.febslet.2008.01.044; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poussard S, 1996, CELL GROWTH DIFFER, V7, P1461; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Rey MA, 2002, FEBS LETT, V532, P401, DOI 10.1016/S0014-5793(02)03722-5; Reynaud EG, 1999, MOL CELL BIOL, V19, P7621; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Seale P, 2004, DEV BIOL, V275, P287, DOI 10.1016/j.ydbio.2004.07.034; Shield MA, 1996, MOL CELL BIOL, V16, P5058; SMITH CK, 1994, J CELL PHYSIOL, V159, P379, DOI 10.1002/jcp.1041590222; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; SORIMACHI H, 1990, BIOL CHEM H-S, V371, P171; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; SORIMACHI H, 1992, BIOCHIM BIOPHYS ACTA, V1160, P55, DOI 10.1016/0167-4838(92)90037-E; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tintignac LA, 2000, EXP CELL RES, V259, P300, DOI 10.1006/excr.2000.4973; Tintignac LAJ, 2004, MOL CELL BIOL, V24, P1809, DOI 10.1128/MCB.24.4.1809-1821.2004; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	71	36	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12670	12683		10.1074/jbc.M109.063966	http://dx.doi.org/10.1074/jbc.M109.063966			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20139084	Green Published, hybrid			2022-12-25	WOS:000276787800026
J	Lachkar, S; Lebois, M; Steinmetz, MO; Guichet, A; Lal, N; Curmi, PA; Sobel, A; Ozon, S				Lachkar, Sylvie; Lebois, Marion; Steinmetz, Michel O.; Guichet, Antoine; Lal, Neha; Curmi, Patrick A.; Sobel, Andre; Ozon, Sylvie			Drosophila Stathmins Bind Tubulin Heterodimers with High and Variable Stoichiometries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAGE-SPECIFIC EXPRESSION; FAMILY PROTEINS; NERVOUS-SYSTEM; IN-VITRO; PHYLOGENETIC CONSERVATION; SUBCELLULAR-LOCALIZATION; SCG10-LIKE PROTEIN; PHOSPHOPROTEIN P19; CELL REGULATIONS; GOLGI-COMPLEX	In vertebrates, stathmins form a family of proteins possessing two tubulin binding repeats (TBRs), which each binds one soluble tubulin heterodimer. The stathmins thus sequester two tubulins in a phosphorylation-dependent manner, providing a link between signal transduction and microtubule dynamics. In Drosophila, we show here that a single stathmin gene (stai) encodes a family of D-stathmin proteins. Two of the D-stathmins are maternally deposited and then restricted to germ cells, and the other two are detected in the nervous system during embryo development. Like in vertebrates, the nervous system-enriched stathmins contain an N-terminal domain involved in subcellular targeting. All the D-stathmins possess a domain containing three or four predicted TBRs, and we demonstrate here, using complementary biochemical and biophysical methods, that all four predicted TBR domains actually bind tubulin. D-stathmins can indeed bind up to four tubulins, the resulting complex being directly visualized by electron microscopy. Phylogenetic analysis shows that the presence of regulated multiple tubulin sites is a conserved characteristic of stathmins in invertebrates and allows us to predict key residues in stathmin for the binding of tubulin. Altogether, our results reveal that the single Drosophila stathmin gene codes for a stathmin family similar to the multigene vertebrate one, but with particular tubulin binding properties.	[Sobel, Andre] UPMC, INSERM, Inst Moulin, UMR S 839, F-75005 Paris, France; [Lachkar, Sylvie; Lebois, Marion; Lal, Neha; Sobel, Andre; Ozon, Sylvie] INSERM, U839, F-75005 Paris, France; [Lebois, Marion; Lal, Neha] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, F-75013 Paris, France; [Curmi, Patrick A.] Univ Evry Val Essonne, INSERM, U829, F-91025 Evry, France; [Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Sobel, A (corresponding author), UPMC, INSERM, Inst Moulin, UMR S 839, 17 Rue Fer Moulin, F-75005 Paris, France.	andre.sobel@inserm.fr	CURMI, Patrick/G-4036-2013; Steinmetz, Michel O/AAA-3349-2022	Steinmetz, Michel O/0000-0001-6157-3687; CURMI, Patrick A./0000-0001-5045-8501	INSERM; Universite Pierre et Marie Curie (UPMC); Association pour la Recherche Contre le Cancer; Association Francaise Contre les Myopathies; Association pour la Recherche sur la Sclerose en Plaque; Agence Nationale pour la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie (UPMC); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur la Sclerose en Plaque; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by INSERM, the Universite Pierre et Marie Curie (UPMC), the Association pour la Recherche Contre le Cancer, the Association Francaise Contre les Myopathies, the Association pour la Recherche sur la Sclerose en Plaque, and the Agence Nationale pour la Recherche.	AMAT JA, 1991, DEV BRAIN RES, V60, P205, DOI 10.1016/0165-3806(91)90049-O; Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Balogh A, 1996, EXP CELL RES, V224, P8, DOI 10.1006/excr.1996.0106; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Charbaut E, 2005, J CELL SCI, V118, P2313, DOI 10.1242/jcs.02349; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Chauvin S, 2008, BIOL CELL, V100, P577, DOI 10.1042/BC20070119; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; DiPaolo G, 1997, J BIOL CHEM, V272, P5175, DOI 10.1074/jbc.272.8.5175; DOYE V, 1992, DIFFERENTIATION, V50, P89, DOI 10.1111/j.1432-0436.1992.tb00489.x; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Giampietro C, 2005, ENDOCRINOLOGY, V146, P1825, DOI 10.1210/en.2004-0972; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Guillaume E, 2001, MOL REPROD DEV, V60, P439, DOI 10.1002/mrd.1108; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Koppel J, 1999, MOL REPROD DEV, V53, P306; Larsson N, 1999, J CELL BIOL, V146, P1289, DOI 10.1083/jcb.146.6.1289; Lawler S, 1998, FEBS LETT, V421, P55, DOI 10.1016/S0014-5793(97)01519-6; Liedtke W, 2002, AM J PATHOL, V160, P469, DOI 10.1016/S0002-9440(10)64866-3; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Maekawa S, 2001, J BIOCHEM-TOKYO, V129, P691, DOI 10.1093/oxfordjournals.jbchem.a002908; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; MAUCUER A, 1990, FEBS LETT, V264, P275, DOI 10.1016/0014-5793(90)80266-L; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; MELHEM RF, 1991, BIOCHEM BIOPH RES CO, V179, P1649, DOI 10.1016/0006-291X(91)91764-4; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Ohkawa N, 2007, J CELL SCI, V120, P1447, DOI 10.1242/jcs.001461; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1999, J NEUROSCI RES, V56, P553, DOI 10.1002/(SICI)1097-4547(19990601)56:5<553::AID-JNR11>3.0.CO;2-J; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Poulain FE, 2008, J NEUROSCI, V28, P7387, DOI 10.1523/JNEUROSCI.1942-08.2008; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHUBART UK, 1992, DIFFERENTIATION, V51, P21, DOI 10.1111/j.1432-0436.1992.tb00676.x; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X	52	14	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11667	11680		10.1074/jbc.M109.096727	http://dx.doi.org/10.1074/jbc.M109.096727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145240	Green Published, hybrid			2022-12-25	WOS:000276286200071
J	Kupferman, ME; Jiffar, T; El-Naggar, A; Yilmaz, T; Zhou, G; Xie, T; Feng, L; Wang, J; Holsinger, FC; Yu, D; Myers, JN				Kupferman, M. E.; Jiffar, T.; El-Naggar, A.; Yilmaz, T.; Zhou, G.; Xie, T.; Feng, L.; Wang, J.; Holsinger, F. C.; Yu, D.; Myers, J. N.			TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma	ONCOGENE			English	Article						TrkB; squamous cell carcinoma; metastasis	EPITHELIAL-MESENCHYMAL TRANSITION; NEUROTROPHIC FACTOR ACTIVATION; PROTECTS NEUROBLASTOMA-CELLS; ORAL-CAVITY; CANCER STATISTICS; TUMOR PROGRESSION; RECEPTOR TRKA; IN-VITRO; EXPRESSION; METASTASIS	Head and neck squamous cell carcinoma (HNSCC) remains a significant public health problem, accounting for over 5% of all cancer-related deaths, and these deaths primarily result from metastatic disease. The molecular processes involved in HNSCC pathogenesis and progression are poorly understood, and here we present experimental evidence for a direct role of the cell surface receptor tyrosine kinase, TrkB, in HNSCC tumor progression. Using immunohistochemical analysis and transcriptional profiling of archival HNSCC tumor specimens, we found that TrkB and its secreted ligand, brain-derived neurotrophic factor (BDNF), are expresses in greater than 50% of human HNSCC tumors, but not in normal upper aerodigestive tract (UADT) epithelia. Studies with HNSCC cell lines reveal that in vitro stimulation with BDNF, the ligand for TrkB, upregulates the migration and invasion of HNSCC cells, and both transient and stable suppressions of TrkB result in significant abrogation of constitutive and ligand-mediated migration and invasion. Furthermore, enforced overexpression of TrkB results in altered expression of molecular mediators of epithelial-to-mesenchymal transition (EMT), including downregulation of E-cadherin and upregulation of Twist. Using an in vivo mouse model of HNSCC, we were able to show that downregulation of TrkB suppresses tumor growth. These results directly implicate TrkB in EMT and the invasive behavior of HNSCC, and correlate with the in vivo overexpression of TrkB in human HNSCC. Taken together, these data suggest that the TrkB receptor may be a critical component in the multi-step tumor progression of HNSCC, and may be an attractive target for much needed new therapies for this disease. Oncogene (2010) 29, 2047-2059; doi: 10.1038/onc.2009.486; published online 18 January 2010	[Kupferman, M. E.; Jiffar, T.; Yilmaz, T.; Zhou, G.; Xie, T.; Holsinger, F. C.; Myers, J. N.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [El-Naggar, A.] Dept Pathol, Houston, TX USA; [Feng, L.] Dept Biostat, Houston, TX USA; [Wang, J.] Dept Bioinformat, Houston, TX USA; [Yu, D.] Dept Mol & Cellular Oncol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center	Kupferman, ME (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, 1400 Pressler St Unit 1445, Houston, TX 77030 USA.	mekupfer@mdanderson.org		Wang, Jennifer Rui/0000-0002-0807-3832; Yu, Dihua/0000-0001-6231-9381	American Head and Neck Society; Young Investigator Award (MEK); MDACC (MEK); NIH [CA16672]; NIDCR (MEK) [K08 DE019185]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE019185] Funding Source: NIH RePORTER	American Head and Neck Society; Young Investigator Award (MEK); MDACC (MEK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR (MEK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank S Jasser, MS, for technical assistance, T Astin for administrative assistance and X Wu, PhD, for critical review of the paper. This study was supported by the following funding sources: American Head and Neck Society; Young Investigator Award (MEK); Head and Neck SPORE ProgramCareer Development Award, MDACC (MEK); and the MD Anderson Cancer Center Physician-Scientist Program (MEK). NIH Cancer Center Support Grant CA16672 (MDACC) and Grant K08 DE019185 from the NIDCR (MEK).	Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Armistead PM, 2007, CANCER, V110, P2293, DOI 10.1002/cncr.23038; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Chao MV, 2004, J ALZHEIMERS DIS, V6, pS7; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eggert A, 2000, KLIN PADIATR, V212, P200, DOI 10.1055/s-2000-9677; Eggert A, 2002, CANCER RES, V62, P1802; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Han G, 2005, J CLIN INVEST, V115, P1714, DOI 10.1172/JCI24399; Ho R, 2002, CANCER RES, V62, P6462; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jaboin J, 2002, CANCER RES, V62, P6756; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Karamouzis MV, 2007, JAMA-J AM MED ASSOC, V298, P70, DOI 10.1001/jama.298.1.70; Ketterer K, 2003, CLIN CANCER RES, V9, P5127; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; Kupferman ME, 2006, OTOLARYNG CLIN N AM, V39, P229, DOI 10.1016/j.otc.2005.11.003; Kupferman Michael E, 2009, J Exp Ther Oncol, V8, P117; Li Z, 2007, CELL DEATH DIFFER, V14, P318, DOI 10.1038/sj.cdd.4401983; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lu CH, 2007, CLIN CANCER RES, V13, P5883, DOI 10.1158/1078-0432.CCR-06-2837; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; MATSUMOTO K, 1995, CANCER RES, V55, P1798; Miknyoczki SJ, 1999, INT J CANCER, V81, P417, DOI 10.1002/(SICI)1097-0215(19990505)81:3<417::AID-IJC16>3.0.CO;2-6; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Nakashima T, 2000, BBA-GENE STRUCT EXPR, V1492, P441, DOI 10.1016/S0167-4781(00)00100-7; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929; Yigitbasi OG, 2004, CANCER RES, V64, P7977, DOI 10.1158/0008-5472.CAN-04-1477; Zhou G, 2008, ONCOGENE, V27, P3527, DOI 10.1038/sj.onc.1211015	41	147	150	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 8	2010	29	14					2047	2059		10.1038/onc.2009.486	http://dx.doi.org/10.1038/onc.2009.486			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101235	Green Accepted			2022-12-25	WOS:000276402800004
J	Aihara, T; Nakamura, M; Ueki, S; Hara, H; Miki, M; Arata, T				Aihara, Tomoki; Nakamura, Motoyoshi; Ueki, Shoji; Hara, Hideyuki; Miki, Masao; Arata, Toshiaki			Switch Action of Troponin on Muscle Thin Filament as Revealed by Spin Labeling and Pulsed EPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; HUMAN CARDIAC TROPONIN; ELECTRON-PARAMAGNETIC-RESONANCE; RABBIT SKELETAL TROPONIN; REGULATORY DOMAIN; CONFORMATIONAL-CHANGES; STRUCTURAL TRANSITION; TROPOMYOSIN COMPLEX; INHIBITORY REGION; TERMINAL REGION	We have used pulsed electron-electron double resonance (PELDOR) spectroscopy to measure the distance between spin labels at Cys(133) of the regulatory region of TnI (TnI133) and a native or genetically substituted cysteine of TnC (TnC44, TnC61, or TnC98). In the +Ca2+ state, the TnC44-TnI133-T distance was 42 angstrom, with a narrow distribution (half-width of 9 angstrom), suggesting that the regulatory region binds the N-lobe of TnC. Distances for TnC61-TnI133 and TnC98-TnI133 were also determined to be 38 angstrom (width of 12 angstrom) and 22 angstrom (width of 3.4 angstrom), respectively. These values were all consistent with recently published crystal structure (Vinogradova, M. V., Stone, D. B., Malanina, G. G., Karatzaferi, C., Cooke, R., Mendelson, R. A., and Fletterick, R. J. (2005) Proc. Natl Acad. Sci. U. S. A. 102, 50385043). Similar distances were obtained with the same spin pairs on a reconstituted thin filament in the +Ca2+ state. In the -Ca2+ state, the distances displayed broad distributions, suggesting that the regulatory region of TnI was physically released from the N-lobe of TnC and consequently fluctuated over a variety of distances on a large scale (20-80 angstrom). The interspin distance appeared longer on the filament than on troponin alone, consistent with the ability of the region to bind actin. These results support a concept that the regulatory region of TnI, as a molecular switch, binds to the exposed hydrophobic patch of TnC and traps the inhibitory region of TnI away from actin in Ca2+ activation of muscle.	Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; [Hara, Hideyuki] Bruker Biospin, Kanagawa 2150022, Japan; [Miki, Masao] Univ Fukui, Grad Sch Engn Sci, Div Appl Chem & Biotechnol, Fukui 9108507, Japan	Osaka University; Bruker Corporation; Bruker BioSpin GmbH; University of Fukui	Arata, T (corresponding author), Machikaneyama Cho 1-1, Osaka 5600043, Japan.	arata@bio.sci.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Japanese Science and Technology Cooperation, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Science and Technology Cooperation, Japan	This work was supported by grants-in-aid for Special Coordination Funds (to T. A. and M. M.) and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, and Core Research for Evolutional Science and Technology program from Japanese Science and Technology Cooperation, Japan (to T. A.).	Aihara T, 2006, BIOCHEM BIOPH RES CO, V340, P462, DOI 10.1016/j.bbrc.2005.12.030; Bacchiocchi C, 2002, BIOPHYS J, V82, P1524, DOI 10.1016/S0006-3495(02)75505-7; Blumenschein TMA, 2005, J BIOL CHEM, V280, P21924, DOI 10.1074/jbc.M500574200; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; CHONG PCS, 1982, J BIOL CHEM, V257, P2549; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; EBASHI S, 1968, J BIOCHEM-TOKYO, V64, P465, DOI 10.1093/oxfordjournals.jbchem.a128918; EBASHI S, 1974, J BIOCHEM-TOKYO, V75, P211, DOI 10.1093/oxfordjournals.jbchem.a130379; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; Ferguson RE, 2003, MOL CELL, V11, P865, DOI 10.1016/S1097-2765(03)00096-0; Fujiwara S, 2007, J MOL BIOL, V367, P16, DOI 10.1016/j.jmb.2006.12.072; Gergely J, 1998, ADV EXP MED BIOL, V453, P169; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; Kimura-Sakiyama C, 2008, J MOL BIOL, V376, P80, DOI 10.1016/j.jmb.2007.10.078; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; LEVINE BA, 1988, EUR J BIOCHEM, V172, P389, DOI 10.1111/j.1432-1033.1988.tb13899.x; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Luo Y, 1997, BIOCHEMISTRY-US, V36, P11027, DOI 10.1021/bi962461w; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; Matsuo N, 2002, J BIOCHEM, V131, P375, DOI 10.1093/oxfordjournals.jbchem.a003112; Maytum R, 2008, J BIOL CHEM, V283, P1902, DOI 10.1074/jbc.M708593200; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; McKay RT, 1997, J BIOL CHEM, V272, P28494, DOI 10.1074/jbc.272.45.28494; McKay RT, 1999, BIOCHEMISTRY-US, V38, P5478; Miki M, 1998, J BIOCHEM-TOKYO, V123, P1104; MIKI M, 1990, EUR J BIOCHEM, V187, P155, DOI 10.1111/j.1432-1033.1990.tb15289.x; Miki M, 1998, J BIOCHEM-TOKYO, V123, P324; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Nakamura M, 2005, J MOL BIOL, V348, P127, DOI 10.1016/j.jmb.2005.02.018; Narita A, 2001, J MOL BIOL, V308, P241, DOI 10.1006/jmbi.2001.4598; OJIMA T, 1988, J BIOCHEM-TOKYO, V104, P9, DOI 10.1093/oxfordjournals.jbchem.a122429; PARK HS, 1994, BIOPHYS J, V66, P2062, DOI 10.1016/S0006-3495(94)81000-8; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; POTTER JD, 1976, J BIOL CHEM, V251, P7551; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; ROSENFELD SS, 1985, J BIOL CHEM, V260, P252; Slupsky CM, 1995, BIOCHEMISTRY-US, V34, P15953, DOI 10.1021/bi00049a010; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sun YB, 2006, P NATL ACAD SCI USA, V103, P17771, DOI 10.1073/pnas.0605430103; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2798; TAO T, 1989, BIOCHEMISTRY-US, V28, P5902, DOI 10.1021/bi00440a029; TONOMURA Y, 1969, BIOCHEMISTRY-US, V8, P2171, DOI 10.1021/bi00833a058; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; Ueki S, 2005, BIOCHEMISTRY-US, V44, P411, DOI 10.1021/bi048110w; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; WAKABAYASHI T, 1975, J MOL BIOL, V93, P477, DOI 10.1016/0022-2836(75)90241-7; Wang H, 2008, BIOPHYS J, V94, P4358, DOI 10.1529/biophysj.107.121129; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535; ZOT HG, 1987, J MUSCLE RES CELL M, V8, P428, DOI 10.1007/BF01578432	57	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10671	10677		10.1074/jbc.M109.082925	http://dx.doi.org/10.1074/jbc.M109.082925			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139080	hybrid, Green Published			2022-12-25	WOS:000276264600054
J	Fougere, M; Gaudineau, B; Barbier, J; Guaddachi, F; Feugeas, JP; Auboeuf, D; Jauliac, S				Fougere, M.; Gaudineau, B.; Barbier, J.; Guaddachi, F.; Feugeas, J-P; Auboeuf, D.; Jauliac, S.			NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene	ONCOGENE			English	Article						NFAT3; LCN2; estrogen receptor alpha; motility; breast	GELATINASE-ASSOCIATED LIPOCALIN; ESTROGEN-RECEPTOR-ALPHA; T-CELLS; PANCREATIC-CANCER; NUCLEAR FACTOR; EXPRESSION; NGAL; IDENTIFICATION; INVASION; PROTEIN	NFAT1 and NFAT5 act as pro-invasive and promigratory transcription factors in breast carcinoma, contributing to the formation of metastases. We report that NFAT3 is specifically expressed in estrogen receptor a positive (ERA +) breast cancer cells. We show that NFAT3 inhibits by itself the invasion capacity of ERA + breast cancer cells and needs to cooperate with ERA to inhibit their migration. Conversely, NFAT3 downregulation results in actin reorganization associated with increased migration and invasion capabilities. NFAT3 signaling reduces migration through inhibition of Lipocalin 2 (LCN2) gene expression. Collectively, our study unravels an earlier unknown NFAT3/LCN2 axis that critically controls motility in breast cancer. Oncogene (2010) 29, 2292-2301; doi: 10.1038/onc.2009.499; published online 25 January 2010	[Fougere, M.; Gaudineau, B.; Guaddachi, F.; Feugeas, J-P; Jauliac, S.] Univ Paris Diderot, Hop St Louis, Inst Hematol, CNRS,UMR7212,INSERM,U944, F-75475 Paris 10, France; [Barbier, J.; Auboeuf, D.] Hop St Louis, INSERM, Inst Hematol, U685,AVENIR,Ctr Hayem, Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Jauliac, S (corresponding author), Univ Paris Diderot, Hop St Louis, Inst Hematol, CNRS,UMR7212,INSERM,U944, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.	sebastien.jauliac@inserm.fr	Jauliac, Sebastien/B-7847-2010; Auboeuf, Didier/M-4610-2014	Jauliac, Sebastien/0000-0002-1712-3416; Auboeuf, Didier/0000-0002-3757-0002	Conseil Regional d'Ile-de-France; Ministere de la Recherche; INSERM Region Ile-de-France; ARC; Canceropole Ile-de-France; Research Ministry; INSERM AVENIR; Ligue Nationale contre le Cancer; Comitede Paris of Ligue Nationale contre le Cancer; Comite Tumeurs de la Fondation de France	Conseil Regional d'Ile-de-France(Region Ile-de-France); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); INSERM Region Ile-de-France(Region Ile-de-France); ARC(Australian Research Council); Canceropole Ile-de-France(Region Ile-de-France); Research Ministry; INSERM AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Comitede Paris of Ligue Nationale contre le Cancer; Comite Tumeurs de la Fondation de France	We thank H de The, D Auboeuf and members of their laboratories for insightful discussions. We thank E Turpin, P Bertheau for providing their microarray data. We thank J L Poyet for providing the T7-pcDNA3 vector and G lazennec for the ER alpha expression vector. We thank T Hoey for providing the human NFAT3 expression vector. We thank J-C Gluckman for reading the paper. We thank N Setterblad at the Service Commun d'Imagerie Cellulaire et Moleculaire of the Institut Universitaire d'Hematologie IFR105 for confocal microscopy. The Service Commun d'Imagerie Cellulaire et Moleculaire is supported by grants from the Conseil Regional d'Ile-de-France and the Ministere de la Recherche. M Fougere was supported by a doctoral grant from INSERM Region Ile-de-France and an ARC fellowship. B Gaudineau was supported by a grant from the Canceropole Ile-de-France and J Barbier by a grant from the Research Ministry. This work was supported by the INSERM AVENIR Program and grants from Ligue Nationale contre le Cancer, the Comitede Paris of Ligue Nationale contre le Cancer, ARC, and the Comite Tumeurs de la Fondation de France and the Canceropole Ile-de-France.	Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Flower DR, 1996, BIOCHEM J, V318, P1; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Furutani M, 1998, CANCER LETT, V122, P209, DOI 10.1016/S0304-3835(97)00391-1; Gruvberger S, 2001, CANCER RES, V61, P5979; Gwira JA, 2005, J BIOL CHEM, V280, P7875, DOI 10.1074/jbc.M413192200; Hill-Eubanks DC, 2003, TRENDS CARDIOVAS MED, V13, P56, DOI 10.1016/S1050-1738(02)00212-8; Ho IC, 1998, P NATL ACAD SCI USA, V95, P15537, DOI 10.1073/pnas.95.26.15537; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Krueger JS, 2001, ONCOGENE, V20, P4209, DOI 10.1038/sj.onc.1204541; Leng X, 2008, ONCOGENE, V27, P6110, DOI 10.1038/onc.2008.209; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Li CI, 2001, J NATL CANCER I, V93, P1008, DOI 10.1093/jnci/93.13.1008; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Platet N, 2000, MOL ENDOCRINOL, V14, P999, DOI 10.1210/me.14.7.999; Playford RJ, 2006, GASTROENTEROLOGY, V131, P809, DOI 10.1053/j.gastro.2006.05.051; PRICE JE, 1990, CANCER RES, V50, P717; Provatopoulou X, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-390; Qin X, 2008, CELL MOL LIFE SCI, V65, P2752, DOI 10.1007/s00018-008-8273-1; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; THOMPSON EW, 1988, CANCER RES, V48, P6764; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhong L, 2004, PROTEOMICS, V4, P1216, DOI 10.1002/pmic.200200679	47	39	42	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	15					2292	2301		10.1038/onc.2009.499	http://dx.doi.org/10.1038/onc.2009.499			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101218				2022-12-25	WOS:000276685200014
J	Santo, L; Vallet, S; Hideshima, T; Cirstea, D; Ikeda, H; Pozzi, S; Patel, K; Okawa, Y; Gorgun, G; Perrone, G; Calabrese, E; Yule, M; Squires, M; Ladetto, M; Boccadoro, M; Richardson, PG; Munshi, NC; Anderson, KC; Raje, N				Santo, L.; Vallet, S.; Hideshima, T.; Cirstea, D.; Ikeda, H.; Pozzi, S.; Patel, K.; Okawa, Y.; Gorgun, G.; Perrone, G.; Calabrese, E.; Yule, M.; Squires, M.; Ladetto, M.; Boccadoro, M.; Richardson, P. G.; Munshi, N. C.; Anderson, K. C.; Raje, N.			AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3 beta activation and RNA polymerase II inhibition	ONCOGENE			English	Article						myeloma; cyclin-dependent kinase; GSK-3 beta; RNA pol II	GLYCOGEN-SYNTHASE KINASE-3; DOWN-REGULATION; CELL-CYCLE; PROTEIN-KINASE; SELICICLIB CYC202; R-ROSCOVITINE; CANCER-CELLS; KAPPA-B; TRANSCRIPTION; SURVIVAL	Dysregulated cell cycling is a universal hallmark of cancer and is often mediated by abnormal activation of cyclin-dependent kinases (CDKs) and their cyclin partners. Overexpression of individual complexes are reported in multiple myeloma (MM), making them attractive therapeutic targets. In this study, we investigate the preclinical activity of a novel small-molecule multi-CDK inhibitor, AT7519, in MM. We show the anti-MM activity of AT7519 displaying potent cytotoxicity and apoptosis; associated with in vivo tumor growth inhibition and prolonged survival. At the molecular level, AT7519 inhibited RNA polymerase II (RNA pol II) phosphorylation, a CDK9, 7 substrate, associated with decreased RNA synthesis confirmed by [(3)H] Uridine incorporation. In addition, AT7519 inhibited glycogen synthase kinase 3 beta (GSK-3 beta) phosphorylation; conversely pretreatment with a selective GSK-3 inhibitor and shRNA GSK-3 beta knockdown restored MM survival, suggesting the involvement of GSK-3 beta in AT7519-induced apoptosis. GSK-3 beta activation was independent of RNA pol II dephosphorylation confirmed by alpha-amanitin, a specific RNA pol II inihibitor, showing potent inhibition of RNA pol II phosphorylation without corresponding effects on GSK-3 beta phosphorylation. These results offer new insights into the crucial, yet controversial role of GSK-3 beta in MM and show significant anti-MM activity of AT7519, providing the rationale for its clinical evaluation in MM. Oncogene (2010) 29, 2325-2336; doi:10.1038/onc.2009.510; published online 25 January 2010	[Santo, L.; Vallet, S.; Hideshima, T.; Cirstea, D.; Ikeda, H.; Pozzi, S.; Okawa, Y.; Gorgun, G.; Perrone, G.; Calabrese, E.; Richardson, P. G.; Munshi, N. C.; Anderson, K. C.; Raje, N.] Harvard Univ, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Dis Ctr, Sch Med, Boston, MA 02115 USA; [Vallet, S.; Pozzi, S.; Patel, K.; Raje, N.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02115 USA; [Yule, M.; Squires, M.] Astex Therapeut Ltd, Cambridge, England; [Ladetto, M.; Boccadoro, M.] Univ Turin, Div Ematol, Turin, Italy	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Astex Pharmaceuticals; University of Turin	Santo, L (corresponding author), Harvard Univ, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Dis Ctr, Sch Med, 44 Binney St, Boston, MA 02115 USA.	loredana_santo@dfci.harvard.edu	Perrone, Giulia/L-4565-2017; Pozzi, Samantha/A-7617-2012; Vallet, Sonia/AHE-3935-2022; Munshi, Nikhil/ABE-2338-2021; ladetto, marco/AAA-5546-2022	Perrone, Giulia/0000-0002-4312-0577; Pozzi, Samantha/0000-0001-7917-1774; Vallet, Sonia/0000-0003-0146-8089; ladetto, marco/0000-0002-8283-2681; Boccadoro, Mario/0000-0001-8130-5209; Patel, Kishan/0000-0002-5526-2900	ASCO CDA; Multiple Myeloma Research Foundation (MMRF); International Myeloma Foundation (IMF); Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA100707, P01CA078378] Funding Source: NIH RePORTER	ASCO CDA; Multiple Myeloma Research Foundation (MMRF); International Myeloma Foundation (IMF); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by ASCO CDA, Multiple Myeloma Research Foundation (MMRF), International Myeloma Foundation (IMF) and Leukemia and Lymphoma Society Clinical Scholar Award.	Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Cai DP, 2006, CANCER RES, V66, P9270, DOI 10.1158/0008-5472.CAN-06-1758; Chauhan D, 1997, BLOOD, V89, P227, DOI 10.1182/blood.V89.1.227.227_227_234; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ely S, 2005, CANCER RES, V65, P11345, DOI 10.1158/0008-5472.CAN-05-2159; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; G-Amlak M, 2002, BIOCHEM BIOPH RES CO, V297, P760, DOI 10.1016/S0006-291X(02)02278-7; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Grimes CA, 2001, PROG NEUROBIOL, V65, P497, DOI 10.1016/S0301-0082(01)00024-7; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hideshima T, 2007, BRIT J HAEMATOL, V138, P783, DOI 10.1111/j.1365-2141.2007.06714.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; McInnes C, 2008, DRUG DISCOV TODAY, V13, P875, DOI 10.1016/j.drudis.2008.06.012; Menu E, 2008, CANCER RES, V68, P5519, DOI 10.1158/0008-5472.CAN-07-6404; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Nakagawa Y, 2006, AM J HEMATOL, V81, P824, DOI 10.1002/ajh.20656; Nekhai S, 2002, BIOCHEM J, V364, P649, DOI 10.1042/BJ20011191; Neri A, 2008, LEUKEMIA LYMPHOMA, V49, P1374, DOI 10.1080/10428190802078289; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Raje N, 2009, LEUKEMIA, V23, P961, DOI 10.1038/leu.2008.378; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Squires MS, 2009, MOL CANCER THER, V8, P324, DOI 10.1158/1535-7163.MCT-08-0890; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Tu YP, 2000, CANCER RES, V60, P6763; Vene R, 2008, CANCER RES, V68, P6987, DOI 10.1158/0008-5472.CAN-07-6362; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; WIELAND T, 1991, EXPERIENTIA, V47, P1186, DOI 10.1007/BF01918382; Wyatt PG, 2008, J MED CHEM, V51, P4986, DOI 10.1021/jm800382h; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885	45	100	105	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	16					2325	2336		10.1038/onc.2009.510	http://dx.doi.org/10.1038/onc.2009.510			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20101221	Green Accepted			2022-12-25	WOS:000276951500002
J	Yu, YL; Lee, P; Ke, YH; Zhang, YK; Yu, Q; Lee, J; Li, MZ; Song, JL; Chen, JG; Dai, JH; Do Couto, FJR; An, ZQ; Zhu, WM; Yu, GL				Yu, Yanlan; Lee, Pierre; Ke, Yaohuang; Zhang, Yongke; Yu, Qiu; Lee, Jonathan; Li, Mingzhen; Song, Jialiang; Chen, Jungang; Dai, Jihong; Do Couto, Fernando Jose Rebelo; An, Zhiqiang; Zhu, Weimin; Yu, Guo-Liang			A Humanized Anti-VEGF Rabbit Monoclonal Antibody Inhibits Angiogenesis and Blocks Tumor Growth in Xenograft Models	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; METASTATIC BREAST-CANCER; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; RECEPTOR-BINDING; PHAGE DISPLAY; KINASE DOMAIN; MOUSE; BEVACIZUMAB; AFFINITY	Rabbit antibodies have been widely used in research and diagnostics due to their high antigen specificity and affinity. Though these properties are also highly desirable for therapeutic applications, rabbit antibodies have remained untapped for human disease therapy. To evaluate the therapeutic potential of rabbit monoclonal antibodies (RabMAbs), we generated a panel of neutralizing RabMAbs against human vascular endothelial growth factor-A (VEGF). These neutralizing RabMAbs are specific to VEGF and do not cross-react to other members of the VEGF protein family. Guided by sequence and lineage analysis of a panel of neutralizing RabMAbs, we humanized the lead candidate by substituting non-critical residues with human residues within both the frameworks and the CDR regions. We showed that the humanized RabMAb retained its parental biological properties and showed potent inhibition of the growth of H460 lung carcinoma and A673 rhabdomyosarcoma xenografts in mice. These studies provide proof of principle for the feasibility of developing humanized RabMAbs as therapeutics.	[Yu, Yanlan] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Lee, Pierre; Ke, Yaohuang; Zhang, Yongke; Yu, Qiu; Lee, Jonathan; Do Couto, Fernando Jose Rebelo; An, Zhiqiang; Zhu, Weimin; Yu, Guo-Liang] Epitomics Inc, Burlingame, CA USA; [Li, Mingzhen; Song, Jialiang; Chen, Jungang; Dai, Jihong] Hangzhou Yikang Biotech Inc, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Yu, YL (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China.	zhiqiang.an@uth.tmc.edu		An, Zhiqiang/0000-0001-9309-2335				Aguayo A, 1999, BLOOD, V94, P3717, DOI 10.1182/blood.V94.11.3717.423k09_3717_3721; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; BYSTRYN JC, 1982, HYBRIDOMA, V1, P465, DOI 10.1089/hyb.1.1982.1.465; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; COUTO FJR, 2005, Patent No. 016950; COUTO FJRD, 2004, Patent No. 7462697; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Gerber HP, 2000, CANCER RES, V60, P6253; Groves DJ, 2000, HYBRIDOMA, V19, P201, DOI 10.1089/02724570050109602; HEIDMANN O, 1984, NATURE, V311, P74, DOI 10.1038/311074a0; High K, 2005, ANAL BIOCHEM, V347, P159, DOI 10.1016/j.ab.2005.09.007; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Huang XM, 1998, BIOCHEM BIOPH RES CO, V252, P643, DOI 10.1006/bbrc.1998.9717; Huang ZD, 2006, APPL IMMUNOHISTO M M, V14, P229, DOI 10.1097/01.pai.0000157906.38495.31; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Jakobovits A, 2007, NAT BIOTECHNOL, V25, P1134, DOI 10.1038/nbt1337; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Lu D, 2003, J BIOL CHEM, V278, P43496, DOI 10.1074/jbc.M307742200; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Oldham RK, 2008, J CLIN ONCOL, V26, P1774, DOI 10.1200/JCO.2007.15.7438; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Pytela R., 2008, United States patent, Patent No. [7, 429-487, 7429487, USP7429487]; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; ROGUSKA MA, 1994, P NATL ACAD SCI USA, V91, P969, DOI 10.1073/pnas.91.3.969; Rossi S, 2005, AM J CLIN PATHOL, V124, P295, DOI 10.1309/NR8HN08GDPVEMU08; Seo Y, 2000, CANCER, V88, P2239, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V; SHAMBLOTT MJ, 1989, EMBO J, V8, P3733, DOI 10.1002/j.1460-2075.1989.tb08549.x; Sitnikova T, 1998, MOL BIOL EVOL, V15, P617, DOI 10.1093/oxfordjournals.molbev.a025965; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Sugihara T, 1998, J BIOL CHEM, V273, P3033, DOI 10.1074/jbc.273.5.3033; Tao GZ, 2006, EXP CELL RES, V312, P411, DOI 10.1016/j.yexcr.2005.11.010; Velders MP, 1998, BRIT J CANCER, V78, P478, DOI 10.1038/bjc.1998.518; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; WELLER A, 1987, DEVELOPMENT, V100, P351; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; ZHU W, 2009, THERAPEUTIC MONOCLON, P889; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039; Zhu Z, 2003, LEUKEMIA, V17, P604, DOI 10.1038/sj.leu.2402831	56	47	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9072	10.1371/journal.pone.0009072	http://dx.doi.org/10.1371/journal.pone.0009072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140208	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442400011
J	Pandey, AK; Munjal, N; Datta, M				Pandey, Amit K.; Munjal, Neha; Datta, Malabika			Gene Expression Profiling and Network Analysis Reveals Lipid and Steroid Metabolism to Be the Most Favored by TNF alpha in HepG2 Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SQUALENE EPOXIDASE INHIBITOR; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; C/EBP-ALPHA; LIVER-REGENERATION; ADIPOSE-TISSUE; RECEPTOR; CHOLESTEROL; MICE	Background: The proinflammatory cytokine, TNF alpha, is a crucial mediator of the pathogenesis of several diseases, more so in cases involving the liver wherein it is critical in maintaining liver homeostasis since it is a major determiner of hepatocyte life and death. Gene expression profiling serves as an appropriate strategy to unravel the underlying signatures to envisage such varied responses and considering this, gene transcription profiling was examined in control and TNF alpha treated HepG2 cells. Methods and Findings: Microarray experiments between control and TNF alpha treated HepG2 cells indicated that TNF alpha could significantly alter the expression profiling of 140 genes; among those up-regulated, several GO (Gene Ontology) terms related to lipid and fat metabolism were significantly (p < 0.01) overrepresented indicating a global preference of fat metabolism within the hepatocyte and those within the down-regulated dataset included genes involved in several aspects of the immune response like immunoglobulin receptor activity and IgE binding thereby indicating a compromise in the immune defense mechanism(s). Conserved transcription factor binding sites were identified in identically clustered genes within a common GO term and SREBP-1 and FOXJ2 depicted increased occupation of their respective binding elements in the presence of TNF alpha. The interacting network of "lipid metabolism, small molecule biochemistry'' was derived to be significantly overrepresented that correlated well with the top canonical pathway of "biosynthesis of steroids''. Conclusions: TNF alpha alters the transcriptome profiling within HepG2 cells with an interesting catalog of genes being affected and those involved in lipid and steroid metabolism to be the most favored. This study represents a composite analysis of the effects of TNF alpha in HepG2 cells that encompasses the altered transcriptome profiling, the functional analysis of the up- and down- regulated genes and the identification of conserved transcription factor binding sites. These could possibly determine TNF alpha mediated alterations mainly the phenotypes of hepatic steatosis and fatty liver associated with several hepatic pathological states.	[Pandey, Amit K.; Munjal, Neha; Datta, Malabika] Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Pandey, AK (corresponding author), Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India.	mdatta@igib.res.in	Pandey, Amit Kumar/AAY-2887-2020	Pandey, Amit Kumar/0000-0002-8886-1694	Department of Science and Technology, New Delhi, India [SR/FT/L-21/2005]; Council of Scientific and Industrial Research, New Delhi, India [NWP0036]	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology, New Delhi, India (SR/FT/L-21/2005). N.M. and A. K. P. are thankful to the Task Force Project (NWP0036) from the Council of Scientific and Industrial Research, New Delhi, India for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Akobeng AK, 2008, ARCH DIS CHILD, V93, P787, DOI 10.1136/adc.2007.128751; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Berry M, 2007, CURR OPIN PHARMACOL, V7, P279, DOI 10.1016/j.coph.2007.03.001; Brenner D, 1998, J GASTROEN HEPATOL, V13, pS93; Cigana C, 2007, ANTIMICROB AGENTS CH, V51, P975, DOI 10.1128/AAC.01142-06; de Wit H, 1998, LEUKEMIA, V12, P363, DOI 10.1038/sj.leu.2400950; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Endo M, 2007, EXP BIOL MED, V232, P614; FEINGOLD KR, 1989, ENDOCRINOLOGY, V125, P267, DOI 10.1210/endo-125-1-267; FEINGOLD KR, 1988, BIOCHEM BIOPH RES CO, V153, P576, DOI 10.1016/S0006-291X(88)81134-3; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; Francoeur C, 2004, AM J PHYSIOL-GASTR L, V287, pG592, DOI 10.1152/ajpgi.00535.2003; Fulop T, 2006, PATHOL BIOL, V54, P375, DOI 10.1016/j.patbio.2006.07.002; Furuyama A, 2008, MATRIX BIOL, V27, P429, DOI 10.1016/j.matbio.2008.02.005; Gho JWM, 2008, CANCER RES, V68, P6743, DOI 10.1158/0008-5472.CAN-07-6469; Gomez-Ferreria MA, 2003, J MOL BIOL, V329, P631, DOI 10.1016/S0022-2836(03)00524-2; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Harada H, 1998, BIOCHIMIE, V80, P641, DOI 10.1016/S0300-9084(99)80017-0; Heyninck K, 2003, BIOCHEM PHARMACOL, V66, P1409, DOI 10.1016/S0006-2952(03)00491-X; HIDAKA Y, 1991, J BIOL CHEM, V266, P13171; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ishii KJ, 2008, CURR OPIN IMMUNOL, V20, P524, DOI 10.1016/j.coi.2008.07.002; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Kallinowski B, 1998, CLIN EXP IMMUNOL, V111, P269; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Katso RMT, 2000, CLIN CANCER RES, V6, P3271; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; Kudo M, 2004, ENDOCRINOLOGY, V145, P4948, DOI 10.1210/en.2004-0180; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Le Jossic-Corcos C, 2005, BIOCHEM J, V385, P787, DOI 10.1042/BJ20040933; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; Li Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-21; Liu XY, 2005, J INTERF CYTOK RES, V25, P617, DOI 10.1089/jir.2005.25.617; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Matzno S, 1997, J LIPID RES, V38, P1639; Mavri-Damelin Demetra, 2007, Int J Biochem Cell Biol, V39, P555, DOI 10.1016/j.biocel.2006.10.007; McClain CJ, 2004, AM J PHYSIOL-GASTR L, V287, pG497, DOI 10.1152/ajpgi.00171.2004; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; MEMON RA, 1993, ENDOCRINOLOGY, V132, P2246, DOI 10.1210/en.132.5.2246; Mulcahy B, 1996, AM J HUM GENET, V59, P676; MUTO Y, 1988, LANCET, V2, P72; Nee LE, 2004, KIDNEY INT, V66, P1376, DOI 10.1111/j.1523-1755.2004.00900.x; Nelson DR, 1997, DIGEST DIS SCI, V42, P2487, DOI 10.1023/A:1018804426724; Oberkofler H, 2002, BBA-GENE STRUCT EXPR, V1575, P75, DOI 10.1016/S0167-4781(02)00279-8; Overdier DG, 1997, J BIOL CHEM, V272, P13725, DOI 10.1074/jbc.272.21.13725; Pantelidis P, 2001, AM J RESP CRIT CARE, V163, P1432, DOI 10.1164/ajrccm.163.6.2006064; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Pedersen TA, 2007, EMBO J, V26, P1081, DOI 10.1038/sj.emboj.7601563; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao LP, 2006, ENDOCRINOLOGY, V147, P3060, DOI 10.1210/en.2005-1507; Qin BL, 2008, AM J PHYSIOL-GASTR L, V294, pG1120, DOI 10.1152/ajpgi.00407.2007; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Roderfeld M, 2006, LIVER INT, V26, P579, DOI 10.1111/j.1478-3231.2006.01271.x; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Sasaki M, 2000, MEDIAT INFLAMM, V9, P155, DOI 10.1080/09629350020002895; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; SATOH T, 1990, J LIPID RES, V31, P2095; Sharma S, 2006, AM J RESP CELL MOL, V35, P488, DOI 10.1165/rcmb.2006-0084OC; SHERON N, 1991, J HEPATOL, V12, P241, DOI 10.1016/0168-8278(91)90945-8; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shiraga T, 2005, EXP CELL RES, V308, P41, DOI 10.1016/j.yexcr.2005.04.008; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82; Tacer KF, 2007, PHYSIOL GENOMICS, V31, P216, DOI 10.1152/physiolgenomics.00264.2006; Teng L, 2008, DEVELOPMENT, V135, P1615, DOI 10.1242/dev.012179; Vock C, 2007, BBA-GEN SUBJECTS, V1770, P1283, DOI 10.1016/j.bbagen.2007.07.001; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Yap YL, 2005, NUCLEIC ACIDS RES, V33, P409, DOI 10.1093/nar/gki188; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zheng JS, 2003, NUCLEIC ACIDS RES, V31, P1995, DOI 10.1093/nar/gkg287	80	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9063	10.1371/journal.pone.0009063	http://dx.doi.org/10.1371/journal.pone.0009063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140224	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474400018
J	Serduc, R; Brauer-Krisch, E; Siegbahn, EA; Bouchet, A; Pouyatos, B; Carron, R; Pannetier, N; Renaud, L; Berruyer, G; Nemoz, C; Brochard, T; Remy, C; Barbier, EL; Bravin, A; Le Duc, G; Depaulis, A; Esteve, F; Laissue, JA				Serduc, Raphael; Braeuer-Krisch, Elke; Siegbahn, Erik A.; Bouchet, Audrey; Pouyatos, Benoit; Carron, Romain; Pannetier, Nicolas; Renaud, Luc; Berruyer, Gilles; Nemoz, Christian; Brochard, Thierry; Remy, Chantal; Barbier, Emmanuel L.; Bravin, Alberto; Le Duc, Geraldine; Depaulis, Antoine; Esteve, Francois; Laissue, Jean A.			High-Precision Radiosurgical Dose Delivery by Interlaced Microbeam Arrays of High-Flux Low-Energy Synchrotron X-Rays	PLOS ONE			English	Article							HUMAN-BRAIN MOTION; GAMMA-KNIFE RADIOSURGERY; RADIATION-THERAPY; CEREBROSPINAL-FLUID; STEREOTACTIC RADIOSURGERY; MICROPLANAR BEAMS; MOUSE-BRAIN; IN-VIVO; CHEMOTHERAPY; TUMORS	Microbeam Radiation Therapy (MRT) is a preclinical form of radiosurgery dedicated to brain tumor treatment. It uses micrometer-wide synchrotron-generated X-ray beams on the basis of spatial beam fractionation. Due to the radioresistance of normal brain vasculature to MRT, a continuous blood supply can be maintained which would in part explain the surprising tolerance of normal tissues to very high radiation doses (hundreds of Gy). Based on this well described normal tissue sparing effect of microplanar beams, we developed a new irradiation geometry which allows the delivery of a high uniform dose deposition at a given brain target whereas surrounding normal tissues are irradiated by well tolerated parallel microbeams only. Normal rat brains were exposed to 4 focally interlaced arrays of 10 microplanar beams (52 mu m wide, spaced 200 mu m on-center, 50 to 350 keV in energy range), targeted from 4 different ports, with a peak entrance dose of 200Gy each, to deliver an homogenous dose to a target volume of 7 mm(3) in the caudate nucleus. Magnetic resonance imaging follow-up of rats showed a highly localized increase in blood vessel permeability, starting 1 week after irradiation. Contrast agent diffusion was confined to the target volume and was still observed 1 month after irradiation, along with histopathological changes, including damaged blood vessels. No changes in vessel permeability were detected in the normal brain tissue surrounding the target. The interlacing radiation-induced reduction of spontaneous seizures of epileptic rats illustrated the potential pre-clinical applications of this new irradiation geometry. Finally, Monte Carlo simulations performed on a human-sized head phantom suggested that synchrotron photons can be used for human radiosurgical applications. Our data show that interlaced microbeam irradiation allows a high homogeneous dose deposition in a brain target and leads to a confined tissue necrosis while sparing surrounding tissues. The use of synchrotron-generated X-rays enables delivery of high doses for destruction of small focal regions in human brains, with sharper dose fall-offs than those described in any other conventional radiation therapy.	[Serduc, Raphael; Renaud, Luc] Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit, Toulouse, France; [Serduc, Raphael; Renaud, Luc] CNRS, CerCo, Toulouse, France; [Serduc, Raphael; Braeuer-Krisch, Elke; Bouchet, Audrey; Berruyer, Gilles; Nemoz, Christian; Brochard, Thierry; Bravin, Alberto; Le Duc, Geraldine] ESRF, Grenoble, France; [Siegbahn, Erik A.] Dept Med Phys, Stockholm, Sweden; [Pouyatos, Benoit; Pannetier, Nicolas; Remy, Chantal; Barbier, Emmanuel L.; Depaulis, Antoine; Esteve, Francois] INSERM, U836, Grenoble, France; [Pouyatos, Benoit; Pannetier, Nicolas; Remy, Chantal; Barbier, Emmanuel L.; Depaulis, Antoine; Esteve, Francois] Univ Grenoble 1, Inst Neurosci, UMR S836, Grenoble, France; [Carron, Romain] CHU Grenoble, Dept Neurosurg, F-38043 Grenoble, France; [Laissue, Jean A.] Univ Bern, Inst Pathol, Bern, Switzerland	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; European Synchrotron Radiation Facility (ESRF); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Bern	Serduc, R (corresponding author), Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit, Toulouse, France.	raph.serduc@gmail.com	Remy, Chantal/L-9459-2014; Bravin, Alberto/R-8633-2016; Audrey, Bouchet/AAR-5929-2021; Serduc, Raphael/D-6398-2017; Barbier, Emmanuel/E-6302-2011; Bravin, Alberto/AAN-6114-2020; Depaulis, Antoine/B-6098-2012; CARRON, Romain/D-5003-2014; bravin, alberto/B-4911-2008; Brauer-Krisch, Elke/O-6026-2017	Bravin, Alberto/0000-0001-6868-2755; Audrey, Bouchet/0000-0001-7228-8830; Serduc, Raphael/0000-0003-3294-8544; Barbier, Emmanuel/0000-0002-4952-1240; Bravin, Alberto/0000-0001-6868-2755; Depaulis, Antoine/0000-0001-6543-6700; Brauer-Krisch, Elke/0000-0003-4587-1160; Pannetier, Nicolas/0000-0002-0744-5155; Pouyatos, Benoit/0000-0001-6828-1257; Siegbahn, Albert/0000-0002-1491-487X	European Synchrotron Radiation Facility; Agence Nationale de la Recherche [ANR-06-BLAN-023803]	European Synchrotron Radiation Facility; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the European Synchrotron Radiation Facility and by a grant from Agence Nationale de la Recherche (ANR-06-BLAN-023803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett GH, 2007, J NEUROSURG, V106, P1, DOI 10.3171/jns.2007.106.1.1; Bartolomei F, 2008, NEUROLOGY, V70, P1658, DOI 10.1212/01.wnl.0000294326.05118.d8; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Brauer-Krisch E, 2005, NUCL INSTRUM METH A, V548, P69, DOI 10.1016/j.nima.2005.03.068; Curtis H J, 1967, Radiat Res Suppl, V7, P250, DOI 10.2307/3583718; Curtis H J, 1967, Radiat Res Suppl, V7, P258, DOI 10.2307/3583719; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Dilmanian F A, 2003, Cardiovasc Radiat Med, V4, P139, DOI 10.1016/S1522-1865(03)00180-X; Dilmanian FA, 2007, EXP HEMATOL, V35, P69, DOI 10.1016/j.exphem.2007.01.014; Dilmanian FA, 2006, P NATL ACAD SCI USA, V103, P9709, DOI 10.1073/pnas.0603567103; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; ENZMANN DR, 1992, RADIOLOGY, V185, P653, DOI 10.1148/radiology.185.3.1438741; FEINBERG DA, 1992, RADIOLOGY, V185, P630, DOI 10.1148/radiology.185.3.1438734; FEINBERG DA, 1987, RADIOLOGY, V163, P793, DOI 10.1148/radiology.163.3.3575734; Fuss M, 2000, INT J RADIAT ONCOL, V48, P53, DOI 10.1016/S0360-3016(00)00590-3; Kondziolka D., 2008, NEUROSURGERY S2, V62, P719; Kondziolka D, 2008, NEUROSURGERY, V62, P707, DOI [10.1227/01.NEU.0000296953.45771.66, 10.1227/01.neu.0000316275.12962.0e]; LAISSUE J, 2003, PRECLINICAL MICROBEA; Laissue JA, 2007, DEV MED CHILD NEUROL, V49, P577, DOI 10.1111/j.1469-8749.2007.00577.x; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; LAISSUE JA, 2001, WEANLING PIGLET CERE, P65; LEKSELL L, 1951, ACTA CHIR SCAND, V102, P316; Levegrun S, 2004, INT J RADIAT ONCOL, V59, P796, DOI 10.1016/j.ijrobp.2003.11.033; Lonardi S, 2005, CANCER TREAT REV, V31, P79, DOI 10.1016/j.ctrv.2004.12.005; Ohye C, 2009, PROG NEUROL SURG, V22, P170, DOI 10.1159/000163416; Pattany PM, 2002, AM J NEURORADIOL, V23, P225; Pena LA, 2000, CANCER RES, V60, P321; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Pollock BE, 1998, NEUROSURGERY, V42, P1239, DOI 10.1097/00006123-199806000-00020; PONCELET BP, 1992, RADIOLOGY, V185, P645, DOI 10.1148/radiology.185.3.1438740; Qin DX, 2001, INT J RADIAT ONCOL, V51, P959, DOI 10.1016/S0360-3016(01)01735-7; Regis J, 2008, NEUROCHIRURGIE, V54, P320, DOI 10.1016/j.neuchi.2008.02.016; REIDY MA, 1981, LAB INVEST, V44, P301; Renier M, 2002, NUCL INSTRUM METH A, V479, P656, DOI 10.1016/S0168-9002(01)00905-6; Salvat F., 2019, WORK P; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; SERDUC R, 2009, PHYS MED BI IN PRESS; SERDUC R, 2006, THESIS U J FOURIER G; Serduc R, 2008, PHYS MED BIOL, V53, P3609, DOI 10.1088/0031-9155/53/13/015; Serduc R, 2008, PHYS MED BIOL, V53, P1153, DOI 10.1088/0031-9155/53/5/001; Serizawa T, 2009, INT J CLIN ONCOL, V14, P289, DOI 10.1007/s10147-009-0910-7; Serizawa T, 2008, J NEUROSURG, V109, P118, DOI 10.3171/JNS/2008/109/12/S18; Siegbahn EA, 2006, MED PHYS, V33, P3248, DOI 10.1118/1.2229422; Siegbahn EA, 2009, MED PHYS, V36, P1128, DOI 10.1118/1.3081934; Sims E, 1999, CLIN ONCOL-UK, V11, P303, DOI 10.1053/clon.1999.9073; SLATKIN DN, 1992, MED PHYS, V19, P1395, DOI 10.1118/1.596771; SLATKIN DN, 1994, METHOD MICROBEAM RAD; Soellinger M, 2007, J MAGN RESON IMAGING, V25, P709, DOI 10.1002/jmri.20882; St George EJ, 2002, J NEUROSURG, V97, P631; Strik C, 2002, J MAGN RESON IMAGING, V15, P251, DOI 10.1002/jmri.10084; Sundgren PC, 2006, MAGN RESON IMAGING, V24, P1131, DOI 10.1016/j.mri.2006.07.008; Thomlinson W, 2000, CELL MOL BIOL, V46, P1053; van Vulpen M, 2002, ONCOL REP, V9, P683; ZEMAN W, 1961, RADIAT RES, V15, P496, DOI 10.2307/3571293	54	74	75	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9028	10.1371/journal.pone.0009028	http://dx.doi.org/10.1371/journal.pone.0009028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140254	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474200014
J	Antic, D; Stubbs, JL; Suyama, K; Kintner, C; Scott, MP; Axelrod, JD				Antic, Dragana; Stubbs, Jennifer L.; Suyama, Kaye; Kintner, Chris; Scott, Matthew P.; Axelrod, Jeffrey D.			Planar Cell Polarity Enables Posterior Localization of Nodal Cilia and Left-Right Axis Determination during Mouse and Xenopus Embryogenesis	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; NEURAL-TUBE CLOSURE; INNER-EAR; POLARIZATION; ZEBRAFISH; NEURULATION; MECHANISMS; EXTENSION; DIVISION; MAMMALS	Left-right asymmetry in vertebrates is initiated in an early embryonic structure called the ventral node in human and mouse, and the gastrocoel roof plate (GRP) in the frog. Within these structures, each epithelial cell bears a single motile cilium, and the concerted beating of these cilia produces a leftward fluid flow that is required to initiate left-right asymmetric gene expression. The leftward fluid flow is thought to result from the posterior tilt of the cilia, which protrude from near the posterior portion of each cell's apical surface. The cells, therefore, display a morphological planar polarization. Planar cell polarity (PCP) is manifested as the coordinated, polarized orientation of cells within epithelial sheets, or as directional cell migration and intercalation during convergent extension. A set of evolutionarily conserved proteins regulates PCP. Here, we provide evidence that vertebrate PCP proteins regulate planar polarity in the mouse ventral node and in the Xenopus gastrocoel roof plate. Asymmetric anterior localization of VANGL1 and PRICKLE2 (PK2) in mouse ventral node cells indicates that these cells are planar polarized by a conserved molecular mechanism. A weakly penetrant Vangl1 mutant phenotype suggests that compromised Vangl1 function may be associated with left-right laterality defects. Stronger functional evidence comes from the Xenopus GRP, where we show that perturbation of VANGL2 protein function disrupts the posterior localization of motile cilia that is required for leftward fluid flow, and causes aberrant expression of the left side-specific gene Nodal. The observation of anterior-posterior PCP in the mouse and in Xenopus embryonic organizers reflects a strong evolutionary conservation of this mechanism that is important for body plan determination.	[Antic, Dragana; Axelrod, Jeffrey D.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Antic, Dragana; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Antic, Dragana; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Antic, Dragana; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Stubbs, Jennifer L.; Kintner, Chris] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Salk Institute	Antic, D (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	mscott@stanford.edu; jaxelrod@stanford.edu			Howard Hughes Medical Institute [R01 GM059823, RO1 GM076507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059823, R01GM076507] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM059823 (J. D. A.), by RO1 GM076507 (C. K.) and by the Howard Hughes Medical Institute. M. P. S. is an Investigator of the H. H. M. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Blum M, 2009, DEV DYNAM, V238, P1215, DOI 10.1002/dvdy.21855; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Crompton LA, 2007, DEV DYNAM, V236, P3137, DOI 10.1002/dvdy.21338; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HASHIMOTO M, NAT CELL BI IN PRESS; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Jiang D, 2005, CURR BIOL, V15, P79; Kaufman M.H., 1992, ATLAS MOUSE DEV; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Sive HL, 1998, EARLY DEV XENOPUS LA; Strutt H, 2009, SEMIN CELL DEV BIOL, V20, P957, DOI 10.1016/j.semcdb.2009.03.006; Stubbs JL, 2006, DEVELOPMENT, V133, P2507, DOI 10.1242/dev.02417; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vick P, 2009, DEV BIOL, V331, P281, DOI 10.1016/j.ydbio.2009.05.547; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	41	123	127	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e8999	10.1371/journal.pone.0008999	http://dx.doi.org/10.1371/journal.pone.0008999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126399	Green Submitted, Green Published, gold			2022-12-25	WOS:000274207200003
J	Batters, C; Zhu, HN; Sale, JE				Batters, Christopher; Zhu, Hannah; Sale, Julian E.			Visualisation of PCNA Monoubiquitination In Vivo by Single Pass Spectral Imaging FRET Microscopy	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; RESONANCE ENERGY-TRANSFER; DNA-DAMAGE TOLERANCE; CROSS-LINK REPAIR; UBIQUITIN CONJUGATION; TRANSLESION SYNTHESIS; FLUORESCENT PROTEINS; GENOMIC INSTABILITY; LIVING CELLS; HUMAN SHPRH	Monoubiquitination of the DNA sliding clamp, PCNA, plays a central role in the control of damage bypass during replication. By combining a widely-spaced FRET donor/acceptor pair (CFP and mRFP) with spectral imaging, we have developed a simple method for the visualisation of PCNA monoubiquitination in both fixed and live cells with a single imaging pass. We validate the method with genetic controls in the avian cell line DT40 and use it to examine the intracellular dynamics of PCNA ubiquitination following subnuclear UV irradiation. This general approach is likely to be of utility for live imaging of post-translational modifications of a wide range of substrates in vivo.	[Zhu, Hannah] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Batters, C (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-8000 Munich, Germany.	jes@mrc-lmb.cam.ac.uk		Sale, Julian/0000-0002-5031-3780	Association for International Cancer Research [05-160, 08-0017]; Medical Research Council [U.1051.03.012.00001.01]; Medical Research Council [MC_U105178808] Funding Source: researchfish; MRC [MC_U105178808] Funding Source: UKRI	Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Association for International Cancer Research (www.aicr.org.uk) Project grants 05-160 and 08-0017. Medical Research Council U.1051.03.012.00001.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen Y, 2007, J MICROSC-OXFORD, V228, P139, DOI 10.1111/j.1365-2818.2007.01838.x; Dinant C, 2008, J MICROSC-OXFORD, V231, P97, DOI 10.1111/j.1365-2818.2008.02020.x; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; FRAMPTON J, 2006, MOL BIOL CELL; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Gillespie David A F, 2006, Subcell Biochem, V40, P359; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hiraoka Y, 2002, CELL STRUCT FUNCT, V27, P367, DOI 10.1247/csf.27.367; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Megias D, 2009, MICROSC RES TECHNIQ, V72, P1, DOI 10.1002/jemt.20633; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Rasband W., 2006, IMAGEJ; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Simpson LJ, 2006, EMBO REP, V7, P927, DOI 10.1038/sj.embor.7400777; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9008	10.1371/journal.pone.0009008	http://dx.doi.org/10.1371/journal.pone.0009008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126408	Green Published, gold, Green Submitted			2022-12-25	WOS:000274207200007
J	Mangone, M; Myers, MP; Herr, W				Mangone, Marco; Myers, Michael P.; Herr, Winship			Role of the HCF-1 Basic Region in Sustaining Cell Proliferation	PLOS ONE			English	Article							MAMMALIAN-CELLS; VP16; PROTEIN; FAMILY; CYTOKINESIS; ASSOCIATION; SEPARATE; POLYPEPTIDES; PROGRESSION; ACTIVATION	Background: The human herpes simplex virus-associated host cell factor 1 (HCF-1) is a conserved human transcriptional coregulator that links positive and negative histone modifying activities with sequence-specific DNA-binding transcription factors. It is synthesized as a 2035 amino acid precursor that is cleaved to generate an amino- (HCF-1(N)) terminal subunit, which promotes G1-to-S phase progression, and a carboxy- (HCF-1(C)) terminal subunit, which controls multiple aspects of cell division during M phase. The HCF-1(N) subunit contains a Kelch domain that tethers HCF-1 to sequence-specific DNA-binding transcription factors, and a poorly characterized so called "Basic'' region (owing to a high ratio of basic vs. acidic amino acids) that is required for cell proliferation and has been shown to associate with the Sin3 histone deacetylase (HDAC) component. Here we studied the role of the Basic region in cell proliferation and G1-to-S phase transition assays. Methodology/Principal Findings: Surprisingly, much like the transcriptional activation domains of sequence-specific DNA-binding transcription factors, there is no unique sequence within the Basic region required for promoting cell proliferation or G1-to-S phase transition. Indeed, the ability to promote these activities is size dependent such that the shorter the Basic region segment the less activity observed. We find, however, that the Basic region requirements for promoting cell proliferation in a temperature-sensitive tsBN67 cell assay are more stringent than for G1-to-S phase progression in an HCF-1 siRNA-depletion HeLa-cell assay. Thus, either half of the Basic region alone can support G1-to-S phase progression but not cell proliferation effectively in these assays. Nevertheless, the Basic region displays considerable structural plasticity because each half is able to promote cell proliferation when duplicated in tandem. Consistent with a potential role in promoting cell-cycle progression, the Sin3a HDAC component can associate independently with either half of the Basic region fused to the HCF-1 Kelch domain. Conclusions/Significance: While conserved, the HCF-1 Basic region displays striking structural flexibility for controlling cell proliferation.	[Mangone, Marco; Myers, Michael P.; Herr, Winship] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Mangone, M (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	winship.herr@unil.ch	Herr, Winship/E-6491-2012; Mangone, Marco/H-2462-2016	Herr, Winship/0000-0002-3606-4546; Mangone, Marco/0000-0001-7551-8793	National Institutes of Health (NIH); Swiss National Science Foundation; University of Lausanne	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne	These studies were supported by the National Institutes of Health (NIH), the Swiss National Science Foundation, Oncosuisse, and the University of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Knez J, 2006, MOL CELL BIOCHEM, V288, P79, DOI 10.1007/s11010-006-9122-x; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001213; Mahajan SS, 2000, MOL CELL BIOL, V20, P919, DOI 10.1128/MCB.20.3.919-928.2000; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NISHIMOTO T, 1980, SOMAT CELL GENET, V6, P465, DOI 10.1007/BF01539150; Reilly PT, 2002, EXP CELL RES, V277, P119, DOI 10.1006/excr.2002.5551; Reilly PT, 2002, MOL CELL BIOL, V22, P6767, DOI 10.1128/MCB.22.19.6767-6778.2002; TYAGI S, 2009, EMBO J IN PRESS; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Wilson AC, 2000, MOL CELL BIOL, V20, P6721, DOI 10.1128/MCB.20.18.6721-6730.2000; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103	23	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9020	10.1371/journal.pone.0009020	http://dx.doi.org/10.1371/journal.pone.0009020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126307	Green Published, gold, Green Accepted			2022-12-25	WOS:000274207200015
J	Perez-Costas, E; Gandy, JC; Melendez-Ferro, M; Roberts, RC; Bijur, GN				Perez-Costas, Emma; Gandy, Johanna C.; Melendez-Ferro, Miguel; Roberts, Rosalinda C.; Bijur, Gautam N.			Light and Electron Microscopy Study of Glycogen Synthase Kinase-3 beta in the Mouse Brain	PLOS ONE			English	Article							PROTEIN-KINASE-I; DIFFERENTIAL REGULATION; ALZHEIMERS-DISEASE; TAU; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; INHIBITION; GSK-3-BETA; ACTIVATION	Glycogen synthase kinase-3 beta (GSK3 beta) is highly abundant in the brain. Various biochemical analyses have indicated that GSK3 beta is localized to different intracellular compartments within brain cells. However, ultrastructural visualization of this kinase in various brain regions and in different brain cell types has not been reported. The goal of the present study was to examine GSK3 beta distribution and subcellular localization in the brain using immunohistochemistry combined with light and electron microscopy. Initial examination by light microscopy revealed that GSK3 beta is expressed in brain neurons and their dendrites throughout all the rostrocaudal extent of the adult mouse brain, and abundant GSK3 beta staining was found in the cortex, hippocampus, basal ganglia, the cerebellum, and some brainstem nuclei. Examination by transmission electron microscopy revealed highly specific subcellular localization of GSK3 beta in neurons and astrocytes. At the subcellular level, GSK3 beta was present in the rough endoplasmic reticulum, free ribosomes, and mitochondria of neurons and astrocytes. In addition GSK3 beta was also present in dendrites and dendritic spines, with some postsynaptic densities clearly labeled for GSK3 beta. Phosphorylation at serine-9 of GSK3 beta (pSer9GSK3 beta) reduces kinase activity. pSer9GSK3 beta labeling was present in all brain regions, but the pattern of staining was clearly different, with an abundance of labeling in microglia cells in all regions analyzed and much less neuronal staining in the subcortical regions. At the subcellular level pSer9GSK3 beta labeling was located in the endoplasmic reticulum, free ribosomes and in some of the nuclei. Overall, in normal brains constitutively active GSK3 beta is predominantly present in neurons while pSer9GSK3 beta is more evident in resting microglia cells. This visual assessment of GSK3 beta localization within the subcellular structures of various brain cells may help in understanding the diverse role of GSK3 beta signaling in the brain.	[Perez-Costas, Emma; Gandy, Johanna C.; Melendez-Ferro, Miguel; Roberts, Rosalinda C.; Bijur, Gautam N.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Perez-Costas, E (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	gautam@uab.edu		PEREZ-COSTAS, EMMA/0000-0002-9050-9593; Pasek, Johanna/0000-0003-1300-6164	National Institutes of Health (NIH) [NS044853, MH66123, MH60744]; University of Alabama at Birmingham Neuroscience Core [NS47466]; Cellular and Molecular Biology Program [GM008111]; Civitan International Research Center Emerging Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066123, R01MH060744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, R01NS044853] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Neuroscience Core; Cellular and Molecular Biology Program; Civitan International Research Center Emerging Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants NS044853 to GNB, MH66123 and MH60744 to RCR, and the University of Alabama at Birmingham Neuroscience Core grant NS47466. JCG is supported by the Cellular and Molecular Biology Program training grant GM008111 and the Civitan International Research Center Emerging Scholars Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimohamad H, 2005, BIOL PSYCHIAT, V57, P533, DOI 10.1016/j.biopsych.2004.11.036; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Sarno P, 2006, NEUROBIOL AGING, V27, P413, DOI 10.1016/j.neurobiolaging.2005.03.003; EldarFinkelman H, 1996, P NATL ACAD SCI USA, V93, P10228, DOI 10.1073/pnas.93.19.10228; Elyaman W, 2002, EUR J NEUROSCI, V15, P651, DOI 10.1046/j.1460-9568.2002.01899.x; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Ferrer I, 2002, ACTA NEUROPATHOL, V104, P583, DOI 10.1007/s00401-002-002-0587-8; GOODE N, 1992, J BIOL CHEM, V267, P16878; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HEMMINGS BA, 1981, EUR J BIOCHEM, V119, P443, DOI 10.1111/j.1432-1033.1981.tb05628.x; Hernandez F, 2008, FEBS LETT, V582, P3848, DOI 10.1016/j.febslet.2008.10.026; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; HOSHI M, 1995, J BIOCHEM-TOKYO, V118, P683, DOI 10.1093/oxfordjournals.jbchem.a124965; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Kim H, 2007, J COMPUT-MEDIAT COMM, V12, P1183, DOI 10.1111/j.1083-6101.2007.00369.x; King TD, 2008, NEUROTOX RES, V14, P367, DOI 10.1007/BF03033861; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kozlovsky N, 2000, AM J PSYCHIAT, V157, P831, DOI 10.1176/appi.ajp.157.5.831; Lee SJ, 2006, NEUROSCI LETT, V409, P134, DOI 10.1016/j.neulet.2006.09.026; Leroy K, 2002, ACTA NEUROPATHOL, V103, P91; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Pandey GN, 2009, NEUROCHEM RES, V34, P274, DOI 10.1007/s11064-008-9770-1; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Petit-Paitel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005491; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; Rowe MK, 2007, NEUROSCI BIOBEHAV R, V31, P920, DOI 10.1016/j.neubiorev.2007.03.002; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; Shiurba RA, 1996, BRAIN RES, V737, P119, DOI 10.1016/0006-8993(96)00717-2; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Takahashi M, 2000, BRAIN RES, V857, P193, DOI 10.1016/S0006-8993(99)02424-5; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Yuskaitis CJ, 2009, CELL SIGNAL, V21, P264, DOI 10.1016/j.cellsig.2008.10.014; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	56	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8911	10.1371/journal.pone.0008911	http://dx.doi.org/10.1371/journal.pone.0008911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111716	Green Published, gold, Green Submitted			2022-12-25	WOS:000274114800014
J	Huang, Y; Pastor, WA; Shen, YH; Tahiliani, M; Liu, DR; Rao, A				Huang, Yun; Pastor, William A.; Shen, Yinghua; Tahiliani, Mamta; Liu, David R.; Rao, Anjana			The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA METHYLATION; TET2 MUTATIONS; CYTOSINE METHYLATION; MAMMALIAN DEVELOPMENT; MLL RECOMBINOME; EUKARYOTIC DNA; THYMINE GLYCOL; CPG SEQUENCES; CANCER	Background: We recently showed that enzymes of the TET family convert 5-mC to 5-hydroxymethylcytosine (5-hmC) in DNA. 5-hmC is present at high levels in embryonic stem cells and Purkinje neurons. The methylation status of cytosines is typically assessed by reaction with sodium bisulfite followed by PCR amplification. Reaction with sodium bisulfite promotes cytosine deamination, whereas 5-methylcytosine (5-mC) reacts poorly with bisulfite and is resistant to deamination. Since 5-hmC reacts with bisulfite to yield cytosine 5-methylenesulfonate (CMS), we asked how DNA containing 5-hmC behaves in bisulfite sequencing. Methodology/Principal Findings: We used synthetic oligonucleotides with different distributions of cytosine as templates for generation of DNAs containing C, 5-mC and 5-hmC. The resulting DNAs were subjected in parallel to bisulfite treatment, followed by exposure to conditions promoting cytosine deamination. The extent of conversion of 5-hmC to CMS was estimated to be 99.7%. Sequencing of PCR products showed that neither 5-mC nor 5-hmC undergo C-to-T transitions after bisulfite treatment, confirming that these two modified cytosine species are indistinguishable by the bisulfite technique. DNA in which CMS constituted a large fraction of all bases (28/201) was much less efficiently amplified than DNA in which those bases were 5-mC or uracil (the latter produced by cytosine deamination). Using a series of primer extension experiments, we traced the inefficient amplification of CMS-containing DNA to stalling of Taq polymerase at sites of CMS modification, especially when two CMS bases were either adjacent to one another or separated by 1-2 nucleotides. Conclusions: We have confirmed that the widely used bisulfite sequencing technique does not distinguish between 5-mC and 5-hmC. Moreover, we show that CMS, the product of bisulfite conversion of 5-hmC, tends to stall DNA polymerases during PCR, suggesting that densely hydroxymethylated regions of DNA may be underrepresented in quantitative methylation analyses.	[Huang, Yun; Pastor, William A.; Tahiliani, Mamta; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Huang, Yun; Pastor, William A.; Tahiliani, Mamta; Rao, Anjana] Immune Dis Inst, Boston, MA USA; [Shen, Yinghua; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shen, Yinghua; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard University; Howard Hughes Medical Institute	Huang, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arao@idi.harvard.edu	Liu, David R./HCH-3132-2022	Huang, Yun/0000-0001-5950-9168	National Institutes of Health (NIH) [R01 AI044432, RC1 DA028422]; Juvenile Diabetes Research Foundation; Howard Hughes Medical Institute; NIH/National Institute of General Medical Sciences (NIGMS) [R01 GM065865]; National Science Foundation and Department of Defense; GlaxoSmithKline-Immune Disease Institute Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028422] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation and Department of Defense; GlaxoSmithKline-Immune Disease Institute Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants R01 AI044432 and RC1 DA028422 and a Scholar Award from the Juvenile Diabetes Research Foundation to A. R., Howard Hughes Medical Institute and NIH/National Institute of General Medical Sciences (NIGMS) (R01 GM065865) funding to D. R. L., and National Science Foundation and Department of Defense graduate fellowships to W. A. P. Y.H. is the recipient of a fellowship from the GlaxoSmithKline-Immune Disease Institute Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Burmeister T, 2009, BLOOD, V113, P4011, DOI 10.1182/blood-2008-10-183483; CLARK JM, 1986, NUCLEIC ACIDS RES, V14, P737, DOI 10.1093/nar/14.2.737; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; GRUENBAUM Y, 1981, FEBS LETT, V124, P67, DOI 10.1016/0014-5793(81)80055-5; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; HAYATSU H, 1970, BIOCHEMISTRY-US, V9, P2858, DOI 10.1021/bi00816a016; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Levine RL, 2009, NEW ENGL J MED, V360, P2355, DOI 10.1056/NEJMe0902257; LISTER R, 2009, NATURE; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Mullighan CG, 2009, NAT GENET, V41, P766, DOI 10.1038/ng0709-766; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rein T, 1998, NUCLEIC ACIDS RES, V26, P2255, DOI 10.1093/nar/26.10.2255; Smith LT, 2007, TRENDS GENET, V23, P449, DOI 10.1016/j.tig.2007.07.005; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Tetzner R, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl955; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	45	516	539	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8888	10.1371/journal.pone.0008888	http://dx.doi.org/10.1371/journal.pone.0008888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126651	Green Submitted, Green Published, gold			2022-12-25	WOS:000273896500011
J	Yip, KY; Alexander, RP; Yan, KK; Gerstein, M				Yip, Kevin Y.; Alexander, Roger P.; Yan, Koon-Kiu; Gerstein, Mark			Improved Reconstruction of In Silico Gene Regulatory Networks by Integrating Knockout and Perturbation Data	PLOS ONE			English	Article								We performed computational reconstruction of the in silico gene regulatory networks in the DREAM3 Challenges. Our task was to learn the networks from two types of data, namely gene expression profiles in deletion strains (the 'deletion data') and time series trajectories of gene expression after some initial perturbation (the 'perturbation data'). In the course of developing the prediction method, we observed that the two types of data contained different and complementary information about the underlying network. In particular, deletion data allow for the detection of direct regulatory activities with strong responses upon the deletion of the regulator while perturbation data provide richer information for the identification of weaker and more complex types of regulation. We applied different techniques to learn the regulation from the two types of data. For deletion data, we learned a noise model to distinguish real signals from random fluctuations using an iterative method. For perturbation data, we used differential equations to model the change of expression levels of a gene along the trajectories due to the regulation of other genes. We tried different models, and combined their predictions. The final predictions were obtained by merging the results from the two types of data. A comparison with the actual regulatory networks suggests that our approach is effective for networks with a range of different sizes. The success of the approach demonstrates the importance of integrating heterogeneous data in network reconstruction.	[Yip, Kevin Y.; Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Alexander, Roger P.; Yan, Koon-Kiu; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA	Yale University; Yale University; Yale University	Yip, KY (corresponding author), Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA.	mark.gerstein@yale.edu	Yan, Koon-Kiu/A-5940-2009; Alexander, Roger/A-8643-2008; Yip, Kevin/AAT-4771-2020	Alexander, Roger/0000-0002-2967-7395; Yip, Kevin/0000-0001-5516-9944	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Boyd S., 2004, CONVEX OPTIMIZATION; Chapelle O., 2006, SEMISUPERVISED LEARN; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Dahlquist G, 2003, NUMERICAL METHODS; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Vaske CJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000274; Vu TT, 2007, NUCLEIC ACIDS RES, V35, P279, DOI 10.1093/nar/gkl1001; Wagner A, 2004, J COMPUT BIOL, V11, P53, DOI 10.1089/106652704773416885; Yeang CH, 2004, J COMPUT BIOL, V11, P243, DOI 10.1089/1066527041410382; DREAM3 CHALLENGES; DREAM DIALOGUE REVER	23	71	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8121	10.1371/journal.pone.0008121	http://dx.doi.org/10.1371/journal.pone.0008121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126643	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500001
J	Lee, SY; Choi, HK; Kim, ST; Chung, S; Park, MK; Cho, JH; Ho, WK; Cho, H				Lee, Seul-Yi; Choi, Hyun-Kyung; Kim, Seong-Tae; Chung, Sungkwon; Park, Myoung Kyu; Cho, Jung-Hwa; Ho, Won-Kyung; Cho, Hana			Cholesterol Inhibits M-type K+ Channels via Protein Kinase C-dependent Phosphorylation in Sympathetic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED INHIBITION; POTASSIUM CHANNELS; DIETARY-CHOLESTEROL; MEMBRANE CHOLESTEROL; TRANSPORT PROTEINS; ARACHIDONIC-ACID; KCNQ CHANNELS; SMOOTH-MUSCLE; MODULATION; CURRENTS	M-type (KCNQ) potassium channels play an important role in regulating the action potential firing in neurons. Here, we investigated the effect of cholesterol on M current in superior cervical ganglion (SCG) sympathetic neurons, using the patch clamp technique. M current was inhibited in a dose-dependent manner by cholesterol loading with a methyl-beta-cyclodextrin-cholesterol complex. This effect was prevented when membrane cholesterol level was restored by including empty methyl-beta-cyclodextrin in the pipette solution. Dialysis of cells with AMP-PNP instead of ATP prevented cholesterol action on M currents. Protein kinase C (PKC) inhibitor, calphostin C, abolished cholesterol-induced inhibition whereas the PKC activator, PDBu, mimicked the inhibition of M currents by cholesterol. The in vitro kinase assay showed that KCNQ2 subunits of M channel can be phosphorylated by PKC. A KCNQ2 mutant that is defective in phosphorylation by PKC failed to show current inhibition not only by PDBu but also by cholesterol. These results indicate that cholesterol-induced inhibition of M currents is mediated by PKC phosphorylation. The inhibition of M currents by PDBu and cholesterol was completely blocked by PIP2 loading, indicating that the decrease in PIP2-channel interaction underlies M channel inhibition by PKC-mediated phosphorylation. We conclude that cholesterol specifically regulates M currents in SCG neurons via PKC activation.	[Cho, Hana] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon 440746, South Korea; [Choi, Hyun-Kyung; Kim, Seong-Tae] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Cho, Jung-Hwa; Ho, Won-Kyung] Seoul Natl Univ, Coll Med, Dept Physiol, WCU Neurocyt Program Project, Seoul 110799, South Korea; [Cho, Jung-Hwa; Ho, Won-Kyung] Neurosci Res Inst, Seoul 110799, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Seoul National University (SNU)	Cho, H (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon 440746, South Korea.	hanacho@med.skku.ac.kr	CHUNG, SUNGKWON/ABF-8293-2021; Ho, Won-Kyung/J-2798-2012; Kim, Seong-Tae/A-9917-2013	Lee, Seul-Yi/0000-0002-9360-131X	Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A080604]	Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea (A080604).	Armstrong D, 2008, BIOPHYS J, V94, P4700, DOI 10.1529/biophysj.107.121426; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Brown SG, 2005, AM J PHYSIOL-CELL PH, V289, pC543, DOI 10.1152/ajpcell.00025.2005; Cho H, 2006, MOL CELLS, V22, P97; Christian AE, 1997, J LIPID RES, V38, P2264; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; EPAND RM, 1990, TRENDS PHARMACOL SCI, V11, P317, DOI 10.1016/0165-6147(90)90234-Y; FRANCIS GS, 1993, CIRCULATION, V87, P40; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Guo J, 2008, MOL MEMBR BIOL, V25, P216, DOI 10.1080/09687680701805541; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Higashida H, 2005, NEUROSCI RES, V51, P231, DOI 10.1016/j.neures.2004.11.009; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hilgemann DW, 2004, SCIENCE, V304, P223, DOI 10.1126/science.1097439; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jia ZF, 2008, J GEN PHYSIOL, V131, P575, DOI 10.1085/jgp.200709924; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; KIM JA, 1991, J LIPID RES, V32, P1125; Libby P, 2000, BBA-MOL CELL BIOL L, V1529, P299, DOI 10.1016/S1388-1981(00)00161-X; Liu BY, 2008, AM J PHYSIOL-CELL PH, V295, pC81, DOI 10.1152/ajpcell.00028.2008; Liu LW, 2001, AM J PHYSIOL-CELL PH, V280, pC1293, DOI 10.1152/ajpcell.2001.280.5.C1293; Liu YB, 2003, CIRC RES, V92, P1145, DOI 10.1161/01.RES.0000072999.51484.92; Luo TY, 2004, J BIOMED SCI, V11, P339, DOI [10.1007/BF02254438, 10.1159/000077102]; MANGER WM, 1982, ADV CARDIOL, P71; Mann RK, 2000, BBA-MOL CELL BIOL L, V1529, P188, DOI 10.1016/S1388-1981(00)00148-7; MARRION NV, 1994, PFLUG ARCH EUR J PHY, V426, P296, DOI 10.1007/BF00374785; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; McNamara DJ, 2000, BBA-MOL CELL BIOL L, V1529, P310, DOI 10.1016/S1388-1981(00)00156-6; Melenovsky V, 2003, AM J CARDIOL, V92, P337, DOI 10.1016/S0002-9149(03)00643-X; Mohler ER, 2007, BIOCHEM BIOPH RES CO, V358, P317, DOI 10.1016/j.bbrc.2007.04.138; Morikage N, 2006, CIRC RES, V99, P299, DOI 10.1161/01.RES.0000235877.33682.e9; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Robbins J, 2006, J NEUROSCI, V26, P7950, DOI 10.1523/JNEUROSCI.2138-06.2006; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Sander D, 2001, NEUROLOGY, V57, P833, DOI 10.1212/WNL.57.5.833; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Sirikci O, 1996, ATHEROSCLEROSIS, V126, P253, DOI 10.1016/0021-9150(96)05909-6; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Sohn JW, 2007, J PHYSIOL-LONDON, V582, P1037, DOI 10.1113/jphysiol.2007.137265; Sohn JW, 2007, J PHYSIOL-LONDON, V580, P411, DOI 10.1113/jphysiol.2006.125914; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stoffel-Wagner B, 2001, EUR J ENDOCRINOL, V145, P669, DOI 10.1530/eje.0.1450669; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	58	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10939	10950		10.1074/jbc.M109.048868	http://dx.doi.org/10.1074/jbc.M109.048868			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123983	Green Published, hybrid			2022-12-25	WOS:000276264600078
J	Ercan, D; Zejnullahu, K; Yonesaka, K; Xiao, Y; Capelletti, M; Rogers, A; Lifshits, E; Brown, A; Lee, C; Christensen, JG; Kwiatkowski, DJ; Engelman, JA; Janne, PA				Ercan, D.; Zejnullahu, K.; Yonesaka, K.; Xiao, Y.; Capelletti, M.; Rogers, A.; Lifshits, E.; Brown, A.; Lee, C.; Christensen, J. G.; Kwiatkowski, D. J.; Engelman, J. A.; Jaenne, P. A.			Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor	ONCOGENE			English	Article						epidermal growth factor receptor; drug resistance; EGFR T790M; amplification; tyrosine kinase inhibitor; non-small cell lung cancer	GROWTH-FACTOR-RECEPTOR; CELL LUNG-CANCER; TYROSINE KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; ACQUIRED-RESISTANCE; DRUG-RESISTANCE; NERATINIB HKI-272; GENE MUTATION; BLAST CRISIS; GEFITINIB	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, gefitinib and erlotinib are effective therapies against mutant non-small cell lung cancers (NSCLCs). Treatment is limited by the development of resistance in part explained by the gain of a secondary EGFR mutation, T790M, at the gatekeeper residue. Irreversible EGFR inhibitors, including PF00299804, are effective in vitro and in vivo against EGFR mutant tumors that contain EGFR T790M and are currently under clinical development. In this study, we generate models of resistance to PF00299804, using cell lines with EGFR T790M and show that the PF00299804-resistant models develop focal amplification of EGFR that preferentially involves the T790M-containing allele. These PF00299804-resistant cell lines remain dependent on EGFR for growth as downregulation of EGFR by shRNA compromises their viability. We show that resistance to PF00299804 arises, at least in part, through selection of a pre-existing EGFR T790M-amplified clone both in vitro and using a xenograft model in vivo. Our findings show that EGFR T790M is a common resistance mechanism to both reversible, and when amplified, the irreversible EGFR kinase inhibitors further emphasizing the need to develop more potent therapies against EGFR T790M. These findings can be used to guide studies of patient tumor specimens from ongoing clinical trials of irreversible EGFR kinase inhibitors. Oncogene (2010) 29, 2346-2356; doi:10.1038/onc.2009.526; published online 1 February 2010	[Ercan, D.; Zejnullahu, K.; Yonesaka, K.; Capelletti, M.; Rogers, A.; Jaenne, P. A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Ercan, D.; Zejnullahu, K.; Yonesaka, K.; Capelletti, M.; Rogers, A.; Jaenne, P. A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Xiao, Y.; Lee, C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lifshits, E.; Engelman, J. A.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Brown, A.] Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Cambridge, MA 02138 USA; [Christensen, J. G.] Pfizer Global Res & Dev, Dept Res Pharmacol, La Jolla Labs, La Jolla, CA USA; [Kwiatkowski, D. J.] Brigham & Womens Hosp, Div Translat Med, Boston, MA 02115 USA; [Jaenne, P. A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Pfizer; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Janne, PA (corresponding author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, D820,44 Binney St, Boston, MA 02115 USA.	pjanne@partners.org	Capelletti, Marzia/L-6317-2016	Capelletti, Marzia/0000-0001-5095-7060	National Institutes of Health [RO1CA114465-04, R01CA135257-01, R01CA137008-01]; National Cancer Institute [P50CA090578]; American Cancer Society [RSG0610201]; Hazel and Samuel Bellin research fund; NATIONAL CANCER INSTITUTE [R01CA137008, P50CA090578, R01CA135257, K08CA120060, R01CA114465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Hazel and Samuel Bellin research fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Institutes of Health RO1CA114465-04 (PAJ), R01CA135257-01 (PAJ, JAE, CL), R01CA137008-01 (JAE, PAJ), National Cancer Institute Lung SPORE P50CA090578 (PAJ, JAE and DJK), American Cancer Society RSG0610201CCE (PAJ, JAE), and the Hazel and Samuel Bellin research fund (PAJ).	Albanell J, 2002, J CLIN ONCOL, V20, P110, DOI 10.1200/JCO.20.1.110; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Besse B, 2008, EJC SUPPL, V6, P64, DOI 10.1016/S1359-6349(08)72135-9; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guo T, 2007, CLIN CANCER RES, V13, P4874, DOI 10.1158/1078-0432.CCR-07-0484; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Janne PA, 2008, J CLIN ONCOL, V26; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; KAUFMAN RJ, 1981, MOL CELL BIOL, V1, P1069, DOI 10.1128/MCB.1.12.1069; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Ono M, 2004, MOL CANCER THER, V3, P465; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Quintas-Cardama A, 2008, CLIN CANCER RES, V14, P4392, DOI 10.1158/1078-0432.CCR-08-0117; Rothenberg SM, 2008, P NATL ACAD SCI USA, V105, P12480, DOI 10.1073/pnas.0803217105; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Schellens JH, 2007, J CLIN ONCOL, V25; SCHIMKE RT, 1978, SCIENCE, V202, P1051, DOI 10.1126/science.715457; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Vikis H, 2007, CANCER RES, V67, P4665, DOI 10.1158/0008-5472.CAN-07-0217; Wong KK, 2009, CLIN CANCER RES, V15, P2552, DOI 10.1158/1078-0432.CCR-08-1978; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yuza Y, 2007, CANCER BIOL THER, V6, P661, DOI 10.4161/cbt.6.5.4003; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	44	186	198	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	16					2346	2356		10.1038/onc.2009.526	http://dx.doi.org/10.1038/onc.2009.526			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20118985	Green Accepted			2022-12-25	WOS:000276951500004
J	Reineke, EL; Liu, Y; Kao, HY				Reineke, Erin L.; Liu, Yu; Kao, Hung-Ying			Promyelocytic Leukemia Protein Controls Cell Migration in Response to Hydrogen Peroxide and Insulin-like Growth Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-BODY FORMATION; TUMOR-SUPPRESSOR PML; BREAST-CANCER; INTEGRIN EXPRESSION; RECEPTOR-ALPHA; BODIES; APOPTOSIS; DEGRADATION; MECHANISMS; MEMBRANE	Promyelocytic leukemia protein (PML) was originally identified as part of a chromosomal translocation that contributes to the development of acute promyelocytic leukemia (APL). Since its discovery, PML has been found to play diverse roles in different cellular processes. Notably, PML has anti-proliferative and pro-apoptotic activity that supports its role as a tumor suppressor. We have previously shown that the peptidyl-prolyl isomerase Pin1 is able to affect cell proliferation and hydrogen peroxide (H2O2)-mediated cell death through modulation of the steady-state levels of PML. We have extended these studies to show that the interaction between PML and Pin1 is targeted by multiple extracellular signals in the cell. We show that H2O2 up-regulates and IGF-1 down-regulates PML expression in a Pin1 dependent manner. Interestingly, we found that H2O2- and IGF1-mediated alteration in PML accumulation regulate MDA-MB231 cell migration. Furthermore, we show that the control of cell migration by PML, and thus H2O2 and IGF-1, results from PML-dependent decreased expression of integrin beta 1 (ITGB1). Knockdown of Pin1 leads to decreased cell migration, lower levels of ITGB1 expression and resistance to IGF-1- and H2O2-induced changes in cell migration and ITGB1 expression. Taken together, our work identifies PML as a common target for H2O2 and IGF-1 and supports a novel tumor suppressive role for PML in controlling cell migration through the expression of ITGB1.	Case Western Reserve Univ, Dept Biochem, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu			National Institutes of Health [R01 DK078965, R01 HL093269]; Pardee Foundation; Aging Cancer Research Program at the Case Comprehensive Cancer Center [P20 CA103736]; NATIONAL CANCER INSTITUTE [P20CA103736] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Foundation; Aging Cancer Research Program at the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole of in part, by National Institutes of Health Grants R01 DK078965 and HL093269. This work was also supported by grants from the Pardee Foundation and the Aging Cancer Research Program at the Case Comprehensive Cancer Center (P20 CA103736).	Bartucci M, 2001, CANCER RES, V61, P6747; Baserga R, 1997, VITAM HORM, V53, P65, DOI 10.1016/S0083-6729(08)60704-9; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Berry MG, 2004, EJSO, V30, P484, DOI 10.1016/j.ejso.2004.01.016; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Buschbeck M, 2007, ONCOGENE, V26, P3415, DOI 10.1038/sj.onc.1210128; Ching RW, 2005, J CELL SCI, V118, P847, DOI 10.1242/jcs.01700; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Fierro FA, 2008, J MOL BIOL, V377, P1082, DOI 10.1016/j.jmb.2008.01.085; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Gui GPH, 1996, EUR J SURG ONCOL, V22, P254, DOI 10.1016/S0748-7983(96)80013-8; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; He DL, 1997, CANCER RES, V57, P1868; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; OYAOHTA Y, 1995, MUTAT RES-FUND MOL M, V326, P99, DOI 10.1016/0027-5107(95)00153-A; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Surmacz E, 2004, J EXP CLIN CANC RES, V23, P385; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Tsiper MV, 2002, J CELL SCI, V115, P1005; VIRADOR VM, 2008, MOL CARCINOG; Wang ZG, 1998, SCIENCE, V279, P1547; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; You H, 2002, J CELL BIOCHEM, V84, P211, DOI 10.1002/jcb.10037; Zhang H, 2009, J BIOL CHEM, V284, P2867, DOI 10.1074/jbc.M807526200; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020; ZUTTER MM, 1993, AM J PATHOL, V142, P1439	38	31	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9485	9492		10.1074/jbc.M109.063362	http://dx.doi.org/10.1074/jbc.M109.063362			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100838	hybrid, Green Published			2022-12-25	WOS:000276165900022
J	Wanngren, J; Franberg, J; Svensson, AI; Laudon, H; Olsson, F; Winblad, B; Liu, F; Naslund, J; Lundkvist, J; Karlstrom, H				Wanngren, Johanna; Franberg, Jenny; Svensson, Annelie I.; Laudon, Hanna; Olsson, Fredrik; Winblad, Bengt; Liu, Frank; Naslund, Jan; Lundkvist, Johan; Karlstrom, Helena			The Large Hydrophilic Loop of Presenilin 1 Is Important for Regulating beta-Secretase Complex Assembly and Dictating the Amyloid beta Peptide (A beta) Profile without Affecting Notch Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENTS; GAMMA-SECRETASE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; TALKING POINT; IN-VIVO; ENDOPROTEOLYSIS; MUTATIONS; INHIBITOR; CLEAVAGE	gamma-Secretase is an enzyme complex that mediates both Notch signaling and beta-amyloid precursor protein (APP) processing, resulting in the generation of Notch intracellular domain, APP intracellular domain, and the amyloid beta peptide (A beta), the latter playing a central role in Alzheimer disease (AD). By a hitherto undefined mechanism, the activity of gamma-secretase gives rise to A beta peptides of different lengths, where A beta 42 is considered to play a particular role in AD. In this study we have examined the role of the large hydrophilic loop (amino acids 320-374, encoded by exon 10) of presenilin 1 (PS1), the catalytic subunit of gamma-secretase, for gamma-secretase complex formation and activity on Notch and APP processing. Deletion of exon 10 resulted in impaired PS1 endoproteolysis, gamma-secretase complex formation, and had a differential effect on A beta-peptide production. Although the production of A beta 38, A beta 39, and A beta 40 was severely impaired, the effect on A beta 42 was affected to a lesser extent, implying that the production of the AD-related A beta 42 peptide is separate from the production of the A beta 38, A beta 39, and A beta 40 peptides. Interestingly, formation of the intracellular domains of both APP and Notch was intact, implying a differential cleavage activity between the epsilon/S3 and gamma sites. The most C-terminal amino acids of the hydrophilic loop were important for regulating APP processing. In summary, the large hydrophilic loop of PS1 appears to differentially regulate the relative production of different A beta peptides without affecting Notch processing, two parameters of significance when considering gamma-secretase as a target for pharmaceutical intervention in AD.	[Wanngren, Johanna; Franberg, Jenny; Svensson, Annelie I.; Laudon, Hanna; Winblad, Bengt; Karlstrom, Helena] Karolinska Inst, Dept Neurobiol Caring Sci & Soc, KI Alzheimer Dis Res Ctr, SE-14186 Stockholm, Sweden; [Olsson, Fredrik; Naslund, Jan; Lundkvist, Johan] AstraZeneca Cent Nervous Syst, Pain Res Area, Div Mol Pharmacol, SE-15185 Sodertalje, Sweden; [Liu, Frank] AstraZeneca, Div Neurosci Biol, Wilmington, DE 19850 USA	Karolinska Institutet; AstraZeneca; AstraZeneca	Karlstrom, H (corresponding author), Karolinska Inst, Dept Neurobiol Caring Sci & Soc, 5th Floor, SE-14157 Stockholm, Sweden.	Helena.Karlstrom@ki.se		Karlstrom, Helena/0000-0002-0498-2473	Swedish Brain Power; Wallenberg Stiftelsen; Loo och Hans Ostermans Stiftelse; Magnus Bergvalls Stiftlelse; Fonden for Alderforskning vid Karolinska Institutet; Stiftelsen for Gamla Tjanarinnor; Gun och Bertil Stohnes Stiftelse	Swedish Brain Power; Wallenberg Stiftelsen; Loo och Hans Ostermans Stiftelse; Magnus Bergvalls Stiftlelse; Fonden for Alderforskning vid Karolinska Institutet; Stiftelsen for Gamla Tjanarinnor; Gun och Bertil Stohnes Stiftelse	This work was supported by grants from Swedish Brain Power, Wallenberg Stiftelsen, Loo och Hans Ostermans Stiftelse, Magnus Bergvalls Stiftlelse, Fonden for Alderforskning vid Karolinska Institutet, Stiftelsen for Gamla Tjanarinnor, and Gun och Bertil Stohnes Stiftelse.	Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Dillen K, 2006, INT REV CYTOL, V254, P215, DOI 10.1016/S0074-7696(06)54005-7; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Henricson A, 2005, FEBS J, V272, P2727, DOI 10.1111/j.1742-4658.2005.04691.x; Hyde LA, 2006, J PHARMACOL EXP THER, V319, P1133, DOI 10.1124/jpet.106.111716; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Stromberg K, 2005, J NEUROCHEM, V95, P880, DOI 10.1111/j.1471-4159.2005.03415.x; Taniguchi Y, 2002, P NATL ACAD SCI USA, V99, P4014, DOI 10.1073/pnas.052017699; TERANISHI Y, 2010, J CELL MOL IN PRESS; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xia XF, 2002, P NATL ACAD SCI USA, V99, P8760, DOI 10.1073/pnas.132045399; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200	43	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8527	8536		10.1074/jbc.M109.055590	http://dx.doi.org/10.1074/jbc.M109.055590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20106965	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000275553700004
J	Lam, YW; Yuan, Y; Isaac, J; Babu, CVS; Meller, J; Ho, SM				Lam, Ying Wai; Yuan, Yong; Isaac, Jared; Babu, C. V. Suresh; Meller, Jarek; Ho, Shuk-Mei			Comprehensive Identification and Modified-Site Mapping of S-Nitrosylated Targets in Prostate Epithelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE/NITROSATIVE STRESS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; REDOX STATE; NOBLE RAT; PROTEIN; CANCER; APOPTOSIS; CARCINOGENESIS	Background: Although overexpression of nitric oxide synthases (NOSs) has been found associated with prostate diseases, the underlying mechanisms for NOS-related prostatic diseases remain unclear. One proposed mechanism is related to the S-nitrosylation of key regulatory proteins in cell-signaling pathways due to elevated levels of NO in the prostate. Thus, our primary objective was to identify S-nitrosylated targets in an immortalized normal prostate epithelial cell line, NPrEC. Methodology/Principal Findings: We treated NPrEC with nitroso-cysteine and used the biotin switch technique followed by gel-based separation and mass spectrometry protein identification (using the LTQ-Orbitrap) to discover S-nitrosylated (SNO) proteins in the treated cells. In parallel, we adapted a peptide pull-down methodology to locate the site(s) of S-nitrosylation on the protein SNO targets identified by the first technique. This combined approach identified 116 SNO proteins and determined the sites of modification for 82 of them. Over 60% of these proteins belong to four functional groups: cell structure/cell motility/protein trafficking, protein folding/protein response/protein assembly, mRNA splicing/processing/transcriptional regulation, and metabolism. Western blot analysis validated a subset of targets related to disease development (proliferating cell nuclear antigen, maspin, integrin beta 4, alpha-catenin, karyopherin [importin] beta 1, and elongation factor 1A1). We analyzed the SNO sequences for their primary and secondary structures, solvent accessibility, and three-dimensional structural context. We found that about 80% of the SNO sites that can be mapped into resolved structures are buried, of which approximately half have charged amino acids in their three-dimensional neighborhood, and the other half residing within primarily hydrophobic pockets. Conclusions/Significance: We here identified 116 potential SNO targets and mapped their putative SNO sites in NPrEC. Elucidation of how this post-translational modification alters the function of these proteins should shed light on the role of NO in prostate pathologies. To our knowledge, this is the first report identifying SNO targets in prostate epithelial cells.	[Lam, Ying Wai; Yuan, Yong; Isaac, Jared; Babu, C. V. Suresh; Meller, Jarek; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Lam, Ying Wai; Meller, Jarek; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH USA; [Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Cincinnati Canc Consortium, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Lam, YW (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	shuk-mei.ho@uc.edu	Meller, Jaroslaw/A-1971-2011	Meller, Jaroslaw/0000-0002-1162-8253	National Institutes of Health [ES006096, CA015776, CA062269, CA112532, ES015584]; Department of Environmental Health; College of Medicine, of the University of Cincinnati; NATIONAL CANCER INSTITUTE [R01CA112532, R01CA015776, R01CA062269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015584, P30ES006096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Environmental Health; College of Medicine, of the University of Cincinnati; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research supported in part with National Institutes of Health (www.nih.gov) grants ES006096, CA015776, CA062269, CA112532, and ES015584 (to SMH), and GM067823 (to JM), and internal funding support from the Department of Environmental Health, College of Medicine, of the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa SH, 2001, ANTICANCER RES, V21, P3101; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Arsova-Sarafinovska Z, 2009, CLIN BIOCHEM, V42, P1228, DOI 10.1016/j.clinbiochem.2009.05.009; Ascenzi P, 2000, BIOL CHEM, V381, P623, DOI 10.1515/BC.2000.081; AZAD N, 2009, AM J RESP C IN PRESS; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Baltaci S, 2001, BJU INT, V88, P100, DOI 10.1046/j.1464-410x.2001.02231.x; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Camerini S, 2007, J PROTEOME RES, V6, P3224, DOI 10.1021/pr0701456; Chaiswing L, 2008, CANCER RES, V68, P5820, DOI 10.1158/0008-5472.CAN-08-0162; Chaiswing L, 2007, FREE RADICAL BIO MED, V43, P202, DOI 10.1016/j.freeradbiomed.2007.03.031; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Crowell JA, 2003, MOL CANCER THER, V2, P815; De Marzo AM, 2007, UROL ONCOL-SEMIN ORI, V25, P398, DOI 10.1016/j.urolonc.2007.05.007; Dua K, 2001, PROTEOMICS, V1, P1191, DOI 10.1002/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO;2-8; Estrada C, 1997, BIOCHEM J, V326, P369, DOI 10.1042/bj3260369; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; FIBBI B, 2009, INT J ANDRO IN PRESS; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Forrester MT, 2006, ACS CHEM BIOL, V1, P355, DOI 10.1021/cb600244c; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Gooding JM, 2004, BIOESSAYS, V26, P497, DOI 10.1002/bies.20033; Gradini R, 1999, J PATHOL, V189, P224; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Han P, 2008, RAPID COMMUN MASS SP, V22, P1137, DOI 10.1002/rcm.3476; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; IGNARRO LJ, 1991, BIOCHEM PHARMACOL, V41, P485, DOI 10.1016/0006-2952(91)90618-F; Iyer AKV, 2008, NITRIC OXIDE-BIOL CH, V19, P146, DOI 10.1016/j.niox.2008.04.019; JAFFREY SR, 2001, SCI STKE, V86, pL1; Jaiswal M, 2001, CANCER RES, V61, P6388; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Kedia G, 2008, WORLD J UROL, V26, P603, DOI 10.1007/s00345-008-0303-y; Lam YW, 2008, PROTEOMICS, V8, P2750, DOI 10.1002/pmic.200700986; Lam YW, 2005, PROTEOMICS, V5, P2927, DOI 10.1002/pmic.200401165; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; LAVAL F, 1994, CARCINOGENESIS, V15, P443, DOI 10.1093/carcin/15.3.443; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lipton SA, 2007, INT REV NEUROBIOL, V82, P1, DOI 10.1016/S0074-7742(07)82001-0; Lockett J, 2006, J CELL BIOCHEM, V97, P651, DOI 10.1002/jcb.20721; LOWENSTEIN CJ, 1992, CELL, V70, P705, DOI 10.1016/0092-8674(92)90301-R; Mannick JB, 2008, METHOD ENZYMOL, V440, P231, DOI 10.1016/S0076-6879(07)00814-2; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Martinez-Ruiz Antonio, 2007, Methods Mol Biol, V357, P215; McKenzie S, 2008, ONCOGENE, V27, P7171, DOI 10.1038/onc.2008.321; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048; Narayanan NK, 2009, PROSTATE, V69, P133, DOI 10.1002/pros.20862; Ng QS, 2007, LANCET ONCOL, V8, P111, DOI 10.1016/S1470-2045(07)70001-3; Olson SY, 2008, NITRIC OXIDE-BIOL CH, V19, P170, DOI 10.1016/j.niox.2008.04.005; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Polytarchou C, 2009, INT J CANCER, V124, P1785, DOI 10.1002/ijc.24084; Pontes-Junior Jose, 2009, J Carcinog, V8, P3; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sciarra A, 2008, J STEROID BIOCHEM, V108, P254, DOI 10.1016/j.jsbmb.2007.09.013; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Tam NNC, 2007, AM J PATHOL, V171, P1334, DOI 10.2353/ajpath.2007.070199; Tam NNC, 2006, PROSTATE, V66, P57, DOI 10.1002/pros.20313; Uotila P, 2001, Urol Res, V29, P23; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146	64	72	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9075	10.1371/journal.pone.0009075	http://dx.doi.org/10.1371/journal.pone.0009075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140087	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442400013
J	Okpechi, IG; Rayner, BL; van der Merwe, L; Mayosi, BM; Adeyemo, A; Tiffin, N; Ramesar, R				Okpechi, Ikechi G.; Rayner, Brian L.; van der Merwe, Lize; Mayosi, Bongani M.; Adeyemo, Adebowale; Tiffin, Nicki; Ramesar, Rajkumar			Genetic Variation at Selected SNPs in the Leptin Gene and Association of Alleles with Markers of Kidney Disease in a Xhosa Population of South Africa	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; UNITED-STATES; BLOOD-PRESSURE; EXCESS RISK; OBESE GENE; POLYMORPHISM; HYPERTENSION	Background: Chronic kidney disease (CKD) is a significant public health problem that leads to end-stage renal disease (ESRD) with as many as 2 million people predicted to need therapy worldwide by 2010. Obesity is a risk factor for CKD and leptin, the obesity hormone, correlates with body fat mass and markers of renal function. A number of clinical and experimental studies have suggested a link between serum leptin and kidney disease. We hypothesised that variants in the leptin gene (LEP) may be associated with markers of CKD in indigenous black Africans. Methodology/Principal Findings: Black South Africans of Xhosa (distinct cultural Bantu-speaking population) descent were recruited for the study and four common polymorphisms of the LEP (rs7799039, rs791620, rs2167270 and STS-U43653 [ENSSNP5824596]) were analysed for genotype and haplotype association with urine albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), Serum creatinine (Scr) and serum leptin level. In one of the four single nucleotide polymorphisms (SNPs) we examined, an association with the renal phenotypes was observed. Hypertensive subjects with the T allele (CT genotype) of the ENSSNP5824596 SNP had a significantly higher eGFR (p = 0.0141), and significantly lower Scr (p = 0.0137). This was confirmed by haplotype analysis. Also, the haplotype GAAC had a modest effect on urine albumin-to-creatinine ratio in normotensive subjects (p = 0.0482). Conclusions/Significance: These results suggest that genetic variations of the LEP may be associated with phenotypes that are markers of CKD in black Africans.	[Okpechi, Ikechi G.; Rayner, Brian L.; Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [van der Merwe, Lize] Univ Cape Town, Dept Stat, ZA-7925 Cape Town, South Africa; [Adeyemo, Adebowale] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Tiffin, Nicki; Ramesar, Rajkumar] Univ Cape Town, Div Human Genet, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Cape Town	Okpechi, IG (corresponding author), Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa.	ikokpechi@yahoo.com	Ramesar, Raj S/I-6941-2015; Rayner, Brian/AAA-3174-2021; Tiffin, Nicki/ABA-9391-2020; Tiffin, Nicki/A-5914-2013; van der Merwe, Lize/D-3148-2012	Ramesar, Raj S/0000-0001-5688-1634; Tiffin, Nicki/0000-0001-5083-2735; van der Merwe, Lize/0000-0001-9705-8126; Adeyemo, Adebowale/0000-0002-3105-3231; Rayner, Brian/0000-0002-0167-9591; Mayosi, Bongani/0000-0001-6641-8950	Wyeth Nephrology Funds	Wyeth Nephrology Funds	This study was supported by the Wyeth Nephrology Funds administered by the University of Cape Town. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballermann BJ, 1999, KIDNEY INT, V56, P1154, DOI 10.1046/j.1523-1755.1999.00650.x; Briley LP, 2006, SEMIN DIALYSIS, V19, P54, DOI 10.1111/j.1525-139X.2006.00119.x; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gaukrodger N, 2005, J MED GENET, V42, P474, DOI 10.1136/jmg.2004.027631; *HAPMAP, 2010, INT HAPMAP PROJ; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hinuy HM, 2006, MOL GENET METAB, V89, P374, DOI 10.1016/j.ymgme.2006.04.012; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Krop JS, 1999, ARCH INTERN MED, V159, P1777, DOI 10.1001/archinte.159.15.1777; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEVEY A, 2001, J AM SOC NEPHROL, V11, P155; Lucantoni R, 2000, J CLIN ENDOCR METAB, V85, P3589, DOI 10.1210/jc.85.10.3589; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Okpechi Ikechi G, 2007, Diab Vasc Dis Res, V4, P365, DOI 10.3132/dvdr.2007.066; Porreca E, 2006, INT J OBESITY, V30, P209, DOI 10.1038/sj.ijo.0803150; Rudberg S, 1998, HORM RES, V50, P297, DOI 10.1159/000023294; Santopinto JJ, 2003, HEART, V89, P1003, DOI 10.1136/heart.89.9.1003; Seedat YK, 1999, J HUM HYPERTENS, V13, P747, DOI 10.1038/sj.jhh.1000911; Shintani M, 2002, J CLIN ENDOCR METAB, V87, P2909, DOI 10.1210/jc.87.6.2909; SINNWELL JP, 2010, HAPLO STATS VERSION; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9086	10.1371/journal.pone.0009086	http://dx.doi.org/10.1371/journal.pone.0009086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140086	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442400022
J	Kim, MS; Chang, XF; LeBron, C; Nagpal, JK; Lee, J; Huang, YP; Yamashita, K; Trink, B; Ratovitski, EA; Sidransky, D				Kim, Myoung Sook; Chang, Xiaofei; LeBron, Cynthia; Nagpal, Jatin K.; Lee, Juna; Huang, Yiping; Yamashita, Keishi; Trink, Barry; Ratovitski, Edward A.; Sidransky, David			Neurofilament Heavy Polypeptide Regulates the Akt-beta-Catenin Pathway in Human Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE ACTIVITY; GROWTH-FACTOR; CANCER-CELLS; C-MYC; PROMOTER HYPERMETHYLATION; MITOCHONDRIAL BIOGENESIS; BIOENERGETIC SIGNATURE; NEOPLASTIC PROGRESSION; PROGNOSTIC MARKER; SIGNALING PATHWAY	Aerobic glycolysis and mitochondrial dysfunction are common features of aggressive cancer growth. We observed promoter methylation and loss of expression in neurofilament heavy polypeptide (NEFH) in a significant proportion of primary esophageal squamous cell carcinoma (ESCC) samples that were of a high tumor grade and advanced stage. RNA interference-mediated knockdown of NEFH accelerated ESCC cell growth in culture and increased tumorigenicity in vivo, whereas forced expression of NEFH significantly inhibited cell growth and colony formation. Loss of NEFH caused upregulation of pyruvate kinase-M2 type and down-regulation of pyruvate dehydrogenase, via activation of the Akt/beta-catenin pathway, resulting in enhanced aerobic glycolysis and mitochondrial dysfunction. The acceleration of glycolysis and mitochondrial dysfunction in NEFH-knockdown cells was suppressed in the absence of beta-catenin expression, and was decreased by the treatment of 2-Deoxyglucose, a glycolytic inhibitor, or API-2, an Akt inhibitor. Loss of NEFH activates the Akt/beta-catenin pathway and increases glycolysis and mitochondrial dysfunction. Cancer cells with methylated NEFH can be targeted for destruction with specific inhibitors of deregulated downstream pathways.	[Kim, Myoung Sook; Chang, Xiaofei; LeBron, Cynthia; Nagpal, Jatin K.; Lee, Juna; Trink, Barry; Sidransky, David] Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Head & Neck Canc Res Div, Baltimore, MD 21205 USA; [Huang, Yiping; Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Yamashita, Keishi] Kitasato Univ Hosp, Dept Surg, Kanagawa, Japan	Johns Hopkins University; Johns Hopkins University; Kitasato University	Kim, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Head & Neck Canc Res Div, Baltimore, MD 21205 USA.	dsidrans@jhmi.edu			National Cancer Institute [U01-CA84986]; Oncomethylome Sciences; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [U01CA084986] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Oncomethylome Sciences; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (U01-CA84986), Oncomethylome Sciences, and the Flight Attendant Medical Research Institute (Myoung S. Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin SB, 1998, ADV CANCER RES, V72, P141; Bobos M, 2006, AM J DERMATOPATH, V28, P99, DOI 10.1097/01.dad.0000183701.67366.c7; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Cieply B, 2009, HEPATOLOGY, V49, P821, DOI 10.1002/hep.22695; Clement G, 2006, ONCOGENE, V25, P3084, DOI 10.1038/sj.onc.1209338; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Fujita M, 2000, CANCER RES, V60, P6683; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GOSEKI N, 1992, CANCER, V69, P1088; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Ishiguro H, 2000, JPN J CANCER RES, V91, P597, DOI 10.1111/j.1349-7006.2000.tb00987.x; KATO J, 1993, GENE DEV, V7, P331; Kawasoe T, 2000, CANCER RES, V60, P3354; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kazakov DV, 2009, AM J DERMATOPATH, V31, P248, DOI 10.1097/DAD.0b013e318198922a; Kihara C, 2000, JPN J CANCER RES, V91, P190, DOI 10.1111/j.1349-7006.2000.tb00931.x; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kimura Y, 1999, INT J CANCER, V84, P174, DOI 10.1002/(SICI)1097-0215(19990420)84:2<174::AID-IJC14>3.0.CO;2-E; Kuroki T, 2003, CANCER RES, V63, P3724; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu SH, 2006, MOL CELL PROTEOMICS, V5, P1019, DOI 10.1074/mcp.M500299-MCP200; Mandard AM, 2000, MUTAT RES-REV MUTAT, V462, P335, DOI 10.1016/S1383-5742(00)00019-3; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mena H, 2001, CANCER, V91, P136, DOI 10.1002/1097-0142(20010101)91:1<136::AID-CNCR18>3.3.CO;2-F; Miettinen M, 2001, AM J SURG PATHOL, V25, P846, DOI 10.1097/00000478-200107000-00002; Mizushima T, 2002, CANCER RES, V62, P277; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; PENG H, 2009, CHIN J CANC, V28, P38; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Polakis P, 1999, ADV EXP MED BIOL, V470, P23; Ren Y, 2005, CLIN CANCER RES, V11, P6190, DOI 10.1158/1078-0432.CCR-04-2553; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Roth MJ, 2005, GENE CHROMOSOME CANC, V44, P423, DOI 10.1002/gcc.20251; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; RUTTLEDGE MH, 1993, NEUROLOGY, V43, P1753, DOI 10.1212/WNL.43.9.1753; SAINIO M, 1995, NEUROLOGY, V45, P1314, DOI 10.1212/WNL.45.7.1314; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; Schleicher RL, 1997, CANCER RES, V57, P3532; SEGAL A, 1994, PATHOLOGY, V26, P439, DOI 10.1080/00313029400169162; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Szebenyi G, 2002, J NEUROSCI RES, V68, P185, DOI 10.1002/jnr.10212; Tanaka Y, 2000, AM J SURG PATHOL, V24, P1295, DOI 10.1097/00000478-200009000-00015; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Wagner OI, 2003, J NEUROSCI, V23, P9046; Wang LD, 2003, WORLD J GASTROENTERO, V9, P1156, DOI 10.3748/wjg.v9.i6.1156; Wang YH, 2005, ONCOGENE, V24, P6637, DOI 10.1038/sj.onc.1208819; *WHO, 1997, WORLD HLTH REP; Wu G, 2006, BIOCHEMISTRY-US, V45, P5319, DOI 10.1021/bi0601149; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Xing EP, 1999, CLIN CANCER RES, V5, P1231; Yan S, 2008, CANCER LETT, V271, P85, DOI 10.1016/j.canlet.2008.05.035; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; You H, 2005, J NEURO-ONCOL, V74, P1, DOI 10.1007/s11060-004-2354-2; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhang G, 2005, PATHOL INT, V55, P310, DOI 10.1111/j.1440-1827.2005.01840.x; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang L, 2003, CARCINOGENESIS, V24, P1039, DOI 10.1093/carcin/bgg062; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559	71	38	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9003	10.1371/journal.pone.0009003	http://dx.doi.org/10.1371/journal.pone.0009003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140245	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474200005
J	Knoth, R; Singec, I; Ditter, M; Pantazis, G; Capetian, P; Meyer, RP; Horvat, V; Volk, B; Kempermann, G				Knoth, Rolf; Singec, Ilyas; Ditter, Margarethe; Pantazis, Georgios; Capetian, Philipp; Meyer, Ralf P.; Horvat, Volker; Volk, Benedikt; Kempermann, Gerd			Murine Features of Neurogenesis in the Human Hippocampus across the Lifespan from 0 to 100 Years	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; ADULT HUMAN HIPPOCAMPUS; TEMPORAL-LOBE EPILEPSY; DOUBLE CORTEX SYNDROME; MOUSE DENTATE GYRUS; NEURAL STEM-CELLS; PROGENITOR CELLS; HUMAN BRAIN; DOUBLECORTIN EXPRESSION; ALZHEIMERS-DISEASE	Background: Essentially all knowledge about adult hippocampal neurogenesis in humans still comes from one seminal study by Eriksson et al. in 1998, although several others have provided suggestive findings. But only little information has been available in how far the situation in animal models would reflect the conditions in the adult and aging human brain. We therefore here mapped numerous features associated with adult neurogenesis in rodents in samples from human hippocampus across the entire lifespan. Such data would not offer proof of adult neurogenesis in humans, because it is based on the assumption that humans and rodents share marker expression patterns in adult neurogenesis. Nevertheless, together the data provide valuable information at least about the presence of markers, for which a link to adult neurogenesis might more reasonably be assumed than for others, in the adult human brain and their change with increasing age. Methods and Findings: In rodents, doublecortin (DCX) is transiently expressed during adult neurogenesis and within the neurogenic niche of the dentate gyrus can serve as a valuable marker. We validated DCX as marker of granule cell development in fetal human tissue and used DCX expression as seed to examine the dentate gyrus for additional neurogenesis-associated features across the lifespan. We studied 54 individuals and detected DCX expression between birth and 100 years of age. Caveats for post-mortem analyses of human tissues apply but all samples were free of signs of ischemia and activated caspase-3. Fourteen markers related to adult hippocampal neurogenesis in rodents were assessed in DCX-positive cells. Total numbers of DCX expressing cells declined exponentially with increasing age, and co-expression of DCX with the other markers decreased. This argued against a non-specific re-appearance of immature markers in specimen from old brains. Early postnatally all 14 markers were co-expressed in DCX-positive cells. Until 30 to 40 years of age, for example, an overlap of DCX with Ki67, Mcm2, Sox2, Nestin, Prox1, PSA-NCAM, Calretinin, NeuN, and others was detected, and some key markers (Nestin, Sox2, Prox1) remained co-expressed into oldest age. Conclusions: Our data suggest that in the adult human hippocampus neurogenesis-associated features that have been identified in rodents show patterns, as well as qualitative and quantitative age-related changes, that are similar to the course of adult hippocampal neurogenesis in rodents. Consequently, although further validation as well as the application of independent methodology (e. g. electron microscopy and cell culture work) is desirable, our data will help to devise the framework for specific research on cellular plasticity in the aging human hippocampus.	[Knoth, Rolf; Singec, Ilyas; Ditter, Margarethe; Pantazis, Georgios; Capetian, Philipp; Meyer, Ralf P.; Volk, Benedikt] Univ Freiburg, Dept Neuropathol, Freiburg, Germany; [Singec, Ilyas] Burnham Inst Med Res, Stem Cell & Regenerat Program, La Jolla, CA USA; [Capetian, Philipp] Univ Freiburg, Lab Mol Neurosurg, Dept Stereotact & Funct Neurosurg, Freiburg, Germany; [Horvat, Volker; Kempermann, Gerd] CRTD Ctr Regenerat Therapies Dresden, Dresden, Germany	University of Freiburg; Sanford Burnham Prebys Medical Discovery Institute; University of Freiburg; Technische Universitat Dresden	Knoth, R (corresponding author), Univ Freiburg, Dept Neuropathol, Freiburg, Germany.	gerd.kempermann@crt-dresden.de	Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061; SINGEC, ILYAS/0000-0003-3941-1838				ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amrein I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000455; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; BENABDALLAH N, 2008, NEUROBIOL AGING, P227, DOI DOI 10.1016/J.NEUROBIOLAGING.2008.1003.1002; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Crespel A, 2005, NEUROBIOL DIS, V19, P436, DOI 10.1016/j.nbd.2005.01.020; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fukuda S, 2003, J NEUROSCI, V23, P9357; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Hermann A, 2006, J NEUROCHEM, V98, P629, DOI 10.1111/j.1471-4159.2006.03916.x; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; KLEMPIN F, 2007, EUR ARCH PSYCHIAT CL, P227; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee KY, 2008, MOL CELLS, V26, P5; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montaron MF, 1999, EUR J NEUROSCI, V11, P1479, DOI 10.1046/j.1460-9568.1999.00579.x; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nagy Z, 2000, NEUROBIOL AGING, V21, P761, DOI 10.1016/S0197-4580(00)00223-2; Ni Dhuill CM, 1999, J NEUROSCI RES, V55, P99, DOI 10.1002/(SICI)1097-4547(19990101)55:1<99::AID-JNR11>3.0.CO;2-S; Osaki M, 2002, INT J MOL MED, V10, P161; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Prives C, 2008, CELL CYCLE, V7, P3840, DOI 10.4161/cc.7.24.7243; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Ratti A, 2006, J CELL SCI, V119, P1442, DOI 10.1242/jcs.02852; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Roy NS, 2000, NAT MED, V6, P271; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Singec I, 2003, J COMP NEUROL, V459, P278, DOI 10.1002/cne.10600; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Verwer RWH, 2007, BRAIN, V130, P3321, DOI 10.1093/brain/awm264; Weber M, 2006, NEUROSCIENCE, V138, P1215, DOI 10.1016/j.neuroscience.2005.11.059; Weimer JM, 2006, NEURON, V49, P3, DOI 10.1016/j.neuron.2005.12.016; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167	75	447	452	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8809	10.1371/journal.pone.0008809	http://dx.doi.org/10.1371/journal.pone.0008809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126454	gold, Green Published, Green Submitted			2022-12-25	WOS:000274139100002
J	Evans, P; Sacan, A; Ungar, L; Tozeren, A				Evans, Perry; Sacan, Ahmet; Ungar, Lyle; Tozeren, Aydin			Sequence Alignment Reveals Possible MAPK Docking Motifs on HIV Proteins	PLOS ONE			English	Article							KINASE; IDENTIFICATION; SEARCH; SITES	Over the course of HIV infection, virus replication is facilitated by the phosphorylation of HIV proteins by human ERK1 and ERK2 mitogen-activated protein kinases (MAPKs). MAPKs are known to phosphorylate their substrates by first binding with them at a docking site. Docking site interactions could be viable drug targets because the sequences guiding them are more specific than phosphorylation consensus sites. In this study we use multiple bioinformatics tools to discover candidate MAPK docking site motifs on HIV proteins known to be phosphorylated by MAPKs, and we discuss the possibility of targeting docking sites with drugs. Using sequence alignments of HIV proteins of different subtypes, we show that MAPK docking patterns previously described for human proteins appear on the HIV matrix, Tat, and Vif proteins in a strain dependent manner, but are absent from HIV Rev and appear on all HIV Nef strains. We revise the regular expressions of previously annotated MAPK docking patterns in order to provide a subtype independent motif that annotates all HIV proteins. One revision is based on a documented human variant of one of the substrate docking motifs, and the other reduces the number of required basic amino acids in the standard docking motifs from two to one. The proposed patterns are shown to be consistent with in silico docking between ERK1 and the HIV matrix protein. The motif usage on HIV proteins is sufficiently different from human proteins in amino acid sequence similarity to allow for HIV specific targeting using small-molecule drugs.	[Evans, Perry; Ungar, Lyle] Univ Penn, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA; [Sacan, Ahmet; Tozeren, Aydin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA	University of Pennsylvania; Drexel University	Evans, P (corresponding author), Univ Penn, Dept Comp & Informat Sci, 200 S 33Rd St, Philadelphia, PA 19104 USA.	aydin.tozeren@drexel.edu			National Institutes of Health (NIH) [232240, T32 HG000046]; National Science Foundation (NSF) [235327]; Drexel University Calhoun Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Drexel University Calhoun Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was supported by the National Institutes of Health (NIH) grant #232240 and by the National Science Foundation (NSF) grant #235327. Additional support came from a Drexel University Calhoun Fellowship (WD) and from NIH training grant T32 HG000046 (PE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Barraud P, 2008, CURR HIV RES, V6, P91, DOI 10.2174/157016208783885056; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BUKRINSKAYA AG, 1996, PHOSPHORYLATION DEPE, P367; Burkhard K, 2009, CURR TOP MED CHEM, V9, P678, DOI 10.2174/156802609789044416; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Dampier W, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-47; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Evans RJ, 2009, GER HIST, V27, P1, DOI 10.1093/gerhis/ghn073; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hancock CN, 2006, MED CHEM, V2, P213, DOI 10.2174/157340606776056151; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Kinoshita T, 2008, BIOCHEM BIOPH RES CO, V377, P1123, DOI 10.1016/j.bbrc.2008.10.127; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Lin HY, 2003, BIOCHEMISTRY-US, V42, P7571, DOI 10.1021/bi0273967; LIU S, 2006, STRUCTURAL BASIS DOC; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; PAN C, 2009, MOL CELLULAR PROTEOM; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Sacan A, 2008, BIOINFORMATICS, V24, P2872, DOI 10.1093/bioinformatics/btn545; Schrager JA, 2002, J BIOL CHEM, V277, P6137, DOI 10.1074/jbc.M107322200; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Toschi E, 2006, MOL BIOL CELL, V17, P1985, DOI 10.1091/mbc.E05-08-0717; YANG X, 1999, AM SOC MICROBIOL, P3460; Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879; ZHANG Y, 2004, PROTEINS STRUCTURE F, V57	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8942	10.1371/journal.pone.0008942	http://dx.doi.org/10.1371/journal.pone.0008942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126615	Green Published, gold, Green Submitted			2022-12-25	WOS:000274138000019
J	Montemayor, C; Montemayor, OA; Ridgeway, A; Lin, F; Wheeler, DA; Pletcher, SD; Pereira, FA				Montemayor, Celina; Montemayor, Oscar A.; Ridgeway, Alex; Lin, Feng; Wheeler, David A.; Pletcher, Scott D.; Pereira, Fred A.			Genome-Wide Analysis of Binding Sites and Direct Target Genes of the Orphan Nuclear Receptor NR2F1/COUP-TFI	PLOS ONE			English	Article							PROMOTER-TRANSCRIPTION FACTOR; MOUSE INNER-EAR; RETINOIC ACID; RESPONSE ELEMENTS; HAIR CELL; COUP-TFI; PROTEIN GENE; HEARING-LOSS; FATTY-ACIDS; EXPRESSION	Background: Identification of bona fide direct nuclear receptor gene targets has been challenging but essential for understanding regulation of organismal physiological processes. Results: We describe a methodology to identify transcription factor binding sites and target genes in vivo by intersecting microarray data, computational binding site queries, and evolutionary conservation. We provide detailed experimental validation of each step and, as a proof of principle, utilize the methodology to identify novel direct targets of the orphan nuclear receptor NR2F1 (COUP-TFI). The first step involved validation of microarray gene expression profiles obtained from wild-type and COUP-TFI-/- inner ear tissues. Secondly, we developed a bioinformatic tool to search for COUP-TFI DNA binding sites in genomes, using a classification-type Hidden Markov Model trained with 49 published COUP-TF response elements. We next obtained a ranked list of candidate in vivo direct COUP-TFI targets by integrating the microarray and bioinformatics analyses according to the degree of binding site evolutionary conservation and microarray statistical significance. Lastly, as proof-of-concept, 5 specific genes were validated for direct regulation. For example, the fatty acid binding protein 7 (Fabp7) gene is a direct COUP-TFI target in vivo because: i) we identified 2 conserved COUP-TFI binding sites in the Fabp7 promoter; ii) Fapb7 transcript and protein levels are significantly reduced in COUP-TFI-/- tissues and in MEFs; iii) chromatin immunoprecipitation demonstrates that COUP-TFI is recruited to the Fabp7 promoter in vitro and in vivo and iv) it is associated with active chromatin having increased H3K9 acetylation and enrichment for CBP and SRC-1 binding in the newborn brain. Conclusion: We have developed and validated a methodology to identify in vivo direct nuclear receptor target genes. This bioinformatics tool can be modified to scan for response elements of transcription factors, cis-regulatory modules, or any flexible DNA pattern.	[Montemayor, Celina; Ridgeway, Alex; Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Montemayor, Celina; Montemayor, Oscar A.; Lin, Feng; Pletcher, Scott D.; Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Pereira, Fred A.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Wheeler, David A.; Pletcher, Scott D.; Pereira, Fred A.] Baylor Coll Med, Program Cell & Mol Biol, Houston, TX 77030 USA; [Wheeler, David A.; Pletcher, Scott D.] Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; [Wheeler, David A.] Baylor Coll Med, Ctr Human Genome, Houston, TX 77030 USA; [Pereira, Fred A.] Rice Univ, Dept Bioengn, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University	Montemayor, C (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	fpereira@bcm.edu	Wheeler, David A/M-9740-2018	Wheeler, David A/0000-0002-9056-6299; Pereira, Fred/0000-0003-2100-0280; Ridgeway, Alex/0000-0001-6055-6375	National Institutes of Health [DC04585]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004585, R55DC004585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health DC04585 to FAP (http://www.nidcd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; [Anonymous], IMAGEJ IMAGE PROCESS; Brown KK, 2009, AM J MED GENET A, V149A, P931, DOI 10.1002/ajmg.a.32764; Cabrero A, 2003, MOL PHARMACOL, V64, P764, DOI 10.1124/mol.64.3.764; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Deblois G, 2008, MOL ENDOCRINOL, V22, P1999, DOI 10.1210/me.2007-0546; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durbin R., 1998, BIOL SEQUENCE ANAL P; EDDY S, 1995, HMMER HIDDEN MARKOV; Faedo A, 2008, CEREB CORTEX, V18, P2117, DOI 10.1093/cercor/bhm238; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009; Klockars T, 2003, JARO-J ASSOC RES OTO, V4, P24, DOI 10.1007/s10162-002-2058-2; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin F, 2002, J BIOL CHEM, V277, P21414, DOI 10.1074/jbc.M201885200; Moreno-Pelayo MA, 2003, J MED GENET, V40, P832, DOI 10.1136/jmg.40.11.832; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Myers SA, 2006, J BIOL CHEM, V281, P24149, DOI 10.1074/jbc.M601941200; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; NAPOLI JL, 1995, J STEROID BIOCHEM, V53, P497, DOI 10.1016/0960-0760(95)00096-I; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; *R PROJ, R PROJ STAT COMP; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Romand R, 2000, EUR J NEUROSCI, V12, P2793, DOI 10.1046/j.1460-9568.2000.00165.x; Romand R, 2003, CURR TOP DEV BIOL, V57, P261, DOI 10.1016/S0070-2153(03)57009-0; RONAN D, 2005, CHOLESTEROL MODULATE; ROTTMAN JN, 1993, J BIOL CHEM, V268, P11994; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Schutz F, 2008, BIOINFORMATICS, V24, P1399, DOI 10.1093/bioinformatics/btn201; SLEPECKY NB, 1993, HEARING RES, V70, P73, DOI 10.1016/0378-5955(93)90053-4; Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024; Stafford JM, 2001, J BIOL CHEM, V276, P3811, DOI 10.1074/jbc.M009389200; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tang LS, 2005, GENE EXPR PATTERNS, V5, P587, DOI 10.1016/j.modgep.2005.03.012; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Varga G, 2007, BIODRUGS, V21, P117, DOI 10.2165/00063030-200721020-00006; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Wu J, 2008, J COMPUT BIOL, V15, P279, DOI 10.1089/cmb.2008.0024; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	58	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8910	10.1371/journal.pone.0008910	http://dx.doi.org/10.1371/journal.pone.0008910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111703	Green Published, gold, Green Submitted			2022-12-25	WOS:000274114800013
J	Baker, R; Kent, CV; Silbermann, RA; Hassell, JA; Young, LJT; Howe, LR				Baker, Rebecca; Kent, Claire V.; Silbermann, Rachel A.; Hassell, John A.; Young, Lawrence J. T.; Howe, Louise R.			Pea3 Transcription Factors and Wnt1-Induced Mouse Mammary Neoplasia	PLOS ONE			English	Article							HUMAN BREAST-CANCER; EPIDERMAL-GROWTH-FACTOR; ETS GENE PEA3; MATRIX-METALLOPROTEINASE GENES; TUMOR PROGRESSION; STEM-CELLS; MOLECULAR CHARACTERIZATION; POLYOMAVIRUS ENHANCER; EXPRESSION PATTERNS; INTESTINAL TUMORS	The role of the PEA3 subfamily of Ets transcription factors in breast neoplasia is controversial. Although overexpression of PEA3 (E1AF/ETV4), and of the related factors ERM (ETV5) and ER81 (ETV1), have been observed in human and mouse breast tumors, PEA3 factors have also been ascribed a tumor suppressor function. Here, we utilized the MMTV/Wnt1 mouse strain to further interrogate the role of PEA3 transcription factors in mammary tumorigenesis based on our previous observation that Pea3 is highly expressed in MMTV/Wnt1 mammary tumors. Pea3 expression in mouse mammary tissues was visualized using a Pea3(NLSlacZ) reporter strain. In normal mammary glands, Pea3 expression is predominantly confined to myoepithelial cells. Wnt1 transgene expression induced marked amplification of this cell compartment in nontumorous mammary glands, accompanied by an apparent increase in Pea3 expression. The pattern of Pea3 expression in MMTV/Wnt1 mammary glands recapitulated the cellular profile of activated beta-catenin/TCF signaling, which was visualized using both beta-catenin immunohistochemistry and the beta-catenin/TCF-responsive reporter Axin2(NLSlacZ). To test the requirement for PEA3 factors in Wnt1-induced tumorigenesis, we employed a mammary-targeted dominant negative PEA3 transgene, Delta NPEA3En. Expression of Delta NPEA3En delayed early-onset tumor formation in MMTV/Wnt1 virgin females (P = 0.03), suggesting a requirement for PEA3 factor function for Wnt1-driven tumor formation. Consistent with this observation, expression of the Delta NPEA3En transgene was profoundly reduced in mammary tumors compared to nontumorous mammary glands from bigenic MMTV/Wnt1, MMTV/Delta NPEA3En mice (P = 0.01). Our data provide the first description of Wnt1-mediated expansion of the Pea3-expressing myoepithelial compartment in nontumorous mammary glands. Consistent with this observation, mammary myoepithelium was selectively responsive to Wnt1. Together these data suggest the MMTV/Wnt1 strain as a potential model of basal breast cancer. Furthermore, this study provides evidence for a protumorigenic role of PEA3 factors in breast neoplasia, and supports targeting the PEA3 transcription factor family in breast cancer.	[Baker, Rebecca; Kent, Claire V.; Silbermann, Rachel A.; Howe, Louise R.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Baker, Rebecca; Silbermann, Rachel A.; Howe, Louise R.] Rockefeller Univ, Strang Canc Res Lab, New York, NY 10021 USA; [Hassell, John A.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Young, Lawrence J. T.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	Cornell University; Rockefeller University; McMaster University; University of California System; University of California Davis	Baker, R (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA.	lrhowe@med.cornell.edu		Howe, Louise/0000-0002-1468-7136	National Institutes of Health [R01 CA131219]; Irving Weinstein Foundation Inc.; NATIONAL CANCER INSTITUTE [R01CA131219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irving Weinstein Foundation Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01 CA131219 (L. R. H.) and the Irving Weinstein Foundation Inc. (L. R. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2008, ONCOLOGY-NY, V22, P1233; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Baert JL, 1997, INT J CANCER, V70, P590, DOI 10.1002/(SICI)1097-0215(19970304)70:5<590::AID-IJC17>3.0.CO;2-H; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barrett JM, 2002, BREAST CANCER RES TR, V72, P227, DOI 10.1023/A:1014993006190; Benz CC, 1997, ONCOGENE, V15, P1513, DOI 10.1038/sj.onc.1201331; Bieche I, 2004, CARCINOGENESIS, V25, P405, DOI 10.1093/carcin/bgh024; Boedefeld WM, 2005, MOL CARCINOGEN, V43, P13, DOI 10.1002/mc.20093; Bojovic BB, 2008, DNA CELL BIOL, V27, P289, DOI 10.1089/dna.2007.0680; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; BUTTICE G, 1993, J BIOL CHEM, V268, P7196; Chen JH, 1996, ONCOGENE, V13, P1667; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Chotteau-Lelievre A, 2001, MECH DEVELOP, V108, P191, DOI 10.1016/S0925-4773(01)00480-4; Chotteau-Lelievre A, 2003, DEV BIOL, V259, P241, DOI 10.1016/S0012-1606(03)00182-9; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Crawford HC, 1996, ENZYME PROTEIN, V49, P20, DOI 10.1159/000468614; Crawford HC, 2001, MOL CELL BIOL, V21, P1370, DOI 10.1128/MCB.21.4.1370-1383.2001; Cui XS, 2000, ONCOGENE, V19, P5988, DOI 10.1038/sj.onc.1203993; D'Orazio D, 1997, GENE, V201, P179, DOI 10.1016/S0378-1119(97)00445-9; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Davidson B, 2003, CLIN CANCER RES, V9, P1412; deLaunoit Y, 1997, BIOCHEM MOL MED, V61, P127, DOI 10.1006/bmme.1997.2605; Discenza MT, 2004, FEBS LETT, V560, P183, DOI 10.1016/S0014-5793(04)00104-8; El-Tanani M, 2004, J BIOL CHEM, V279, P20794, DOI 10.1074/jbc.M311131200; Firlej V, 2005, J BIOL CHEM, V280, P887, DOI 10.1074/jbc.M408017200; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Fleming FJ, 2004, J CLIN PATHOL, V57, P1069, DOI 10.1136/jcp.2004.016733; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Guo BQ, 2006, MOL CELL BIOL, V26, P4529, DOI 10.1128/MCB.01667-05; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hesselbrock DR, 2005, BREAST CANCER RES TR, V89, P289, DOI 10.1007/s10549-004-2622-z; Hida K, 1997, AM J PATHOL, V150, P2125; HIGASHINO F, 1993, NUCLEIC ACIDS RES, V21, P547, DOI 10.1093/nar/21.3.547; Hiroumi H, 2001, INT J CANCER, V93, P786, DOI 10.1002/ijc.1410; Horiuchi S, 2003, J PATHOL, V200, P568, DOI 10.1002/path.1387; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Howe LR, 2002, CANCER RES, V62, P5405; Howe LR, 2003, CANCER RES, V63, P1906; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; Iwasaki M, 2004, EXP CELL RES, V299, P525, DOI 10.1016/j.yexcr.2004.06.020; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang JH, 2007, BIOCHEM BIOPH RES CO, V358, P53, DOI 10.1016/j.bbrc.2007.04.043; Kaya M, 1996, ONCOGENE, V12, P221; Kinoshita J, 2002, SURGERY, V131, pS222, DOI 10.1067/msy.2002.119792; Kurpios NA, 2009, DEV BIOL, V325, P106, DOI 10.1016/j.ydbio.2008.09.033; Ladle DR, 2002, PHYSIOL BEHAV, V77, P571, DOI 10.1016/S0031-9384(02)00907-1; Laing MA, 2000, MOL CELL BIOL, V20, P9337, DOI 10.1128/MCB.20.24.9337-9345.2000; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lynch CC, 2004, INT J ONCOL, V24, P1565; MARTIN ME, 1988, P NATL ACAD SCI USA, V85, P5839, DOI 10.1073/pnas.85.16.5839; Matsui K, 2006, ONCOL REP, V16, P153; Menendez JA, 2006, CURR PHARM BIOTECHNO, V7, P495, DOI 10.2174/138920106779116900; MONTE D, 1995, ONCOGENE, V11, P771; MONTE D, 1994, ONCOGENE, V9, P1397; Monte D, 1996, GENOMICS, V35, P236, DOI 10.1006/geno.1996.0345; Myers E, 2006, BRIT J CANCER, V95, P1404, DOI 10.1038/sj.bjc.6603427; Nishida T, 2007, BIOCHEM BIOPH RES CO, V360, P226, DOI 10.1016/j.bbrc.2007.06.037; Nosho K, 2005, CARCINOGENESIS, V26, P892, DOI 10.1093/carcin/bgi029; Perez A, 2003, J BIOL CHEM, V278, P36942, DOI 10.1074/jbc.M300264200; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; RORTH P, 1990, NUCLEIC ACIDS RES, V18, P5009, DOI 10.1093/nar/18.17.5009; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Scott GK, 2000, ONCOGENE, V19, P6490, DOI 10.1038/sj.onc.1204041; SCOTT GK, 1994, J BIOL CHEM, V269, P19848; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shepherd T, 2001, J MAMMARY GLAND BIOL, V6, P129, DOI 10.1023/A:1009576801226; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Span PN, 2003, BREAST CANCER RES TR, V79, P129, DOI 10.1023/A:1023338424677; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; TRIMBLE MS, 1993, ONCOGENE, V8, P3037; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Upadhyay S, 2006, CANCER RES, V66, P7870, DOI 10.1158/0008-5472.CAN-05-2902; Wang SC, 2001, SEMIN ONCOL, V28, P115, DOI 10.1016/S0093-7754(01)90289-1; Wang SC, 2000, DRUGS TODAY, V36, P835; WASYLYK C, 1989, EMBO J, V8, P3371, DOI 10.1002/j.1460-2075.1989.tb08500.x; Xia WY, 2006, BREAST CANCER RES TR, V98, P295, DOI 10.1007/s10549-006-9162-7; XIN JH, 1992, GENE DEV, V6, P481, DOI 10.1101/gad.6.3.481; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294; Yamamoto H, 2004, CARCINOGENESIS, V25, P325, DOI 10.1093/carcin/bgh011; Yu ZM, 2006, MOL CARCINOGEN, V45, P667, DOI 10.1002/mc.20212	96	17	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8854	10.1371/journal.pone.0008854	http://dx.doi.org/10.1371/journal.pone.0008854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107508	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896100018
J	Miao, L; Wang, M; Yin, WX; Yuan, Q; Chen, YX; Fleischmann, B; Hescheler, J; Ji, GJ				Miao, Lin; Wang, Min; Yin, Wen-Xuan; Yuan, Qi; Chen, Ying-Xiao; Fleischmann, Bernd; Hescheler, Juergen; Ji, Guangju			Atrial Natriuretic Peptide Regulates Ca2+ Channel in Early Developmental Cardiomyocytes	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-GMP; GUANYLATE-CYCLASE; ADENYLYL-CYCLASE; CALCIUM CURRENT; K+ CURRENT; IN-VITRO; RECEPTORS; CELLS; NO	Background: Cardiomyocytes derived from murine embryonic stem (ES) cells possess various membrane currents and signaling cascades link to that of embryonic hearts. The role of atrial natriuretic peptide (ANP) in regulation of membrane potentials and Ca2+ currents has not been investigated in developmental cardiomyocytes. Methodology/Principal Findings: We investigated the role of ANP in regulating L-type Ca2+ channel current (I-CaL) in different developmental stages of cardiomyocytes derived from ES cells. ANP decreased the frequency of action potentials (APs) in early developmental stage (EDS) cardiomyocytes, embryonic bodies (EB) as well as whole embryo hearts. ANP exerted an inhibitory effect on basal I-CaL in about 70% EDS cardiomyocytes tested but only in about 30% late developmental stage (LDS) cells. However, after stimulation of I-CaL by isoproterenol (ISO) in LDS cells, ANP inhibited the response in about 70% cells. The depression of I-CaL induced by ANP was not affected by either N omega, Nitro-L-Arginine methyl ester (L-NAME), a nitric oxide synthetase (NOS) inhibitor, or KT5823, a cGMP-dependent protein kinase (PKG) selective inhibitor, in either EDS and LDS cells; whereas depression of I-CaL by ANP was entirely abolished by erythro-9-(2-Hydroxy-3-nonyl) adenine (EHNA), a selective inhibitor of type 2 phosphodiesterase(PDE2) in most cells tested. Conclusion/Significances: Taken together, these results indicate that ANP induced depression of action potentials and I-CaL is due to activation of particulate guanylyl cyclase (GC), cGMP production and cGMP-activation of PDE2 mediated depression of adenosine 3', 5'-cyclic monophophate (cAMP)-cAMP-dependent protein kinase (PKA) in early cardiomyogenesis.	[Miao, Lin; Wang, Min; Yin, Wen-Xuan; Yuan, Qi; Chen, Ying-Xiao; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Fleischmann, Bernd] Univ Bonn, Inst Physiol, D-5300 Bonn, Germany; [Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, Cologne, Germany	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Bonn; University of Cologne	Miao, L (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	J.Hescheler@uni-koeln.de; gj28@ibp.ac.cn	Yuan, Qi/M-9887-2018	Yuan, Qi/0000-0002-4028-8876; Ji, Guangju/0000-0001-8626-3490	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-R-50]; 973 Program [2007CB512100, 2009CB918701]; Foundation of Science and Technology [30670505]; 863 project [2006AA02A106]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); 973 Program(National Basic Research Program of China); Foundation of Science and Technology; 863 project(National High Technology Research and Development Program of China)	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No: KSCX2-YW-R-50), 973 Program (2007CB512100 and 2009CB918701), Foundation of Science and Technology (# 30670505), and 863 project (2006AA02A106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2006, BIOCHEM BIOPH RES CO, V340, P689, DOI 10.1016/j.bbrc.2005.12.057; ANANDSRIVASTAVA MB, 1993, AM J HYPERTENS, V6, P538, DOI 10.1093/ajh/6.6.538; ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; Baumgarten CM, 1995, AM J PHYSIOL-CELL PH, V269, pC1356, DOI 10.1152/ajpcell.1995.269.6.C1356; BKAILY G, 1993, J MOL CELL CARDIOL, V25, P1305, DOI 10.1006/jmcc.1993.1143; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Clemo HF, 1996, J CARDIOVASC ELECTR, V7, P149, DOI 10.1111/j.1540-8167.1996.tb00510.x; CLEMO HF, 1992, J GEN PHYSIOL, V100, P89, DOI 10.1085/jgp.100.1.89; Doyle DD, 1997, CIRC RES, V81, P86, DOI 10.1161/01.RES.81.1.86; Favaretto AIV, 1997, PEPTIDES, V18, P1377, DOI 10.1016/S0196-9781(97)00209-X; Fischmeister R, 2005, COMP BIOCHEM PHYS A, V142, P136, DOI 10.1016/j.cbpb.2005.04.012; GAPOSCHKIN CG, 1990, AM J PHYSIOL, V258, pE543, DOI 10.1152/ajpendo.1990.258.3.E543; GISBERT MP, 1988, CIRC RES, V62, P660, DOI 10.1161/01.RES.62.4.660; HAN R, 1993, J PHYSIOL-LONDON, V461, P743; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; HIWATARI M, 1986, CLIN EXP PHARMACOL P, V13, P163, DOI 10.1111/j.1440-1681.1986.tb00331.x; Ji GJ, 1999, FASEB J, V13, P313, DOI 10.1096/fasebj.13.2.313; KIRSTEIN M, 1995, J CLIN INVEST, V95, P794, DOI 10.1172/JCI117729; KOHYA T, 1989, JPN CIRC J, V53, P1399, DOI 10.1253/jcj.53.1399; Lainchbury JG, 2000, AM J PHYSIOL-HEART C, V278, pH33, DOI 10.1152/ajpheart.2000.278.1.H33; LEGRAND B, 1992, PFLUG ARCH EUR J PHY, V421, P486, DOI 10.1007/BF00370260; LEVI RC, 1989, PFLUG ARCH EUR J PHY, V413, P685, DOI 10.1007/BF00581823; LIN XB, 1995, CIRC RES, V77, P750, DOI 10.1161/01.RES.77.4.750; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; MCCALL D, 1990, J MOL CELL CARDIOL, V22, P201, DOI 10.1016/0022-2828(90)91116-O; MERY PF, 1993, J BIOL CHEM, V268, P26286; MERY PF, 1991, P NATL ACAD SCI USA, V88, P1197, DOI 10.1073/pnas.88.4.1197; NILIUS B, 1986, GEN PHYSIOL BIOPHYS, V5, P473; ONO K, 1991, J PHYSIOL-LONDON, V443, P387, DOI 10.1113/jphysiol.1991.sp018839; Pedram A, 2000, J BIOL CHEM, V275, P7365, DOI 10.1074/jbc.275.10.7365; RESINK TJ, 1988, EUR J BIOCHEM, V174, P531, DOI 10.1111/j.1432-1033.1988.tb14131.x; RUGG EL, 1989, BIOCHEM BIOPH RES CO, V162, P1339, DOI 10.1016/0006-291X(89)90820-6; SAVOIE P, 1995, FEBS LETT, V370, P6, DOI 10.1016/0014-5793(95)00780-D; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SEMIGRAN MJ, 1992, J AM COLL CARDIOL, V20, P98, DOI 10.1016/0735-1097(92)90144-C; SEMMEKROT B, 1991, BIOL NEONATE, V60, P341; SHEETS MF, 1991, SCIENCE, V252, P449, DOI 10.1126/science.1850170; Tajima M, 1998, CIRCULATION, V98, P2760, DOI 10.1161/01.CIR.98.24.2760; TOHSE N, 1995, BRIT J PHARMACOL, V114, P1076, DOI 10.1111/j.1476-5381.1995.tb13316.x; Yoshida T, 2008, INT J CARDIOL, V123, P147, DOI 10.1016/j.ijcard.2006.12.005; ZHOU ZF, 1992, J PHYSIOL-LONDON, V453, P503, DOI 10.1113/jphysiol.1992.sp019242; ZONGAZO MA, 1992, J PHYSIOL-PARIS, V86, P167, DOI 10.1016/0928-4257(92)90003-X	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8847	10.1371/journal.pone.0008847	http://dx.doi.org/10.1371/journal.pone.0008847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107504	gold, Green Published			2022-12-25	WOS:000273896100012
J	Hao, WS; Chang, CPB; Tsao, CC; Xu, J				Hao, Wenshan; Chang, Chao-Pei Betty; Tsao, Cheng-Chung; Xu, Jun			Oligomycin-induced Bioenergetic Adaptation in Cancer Cells with Heterogeneous Bioenergetic Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE; GLYCOLYSIS; METABOLISM; AMPK; 6-PHOSPHOFRUCTO-2-KINASE; PHOSPHORYLATION; PROLIFERATION; TRANSLOCATION; STIMULATION	Cancer cells constantly adapt to oxidative phosphorylation (OXPHOS) suppression resulting from hypoxia or mitochondria defects. Under the OXPHOS suppression, AMP-activated protein kinase (AMPK) regulates global metabolism adjustments, but its activation has been found to be transient. Whether cells can maintain cellular ATP homeostasis and survive beyond the transient AMPK activation is not known. Here, we study the bioenergetic adaptation to the OXPHOS inhibitor oligomycin in a group of cancer cells. We found that oligomycin at 100 ng/ml completely inhibits OXPHOS activity in 1 h and induces various levels of glycolysis gains by 6 h, from which we calculate the bioenergetic organizations of cancer cells. In glycolysis-dominant cells, oligomycin does not induce much energy stress as measured by glycolysis acceleration, ATP imbalance, AMPK activation, AMPK substrate acetyl-CoA carboxylase phosphorylation at Ser(79), and cell growth inhibition. In OXPHOS-dependent LKB1 wild type cells, oligomycin induces 5-8% ATP drops and transient AMPK activation during the initial 1-2 h. After AMPK activation is completed, oligomycin-induced increase of acetyl-CoA carboxylase phosphorylation at Ser(79) is still detected, and cellular ATP is back at preoligomycin treatment levels by sustained elevation of glycolysis. Cell growth, however, is inhibited without an increase in cell death and alteration in cell cycle distribution. In OXPHOS-dependent LKB1-null cells, no AMPK activation by oligomycin is detected, yet cells still show a similar adaptation. We also demonstrate that the adaptation to oligomycin does not invoke activation of hypoxia-induced factor. Our data suggest that cancer cells may grow and survive persistent OXPHOS suppression through an as yet unidentified regulatory mechanism.	[Hao, Wenshan; Chang, Chao-Pei Betty; Tsao, Cheng-Chung; Xu, Jun] Wyeth Res, Dept Oncol, Pearl River, NY 10965 USA	Pfizer	Hao, WS (corresponding author), Wyeth Res, Dept Oncol, 401 Middletown Rd 200-4614, Pearl River, NY 10965 USA.	ytwhao@yahoo.com						Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Capuano F, 1997, J BIOENERG BIOMEMBR, V29, P379, DOI 10.1023/A:1022402915431; Cuezva JM, 2002, CANCER RES, V62, P6674; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hardie DG, 2000, CURR BIOL, V10, pR757, DOI 10.1016/S0960-9822(00)00744-2; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	24	88	92	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12647	12654		10.1074/jbc.M109.084194	http://dx.doi.org/10.1074/jbc.M109.084194			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20110356	Green Published, hybrid			2022-12-25	WOS:000276787800023
J	Zhang, Y; Raudah, S; Teo, H; Teo, GWS; Fan, RL; Sun, XM; Orner, BP				Zhang, Yu; Raudah, Siti; Teo, Huihian; Teo, Gwenda W. S.; Fan, Rongli; Sun, Xiaoming; Orner, Brendan P.			Alanine-shaving Mutagenesis to Determine Key Interfacial Residues Governing the Assembly of a Nano-cage Maxi-ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HOT-SPOTS; PROTEIN CAGES; H-CHAIN; BUILDING-BLOCKS; VIRUS-PARTICLES; HORSE SPLEEN; HELIX; DNA; BACTERIOFERRITIN	The fundamental process of protein self-assembly is governed by protein-protein interactions between subunits, which combine to form structures that are often on the nano-scale. The nano-cage protein, bacterioferritin from Escherichia coli, a maxi-ferritin made up of 24 subunits, was chosen as the basis for an alanine-shaving mutagenesis study to discover key amino acid residues at symmetry-related protein-protein interfaces that control protein stability and self-assembly. By inspection of these interfaces and "virtual alanine scanning," nine mutants were designed, expressed, purified, and characterized using transmission electron microscopy, size exclusion chromatography, dynamic light scattering, native PAGE, and temperature-dependent CD. Many of the selected amino acids act as hot spot residues. Four of these (Arg-30, which is located at the two-fold axis, and Arg-61, Tyr-114, and Glu-128, which are located at the three-fold axis), when individually mutated to alanine, completely shut down detectable solution formation of 24-mer, favoring a cooperatively folded dimer, suggesting that they may be oligomerization "switch residues." Furthermore, two residues, Arg-30 and Arg-61, when changed to alanine form mutants that are more thermodynamically stable than the native protein. This investigation into the structure and energetics of this self-assembling nano-cage protein not only can act as a jumping off point for the eventual design of novel protein nanostructures but can also help to understand the role that structure plays on the function of this important class of proteins.	[Zhang, Yu; Raudah, Siti; Teo, Huihian; Teo, Gwenda W. S.; Fan, Rongli; Sun, Xiaoming; Orner, Brendan P.] Nanyang Technol Univ, Div Chem & Biol Chem, Sch Phys & Math Sci, Singapore 637371, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Orner, BP (corresponding author), Nanyang Technol Univ, Div Chem & Biol Chem, Sch Phys & Math Sci, 21 Nanyang Link, Singapore 637371, Singapore.	orner@ntu.edu.sg	Lazim, Raudah/N-2119-2018	ZHANG, YU/0000-0002-2614-5975	School of Physical and Mathematical Sciences (SPMS); Singapore Ministry of Education Academic Research Fund Tier 1 [RG 53/06]	School of Physical and Mathematical Sciences (SPMS); Singapore Ministry of Education Academic Research Fund Tier 1(Ministry of Education, Singapore)	This work was supported by a School of Physical and Mathematical Sciences (SPMS) start up grant and Singapore Ministry of Education Academic Research Fund Tier 1 Grant RG 53/06.	ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ANDREWS SC, 1993, EUR J BIOCHEM, V213, P329, DOI 10.1111/j.1432-1033.1993.tb17766.x; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bromley EHC, 2008, ACS CHEM BIOL, V3, P38, DOI 10.1021/cb700249v; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Calhoun JR, 2008, J AM CHEM SOC, V130, P9188, DOI 10.1021/ja801657y; Chamberlain AK, 2004, J MOL BIOL, V339, P471, DOI 10.1016/j.jmb.2004.03.072; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Dautant A, 1998, ACTA CRYSTALLOGR D, V54, P16, DOI 10.1107/S0907444997006811; Destito G, 2007, CHEM BIOL, V14, P1152, DOI 10.1016/j.chembiol.2007.08.015; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Fan RL, 2009, BIOCHEMISTRY-US, V48, P5623, DOI 10.1021/bi900387t; Fletcher S, 2007, CURR TOP MED CHEM, V7, P922, DOI 10.2174/156802607780906735; GERL M, 1988, BIOCHEMISTRY-US, V27, P4089, DOI 10.1021/bi00411a027; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Ingrassia R, 2006, J BIOCHEM, V139, P881, DOI 10.1093/jb/mvj101; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; JIN L, 1994, PROTEIN SCI, V3, P2351, DOI 10.1002/pro.5560031219; Kennedy D, 2005, SCIENCE, V309, P75, DOI 10.1126/science.309.5731.75; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; KORTEMME T, 2004, SCI STKE, P12, DOI DOI 10.1126/STKE.2192004P12; Levi S, 2005, BEST PRACT RES CL HA, V18, P265, DOI 10.1016/j.beha.2004.08.021; LEVI S, 1989, BIOCHEM J, V264, P381, DOI 10.1042/bj2640381; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; LUZZAGO A, 1989, EMBO J, V8, P569, DOI 10.1002/j.1460-2075.1989.tb03411.x; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104; Pieraccini S, 2009, NAT CHEM, V1, P642, DOI [10.1038/nchem.401, 10.1038/NCHEM.401]; Ren Y, 2007, BIOCONJUGATE CHEM, V18, P836, DOI 10.1021/bc060361p; SEGREST JP, 1992, J LIPID RES, V33, P141; Seringhaus M, 2007, SCIENCE, V315, P40, DOI 10.1126/science.315.5808.40; STEFANINI S, 1987, BIOCHEMISTRY-US, V26, P1831, DOI 10.1021/bi00381a007; Tong GJ, 2009, J AM CHEM SOC, V131, P11174, DOI 10.1021/ja903857f; Turk JA, 2001, J ORG CHEM, V66, P8328, DOI 10.1021/jo0106849; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Vidal R, 2003, J NEUROL SCI, V207, P110, DOI 10.1016/S0022-510X(02)00435-5; Wang Q, 2002, ANGEW CHEM INT EDIT, V41, P459; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P457, DOI 10.1016/j.autrev.2007.01.016	45	41	43	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12078	12086		10.1074/jbc.M109.092445	http://dx.doi.org/10.1074/jbc.M109.092445			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20139406	hybrid, Green Published			2022-12-25	WOS:000276787100037
J	Hong, MP; Vu, K; Bautos, J; Gelli, A				Hong, Min-Pyo; Vu, Kiem; Bautos, Jennifer; Gelli, Angie			Cch1 Restores Intracellular Ca2+ in Fungal Cells during Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENOMIC ANALYSIS; PLASMA-MEMBRANE; CALCIUM-ENTRY; CRAC CHANNELS; STORE; PROTEIN; GROWTH; HOMOLOG; INFLUX	Pathogens endure and proliferate during infection by exquisitely coping with the many stresses imposed by the host to prevent pathogen survival. Recent evidence has shown that fungal pathogens and yeast respond to insults to the endoplasmic reticulum (ER) by initiating Ca2(+) influx across their plasma membrane. Although the high affinity Ca2(+) channel, Cch1, and its subunit Mid1, have been suggested as the protein complex responsible for mediating Ca2(+) influx, a direct demonstration of the gating mechanism of the Cch1 channel remains elusive. In this first mechanistic study of Cch1 channel activity we show that the Cch1 channel from the model human fungal pathogen, Cryptococcus neoformans, is directly activated by the depletion of intracellular Ca2(+) stores. Electrophysiological analysis revealed that agents that enable ER Ca2(+) store depletion promote the development of whole cell inward Ca2(+) currents through Cch1 that are effectively blocked by La3(+) and dependent on the presence of Mid1. Cch1 is permeable to both Ca2(+) and Ba2(+); however, unexpectedly, in contrast to Ca2(+) currents, Ba2(+) currents are steeply voltage-dependent. Cch1 maintains a strong Ca2(+) selectivity even in the presence of high concentrations of monovalent ions. Single channel analysis indicated that Cch1 channel conductance is small, similar to that reported for the Ca2(+) current I-CRAC. This study demonstrates that Cch1 functions as a store-operated Ca2(+)-selective channel that is gated by intracellular Ca2(+) depletion. The inability of cryptococcal cells that lacked the Cch1-Mid1 channel to survive ER stress suggests that Cch1 and its co-regulator, Mid1, are critical players in the restoration of Ca2(+) homeostasis.	[Hong, Min-Pyo; Vu, Kiem; Bautos, Jennifer; Gelli, Angie] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA	University of California System; University of California Davis	Gelli, A (corresponding author), Genome & Biomed Sci Facil, 451 Hlth Sci Dr, Davis, CA 95616 USA.	acgelli@ucdavis.edu	Vu, Kiem/GQZ-3955-2022; Gelli, Angie/F-1764-2018		National Institutes of Health [AI054477, AI078848]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078848, R01AI054477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI054477 and AI078848 ( to A. G.).	Bakowski D, 2007, CELL CALCIUM, V42, P333, DOI 10.1016/j.ceca.2007.01.005; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Durell SR, 2004, BIOPHYS J, V87, P2116, DOI 10.1529/biophysj.104.040618; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fan W, 2007, INFECT IMMUN, V75, P3394, DOI 10.1128/IAI.01977-06; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Hallen HE, 2008, EUKARYOT CELL, V7, P415, DOI 10.1128/EC.00248-07; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; Kauffman CA, 2006, CURR OPIN MICROBIOL, V9, P483, DOI 10.1016/j.mib.2006.08.001; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; Liu M, 2008, EUKARYOT CELL, V7, P1118, DOI 10.1128/EC.00116-08; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Vu K, 2009, ANAL BIOCHEM, V393, P234, DOI 10.1016/j.ab.2009.06.039; Yoshimura H, 2004, EXP CELL RES, V293, P185, DOI 10.1016/j.yexcr.2003.09.020; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	40	44	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10951	10958		10.1074/jbc.M109.056218	http://dx.doi.org/10.1074/jbc.M109.056218			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123986	Green Published, hybrid			2022-12-25	WOS:000276264600079
J	Venkataramani, V; Rossner, C; Iffland, L; Schweyer, S; Tamboli, IY; Walter, J; Wirths, O; Bayer, TA				Venkataramani, Vivek; Rossner, Christian; Iffland, Lara; Schweyer, Stefan; Tamboli, Irfan Y.; Walter, Jochen; Wirths, Oliver; Bayer, Thomas A.			Histone Deacetylase Inhibitor Valproic Acid Inhibits Cancer Cell Proliferation via Down-regulation of the Alzheimer Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA-CELLS; BETA-PROTEIN; IN-VIVO; INCREASED EXPRESSION; RNA INTERFERENCE; SODIUM VALPROATE; GENE-EXPRESSION; CARCINOMA-CELLS; ALPHA-SECRETASE; GROWTH	The beta-amyloid precursor protein (APP) represents a type I transmembrane glycoprotein that is ubiquitously expressed. In the brain, it is a key player in the molecular pathogenesis of Alzheimer disease. Its physiological function is however less well understood. Previous studies showed that APP is up-regulated in prostate, colon, pancreatic tumor, and oral squamous cell carcinoma. In this study, we show that APP has an essential role in growth control of pancreatic and colon cancer. Abundant APP staining was found in human pancreatic adenocarcinoma and colon cancer tissue. Interestingly, treating pancreatic and colon cancer cells with valproic acid (VPA, 2-propylpentanoic acid), a known histone deacetylase (HDAC) inhibitor, leads to up-regulation of GRP78, an endoplasmic reticulum chaperone immunoglobulin-binding protein. GRP78 is involved in APP maturation and inhibition of tumor cell growth by down-regulation of APP and secreted soluble APP alpha. Trichostatin A, a pan-HDAC inhibitor, also lowered APP and increased GRP78 levels. In contrast, treating cells with valpromide, a VPA derivative lacking HDAC inhibitory properties, had no effect on APP levels. VPA did not modify the level of epidermal growth factor receptor, another type I transmembrane protein, and APLP2, a member of the APP family, demonstrating the specificity of the VPA effect on APP. Small interfering RNA-mediated knockdown of APP also resulted in significantly decreased cell growth. Based on these observations, the data suggest that APP downregulation via HDAC inhibition provides a novel mechanism for pancreatic and colon cancer therapy.	[Venkataramani, Vivek; Rossner, Christian; Iffland, Lara; Wirths, Oliver; Bayer, Thomas A.] Univ Goettingen, Dept Mol Psychiat, Alzheimer PhD Grad Sch, D-37075 Gottingen, Germany; [Schweyer, Stefan] Univ Goettingen, Dept Pathol, D-37075 Gottingen, Germany; [Tamboli, Irfan Y.; Walter, Jochen] Univ Bonn, Dept Mol Cell Biol, D-53127 Bonn, Germany	University of Gottingen; University of Gottingen; University of Bonn	Bayer, TA (corresponding author), Univ Med, Div Mol Psychiat, Von Siebold Str 5, D-37075 Gottingen, Germany.	tbayer@gwdg.de	Wirths, Oliver/C-7342-2019; Wang, Caihong/T-5837-2019; Rossner, Christian/R-1901-2016; Walter, Jochen/B-3677-2014	Wirths, Oliver/0000-0002-4115-0334; Wang, Caihong/0000-0002-6808-3709; Rossner, Christian/0000-0002-3428-3542; Walter, Jochen/0000-0002-4678-2912; Venkataramani, Vivek/0000-0002-6771-365X	Alzheimer Forschung Initiative e.V.; European Commission [MEST-CT-2005-020013]	Alzheimer Forschung Initiative e.V.; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Alzheimer Forschung Initiative e.V. (to O. W.) and the European Commission (Marie Curie Early Stage Training, MEST-CT-2005-020013 (NEURAD)).	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; Bayer TA, 2001, BRAIN PATHOL, V11, P1; Bayer TA, 1999, MOL PSYCHIATR, V4, P524, DOI 10.1038/sj.mp.4000552; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Blaheta RA, 2002, MED RES REV, V22, P492, DOI 10.1002/med.10017; Blaheta RA, 2005, MED RES REV, V25, P383, DOI 10.1002/med.20027; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Botelho MG, 2010, J INVEST DERMATOL, V130, P1400, DOI 10.1038/jid.2009.296; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chavez-Blanco A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-2; Chen CL, 2006, J PHARMACOL EXP THER, V319, P533, DOI 10.1124/jpet.106.106658; Christensen DZ, 2008, ACTA NEUROPATHOL, V116, P647, DOI 10.1007/s00401-008-0451-6; Cinatl J, 1997, ANTI-CANCER DRUG, V8, P958, DOI 10.1097/00001813-199711000-00007; Cohen G, 2006, CANCER RES, V66, P5656, DOI 10.1158/0008-5472.CAN-05-0308; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Duenas-Gonzalez A, 2008, CANCER TREAT REV, V34, P206, DOI 10.1016/j.ctrv.2007.11.003; Duncan S, 2007, CURR OPIN NEUROL, V20, P175, DOI 10.1097/WCO.0b013e32805866fb; DYRKS T, 1992, FEBS LETT, V309, P20, DOI 10.1016/0014-5793(92)80730-5; Erhuma M, 2007, INT J CANCER, V120, P2393, DOI 10.1002/ijc.22252; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; GRAY CW, 1993, NEUROREPORT, V4, P811, DOI 10.1097/00001756-199306000-00054; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansel DE, 2003, CANCER RES, V63, P7032; Henry Thomas R, 2003, Psychopharmacol Bull, V37 Suppl 2, P5; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hoffmann J, 2000, EUR J CELL BIOL, V79, P905, DOI 10.1078/0171-9335-00117; Hooper NM, 2002, CURR MED CHEM, V9, P1107, DOI 10.2174/0929867023370121; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; JIN LW, 1994, J NEUROSCI, V14, P5461; Khabele D, 2007, CANCER BIOL THER, V6, P795, DOI 10.4161/cbt.6.5.4007; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Knupfer MM, 1998, ANTICANCER RES, V18, P3585; Ko SY, 2004, INT J CANCER, V111, P727, DOI 10.1002/ijc.20328; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Lagace DC, 2004, J BIOL CHEM, V279, P18851, DOI 10.1074/jbc.M312795200; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; LOSCHER W, 1985, NEUROPHARMACOLOGY, V24, P427, DOI 10.1016/0028-3908(85)90028-0; Meng JY, 2001, INT J CANCER, V92, P31, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1155>3.3.CO;2-8; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; Mote PL, 1998, MECH AGEING DEV, V104, P149, DOI 10.1016/S0047-6374(98)00064-5; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Ott MO, 2001, DEV GENES EVOL, V211, P355; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Pietrzik CU, 1998, P NATL ACAD SCI USA, V95, P1770, DOI 10.1073/pnas.95.4.1770; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; RADINSKY R, 1995, CLIN CANCER RES, V1, P19; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Roe CM, 2010, NEUROLOGY, V74, P106, DOI 10.1212/WNL.0b013e3181c91873; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Rossner S, 1998, PROG NEUROBIOL, V56, P541, DOI 10.1016/S0301-0082(98)00044-6; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Sakai T, 2006, CELL BIOL INT, V30, P952, DOI 10.1016/j.cellbi.2006.06.018; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; SERRANO J, 2010, ONCOGENE        0125, DOI DOI 10.1038/ONC.2009.503; Shi YY, 2007, BIOORG MED CHEM LETT, V17, P4491, DOI 10.1016/j.bmcl.2007.06.006; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Small D H, 1999, J Alzheimers Dis, V1, P275; Sondag CM, 2004, J BIOL CHEM, V279, P14456, DOI 10.1074/jbc.M313747200; Stettner M, 2007, MOL CANCER THER, V6, P2626, DOI 10.1158/1535-7163.MCT-07-0197; Stockhausen MT, 2005, BRIT J CANCER, V92, P751, DOI 10.1038/sj.bjc.6602309; Takayama KI, 2009, CANCER RES, V69, P137, DOI 10.1158/0008-5472.CAN-08-3633; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Valentini A, 2007, CANCER BIOL THER, V6, P185, DOI 10.4161/cbt.6.2.3578; Van Broeck B, 2007, NEURODEGENER DIS, V4, P349, DOI 10.1159/000105156; Villa A, 2001, J NEUROCHEM, V77, P1077, DOI 10.1046/j.1471-4159.2001.00315.x; Wang JF, 1999, MOL PHARMACOL, V55, P521; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; Wirths O, 2007, BRAIN RES, V1152, P209, DOI 10.1016/j.brainres.2007.03.029; Witt O, 2009, CANCER LETT, V280, P123, DOI 10.1016/j.canlet.2009.02.038; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xia QH, 2006, CANCER RES, V66, P7237, DOI 10.1158/0008-5472.CAN-05-0487; YAMAMOTO K, 1994, J NEUROBIOL, V25, P585, DOI 10.1002/neu.480250510; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	87	99	106	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10678	10689		10.1074/jbc.M109.057836	http://dx.doi.org/10.1074/jbc.M109.057836			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145244	Green Published, hybrid			2022-12-25	WOS:000276264600055
J	Walls, KC; Ghosh, AP; Franklin, AV; Klocke, BJ; Ballestas, M; Shacka, JJ; Zhang, JH; Roth, KA				Walls, Ken C.; Ghosh, Arindam P.; Franklin, Aimee V.; Klocke, Barbara J.; Ballestas, Mary; Shacka, John J.; Zhang, Jianhua; Roth, Kevin A.			Lysosome Dysfunction Triggers Atg7-dependent Neural Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; AUTOPHAGIC CELL-DEATH; DEFICIENT MICE; BCL-2 FAMILY; DEPENDENT APOPTOSIS; CASPASE ACTIVATION; MEDIATED CLEAVAGE; P53; BRAIN; 3-KINASE	Macroautophagy (autophagy) is a process wherein bulk cytosolic proteins and damaged organelles are sequestered and degraded via the lysosome. Alterations in autophagy-associated proteins have been shown to cause neural tube closure defects, neurodegeneration, and tumor formation. Normal lysosome function is critical for autophagy completion and when altered may lead to an accumulation of autophagic vacuoles (AVs) and caspase activation. The tumor suppressor p53 is highly expressed in neural precursor cells (NPCs) and has an important role in the regulation of both autophagy and apoptosis. We hypothesized that altered lysosome function would lead to NPC death via an interaction between autophagy-and apoptosis-associated proteins. To test our hypothesis, we utilized FGF2-expanded NPCs and the neural stem cell line, C17.2, in combination with the lysosomotropic agent chloroquine (CQ) and the vacuolar ATPase inhibitor bafilomycin A1 (Baf A1). Both CQ and Baf A1 caused concentration-and time-dependent AV accumulation, p53 phosphorylation, increased damage regulator autophagy modulator levels, caspase-3 activation, and cell death. Short hairpin RNA knockdown of Atg7, but not Beclin1, expression significantly inhibited CQ-and Baf A1-induced cell death, indicating that Atg7 is an upstream mediator of lysosome dysfunction-induced cell death. Cell death and/or caspase-3 activation was also attenuated by protein synthesis inhibition, p53 deficiency, or Bax deficiency, indicating involvement of the intrinsic apoptotic death pathway. In contrast to lysosome dysfunction, starvation-induced AV accumulation was inhibited by either Atg7 or Beclin1 knockdown, and Atg7 knockdown had no effect on starvation-induced death. These findings indicate that Atg7-and Beclin1-induced autophagy plays a cytoprotective role during starvation but that Atg7 has a unique pro-apoptotic function in response to lysosome dysfunction.	[Walls, Ken C.; Ghosh, Arindam P.; Franklin, Aimee V.; Klocke, Barbara J.; Shacka, John J.; Zhang, Jianhua; Roth, Kevin A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Walls, Ken C.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Ghosh, Arindam P.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Ballestas, Mary] Univ Alabama Birmingham, Dept Pediat & Infect Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Walls, KC (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	kcwalls@uab.edu; karoth@uab.edu	zhang, jianhua/D-3404-2009	Ballestas, Mary/0000-0003-0660-9477; Roth, Kevin/0000-0002-0643-995X; Zhang, Jianhua/0000-0002-2128-9574	National Institutes of Health [NS35107, NS41962, CA134773]; NATIONAL CANCER INSTITUTE [R01CA134773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035107, P30NS057098, R01NS041962, P30NS047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS35107, NS41962, and CA134773.	Akhtar RS, 2006, CELL DEATH DIFFER, V13, P1727, DOI 10.1038/sj.cdd.4401879; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Canu N, 2005, J NEUROCHEM, V92, P1228, DOI 10.1111/j.1471-4159.2004.02956.x; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Clarke PGH, 2002, TRENDS PHARMACOL SCI, V23, P308, DOI 10.1016/S0165-6147(02)02041-2; Codogno P, 2006, NAT CELL BIOL, V8, P1045, DOI 10.1038/ncb1006-1045; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Eizenberg O, 1996, MOL CELL BIOL, V16, P5178; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Geng Y, 2007, J NEUROPATH EXP NEUR, V66, P66, DOI 10.1097/nen.0b013e31802d4ab4; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Guillon-Munos A, 2005, APOPTOSIS, V10, P1031, DOI 10.1007/s10495-005-0741-6; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Saftig P, 1997, J BIOL CHEM, V272, P18628, DOI 10.1074/jbc.272.30.18628; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1299, DOI 10.1038/sj.cdd.4401974; Shacka JJ, 2006, AUTOPHAGY, V2, P228, DOI 10.4161/auto.2703; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shacka JJ, 2007, J NEUROSCI, V27, P2081, DOI 10.1523/JNEUROSCI.5577-06.2007; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Wagner M, 2005, NAT CELL BIOL, V7, P212, DOI 10.1038/ncb0305-212; Walls KC, 2007, AUTOPHAGY, V3, P222, DOI 10.4161/auto.3822; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Windelborn JA, 2008, J NEUROCHEM, V106, P56, DOI 10.1111/j.1471-4159.2008.05349.x; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zaidi AU, 2001, J NEUROPATH EXP NEUR, V60, P937, DOI 10.1093/jnen/60.10.937	51	67	69	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10497	10507		10.1074/jbc.M110.103747	http://dx.doi.org/10.1074/jbc.M110.103747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123985	hybrid, Green Published			2022-12-25	WOS:000276264600036
J	Lin, E; Kiniboro, B; Gray, L; Dobbie, S; Robinson, L; Laumaea, A; Schopflin, S; Stanisic, D; Betuela, I; Blood-Zikursh, M; Siba, P; Felger, I; Schofield, L; Zimmerman, P; Mueller, I				Lin, Enmoore; Kiniboro, Benson; Gray, Laurie; Dobbie, Stuart; Robinson, Leanne; Laumaea, Annemarie; Schoepflin, Sonja; Stanisic, Danielle; Betuela, Inoni; Blood-Zikursh, Melinda; Siba, Peter; Felger, Ingrid; Schofield, Louis; Zimmerman, Peter; Mueller, Ivo			Differential Patterns of Infection and Disease with P. falciparum and P. vivax in Young Papua New Guinean Children	PLOS ONE			English	Article							DUFFY-BINDING-PROTEIN; EAST SEPIK PROVINCE; PLASMODIUM-VIVAX; RETROSPECTIVE EXAMINATION; ANTIGENIC VARIATION; ACQUIRED-IMMUNITY; MALARIA PARASITES; CLINICAL IMMUNITY; KAREN POPULATION; SURFACE-ANTIGENS	Background: Where P. vivax and P. falciparum occur in the same population, the peak burden of P. vivax infection and illness is often concentrated in younger age groups. Experiences from malaria therapy patients indicate that immunity is acquired faster to P. vivax than to P. falciparum challenge. There is however little prospective data on the comparative risk of infection and disease from both species in young children living in co-endemic areas. Methodology/Principal Findings: A cohort of 264 Papua New Guinean children aged 1-3 years (at enrolment) were actively followed-up for Plasmodium infection and febrile illness for 16 months. Infection status was determined by light microscopy and PCR every 8 weeks and at each febrile episode. A generalised estimating equation (GEE) approach was used to analyse both prevalence of infection and incidence of clinical episodes. A more pronounced rise in prevalence of P. falciparum compared to P. vivax infection was evident with increasing age. Although the overall incidence of clinical episodes was comparable (P. falciparum: 2.56, P. vivax 2.46 episodes / child / yr), P. falciparum and P. vivax infectious episodes showed strong but opposing age trends: P. falciparum incidence increased until the age of 30 months with little change thereafter, but incidence of P. vivax decreased significantly with age throughout the entire age range. For P. falciparum, both prevalence and incidence of P. falciparum showed marked seasonality, whereas only P. vivax incidence but not prevalence decreased in the dry season. Conclusions/Significance: Under high, perennial exposure, children in PNG begin acquiring significant clinical immunity, characterized by an increasing ability to control parasite densities below the pyrogenic threshold to P. vivax, but not to P. falciparum, in the 2(nd) and 3(rd) year of life. The ability to relapse from long-lasting liver-stages restricts the seasonal variation in prevalence of P. vivax infections.	[Lin, Enmoore; Kiniboro, Benson; Dobbie, Stuart; Laumaea, Annemarie; Stanisic, Danielle; Betuela, Inoni; Siba, Peter; Mueller, Ivo] PNG Inst Med Res, Madang, Papua N Guinea; [Gray, Laurie; Blood-Zikursh, Melinda; Zimmerman, Peter] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Robinson, Leanne; Stanisic, Danielle; Schofield, Louis] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Robinson, Leanne] Univ Melbourne, Dept Med Biol, Melbourne, Australia; [Schoepflin, Sonja; Felger, Ingrid] Swiss Trop Inst, CH-4002 Basel, Switzerland	PNG Institute Of Medical Research; Case Western Reserve University; Walter & Eliza Hall Institute; University of Melbourne; University of Basel; Swiss Tropical & Public Health Institute	Lin, E (corresponding author), PNG Inst Med Res, Madang, Papua N Guinea.	ivomueller@fastmail.fm	Mueller, Ivo/C-7251-2013; Laumaea, Annemarie/AGC-1405-2022	Mueller, Ivo/0000-0001-6554-6889; Stanisic, Danielle/0000-0003-3908-7468; Lin, Enmoore/0000-0002-8584-7627; Laumaea, Annemarie/0000-0002-4934-597X; Felger, Ingrid/0000-0003-1255-2606; Zimmerman, Peter/0000-0002-5349-4513	National Institutes of Health [AI063135, AI-46919, TW007872]; Swiss National Science Foundation [31003A-112196]; Australian Agency for International Development (AusAID); National Health and Medical Research Council [516735]; FOGARTY INTERNATIONAL CENTER [R01TW007872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI063135, R01AI046919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported with funding from National Institutes of Health (AI063135, AI-46919, and TW007872), the Swiss National Science Foundation (grant no. 31003A-112196), the Australian Agency for International Development (AusAID) and the National Health and Medical Research Council (Grant no. 516735). LS is an International Research Scholar of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Arevalo-Herrera M, 2001, MOL IMMUNOL, V38, P443, DOI 10.1016/S0161-5890(01)00080-3; BALFOUR M. C., 1935, American Journal of Tropical Medicine, V15, P301; Beeson JG, 2002, CELL MOL LIFE SCI, V59, P258, DOI 10.1007/s00018-002-8421-y; Bockarie MJ, 1996, T ROY SOC TROP MED H, V90, P23, DOI 10.1016/S0035-9203(96)90465-4; Bockarie MJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-15; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Ciuca M., 1934, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V27, P619, DOI 10.1016/S0035-9203(34)90111-5; Cole-Tobian JL, 2002, J INFECT DIS, V186, P531, DOI 10.1086/341776; Collins WE, 2004, AM J TROP MED HYG, V70, P642, DOI 10.4269/ajtmh.2004.70.642; Collins WE, 2004, AM J TROP MED HYG, V70, P638, DOI 10.4269/ajtmh.2004.70.638; Collins WE, 1999, AM J TROP MED HYG, V61, P20, DOI 10.4269/tropmed.1999.61-020; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; D'Ombrain MC, 2008, CLIN INFECT DIS, V47, P1380, DOI 10.1086/592971; EARLE W. C., 1939, Puerto Rico Journal of Public Health and Tropical Medicine, V15, P3; Fernandez-Becerra C, 2009, TRENDS PARASITOL, V25, P44, DOI 10.1016/j.pt.2008.09.012; GENTON B, 1995, ANN TROP MED PARASIT, V89, P377, DOI 10.1080/00034983.1995.11812966; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; GRAVES PM, 1988, PARASITOLOGY, V96, P251, DOI 10.1017/S003118200005825X; GUNEWARDENA DM, 1994, MEM I OSWALDO CRUZ, V89, P63, DOI 10.1590/S0074-02761994000600015; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Kasehagen LJ, 2006, AM J TROP MED HYG, V75, P588, DOI 10.4269/ajtmh.2006.75.588; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; LUXEMBURGER C, 1994, T ROY SOC TROP MED H, V88, P155, DOI 10.1016/0035-9203(94)90273-9; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; McNamara DT, 2006, AM J TROP MED HYG, V74, P413, DOI 10.4269/ajtmh.2006.74.413; McNamara DT, 2004, J CLIN MICROBIOL, V42, P2403, DOI 10.1128/JCM.42.6.2403-2410.2004; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mueller Ivo, 2009, Malar J, V8, P41, DOI 10.1186/1475-2875-8-41; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; MULLER I, MALAR J IN PRESS; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Smith T, 2001, T ROY SOC TROP MED H, V95, P1, DOI 10.1016/S0035-9203(01)90314-1; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Vestergaard LS, 2008, INFECT IMMUN, V76, P2706, DOI 10.1128/IAI.01401-06; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x; Yazdani SS, 2006, CURR MOL MED, V6, P187, DOI 10.2174/156652406776055212	50	107	108	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9047	10.1371/journal.pone.0009047	http://dx.doi.org/10.1371/journal.pone.0009047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140220	Green Published, Green Accepted, gold			2022-12-25	WOS:000274474400006
J	Turcan, S; Slonim, DK; Vetter, DE				Turcan, Sevin; Slonim, Donna K.; Vetter, Douglas E.			Lack of nAChR Activity Depresses Cochlear Maturation and Up-Regulates GABA System Components: Temporal Profiling of Gene Expression in alpha 9 Null Mice	PLOS ONE			English	Article							INNER HAIR-CELLS; NICOTINIC CHOLINERGIC-RECEPTOR; UBIQUITIN PROTEASOME SYSTEM; SUPERIOR OLIVARY COMPLEX; POTASSIUM CHANNELS; SYNAPTIC GROWTH; GUINEA-PIG; OLIVOCOCHLEAR PROJECTIONS; CHRONIC DEEFFERENTATION; ACETYLCHOLINE-RECEPTOR	Background: It has previously been shown that deletion of chrna9, the gene encoding the alpha 9 nicotinic acetylcholine receptor (nAChR) subunit, results in abnormal synaptic terminal structure. Additionally, all nAChR-mediated cochlear activity is lost, as characterized by a failure of the descending efferent system to suppress cochlear responses to sound. In an effort to characterize the molecular mechanisms underlying the structural and functional consequences following loss of alpha 9 subunit expression, we performed whole-transcriptome gene expression analyses on cochleae of wild type and alpha 9 knockout (alpha 9(-/-)) mice during postnatal days spanning critical periods of synapse formation and maturation. Principal Findings: Data revealed that loss of alpha 9 receptor subunit expression leads to an up-regulation of genes involved in synaptic transmission and ion channel activity. Unexpectedly, loss of alpha 9 receptor subunit expression also resulted in an increased expression of genes encoding GABA receptor subunits and the GABA synthetic enzyme, glutamic acid decarboxylase. These data suggest the existence of a previously unrecognized association between the nicotinic cholinergic and GABAergic systems in the cochlea. Computational analyses have highlighted differential expression of several gene sets upon loss of nicotinic cholinergic activity in the cochlea. Time-series analysis of whole transcriptome patterns, represented as self-organizing maps, revealed a disparate pattern of gene expression between alpha 9(-/-) and wild type cochleae at the onset of hearing (P13), with knockout samples resembling immature postnatal ages. Conclusions: We have taken a systems biology approach to provide insight into molecular programs influenced by the loss of nicotinic receptor-based cholinergic activity in the cochlea and to identify candidate genes that may be involved in nicotinic cholinergic synapse formation, stabilization or function within the inner ear. Additionally, our data indicate a change in the GABAergic system upon loss of alpha 9 nicotinic receptor subunit within the cochlea.	[Turcan, Sevin] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Slonim, Donna K.] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Turcan, Sevin; Vetter, Douglas E.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Turcan, S (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	douglas.vetter@tufts.edu	Vetter, Douglas E./O-8150-2019; Turcan, Sevin/AAF-1095-2019	Turcan, Sevin/0000-0002-0885-5607; Slonim, Donna/0000-0003-3357-437X; Vetter, Douglas/0000-0003-4580-3491	National Institutes of Health (NIH) [R01DC006258, R01HD058880, P30NS047243]; Tufts Center for Neuroscience Research (CNR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006258] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neuroscience Research (CNR)(Consiglio Nazionale delle Ricerche (CNR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) awards R01DC006258 (D. E. V.), R01HD058880 (D. K. S.), and P30NS047243 (to The Tufts Center for Neuroscience Research (CNR), which supports the CNR Genomics Core and Confocal Imaging Core). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Aleman IT, 2005, ADV EXP MED BIOL, V567, P243; Alonso G, 1997, NEUROSCIENCE, V77, P617; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Barnes CM, 2005, P NATL ACAD SCI USA, V102, P19097, DOI 10.1073/pnas.0509579102; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brors D, 2003, J COMP NEUROL, V462, P90, DOI 10.1002/cne.10707; Burgess BJ, 1997, HEARING RES, V108, P74, DOI 10.1016/S0378-5955(97)00040-3; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Cheng Y., 2000, P 8 INT C INT SYST M, P93; Chou JW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-272; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duzhyy D, 2005, J BIOL CHEM, V280, P15165, DOI 10.1074/jbc.M500111200; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Fechner FP, 1998, J COMP NEUROL, V400, P299, DOI 10.1002/(SICI)1096-9861(19981026)400:3<299::AID-CNE1>3.0.CO;2-3; Fuchs PA, 1996, CURR OPIN NEUROBIOL, V6, P514, DOI 10.1016/S0959-4388(96)80058-4; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Goold CP, 2007, NEURON, V56, P109, DOI 10.1016/j.neuron.2007.08.006; Goutman JD, 2005, J PHYSIOL-LONDON, V566, P49, DOI 10.1113/jphysiol.2005.087460; GUINAN JJ, 1984, J COMP NEUROL, V226, P21, DOI 10.1002/cne.902260103; GUINAN JJ, 1983, J COMP NEUROL, V221, P358, DOI 10.1002/cne.902210310; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hossain WA, 2005, J NEUROSCI, V25, P6857, DOI 10.1523/JNEUROSCI.0123-05.2005; Howard MA, 2003, HEARING RES, V178, P118, DOI 10.1016/S0378-5955(03)00068-6; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Katz E, 2000, HEARING RES, V141, P117, DOI 10.1016/S0378-5955(99)00214-2; Katz E, 2004, J NEUROSCI, V24, P7814, DOI 10.1523/JNEUROSCI.2102-04.2004; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Kujawa SG, 1997, J NEUROPHYSIOL, V78, P3095, DOI 10.1152/jn.1997.78.6.3095; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Lee KH, 2005, LARYNGOSCOPE, V115, P1021, DOI 10.1097/01.MLG.0000162650.75806.A1; Liu Z, 2007, BIOCHEM PHARMACOL, V74, P1112, DOI 10.1016/j.bcp.2007.05.022; Liu ZP, 2006, SCIENCE, V314, P1610, DOI 10.1126/science.1134246; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Maison SF, 2003, J COMP NEUROL, V455, P406, DOI 10.1002/cne.10490; Maison SF, 2006, J NEUROSCI, V26, P10315, DOI 10.1523/JNEUROSCI.2395-06.2006; Maison SF, 2009, JARO-J ASSOC RES OTO, V10, P50, DOI 10.1007/s10162-008-0138-7; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Matsunobu T, 2001, J NEUROSCI RES, V63, P252, DOI 10.1002/1097-4547(20010201)63:3<252::AID-JNR1018>3.0.CO;2-0; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MURTHY V, 2009, DEV NEUROBI IN PRESS; Murthy V, 2009, DEV NEUROBIOL, V69, P931, DOI 10.1002/dneu.20753; Murthy V, 2009, MOL CELL NEUROSCI, V40, P39, DOI 10.1016/j.mcn.2008.08.011; Nero D, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-59; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Plazas PV, 2005, J NEUROSCI, V25, P10905, DOI 10.1523/JNEUROSCI.3805-05.2005; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; RAJAN R, 1988, BRAIN RES, V459, P241, DOI 10.1016/0006-8993(88)90640-3; Ramsey MM, 2005, J NEUROPHYSIOL, V94, P247, DOI 10.1152/jn.00768.2004; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; Sanchez S, 2001, J NEUROCHEM, V78, P468, DOI 10.1046/j.1471-4159.2001.00453.x; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Simmons DD, 1996, DEV BRAIN RES, V95, P213; Smyth G.K., 2004, STAT APPL GENET MOL; Sokolowski BHA, 2004, J NEUROSCI, V24, P6265, DOI 10.1523/JNEUROSCI.1291-04.2004; Song WJ, 1998, J NEUROSCI, V18, P3124; SRETAVAN DW, 1986, J NEUROSCI, V6, P990; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Torres-Aleman I, 1999, HORM METAB RES, V31, P114, DOI 10.1055/s-2007-978707; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Walsh EJ, 1998, J NEUROSCI, V18, P3859; Wanaverbecq N, 2007, J NEUROSCI, V27, P5683, DOI 10.1523/JNEUROSCI.1732-07.2007; WARR WB, 1979, BRAIN RES, V173, P152, DOI 10.1016/0006-8993(79)91104-1; Yuhas WA, 1999, J COMP PHYSIOL A, V185, P455, DOI 10.1007/s003590050406; Zhang JM, 2007, J PHYSIOL-LONDON, V579, P753, DOI 10.1113/jphysiol.2006.124578; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4; Zheng XY, 1997, HEARING RES, V107, P147, DOI 10.1016/S0378-5955(97)00031-2	89	16	16	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9058	10.1371/journal.pone.0009058	http://dx.doi.org/10.1371/journal.pone.0009058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140217	gold, Green Published, Green Submitted			2022-12-25	WOS:000274474400016
J	Chung, JH; Kubota, H; Ozaki, Y; Uda, S; Kuroda, S				Chung, Jaehoon; Kubota, Hiroyuki; Ozaki, Yu-ichi; Uda, Shinsuke; Kuroda, Shinya			Timing-Dependent Actions of NGF Required for Cell Differentiation	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR RECEPTOR; PC12 PHEOCHROMOCYTOMA CELLS; 2 DISTINCT PHASES; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; PHOSPHATIDYLINOSITOL-3 KINASE; SIGNAL-TRANSDUCTION; ERK ACTIVATION; EXPRESSION	Background: Continuous NGF stimulation induces PC12 cell differentiation. However, why continuous NGF stimulation is required for differentiation is unclear. In this study, we investigated the underlying mechanisms of the timing-dependent requirement of NGF action for cell differentiation. Methodology/Principal Findings: To address the timing-dependency of the NGF action, we performed a discontinuous stimulation assay consisting of a first transient stimulation followed by an interval and then a second sustained stimulation and quantified the neurite extension level. Consequently, we observed a timing-dependent action of NGF on cell differentiation, and discontinuous NGF stimulation similarly induced differentiation. The first stimulation did not induce neurite extension, whereas the second stimulation induced fast neurite extension; therefore, the first stimulation is likely required as a prerequisite condition. These observations indicate that the action of NGF can be divided into two processes: an initial stimulation-driven latent process and a second stimulation-driven extension process. The latent process appears to require the activities of ERK and transcription, but not PI3K, whereas the extension-process requires the activities of ERK and PI3K, but not transcription. We also found that during the first stimulation, the activity of NGF can be replaced by PACAP, but not by insulin, EGF, bFGF or forskolin; during the second stimulation, however, the activity of NGF cannot be replaced by any of these stimulants. These findings allowed us to identify potential genes specifically involved in the latent process, rather than in other processes, using a microarray. Conclusions/Significance: These results demonstrate that NGF induces the differentiation of PC12 cells via mechanically distinct processes: an ERK-driven and transcription-dependent latent process, and an ERK- and PI3K-driven and transcription-independent extension process.	[Chung, Jaehoon; Kubota, Hiroyuki; Ozaki, Yu-ichi; Uda, Shinsuke; Kuroda, Shinya] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, CREST,Japan Sci & Technol Agcy, Tokyo 113, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Chung, JH (corresponding author), Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, CREST,Japan Sci & Technol Agcy, Tokyo 113, Japan.	skuroda@bi.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [17017005, 18200021]; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by a grant in-aid for scientific research on priority areas "Systems Genomics'' (17017005), and Scientific Research (A) (18200021) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and by a grant in-aid from Uehara Memorial Foundation. J.C. was supported by a scholarship from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; BURSTEIN DE, 1978, P NATL ACAD SCI USA, V75, P6059, DOI 10.1073/pnas.75.12.6059; BURSTEIN DE, 1982, BRAIN RES, V247, P115, DOI 10.1016/0006-8993(82)91033-2; Cazillis M, 2004, EUR J NEUROSCI, V19, P798, DOI 10.1111/j.0953-816X.2004.03138.x; Chang JH, 2003, J BIOL CHEM, V278, P42877, DOI 10.1074/jbc.M308155200; Chen L, 2008, MOL ENDOCRINOL, V22, P454, DOI 10.1210/me.2007-0384; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DIJKMANS TF, 2008, J NEUROCHEM; Draghetti C, 2009, J BIOL CHEM, V284, P32053, DOI 10.1074/jbc.M109.009324; Farias-Eisner R, 2001, J NEUROSCI RES, V63, P341, DOI 10.1002/1097-4547(20010215)63:4<341::AID-JNR1028>3.0.CO;2-P; Farias-Eisner R, 2000, J NEUROSCI, V20, P230, DOI 10.1523/JNEUROSCI.20-01-00230.2000; GERDIN MJ, 2007, SCI STKE; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; HASHIMOTO S, 1988, J CELL BIOL, V107, P1531, DOI 10.1083/jcb.107.4.1531; Higuchi M, 2003, GENES CELLS, V8, P657, DOI 10.1046/j.1365-2443.2003.00663.x; Jackson TR, 1996, J CELL SCI, V109, P289; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Jones SM, 1999, CURR BIOL, V9, P512, DOI 10.1016/S0960-9822(99)80235-8; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; KLIMASCHEWSKI L, 1995, NEUROSCI LETT, V195, P133, DOI 10.1016/0304-3940(95)11799-3; Korhonen JM, 1999, J BIOL CHEM, V274, P37307, DOI 10.1074/jbc.274.52.37307; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Munitic I, 2005, J IMMUNOL, V174, P4010, DOI 10.4049/jimmunol.174.7.4010; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schimmelpfeng J, 2004, J NEUROSCI METH, V139, P299, DOI 10.1016/j.jneumeth.2004.05.010; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	51	37	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9011	10.1371/journal.pone.0009011	http://dx.doi.org/10.1371/journal.pone.0009011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126402	Green Published, Green Submitted, gold			2022-12-25	WOS:000274207200010
J	Baldridge, GD; Burkhardt, NY; Oliva, AS; Kurtti, TJ; Munderloh, UG				Baldridge, Gerald D.; Burkhardt, Nicole Y.; Oliva, Adela S.; Kurtti, Timothy J.; Munderloh, Ulrike G.			Rickettsial ompB Promoter Regulated Expression of GFP(uv) in Transformed Rickettsia montanensis	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; FEVER GROUP RICKETTSIAE; MOUNTAIN WOOD TICK; SPOTTED-FEVER; DERMACENTOR-ANDERSONI; IXODES-SCAPULARIS; TRANSPOSON MUTAGENESIS; WESTERN MONTANA; GENE-EXPRESSION; CAPE-COD	Background: Rickettsia spp. (Rickettsiales: Rickettsiaceae) are Gram-negative, obligate intracellular, alpha-proteobacteria that have historically been associated with blood-feeding arthropods. Certain species cause typhus and spotted fevers in humans, but others are of uncertain pathogenicity or may be strict arthropod endosymbionts. Genetic manipulation of rickettsiae should facilitate a better understanding of their interactions with hosts. Methodology/Principal Findings: We transformed a species never associated with human disease, Rickettsia montanensis, by electroporation with a TN5 transposon (pMOD700) containing green fluorescent protein (GFPuv) and chloramphenicol acetyltransferase (CAT) genes under regulation of promoters cloned from the Rickettsia rickettsii ompB gene, and isolated a Chloramphenicol-resistant GFP-fluorescent rickettsiae population (Rmontanensis700). The Rmontanensis700 rickettsiae contained a single transposon integrated near an acetyl-CoA acetyltransferase gene in the rickettsial chromosome. Northern blots showed that GFPuv and CAT mRNAs were both expressed as two transcripts of larger and smaller than predicted length. Western immunoblots showed that Rmontanensis700 and E. coli transformed with a plasmid containing the pMOD700 transposon both expressed GFPuv proteins of the predicted molecular weight. Conclusions/Significance: Long-standing barriers to transformation of rickettsiae have been overcome by development of transposon-based rickettsial transformation vectors. The ompB promoter may be the most problematic of the four promoters so far employed in those vectors.	[Baldridge, Gerald D.; Burkhardt, Nicole Y.; Oliva, Adela S.; Kurtti, Timothy J.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Baldridge, GD (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	baldr001@umn.edu		Oliva Chavez, Adela/0000-0003-2397-0846	NIH [RO1 AI49424]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049424, R01AI081690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: NIH grant RO1 AI49424. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman NC, 2004, EMERG INFECT DIS, V10, P1478, DOI 10.3201/eid1008.030882; ANDERSON BE, 1990, INFECT IMMUN, V58, P2760, DOI 10.1128/IAI.58.9.2760-2769.1990; ANDERSON JF, 1986, AM J TROP MED HYG, V35, P187, DOI 10.4269/ajtmh.1986.35.187; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Baldridge GD, 2004, APPL ENVIRON MICROB, V70, P6628, DOI 10.1128/AEM.70.11.6628-6636.2004; Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Baldridge GD, 2007, J INVERTEBR PATHOL, V94, P163, DOI 10.1016/j.jip.2006.10.003; BELL EJ, 1963, J IMMUNOL, V90, P770; Benson MJ, 2004, APPL ENVIRON MICROB, V70, P616, DOI 10.1128/AEM.70.1.616-620.2004; BREITSCHWERDT EB, 1988, AM J VET RES, V49, P70; BURGDORFER W, 1975, ANN NY ACAD SCI, V266, P61, DOI 10.1111/j.1749-6632.1975.tb35088.x; Burgdorfer W., 1981, RICKETTSIAE RICKETTS, P585; Ceraul SM, 2007, INFECT IMMUN, V75, P1973, DOI 10.1128/IAI.01815-06; Cohen J, 1999, SCAND J INFECT DIS, V31, P202, DOI 10.1080/003655499750006290; DASCH GA, 2003, AM SOC RICK 18 M CUM; Dergousoff SJ, 2009, APPL ENVIRON MICROB, V75, P1786, DOI 10.1128/AEM.02554-08; Donovan BJ, 2002, ANN PHARMACOTHER, V36, P1590, DOI 10.1345/aph.1C089; FENG WC, 1980, AM J TROP MED HYG, V29, P691, DOI 10.4269/ajtmh.1980.29.691; FENG WC, 1980, INFECT IMMUN, V28, P627; Frati F, 2006, J INVERTEBR PATHOL, V93, P150, DOI 10.1016/j.jip.2006.07.002; Kurtti TJ, 2005, J INVERTEBR PATHOL, V90, P177, DOI 10.1016/j.jip.2005.09.001; LACKMAN D B, 1965, Health Lab Sci, V2, P135; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Macaluso KR, 2003, ANN NY ACAD SCI, V990, P568, DOI 10.1111/j.1749-6632.2003.tb07428.x; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; Mulenga A, 2003, INSECT MOL BIOL, V12, P185, DOI 10.1046/j.1365-2583.2003.00400.x; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Niebylski ML, 1997, INT J SYST BACTERIOL, V47, P446, DOI 10.1099/00207713-47-2-446; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; NORMENT BR, 1984, AM J VET RES, V45, P1706; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Perotti MA, 2006, FASEB J, V20, P2372, DOI 10.1096/fj.06-5870fje; PHILIP RN, 1981, AM J TROP MED HYG, V30, P230, DOI 10.4269/ajtmh.1981.30.230; PICKERING LK, 2000, 2000 RED BOOK REPORT, P491; POLICASTRO PF, 1994, MICROBIOL-SGM, V140, P2941, DOI 10.1099/13500872-140-11-2941; PRETZMAN C, 1990, ANN NY ACAD SCI, V590, P227, DOI 10.1111/j.1749-6632.1990.tb42224.x; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rachek LI, 2000, J BACTERIOL, V182, P3289, DOI 10.1128/JB.182.11.3289-3291.2000; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Renesto P, 2002, MICROB PATHOGENESIS, V33, P17, DOI 10.1006/mpat.2002.0508; Simser JA, 2002, APPL ENVIRON MICROB, V68, P4559, DOI 10.1128/AEM.68.9.4559-4566.2002; Simser JA, 2001, APPL ENVIRON MICROB, V67, P546, DOI 10.1128/AEM.67.2.546-552.2001; Troyer JM, 1999, INFECT IMMUN, V67, P3308, DOI 10.1128/IAI.67.7.3308-3311.1999; Tucker AM, 2005, ANN NY ACAD SCI, V1063, P35, DOI 10.1196/annals.1355.005; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Weller SJ, 1998, J CLIN MICROBIOL, V36, P1305, DOI 10.1128/JCM.36.5.1305-1317.1998; Wood DO, 2000, INFECT IMMUN, V68, P6091, DOI 10.1128/IAI.68.11.6091-6093.2000	52	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8965	10.1371/journal.pone.0008965	http://dx.doi.org/10.1371/journal.pone.0008965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126457	gold, Green Published, Green Submitted			2022-12-25	WOS:000274139100013
J	Khallou-Laschet, J; Varthaman, A; Fornasa, G; Compain, C; Gaston, AT; Clement, M; Dussiot, M; Levillain, O; Graff-Dubois, S; Nicoletti, A; Caligiuri, G				Khallou-Laschet, Jamila; Varthaman, Aditi; Fornasa, Giulia; Compain, Caroline; Gaston, Anh-Thu; Clement, Marc; Dussiot, Michael; Levillain, Olivier; Graff-Dubois, Stephanie; Nicoletti, Antonino; Caligiuri, Giuseppina			Macrophage Plasticity in Experimental Atherosclerosis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CD4(+) T-CELLS; ALTERNATIVE ACTIVATION; PPAR-GAMMA; MONONUCLEAR PHAGOCYTES; ARGINASE BALANCE; MICE; INFLAMMATION; EXPRESSION; PHENOTYPE	As in human disease, macrophages (M empty set) are central players in the development and progression of experimental atherosclerosis. In this study we have evaluated the phenotype of Mempty set associated with progression of atherosclerosis in the apolipoprotein E (ApoE) knockout (KO) mouse model. We found that bone marrow-derived Mempty set submitted to M1 and M2 polarization specifically expressed arginase (Arg) II and Arg I, respectively. This distinct arginase expression was used to evaluate the frequency and distribution of M1 and M2 Mempty set in cross-sections of atherosclerotic plaques of ApoE KO mice. Early lesions were infiltrated by Arg I+ (M2) Mempty set. This type of M empty set favored the proliferation of smooth muscle cells, in vitro. Arg II+ (M1) Mempty set appeared and prevailed in lesions of aged ApoE KO mice and lesion progression was correlated with the dominance of M1 over the M2 Mempty set phenotype. In order to address whether the M2->M1 switch could be due to a phenotypic switch of the infiltrated cells, we performed in vitro repolarization experiments. We found that fully polarized Mempty set retained their plasticity since they could revert their phenotype. The analysis of the distribution of Arg I-and Arg II-expressing Mempty set also argued against a recent recruitment of M1 Mempty set in the lesion. The combined data therefore suggest that the M2->M1 switch observed in vivo is due to a conversion of cells already present in the lesion. Our study suggests that interventional tools able to revert the Mempty set infiltrate towards the M2 phenotype may exert an atheroprotective action.	[Khallou-Laschet, Jamila; Varthaman, Aditi; Fornasa, Giulia; Compain, Caroline; Gaston, Anh-Thu; Clement, Marc; Dussiot, Michael; Graff-Dubois, Stephanie; Nicoletti, Antonino; Caligiuri, Giuseppina] INSERM, UMRS698, Paris, France; [Khallou-Laschet, Jamila; Nicoletti, Antonino] Univ Paris 07, Paris, France; [Levillain, Olivier] Univ Lyon 1, UMR5123, F-69622 Villeurbanne, France; [Graff-Dubois, Stephanie] Univ Paris 06, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Sorbonne Universite	Khallou-Laschet, J (corresponding author), INSERM, UMRS698, Paris, France.	giuseppina.caligiuri@inserm.fr	CLEMENT, Marc/GVS-8052-2022; Caligiuri, Giuseppina/G-4810-2015; Nicoletti, Antonino/A-9460-2015; Fornasa, Giulia/AAB-8912-2019; Graff-Dubois, Stephanie/GQA-4845-2022	CLEMENT, Marc/0000-0002-6479-8360; Caligiuri, Giuseppina/0000-0003-4973-2205; Nicoletti, Antonino/0000-0002-2623-0897; Fornasa, Giulia/0000-0002-2250-7983; Varthaman, Aditi/0000-0002-8703-5534; Laschet, Jamila/0000-0002-5090-4417; Graff-Dubois, Stephanie/0000-0001-7273-3930	Fondation de France [Engt 2008-002724]; Fondation pour la Recherche Medicale [DCV2007-0409268]; Agence Nationale de la Recherche; French Ministry of Foreign and European Affairs [Egide 636511F]	Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of Foreign and European Affairs	This work was supported in part by grants from the Fondation de France (www.fdf.org, Engt 2008-002724), the Fondation pour la Recherche Medicale (www.frm.org, DCV2007-0409268) and the Agence Nationale de la Recherche (www.agence-nationale-recherche.fr, ANR project RELATE and project BROSCI). G. F. is the recipient of a Eiffel excellence scholarship from the French Ministry of Foreign and European Affairs (www.egide.asso.fr/eiffel, l). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Khallou-Laschet J, 2006, ARTERIOSCL THROM VAS, V26, P353, DOI 10.1161/01.ATV.0000198401.05221.13; Levillain O, 2005, PFLUG ARCH EUR J PHY, V449, P491, DOI 10.1007/s00424-004-1336-8; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munder M, 1998, J IMMUNOL, V160, P5347; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Nicoletti A, 1998, J CLIN INVEST, V102, P910, DOI 10.1172/JCI119892; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Staels B, 2005, CURR MED RES OPIN, V21, pS13, DOI 10.1185/030079905X36440; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	32	380	405	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8852	10.1371/journal.pone.0008852	http://dx.doi.org/10.1371/journal.pone.0008852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111605	Green Published, gold			2022-12-25	WOS:000273896300006
J	Jing, LL; Gordon, LR; Shtibin, E; Granato, M				Jing, Lili; Gordon, Laura R.; Shtibin, Elena; Granato, Michael			Temporal and Spatial Requirements of unplugged/MuSK Function during Zebrafish Neuromuscular Development	PLOS ONE			English	Article							MOTOR AXON OUTGROWTH; SKELETAL-MUSCLE; IN-VIVO; JUNCTION; RECEPTOR; MUSK; KINASE; INNERVATION; SYNAPSE; AGRIN	One of the earliest events in neuromuscular junction (NMJ) development is the accumulation of acetylcholine receptor (AChR) at the center of muscle cells. The unplugged/MuSK (muscle specific tyrosine kinase) gene is essential to initiate AChR clustering but also to restrict approaching growth cones to the muscle center, thereby coordinating pre- and postsynaptic development. To determine how unplugged/MuSK signaling coordinates these two processes, we examined the temporal and spatial requirements of unplugged/MuSK in zebrafish embryos using heat-shock inducible transgenes. Here, we show that despite its expression in muscle cells from the time they differentiate, unplugged/MuSK activity is first required just prior to the appearance of AChR clusters to simultaneously induce AChR accumulation and to guide motor axons. Furthermore, we demonstrate that ectopic expression of unplugged/MuSK throughout the muscle membrane results in wildtype-like AChR prepattern and neuromuscular synapses in the central region of muscle cells. We propose that AChR prepatterning and axonal guidance are spatio-temporally coordinated through common unplugged/MuSK signals, and that additional factor(s) restrict unplugged/MuSK signaling to a central muscle zone critical for establishing mid-muscle synaptogenesis.	[Jing, Lili; Gordon, Laura R.; Shtibin, Elena; Granato, Michael] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Jing, Lili] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Jing, LL (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu			National Institutes of Health (NIH) [R01HD037975]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037975] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a National Institutes of Health (NIH) grant (R01HD037975) to M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936; Cortes F, 2003, DEV CELL, V5, P865, DOI 10.1016/S1534-5807(03)00362-9; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Devoto SH, 1996, DEVELOPMENT, V122, P3371; FLANAGANSTEET H, 2005, DEVELOPMENT; FRANK E, 1974, J PHYSIOL-LONDON, V240, pP24; Hesser BA, 2006, MOL CELL NEUROSCI, V31, P470, DOI 10.1016/j.mcn.2005.10.020; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Kim HA, 2008, STRUCT MULTIDISCIP O, V36, P1, DOI 10.1007/s00158-008-0256-1; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lefebvre JL, 2007, P NATL ACAD SCI USA, V104, P2483, DOI 10.1073/pnas.0610822104; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350	31	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8843	10.1371/journal.pone.0008843	http://dx.doi.org/10.1371/journal.pone.0008843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107509	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896100009
J	Kostiuk, MA; Keller, BO; Berthiaume, LG				Kostiuk, Morris A.; Keller, Bernd O.; Berthiaume, Luc G.			Palmitoylation of ketogenic enzyme HMGCS2 enhances its interaction with PPAR alpha and transcription at the Hmgcs2 PPRE	FASEB JOURNAL			English	Article						HMG-CoA synthase 2; ketone bodies; mitochondria	PROLIFERATOR-ACTIVATED RECEPTORS; MITOCHONDRIAL 3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE; SITE FATTY ACYLATION; PROTEIN PALMITOYLATION; DIABETIC-KETOACIDOSIS; MAMMALIAN-CELLS; ACID; METABOLISM; COA; LOCALIZATION	Excessive liver production of ketone bodies is one of many metabolic complications that can arise from diabetes, and in severe untreated cases, it can result in ketoacidosis, coma, and death. Mitochondrial HMG-CoA synthase (HMGCS2), the rate-limiting enzyme in ketogenesis, has been shown to interact with PPAR alpha and act as a coactivator to up-regulate transcription from the PPRE of its own gene. Although protein palmitoylation is typically a cytosolic process that promotes membrane association, we recently identified 21 palmitoylated proteins in rat liver mitochondria, including HMGCS2. Herein, our data support a mechanism whereby palmitate is first added onto HMGCS2 active site Cys166 and then transacylated to Cys305. Palmitoylation promotes the HMGCS2/PPAR alpha interaction, resulting in transcriptional activation from the Hmgcs2 PPRE. These results, together with the fact that 8 of the 21 palmitoylated mitochondrial proteins that we previously identified have nuclear receptor interacting motifs, demonstrate a novel-and perhaps ubiquitous-role for palmitoylation as a modulator of transcription.-Kostiuk, M. A., Keller, B. O., Berthiaume, L. G. Palmitoylation of ketogenic enzyme HMGCS2 enhances its interaction with PPAR alpha and transcription at the Hmgcs2 PPRE. FASEB J. 24, 1914-1924 (2010). www.fasebj.org	[Kostiuk, Morris A.; Berthiaume, Luc G.] Univ Alberta, Dept Cell Biol, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada; [Keller, Bernd O.] Univ British Columbia, Dept Pathol & Lab Med, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	University of Alberta; Child & Family Research Institute; University of British Columbia	Berthiaume, LG (corresponding author), Univ Alberta, Dept Cell Biol, Fac Med & Dent, 5-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	luc.berthiaume@ualberta.ca		Berthiaume, Luc/0000-0003-0926-059X; Keller, Bernd/0000-0002-6154-5173	Canadian Institutes of Health Research [MOP 81248]; Heart and Stroke Foundation; Province of Alberta graduate scholarship; University of British Columbia's Child and Family Research Institute; Canada Foundation for Innovation; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Province of Alberta graduate scholarship; University of British Columbia's Child and Family Research Institute; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was funded by Canadian Institutes of Health Research grant MOP 81248 and a Heart and Stroke Foundation grant to L.G.B. M.A.K. held a Province of Alberta graduate scholarship. The authors thank Megan C. Yap for technical assistance. B.O.K. thanks the University of British Columbia's Child and Family Research Institute for an Establishment Award. The authors thank Sheila Innis, Roger Dyer, Jurgen Kast, Jason Rogalski, and Suzanne Perry (University of British Columbia) for access to and help with the mass spectrometric equipment, which is funded through grants from the Canada Foundation for Innovation and the Michael Smith Foundation for Health Research.	BERTHIAUME L, 1994, J BIOL CHEM, V269, P6498; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bizzozero OA, 2001, BBA-PROTEIN STRUCT M, V1545, P278, DOI 10.1016/S0167-4838(00)00291-0; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Casteels K, 2003, REV ENDOCR METAB DIS, V4, P159, DOI 10.1023/A:1022942120000; Corvi MM, 2001, J BIOL CHEM, V276, P45704, DOI 10.1074/jbc.M102766200; Cullingford TE, 2004, PROSTAG LEUKOTR ESS, V70, P253, DOI 10.1016/j.plefa.2003.09.008; Dai YQ, 1999, ANAL CHEM, V71, P1087, DOI 10.1021/ac980684h; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Eledrisi MS, 2006, AM J MED SCI, V331, P243, DOI 10.1097/00000441-200605000-00002; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; ISOLA LM, 1995, P NATL ACAD SCI USA, V92, P9866, DOI 10.1073/pnas.92.21.9866; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kostiuk MA, 2008, FASEB J, V22, P721, DOI 10.1096/fj.07-9199com; Kyrou I, 2006, ANN NY ACAD SCI, V1083, P77, DOI 10.1196/annals.1367.008; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LOWE DM, 1985, BIOCHEM J, V232, P37, DOI 10.1042/bj2320037; LOWE DM, 1985, BIOCHEM J, V227, P591, DOI 10.1042/bj2270591; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Meertens LM, 1998, EMBO J, V17, P6972, DOI 10.1093/emboj/17.23.6972; MIZIORKO HM, 1977, J BIOL CHEM, V252, P1414; OBRIEN PJ, 1987, J BIOL CHEM, V262, P5210; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; SERRA D, 1993, ARCH BIOCHEM BIOPHYS, V307, P40, DOI 10.1006/abbi.1993.1557; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; STUCKI JW, 1989, J BIOL CHEM, V264, P6376; VALERA A, 1994, J BIOL CHEM, V269, P6267; Wolfsdorf J, 2007, PEDIATR DIABETES, V8, P28, DOI 10.1111/j.1399-5448.2007.00224.x; Yang JY, 2005, BIOCHEMISTRY-US, V44, P11903, DOI 10.1021/bi0508082; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	44	51	54	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2010	24	6					1914	1924		10.1096/fj.09-149765	http://dx.doi.org/10.1096/fj.09-149765			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20124434	Green Published			2022-12-25	WOS:000278200000026
J	Cuddapah, VA; Sontheimer, H				Cuddapah, Vishnu Anand; Sontheimer, Harald			Molecular Interaction and Functional Regulation of ClC-3 by Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) in Human Malignant Glioma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL REGULATION; BK CHANNELS; CELL-VOLUME; HYPOTONIC ACTIVATION; HUMAN GLIOBLASTOMA; ACTIN-FILAMENTS; PLASMA-MEMBRANE; CL-CHANNEL; RAT-BRAIN; EXPRESSION	Glioblastoma multiforme is the most common and lethal primary brain cancer in adults. Tumor cells diffusely infiltrate the brain making focal surgical and radiation treatment challenging. The invasion of glioma cells into normal brain is facilitated by the activity of ion channels aiding dynamic regulation of cell volume. Recent studies have specifically implicated ClC-3, a voltage-gated chloride channel, in this process. However, the interaction between ClC-3 activity and cell movement is poorly understood. Here, we demonstrate that ClC-3 is highly expressed on the plasma membrane of human glioma cells where its activity is regulated through phosphorylation via Ca2+/calmodulin-dependent protein kinase II (CaMKII). Intracellular infusion of autoactivated CaMKII via patch pipette enhanced chloride currents 3-fold, and this regulation was inhibited by autocamtide-2 related inhibitory peptide, a CaMKII-specific inhibitor. CaMKII modulation of chloride currents was also lost upon stable small hairpin RNA knockdown of ClC-3 channels indicating a specific interaction of ClC-3 and CaMKII. In ClC-3-expressing cells, inhibition of CaMKII reduced glioma invasion to the same extent as direct inhibition of ClC-3. The importance of the molecular interaction of ClC-3 and CaMKII is further supported by our finding that CaMKII co-localizes and co-immunoprecipitates with ClC-3. ClC-3 and CaMKII also co-immunoprecipitate in tissue biopsies from patients diagnosed with grade IV glioblastoma. These tumor samples show 10-fold higher ClC-3 protein expression than nonmalignant brain. These data suggest that CaMKII is a molecular link translating intracellular calcium changes, which are intrinsically associated with glioma migration, to changes in ClC-3 conductance required for cell movement.	[Sontheimer, Harald] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, Ctr Glial Biol Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sontheimer, H (corresponding author), Univ Alabama, Dept Neurobiol, 1719 6th Ave S,CIRC 410, Birmingham, AL 35294 USA.	sontheimer@uab.edu		Sontheimer, Harald/0000-0002-5843-9871; Cuddapah, Vishnu/0000-0002-4606-673X	National Institutes of Health [RO1-NS-31234, RO1-NS-36692]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031234, R01NS036692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-NS-31234 and RO1-NS-36692 (to H. S.).	Arreola J, 2002, J PHYSIOL-LONDON, V545, P207, DOI 10.1113/jphysiol.2002.021980; Berdiev BK, 1996, J BIOL CHEM, V271, P17704, DOI 10.1074/jbc.271.30.17704; BERNSTEIN JJ, 1989, J NEUROSCI RES, V22, P134, DOI 10.1002/jnr.490220205; Bordey A, 2000, J MEMBRANE BIOL, V176, P31, DOI 10.1007/s002320001073; CANTIELLO HF, 1991, AM J PHYSIOL, V261, P882; CHAN HC, 1994, J BIOL CHEM, V269, P32464; Deriy LV, 2009, CELL METAB, V10, P316, DOI 10.1016/j.cmet.2009.08.012; Duan D, 1999, J GEN PHYSIOL, V113, P57, DOI 10.1085/jgp.113.1.57; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Gong WQ, 2004, CELL PHYSIOL BIOCHEM, V14, P213, DOI 10.1159/000080330; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Habela CW, 2008, J NEUROSCI, V28, P9205, DOI 10.1523/JNEUROSCI.1897-08.2008; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Liu JX, 2006, NAT NEUROSCI, V9, P41, DOI 10.1038/nn1602; Liu Q, 2007, J NEUROSCI, V27, P10404, DOI 10.1523/JNEUROSCI.5634-06.2007; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Mamelak AN, 2006, J CLIN ONCOL, V24, P3644, DOI 10.1200/JCO.2005.05.4569; Mao JW, 2008, BIOCHEM PHARMACOL, V75, P1706, DOI 10.1016/j.bcp.2008.01.008; Mao JW, 2009, BIOCHEM PHARMACOL, V77, P159, DOI 10.1016/j.bcp.2008.10.009; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; McCloskey DT, 2007, J BIOL CHEM, V282, P16871, DOI 10.1074/jbc.M700379200; Mitchell J, 2008, CURR BIOL, V18, P1600, DOI 10.1016/j.cub.2008.08.073; Olsen ML, 2003, J NEUROSCI, V23, P5572; Qian JS, 2009, CELL PHYSIOL BIOCHEM, V24, P461, DOI 10.1159/000257485; Ransom CB, 2002, GLIA, V38, P281, DOI 10.1002/glia.10064; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; Robinson NC, 2004, J PHYSIOL-LONDON, V556, P353, DOI 10.1113/jphysiol.2003.058032; Ronde P, 2000, BBA-MOL CELL RES, V1498, P273, DOI 10.1016/S0167-4889(00)00102-6; Rossow CF, 2006, ACTA PHYSIOL, V187, P5, DOI 10.1111/j.1748-1716.2006.01550.x; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Shimada K, 2000, AM J PHYSIOL-GASTR L, V279, pG268, DOI 10.1152/ajpgi.2000.279.2.G268; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tang YB, 2008, CELL PROLIFERAT, V41, P775, DOI 10.1111/j.1365-2184.2008.00551.x; Vessey JP, 2004, BIOCHEM CELL BIOL, V82, P708, DOI 10.1139/O04-107; Volk APD, 2008, J BIOL CHEM, V283, P34315, DOI 10.1074/jbc.M803141200; Wang GX, 2004, AM J PHYSIOL-HEART C, V287, pH533, DOI 10.1152/ajpheart.00228.2003; Wang XQ, 2006, NEURON, V52, P321, DOI 10.1016/j.neuron.2006.08.035; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xiong DZ, 2009, CLIN EXP PHARMACOL P, V36, P386, DOI 10.1111/j.1440-1681.2008.05069.x; Yamamoto-Mizuma S, 2004, J PHYSIOL-LONDON, V557, P439, DOI 10.1113/jphysiol.2003.059261; Ye ZC, 1999, CANCER RES, V59, P4383; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200	60	96	108	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11188	11196		10.1074/jbc.M109.097675	http://dx.doi.org/10.1074/jbc.M109.097675			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139089	Green Published, hybrid			2022-12-25	WOS:000276286200024
J	Gao, YS; Hubbert, CC; Yao, TP				Gao, Ya-Sheng; Hubbert, Charlotte C.; Yao, Tso-Pang			The Microtubule-associated Histone Deacetylase 6 (HDAC6) Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATE ENDOSOMES; ALPHA-TUBULIN; ACETYLATION; CELLS; TRANSPORT; DYNEIN; MORPHOGENESIS; INHIBITION; LYSOSOMES; CANCER	Histone deacetylase 6 (HDAC6) is a microtubule-associated deacetylase with tubulin deacetylase activity, and it binds dynein motors. Recent studies revealed that microtubule acetylation affects the affinity and processivity of microtubule motors. These unique properties implicate a role for HDAC6 in intracellular organelle transport. Here, we show that HDAC6 associates with the endosomal compartments and controls epidermal growth factor receptor (EGFR) trafficking and degradation. We found that loss of HDAC6 promoted EGFR degradation. Mechanistically, HDAC6deficiency did not cause aberrant EGFR internalization and recycling. Rather, it resulted in accelerated segregation of EGFR from early endosomes and premature delivery of EGFR to the late endosomal and lysosomal compartments. The deregulated EGFR endocytic trafficking was accompanied by an increase in microtubule-dependent movement of EGFR-bearing vesicles, revealing a novel regulation of EGFR vesicular trafficking and degradation by the microtubule deacetylase HDAC6.	[Gao, Ya-Sheng; Hubbert, Charlotte C.; Yao, Tso-Pang] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Yao, TP (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, C325 LSRC,Box 3813,Res Dr, Durham, NC 27710 USA.	yao00001@mc.duke.edu			National Institutes of Health [NS053825]; Department of Defense [PC 050119]; DAMD [17-01-1-0054]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); DAMD; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part, by National Institutes of Health Grant NS053825. This work was also supported by Department of Defense Grants PC 050119 (to Y.-s.G.) and DAMD 17-01-1-0054 and the Leukemia and Lymphoma Society (to T.-P.Y.).	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kamemura K, 2008, BIOCHEM BIOPH RES CO, V374, P84, DOI 10.1016/j.bbrc.2008.06.092; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	28	116	127	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11219	11226		10.1074/jbc.M109.042754	http://dx.doi.org/10.1074/jbc.M109.042754			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20133936	Green Published, hybrid			2022-12-25	WOS:000276286200027
J	Matsushita, S; Nakata, H; Kubo, Y; Tateyama, M				Matsushita, Shinichi; Nakata, Hiroyasu; Kubo, Yoshihiro; Tateyama, Michihiro			Ligand-induced Rearrangements of the GABA(B) Receptor Revealed by Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; METABOTROPIC GLUTAMATE-RECEPTOR; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; EXTRACELLULAR REGIONS; ALLOSTERIC MODULATION; ACTIVATION MECHANISM; HEPTAHELICAL DOMAIN; STRUCTURAL BASIS; LIVING CELLS	The gamma-aminobutyric acid type B receptor (GABA(B)R), one of the family C G-protein-coupled receptor members, exists as a heterodimer comprised of subunits GB1 and GB2. To clarify the ligand-induced activation mechanism of the GABA(B)R, each subunit was fused with either Cerulean or enhanced yellow fluorescent protein at its intracellular loop, and fluorescence resonance energy transfer (FRET) changes upon agonist application were monitored. As a result, FRET decreases were observed between GB1a loop 2 and GB2 loop 2 and between GB1a loop 2 and GB2 loop 1, suggesting the dissociation of intracellular domains during the receptor activation. Both intersubunit FRET pairs were expected to faithfully capture the activation of the original receptor as their pharmacological properties were highly similar to that of the wild-type receptor. However, the intrasubunit data suggest that the receptor activation does not involve major structural changes within the transmembrane domain of each subunit. By combining the results obtained from two different levels, it was concluded that the GABA(B)R activation by agonist is associated with an asymmetrical intersubunit rearrangement of GB1a and GB2 on the membrane. This type of activation mode, an intersubunit rearrangement without apparent intrahelical structural changes, appears commonly shared by the GABA(B)R and the metabotropic glutamate receptor 1 alpha, another family C G-protein-coupled receptor previously studied by our group. Nevertheless, the directions of intracellular domain movements and its asymmetry observed here highlight the qualitative difference between the two receptors.	[Matsushita, Shinichi; Kubo, Yoshihiro; Tateyama, Michihiro] Natl Inst Physiol Sci, Div Biophys & Neurobiol, Dept Mol Physiol, Okazaki, Aichi 4448585, Japan; [Matsushita, Shinichi; Kubo, Yoshihiro; Tateyama, Michihiro] Grad Univ Adv Studies, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Kubo, Yoshihiro; Tateyama, Michihiro] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Nakata, Hiroyasu] Tokyo Metropolitan Inst Neurosci, Dept Immunol & Signal Transduct, Tokyo 1838526, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Tateyama, M (corresponding author), 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	tateyama@nips.ac.jp	Centeno, Patricia Pacios/O-8368-2016	Kubo, Yoshihiro/0000-0001-6707-0837	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. T. and Y. K.) and from the Japan Society for the Promotion of Science (to Y. K.).	Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brauner-Osborne H, 1999, BRIT J PHARMACOL, V128, P1370, DOI 10.1038/sj.bjp.0702914; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; Gether U, 2002, PHARMACOL TOXICOL, V91, P304, DOI 10.1034/j.1600-0773.2002.910607.x; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nomura R, 2008, J BIOL CHEM, V283, P4665, DOI 10.1074/jbc.M705202200; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parmentier ML, 2002, TRENDS PHARMACOL SCI, V23, P268, DOI 10.1016/S0165-6147(02)02016-3; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Urwyler S, 2005, NEUROPHARMACOLOGY, V48, P343, DOI 10.1016/j.neuropharm.2004.10.013; Urwyler S, 2001, MOL PHARMACOL, V60, P963, DOI 10.1124/mol.60.5.963; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Yamashita T, 2008, J NEUROCHEM, V106, P850, DOI 10.1111/j.1471-4159.2008.05443.x; Yanagawa M, 2009, MOL PHARMACOL, V76, P201, DOI 10.1124/mol.109.056549	37	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10291	10299		10.1074/jbc.M109.077990	http://dx.doi.org/10.1074/jbc.M109.077990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20129919	Green Published, hybrid			2022-12-25	WOS:000276264600013
J	Munro, S; Khaire, N; Inche, A; Carr, S; La Thangue, NB				Munro, S.; Khaire, N.; Inche, A.; Carr, S.; La Thangue, N. B.			Lysine methylation regulates the pRb tumour suppressor protein	ONCOGENE			English	Article						tumour suppressor; pRb; lysine methylation; Set7/9; HP1	RETINOBLASTOMA GENE-PRODUCT; CELL-CYCLE CONTROL; TRANSCRIPTION FACTOR; HISTONE METHYLATION; MUSCLE-CELLS; IN-VIVO; DIFFERENTIATION; E2F; ACETYLATION; BINDING	The pRb tumour suppressor protein has a central role in coordinating early cell cycle progression. An important level of control imposed on pRb occurs through post-translational modi. cation, for example, phosphorylation. We describe here a new level of regulation on pRb, mediated through the targeted methylation of lysine residues, by the methyltransferase Set7/9. Set7/9 methylates the C-terminal region of pRb, both in vitro and in cells, and methylated pRb interacts with heterochromatin protein HP1. pRb methylation is required for pRb-dependent cell cycle arrest and transcriptional repression, as well as pRb-dependent differentiation. Our results indicate that methylation can influence the properties of pRb, and raise the interesting possibility that methylation modulates pRb tumour suppressor activity. Oncogene (2010) 29, 2357-2367; doi:10.1038/onc.2009.511; published online 8 February 2010	[Munro, S.; Khaire, N.; Inche, A.; Carr, S.; La Thangue, N. B.] Univ Oxford, Canc Biol Lab, Dept Clin Pharmacol, Div Med Sci, Oxford OX3 7DQ, England	University of Oxford	La Thangue, NB (corresponding author), Univ Oxford, Canc Biol Lab, Dept Clin Pharmacol, Div Med Sci, Old Rd Campus Res Bldg,Old Rd Campus, Oxford OX3 7DQ, England.	Nick.LaThangue@clinpharm.ox.ac.uk			CRUK; EU; LRF; MRC; AICR; MRC [G9400953, G0500905] Funding Source: UKRI; Medical Research Council [G0500905, G9400953] Funding Source: researchfish	CRUK(Cancer Research UK); EU(European Commission); LRF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AICR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the CRUK, EU, LRF, MRC and AICR for supporting this work and R Williams for assistance in preparing the paper.	BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Fry CJ, 1997, MOL CELL BIOL, V17, P1966, DOI 10.1128/MCB.17.4.1966; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kinkade R, 2008, CANCER RES, V68, P3810, DOI 10.1158/0008-5472.CAN-07-6672; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; LEE SW, 1992, BIOCHIM BIOPHYS ACTA, V1135, P115, DOI 10.1016/0167-4889(92)90126-V; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Markham D, 2006, EMBO REP, V7, P192, DOI 10.1038/sj.embor.7400591; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Sherr CJ, 2000, CANCER RES, V60, P3689; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; THORBURN AM, 1993, MOL BIOL CELL, V4, P705, DOI 10.1091/mbc.4.7.705; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Vandromme M, 2008, MOL CANCER RES, V6, P418, DOI 10.1158/1541-7786.MCR-07-0381; Wang J, 1997, CANCER RES, V57, P351; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zalmas LP, 2008, EMBO REP, V9, P252, DOI 10.1038/sj.embor.7401158; ZAMANIAN M, 1992, EMBO J, V11, P2603, DOI 10.1002/j.1460-2075.1992.tb05325.x; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	46	82	87	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	16					2357	2367		10.1038/onc.2009.511	http://dx.doi.org/10.1038/onc.2009.511			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20140018				2022-12-25	WOS:000276951500005
J	Chen, PW; Lin, SJ; Tsai, SC; Lin, JH; Chen, MR; Wang, JT; Lee, CP; Tsai, CH				Chen, Po-Wen; Lin, Sue-Jane; Tsai, Shu-Chun; Lin, Jiun-Han; Chen, Mei-Ru; Wang, Jiin-Tarng; Lee, Chung-Pei; Tsai, Ching-Hwa			Regulation of Microtubule Dynamics through Phosphorylation on Stathmin by Epstein-Barr Virus Kinase BGLF4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; HERPES-SIMPLEX-VIRUS; PROTEIN-KINASE; ONCOPROTEIN 18; PHYLOGENETIC CONSERVATION; MULTISITE PHOSPHORYLATION; VIRAL TRANSPORT; LEUKEMIC-CELLS; VACCINIA VIRUS; IDENTIFICATION	Stathmin is an important microtubule (MT)-destabilizing protein, and its activity is differently attenuated by phosphorylation at one or more of its four phosphorylatable serine residues (Ser-16, Ser-25, Ser-38, and Ser-63). This phosphorylation of stathmin plays important roles in mitotic spindle formation. We observed increasing levels of phosphorylated stathmin in Epstein-Barr virus (EBV)-harboring lymphoblastoid cell lines (LCLs) and nasopharyngeal carcinoma (NPC) cell lines during the EBV lytic cycle. These suggest that EBV lytic products may be involved in the regulation of stathmin phosphorylation. BGLF4 is an EBV-encoded kinase and has similar kinase activity to cdc2, an important kinase that phosphorylates serine residues 25 and 38 of stathmin during mitosis. Using an siRNA approach, we demonstrated that BGLF4 contributes to the phosphorylation of stathmin in EBV-harboring NPC. Moreover, we confirmed that BGLF4 interacts with and phosphorylates stathmin using an in vitro kinase assay and an in vivo two-dimensional electrophoresis assay. Interestingly, unlike cdc2, BGLF4 was shown to phosphorylate non-proline directed serine residues of stathmin (Ser-16) and it mediated phosphorylation of stathmin predominantly at serines 16, 25, and 38, indicating that BGLF4 can down-regulate the activity of stathmin. Finally, we demonstrated that the pattern of MT organization was changed in BGLF4-expressing cells, possibly through phosphorylation of stathmin. In conclusion, we have shown that a viral Ser/Thr kinase can directly modulate the activity of stathmin and this contributes to alteration of cellular MT dynamics and then may modulate the associated cellular processes.	[Chen, Po-Wen; Tsai, Shu-Chun; Lin, Jiun-Han; Chen, Mei-Ru; Wang, Jiin-Tarng; Lee, Chung-Pei; Tsai, Ching-Hwa] Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10051, Taiwan; [Lin, Sue-Jane] Chang Gung Univ, Res Ctr Emerging Viral Infect, Tao Yuan 333, Taiwan; [Lin, Sue-Jane] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan	National Taiwan University; Chang Gung University; Chang Gung University	Tsai, CH (corresponding author), Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Rm 714,1,1st Sect,Jen Ai Rd, Taipei 10051, Taiwan.	chtsai@ntu.edu.tw		CHEN, MEI-RU/0000-0002-7007-8036	National Health Research Institute [NHRI-EX98-9726BI, NHRI-EX99-9726BI]; National Science Council [NSC97-2320-B-002-003, NSC98-3112-B-002-033, NSC99-3112-B-002-022]; Frontier and Innovative Research of National Taiwan University [97R0331]; National Taiwan University	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Frontier and Innovative Research of National Taiwan University(National Taiwan University); National Taiwan University(National Taiwan University)	This work was supported by the National Health Research Institute (NHRI-EX98-9726BI and NHRI-EX99-9726BI), National Science Council (Grants NSC97-2320-B-002-003, NSC98-3112-B-002-033, and NSC99-3112-B-002-022), Frontier and Innovative Research of National Taiwan University (97R0331), and a research training fellowship from the National Taiwan University.	Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; Asai R, 2009, J GEN VIROL, V90, P1575, DOI 10.1099/vir.0.010462-0; Baik SY, 2007, CELL PROLIFERAT, V40, P268, DOI 10.1111/j.1365-2184.2007.00429.x; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; CHEE MS, 1989, J GEN VIROL, V70, P1151, DOI 10.1099/0022-1317-70-5-1151; Chua HH, 2007, J VIROL, V81, P2459, DOI 10.1128/JVI.02289-06; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Cudmore S, 1997, TRENDS MICROBIOL, V5, P142, DOI 10.1016/S0966-842X(97)01011-1; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; Gavet O, 1998, J CELL SCI, V111, P3333; Gershburg E, 2004, J VIROL, V78, P12140, DOI 10.1128/JVI.78.22.12140-12146.2004; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Holmfeldt P, 2001, MOL BIOL CELL, V12, P73, DOI 10.1091/mbc.12.1.73; Holmfeldt P, 2006, MOL BIOL CELL, V17, P2921, DOI 10.1091/mbc.e06-02-0165; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Hsu TY, 2005, J GEN VIROL, V86, P317, DOI 10.1099/vir.0.80556-0; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; Kawaguchi Y, 2003, REV MED VIROL, V13, P331, DOI 10.1002/rmv.402; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Lawler S, 1998, CURR BIOL, V8, pR212, DOI 10.1016/S0960-9822(98)70128-9; Lee CP, 2007, J VIROL, V81, P5166, DOI 10.1128/JVI.00120-07; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; Lin XC, 2009, INT J CANCER, V124, P1020, DOI 10.1002/ijc.23767; LUO XN, 1994, J BIOL CHEM, V269, P10312; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; MARKLUND U, 1994, J BIOL CHEM, V269, P30626; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Sankar S, 2006, CELL SIGNAL, V18, P982, DOI 10.1016/j.cellsig.2005.08.006; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; SMITH RF, 1989, J VIROL, V63, P450, DOI 10.1128/JVI.63.1.450-455.1989; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Tsai CH, 1997, J BIOMED SCI, V4, P69, DOI 10.1007/BF02255596; Wang JT, 2009, J VIROL, V83, P1856, DOI 10.1128/JVI.01099-08; Wang JT, 2005, J GEN VIROL, V86, P3215, DOI 10.1099/vir.0.81313-0; Yan GG, 2006, PROTEOMICS, V6, P1810, DOI 10.1002/pmic.200500156; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhu J, 2009, J VIROL, V83, P5219, DOI 10.1128/JVI.02378-08	60	25	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10053	10063		10.1074/jbc.M109.044420	http://dx.doi.org/10.1074/jbc.M109.044420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110360	hybrid, Green Published			2022-12-25	WOS:000276165900073
J	Courtois, ET; Castillo, CG; Seiz, EG; Ramos, M; Bueno, C; Liste, I; Martinez-Serrano, A				Courtois, Elise T.; Castillo, Claudia G.; Seiz, Emma G.; Ramos, Milagros; Bueno, Carlos; Liste, Isabel; Martinez-Serrano, Alberto			In Vitro and in Vivo Enhanced Generation of Human A9 Dopamine Neurons from Neural Stem Cells by Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-HYDROXYLASE EXPRESSION; MESENCEPHALIC PRECURSOR CELLS; FETAL VENTRAL MESENCEPHALON; LONG-TERM PROLIFERATION; PARKINSONS-DISEASE; PROGENITOR CELLS; ALPHA-SYNUCLEIN; DIFFERENTIATION; DEATH; LINE	Human neural stem cells derived from the ventral mesencephalon (VM) are powerful research tools and candidates for cell therapies in Parkinson disease. Previous studies with VM dopaminergic neuron (DAn) precursors indicated poor growth potential and unstable phenotypical properties. Using the model cell line hVM1 (human ventral mesencephalic neural stem cell line 1; a new human fetal VM stem cell line), we have found that Bcl-X-L enhances the generation of DAn from VM human neural stem cells. Mechanistically, Bcl-X-L not only exerts the expected antiapoptotic effect but also induces pro-neural (NGN2 and NEUROD1) and dopamine-related transcription factors, resulting in a high yield of DAn with the correct phenotype of substantia nigra pars compacta (SNpc). The expression of key genes directly involved in VM/SNpc dopaminergic patterning, differentiation, and maturation (EN1, LMX1B, PITX3, NURR1, VMAT2, GIRK2, and dopamine transporter) is thus enhanced by Bcl-X-L. These effects on neurogenesis occur in parallel to a decrease in glia generation. These in vitro Bcl-X-L effects are paralleled in vivo, after transplantation in hemiparkinsonian rats, where hVM1-Bcl-X-L cells survive, integrate, and differentiate into DAn, alleviating behavioral motor asymmetry. Bcl-X-L then allows for human fetal VM stem cells to stably generate mature SNpc DAn both in vitro and in vivo and is thus proposed as a helpful factor for the development of cell therapies for neurodegenerative conditions, Parkinson disease in particular.	[Courtois, Elise T.; Castillo, Claudia G.; Seiz, Emma G.; Ramos, Milagros; Liste, Isabel; Martinez-Serrano, Alberto] Autonomous Univ Madrid, Ctr Mol Biol Severo Ochoa, CSIC, Dept Mol Biol, E-28049 Madrid, Spain; [Bueno, Carlos] Univ Miguel Hernandez Elche, Inst Neurosci, Alicante 03550, Spain; [Castillo, Claudia G.] Univ San Luis Potosi, Dept Biochem, Fac Med, San Luis Potosi 782, Mexico	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad Miguel Hernandez de Elche; Universidad Autonoma de San Luis Potosi	Martinez-Serrano, A (corresponding author), Autonomous Univ Madrid, Ctr Mol Biol Severo Ochoa, CSIC, Dept Mol Biol, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	amserrano@cbm.uam.es	Martínez-Serrano, Alberto/J-8146-2014	RAMOS GOMEZ, MILAGROS/0000-0001-5798-9508; Martinez Serrano, Alberto/0000-0003-3927-6699; Courtois, Elise/0000-0002-8749-2719; Liste, Isabel/0000-0002-3294-9558	European Union [QLK3-CT-2001-02120 DANCE, CP-FP-214706-2 EXCELL]; Spanish Ministry of Science and Technology [SAF2001-0841, SAF2004-03405]; Spanish Ministry of Science and Innovation [BIO2007-66807]; Carlos III Institute of Health [RETICS TerCel RD06/0010/0009]; La Caixa Foundation [BM05-22-0]; Comunidad Auto noma de Madrid [GR/SAL/0115/2004]; Foundation Ramon Areces to the Center of Molecular Biology Severo Ochoa	European Union(European Commission); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Institute of Health(Instituto de Salud Carlos III); La Caixa Foundation(La Caixa Foundation); Comunidad Auto noma de Madrid(Comunidad de Madrid); Foundation Ramon Areces to the Center of Molecular Biology Severo Ochoa	This work was supported by European Union Grants QLK3-CT-2001-02120 DANCE and CP-FP-214706-2 EXCELL, Spanish Ministry of Science and Technology Grants SAF2001-0841 and SAF2004-03405, Spanish Ministry of Science and Innovation Grant BIO2007-66807, Carlos III Institute of Health Grant RETICS TerCel RD06/0010/0009, La Caixa Foundation Grant BM05-22-0), and Comunidad Auto noma de Madrid Grant GR/SAL/0115/2004. This work was also supported by an institutional grant from Foundation Ramon Areces to the Center of Molecular Biology Severo Ochoa.	Alavian KN, 2008, MOVEMENT DISORD, V23, P319, DOI 10.1002/mds.21640; Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128; Andersson EKI, 2007, EXP CELL RES, V313, P1172, DOI 10.1016/j.yexcr.2006.12.014; Aouadi M, 2006, STEM CELLS, V24, P1399, DOI 10.1634/stemcells.2005-0398; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Caldwell MA, 1998, EXP NEUROL, V152, P1, DOI 10.1006/exnr.1998.6815; Chang MY, 2007, MOL CELL BIOL, V27, P4293, DOI 10.1128/MCB.00031-07; Christophersen NS, 2006, BRAIN RES BULL, V70, P457, DOI 10.1016/j.brainresbull.2006.07.001; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Duval D, 2006, CELL DEATH DIFFER, V13, P564, DOI 10.1038/sj.cdd.4401789; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; Haughn L, 2003, J BIOL CHEM, V278, P25158, DOI 10.1074/jbc.M212849200; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Itoh T, 2003, J NEUROCHEM, V85, P1500, DOI 10.1046/j.1471-4159.2003.01795.x; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Jensen P, 2007, J NEUROSCI RES, V85, P1884, DOI 10.1002/jnr.21327; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Khan Z, 2007, EXP CELL RES, V313, P2958, DOI 10.1016/j.yexcr.2007.05.004; Kim HJ, 2007, EXP NEUROL, V203, P394, DOI 10.1016/j.expneurol.2006.08.029; Ko JY, 2009, MOL THER, V17, P1761, DOI 10.1038/mt.2009.148; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205; Liste I, 2004, J NEUROSCI, V24, P10786, DOI 10.1523/JNEUROSCI.3208-04.2004; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Morizane A, 2008, CELL TISSUE RES, V331, P323, DOI 10.1007/s00441-007-0541-0; Morrow BA, 2007, EXP NEUROL, V204, P802, DOI 10.1016/j.expneurol.2007.01.009; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Paul G, 2007, MOL CELL NEUROSCI, V34, P390, DOI 10.1016/j.mcn.2006.11.010; Ravindran G, 2008, BIOCHEM BIOPH RES CO, V373, P258, DOI 10.1016/j.bbrc.2008.06.022; Rawal N, 2007, CELL DEATH DIFFER, V14, P381, DOI 10.1038/sj.cdd.4402010; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Shim JW, 2004, J NEUROSCI, V24, P843, DOI 10.1523/JNEUROSCI.3977-03.2004; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; SPECTOR S, 1965, J PHARMACOL EXP THER, V147, P86; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Suzuki A, 1998, BRAIN RES, V801, P59, DOI 10.1016/S0006-8993(98)00523-X; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Trouillas M, 2008, CELL DEATH DIFFER, V15, P1450, DOI 10.1038/cdd.2008.63; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Villa A, 2009, EXP CELL RES, V315, P1860, DOI 10.1016/j.yexcr.2009.03.011; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504	60	47	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9881	9897		10.1074/jbc.M109.054312	http://dx.doi.org/10.1074/jbc.M109.054312			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106970	Green Published, hybrid			2022-12-25	WOS:000276165900059
J	Gu, XG; Glushka, J; Yin, YB; Xu, Y; Denny, T; Smith, J; Jiang, YN; Bar-Peled, M				Gu, Xiaogang; Glushka, John; Yin, Yanbin; Xu, Ying; Denny, Timothy; Smith, James; Jiang, Yingnan; Bar-Peled, Maor			Identification of a Bifunctional UDP-4-keto-pentose/UDP-xylose Synthase in the Plant Pathogenic Bacterium Ralstonia solanacearum Strain GMI1000, a Distinct Member of the 4,6-Dehydratase and Decarboxylase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-SPECIFIC POLYSACCHARIDE; UDP-GLUCURONIC ACID; BETA-D-XYLOSYLTRANSFERASE; ESCHERICHIA-COLI; D-XYLOSE; STRUCTURAL-CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; STREPTOMYCES-FRADIAE; FUNCTIONAL CLONING; 4-AMINO-4-DEOXY-L-ARABINOSE	The UDP-sugar interconverting enzymes involved in UDPGlcA metabolism are well described in eukaryotes but less is known in prokaryotes. Here we identify and characterize a gene (RsU4kpxs) from Ralstonia solanacearum str. GMI1000, which encodes a dual function enzyme not previously described. One activity is to decarboxylate UDP-glucuronic acid to UDP-beta-L-threo-pentopyranosyl-4 ''-ulose in the presence of NAD(+). The second activity converts UDP-beta-L-threo-pentopyranosyl-4 ''-ulose and NADH to UDP-xylose and NAD(+), albeit at a lower rate. Our data also suggest that following decarboxylation, there is stereospecific protonation at the C5 pro-R position. The identification of the R. solanacearum enzyme enables us to propose that the ancestral enzyme of UDP-xylose synthase and UDP-apiose/UDP-xylose synthase was diverged to two distinct enzymatic activities in early bacteria. This separation gave rise to the current UDP-xylose synthase in animal, fungus, and plant as well as to the plant Uaxs and bacterial ArnA and U4kpxs homologs.	[Gu, Xiaogang; Glushka, John; Smith, James; Jiang, Yingnan; Bar-Peled, Maor] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Yin, Yanbin; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Denny, Timothy] Univ Georgia, Dept Plant Pathogen, Athens, GA 30602 USA; [Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), CCRC 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu	gu, xiaogang/F-7440-2015; Yin, Yanbin/C-9788-2010; Yin, Yanbin/AAH-2665-2020	Yin, Yanbin/0000-0001-7667-881X; Yin, Yanbin/0000-0001-7667-881X	National Science Foundation [IOB-0453664]; Office of Biological and Environmental Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant IOB-0453664 (to M. B.-P.) and in part by the BioEnergy Science Center, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakker H, 2009, J BIOL CHEM, V284, P2576, DOI 10.1074/jbc.M804394200; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Breazeale SD, 2002, J BIOL CHEM, V277, P2886, DOI 10.1074/jbc.M109377200; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; Forsberg LS, 2008, J BIOL CHEM, V283, P16037, DOI 10.1074/jbc.M709615200; Gatzeva-Topalova PZ, 2004, BIOCHEMISTRY-US, V43, P13370, DOI 10.1021/bi048551f; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Gu XG, 2004, PLANT PHYSIOL, V136, P4256, DOI 10.1104/pp.104.052365; Gu XG, 2009, J BIOCHEM, V146, P527, DOI 10.1093/jb/mvp099; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; KNIREL YA, 1987, EUR J BIOCHEM, V167, P549, DOI 10.1111/j.1432-1033.1987.tb13372.x; KOCHAROVA NA, 1993, CARBOHYD RES, V250, P275, DOI 10.1016/0008-6215(93)84006-R; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Ma LY, 2007, J BACTERIOL, V189, P8353, DOI 10.1128/JB.00620-07; Melancon CE, 2007, BIOCHEMISTRY-US, V46, P577, DOI 10.1021/bi061907y; MOHNEN D, 2008, BIOSYNTHESIS PLANT C, P1; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; O'Neill M. A., 2003, PLANT CELL WALL, P1, DOI DOI 10.1002/9781119312994.APR0067; Pauly M, 2000, ANAL BIOCHEM, V278, P69, DOI 10.1006/abio.1999.4411; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Shashkov AS, 1999, CARBOHYD RES, V319, P199, DOI 10.1016/S0008-6215(99)00132-9; Tello M, 2008, CHEMBIOCHEM, V9, P1295, DOI 10.1002/cbic.200800021; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Varbanets LD, 2003, MICROBIOLOGY+, V72, P12, DOI 10.1023/A:1022261619561; Veshtort M, 2006, J MAGN RESON, V178, P248, DOI 10.1016/j.jmr.2005.07.018; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Williams GJ, 2005, J BIOL CHEM, V280, P23000, DOI 10.1074/jbc.M501534200; Xu XJ, 2004, CARBOHYD RES, V339, P1631, DOI 10.1016/j.carres.2004.04.006; Zdorovenko EL, 2008, BIOMACROMOLECULES, V9, P2215, DOI 10.1021/bm800326u	39	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9030	9040		10.1074/jbc.M109.066803	http://dx.doi.org/10.1074/jbc.M109.066803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20118241	Green Published, hybrid			2022-12-25	WOS:000275553700054
J	Mueller, M; Renzullo, S; Brooks, R; Ruggli, N; Hofmann, MA				Mueller, Matthias; Renzullo, Sandra; Brooks, Roxann; Ruggli, Nicolas; Hofmann, Martin A.			Antigenic Characterization of Recombinant Hemagglutinin Proteins Derived from Different Avian Influenza Virus Subtypes	PLOS ONE			English	Article							A VIRUS; MONOCLONAL-ANTIBODIES; INSECT CELLS; H5N1 VIRUS; H1; STRAINS; ELISA; H2	Since the advent of highly pathogenic variants of avian influenza virus (HPAIV), the main focus of avian influenza research has been the characterization and detection of HPAIV hemagglutinin (HA) from H5 and H7 subtypes. However, due to the high mutation and reassortation rate of influenza viruses, in theory any influenza strain may acquire increased pathogenicity irrespective of its subtype. A comprehensive antigenic characterization of influenza viruses encompassing all 16 HA and 9 neuraminidase subtypes will provide information useful for the design of differential diagnostic tools, and possibly, vaccines. We have expressed recombinant HA proteins from 3 different influenza virus HA subtypes in the baculovirus system. These proteins were used to generate polyclonal rabbit antisera, which were subsequently employed in epitope scanning analysis using peptide libraries spanning the entire HA. Here, we report the identification and characterization of linear, HA subtype-specific as well as inter subtype-conserved epitopes along the HA proteins. Selected subtype-specific epitopes were shown to be suitable for the differentiation of anti-HA antibodies in an ELISA.	[Mueller, Matthias; Renzullo, Sandra; Brooks, Roxann; Ruggli, Nicolas; Hofmann, Martin A.] IVI, Mittelhausern, Switzerland		Mueller, M (corresponding author), IVI, Mittelhausern, Switzerland.	matthias.mueller@ivi.admin.ch		Ruggli, Nicolas/0000-0002-7679-6290	Swiss Federal Veterinary Office [01.06.09/7111024]	Swiss Federal Veterinary Office	The study was funded by the Swiss Federal Veterinary Office (www.bvet.admin.ch), grant no. 01.06.09/7111024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; EKIERT DC, 2009, SCIENCE; Gerdon AE, 2005, BIOMACROMOLECULES, V6, P3419, DOI 10.1021/bm050475o; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hofmann MA, 2008, VIRUS GENES, V37, P407, DOI 10.1007/s11262-008-0285-2; Huang HL, 2007, MOL IMMUNOL, V44, P1052, DOI 10.1016/j.molimm.2005.07.031; Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X; KALTHOFF D, 2009, VET MICROBIOL; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kelly TR, 2008, J AVIAN MED SURG, V22, P1, DOI 10.1647/2006-036R.1; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; NAYAK DP, 1985, VACCINE, V3, P165, DOI 10.1016/0264-410X(85)90097-0; NESTOROWICZ A, 1985, MOL IMMUNOL, V22, P145, DOI 10.1016/S0161-5890(85)80008-0; OIE, 2008, MAN DIAGN TESTS VACC, V1; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Rao SS, 2009, POULTRY SCI, V88, P860, DOI 10.3382/ps.2008-00360; SCHULZEGAHMEN U, 1986, EUR J BIOCHEM, V159, P283, DOI 10.1111/j.1432-1033.1986.tb09865.x; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Smirnov YA, 1999, ACTA VIROL, V43, P237; Starick E, 2006, J VET MED B, V53, P370, DOI 10.1111/j.1439-0450.2006.01007.x; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7; Vareckova E, 2002, J CLIN MICROBIOL, V40, P2220, DOI 10.1128/JCM.40.6.2220-2223.2002; VARECKOVA E, 2007, VIRUS RES; VELUMANI S, 2007, J VIROL METHODS; Watson DS, 2009, J IMMUNOL METHODS, V340, P123, DOI 10.1016/j.jim.2008.10.007; Zander H, 2007, J MOL RECOGNIT, V20, P185, DOI 10.1002/jmr.823; Zou SM, 1997, J CLIN MICROBIOL, V35, P2623, DOI 10.1128/JCM.35.10.2623-2627.1997	33	12	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9097	10.1371/journal.pone.0009097	http://dx.doi.org/10.1371/journal.pone.0009097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140098	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442400026
J	Fujikawa, K; Iwata, T; Inoue, K; Akahori, M; Kadotani, H; Fukaya, M; Watanabe, M; Chang, Q; Barnett, EM; Swat, W				Fujikawa, Keiko; Iwata, Takeshi; Inoue, Kaoru; Akahori, Masakazu; Kadotani, Hanako; Fukaya, Masahiro; Watanabe, Masahiko; Chang, Qing; Barnett, Edward M.; Swat, Wojciech			VAV2 and VAV3 as Candidate Disease Genes for Spontaneous Glaucoma in Mice and Humans	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; AQUEOUS-HUMOR DYNAMICS; TRABECULAR MESHWORK; INTRAOCULAR-PRESSURE; JAPANESE PATIENTS; LOXL1 VARIANTS; IRIS ATROPHY; OUTFLOW; PROTEIN	Background: Glaucoma is a leading cause of blindness worldwide. Nonetheless, the mechanism of its pathogenesis has not been well-elucidated, particularly at the molecular level, because of insufficient availability of experimental genetic animal models. Methodology/Principal Findings: Here we demonstrate that deficiency of Vav2 and Vav3, guanine nucleotides exchange factors for Rho guanosine triphosphatases, leads to an ocular phenotype similar to human glaucoma. Vav2/Vav3-deficient mice, and to a lesser degree Vav2-deficient mice, show early onset of iridocorneal angle changes and elevated intraocular pressure, with subsequent selective loss of retinal ganglion cells and optic nerve head cupping, which are the hallmarks of glaucoma. The expression of Vav2 and Vav3 tissues was demonstrated in the iridocorneal angle and retina in both mouse and human eyes. In addition, a genome-wide association study screening glaucoma susceptibility loci using single nucleotide polymorphisms analysis identified VAV2 and VAV3 as candidates for associated genes in Japanese open-angle glaucoma patients. Conclusions/Significance: Vav2/Vav3-deficient mice should serve not only as a useful murine model of spontaneous glaucoma, but may also provide a valuable tool in understanding of the pathogenesis of glaucoma in humans, particularly the determinants of altered aqueous outflow and subsequent elevated intraocular pressure.	[Fujikawa, Keiko; Kadotani, Hanako] Hokkaido Univ, Grad Sch Med, Dept Pathol & Immunol, Sapporo, Hokkaido, Japan; [Iwata, Takeshi; Akahori, Masakazu] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan; [Fujikawa, Keiko; Inoue, Kaoru] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Fukaya, Masahiro; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Chang, Qing; Barnett, Edward M.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Fujikawa, Keiko; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Hokkaido University; Hokkaido University; Hokkaido University; Washington University (WUSTL); Washington University (WUSTL)	Fujikawa, K (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol & Immunol, Sapporo, Hokkaido, Japan.	fujikawa@med.hokudai.ac.jp	Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work described in this report was funded in parts by a grant from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; BILL A, 1972, ACTA OPHTHALMOL, V50, P295; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Cella M, 2004, J EXP MED, V200, P817, DOI 10.1084/jem.20031847; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Diskin S, 2009, GLYCOBIOLOGY, V19, P29, DOI 10.1093/glycob/cwn100; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Filla MS, 2006, INVEST OPHTH VIS SCI, V47, P1956, DOI 10.1167/iovs.05-0626; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fukaya M, 2005, EUR J NEUROSCI, V21, P1432, DOI 10.1111/j.1460-9568.2005.03957.x; Funayama T, 2006, INVEST OPHTH VIS SCI, V47, P5368, DOI 10.1167/iovs.06-0196; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Goldblum D, 2007, INVEST OPHTH VIS SCI, V48, P5085, DOI 10.1167/iovs.06-1249; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Inagaki Y, 2006, MOL VIS, V12, P673; Ishikawa K, 2005, MOL VIS, V11, P431; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Karali A, 2000, INVEST OPHTH VIS SCI, V41, P729; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kumar A, 2007, MOL VIS, V13, P667; Liu YT, 2008, INVEST OPHTH VIS SCI, V49, P3465, DOI 10.1167/iovs.08-1850; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; NEUFELD AH, 1979, SURV OPHTHALMOL, V23, P363, DOI 10.1016/0039-6257(79)90229-7; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; Peterson JA, 2005, J BIOL CHEM, V280, P6915, DOI 10.1074/jbc.M406625200; Pfeiffer N, 1997, SURV OPHTHALMOL, V42, P137, DOI 10.1016/S0039-6257(97)00053-2; Rao PV, 2008, INVEST OPHTH VIS SCI, V49, P2464, DOI 10.1167/iovs.07-1639; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Sud A, 2008, MOL VIS, V14, P1319; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tanihara H, 2008, ARCH OPHTHALMOL-CHIC, V126, P309, DOI 10.1001/archophthalmol.2007.76; Tanito M, 2008, MOL VIS, V14, P1898; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Weinreb RN, 2002, SURV OPHTHALMOL, V47, pS53, DOI 10.1016/S0039-6257(02)00306-5; WIEDERHOLT M, 1995, EXP EYE RES, V61, P223, DOI 10.1016/S0014-4835(05)80042-9; Wolf C, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-91	49	39	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9050	10.1371/journal.pone.0009050	http://dx.doi.org/10.1371/journal.pone.0009050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140222	Green Published, gold			2022-12-25	WOS:000274474400009
J	Dechmann, DKN; Kranstauber, B; Gibbs, D; Wikelski, M				Dechmann, Dina K. N.; Kranstauber, Bart; Gibbs, David; Wikelski, Martin			Group Hunting-A Reason for Sociality in Molossid Bats?	PLOS ONE			English	Article							ECHOLOCATION; CALLS; EVOLUTION	Many bat species live in groups, some of them in highly complex social systems, but the reasons for sociality in bats remain largely unresolved. Increased foraging efficiency through passive information transfer in species foraging for ephemeral insects has been postulated as a reason for group formation of male bats in the temperate zones. We hypothesized that benefits from group hunting might also entice tropical bats of both sexes to live in groups. Here we investigate whether Molossus molossus, a small insectivorous bat in Panama, hunts in groups. We use a phased antenna array setup to reduce error in telemetry bearings. Our results confirmed that simultaneously radiotracked individuals from the same colony foraged together significantly more than expected by chance. Our data are consistent with the hypothesis that many bats are social because of information transfer between foraging group members. We suggest this reason for sociality to be more widespread than currently assumed. Furthermore, benefits from group hunting may also have contributed to the evolution of group living in other animals specialized on ephemeral food sources.	[Dechmann, Dina K. N.; Wikelski, Martin] Univ Konstanz, Chair Ornithol, Constance, Germany; [Dechmann, Dina K. N.; Kranstauber, Bart; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Gibbs, David; Wikelski, Martin] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Konstanz; Max Planck Society; Princeton University	Dechmann, DKN (corresponding author), Univ Konstanz, Chair Ornithol, Constance, Germany.	ddechmann@orn.mpg.de		Dechmann, Dina/0000-0003-0043-8267; Kranstauber, Bart/0000-0001-8303-780X	Princeton University; Max Planck Institute of Ornithology in Radolfzell, Germany	Princeton University(Princeton University); Max Planck Institute of Ornithology in Radolfzell, Germany	This study was conducted during a student course with students from Princeton University and the University of Konstanz ( see acknowledgments) and carried out with very little funding. Funding was received from Princeton University and the Max Planck Institute of Ornithology in Radolfzell, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; BALCOMBE JP, 1988, ETHOLOGY, V79, P158, DOI 10.1111/j.1439-0310.1988.tb00708.x; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; Beauchamp G, 2001, EVOL ECOL RES, V3, P703; BROWN CR, 1986, SCIENCE, V234, P83, DOI 10.1126/science.234.4772.83; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Buckley NJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P267, DOI 10.1007/s002650050388; Cochran WW, 2001, WILDLIFE SOC B, V29, P594; DECHMANN DKN, 2009, P ROY SOC LOND B BIO, P2721; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; GIRALDEAU LA, 2005, BEHAV ECOLOGY, V16, P352; Jones G, 2003, BAT ECOLOGY, P301; Kenward R.E., 2000, MANUAL WILDLIFE RADI; Leigh JEG, 1999, TROPICAL FOREST ECOL; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Lourenco SI, 2007, J ZOOL, V273, P161, DOI 10.1111/j.1469-7998.2007.00322.x; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; R Development Core Team, 2009, R FDN STAT COMP; RACEY PA, 1987, ENERGY COSTS PREGNAN, P107; Ratcliffe JM, 2005, BIOL LETTERS, V1, P72, DOI 10.1098/rsbl.2004.0252; SAFI K, 2009, EVOLUTIONARY ECOLOGY; Safi K, 2007, AM NAT, V170, P465, DOI 10.1086/520116; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; von Frisch K, 1969, DANCE LANGUAGE ORIEN; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILKINSON GS, 1988, ETHOL SOCIOBIOL, V9, P85, DOI 10.1016/0162-3095(88)90015-5; Wilkinson GS, 1998, ANIM BEHAV, V55, P337, DOI 10.1006/anbe.1997.0557; Windsor D.M, 1990, SMITHSON CONTRIB EAR, V29, P1, DOI [10.5479/SI.00810274.29.1, DOI 10.5479/SI.00810274.29.1]	32	61	63	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9012	10.1371/journal.pone.0009012	http://dx.doi.org/10.1371/journal.pone.0009012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140247	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474200009
J	Elstgeest, LE; Martens, SE; Lopriore, E; Walther, FJ; te Pas, AB				Elstgeest, Liset E.; Martens, Shirley E.; Lopriore, Enrico; Walther, Frans J.; te Pas, Arjan B.			Does Parenteral Nutrition Influence Electrolyte and Fluid Balance in Preterm Infants in the First Days after Birth?	PLOS ONE			English	Article							POSTNATAL SODIUM SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; PATENT DUCTUS-ARTERIOSUS; GESTATIONAL-AGE; WEIGHT INFANTS; BODY-COMPOSITION; ASSOCIATION	Background: New national guidelines recommend more restricted fluid intake and early initiation of total parenteral nutrition (TPN) in very preterm infants. The aim was study the effect of these guidelines on serum sodium and potassium levels and fluid balance in the first three days after birth. Methods: Two cohorts of infants <28 weeks gestational age, born at the Leiden University Medical Center in the Netherlands, were compared retrospectively before (2002-2004, late-TPN) and after (2006-2007, early-TPN) introduction of the new Dutch guideline. Outcome measures were serum sodium and potassium levels, diuresis, and changes in body weight in the first three postnatal days. Results: In the first three postnatal days no differences between late-TPN (N = 70) and early-TPN cohort (N = 73) in mean (SD) serum sodium (141.1 (3.8) vs 141.0 (3.7) mmol/l) or potassium (4.3 (0.5) vs 4.3 (0.5) mmol/l) were found, but in the early-TPN cohort diuresis (4.5 (1.6) vs 3.2 (1.4) ml/kg/h) and loss of body weight were decreased (26.0% (7.7) vs 20.8% (8.0)). Conclusions: Initiation of TPN immediately after birth and restricted fluid intake in very preterm infants do not seem to influence serum sodium and potassium levels in first three postnatal days. Further research is needed to see if a decreased diuresis and loss of body weight in the first days is the result of a delayed postnatal adaptation or better energy balance.	[Elstgeest, Liset E.; Martens, Shirley E.; Lopriore, Enrico; Walther, Frans J.; te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Elstgeest, LE (corresponding author), Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands.	a.b.te_pas@lumc.nl	Lopriore, Enrico/ABE-3576-2021; pas, arjan te/AAA-9019-2020	Lopriore, Enrico/0000-0002-3513-5066; pas, arjan te/0000-0001-7831-8797; Walther, Frans/0000-0003-1931-159X				Aggarwal Rajiv, 2001, Indian Journal of Pediatrics, V68, P1139, DOI 10.1007/BF02722931; Bell EF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000503.pub2; BELL EF, 1979, LANCET, V2, P90; BELL EF, 1980, NEW ENGL J MED, V302, P598, DOI 10.1056/NEJM198003133021103; Bhatia J, 2006, J PERINATOL, V26, pS19, DOI 10.1038/sj.jp.7211466; Braake FWJT, 2007, SEMIN FETAL NEONAT M, V12, P11, DOI 10.1016/j.siny.2006.10.002; COCKBURN F, 1993, LANCET, V342, P193; COSTARINO AT, 1992, J PEDIATR-US, V120, P99, DOI 10.1016/S0022-3476(05)80611-0; DELL KM, 2006, FANAROFF MARTINS NEO, P695; Gawlowski Z, 2006, J PAEDIATR CHILD H, V42, P771, DOI 10.1111/j.1440-1754.2006.00975.x; Hartnoll G, 2000, ARCH DIS CHILD-FETAL, V82, pF19, DOI 10.1136/fn.82.1.F19; Hartnoll G, 2000, ARCH DIS CHILD-FETAL, V82, pF24, DOI 10.1136/fn.82.1.F24; Hartnoll G, 2001, ARCH DIS CHILD-FETAL, V85, pF29, DOI 10.1136/fn.85.1.F29; HEIMLER R, 1993, J PEDIATR-US, V122, P110, DOI 10.1016/S0022-3476(05)83502-4; KOOLEN AMP, 2004, WERKBOEK ENTERALE PA, P17; LORENZ JM, 1982, J PEDIATR-US, V101, P423, DOI 10.1016/S0022-3476(82)80078-4; Lorenz JM, 1997, J PEDIATR-US, V131, P81, DOI 10.1016/S0022-3476(97)70128-8; Mildenberger E, 2002, EUR J PEDIATR, V161, P415, DOI 10.1007/s00431-002-0986-9; Modi N, 2004, ARCH DIS CHILD-FETAL, V89, P108, DOI 10.1136/adc.2001.004275; MODI N, 1993, ARCH DIS CHILD-FETAL, V69, P87, DOI 10.1136/adc.69.1_Spec_No.87; Oh W, 2005, J PEDIATR-US, V147, P786, DOI 10.1016/j.jpeds.2005.06.039; Omar SA, 2000, PEDIATRICS, V106, P561, DOI 10.1542/peds.106.3.561; Poindexter BB, 2006, J PEDIATR-US, V148, P300, DOI 10.1016/j.jpeds.2005.10.038; POINDEXTER BB, 2006, FANAROFF MARTINS NEO, P679; PUTHOFF TD, 2004, NEWBORN INFANT NURS, V4, P98; SHAFFER SG, 1989, J PEDIATR-US, V115, P285, DOI 10.1016/S0022-3476(89)80087-3; STEVENSON JG, 1977, J PEDIATR-US, V90, P257, DOI 10.1016/S0022-3476(77)80645-8; Tang W, 1997, ARCH DIS CHILD-FETAL, V77, pF28, DOI 10.1136/fn.77.1.F28; Van den Akker CHP, 2006, PEDIATR RES, V59, P732, DOI 10.1203/01.pdr.0000214990.86879.26; VANMARTER LJ, 1990, J PEDIATR-US, V116, P942; Wadhawan R, 2007, J PERINATOL, V27, P359, DOI 10.1038/sj.jp.7211751	31	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9033	10.1371/journal.pone.0009033	http://dx.doi.org/10.1371/journal.pone.0009033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140260	gold, Green Published, Green Submitted			2022-12-25	WOS:000274474200019
J	Thaller, MC; Migliore, L; Marquez, C; Tapia, W; Cedeno, V; Rossolini, GM; Gentile, G				Thaller, Maria Cristina; Migliore, Luciana; Marquez, Cruz; Tapia, Washington; Cedeno, Virna; Rossolini, Gian Maria; Gentile, Gabriele			Tracking Acquired Antibiotic Resistance in Commensal Bacteria of Galapagos Land Iguanas: No Man, No Resistance	PLOS ONE			English	Article							MECHANISMS; WILD	Background: Antibiotic resistance, evolving and spreading among bacterial pathogens, poses a serious threat to human health. Antibiotic use for clinical, veterinary and agricultural practices provides the major selective pressure for emergence and persistence of acquired resistance determinants. However, resistance has also been found in the absence of antibiotic exposure, such as in bacteria from wildlife, raising a question about the mechanisms of emergence and persistence of resistant strains under similar conditions, and the implications for resistance control strategies. Since previous studies yielded some contrasting results, possibly due to differences in the ecological landscapes of the studied wildlife, we further investigated this issue in wildlife from a remote setting of the Galapagos archipelago. Methodology/Principal Findings: Screening for acquired antibiotic resistance was carried out in commensal enterobacteria from Conolophus pallidus, the terrestrial iguana of Isla Santa Fe, where: i) the abiotic conditions ensure to microbes good survival possibilities in the environment; ii) the animal density and their habits favour microbial circulation between individuals; and iii) there is no history of antibiotic exposure and the impact of humans and introduced animal species is minimal except for restricted areas. Results revealed that acquired antibiotic resistance traits were exceedingly rare among bacteria, occurring only as non-dominant strains from an area of minor human impact. Conclusions/Significance: Where both the exposure to antibiotics and the anthropic pressure are minimal, acquired antibiotic resistance traits are not normally found in bacteria from wildlife, even if the ecological landscape is highly favourable to bacterial circulation among animals. Monitoring antibiotic resistance in wildlife from remote areas could also be a useful tool to evaluate the impact of anthropic pressure.	[Thaller, Maria Cristina; Migliore, Luciana; Gentile, Gabriele] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Marquez, Cruz; Tapia, Washington] Galapagos Natl Pk Serv, Puerto Ayora, Galapagos Isl, Ecuador; [Cedeno, Virna] Epidemiol & Pathol Lab F Valverde, Puerto Ayora, Galapagos Isl, Ecuador; [Cedeno, Virna] Concepto Azul, Guayaquil, Ecuador; [Rossolini, Gian Maria] Univ Siena, Dipartimento Biol Mol, Siena, Italy	University of Rome Tor Vergata; University of Siena	Thaller, MC (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy.	thaller@uniroma2.it	Migliore, Luciana/AAB-4245-2020; Gentile, Gabriele/E-8945-2013	Migliore, Luciana/0000-0003-3554-3841; Gentile, Gabriele/0000-0002-1045-6816; Tapia, Washington/0000-0002-5222-1804; THALLER, MARIA CRISTINA/0000-0003-2788-3563; ROSSOLINI, Gian Maria/0000-0002-9386-0434	Italian Ministry of Education, University and Research; CITES [IT/IM/2004/MCE/00041]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); CITES	This work was supported by a grant of the Italian Ministry of Education, University and Research to G. Gentile and by the Tor Vergata University Grant "Ricerche di Ateneo'' 2006-2007 to M.C. Thaller. Samples were collected under CITES permit IT/IM/2004/MCE/00041 granted to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoloni A, 2006, T ROY SOC TROP MED H, V100, P119, DOI 10.1016/j.trstmh.2005.06.027; Bonomo RA, 2008, EXPERT REV ANTI-INFE, V6, P549, DOI 10.1586/14787210.6.5.549; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute, 2007, M100S17 CLIN LAB S S; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; IUCN, 2001, IUCN RED LIST CAT CR; Mascaretti O.A., 2003, BACTERIA VERSUS ANTI; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173; Pallecchi L, 2008, EXPERT REV ANTI-INFE, V6, P725, DOI 10.1586/14787210.6.5.725; Singer RS, 2006, NAT REV MICROBIOL, V4, P943, DOI 10.1038/nrmicro1553; Sjolund M, 2008, EMERG INFECT DIS, V14, P70, DOI 10.3201/eid1401.070704	15	68	74	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8989	10.1371/journal.pone.0008989	http://dx.doi.org/10.1371/journal.pone.0008989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126545	Green Published, gold, Green Submitted			2022-12-25	WOS:000274209700015
J	Martins, FS; Dalmasso, G; Arantes, RME; Doye, A; Lemichez, E; Lagadec, P; Imbert, V; Peyron, JF; Rampal, P; Nicoli, JR; Czerucka, D				Martins, Flaviano S.; Dalmasso, Guillaume; Arantes, Rosa M. E.; Doye, Anne; Lemichez, Emmanuel; Lagadec, Patricia; Imbert, Veronique; Peyron, Jean-Francois; Rampal, Patrick; Nicoli, Jacques R.; Czerucka, Dorota			Interaction of Saccharomyces boulardii with Salmonella enterica Serovar Typhimurium Protects Mice and Modifies T84 Cell Response to the Infection	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; INTERFERES; ACTIVATION; PATHWAYS	Background: Salmonella pathogenesis engages host cells in two-way biochemical interactions: phagocytosis of bacteria by recruitment of cellular small GTP-binding proteins induced by the bacteria, and by triggering a pro-inflammatory response through activation of MAPKs and nuclear translocation of NF-kappa B. Worldwide interest in the use of functional foods containing probiotic bacteria for health promotion and disease prevention has increased significantly. Saccharomyces boulardii is a non-pathogenic yeast used as a probiotic in infectious diarrhea. Methodology/Principal Findings: In this study, we reported that S. boulardii (Sb) protected mice from Salmonella enterica serovar Typhimurium (ST)-induced death and prevented bacterial translocation to the liver. At a molecular level, using T84 human colorectal cancer cells, we demonstrate that incubation with Sb before infection totally abolished Salmonella invasion. This correlates with a decrease of activation of Rac1. Sb preserved T84 barrier function and decreased ST-induced IL-8 synthesis. This anti-inflammatory effect was correlated with an inhibitory effect of Sb on ST-induced activation of the MAPKs ERK1/2, p38 and JNK as well as on activation of NF-kappa B. Electron and confocal microscopy experiments showed an adhesion of bacteria to yeast cells, which could represent one of the mechanisms by which Sb exerts its protective effects. Conclusions: Sb shows modulating effects on permeability, inflammation, and signal transduction pathway in T84 cells infected by ST and an in vivo protective effect against ST infection. The present results also demonstrate that Sb modifies invasive properties of Salmonella.	[Martins, Flaviano S.; Dalmasso, Guillaume; Lagadec, Patricia; Imbert, Veronique; Peyron, Jean-Francois; Czerucka, Dorota] Ctr Mediterraneen Med Mol, Team Inflammat Canc Canc Stem Cells 4, INSERM, U895,C3M, Nice, France; [Doye, Anne; Lemichez, Emmanuel] Ctr Mediterraneen Med Mol, Team Toxines Microbiennes Relat Hote Pathogenes 6, INSERM, U895,C3M, Nice, France; [Martins, Flaviano S.; Dalmasso, Guillaume; Doye, Anne; Lemichez, Emmanuel; Lagadec, Patricia; Imbert, Veronique; Peyron, Jean-Francois; Czerucka, Dorota] Univ Nice Sophia Antipolis, UFR Med, IFR50, Fac Med, Nice, France; [Peyron, Jean-Francois] Hop Archet, Serv Pediat, CHU Nice, Nice, France; [Peyron, Jean-Francois] Hop Archet, Serv Hematol Clin, CHU Nice, Nice, France; [Lemichez, Emmanuel] Hop Archet, Serv Bacteriol, CHU Nice, Nice, France; [Rampal, Patrick] Ctr Hosp Princesse Grace, Serv Hepatogastroenterol, Monaco, Monaco; [Martins, Flaviano S.; Nicoli, Jacques R.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Arantes, Rosa M. E.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Martins, Flaviano S.] Univ Fed Minas Gerais, Dept Pediat, Fac Med, Belo Horizonte, MG, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CHU Nice; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Martins, FS (corresponding author), Univ Alberta, Div Gastroenterol, Fac Med & Dent, Katz Grp Rexall Ctr, Edmonton, AB, Canada.	czerucka@unice.fr	LAGADEC, Patricia/P-4538-2016; Jean-Francois, Peyron/AAA-9496-2022; Imbert, Véronique/I-6093-2016; Arantes, Rosa ME/C-5749-2013; Nicoli, Jacques R/K-4807-2015; Lemichez, Emmanuel/G-3559-2013; Peyron, Jean-Francois/M-5682-2016; Dalmasso, Guillaume/N-2443-2018	LAGADEC, Patricia/0000-0002-5105-782X; Jean-Francois, Peyron/0000-0001-6113-916X; Imbert, Véronique/0000-0003-2103-6718; Arantes, Rosa ME/0000-0003-1428-9717; Nicoli, Jacques R/0000-0003-2390-2608; Lemichez, Emmanuel/0000-0001-9080-7761; Peyron, Jean-Francois/0000-0001-6113-916X; Dalmasso, Guillaume/0000-0002-3433-870X; Martins, Flaviano/0000-0003-0741-3062	BIOCODEX S.A. (Gentilly, France); Region Provence-Alpes Cote dAzur; Conseil General des Alpes Maritimes; Faculte de Medecine de l'Universite de Nice-Sophia Antipolis; Centre Hospitalier Regional de Nice; INSERM; CAPES, Brazil	BIOCODEX S.A. (Gentilly, France); Region Provence-Alpes Cote dAzur(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Faculte de Medecine de l'Universite de Nice-Sophia Antipolis; Centre Hospitalier Regional de Nice; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by BIOCODEX S.A. (Gentilly, France), the Region Provence-Alpes Cote dAzur, the Conseil General des Alpes Maritimes, the Faculte de Medecine de l'Universite de Nice-Sophia Antipolis, and the Centre Hospitalier Regional de Nice. This work was financed in part by an institutional grant from INSERM. F. S. Martins is recipient of a doctoral fellowship from CAPES, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandao RL, 1998, APPL ENVIRON MICROB, V64, P564; Castagliuolo I, 1996, INFECT IMMUN, V64, P5225, DOI 10.1128/IAI.64.12.5225-5232.1996; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; CZERUCKA D, 1994, GASTROENTEROLOGY, V106, P65, DOI 10.1016/S0016-5085(94)94403-2; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Czerucka D, 2002, MICROBES INFECT, V4, P733, DOI 10.1016/S1286-4579(02)01592-7; Czerucka D, 2000, INFECT IMMUN, V68, P5998, DOI 10.1128/IAI.68.10.5998-6004.2000; Dahan S, 2003, INFECT IMMUN, V71, P766, DOI 10.1128/IAI.71.2.766-773.2003; DOYE A, 2002, METHOD ENZYMOL, V406, P447; FAO/WHO, 2002, FOOD AGR ORG UN WHO; Galan JE, 1996, ANNU REV CELL DEV BI, V12, P221, DOI 10.1146/annurev.cellbio.12.1.221; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gedek BR, 1999, MYCOSES, V42, P261, DOI 10.1046/j.1439-0507.1999.00449.x; GIANNELLA RA, 1979, INFECT IMMUN, V23, P140, DOI 10.1128/IAI.23.1.140-145.1979; Hobbie S, 1997, J IMMUNOL, V159, P5550; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hopkins KL, 2008, EMERG INFECT DIS, V14, P340, DOI 10.3201/eid1402.070573; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; JUNG HC, 1995, J BIOL INVESTIG, V95, P647; KORHONEN TK, 1981, INFECT IMMUN, V32, P796, DOI 10.1128/IAI.32.2.796-804.1981; Martins FS, 2007, J MED MICROBIOL, V56, P352, DOI 10.1099/jmm.0.46525-0; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; POTHOULAKIS C, 1993, GASTROENTEROLOGY, V104, P1108, DOI 10.1016/0016-5085(93)90280-P; Rodrigues ACP, 1996, J APPL BACTERIOL, V81, P251, DOI 10.1111/j.1365-2672.1996.tb04325.x; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Van Nhieu GT, 2005, CURR OPIN MICROBIOL, V8, P16, DOI 10.1016/j.mib.2004.12.006; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Whichard JM, 2007, EMERG INFECT DIS, V13, P1681, DOI 10.3201/eid1311.061438	32	74	79	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8925	10.1371/journal.pone.0008925	http://dx.doi.org/10.1371/journal.pone.0008925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111723	Green Published, gold, Green Submitted			2022-12-25	WOS:000274114800026
J	Wang, JY; Ma, H; Tong, C; Zhang, HY; Lawlis, GB; Li, YD; Zang, MW; Ren, J; Nijland, MJ; Ford, SP; Nathanielsz, PW; Li, J				Wang, Jingying; Ma, Heng; Tong, Chao; Zhang, Hanying; Lawlis, Gavin B.; Li, Yuanda; Zang, Mengwei; Ren, Jun; Nijland, Mark J.; Ford, Stephen P.; Nathanielsz, Peter W.; Li, Ji			Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart	FASEB JOURNAL			English	Article						cardiac dysfunction; signaling transduction; insulin resistance	ACTIVATED PROTEIN-KINASE; MYOCARDIAL SUBSTRATE METABOLISM; INSULIN-RESISTANCE; OXIDATIVE STRESS; SKELETAL-MUSCLE; PREPREGNANCY WEIGHT; RISK; PATHWAY; AKT; JNK	Maternal obesity in pregnancy predisposes offspring to insulin resistance and associated cardiovascular disease. Here, we used a well-established sheep model to investigate the effects of maternal obesity on cardiac functions. Multiparous ewes were assigned to a control (CON) diet [100% of National Research Council (NRC) recommendations] or an obesogenic (OB) diet (150% of NRC recommendations) from 60 d before conception to necropsy on d 135 of pregnancy. Fetal blood glucose and insulin were increased (P<0.01, n = 8) in OB (35.09 +/- 2.03 mg/dl and 3.40 +/- 1.43 mu U/ml, respectively) vs. CON ewes (23.80 +/- 1.38 mg/dl and 0.769 +/- 0.256 mu U/ml). Phosphorylation of AMP-activated protein kinase (AMPK), a cardioprotective signaling pathway, was reduced (P<0.05), while the stress signaling pathway, p38 MAPK, was up-regulated (P<0.05) in OB maternal and fetal hearts. Phosphorylation of c-Jun Nterminal kinase (JNK) and insulin receptor substrate-1 (IRS-1) at Ser-307 were increased (P<0.05) in OB fetal heart associated with lower downstream PI3K-Akt activity (P<0.05), indicating impaired cardiac insulin signaling. Although OB fetal hearts exhibited a normal contractile function vs. CON fetal hearts during basal perfusion, they developed an impaired heart-rate-left-ventricular- developed pressure product in response to high workload stress. Taken together, fetuses of OB mothers demonstrate alterations in cardiac PI3K-Akt, AMPK, and JNK-IRS-1 signaling pathways that would predispose them to insulin resistance and cardiac dysfunction.- Wang, J., Ma, H., Tong, C., Zhang, H., Lawlis, G. B., Li, Y., Zang, M., Ren, J., Nijland, M. J., Ford, S. P., Nathanielsz, P. W., Li, J. Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart. FASEB J. 24, 2066-2076 (2010). www.fasebj.org	[Wang, Jingying; Tong, Chao; Li, Ji] SUNY Buffalo, Dept Pharmacol & Toxicol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Wang, Jingying; Ma, Heng; Tong, Chao; Zhang, Hanying; Lawlis, Gavin B.; Li, Yuanda; Ren, Jun; Li, Ji] Univ Wyoming, Div Pharmaceut Sci, Laramie, WY 82071 USA; [Ford, Stephen P.] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Zang, Mengwei] Boston Univ, Sch Med, Boston, MA 02118 USA; [Nijland, Mark J.; Nathanielsz, Peter W.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Pregnancy & Newborn Res, Dept Obstet & Gynecol, San Antonio, TX 78229 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Wyoming; University of Wyoming; Boston University; University of Texas System; University of Texas Health San Antonio	Li, J (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	jli23@buffalo.edu	Tong, Chao/AAM-2225-2020; Wang, Jingying/G-5568-2012; Ren, Jun/ACG-5366-2022	Tong, Chao/0000-0003-0828-2674; Wang, Jingying/0000-0001-8692-6928; Ren, Jun/0000-0002-0275-0783; Nijland, Mark/0000-0003-0998-8804; Nathanielsz, Peter/0000-0001-8410-6280; Zang, Mengwei/0000-0002-2502-2586	U.S. National Institute on Aging (NIA)/National Institutes of Health (NIH) [R03AG028163]; American Federation for Aging Research [08007]; NIH University of Wyoming Northern Rockies Regional Idea Network of Biomedical Research Excellence (INBRE) [5P20RR016474]; National Center for Research Resources [1UL1RR025014-01]; NIH INBRE [P20 RR16474-04]; American Diabetes Association [7-08-RA-130]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021350] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014, P20RR016474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG028163] Funding Source: NIH RePORTER	U.S. National Institute on Aging (NIA)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; NIH University of Wyoming Northern Rockies Regional Idea Network of Biomedical Research Excellence (INBRE); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institute on Aging (NIA)/National Institutes of Health (NIH) grant R03AG028163 (J.L.), American Federation for Aging Research grant 08007 (J.L.), NIH University of Wyoming Northern Rockies Regional Idea Network of Biomedical Research Excellence (INBRE) pilot grant 5P20RR016474 (J.L.), National Center for Research Resources pilot grant 1UL1RR025014-01 (J.L.), NIH INBRE program project P20 RR16474-04 (S.P.F.), and American Diabetes Association grant 7-08-RA-130 (J.R.).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7; Calvert JW, 2009, EXP PHYSIOL, V94, P805, DOI 10.1113/expphysiol.2009.047183; Chen A, 2009, EPIDEMIOLOGY, V20, P74, DOI 10.1097/EDE.0b013e3181878645; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Corrigan N, 2009, BIRTH DEFECTS RES A, V85, P523, DOI 10.1002/bdra.20567; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; Ehrenberg HM, 2002, AM J OBSTET GYNECOL, V187, P1189, DOI 10.1067/mob.2002.127125; Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Hintz KK, 2003, INT J OBESITY, V27, P1196, DOI 10.1038/sj.ijo.0802389; Hiromura M, 2004, J BIOL CHEM, V279, P53407, DOI 10.1074/jbc.M403775200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hull HR, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.796; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; Li J, 2003, FREE RADICAL BIO MED, V35, P292, DOI 10.1016/S0891-5849(03)00308-3; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; Ma H, 2009, J AM COLL CARDIOL, V54, P2187, DOI 10.1016/j.jacc.2009.04.100; Mighty Hugh E, 2007, Curr Diab Rep, V7, P289, DOI 10.1007/s11892-007-0046-y; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Okamoto F, 1998, JPN CIRC J, V62, P499, DOI 10.1253/jcj.62.499; OPIE LH, 1968, AM HEART J, V76, P685, DOI 10.1016/0002-8703(68)90168-3; Palinski W, 2009, J CARDIOVASC TRANSL, V2, P277, DOI 10.1007/s12265-009-9108-7; Peterson LR, 2006, CURR HYPERTENS REP, V8, P451, DOI 10.1007/s11906-006-0022-y; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767, DOI 10.1161/01.ATV.14.11.1767; Reece EA, 2008, AM J OBSTET GYNECOL, V198, P23, DOI 10.1016/j.ajog.2007.06.076; RODRIGUES B, 1992, CARDIOVASC RES, V26, P913, DOI 10.1093/cvr/26.10.913; SANSON DW, 1993, J ANIM SCI, V71, P1112, DOI 10.2527/1993.7151112x; Schmatz M, 2010, J PERINATOL, V30, P441, DOI 10.1038/jp.2009.182; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Skalicky J, 2008, CLIN CHEM LAB MED, V46, P499, DOI 10.1515/CCLM.2008.096; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V290, pE129, DOI 10.1152/ajpendo.00248.2005; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Steinberg GR, 2007, CELL CYCLE, V6, P888, DOI 10.4161/cc.6.8.4135; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Tong J, 2008, J ANIM SCI, V86, P1296, DOI 10.2527/jas.2007-0794; Trovato GM, 2001, DIABETES NUTR METAB, V14, P325; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Wang MY, 2005, AM J PHYSIOL-ENDOC M, V288, pE216, DOI 10.1152/ajpendo.00004.2004; Watanabe K, 1998, JPN CIRC J, V62, P541, DOI 10.1253/jcj.62.541; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Woods LL, 2000, CURR OPIN NEPHROL HY, V9, P419, DOI 10.1097/00041552-200007000-00014; Young LH, 2005, TRENDS CARDIOVAS MED, V15, P110, DOI 10.1016/j.tcm.2005.04.005; Yu Ye-Rong, 2003, Zhonghua Yi Xue Za Zhi, V83, P1467; Zhao P, 2009, BIOCHEM PHARMACOL, V77, P1002, DOI 10.1016/j.bcp.2008.11.018; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633	60	81	88	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2066	2076		10.1096/fj.09-142315	http://dx.doi.org/10.1096/fj.09-142315			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20110268	Green Published			2022-12-25	WOS:000278200000040
J	Turner, N; Lambros, MB; Horlings, HM; Pearson, A; Sharpe, R; Natrajan, R; Geyer, FC; van Kouwenhove, M; Kreike, B; Mackay, A; Ashworth, A; de Vijver, MJV; Reis-Filho, JS				Turner, N.; Lambros, M. B.; Horlings, H. M.; Pearson, A.; Sharpe, R.; Natrajan, R.; Geyer, F. C.; van Kouwenhove, M.; Kreike, B.; Mackay, A.; Ashworth, A.; de Vijver, M. J. van; Reis-Filho, J. S.			Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets	ONCOGENE			English	Article						triple negative breast cancer; microarrays; gene expression; comparative genomic hybridization; FGFR2	COMPARATIVE GENOMIC HYBRIDIZATION; COPY-NUMBER ALTERATIONS; MICROARRAY PLATFORMS; IN-SITU; EXPRESSION; PATTERNS; GENES; CELLS; ARRAY; RESOLUTION	Triple negative breast cancers (TNBCs) have a relatively poor prognosis and cannot be effectively treated with current targeted therapies. We searched for genes that have the potential to be therapeutic targets by identifying genes consistently overexpressed when amplified. Fifty-six TNBCs were subjected to high-resolution microarray-based comparative genomic hybridization (aCGH), of which 24 were subjected to genome-wide gene expression analysis. TNBCs were genetically heterogeneous; no individual focal amplification was present at high frequency, although 78.6% of TNBCs harboured at least one focal amplification. Integration of aCGH and expression data revealed 40 genes significantly overexpressed when amplified, including the known oncogenes and potential therapeutic targets, FGFR2 (10q26.3), BUB3 (10q26.3), RAB20 (13q34), PKN1 (19p13.12) and NOTCH3 (19p13.12). We identified two TNBC cell lines with FGFR2 amplification, which both had constitutive activation of FGFR2. Amplified cell lines were highly sensitive to FGFR inhibitor PD173074, and to RNAi silencing of FGFR2. Treatment with PD173074 induced apoptosis resulting partly from inhibition of PI3K-AKT signalling. Independent validation using publicly available aCGH data sets revealed FGFR2 gene was amplified in 4% (6/165) of TNBC, but not in other subtypes (0/214, P = 0.0065). Our analysis demonstrates that TNBCs are heterogeneous tumours with amplifications of FGFR2 in a subgroup of tumours. Oncogene (2010) 29, 2013-2023; doi: 10.1038/onc.2009.489; published online 18 January 2010	[Turner, N.; Lambros, M. B.; Pearson, A.; Sharpe, R.; Natrajan, R.; Geyer, F. C.; Mackay, A.; Ashworth, A.; Reis-Filho, J. S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Horlings, H. M.; van Kouwenhove, M.; de Vijver, M. J. van] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Horlings, H. M.; de Vijver, M. J. van] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; [Kreike, B.] Netherlands Canc Inst, Div Radiat Oncol, NL-1066 CX Amsterdam, Netherlands	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute	Turner, N (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	nicholas.turner@icr.ac.uk; jorge.reis-filho@icr.ac.uk		Turner, Nicholas/0000-0001-8937-0873; Natrajan, Rachael/0000-0002-9987-2946; van de Vijver, Marc/0000-0002-0385-4787; Kreike, Bas/0000-0003-0030-8200	Cancer Research UK and Breakthrough Breast Cancer; NHS	Cancer Research UK and Breakthrough Breast Cancer; NHS	This work was supported by grants from Cancer Research UK and Breakthrough Breast Cancer. Dr Nicholas Turner is a CRUK clinician scientist. We acknowledge NHS funding to the NIHR Biomedical Research Centre.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Agrawal G, 2007, J CLIN ONCOL, V25, P2618, DOI 10.1200/JCO.2007.11.3084; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard-Pierrot I, 2008, CANCER RES, V68, P7165, DOI 10.1158/0008-5472.CAN-08-1360; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gunnarsson R, 2008, GENE CHROMOSOME CANC, V47, P697, DOI 10.1002/gcc.20575; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Hannemann J, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1613; Harris LN, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1622; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Lambros MBK, 2006, LAB INVEST, V86, P398, DOI 10.1038/labinvest.3700390; Mackay A, 2009, BREAST CANCER RES TR, V118, P481, DOI 10.1007/s10549-008-0296-7; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Marchio C, 2008, J PATHOL, V216, P399, DOI 10.1002/path.2423; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; NATRAJAN R, 2009, BREAST CANC RES TREA; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Ng G, 2006, J MOL DIAGN, V8, P449, DOI 10.2353/jmoldx.2006.060033; Orsetti B, 2004, CANCER RES, V64, P6453, DOI 10.1158/0008-5472.CAN-04-0756; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Reis-Filho JS, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809b; Reis JS, 2006, CLIN CANCER RES, V12, P6652, DOI 10.1158/1078-0432.CCR-06-1164; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Tan DSP, 2007, LAB INVEST, V87, P737, DOI 10.1038/labinvest.3700593; Tannheimer SL, 2000, BREAST CANCER RES, V2, P311, DOI 10.1186/bcr73; Tischkowitz MD, 2006, CELL CYCLE, V5, P963, DOI 10.4161/cc.5.9.2713; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Weigelt B, 2008, J PATHOL, V216, P141, DOI 10.1002/path.2407; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	47	295	304	3	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 8	2010	29	14					2013	2023		10.1038/onc.2009.489	http://dx.doi.org/10.1038/onc.2009.489			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101236	Green Submitted, Green Accepted			2022-12-25	WOS:000276402800001
J	Lochhead, PA; Wickman, G; Mezna, M; Olson, MF				Lochhead, P. A.; Wickman, G.; Mezna, M.; Olson, M. F.			Activating ROCK1 somatic mutations in human cancer	ONCOGENE			English	Article						ROCK; kinase; Rho; actin; cytoskeleton; cancer	RHO-ASSOCIATED KINASE; CASPASE-MEDIATED ACTIVATION; PROGRESSION; INHIBITOR; TUMOR; METASTASIS; INVASION; PATHWAY; GTPASES; DOWNSTREAM	Cancer cells acquire characteristics of deregulated growth, survival and increased metastatic potential. Genetic mutations that provide a selective advantage by promoting these characteristics have been termed 'drivers,' whereas mutations that do not contribute to disease initiation/progression are termed 'passengers.' The advent of high-throughput methodologies has facilitated large-scale screening of cancer genomes and the subsequent identification of novel somatic mutations. Although this approach has generated valuable results, the data remain incomplete until the functional consequences of these mutations are determined to differentiate potential drivers from passengers. ROCK1 is an essential effector kinase downstream of Rho GTPases, an important pathway involved in cell migration. The Cancer Genome Project identified three nonsynonymous mutations in the ROCK1 gene. We now show that these somatic ROCK1 mutations lead to elevated kinase activity and drive actin cytoskeleton rearrangements that promote increased motility and decreased adhesion, characteristics of cancer progression. Mapping of the kinase-interacting regions of the carboxy terminus combined with structural modeling provides an insight into how these mutations likely affect the regulation of ROCK1. Consistent with the frequency of ROCK1 mutations in human cancer, these results support the conclusion that there is selective pressure for the ROCK1 gene to acquire 'driver' mutations that result in kinase activation. Oncogene (2010) 29, 2591-2598; doi:10.1038/onc.2010.3; published online 8 February 2010	[Lochhead, P. A.; Wickman, G.; Mezna, M.; Olson, M. F.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Olson, MF (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	m.olson@beatson.gla.ac.uk	Olson, Michael/ABA-4240-2021; Olson, Michael F/A-3240-2011	Olson, Michael/0000-0003-3428-3507; 	Cancer Research UK; NIH [CA030721]; NATIONAL CANCER INSTITUTE [R01CA030721] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Cancer Research UK and by a grant to MFO from the NIH (CA030721). Assistance with protein modeling was provided by Felix Krueger (Babraham Institute).	Abe H, 2008, BIOMED RES-TOKYO, V29, P155, DOI 10.2220/biomedres.29.155; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Bokoch GM, 1998, CELL DEATH DIFFER, V5, P637, DOI 10.1038/sj.cdd.4400405; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; DOKI Y, 1993, CANCER RES, V53, P3421; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kamai T, 2002, BJU INT, V89, P449, DOI 10.1046/j.1464-4096.2001.01920.x; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Nakajima M, 2003, CANCER CHEMOTH PHARM, V52, P319, DOI 10.1007/s00280-003-0641-9; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Ogawa T, 2007, AM J TRANSPLANT, V7, P347, DOI 10.1111/j.1600-6143.2006.01647.x; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Wen WY, 2008, J BIOL CHEM, V283, P26263, DOI 10.1074/jbc.M803417200; Xue F, 2008, HEPATOL RES, V38, P810, DOI 10.1111/j.1872-034X.2008.00333.x; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440	24	74	78	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	17					2591	2598		10.1038/onc.2010.3	http://dx.doi.org/10.1038/onc.2010.3			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20140017				2022-12-25	WOS:000277169400014
J	Song, J; Sandoval, R; Pilkinton, MA; Tian, X; Raychaudhuri, P; Colamonici, OR				Song, J.; Sandoval, R.; Pilkinton, M. A.; Tian, X.; Raychaudhuri, P.; Colamonici, O. R.			ARF-induced downregulation of Mip130/LIN-9 protein levels mediates a positive feedback that leads to increased expression of p16(Ink4a) and p19(Arf)	ONCOGENE			English	Article						LIN-9; ARF; p53; senescence and cell cycle	CELL-CYCLE ARREST; GROWTH SUPPRESSION; ONCOGENIC RAS; CDKN2A LOCUS; G(1) CONTROL; B-MYB; SENESCENCE; P53; P14(ARF); GENE	The ARF-MDM2-p53 pathway constitutes one of the most important mechanisms of surveillance against oncogenic transformation, and its inactivation occurs in a large proportion of cancers. Here, we show that ARF regulates Mip130/LIN-9 by inducing its translocation to the nucleolus and decreasing the expression of the Mip130/LIN-9 protein through a post-transcriptional mechanism. The knockdown of Mip130/LIN-9 in p53(-/-) and Arf(-/-) mouse embryonic fibroblasts (MEFs) mimics some effects of ARF, such as the downregulation of B-Myb, impaired induction of G2/M genes, and a decrease in cell proliferation. Importantly, although the knockdown of Mip130/LIN-9 reduced the proliferation of p53 or Arf-null MEFs, only p53(-/-) MEFs showed a senescence-like state and an increase in the expression of Arf and p16. Interestingly, the increase in p16 and ARF is indirect because the Mip130/LIN-9 knockdown decreased the transcription of negative regulators of the Ink4a/Arf locus, such as BUBR1 and CDC6. Chromatin immunoprecipitation assays also reveal that Mip130/LIN-9 occupies the promoters of the BubR1 and cdc6 genes, suggesting that Mip130/LIN-9 is necessary for the expression of these genes. Altogether, these results indicate that there is a feedback mechanism between ARF and Mip130/LIN-9 in which either the increase of ARF or the decrease in Mip130/LIN-9 causes a further increase in the expression of Arf and p16. Oncogene (2010) 29, 1976-1986; doi:10.1038/onc.2009.485; published online 18 January 2010	[Song, J.; Sandoval, R.; Pilkinton, M. A.; Colamonici, O. R.] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Tian, X.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Raychaudhuri, P.] Univ Illinois, Dept Biochem Mol Genet, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colamonici, OR (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave,MC868,Rm E403, Chicago, IL 60612 USA.	ocolamon@uic.edu			National Institutes of Health [RO1 GM81562, NCI-KO1CA127862, T32]; Ruth L Kirschstein National Research Service Award [NOT-OD-06-093]; Training Program in Signal Transduction and Cellular Endocrinology [DK07739]; NATIONAL CANCER INSTITUTE [K01CA127862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Signal Transduction and Cellular Endocrinology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs Charles Sherr and Martine Roussel, St Jude Children's Research Hospital, for the Arf and p53 plasmid constructs and Arf<SUP>-/-</SUP> and p53<SUP>-/-</SUP> MEFs. This work was supported by Public Health Service Grants RO1 GM81562 (ORC) and NCI-KO1CA127862 (RS) from the National Institutes of Health. JS and MP were supported by NIH Institutional T32 training grants, Ruth L Kirschstein National Research Service Award NOT-OD-06-093 and Training Program in Signal Transduction and Cellular Endocrinology DK07739, respectively.	Baker DJ, 2008, CELL CYCLE, V7, P2795, DOI 10.4161/cc.7.18.6687; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Datta A, 2005, MOL CELL BIOL, V25, P8024, DOI 10.1128/MCB.25.18.8024-8036.2005; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gazzeri S, 1998, CANCER RES, V58, P3926; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Hemmati PG, 2005, ONCOGENE, V24, P4114, DOI 10.1038/sj.onc.1208579; Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Leng XH, 2002, MOL CELL BIOL, V22, P2242, DOI 10.1128/MCB.22.7.2242-2254.2002; Lindeman GJ, 1997, P NATL ACAD SCI USA, V94, P5095, DOI 10.1073/pnas.94.10.5095; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Modestou M, 2001, CANCER RES, V61, P3145; Muller H, 1997, MOL CELL BIOL, V17, P5508; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; QUELLE DE, 1995, CELL, V83, P993; Saadatmandi N, 2002, CANCER GENE THER, V9, P830, DOI 10.1038/sj.cgt.7700505; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sandoval R, 2006, EXP CELL RES, V312, P2465, DOI 10.1016/j.yexcr.2006.04.002; Sandoval R, 2009, EXP CELL RES, V315, P2914, DOI 10.1016/j.yexcr.2009.07.014; Schmunis GA, 2007, ISBT SCI SERIES, V2, P6, DOI 10.1111/j.1751-2824.2007.00052.x; Serrano M, 2000, CARCINOGENESIS, V21, P865, DOI 10.1093/carcin/21.5.865; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sotillo R, 2001, P NATL ACAD SCI USA, V98, P13312, DOI 10.1073/pnas.241338598; Sotillo R, 2001, EMBO J, V20, P6637, DOI 10.1093/emboj/20.23.6637; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Xiao ZX, 1996, P NATL ACAD SCI USA, V93, P4633, DOI 10.1073/pnas.93.10.4633; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	63	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	13					1976	1986		10.1038/onc.2009.485	http://dx.doi.org/10.1038/onc.2009.485			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20101237	Green Accepted			2022-12-25	WOS:000276199600010
J	Bavencoffe, A; Gkika, D; Kondratskyi, A; Beck, B; Borowiec, AS; Bidaux, G; Busserolles, J; Eschalier, A; Shuba, Y; Skryma, R; Prevarskaya, N				Bavencoffe, Alexis; Gkika, Dimitra; Kondratskyi, Artem; Beck, Benjamin; Borowiec, Anne-Sophie; Bidaux, Gabriel; Busserolles, Jerome; Eschalier, Alain; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia			The Transient Receptor Potential Channel TRPM8 Is Inhibited via the alpha 2A Adrenoreceptor Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE INJURY; PRIMARY SENSORY NEURONS; COLD RECEPTOR; NEUROPATHIC PAIN; MENTHOL; ACTIVATION; MICE; IDENTIFICATION; EXPRESSION; MECHANISM	The transient receptor potential channel melastatin member 8 (TRPM8) is expressed in sensory neurons, where it constitutes the main receptor of environmental innocuous cold (10-25 degrees C). Among several types of G protein-coupled receptors expressed in sensory neurons, G(i)-coupled alpha 2A-adrenoreceptor (alpha 2A-AR), is known to be involved in thermoregulation; however, the underlying molecular mechanisms remain poorly understood. Here we demonstrated that stimulation of alpha 2A-AR inhibited TRPM8 in sensory neurons from rat dorsal root ganglia (DRG). In addition, using specific pharmacological and molecular tools combined with patch-clamp current recordings, we found that in heterologously expressed HEK-293 (human embryonic kidney) cells, TRPM8 channel is inhibited by the G(i) protein/adenylate cyclase (AC)/cAMP/protein kinase A (PKA) signaling cascade. We further identified the TRPM8 S9 and T17 as two key PKA phosphorylation sites regulating TRPM8 channel activity. We therefore propose that inhibition of TRPM8 through the alpha 2A-AR signaling cascade could constitute a new mechanism of modulation of thermosensation in both physiological and pathological conditions.	[Bavencoffe, Alexis; Gkika, Dimitra; Beck, Benjamin; Borowiec, Anne-Sophie; Bidaux, Gabriel; Skryma, Roman; Prevarskaya, Natalia] Univ Sci & Technol Lille, INSERM, U800, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France; [Kondratskyi, Artem; Shuba, Yaroslav] Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, Kiev, Ukraine; [Kondratskyi, Artem; Shuba, Yaroslav] Natl Acad Sci Ukraine, Int Ctr Mol Physiol, Kiev, Ukraine; [Busserolles, Jerome; Eschalier, Alain] Univ Auvergne, INSERM, U766, Fac Med, F-63001 Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; National Academy of Sciences Ukraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Prevarskaya, N (corresponding author), Univ Sci & Technol Lille, INSERM, U800, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France.	natacha.prevarskaya@univ-lille1.fr	Busserolles, Jerome/K-4232-2014; Gkika, Dimitra/S-3054-2019; ESCHALIER, Alain/L-9957-2015; Shuba, Yaroslav/AAT-6758-2021; Busserolles, Jerome/AAJ-1196-2020; Bidaux, Gabriel/F-1294-2016	Busserolles, Jerome/0000-0001-7542-9520; Gkika, Dimitra/0000-0001-8612-0836; Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Kondratskyi, Artem/0000-0003-3290-0524; Beck, Benjamin/0000-0001-8162-7566; Prevarskaya, natacha/0000-0003-0316-197X; Bidaux, Gabriel/0000-0002-6162-3223	INSERM; la Ligue Nationale contre le Cancer; le Ministere de l'Education Nationale; la Region Nord/Pas-de-Calais; INTAS [05-1000008-8223]; Institut National du Cancer (INCa)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); le Ministere de l'Education Nationale; la Region Nord/Pas-de-Calais(Region Hauts-de-France); INTAS(INTASEuropean Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	This work was supported by grants from INSERM, la Ligue Nationale contre le Cancer, le Ministere de l'Education Nationale, la Region Nord/Pas-de-Calais, and INTAS 05-1000008-8223.; Supported by a post-doctoral fellowship from the Institut National du Cancer (INCa).	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Beck B, 2007, CELL CALCIUM, V41, P285, DOI 10.1016/j.ceca.2006.07.002; Birder LA, 1999, J PHYSIOL-LONDON, V515, P533, DOI 10.1111/j.1469-7793.1999.533ac.x; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cho HJ, 1997, NEUROREPORT, V8, P3119, DOI 10.1097/00001756-199709290-00022; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Chung MK, 2007, NEURON, V54, P345, DOI 10.1016/j.neuron.2007.04.025; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Duflo F, 2002, ANESTHESIOLOGY, V97, P636, DOI 10.1097/00000542-200209000-00018; Hocker J, 2008, ANESTHESIOLOGY, V109, P95, DOI 10.1097/ALN.0b013e31817c02fc; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pinchenko VO, 2005, BBA-GEN SUBJECTS, V1724, P1, DOI 10.1016/j.bbagen.2005.04.008; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T., 2007, V179, P329; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007	33	50	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9410	9419		10.1074/jbc.M109.069377	http://dx.doi.org/10.1074/jbc.M109.069377			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110357	Green Published, hybrid			2022-12-25	WOS:000276165900013
J	Choi, BH; Feng, L; Yoon, HS				Choi, Bo-Hwa; Feng, Lin; Yoon, Ho Sup			FKBP38 Protects Bcl-2 from Caspase-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; MOLECULAR CHARACTERIZATION; FK-506 BINDING-PROTEIN-38; S-NITROSYLATION; TARGETS BCL-2; PROTEASOME; INHIBITOR; FAMILY; EXPRESSION; REGULATOR	The cellular processes that regulate Bcl-2 at the posttranslational levels are as important as those that regulate bcl-2 synthesis. Previously we demonstrated that the suppression of FK506-binding protein 38 (FKBP38) contributes to the instability of Bcl-2 or leaves Bcl-2 unprotected from degradation in an unknown mechanism. Here, we studied the underlying molecular mechanism mediating this process. We first showed that Bcl-2 binding-defective mutants of FKBP38 fail to accumulate Bcl-2 protein. We demonstrated that the FKBP38-mediated Bcl-2 stability is specific as the levels of other anti-apoptotic proteins such as Bcl-XL and Mcl-1 remained unaffected. FKBP38 enhanced the Bcl-2 stability under the blockade of de novo protein synthesis, indicating it is posttranslational. We showed that the overexpression of FKBP38 attenuates reduction rate of Bcl-2, thus resulting in an increment of the intracellular Bcl-2 level, contributing to the resistance of apoptotic cell death induced by the treatment of kinetin riboside, an anticancer drug. Caspase inhibitors markedly induced the accumulation of Bcl-2. In caspase-3-activated cells, the knockdown of endogenous FKBP38 by small interfering RNA resulted in Bcl-2 down-regulation as well, which was significantly recovered by the treatment with caspase inhibitors or overexpression of FKBP38. Finally we presented that the Bcl-2 cleavage by caspase-3 is blocked when Bcl-2 binds to FKBP38 through the flexible loop. Taken together, these results suggest that FKBP38 is a key player in regulating the function of Bcl-2 by antagonizing caspase-dependent degradation through the direct interaction with the flexible loop domain of Bcl-2, which contains the caspase cleavage site.	[Choi, Bo-Hwa; Feng, Lin; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yoon, HS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	hsyoon@ntu.edu.sg	Yoon, Ho Sup/A-2193-2011; Feng, Lin/G-5147-2013	Yoon, Ho Sup/0000-0002-8243-3904; Feng, Lin/0000-0002-3878-3608	A*STAR-Biomedical Research Council of Singapore [04/1/22/12/362]	A*STAR-Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by A*STAR-Biomedical Research Council of Singapore Grant 04/1/22/12/362.	Amundson SA, 2000, CANCER RES, V60, P6101; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Baliga BC, 2002, HEMATOL ONCOL, V20, P63, DOI 10.1002/hon.685; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Blanc C, 2000, CANCER RES, V60, P4386; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Buolamwini JK, 1999, CURR OPIN CHEM BIOL, V3, P500, DOI 10.1016/S1367-5931(99)80073-8; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chen M, 2007, J BIOL CHEM, V282, P33888, DOI 10.1074/jbc.M702969200; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Choi BH, 2008, CANCER LETT, V261, P37, DOI 10.1016/j.canlet.2007.11.014; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Fong S, 2003, P NATL ACAD SCI USA, V100, P14253, DOI 10.1073/pnas.2332307100; Grandgirard D, 1998, EMBO J, V17, P1268, DOI 10.1093/emboj/17.5.1268; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Haendeler J, 1996, EUR J PHARMACOL, V317, P407, DOI 10.1016/S0014-2999(96)00759-5; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Kang CB, 2005, BIOCHEM BIOPH RES CO, V337, P30, DOI 10.1016/j.bbrc.2005.09.023; Kang CB, 2005, FEBS LETT, V579, P1469, DOI 10.1016/j.febslet.2005.01.053; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Ling YH, 2002, MOL CANCER THER, V1, P841; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Paradis E, 1996, J NEUROSCI, V16, P7533; Pedersen KM, 1999, ELECTROPHORESIS, V20, P249, DOI 10.1002/(SICI)1522-2683(19990201)20:2<249::AID-ELPS249>3.0.CO;2-F; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Ramsey AJ, 2000, J BIOL CHEM, V275, P17857, DOI 10.1074/jbc.M001625200; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Snyder SH, 1998, NEURON, V21, P283, DOI 10.1016/S0896-6273(00)80538-3; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06	47	32	33	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9770	9779		10.1074/jbc.M109.032466	http://dx.doi.org/10.1074/jbc.M109.032466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20139069	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000276165900049
J	Zhang, P; Zheng, Y; Shi, J; Zhang, YX; Liu, SL; Liu, YX; Zheng, DX				Zhang, Peng; Zheng, Yong; Shi, Juan; Zhang, Yaxi; Liu, Shilian; Liu, Yanxin; Zheng, Dexian			Targeting a Novel N-terminal Epitope of Death Receptor 5 Triggers Tumor Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; AGONISTIC MONOCLONAL-ANTIBODY; RESISTANT CANCER-CELLS; KAPPA-B; TUMORICIDAL ACTIVITY; CRYSTAL-STRUCTURE; DECOY RECEPTOR; LIGAND TRAIL; IN-VIVO; C-FLIP	Tumor necrosis factor-related apoptosis-inducing ligand receptors death receptor (DR) 4 and DR5 are potential targets for antibody-based cancer therapy. Activation of the proapoptotic DR5 in various cancer cells triggers the extrinsic and/or intrinsic pathway of apoptosis. It has been shown that there are several functional domains in the DR5 extracellular domain. The cysteine-rich domains of DR5 have a conservative role in tumor necrosis factor-related apoptosis-inducing ligand-DR5-mediated apoptosis, and the pre-ligand assembly domain within the N1-cap contributes to the ligand-independent formation of receptor complexes. However, the role of the N-terminal region (NTR) preceding the N1-cap of DR5 remains unclear. In this study, we demonstrate that NTR could mediate DR5 activation that transmits an apoptotic signal when bound to a specific agonistic monoclonal antibody. A novel epitope in the NTR of DR5 was identified by peptide array. Antibodies against the antigenic determinant showed high affinities for DR5 and triggered caspase activation in a time-dependent manner, suggesting the NTR of DR5 might function as a potential death-inducing region. Moreover, permutation analysis showed that Leu(6) was pivotal for the interaction of DR5 and the agonistic antibody. Synthetic wild-type epitopes eliminated the cytotoxicity of all three agonistic monoclonal antibodies, AD5-10, Adie-1, and Adie-2. These results indicate that the NTR of DR5 could be a potential target site for the development of new strategies for cancer immunotherapy. Also, our findings expand the current knowledge about DR5 extracellular functional domains and provide insights into the mechanism of DR5-mediated cell death.	[Zhang, Peng; Shi, Juan; Zhang, Yaxi; Liu, Shilian; Liu, Yanxin; Zheng, Dexian] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Zhang, Peng; Shi, Juan; Zhang, Yaxi; Liu, Shilian; Liu, Yanxin; Zheng, Dexian] Peking Union Med Coll, Beijing 100005, Peoples R China; [Zheng, Yong] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Liu, YX (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	liuyx2000@tom.com; zhengdx@pumc.edu.cn	Zhang, Peng/N-4773-2016	Zheng, Dexian/0000-0003-3966-1212	Natural Science Foundation of China [30623009, 30721063, 30772495, 30972684]; State Key Basic Research Program of China [2007CB507404, 2006CB504200]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by Natural Science Foundation of China Grants 30623009, 30721063, 30772495, and 30972684 and State Key Basic Research Program of China Grants 2007CB507404 and 2006CB504200.	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chen CF, 2009, CELL RES, V19, P984, DOI 10.1038/cr.2009.60; Chen F, 2009, CANCER SCI, V100, P940, DOI 10.1111/j.1349-7006.2009.01119.x; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chuntharapai A, 2001, J IMMUNOL, V166, P4891, DOI 10.4049/jimmunol.166.8.4891; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Guo YB, 2005, J BIOL CHEM, V280, P41940, DOI 10.1074/jbc.M503621200; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Harper N, 2001, J BIOL CHEM, V276, P34743, DOI 10.1074/jbc.M105693200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hotte SJ, 2008, CLIN CANCER RES, V14, P3450, DOI 10.1158/1078-0432.CCR-07-1416; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kim MR, 2001, FEBS LETT, V505, P179, DOI 10.1016/S0014-5793(01)02816-2; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Li B, 2006, J MOL BIOL, V361, P522, DOI 10.1016/j.jmb.2006.06.042; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Marini P, 2006, ONCOGENE, V25, P5145, DOI 10.1038/sj.onc.1209516; MATSUDA S, 1993, P NATL ACAD SCI USA, V90, P10803, DOI 10.1073/pnas.90.22.10803; Mayaan E, 2007, J COMPUT CHEM, V28, P495, DOI 10.1002/jcc.20474; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Miyashita T, 2004, CLIN EXP IMMUNOL, V137, P430, DOI 10.1111/j.1365-2249.2004.02534.x; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Muhlethaler-Mottet A, 2004, ONCOGENE, V23, P5415, DOI 10.1038/sj.onc.1207704; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Park KJ, 2007, CANCER RES, V67, P7327, DOI 10.1158/0008-5472.CAN-06-4766; Plummer R, 2007, CLIN CANCER RES, V13, P6187, DOI 10.1158/1078-0432.CCR-07-0950; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Shi J, 2006, CANCER RES, V66, P11946, DOI 10.1158/0008-5472.CAN-06-1227; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wang P, 2007, CELL SIGNAL, V19, P2237, DOI 10.1016/j.cellsig.2007.06.001; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Wassenaar TA, 2008, PROTEINS, V70, P333, DOI 10.1002/prot.21541; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yada A, 2008, ANN ONCOL, V19, P1060, DOI 10.1093/annonc/mdn015; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	53	8	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8953	8966		10.1074/jbc.M109.070680	http://dx.doi.org/10.1074/jbc.M109.070680			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20106985	Green Published, hybrid			2022-12-25	WOS:000275553700047
J	Chen, L; Wei, Y; Wang, XQ; He, RQ				Chen, Lan; Wei, Yan; Wang, Xueqing; He, Rongqiao			Ribosylation Rapidly Induces alpha-Synuclein to Form Highly Cytotoxic Molten Globules of Advanced Glycation End Products	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; PROTEIN AGGREGATION; D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; NONENZYMATIC GLYCATION; OXIDATIVE STRESS; CROSS-LINKING; LEWY BODIES; TAU-PROTEIN; IN-VITRO; STATE	Background: Alpha synuclein (alpha-Syn) is the main component of Lewy bodies which are associated with several neurodegenerative diseases such as Parkinson's disease. While the glycation with D-glucose that results in alpha-Syn misfold and aggregation has been studied, the effects of glycation with D-ribose on alpha-Syn have not been investigated. Methodology/Principal Findings: Here, we show that ribosylation induces alpha-Syn misfolding and generates advanced glycation end products (AGEs) which form protein molten globules with high cytotoxcity. Results from native- and SDS-PAGE showed that D-ribose reacted rapidly with alpha-Syn, leading to dimerization and polymerization. Trypsin digestion and sequencing analysis revealed that during ribosylation the lysinyl residues (K-58, K-60, K-80, K-96, K-97 and K-102) in the C-terminal region reacted more quickly with D-ribose than those of the N-terminal region. Using Western blotting, AGEs resulting from the glycation of alpha-Syn were observed within 24 h in the presence of D-ribose, but were not observed in the presence of D-glucose. Changes in fluorescence at 410 nm demonstrated again that AGEs were formed during early ribosylation. Changes in the secondary structure of ribosylated alpha-Syn were not clearly detected by CD spectrometry in studies on protein conformation. However, intrinsic fluorescence at 310 nm decreased markedly in the presence of D-ribose. Observations with atomic force microscopy showed that the surface morphology of glycated alpha-Syn looked like globular aggregates. thioflavin T (ThT) fluorescence increased during alpha-Syn incubation regardless of ribosylation. As incubation time increased, ribosylation of alpha-Syn resulted in a blue-shift (similar to 100 nm) in the fluorescence of ANS. The light scattering intensity of ribosylated alpha-Syn was not markedly different from native alpha-Syn, suggesting that ribosylated alpha-Syn is present as molten protein globules. Ribosylated products had a high cytotoxicity to SH-SY5Y cells, leading to LDH release and increase in the levels of reactive oxygen species (ROS). Conclusions/Significance: alpha-Syn is rapidly glycated in the presence of D-ribose generating molten globule-like aggregations which cause cell oxidative stress and result in high cytotoxicity.	[Chen, Lan; Wei, Yan; Wang, Xueqing; He, Rongqiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [He, Rongqiao] Chinese Acad Sci, Inst Psychol, Lab Mental Hlth, Beijing 100080, Peoples R China; [Wei, Yan; He, Rongqiao] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, L (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	herq@sun5.ibp.ac.cn			973-project [2006CB500703, 2010CB912303]; CAS [KSCX2-YW-R-119, KSCX2-YW-R-256]; NSFC [30621004]	973-project(National Basic Research Program of China); CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	This project was supported by the following grants: 973-project-2006CB500703, 2010CB912303, CAS-KSCX2-YW-R-119, KSCX2-YW-R-256 and NSFC-30621004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JR, 1985, CLIN CHEM, V31, P1550; Barzilai A, 2003, TRENDS MOL MED, V9, P126, DOI 10.1016/S1471-4914(03)00020-0; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Ceru S, 2008, FEBS LETT, V582, P203, DOI 10.1016/j.febslet.2007.12.002; Chen L, 2009, CELL MOL LIFE SCI, V66, P2559, DOI 10.1007/s00018-009-0058-7; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Coussons PJ, 1997, FREE RADICAL BIO MED, V22, P1217, DOI 10.1016/S0891-5849(96)00557-6; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Eblan MJ, 2005, NEW ENGL J MED, V352, P728; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Ferrer E, 2005, J AGR FOOD CHEM, V53, P4911, DOI 10.1021/jf0403585; Fink AL, 1998, FOLD DES, V3, P19, DOI 10.1016/S1359-0278(98)00005-4; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GARLICK RL, 1983, J CLIN INVEST, V71, P1062, DOI 10.1172/JCI110856; Hasegawa Y, 2002, THROMB RES, V107, P319, DOI 10.1016/S0049-3848(02)00348-1; HE RQ, 1995, BIOCHEM J, V309, P133, DOI 10.1042/bj3090133; HE RQ, 1995, BBA-PROTEIN STRUCT M, V1253, P47, DOI 10.1016/0167-4838(95)00145-K; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Iwatsubo T, 1996, AM J PATHOL, V148, P1517; Iwatsubo T, 2007, NEUROPATHOLOGY, V27, P474, DOI 10.1111/j.1440-1789.2007.00785.x; James PE, 2004, CIRC RES, V94, P976, DOI 10.1161/01.RES.0000122044.21787.01; Ko LW, 1999, BRAIN RES, V830, P301, DOI 10.1016/S0006-8993(99)01415-8; Koga K, 2002, INT J CLIN PHARM RES, V22, P13; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6; Liu XM, 2007, J DAIRY SCI, V90, P24, DOI 10.3168/jds.S0022-0302(07)72605-X; Mak W., 2005, Hong Kong Medical Journal, V11, P457; Matiacevich SB, 2006, FOOD CHEM, V95, P423, DOI 10.1016/j.foodchem.2005.01.027; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Mayo L, 2007, CELL DEATH DIFFER, V14, P183, DOI 10.1038/sj.cdd.4401989; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; Mendez DL, 2005, ARCH BIOCHEM BIOPHYS, V444, P92, DOI 10.1016/j.abb.2005.10.019; Moreaux V, 1997, J AGR FOOD CHEM, V45, P1905, DOI 10.1021/jf9605005; MOSCA A, 1987, CLIN CHEM, V33, P1141; Munch G, 2003, BIOCHEM SOC T, V31, P1397; Munch G, 2000, J CHEM NEUROANAT, V20, P253, DOI 10.1016/S0891-0618(00)00096-X; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Necula M, 2004, J BIOL CHEM, V279, P49694, DOI 10.1074/jbc.M405527200; Nie Chun Lai, 2007, BMC Neurosci, V8, P9, DOI 10.1186/1471-2202-8-9; Nie CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000629; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Pande VS, 1998, P NATL ACAD SCI USA, V95, P1490, DOI 10.1073/pnas.95.4.1490; PLIML W, 1992, LANCET, V340, P507, DOI 10.1016/0140-6736(92)91709-H; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; RACHER AJ, 1990, CYTOTECHNOLOGY, V3, P301, DOI 10.1007/BF00365494; REIM DF, 1994, ANAL BIOCHEM, V216, P213, DOI 10.1006/abio.1994.1027; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Sanghera N, 2008, BBA-PROTEINS PROTEOM, V1784, P873, DOI 10.1016/j.bbapap.2008.02.017; Sattarahmady N, 2007, BBA-GEN SUBJECTS, V1770, P933, DOI 10.1016/j.bbagen.2007.02.001; SCOTT ML, 1982, NUTR CHICKEN, P100; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SEUFFER R, 1977, J CLIN CHEM CLIN BIO, V15, P663; Shaikh S, 2008, J NEUROSCI RES, V86, P2071, DOI 10.1002/jnr.21644; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; Sheng ZL, 2008, PROG BIOCHEM BIOPHYS, V35, P1202; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, J CELL BIOL, V169, P331, DOI 10.1083/jcb.200410041; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; SYROVY I, 1994, J BIOCHEM BIOPH METH, V28, P115, DOI 10.1016/0165-022X(94)90025-6; Tabner BJ, 2005, BIOCHEM SOC T, V33, P1082, DOI 10.1042/BST0331082; TSOU CL, 1988, BIOCHEMISTRY-US, V27, P1809, DOI 10.1021/bi00406a001; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Xu YJ, 2002, CLIN CHIM ACTA, V325, P127, DOI 10.1016/S0009-8981(02)00277-2; Xu Zhong, 2005, Chin J Traumatol, V8, P179; YAN SD, 1994, P NATL ACAD SCI USA, V91, P7787, DOI 10.1073/pnas.91.16.7787	75	87	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9052	10.1371/journal.pone.0009052	http://dx.doi.org/10.1371/journal.pone.0009052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140223	gold, Green Published, Green Submitted			2022-12-25	WOS:000274474400011
J	Storms, V; Claeys, M; Sanchez, A; De Moor, B; Verstuyf, A; Marchal, K				Storms, Valerie; Claeys, Marleen; Sanchez, Aminael; De Moor, Bart; Verstuyf, Annemieke; Marchal, Kathleen			The Effect of Orthology and Coregulation on Detecting Regulatory Motifs	PLOS ONE			English	Article							FUNCTIONAL ELEMENTS; GIBBS SAMPLER; CONSERVATION; GENES; IDENTIFICATION; DISCOVERY; EVOLUTION	Background: Computational de novo discovery of transcription factor binding sites is still a challenging problem. The growing number of sequenced genomes allows integrating orthology evidence with coregulation information when searching for motifs. Moreover, the more advanced motif detection algorithms explicitly model the phylogenetic relatedness between the orthologous input sequences and thus should be well adapted towards using orthologous information. In this study, we evaluated the conditions under which complementing coregulation with orthologous information improves motif detection for the class of probabilistic motif detection algorithms with an explicit evolutionary model. Methodology: We designed datasets (real and synthetic) covering different degrees of coregulation and orthologous information to test how well Phylogibbs and Phylogenetic sampler, as representatives of the motif detection algorithms with evolutionary model performed as compared to MEME, a more classical motif detection algorithm that treats orthologs independently. Results and Conclusions: Under certain conditions detecting motifs in the combined coregulation-orthology space is indeed more efficient than using each space separately, but this is not always the case. Moreover, the difference in success rate between the advanced algorithms and MEME is still marginal. The success rate of motif detection depends on the complex interplay between the added information and the specificities of the applied algorithms. Insights in this relation provide information useful to both developers and users. All benchmark datasets are available at http://homes.esat.kuleuven.be/,kmarchal/Supplementary_Storms_Valerie_PlosONE.	[Storms, Valerie; Claeys, Marleen; Sanchez, Aminael; Marchal, Kathleen] Katholieke Univ Leuven, CMPG, Dept Microbial & Mol Syst, Louvain, Belgium; [Sanchez, Aminael] Cent Univ Marta Abreu Las Villas UCLV, Inst Plant Biotechnol, Mol Biol Lab, Santa Clara, Cuba; [De Moor, Bart] Katholieke Univ Leuven, Dept Elect Engn, ESAT SCD, Louvain, Belgium; [Verstuyf, Annemieke] Katholieke Univ Leuven, Lab Expt Med & Endocrinol LEGENDO, Louvain, Belgium	KU Leuven; Universidad Central "Marta Abreu" de Las Villas; KU Leuven; KU Leuven	Storms, V (corresponding author), Katholieke Univ Leuven, CMPG, Dept Microbial & Mol Syst, Louvain, Belgium.	kathleen.marchal@biw.kuleuven.be	Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017	Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Verstuyf, Annemieke/0000-0003-3193-2698	Katholieke Universiteit Leuven [GOA/08/011, CoE EF/05/007, CREA/08/023]; Institute for the Promotion of Innovation by Science and Technology in Flanders [SBO-BioFrame]; Interuniversitaire attractiepolen [P6/25]; Fonds wetenschappelijk onderzoek [G. 031805, G. 032909]; Human frontier science program [RGY0079/207C]	Katholieke Universiteit Leuven(KU Leuven); Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Interuniversitaire attractiepolen; Fonds wetenschappelijk onderzoek(FWO); Human frontier science program(Human Frontier Science Program)	This work was supported by the 'Katholieke Universiteit Leuven' [GOA/08/011, CoE EF/05/007, CREA/08/023]; the Institute for the Promotion of Innovation by Science and Technology in Flanders [SBO-BioFrame]; the 'Interuniversitaire attractiepolen' [P6/25 (BioMaGNet)]; the 'Fonds wetenschappelijk onderzoek' [G. 031805; G. 032909]; and the Human frontier science program [RGY0079/207C]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Cai XH, 2007, BIOINFORMATICS, V23, P2013, DOI 10.1093/bioinformatics/btm282; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Gelfand MS, 2000, NUCLEIC ACIDS RES, V28, P695, DOI 10.1093/nar/28.3.695; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Li XM, 2005, P NATL ACAD SCI USA, V102, P9481, DOI 10.1073/pnas.0501620102; Liu J. S., 2001, SPRINGER SERIES STAT; Liu YY, 2004, GENOME RES, V14, P451, DOI 10.1101/gr.1327604; Marchal K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r9; McGuire AM, 2000, GENOME RES, V10, P744, DOI 10.1101/gr.10.6.744; Monsieurs P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-160; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Moses AM, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P324; Newberg LA, 2007, BIOINFORMATICS, V23, P1718, DOI 10.1093/bioinformatics/btm241; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Prakash A, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P348; Ray P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000090; Reddy TE, 2007, PLOS COMPUT BIOL, V3, P844, DOI 10.1371/journal.pcbi.0030090; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; Thompson WA, 2007, NUCLEIC ACIDS RES, V35, pW232, DOI 10.1093/nar/gkm265; Tompa M, 2001, GENOME RES, V11, P1143, DOI 10.1101/gr.197101; Van Hellemont R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r113; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329	34	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e8938	10.1371/journal.pone.0008938	http://dx.doi.org/10.1371/journal.pone.0008938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140085	gold, Green Published			2022-12-25	WOS:000274474200002
J	Tremblay, L; Nguyen, T				Tremblay, Luc; Nguyen, Thanh			Real-Time Decreased Sensitivity to an Audio-Visual Illusion during Goal-Directed Reaching	PLOS ONE			English	Article							TACTILE DETECTION; HUMANS; SENSES; SOUND	In humans, sensory afferences are combined and integrated by the central nervous system (Ernst MO, Bulthoff HH (2004) Trends Cogn. Sci. 8: 162-169) and appear to provide a holistic representation of the environment. Empirical studies have repeatedly shown that vision dominates the other senses, especially for tasks with spatial demands. In contrast, it has also been observed that sound can strongly alter the perception of visual events. For example, when presented with 2 flashes and 1 beep in a very brief period of time, humans often report seeing 1 flash (i.e. fusion illusion, Andersen TS, Tiippana K, Sams M (2004) Brain Res. Cogn. Brain Res. 21: 301-308). However, it is not known how an unfolding movement modulates the contribution of vision to perception. Here, we used the audio-visual illusion to demonstrate that goal-directed movements can alter visual information processing in real-time. Specifically, the fusion illusion was linearly reduced as a function of limb velocity. These results suggest that cue combination and integration can be modulated in real-time by goal-directed behaviors; perhaps through sensory gating (Chapman CE, Beauchamp E (2006) J. Neurophysiol. 96: 1664-1675) and/or altered sensory noise (Ernst MO, Bulthoff HH (2004) Trends Cogn. Sci. 8: 162-169) during limb movements.	[Tremblay, Luc; Nguyen, Thanh] Univ Toronto, Fac Phys Educ & Hlth, Toronto, ON, Canada	University of Toronto	Tremblay, L (corresponding author), Univ Toronto, Fac Phys Educ & Hlth, Toronto, ON, Canada.	luc.tremblay@utoronto.ca		, Luc/0000-0002-1148-1722	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Ontario Research Fund (ORF)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF)	Funding: Supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Foundation for Innovation (CFI), and the Ontario Research Fund (ORF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TS, 2004, COGNITIVE BRAIN RES, V21, P301, DOI 10.1016/j.cogbrainres.2004.06.004; Chapman CE, 2006, J NEUROPHYSIOL, V96, P1664, DOI 10.1152/jn.00214.2006; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Howard I. P., 1966, HUMAN SPATIAL ORIENT; JIANG W, 1991, EXP BRAIN RES, V84, P342; Liu Q, 2007, NEUROREPORT, V18, P1861, DOI 10.1097/WNR.0b013e3282f1ab1d; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; Williams SR, 2002, J NEUROPHYSIOL, V88, P1968, DOI 10.1152/jn.2002.88.4.1968; Witten IB, 2005, NEURON, V48, P489, DOI 10.1016/j.neuron.2005.10.020	15	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8952	10.1371/journal.pone.0008952	http://dx.doi.org/10.1371/journal.pone.0008952			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126451	Green Published, gold			2022-12-25	WOS:000274139100004
J	Dyszel, JL; Soares, JA; Swearingen, MC; Lindsay, A; Smith, JN; Ahmer, BMM				Dyszel, Jessica L.; Soares, Jitesh A.; Swearingen, Matthew C.; Lindsay, Amber; Smith, Jenee N.; Ahmer, Brian M. M.			E. coli K-12 and EHEC Genes Regulated by SdiA	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; GRAM-NEGATIVE BACTERIA; FISCHERI LUXR PROTEIN; SALMONELLA-ENTERICA; ACID RESISTANCE; EXPRESSION; VIRULENCE; PLASMIDS; HOMOLOG	Background: Escherichia and Salmonella encode SdiA, a transcription factor of the LuxR family that regulates genes in response to N-acyl homoserine lactones (AHLs) produced by other species of bacteria. E. coli genes that change expression in the presence of plasmid-encoded sdiA have been identified by several labs. However, many of these genes were identified by overexpressing sdiA on a plasmid and have not been tested for a response to sdiA produced from its natural position in the chromosome or for a response to AHL. Methodology/Principal Findings: We determined that two important loci reported to respond to plasmid-based sdiA, ftsQAZ and acrAB, do not respond to sdiA expressed from its natural position in the chromosome or to AHLs. To identify genes that are regulated by chromosomal sdiA and/or AHLs, we screened 10,000 random transposon-based luciferase fusions in E. coli K-12 and a further 10,000 in E. coli O157:H7 for a response to AHL and then tested these genes for sdiA-dependence. We found that genes encoding the glutamate-dependent acid resistance system are up-regulated, and fliE is down-regulated, by sdiA. Gene regulation by sdiA of E. coli is only partially dependent upon AHL. Conclusions/Significance: The genes of E. coli that respond to plasmid-based expression of sdiA are largely different than those that respond to chromosomal sdiA and/or AHL. This has significant implications for determining the true function of AHL detection by E. coli.	[Dyszel, Jessica L.; Soares, Jitesh A.; Swearingen, Matthew C.; Lindsay, Amber; Smith, Jenee N.; Ahmer, Brian M. M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Dyszel, JL (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ahmer.1@osu.edu	Ahmer, Brian M. M./F-2228-2010	Ahmer, Brian M. M./0000-0002-4267-7322	Public Health Service [AI0500002, AI073971]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073971, R01AI050002] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI0500002 and AI073971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 1998, J BACTERIOL, V180, P1185, DOI 10.1128/JB.180.5.1185-1193.1998; Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Ahmer BMM, 1999, MOL MICROBIOL, V31, P971, DOI 10.1046/j.1365-2958.1999.01244.x; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dunlap Paul V., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P5; DYSZEL JL, 2009, J BACTERIOLOGY; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Goodier RI, 2001, J BACTERIOL, V183, P2249, DOI 10.1128/JB.183.7.2249-2258.2001; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Janssens JCA, 2007, APPL ENVIRON MICROB, V73, P535, DOI 10.1128/AEM.01451-06; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kanamaru K, 2000, MOL MICROBIOL, V38, P805, DOI 10.1046/j.1365-2958.2000.02171.x; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kim W, 2006, J BACTERIOL, V188, P431, DOI 10.1128/JB.188.2.431-440.2006; Lee J, 2008, ISME J, V2, P1007, DOI 10.1038/ismej.2008.54; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Lindsay A, 2005, J BACTERIOL, V187, P5054, DOI 10.1128/JB.187.14.5054-5058.2005; Lupp C, 2003, MOL MICROBIOL, V50, P319, DOI 10.1046/j.1365-2958.2003.t01-1-03585.x; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; Meighen EA, 1999, LUMINESCENCE, V14, P3, DOI 10.1002/(SICI)1522-7243(199901/02)14:1<3::AID-BIO507>3.0.CO;2-4; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Michael B, 2001, J BACTERIOL, V183, P5733, DOI 10.1128/JB.183.19.5733-5742.2001; MILLER JH, SHORT COURSE BACTERI; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Rahmati S, 2002, MOL MICROBIOL, V43, P677, DOI 10.1046/j.1365-2958.2002.02773.x; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith Debra, 2006, Science Progress, V89, P167, DOI 10.3184/003685006783238335; Smith JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002826; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Stevens AM, 1999, CELL-CELL SIGNALING IN BACTERIA, P231; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Swift S, 1999, CELL-CELL SIGNALING IN BACTERIA, P291; Van Houdt R, 2006, FEMS MICROBIOL LETT, V256, P83, DOI 10.1111/j.1574-6968.2006.00103.x; WANG XD, 1991, EMBO J, V10, P3363, DOI 10.1002/j.1460-2075.1991.tb04900.x; Wei Y, 2001, J BACTERIOL, V183, P2259, DOI 10.1128/JB.183.7.2259-2264.2001; Wei Y, 2001, J BACTERIOL, V183, P2265, DOI 10.1128/JB.183.7.2265-2272.2001; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x	52	56	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8946	10.1371/journal.pone.0008946	http://dx.doi.org/10.1371/journal.pone.0008946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126629	Green Published, Green Submitted, gold			2022-12-25	WOS:000274138000021
J	Hsieh, YH; Chen, KF; Gaydos, CA; Rothman, RE; Kelen, GD				Hsieh, Yu-Hsiang; Chen, Kuan-Fu; Gaydos, Charlotte A.; Rothman, Richard E.; Kelen, Gabor D.			Antiviral Prescriptions to US Ambulatory Care Visits with a Diagnosis of Influenza before and after High Level of Adamantane Resistance 2005-06 Season	PLOS ONE			English	Article							FOR-DISEASE-CONTROL; ORDER-ENTRY; INFECTIONS; RECOMMENDATIONS; VIRUS; RATES	Background: Rapid emergence of influenza A viruses resistance to anti-influenza drugs has been observed in the past five years. Our objective was to compare antiviral prescription patterns of ambulatory care providers to patients with a diagnosis of influenza before and after the 2005-2006 influenza season, which was temporally concordant with the emergence of adamantane resistance. We also determined providers' adherence to Centers for Disease Control and Prevention (CDC) 2006 interim treatment guidelines for influenza after the dissemination of guidelines. Methodology/Principal Findings: We conducted a multi-year cross-sectional analysis using 2002-2006 data from the national representative ambulatory care surveys, National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. Our main outcome measure was prescription of any anti-influenza pharmaceutical medication, including amantadine, rimantadine, oseltamivir, and zanamivir. Analyses were performed using procedures taking into account the multi-stage survey design and weighted sampling probabilities of the data source. Overall, there were 941 visits to U. S. ambulatory care providers for which the diagnosis of influenza was made, representing 12,140,727 visits nationally. Antiviral drugs were prescribed in 21.7% of visits. Even though prescription rates were not significantly different by influenza season (2001-02: 26.4%; 2002-03: 11.2%; 2003-04: 16.5%; 2004-05: 18.0%; 2005-06: 35.8%; 2006-07: 46.5%, p = 0.061), significantly higher prescription rates were observed in the high adamantane resistance period (18.7% versus 37.0%, p = 0.023), and after the announcement of the 2006 guidelines (18.5% versus 38.8%, p = 0.032). Use of adamantanes decreased over time, in that they were commonly used during influenza seasons 2001-03 (60.1%), but used much less frequently during seasons 2003-05 (31.9%), and used rarely after high adamantane resistance emerged (2.2%) (p<0.001). Adherence to 2006 guidelines was 97.7%. After March 2006, no prescriptions for adamantanes were given to patients with a diagnosis of influenza. Conclusions/Significance: In this nationally representative study of U. S. ambulatory care visits, we found a complete absence of the use of adamantanes in all ambulatory care settings after March 2006, closely corresponding to release of the 2006 CDC interim guidelines. Adherence to such practice is an essential element for control and prevention of influenza, especially during the era of emergence of resistance to anti-viral drugs.	[Hsieh, Yu-Hsiang; Chen, Kuan-Fu; Rothman, Richard E.; Kelen, Gabor D.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Gaydos, Charlotte A.; Rothman, Richard E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Chen, Kuan-Fu] Chang Gung Mem Hosp, Dept Emergency Med, Taipei 10591, Taiwan	Johns Hopkins University; Johns Hopkins University; Chang Gung Memorial Hospital	Hsieh, YH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.	yhsieh1@jhmi.edu	Gaydos, Charlotte A./E-9937-2010	Rothman, Richard/0000-0002-1017-9505; Kelen, Gabor/0000-0002-3236-8286; Chen, Kuan-Fu/0000-0001-7287-9497	United States Department of Homeland Security [N00014-D6-1-0991]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	United States Department of Homeland Security(United States Department of Homeland Security (DHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Dr. Hsieh, Dr. Gaydos, Dr. Rothman and Dr. Kelen are supported in part by a grant from the United States Department of Homeland Security (Grant Number N00014-D6-1-0991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaro PV, 2006, ACAD EMERG MED, V13, P452, DOI 10.1197/j.aem.2005.09.015; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; *CDCP, 2008, INT REC US INFL ANT; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; *HLTH AL NETW, 2006, CDC REC US AM RIM TR; Hsieh YH, 2008, AIDS, V22, P2127, DOI 10.1097/QAD.0b013e328310e066; Kane BG, 2004, ACAD EMERG MED, V11, P371, DOI 10.1197/j.aem.2003.11.016; Linder JA, 2005, PHARMACOEPIDEM DR S, V14, P531, DOI 10.1002/pds.1067; Magid DJ, 2003, SEX TRANSM DIS, V30, P30, DOI 10.1097/00007435-200301000-00007; MCCAIG L, 2006, ANAL DATA NAMCS NHAM; *NAT CTR HLTH STAT, 2007, NAT AMB MED CAR SURV; Ozdas A, 2006, J AM MED INFORM ASSN, V13, P188, DOI 10.1197/jamia.M1656; Tracy CR, 2009, WORLD J UROL, V27, P259, DOI 10.1007/s00345-008-0338-0; Vanderweil SG, 2007, ACAD EMERG MED, V14, P366, DOI 10.1197/j.aem.2006.10.096; WHO (World Health Organization), 2009, ANT US RISK DRUG RES	20	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8945	10.1371/journal.pone.0008945	http://dx.doi.org/10.1371/journal.pone.0008945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126611	Green Published, gold, Green Submitted			2022-12-25	WOS:000274138000020
J	Boivin, MJ; Bangirana, P; Smith, RC				Boivin, Michael J.; Bangirana, Paul; Smith, Rebecca C.			The Relationship between Visual-Spatial and Auditory-Verbal Working Memory Span in Senegalese and Ugandan Children	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; CEREBRAL MALARIA	Background: Using the Kaufman Assessment Battery for Children (K-ABC) Conant et al. (1999) observed that visual and auditory working memory (WM) span were independent in both younger and older children from DR Congo, but related in older American children and in Lao children [1]. The present study evaluated whether visual and auditory WM span were independent in Ugandan and Senegalese children. Method: In a linear regression analysis we used visual ( Spatial Memory, Hand Movements) and auditory (Number Recall) WM along with education and physical development (weight/height) as predictors. The predicted variable in this analysis was Word Order, which is a verbal memory task that has both visual and auditory memory components. Results: Both the younger (< 8.5 yrs) and older (> 8.5 yrs) Ugandan children had auditory memory span ( Number Recall) that was strongly predictive of Word Order performance. For both the younger and older groups of Senegalese children, only visual WM span ( Spatial Memory) was strongly predictive of Word Order. Number Recall was not significantly predictive of Word Order in either age group. Conclusions: It is possible that greater literacy from more schooling for the Ugandan age groups mediated their greater degree of interdependence between auditory and verbal WM. Our findings support those of Conant et al., who observed in their cross-cultural comparisons that stronger education seemed to enhance the dominance of the phonological-auditory processing loop for WM.	[Boivin, Michael J.] Michigan State Univ, Int Psychiat & Epidemiol Program, E Lansing, MI 48824 USA; [Boivin, Michael J.] Univ Michigan, Dept Psychiat, Neuropsychol Sect, Ann Arbor, MI 48109 USA; [Bangirana, Paul] Makerere Univ, Sch Med, Dept Psychiat, Kampala, Uganda; [Smith, Rebecca C.] Chestnut Hills Profess Sch Psychol, Grad Psychol Program, Philadelphia, PA USA	Michigan State University; University of Michigan System; University of Michigan; Makerere University	Boivin, MJ (corresponding author), Michigan State Univ, Int Psychiat & Epidemiol Program, E Lansing, MI 48824 USA.	boivin@msu.edu		Bangirana, Paul/0000-0002-7136-0594	West African Research Association (WARA); Institut Pasteur, Paris, France; Fulbright African Regional Research; National Institutes of Health [TW06794-01]; FOGARTY INTERNATIONAL CENTER [R21TW006794] Funding Source: NIH RePORTER	West African Research Association (WARA); Institut Pasteur, Paris, France; Fulbright African Regional Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Senegal study was made possible through a West African Research Association (WARA) Summer Research Fellowship award to Michael J. Boivin. The Institut Pasteur, Paris, France, provided funding to Dr. Ngagne Mbaye for the rural medical outpost, vehicle, and weekly outpatient clinic services in Bandia, Senegal. The authors very much appreciated his support of their assessment efforts in Bandia. Likewise, the authors are grateful to the World Vision Program of Senegal for its support of their assessment efforts in Maka Saar, Senegal. The Ugandan study was supported by a Fulbright African Regional Research Award to Michael J. Boivin, Ph.D., MPH, and by a National Institutes of Health Fogarty R21 award ( Grant TW06794-01) to Principal Investigator Chandy C. John. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACREDOLO LP, 1975, DEV PSYCHOL, V11, P495, DOI 10.1037/h0076667; APPEL LF, 1972, CHILD DEV, V43, P1365, DOI 10.2307/1127522; Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851; Bagenda D, 2006, PEDIATRICS, V117, P729, DOI 10.1542/peds.2004-2699; Bangirana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007898; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; Conant LL, 2003, J CLIN EXP NEUROPSYC, V25, P1102, DOI 10.1076/jcen.25.8.1102.16722; Conant LL, 1999, J CLIN EXP NEUROPSYC, V21, P375, DOI 10.1076/jcen.21.3.375.912; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; HITCH GJ, 1988, MEM COGNITION, V16, P120, DOI 10.3758/BF03213479; HITCH GJ, 1989, MEM COGNITION, V17, P175, DOI 10.3758/BF03197067; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; Vygotsky L.S., 1980, MIND SOC DEV HIGHER, DOI DOI 10.2307/J.CTVJF9VZ4.11; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WELLMAN HM, 1975, DEV PSYCHOL, V11, P780, DOI 10.1037/0012-1649.11.6.780	19	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8914	10.1371/journal.pone.0008914	http://dx.doi.org/10.1371/journal.pone.0008914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	550FX	20111706	Green Published, Green Submitted, gold			2022-12-25	WOS:000274114800017
J	Guo, T; Gong, LC; Sui, SF				Guo, Ting; Gong, Lin-Chen; Sui, Sen-Fang			An Electrostatically Preferred Lateral Orientation of SNARE Complex Suggests Novel Mechanisms for Driving Membrane Fusion	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; SYNAPTOTAGMIN; BINDING; MODEL; SEQUESTRATION; ASSOCIATION; HEMIFUSION; PIP2	Biological membrane fusion is a basic cellular process catalyzed by SNARE proteins and additional auxiliary factors. Yet, the critical mechanistic details of SNARE-catalyzed membrane fusion are poorly understood, especially during rapid synaptic transmission. Here, we systematically assessed the electrostatic forces between SNARE complex, auxiliary proteins and fusing membranes by the nonlinear Poisson-Boltzmann equation using explicit models of membranes and proteins. We found that a previously unrecognized, structurally preferred and energetically highly favorable lateral orientation exists for the SNARE complex between fusing membranes. This preferred orientation immediately suggests a novel and simple synaptotagmin-dependent mechanistic trigger of membrane fusion. Moreover, electrostatic interactions between membranes, SNARE complex, and auxiliary proteins appear to orchestrate a series of membrane curvature events that set the stage for rapid synaptic vesicle fusion. Together, our electrostatic analyses of SNAREs and their regulatory factors suggest unexpected and potentially novel mechanisms for eukaryotic membrane fusion proteins.	[Guo, Ting; Sui, Sen-Fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Gong, Lin-Chen] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China; [Gong, Lin-Chen] Tsinghua Univ, Ctr Adv Study, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Guo, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	suisf@mail.tsinghua.edu.cn			National Natural Science Foundation of China [30970591]; National Basic Research Program of China [2010CD833706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work is supported by National Natural Science Foundation of China ( 30970591) and National Basic Research Program of China (2010CD833706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bollinger JG, 2004, BIOCHEMISTRY-US, V43, P13293, DOI 10.1021/bi049390i; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chernomordik LV, 2006, J CELL BIOL, V175, P201, DOI 10.1083/jcb.200607083; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; CHERNOMORDIK LV, 1995, CURR OPIN STRUC BIOL, V5, P541, DOI 10.1016/0959-440X(95)80041-7; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Diraviyam K, 2006, BIOCHEMISTRY-US, V45, P2584, DOI 10.1021/bi051901t; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Duman JG, 2003, AM J PHYSIOL-CELL PH, V285, pC237, DOI 10.1152/ajpcell.00091.2003; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harbury PAB, 1998, STRUCT FOLD DES, V6, P1487, DOI 10.1016/S0969-2126(98)00147-6; HELFRICH WZ, 1973, NATURFORSCH C, V28, P11; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kozlovsky Y, 2002, BIOPHYS J, V83, P2634, DOI 10.1016/S0006-3495(02)75274-0; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Liu JG, 2006, BIOCHEM BIOPH RES CO, V347, P413, DOI 10.1016/j.bbrc.2006.06.085; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Marz KE, 2002, TRENDS NEUROSCI, V25, P381, DOI 10.1016/S0166-2236(02)02207-5; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Murray D, 2001, J BIOL CHEM, V276, P45153, DOI 10.1074/jbc.M101784200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ulmschneider MB, 2007, BIOPHYS J, V92, P2338, DOI 10.1529/biophysj.106.081810; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JY, 2004, BIOPHYS J, V86, P1969, DOI 10.1016/S0006-3495(04)74260-5; Zimmerberg J, 2006, NAT STRUCT MOL BIOL, V13, P301, DOI 10.1038/nsmb0406-301	49	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8900	10.1371/journal.pone.0008900	http://dx.doi.org/10.1371/journal.pone.0008900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126653	Green Submitted, Green Published, gold			2022-12-25	WOS:000273896500020
J	Long, ET; Baker, S; Oliveira, V; Sawitzki, B; Wood, KJ				Long, Elaine T.; Baker, Stephanie; Oliveira, Vanessa; Sawitzki, Birgit; Wood, Kathryn J.			Alpha-1,2-Mannosidase and Hence N-Glycosylation Are Required for Regulatory T Cell Migration and Allograft Tolerance in Mice	PLOS ONE			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; L-SELECTIN EXPRESSION; LYMPH-NODES; DIFFERENTIAL GLYCOSYLATION; TRANSPLANTATION TOLERANCE; MYCOPHENOLATE-MOFETIL; ENDOTHELIAL-CELLS; ALPHA-MANNOSIDASE; GRAFT-REJECTION; DENDRITIC CELLS	Background: Specific immunological unresponsiveness to alloantigens can be induced in vivo by treating mice with a donor alloantigen in combination with a non-depleting anti-CD4 antibody. This tolerance induction protocol enriches for alloantigen reactive regulatory T cells (Treg). We previously demonstrated that alpha-1,2-mannosidase, an enzyme involved in the synthesis and processing of N-linked glycoproteins, is highly expressed in tolerant mice, in both graft infiltrating leukocytes and peripheral blood lymphocytes. Principal Findings: In this study we have identified that alpha-1,2-mannosidase expression increases in CD25(+)CD4(+) Treg when they encounter alloantigen in vivo. When alpha-1,2-mannosidase enzyme activity was blocked, Treg retained their capacity to suppress T cell proliferation in vitro but were unable to bind to physiologically relevant ligands in vitro. Further in vivo analysis demonstrated that blocking alpha-1,2-mannosidase in Treg resulted in the migration of significantly lower numbers to the peripheral lymph nodes in skin grafted mice following adoptive transfer, where they were less able to inhibit the proliferation of naive T cells responding to donor alloantigen and hence unable prevent allograft rejection in vivo. Significance: Taken together, our results suggest that activation of alloantigen reactive Treg results in increased alpha-1,2-mannosidase expression and altered N-glycosylation of cell surface proteins. In our experimental system, altered N-glycosylation is not essential for intrinsic Treg suppressive capacity, but is essential in vivo as it facilitates Treg migration to sites where they can regulate immune priming. Migration of Treg is central to their role in regulating in vivo immune responses and may require specific changes in N-glycosylation upon antigen encounter.	[Long, Elaine T.; Baker, Stephanie; Oliveira, Vanessa; Sawitzki, Birgit; Wood, Kathryn J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplant Res Immunol Grp, Oxford OX3 9DU, England	University of Oxford	Long, ET (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplant Res Immunol Grp, Oxford OX3 9DU, England.	elaine.long@nds.ox.ac.uk	Sawitzki, Birgit S/S-2307-2016	Goncalves de Oliveira, Vanessa Alexandra/0000-0001-6884-2675; Sawitzki, Birgit/0000-0001-8166-8579	Wellcome Trust; European Union; British Heart Foundation; Garfield Weston Trust	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); British Heart Foundation(British Heart Foundation); Garfield Weston Trust	This work was supported by The Wellcome Trust, the European Union through the RISET Integrated Project, British Heart Foundation and the Garfield Weston Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2005, TRANSPLANTATION, V80, pS181, DOI 10.1097/01.tp.0000186390.10150.66; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Betti M, 2006, ANN ONCOL, V17, P235; Blaheta RA, 1999, TRANSPLANT P, V31, P1250, DOI 10.1016/S0041-1345(98)01984-8; BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Bushell A, 2007, AM J TRANSPLANT, V7, P759, DOI 10.1111/j.1600-6143.2006.01716.x; Bushell A, 2003, TRANSPLANTATION, V76, P449, DOI 10.1097/01.TP.0000083043.84630.99; Carvalho-Gaspar M, 2008, J IMMUNOL, V180, P6640, DOI 10.4049/jimmunol.180.10.6640; CHEN HL, DEMETRIOU M T CELL R; Chen X, 2006, EUR J IMMUNOL, V36, P671, DOI 10.1002/eji.200535353; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DENNIS JW, 1989, CANCER RES, V49, P945; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Fieger C B, 2001, Biochim Biophys Acta, V1524, P75; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Heemann U, 1996, Transpl Immunol, V4, P64, DOI 10.1016/S0966-3274(96)80039-6; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hiura T, 2005, J IMMUNOL, V175, P5058, DOI 10.4049/jimmunol.175.8.5058; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Jones ND, 2006, J IMMUNOL, V176, P2316, DOI 10.4049/jimmunol.176.4.2316; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kosuge T, 2000, BIOL PHARM BULL, V23, P1; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Ma BY, 2004, BIOCHEM BIOPH RES CO, V317, P60, DOI 10.1016/j.bbrc.2004.03.012; Masteller EL, 2006, SEMIN IMMUNOL, V18, P103, DOI 10.1016/j.smim.2006.01.004; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; OLIVEIRA V, 2008, ANTICD4 MEDIATED SEL; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; Qu L, 2006, CELL RES, V16, P622, DOI 10.1038/sj.cr.7310065; RENKONEN R, 1991, EUR J IMMUNOL, V21, P777, DOI 10.1002/eji.1830210334; Bono MR, 2007, CYTOKINE GROWTH F R, V18, P33, DOI 10.1016/j.cytogfr.2007.01.004; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; Saitovitch D, 1996, TRANSPLANTATION, V61, P1642, DOI 10.1097/00007890-199606150-00016; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Sawitzki B, 2007, AM J TRANSPLANT, V7, P1091, DOI 10.1111/j.1600-6143.2007.01768.x; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Siewert C, 2007, EUR J IMMUNOL, V37, P978, DOI 10.1002/eji.200636575; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; SPONAAS AM, 1994, INT IMMUNOL, V6, P277, DOI 10.1093/intimm/6.2.277; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Tang MLK, 1998, J IMMUNOL, V160, P5113; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; TURUNEN JP, 1995, J EXP MED, V182, P1133, DOI 10.1084/jem.182.4.1133; van Maurik A, 2002, J IMMUNOL, V169, P5401; Venturi GM, 2007, J IMMUNOL, V178, P291, DOI 10.4049/jimmunol.178.1.291; Weng SA, 1996, ARCH BIOCHEM BIOPHYS, V325, P113, DOI 10.1006/abbi.1996.0014; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076	59	21	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8894	10.1371/journal.pone.0008894	http://dx.doi.org/10.1371/journal.pone.0008894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126660	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500017
J	Kage-Nakadai, E; Kobuna, H; Kimura, M; Gengyo-Ando, K; Inoue, T; Arai, H; Mitani, S				Kage-Nakadai, Eriko; Kobuna, Hiroyuki; Kimura, Masako; Gengyo-Ando, Keiko; Inoue, Takao; Arai, Hiroyuki; Mitani, Shohei			Two Very Long Chain Fatty Acid Acyl-CoA Synthetase Genes, acs-20 and acs-22, Have Roles in the Cuticle Surface Barrier in Caenorhabditis elegans	PLOS ONE			English	Article							TRANSPORT PROTEIN-4; WRINKLE-FREE; C-ELEGANS; CLONING; EXPRESSION; LACS2; MUTATIONS; FEATURES; FAMILY; MOUSE	In multicellular organisms, the surface barrier is essential for maintaining the internal environment. In mammals, the barrier is the stratum corneum. Fatty acid transport protein 4 (FATP4) is a key factor involved in forming the stratum corneum barrier. Mice lacking Fatp4 display early neonatal lethality with features such as tight, thick, and shiny skin, and a defective skin barrier. These symptoms are strikingly similar to those of a human skin disease called restrictive dermopathy. FATP4 is a member of the FATP family that possesses acyl-CoA synthetase activity for very long chain fatty acids. How Fatp4 contributes to skin barrier function, however, remains to be elucidated. In the present study, we characterized two Caenorhabditis elegans genes, acs-20 and acs-22, that are homologous to mammalian FATPs. Animals with mutant acs-20 exhibited defects in the cuticle barrier, which normally prevents the penetration of small molecules. acs-20 mutant animals also exhibited abnormalities in the cuticle structure, but not in epidermal cell fate or cell integrity. The acs-22 mutants rarely showed a barrier defect, whereas acs-20; acs-22 double mutants had severely disrupted barrier function. Moreover, the barrier defects of acs-20 and acs-20; acs-22 mutants were rescued by acs-20, acs-22, or human Fatp4 transgenes. We further demonstrated that the incorporation of exogenous very long chain fatty acids into sphingomyelin was reduced in acs-20 and acs-22 mutants. These findings indicate that C. elegans Fatp4 homologue(s) have a crucial role in the surface barrier function and this model might be useful for studying the fundamental molecular mechanisms underlying human skin barrier and relevant diseases.	[Kage-Nakadai, Eriko; Kobuna, Hiroyuki; Gengyo-Ando, Keiko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kimura, Masako; Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Kage-Nakadai, Eriko; Kobuna, Hiroyuki; Gengyo-Ando, Keiko; Inoue, Takao; Arai, Hiroyuki; Mitani, Shohei] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan	Tokyo Women's Medical University; University of Tokyo; Japan Science & Technology Agency (JST)	Kage-Nakadai, E (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan.	mitani1@research.twmu.ac.jp	Gengyo-Ando, Keiko/AAC-4504-2019; Gengyo-Ando, Keiko/B-2753-2012		Japan Society for the promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Science and Technology Agency (JST); Core Research for Evolutional Science and Technology (CREST); Kao Foundation for Arts and Sciences	Japan Society for the promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Kao Foundation for Arts and Sciences	This study was supported by Grants-in-Aid for Scientific Research from Japan Society for the promotion of Science (JSPS) (to E. K.-N. and S. M.) and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The study was supported by Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST). The study was also supported by the Kao Foundation for Arts and Sciences (to E. K.-N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT GR, 1959, J BIOL CHEM, V234, P469; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRENNER S, 1974, GENETICS, V77, P71; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Gerdt S, 1997, GLYCOBIOLOGY, V7, P265, DOI 10.1093/glycob/7.2.265; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Lu SY, 2009, PLANT J, V59, P553, DOI 10.1111/j.1365-313X.2009.03892.x; Mack Judith A., 2005, Birth Defects Research, V75, P314, DOI 10.1002/bdrc.20055; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mihalik SJ, 2002, J BIOL CHEM, V277, P24771, DOI 10.1074/jbc.M203295200; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Min J, 2007, NAT CHEM BIOL, V3, P55, DOI 10.1038/nchembio833; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Moulson CL, 2007, J BIOL CHEM, V282, P15912, DOI 10.1074/jbc.M701779200; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; Page A.P., 2007, CUTICLE, P1; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Pei ZT, 2004, J BIOL CHEM, V279, P54454, DOI 10.1074/jbc.M410091200; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Ramstedt B, 2002, FEBS LETT, V531, P33, DOI 10.1016/S0014-5793(02)03406-3; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Tang DZ, 2007, PLANT PHYSIOL, V144, P1093, DOI 10.1104/pp.106.094318; Uchiyama A, 1996, J BIOL CHEM, V271, P30360, DOI 10.1074/jbc.271.48.30360; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006	38	46	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8857	10.1371/journal.pone.0008857	http://dx.doi.org/10.1371/journal.pone.0008857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111596	gold, Green Published, Green Submitted			2022-12-25	WOS:000273896300009
J	Graham, BH; Li, ZH; Alesii, EP; Versteken, P; Lee, C; Wang, J; Craigen, WJ				Graham, Brett H.; Li, Zhihong; Alesii, Erminio P.; Versteken, Patrik; Lee, Cynthia; Wang, Jennifer; Craigen, William J.			Neurologic Dysfunction and Male Infertility in Drosophila porin Mutants A NEW MODEL FOR MITOCHONDRIAL DYSFUNCTION AND DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; GENE DISRUPTION PROJECT; BEHAVIORAL MUTANTS; SENSITIVE MUTANTS; OUTER-MEMBRANE; ALPHA-SUBUNIT; CYTOCHROME-C; MELANOGASTER; PROTEIN; EXPRESSION	Voltage-dependent anion channels (VDACs) are a family of small pore-forming proteins of the mitochondrial outer membrane found in all eukaryotes. VDACs play an important role in the regulated flux of metabolites between the cytosolic and mitochondrial compartments, and three distinct mammalian isoforms have been identified. Animal and cell culture experiments suggest that the various isoforms act in disparate roles such as apoptosis, synaptic plasticity, learning, muscle bioenergetics, and reproduction. In Drosophila melanogaster, porin is the ubiquitously expressed VDAC isoform. Through imprecise excision of a P element insertion in the porin locus, a series of hypomorphic alleles have been isolated, and analyses of flies homozygous for these mutant alleles reveal phenotypes remarkably reminiscent of mouse VDAC mutants. These include partial lethality, defects of mitochondrial respiration, abnormal muscle mitochondrial morphology, synaptic dysfunction, and male infertility, which are features often observed in human mitochondrial disorders. Furthermore, the observed synaptic dysfunction at the neuromuscular junction in porin mutants is associated with a paucity of mitochondria in presynaptic termini. The similarity of VDAC mutant phenotypes in the fly and mouse clearly indicate a fundamental conservation of VDAC function. The establishment and validation of a new in vivo model for VDAC function in Drosophila should provide a valuable tool for further genetic dissection of VDAC role(s) in mitochondrial biology and disease, and as a model of mitochondrial disorders potentially amenable to the development of treatment strategies.	[Graham, Brett H.; Li, Zhihong; Alesii, Erminio P.; Lee, Cynthia; Wang, Jennifer; Craigen, William J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Craigen, William J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Versteken, Patrik] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Versteken, Patrik] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium	Baylor College of Medicine; Baylor College of Medicine; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Graham, BH (corresponding author), Rm T536,BCM225,1 Baylor Plaza, Houston, TX 77030 USA.	bgraham@bcm.edu	Verstreken, Patrik/AAC-7591-2022; Graham, Brett/R-8685-2018	Verstreken, Patrik/0000-0002-5073-5393; Graham, Brett/0000-0001-8451-8154	National Institutes of Health [K08 HD44808, R01 NS0423193]; March of Dimes [FY-99-323]; Fund for Scientific Research Flanders (FWO) [G.0747.09]; Research Fund Katholieke Universiteit Leuven; Marie Curie Excellence [MEXT-CT-2006-042267]; Baylor College of Medicine Mental Retardation Developmental Disabilities Research Center (MRDDRC) [HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD044808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Fund for Scientific Research Flanders (FWO)(FWO); Research Fund Katholieke Universiteit Leuven; Marie Curie Excellence(European Commission); Baylor College of Medicine Mental Retardation Developmental Disabilities Research Center (MRDDRC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 HD44808 (to B. H. G.) and R01 NS0423193 (to W. J. C.). This work was also supported by March of Dimes FY-99-323 (to W. J. C.), Fund for Scientific Research Flanders (FWO, G.0747.09) (to P. V.), Research Fund Katholieke Universiteit Leuven (P. V.), a Marie Curie Excellence Grant (MEXT-CT-2006-042267) (to P. V.), The Baylor College of Medicine Mental Retardation Developmental Disabilities Research Center (MRDDRC HD024064), and VIB (to P. V.).	Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BELLEN HJ, 2000, DROSOPHILA PROTOCOLS, P175; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; BlachlyDyson E, 1997, MOL CELL BIOL, V17, P5727, DOI 10.1128/MCB.17.10.5727; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; GANETZKY B, 1982, J NEUROPHYSIOL, V47, P501, DOI 10.1152/jn.1982.47.3.501; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Graham BH, 2005, MOL GENET METAB, V85, P308, DOI 10.1016/j.ymgme.2005.03.009; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Guarino F, 2006, BIOCHEM BIOPH RES CO, V346, P665, DOI 10.1016/j.bbrc.2006.05.172; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; HOMYK T, 1977, GENETICS, V87, P105; HOMYK T, 1980, MOL GEN GENET, V177, P553; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Huizing M, 1996, PEDIATR RES, V39, P760, DOI 10.1203/00006450-199605000-00003; Jacobs H, 1998, MOL GEN GENET, V259, P383, DOI 10.1007/s004380050826; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Komarov AG, 2004, BIOPHYS J, V86, P152, DOI 10.1016/S0006-3495(04)74093-X; Kuebler D, 2000, J NEUROPHYSIOL, V83, P998, DOI 10.1152/jn.2000.83.2.998; Lee J, 2002, J NEUROSCI, V22, P11065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LO MVC, 1981, J GEN PHYSIOL, V77, P155, DOI 10.1085/jgp.77.2.155; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; McQuibban GA, 2006, CURR BIOL, V16, P982, DOI 10.1016/j.cub.2006.03.062; Messina A, 1996, FEBS LETT, V384, P9, DOI 10.1016/0014-5793(96)00268-2; Oliva M, 2002, MOL GENET GENOMICS, V267, P746, DOI 10.1007/s010438-002-0714-1; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2; Rahmani Z, 1998, EUR J HUM GENET, V6, P337, DOI 10.1038/sj.ejhg.5200198; RAMASWAMI M, 1989, P NATL ACAD SCI USA, V86, P2079, DOI 10.1073/pnas.86.6.2079; ROBERTSON HM, 1988, GENETICS, V118, P461; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; Ryerse J, 1997, BBA-BIOMEMBRANES, V1327, P204, DOI 10.1016/S0005-2736(97)00059-X; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; SCHUBIGER M, 1994, NEURON, V12, P373, DOI 10.1016/0896-6273(94)90278-X; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; SORGATO MC, 1993, CRIT REV BIOCHEM MOL, V28, P127; Spradling AC, 1999, GENETICS, V153, P135; Tong JJY, 2007, BIOL BULL-US, V212, P169, DOI 10.2307/25066594; Trotta N, 2004, J NEUROBIOL, V60, P328, DOI 10.1002/neu.20017; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zhang YQ, 1999, GENETICS, V153, P891	62	31	31	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11143	11153		10.1074/jbc.M109.080317	http://dx.doi.org/10.1074/jbc.M109.080317			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20110367	hybrid, Green Published			2022-12-25	WOS:000276286200019
J	Chapot-Chartier, MP; Vinogradov, E; Sadovskaya, I; Andre, G; Mistou, MY; Trieu-Cuot, P; Furlan, S; Bidnenko, E; Courtin, P; Pechoux, C; Hols, P; Dufrene, YF; Kulakauskas, S				Chapot-Chartier, Marie-Pierre; Vinogradov, Evgeny; Sadovskaya, Irina; Andre, Guillaume; Mistou, Michel-Yves; Trieu-Cuot, Patrick; Furlan, Sylviane; Bidnenko, Elena; Courtin, Pascal; Pechoux, Christine; Hols, Pascal; Dufrene, Yves F.; Kulakauskas, Saulius			Cell Surface of Lactococcus lactis Is Covered by a Protective Polysaccharide Pellicle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; GRAM-POSITIVE BACTERIA; COMPLETE GENOME SEQUENCE; ACID BACTERIA; GENE-CLUSTER; EXOPOLYSACCHARIDE BIOSYNTHESIS; MOLECULAR CHARACTERIZATION; STREPTOCOCCUS-AGALACTIAE; FUNCTIONAL-ANALYSIS; TEICHOIC-ACIDS	In Gram-positive bacteria, the functional role of surface polysaccharides (PS) that are not of capsular nature remains poorly understood. Here, we report the presence of a novel cell wall PS pellicle on the surface of Lactococcus lactis. Spontaneous PS-negative mutants were selected using semi-liquid growth conditions, and all mutations were mapped in a single chromosomal locus coding for PS biosynthesis. PS molecules were shown to be composed of hexasaccharide phosphate repeating units that are distinct from other bacterial PS. Using complementary atomic force and transmission electron microscopy techniques, we showed that the PS layer forms an outer pellicle surrounding the cell. Notably, we found that this cell wall layer confers a protective barrier against host phagocytosis by murine macrophages. Altogether, our results suggest that the PS pellicle could represent a new cell envelope structural component of Gram-positive bacteria.	[Chapot-Chartier, Marie-Pierre; Mistou, Michel-Yves; Furlan, Sylviane; Bidnenko, Elena; Courtin, Pascal; Kulakauskas, Saulius] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Vinogradov, Evgeny] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Sadovskaya, Irina] Univ Lille Nord France, F-59000 Lille, France; [Sadovskaya, Irina] Univ Littoral Cote dOpale, UMT 08, LR2B, F-62327 Boulogne, France; [Andre, Guillaume; Dufrene, Yves F.] Catholic Univ Louvain, Unite Chim Interfaces, B-1348 Louvain, Belgium; [Mistou, Michel-Yves; Trieu-Cuot, Patrick] Inst Pasteur, CNRS, Unite Biol Bacteries Pathogenes Gram Positif, URA 2172, F-75724 Paris, France; [Pechoux, Christine] INRA, Genom & Physiol Lactat UR1196, F-78350 Jouy En Josas, France; [Hols, Pascal] Catholic Univ Louvain, Unite Genet, Inst Sci Vie, B-1348 Louvain, Belgium	INRAE; UDICE-French Research Universities; Universite Paris Saclay; National Research Council Canada; Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Catholique Louvain	Kulakauskas, S (corresponding author), INRA, Micalis UMR1319, F-78352 Jouy En Josas, France.	saulius.kulakauskas@jouy.inra.fr	Mistou, Michel-Yves/AAY-2688-2021	TRIEU-CUOT, Patrick/0000-0002-2768-9587; Dufrene, Yves/0000-0002-7289-4248; Mistou, Michel-Yves/0000-0001-9732-3970; Vinogradov, Evgeny/0000-0002-5364-1376; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	INRA	INRA	This work was supported in part by INRA (to M.-P. C.-C., M.-Y.M., S. F., E. B., P. C., C. P., and S. K.).	Areschoug Thomas, 2008, V15, P45, DOI 10.1159/000135685; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; CERNING J, 1990, FEMS MICROBIOL LETT, V87, P113, DOI 10.1111/j.1574-6968.1990.tb04883.x; Chandry PS, 1997, MOL MICROBIOL, V26, P49, DOI 10.1046/j.1365-2958.1997.5491926.x; Chapot-Chartier MP, 1994, INT DAIRY J, V4, P251, DOI 10.1016/0958-6946(94)90016-7; Chen PM, 2008, MICROBES INFECT, V10, P293, DOI 10.1016/j.micinf.2007.12.006; CHEN PS, 1956, ANAL CHEM, V28, P1758; Chia JS, 2001, INFECT IMMUN, V69, P6987, DOI 10.1128/IAI.69.11.6987-6998.2001; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Dabour N, 2005, APPL ENVIRON MICROB, V71, P7414, DOI 10.1128/AEM.71.11.7414-7425.2005; Dabour N, 2006, J DAIRY SCI, V89, P95, DOI 10.3168/jds.S0022-0302(06)72073-2; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; DUBOIS M, 1956, ANAL CHEM, V28, P356; Dufrene YF, 2008, NAT REV MICROBIOL, V6, P674, DOI 10.1038/nrmicro1948; Dufrene YF, 2008, NAT PROTOC, V3, P1132, DOI 10.1038/nprot.2008.101; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5825, DOI 10.1128/AEM.70.10.5825-5832.2004; ENGHOFER E, 1979, CARBOHYD RES, V76, P233, DOI 10.1016/0008-6215(79)80022-1; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; Francius G, 2008, ACS NANO, V2, P1921, DOI 10.1021/nn800341b; GASSON MJ, 1983, J BACTERIOL, V154, P1; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Le Gouellec A, 2008, J BACTERIOL, V190, P4501, DOI 10.1128/JB.00376-08; Mercier C, 2000, FEMS MICROBIOL LETT, V187, P47, DOI 10.1111/j.1574-6968.2000.tb09135.x; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Mifune J, 2009, APPL ENVIRON MICROB, V75, P4668, DOI 10.1128/AEM.00487-09; Morlot C, 2003, MOL MICROBIOL, V50, P845, DOI 10.1046/j.1365-2958.2003.03767.x; Naumova IB, 1997, BIOCHEMISTRY-MOSCOW+, V62, P809; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; POOLEY HM, 1972, J BACTERIOL, V109, P423, DOI 10.1128/JB.109.1.423-431.1972; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Sadovskaya I, 2004, CARBOHYD RES, V339, P1467, DOI 10.1016/j.carres.2004.03.017; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Stukalov O, 2008, APPL ENVIRON MICROB, V74, P5457, DOI 10.1128/AEM.02075-07; Sutcliffe IC, 2008, MICROBIOL-SGM, V154, P1354, DOI 10.1099/mic.0.2007/014522-0; Toukach P, 2007, NUCLEIC ACIDS RES, V35, pD280, DOI 10.1093/nar/gkl883; van Kranenburg R, 1999, J BACTERIOL, V181, P6347, DOI 10.1128/JB.181.20.6347-6353.1999; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Vlieg JETV, 2006, CURR OPIN BIOTECH, V17, P183, DOI 10.1016/j.copbio.2006.02.007; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Zechini B, 2006, DIAGN MICR INFEC DIS, V56, P325, DOI 10.1016/j.diagmicrobio.2006.04.011	49	125	130	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10464	10471		10.1074/jbc.M109.082958	http://dx.doi.org/10.1074/jbc.M109.082958			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20106971	Green Published, hybrid			2022-12-25	WOS:000276264600032
J	Chen, XW; Chern, M; Canlas, PE; Jiang, CY; Ruan, DL; Cao, PJ; Ronald, PC				Chen, Xuewei; Chern, Mawsheng; Canlas, Patrick E.; Jiang, Caiying; Ruan, Deling; Cao, Peijian; Ronald, Pamela C.			A Conserved Threonine Residue in the Juxtamembrane Domain of the XA21 Pattern Recognition Receptor Is Critical for Kinase Autophosphorylation and XA21-mediated Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORYZAE PV. ORYZAE; DISEASE-RESISTANCE GENE; NEGATIVE REGULATOR; STRUCTURAL BASIS; RICE; PHOSPHORYLATION; BINDING; INNATE; FLS2; IDENTIFICATION	Despite the key role that pattern recognition receptors (PRRs) play in regulating immunity in plants and animals, the mechanism of activation of the associated non-arginine-aspartate (non-RD) kinases is unknown. The rice PRR XA21 recognizes the pathogen-associated molecular pattern, Ax21 (activator of XA21-mediated immunity). Here we show that the XA21 juxtamembrane (JM) domain is required for kinase autophosphorylation. Threonine 705 in the XA21 JM domain is essential for XA21 autophosphorylation in vitro and XA21-mediated innate immunity in vivo. The replacement of Thr705 by an alanine or glutamic acid abolishes XA21 autophosphorylation and eliminates interactions between XA21 and four XA21-binding proteins in yeast and rice. Although threonine residues analogous to Thr705 of XA21 are present in the JM domains of most RD and non-RD plant receptor-like kinases, this residue is not required for autophosphorylation of the Arabidopsis RD RLK BRI1 (brassinosteroid insensitive 1). The threonine 705 of XA21 is conserved only in the JM domains of plant RLKs but not in those of fly, human, or mouse suggesting distinct regulatory mechanisms. These results contribute to growing knowledge regarding the mechanism by which non-RD RLKs function in plant.	[Chen, Xuewei; Chern, Mawsheng; Canlas, Patrick E.; Jiang, Caiying; Ruan, Deling; Cao, Peijian; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Ronald, PC (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu	Ronald, Pamela/AAK-7664-2020; Cao, Peijian/U-6776-2019		National Institutes of Health [GM055962]; United States Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative [2004-35317-14867]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM055962 (to P. C. R.). This work was also supported in part by the United States Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Applied Plant Genomics Program RiceCAP Grant 2004-35317-14867 (to P. C. R.).	Agosti V, 2009, EXP HEMATOL, V37, P159, DOI 10.1016/j.exphem.2008.10.009; Aifa S, 2006, PROTEINS, V62, P1036, DOI 10.1002/prot.20780; Aifa S, 2006, BIOCHEM BIOPH RES CO, V347, P381, DOI 10.1016/j.bbrc.2006.05.200; Andaya CB, 2003, PHYSIOL MOL PLANT P, V62, P203, DOI 10.1016/S0885-5765(03)00060-2; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Brueggeman R, 2002, P NATL ACAD SCI USA, V99, P9328, DOI 10.1073/pnas.142284999; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Heiss E, 2006, BLOOD, V108, P1542, DOI 10.1182/blood-2005-07-008896; Hubbard SR, 2001, MOL CELL, V8, P481, DOI 10.1016/S1097-2765(01)00350-1; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; Jung KH, 2008, NAT REV GENET, V9, P91, DOI 10.1038/nrg2286; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Liu GZ, 2002, J BIOL CHEM, V277, P20264, DOI 10.1074/jbc.M110999200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Xu WH, 2006, PLANT J, V45, P740, DOI 10.1111/j.1365-313X.2005.02638.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	43	49	55	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10454	10463		10.1074/jbc.M109.093427	http://dx.doi.org/10.1074/jbc.M109.093427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118235	hybrid, Green Published			2022-12-25	WOS:000276264600031
J	Methner, DNR; Mayfield, RD				Methner, D. Nicole Riherd; Mayfield, R. Dayne			Ethanol Alters Endosomal Recycling of Human Dopamine Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROLOGOUSLY EXPRESSING CELLS; VENTRAL TEGMENTAL AREA; SURFACE EXPRESSION; PLASMA-MEMBRANE; MONOAMINE TRANSPORTERS; FUNCTIONAL REGULATION; NUCLEUS-ACCUMBENS; GLUCOSE-UPTAKE; UP-REGULATION; AMPHETAMINE	Dynamic membrane trafficking of the monoamine dopamine transporter (DAT) regulates dopaminergic signaling. Various intrinsic and pharmacological modulators can alter this trafficking. Previously we have shown ethanol potentiates in vitro DAT function and increases surface expression. However, the mechanism underlying these changes is unclear. In the present study, we found ethanol directly regulates DAT function by altering endosomal recycling of the transporter. We defined ethanol action on transporter regulation by [H-3]DA uptake functional analysis combined with biochemical and immunological assays in stably expressing DAT HEK-293 cells. Shortterm ethanol exposure potentiated DAT function in a concentration-, but not time-dependent manner. This potentiation was accompanied by a parallel increase in DAT surface expression. Ethanol had no effect on function or surface localization of the ethanol-insensitive mutant (G130T DAT), suggesting a trafficking-dependent mechanism in mediating the ethanol sensitivity of the transporter. The ethanol-induced increase in DAT surface expression occurred without altering the overall size of DAT endosomal recycling pools. We found ethanol increased the DAT membrane insertion rate while having no effect on internalization of the transporter. Ethanol had no effect on the surface expression or trafficking of the endogenously expressing transferrin receptor, suggesting ethanol does not have a nonspecific effect on endosomal recycling. These results define a novel trafficking mechanism by which ethanol regulates DAT function.	[Methner, D. Nicole Riherd; Mayfield, R. Dayne] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Mayfield, RD (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, MBB1-124,2500 Speedway, Austin, TX 78712 USA.	dayne.mayfield@mail.utexas.edu						Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Boudanova E, 2008, NEUROPHARMACOLOGY, V54, P605, DOI 10.1016/j.neuropharm.2007.11.007; Brodie MS, 1998, ALCOHOL CLIN EXP RES, V22, P236, DOI 10.1111/j.1530-0277.1998.tb03644.x; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Chen NH, 2007, J NEUROCHEM, V101, P377, DOI 10.1111/j.1471-4159.2006.04384.x; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Conti AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005697; Cruz-Muros I, 2009, NEUROBIOL AGING, V30, P973, DOI 10.1016/j.neurobiolaging.2007.09.009; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Duan SM, 1999, J NEUROSCI, V19, P10193; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Garzon M, 2006, J COMP NEUROL, V498, P821, DOI 10.1002/cne.21082; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Hersch SM, 1997, J COMP NEUROL, V388, P211; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Imoukhuede PI, 2009, BIOPHYS J, V96, P2949, DOI 10.1016/j.bpj.2008.11.070; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; Jayanthi LD, 2005, AAPS J, V7, pE728, DOI 10.1208/aapsj070373; Johnson LA, 2005, NEUROPHARMACOLOGY, V49, P750, DOI 10.1016/j.neuropharm.2005.08.018; Kahlig KM, 2006, MOL PHARMACOL, V70, P542, DOI 10.1124/mol.106.023952; LIN AMY, 1993, NEUROSCI LETT, V164, P71, DOI 10.1016/0304-3940(93)90860-N; Lin AMY, 1997, BRAIN RES, V756, P287, DOI 10.1016/S0006-8993(97)00229-1; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Maiya R, 2002, J BIOL CHEM, V277, P30724, DOI 10.1074/jbc.M204914200; Mayfield RD, 2001, J NEUROCHEM, V79, P1070, DOI 10.1046/j.1471-4159.2001.00656.x; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miller GW, 1997, ANN NEUROL, V41, P530, DOI 10.1002/ana.410410417; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Mochizuki H, 2005, NEUROCHEM INT, V46, P93, DOI 10.1016/j.neuint.2004.08.008; Nelson N, 1998, J NEUROCHEM, V71, P1785; Riherd DN, 2008, ALCOHOL, V42, P499, DOI 10.1016/j.alcohol.2008.04.009; RITZ MC, 1988, PROG NEURO-PSYCHOPH, V12, P233, DOI 10.1016/0278-5846(88)90040-1; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; Tomas M, 2003, J NEUROCHEM, V87, P220, DOI 10.1046/j.1471-4159.2003.01993.x; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Whitworth TL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0003.2002; Whitworth TL, 2001, BIOCHEM SOC T, V29, P736, DOI 10.1042/BST0290736; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; YOSHIMOTO K, 1992, ALCOHOL, V9, P17, DOI 10.1016/0741-8329(92)90004-T; Yu B, 2000, AM J PHYSIOL-ENDOC M, V279, pE1358, DOI 10.1152/ajpendo.2000.279.6.E1358; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	49	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10310	10317		10.1074/jbc.M109.029561	http://dx.doi.org/10.1074/jbc.M109.029561			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133946	Green Published, hybrid			2022-12-25	WOS:000276264600015
J	Macurek, L; Lindqvist, A; Voets, O; Kool, J; Vos, HR; Medema, RH				Macurek, L.; Lindqvist, A.; Voets, O.; Kool, J.; Vos, H. R.; Medema, R. H.			Wip1 phosphatase is associated with chromatin and dephosphorylates gamma H2AX to promote checkpoint inhibition	ONCOGENE			English	Article						DNA damage; checkpoint inhibition; phosphatase; cancer	DOUBLE-STRAND BREAKS; DNA-DAMAGE CHECKPOINT; HISTONE H2AX PHOSPHORYLATION; ACTIVATION IN-VIVO; PROTEIN PHOSPHATASE; ATM ACTIVATION; RADIOSENSITIZING AGENT; IONIZING-RADIATION; SIGNALING PATHWAYS; REPAIR PROTEINS	DNA double-stranded breaks (DSBs) elicit a checkpoint response that causes a delay in cell cycle progression. Early in the checkpoint response, histone H2AX is phosphorylated in the chromatin region flanking the DSB by ATM/ATR and DNA-PK kinases. The resulting foci of phosphorylated H2AX (gamma-H2AX) serve as a platform for recruitment and retention of additional components of the checkpoint-signaling cascade that enhance checkpoint signaling and DSB repair. Upon repair, both the assembled protein complexes and the chromatin modifications are removed to quench the checkpoint signal. In this study, we show that the DNA damage-responsive Wip1 phosphatase is bound to chromatin. Moreover, Wip1 directly dephosphorylates gamma-H2AX and cells depleted of Wip1 fail to dephosphorylate gamma-H2AX during checkpoint recovery. Conversely, premature activation of Wip1 leads to displacement of MDC1 from damage foci and prevents activation of the checkpoint. Taken together, our data show that Wip1 has an essential role in dephosphorylation of gamma-H2AX to silence the checkpoint and restore chromatin structure once DNA damage is repaired. Oncogene (2010) 29, 2281-2291; doi: 10.1038/onc.2009.501; published online 25 January 2010	[Macurek, L.; Lindqvist, A.; Voets, O.; Kool, J.; Medema, R. H.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [Macurek, L.; Lindqvist, A.; Voets, O.; Kool, J.; Vos, H. R.; Medema, R. H.] Univ Med Ctr Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [Macurek, L.] Acad Sci Czech Republic, Inst Mol Genet, Dept Genome Integr, Vvi, Prague, Czech Republic; [Vos, H. R.] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Utrecht University; Utrecht University Medical Center	Medema, RH (corresponding author), Univ Med Ctr Utrecht, Dept Med Oncol, Univ Sweg 100,Str 2-118, NL-3584 CG Utrecht, Netherlands.	r.h.medema@umcutrecht.nl	Medema, Rene H/G-5415-2011; Medema, Rene H/E-2981-2013; Lindqvist, Arne/B-6792-2008; Macurek, Libor/C-7865-2014	Macurek, Libor/0000-0002-0987-1238; Lindqvist, Arne/0000-0002-0141-1579; Medema, Rene/0000-0002-6754-0381; Vos, Harmjan/0000-0002-4696-6068	Netherlands Genomics Initiative of NWO; Dutch Cancer Society [UU2006-3579]; Grant Agency of the Czech Republic [P305/10/P420]; Wenner-Gren foundation; Netherlands Organization for Scientific Research (NWO) [ZonMw 916.86.083]; Center for Translational Molecular Medicine (CTMM)	Netherlands Genomics Initiative of NWO; Dutch Cancer Society(KWF Kankerbestrijding); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Wenner-Gren foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center for Translational Molecular Medicine (CTMM)	We are thankful to Dr Lukas for providing MDC-EGFP plasmid, Dr Donehower for Wip1-FLAG, Dr Dansen and P Charitou for providing reagents, Livio Kleij for maintenance of the microscopes and Monica Alvarez for critical reading of the article. RHM and LM were funded by the Netherlands Genomics Initiative of NWO and the Dutch Cancer Society (UU2006-3579), LM by Grant Agency of the Czech Republic (P305/10/P420), AL by the Wenner-Gren foundation and by the Netherlands Organization for Scientific Research (NWO) (ZonMw 916.86.083) and HV by the Center for Translational Molecular Medicine (CTMM).	Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Block WD, 2004, NUCLEIC ACIDS RES, V32, P1967, DOI 10.1093/nar/gkh508; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Chuman Y, 2009, J BIOCHEM, V145, P1, DOI 10.1093/jb/mvn135; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Foster ER, 2005, FEBS J, V272, P3231, DOI 10.1111/j.1742-4658.2005.04741.x; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Goodarzi AA, 2004, EMBO J, V23, P4451, DOI 10.1038/sj.emboj.7600455; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harrison M, 2004, TRENDS MOL MED, V10, P359, DOI 10.1016/j.molmed.2004.06.010; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Lindqvist A, 2009, EMBO J, V28, P3196, DOI 10.1038/emboj.2009.246; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Svetlova M, 2007, BIOCHEM BIOPH RES CO, V358, P650, DOI 10.1016/j.bbrc.2007.04.188; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Yamaguchi H, 2007, BIOCHEMISTRY-US, V46, P12594, DOI 10.1021/bi701096s	59	113	116	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2281	2291		10.1038/onc.2009.501	http://dx.doi.org/10.1038/onc.2009.501			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101220				2022-12-25	WOS:000276685200013
J	Liu, X; Shu, S; Hong, MSS; Yu, B; Korn, ED				Liu, Xiong; Shu, Shi; Hong, Myoung-Soon S.; Yu, Bin; Korn, Edward D.			Mutation of Actin Tyr-53 Alters the Conformations of the DNase I-binding Loop and the Nucleotide-binding Cleft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM MYOSIN-II; TYROSINE PHOSPHORYLATION; MONOMERIC ACTIN; CRYSTAL-STRUCTURES; SUBDOMAIN 2; CELLS; DISCOIDEUM; FILAMENT; DYNAMICS; STATE	All but 11 of the 323 known actin sequences have Tyr at position 53, and the 11 exceptions have the conservative substitution Phe, which raises the following questions. What is the critical role(s) of Tyr-53, and, if it can be replaced by Phe, why has this happened so infrequently? We compared the properties of purified endogenous Dictyostelium actin and mutant constructs with Tyr-53 replaced by Phe, Ala, Glu, Trp, and Leu. The Y53F mutant did not differ significantly from endogenous actin in any of the properties assayed, but the Y53A and Y53E mutants differed substantially; affinity for DNase I was reduced, the rate of nucleotide exchange was increased, the critical concentration for polymerization was increased, filament elongation was inhibited, and polymerized actin was in the form of small oligomers and imperfect filaments. Growth and/or development of cells expressing these actin mutants were also inhibited. The Trp and Leu mutations had lesser but still significant effects on cell phenotype and the biochemical properties of the purified actins. We conclude that either Tyr or Phe is required to maintain the functional conformations of the DNase I-binding loop (D-loop) in both G- and F-actin, and that the conformation of the D-loop affects not only the properties that directly involve the D-loop (binding to DNase I and polymerization) but also allosterically modifies the conformation of the nucleotide-binding cleft, thus increasing the rate of nucleotide exchange. The apparent evolutionary "preference" for Tyr at position 53 may be the result of Tyr allowing dynamic modification of the D-loop conformation by phosphorylation (Baek, K., Liu, X., Ferron, F., Shu, S., Korn, E. D., and Dominguez, R. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 11748-11753) with effects similar, but not identical, to those of the Ala and Glu mutations.	[Liu, Xiong; Shu, Shi; Hong, Myoung-Soon S.; Yu, Bin; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Korn, ED (corresponding author), NHLBI, Cell Biol Lab, NIH, Bldg 50,Rm 2517,9000 Rockville Pike, Bethesda, MD 20892 USA.	edk@nih.gov	Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006035, ZIAHL000506] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Chu JW, 2005, P NATL ACAD SCI USA, V102, P13111, DOI 10.1073/pnas.0503732102; Gauthier ML, 1997, CELL SIGNAL, V9, P79, DOI 10.1016/S0898-6568(96)00113-1; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2009, NATURE, V457, P389, DOI 10.1038/457389a; HOWARD PK, 1993, SCIENCE, V259, P241, DOI 10.1126/science.7678470; Ito K, 1999, BIOPHYS J, V76, P985, DOI 10.1016/S0006-3495(99)77262-0; Joseph JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002654; JUNGBLUTH A, 1994, J CELL SCI, V107, P117; JUNGBLUTH A, 1995, FEBS LETT, V375, P87, DOI 10.1016/0014-5793(95)01165-B; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kameyama K, 2000, NATURE, V407, P37, DOI 10.1038/35024149; Kanzawa N, 2006, PLANT CELL PHYSIOL, V47, P531, DOI 10.1093/pcp/pcj022; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; KHAITLINA SY, 1991, FEBS LETT, V279, P49, DOI 10.1016/0014-5793(91)80247-Z; Khaitlina SY, 2002, BIOPHYS J, V82, P321, DOI 10.1016/S0006-3495(02)75397-6; Kim E, 1995, BIOPHYS J, V69, P2024, DOI 10.1016/S0006-3495(95)80072-X; Kishi Y, 1998, J CELL SCI, V111, P2923; LAEMMLI UK, 1970, NATURE, V227, P685; Liu X, 2005, J BIOL CHEM, V280, P26974, DOI 10.1074/jbc.M504453200; Liu X, 2000, BIOCHEM BIOPH RES CO, V271, P75, DOI 10.1006/bbrc.2000.2582; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; Moraczewska J, 1996, BIOCHEM J, V317, P605, DOI 10.1042/bj3170605; Nair UB, 2008, J MOL BIOL, V384, P848, DOI 10.1016/j.jmb.2008.09.082; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pfaendtner J, 2009, P NATL ACAD SCI USA, V106, P12723, DOI 10.1073/pnas.0902092106; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; ROMANS P, 1985, J MOL BIOL, V186, P337, DOI 10.1016/0022-2836(85)90109-3; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sameshima M, 2001, J STRUCT BIOL, V136, P7, DOI 10.1006/jsbi.2001.4424; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; SCHWEIGER A, 1992, J CELL SCI, V102, P601; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SCHWYTER DH, 1990, J CELL BIOL, V111, P465, DOI 10.1083/jcb.111.2.465; SHETERLINE P, 1998, PROTEIN PROFILE ACTI, P44; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; VANDEKERCKHOVE J, 1980, NATURE, V284, P475, DOI 10.1038/284475a0; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	43	16	16	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9729	9739		10.1074/jbc.M109.073452	http://dx.doi.org/10.1074/jbc.M109.073452			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100837	hybrid, Green Published			2022-12-25	WOS:000276165900045
J	Benos, DJ				Benos, Dale J.			Biochemistry in Medicine: Hypertension Minireview Series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama, Dept Physiol & Biophys, UAb Stn, Birmingham, AL 35294 USA.	benos@uab.edu							0	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8507	8507		10.1074/jbc.R109.025072	http://dx.doi.org/10.1074/jbc.R109.025072			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20118247	Green Published, hybrid			2022-12-25	WOS:000275553700001
J	Brookes, SM; Nunez, A; Choudhury, B; Matrosovich, M; Essen, SC; Clifford, D; Slomka, MJ; Kuntz-Simon, G; Garcon, F; Nash, B; Hanna, A; Heegaard, PMH; Queguiner, S; Chiapponi, C; Bublot, M; Garcia, JM; Gardner, R; Foni, E; Loeffen, W; Larsen, L; Van Reeth, K; Banks, J; Irvine, RM; Brown, IH				Brookes, Sharon M.; Nunez, Alejandro; Choudhury, Bhudipa; Matrosovich, Mikhail; Essen, Stephen C.; Clifford, Derek; Slomka, Marek J.; Kuntz-Simon, Gaelle; Garcon, Fanny; Nash, Bethany; Hanna, Amanda; Heegaard, Peter M. H.; Queguiner, Stephane; Chiapponi, Chiara; Bublot, Michel; Maldonado Garcia, Jaime; Gardner, Rebecca; Foni, Emanuela; Loeffen, Willie; Larsen, Lars; Van Reeth, Kristien; Banks, Jill; Irvine, Richard M.; Brown, Ian H.			Replication, Pathogenesis and Transmission of Pandemic (H1N1) 2009 Virus in Non-Immune Pigs	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUSES; ACUTE-PHASE PROTEIN; RECEPTOR-BINDING PROPERTIES; C-REACTIVE PROTEIN; INTERSPECIES TRANSMISSION; EXPERIMENTAL-INFECTION; MDCK CELLS; HEMAGGLUTININ; STRAINS; FERRETS	The declaration of the human influenza A pandemic (H1N1) 2009 (H1N1/09) raised important questions, including origin and host range [1,2]. Two of the three pandemics in the last century resulted in the spread of virus to pigs (H1N1, 1918; H3N2, 1968) with subsequent independent establishment and evolution within swine worldwide [3]. A key public and veterinary health consideration in the context of the evolving pandemic is whether the H1N1/09 virus could become established in pig populations [4]. We performed an infection and transmission study in pigs with A/California/07/09. In combination, clinical, pathological, modified influenza A matrix gene real time RT-PCR and viral genomic analyses have shown that infection results in the induction of clinical signs, viral pathogenesis restricted to the respiratory tract, infection dynamics consistent with endemic strains of influenza A in pigs, virus transmissibility between pigs and virus-host adaptation events. Our results demonstrate that extant H1N1/09 is fully capable of becoming established in global pig populations. We also show the roles of viral receptor specificity in both transmission and tissue tropism. Remarkably, following direct inoculation of pigs with virus quasispecies differing by amino acid substitutions in the haemagglutinin receptor-binding site, only virus with aspartic acid at position 225 (225D) was detected in nasal secretions of contact infected pigs. In contrast, in lower respiratory tract samples from directly inoculated pigs, with clearly demonstrable pulmonary pathology, there was apparent selection of a virus variant with glycine (225G). These findings provide potential clues to the existence and biological significance of viral receptor-binding variants with 225D and 225G during the 1918 pandemic [5].	[Brookes, Sharon M.; Nunez, Alejandro; Choudhury, Bhudipa; Essen, Stephen C.; Clifford, Derek; Slomka, Marek J.; Garcon, Fanny; Nash, Bethany; Hanna, Amanda; Gardner, Rebecca; Banks, Jill; Irvine, Richard M.; Brown, Ian H.] Vet Labs Agcy Weybridge, EU, OIE, FAO Reference Lab Avian Influenza & Newcastle Dis, Addlestone, Surrey, England; [Van Reeth, Kristien] Univ Ghent, Merelbeke, Belgium; [Kuntz-Simon, Gaelle; Queguiner, Stephane] Agence Francaise Securite Sanitaire Aliments, LERAPP, Unite Virol Immunol Porcines, Zoopole Les Croix, Ploufragan, France; [Loeffen, Willie] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Chiapponi, Chiara; Foni, Emanuela] Ist Zooprofilatt Sperimentale Lombardia Emilia Ro, Sez Parma, Parma, Italy; [Heegaard, Peter M. H.; Larsen, Lars] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark; [Matrosovich, Mikhail] Univ Marburg, Inst Virol, D-3550 Marburg, Germany; [Bublot, Michel] R&D, SAS, Lyon, France; [Maldonado Garcia, Jaime] Labs HIPRA, Amer Girona, Spain; [Choudhury, Bhudipa] World Org Anim Hlth, OFFLU, Paris, France	Food & Agriculture Organization of the United Nations (FAO); Veterinary Laboratories Agency; Ghent University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Wageningen University & Research; IZS Lombardia e Emilia; Technical University of Denmark; Philipps University Marburg; HIPRA	Brookes, SM (corresponding author), Vet Labs Agcy Weybridge, EU, OIE, FAO Reference Lab Avian Influenza & Newcastle Dis, Addlestone, Surrey, England.	i.h.brown@vla.defra.gsi.gov.uk	Simon, Gaelle/ABI-1479-2020; Hanna, Amanda/D-8522-2011; Brookes, Sharon M/C-8016-2011; Choudhury, Bhudipa/D-3863-2011; Irvine, Richard M/E-2556-2011; Clifford, Derek/D-3034-2011; Nash, Bethany J/C-8160-2011; Castel, Alejandro Núñez/C-2560-2011; Loeffen, Willie/M-5344-2015; Garcon, Fanny/D-8001-2011; Brookes, Sharon M/W-2128-2019; Slomka, Marek J/D-8012-2011; Brown, Ian H/E-1119-2011; Banks, Jill/D-8848-2011; Essen, Stephen/E-9721-2011; Larsen, Lars E/G-3827-2015; Heegaard, Peter/E-9794-2015	Simon, Gaelle/0000-0003-1099-5075; Hanna, Amanda/0000-0001-9045-3553; Brookes, Sharon M/0000-0001-9207-6659; Choudhury, Bhudipa/0000-0002-1392-6414; Irvine, Richard M/0000-0002-1584-4076; Loeffen, Willie/0000-0003-4732-4590; Brookes, Sharon M/0000-0001-9207-6659; Larsen, Lars E/0000-0003-0730-5555; Nunez, Alejandro/0000-0001-5926-7541; Chiapponi, Chiara/0000-0001-8808-4680; Matrosovich, Mikhail/0000-0003-1618-2083; Heegaard, Peter/0000-0003-4506-4932	European Commission; Department of Environment, Food and Rural Affairs (United Kingdom)	European Commission(European CommissionEuropean Commission Joint Research Centre); Department of Environment, Food and Rural Affairs (United Kingdom)(Department for Environment, Food & Rural Affairs (DEFRA))	The study was financially supported by the European Commission (DG SANCO, Unit D1 Animal Health) and the Department of Environment, Food and Rural Affairs (United Kingdom). Two authors (Bublot and Maldonado Garcia) are employed by commercial companies. The authors contributed intellectually to study design and result analyses, but no funds were provided by their employers directly to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown Ian H., 2008, V27, P88; BROWN IH, 1993, VET REC, V132, P598, DOI 10.1136/vr.132.24.598; COATES DM, 1986, J GEN VIROL, V67, P419, DOI 10.1099/0022-1317-67-3-419; Gambaryan AS, 2005, VIRUS RES, V114, P15, DOI 10.1016/j.virusres.2005.05.005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Heegaard PMH, 2009, J IMMUNOL METHODS, V343, P112, DOI 10.1016/j.jim.2009.02.002; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Lipatov AS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000102; Londt B, 2008, AVIAN PATHOL, V37, P619, DOI 10.1080/03079450802499126; MA W, 2009, ZOONOSES PUBLIC HLTH; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matrosovich Mikhail N., 2008, V27, P134; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Mochalova L, 2003, VIROLOGY, V313, P473, DOI 10.1016/S0042-6822(03)00377-5; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; *OIE, 2009, ANIMAL HLTH INFORM, V22; *OIE, 2009, OIE DIS NOT PIGS CAN; *OIE, 2009, OIE DIS NOT PIGS ARG; *OIE WORLD ORG AN, 2008, SWIN INFL MAN DIAGN; Olsen C.W., DIS SWINE, P469; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Park AW, 2004, P ROY SOC B-BIOL SCI, V271, P1547, DOI 10.1098/rspb.2004.2766; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Slomka MJ, 2009, INFLUENZA OTHER RESP, V3, P151, DOI 10.1111/j.1750-2659.2009.00083.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sorensen NS, 2006, VET IMMUNOL IMMUNOP, V113, P157, DOI 10.1016/j.vetimm.2006.04.008; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; STRETA D, 2009, VIROL J, V25, P34; TOMS GL, 1977, LANCET, V1, P68; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van Reeth K, 2009, VACCINE, V27, P6330, DOI 10.1016/j.vaccine.2009.03.021; Weingartl HM, 2009, J VIROL, V83, P4287, DOI 10.1128/JVI.02399-08	35	126	128	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9068	10.1371/journal.pone.0009068	http://dx.doi.org/10.1371/journal.pone.0009068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140096	Green Published, gold, Green Submitted			2022-12-25	WOS:000274442400008
J	Kugler, JM; Lem, C; Lasko, P				Kugler, Jan-Michael; Lem, Christopher; Lasko, Paul			Reduced cul-5 Activity Causes Aberrant Follicular Morphogenesis and Germ Cell Loss in Drosophila Oogenesis	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; OOCYTE DIFFERENTIATION; NEUROGENIC GENES; CYST FORMATION; EGG CHAMBER; UBIQUITIN; FATE; LOCALIZATION; POLARITY; FUSOME	Drosophila oogenesis is especially well suited for studying stem cell biology, cellular differentiation, and morphogenesis. The small modifier protein ubiquitin regulates many cellular pathways. Ubiquitin is conjugated to target proteins by a diverse class of enzymes called ubiquitin E3 ligases. Here we characterize the requirement of Cul-5, a key component of a subgroup of Cullin-RING-type ubiquitin E3 ligases, in Drosophila oogenesis. We find that reduced cul-5 activity causes the formation of aberrant follicles that are characterized by excess germ cells. We show that germ line cells overproliferate in cul-5 mutant females, causing the formation of abnormally large germ line cysts. Also, the follicular epithelium that normally encapsulates single germ line cysts develops aberrantly in cul-5 mutant, leading to defects in cyst formation. We additionally found that Cul-5 is required for germ cell maintenance, as germ cells are depleted in a substantial fraction of cul-5 mutant ovaries. All of these cul-5 phenotypes are strongly enhanced by reduced activity of gustavus (gus), which encodes a substrate receptor of Cul-5-based ubiquitin E3 ligases. Taken together, our results implicate Cul-5/Gus ubiquitin E3 ligases in ovarian tissue morphogenesis, germ cell proliferation and maintenance of the ovarian germ cell population.	[Kugler, Jan-Michael; Lem, Christopher; Lasko, Paul] McGill Univ, Dept Biol, Dev Biol Res Initiat, Montreal, PQ H3A 1B1, Canada; [Lasko, Paul] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada	McGill University; McGill University	Kugler, JM (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	Paul.Lasko@mcgill.ca	Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501	National Institute of Child Health and Development (NICHD) [R01-HD036631]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036631] Funding Source: NIH RePORTER	National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant R01-HD036631 from the National Institute of Child Health and Development (NICHD) to P. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; Ayyub C, 2005, DEV DYNAM, V232, P865, DOI 10.1002/dvdy.20322; Bai JW, 2002, DEVELOPMENT, V129, P5377, DOI 10.1242/dev.00115; Barry Michele, 2006, Sci STKE, V2006, ppe21; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Bolivar J, 2006, DEV DYNAM, V235, P2969, DOI 10.1002/dvdy.20967; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Fichelson Pierre, 2007, Prog Mol Subcell Biol, V45, P97; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P3635; GOODE S, 1992, DEVELOPMENT, V116, P177; Goode S, 1996, DEVELOPMENT, V122, P3863; Goode S, 1996, DEV BIOL, V178, P35, DOI 10.1006/dbio.1996.0196; Grammont M, 2001, DEVELOPMENT, V128, P2243; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Hawkins NC, 1996, DEVELOPMENT, V122, P281; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; Jackson SM, 1997, DEVELOPMENT, V124, P3663; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Laszlo GS, 2009, CURR BIOL, V19, P157, DOI 10.1016/j.cub.2008.12.007; Lilly MA, 2000, DEV BIOL, V218, P53, DOI 10.1006/dbio.1999.9570; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Narbonne-Reveau K, 2009, MOL BIOL CELL, V20, P1960, DOI 10.1091/mbc.E08-09-0916; Ohlmeyer JT, 2003, DEVELOPMENT, V130, P6339, DOI 10.1242/dev.00855; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Reynolds PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002918; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rubsam R, 1998, MECH DEVELOP, V72, P131, DOI 10.1016/S0925-4773(98)00023-9; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; Spradling Allan C., 1993, P1; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Torres IL, 2003, DEV CELL, V5, P547, DOI 10.1016/S1534-5807(03)00272-7; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004	45	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9048	10.1371/journal.pone.0009048	http://dx.doi.org/10.1371/journal.pone.0009048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140218	Green Published, Green Submitted, gold			2022-12-25	WOS:000274474400007
J	Altmann, DR; Korte, W; Maeder, MT; Fehr, T; Haager, P; Rickli, H; Kleger, GR; Rodriguez, R; Ammann, P				Altmann, David R.; Korte, Wolfgang; Maeder, Micha T.; Fehr, Thomas; Haager, Philipp; Rickli, Hans; Kleger, Gian-Reto; Rodriguez, Regulo; Ammann, Peter			Elevated Cardiac Troponin I in Sepsis and Septic Shock: No Evidence for Thrombus Associated Myocardial Necrosis	PLOS ONE			English	Article							PLATELET; THROMBOELASTOGRAPHY; THROMBELASTOGRAPHY; HYPERCOAGULABILITY; DYSFUNCTION; ACTIVATION; DEPRESSION; RELEASE; RISK	Background: Elevated cardiac troponin I (cTnI) is frequently observed in patients with severe sepsis and septic shock. However, the mechanisms underlying cTnI release in these patients are still unknown. To date no data regarding coagulation disturbances as a possible mechanism for cTnI release during sepsis are available. Methodology/Principal Findings: Consecutive patients with systemic inflammatory response syndrome (SIRS), sepsis or septic shock without evidence of an acute coronary syndrome were analyzed. Coagulation parameters (clotting time (CT), clot formation time (CFT), maximum clot firmness (MCF), alpha-angle) were assessed in native whole blood samples, and using specific activators to evaluate the extrinsic and intrinsic as well as the fibrin component of the coagulation pathway with the use of rotational thrombelastometry (ROTEM). Thirty-eight patients were included and 22 (58%) were cTnI-positive. Baseline characteristics between TnI-positive and -negative patients were similar. The CT, CFT, MCF and the a-angle were similar between the groups with trends towards shorter CT in the extrinsic and fibrin activation. Conclusions/Significance: We found no differences in coagulation parameters analyzed with rotational thrombelastometry between cTnI-positive and -negative patients with SIRS, severe sepsis, and septic shock. These findings suggest that pathophysiological mechanisms other than thrombus-associated myocardial damage might play a major role, including reversible myocardial membrane leakage and/or cytokine mediated apoptosis in these patients.	[Altmann, David R.; Haager, Philipp; Rickli, Hans; Ammann, Peter] Kantonsspital St Gallen, Div Cardiol, St Gallen, Switzerland; [Korte, Wolfgang] Kantonsspital St Gallen, Inst Clin Chem & Hematol, St Gallen, Switzerland; [Maeder, Micha T.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Fehr, Thomas] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Kleger, Gian-Reto] Kantonsspital St Gallen, Dept Internal Med, Intens Care Unit, St Gallen, Switzerland; [Rodriguez, Regulo] Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland	Kantonsspital St. Gallen; Kantonsspital St. Gallen; Baker Heart and Diabetes Institute; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; Kantonsspital St. Gallen	Altmann, DR (corresponding author), Kantonsspital St Gallen, Div Cardiol, St Gallen, Switzerland.	peter.ammann@kssg.ch			Pentapharm GmbH	Pentapharm GmbH	There was no funding for this work. The rotational thrombelastometry (ROTEM) analysis was sponsored by Pentapharm GmbH. The sponsor had no role in the study design, data acquisition or analysis.	*AM COLL CHEST PHY, CRIT CARE MED, V20, P864; Ammann P, 2001, INTENS CARE MED, V27, P965, DOI 10.1007/s001340100920; Ammann P, 2003, J AM COLL CARDIOL, V41, P2004, DOI 10.1016/S0735-1097(03)00421-2; Bonz AW, 2002, J AM COLL CARDIOL, V40, P662, DOI 10.1016/S0735-1097(02)02014-4; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; Coakley M, 2006, J CARDIOTHOR VASC AN, V20, P548, DOI 10.1053/j.jvca.2006.01.016; Cuisset T, 2007, THROMB HAEMOSTASIS, V97, P282, DOI 10.1160/TH06-07-0362; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Gonano C, 2006, CRIT CARE, V10, DOI 10.1186/cc5098; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Luddington RJ, 2005, CLIN LAB HAEMATOL, V27, P81, DOI 10.1111/j.1365-2257.2005.00681.x; Maeder M, 2006, CHEST, V129, P1349, DOI 10.1378/chest.129.5.1349; Mahla E, 2001, ANESTH ANALG, V92, P572, DOI 10.1097/00000539-200103000-00004; MAZEIKA PK, 1992, J AM COLL CARDIOL, V19, P1203, DOI 10.1016/0735-1097(92)90325-H; McCrath DJ, 2005, ANESTH ANALG, V100, P1576, DOI 10.1213/01.ANE.0000155290.86795.12; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; PARRILLO JE, 1985, J CLIN INVEST, V76, P1539, DOI 10.1172/JCI112135; Poulsen LH, 2006, SCAND J CLIN LAB INV, V66, P329, DOI 10.1080/00365510600672783; Ray MJ, 2005, INT J CARDIOL, V101, P249, DOI 10.1016/j.ijcard.2004.03.033; Reinhofer M, 2008, BLOOD COAGUL FIBRIN, V19, P212, DOI 10.1097/MBC.0b013e3282f3f9d4; Rinder CS, 2002, ANESTHESIOLOGY, V97, P1118, DOI 10.1097/00000542-200211000-00013; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; ver Elst KM, 2000, CLIN CHEM, V46, P650; Wu AHB, 2001, INTENS CARE MED, V27, P959, DOI 10.1007/s001340100970; ZUCKERMAN L, 1981, THROMB HAEMOSTASIS, V46, P752	28	49	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9017	10.1371/journal.pone.0009017	http://dx.doi.org/10.1371/journal.pone.0009017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140242	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474200011
J	Nencioni, A; Cea, M; Garuti, A; Passalacqua, M; Raffaghello, L; Soncini, D; Moran, E; Zoppoli, G; Pistoia, V; Patrone, F; Ballestrero, A				Nencioni, Alessio; Cea, Michele; Garuti, Anna; Passalacqua, Mario; Raffaghello, Lizzia; Soncini, Debora; Moran, Eva; Zoppoli, Gabriele; Pistoia, Vito; Patrone, Franco; Ballestrero, Alberto			Grb7 Upregulation Is a Molecular Adaptation to HER2 Signaling Inhibition Due to Removal of Akt-Mediated Gene Repression	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HER2-POSITIVE BREAST-CANCER; TRANSCRIPTION FACTOR FKHR; FOCAL ADHESION KINASE; CELL-MIGRATION; SH2 DOMAIN; ADJUVANT CHEMOTHERAPY; TYROSINE KINASES; TRASTUZUMAB; EXPRESSION	The efficacy of anti-HER2 therapeutics, such as lapatinib and trastuzumab, is limited by primary and acquired resistance. Cellular adaptations that allow breast cancer cell to survive prolonged HER2 inhibition include de-repression of the transcription factor FOXO3A with consequent estrogen receptor activation, and/or increased HER3 signaling. Here, we used low-density arrays, quantitative PCR, and western blotting to determine how HER2 signaling inhibition with lapatinib or PI3K inhibitors affects the expression of genes involved in breast cancer metastatic spread and overall prognosis. Retroviral transgenesis was used to express constitutively active forms of Akt in the HER2(+) breast cancer cell line SKBR3, and Grb7 in MCF7 cells. Specific gene silencing was obtained by siRNAs transfection. A murine BT474 xenograft cancer model was used to assess the effect of lapatinib on gene expression in vivo. We found that lapatinib induces upregulation of Grb7, an adaptor protein involved in receptor tyrosine kinase signaling and promoting cell survival and cell migration. Grb7 upregulation induced by lapatinib was found to occur in cancer cells in vitro and in vivo. We demonstrate that Grb7 upregulation is recreated by PI3K inhibitors while being prevented by constitutively active Akt. Thus, Grb7 is repressed by PI3K signaling and lapatinib-mediated Akt inhibition is responsible for Grb7 de-repression. Finally, we show that Grb7 removal by RNA-interference reduces breast cancer cell viability and increases the activity of lapatinib. In conclusion, Grb7 upregulation is a potentially adverse consequence of HER2 signaling inhibition. Preventing Grb7 accumulation and/or its interaction with receptor tyrosine kinases may increase the benefit of HER2-targeting drugs.	[Nencioni, Alessio; Cea, Michele; Garuti, Anna; Soncini, Debora; Moran, Eva; Zoppoli, Gabriele; Patrone, Franco; Ballestrero, Alberto] Univ Genoa, Dept Internal Med, Ctr Excellence Biomed Res, I-16126 Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Dept Expt Med, Biochem Sect, Ctr Excellence Biomed Res, I-16126 Genoa, Italy; [Passalacqua, Mario] INBB, Rome, Italy; [Raffaghello, Lizzia; Pistoia, Vito] G Gaslini Inst Children, Lab Oncol, Dept Expt & Lab Med, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini	Nencioni, A (corresponding author), Univ Genoa, Dept Internal Med, Ctr Excellence Biomed Res, I-16126 Genoa, Italy.	A.Nencioni@gmx.net	Zoppoli, Gabriele/B-6935-2016; Zoppoli, Gabriele/A-9540-2010; Passalacqua, Mario/W-1973-2019; Ballestrero, Alberto/K-7546-2016; Nencioni, Alessio/K-3692-2018; Soncini, Debora/AAB-2230-2019; cea, Michele/K-3863-2018; Zoppoli, Gabriele/B-6935-2016	Zoppoli, Gabriele/0000-0003-3890-5588; Passalacqua, Mario/0000-0003-2779-6259; Ballestrero, Alberto/0000-0002-2601-7711; Soncini, Debora/0000-0001-5156-498X; cea, Michele/0000-0002-1530-6729; Zoppoli, Gabriele/0000-0002-1619-1708; Raffaghello, Lizzia/0000-0003-2357-0607; NENCIONI, ALESSIO/0000-0001-5068-8884	Associazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Lotta a Leucemie-Linfomi e Mieloma (AIL) Sezione Liguria; University of Genoa; Fondazione Italiana per la Lotta al Neuroblastoma	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Lotta a Leucemie-Linfomi e Mieloma (AIL) Sezione Liguria(Fondazione AIRC per la ricerca sul cancro); University of Genoa; Fondazione Italiana per la Lotta al Neuroblastoma	This study was supported by the Associazione Italiana per la Ricerca sul Cancro (START-UP grant to A.N., MFAG to L. R.), the Associazione Italiana per la Lotta a Leucemie-Linfomi e Mieloma (AIL) Sezione Liguria (F. P., A. B., A. G.), and the University of Genoa. L. R. is a recipient of a fellowship from the Fondazione Italiana per la Lotta al Neuroblastoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrechek ER, 2003, CANCER RES, V63, P4920; Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Chen FL, 2008, CLIN CANCER RES, V14, P6730, DOI 10.1158/1078-0432.CCR-08-0581; CHU PY, 2009, J BIOL CHEM; Cobleigh MA, 2005, CLIN CANCER RES, V11, P8623, DOI 10.1158/1078-0432.CCR-05-0735; Fiddes RJ, 1998, J BIOL CHEM, V273, P7717, DOI 10.1074/jbc.273.13.7717; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Girault I, 2003, CLIN CANCER RES, V9, P1259; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hodgson JG, 2005, CANCER RES, V65, P9695, DOI 10.1158/0008-5472.CAN-05-0755; Hussain MHA, 2007, J CLIN ONCOL, V25, P2218, DOI 10.1200/JCO.2006.08.0994; Jimeno A, 2005, CANCER RES, V65, P3003, DOI 10.1158/0008-5472.CAN-04-3586; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kauraniemi P, 2001, CANCER RES, V61, P8235; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Ravaud A, 2008, J CLIN ONCOL, V26, P2285, DOI 10.1200/JCO.2007.14.5029; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spector NL, 2005, J CLIN ONCOL, V23, P2502, DOI 10.1200/JCO.2005.12.157; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; van Agthoven T, 2009, J CLIN ONCOL, V27, P542, DOI 10.1200/JCO.2008.17.1462; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Yokote K, 1996, J BIOL CHEM, V271, P30942, DOI 10.1074/jbc.271.48.30942; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163	43	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9024	10.1371/journal.pone.0009024	http://dx.doi.org/10.1371/journal.pone.0009024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126311	gold, Green Published, Green Submitted			2022-12-25	WOS:000274207200019
J	Abraira, VE; Satoh, T; Fekete, DM; Goodrich, LV				Abraira, Victoria E.; Satoh, Takunori; Fekete, Donna M.; Goodrich, Lisa V.			Vertebrate Lrig3-ErbB Interactions Occur In Vitro but Are Unlikely to Play a Role in Lrig3-Dependent Inner Ear Morphogenesis	PLOS ONE			English	Article							SEMICIRCULAR CANAL FORMATION; GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSOR GENE; CARDIAC DEVELOPMENT; NEGATIVE REGULATOR; NEUREGULIN RECEPTOR; BREAST-CANCER; NETRIN 1; EXPRESSION; LRIG1	Background: The Lrig genes encode a family of transmembrane proteins that have been implicated in tumorigenesis, psoriasis, neural crest development, and complex tissue morphogenesis. Whether these diverse phenotypes reflect a single underlying cellular mechanism is not known. However, Lrig proteins contain evolutionarily conserved ectodomains harboring both leucine-rich repeats and immunoglobulin domains, suggesting an ability to bind to common partners. Previous studies revealed that Lrig1 binds to and inhibits members of the ErbB family of receptor tyrosine kinases by inducing receptor internalization and degradation. In addition, other receptor tyrosine kinase binding partners have been identified for both Lrig1 and Lrig3, leaving open the question of whether defective ErbB signaling is responsible for the observed mouse phenotypes. Methodology/Principal Findings: Here, we report that Lrig3, like Lrig1, is able to interact with ErbB receptors in vitro. We examined the in vivo significance of these interactions in the inner ear, where Lrig3 controls semicircular canal formation by determining the timing and extent of Netrin1 expression in the otic vesicle epithelium. We find that ErbB2 and ErbB3 are present in the early otic epithelium, and that Lrig3 acts cell-autonomously here, as would be predicted if Lrig3 regulates ErbB2/B3 activity. However, inhibition of ErbB activation in the chick otic vesicle has no detectable effect on Netrin gene expression or canal morphogenesis. Conclusions/Significance: Our results suggest that although both Lrig1 and Lrig3 can interact with ErbB receptors in vitro, modulation of Neuregulin signaling is unlikely to contribute to Lrig3-dependent processes of inner ear morphogenesis. These results highlight the similar binding properties of Lrig1 and Lrig3 and underscore the need to determine how these two family members bind to and regulate different receptors to affect diverse aspects of cell behavior in vivo.	[Abraira, Victoria E.; Goodrich, Lisa V.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Abraira, Victoria E.; Goodrich, Lisa V.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Satoh, Takunori] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Aichi, Japan; [Fekete, Donna M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Nagoya University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Abraira, VE (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Lisa_Goodrich@hms.harvard.edu	Fekete, Donna M/B-9170-2009	Fekete, Donna M/0000-0003-0662-0246	National Institute on Deafness [R01 DC007195, R01 DC002756, F31 DC008450]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007195, R01DC002756, F31DC008450] Funding Source: NIH RePORTER	National Institute on Deafness(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the following grants from the National Institute on Deafness and other Communication Disorders (www.nidcd.nih.gov): R01 DC007195 (L.V.G.), R01 DC002756 (D.M.F.), and F31 DC008450 (V.E.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2008, DEVELOPMENT, V135, P4091, DOI 10.1242/dev.029330; Alavizadeh A, 2001, DEV BIOL, V234, P244, DOI 10.1006/dbio.2001.0241; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Carraway KL, 1997, J MAMMARY GLAND BIOL, V2, P187, DOI 10.1023/A:1026360032602; Carraway KL, 2005, J CELL BIOCHEM, V96, P914, DOI 10.1002/jcb.20612; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Dammann CEL, 2003, AM J RESP CRIT CARE, V167, P1711, DOI 10.1164/rccm.200205-468OC; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Erickson SL, 1997, DEVELOPMENT, V124, P4999; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Ghiglione C, 2003, DEVELOPMENT, V130, P4483, DOI 10.1242/dev.00617; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Gilmore JL, 2008, BREAST CANCER RES TR, V110, P493, DOI 10.1007/s10549-007-9748-8; Golding JP, 2004, DEV BIOL, V266, P361, DOI 10.1016/j.ydbio.2003.11.003; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Guo DS, 2006, ACTA NEUROPATHOL, V111, P238, DOI 10.1007/s00401-006-0032-5; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Holmlund C, 2004, GENE, V332, P35, DOI 10.1016/j.gene.2004.02.002; Hume CR, 2003, JARO-J ASSOC RES OTO, V4, P422, DOI 10.1007/s10162-002-3008-8; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; KENNEDY TE, 1994, CELL, V78, P435; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; LeBras S, 1998, DIABETOLOGIA, V41, P1474, DOI 10.1007/s001250051094; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; LINDSTROM AK, 2007, INT J GYNECOL CANC; LJUSLINDER I, 2007, ACTA ONCOL, P1; Loftus SK, 2001, DNA RES, V8, P221, DOI 10.1093/dnares/8.5.221; MARTIN P, 1993, DEV BIOL, V159, P549, DOI 10.1006/dbio.1993.1263; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Miyazaki Y, 2004, DEV DYNAM, V230, P591, DOI 10.1002/dvdy.20078; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2004, DEV BIOL, V273, P350, DOI 10.1016/j.ydbio.2004.06.010; Qu SM, 2006, GENESIS, V44, P477, DOI 10.1002/dvg.20243; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sakakibara A, 2006, J CELL SCI, V119, P3583, DOI 10.1242/jcs.03080; Salminen M, 2000, DEVELOPMENT, V127, P13; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wong RWC, 2003, CELL MOL LIFE SCI, V60, P113, DOI 10.1007/s000180300007; Xiong Zongqiang, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P86; Yang WM, 2006, BJU INT, V98, P898, DOI 10.1111/j.1464-410X.2006.06405.x; Zhang M, 2002, HEARING RES, V169, P56, DOI 10.1016/S0378-5955(02)00339-8; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073	65	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8981	10.1371/journal.pone.0008981	http://dx.doi.org/10.1371/journal.pone.0008981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126551	Green Published, Green Submitted, gold			2022-12-25	WOS:000274209700010
J	Toyohara, J; Ishiwata, K; Sakata, M; Wu, J; Nishiyama, S; Tsukada, H; Hashimoto, K				Toyohara, Jun; Ishiwata, Kiichi; Sakata, Muneyuki; Wu, Jin; Nishiyama, Shingo; Tsukada, Hideo; Hashimoto, Kenji			In Vivo Evaluation of alpha 7 Nicotinic Acetylcholine Receptor Agonists [C-11]A-582941 and [C-11]A-844606 in Mice and Conscious Monkeys	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; BINDING-SITES; HUMAN BRAIN; DOPAMINE TRANSPORTERS; RADIOLIGAND BINDING; POSTMORTEM BRAIN; MESSENGER-RNA; PET; LOCALIZATION	Background: The alpha 7 nicotinic acetylcholine receptors (nAChRs) play an important role in the pathophysiology of neuropsychiatric diseases such as schizophrenia and Alzheimer's disease. The goal of this study was to evaluate the two carbon-11-labeled alpha 7 nAChR agonists [C-11]A-582941 and [C-11]A-844606 for their potential as novel positron emission tomography (PET) tracers. Methodology/Principal Findings: The two tracers were synthesized by methylation of the corresponding desmethyl precursors using [C-11] methyl triflate. Effects of receptor blockade in mice were determined by coinjection of either tracer along with a carrier or an excess amount of a selective alpha 7 nAChR agonist (SSR180711). Metabolic stability was investigated using radio-HPLC. Dynamic PET scans were performed in conscious monkeys with/without SSR180711-treatment. [C-11]A-582941 and [C-11]A-844606 showed high uptake in the mouse brain. Most radioactive compounds in the brain were detected as an unchanged form. However, regional selectivity and selective receptor blockade were not clearly observed for either compound in the mouse brain. On the other hand, the total distribution volume of [C-11]A-582941 and [C-11]A-844606 was high in the hippocampus and thalamus but low in the cerebellum in the conscious monkey brain, and reduced by pretreatment with SSR180711. Conclusions/Significance: A nonhuman primate study suggests that [C-11]A-582941 and [C-11]A-844606 would be potential PET ligands for imaging alpha 7 nAChRs in the human brain.	[Toyohara, Jun; Wu, Jin; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Toyohara, Jun; Ishiwata, Kiichi; Sakata, Muneyuki] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Tokyo, Japan; [Nishiyama, Shingo; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Shizuoka, Japan	Chiba University; Tokyo Metropolitan Institute of Gerontology; Hamamatsu Photonics	Toyohara, J (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Toyohara, Jun/C-4461-2011; Hashimoto, Kenji/I-5800-2015	Toyohara, Jun/0000-0003-4721-405X; Hashimoto, Kenji/0000-0002-8892-0439	National Institute of Biomedical Innovation of Japan [06-46]	National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation)	This work was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan (Grant ID: 06-46, to K. H.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2008, J PHARMACOL EXP THER, V324, P179, DOI 10.1124/jpet.107.130062; Basha A., 2005, US Patent, Patent No. [2005/0101602Al, 20050101602]; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Biton B, 2007, NEUROPSYCHOPHARMACOL, V32, P1, DOI 10.1038/sj.npp.1301189; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Briggs CA, 2008, BRIT J PHARMACOL, V153, P1054, DOI 10.1038/sj.bjp.0707649; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Bunnelle WH, 2009, J MED CHEM, V52, P4126, DOI 10.1021/jm900249k; Burghaus L, 2000, MOL BRAIN RES, V76, P385; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CIMINO M, 1992, NEUROSCIENCE, V51, P77, DOI 10.1016/0306-4522(92)90472-E; Court J, 2001, BIOL PSYCHIAT, V49, P175, DOI 10.1016/S0006-3223(00)01116-1; Court JA, 2000, J CHEM NEUROANAT, V20, P281, DOI 10.1016/S0891-0618(00)00110-1; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; Davies ARL, 1999, NEUROPHARMACOLOGY, V38, P679, DOI 10.1016/S0028-3908(98)00221-4; Ding YS, 2005, J NEUROCHEM, V94, P337, DOI 10.1111/j.1471-4159.2005.03202.x; Falk L, 2003, DEV BRAIN RES, V142, P151, DOI 10.1016/S0165-3806(03)00063-4; FREEDMAN R, 1994, HARVARD REV PSYCHIAT, V2, P179, DOI 10.3109/10673229409017136; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Fujio M, 2002, NUCL MED BIOL, V29, P657, DOI 10.1016/S0969-8051(02)00305-0; Gotti C, 1997, PROG NEUROBIOL, V53, P199, DOI 10.1016/S0301-0082(97)00034-8; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Han ZY, 2003, J COMP NEUROL, V461, P49, DOI 10.1002/cne.10659; Hashimoto K, 2004, NEUROPSYCHOPHARMACOL, V29, P2018, DOI 10.1038/sj.npp.1300512; Hashimoto K, 2007, BIOL PSYCHIAT, V61, P577, DOI 10.1016/j.biopsych.2006.03.019; Hashimoto Kenji, 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P171, DOI 10.2174/1568015054863828; Hashimoto K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003231; Hellstrom-Lindahl E, 1999, MOL BRAIN RES, V66, P94, DOI 10.1016/S0169-328X(99)00030-3; Ishiwata K, 2004, NUCL MED BIOL, V31, P493, DOI 10.1016/j.nucmedbio.2003.11.005; Ishiwata K, 2001, NUCL MED BIOL, V28, P281, DOI 10.1016/S0969-8051(00)00170-0; Ishiwata K, 1998, NUCL MED BIOL, V25, P195, DOI 10.1016/S0969-8051(97)00170-4; Kawamura K, 2004, ANN NUCL MED, V18, P165, DOI 10.1007/BF02985109; Kulak JM, 2004, BRAIN RES, V999, P193, DOI 10.1016/j.brainres.2003.10.062; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; LUKAS RJ, 1997, PHARMACOL REV, V51, P397; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; Nomikos GG, 2000, BEHAV BRAIN RES, V113, P97, DOI 10.1016/S0166-4328(00)00204-7; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; ONOE H, 1994, BRAIN RES, V663, P191, DOI 10.1016/0006-8993(94)91263-7; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Quik M, 2000, J COMP NEUROL, V425, P58, DOI 10.1002/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; SCHRIMPF MR, 2005, Patent No. 20050234031; Sullivan JP, 1996, NEUROPHARMACOLOGY, V35, P725, DOI 10.1016/0028-3908(96)84644-2; TAKECHI H, 1994, NEUROSCI LETT, V182, P279, DOI 10.1016/0304-3940(94)90816-8; Tashiro M, 2006, BRIT J CLIN PHARMACO, V61, P16, DOI 10.1111/j.1365-2125.2005.02514.x; Tietje KR, 2008, CNS NEUROSCI THER, V14, P65, DOI 10.1111/j.1527-3458.2008.00037.x; TOYOHARA J, 2010, OPEN MED CH IN PRESS; Toyohara J, 2009, ANN NUCL MED, V23, P301, DOI 10.1007/s12149-009-0240-x; Watanabe M, 1997, IEEE T NUCL SCI, V44, P1277, DOI 10.1109/23.597001; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x	52	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8961	10.1371/journal.pone.0008961	http://dx.doi.org/10.1371/journal.pone.0008961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126539	Green Submitted, Green Published, gold			2022-12-25	WOS:000274209700005
J	Espinosa, MC; Rehman, MA; Chisamore-Robert, P; Jeffery, D; Yankulov, K				Espinosa, Maria Claudia; Rehman, Muhammad Attiq; Chisamore-Robert, Patricia; Jeffery, Daniel; Yankulov, Krassimir			GCN5 Is a Positive Regulator of Origins of DNA Replication in Saccharomyces cerevisiae	PLOS ONE			English	Article							HISTONE ACETYLATION; MYST FAMILY; ROLES; HBO1; INITIATION; PROTEIN; SAGA; ACETYLTRANSFERASES; PHOSPHORYLATION; MAINTENANCE	GCN5 encodes one of the non-essential Histone Acetyl Transferases in Saccharomyces cerevisiae. Extensive evidence has indicated that GCN5 is a key regulator of gene expression and could also be involved in transcriptional elongation, DNA repair and centromere maintenance. Here we show that the deletion of GCN5 decreases the stability of mini-chromosomes; that the tethering of Gcn5p to a crippled origin of replication stimulates its activity; that high dosage of GCN5 suppresses conditional phenotypes caused by mutant alleles of bona fide replication factors, orc2-1, orc5-1 and mcm5-461. Furthermore, Gcn5p physically associates with origins of DNA replication, while its deletion leads to localized condensation of chromatin at origins. Finally, Dgcn5 cells display a deficiency in the assembly of pre-replicative complexes. We propose that GCN5 acts as a positive regulator of DNA replication by counteracting the inhibitory effect of Histone Deacetylases.	[Espinosa, Maria Claudia; Rehman, Muhammad Attiq; Chisamore-Robert, Patricia; Jeffery, Daniel; Yankulov, Krassimir] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Espinosa, MC (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	yankulov@uoguelph.ca	Rehman, Muhammad/L-1283-2019; Jeffery, Daniel/GVS-0791-2022	Rehman, Muhammad/0000-0002-2062-1969; Yankulov, Krassimir/0000-0001-9440-9234	Natural Sciences and Engineering Research Council (NSERC) [043230]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: This study was supported by a grant from Natural Sciences and Engineering Research Council (NSERC) (043230) to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Clarke AS, 2006, MOL BIOL CELL, V17, P1744, DOI 10.1091/mbc.E05-07-0613; Crampton A, 2008, MOL CELL, V30, P156, DOI 10.1016/j.molcel.2008.02.019; Dillin A, 1997, GENETICS, V147, P1053; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; Gauthier L, 2002, GENETICS, V162, P1117; Gregory PD, 1999, METH MOL B, V119, P417; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; HARPER JW, 1993, CELL, V75, P805; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r46; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 2008, MOL CELL BIOL, V28, P140, DOI 10.1128/MCB.00662-07; Irlbacher H, 2005, GENE DEV, V19, P1811, DOI 10.1101/gad.334805; Jacobson S, 2004, MOL CELL BIOL, V24, P6029, DOI 10.1128/MCB.24.13.6029-6039.2004; Johmura Y, 2008, J BIOL CHEM, V283, P2265, DOI 10.1074/jbc.M707880200; Knott SRV, 2009, EPIGENETICS-US, V4, P262; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Kramer DJH, 2002, BIOTECHNIQUES, V32, P1036; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Lafon A, 2007, ONCOGENE, V26, P5373, DOI 10.1038/sj.onc.1210606; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li R, 1998, MOL CELL BIOL, V18, P1296, DOI 10.1128/MCB.18.3.1296; MAINE GT, 1984, GENETICS, V106, P365; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Pappas DL, 2004, GENE DEV, V18, P769, DOI 10.1101/gad.1173204; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rehman MA, 2006, GENETICS, V174, P1801, DOI 10.1534/genetics.106.063446; Rehman MA, 2009, MOL BIOL CELL, V20, P631, DOI 10.1091/mbc.E08-01-0099; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Saleh A, 1997, J BIOL CHEM, V272, P5571, DOI 10.1074/jbc.272.9.5571; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Tye BK, 1999, METHODS, V18, P329, DOI 10.1006/meth.1999.0793; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Vernarecci S, 2008, MOL CELL BIOL, V28, P988, DOI 10.1128/MCB.01366-07; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zou YF, 2008, NUCLEIC ACIDS RES, V36, P5189, DOI 10.1093/nar/gkn465	53	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8964	10.1371/journal.pone.0008964	http://dx.doi.org/10.1371/journal.pone.0008964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126453	Green Submitted, Green Published, gold			2022-12-25	WOS:000274139100012
J	Medina-Navarro, R; Duran-Reyes, G; Diaz-Flores, M; Vilar-Rojas, C				Medina-Navarro, Rafael; Duran-Reyes, Genoveva; Diaz-Flores, Margarita; Vilar-Rojas, Cecilia			Protein Antioxidant Response to the Stress and the Relationship between Molecular Structure and Antioxidant Function	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; HUMAN-BLOOD PLASMA; METHIONINE RESIDUES; OXIDATIVE STRESS; SULFENIC ACIDS; LUNG-CANCER; CAPACITY; SYSTEMS; PEROXIDATION; BILIRUBIN	Background: Proteins have long been considered a principal target for oxidants as a result of their abundance in biological systems. However, there is increasing evidence about the significant antioxidant activity in proteins such as albumin. It is leading to new concepts that even consider albumin not only as an antioxidant but as the major antioxidant in plasma known to be exposed to continuous oxidative stress. Evidence presented here establishes a previously unrecognized relationship between proteins' antioxidant capacity and structural stress. Methodology/Principal Findings: A chemiluminiscence based antioxidant assay was achieved to quantify the antioxidant capacity of albumin and other proteins. The capabilities of proteins as antioxidants were presented, but in addition a new and powerful component of the protein antioxidant capacity was discovered. The intrinsic component, designated as Response Surplus (RS), represents a silent reserve of antioxidant power that awakens when proteins face a structural perturbation (stressor) such as temperature, short wave UV light, the same reactive oxygen species, and more extreme changes like glucose or aldehyde-mediated structural modifications. The work also highlights the importance of structural changes in protein antioxidant properties and the participation of sulfhydryl groups (SHs) in the RS antioxidant component. Based on recent evidence about the SH group chemistry, a possible model for explaining RS is proposed. Conclusions/Significance: The data presented show the significant antioxidant behavior of proteins and demonstrate the existence of a previously unrecognized antioxidant response to the stress. Several implications, including changes in elementary concepts about antioxidants and protein function, should emerge from here.	[Medina-Navarro, Rafael] Ctr Biomed Res Michoacan CIBIMI IMSS, Dept Expt Metab, Morelia, Michoacan, Mexico; [Duran-Reyes, Genoveva; Diaz-Flores, Margarita; Vilar-Rojas, Cecilia] IMSS, Biochem Med Res Unit, Natl Med Ctr, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social	Medina-Navarro, R (corresponding author), Ctr Biomed Res Michoacan CIBIMI IMSS, Dept Expt Metab, Morelia, Michoacan, Mexico.	rafael.medina@imss.gob.mx		DIAZ-FLORES, MARGARITA/0000-0001-9764-2701; Medina-Navarro, Rafael/0000-0002-7183-6126	RMN; Fundacion Mexicana para la Salud	RMN; Fundacion Mexicana para la Salud	Funding: The work was financially supported partially by the funds derived from a prize won by RMN; Fundacion Mexicana para la Salud (FUNSALUD PRIZE MEXICO 1999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aejmelaeus RT, 1997, FREE RADICAL BIO MED, V23, P69, DOI 10.1016/S0891-5849(96)00591-6; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Bourdon E, 1999, FASEB J, V13, P233, DOI 10.1096/fasebj.13.2.233; Bourdon E, 2005, FREE RADICAL RES, V39, P15, DOI 10.1080/10715760400024935; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREMS DN, 1991, J BIOL CHEM, V266, P1611; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Ceriello A, 1997, DIABETES CARE, V20, P194, DOI 10.2337/diacare.20.2.194; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; Erhola M, 1996, FREE RADICAL BIO MED, V21, P383, DOI 10.1016/0891-5849(96)00041-X; Erhola M, 1998, J EXP CLIN CANC RES, V17, P325; Faure P, 2005, DIABETES METAB, V31, P169, DOI 10.1016/S1262-3636(07)70183-0; Faure P, 2008, CLIN SCI, V114, P251, DOI 10.1042/CS20070276; GUTTERIDGE JMC, 1986, BIOCHIM BIOPHYS ACTA, V869, P119, DOI 10.1016/0167-4838(86)90286-4; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; HALLIWELL B, 1995, FREE RADICAL BIO MED, V18, P125, DOI 10.1016/0891-5849(95)91457-3; HALLIWELL B, 2003, FREE RADICAL BIO MED, P166; Halliwell B., 2007, FREE RADICALS BIOL M; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; JACOBSEN C, 1978, BIOCHEM J, V171, P453, DOI 10.1042/bj1710453; JOCELYN PC, 1987, METHOD ENZYMOL, V143, P44; KALYANARAMAN B, 1985, J BIOL CHEM, V260, P4003; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Medina-Navarro R, 2007, CHEM RES TOXICOL, V20, P1477, DOI 10.1021/tx7001355; MORENO SNJ, 1988, ARCH BIOCHEM BIOPHYS, V265, P267, DOI 10.1016/0003-9861(88)90127-0; NEUZIL J, 1994, J BIOL CHEM, V269, P16712; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rezaei-Tavirani M, 2006, J BIOCHEM MOL BIOL, V39, P530, DOI 10.5483/BMBRep.2006.39.5.530; Satoh K, 1997, ANTICANCER RES, V17, P4377; SORIANI M, 1994, ARCH BIOCHEM BIOPHYS, V312, P180, DOI 10.1006/abbi.1994.1297; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Vaidya V, 2009, ANGEW CHEM INT EDIT, V48, P157, DOI 10.1002/anie.200804560; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; WETZEL R, 1980, EUR J BIOCHEM, V104, P469, DOI 10.1111/j.1432-1033.1980.tb04449.x; WHITEHEAD TP, 1992, ANAL CHIM ACTA, V266, P265, DOI 10.1016/0003-2670(92)85052-8	41	30	31	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8971	10.1371/journal.pone.0008971	http://dx.doi.org/10.1371/journal.pone.0008971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126468	Green Submitted, Green Published, gold			2022-12-25	WOS:000274139100019
J	Mouro-Chanteloup, I; Cochet, S; Chami, M; Genetet, S; Zidi-Yahiaoui, N; Engel, A; Colin, Y; Bertrand, O; Ripoche, P				Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Chami, Mohamed; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Engel, Andreas; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre			Functional Reconstitution into Liposomes of Purified Human RhCG Ammonia Channel	PLOS ONE			English	Article							RED-BLOOD-CELLS; NITROSOMONAS-EUROPAEA; TRANSPORT; PROTEINS; GLYCOPROTEIN; EXPRESSION; MEMBRANE; KIDNEY; WATER; RHBG	Background: Rh glycoproteins (RhAG, RhBG, RhCG) are members of the Amt/Mep/Rh family which facilitate movement of ammonium across plasma membranes. Changes in ammonium transport activity following expression of Rh glycoproteins have been described in different heterologous systems such as yeasts, oocytes and eukaryotic cell lines. However, in these complex systems, a potential contribution of endogenous proteins to this function cannot be excluded. To demonstrate that Rh glycoproteins by themselves transport NH(3), human RhCG was purified to homogeneity and reconstituted into liposomes, giving new insights into its channel functional properties. Methodology/Principal Findings: An HA-tag introduced in the second extracellular loop of RhCG was used to purify to homogeneity the HA-tagged RhCG glycoprotein from detergent-solubilized recombinant HEK293E cells. Electron microscopy analysis of negatively stained purified RhCG-HA revealed, after image processing, homogeneous particles of 9 nm diameter with a trimeric protein structure. Reconstitution was performed with sphingomyelin, phosphatidylcholine and phosphatidic acid lipids in the presence of the C(12)E(8) detergent which was subsequently removed by Biobeads. Control of protein incorporation was carried out by freeze-fracture electron microscopy. Particle density in liposomes was a function of the Lipid/Protein ratio. When compared to empty liposomes, ammonium permeability was increased two and three fold in RhCG-proteoliposomes, depending on the Lipid/Protein ratio (1/300 and 1/150, respectively). This strong NH(3) transport was reversibly inhibited by mercuric and copper salts and exhibited a low Arrhenius activation energy. Conclusions/Significance: This study allowed the determination of ammonia permeability per RhCG monomer, showing that the apparent Punit(NH3) (around 1 x 10(-3) mu m(3).s(-1)) is close to the permeability measured in HEK293E cells expressing a recombinant human RhCG (1.60 x 10(-3) mu m(3).s(-1)), and in human red blood cells endogenously expressing RhAG (2.18 x 10(-3) mu m(3).s(-1)). The major finding of this study is that RhCG protein is active as an NH(3) channel and that this function does not require any protein partner.	[Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] INSERM, UMR S 665, Paris, France; [Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] Univ Paris Diderot Paris 7, Paris, France; [Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Chami, Mohamed; Engel, Andreas] Univ Basel, Biozentrum, E Muller Inst Struct Biol, Ctr Imaging & Nanoanalyt,C CINA, Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Basel	Mouro-Chanteloup, I (corresponding author), INSERM, UMR S 665, Paris, France.	isabelle.mouro-chanteloup@inserm.fr	colin, yves/O-1910-2017; Isabelle, Mouro-Chanteloup/M-9750-2018	colin, yves/0000-0001-5196-4254; Isabelle, Mouro-Chanteloup/0000-0002-6368-9904; GENETET, Sandrine/0000-0001-8497-0087	Institut National de la Transfusion Sanguine, Paris; INSERM, Paris; Societe Francaise d'Hematologie; Societe Francaise de Nephrologie; Fondation pour la Recherche Medicale	Institut National de la Transfusion Sanguine, Paris; INSERM, Paris(Institut National de la Sante et de la Recherche Medicale (Inserm)); Societe Francaise d'Hematologie; Societe Francaise de Nephrologie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Institut National de la Transfusion Sanguine, Paris and INSERM, Paris. N.Z.-Y. acknowledges the financial support of the Societe Francaise d'Hematologie, of the Societe Francaise de Nephrologie and of the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Bruce LJ, 2009, BLOOD, V113, P1350, DOI 10.1182/blood-2008-07-171140; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Butterworth RF, 2003, ALCOHOL RES HEALTH, V27, P143; Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; Han KH, 2009, AM J PHYSIOL-LUNG C, V297, pL153, DOI 10.1152/ajplung.90524.2008; HODAK M, 2009, P NATL ACAD SCI US; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; PRIVER NA, 1993, BIOCHEMISTRY-US, V32, P2459, DOI 10.1021/bi00061a002; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Stewart GS, 2006, AM J PHYSIOL-RENAL, V290, pF1437, DOI 10.1152/ajprenal.00449.2005; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; VERKMAN AS, 1989, AM J PHYSIOL, V257, pC837, DOI 10.1152/ajpcell.1989.257.5.C837; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Weidinger K, 2007, FEMS MICROBIOL LETT, V273, P260, DOI 10.1111/j.1574-6968.2007.00805.x; Weiner ID, 2007, ANNU REV PHYSIOL, V69, P317, DOI 10.1146/annurev.physiol.69.040705.142215; Weiner ID, 2006, TRANSFUS CLIN BIOL, V13, P159, DOI 10.1016/j.tracli.2006.02.002; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657; ZIDIYAHIAOUI N, 2009, AM J PHYSL CELL PHYS	43	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8921	10.1371/journal.pone.0008921	http://dx.doi.org/10.1371/journal.pone.0008921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126667	Green Published, gold, Green Submitted			2022-12-25	WOS:000274138000004
J	Tasseff, R; Nayak, S; Salim, S; Kaushik, P; Rizvi, N; Varner, JD				Tasseff, Ryan; Nayak, Satyaprakash; Salim, Saniya; Kaushik, Poorvi; Rizvi, Noreen; Varner, Jeffrey D.			Analysis of the Molecular Networks in Androgen Dependent and Independent Prostate Cancer Revealed Fragile and Robust Subsystems	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-TYROSINE-PHOSPHATASE; ACID-PHOSPHATASE; FACTOR RECEPTOR; MAP KINASE; SENSITIVITY-ANALYSIS; CELL-PROLIFERATION; SIGNALING PATHWAYS; SYSTEMS BIOLOGY; PHASE-II	Androgen ablation therapy is currently the primary treatment for metastatic prostate cancer. Unfortunately, in nearly all cases, androgen ablation fails to permanently arrest cancer progression. As androgens like testosterone are withdrawn, prostate cancer cells lose their androgen sensitivity and begin to proliferate without hormone growth factors. In this study, we constructed and analyzed a mathematical model of the integration between hormone growth factor signaling, androgen receptor activation, and the expression of cyclin D and Prostate-Specific Antigen in human LNCaP prostate adenocarcinoma cells. The objective of the study was to investigate which signaling systems were important in the loss of androgen dependence. The model was formulated as a set of ordinary differential equations which described 212 species and 384 interactions, including both the mRNA and protein levels for key species. An ensemble approach was chosen to constrain model parameters and to estimate the impact of parametric uncertainty on model predictions. Model parameters were identified using 14 steady-state and dynamic LNCaP data sets taken from literature sources. Alterations in the rate of Prostatic Acid Phosphatase expression was sufficient to capture varying levels of androgen dependence. Analysis of the model provided insight into the importance of network components as a function of androgen dependence. The importance of androgen receptor availability and the MAPK/Akt signaling axes was independent of androgen status. Interestingly, androgen receptor availability was important even in androgen-independent LNCaP cells. Translation became progressively more important in androgen-independent LNCaP cells. Further analysis suggested a positive synergy between the MAPK and Akt signaling axes and the translation of key proliferative markers like cyclin D in androgen-independent cells. Taken together, the results support the targeting of both the Akt and MAPK pathways. Moreover, the analysis suggested that direct targeting of the translational machinery, specifically eIF4E, could be efficacious in androgen-independent prostate cancers.	[Tasseff, Ryan; Nayak, Satyaprakash; Kaushik, Poorvi; Rizvi, Noreen; Varner, Jeffrey D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Salim, Saniya] Cornell Univ, Sch Biomed Engn, Ithaca, NY USA	Cornell University; Cornell University	Tasseff, R (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	jdv27@cornell.edu			Office of Naval Research [N000140610293]; SN; National Science Foundation	Office of Naval Research(Office of Naval Research); SN; National Science Foundation(National Science Foundation (NSF))	The authors acknowledge the generous financial support of the Office of Naval Research(#N000140610293) to JDV, the support of SN, and the gracious financial support of RT by a National Science Foundation IGERT Nonlinear Systems Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Asthagiri AR, 2001, BIOTECHNOL PROGR, V17, P227, DOI 10.1021/bp010009k; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Bandara S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000558; Barnes-Ellerbe S, 2004, MOL PHARMACOL, V66, P502, DOI 10.1124/mol.104.000356; Battogtokh D, 2002, P NATL ACAD SCI USA, V99, P16904, DOI 10.1073/pnas.262658899; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Canil CM, 2005, J CLIN ONCOL, V23, P455, DOI 10.1200/JCO.2005.02.129; Cardillo MR, 2003, ANTICANCER RES, V23, P3825; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; CULIG Z, 1994, CANCER RES, V54, P5474; de Souza PL, 2009, CURR CANCER DRUG TAR, V9, P163, DOI 10.2174/156800909787581006; DICKINSON RP, 1976, J COMPUT PHYS, V21, P123, DOI 10.1016/0021-9991(76)90007-3; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; Gadkar KG, 2005, SYSTEMS BIOL, V2, P17, DOI 10.1049/sb:20045029; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gennemark P, 2009, BIOINFORMATICS, V25, P780, DOI 10.1093/bioinformatics/btp050; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Helmy M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004661; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hu YC, 2004, J BIOL CHEM, V279, P33438, DOI 10.1074/jbc.M401781200; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Huggins C, 1941, CANCER RES, V1, P293; Igawa T, 2003, PROSTATE, V55, P247, DOI 10.1002/pros.10240; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330; KURIYAMA M, 1982, J NATL CANCER I, V68, P99; Lee MS, 2003, ONCOGENE, V22, P781, DOI 10.1038/sj.onc.1206066; Li H, 2009, CANCER-AM CANCER SOC, V115, P4246, DOI 10.1002/cncr.24485; LIN MF, 1988, MOL CELL BIOL, V8, P5477, DOI 10.1128/MCB.8.12.5477; Lin MF, 2000, CELL BIOL INT, V24, P681, DOI 10.1006/cbir.2000.0433; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Lukas J, 1996, MOL CELL BIOL, V16, P6917; Mayawala K, 2004, BIOPHYS J, V87, pL1, DOI 10.1529/biophysj.104.051888; MCCONNELL JD, 1955, BR J UROL, V76, P5; Meng TC, 2000, ONCOGENE, V19, P2664, DOI 10.1038/sj.onc.1203576; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nayak S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002016; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Palmer TN, 2005, ANNU REV EARTH PL SC, V33, P163, DOI 10.1146/annurev.earth.33.092203.122552; PAPSIDERO LD, 1980, CANCER RES, V40, P2428; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921, DOI 10.1210/mend-5-12-1921; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; SAKAI H, 1991, PROSTATE, V19, P265, DOI 10.1002/pros.2990190307; Sampson ER, 2001, J BIOL REG HOMEOS AG, V15, P123; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Selvarajoo Kumar, 2009, Journal of Bioinformatics and Computational Biology, V7, P243, DOI 10.1142/S0219720009003947; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; SINHA AA, 1988, PROSTATE, V13, P1, DOI 10.1002/pros.2990130102; Song SO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006758; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stites EC, 2007, SCIENCE, V318, P463, DOI 10.1126/science.1144642; Tam L, 2007, BRIT J CANCER, V97, P378, DOI 10.1038/sj.bjc.6603871; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; VIHKO P, 1979, INVEST UROL, V16, P349; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Ziada A, 2004, PROSTATE, V60, P332, DOI 10.1002/pros.20065; 2006, CLIN CANC RES, V12, P2730; NAT BIOTECHNOL, V20, P370; CANC RES, V66, P11389	85	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8864	10.1371/journal.pone.0008864	http://dx.doi.org/10.1371/journal.pone.0008864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126616	Green Submitted, gold, Green Published			2022-12-25	WOS:000274138000003
J	Samhouri, JF; Levin, PS; Ainsworth, CH				Samhouri, Jameal F.; Levin, Phillip S.; Ainsworth, Cameron H.			Identifying Thresholds for Ecosystem-Based Management	PLOS ONE			English	Article							FOOD-WEB MODELS; ECOLOGICAL INDICATORS; MARINE ECOSYSTEMS; REGIME SHIFTS; FISHERIES; RESILIENCE; STABILITY; BIODIVERSITY; COMPLEXITY; FRAMEWORK	Background: One of the greatest obstacles to moving ecosystem-based management (EBM) from concept to practice is the lack of a systematic approach to defining ecosystem-level decision criteria, or reference points that trigger management action. Methodology/Principal Findings: To assist resource managers and policymakers in developing EBM decision criteria, we introduce a quantitative, transferable method for identifying utility thresholds. A utility threshold is the level of human-induced pressure (e. g., pollution) at which small changes produce substantial improvements toward the EBM goal of protecting an ecosystem's structural (e. g., diversity) and functional (e. g., resilience) attributes. The analytical approach is based on the detection of nonlinearities in relationships between ecosystem attributes and pressures. We illustrate the method with a hypothetical case study of (1) fishing and (2) nearshore habitat pressure using an empirically-validated marine ecosystem model for British Columbia, Canada, and derive numerical threshold values in terms of the density of two empirically-tractable indicator groups, sablefish and jellyfish. We also describe how to incorporate uncertainty into the estimation of utility thresholds and highlight their value in the context of understanding EBM trade-offs. Conclusions/Significance: For any policy scenario, an understanding of utility thresholds provides insight into the amount and type of management intervention required to make significant progress toward improved ecosystem structure and function. The approach outlined in this paper can be applied in the context of single or multiple human-induced pressures, to any marine, freshwater, or terrestrial ecosystem, and should facilitate more effective management.	[Samhouri, Jameal F.] Pacific States Marine Fisheries Commiss, Portland, OR USA; [Levin, Phillip S.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA USA; [Ainsworth, Cameron H.] Marine Resources Assessment Grp Amer Inc, St Petersburg, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA	Samhouri, JF (corresponding author), Pacific States Marine Fisheries Commiss, Portland, OR USA.	Jameal.Samhouri@noaa.gov	Ainsworth, Cameron/E-8507-2011		NOAA Fisheries (Northwest Fisheries Science Center)	NOAA Fisheries (Northwest Fisheries Science Center)(National Oceanic Atmospheric Admin (NOAA) - USA)	This research was supported by NOAA Fisheries (Northwest Fisheries Science Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2008, ECOL MODEL, V216, P354, DOI 10.1016/j.ecolmodel.2008.05.005; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker B. M., 2008, BBMLE TOOLS GEN MAXI; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carwardine J, 2009, CONSERV LETT, V2, P3, DOI 10.1111/j.1755-263X.2008.00042.x; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V., 2005, ECOPATH ECOSIM USERS; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; de Mutsert K, 2008, P NATL ACAD SCI USA, V105, P2740, DOI 10.1073/pnas.0704354105; DeLuca WV, 2008, BIOL CONSERV, V141, P2669, DOI 10.1016/j.biocon.2008.07.023; Field JC, 2006, PROG OCEANOGR, V68, P238, DOI 10.1016/j.pocean.2006.02.010; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Framstad E, 1997, P ROY SOC B-BIOL SCI, V264, P31, DOI 10.1098/rspb.1997.0005; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Greenstreet SPR, 2006, ICES J MAR SCI, V63, P573, DOI 10.1016/j.icesjms.2005.12.009; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; GRUMBINE RE, 1994, CONSERV BIOL, V8, P27, DOI 10.1046/j.1523-1739.1994.08010027.x; HAIST V, 2001, CANADIAN STOCK ASSES, V135, P1; Hunter ML, 2009, CONSERV BIOL, V23, P1053, DOI 10.1111/j.1523-1739.2009.01205.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Link JS, 2005, ICES J MAR SCI, V62, P569, DOI 10.1016/j.icesjms.2004.12.015; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1; McLeod K.L., 2005, SCI CONSENSUS STATEM; Methratta ET, 2006, ECOL INDIC, V6, P575, DOI 10.1016/j.ecolind.2005.08.022; Morissette L, 2009, PROG OCEANOGR, V81, P174, DOI 10.1016/j.pocean.2009.04.013; Morris W. F., 2002, QUANTITATIVE CONSERV; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pirrone N, 2005, REG ENVIRON CHANGE, V5, P111, DOI 10.1007/s10113-004-0092-9; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; R Development Core Team, 2009, R FDN STAT COMP; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Samhouri JF, 2009, ECOSYSTEMS, V12, P1283, DOI 10.1007/s10021-009-9286-9; Samhouri JF, 2009, OECOLOGIA, V160, P257, DOI 10.1007/s00442-009-1307-z; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2000, ECOSYSTEMS, V3, P451, DOI 10.1007/s100210000040; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Shannon LJ, 2009, ECOL INDIC, V9, P1078, DOI 10.1016/j.ecolind.2008.12.007; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suter II G.W., 2007, ECOLOGICAL RISK ASSE; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Vasconcellos M, 1997, ECOL MODEL, V100, P125, DOI 10.1016/S0304-3800(97)00150-6; Vermaat JE, 2009, ECOLOGY, V90, P278, DOI 10.1890/07-0978.1; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Weible C, 2004, POLICY STUD J, V32, P187, DOI 10.1111/j.1541-0072.2004.00060.x	63	123	125	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8907	10.1371/journal.pone.0008907	http://dx.doi.org/10.1371/journal.pone.0008907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126647	Green Submitted, Green Published, gold			2022-12-25	WOS:000273896500025
J	Holland, JP; Caldas-Lopes, E; Divilov, V; Longo, VA; Taldone, T; Zatorska, D; Chiosis, G; Lewis, JS				Holland, Jason P.; Caldas-Lopes, Eloisi; Divilov, Vadim; Longo, Valerie A.; Taldone, Tony; Zatorska, Danuta; Chiosis, Gabriela; Lewis, Jason S.			Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using Zr-89-DFO-Trastuzumab	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EMITTING RADIOTHERAPEUTIC AGENT; BREAST-CANCER XENOGRAFTS; ZR-89 IMMUNO-PET; MONOCLONAL-ANTIBODIES; BIODISTRIBUTION; DOSIMETRY; PERFORMANCE; MICROPET; THERAPY	Background: The positron-emitting radionuclide Zr-89 (t(1/2) = 3.17 days) was used to prepare Zr-89-radiolabeled trastuzumab for use as a radiotracer for characterizing HER2/neu-positive breast tumors. In addition, pharmacodynamic studies on HER2/neu expression levels in response to therapeutic doses of PU-H71 (a specific inhibitor of heat-shock protein 90 [Hsp90]) were conducted. Methodology/Principal Findings: Trastuzumab was functionalized with desferrioxamine B (DFO) and radiolabeled with [Zr-89] Zr-oxalate at room temperature using modified literature methods. ImmunoPET and biodistribution experiments in female, athymic nu/nu mice bearing sub-cutaneous BT-474 (HER2/neu positive) and/or MDA-MB-468 (HER2/neu negative) tumor xenografts were conducted. The change in Zr-89-DFO-trastuzumab tissue uptake in response to high-and low-specific-activity formulations and co-administration of PU-H71 was evaluated by biodistribution studies, Western blot analysis and immunoPET. Zr-89-DFO-trastuzumab radiolabeling proceeded in high radiochemical yield and specific-activity 104.3+/-2.1 MBq/mg (2.82+/-0.05 mCi/mg of mAb). In vitro assays demonstrated >99% radiochemical purity with an immunoreactive fraction of 0.87+/-0.07. In vivo biodistribution experiments revealed high specific BT-474 uptake after 24, 48 and 72 h (64.68+/-13.06% ID/g; 71.71+/-10.35% ID/g and 85.18+/-11.10% ID/g, respectively) with retention of activity for over 120 h. Pre-treatment with PU-H71 was followed by biodistribution studies and immunoPET of Zr-89-DFO-trastuzumab. Expression levels of HER2/neu were modulated during the first 24 and 48 h post-administration (29.75+/-4.43% ID/g and 41.42+/-3.64% ID/g, respectively). By 72 h radiotracer uptake (73.64+/-12.17% ID/g) and Western blot analysis demonstrated that HER2/neu expression recovered to baseline levels. Conclusions/Significance: The results indicate that Zr-89-DFO-trastuzumab provides quantitative and highly-specific delineation of HER2/neu positive tumors, and has potential to be used to measure the efficacy of long-term treatment with Hsp90 inhibitors, like PU-H71, which display extended pharmacodynamic profiles.	[Holland, Jason P.; Divilov, Vadim; Lewis, Jason S.] Mem Sloan Kettering Canc Ctr, Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiochem Serv, New York, NY USA; [Caldas-Lopes, Eloisi; Taldone, Tony; Zatorska, Danuta; Chiosis, Gabriela; Lewis, Jason S.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Pharmacol & Chem, New York, NY 10021 USA; [Longo, Valerie A.] Mem Sloan Kettering Canc Ctr, Small Anim Imaging Core Facil, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Holland, JP (corresponding author), Mem Sloan Kettering Canc Ctr, Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiochem Serv, New York, NY USA.	lewisj2@mskcc.org	Holland, Jason P./AAO-5718-2020	Holland, Jason P./0000-0002-0066-219X; Lewis, Jason/0000-0001-7065-4534	Geoffrey Beene Cancer Research Center of Memorial Sloan-Kettering Cancer Center; Office of Science (BER), U.S. Department of Energy [DE-SC0002456]; U.S. Department of Defense Breast Cancer Research Program [BC085588]; Susan G. Komen for the Cure [KG091313]; National Institutes of Health (NIH) [R24-CA83084, P50-CA086438, P30-CA08748]; NATIONAL CANCER INSTITUTE [P50CA086438, P30CA008748, R01CA172546, R24CA083084] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Center of Memorial Sloan-Kettering Cancer Center; Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Defense Breast Cancer Research Program(United States Department of Defense); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Geoffrey Beene Cancer Research Center of Memorial Sloan-Kettering Cancer Center (JSL), the Office of Science (BER), U.S. Department of Energy (Award DE-SC0002456, JSL), the U.S. Department of Defense Breast Cancer Research Program (BC085588, GC) and the Susan G. Komen for the Cure (Postdoctoral Fellowship, KG091313, TT). Technical services provided by the MSKCC Small-Animal Imaging Core Facility were supported in part by National Institutes of Health (NIH) grants R24-CA83084, P50-CA086438 and P30-CA08748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2009, J NUCL MED, V50, P123, DOI 10.2967/jnumed.108.054312; ANDERSON CJ, 1995, J NUCL MED, V36, P850; ANDERSON CJ, 1992, J NUCL MED, V33, P1685; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; BAUGHMAN SA, Patent No. 6627196; Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; Borjesson PKE, 2009, J NUCL MED, V50, P1828, DOI 10.2967/jnumed.109.065862; Borjesson PKE, 2006, CLIN CANCER RES, V12, P2133, DOI 10.1158/1078-0432.CCR-05-2137; Boswell CA, 2007, NUCL MED BIOL, V34, P757, DOI 10.1016/j.nucmedbio.2007.04.001; Brouwers A, 2004, CANCER BIOTHER RADIO, V19, P155, DOI 10.1089/108497804323071922; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Chandarlapaty S, 2008, CLIN CANCER RES, V14, P240, DOI 10.1158/1078-0432.CCR-07-1667; Citri A, 2004, CELL CYCLE, V3, P51; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Costantini DL, 2008, J NUCL MED, V49, P1498, DOI 10.2967/jnumed.108.051771; Dijkers ECF, 2009, J NUCL MED, V50, P974, DOI 10.2967/jnumed.108.060392; Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f; Garmestani K, 2002, NUCL MED BIOL, V29, P599, DOI 10.1016/S0969-8051(02)00322-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holland JP, 2009, NUCL MED BIOL, V36, P729, DOI 10.1016/j.nucmedbio.2009.05.007; Hynes N., 2005, NAT REV CANCER, V5, P580; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Kim JS, 2007, J NUCL MED, V48, P1527, DOI 10.2967/jnumed.107.040550; Kramer-Marek G, 2009, J NUCL MED, V50, P1131, DOI 10.2967/jnumed.108.057695; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Meijs WE, 1996, NUCL MED BIOL, V23, P439, DOI 10.1016/0969-8051(96)00020-0; MEIJS WE, 1994, APPL RADIAT ISOTOPES, V45, P1143, DOI 10.1016/0969-8043(94)90029-9; MEIJS WE, 1992, APPL RADIAT ISOTOPES, V43, P1443, DOI 10.1016/0883-2889(92)90170-J; Meijs WE, 1997, J NUCL MED, V38, P112; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Nayak TK, 2009, BIOCONJUGATE CHEM, V20, P825, DOI 10.1021/bc800299f; Niu G., 2009, EUR J NUCL MED MOL I; Orlova A, 2009, J NUCL MED, V50, P417, DOI 10.2967/jnumed.108.057919; Palm S, 2003, J NUCL MED, V44, P1148; Perik PJ, 2006, J CLIN ONCOL, V24, P2276, DOI 10.1200/JCO.2005.03.8448; Perk LR, 2008, EUR J NUCL MED MOL I, V35, P1857, DOI 10.1007/s00259-008-0774-5; Perk LR, 2006, EUR J NUCL MED MOL I, V33, P1337, DOI 10.1007/s00259-006-0160-0; Perk LR, 2005, J NUCL MED, V46, P1898; PERK LR, 2008, NATURE PROTOCOLS; Reilly RM, 2006, J NUCL MED, V47, P1023; Smith-Jones PM, 2006, J NUCL MED, V47, P793; Smith-Jones PM, 2004, NAT BIOTECHNOL, V22, P701, DOI 10.1038/nbt968; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Tang Y, 2005, NUCL MED BIOL, V32, P51, DOI 10.1016/j.nucmedbio.2004.08.003; Verel I, 2005, J NUCL MED, V46, p164S; Verel I, 2004, EUR J NUCL MED MOL I, V31, P1645, DOI 10.1007/s00259-004-1632-8; Verel I, 2003, CANCER BIOTHER RADIO, V18, P655, DOI 10.1089/108497803322287745; Verel I, 2003, J NUCL MED, V44, P1663; Verel I, 2003, J NUCL MED, V44, P1271; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu AM, 2008, CANCER J, V14, P191, DOI 10.1097/PPO.0b013e31817b07ae; Wu AM, 2009, J NUCL MED, V50, P2, DOI 10.2967/jnumed.108.056887; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zanzonico P, 2008, J NUCL MED, V49, P1114, DOI 10.2967/jnumed.107.050203	58	112	116	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8859	10.1371/journal.pone.0008859	http://dx.doi.org/10.1371/journal.pone.0008859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111600	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896300011
J	Cadieu, N; Fruchard, S; Cadieu, JC				Cadieu, Nicole; Fruchard, Stephane; Cadieu, Jean-Claude			Innovative Individuals Are Not Always the Best Demonstrators: Feeding Innovation and Social Transmission in Serinus canaria	PLOS ONE			English	Article							TAENIOPYGIA-GUTTATA; ZEBRA FINCHES; COMMON MARMOSETS; TOOL-USE; FOOD; CHIMPANZEES; BEHAVIOR; PREFERENCES; HENS	Background: Feeding innovation occurs when individuals choose a novel, unknown type of food and/or acquire new feeding skills. Here we studied feeding innovation and social transmission of the new feeding habit in canaries. Adult canaries eat a wide variety of seeds but avoid larger ones such as those of sunflowers. We determined whether adults of both sexes are equally prone to innovate when confronted with sunflower seeds and whether free-interactions facilitate transmission of the new feeding habit in a sex-dependent manner. Methodology/Principal Findings: First we determined which sex was more innovative, i.e., was more successful at husking and eating the novel seeds. Males were clearly more innovative than females. Due to this, experienced males served as model for either male or female observers in three different conditions (free interaction with a demonstrator, visual interaction with a demonstrator placed behind a transparent wall and access to seeds in the presence of a non-demonstrating bird). During free interactions, the new feeding habit was only transmitted to females. In contrast, transmission of seed handling to male observers only occurred if demonstrator and observer were separated by the transparent wall. Indeed, aggressive behaviors between males prevented social transmission during free interactions. Finally, we studied the influence of the less innovative females in feeding-habit transmission. First, we obtained female demonstrators by making them freely interact with male demonstrators. Once they acquired innovative responses to sunflower seeds we studied feeding-habit transmission towards male and female observers. Observers of both sexes learned during free interactions with female demonstrators. No aggressive behavior occurred. Males were also able to learn after visual interactions with the female demonstrator. Conclusions/Significance: Our results show that the most innovative individuals (males) are not always the best demonstrators, and that social relationship and sex are crucial factors for the spread of a new feeding habit among canaries. These factors determine the kind of interaction between individuals and the time spent together, thus affecting the transmission of novel habits within the population.	[Cadieu, Nicole; Fruchard, Stephane; Cadieu, Jean-Claude] Univ Toulouse, Ctr Rech Cognit Anim, UPS, Toulouse, France; [Cadieu, Nicole; Fruchard, Stephane; Cadieu, Jean-Claude] Ctr Rech Cognit Anim, CNRS, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cadieu, N (corresponding author), Univ Toulouse, Ctr Rech Cognit Anim, UPS, Toulouse, France.	cadieu@cict.fr			French Research Council (CNRS); University Paul Sabatier (Toulouse III)	French Research Council (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier (Toulouse III)	This study was supported by the French Research Council (CNRS) and the University Paul Sabatier (Toulouse III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISNER R, 1992, ANIM BEHAV, V44, P327, DOI 10.1016/0003-3472(92)90038-B; BEAUCHAMP G, 1991, ANIM BEHAV, V41, P247, DOI 10.1016/S0003-3472(05)80476-2; Benskin CMWH, 2002, ANIM BEHAV, V64, P823, DOI 10.1006/anbe.2002.2005; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; CADIEU JC, 1995, ANIM BEHAV, V50, P793, DOI 10.1016/0003-3472(95)80139-1; Cadieu N, 2008, BEHAV ECOL SOCIOBIOL, V62, P795, DOI 10.1007/s00265-007-0505-0; Cadieu N, 2004, ANIM BEHAV, V67, P1051, DOI 10.1016/j.anbehav.2003.10.004; Caldwell CA, 2003, ANIM BEHAV, V65, P1085, DOI 10.1006/anbe.2003.2145; COLEMAN SL, 1994, ANIM BEHAV, V48, P903, DOI 10.1006/anbe.1994.1315; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; DAGNELIE GB, 1975, THEORIES METHODES ST, P241; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; FISHER J., 1949, BRITISH BIRDS, V42, P347; Fragaszy Dorothy M., 1996, P65, DOI 10.1016/B978-012273965-1/50005-4; Fritz J, 1999, ANIM BEHAV, V57, P785, DOI 10.1006/anbe.1998.1035; Gajdon GK, 2006, ANIM COGN, V9, P173, DOI 10.1007/s10071-006-0018-7; Galef B.G. Jr, 1988, P3; Gandolfi G., 1973, Bollettino Zool, V40, P69; GIRALDEAU LA, 1987, ANIM BEHAV, V35, P387, DOI 10.1016/S0003-3472(87)80262-2; GOODALL J, 1973, PRECULTURAL PRIMATE, P144; Greenberg Russell, 2003, P175; Hirata S, 2003, ANIM COGN, V6, P235, DOI 10.1007/s10071-003-0187-6; Katz M, 2003, ANIM COGN, V6, P11, DOI 10.1007/s10071-003-0158-y; KEAR JANET, 1962, PROC ZOOL SOC LONDON, V138, P163; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; Kwai M., 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; Leitner S, 2003, GEN COMP ENDOCR, V130, P102, DOI 10.1016/S0016-6480(02)00574-9; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Midford PE, 2000, ANIM BEHAV, V59, P1199, DOI 10.1006/anbe.1999.1419; Nicol CJ, 1999, ANIM BEHAV, V57, P163, DOI 10.1006/anbe.1998.0920; Ramsey G, 2007, BEHAV BRAIN SCI, V30, P393, DOI 10.1017/S0140525X07002373; Range F, 2007, ANIM BEHAV, V73, P1033, DOI 10.1016/j.anbehav.2006.07.015; Reader S. M., 2003, ANIMAL INNOVATION, P3, DOI DOI 10.1093/ACPROF:OSO/9780198526223.001.0001; SCHWARTZ D, 1968, METHODES STAT USAGE; Sherwin CM, 2002, ANIM BEHAV, V63, P933, DOI 10.1006/anbe.2002.2000; Thorpe, 1963, LEARNING INSTINCT AN; Voigt C., 1998, Boletim do Museu Municipal do Funchal, P117; Voigt C, 2003, J ORNITHOL, V144, P86, DOI 10.1007/BF02465520; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; [No title captured]	42	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8841	10.1371/journal.pone.0008841	http://dx.doi.org/10.1371/journal.pone.0008841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20111590	Green Published, gold			2022-12-25	WOS:000273896100007
J	Doxakis, E				Doxakis, Epaminondas			Post-transcriptional Regulation of alpha-Synuclein Expression by mir-7 and mir-153	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; GENE-EXPRESSION; MESSENGER-RNAS; MICRORNAS; TARGET; AGGREGATION; DEGRADATION; AUTOPHAGY; INSIGHTS; MONKEYS	Genetic and biochemical studies have established a central role for alpha-synuclein accumulation in the pathogenesis of Parkinson disease. Here, two microRNAs, namely mir-7 and mir-153, have been identified to regulate alpha-synuclein levels post-transcriptionally. These microRNAs bind specifically to the 3'-untranslated region of alpha-synuclein and down-regulate its mRNA and protein levels, with their effect being additive. They are expressed predominantly in the brain with a pattern that mirrors synuclein expression in different tissues as well as during neuronal development, indicating that they play a tuning role in the amount of alpha-synuclein produced. Overexpression of mir-7 and mir-153 significantly reduces endogenous alpha-synuclein levels, whereas inhibition of mir-7 and mir-153 enhances translation of a luciferase construct bearing the alpha-synuclein 3'-untranslated region in primary neurons. These findings reveal a significant additional mechanism by which alpha-synuclein is regulated and point toward new therapeutic regimes for lowering endogenous alpha-synuclein levels in patients with familial or sporadic Parkinson disease.	Acad Athens, Basic Neurosci Div, Biomed Res Fdn, Athens 11527, Greece	Academy of Athens	Doxakis, E (corresponding author), Acad Athens, Basic Neurosci Div, Biomed Res Fdn, Soranou Efesiou 4, Athens 11527, Greece.			Doxakis, Epaminondas/0000-0003-1305-0739	Biomedical Research Foundation, Academy of Athens	Biomedical Research Foundation, Academy of Athens	Recipient of seed funding from the Biomedical Research Foundation, Academy of Athens.	Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Doxakis E, 2004, CURR BIOL, V14, P1761, DOI 10.1016/j.cub.2004.09.050; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; EULALIO A, 2009, RNA, V32, P15; Ge LM, 1997, BIOTECHNIQUES, V22, P28, DOI 10.2144/97221bm03; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Walker SJ, 2006, ALCOHOL, V38, P1, DOI 10.1016/j.alcohol.2006.03.008; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Winkler S, 2007, NEUROLOGY, V69, P1745, DOI 10.1212/01.wnl.0000275524.15125.f4	36	345	366	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12726	12734		10.1074/jbc.M109.086827	http://dx.doi.org/10.1074/jbc.M109.086827			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20106983	Green Published, hybrid			2022-12-25	WOS:000276787800031
J	Donelan, W; Koya, V; Li, SW; Yang, LJ				Donelan, William; Koya, Vijay; Li, Shi-Wu; Yang, Li-Jun			Distinct Regulation of Hepatic Nuclear Factor 1 alpha by NKX6.1 in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; DNA-BINDING; FACTOR-I; MOLECULAR-GENETICS; INSULIN-SECRETION; P1 PROMOTER; EXPRESSION; GENES; HNF-1-ALPHA; HNF1	Hepatic nuclear factor 1 alpha (HNF1 alpha) is a key regulator of development and function in pancreatic beta cells and is specifically involved in regulation of glycolysis and glucose-stimulated insulin secretion. Abnormal expression of HNF1 alpha leads to development of MODY3 (maturity-onset diabetes of the young 3). We report that NK6 homeodomain 1 (NKX6.1) binds to a cis-regulatory element in the HNF1 alpha promoter and is a major regulator of this gene in beta cells. We identified an NKX6.1 recognition sequence in the distal region of the HNF1 alpha promoter and demonstrated specific binding of NKX6.1 in beta cells by electrophoretic mobility shift and chromatin immunoprecipitation assays. Site-directed mutagenesis of the NKX6.1 core-binding sequence eliminated NKX6.1-mediated activation and substantially decreased activity of the HNF1 alpha promoter in beta cells. Overexpression or small interfering RNA-mediated knockdown of the Nkx6.1 gene resulted in increased or diminished HNF1 alpha gene expression, respectively, in beta cells. We conclude that NKX6.1 is a novel regulator of HNF1 alpha in pancreatic beta cells. This novel regulatory mechanism for HNF1 alpha in beta cells may provide new molecular targets for the diagnosis of MODY3.	[Donelan, William; Koya, Vijay; Li, Shi-Wu; Yang, Li-Jun] Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Yang, LJ (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Dent Sci Bldg D6-28,1600 SW Archer Rd, Gainesville, FL 32610 USA.	yanglj@pathology.ufl.edu		Donelan, William/0000-0001-7742-8089	National Institutes of Health [DK071831, DK64054]; NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK064054, R01DK071831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DK071831 and DK64054 (to L.-J.Y.) from NIDDK.	BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Ban N, 2002, DIABETES, V51, P1409, DOI 10.2337/diabetes.51.5.1409; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; DELLA MT, 2007, J PEDIAT, V83, pS178; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; EMENS LA, 1992, P NATL ACAD SCI USA, V89, P7300, DOI 10.1073/pnas.89.16.7300; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Fodor A, 2007, DIABETOLOGIA, V50, P121, DOI 10.1007/s00125-006-0509-8; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; Gauthier BR, 2007, BIOCHEM J, V403, P593, DOI 10.1042/BJ20070053; GREGORI C, 1993, NUCLEIC ACIDS RES, V21, P897, DOI 10.1093/nar/21.4.897; Hansen SK, 2002, J CLIN INVEST, V110, P827, DOI 10.1172/JCI200215085; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Harries LW, 2006, HUM MOL GENET, V15, P2216, DOI 10.1093/hmg/ddl147; Hattersley A, 2006, PEDIATR DIABETES, V7, P352, DOI 10.1111/j.1399-5448.2006.00217.x; Hattersley AT, 2005, CLIN MED, V5, P476, DOI 10.7861/clinmedicine.5-5-476; Huang JM, 2008, DIABETES-METAB RES, V24, P533, DOI 10.1002/dmrr.870; Huang JM, 2009, EXP CELL RES, V315, P1200, DOI 10.1016/j.yexcr.2009.01.004; Ihara A, 2005, BIOCHEM BIOPH RES CO, V329, P984, DOI 10.1016/j.bbrc.2005.02.072; Iype T, 2004, MOL ENDOCRINOL, V18, P1363, DOI 10.1210/me.2004-0006; Jorgensen MC, 1999, FEBS LETT, V461, P287, DOI 10.1016/S0014-5793(99)01436-2; Koya V, 2008, DIABETES, V57, P757, DOI 10.2337/db07-1441; Kulkarni RN, 2004, SCIENCE, V303, P1311, DOI 10.1126/science.1095486; KUO CJ, 1990, P NATL ACAD SCI USA, V87, P9838, DOI 10.1073/pnas.87.24.9838; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Luco RF, 2006, DIABETES, V55, P2202, DOI 10.2337/db05-1534; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Marchetti P, 2006, NUTR METAB CARDIOVAS, V16, pS3, DOI 10.1016/j.numecd.2005.10.017; McCarthy MI, 2008, DIABETES, V57, P2889, DOI 10.2337/db08-0343; MENDEL DB, 1991, J BIOL CHEM, V266, P677; Mirmira RG, 2000, J BIOL CHEM, V275, P14743, DOI 10.1074/jbc.275.19.14743; Mitchell SMS, 2002, MOL GENET METAB, V77, P35, DOI 10.1016/S1096-7192(02)00150-6; MIURA N, 1993, NUCLEIC ACIDS RES, V21, P3731, DOI 10.1093/nar/21.16.3731; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Oster A, 1998, J HISTOCHEM CYTOCHEM, V46, P707, DOI 10.1177/002215549804600602; Pearson ER, 2000, DIABETIC MED, V17, P543, DOI 10.1046/j.1464-5491.2000.00305.x; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1997, MOL CELL BIOL, V17, P4948, DOI 10.1128/MCB.17.9.4948; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Sander M, 2000, DEVELOPMENT, V127, P5533; Satoh S, 2005, J BIOL CHEM, V280, P39827, DOI 10.1074/jbc.M507303200; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Shepherd M, 2003, DIABETES CARE, V26, P3191, DOI 10.2337/diacare.26.11.3191-a; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Taylor DG, 2005, BIOCHEMISTRY-US, V44, P11269, DOI 10.1021/bi050821m; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; Uchizono Y, 2009, DIABETES RES CLIN PR, V84, P19, DOI 10.1016/j.diabres.2008.12.014; Watada H, 2000, J BIOL CHEM, V275, P34224, DOI 10.1074/jbc.M004981200; Weber H, 1996, INT J DEV BIOL, V40, P297; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200	57	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12181	12189		10.1074/jbc.M109.064238	http://dx.doi.org/10.1074/jbc.M109.064238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20106981	Green Published, hybrid			2022-12-25	WOS:000276787100048
J	Jacobsen, KT; Adlerz, L; Multhaup, G; Iverfeldt, K				Jacobsen, Kristin T.; Adlerz, Linda; Multhaup, Gerd; Iverfeldt, Kerstin			Insulin-like Growth Factor-1 (IGF-1)-induced Processing of Amyloid-beta Precursor Protein (APP) and APP-like Protein 2 Is Mediated by Different Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; UP-REGULATION; KINASE-C; ECTODOMAIN; PHOSPHORYLATION; FAMILY; APLP2; EXPRESSION	alpha-Secretase cleavage of the amyloid precursor protein (APP) is of great interest because it prevents the formation of the Alzheimer-linked amyloid-beta peptide. APP belongs to a conserved gene family including the two paralogues APP-like protein (APLP) 1 and 2. Insulin-like growth factor-1 (IGF-1) stimulates the shedding of all three proteins. IGF-1-induced shedding of both APP and APLP1 is dependent on phosphatidylinositol 3-kinase (PI3-K), whereas APLP2 shedding is independent of this signaling pathway. Here, we used human neuroblastoma SH-SY5Y cells to investigate the involvement of protein kinase C (PKC) in the proteolytic processing of endogenously expressed members of the APP family. Processing was induced by IGF-1 or retinoic acid, another known stimulator of APP alpha-secretase shedding. Our results show that stimulation of APP and APLP1 processing involves multiple signaling pathways, whereas APLP2 processing is mainly dependent on PKC. Next, we wanted to investigate whether the difference in the regulation of APLP2 shedding compared with APP shedding could be due to involvement of different processing enzymes. We focused on the two major alpha-secretase candidates ADAM10 and TACE, which both are members of the ADAM(a disintegrin and metalloprotease) family. Shedding was analyzed in the presence of the ADAM10 inhibitor GI254023X, or after transfection with small interfering RNAs targeted against TACE. The results clearly demonstrate that different alpha-secretases are involved in IGF-1-induced processing. APP is mainly cleaved by ADAM10, whereas APLP2 processing is mediated by TACE. Finally, we also show that IGF-1 induces PKC-dependent phosphorylation of TACE.	[Jacobsen, Kristin T.; Adlerz, Linda; Iverfeldt, Kerstin] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden; [Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Stockholm University; Free University of Berlin	Iverfeldt, K (corresponding author), Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden.	kerstin@neurochem.su.se			Swedish Research Council; Salen Stiftelsen; Magn. Bergvalls Stiftelse; Alzheimerfonden; Langmanska kulturfonden; Deutsche Forschungsgemeinschaft	Swedish Research Council(Swedish Research CouncilEuropean Commission); Salen Stiftelsen; Magn. Bergvalls Stiftelse; Alzheimerfonden; Langmanska kulturfonden; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Swedish Research Council (to K. I.), Salen Stiftelsen (to K. I.), Magn. Bergvalls Stiftelse (to K. I.), Alzheimerfonden (to K. I. and L. A.), Langmanska kulturfonden (to K. I.), and the Deutsche Forschungsgemeinschaft (to G. M.).	Adlerz L, 2007, J BIOL CHEM, V282, P10203, DOI 10.1074/jbc.M611183200; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Beckman M, 1997, NEUROSCI LETT, V221, P73, DOI 10.1016/S0304-3940(96)13292-4; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Carro E, 2006, NEUROBIOL AGING, V27, P1250, DOI 10.1016/j.neurobiolaging.2005.06.015; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; DAVIS PD, 1992, J MED CHEM, V35, P994, DOI 10.1021/jm00084a004; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Heber S, 2000, J NEUROSCI, V20, P7951; Holback S, 2005, J NEUROCHEM, V95, P1059, DOI 10.1111/j.1471-4159.2005.03440.x; Holback S, 2008, BIOCHEM BIOPH RES CO, V365, P298, DOI 10.1016/j.bbrc.2007.10.167; Hong F, 2001, BIOCHEM BIOPH RES CO, V282, P816, DOI 10.1006/bbrc.2001.4644; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Maniar R, 2005, MOL CELL BIOCHEM, V275, P15, DOI 10.1007/s11010-005-7264-x; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Minogue AM, 2009, BRAIN RES, V1262, P89, DOI 10.1016/j.brainres.2009.01.008; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Needham BE, 2008, J PATHOL, V215, P155, DOI 10.1002/path.2343; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Paliga K, 1997, EUR J BIOCHEM, V250, P354, DOI 10.1111/j.1432-1033.1997.0354a.x; Reddy ABM, 2009, ENDOCRINOLOGY, V150, P63, DOI 10.1210/en.2008-0677; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Slack BE, 2001, BIOCHEM J, V357, P787, DOI 10.1042/0264-6021:3570787; Slack BE, 1997, BIOCHEM J, V327, P245, DOI 10.1042/bj3270245; Solano DC, 2000, FASEB J, V14, P1015, DOI 10.1096/fasebj.14.7.1015; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Xu KP, 2001, AM J PHYSIOL-CELL PH, V281, pC603, DOI 10.1152/ajpcell.2001.281.2.C603	43	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10223	10231		10.1074/jbc.M109.038224	http://dx.doi.org/10.1074/jbc.M109.038224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139073	Green Published, hybrid			2022-12-25	WOS:000276264600006
J	Olson, ED; Nelson, J; Griffith, K; Nguyen, T; Streeter, M; Wilson-Ashworth, HA; Gelb, MH; Judd, AM; Bell, JD				Olson, Erin D.; Nelson, Jennifer; Griffith, Katalyn; Nguyen, Thaothanh; Streeter, Michael; Wilson-Ashworth, Heather A.; Gelb, Michael H.; Judd, Allan M.; Bell, John D.			Kinetic Evaluation of Cell Membrane Hydrolysis during Apoptosis by Human Isoforms of Secretory Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROUP-IIA; GROUP-X; GROUP-V; ARACHIDONIC-ACID; PHOSPHATIDYLCHOLINE VESICLES; INTERFACIAL BINDING; PHYSICAL-PROPERTIES; CORTICAL-NEURONS; GROUP-I; SUSCEPTIBILITY	Some isoforms of secretory phospholipase A(2) (sPLA(2)) distinguish between healthy and damaged or apoptotic cells. This distinction reflects differences in membrane physical properties. Because various sPLA(2) isoforms respond differently to properties of artificial membranes such as surface charge, they should also behave differently as these properties evolve during a dynamic physiological process such as apoptosis. To test this idea, S49 lymphoma cell death was induced by glucocorticoid (6-48 h) or calcium ionophore. Rates of membrane hydrolysis catalyzed by various concentrations of snake venom and human groups IIa, V, and X sPLA(2) were compared after each treatment condition. The data were analyzed using a model that evaluates the adsorption of enzyme to the membrane surface and subsequent binding of substrate to the active site. Results were compared temporally to changes in membrane biophysics and composition. Under control conditions, membrane hydrolysis was confined to the few unhealthy cells present in each sample. Increased hydrolysis during apoptosis and necrosis appeared to reflect substrate access to adsorbed enzyme for the snake venom and group X isoforms corresponding to weakened lipid-lipid interactions in the membrane. In contrast, apoptosis promoted initial adsorption of human groups V and IIa concurrent with phosphatidylserine exposure on the membrane surface. However, this observation was inadequate to explain the behavior of the groups V and IIa enzymes toward necrotic cells where hydrolysis was reduced or absent. Thus, a combination of changes in cell membrane properties during apoptosis and necrosis capacitates the cell for hydrolysis differently by each isoform.	[Olson, Erin D.; Nelson, Jennifer; Griffith, Katalyn; Nguyen, Thaothanh; Streeter, Michael; Judd, Allan M.; Bell, John D.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA; [Wilson-Ashworth, Heather A.] Utah Valley State Coll, Dept Biol, Orem, UT 84058 USA; [Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Brigham Young University; Utah System of Higher Education; Utah Valley University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bell, JD (corresponding author), Brigham Young Univ, Dept Physiol & Dev Biol, 302A MSRB, Provo, UT 84602 USA.	john_bell@byu.edu		gelb, michael/0000-0001-7000-5219	National Institutes of Health [GM073997]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM073997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073997.	Atsumi G, 1997, BBA-LIPID LIPID MET, V1349, P43, DOI 10.1016/S0005-2760(97)00082-9; Bailey RW, 2007, BIOPHYS J, V93, P2350, DOI 10.1529/biophysj.107.104679; Bailey RW, 2009, BIOPHYS J, V96, P2709, DOI 10.1016/j.bpj.2008.12.3925; Baker SF, 1998, BIOCHEMISTRY-US, V37, P13203, DOI 10.1021/bi981223t; Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1; Beers SA, 2003, BIOCHEMISTRY-US, V42, P7326, DOI 10.1021/bi0343222; Beers SA, 2002, J BIOL CHEM, V277, P1788, DOI 10.1074/jbc.M109777200; BELL JD, 1989, J BIOL CHEM, V264, P225; BELL JD, 1992, BIOCHIM BIOPHYS ACTA, V1127, P208, DOI 10.1016/0005-2760(92)90279-5; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Cho WW, 1999, METH MOL B, V109, P31; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Fadeel B, 2004, ANTIOXID REDOX SIGN, V6, P269, DOI 10.1089/152308604322899332; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Fujimoto K, 1999, FEBS LETT, V446, P113, DOI 10.1016/S0014-5793(99)00204-5; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; Gimenez AP, 2004, J IMMUNOL, V173, P521, DOI 10.4049/jimmunol.173.1.521; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Harris FM, 2001, J BIOL CHEM, V276, P22722, DOI 10.1074/jbc.M010879200; Henshaw JB, 1998, BIOCHEMISTRY-US, V37, P10709, DOI 10.1021/bi9728809; Huhtinen HT, 2006, APMIS, V114, P127, DOI 10.1111/j.1600-0463.2006.apm_330.x; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V980, P23, DOI 10.1016/0005-2736(89)90195-8; Jensen LB, 2005, BIOPHYS J, V88, P2692, DOI 10.1529/biophysj.104.056457; Jourdheuil D, 1996, CAN J PHYSIOL PHARM, V74, P706, DOI 10.1139/cjpp-74-6-706; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kinkaid AR, 1995, BIOCHEM SOC T, V23, pS556, DOI 10.1042/bst023556s; Koduri RS, 1998, J BIOL CHEM, V273, P32142, DOI 10.1074/jbc.273.48.32142; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Koprivnjak T, 2002, J BIOL CHEM, V277, P47636, DOI 10.1074/jbc.M205104200; Kottilil S, 2001, CELL IMMUNOL, V214, P1, DOI 10.1006/cimm.2001.1876; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; LYONS AB, 1992, CYTOMETRY, V13, P809; MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839; Markova M, 2005, ONCOGENE, V24, P6450, DOI 10.1038/sj.onc.1208791; Moulin M, 2007, APOPTOSIS, V12, P1703, DOI 10.1007/s10495-007-0096-2; MOWER DA, 1994, J IMMUNOL, V152, P4832; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; Nielson KH, 2000, BBA-MOL CELL BIOL L, V1484, P163, DOI 10.1016/S1388-1981(00)00004-4; Pan YH, 2002, J BIOL CHEM, V277, P29086, DOI 10.1074/jbc.M202531200; Piris-Gimenez A, 2005, J IMMUNOL, V175, P6786, DOI 10.4049/jimmunol.175.10.6786; Raghavendra PB, 2007, MOL IMMUNOL, V44, P2292, DOI 10.1016/j.molimm.2006.11.009; SALGO MG, 1993, ARCH BIOCHEM BIOPHYS, V304, P123, DOI 10.1006/abbi.1993.1330; SEVANIAN A, 1988, BIOCHIM BIOPHYS ACTA, V961, P316, DOI 10.1016/0005-2760(88)90079-3; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Smith SK, 2001, J BIOL CHEM, V276, P22732, DOI 10.1074/jbc.M010880200; Tyurin VA, 2008, METHOD ENZYMOL, V442, P375, DOI [10.1017/S0076-6879(08)01419-5, 10.1016/S0076-6879(08)01419-5]; Tyurin VA, 2009, J CHROMATOGR B, V877, P2863, DOI 10.1016/j.jchromb.2009.03.007; Tyurin VA, 2008, J NEUROCHEM, V107, P1614, DOI 10.1111/j.1471-4159.2008.05728.x; VITALE M, 1993, HISTOCHEMISTRY, V100, P223, DOI 10.1007/BF00269095; Wilson HA, 1997, BBA-LIPID LIPID MET, V1349, P142, DOI 10.1016/S0005-2760(97)00089-1; Wilson HA, 1999, J BIOL CHEM, V274, P11494, DOI 10.1074/jbc.274.17.11494	56	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10993	11002		10.1074/jbc.M109.070797	http://dx.doi.org/10.1074/jbc.M109.070797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139082	hybrid, Green Published			2022-12-25	WOS:000276264600083
J	Ratnakumar, S; Young, ET				Ratnakumar, Sooraj; Young, Elton T.			Snf1 Dependence of Peroxisomal Gene Expression Is Mediated by Adr1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS PIP2P; OLEATE-RESPONSIVE GENES; SACCHAROMYCES-CEREVISIAE; FATTY-ACID; BETA-OXIDATION; ADH2 EXPRESSION; IDENTIFY GENES; UP-REGULATION; OLEIC-ACID; PROTEIN	Eukaryotes utilize fatty acids by beta-oxidation, which occurs in the mitochondria and peroxisomes in higher organisms and in the peroxisomes in yeast. The AMP-activated protein kinase regulates this process in mammalian cells, and its homolog Snf1, together with the transcription factors Adr1, Oaf1, and Pip2, regulates peroxisome proliferation and beta-oxidation in yeast. A constitutive allele of Adr1 (Adr1(c)) lacking the glucose-and Snf1-regulated phosphorylation substrate Ser-230 was found to be Snf1-independent for regulation of peroxisomal genes. In addition, it could compensate for and even suppress the requirement for Oaf1 or Pip2 for gene induction. Peroxisomal genes were found to be regulated by oleate in the presence of glucose, as long as Adr1(c) was expressed, suggesting that the Oaf1/Pip2 heterodimer is Snf1-independent. Consistent with this observation, Oaf1 binding to promoters in the presence of oleate was not reduced in a snf1 Delta strain. Exploring the mechanism by which Adr1(c) permits Snf1-independent peroxisomal gene induction, we found that strength of promoter binding did not correlate with transcription, suggesting that stable binding is not a prerequisite for enhanced transcription. Instead, enhanced transcriptional activation and suppression of Oaf1, Pip2, and Snf1 by Adr1(c) may be related to the ability of Adr1(c) to suppress the requirement for and enhance the recruitment of transcriptional coactivators in a promoter- and growth medium-dependent manner.	[Ratnakumar, Sooraj; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, 1705 NE Pacific St, Seattle, WA 98195 USA.	ety@u.washington.edu			National Institutes of Health [GM26079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM26079 (to E. T. Y.).	Baumgartner U, 1999, J BIOL CHEM, V274, P22208, DOI 10.1074/jbc.274.32.22208; BEMIS LT, 1988, MOL CELL BIOL, V8, P2125, DOI 10.1128/MCB.8.5.2125; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; CIRIACY M, 1979, MOL GEN GENET, V176, P427, DOI 10.1007/BF00333107; COLLART M, 1993, CURRENT PROTOCOLS MO; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; DENIS CL, 1986, MOL CELL BIOL, V6, P4026, DOI 10.1128/MCB.6.11.4026; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DOMBEK KM, 1993, MOL CELL BIOL, V13, P4391, DOI 10.1128/MCB.13.7.4391; DONOVIEL MS, 1995, MOL CELL BIOL, V15, P3442; EINERHAND AWC, 1991, EUR J BIOCHEM, V200, P113, DOI 10.1111/j.1432-1033.1991.tb21056.x; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gurvitz A, 2001, J BIOL CHEM, V276, P31825, DOI 10.1074/jbc.M105989200; Gurvitz A, 1997, MOL MICROBIOL, V26, P675, DOI 10.1046/j.1365-2958.1997.5931969.x; Gurvitz A, 1999, MOL GEN GENET, V262, P481; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; Gurvitz Aner, 2000, Molecular Cell Biology Research Communications, V4, P81, DOI 10.1006/mcbr.2000.0261; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; ISHII H, 1980, BIOCHIM BIOPHYS ACTA, V617, P1, DOI 10.1016/0005-2760(80)90218-0; Kacherovsky N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003213; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Karpichev IV, 2008, J BIOL CHEM, V283, P10264, DOI 10.1074/jbc.M708215200; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Luo Y, 1996, J BIOL CHEM, V271, P12068, DOI 10.1074/jbc.271.20.12068; Naar AM, 2009, GENE DEV, V23, P419, DOI 10.1101/gad.1743009; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Ratnakumar S, 2009, GENETICS, V182, P735, DOI 10.1534/genetics.109.103432; REDDY JK, 1975, SCIENCE, V190, P787, DOI 10.1126/science.1198095; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Rottensteiner H, 1996, EMBO J, V15, P2924, DOI 10.1002/j.1460-2075.1996.tb00655.x; Rottensteiner H, 2003, J BIOL CHEM, V278, P27605, DOI 10.1074/jbc.M304097200; Rottensteiner H, 2003, EUR J BIOCHEM, V270, P2013, DOI 10.1046/j.1432-1033.2003.03575.x; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIMON M, 1991, MOL CELL BIOL, V11, P699, DOI 10.1128/MCB.11.2.699; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; TAYLOR WE, 1990, P NATL ACAD SCI USA, V87, P4098, DOI 10.1073/pnas.87.11.4098; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; Trzcinska-Danielewicz J, 2008, BIOCHEM BIOPH RES CO, V374, P763, DOI 10.1016/j.bbrc.2008.07.105; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; Walther K, 2001, MICROBIOL-SGM, V147, P2037, DOI 10.1099/00221287-147-8-2037; WANG TW, 1994, J BIOL CHEM, V269, P24480; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Young ET, 2002, J BIOL CHEM, V277, P38095, DOI 10.1074/jbc.M206158200	57	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10703	10714		10.1074/jbc.M109.079848	http://dx.doi.org/10.1074/jbc.M109.079848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139423	Green Published, hybrid			2022-12-25	WOS:000276264600057
J	Gandhi, M; Dillon, LW; Pramanik, S; Nikiforov, YE; Wang, YH				Gandhi, M.; Dillon, L. W.; Pramanik, S.; Nikiforov, Y. E.; Wang, Y-H			DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells	ONCOGENE			English	Article						fragile site; RET/PTC rearrangement; FRA10C/FRA10G; papillary thyroid carcinomas	HUMAN-CHROMOSOME 7; IN-VITRO; TRINUCLEOTIDE REPEATS; RET REARRANGEMENTS; LATE REPLICATION; COMMON; CARCINOMAS; INDUCTION; RADIATION; CANCER	Human chromosomal fragile sites are regions of the genome that are prone to DNA breakage, and are classified as common or rare, depending on their frequency in the population. Common fragile sites frequently coincide with the location of genes involved in carcinogenic chromosomal translocations, suggesting their role in cancer formation. However, there has been no direct evidence linking breakage at fragile sites to the formation of a cancer-specific translocation. Here, we studied the involvement of fragile sites in the formation of RET/PTC rearrangements, which are frequently found in papillary thyroid carcinoma (PTC). These rearrangements are commonly associated with radiation exposure; however, most of the tumors found in adults are not linked to radiation. In this study, we provide structural and biochemical evidence that the RET, CCDC6 and NCOA4 genes participating in two major types of RET/PTC rearrangements, are located in common fragile sites FRA10C and FRA10G, and undergo DNA breakage after exposure to fragile site-inducing chemicals. Moreover, exposure of human thyroid cells to these chemicals results in the formation of cancer-specific RET/PTC rearrangements. These results provide the direct evidence for the involvement of chromosomal fragile sites in the generation of cancer-specific rearrangements in human cells. Oncogene (2010) 29, 2272-2280; doi: 10.1038/onc.2009.502; published online 25 January 2010	[Dillon, L. W.; Pramanik, S.; Wang, Y-H] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Gandhi, M.; Nikiforov, Y. E.] Univ Pittsburgh, Dept Pathol & Lab Med, Pittsburgh, PA USA	Wake Forest University; Wake Forest Baptist Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, YH (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, 1 Med Ctr Blvd,2051 Hanes Bldg, Winston Salem, NC 27157 USA.	ywang@wfubmc.edu	Pramanik, Sreemanta/AAK-3772-2020; Pramanik, Sreemanta/E-2800-2013	Pramanik, Sreemanta/0000-0003-0448-2118; Pramanik, Sreemanta/0000-0003-0448-2118	National Cancer Institute [CA113863]; NATIONAL CANCER INSTITUTE [R01CA113863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM095440] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Cancer Institute (CA113863 to Y-H Wang and YE Nikiforov).	Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Boldog F, 1997, HUM MOL GENET, V6, P193, DOI 10.1093/hmg/6.2.193; Bongarzone I, 1997, GENOMICS, V42, P252, DOI 10.1006/geno.1997.4685; Burrow AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-59; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Casper AM, 2004, AM J HUM GENET, V75, P654, DOI 10.1086/422701; Caudill CM, 2005, J CLIN ENDOCR METAB, V90, P2364, DOI 10.1210/jc.2004-1811; Ciampi R, 2005, ENDOCR PATHOL, V16, P99, DOI 10.1385/EP:16:2:099; Coquelle A, 1998, MOL CELL, V2, P259, DOI 10.1016/S1097-2765(00)80137-9; Corbin S, 2002, CANCER RES, V62, P3477; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Fenton CL, 2000, J CLIN ENDOCR METAB, V85, P1170, DOI 10.1210/jc.85.3.1170; FUGAZZOLA L, 1995, CANCER RES, V55, P5617; GACY AM, 1995, CELL, V81, P533; Gasparini P, 2007, J CELL BIOCHEM, V102, P320, DOI 10.1002/jcb.21481; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; GLOVER TW, 1987, AM J HUM GENET, V41, P882; GLOVER TW, 1988, AM J HUM GENET, V43, P265; Handt O, 2000, CHROMOSOME RES, V8, P677, DOI 10.1023/A:1026737203447; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Hellman A, 2002, CANCER CELL, V1, P89, DOI 10.1016/S1535-6108(02)00017-X; Hewett DR, 1998, MOL CELL, V1, P773, DOI 10.1016/S1097-2765(00)80077-5; Klugbauer S, 2001, GENOMICS, V73, P149, DOI 10.1006/geno.2000.6434; Kong QZ, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e33; KUWANO A, 1987, HUM GENET, V75, P75; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; MITELMAN F, 2008, MITELMAN DATABASE CH; Motomura T, 1998, THYROID, V8, P485, DOI 10.1089/thy.1998.8.485; MURANO I, 1989, HUM GENET, V83, P45, DOI 10.1007/BF00274145; Musio A, 1997, ENVIRON MOL MUTAGEN, V29, P250, DOI 10.1002/(SICI)1098-2280(1997)29:3&lt;250::AID-EM4&gt;3.0.CO;2-G; Nikiforov YE, 1999, ONCOGENE, V18, P6330, DOI 10.1038/sj.onc.1203019; Nikiforov YE, 1997, CANCER RES, V57, P1690; Nikiforov YE, 2008, MODERN PATHOL, V21, pS37, DOI 10.1038/modpathol.2008.10; Nikiforova MN, 2008, EXPERT REV MOL DIAGN, V8, P83, DOI 10.1586/14737159.8.1.83; Palakodeti A, 2004, GENE CHROMOSOME CANC, V39, P71, DOI 10.1002/gcc.10290; Pelliccia F, 2008, CYTOGENET GENOME RES, V121, P196, DOI 10.1159/000138885; Popescu NC, 2003, CANCER LETT, V192, P1, DOI 10.1016/S0304-3835(02)00596-7; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Santoro M, 2006, EUR J ENDOCRINOL, V155, P645, DOI 10.1530/eje.1.02289; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; SMANIK PA, 1995, HUM MOL GENET, V4, P2313, DOI 10.1093/hmg/4.12.2313; SUTHERLAND GR, 1985, HUM GENET, V69, P233, DOI 10.1007/BF00293031; SUTHERLAND GR, 1991, GENET ANAL-BIOMOL E, V8, P161, DOI 10.1016/1050-3862(91)90056-W; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; Wang L, 1999, HUM MOL GENET, V8, P431, DOI 10.1093/hmg/8.3.431; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	51	64	66	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	15					2272	2280		10.1038/onc.2009.502	http://dx.doi.org/10.1038/onc.2009.502			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	583NT	20101222	Green Accepted			2022-12-25	WOS:000276685200012
J	Henn, MR; Sullivan, MB; Stange-Thomann, N; Osburne, MS; Berlin, AM; Kelly, L; Yandava, C; Kodira, C; Zeng, QD; Weiand, M; Sparrow, T; Saif, S; Giannoukos, G; Young, SK; Nusbaum, C; Birren, BW; Chisholm, SW				Henn, Matthew R.; Sullivan, Matthew B.; Stange-Thomann, Nicole; Osburne, Marcia S.; Berlin, Aaron M.; Kelly, Libusha; Yandava, Chandri; Kodira, Chinnappa; Zeng, Qiandong; Weiand, Michael; Sparrow, Todd; Saif, Sakina; Giannoukos, Georgia; Young, Sarah K.; Nusbaum, Chad; Birren, Bruce W.; Chisholm, Sallie W.			Analysis of High-Throughput Sequencing and Annotation Strategies for Phage Genomes	PLOS ONE			English	Article							MARINE SYNECHOCOCCUS STRAINS; PHOTOSYNTHESIS GENES; MICROBIAL GENOMES; PROTEIN FAMILIES; RNA GENES; VIRUSES; PROCHLOROCOCCUS; IDENTIFICATION; BACTERIOPHAGE; DATABASE	Background: Bacterial viruses (phages) play a critical role in shaping microbial populations as they influence both host mortality and horizontal gene transfer. As such, they have a significant impact on local and global ecosystem function and human health. Despite their importance, little is known about the genomic diversity harbored in phages, as methods to capture complete phage genomes have been hampered by the lack of knowledge about the target genomes, and difficulties in generating sufficient quantities of genomic DNA for sequencing. Of the approximately 550 phage genomes currently available in the public domain, fewer than 5% are marine phage. Methodology/Principal Findings: To advance the study of phage biology through comparative genomic approaches we used marine cyanophage as a model system. We compared DNA preparation methodologies (DNA extraction directly from either phage lysates or CsCl purified phage particles), and sequencing strategies that utilize either Sanger sequencing of a linker amplification shotgun library (LASL) or of a whole genome shotgun library (WGSL), or 454 pyrosequencing methods. We demonstrate that genomic DNA sample preparation directly from a phage lysate, combined with 454 pyrosequencing, is best suited for phage genome sequencing at scale, as this method is capable of capturing complete continuous genomes with high accuracy. In addition, we describe an automated annotation informatics pipeline that delivers high-quality annotation and yields few false positives and negatives in ORF calling. Conclusions/Significance: These DNA preparation, sequencing and annotation strategies enable a high-throughput approach to the burgeoning field of phage genomics.	[Henn, Matthew R.; Stange-Thomann, Nicole; Berlin, Aaron M.; Yandava, Chandri; Kodira, Chinnappa; Zeng, Qiandong; Weiand, Michael; Sparrow, Todd; Saif, Sakina; Giannoukos, Georgia; Young, Sarah K.; Nusbaum, Chad; Birren, Bruce W.] MIT & Harvard, Broad Inst, Cambridge, MA 02139 USA; [Sullivan, Matthew B.; Osburne, Marcia S.; Kelly, Libusha; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Henn, MR (corresponding author), MIT & Harvard, Broad Inst, Cambridge, MA 02139 USA.	mhenn@broadinstitute.org	Berlin, Aaron M/AFY-6549-2022; Zeng, Qiandong/AAF-3305-2019; Sullivan, Matthew B/H-3256-2011	Berlin, Aaron M/0000-0002-0714-2808; Sullivan, Matthew B/0000-0003-4040-9831; Chisholm, Sallie/0000-0003-1480-2445	Gordon and Betty Moore Foundation; NSF; DOE	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	This project is funded in large part by the Gordon and Betty Moore Foundation (through grants to MRH and to SWC), and in part by grants to SWC from NSF and DOE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Heineman RH, 2009, MOL BIOL EVOL, V26, P1289, DOI 10.1093/molbev/msp037; Ireland DC, 1998, CLIN EXP IMMUNOL, V112, P255; Krause L, 2007, NUCLEIC ACIDS RES, V35, P540, DOI 10.1093/nar/gkl1083; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Millard AD, 2009, ENVIRON MICROBIOL, V11, P2370, DOI 10.1111/j.1462-2920.2009.01966.x; Mills SD, 2004, ANTIMICROB AGENTS CH, V48, P2524, DOI 10.1128/AAC.48.7.2524-2530.2004; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Oakey HJ, 2002, J APPL MICROBIOL, V93, P1089, DOI 10.1046/j.1365-2672.2002.01776.x; Paul JH, 2005, CURR OPIN BIOTECH, V16, P299, DOI 10.1016/j.copbio.2005.03.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Rohwer F, 2001, BIOTECHNIQUES, V31, P108, DOI 10.2144/01311rr02; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Wang YL, 2000, CELL MOL NEUROBIOL, V20, P509, DOI 10.1023/A:1007027232412; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; 2002, NUCL ACIDS RES, V30, P2478; 2002, J BACTERIOL, V184, P6592	54	63	66	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9083	10.1371/journal.pone.0009083	http://dx.doi.org/10.1371/journal.pone.0009083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140207	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442400019
J	Ray, TS				Ray, Thomas S.			Psychedelics and the Human Receptorome	PLOS ONE			English	Article							PHARMACOLOGICAL CHARACTERIZATION; SEROTONIN RECEPTORS; IN-VITRO; CLASSICAL HALLUCINOGENS; CANNABINOID RECEPTOR; BINDING-SITES; AGONIST; AGENTS; MECHANISM; CLASSIFICATION	We currently understand the mental effects of psychedelics to be caused by agonism or partial agonism of 5-HT(2A) (and possibly 5-HT(2C)) receptors, and we understand that psychedelic drugs, especially phenylalkylamines, are fairly selective for these two receptors. This manuscript is a reference work on the receptor affinity pharmacology of psychedelic drugs. New data is presented on the affinity of twenty-five psychedelic drugs at fifty-one receptors, transporters, and ion channels, assayed by the National Institute of Mental Health-Psychoactive Drug Screening Program (NIMH-PDSP). In addition, comparable data gathered from the literature on ten additional drugs is also presented (mostly assayed by the NIMH-PDSP). A new method is introduced for normalizing affinity (K(i)) data that factors out potency so that the multi-receptor affinity profiles of different drugs can be directly compared and contrasted. The method is then used to compare the thirty-five drugs in graphical and tabular form. It is shown that psychedelic drugs, especially phenylalkylamines, are not as selective as generally believed, interacting with forty-two of forty-nine broadly assayed sites. The thirty-five drugs of the study have very diverse patterns of interaction with different classes of receptors, emphasizing eighteen different receptors. This diversity of receptor interaction may underlie the qualitative diversity of these drugs. It should be possible to use this diverse set of drugs as probes into the roles played by the various receptor systems in the human mind.	Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Ray, TS (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	tray@ou.edu			NIMH-PDSP; National Institute on Drug Abuse Drug Supply Program	NIMH-PDSP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse Drug Supply Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work resulted from a large set of receptor affinity assays performed by the NIMH-PDSP (http://pdsp.med.unc.edu/). Although the project was specifically approved for the author by the NIMH and the NIMH-PDSP, it did not result in a grant in the sense of funds that flow through the author's institution. The funding went directly to the NIMH-PDSP which was at Case Western Reserve University at the time. Also, the National Institute on Drug Abuse Drug Supply Program (http://www.nida.nih.gov/) provided many of the drugs, but they also went directly to the NIMH-PDSP at Case Western. There was no other funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This statement is true except that the NIMH-PDSP actually produced the affinity data for twenty-five drugs, and provided it exclusively to the author.	Blair JB, 2000, J MED CHEM, V43, P4701, DOI 10.1021/jm000339w; CASTANAS E, 1985, J NEUROCHEM, V45, P677, DOI 10.1111/j.1471-4159.1985.tb04046.x; CLARK JA, 1988, MOL PHARMACOL, V34, P308; DARMANI NA, 1992, PHARMACOL BIOCHEM BE, V43, P765, DOI 10.1016/0091-3057(92)90406-6; DARMANI NA, 1994, PHARMACOL BIOCHEM BE, V48, P383, DOI 10.1016/0091-3057(94)90542-8; DE VJ, 2004, J PHARMACOL EXP THER, V310, P620; Gharagozlou Parham, 2003, BMC Pharmacol, V3, P1, DOI 10.1186/1471-2210-3-1; GLENNON RA, 1986, PSYCHOPHARMACOL BULL, V22, P953; Glennon RA, 2000, J MED CHEM, V43, P1011, DOI 10.1021/jm990550b; GLENNON RA, 1991, PHARMACOL BIOCHEM BE, V40, P1009, DOI 10.1016/0091-3057(91)90121-H; GLENNON RA, 1983, EUR J PHARMACOL, V91, P189, DOI 10.1016/0014-2999(83)90464-8; GLENNON RA, 1990, NEUROPSYCHOPHARMACOL, V3, P509; GLENNON RA, 1984, LIFE SCI, V35, P2505, DOI 10.1016/0024-3205(84)90436-3; GLENNON RA, 1991, LIFE SCI, V48, P2493, DOI 10.1016/0024-3205(91)90603-9; GLENNON RA, 1996, HANDB EXP PHARM, V118, P343; Griffin G, 2000, J PHARMACOL EXP THER, V292, P886; Iwamura H, 2001, J PHARMACOL EXP THER, V296, P420; LARGENT BL, 1984, P NATL ACAD SCI-BIOL, V81, P4983, DOI 10.1073/pnas.81.15.4983; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Nichols DE, 2002, J MED CHEM, V45, P4344, DOI 10.1021/jm020153s; NICHOLS DE, 1986, J PSYCHOACTIVE DRUGS, V18, P305, DOI 10.1080/02791072.1986.10472362; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Schiller PW, 2000, EUR J MED CHEM, V35, P895, DOI 10.1016/S0223-5234(00)01171-5; Spetea M, 2003, EUR J NEUROSCI, V18, P290, DOI 10.1046/j.1460-9568.2003.02744.x; STANDIFER KM, 1994, J PHARMACOL EXP THER, V270, P1246; Valenzano KJ, 2004, J PHARMACOL EXP THER, V310, P783, DOI 10.1124/jpet.103.063313; WOLOZIN BL, 1981, P NATL ACAD SCI-BIOL, V78, P6181, DOI 10.1073/pnas.78.10.6181; Zhao GM, 2003, J PHARMACOL EXP THER, V307, P947, DOI 10.1124/jpet.103.054775	31	132	137	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9019	10.1371/journal.pone.0009019	http://dx.doi.org/10.1371/journal.pone.0009019			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126400	Green Submitted, gold, Green Published			2022-12-25	WOS:000274207200014
J	Rohlfing, AK; Miteva, Y; Hannenhalli, S; Lamitina, T				Rohlfing, Anne-Katrin; Miteva, Yana; Hannenhalli, Sridhar; Lamitina, Todd			Genetic and Physiological Activation of Osmosensitive Gene Expression Mimics Transcriptional Signatures of Pathogen Infection in C. elegans	PLOS ONE			English	Article							PORE-FORMING TOXINS; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; INNATE IMMUNITY; OSMOTIC-STRESS; BACTERIAL PATHOGENESIS; FUNGAL PATHOGENS; FACTOR SKN-1; GATA-FACTOR; PROTEIN	The soil-dwelling nematode C. elegans is a powerful system for comparative molecular analyses of environmental stress response mechanisms. Infection of worms with bacterial and fungal pathogens causes the activation of well-characterized innate immune transcriptional programs in pathogen-exposed hypodermal and intestinal tissues. However, the pathophysiological events that drive such transcriptional responses are not understood. Here, we show that infection-activated transcriptional responses are, in large part, recapitulated by either physiological or genetic activation of the osmotic stress response. Microarray profiling of wild type worms exposed to non-lethal hypertonicity identified a suite of genes that were also regulated by infection. Expression profiles of five different osmotic stress resistant (osr) mutants under isotonic conditions reiterated the wild type transcriptional response to osmotic stress and also showed substantial similarity to infection-induced gene expression under isotonic conditions. Computational, transgenic, and functional approaches revealed that two GATA transcription factors previously implicated in infection-induced transcriptional responses, elt-2 and elt-3, are also essential for coordinated tissue-specific activation of osmosensitive gene expression and promote survival under osmotically stressful conditions. Together, our data suggest infection and osmotic adaptation share previously unappreciated transcriptional similarities which might be controlled via regulation of tissue-specific GATA transcription factors.	[Rohlfing, Anne-Katrin; Miteva, Yana; Lamitina, Todd] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Hannenhalli, Sridhar] Univ Penn, Dept Genet, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Rohlfing, AK (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	lamitina@mail.med.upenn.edu			University of Pennsylvania Center of Excellence in Environmental Toxicology [1R01AA017580, R01GM085226, P30 ES013508]; National Institutes of Health (NIH); National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017580] Funding Source: NIH RePORTER	University of Pennsylvania Center of Excellence in Environmental Toxicology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	1R01AA017580 to T. L. R01GM085226 to S. H. P30 ES013508 to the University of Pennsylvania Center of Excellence in Environmental Toxicology (T. L. member). Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Komatsu T, 2008, CATAL SURV ASIA, V12, P6, DOI 10.1007/s10563-007-9031-3; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Petersen UM, 1999, EMBO J, V18, P4013, DOI 10.1093/emboj/18.14.4013; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Romney SJ, 2008, J BIOL CHEM, V283, P716, DOI 10.1074/jbc.M707043200; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Stergiopoulos K, 2009, PHYSIOL GENOMICS, V37, P1, DOI 10.1152/physiolgenomics.90360.2008; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639	51	53	63	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9010	10.1371/journal.pone.0009010	http://dx.doi.org/10.1371/journal.pone.0009010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126308	Green Published, gold, Green Submitted			2022-12-25	WOS:000274207200009
J	Orbach, DN; Veselka, N; Dzal, Y; Lazure, L; Fenton, MB				Orbach, Dara N.; Veselka, Nina; Dzal, Yvonne; Lazure, Louis; Fenton, M. Brock			Drinking and Flying: Does Alcohol Consumption Affect the Flight and Echolocation Performance of Phyllostomid Bats?	PLOS ONE			English	Article							FRUIT-EATING BATS; CAROLLIA-PERSPICILLATA; FORAGING BEHAVIOR; ETHANOL; FOOD; OLFACTION; DIET; CUES; APPETITE; ECOLOGY	levels of ethanol that could induce inebriation. To understand if consumption of ethanol by bats alters their access to food and general survival requires examination of behavioural responses to its ingestion, as well as assessment of interspecific variation in those responses. We predicted that bats fed ethanol would show impaired flight and echolocation behaviour compared to bats fed control sugar water, and that there would be behavioural differences among species. Methodology/Principal Findings: We fed wild caught Artibeus jamaicensis, A. lituratus, A. phaeotis, Carollia sowelli, Glossophaga soricina, and Sturnira lilium (Chiroptera, Phyllostomidae) sugar water (44 g of table sugar in 500 ml of water) or sugar water with ethanol before challenging them to fly through an obstacle course while we simultaneously recorded their echolocation calls. We used bat saliva, a non-invasive proxy, to measure blood ethanol concentrations ranging from 0 to .0.3% immediately before flight trials. Flight performance and echolocation behaviour were not significantly affected by consumption of ethanol, but species differed in their blood alcohol concentrations after consuming it. Conclusions/Significance: The bats we studied display a tolerance for ethanol that could have ramifications for the adaptive radiation of frugivorous and nectarivorous bats by allowing them to use ephemeral food resources over a wide span of time. By sampling across phyllostomid genera, we show that patterns of apparent ethanol tolerance in New World bats are broad, and thus may have been an important early step in the evolution of frugivory and nectarivory in these animals.	[Orbach, Dara N.; Veselka, Nina; Lazure, Louis; Fenton, M. Brock] Univ Western Ontario, Dept Biol, London, ON, Canada; [Dzal, Yvonne] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada	Western University (University of Western Ontario); University of Regina	Orbach, DN (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	bfenton@uwo.ca	Dzal, Yvonne/AAA-3220-2022	Dzal, Yvonne/0000-0002-4391-0712	University of Western Ontario; Kenneth M Molson Foundation; Natural Sciences and Engineering Research Council of Canada [R3516A03]	University of Western Ontario; Kenneth M Molson Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This project was supported by a grant from the University of Western Ontario (Graduate Thesis Research Award) to DN Orbach, and grants from the Kenneth M Molson Foundation and the Natural Sciences and Engineering Research Council of Canada (Discovery Grant R3516A03) to MB Fenton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2005, ALCOHOL, V36, P187, DOI 10.1016/j.alcohol.2005.09.001; Acharya KK, 1998, BEHAV PROCESS, V44, P59, DOI 10.1016/S0376-6357(98)00028-X; ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Banack SA, 1998, ECOLOGY, V79, P1949, DOI 10.1890/0012-9658(1998)079[1949:DSARUB]2.0.CO;2; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; BATTCOCK M, 1998, FAO AGR SERVICE B, V134; BONACCORSO FJ, 1987, J ANIM ECOL, V56, P907, DOI 10.2307/4956; BOSRON WF, 1984, ALCOHOL CLIN EXP RES, V8, P196, DOI 10.1111/j.1530-0277.1984.tb05837.x; Caton SJ, 2004, PHYSIOL BEHAV, V81, P51, DOI 10.1016/j.physbeh.2003.12.017; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; Crabbe JC, 2002, ANNU REV PSYCHOL, V53, P435, DOI 10.1146/annurev.psych.53.100901.135142; DEBUSSCHE M, 1987, OIKOS, V49, P244, DOI 10.2307/3565758; DENNIS J. V., 1987, BIRDERS WORLD, V1, P15; DiBattista D, 1998, ALCOHOL, V15, P55, DOI 10.1016/S0741-8329(97)00098-0; Dominy NJ, 2004, INTEGR COMP BIOL, V44, P295, DOI 10.1093/icb/44.4.295; Dubowski KM, 2002, FORENSIC SCI MED, P77; DUBOWSKI KM, 1975, Z RECHTSMED, V76, P93; Dudley R, 2004, INTEGR COMP BIOL, V44, P315, DOI 10.1093/icb/44.4.315; Dudley R, 2002, ADDICTION, V97, P381, DOI 10.1046/j.1360-0443.2002.00002.x; Dudley R, 2000, Q REV BIOL, V75, P3, DOI 10.1086/393255; Dumont ER, 2003, BAT ECOLOGY, P398; Fenton MB, 1999, ACTA CHIROPTEROL, V1, P127; Fenton MB, 2001, J TROP ECOL, V17, P511, DOI 10.1017/S0266467401001389; FITZGERALD SD, 1990, AVIAN DIS, V34, P488, DOI 10.2307/1591442; FUNAKOSHI K, 1993, J ZOOL, V230, P221, DOI 10.1111/j.1469-7998.1993.tb02684.x; GARRIOT JC, 2003, MED LEGAL ASPECTS AL; da Silva AG, 2008, J MAMMAL, V89, P43, DOI 10.1644/06-MAMM-A-300.1; Herrera LG, 2002, OECOLOGIA, V133, P280, DOI 10.1007/s00442-002-1036-z; Hetherington MM, 2001, PHYSIOL BEHAV, V74, P283, DOI 10.1016/S0031-9384(01)00598-4; HOFFMANN AA, 1984, BIOL J LINN SOC, V22, P43, DOI 10.1111/j.1095-8312.1984.tb00798.x; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Jones G, 1999, J EXP BIOL, V202, P3359; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kalko EKV, 1998, FUNCT ECOL, V12, P364, DOI 10.1046/j.1365-2435.1998.00198.x; Korine C, 2005, BEHAV ECOL SOCIOBIOL, V59, P12, DOI 10.1007/s00265-005-0003-1; Korine C, 1999, BIOL CONSERV, V88, P301, DOI 10.1016/S0006-3207(98)00126-8; KRULL KR, 1993, ALCOHOL CLIN EXP RES, V17, P771, DOI 10.1111/j.1530-0277.1993.tb00839.x; LASKA M, 1990, J COMP PHYSIOL A, V166, P395; Luft S, 2003, NATURWISSENSCHAFTEN, V90, P84, DOI 10.1007/s00114-002-0393-0; Lutz Fritz-Ulrich, 1993, Blutalkohol, V30, P240; Mazeh S, 2008, BEHAV PROCESS, V77, P369, DOI 10.1016/j.beproc.2007.10.003; Middaugh LD, 1999, ALCOHOL, V17, P175, DOI 10.1016/S0741-8329(98)00055-X; Morris S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P363, DOI 10.1086/499983; Nelson Suzanne L., 2000, Pacific Science, V54, P301; NEWLAND MC, 1992, J STUD ALCOHOL, V53, P80, DOI 10.15288/jsa.1992.53.80; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; ORBACH DO, 2008, 38 ANN N AM S BAT RE; Prinzinger R, 1996, J ORNITHOL, V137, P319, DOI 10.1007/BF01651072; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; REID FA, 1998, FIELD GUIDE MAMMALS, P71; RIEGER JF, 1988, BIOTROPICA, V20, P161, DOI 10.2307/2388189; Sanchez F, 2004, INTEGR COMP BIOL, V44, P290, DOI 10.1093/icb/44.4.290; Sanchez F, 2008, J EXP BIOL, V211, P1475, DOI 10.1242/jeb.013268; Sanchez F, 2008, NATURWISSENSCHAFTEN, V95, P561, DOI 10.1007/s00114-008-0359-y; Sanchez F, 2006, J CHEM ECOL, V32, P1289, DOI 10.1007/s10886-006-9085-0; SCHWARTZ RH, 1989, ANN EMERG MED, V18, P1001, DOI 10.1016/S0196-0644(89)80470-6; SEDMAN AJ, 1976, J STUD ALCOHOL, V37, P1197, DOI 10.15288/jsa.1976.37.1197; Siegel R. K., 1989, INTOXICATION LIFE PU; Smolle KH, 1999, INTENS CARE MED, V25, P492, DOI 10.1007/s001340050886; Stephen L. J., 2000, Blue Jay, V58, P33; SUTTON D, 1970, PHYSIOL BEHAV, V5, P889, DOI 10.1016/0031-9384(70)90177-0; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; WEINS F, 2008, P NATL ACAD SCI USA, V105, P10426; WILSON DE, 1973, SYST ZOOL, V22, P14, DOI 10.2307/2412374; Yeomans MR, 2004, BRIT J NUTR, V92, pS31, DOI 10.1079/BJN20041139	66	11	11	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8993	10.1371/journal.pone.0008993	http://dx.doi.org/10.1371/journal.pone.0008993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126552	gold, Green Published			2022-12-25	WOS:000274209700019
J	Lermen, D; Gorjup, E; Dyce, PW; von Briesen, H; Muller, P				Lermen, Dominik; Gorjup, Erwin; Dyce, Paul W.; von Briesen, Hagen; Mueller, Paul			Neuro-Muscular Differentiation of Adult Porcine Skin Derived Stem Cell-Like Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; SIDE POPULATION CELLS; PROGENITOR CELLS; SELF-RENEWAL; IN-VITRO; NESTIN EXPRESSION; STROMAL CELLS; GENE-EXPRESSION; PRECURSOR CELLS; GROWTH-FACTOR	Background: Due to the genetic relationship to humans, porcine stem cells are a very important model system to investigate cell differentiation, associated cell signaling pathways, and cell fate. Porcine skin derived stem cells have been isolated from mid-gestation porcine fetus recently. To our knowledge, stem cells from the skin of the adult porcine organism have not been isolated until now. Hence, to our knowledge, we here describe the isolation, expansion, characterization and differentiation of multipotent porcine skin derived stem cell-like cells (pSSCs) from the adult porcine organism for the first time. Methodology/Principal Findings: pSSCs had a spindle shaped morphology similar to mesenchymal stem cells (MSCs). They could be maintained proliferatively active in vitro for more than 120 days and were able to form colonies from single cells. pSSCs expressed Sox2 and Oct3/4, both transcription factors essential to the pluripotent and self-renewing phenotypes of embryonic stem cells, which recently gained attention due to their function in inducing pluripotent stem cells. Furthermore, the expression of the progenitor marker nestin, the somatic stem cell markers Bcrp1/ABCG2, Bmi1, and Stat3 was detected by reverse transcriptase-polymerase chain reaction (RT-PCR) in undifferentiated pSSCs. Flow cytometry revealed the expression of the MSC related proteins CD9, CD29, CD44 and CD105, but not CD90. After neuronal differentiation cells with a characteristic morphology of neuronal and smooth muscle-like cells were present in the cultures. Subsequent immunochemistry and flow cytometry revealed the down-regulation of nestin and the up-regulation of the neuron specific protein beta-III-tubulin and the astrocyte marker GFAP. Also, alpha-SMA expressing cells increased during differentiation suggesting the neuro-muscular differentiation of these skin derived cells. pSSCs could also be induced to differentiate into adipocyte-like cells when cultured under specific conditions. Conclusions/Significance: Adult porcine skin harbors a population of stem cell-like cells (pSSCs) that can be isolated via enzymatic digestion. These pSSCs show characteristic features of MSCs originated in other tissues and express the embryonic stem cell marker Oct3/4, Sox2, and Stat3. Furthermore, pSSCs have the potential to differentiate into cells from two different germ lines, the ectoderm (neurons, astrocytes) and the mesoderm (smooth muscle cells, adipocytes).	[Lermen, Dominik; Mueller, Paul] Univ Trier, Dept Biogeog, Trier, Germany; [Gorjup, Erwin; von Briesen, Hagen] Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, St Ingbert, Germany; [Dyce, Paul W.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada	Universitat Trier; Fraunhofer Gesellschaft; University of Guelph	Lermen, D (corresponding author), Univ Trier, Dept Biogeog, Trier, Germany.	lermen@uni-trier.de		Dyce, Paul/0000-0002-4574-3321	DFG; German Research Foundation	DFG(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	Funding: This work was supported by the DFG, the German Research Foundation (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2005, EXP CELL RES, V310, P383, DOI 10.1016/j.yexcr.2005.08.015; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Danner S, 2007, MOL HUM REPROD, V13, P11, DOI 10.1093/molehr/gal096; DICK IP, 1992, J PHARM PHARMACOL, V44, P640, DOI 10.1111/j.2042-7158.1992.tb05485.x; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Dunnwald M, 2001, EXP DERMATOL, V10, P45, DOI 10.1034/j.1600-0625.2001.100106.x; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Go MJ, 2008, EXP CELL RES, V314, P1147, DOI 10.1016/j.yexcr.2007.11.021; Gorjup E, 2009, EUR J CELL BIOL, V88, P409, DOI 10.1016/j.ejcb.2009.02.187; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Holt WV, 2004, REPRODUCTION, V127, P317, DOI 10.1530/rep.1.00074; Hoogduijn MJ, 2006, STEM CELLS DEV, V15, P49, DOI 10.1089/scd.2006.15.49; Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobi U, 2007, SKIN RES TECHNOL, V13, P19, DOI 10.1111/j.1600-0846.2006.00179.x; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kajahn J, 2008, EUR J CELL BIOL, V87, P39, DOI 10.1016/j.ejcb.2007.07.004; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim M, 2002, CLIN CANCER RES, V8, P22; Kim MK, 2007, CLONING STEM CELLS, V9, P130, DOI 10.1089/clo.2006.0034; Kruse C, 2004, APPL PHYS A-MATER, V79, P1617, DOI 10.1007/s00339-004-2816-6; Kruse C, 2006, EXP DERMATOL, V15, P794, DOI 10.1111/j.1600-0625.2006.00471.x; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leon-Quinto T, 2009, ANIM REPROD SCI, V112, P347, DOI 10.1016/j.anireprosci.2008.05.070; Lermen D, 2009, MOL ECOL, V18, P1030, DOI 10.1111/j.1365-294X.2008.04062.x; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liang LC, 2002, STEM CELLS, V20, P21, DOI 10.1634/stemcells.20-1-21; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; LOO DT, 1994, NEUROREPORT, V5, P1585, DOI 10.1097/00001756-199408150-00011; MALCOLM RA, 2003, J PATHOL, V200, P547; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MISKO TP, 1987, J EXP BIOL, V132, P177; Moreels M, 2008, NEUROPATH APPL NEURO, V34, P532, DOI 10.1111/j.1365-2990.2007.00910.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramsay TG, 1998, J ANIM SCI, V76, P484; REYNOLDS AJ, 1991, J CELL SCI, V99, P373; Ringe J, 2002, CELL TISSUE RES, V307, P321, DOI 10.1007/s00441-002-0525-z; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schwartz PH, 2005, STEM CELLS, V23, P1286, DOI 10.1634/stemcells.2004-0306; Shi CM, 2004, MED HYPOTHESES, V62, P683, DOI 10.1016/j.mehy.2003.12.022; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125; Shim H, 1997, BIOL REPROD, V57, P1089, DOI 10.1095/biolreprod57.5.1089; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; STROJEK RM, 1990, THERIOGENOLOGY, V33, P901, DOI 10.1016/0093-691X(90)90825-E; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Xiang Ying, 2007, Journal of Zhejiang University-Science B, V8, P136, DOI 10.1631/jzus.2007.B0136; Zeng LP, 2006, STEM CELLS, V24, P2355, DOI 10.1634/stemcells.2005-0551; Zhao MT, 2009, CLONING STEM CELLS, V11, P111, DOI 10.1089/clo.2008.0071; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	92	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8968	10.1371/journal.pone.0008968	http://dx.doi.org/10.1371/journal.pone.0008968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126464	Green Published, gold, Green Submitted			2022-12-25	WOS:000274139100016
J	Rico, A; Bennett, MH; Forcat, S; Huang, WE; Preston, GM				Rico, Arantza; Bennett, Mark H.; Forcat, Silvia; Huang, Wei E.; Preston, Gail M.			Agroinfiltration Reduces ABA Levels and Suppresses Pseudomonas syringae-Elicited Salicylic Acid Production in Nicotiana tabacum	PLOS ONE			English	Article							PV. TOMATO DC3000; SYSTEMIC ACQUIRED-RESISTANCE; HYPERSENSITIVE CELL-DEATH; ACINETOBACTER SP ADP1; AGROBACTERIUM-TUMEFACIENS; INNATE IMMUNITY; DISEASE RESISTANCE; GENE-EXPRESSION; TOBACCO-LEAVES; CROWN-GALL	Background: Agrobacterium tumefaciens strain GV3101 (pMP90) is widely used in transient gene expression assays, including assays to study pathogen effectors and plant disease resistance mechanisms. However, inoculation of A. tumefaciens GV3101 into Nicotiana tabacum (tobacco) leaves prior to infiltration with pathogenic and non-host strains of Pseudomonas syringae results in suppression of macroscopic symptoms when compared with leaves pre-treated with a buffer control. Methodology/Findings: To gain further insight into the mechanistic basis of symptom suppression by A. tumefaciens we examined the effect of pre-treatment with A. tumefaciens on the growth of P. syringae, the production of the plant signalling molecules salicylic acid (SA) and abscisic acid (ABA), and the presence of callose deposits. Pre-treatment with A. tumefaciens reduced ABA levels, P. syringae multiplication and P. syringae-elicited SA and ABA production, but promoted increased callose deposition. However, pre-treatment with A. tumefaciens did not suppress necrosis or SA production in leaves inoculated with the elicitor HrpZ. Conclusions/Significance: Collectively, these results show that inoculation of N. tabacum leaves with A. tumefaciens alters plant hormone levels and plant defence responses to P. syringae, and demonstrate that researchers should consider the impact of A. tumefaciens on plant signal transduction when using A. tumefaciens-mediated transient expression assays to investigate ABA-regulated processes or pathogenicity and plant defence mechanisms.	[Rico, Arantza; Preston, Gail M.] Univ Oxford, Dept Plant Sci, Oxford, England; [Bennett, Mark H.; Forcat, Silvia] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England; [Huang, Wei E.] Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England	University of Oxford; Imperial College London; University of Sheffield	Rico, A (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	gail.preston@plants.ox.ac.uk	Huang, Wei/N-6880-2019; Rico, Arantza/Z-2414-2019	Huang, Wei/0000-0003-1302-6528; Rico, Arantza/0000-0002-4008-5569; Preston, Gail/0000-0003-3882-4438	Basque Government (Beca para la Formacion de Investigadores_DK); Biotechnology and Biological Sciences Research Council [BB/E007872/1]; Royal Society University; BBSRC [BB/E007872/1] Funding Source: UKRI	Basque Government (Beca para la Formacion de Investigadores_DK)(Basque Government); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: A. Rico was supported by a fellowship from the Basque Government (Beca para la Formacion de Investigadores_DK) and by Biotechnology and Biological Sciences Research Council Grant BB/E007872/1. G. M. Preston is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 2000, PLANT MOL BIOL, V44, P429, DOI 10.1023/A:1026561029533; Asselbergh B, 2008, MOL PLANT PATHOL, V9, P11, DOI [10.1111/J.1364-3703.2007.00437.X, 10.1111/j.1364-3703.2007.00437.x]; Bozso Z, 2005, J PHYTOPATHOL, V153, P596, DOI 10.1111/j.1439-0434.2005.01026.x; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; De Vleesschauwer D, 2008, PLANT PHYSIOL, V148, P1996, DOI 10.1104/pp.108.127878; DETORRESZABALA M, 2009, PLANT J, V59, P375, DOI DOI 10.1111/J.1365-313X.2009.03875.X; Ditt RF, 2001, P NATL ACAD SCI USA, V98, P10954, DOI 10.1073/pnas.191383498; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Forcat S, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-16; GARFINKEL DJ, 1981, CELL, V27, P143, DOI 10.1016/0092-8674(81)90368-8; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Huang J, 2003, PLANTA, V217, P767, DOI 10.1007/s00425-003-1039-y; Huang WE, 2005, ENVIRON MICROBIOL, V7, P1339, DOI 10.1111/j.1462-5822.2005.00821.x; Huang WE, 2006, PLANT J, V46, P1073, DOI 10.1111/j.1365-313X.2006.02758.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Klement Z, 2003, PEST MANAG SCI, V59, P465, DOI 10.1002/ps.694; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Laurie-Berry N, 2006, MOL PLANT MICROBE IN, V19, P789, DOI 10.1094/MPMI-19-0789; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Lopez MA, 2008, CURR OPIN PLANT BIOL, V11, P420, DOI 10.1016/j.pbi.2008.05.002; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Oh HS, 2005, PLANT J, V44, P348, DOI 10.1111/j.1365-313X.2005.02529.x; Peng JL, 2003, PHYSIOL MOL PLANT P, V62, P317, DOI 10.1016/S0885-5765(03)00078-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pruss GJ, 2008, MOL PLANT MICROBE IN, V21, P1528, DOI 10.1094/MPMI-21-12-1528; RICO A, 2008, PSEUDOMONAS SYRINGAE, P97; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; ROBINETTE D, 1990, J BACTERIOL, V172, P5742, DOI 10.1128/jb.172.10.5742-5749.1990; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sambrook J, 2001, MOL CLONING LAB MANU; Samuel MA, 2005, PLANT J, V42, P406, DOI 10.1111/j.1365-313X.2005.02382.x; Sawers RJH, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-15; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; STACHEL SE, 1986, EMBO J, V5, P1445, DOI 10.1002/j.1460-2075.1986.tb04381.x; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; Vaquero C, 1999, P NATL ACAD SCI USA, V96, P11128, DOI 10.1073/pnas.96.20.11128; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; WATSON B, 1975, J BACTERIOL, V123, P255, DOI 10.1128/JB.123.1.255-264.1975; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	64	32	33	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8977	10.1371/journal.pone.0008977	http://dx.doi.org/10.1371/journal.pone.0008977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126459	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000274139100023
J	Craft, JA; Gilbert, JA; Temperton, B; Dempsey, KE; Ashelford, K; Tiwari, B; Hutchinson, TH; Chipman, JK				Craft, John A.; Gilbert, Jack A.; Temperton, Ben; Dempsey, Kate E.; Ashelford, Kevin; Tiwari, Bela; Hutchinson, Tom H.; Chipman, J. Kevin			Pyrosequencing of Mytilus galloprovincialis cDNAs: Tissue-Specific Expression Patterns	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; FLOUNDER PLATICHTHYS-FLESUS; DEPENDENT SEX-RATIO; MITOCHONDRIAL-DNA; GENE-EXPRESSION; M-TROSSULUS; SMALL RNAS; EDULIS; MUSSELS; SEQUENCES	Background: Mytilus species are important in marine ecology and in environmental quality assessment, yet their molecular biology is poorly understood. Molecular aspects of their reproduction, hybridisation between species, mitochondrial inheritance, skewed sex ratios of offspring and adaptation to climatic and pollution factors are priority areas. Methodology/Principal Findings: To start to address this situation, expressed genetic transcripts from M. galloprovincialis were pyrosequenced. Transcripts were isolated from the digestive gland, foot, gill and mantle of both male and female mussels. In total, 175,547 sequences were obtained and for foot and mantle, 90% of the sequences could be assembled into contiguous fragments but this reduced to 75% for the digestive gland and gill. Transcripts relating to protein metabolism and respiration dominated including ribosomal proteins, cytochrome oxidases and NADH dehydrogenase subunits. Tissue specific variation was identified in transcripts associated with mitochondrial energy metabolism, with the digestive gland and gill having the greatest transcript abundance. Using fragment recruitment it was also possible to identify sites of potential small RNAs involved in mitochondrial transcriptional regulation. Sex ratios based on Vitelline Envelop Receptor for Lysin and Vitelline Coat Lysin transcript abundances, indicated that an equal sex distribution was maintained. Taxonomic profiling of the M. galloprovincialis tissues highlighted an abundant microbial flora associated with the digestive gland. Profiling of the tissues for genes involved in intermediary metabolism demonstrated that the gill and digestive gland were more similar to each other than to the other two tissues, and specifically the foot transcriptome was most dissimilar. Conclusions: Pyrosequencing has provided extensive genomic information for M. galloprovincialis and generated novel observations on expression of different tissues, mitochondria and associated microorganisms. It will also facilitate the much needed production of an oligonucleotide microarray for the organism.	[Craft, John A.; Dempsey, Kate E.] Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland; [Gilbert, Jack A.; Temperton, Ben; Hutchinson, Tom H.] Univ Liverpool, Plymouth Marine Lab, Liverpool L69 3BX, Merseyside, England; [Ashelford, Kevin] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Tiwari, Bela] Ctr Ecol & Hydrol, Nat Environm Res Council Environm Bioinformat Ctr, Wallingford, Oxon, England; [Chipman, J. Kevin] Univ Birmingham, Sch Biol Sci, Birmingham B15 2TT, W Midlands, England	Glasgow Caledonian University; Plymouth Marine Laboratory; University of Liverpool; University of Liverpool; UK Centre for Ecology & Hydrology (UKCEH); University of Birmingham	Craft, JA (corresponding author), Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland.	j.a.craft@gcal.ac.uk	Gilbert, Jack/AAF-3270-2019; Temperton, Ben/AAE-2785-2021	Hutchinson, Tom/0000-0001-8823-5442; Temperton, Ben/0000-0002-3667-8302; Ashelford, Kevin/0000-0003-3217-2811	Natural Environment Research Council (NERC); NERC [NBAF010002, pml010004] Funding Source: UKRI; Natural Environment Research Council [NBAF010002, CEH010021, pml010004] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NERC) (www.nerc.ac.uk) by making available staff and pyrosequencing facilities at the NERC Biomolecular Analysis Facility at the University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierne N, 2003, MOL ECOL, V12, P447, DOI 10.1046/j.1365-294X.2003.01730.x; Blunt RE, 2007, ENVIRON SCI POLLUT R, V14, P293, DOI 10.1065/espr2007.06.431; Brown M, 2006, MAR ENVIRON RES, V62, pS128, DOI 10.1016/j.marenvres.2006.04.057; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Diz AP, 2009, MOL CELL PROTEOMICS, V8, P132, DOI 10.1074/mcp.M800237-MCP200; Dondero F, 2006, GENE, V376, P24, DOI 10.1016/j.gene.2006.02.015; Falciani F, 2008, AQUAT TOXICOL, V90, P92, DOI 10.1016/j.aquatox.2008.07.020; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Fernandez-Vizarra E, 2008, CURR GENET, V54, P13, DOI 10.1007/s00294-008-0194-x; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Goldberg ED, 2000, SCI TOTAL ENVIRON, V247, P165, DOI 10.1016/S0048-9697(99)00488-X; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; Hilbish TJ, 2002, MAR BIOL, V140, P137, DOI 10.1007/s002270100631; Hines A, 2007, ANAL BIOCHEM, V369, P175, DOI 10.1016/j.ab.2007.06.008; Hines A, 2007, ENVIRON SCI TECHNOL, V41, P3375, DOI 10.1021/es062745w; Inoue K, 1995, BIOL BULL, V189, P370, DOI 10.2307/1542155; Kenchington E, 2002, GENETICS, V161, P1579; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Mitchelmore CL, 1998, MUTAT RES-FUND MOL M, V399, P135, DOI 10.1016/S0027-5107(97)00252-2; Mizi A, 2005, MOL BIOL EVOL, V22, P952, DOI 10.1093/molbev/msi079; Murata-Kamiya N, 2000, Nucleic Acids Symp Ser, P3; Nakamura T, 2009, PHARMACOL RES, V60, P515, DOI 10.1016/j.phrs.2009.05.002; PENNEC GL, 2003, AQUAT TOXICOL, V64, P131; Saavedra C, 1997, GENETICS, V145, P1073; SEDIK W, 2009, MARINE BIOL IN PRESS; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; SKIBINSKI DOF, 1983, BIOL J LINN SOC, V19, P137, DOI 10.1111/j.1095-8312.1983.tb00782.x; SKIBINSKI DOF, 1994, GENETICS, V138, P801; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Toro JE, 2002, MAR BIOL, V141, P897, DOI 10.1007/s00227-002-0897-3; Torrado M, 1998, CELL TISSUE RES, V294, P537, DOI 10.1007/s004410051204; Vander Jagt David L., 2008, Drug Metabolism and Drug Interactions, V23, P93; Venier P, 2003, GENE, V314, P29, DOI 10.1016/S0378-1119(03)00708-X; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Widdows J, 2002, MAR ENVIRON RES, V53, P327, DOI 10.1016/S0141-1136(01)00120-9; Williams TD, 2007, TOXICOL LETT, V168, P236, DOI 10.1016/j.toxlet.2006.10.020; Williams TD, 2006, ENVIRON SCI TECHNOL, V40, P6479, DOI 10.1021/es061142h; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0	43	103	106	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8875	10.1371/journal.pone.0008875	http://dx.doi.org/10.1371/journal.pone.0008875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111607	Green Published, gold, Green Accepted			2022-12-25	WOS:000273896300024
J	Puente, N; Elezgarai, I; Lafourcade, M; Reguero, L; Marsicano, G; Georges, F; Manzoni, OJ; Grandes, P				Puente, Nagore; Elezgarai, Izaskun; Lafourcade, Mathieu; Reguero, Leire; Marsicano, Giovanni; Georges, Francois; Manzoni, Olivier J.; Grandes, Pedro			Localization and Function of the Cannabinoid CB1 Receptor in the Anterolateral Bed Nucleus of the Stria Terminalis	PLOS ONE			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; VENTRAL TEGMENTAL AREA; STRESS-INDUCED RELAPSE; ADULT-RAT BRAIN; ENDOCANNABINOID SYSTEM; GLUTAMATERGIC SYNAPSES; ANANDAMIDE HYDROLYSIS; OPIATE WITHDRAWAL; EXTENDED AMYGDALA; COCAINE-SEEKING	Background: The bed nucleus of the stria terminalis (BNST) is involved in behaviors related to natural reward, drug addiction and stress. In spite of the emerging role of the endogenous cannabinoid (eCB) system in these behaviors, little is known about the anatomy and function of this system in the anterolateral BNST (alBNST). The aim of this study was to provide a detailed morphological characterization of the localization of the cannabinoid 1 (CB1) receptor a necessary step toward a better understanding of the physiological roles of the eCB system in this region of the brain. Methodology/Principal Findings: We have combined anatomical approaches at the confocal and electron microscopy level to ex-vivo electrophysiological techniques. Here, we report that CB1 is localized on presynaptic membranes of about 55% of immunopositive synaptic terminals for the vesicular glutamate transporter 1 (vGluT1), which contain abundant spherical, clear synaptic vesicles and make asymmetrical synapses with alBNST neurons. About 64% of vGluT1 immunonegative synaptic terminals show CB1 immunolabeling. Furthermore, 30% and 35% of presynaptic boutons localize CB1 in alBNST of conditional mutant mice lacking CB1 mainly from GABAergic neurons (GABA-CB1-KO mice) and mainly from cortical glutamatergic neurons (Glu-CB1-KO mice), respectively. Extracellular field recordings and whole cell patch clamp in the alBNST rat brain slice preparation revealed that activation of CB1 strongly inhibits excitatory and inhibitory synaptic transmission. Conclusions/Significance: This study supports the anterolateral BNST as a potential neuronal substrate of the effects of cannabinoids on stress-related behaviors.	[Puente, Nagore; Elezgarai, Izaskun; Reguero, Leire; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Bilbao, Spain; [Lafourcade, Mathieu; Georges, Francois; Manzoni, Olivier J.] INSERM, Equipe Physiopathol Transmiss & Plast Synapt, U862, Bordeaux, France; [Marsicano, Giovanni] Univ Bordeaux 2, INSERM, U862, NeuroCtr Magendie, F-33076 Bordeaux, France	University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Puente, N (corresponding author), Univ Basque Country, Fac Med & Dent, Dept Neurosci, Bilbao, Spain.	olivier.manzoni@inserm.fr; pedro.grandes@ehu.es	Puente, Nagore/H-7054-2015; Grandes, Pedro/H-7494-2015; Lafourcade, Mathieu/GQZ-7267-2022; Grandes, Pedro/AAA-1627-2019; Elezgarai, Izaskun/H-7076-2015; Marsicano, Giovanni/I-9603-2016; Manzoni, Olivier/M-7899-2016; Reguero, Leire/H-6865-2015	Puente, Nagore/0000-0003-0866-5747; Grandes, Pedro/0000-0003-3947-4230; Elezgarai, Izaskun/0000-0003-0880-8058; Manzoni, Olivier/0000-0002-5579-6208; Reguero, Leire/0000-0002-0267-5568; Lafourcade, Mathieu/0000-0001-6117-1194; GEORGES, Francois/0000-0002-2628-2638; Marsicano, Giovanni/0000-0003-3804-1951	The Basque Country Government [GIC07/70-IT-432-07]; Red de Trastornos Adictivos (RETICS); Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion (MICINN) [RD07/0001/2001, SAF2009-07065]; Basque Country University; Basque Country Government; INSERM; ANR [ANR-06-NEURO-043-01]; Region Aquitaine; AVENIR/INSERM; European Foundation for the Study of Diabetes (EFSD); EU [HEALTH-F2-2008-223713]; European Commission [LSHM-CT-2005-19063]	The Basque Country Government; Red de Trastornos Adictivos (RETICS); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Country University; Basque Country Government(Basque Government); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Region Aquitaine(Region Nouvelle-Aquitaine); AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Foundation for the Study of Diabetes (EFSD); EU(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	Dr. Pedro Grandes' laboratory is supported by The Basque Country Government grant GIC07/70-IT-432-07, by Red de Trastornos Adictivos (RETICS), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (MICINN), grant RD07/0001/2001 and MICINN grant SAF2009-07065. Nagore Puente is supported by a Basque Country University grant for PhD Researcher's Specialization. Leire Reguero is in receipt of a predoctoral fellowship from the Basque Country Government. Dr. Olivier J. Manzoni's laboratory is supported by INSERM, ANR Neurosciences "Neurologie et Psychiatrie ANR-06-NEURO-043-01" and Region Aquitaine. Dr. Giovanni Marsicano's laboratory is supported by AVENIR/INSERM (with the Fondation Bettencourt-Schueller), by ANR (ANR-06-NEURO-043-01), by European Foundation for the Study of Diabetes (EFSD), by the EU-FP7 (REPROBESITY, contract number HEALTH-F2-2008-223713) and European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo C, 2001, PHARMACOL BIOCHEM BE, V70, P123, DOI 10.1016/S0091-3057(01)00578-0; Aston-Jones G, 1999, ANN NY ACAD SCI, V877, P486, DOI 10.1111/j.1749-6632.1999.tb09284.x; Bangasser DA, 2008, J NEUROSCI, V28, P6383, DOI 10.1523/JNEUROSCI.0831-08.2008; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Clapper JR, 2009, NEUROPHARMACOLOGY, V56, P235, DOI 10.1016/j.neuropharm.2008.07.018; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2004, J COMP NEUROL, V468, P277, DOI 10.1002/cne.10949; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Dumont EC, 2005, NAT NEUROSCI, V8, P413, DOI 10.1038/nn1414; Egli RE, 2005, NEUROPSYCHOPHARMACOL, V30, P657, DOI 10.1038/sj.npp.1300639; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Fortin DA, 2007, CEREB CORTEX, V17, P163, DOI 10.1093/cercor/bhj133; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Grueter BA, 2006, J NEUROSCI, V26, P3210, DOI 10.1523/JNEUROSCI.0170-06.2006; Grueter BA, 2005, NEUROPSYCHOPHARMACOL, V30, P1302, DOI 10.1038/sj.npp.1300672; Haller J, 2002, EUR J NEUROSCI, V16, P1395, DOI 10.1046/j.1460-9568.2002.02192.x; Harris GC, 2007, BEHAV BRAIN RES, V176, P251, DOI 10.1016/j.bbr.2006.10.012; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hill MN, 2005, EUR NEUROPSYCHOPHARM, V15, P593, DOI 10.1016/j.euroneuro.2005.03.003; Hoffman AF, 2003, EUR J NEUROSCI, V18, P524, DOI 10.1046/j.1460-9568.2003.02773.x; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Larriva-Sahd J, 2006, J COMP NEUROL, V497, P772, DOI 10.1002/cne.21011; Lovinger David M., 2008, V184, P435; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Mackie K, 2007, PLOS BIOL, V5, P2106, DOI 10.1371/journal.pbio.0050280; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin JR, 2002, PHARMACOL BIOCHEM BE, V71, P615, DOI 10.1016/S0091-3057(01)00713-4; Massi L, 2008, J NEUROSCI, V28, P10496, DOI 10.1523/JNEUROSCI.2291-08.2008; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; Matyas F, 2008, NEUROPHARMACOLOGY, V54, P95, DOI 10.1016/j.neuropharm.2007.05.028; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Navarro M, 1997, NEUROREPORT, V8, P491, DOI 10.1097/00001756-199701200-00023; Nyiri G, 2005, NEUROSCIENCE, V136, P811, DOI 10.1016/j.neuroscience.2005.01.026; Olsen CM, 2008, PHYSIOL GENOMICS, V32, P283, DOI 10.1152/physiolgenomics.00224.2006; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; PUENTE, 2009, 4 EUR WORKSH CANN RE; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2001, J NEUROSCI, V21, P109, DOI 10.1523/JNEUROSCI.21-01-00109.2001; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Stewart J, 2000, J PSYCHIATR NEUROSCI, V25, P125; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	56	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8869	10.1371/journal.pone.0008869	http://dx.doi.org/10.1371/journal.pone.0008869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111610	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896300018
J	Moon, SH; Lin, L; Zhang, XN; Nguyen, TA; Darlington, Y; Waldman, AS; Lu, XB; Donehower, LA				Moon, Sung-Hwan; Lin, Lin; Zhang, Xinna; Nguyen, Thuy-Ai; Darlington, Yolanda; Waldman, Alan S.; Lu, Xiongbin; Donehower, Lawrence A.			Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant gamma-H2AX and Suppresses DNA Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-RESPONSE; MAMMALIAN CHROMOSOMES; PROTEIN PHOSPHATASE; GENOMIC INSTABILITY; TUMOR-SUPPRESSOR; WIP1; ATM; PPM1D; MDC1; H2AX	In response to DNA double strand breaks, the histone variant H2AX at the break site is phosphorylated at serine 139 by DNA damage sensor kinases such as ataxia telangiectasia-mutated, forming gamma-H2AX. This phosphorylation event is critical for sustained recruitment of other proteins to repair the break. After repair, restoration of the cell to a prestress state is associated with gamma-H2AX dephosphorylation and dissolution of gamma-H2AX-associated damage foci. The phosphatases PP2A and PP4 have previously been shown to dephosphorylate gamma-H2AX. Here, we demonstrate that the wild-type p53-induced phosphatase 1 (WIP1) also dephosphorylates gamma-H2AX at serine 139 in vitro and in vivo. Overexpression of WIP1 reduces formation of gamma-H2AX foci in response to ionizing and ultraviolet radiation and blocks recruitment of MDC1 (mediator of DNA damage checkpoint 1) and 53BP1 (p53 binding protein 1) to DNA damage foci. Finally, these inhibitory effects of WIP1 on gamma-H2AX are accompanied by WIP1 suppression of DNA double strand break repair. Thus, WIP1 has a homeostatic role in reversing the effects of ataxia telangiectasia-mutated phosphorylation of H2AX.	[Moon, Sung-Hwan; Donehower, Lawrence A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Nguyen, Thuy-Ai; Darlington, Yolanda; Donehower, Lawrence A.] Baylor Coll Med, Interdepartmental Grad Program Cell & Mol Biol, Houston, TX 77030 USA; [Lin, Lin; Zhang, Xinna; Waldman, Alan S.; Lu, Xiongbin] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Lu, Xiongbin] Univ S Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Baylor College of Medicine	Lu, XB (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	xlu@biol.sc.edu; larryd@bcm.tmc.edu	Nguyen, Thuy-Ai/Q-4082-2019	Nguyen, Thuy-Ai/0000-0001-8778-0078	NCI [CA100420]; Department of Defense Breast Cancer Research Program; National Institutes of Health Grant [CA136549]; NATIONAL CANCER INSTITUTE [R01CA136549, R01CA100420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081472] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Breast Cancer Research Program(United States Department of Defense); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100420 from the NCI (to L. A. D.).; Supported by grants from the Department of Defense Breast Cancer Research Program.; Supported by the Center for Colon Cancer Research at the University of South Carolina and by National Institutes of Health Grant CA136549. To whom correspondence may be addressed: Dept. of Biological Sciences, University of South Carolina, Columbia, SC 29208. Fax: 803-777-4002; E-mail: xlu@biol.sc.edu.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2004, TRENDS CELL BIOL, V14, P339, DOI 10.1016/j.tcb.2004.05.001; Bannister LA, 2004, DNA REPAIR, V3, P465, DOI 10.1016/j.dnarep.2004.01.001; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, CELL CYCLE, V3, P1363, DOI 10.4161/cc.3.11.1241; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Smith JA, 2007, MOL CELL BIOL, V27, P7816, DOI 10.1128/MCB.00455-07; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; YAGINUMA Y, 1991, CANCER RES, V51, P6506; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; Yamaguchi H, 2007, BIOCHEMISTRY-US, V46, P12594, DOI 10.1021/bi701096s; Yoda A, 2008, J BIOL CHEM, V283, P18969, DOI 10.1074/jbc.M800560200	56	84	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12935	12947		10.1074/jbc.M109.071696	http://dx.doi.org/10.1074/jbc.M109.071696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20118229	Green Published, hybrid			2022-12-25	WOS:000276787800052
J	Dodge-Kafka, KL; Bauman, A; Mayer, N; Henson, E; Heredia, L; Ahn, J; McAvoy, T; Nairn, AC; Kapiloff, MS				Dodge-Kafka, Kimberly L.; Bauman, Andrea; Mayer, Nicole; Henson, Edward; Heredia, Lorena; Ahn, Jung; McAvoy, Thomas; Nairn, Angus C.; Kapiloff, Michael S.			cAMP-stimulated Protein Phosphatase 2A Activity Associated with Muscle A Kinase-anchoring Protein (mAKAP) Signaling Complexes Inhibits the Phosphorylation and Activity of the cAMP-specific Phosphodiesterase PDE4D3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTE HYPERTROPHY; CHANNEL RYANODINE RECEPTOR; ACTIVATION; HEART; COMPARTMENTATION; CALCIUM; CONTRACTION; INVOLVEMENT	The concentration of the second messenger cAMP is tightly controlled in cells by the activity of phosphodiesterases. We have previously described how the protein kinase A-anchoring protein mAKAP serves as a scaffold for the cAMP-dependent protein kinase PKA and the cAMP-specific phosphodiesterase PDE4D3 in cardiac myocytes. PKA and PDE4D3 constitute a negative feedback loop whereby PKA-catalyzed phosphorylation and activation of PDE4D3 attenuate local cAMP levels. We now show that protein phosphatase 2A (PP2A) associated with mAKAP complexes is responsible for reversing the activation of PDE4D3 by catalyzing the dephosphorylation of PDE4D3 serine residue 54. Mapping studies reveal that a C-terminal mAKAP domain (residues 2085-2319) binds PP2A. Binding to mAKAP is required for PP2A function, such that deletion of the C-terminal domain enhances both base-line and forskolin-stimulated PDE4D3 activity. Interestingly, PP2A holoenzyme associated with mAKAP complexes in the heart contains the PP2A targeting subunit B56 delta. Like PDE4D3, B56 delta is a PKA substrate, and PKA phosphorylation of mAKAP-bound B56 delta enhances phosphatase activity 2-fold in the complex. Accordingly, expression of a B56 delta mutant that cannot be phosphorylated by PKA results in increased PDE4D3 phosphorylation. Taken together, our findings demonstrate that PP2A associated with mAKAP complexes promotes PDE4D3 dephosphorylation, serving both to inhibit PDE4D3 in unstimulated cells and also to mediate a cAMP-induced positive feedback loop following adenylyl cyclase activation and B56 delta phosphorylation. In general, PKA.PP2A.mAKAP complexes exemplify how protein kinases and phosphatases may participate in molecular signaling complexes to dynamically regulate localized intracellular signaling.	[Dodge-Kafka, Kimberly L.; Mayer, Nicole] Univ Connecticut, Ctr Hlth, Pat & Jim Calhoun Ctr Cardiol, Farmington, CT 06030 USA; [Bauman, Andrea] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA; [Henson, Edward; Heredia, Lorena; Kapiloff, Michael S.] Univ Miami, Miller Sch Med, Dept Pediat, Interdisciplinary Stem Cell Inst, Miami, FL 33101 USA; [Henson, Edward; Heredia, Lorena; Kapiloff, Michael S.] Univ Miami, Miller Sch Med, Dept Med, Interdisciplinary Stem Cell Inst, Miami, FL 33101 USA; [Ahn, Jung] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul 158710, South Korea; [McAvoy, Thomas] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Nairn, Angus C.] Yale Univ, Dept Psychiat, New Haven, CT 06511 USA	University of Connecticut; Oregon Health & Science University; University of Miami; University of Miami; Ewha Womans University; Rockefeller University; Yale University	Dodge-Kafka, KL (corresponding author), Univ Connecticut, Ctr Hlth, MC3946,EGO28,263 Farmington Ave, Farmington, CT 06032 USA.	dodge@uchc.edu		Kapiloff, Michael/0000-0002-7005-6953; McAvoy, Thomas/0000-0002-1917-5797; Nairn, Angus/0000-0002-7075-0195; Ahn, Jung-Hyuck/0000-0001-9589-3881	National Institutes of Health [HL82705, HL075398, DA10044, MH074866]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075398, R01HL082705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL82705 (to K. L. D.- K.), HL075398 (to M. S. K.), and DA10044 and MH074866 (to A. C. N.).	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Beavo J A, 1974, Methods Enzymol, V38, P299; BRUNTON LL, 1979, NATURE, V280, P78, DOI 10.1038/280078a0; CARLISLE MJJ, 2004, BIOCHEM J, V381, P587; De Arcangelis V, 2008, MOL PHARMACOL, V74, P1453, DOI 10.1124/mol.108.049718; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2006, EUR J CELL BIOL, V85, P593, DOI 10.1016/j.ejcb.2006.01.007; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Dubell WH, 2002, AM J PHYSIOL-HEART C, V282, pH38, DOI 10.1152/ajpheart.00536.2001; duBell WH, 1996, J PHYSIOL-LONDON, V493, P793, DOI 10.1113/jphysiol.1996.sp021423; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Gigena MS, 2005, AM J PHYSIOL-HEART C, V289, pH285, DOI 10.1152/ajpheart.01291.2004; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kapiloff MS, 2001, J CELL SCI, V114, P3167; KEELY SL, 1977, RES COMMUN CHEM PATH, V18, P283; KEELY SL, 1979, MOL PHARMACOL, V15, P235; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Li JL, 2010, J MOL CELL CARDIOL, V48, P387, DOI 10.1016/j.yjmcc.2009.10.023; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Reiken S, 2001, CIRCULATION, V104, P2843, DOI 10.1161/hc4701.099578; Resjo S, 1999, BIOCHEM J, V341, P839, DOI 10.1042/0264-6021:3410839; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Wong W, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000026	39	69	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11078	11086		10.1074/jbc.M109.034868	http://dx.doi.org/10.1074/jbc.M109.034868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20106966	hybrid, Green Published			2022-12-25	WOS:000276286200011
J	Taylor, SD; Solem, A; Kawaoka, J; Pyle, AM				Taylor, Sean David; Solem, Amanda; Kawaoka, Jane; Pyle, Anna Marie			The NPH-II Helicase Displays Efficient DNA center dot RNA Helicase Activity and a Pronounced Purine Sequence Bias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION TERMINATION FACTOR; HEPATITIS-C VIRUS; VACCINIA VIRIONS; CRYSTAL-STRUCTURE; BOX PROTEINS; EARLY GENES; BASE-PAIR; STABILITY; SPECIFICITY; DOMAIN	The superfamily 2 vaccinia viral helicase nucleoside triphosphate phosphohydrolase-II (NPH-II) exhibits robust RNA helicase activity but typically displays little activity on DNA substrates. NPH-II is thus believed to make primary contacts with backbone residues of an RNA substrate. We report an unusual nucleobase bias, previously unreported in any superfamily 1 or 2 helicase, whereby purines are heavily preferred as components of both RNA and DNA tracking strands. The observed sequence bias allows NPH-II to efficiently unwind a DNA center dot RNA hybrid containing a purine-rich DNA track derived from the 3'-untranslated region of an early vaccinia gene. These results provide insight into potential biological functions of NPH-II and the role of sequence in targeting NPH-II to appropriate substrates. Furthermore, they demonstrate that in addition to backbone contacts, nucleotide bases play an important role in modulating the behavior of NPH-II. They also establish that processive helicase enzymes can display sequence selectivity.	[Solem, Amanda; Pyle, Anna Marie] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Taylor, Sean David] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Kawaoka, Jane] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Pyle, Anna Marie] Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Columbia University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	anna.pyle@yale.edu	Solem, Amanda/M-5959-2013; Solem, Amanda/A-3553-2010	Solem, Amanda/0000-0002-2056-9419; 	National Institutes of Health [GM60620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60620 (to A. M. P.).	Bayliss CD, 1996, J VIROL, V70, P794, DOI 10.1128/JVI.70.2.794-800.1996; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; BORK P, 1993, NUCLEIC ACIDS RES, V21, P751, DOI 10.1093/nar/21.3.751; Boudvillain M, 2000, NATURE, V406, P315, DOI 10.1038/35018589; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Fedorova O., 2005, HDB RNA BIOCH, P259; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Gross CH, 1996, J VIROL, V70, P2615, DOI 10.1128/JVI.70.4.2615-2619.1996; Gross CH, 1998, J VIROL, V72, P4729, DOI 10.1128/JVI.72.6.4729-4736.1998; Gross CH, 1996, J VIROL, V70, P8549, DOI 10.1128/JVI.70.12.8549-8557.1996; HUNG SH, 1994, NUCLEIC ACIDS RES, V22, P4326, DOI 10.1093/nar/22.20.4326; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kawaoka J, 2005, NUCLEIC ACIDS RES, V33, P644, DOI 10.1093/nar/gki208; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KOONIN EV, 1992, J GEN VIROL, V73, P989, DOI 10.1099/0022-1317-73-4-989; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; MOSS B, 2001, FIELDS VIROLOGY, P2850; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; Piacente S, 2008, VIROLOGY, V376, P211, DOI 10.1016/j.virol.2008.03.011; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; Ryder SP, 1999, METHODS, V18, P38, DOI 10.1006/meth.1999.0755; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Schwartz A, 2009, NAT STRUCT MOL BIOL, V16, P1309, DOI 10.1038/nsmb.1711; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1989, J BIOL CHEM, V264, P21356; SHUMAN S, 1993, J BIOL CHEM, V268, P11798; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; VENKATESAN S, 1982, J VIROL, V44, P637, DOI 10.1128/JVI.44.2.637-646.1982; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	44	14	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11692	11703		10.1074/jbc.M109.088559	http://dx.doi.org/10.1074/jbc.M109.088559			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20110368	Green Published, hybrid			2022-12-25	WOS:000276286200073
J	van Dieck, J; Brandt, T; Teufel, DP; Veprintsev, DB; Joerger, AC; Fersht, AR				van Dieck, J.; Brandt, T.; Teufel, D. P.; Veprintsev, D. B.; Joerger, A. C.; Fersht, A. R.			Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73	ONCOGENE			English	Article						S100; p63; p73; tumor suppressor; protein-protein interaction	SQUAMOUS-CELL CARCINOMA; CALCIUM-BINDING PROTEIN; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL ACTIVITY; DNA-BINDING; KINASE-C; FAMILY; CANCER; EXPRESSION; GENE	S100 proteins modulate p53 activity by interacting with its tetramerization (p53TET, residues 325-355) and transactivation (residues 1-57) domains. In this study, we characterized biophysically the binding of S100A1, S100A2, S100A4, S100A6 and S100B to homologous domains of p63 and p73 in vitro by fluorescence anisotropy, analytical ultracentrifugation and analytical gel filtration. We found that S100A1, S100A2, S100A4, S100A6 and S100B proteins bound different p63 and p73 tetramerization domain variants and naturally occurring isoforms with varying affinities in a calcium-dependent manner. Additional interactions were observed with peptides derived from the p63 and p73 N-terminal transactivation domains. Importantly, S100 proteins bound p63 and p73 with different affinities in their different oligomeric states, similarly to the differential modes of binding to p53. On the basis of our data, we hypothesize that S100 proteins regulate the oligomerization state of all three p53 family members and their isoforms, with a potential physiological relevance in developmental and disease-related processes. The regulation of the p53 family by S100 is complicated and depends on the target preference of each individual S100 protein, the concentration of the proteins and calcium, as well as the splicing variation of p63 or p73. Our results outlining the complexity of the interaction should be considered when studying the functional effects of S100 proteins in their biological context. Oncogene (2010) 29, 2024-2035; doi: 10.1038/onc.2009.490; published online 8 February 2010	[van Dieck, J.; Brandt, T.; Teufel, D. P.; Veprintsev, D. B.; Joerger, A. C.; Fersht, A. R.] Univ Cambridge, MRC Ctr Prot Engn, Cambridge CB2 0QH, Cambs, England	MRC Laboratory Molecular Biology; University of Cambridge	Fersht, AR (corresponding author), Univ Cambridge, MRC Ctr Prot Engn, Hills Rd, Cambridge CB2 0QH, Cambs, England.	arf25@cam.ac.uk	Veprintsev, Dmitry B/H-2228-2012; Fersht, Alan R/B-2189-2008	Veprintsev, Dmitry B/0000-0002-3583-5409; Teufel, Daniel/0000-0002-6527-2117; Joerger, Andreas/0000-0002-1232-0138	Medical Research Council [MC_U105474168] Funding Source: Medline; MRC [MC_U105474168] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Boldrup L, 2009, J PATHOL, V218, P428, DOI 10.1002/path.2560; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Buckiova D, 2009, J COMP NEUROL, V513, P469, DOI 10.1002/cne.21967; Burge S, 2009, P NATL ACAD SCI USA, V106, P3142, DOI 10.1073/pnas.0900383106; Chan WY, 2003, MICROSC RES TECHNIQ, V60, P600, DOI 10.1002/jemt.10302; Danilova N, 2008, MECH DEVELOP, V125, P919, DOI 10.1016/j.mod.2008.09.003; Dean B, 2006, AUST NZ J PSYCHIAT, V40, P217, DOI 10.1080/j.1440-1614.2006.01777.x; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Dotto JE, 2006, J CUTAN PATHOL, V33, P413, DOI 10.1111/j.0303-6987.2006.00477.x; FANO G, 1995, PROG NEUROBIOL, V46, P71, DOI 10.1016/0301-0082(94)00062-M; Fernandez-Fernandez MR, 2008, PROTEIN SCI, V17, P1663, DOI 10.1110/ps.035527.108; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Finlan LE, 2007, CELL CYCLE, V6, P1062, DOI 10.4161/cc.6.9.4162; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Ilg EC, 1996, INT J CANCER, V68, P325, DOI 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kirschner RD, 2008, NUCLEIC ACIDS RES, V36, P2969, DOI 10.1093/nar/gkn132; Langenbacher A, 2008, DEV DYNAM, V237, P3491, DOI 10.1002/dvdy.21704; Lapi E, 2006, ONCOGENE, V25, P3628, DOI 10.1038/sj.onc.1209401; Lauriola L, 2000, INT J CANCER, V89, P345, DOI 10.1002/1097-0215(20000720)89:4<345::AID-IJC5>3.0.CO;2-T; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Pelosi G, 2002, J PATHOL, V198, P100, DOI 10.1002/path.1166; Pruneri G, 2002, LAB INVEST, V82, P1327, DOI 10.1097/01.LAB.0000032373.99569.73; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Rosenbluth JM, 2008, GENE DEV, V22, P2591, DOI 10.1101/gad.1727408; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scotto C, 1998, MOL CELL BIOL, V18, P4272, DOI 10.1128/MCB.18.7.4272; Scotto C, 1999, MOL CELL BIOL, V19, P7168; Scoumanne A, 2005, CANCER BIOL THER, V4, P1178, DOI 10.4161/cbt.4.11.2254; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Slomnicki LP, 2009, INT J BIOCHEM CELL B, V41, P784, DOI 10.1016/j.biocel.2008.08.007; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Vigliano FA, 2009, FISH SHELLFISH IMMUN, V26, P146, DOI 10.1016/j.fsi.2008.02.016; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Whitaker M, 2008, PHILOS T R SOC B, V363, P1401, DOI 10.1098/rstb.2008.2259; Yamaguchi K, 2000, INT J CANCER, V86, P684, DOI 10.1002/(SICI)1097-0215(20000601)86:5<684::AID-IJC13>3.0.CO;2-M; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	56	40	40	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 8	2010	29	14					2024	2035		10.1038/onc.2009.490	http://dx.doi.org/10.1038/onc.2009.490			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20140014	Bronze			2022-12-25	WOS:000276402800002
J	Huang, YH; Colgrave, ML; Clark, RJ; Kotze, AC; Craik, DJ				Huang, Yen-Hua; Colgrave, Michelle L.; Clark, Richard J.; Kotze, Andrew C.; Craik, David J.			Lysine-scanning Mutagenesis Reveals an Amendable Face of the Cyclotide Kalata B1 for the Optimization of Nematocidal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS 3C PROTEASE; PLANT CYCLOTIDES; INSECTICIDAL ACTIVITY; HAEMONCHUS-CONTORTUS; MACROCYCLIC PEPTIDES; BIOLOGICAL-ACTIVITY; KNOTTED PROTEINS; FOLDING PATHWAYS; CIRCULAR PROTEIN; DRUG-RESISTANCE	Cyclotides are a family of macrocyclic peptides that combine the unique features of a head-to-tail cyclic backbone and a cystine knot motif, the combination of which imparts them with extraordinary stability. The prototypic cyclotide kalata B1 is toxic against two economically important gastrointestinal nematode parasites of sheep, Haemonchus contortus and Trichostrongylus colubriformis. A lysine scan was conducted to examine the effect of the incorporation of positive charges into the kalata B1 cyclotide framework. Each of the non-cysteine residues in this 29-amino acid peptide was successively substituted with lysine, and the nematocidal and hemolytic activities of the suite of mutants were determined. Substitution of 11 residues within kalata B1 decreased the nematocidal activity dramatically. On the other hand, six other residues that are clustered on the surface of kalata B1 were tolerant to Lys substitution, and indeed the introduction of positively charged residues into this region increased nematocidal activity. This activity was increased further in double and triple lysine mutants, with a maximal increase (relative to the native kalata B1) of 13-fold obtained with a triple lysine mutant (mutated at positions Thr-20, Asn-29, and Gly-1). Hemolytic activity correlated with the nematocidal activity of all lysine mutants. Our data clearly highlight the residues crucial for nematocidal and hemolytic activity in cyclotides, and demonstrate that the nematocidal activity of cyclotides can be increased by incorporation of basic amino acids.	[Huang, Yen-Hua; Colgrave, Michelle L.; Clark, Richard J.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Colgrave, Michelle L.; Kotze, Andrew C.] CSIRO, CSIRO Div Livestock Ind, Brisbane, Qld 4072, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Craik, David/B-1695-2010; Clark, Richard J/G-8848-2012; Kotze, andrew C/B-5995-2012; Huang, Yen-Hua/J-9056-2014; Colgrave, Michelle/A-5710-2012	Craik, David/0000-0003-0007-6796; Clark, Richard J/0000-0002-6807-5426; Kotze, andrew C/0000-0002-8224-7634; Huang, Yen-Hua/0000-0001-6937-2660; Colgrave, Michelle/0000-0001-8463-805X	Australian Research Council; Commonwealth Scientific and Industrial Research Organization	Australian Research Council(Australian Research Council); Commonwealth Scientific and Industrial Research Organization	This work was supported in part by grants from the Australian Research Council (to D. J. C.) and a grant from Commonwealth Scientific and Industrial Research Organization (to A. C. K.).	Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; Besier B, 2007, TRENDS PARASITOL, V23, P21, DOI 10.1016/j.pt.2006.11.004; Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; Chen B, 2006, J NAT PROD, V69, P23, DOI 10.1021/np050317i; Claeson P, 1998, J NAT PROD, V61, P77, DOI 10.1021/np970342r; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2009, ACTA TROP, V109, P163, DOI 10.1016/j.actatropica.2008.11.003; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, TOXICON, V39, P1809, DOI 10.1016/S0041-0101(01)00129-5; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Curry S, 2007, BIOCHEM SOC T, V35, P594, DOI 10.1042/BST0350594; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Goransson U, 2004, J NAT PROD, V67, P1287, DOI 10.1021/np0499719; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hallock YF, 2000, J ORG CHEM, V65, P124, DOI 10.1021/jo990952r; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; HUBERT J, 1984, CAN J COMP MED, V48, P63; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Ireland DC, 2006, BIOCHEM J, V400, P1, DOI 10.1042/BJ20060627; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Kotze AC, 2001, INT J PARASITOL, V31, P1563, DOI 10.1016/S0020-7519(01)00303-4; Lacey E., 1990, Resistance of parasites to antiparasitic drugs: Round Table Conference, ICOPA VII Paris 1990., P177; O'Grady J, 2004, EXP PARASITOL, V106, P164, DOI 10.1016/j.exppara.2004.03.007; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Sweeney TR, 2007, J VIROL, V81, P115, DOI 10.1128/JVI.01587-06; Tam JP, 1998, PROTEIN SCI, V7, P1583, DOI 10.1002/pro.5560070712; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Trabi M, 2009, ORG BIOMOL CHEM, V7, P2378, DOI 10.1039/b823020j; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	51	87	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10797	10805		10.1074/jbc.M109.089854	http://dx.doi.org/10.1074/jbc.M109.089854			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20103593	Green Published, hybrid			2022-12-25	WOS:000276264600065
J	Marcello, E; Gardoni, F; Di Luca, M; Perez-Otano, I				Marcello, Elena; Gardoni, Fabrizio; Di Luca, Monica; Perez-Otano, Isabel			An Arginine Stretch Limits ADAM10 Exit from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; ALPHA-SECRETASE ADAM10; SURFACE EXPRESSION; POTASSIUM CHANNELS; MEMBRANE-PROTEINS; TRAFFICKING; NMDA; PHOSPHORYLATION; SHEDDASES; PATHWAY	A disintegrin and metalloproteinase 10 (ADAM10) is a type I transmembrane glycoprotein responsible for the ectodomain shedding of a number of proteins implicated in the pathogenesis of diseases ranging from cancer to Alzheimer Disease. ADAM10 is synthesized in an inactive form, which is proteolytically activated during its forward transport along the secretory pathway and at the plasma membrane. Therefore, modulation of its trafficking could provide a mechanism to finely tune its shedding activity. Here we report the identification of an endoplasmic reticulum (ER) retention motif within the ADAM10 intracellular C-terminal tail. Sequential deletion/mutagenesis analyses showed that an arginine-rich ((RRR)-R-723) sequence was responsible for the retention of ADAM10 in the ER and its inefficient surface trafficking. Mutating the second arginine to alanine was sufficient to allow ER exit and surface expression in both heterologous cells and hippocampal neurons. As synapse-associated protein 97 (SAP97) binds ADAM10 at its cytoplasmic tail and facilitates forward ADAM10 trafficking in neurons, we tested whether SAP97 could modulate ER export. However, neither expression nor Ser-39 phosphorylation of SAP97 in heterologous cells or hippocampal neurons were sufficient to allow the ER exit of ADAM10, suggesting that other signaling pathways or alternative binding partners are responsible for ADAM10 ER exit. Together, these results identify a novel mechanism regulating the intracellular trafficking and membrane delivery of ADAM10.	[Marcello, Elena] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy; [Perez-Otano, Isabel] Univ Navarra, CIMA, Dept Neurosci, Cellular Neurobiol Lab, Pamplona 31008, Spain	University of Milan; University of Milan; University of Navarra	Marcello, E (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	elena.marcello@unimi.it	Marcello, Elena/A-4687-2015; DiLuca, Monica/A-7632-2012; Gardoni, Fabrizio/A-3135-2009; Perez-Otano, Isabel/S-9613-2017	Marcello, Elena/0000-0003-0452-762X; DiLuca, Monica/0000-0003-2298-615X; Gardoni, Fabrizio/0000-0003-4598-5563; Perez-Otano, Isabel/0000-0002-7222-8202	EC [LSHM-CT-2008-217902]; CARIPLO 2008; MIUR Italy-Spain Integrated Action; Kemali Foundation; UTE project CIMA; Spanish Ministry of Education and Science grants [SAF200610025, CSD2008-00005]	EC(European CommissionEuropean Commission Joint Research Centre); CARIPLO 2008; MIUR Italy-Spain Integrated Action; Kemali Foundation; UTE project CIMA; Spanish Ministry of Education and Science grants(Spanish Government)	This work was supported by EC Contract LSHM-CT-2008-217902 (cPADs), CARIPLO 2008, MIUR Italy-Spain Integrated Action (to M. D. L.), Kemali Foundation fellowship (to E. M.), UTE project CIMA and Spanish Ministry of Education and Science grants (Spain-Italy Integrated Action, SAF200610025, CSD2008-00005) (to I. P.-O.).	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; El Meskini R, 2001, J BIOL CHEM, V276, P3384, DOI 10.1074/jbc.M008062200; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Gardoni F, 2002, EUR J NEUROSCI, V16, P777, DOI 10.1046/j.1460-9568.2002.02141.x; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Godde NJ, 2006, J CELL SCI, V119, P3296, DOI 10.1242/jcs.03065; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Jansen EJR, 1998, J CELL SCI, V111, P2999; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Moss ML, 2004, BIOCHEMISTRY-US, V43, P7227, DOI 10.1021/bi049677f; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; Schroeder A, 2009, J ALZHEIMERS DIS, V16, P309, DOI 10.3233/JAD-2009-0952; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Wouters S, 1998, BIOCHEM J, V336, P311, DOI 10.1042/bj3360311; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	39	46	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10376	10384		10.1074/jbc.M109.055947	http://dx.doi.org/10.1074/jbc.M109.055947			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20100836	hybrid, Green Published			2022-12-25	WOS:000276264600023
J	Verdoliva, A; Bellofiore, P; Rivieccio, V; Catello, S; Colombo, M; Albertoni, C; Rosi, A; Leoni, B; Anastasi, AM; De Santis, R				Verdoliva, Antonio; Bellofiore, Piero; Rivieccio, Vincenzo; Catello, Sergio; Colombo, Maurizio; Albertoni, Claudio; Rosi, Antonio; Leoni, Barbara; Anastasi, Anna Maria; De Santis, Rita			Biochemical and Biological Characterization of a New Oxidized Avidin with Enhanced Tissue Binding Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAOPERATIVE AVIDINATION; RADIONUCLIDE TREATMENT; BIOTIN-BINDING; CHICKEN AVIDIN; ACIDIC MUTANT; PHASE-II; STREPTAVIDIN; BRACHYTHERAPY; CARBOHYDRATE; DELIVERY	Chicken avidin and bacterial streptavidin are widely employed in vitro for their capacity to bind biotin, but their pharmacokinetics and immunological properties are not always optimal, thereby limiting their use in medical treatments. Here we investigate the biochemical and biological properties of a new modified avidin, obtained by ligand-assisted sodium periodate oxidation of avidin. This method allows protection of biotin-binding sites of avidin from inactivation caused by the oxidation step and delay of avidin clearance from injected tissue by generation of aldehyde groups from avidin carbohydrate moieties. Oxidized avidin shows spectroscopic properties similar to that of native avidin, indicating that tryptophan residues are spared from oxidation damage. In strict agreement with these results, circular dichroism and isothermal titration calorimetry analyses confirm that the ligand-assisted oxidation preserves the avidin protein structure and its biotin binding capacity. In vitro cell binding and in vivo tissue residence experiments demonstrate that aldehyde groups provide oxidized avidin the property to bind cellular and interstitial protein amino groups through Schiff's base formation, resulting in a tissue half-life of 2 weeks, compared with 2 h of native avidin. In addition, the efficient uptake of the intravenously injected In-111-BiotinDOTA (ST2210) in the site previously treated with modified avidin underlines that tissue-bound oxidized avidin retains its biotin binding capacity in vivo. The results presented here indicate that oxidized avidin could be employed to create a stable artificial receptor in diseased tissues for the targeting of biotinylated therapeutics.	[Albertoni, Claudio; Rosi, Antonio; Leoni, Barbara; Anastasi, Anna Maria; De Santis, Rita] Sigma Tau Pharmaceut Co, Dept Res & Dev, I-00040 Rome, Italy; [Verdoliva, Antonio; Bellofiore, Piero; Rivieccio, Vincenzo; Catello, Sergio; Colombo, Maurizio] Tecnogen SpA, Dept Res & Dev, I-81013 Piana Monte Verna, Caserta, Italy	Leadiant Biosciences	De Santis, R (corresponding author), Sigma Tau SpA R&D, Via Pontina Km 30-400, I-00040 Rome, Italy.	rita.desantis@sigma-tau.it		DE SANTIS, Rita/0000-0002-5037-0611				Adkison JB, 2008, BRACHYTHERAPY, V7, P43, DOI 10.1016/j.brachy.2007.11.001; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256; Bench BJ, 2004, J COLLOID INTERF SCI, V270, P315, DOI 10.1016/j.jcis.2003.11.005; BRUCH RC, 1982, BIOCHEMISTRY-US, V21, P5334, DOI 10.1021/bi00264a033; Caliceti P, 2002, J CONTROL RELEASE, V83, P97, DOI 10.1016/S0168-3659(02)00199-2; Chinol M, 1998, BRIT J CANCER, V78, P189, DOI 10.1038/bjc.1998.463; Chung WG, 2008, ELECTROPHORESIS, V29, P1317, DOI 10.1002/elps.200700606; De Santis R, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/921434; DELANGE RJ, 1970, J BIOL CHEM, V245, P907; Denecke T., 2008, V177, P95; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; GREEN NM, 1963, BIOCHEM J, V89, P599, DOI 10.1042/bj0890599; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; GREEN NM, 1965, BIOCHEM J, V94, pC23, DOI 10.1042/bj0940023C; HILLER Y, 1987, BIOCHEM J, V248, P167, DOI 10.1042/bj2480167; HNATOWICH DJ, 1987, J NUCL MED, V28, P1294; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; Jansen N, 2007, INT J RADIAT ONCOL, V67, P1052, DOI 10.1016/j.ijrobp.2006.10.031; Kaufman SA, 2007, BRACHYTHERAPY, V6, P286, DOI 10.1016/j.brachy.2007.09.001; Kim YB, 2008, INT J RADIAT ONCOL, V71, P305, DOI 10.1016/j.ijrobp.2008.01.024; Knox SJ, 2000, CLIN CANCER RES, V6, P406; Laitinen OH, 2003, J BIOL CHEM, V278, P4010, DOI 10.1074/jbc.M205844200; Lehtolainen P, 2002, J BIOL CHEM, V277, P8545, DOI 10.1074/jbc.M109431200; MARSHALL D, 1995, BRIT J CANCER, V71, P18, DOI 10.1038/bjc.1995.5; Marttila AT, 1998, FEBS LETT, V441, P313, DOI 10.1016/S0014-5793(98)01570-1; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; Meyer DL, 2001, PROTEIN SCI, V10, P491, DOI 10.1110/ps.19901; Mirzaei H, 2008, PROTEOMICS, V8, P2764, DOI 10.1002/pmic.200890044; Murray S, 2002, BBA-GEN SUBJECTS, V1570, P81, DOI 10.1016/S0304-4165(02)00157-5; Nardone E, 1998, EUR J BIOCHEM, V256, P453, DOI 10.1046/j.1432-1327.1998.2560453.x; Nordlund HR, 2003, J BIOL CHEM, V278, P2479, DOI 10.1074/jbc.M210721200; OEHR P, 1988, J NUCL MED, V29, P728; OSHANNESSY DJ, 1987, J IMMUNOL METHODS, V99, P153, DOI 10.1016/0022-1759(87)90120-7; PAGANELLI G, 1991, NUCL MED COMMUN, V12, P211, DOI 10.1097/00006231-199103000-00006; Paganelli G, 2007, BREAST, V16, P17, DOI 10.1016/j.breast.2006.10.003; Paganelli G, 2007, CLIN CANCER RES, V13, p5646S, DOI 10.1158/1078-0432.CCR-07-1058; Paganelli G, 2010, EUR J NUCL MED MOL I, V37, P203, DOI 10.1007/s00259-009-1260-4; PIMM MV, 1988, NUCL MED COMMUN, V9, P931, DOI 10.1097/00006231-198811000-00010; Quesenberry MS, 1996, ANAL BIOCHEM, V234, P50, DOI 10.1006/abio.1996.0048; Rosebrough SF, 1996, J NUCL MED, V37, P1380; ROSEBROUGH SF, 1993, NUCL MED BIOL, V20, P663, DOI 10.1016/0969-8051(93)90037-U; Saito S, 2007, INT J CLIN ONCOL, V12, P395, DOI 10.1007/s10147-007-0710-x; Sakahara H, 1999, ADV DRUG DELIVER REV, V37, P89, DOI 10.1016/S0169-409X(98)00101-X; Salmaso S, 2007, INT J PHARMACEUT, V340, P20, DOI 10.1016/j.ijpharm.2007.03.010; SCHECHTER B, 1990, EUR J BIOCHEM, V189, P327, DOI 10.1111/j.1432-1033.1990.tb15493.x; SCHECHTER B, 1995, KIDNEY INT, V47, P1327, DOI 10.1038/ki.1995.188; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Subramanian N, 1997, BIOCHEM MOL BIOL INT, V43, P375; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; TOTH CA, 1982, BIOCHEM J, V204, P377, DOI 10.1042/bj2040377; TOWNSEND R, 1981, BIOCHEM J, V194, P209, DOI 10.1042/bj1940209; Urbano N, 2007, EUR J NUCL MED MOL I, V34, P68, DOI 10.1007/s00259-006-0124-4; Van Tomme SR, 2007, EXPERT REV MED DEVIC, V4, P147, DOI 10.1586/17434440.4.2.147; Veyrat-Follet C, 2009, J THROMB HAEMOST, V7, P559, DOI 10.1111/j.1538-7836.2009.03298.x; Weiden PL, 2001, CRIT REV ONCOL HEMAT, V40, P37, DOI 10.1016/S1040-8428(01)00133-0; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5; Yao ZS, 1998, JNCI-J NATL CANCER I, V90, P25, DOI 10.1093/jnci/90.1.25; Yao ZS, 1999, J NUCL MED, V40, P479; ZABORSKY OR, 1974, BIOCHEM BIOPH RES CO, V61, P210, DOI 10.1016/0006-291X(74)90554-3; Zavaleta CL, 2007, INT J PHARM, V337, P316, DOI 10.1016/j.ijpharm.2007.01.010	61	26	27	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9090	9099		10.1074/jbc.M109.080457	http://dx.doi.org/10.1074/jbc.M109.080457			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20100839	Green Published, hybrid			2022-12-25	WOS:000275553700059
J	Cremasco, V; Benasciutti, E; Cella, M; Kisseleva, M; Croke, M; Faccio, R				Cremasco, Viviana; Benasciutti, Elisa; Cella, Marina; Kisseleva, Marina; Croke, Monica; Faccio, Roberta			Phospholipase C Gamma 2 Is Critical for Development of a Murine Model of Inflammatory Arthritis by Affecting Actin Dynamics in Dendritic Cells	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ANTIGEN PRESENTATION; IN-VIVO; B-CELL; ACTIVATION; PODOSOMES; MIGRATION; C-GAMMA-2; PLC-GAMMA-2; REQUIREMENT	Background: Dendritic cells (DCs) are highly specialized cells, which capture antigen in peripheral tissues and migrate to lymph nodes, where they dynamically interact with and activate T cells. Both migration and formation of DC-T cell contacts depend on cytoskeleton plasticity. However, the molecular bases governing these events have not been completely defined. Methodology/Principal Findings: Utilizing a T cell-dependent model of arthritis, we find that PLC gamma 2-/- mice are protected from local inflammation and bone erosion. PLC gamma 2 controls actin remodeling in dendritic cells, thereby affecting their capacity to prime T cells. DCs from PLC gamma 2-/- mice mature normally, however they lack podosomes, typical actin structures of motile cells. Absence of PLC gamma 2 impacts both DC trafficking to the lymph nodes and migration towards CCL21. The interaction with T cells is also affected by PLC gamma 2 deficiency. Mechanistically, PLC gamma 2 is activated by CCL21 and modulates Rac activation. Rac1/2-/- DCs also lack podosomes and do not respond to CCL21. Finally, antigen pulsed PLC gamma 2-/- DCs fail to promote T cell activation and induce inflammation in vivo when injected into WT mice. Conversely, injection of WT DCs into PLC gamma 2-/- mice rescues the inflammatory response but not focal osteolysis, confirming the importance of PLC gamma 2 both in immune and bone systems. Conclusions/Significance: This study demonstrates a critical role for PLC gamma 2 in eliciting inflammatory responses by regulating actin dynamics in DCs and positions the PLC gamma 2 pathway as a common orchestrator of bone and immune cell functions during arthritis.	[Cremasco, Viviana; Benasciutti, Elisa; Faccio, Roberta] Washington Univ, Sch Med, Dept Orthopaed, St Louis, MO 63130 USA; [Cremasco, Viviana; Faccio, Roberta] Univ Bari, Dept Human Anat & Histol, Bari, Italy; [Benasciutti, Elisa] Ist Sci San Raffaele, Dept Mol Genet, I-20132 Milan, Italy; [Cella, Marina; Croke, Monica] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Kisseleva, Marina] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Universita degli Studi di Bari Aldo Moro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Washington University (WUSTL); Washington University (WUSTL)	Cremasco, V (corresponding author), Washington Univ, Sch Med, Dept Orthopaed, St Louis, MO 63130 USA.	faccior@wustl.edu	Cella, Marina/G-8850-2011; Cella, Marina/ABA-8564-2020	Cella, Marina/0000-0003-1230-1313	Arthritis Foundation; NIH [R01 AR52921]; ARRA [63181]; Children Discovery Institute [42826]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER	Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children Discovery Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by research funding from: the Arthritis Foundation to R. F., NIH to R. F. (R01 AR52921), ARRA to R. F.(63181), and CDI from the Children Discovery Institute to R. F. (42826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Boes M, 2004, TRENDS CELL BIOL, V14, P175, DOI 10.1016/j.tcb.2004.02.004; Bouma G, 2007, BLOOD, V110, P4278, DOI 10.1182/blood-2007-06-096875; BOUSSO P, 2008, T CELL ACTIVATION DE; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chou HC, 2006, CURR BIOL, V16, P2337, DOI 10.1016/j.cub.2006.10.037; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; Cope AP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2412; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Cresswell P, 2005, IMMUNOL REV, V207, P5, DOI 10.1111/j.0105-2896.2005.00320.x; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; GOLDFIEN RD, 1991, J IMMUNOL, V146, P3703; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Leung BP, 2002, J IMMUNOL, V169, P7071, DOI 10.4049/jimmunol.169.12.7071; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lutzky V, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2200; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Minobe S, 2009, NEUROSCI RES, V63, P294, DOI 10.1016/j.neures.2009.01.006; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; PANAYI GS, 1992, CLIN EXP RHEUMATOL, V10, P305; Sarkar S, 2005, FRONT BIOSCI-LANDMRK, V10, P656, DOI 10.2741/1560; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Tassi I, 2009, EUR J IMMUNOL, V39, P1369, DOI 10.1002/eji.200839313; van Golen KL, 2008, J CELL BIOCHEM, V104, P1587, DOI 10.1002/jcb.21652; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; XU S, 2009, J BIOL CHEM; XU S, 2009, J BIOL CHEM; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264	42	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8909	10.1371/journal.pone.0008909	http://dx.doi.org/10.1371/journal.pone.0008909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111715	gold, Green Published			2022-12-25	WOS:000274114800012
J	Yang, H; Liu, C; Zhong, YW; Luo, SQ; Monteiro, MJ; Fang, SY				Yang, Hui; Liu, Chao; Zhong, Yongwang; Luo, Shouqing; Monteiro, Mervyn J.; Fang, Shengyun			Huntingtin Interacts with the Cue Domain of gp78 and Inhibits gp78 Binding to Ubiquitin and p97/VCP	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; TERMINAL MUTANT HUNTINGTIN; ENDOPLASMIC-RETICULUM; ER STRESS; MISFOLDED PROTEINS; AAA ATPASE; NEURODEGENERATIVE DISEASES; POLYUBIQUITIN CHAINS; RETRO-TRANSLOCATION; CONJUGATING ENZYME	Huntington's disease (HD) is caused by polyglutamine expansion in huntingtin (htt) protein, but the exact mechanism of HD pathogenesis remains uncertain. Recent evidence suggests that htt proteins with expanded polyglutamine tracts induce endoplasmic reticulum (ER) stress, probably by interfering with ER-associated degradation (ERAD). Here we report that mutant htt interacts and interferes with the function of gp78, an ER membrane-anchored ubiquitin ligase (E3) involved in ERAD. Mapping studies showed that the HEAT repeats 2&3 of htt interact with the cue domain of gp78. The interaction competitively reduces polyubiquitinated protein binding to gp78 and also sterically blocks gp78 interaction of p97/VCP, a molecular chaperone that is essential for ERAD. These effects of htt negatively regulate the function of gp78 in ERAD and are aggravated by polyglutamine expansion. Paradoxically, gp78 is still able to ubiquitinate and facilitate degradation of htt proteins with expanded polyglutamine. The impairment of ERAD by mutant htt proteins is associated with induction of ER stress. Our studies provide a novel molecular mechanism that supports the involvement of ER stress in HD pathogenesis.	[Yang, Hui; Liu, Chao; Zhong, Yongwang; Monteiro, Mervyn J.; Fang, Shengyun] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Luo, Shouqing] Cambridge Inst Med Res, Dept Med Genet, Cambridge, England	University System of Maryland; University of Maryland Baltimore; University of Cambridge	Yang, H (corresponding author), Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	fangs@umbi.umd.edu	Fang, Shengyun/H-3802-2011; Zhong, Yongwang/A-2527-2012; Monteiro, Mervyn J/H-3813-2011	Fang, Shengyun/0000-0001-7280-5463	NIH [5R01GM069967, 5R01GM066287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066287, R01GM069967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by NIH grants 5R01GM069967 (SF) and 5R01GM066287 (MJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Ballar P, 2010, INT J BIOCHEM CELL B, V42, P167, DOI 10.1016/j.biocel.2009.10.005; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen LZ, 2002, NEUROCHEM RES, V27, P891, DOI 10.1023/A:1020387414086; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Kazantsev AG, 2007, PROG NEUROBIOL, V83, P249, DOI 10.1016/j.pneurobio.2007.02.005; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Li XJ, 2010, BBA-MOL BASIS DIS, V1802, P62, DOI 10.1016/j.bbadis.2009.06.008; Li XY, 2009, MOL CELL BIOL, V29, P6106, DOI 10.1128/MCB.00420-09; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Luo SQ, 2008, HUM MOL GENET, V17, P895, DOI 10.1093/hmg/ddm362; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Noh JY, 2009, J BIOL CHEM, V284, P11318, DOI 10.1074/jbc.M807620200; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roze E, 2008, CURR OPIN NEUROL, V21, P497, DOI 10.1097/WCO.0b013e328304b692; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Ying Z, 2009, HUM MOL GENET, V18, P4268, DOI 10.1093/hmg/ddp380; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	67	140	146	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8905	10.1371/journal.pone.0008905	http://dx.doi.org/10.1371/journal.pone.0008905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126661	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500024
J	Ulici, V; James, CG; Hoenselaar, KD; Beier, F				Ulici, Veronica; James, Claudine G.; Hoenselaar, Katie D.; Beier, Frank			Regulation of Gene Expression by PI3K in Mouse Growth Plate Chondrocytes	PLOS ONE			English	Article							TRANSGLUTAMINASE FACTOR XIIIA; ENDOCHONDRAL BONE-GROWTH; PROTEIN-KINASE B/AKT; SET ENRICHMENT; UP-REGULATION; II COLLAGEN; CARTILAGE; DIFFERENTIATION; TRANSCRIPTION; HYPERTROPHY	Background: Endochondral ossification, the process through which long bones are formed, involves chondrocyte proliferation and hypertrophic differentiation in the cartilage growth plate. In a previous publication we showed that pharmacological inhibition of the PI3K signaling pathway results in reduced endochondral bone growth, and in particular, shortening of the hypertrophic zone in a tibia organ culture system. In this current study we aimed to investigate targets of the PI3K signaling pathway in hypertrophic chondrocytes. Methodology/Principal Findings: Through the intersection of two different microarray analyses methods (classical single gene analysis and GSEA) and two different chondrocyte differentiation systems (primary chondrocytes treated with a pharmacological inhibitor of PI3K and microdissected growth plates), we were able to identify a high number of genes grouped in GSEA functional categories regulated by the PI3K signaling pathway. Genes such as Phlda2 and F13a1 were down-regulated upon PI3K inhibition and showed increased expression in the hypertrophic zone compared to the proliferative/resting zone of the growth plate. In contrast, other genes including Nr4a1 and Adamts5 were up-regulated upon PI3K inhibition and showed reduced expression in the hypertrophic zone. Regulation of these genes by PI3K signaling was confirmed by quantitative RT-PCR. We focused on F13a1 as an interesting target because of its known role in chondrocyte hypertrophy and osteoarthritis. Mouse E15.5 tibiae cultured with LY294002 (PI3K inhibitor) for 6 days showed decreased expression of factor XIIIa in the hypertrophic zone compared to control cultures. Conclusions/Significance: Discovering targets of signaling pathways in hypertrophic chondrocytes could lead to targeted therapy in osteoarthritis and a better understanding of the cartilage environment for tissue engineering.	[Ulici, Veronica; James, Claudine G.; Hoenselaar, Katie D.; Beier, Frank] Univ Western Ontario, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodeling, London, ON, Canada	Western University (University of Western Ontario)	Ulici, V (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodeling, London, ON, Canada.	fbeier@uwo.ca	Beier, Frank/T-4734-2019; Beier, Frank/G-4595-2013	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537	Canadian Arthritis Network; Natural Sciences and Engineering Research Council; Canada Research Chair Award; Canadian Institutes of Health Research [MOP 43899]	Canadian Arthritis Network; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	VU was the recipient of a graduate scholarship from the Canadian Arthritis Network (http://www.arthritisnetwork.ca/). KH was the recipient of summer studentships from the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/). FB is the recipient of a Canada Research Chair Award. Work in the lab of FB was supported by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html): MOP 43899. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston H, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-18; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BUCKWALTER JA, 1986, J BONE JOINT SURG AM, V68A, P243, DOI 10.2106/00004623-198668020-00010; Cancedda R, 2000, INT J DEV BIOL, V44, P707; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen YL, 2008, MOL PHARMACOL, V74, P1046, DOI 10.1124/mol.107.044800; Chung UI, 2004, ENDOCR J, V51, P19, DOI 10.1507/endocrj.51.19; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; HUNZIKER EB, 1987, J BONE JOINT SURG AM, V69A, P162, DOI 10.2106/00004623-198769020-00002; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; James CG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-205; Johnson K, 2001, AM J PATHOL, V159, P149, DOI 10.1016/S0002-9440(10)61682-3; Jung YD, 1999, CANCER RES, V59, P4804; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhn I, 2001, PHYSIOL GENOMICS, V7, P105, DOI 10.1152/physiolgenomics.00052.2001; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakano Y, 2007, J HISTOCHEM CYTOCHEM, V55, P675, DOI 10.1369/jhc.6A7091.2007; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Nurminskaya MV, 2002, DEV DYNAM, V223, P24, DOI 10.1002/dvdy.1230; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Silverman JS, 1996, BLOOD, V88, P4072, DOI 10.1182/blood.V88.10.4072b.bloodjournal88104072b; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tchetina EV, 2007, MATRIX BIOL, V26, P247, DOI 10.1016/j.matbio.2007.01.006; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; WOODS A, 2009, J CELL MOL MED	43	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8866	10.1371/journal.pone.0008866	http://dx.doi.org/10.1371/journal.pone.0008866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111593	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896300015
J	Morgan, HP; McNae, IW; Nowicki, MW; Hannaert, V; Michels, PAM; Fothergill-Gilmore, LA; Walkinshaw, MD				Morgan, Hugh P.; McNae, Iain W.; Nowicki, Matthew W.; Hannaert, Veronique; Michels, Paul A. M.; Fothergill-Gilmore, Linda A.; Walkinshaw, Malcolm D.			Allosteric Mechanism of Pyruvate Kinase from Leishmania mexicana Uses a Rock and Lock Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; STRUCTURAL BASIS; MOLECULAR-BASIS; PROTEINS; M2; TRANSITIONS; ENZYME	Allosteric regulation provides a rate management system for enzymes involved in many cellular processes. Ligand-controlled regulation is easily recognizable, but the underlying molecular mechanisms have remained elusive. We have obtained the first complete series of allosteric structures, in all possible ligated states, for the tetrameric enzyme, pyruvate kinase, from Leishmania mexicana. The transition between inactive T-state and active R-state is accompanied by a simple symmetrical 6 degrees rigid body rocking motion of the A- and C-domain cores in each of the four subunits. However, formation of the R-state in this way is only part of the mechanism; eight essential salt bridge locks that form across the C-C interface provide tetramer rigidity with a coupled 7-fold increase in rate. The results presented here illustrate how conformational changes coupled with effector binding correlate with loss of flexibility and increase in thermal stability providing a general mechanism for allosteric control.	[Fothergill-Gilmore, Linda A.; Walkinshaw, Malcolm D.] Univ Edinburgh, Struct Biochem Grp, Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Hannaert, Veronique; Michels, Paul A. M.] Catholic Univ Louvain, Trop Dis Res Unit, Duve Inst, B-1200 Brussels, Belgium; [Hannaert, Veronique; Michels, Paul A. M.] Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium	University of Edinburgh; Universite Catholique Louvain; Universite Catholique Louvain	Walkinshaw, MD (corresponding author), Univ Edinburgh, Struct Biochem Grp, Inst Struct & Mol Biol, Michael Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	m.walkinshaw@ed.ac.uk	Michels, Paul A/A-5637-2009; walkinshaw, malcolm/AAB-7497-2019	Michels, Paul A/0000-0003-3726-6104; McNae, Iain/0000-0002-6312-7936; walkinshaw, malcolm/0000-0001-5955-9325	Medical Research Council; European Commission; Wellcome Trust; Biotechnology and Biological Sciences Research Council; Medical Research Council [G0500367, G0600014] Funding Source: researchfish; MRC [G0600014, G0500367] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, by the European Commission through its International Cooperation with Developing Countries programme. The Centre for Translational and Chemical Biology and Edinburgh Protein Production Facility were funded by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council.	BLUNDELL TL, 1976, PROTEIN CRYSTALLOGRA, P75; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Collins RA, 1996, PROTEIN ENG, V9, P1203, DOI 10.1093/protein/9.12.1203; CONSLER TG, 1988, J BIOL CHEM, V263, P2794; Daily MD, 2007, PROTEINS, V67, P385, DOI 10.1002/prot.21300; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELANO WL, 2002, PYMOL V1 2; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; ERNEST I, 1994, MOL BIOCHEM PARASIT, V64, P43, DOI 10.1016/0166-6851(94)90133-3; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Hannaert V, 2002, FEBS LETT, V514, P255, DOI 10.1016/S0014-5793(02)02374-8; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; Jardetzky O, 1996, PROG BIOPHYS MOL BIO, V65, P171, DOI 10.1016/S0079-6107(96)00010-7; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Lee JC, 2008, ACTA BIOCH BIOPH SIN, V40, P663, DOI 10.1111/j.1745-7270.2008.00445.x; Lindsley JE, 2006, P NATL ACAD SCI USA, V103, P10533, DOI 10.1073/pnas.0604452103; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pendergrass DC, 2006, IUBMB LIFE, V58, P31, DOI 10.1080/15216540500531705; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tulloch LB, 2008, J MOL BIOL, V383, P615, DOI 10.1016/j.jmb.2008.08.037; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200	36	60	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12892	12898		10.1074/jbc.M109.079905	http://dx.doi.org/10.1074/jbc.M109.079905			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20123988	hybrid, Green Published			2022-12-25	WOS:000276787800047
J	Cervera, A; Planas, AM; Justicia, C; Urra, X; Jensenius, JC; Torres, F; Lozano, F; Chamorro, A				Cervera, Alvaro; Planas, Anna M.; Justicia, Carles; Urra, Xabier; Jensenius, Jens C.; Torres, Ferran; Lozano, Francisco; Chamorro, Angel			Genetically-Defined Deficiency of Mannose-Binding Lectin Is Associated with Protection after Experimental Stroke in Mice and Outcome in Human Stroke	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ISCHEMIA-REPERFUSION INJURY; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; COMPLEMENT ACTIVATION; SERINE PROTEASES; BRAIN; PATHWAY; INFECTION; CELLS	Background: The complement system is a major effector of innate immunity that has been involved in stroke brain damage. Complement activation occurs through the classical, alternative and lectin pathways. The latter is initiated by mannosebinding lectin (MBL) and MBL-associated serine proteases (MASPs). Here we investigated whether the lectin pathway contributes to stroke outcome in mice and humans. Methodology/Principal Findings: Focal cerebral ischemia/reperfusion in MBL-null mice induced smaller infarctions, better functional outcome, and diminished C3 deposition and neutrophil infiltration than in wild-type mice. Accordingly, reconstitution of MBL-null mice with recombinant human MBL (rhMBL) enhanced brain damage. In order to investigate the clinical relevance of these experimental observations, a study of MBL2 and MASP-2 gene polymorphism rendering the lectin pathway dysfunctional was performed in 135 stroke patients. In logistic regression adjusted for age, gender and initial stroke severity, unfavourable outcome at 3 months was associated with MBL-sufficient genotype (OR 10.85, p = 0.008) and circulating MBL levels (OR 1.29, p = 0.04). Individuals carrying MBL-low genotypes (17.8%) had lower C3, C4, and CRP levels, and the proinflammatory cytokine profile was attenuated versus MBL-sufficient genotypes. Conclusions/Significance: In conclusion, genetically defined MBL-deficiency is associated with a better outcome after acute stroke in mice and humans.	[Cervera, Alvaro; Urra, Xabier; Chamorro, Angel] Univ Barcelona, Sch Med, Comprehens Stroke Ctr, IDIBAPS,Hosp Clin, Barcelona, Spain; [Planas, Anna M.; Justicia, Carles] CSIC, Dept Brain Ischemia & Neurodegenerat, IIBB, IDIBAPS, Barcelona, Spain; [Jensenius, Jens C.] Univ Aarhus, Dept Med Microbiol & Immunol, Aarhus, Denmark; [Torres, Ferran] Univ Barcelona, Sch Med, Clin Pharmacol Unit, IDIBAPS,Hosp Clin, Barcelona, Spain; [Torres, Ferran; Lozano, Francisco] Univ Barcelona, Sch Med, Dept Cellular Biol Immunol & Neurosci, Barcelona, Spain; [Lozano, Francisco] IDIBAPS, Hosp Clin, Dept Immunol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Aarhus University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Cervera, A (corresponding author), Univ Barcelona, Sch Med, Comprehens Stroke Ctr, IDIBAPS,Hosp Clin, Barcelona, Spain.	Flozano@clinic.ub.es; achamorro@ub.edu	Justicia, Carles/H-7762-2015; Urra, Xabier/B-7637-2019; Torres, Ferran/D-1296-2011; LOZANO, FRANCISCO/AAB-7888-2019; Planas, Anna M/J-5991-2014; Lozano-Soto, Francisco/AAB-7930-2019	Justicia, Carles/0000-0003-0969-6158; Urra, Xabier/0000-0002-4763-5252; Torres, Ferran/0000-0002-7355-7913; LOZANO, FRANCISCO/0000-0003-1119-4368; Planas, Anna M/0000-0002-6147-1880; Lozano-Soto, Francisco/0000-0003-3714-2304	European Community [FP7/2007-2013]; Spanish Ministry of Education and Science [SAF200804515- CO2-01]; Fundacio n Melchor Colet; Spanish Network for the Research in Infectious Diseases [RD06/0008/1013]	European Community(European Commission); Spanish Ministry of Education and Science(Spanish Government); Fundacio n Melchor Colet; Spanish Network for the Research in Infectious Diseases	Financed in part by the European Community (FP7/2007-2013; grant agreement nu 201024), the Spanish Ministry of Education and Science (SAF200804515- CO2-01 to AMP), the non-profitable foundation 'Fundacio n Melchor Colet' to A. Ch., and the Spanish Network for the Research in Infectious Diseases (REIPI, RD06/0008/1013) to F. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. Cervera and X. Urra are recipients of grants from the Spanish Institute of Health Carlos III.	Atkinson C, 2006, J IMMUNOL, V177, P7266, DOI 10.4049/jimmunol.177.10.7266; CARROLL MC, 2005, ADV IMMUNOL, V86, P37; Casanova JL, 2004, J EXP MED, V199, P1295, DOI 10.1084/jem.20040537; Chaka W, 1997, J IMMUNOL, V159, P2979; Chamorro A, 2005, STROKE, V36, P1495, DOI 10.1161/01.STR.0000170644.15504.49; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; CLARK WM, 1997, NEUROL RES, V19, P642; Cowell RM, 2003, J NEUROSCI, V23, P9459; De Simoni MG, 2004, AM J PATHOL, V164, P1857, DOI 10.1016/S0002-9440(10)63744-3; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; Di Napoli M, 2005, STROKE, V36, P1316, DOI 10.1161/01.STR.0000165929.78756.ed; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; GESUETE R, 2009, ANN NEUROL IN PRESS; Gill R, 2004, J CEREBR BLOOD F MET, V24, P1214, DOI 10.1097/01.WCB.0000136517.61642.99; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Justicia  C., 2006, J CEREB BLOOD FLOW M, V26, P321; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; Lindsberg PJ, 1996, ANN NEUROL, V40, P587, DOI 10.1002/ana.410400408; Lozano F, 2005, TISSUE ANTIGENS, V66, P131, DOI 10.1111/j.1399-0039.2005.00436.x; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Mocco J, 2006, NEUROSURGERY, V59, P28, DOI [10.1227/01.NEU.0000219221.14280.65, 10.1227/01.neu.0000243280.75920.f4]; Moller-Kristensen M, 2005, SCAND J IMMUNOL, V61, P426, DOI 10.1111/j.1365-3083.2005.01591.x; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; Mullighan CG, 2002, BLOOD, V99, P3524, DOI 10.1182/blood.V99.10.3524; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Pedersen ED, 2004, CLIN EXP IMMUNOL, V137, P117, DOI 10.1111/j.1365-2249.2004.02489.x; Petersen KA, 2006, J CLIN IMMUNOL, V26, P465, DOI 10.1007/s10875-006-9037-z; Planas AM, 2009, NAT MED, V15, P138, DOI 10.1038/nm0209-138; Schwaeble W, 2002, IMMUNOBIOLOGY, V205, P455, DOI 10.1078/0171-2985-00146; Shiratsuchi A, 2008, IMMUNOLOGY, V124, P575, DOI 10.1111/j.1365-2567.2008.02811.x; Sorensen R, 2005, SPRINGER SEMIN IMMUN, V27, P299, DOI 10.1007/s00281-005-0006-z; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Thiel S, 2002, IMMUNOBIOLOGY, V205, P446, DOI 10.1078/0171-2985-00145; Turner M W, 2000, Rev Immunogenet, V2, P305; Urra X, 2009, J CEREBR BLOOD F MET, V29, P994, DOI 10.1038/jcbfm.2009.25; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56	43	115	118	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e8433	10.1371/journal.pone.0008433	http://dx.doi.org/10.1371/journal.pone.0008433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140243	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474200001
J	Miotto, O; Heiny, AT; Albrecht, R; Garcia-Sastre, A; Tan, TW; August, JT; Brusic, V				Miotto, Olivo; Heiny, A. T.; Albrecht, Randy; Garcia-Sastre, Adolfo; Tan, Tin Wee; August, J. Thomas; Brusic, Vladimir			Complete-Proteome Mapping of Human Influenza A Adaptive Mutations: Implications for Human Transmissibility of Zoonotic Strains	PLOS ONE			English	Article							HOST-RANGE RESTRICTION; NUCLEAR EXPORT SIGNAL; AVIAN INFLUENZA; NS1 PROTEIN; VIRUS NUCLEOPROTEIN; POLYMERASE PROTEINS; PANDEMIC INFLUENZA; SEQUENCE-ANALYSIS; CRYSTAL-STRUCTURE; HIGH VIRULENCE	Background: There is widespread concern that H5N1 avian influenza A viruses will emerge as a pandemic threat, if they become capable of human-to-human (H2H) transmission. Avian strains lack this capability, which suggests that it requires important adaptive mutations. We performed a large-scale comparative analysis of proteins from avian and human strains, to produce a catalogue of mutations associated with H2H transmissibility, and to detect their presence in avian isolates. Methodology/Principal Findings: We constructed a dataset of influenza A protein sequences from 92,343 public database records. Human and avian sequence subsets were compared, using a method based on mutual information, to identify characteristic sites where human isolates present conserved mutations. The resulting catalogue comprises 68 characteristic sites in eight internal proteins. Subtype variability prevented the identification of adaptive mutations in the hemagglutinin and neuraminidase proteins. The high number of sites in the ribonucleoprotein complex suggests interdependence between mutations in multiple proteins. Characteristic sites are often clustered within known functional regions, suggesting their functional roles in cellular processes. By isolating and concatenating characteristic site residues, we defined adaptation signatures, which summarize the adaptive potential of specific isolates. Most adaptive mutations emerged within three decades after the 1918 pandemic, and have remained remarkably stable thereafter. Two lineages with stable internal protein constellations have circulated among humans without reassorting. On the contrary, H5N1 avian and swine viruses reassort frequently, causing both gains and losses of adaptive mutations. Conclusions: Human host adaptation appears to be complex and systemic, involving nearly all influenza proteins. Adaptation signatures suggest that the ability of H5N1 strains to infect humans is related to the presence of an unusually high number of adaptive mutations. However, these mutations appear unstable, suggesting low pandemic potential of H5N1 in its current form. In addition, adaptation signatures indicate that pandemic H1N1/09 strain possesses multiple human-transmissibility mutations, though not an unusually high number with respect to swine strains that infected humans in the past. Adaptation signatures provide a novel tool for identifying zoonotic strains with the potential to infect humans.	[Miotto, Olivo] Univ Oxford, Ctr Genom & Global Hlth, Oxford, England; [Miotto, Olivo] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok, Thailand; [Heiny, A. T.; Tan, Tin Wee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Albrecht, Randy; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Emerging Pathogens Inst, New York, NY USA; [August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Brusic, Vladimir] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA	University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; National University of Singapore; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute	Miotto, O (corresponding author), Univ Oxford, Ctr Genom & Global Hlth, Oxford, England.	olivo.miotto@ndm.ox.ac.uk	Miotto, Olivo/AAE-7124-2019; Tan, Tin Wee/B-8963-2009; Brusic, Vladimir/B-1478-2008; Albrecht, Randy A./H-5119-2019	Miotto, Olivo/0000-0001-8060-6771; Tan, Tin Wee/0000-0002-4062-2854; Brusic, Vladimir/0000-0003-0523-5266; Albrecht, Randy A./0000-0003-4008-503X; Garcia-Sastre, Adolfo/0000-0002-6551-1827	Medical Research Council, United Kingdom; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, United States of America [5 U19 AI56541, HHSN2662-00400085C, HHSN2662-00700010C]; EC [FP6-2004-IST-4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge support by the Medical Research Council, United Kingdom; Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, United States of America, under Grant No. 5 U19 AI56541 and Contract Nos. HHSN2662-00400085C and HHSN2662-00700010C. VB acknowledges support in part by the ImmunoGrid project, under EC contract FP6-2004-IST-4, NO 028069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; BAEZ M, 1981, VIROLOGY, V113, P397, DOI 10.1016/0042-6822(81)90166-5; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; BUCKLERWHITE AJ, 1986, J VIROL, V57, P697, DOI 10.1128/JVI.57.2.697-700.1986; BUONAGURIO DA, 1986, SCIENCE, V232, P980, DOI 10.1126/science.2939560; Capua I, 2002, ACTA TROP, V83, P1, DOI 10.1016/S0001-706X(02)00050-5; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Hui EKW, 2003, J VIROL, V77, P7078, DOI 10.1128/JVI.77.12.7078-7092.2003; Iwatsuki-Horimoto K, 2004, J VIROL, V78, P10149, DOI 10.1128/JVI.78.18.10149-10155.2004; JONES IM, 1986, EMBO J, V5, P2371, DOI 10.1002/j.1460-2075.1986.tb04506.x; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; KENDAL AP, 1978, VIROLOGY, V89, P632, DOI 10.1016/0042-6822(78)90207-6; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S7; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; MUKAIGAWA J, 1991, J VIROL, V65, P245, DOI 10.1128/JVI.65.1.245-253.1991; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; PEIRIS JS, 2009, EUR J IMMUNOL; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Qian XY, 1995, RNA, V1, P948; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; SCHOLTISSEK C, 1983, VIROLOGY, V129, P521, DOI 10.1016/0042-6822(83)90194-0; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TREANOR JJ, 1989, VIROLOGY, V171, P1, DOI 10.1016/0042-6822(89)90504-7; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017	66	60	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9025	10.1371/journal.pone.0009025	http://dx.doi.org/10.1371/journal.pone.0009025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140252	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474200012
J	Nalbantoglu, U; Sayood, K; Dempsey, MP; Iwen, PC; Francesconi, SC; Barabote, RD; Xie, G; Brettin, TS; Hinrichs, SH; Fey, PD				Nalbantoglu, Ufuk; Sayood, Khalid; Dempsey, Michael P.; Iwen, Peter C.; Francesconi, Stephen C.; Barabote, Ravi D.; Xie, Gary; Brettin, Thomas S.; Hinrichs, Steven H.; Fey, Paul D.			Large Direct Repeats Flank Genomic Rearrangements between a New Clinical Isolate of Francisella tularensis subsp tularensis A1 and Schu S4	PLOS ONE			English	Article							UNITED-STATES; POPULATION-STRUCTURE; MOLECULAR ANALYSIS; IDENTIFICATION; TULAREMIA; SEQUENCE; STRAIN	Francisella tularensis subspecies tularensis consists of two separate populations A1 and A2. This report describes the complete genome sequence of NE061598, an F. tularensis subspecies tularensis A1 isolated in 1998 from a human with clinical disease in Nebraska, United States of America. The genome sequence was compared to Schu S4, an F. tularensis subspecies tularensis A1a strain originally isolated in Ohio in 1941. It was determined that there were 25 nucleotide polymorphisms (22 SNPs and 3 indels) between Schu S4 and NE061598; two of these polymorphisms were in potential virulence loci. Pulsed-field gel electrophoresis analysis demonstrated that NE061598 was an A1a genotype. Other differences included repeat sequences (n = 11 separate loci), four of which were contained in coding sequences, and an inversion and rearrangement probably mediated by insertion sequences and the previously identified direct repeats I, II, and III. Five new variable-number tandem repeats were identified; three of these five were unique in NE061598 compared to Schu S4. Importantly, there was no gene loss or gain identified between NE061598 and Schu S4. Interpretation of these data suggests there is significant sequence conservation and chromosomal synteny within the A1 population. Further studies are needed to determine the biological properties driving the selective pressure that maintains the chromosomal structure of this monomorphic pathogen.	[Nalbantoglu, Ufuk; Sayood, Khalid] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA; [Iwen, Peter C.; Hinrichs, Steven H.; Fey, Paul D.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Barabote, Ravi D.; Xie, Gary] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Barabote, Ravi D.; Xie, Gary] DOE Joint Genome Inst, Walnut Creek, CA USA; [Dempsey, Michael P.] Armed Forces Inst Pathol, Div Microbiol, Washington, DC 20306 USA; [Francesconi, Stephen C.] USN, Med Res Ctr, Silver Spring, MD USA; [Brettin, Thomas S.] Oak Ridge Natl Lab, Oak Ridge, TN USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); United States Department of Defense; United States Department of Defense; United States Navy; United States Department of Energy (DOE); Oak Ridge National Laboratory	Nalbantoglu, U (corresponding author), Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.	pfey@unmc.edu	Barabote, Ravi/B-8727-2011; Dempsey, Michael/GSM-7774-2022; Nalbantoglu, Ozkan Ufuk/AAK-5238-2021; Nalbantoglu, Ufuk/AAA-8033-2022; Barabote, Ravi/C-1299-2017	Nalbantoglu, Ozkan Ufuk/0000-0002-2278-7786; Barabote, Ravi/0000-0002-0403-246X; xie, gary/0000-0002-9176-924X	Department of Defense, Defense Advanced Research Program Agency [W911NF0510275]	Department of Defense, Defense Advanced Research Program Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by a grant from the Department of Defense, Defense Advanced Research Program Agency ( award W911NF0510275) to S. H. H. The opinions expressed in this manuscript are the private views of the authors and are not the official views of the Armed Forces Institute of Pathology, the Department of the Army, the United States Air Force, or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Fey PD, 2007, AM J CLIN PATHOL, V128, P926, DOI 10.1309/JN3NTHK4VVWKJT4A; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lin YC, 2006, NUCLEIC ACIDS RES, V34, pW696, DOI 10.1093/nar/gkl169; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; VOGLER AJ, 2009, J BACTERIOL	18	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9007	10.1371/journal.pone.0009007	http://dx.doi.org/10.1371/journal.pone.0009007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140244	Green Submitted, Green Published, gold			2022-12-25	WOS:000274474200008
J	Greatorex, JS; Page, RF; Curran, MD; Digard, P; Enstone, JE; Wreghitt, T; Powell, PP; Sexton, DW; Vivancos, R; Nguyen-Van-Tam, JS				Greatorex, Jane S.; Page, Rosanna F.; Curran, Martin D.; Digard, Paul; Enstone, Joanne E.; Wreghitt, Tim; Powell, Penny P.; Sexton, Darren W.; Vivancos, Roberto; Nguyen-Van-Tam, Jonathan S.			Effectiveness of Common Household Cleaning Agents in Reducing the Viability of Human Influenza A/H1N1	PLOS ONE			English	Article							TIME RT-PCR; A VIRUS; INACTIVATION; ENVIRONMENTS	Background: In the event of an influenza pandemic, the majority of people infected will be nursed at home. It is therefore important to determine simple methods for limiting the spread of the virus within the home. The purpose of this work was to test a representative range of common household cleaning agents for their effectiveness at killing or reducing the viability of influenza A virus. Methodology/Principal Findings: Plaque assays provided a robust and reproducible method for determining virus viability after disinfection, while a National Standard influenza virus RT-PCR assay (VSOP 25, www.hpa-standardmethods.org.uk) was adapted to detect viral genome, and a British Standard (BS:EN 14476: 2005) was modified to determine virus killing. Conclusions/Significance: Active ingredients in a number of the cleaning agents, wipes, and tissues tested were able to rapidly render influenza virus nonviable, as determined by plaque assay. Commercially available wipes with a claimed antiviral or antibacterial effect killed or reduced virus infectivity, while nonmicrobiocidal wipes and those containing only low concentrations (<5%) of surfactants showed lower anti-influenza activity. Importantly, however, our findings indicate that it is possible to use common, low-technology agents such as 1% bleach, 10% malt vinegar, or 0.01% washing-up liquid to rapidly and completely inactivate influenza virus. Thus, in the context of the ongoing pandemic, and especially in low-resource settings, the public does not need to source specialized cleaning products, but can rapidly disinfect potentially contaminated surfaces with agents readily available in most homes.	[Greatorex, Jane S.; Curran, Martin D.; Wreghitt, Tim] Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England; [Page, Rosanna F.; Digard, Paul] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Enstone, Joanne E.; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Nottingham NG7 2RD, England; [Powell, Penny P.; Sexton, Darren W.; Vivancos, Roberto] Univ E Anglia, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Nguyen-Van-Tam, Jonathan S.] Hlth Protect Agcy, Nottingham, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge; University of Cambridge; University of Nottingham; University of East Anglia; Health Protection Agency	Greatorex, JS (corresponding author), Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England.	jvt@nottingham.ac.uk	Sexton, Darren/AAF-3171-2020; Nguyen-Van-Tam, Jonathan/I-2162-2019; Digard, Paul/B-7717-2008	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Digard, Paul/0000-0002-0872-9440; Sexton, Darren/0000-0003-3344-3150; Vivancos, Roberto/0000-0002-8203-8867; Powell, Penny/0000-0002-5347-0490	United Kingdom Health Protection Agency	United Kingdom Health Protection Agency	Funded by the United Kingdom Health Protection Agency. The funder had no role in study design, data collection and analysis, or preparation of the manuscript. However, the manuscript was cleared for submission under the funder's manuscript approval standard operating procedures.	Abe M, 2007, JPN J INFECT DIS, V60, P342; *AUSVETPLAN, 2000, AUSTR VET EM PLAN OP; De Benedictis P, 2007, ZOONOSES PUBLIC HLTH, V54, P51, DOI 10.1111/j.1863-2378.2007.01029.x; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Healing T., 2006, COLL PRES SHIPP SPEC; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; Lombardi ME, 2008, AVIAN DIS, V52, P118, DOI 10.1637/8055-070907-Reg; Lu H, 2003, AVIAN DIS, V47, P1015, DOI 10.1637/0005-2086-47.s3.1015; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; MUHAMMAD K, 2001, INT J AGR BIOL, V3, P416; Rennie P, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-38; Rice EW, 2007, EMERG INFECT DIS, V13, P1568, DOI 10.3201/eid1310.070323; Rolfe KJ, 2007, J CLIN VIROL, V39, P318, DOI 10.1016/j.jcv.2007.05.005; SATO SB, 1983, P NATL ACAD SCI-BIOL, V80, P3153, DOI 10.1073/pnas.80.11.3153; Suarez DL, 2003, AVIAN DIS, V47, P1091, DOI 10.1637/0005-2086-47.s3.1091; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; BSEN144762005	18	31	31	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8987	10.1371/journal.pone.0008987	http://dx.doi.org/10.1371/journal.pone.0008987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126543	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000274209700013
J	Schwarz, J; Burguet, J; Rampin, O; Fromentin, G; Andrey, P; Tome, D; Maurin, Y; Darcel, N				Schwarz, Jessica; Burguet, Jasmine; Rampin, Olivier; Fromentin, Gilles; Andrey, Philippe; Tome, Daniel; Maurin, Yves; Darcel, Nicolas			Three-Dimensional Macronutrient-Associated Fos Expression Patterns in the Mouse Brainstem	PLOS ONE			English	Article							FOOD-INTAKE; 5-HT3 RECEPTORS; CHOLECYSTOKININ; PROTEIN; RAT; INFUSIONS; SATIETY; SYSTEM; FORMS	Background: The caudal brainstem plays an important role in short-term satiation and in the control of meal termination. Meal-related stimuli sensed by the gastrointestinal (GI) tract are transmitted to the area postrema (AP) via the bloodstream, or to the nucleus tractus solitarii (NTS) via the vagus nerve. Little is known about the encoding of macronutrient-specific signals in the caudal brainstem. We hypothesized that sucrose and casein peptone activate spatially distinct sub-populations of NTS neurons and thus characterized the latter using statistical three-dimensional modeling. Methodology/Principal Findings: Using immunolabeling of the proto-oncogene Fos as a marker of neuronal activity, in combination with a statistical three-dimensional modeling approach, we have shown that NTS neurons activated by sucrose or peptone gavage occupy distinct, although partially overlapping, positions. Specifically, when compared to their homologues in peptone-treated mice, three-dimensional models calculated from neuronal density maps following sucrose gavage showed that Fos-positive neurons occupy a more lateral position at the rostral end of the NTS, and a more dorsal position at the caudal end. Conclusion/Significance: To our knowledge, this is the first time that subpopulations of NTS neurons have be distinguished according to the spatial organization of their functional response. Such neuronal activity patterns may be of particular relevance to understanding the mechanisms that support the central encoding of signals related to the presence of macronutrients in the GI tract during digestion. Finally, this finding also illustrates the usefulness of statistical three-dimensional modeling to functional neuroanatomical studies.	[Schwarz, Jessica; Fromentin, Gilles; Tome, Daniel; Darcel, Nicolas] AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Schwarz, Jessica; Fromentin, Gilles; Tome, Daniel; Darcel, Nicolas] INRA, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Burguet, Jasmine; Rampin, Olivier; Andrey, Philippe; Maurin, Yves] INRA, UMR Neurobiol Olfact & Prise Alimentaire 1197, Jouy En Josas, France; [Burguet, Jasmine; Rampin, Olivier; Andrey, Philippe; Maurin, Yves] Univ Paris 11, UMR 1197, Orsay, France; [Burguet, Jasmine; Rampin, Olivier; Andrey, Philippe; Maurin, Yves] IFR 144 Neuro Sud Paris, Paris, France; [Andrey, Philippe] Univ Paris 06, Paris, France	AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Schwarz, J (corresponding author), AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France.	nicolas.darcel@agroparistech.fr	Schwarz, Jessica/J-3374-2012; Andrey, Philippe/AAS-7228-2021	Schwarz, Jessica/0000-0002-2594-2200	European Commission's Sixth Framework Programme (FP6) [MEST-CT-20058-020494]	European Commission's Sixth Framework Programme (FP6)	The research that led to these results received funding from the European Commission's Sixth Framework Programme (FP6) under NuSISCO Contract No. MEST-CT-20058-020494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Andrey P, 2005, J NEUROSCI METH, V145, P233, DOI 10.1016/j.jneumeth.2005.01.006; ANDREY P, 2008, 5 IEEE INT S BIOM IM, P1183; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Bowen J, 2006, J CLIN ENDOCR METAB, V91, P1477, DOI 10.1210/jc.2005-1856; Burguet J, 2009, J COMP NEUROL, V513, P483, DOI 10.1002/cne.21954; Freeman SL, 2006, AM J PHYSIOL-GASTR L, V291, pG439, DOI 10.1152/ajpgi.00079.2006; Hayes MR, 2004, PHYSIOL BEHAV, V82, P663, DOI 10.1016/j.physbeh.2004.06.001; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; LIDDLE RA, 1985, J CLIN INVEST, V75, P1144, DOI 10.1172/JCI111809; LUO F, 2009, 3 DIMENSIONAL TONOTO; Malmierca MS, 2008, J NEUROSCI, V28, P4767, DOI 10.1523/JNEUROSCI.0238-08.2008; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Maschino E, 2006, COMPUT VIS IMAGE UND, V101, P16, DOI 10.1016/j.cviu.2005.06.004; Moran TH, 2004, AM J PHYSIOL-GASTR L, V286, pG183, DOI 10.1152/ajpgi.00434.2003; Morens C, 2000, J NUTR, V130, P2312, DOI 10.1093/jn/130.9.2312; NORGREN R, 1988, J COMP NEUROL, V273, P207, DOI 10.1002/cne.902730206; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petersen CCH, 2003, PFLUG ARCH EUR J PHY, V447, P126, DOI 10.1007/s00424-003-1167-z; Phifer CB, 1998, AM J PHYSIOL-REG I, V274, pR1725, DOI 10.1152/ajpregu.1998.274.6.R1725; Raybould HE, 2003, AM J PHYSIOL-GASTR L, V284, pG367, DOI 10.1152/ajpgi.00292.2001; Raybould HE, 1999, AM J PHYSIOL-GASTR L, V277, pG751, DOI 10.1152/ajpgi.1999.277.4.G751; Raybould HE, 2006, AUTON NEUROSCI-BASIC, V125, P28, DOI 10.1016/j.autneu.2006.01.016; Schwartz GJ, 2006, PHILOS T R SOC B, V361, P1275, DOI 10.1098/rstb.2006.1862; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Silverman B.W., 1986, DENSITY ESTIMATION S; TEAM RDC, 2009, R A LANGUAGE ENV STA; Tome D, 2004, BRIT J NUTR, V92, pS27, DOI 10.1079/BJN20041138; WEI Y, 1995, FEBS LETT, V358, P219, DOI 10.1016/0014-5793(94)01430-9; Yamamoto T, 2000, BRAIN RES, V866, P144, DOI 10.1016/S0006-8993(00)02242-3; ZITTEL TT, 1994, BRAIN RES, V663, P266, DOI 10.1016/0006-8993(94)91272-6	31	23	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8974	10.1371/journal.pone.0008974	http://dx.doi.org/10.1371/journal.pone.0008974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126542	gold, Green Published, Green Submitted			2022-12-25	WOS:000274209700006
J	Rodelsperger, C; Dieterich, C				Roedelsperger, Christian; Dieterich, Christoph			CYNTENATOR: Progressive Gene Order Alignment of 17 Vertebrate Genomes	PLOS ONE			English	Article							CHROMOSOMAL HOMOLOGY; SYNTENY; ARABIDOPSIS; CONSTRAINT; CLUSTERS; REGIONS; P300	Whole genome gene order evolution in higher eukaryotes was initially considered as a random process. Gene order conservation or conserved synteny was seen as a feature of common descent and did not imply the existence of functional constraints. This view had to be revised in the light of results from sequencing dozens of vertebrate genomes. It became apparent that other factors exist that constrain gene order in some genomic regions over long evolutionary time periods. Outside of these regions, genomes diverge more rapidly in terms of gene content and order. We have developed CYNTENATOR, a progressive gene order alignment software, to identify genomic regions of conserved synteny over a large set of diverging species. CYNTENATOR does not depend on nucleotide-level alignments and a priori homology assignment. Our software implements an improved scoring function that utilizes the underlying phylogeny. In this manuscript, we report on our progressive gene order alignment approach, a and give a comparison to previous software and an analysis of 17 vertebrate genomes for conservation in gene order. CYNTENATOR has a runtime complexity of O(n(3)) and a space complexity of O(n(2)) with n being the gene number in a genome. CYNTENATOR performs as good as state-of-the-art software on simulated pairwise gene order comparisons, but is the only algorithm that works in practice for aligning dozens of vertebrate-sized gene orders. Lineage-specific characterization of gene order across 17 vertebrate genomes revealed mechanisms for maintaining conserved synteny such as enhancers and coregulation by bidirectional promoters. Genes outside conserved synteny blocks show enrichments for genes involved in responses to external stimuli, stimuli such as immunity and olfactory response in primate genome comparisons. We even see significant gene ontology term enrichments for breakpoint regions of ancestral nodes close to the root of the phylogeny. Additionally, our analysis of transposable elements has revealed a significant accumulation of LINE-1 elements in mammalian breakpoint regions. In summary, CYNTENATOR is a flexible and scalable tool for the identification of conserved gene orders across multiple species over long evolutionary distances.	[Roedelsperger, Christian] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Roedelsperger, Christian] Max Planck Inst Mol Genet, Berlin, Germany; [Dieterich, Christoph] Berlin Inst Med Syst Biol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Rodelsperger, C (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	christoph.dieterich@mdc-berlin.de	, roedelsberg/Q-3831-2019; Dieterich, Christoph/ABF-8459-2021	, roedelsberg/0000-0002-7905-9675; 	Max Planck Society; Helmholtz Society	Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Society(Helmholtz Association)	CR acknowledges funding by the Max Planck Society. CD acknowledges funding by the Helmholtz Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Boyer F, 2005, BIOINFORMATICS, V21, P4209, DOI 10.1093/bioinformatics/bti711; Calabrese PP, 2003, BIOINFORMATICS, V19, pi74, DOI 10.1093/bioinformatics/btg1008; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Gregory T. R., 2011, EVOLUTION GENOME; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hampson S, 2003, GENOME RES, V13, P999, DOI 10.1101/gr.814403; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Ling X, 2009, BIOINFORMATICS, V25, P571, DOI 10.1093/bioinformatics/btp027; Luc N, 2003, COMPUT BIOL CHEM, V27, P59, DOI 10.1016/S1476-9271(02)00097-X; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Ng MP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-192; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; OSTLUND G, 2009, NUCL ACIDS RES; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Rodelsperger C, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-14; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vandepoele K, 2002, GENOME RES, V12, P1792, DOI 10.1101/gr.400202; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang XY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-447; WATERMAN MS, 1987, J MOL BIOL, V197, P723, DOI 10.1016/0022-2836(87)90478-5; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yang MQ, 2007, PLOS COMPUT BIOL, V3, P733, DOI 10.1371/journal.pcbi.0030072; Yang MQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S9; Zeng X, 2008, P 11 INT C EXT DAT T	40	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8861	10.1371/journal.pone.0008861	http://dx.doi.org/10.1371/journal.pone.0008861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126624	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000274138000002
J	Semmens, BX; Auster, PJ; Paddack, MJ				Semmens, Brice X.; Auster, Peter J.; Paddack, Michelle J.			Using Ecological Null Models to Assess the Potential for Marine Protected Area Networks to Protect Biodiversity	PLOS ONE			English	Article							REEF FISH DIVERSITY; CORAL-REEFS; SPECIES COOCCURRENCE; HABITAT COMPLEXITY; TROPHIC CASCADES; ASSEMBLY RULES; NESTEDNESS; RESERVES; ABUNDANCE; COMMUNITIES	Marine protected area (MPA) networks have been proposed as a principal method for conserving biological diversity, yet patterns of diversity may ultimately complicate or compromise the development of such networks. We show how a series of ecological null models can be applied to assemblage data across sites in order to identify non-random biological patterns likely to influence the effectiveness of MPA network design. We use fish census data from Caribbean fore-reefs as a test system and demonstrate that: 1) site assemblages were nested, such that species found on sites with relatively few species were subsets of those found on sites with relatively many species, 2) species co-occurred across sites more than expected by chance once species-habitat associations were accounted for, and 3) guilds were most evenly represented at the richest sites and richness among all guilds was correlated (i.e., species and trophic diversity were closely linked). These results suggest that the emerging Caribbean marine protected area network will likely be successful at protecting regional diversity even if planning is largely constrained by insular, inventory-based design efforts. By recasting ecological null models as tests of assemblage patterns likely to influence management action, we demonstrate how these classic tools of ecological theory can be brought to bear in applied conservation problems.	[Semmens, Brice X.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Auster, Peter J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Auster, Peter J.] Univ Connecticut, Natl Undersea Res Ctr, Groton, CT USA; [Paddack, Michelle J.] Santa Barbara City Coll, Dept Biol, Santa Barbara, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Connecticut; University of Connecticut	Semmens, BX (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.	brice.semmens@noaa.gov	Auster, Peter/ABI-3568-2020		STAR EPA; National Research Council through the Northwest Fisheries Science Center, NOAA; Pew Marine Conservation; UK Natural Environment Resource Council [NE/C004442/1]; NERC [NE/C004442/1] Funding Source: UKRI; Natural Environment Research Council [NE/C004442/1] Funding Source: researchfish	STAR EPA; National Research Council through the Northwest Fisheries Science Center, NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Pew Marine Conservation; UK Natural Environment Resource Council; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a STAR EPA fellowship and a National Research Council post-doctoral fellowship through the Northwest Fisheries Science Center, NOAA, to BXS, a Pew Marine Conservation Fellowship to PJA, and a grant from the UK Natural Environment Resource Council NE/C004442/1 to MJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2004, ECOLOGY, V85, P2933, DOI 10.1890/03-3150; Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; Auster PJ, 2005, ENVIRON BIOL FISH, V74, P187, DOI 10.1007/s10641-005-8078-0; Ball IR, 2000, MARINE RESERVE DESIG; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Boecklen WJ, 1997, OECOLOGIA, V112, P123, DOI 10.1007/s004420050292; Brune J. F., 2007, PLOS ONE         AUG, P1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cowie-Haskell BD, 2003, MAR TECHNOL SOC J, V37, P68, DOI 10.4031/002533203787537447; Diamond J.M., 1975, P342; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; EHRLICH PR, 1973, AM NAT, V107, P157, DOI 10.1086/282823; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Feeley K, 2003, OECOLOGIA, V137, P104, DOI 10.1007/s00442-003-1321-5; Fischer J, 2002, OIKOS, V99, P193, DOI 10.1034/j.1600-0706.2002.990121.x; Fraschetti S, 2005, MAR ENVIRON RES, V59, P309, DOI 10.1016/j.marenvres.2004.05.007; Gotelli N.J., 1996, NULL MODELS ECOLOGY, DOI DOI 10.1098/rspb.2014.0675; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.1890/0012-9658(2002)083[2091:SCOAMA]2.0.CO;2; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Halpern BS, 2003, ECOL APPL, V13, pS117; Heino J, 2009, FRESHWATER BIOL, V54, P1947, DOI 10.1111/j.1365-2427.2009.02250.x; Hixon MA, 2005, ECOLOGY, V86, P2847, DOI 10.1890/04-1455; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; HOLM S, 1979, SCAND J STAT, V6, P65; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; KELLEHER G, 1999, SERIES IUCN PROTECTE, V3; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; LUKOSCHEK V, 2000, P 9 INT COR REEF S B, V1, P23; Maiorano L, 2009, ICES J MAR SCI, V66, P137, DOI 10.1093/icesjms/fsn148; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marks K. W., 2007, ATLANTIC GULF RAPID; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Peres-Neto PR, 2001, OIKOS, V93, P110, DOI 10.1034/j.1600-0706.2001.930112.x; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Ripple WJ, 2008, BIOL CONSERV, V141, P1249, DOI 10.1016/j.biocon.2008.02.028; Roberts CM, 2003, ECOL APPL, V13, pS215; Roberts CM, 2003, ECOL APPL, V13, pS199; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; ROBERTSON DR, 1986, ECOLOGY, V67, P1372, DOI 10.2307/1938693; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; Smith RJ, 2009, ICES J MAR SCI, V66, P188, DOI 10.1093/icesjms/fsn198; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; Stewart RR, 2003, MAR ECOL PROG SER, V253, P25, DOI 10.3354/meps253025; STONE L, 1992, OECOLOGIA, V91, P419, DOI 10.1007/BF00317632; STRAND S, 1988, COPEIA, P351, DOI 10.2307/1445875; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Ward TJ, 1999, ECOL APPL, V9, P691; Webster MS, 2002, ECOL LETT, V5, P549, DOI 10.1046/j.1461-0248.2002.00355.x; Weiher E., 1999, ECOLOGICAL ASSEMBLY; Williams D. McB, 1991, ECOLOGY FISHES CORAL, P437; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; WILSON JB, 1989, OECOLOGIA, V80, P263, DOI 10.1007/BF00380161; *WORLD COMM PROT A, 2007, WORLD DAT PROT AR; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	75	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8895	10.1371/journal.pone.0008895	http://dx.doi.org/10.1371/journal.pone.0008895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111711	Green Published, Green Submitted, gold			2022-12-25	WOS:000274114800010
J	Hsieh, CC; Hernandez-Ledesma, B; Jeong, HJ; Park, JH; de Lumen, BO				Hsieh, Chia-Chien; Hernandez-Ledesma, Blanca; Jeong, Hyun Jin; Park, Jae Ho; de Lumen, Ben O.			Complementary Roles in Cancer Prevention: Protease Inhibitor Makes the Cancer Preventive Peptide Lunasin Bioavailable	PLOS ONE			English	Article							BOWMAN-BIRK INHIBITOR; CORE HISTONE ACETYLATION; MAMMALIAN-CELLS; SOY PROTEIN; HUMAN BREAST; FEMALE RATS; NUDE-MICE; IN-VITRO; GROWTH; CARCINOGENESIS	Background: The lower incidence of breast cancer among Asian women compared with Western countries has been partly attributed to soy in the Asian diet, leading to efforts to identify the bioactive components that are responsible. Soy Bowman Birk Inhibitor Concentrate (BBIC) is a known cancer preventive agent now in human clinical trials. Methodology/Principal Findings: The objectives of this work are to establish the presence and delineate the in vitro activity of lunasin and BBI found in BBIC, and study their bioavailability after oral administration to mice and rats. We report that lunasin and BBI are the two main bioactive ingredients of BBIC based on inhibition of foci formation, lunasin being more efficacious than BBI on an equimolar basis. BBI and soy Kunitz Trypsin Inhibitor protect lunasin from in vitro digestion with pancreatin. Oral administration of H-3-labeled lunasin with lunasin-enriched soy results in 30% of the peptide reaching target tissues in an intact and bioactive form. In a xenograft model of nude mice transplanted with human breast cancer MDA-MB-231 cells, intraperitoneal injections of lunasin, at 20 mg/kg and 4 mg/kg body weight, decrease tumor incidence by 49% and 33%, respectively, compared with the vehicle-treated group. In contrast, injection with BBI at 20 mg/kg body weight shows no effect on tumor incidence. Tumor generation is significantly reduced with the two doses of lunasin, while BBI is ineffective. Lunasin inhibits cell proliferation and induces cell death in the breast tumor sections. Conclusions/Significance: We conclude that lunasin is actually the bioactive cancer preventive agent in BBIC, and BBI simply protects lunasin from digestion when soybean and other seed foods are eaten by humans.	[Hsieh, Chia-Chien; Hernandez-Ledesma, Blanca; de Lumen, Ben O.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Jeong, Hyun Jin; Park, Jae Ho] Andong Natl Univ, Andong, South Korea	University of California System; University of California Berkeley; Andong National University	Hsieh, CC (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	nitto@berkeley.edu	Hernández-Ledesma, Blanca/M-8637-2013	Hernández-Ledesma, Blanca/0000-0001-7192-6044; de Lumen, Ben/0000-0001-9569-1921	American Institute for Cancer Research [05B087]; United States Department of Defense [W81XWH-04-1-0128]; European Commission [LUNAMICE 039241]; Spanish National Research Council for the Marie-Curie postdoctoral fellowship of BHL	American Institute for Cancer Research; United States Department of Defense(United States Department of Defense); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish National Research Council for the Marie-Curie postdoctoral fellowship of BHL	Project number 05B087 awarded by the American Institute for Cancer Research (http://www.aicr.org/site/PageServer). Project number W81XWH-04-1-0128 awarded by the United States Department of Defense Congressionally Directed Medical Research Program (https://cdmrp.org). Project LUNAMICE 039241 awarded by the European Commission and the Spanish National Research Council for the Marie-Curie postdoctoral fellowship of BHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ CHT, 1995, J NUTR, V125, pS757, DOI 10.1093/jn/125.3_Suppl.757S; Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; BARNES S, 1990, PROG CLIN BIOL RES, V347, P239; Beliveau R, 2007, CAN FAM PHYSICIAN, V53, P1905; *BOARD TRUST, 1995, SIM GASTR FLUID SIM; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; Clemente A, 2005, J AGR FOOD CHEM, V53, P8979, DOI 10.1021/jf051528w; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; de Lumen BO, 2005, NUTR REV, V63, P16, DOI [10.1301/nr.2004.janr.16-21, 10.1111/j.1753-4887.2005.tb00106.x]; Dia VP, 2009, J AGR FOOD CHEM, V57, P1260, DOI 10.1021/jf803303k; Du XT, 2001, CANCER LETT, V164, P135, DOI 10.1016/S0304-3835(01)00381-0; Galvez AF, 2001, CANCER RES, V61, P7473; Galvez AF, 1999, NAT BIOTECHNOL, V17, P495, DOI 10.1038/8676; Hakkak R, 2000, CANCER EPIDEM BIOMAR, V9, P113; Hernandez-Ledesma B, 2009, FOOD CHEM, V115, P574, DOI 10.1016/j.foodchem.2008.12.054; Hsieh EA, 2004, J INVEST DERMATOL, V123, P530, DOI 10.1111/j.0022-202X.2004.23303.x; Jeong HJ, 2002, J AGR FOOD CHEM, V50, P5903, DOI 10.1021/jf0256945; Jeong HJ, 2007, CANCER LETT, V255, P42, DOI 10.1016/j.canlet.2007.03.022; Jeong HJ, 2007, J AGR FOOD CHEM, V55, P632, DOI 10.1021/jf062405u; Jeong JB, 2007, J AGR FOOD CHEM, V55, P10707, DOI 10.1021/jf072363p; Johnson WD, 2006, INT J TOXICOL, V25, P219, DOI 10.1080/10915810600683366; Kennedy AR, 1998, PHARMACOL THERAPEUT, V78, P167, DOI 10.1016/S0163-7258(98)00010-2; Kennedy AR, 1996, CANCER RES, V56, P679; Kennedy AR, 2003, PHARM RES, V20, P1908, DOI 10.1023/B:PHAM.0000008035.02046.cb; KENNEDY AR, 1993, NUTR CANCER, V19, P281, DOI 10.1080/01635589309514259; KENNEDY AR, 1993, NUTR CANCER, V19, P191, DOI 10.1080/01635589309514249; Lam Y, 2003, NUTR CANCER, V47, P88, DOI 10.1207/s15327914nc4701_11; LAMBERT JD, 2008, CABI BOT MED CLIN PR, P328; Losso JN, 2008, CRIT REV FOOD SCI, V48, P94, DOI 10.1080/10408390601177589; Mai ZM, 2007, CARCINOGENESIS, V28, P1217, DOI 10.1093/carcin/bgm004; Mukhopadhyay S, 2006, MOL CELL BIOCHEM, V290, P169, DOI 10.1007/s11010-006-9184-9; Park JH, 2007, J AGR FOOD CHEM, V55, P10703, DOI 10.1021/jf072107c; Power KA, 2006, INT J CANCER, V118, P1316, DOI 10.1002/ijc.21464; Prasain JK, 2007, MOL PHARMACEUT, V4, P846, DOI 10.1021/mp700116u; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Silva-Sanchez C, 2008, J AGR FOOD CHEM, V56, P1233, DOI 10.1021/jf072911z; TROLL W, 1980, CARCINOGENESIS, V1, P469, DOI 10.1093/carcin/1.6.469; Vantyghem SA, 2005, CANCER RES, V65, P3396, DOI 10.1158/0008-5472.CAN-04-4109; Wan XS, 1999, PROSTATE, V41, P243; Zhang LL, 1999, NUTR CANCER, V33, P165, DOI 10.1207/S15327914NC330208	41	87	89	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8890	10.1371/journal.pone.0008890	http://dx.doi.org/10.1371/journal.pone.0008890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126654	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500013
J	Watts, SM; Uhl, MM; Maurano, SP; Nuccio, EE				Watts, Sean M.; Uhl, Melissa M.; Maurano, Stephen P.; Nuccio, Erin E.			Using Small-Scale Studies to Prioritize Threats and Guide Recovery of a Rare Hemiparasitic Plant: Cordylanthus rigidus ssp littoralis	PLOS ONE			English	Article							CHAPARRAL SHRUB; UNITED-STATES; FIRE; CONSERVATION; GERMINATION; GRASSLAND; IMPACTS	Background: Recovering endangered species would benefit from identifying and ranking of the factors that threaten them. Simply managing for multiple positive influences will often aid in recovery; however, the relative impacts of multiple threats and/or interactions among them are not always predictable. We used a series of experiments and quantitative observational studies to examine the importance of five potential limiting factors to the abundance of a state-listed endangered hemiparasitic annual forb, Cordylanthus rigidus ssp. littoralis (C.r.l., California, USA): host availability, mammalian herbivores, insect seed predators, fire suppression, and exotic species. While this initial assessment is certainly not a complete list, these factors stem from direct observation and can inform provisional recommendations for management and further research. Methodology and Principal Findings: Studies were conducted at five sites and included assessments of the influence of host availability, exotic species, exclusion of mammalian herbivores and insect seed predators on C.r.l. productivity, and simulated effects of fire on seed germination. C.r.l. was limited by multiple threats: individuals with access to host species produced up to three times more inflorescences than those lacking hosts, mammalian herbivory reduced C.r.l. size and fecundity by more than 50% and moth larvae reduced seed production by up to 40%. Litter deposition and competition from exotic plant species also appears to work in conjunction with other factors to limit C.r.l. throughout its life cycle. Conclusions and Significance: The work reported here highlights the contribution that a series of small-scale studies can make to conservation and restoration. Taken as a whole, the results can be used immediately to inform current management and species recovery strategies. Recovery of C.r.l. will require management that addresses competition with exotic plant species, herbivore pressure, and availability of preferred host species.	[Watts, Sean M.; Uhl, Melissa M.; Maurano, Stephen P.] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Nuccio, Erin E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Santa Clara University; University of California System; University of California Berkeley	Watts, SM (corresponding author), Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA.	SWatts@scu.edu		Nuccio, Erin/0000-0003-0189-183X	Santa Clara University [14007, 14009, 14015]	Santa Clara University	This work was funded by internal grants from Santa Clara University (http://www.scu.edu/; fund numbers: 14007, 14009 and 14015 to SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbitt RJF, 2001, CONSERV BIOL, V15, P1274, DOI 10.1046/j.1523-1739.2001.00430.x; BARTHOLOMEW B, 1970, SCIENCE, V170, P1210, DOI 10.1126/science.170.3963.1210; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; BOYD RS, 1992, AM J BOT, V79, P1264, DOI 10.2307/2445054; *CA DFG, 2000, STAT RAR THREAT END, P131; *CA DFG, 2009, STAT FED END THREAT; CHUANG TI, 1971, AM J BOT, V58, P218, DOI 10.2307/2441157; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Deveny AJ, 2006, OECOLOGIA, V150, P69, DOI 10.1007/s00442-006-0503-3; Dyer AR, 1997, ECOL APPL, V7, P484, DOI 10.1890/1051-0761(1997)007[0484:IADCTR]2.0.CO;2; Gordon B. L., 1996, MONTEREY BAY AREA NA; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Keeley JE, 2006, CONSERV BIOL, V20, P375, DOI 10.1111/J.1523-1739.2006.00339.X; KEELEY JE, 1985, J ECOL, V73, P445, DOI 10.2307/2260486; KEELEY JE, 1987, ECOLOGY, V68, P434, DOI 10.2307/1939275; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; Lepetz V, 2009, BIODIVERS CONSERV, V18, P3185, DOI 10.1007/s10531-009-9636-0; LOUDA SM, 1995, ECOLOGY, V76, P229, DOI 10.2307/1940645; Marvier MA, 1997, CONSERV BIOL, V11, P839, DOI 10.1046/j.1523-1739.1997.96223.x; RABINOWITZ D, 1981, BIOL ASPECTS RARE PL; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Synge H, 1981, BIOL ASPECTS RARE PL; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	24	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8892	10.1371/journal.pone.0008892	http://dx.doi.org/10.1371/journal.pone.0008892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126657	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896500015
J	Willis, CG; Ruhfel, BR; Primack, RB; Miller-Rushing, AJ; Losos, JB; Davis, CC				Willis, Charles G.; Ruhfel, Brad R.; Primack, Richard B.; Miller-Rushing, Abraham J.; Losos, Jonathan B.; Davis, Charles C.			Favorable Climate Change Response Explains Non-Native Species' Success in Thoreau's Woods	PLOS ONE			English	Article							FLOWERING TIMES; PLANT; PHENOLOGY; TRAITS	Invasive species have tremendous detrimental ecological and economic impacts. Climate change may exacerbate species invasions across communities if non-native species are better able to respond to climate changes than native species. Recent evidence indicates that species that respond to climate change by adjusting their phenology (i.e., the timing of seasonal activities, such as flowering) have historically increased in abundance. The extent to which non-native species success is similarly linked to a favorable climate change response, however, remains untested. We analyzed a dataset initiated by the conservationist Henry David Thoreau that documents the long-term phenological response of native and non-native plant species over the last 150 years from Concord, Massachusetts (USA). Our results demonstrate that non-native species, and invasive species in particular, have been far better able to respond to recent climate change by adjusting their flowering time. This demonstrates that climate change has likely played, and may continue to play, an important role in facilitating non-native species naturalization and invasion at the community level.	[Willis, Charles G.; Ruhfel, Brad R.; Davis, Charles C.] Harvard Univ Hebaria, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Willis, Charles G.] Duke Univ, Dept Biol, Durham, NC USA; [Primack, Richard B.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Miller-Rushing, Abraham J.] USA Natl Phenol Network, Tucson, AZ USA; [Miller-Rushing, Abraham J.] Wildlife Soc, Bethesda, MD USA; [Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Duke University; Boston University; Harvard University	Willis, CG (corresponding author), Harvard Univ Hebaria, Dept Organism & Evolutionary Biol, 22 Divin Ave, Cambridge, MA 02138 USA.	cdavis@oeb.harvard.edu	Miller-Rushing, Abraham/D-5102-2009	Miller-Rushing, Abraham/0000-0003-3203-0143; Ruhfel, Brad/0000-0002-0230-4185; Willis, Charles/0000-0003-2543-246X	National Science Foundation [EF 04-31242]; Division of Environmental Biology (DEB) [0413458/0842749]	National Science Foundation(National Science Foundation (NSF)); Division of Environmental Biology (DEB)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	C. C. D. and R. B. P. were supported by National Science Foundation Grants Assembling the Tree of Life (AToL) EF 04-31242 and Division of Environmental Biology (DEB) 0413458/0842749, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; BIERZYCHUDEK P, 1981, AM NAT, V117, P838, DOI 10.1086/283773; BOLKER B, 2007, APE ANAL PHYLOGENETI; Cadotte MW, 2009, DIVERS DISTRIB, V15, P481, DOI 10.1111/j.1472-4642.2009.00560.x; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; CLEMENTS S, 2006, WILDFLOWERS FIELD FO; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Faegri K., 1978, PRINCIPLES POLLINATI; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; FLYNN S, 2006, ROYAL BOT GARDENS; Gleason H.A., 1991, MANUAL VASCULAR PLAN, V2nd ed.; Knight KS, 2007, BIOL INVASIONS, V9, P925, DOI 10.1007/s10530-007-9091-3; Mack RN, 2002, ANN MO BOT GARD, V89, P176, DOI 10.2307/3298562; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mehrhoff L.J., 2003, IPANE INVASIVE PLANT; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Miller-Rushing AJ, 2008, J ECOL, V96, P1289, DOI 10.1111/j.1365-2745.2008.01436.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Miller-Rushing AJ, 2006, AM J BOT, V93, P1667, DOI 10.3732/ajb.93.11.1667; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Paradis E, 2002, J THEOR BIOL, V218, P175, DOI 10.1006/jtbi.2002.3066; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Primack RB, 2009, NEW PHYTOL, V182, P303, DOI 10.1111/j.1469-8137.2009.02800.x; Primack RB, 2009, BIOL CONSERV, V142, P500, DOI 10.1016/j.biocon.2008.10.038; Pysek Petr, 2007, V193, P97; Reich PB, 2007, ECOL APPL, V17, P1982, DOI 10.1890/06-1803.1; Simberloff D, 2000, SCI TOTAL ENVIRON, V262, P253, DOI 10.1016/S0048-9697(00)00527-1; Sola AJ, 2007, J ECOL, V95, P208, DOI 10.1111/j.1365-2745.2006.01191.x; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Thuiller Wilfried, 2007, V193, P197; United States Department of Agriculture (USDA), PLANTS DAT; VilO M., 2007, TERRESTRIAL ECOSYSTE, P93, DOI DOI 10.1007/978-3-540-32730-1_8; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; WEBB CO, 2008, PHYLOCOM SOFTWARE AN; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y	42	182	192	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8878	10.1371/journal.pone.0008878	http://dx.doi.org/10.1371/journal.pone.0008878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126652	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896500007
J	Ganachari, M; Ruiz-Morales, JA; Pretell, JCGD; Dinh, J; Granados, J; Flores-Villanueva, PO				Ganachari, Malathesha; Ruiz-Morales, Jorge A.; de la Torre Pretell, Juan C. Gomez; Dinh, Jeffrey; Granados, Julio; Flores-Villanueva, Pedro O.			Joint Effect of MCP-1 Genotype GG and MMP-1 Genotype 2G/2G Increases the Likelihood of Developing Pulmonary Tuberculosis in BCG-Vaccinated Individuals	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; EXPRESSION; INFECTION; SUSCEPTIBILITY; POLYMORPHISMS; GRANULOMAS; REACTIVITY	We previously reported that the - 2518 MCP-1 genotype GG increases the likelihood of developing tuberculosis (TB) in non-BCG-vaccinated Mexicans and Koreans. Here, we tested the hypothesis that this genotype, alone or together with the 1607 MMP-1 functional polymorphism, increases the likelihood of developing TB in BCG-vaccinated individuals. We conducted population-based case-control studies of BCG-vaccinated individuals in Mexico and Peru that included 193 TB cases and 243 healthy tuberculin-positive controls from Mexico and 701 TB cases and 796 controls from Peru. We also performed immunohistochemistry (IHC) analysis of lymph nodes from carriers of relevant two-locus genotypes and in vitro studies to determine how these variants may operate to increase the risk of developing active disease. We report that a joint effect between the - 2518 MCP-1 genotype GG and the - 1607 MMP-1 genotype 2G/2G consistently increases the odds of developing TB 3.59-fold in Mexicans and 3.9-fold in Peruvians. IHC analysis of lymph nodes indicated that carriers of the two-locus genotype MCP-1 GG MMP-1 2G/2G express the highest levels of both MCP-1 and MMP-1. Carriers of these susceptibility genotypes might be at increased risk of developing TB because they produce high levels of MCP-1, which enhances the induction of MMP-1 production by M. tuberculosis-sonicate antigens to higher levels than in carriers of the other two-locus MCP-1 MMP-1 genotypes studied. This notion was supported by in vitro experiments and luciferase based promoter activity assay. MMP-1 may destabilize granuloma formation and promote tissue damage and disease progression early in the infection. Our findings may foster the development of new and personalized therapeutic approaches targeting MCP-1 and/or MMP-1.	[Ganachari, Malathesha; Ruiz-Morales, Jorge A.; Dinh, Jeffrey; Flores-Villanueva, Pedro O.] Methodist Hosp, Methodist Hosp Res Inst, Houston, TX 77030 USA; [de la Torre Pretell, Juan C. Gomez] Nongovt Org VIMASI, Lima, Peru; [Granados, Julio] Mexican Natl Inst Med & Nutr Salvador Zubiran, Dept Transplantat Immunol, Div Immunogenet, Mexico City, DF, Mexico	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute	Ganachari, M (corresponding author), Methodist Hosp, Methodist Hosp Res Inst, 6535 Fannin, Houston, TX 77030 USA.	poflores-villanueva@tmhs.org	Ganachari, malathesha/B-3015-2011	GOMEZ DE LA TORRE, JUAN CARLOS/0000-0003-4566-2027; Flores-Villanueva, Pedro/0000-0002-6184-4616	National Institutes of Health [R01 HL084347]; Methodist Hospital Research Institute (TMHRI), Houston, Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Methodist Hospital Research Institute (TMHRI), Houston, Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grant R01 HL084347 and by recruitment funds from the Methodist Hospital Research Institute (TMHRI), Houston, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929; BAILEY BE, 1995, B WORLD HEALTH ORGAN, V73, P673; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Behr MA, 1999, VACCINE, V17, P915, DOI 10.1016/S0264-410X(98)00277-1; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Castillo-Rodal AI, 2006, INFECT IMMUN, V74, P1718, DOI 10.1128/IAI.74.3.1718-1724.2006; CAWSTON TE, 1986, FEBS LETT, V209, P9, DOI 10.1016/0014-5793(86)81074-2; Cerda-Flores RM, 2002, AM J HUM BIOL, V14, P257, DOI 10.1002/ajhb.10020; CERVANTES J, 2002, B I FR ETUDES ANDINE, V2, P213; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; COLOTTA F, 1992, J IMMUNOL, V148, P760; Coraux Christelle, 2008, Proc Am Thorac Soc, V5, P689, DOI 10.1513/pats.200801-010AW; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Barros R. P., MEASURING INEQUALITY; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; DUPONT WD, 2002, STAT MODELING BIOMED, P207; Elkington PTG, 2005, AM J RESP CRIT CARE, V172, P1596, DOI 10.1164/rccm.200505-753OC; Field SK, 2006, CHEST, V129, P1653, DOI 10.1378/chest.129.6.1653; FITZGERALD D, 2005, MANDELL DOUGLAS BENN, P2852; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; HARTL DL, 1997, PRINCIPLES POPULATIO, P140; Hoheisel G, 2001, TUBERCULOSIS, V81, P203, DOI 10.1054/tube.2000.0276; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Johnson MM, 2008, CURR OPIN PULM MED, V14, P203, DOI 10.1097/MCP.0b013e3282f9e650; Kaarteenaho-Wiik R, 2007, HUM PATHOL, V38, P147, DOI 10.1016/j.humpath.2006.07.001; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Luna JA, 2004, TUBERCULOSIS GUIDE S; LYNCH M, 1998, GENETICS ANAL QUANTI, P54; MOLINAGAMBOA JD, 1994, CLIN INFECT DIS, V19, P784, DOI 10.1093/clinids/19.4.784; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; O'Reilly PJ, 2008, CURR OPIN PHARMACOL, V8, P242, DOI 10.1016/j.coph.2008.02.003; Oettinger T., 1999, Tubercle and Lung Disease, V79, P243, DOI 10.1054/tuld.1999.0206; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Rand L, 2009, J IMMUNOL, V182, P5865, DOI 10.4049/jimmunol.0801935; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Rutter JL, 1998, CANCER RES, V58, P5321; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Sherf BA., 1996, PROMEGA NOTES, V57, P2; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; SZKLO M, 1999, EPIDEMIOLOGY BASICS, P211; Takiff HE, 2007, TUBERCULOSIS 2007 BA, P207; THOMAS DC, 2004, TESTING CANDIDATE GE, P253; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Viera AJ, 2005, FAM MED, V37, P360; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; World Health Organization, 2008, GLOB TUB CONTR SURV; Wu B, 2007, INFECT IMMUN, V75, P3658, DOI 10.1128/IAI.00244-07; Xu Zhen-e, 2009, Zhonghua Er Ke Za Zhi, V47, P200; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88	61	44	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8881	10.1371/journal.pone.0008881	http://dx.doi.org/10.1371/journal.pone.0008881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111728	Green Submitted, Green Published, gold			2022-12-25	WOS:000273896300025
J	Mashimo, T; Takizawa, A; Voigt, B; Yoshimi, K; Hiai, H; Kuramoto, T; Serikawa, T				Mashimo, Tomoji; Takizawa, Akiko; Voigt, Birger; Yoshimi, Kazuto; Hiai, Hiroshi; Kuramoto, Takashi; Serikawa, Tadao			Generation of Knockout Rats with X-Linked Severe Combined Immunodeficiency (X-SCID) Using Zinc-Finger Nucleases	PLOS ONE			English	Article							INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; EMBRYONIC STEM-CELLS; LYMPHOID DEVELOPMENT; NOG MICE; GENE; MODELS; MUTAGENESIS; MUTANT; BLASTOCYSTS; MUTATION	Background: Although the rat is extensively used as a laboratory model, the inability to utilize germ line-competent rat embryonic stem (ES) cells has been a major drawback for studies that aim to elucidate gene functions. Recently, zinc-finger nucleases (ZFNs) were successfully used to create genome-specific double-stranded breaks and thereby induce targeted gene mutations in a wide variety of organisms including plants, drosophila, zebrafish, etc. Methodology/Principal Findings: We report here on ZFN-induced gene targeting of the rat interleukin 2 receptor gamma (Il2rg) locus, where orthologous human and mouse mutations cause X-linked severe combined immune deficiency (X-SCID). Co-injection of mRNAs encoding custom-designed ZFNs into the pronucleus of fertilized oocytes yielded genetically modified offspring at rates greater than 20%, which possessed a wide variety of deletion/insertion mutations. ZFN-modified founders faithfully transmitted their genetic changes to the next generation along with the severe combined immune deficiency phenotype. Conclusions and Significance: The efficient and rapid generation of gene knockout rats shows that using ZFN technology is a new strategy for creating gene-targeted rat models of human diseases. In addition, the X-SCID rats that were established in this study will be valuable in vivo tools for evaluating drug treatment or gene therapy as well as model systems for examining the treatment of xenotransplanted malignancies.	[Mashimo, Tomoji; Takizawa, Akiko; Voigt, Birger; Yoshimi, Kazuto; Kuramoto, Takashi; Serikawa, Tadao] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan; [Hiai, Hiroshi] Shiga Med Ctr Adult Dis, Moriyama, Japan	Kyoto University	Mashimo, T (corresponding author), Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan.	tmashimo@anim.med.kyoto-u.ac.jp		Yoshimi, Kazuto/0000-0001-5110-1440	Ministry of Health, Labour, and Welfare	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant-in-aid for cancer research from the Ministry of Health, Labour, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Dao MA, 1999, CURR OPIN MOL THER, V1, P553; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Kandavelou K, 2009, BIOCHEM BIOPH RES CO, V388, P56, DOI 10.1016/j.bbrc.2009.07.112; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kitada K, 2007, NAT METHODS, V4, P131, DOI 10.1038/nmeth1002; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Machida K, 2009, J TOXICOL SCI, V34, P123, DOI 10.2131/jts.34.123; Mashimo T, 2008, NAT GENET, V40, P514, DOI 10.1038/ng0508-514; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Shinohara T, 2006, P NATL ACAD SCI USA, V103, P13624, DOI 10.1073/pnas.0604205103; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Thomsen M, 2005, TISSUE ANTIGENS, V66, P73, DOI 10.1111/j.1399-0039.2005.00409.x; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Voigt B, 2009, DIS MODEL MECH, V2, P341, DOI 10.1242/dmm.002824; Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8; YOSHIMI K, 2009, CANC SCI; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830	34	183	214	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8870	10.1371/journal.pone.0008870	http://dx.doi.org/10.1371/journal.pone.0008870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111598	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896300019
J	Phillips, G; Chikwana, VM; Maxwell, A; El-Yacoubi, B; Swairjo, MA; Iwata-Reuyl, D; de Crecy-Lagard, V				Phillips, Gabriela; Chikwana, Vimbai M.; Maxwell, Adrienne; El-Yacoubi, Basma; Swairjo, Manal A.; Iwata-Reuyl, Dirk; de Crecy-Lagard, Valerie			Discovery and Characterization of an Amidinotransferase Involved in the Modification of Archaeal tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL MODIFICATION; GUANINE TRANSGLYCOSYLASE; HALOBACTERIUM-VOLCANII; THERMOPHILIC ARCHAEA; AMINO-ACIDS; BIOSYNTHESIS; BINDING; RECOGNITION; TOYOCAMYCIN; NUCLEOSIDES	The presence of the 7-deazaguanosine derivative archaeosine (G(+)) at position 15 in tRNA is one of the diagnostic molecular characteristics of the Archaea. The biosynthesis of this modified nucleoside is especially complex, involving the initial production of 7-cyano-7-deazaguanine (preQ(0)), an advanced precursor that is produced in a tRNA-independent portion of the biosynthesis, followed by its insertion into the tRNA by the enzyme tRNA-guanine transglycosylase (arcTGT), which replaces the target guanine base yielding preQ(0)-tRNA. The enzymes responsible for the biosynthesis of preQ(0) were recently identified, but the enzyme(s) catalyzing the conversion of preQ(0)-tRNA to G(+)-tRNA have remained elusive. Using a comparative genomics approach, we identified a protein family implicated in the late stages of archaeosine biosynthesis. Notably, this family is a paralog of arcTGT and is generally annotated as TgtA2. Structure-based alignments comparing arcTGT and TgtA2 reveal that TgtA2 lacks key arcTGT catalytic residues and contains an additional module. We constructed a Haloferax volcanii Delta tgtA2 derivative and demonstrated that tRNA from this strain lacks G(+) and instead accumulates preQ(0). We also cloned the corresponding gene from Methanocaldococcus jannaschii (mj1022) and characterized the purified recombinant enzyme. Recombinant MjTgtA2 was shown to convert preQ(0)-tRNA to G(+)-tRNA using several nitrogen sources and to do so in an ATP-independent process. This is the only example of the conversion of a nitrile to a formamidine known in biology and represents a new class of amidinotransferase chemistry.	[Chikwana, Vimbai M.; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol, Gainesville, FL 32611 USA; [de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Swairjo, Manal A.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Portland State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute	Iwata-Reuyl, D (corresponding author), Portland State Univ, Dept Chem, POB 751, Portland, OR 97207 USA.	iwatareuyld@pdx.edu; vcrecy@ufl.edu	Swairjo, Manal/AAR-9137-2021; de Crecy-Lagard, Valerie/AAN-8995-2020		National Institutes of Health [GM70641]; National Science Foundation [MCB-05169448]; NASA [NNX07AJ26G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM70641 (to V. C. L.), National Science Foundation Grant MCB-05169448 (to V. C. L.), and NASA Grant NNX07AJ26G (to D. I. R.).	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Bai Y, 2000, J BIOL CHEM, V275, P28731, DOI 10.1074/jbc.M002174200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; EDMONDS CG, 1991, J BACTERIOL, V173, P3138, DOI 10.1128/JB.173.10.3138-3148.1991; Fukai S, 2003, RNA, V9, P100, DOI 10.1261/rna.2760703; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREGSON JM, 1993, J BIOL CHEM, V268, P10076; GUPTA R, 1984, J BIOL CHEM, V259, P9461; GUPTA R, 1986, SYST APPL MICROBIOL, V7, P102, DOI 10.1016/S0723-2020(86)80131-X; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KUCHINO Y, 1976, NUCLEIC ACIDS RES, V3, P393, DOI 10.1093/nar/3.2.393; McCloskey J A, 2000, Nucleic Acids Symp Ser, P267; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; Oliva R, 2007, RNA, V13, P1427, DOI 10.1261/rna.574407; Ortlund E, 2000, BIOCHEMISTRY-US, V39, P1199, DOI 10.1021/bi991797d; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Phillips G, 2008, J BACTERIOL, V190, P7876, DOI 10.1128/JB.00874-08; Sabina J, 2006, J BIOL CHEM, V281, P6993, DOI 10.1074/jbc.M512841200; Schneider KL, 2006, NUCLEIC ACIDS RES, V34, pD407, DOI 10.1093/nar/gkj134; SMULSON ME, 1967, J BIOL CHEM, V242, P2872; Sprinzl M., 1989, Nucleic Acids Research, V17, P1; SUHADOLN.RJ, 1970, J BIOL CHEM, V245, P4365; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; Uematsu T, 1975, Methods Enzymol, V43, P759; UEMATSU T, 1974, ARCH BIOCHEM BIOPHYS, V162, P614, DOI 10.1016/0003-9861(74)90223-9; Watanabe M, 1997, J BIOL CHEM, V272, P20146, DOI 10.1074/jbc.272.32.20146	33	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12706	12713		10.1074/jbc.M110.102236	http://dx.doi.org/10.1074/jbc.M110.102236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20129918	Green Published, hybrid			2022-12-25	WOS:000276787800029
J	Alegre-Cebollada, J; Badilla, CL; Fernandez, JM				Alegre-Cebollada, Jorge; Badilla, Carmen L.; Fernandez, Julio M.			Isopeptide Bonds Block the Mechanical Extension of Pili in Pathogenic Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; GRAM-POSITIVE BACTERIA; CORYNEBACTERIUM-DIPHTHERIAE; STABILIZING ISOPEPTIDE; DISULFIDE BONDS; SINGLE-PROTEIN; TITIN; MICROSCOPY; ADHESION; MODULES	In the early stages of an infection, pathogenic bacteria use long fibrous structures known as pili as adhesive anchors for attachment to the host cells. These structures also play key roles in colony and biofilm formation. In all those processes, pili must withstand large mechanical forces. The pili of the nasty Gram-positive human pathogen Streptococcus pyogenes are assembled as single, micrometer long tandem modular proteins of covalently linked repeats of pilin proteins. Here we use single molecule force spectroscopy techniques to study the mechanical properties of the major pilin Spy0128. In our studies, we engineer polyproteins containing repeats of Spy0128 flanked by the well characterized I27 protein which provides an unambiguous mechanical fingerprint. We find that Spy0128 is an inextensible protein, even when pulled at forces of up to 800 pN. We also found that this remarkable mechanical resilience, unique among the modular proteins studied to date, results from the strategically located intramolecular isopeptide bonds recently identified in the x-ray structure of Spy0128. Removal of the isopeptide bonds by mutagenesis readily allowed Spy0128 domains to unfold and extend, albeit at relatively high forces of 172 pN (N-terminal domain) or 250 pN (C-terminal domain). Our results show that in contrast to the elastic roles played by large tandem modular proteins such as titin and fibronectin, the giant pili of S. pyogenes evolved to abrogate mechanical extensibility, a property that may be crucial in the pathogenesis of this most virulent bacterium and, therefore, become the target of new therapeutic approaches against its infections.	[Alegre-Cebollada, Jorge; Badilla, Carmen L.; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Alegre-Cebollada, J (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	ja2544@columbia.edu; jfernandez@columbia.edu	Alegre-Cebollada, Jorge/I-4301-2014	Alegre-Cebollada, Jorge/0000-0003-0542-0170	National Institutes of Health [HL66030, HL61228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL66030 and HL61228 (to J.M.F.).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Biais N, 2008, PLOS BIOL, V6, P907, DOI 10.1371/journal.pbio.0060087; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2006, J CLIN INVEST, V116, P2582, DOI 10.1172/JCI30088; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; Fallman E, 2005, EMBO REP, V6, P52, DOI 10.1038/sj.embor.7400310; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Forman JR, 2007, CURR OPIN STRUC BIOL, V17, P58, DOI 10.1016/j.sbi.2007.01.006; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Improta S, 1998, J MOL BIOL, V284, P761, DOI 10.1006/jmbi.1998.2028; Jass J, 2004, BIOPHYS J, V87, P4271, DOI 10.1529/biophysj.104.044867; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Li HB, 2003, J MOL BIOL, V334, P75, DOI 10.1016/j.jmb.2003.09.036; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Sikora M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000547; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398	49	85	86	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11235	11242		10.1074/jbc.M110.102962	http://dx.doi.org/10.1074/jbc.M110.102962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139067	Green Published, hybrid			2022-12-25	WOS:000276286200029
J	Nemeria, NS; Arjunan, P; Chandrasekhar, K; Mossad, M; Tittmann, K; Furey, W; Jordan, F				Nemeria, Natalia S.; Arjunan, Palaniappa; Chandrasekhar, Krishnamoorthy; Mossad, Madouna; Tittmann, Kai; Furey, William; Jordan, Frank			Communication between Thiamin Cofactors in the Escherichia coli Pyruvate Dehydrogenase Complex E1 Component Active Centers EVIDENCE FOR A "DIRECT PATHWAY" BETWEEN THE 4 '-AMINOPYRIMIDINE N1' ATOMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIENZYME COMPLEX; 1',4'-IMINOPYRIMIDINE TAUTOMER; DEPENDENT ENZYMES; DIPHOSPHATE; SITES; IONIZATION; ACTIVATION; SUBSTRATE; SUBUNIT; BINDING	Kinetic, spectroscopic, and structural analysis tested the hypothesis that a chain of residues connecting the 4'-aminopyrimidine N1' atoms of thiamin diphosphates (ThDPs) in the two active centers of the Escherichia coli pyruvate dehydrogenase complex E1 component provides a signal transduction pathway. Substitution of the three acidic residues (Glu(571), Glu(235), and Glu(237)) and Arg(606) resulted in impaired binding of the second ThDP, once the first active center was filled, suggesting a pathway for communication between the two ThDPs. 1) Steady-state kinetic and fluorescence quenching studies revealed that upon E571A, E235A, E237A, and R606A substitutions, ThDP binding in the second active center was affected. 2) Analysis of the kinetics of thiazolium C2 hydrogen/deuterium exchange of enzyme-bound ThDP suggests half-of-the-sites reactivity for the E1 component, with fast (activated site) and slow exchanging sites (dormant site). The E235A and E571A variants gave no evidence for the slow exchanging site, indicating that only one of two active sites is filled with ThDP. 3) Titration of the E235A and E237A variants with methyl acetylphosphonate monitored by circular dichroism suggested that only half of the active sites were filled with a covalent predecarboxylation intermediate analog. 4) Crystal structures of E235A and E571A in complex with ThDP revealed the structural basis for the spectroscopic and kinetic observations and showed that either substitution affects cofactor binding, despite the fact that Glu(235) makes no direct contact with the cofactor. The role of the conserved Glu(571) residue in both catalysis and cofactor orientation is revealed by the combined results for the first time.	[Arjunan, Palaniappa; Chandrasekhar, Krishnamoorthy; Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Arjunan, Palaniappa; Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA; [Nemeria, Natalia S.; Mossad, Madouna; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Tittmann, Kai] Univ Gottingen, Abt Bioanalyt, Albrecht von Haller Inst, D-37077 Gottingen, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Rutgers State University Newark; Rutgers State University New Brunswick; University of Gottingen	Furey, W (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	fureyw@pitt.edu; frjordan@rutgers.edu			National Institutes of Health [GM-050380, GM-061791]; Veterans Affairs Merit Review Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061791, R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-050380 (to F. J.) and GM-061791 (to W. F.). This work was also supported by the Veterans Affairs Merit Review Program (to W. F.).	Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Jordan F, 2005, ACCOUNTS CHEM RES, V38, P755, DOI 10.1021/ar040244e; Jordan F, 2004, SCIENCE, V306, P818, DOI 10.1126/science.1105457; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; JORDAN F, 2004, THIAMINE CATALYTIC M, P407; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Li J, 2007, J BIOL CHEM, V282, P11904, DOI 10.1074/jbc.M610843200; Nemeria N, 1998, BIOCHEMISTRY-US, V37, P911, DOI 10.1021/bi9722251; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Segel I. H., 1993, ENZYME KINETICS BEHA, P73; Seifert F, 2006, BIOCHEMISTRY-US, V45, P12775, DOI 10.1021/bi061582l; YAN Y, 2003, THESIS RUTGERS U NEW; Yi JZ, 1996, J BIOL CHEM, V271, P33192, DOI 10.1074/jbc.271.52.33192	23	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11197	11209		10.1074/jbc.M109.069179	http://dx.doi.org/10.1074/jbc.M109.069179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20106967	hybrid, Green Published			2022-12-25	WOS:000276286200025
J	Imoto, A; Okada, M; Okazaki, T; Kitasato, H; Harigae, H; Takahashi, S				Imoto, Akemi; Okada, Mami; Okazaki, Toshio; Kitasato, Hidero; Harigae, Hideo; Takahashi, Shinichiro			Metallothionein-1 Isoforms and Vimentin Are Direct PU.1 Downstream Target Genes in Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PU.1; ACUTE MYELOID-LEUKEMIA; PROGNOSTIC-SIGNIFICANCE; TANDEM DUPLICATION; MESSENGER-RNA; EXPRESSION; REPRESSOR; COMPLEX; FLT3; PROMOTER	PU.1 is a key transcription factor for hematopoiesis and plays important roles in various hematological malignancies. To clarify the molecular function of PU.1, we initially tried to identify bona fide target genes regulated by PU.1. Dual microarrays were employed for this study to compare PU.1-knockdown K562 cells (K562PU.1KD) stably expressing PU.1 short inhibitory RNAs versus control cells and PU.1-overexpressing K562 cells (K562PU.1OE) versus control cells. In these analyses, we found that several genes, including metallothionein (MT)-1 isoforms (MT-1G and MT-1A) and vimentin (VIM), were markedly induced while Jun dimerization protein (JDP) 2 was suppressed in K562PU.1KD cells. Furthermore, the mRNA expressions of the MT-1 and VIM genes were inversely correlated and the mRNA expression of JDP2 was positively correlated with PU.1 mRNA expression in 43 primary acute myeloid leukemia specimens (MT-1G: R = -0.50, p < 0.001; MT-1A: R = -0.58, p < 0.0005; VIM: R = -0.39, p < 0.01; and JDP2: R = 0.30, p < 0.05). Next, we analyzed the regulation of the MT-1 and VIM genes. We observed increased associations of acetylated histones H3 and H4 with the promoters of these genes in K562PU.1KD cells. Sequence analyses of the regions similar to 1 kb upstream from the transcription start sites of these genes revealed numerous CpG sites, which are potential targets for DNA methylation. Chromatin immunoprecipitation assays revealed that methyl CpG-binding protein 2 (MeCP2) and PU.1 bound to the CpG-rich regions in the MT-1 and VIM promoters. Bisulfite sequencing analyses of the PU.1-bound regions of these promoters revealed that the proportions of methylated CpG sites were tightly related to the PU.1 expression levels.	[Okazaki, Toshio; Takahashi, Shinichiro] Kitasato Univ, Sch Allied Hlth Sci, Div Hematol, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Kitasato, Hidero] Kitasato Univ, Sch Allied Hlth Sci, Div Microbiol, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Imoto, Akemi; Okada, Mami; Okazaki, Toshio; Takahashi, Shinichiro] Kitasato Univ, Sch Med Sci, Div Mol Hematol, Sagamihara, Kanagawa 2520373, Japan; [Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Kitasato University; Kitasato University; Kitasato University; Tohoku University	Takahashi, S (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Div Hematol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	shin@kitasato-u.ac.jp	Takahashi, Shinichiro/AAX-7125-2020	Takahashi, Shinichiro/0000-0003-0011-6065	Nakayama Foundation for Human Science; Kitasato University School of Allied Health Sciences [2007-1003, 2008-1001, 2009-1001]; Kitasato University Graduate School of Medical Sciences Research Project	Nakayama Foundation for Human Science; Kitasato University School of Allied Health Sciences; Kitasato University Graduate School of Medical Sciences Research Project	This work was supported in part by grants from Nakayama Foundation for Human Science, the Foundation from the Kitasato University School of Allied Health Sciences (Grants-in-Aid for Research Project, 2007-1003, 2008-1001, and 2009-1001), and the Foundation from the Kitasato University Graduate School of Medical Sciences Research Project.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Belichenko I, 2001, ARCH BIOCHEM BIOPHYS, V390, P57, DOI 10.1006/abbi.2001.2365; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; FERRARI S, 1986, MOL CELL BIOL, V6, P3614, DOI 10.1128/MCB.6.11.3614; FERRIER AF, 1992, J CELL BIOCHEM, V50, P245, DOI 10.1002/jcb.240500305; FOSTER R, 1988, J BIOL CHEM, V263, P11528; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Heinrich R, 2004, J BIOL CHEM, V279, P5708, DOI 10.1074/jbc.M307608200; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Huh HJ, 2009, INT J LAB HEMATOL, V31, P344, DOI 10.1111/j.1751-553X.2008.01056.x; Inomata M, 2006, LEUKEMIA RES, V30, P659, DOI 10.1016/j.leukres.2005.07.015; Iseki Y, 2009, LEUKEMIA RES, V33, P1658, DOI 10.1016/j.leukres.2009.04.010; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; KACZMAREK L, 1987, EXP CELL RES, V173, P70, DOI 10.1016/0014-4827(87)90332-6; Kihara-Negishi F, 2001, ONCOGENE, V20, P6039, DOI 10.1038/sj.onc.1204756; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; Mididoddi S, 1996, TOXICOL LETT, V85, P17, DOI 10.1016/0378-4274(96)03632-6; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; PETTERSSON M, 1995, BLOOD, V86, P2747; Poulsen CB, 2006, BLOOD, V108, P3514, DOI 10.1182/blood-2006-04-015305; RITTLING SR, 1987, MOL CELL BIOL, V7, P3908, DOI 10.1128/MCB.7.11.3908; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Sauerbrey A, 1998, ANTICANCER RES, V18, P1231; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shimoda R, 2003, TOXICOL SCI, V73, P294, DOI 10.1093/toxsci/kfg095; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Sugimoto T, 2009, BIOCHEM BIOPH RES CO, V390, P48, DOI 10.1016/j.bbrc.2009.09.059; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Takahashi S, 2005, BRIT J HAEMATOL, V130, P428, DOI 10.1111/j.1365-2141.2005.05621.x; Takahashi S, 2005, LEUKEMIA RES, V29, P893, DOI 10.1016/j.leukres.2005.01.008; Takahashi S, 2004, BLOOD, V103, P4650, DOI 10.1182/blood-2003-08-2759; Torlakovic EE, 2006, J PATHOL, V209, P352, DOI 10.1002/path.1986; Wang GW, 2001, J PHARMACOL EXP THER, V298, P461; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Zou HZ, 2007, CANCER EPIDEM BIOMAR, V16, P2686, DOI 10.1158/1055-9965.EPI-07-0518	40	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10300	10309		10.1074/jbc.M109.095810	http://dx.doi.org/10.1074/jbc.M109.095810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139074	Green Published, hybrid			2022-12-25	WOS:000276264600014
J	Krzystanek, M; Pedersen, TX; Bartels, ED; Kjaehr, J; Straarup, EM; Nielsen, LB				Krzystanek, Marcin; Pedersen, Tanja Xenia; Bartels, Emil Daniel; Kjaehr, Jacob; Straarup, Ellen Marie; Nielsen, Lars Bo			Expression of Apolipoprotein B in the Kidney Attenuates Renal Lipid Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LIPOPROTEIN-LIPASE; PPAR-ALPHA; HEART; DYSFUNCTION; SECRETION; OBESITY; MUSCLE; GENES; FAT	The ability to produce apolipoprotein (apo) B-containing lipoproteins enables hepatocytes, enterocytes, and cardiomyocytes to export triglycerides. In this study, we examined secretion of apoB-containing lipoproteins from mouse kidney and its putative impact on triglyceride accumulation in the tubular epithelium. Mouse kidney expressed both the apoB and microsomal triglyceride transfer protein genes, which permit lipoprotein formation. To examine de novo lipoprotein secretion, kidneys from human apoB-transgenic mice were minced and placed in medium with S-35-amino acids. Upon sucrose gradient ultracentrifugation of the labeled medium, fractions were analyzed by apoB immunoprecipitation. S-35-Labeled apoB100 was recovered in similar to 1.03-1.04 g/ ml lipoproteins (i. e. similar to the density of plasma low density lipoproteins). Immunohistochemistry of kidney sections suggested that apoB mainly is produced by tubular epithelial cells. ApoB expression in the kidney cortex was reduced similar to 90% in vivo by treating wild type mice with apoBantisense locked nucleic acid oligonucleotide. Inhibition of apoB expression increased fasting-induced triglyceride accumulation in the kidney cortex by 20-25% (p = 0.008). Cholesterol stores were unaffected. Treatment with control oligonucleotides with 1 or 4 mismatching base pairs affected neither the triglyceride nor the cholesterol content of the kidney cortex. The results suggest that mammalian kidney secretes apoB100containing lipoproteins. One biological effect may be to dampen excess storage of triglycerides in proximal tubule cells.	[Krzystanek, Marcin; Pedersen, Tanja Xenia; Bartels, Emil Daniel; Kjaehr, Jacob; Nielsen, Lars Bo] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Straarup, Ellen Marie] Santaris Pharma, DK-2970 Horsholm, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Nielsen, LB (corresponding author), Rigshosp, Dept Clin Biochem KB3011, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	larsbo@rh.dk	Bartels, Emil/AAY-3268-2020	Pedersen, Tanja Xenia/0000-0003-2515-3022	Danish National Research Council; Ingeborg; Leo Danins Foundations; Henry Hansen and Hustru's Fund; NovoNordisk Foundation	Danish National Research Council(Danmarks Grundforskningsfond); Ingeborg; Leo Danins Foundations; Henry Hansen and Hustru's Fund; NovoNordisk Foundation(Novo Nordisk Foundation)	This work was supported by grants from Danish National Research Council, Ingeborg and Leo Danins Foundations, Henry Hansen and Hustru's Fund, and the NovoNordisk Foundation (to L. B. N.).	Bang CA, 2007, AM J PHYSIOL-RENAL, V293, pF1325, DOI 10.1152/ajprenal.00039.2007; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Bartels ED, 2007, ATHEROSCLEROSIS, V195, pE42, DOI 10.1016/j.atherosclerosis.2007.05.002; Bartels ED, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005300; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Boren J, 1998, J CLIN INVEST, V101, P1197, DOI 10.1172/JCI1785; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; DEMMER LA, 1986, P NATL ACAD SCI USA, V83, P8102, DOI 10.1073/pnas.83.21.8102; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Fujihara M, 2009, EXP EYE RES, V88, P1115, DOI 10.1016/j.exer.2009.01.017; Gregg Richard E., 1994, Current Opinion in Lipidology, V5, P81, DOI 10.1097/00041433-199404000-00003; LADU MJ, 1991, AM J PHYSIOL, V260, pR953, DOI 10.1152/ajpregu.1991.260.5.R953; Ledmyr H, 2004, CIRCULATION, V109, P2279, DOI 10.1161/01.CIR.0000130070.96758.7b; Li SY, 2004, AM J PHYSIOL-RENAL, V286, pF572, DOI 10.1152/ajprenal.00190.2003; Lindegaard MLS, 2008, METABOLISM, V57, P766, DOI 10.1016/j.metabol.2008.01.016; LINTON MF, 1993, J CLIN INVEST, V92, P3029, DOI 10.1172/JCI116927; Madsen EM, 2004, J BIOL CHEM, V279, P55271, DOI 10.1074/jbc.M411404200; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Nielsen LB, 1997, J BIOL CHEM, V272, P29752, DOI 10.1074/jbc.272.47.29752; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Nielsen LB, 1998, CIRCULATION, V98, P13, DOI 10.1161/01.CIR.98.1.13; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; ONG JM, 1994, J LIPID RES, V35, P1542; Portilla D, 2006, KIDNEY INT, V69, P2194, DOI 10.1038/sj.ki.5000433; Portilla D, 2002, KIDNEY INT, V62, P1208, DOI 10.1046/j.1523-1755.2002.00553.x; Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; TAN MH, 1977, J LIPID RES, V18, P363; Tarugi P, 1998, J LIPID RES, V39, P731; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Walzem RL, 1999, J NUTR, V129, p467S, DOI 10.1093/jn/129.2.467S; WETTERAU JR, 1986, BIOCHIM BIOPHYS ACTA, V875, P610, DOI 10.1016/0005-2760(86)90084-6; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574; Zager RA, 2005, KIDNEY INT, V67, P111, DOI 10.1111/j.1523-1755.2005.00061.x	36	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10583	10590		10.1074/jbc.M109.078006	http://dx.doi.org/10.1074/jbc.M109.078006			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20103594	Green Published, hybrid			2022-12-25	WOS:000276264600045
J	Sucic, S; Dallinger, S; Zdrazil, B; Weissensteiner, R; Jorgensen, TN; Holy, M; Kudlacek, O; Seidel, S; Cha, JH; Gether, U; Newman, AH; Ecker, GF; Freissmuth, M; Sitte, HH				Sucic, Sonja; Dallinger, Stefan; Zdrazil, Barbara; Weissensteiner, Rene; Jorgensen, Trine N.; Holy, Marion; Kudlacek, Oliver; Seidel, Stefan; Cha, Joo Hwan; Gether, Ulrik; Newman, Amy H.; Ecker, Gerhard F.; Freissmuth, Michael; Sitte, Harald H.			The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DOPAMINE TRANSPORTER; HUMAN SEROTONIN TRANSPORTER; ENERGY-TRANSFER MICROSCOPY; INDUCED REVERSE TRANSPORT; NEUROTRANSMITTER TRANSPORTERS; GABA TRANSPORTER-1; NOREPINEPHRINE TRANSPORTERS; OUTWARD TRANSPORT; LIVING CELLS; BINDING-SITE	The serotonin transporter (SERT) terminates neurotransmission by removing serotonin from the synaptic cleft. In addition, it is the site of action of antidepressants (which block the transporter) and of amphetamines (which induce substrate efflux). We explored the functional importance of the N terminus in mediating the action of amphetamines by focusing initially on the highly conserved threonine residue at position 81, a candidate site for phosphorylation by protein kinase C. Molecular dynamics simulations of the wild type SERT, compared with its mutations SERTT81A and SERTT81D, suggested structural changes in the inner vestibule indicative of an opening of the inner vestibule. Predictions from this model (e. g. the preferential accumulation of SERTT81A in the inward conformation, its reduced turnover number, and a larger distance between its N and C termini) were verified. Most importantly, SERTT81A (and the homologous mutations in noradrenaline and dopamine) failed to support amphetamine-induced efflux, and this was not remedied by aspartate at this position. Amphetamine-induced currents through SERTT81A were comparable with those through the wild type transporter. Both abundant Na+ entry and accumulation of SERTT81A in the inward facing conformation ought to favor amphetamine-induced efflux. Thus, we surmised that the N terminus must play a direct role in driving the transporter into a state that supports amphetamine-induced efflux. This hypothesis was verified by truncating the first 64 amino acids and by tethering the N terminus to an additional transmembrane helix. Either modification abolished amphetamine-induced efflux. We therefore conclude that the N terminus of monoamine transporters acts as a lever that sustains reverse transport.	[Kudlacek, Oliver; Seidel, Stefan; Sitte, Harald H.] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Zdrazil, Barbara; Weissensteiner, Rene; Ecker, Gerhard F.] Univ Vienna, Dept Med Chem, A-1090 Vienna, Austria; [Jorgensen, Trine N.; Gether, Ulrik] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Cha, Joo Hwan; Newman, Amy H.] NIDA, Med Chem Sect, Intramural Res Program, Baltimore, MD 21224 USA	Medical University of Vienna; University of Vienna; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Sitte, HH (corresponding author), Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.	harald.sitte@meduniwien.ac.at	Zdrazil, Barbara/F-1021-2013; Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013	Zdrazil, Barbara/0000-0001-9395-1515; Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Freissmuth, Michael/0000-0001-9398-1765; Ecker, Gerhard/0000-0003-4209-6883; Gether, Ulrik/0000-0002-0020-3807; Sucic, Sonja/0000-0001-5136-8022; Kudlacek, Oliver/0000-0002-3086-8551	National Institutes of Health [P01 DA 12408]; National Institute on Drug Abuse; FWF [P18706, SFB3506, SFB3502, SFB3510]; Austrian Science Fund (FWF) [F 3506, F 3502] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000389, P01DA012408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G.) and the National Institute on Drug Abuse Intramural Research Program (to A. H. N.). This work was also supported by FWF Grants P18706 and SFB3506 (to H. H. S.), SFB3502 (to G. F. E.), and SFB3510 (to M. F.).	Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Beckman ML, 1998, J NEUROSCI, V18, P6103; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Chen NH, 2001, J NEUROCHEM, V77, P1116, DOI 10.1046/j.1471-4159.2001.00312.x; Chen Nian-Hang, 2002, P53; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Foster JD, 2006, HANDB EXP PHARM, V175, P197; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; GALLI A, 1995, J EXP BIOL, V198, P2197; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; Gerstbrein K, 2006, HANDB EXP PHARM, V175, P95; Gnegy ME, 2003, EUR J PHARMACOL, V479, P83, DOI 10.1016/j.ejphar.2003.08.059; Gobbi M, 2008, J NEUROCHEM, V105, P1770, DOI 10.1111/j.1471-4159.2008.05272.x; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Gu HH, 2001, MOL BIOL CELL, V12, P3797, DOI 10.1091/mbc.12.12.3797; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Haase J, 2001, BIOCHEM SOC T, V29, P722, DOI 10.1042/BST0290722; Hansra N, 2004, J NEUROSCI, V24, P4082, DOI 10.1523/JNEUROSCI.0664-04.2004; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Mazei-Robison MS, 2008, J NEUROSCI, V28, P7040, DOI 10.1523/JNEUROSCI.0473-08.2008; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; Norgaard-Nielsen K, 2006, HANDB EXP PHARM, V175, P1; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Rudnick G, 2006, HANDB EXP PHARM, V175, P59; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Rudnick G, 1998, METHOD ENZYMOL, V296, P233; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sakai N, 1997, J NEUROCHEM, V68, P2618; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sitte HH, 2001, MOL PHARMACOL, V59, P1129, DOI 10.1124/mol.59.5.1129; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Sucic S, 2002, MOL BRAIN RES, V108, P40, DOI 10.1016/S0169-328X(02)00512-0; Sucic S, 2007, EUR J PHARMACOL, V556, P27, DOI 10.1016/j.ejphar.2006.10.058; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; WALDMANN TA, 1991, J BIOL CHEM, V266, P2681; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	71	101	104	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10924	10938		10.1074/jbc.M109.083154	http://dx.doi.org/10.1074/jbc.M109.083154			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118234	Green Published, hybrid			2022-12-25	WOS:000276264600077
J	Yang, RQ; Zhan, M; Nalabothula, NR; Yang, QY; Indig, FE; Carrier, F				Yang, Ruiqing; Zhan, Ming; Nalabothula, Narasimha Rao; Yang, Qingyuan; Indig, Fred E.; Carrier, France			Functional Significance for a Heterogenous Ribonucleoprotein A18 Signature RNA Motif in the 3 '-Untranslated Region of Ataxia Telangiectasia Mutated and Rad3-related (ATR) Transcript	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCIBLE TRANSCRIPTS; TARGET MESSENGER-RNAS; POSTTRANSCRIPTIONAL REGULATION; BINDING PROTEINS; KINASE; IDENTIFICATION; GENOME; THIOREDOXIN; INHIBITION; COMPLEXES	The predominantly nuclear heterogenous ribonucleoprotein A18 (hnRNP A18) translocates to the cytosol in response to cellular stress and increases translation by specifically binding to the 3'-untranslated region (UTR) of several mRNA transcripts and the eukaryotic initiation factor 4G. Here, we identified a 51-nucleotide motif that is present 11.49 times more often in the 3'-UTR of hnRNP A18 mRNA targets than in the UniGene data base. This motif was identified by computational analysis of primary sequences and secondary structures of hnRNP A18 mRNA targets against the unaligned sequences. Band shift analyses indicate that the motif is sufficient to confer binding to hnRNP A18. A search of the entire UniGene data base indicates that the hnRNP A18 motif is also present in the 3'-UTR of the ataxia telangiectasia mutated and Rad3-related (ATR) mRNA. Validation of the predicted hnRNP A18 motif is provided by amplification of endogenous ATR transcript on polysomal fractions immunoprecipitated with hnRNP A18. Moreover, overexpression of hnRNP A18 results in increased ATR protein levels and increased phosphorylation of Chk1, a preferred ATR substrate, in response to UV radiation. In addition, our data indicate that inhibition of casein kinase II or GSK3 beta significantly reduced hnRNP A18 cytosolic translocation in response to UV radiation. To our knowledge, this constitutes the first demonstration of a post-transcriptional regulatory mechanism for ATR activity. hnRNP A18 could thus become a new target to trigger ATR activity as back-up stress response mechanisms to functionally compensate for absent or defective responders.	[Yang, Ruiqing; Nalabothula, Narasimha Rao; Yang, Qingyuan; Carrier, France] Univ Maryland, Dept Radiat Oncol, Marlene & Stewart Greenebaum Canc Ctr, Sch Med, Baltimore, MD 21201 USA; [Zhan, Ming] NIA, Res Resources Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Indig, Fred E.] NIA, NIH, Baltimore, MD 21224 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Carrier, F (corresponding author), 655 W Baltimore St, Baltimore, MD 21201 USA.	fcarr001@umaryland.edu		Carrier, France/0000-0002-5517-5284	National Institutes of Health [RO1 GM57827, RO1 1CA116491-01]; University of Maryland, Baltimore; NATIONAL CANCER INSTITUTE [R01CA116491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000615, ZICAG000619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland, Baltimore; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants RO1 GM57827 and RO1 1CA116491-01 (to F. C.). This work was also supported by funds from the graduate program in biochemistry of the University of Maryland, Baltimore (to R. Y.).	Abraham RT, 2004, DNA REPAIR, V3, P919, DOI 10.1016/j.dnarep.2004.04.003; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Connelly MA, 1996, GENE, V175, P271, DOI 10.1016/0378-1119(96)00135-7; Cuadrado M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-7; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; Hammond EM, 2004, CANCER RES, V64, P6556, DOI 10.1158/0008-5472.CAN-04-1520; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kelley MR, 2008, ANTI-CANCER AGENT ME, V8, P417, DOI 10.2174/187152008784220294; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Liu QH, 2000, GENE DEV, V14, P1448; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Mannino JL, 2001, GENE, V272, P35, DOI 10.1016/S0378-1119(01)00543-1; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; Savitsky K, 1997, NUCLEIC ACIDS RES, V25, P1678, DOI 10.1093/nar/25.9.1678; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Sheikh MS, 1997, J BIOL CHEM, V272, P26720, DOI 10.1074/jbc.272.42.26720; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang RQ, 2006, NUCLEIC ACIDS RES, V34, P1224, DOI 10.1093/nar/gkj519	33	40	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8887	8893		10.1074/jbc.M109.013128	http://dx.doi.org/10.1074/jbc.M109.013128			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20103595	hybrid, Green Published			2022-12-25	WOS:000275553700040
J	Gustafson, WC; Weiss, WA				Gustafson, W. C.; Weiss, W. A.			Myc proteins as therapeutic targets	ONCOGENE			English	Review						myc; mycn; neuroblastoma; N-myc; mTor; PI3K	ANAPLASTIC LYMPHOMA KINASE; INITIAL TESTING STAGE-1; ARF TUMOR-SUPPRESSOR; C-MYC; N-MYC; GENE-EXPRESSION; DNA-BINDING; CELL-LINES; TRANSCRIPTIONAL CONTROL; MALIGNANT PROGRESSION	Myc proteins (c-myc, Mycn and Mycl) target proliferative and apoptotic pathways vital for progression in cancer. Amplification of the MYCN gene has emerged as one of the clearest indicators of aggressive and chemotherapy-refractory disease in children with neuroblastoma, the most common extracranial solid tumor of childhood. Phosphorylation and ubiquitin-mediated modulation of Myc protein influence stability and represent potential targets for therapeutic intervention. Phosphorylation of Myc proteins is controlled in-part by the receptor tyrosine kinase/phosphatidylinositol 3-kinase/Akt/mTOR signaling, with additional contributions from Aurora A kinase. Myc proteins regulate apoptosis in part through interactions with the p53/Mdm2/Arf signaling pathway. Mutation in p53 is commonly observed in patients with relapsed neuroblastoma, contributing to both biology and therapeutic resistance. This review examines Myc function and regulation in neuroblastoma, and discusses emerging therapies that target Mycn. Oncogene (2010) 29, 1249-1259; doi:10.1038/onc.2009.512; published online 25 January 2010	[Gustafson, W. C.; Weiss, W. A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Gustafson, W. C.] Univ Calif San Francisco, Div Pediat Hematol Oncol, San Francisco, CA 94143 USA; [Weiss, W. A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weiss, W. A.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gustafson, WC (corresponding author), Univ Calif San Francisco, Dept Pediat, Helen Diller Family Canc Res Bldg,1450 3rd St, San Francisco, CA 94158 USA.	GustafsonC@peds.ucsf.edu		Weiss, William/0000-0003-2230-9132	NIH [CA133091, NS055750, CA102321, CA097257, CA128583]; Burroughs Wellcome Fund; American Brain Tumor Association; Brain Tumor Society; Accelerate Brain Cancer Cure; Alex's Lemonade Stand Foundation; Children's National Brain Tumor Foundation; Wallace H. Coulter Foundation; Katie Dougherty Foundation; Pediatric Brain Tumor Foundation; Samuel G Waxman Foundation; V Foundation; NATIONAL CANCER INSTITUTE [R01CA102321, R01CA133091, R01CA148699, P01CA081403, T32CA128583, P50CA097257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Brain Tumor Association; Brain Tumor Society; Accelerate Brain Cancer Cure; Alex's Lemonade Stand Foundation; Children's National Brain Tumor Foundation; Wallace H. Coulter Foundation; Katie Dougherty Foundation; Pediatric Brain Tumor Foundation; Samuel G Waxman Foundation; V Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Chris Hackett and Theo Nicolaides for critical review. We acknowledge support from NIH grants CA133091, NS055750, CA102321, CA097257, CA128583; Burroughs Wellcome Fund, American Brain Tumor Association, The Brain Tumor Society, Accelerate Brain Cancer Cure; Alex's Lemonade Stand, Children's National Brain Tumor, Wallace H. Coulter, Katie Dougherty, Pediatric Brain Tumor, Samuel G Waxman and V Foundations.	Alaminos M, 2003, CANCER RES, V63, P4538; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Amente S, 2007, FEBS LETT, V581, P821, DOI 10.1016/j.febslet.2007.01.062; ARMSTRONG BC, 1992, CELL GROWTH DIFFER, V3, P385; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; ASKEW DS, 1991, ONCOGENE, V6, P1915; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Barbieri E, 2006, MOL CANCER THER, V5, P2358, DOI 10.1158/1535-7163.MCT-06-0305; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Bell E, 2007, CELL CYCLE, V6, P1249, DOI 10.4161/cc.6.10.4222; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; BERBERICH SJ, 1992, GENE DEV, V6, P166, DOI 10.1101/gad.6.2.166; Berg T, 2008, CURR OPIN CHEM BIOL, V12, P464, DOI 10.1016/j.cbpa.2008.07.023; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BLACKWOOD EM, 1992, GENE DEV, V6, P71, DOI 10.1101/gad.6.1.71; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; Chan HSL, 1997, CLIN CANCER RES, V3, P1699; Chen QR, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-70; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Cheng AJ, 2007, EUR J CANCER, V43, P1467, DOI 10.1016/j.ejca.2007.03.008; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Chesler L, 2007, CANCER RES, V67, P9435, DOI 10.1158/0008-5472.CAN-07-1316; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; CLAUSEN N, 1989, ACTA PAEDIATR SCAND, V78, P736, DOI 10.1111/j.1651-2227.1989.tb11135.x; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; Cohn SL, 2000, J CLIN ONCOL, V18, P3604, DOI 10.1200/JCO.2000.18.21.3604; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Coutts AS, 2009, DNA REPAIR, V8, P483, DOI 10.1016/j.dnarep.2009.01.008; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; DOWNS KM, 1989, GENE DEV, V3, P860, DOI 10.1101/gad.3.6.860; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fulda S, 1999, ONCOGENE, V18, P1479, DOI 10.1038/sj.onc.1202435; Fulda S, 2009, CURR CANCER DRUG TAR, V9, P729, DOI 10.2174/156800909789271521; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gingras AC, 2001, GENE DEV, V15, P2852; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guo C, 1999, ONCOGENE, V18, P4948, DOI 10.1038/sj.onc.1202887; Hackett CS, 2003, CANCER RES, V63, P5266; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; Herbst A, 2004, ONCOGENE, V23, P3863, DOI 10.1038/sj.onc.1207492; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; HIRNING U, 1991, MECH DEVELOP, V33, P119, DOI 10.1016/0925-4773(91)90078-K; HIRVONEN H, 1990, ONCOGENE, V5, P1787; Ho R, 2002, CANCER RES, V62, P6462; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hossain MS, 2008, ONCOGENE, V27, P6075, DOI 10.1038/onc.2008.200; Houghton PJ, 2008, PEDIATR BLOOD CANCER, V50, P799, DOI 10.1002/pbc.21296; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Ikegaki N, 2007, CLIN CANCER RES, V13, P6001, DOI 10.1158/1078-0432.CCR-07-0071; Inge TH, 2002, SURGERY, V132, P232, DOI 10.1067/msy.2002.125387; Jacobs JFM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-239; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kanemaru KK, 2008, PEDIATR BLOOD CANCER, V50, P806, DOI 10.1002/pbc.21273; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; KATO GJ, 1992, GENE DEV, V6, P81, DOI 10.1101/gad.6.1.81; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Keshelava N, 1998, CANCER RES, V58, P5396; Keshelava N, 1997, EUR J CANCER, V33, P2002, DOI 10.1016/S0959-8049(97)00213-X; Keshelava N, 2000, MED PEDIATR ONCOL, V35, P563, DOI 10.1002/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Koppen A, 2007, CANCER LETT, V256, P218, DOI 10.1016/j.canlet.2007.06.011; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; KRYSTAL GW, 1990, MOL CELL BIOL, V10, P4180, DOI 10.1128/MCB.10.8.4180; Li RS, 2008, MED RES REV, V28, P372, DOI 10.1002/med.20109; Li ZL, 2009, CELL CYCLE, V8, P2703, DOI 10.4161/cc.8.17.9418; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Liu T, 2009, EUR J CANCER, V45, P1846, DOI 10.1016/j.ejca.2009.03.002; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Lutterbach B, 1999, J CELL BIOCHEM, V72, P483, DOI 10.1002/(SICI)1097-4644(19990315)72:4<483::AID-JCB4>3.0.CO;2-I; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Manohar CF, 2004, ONCOGENE, V23, P753, DOI 10.1038/sj.onc.1207151; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Maris JM, 2008, PEDIATR BLOOD CANCER, V51, P42, DOI 10.1002/pbc.21535; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2009, CANCER CELL, V15, P5, DOI 10.1016/j.ccr.2008.12.008; Marques M, 2008, MOL CELL BIOL, V28, P2803, DOI 10.1128/MCB.01786-07; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Martins RAP, 2008, GENE DEV, V22, P179, DOI 10.1101/gad.1608008; Marzec M, 2007, ONCOGENE, V26, P5606, DOI 10.1038/sj.onc.1210346; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Mill P, 2005, DEV CELL, V9, P293, DOI 10.1016/j.devcel.2005.05.009; Moore HC, 2008, J CLIN PATHOL, V61, P1098, DOI 10.1136/jcp.2007.054627; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2009, CLIN CANCER RES, V15, P5609, DOI 10.1158/1078-0432.CCR-08-2762; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Norris MD, 2000, MED PEDIATR ONCOL, V35, P585, DOI 10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.3.CO;2-G; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Paffhausen T, 2007, CANCER LETT, V250, P17, DOI 10.1016/j.canlet.2006.09.010; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; PAYNE GS, 1982, NATURE, V295, P209, DOI 10.1038/295209a0; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; PULVERER BJ, 1994, ONCOGENE, V9, P59; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Raabe EH, 2008, ONCOGENE, V27, P469, DOI 10.1038/sj.onc.1210659; Riley RD, 2004, CLIN CANCER RES, V10, P4, DOI 10.1158/1078-0432.CCR-1051-2; Rohrer T, 2002, PEDIATR PULM, V33, P71, DOI 10.1002/ppul.10031; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; SAKSELA K, 1992, ONCOGENE, V7, P347; Schramm A, 2005, ONCOGENE, V24, P7902, DOI 10.1038/sj.onc.1208936; Schramm A, 2009, CANCER LETT, V282, P55, DOI 10.1016/j.canlet.2009.02.052; Schulte JH, 2009, CANCER LETT, V274, P10, DOI 10.1016/j.canlet.2008.06.010; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Shang XY, 2009, MOL CANCER THER, V8, P2461, DOI 10.1158/1535-7163.MCT-08-0857; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Slack A, 2005, CANCER LETT, V228, P21, DOI 10.1016/j.canlet.2005.01.050; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; SmithSorensen B, 1996, J BIOL CHEM, V271, P5513, DOI 10.1074/jbc.271.10.5513; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Tang XX, 2006, CANCER RES, V66, P2826, DOI 10.1158/0008-5472.CAN-05-0854; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Trochet D, 2005, AM J HUM GENET, V76, P421, DOI 10.1086/428366; Tweddle DA, 2001, CANCER RES, V61, P8; Ushmorov A, 2008, ONCOGENE, V27, P3424, DOI 10.1038/sj.onc.1211017; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Van Maerken T, 2009, CELL DEATH DIFFER, V16, P1563, DOI 10.1038/cdd.2009.138; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; VOGAN K, 1993, CANCER RES, V53, P5269; Wagner LM, 2009, J CELL BIOCHEM, V107, P46, DOI 10.1002/jcb.22094; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Wang WG, 2006, P NATL ACAD SCI USA, V103, P11003, DOI 10.1073/pnas.0604507103; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weiss WA, 2000, CANCER RES, V60, P2483; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Witt O, 2009, CURR PHARM DESIGN, V15, P436, DOI 10.2174/138161209787315774; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Xue C, 2007, CANCER RES, V67, P10351, DOI 10.1158/0008-5472.CAN-06-4345; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zask A, 2009, J MED CHEM, V52, P5013, DOI 10.1021/jm900851f; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	199	148	154	1	38	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2010	29	9					1249	1259		10.1038/onc.2009.512	http://dx.doi.org/10.1038/onc.2009.512			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	563XJ	20101214	Green Accepted			2022-12-25	WOS:000275170600001
J	Furtak, V; Mulky, A; Rawlings, SA; Kozhaya, L; Lee, K; KewalRamani, VN; Unutmaz, D				Furtak, Vyacheslav; Mulky, Alok; Rawlings, Stephen A.; Kozhaya, Lina; Lee, KyeongEun; KewalRamani, Vineet N.; Unutmaz, Derya			Perturbation of the P-Body Component Mov10 Inhibits HIV-1 Infectivity	PLOS ONE			English	Article							VIRUS TYPE-1 RNA; STRESS GRANULES; PROTEIN; BODIES; REPLICATION; FAMILY; OVEREXPRESSION; IDENTIFICATION; ASSOCIATION; COMPLEXES	Exogenous retroviruses are obligate cellular parasites that co-opt a number of host proteins and functions to enable their replication and spread. Several host factors that restrict HIV and other retroviral infections have also recently been described. Here we demonstrate that Mov10, a protein associated with P-bodies that has a putative RNA-helicase domain, when overexpressed in cells can inhibit the production of infectious retroviruses. Interestingly, reducing the endogenous Mov10 levels in virus-producing cells through siRNA treatment also modestly suppresses HIV infectivity. The actions of Mov10 are not limited to HIV, however, as ectopic expression of Mov10 restricts the production of other lentiviruses as well as the gammaretrovirus, murine leukemia virus. We found that HIV produced in the presence of high levels of Mov10 is restricted at the pre-reverse transcription stage in target cells. Finally, we show that either helicase mutation or truncation of the C-terminal half of Mov10, where a putative RNA-helicase domain is located, maintained most of its HIV inhibition; whereas removing the N-terminal half of Mov10 completely abolished its activity on HIV. Together these results suggest that Mov10 could be required during the lentiviral lifecycle and that its perturbation disrupts generation of infectious viral particles. Because Mov10 is implicated as part of the P-body complex, these findings point to the potential role of cytoplasmic RNA processing machinery in infectious retroviral production.	[Furtak, Vyacheslav; Rawlings, Stephen A.; Kozhaya, Lina; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY USA; [Mulky, Alok; Lee, KyeongEun; KewalRamani, Vineet N.] NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA	New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Furtak, V (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	vineet@mac.com; derya@mac.com	Rawlings, Stephen/ABA-6797-2020; KewalRamani, Vineet/V-5084-2019	Rawlings, Stephen/0000-0003-3637-1447; 	National Institutes of Health [R21 AI078839]; National Cancer Institute's intramural Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute's intramural Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R21 AI078839 to D. U. and in part by the National Cancer Institute's intramural Center for Cancer Research, which supports the HIV Drug Resistance Program of V.N.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askjaer P, 2000, J BIOL CHEM, V275, P11561, DOI 10.1074/jbc.275.16.11561; Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Bartz SR, 1997, METHODS, V12, P337, DOI 10.1006/meth.1997.0487; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Beliakova-Bethell N, 2006, RNA, V12, P94, DOI 10.1261/rna.2264806; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; CHECKLEY MA, MOL CELL BIOL, V30, P382; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Ma J, 2008, VIROLOGY, V375, P253, DOI 10.1016/j.virol.2008.01.025; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Ott DE, 2008, REV MED VIROL, V18, P159, DOI 10.1002/rmv.570; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; SCHNIEKE A, 1983, J VIROL, V45, P505, DOI 10.1128/JVI.45.2.505-513.1983; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Southey R., 1837, STORY 3 BEARS; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Zhou YD, 2008, VIROLOGY, V372, P97, DOI 10.1016/j.virol.2007.10.027	33	92	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9081	10.1371/journal.pone.0009081	http://dx.doi.org/10.1371/journal.pone.0009081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140200	Green Submitted, Green Published, gold			2022-12-25	WOS:000274442400017
J	Sweiss, NJ; Salloum, R; Ghandi, S; Alegre, ML; Sawaqed, R; Badaracco, M; Pursell, K; Pitrak, D; Baughman, RP; Moller, DR; Garcia, JGN; Niewold, TB				Sweiss, Nadera J.; Salloum, Rafah; Ghandi, Seema; Alegre, Maria-Luisa; Sawaqed, Ray; Badaracco, Maria; Pursell, Kenneth; Pitrak, David; Baughman, Robert P.; Moller, David R.; Garcia, Joe G. N.; Niewold, Timothy B.			Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease Manifestations	PLOS ONE			English	Article								Background: Sarcoidosis is a poorly understood chronic inflammatory condition. Infiltration of affected organs by lymphocytes is characteristic of sarcoidosis, however previous reports suggest that circulating lymphocyte counts are low in some patients with the disease. The goal of this study was to evaluate lymphocyte subsets in peripheral blood in a cohort of sarcoidosis patients to determine the prevalence, severity, and clinical features associated with lymphopenia in major lymphocyte subsets. Methodology/Principal Findings: Lymphocyte subsets in 28 sarcoid patients were analyzed using flow cytometry to determine the percentage of CD4, CD8, and CD19 positive cells. Greater than 50% of patients had abnormally low CD4, CD8, or CD19 counts (p<4x10(-10)). Lymphopenia was profound in some cases, and five of the patients had absolute CD4 counts below 200. CD4, CD8, and CD19 lymphocyte subset counts were significantly correlated (Spearman's rho 0.57, p = 0.0017), and 10 patients had low counts in all three subsets. Patients with severe organ system involvement including neurologic, cardiac, ocular, and advanced pulmonary disease had lower lymphocyte subset counts as a group than those patients with less severe manifestations (CD4 p = 0.0043, CD8 p = 0.026, CD19 p = 0.033). No significant relationships were observed between various medical therapies and lymphocyte counts, and lymphopenia was present in patients who were not receiving any medical therapy. Conclusions/Significance: Significant lymphopenia involving CD4, CD8, and CD19 positive cells was common in sarcoidosis patients and correlated with disease severity. Our findings suggest that lymphopenia relates more to disease pathology than medical treatment.	[Sweiss, Nadera J.] Univ Chicago, Rheumatol Sect, Sarcoidosis & Scleroderma Clin, Chicago, IL 60637 USA; [Ghandi, Seema] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sawaqed, Ray] Methodist Hosp, Merrillville, IN USA; [Pursell, Kenneth; Pitrak, David] Univ Chicago, Sect Infect Dis & Global Hlth, Chicago, IL 60637 USA; [Baughman, Robert P.] Univ Cincinnati, Med Ctr, Div Pulm & Crit Care, Cincinnati, OH 45267 USA; [Moller, David R.] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Garcia, Joe G. N.] Univ Chicago, Sect Pulm Crit Care, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University System of Ohio; University of Cincinnati; Johns Hopkins University; University of Chicago	Sweiss, NJ (corresponding author), Univ Chicago, Rheumatol Sect, Sarcoidosis & Scleroderma Clin, Chicago, IL 60637 USA.	nsweiss@medicine.bsd.uchicago.edu	Garcia, Joe GN/E-8862-2010; Niewold, Timothy/D-2669-2018	Niewold, Timothy/0000-0003-3532-6660; Gandhi, Seema/0000-0002-2363-2655; Sweiss, Nadera/0000-0003-2215-0221	NIH [K08 AI083790]; NIAID [AI071651]; Arthritis National Research Foundation Eng Tan Scholar Award; Lupus Research Institute; University of Chicago CTSA; Collaborative University of Chicago/Northshore University Health System [UL1 RR024999]; Abbott, Genentech; BMS; Foundation for Sarcoidosis Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI083790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Arthritis National Research Foundation Eng Tan Scholar Award(National Research Foundation of Korea); Lupus Research Institute; University of Chicago CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Collaborative University of Chicago/Northshore University Health System; Abbott, Genentech(Abbott LaboratoriesRoche HoldingGenentech); BMS(Bristol-Myers Squibb); Foundation for Sarcoidosis Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support and Disclosures: TB Niewold: NIH K08 AI083790, NIAID Clinical Research Loan Repayment AI071651, Arthritis National Research Foundation Eng Tan Scholar Award, Lupus Research Institute, University of Chicago CTSA Core Subsidy Grant and Collaborative University of Chicago/Northshore University Health System Translational Research Pilot Grant from UL1 RR024999. NJ Sweiss: Investigator initiated grant support from Abbott, Genentech and BMS for sarcoidosis research, Young investigator award, Foundation for Sarcoidosis Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUGHMAN RP, 1985, CLIN EXP IMMUNOL, V61, P535; Gerke AK, 2008, CLIN CHEST MED, V29, P379, DOI 10.1016/j.ccm.2008.03.014; HEDFORS E, 1974, CLIN EXP IMMUNOL, V17, P219; KATARIA YP, 1976, ANN NY ACAD SCI, V278, P69, DOI 10.1111/j.1749-6632.1976.tb47017.x; Lower E E, 1988, Sarcoidosis, V5, P51; Noor A, 2007, CLIN DERMATOL, V25, P250, DOI 10.1016/j.clindermatol.2007.03.002; SELROOS O, 1979, ACTA MED SCAND, V206, P259; SLADE JD, 1983, J LAB CLIN MED, V101, P479; Zissel G, 2007, SEMIN RESP CRIT CARE, V28, P3, DOI 10.1055/s-2007-970329	9	79	81	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9088	10.1371/journal.pone.0009088	http://dx.doi.org/10.1371/journal.pone.0009088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140091	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442400024
J	Lehner, B				Lehner, Ben			Genes Confer Similar Robustness to Environmental, Stochastic, and Genetic Perturbations in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EVOLUTIONARY PLASTICITY; MORPHOLOGICAL EVOLUTION; INTERACTION NETWORKS; CANALIZATION; CAPACITOR; HSP90; EVOLVABILITY; PHENOTYPE; GENOME	Gene inactivation often has little or no apparent consequence for the phenotype of an organism. This property-enetic (or mutational) robustness-is pervasive, and has important implications for disease and evolution, but is not well understood. Dating back to at least Waddington, it has been suggested that mutational robustness may be related to the requirement to withstand environmental or stochastic perturbations. Here I show that global quantitative data from yeast are largely consistent with this idea. Considering the effects of mutations in all nonessential genes shows that genes that confer robustness to environmental or stochastic change also buffer the effects of genetic change, and with similar efficacy. This means that selection during evolution for environmental or stochastic robustness (also referred to as canalization) may frequently have the side effect of increasing genetic robustness. A dynamic environment may therefore promote the evolution of phenotypic complexity. It also means that "hub'' genes in genetic interaction (synthetic lethal) networks are generally genes that confer environmental resilience and phenotypic stability.	[Lehner, Ben] European Mol Biol Lab, Barcelona, Spain; [Lehner, Ben] Univ Pompeu Fabra, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	European Molecular Biology Laboratory (EMBL); ICREA; Pompeu Fabra University	Lehner, B (corresponding author), European Mol Biol Lab, Barcelona, Spain.	ben.lehner@crg.es	Lehner, Ben/L-3413-2014; Lehner, Ben/ABH-6562-2020	Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124	European Research Council; InstitucioCatalana de Recerca i Estudis Avancats; Ministerio de Ciencia e Innovacion Plan Nacional; Agencia de Gestiod'Ajuts Universitaris i de Recerca; European Molecular Biology-Centre for Genomic Regulation Systems Biology; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); InstitucioCatalana de Recerca i Estudis Avancats(ICREA); Ministerio de Ciencia e Innovacion Plan Nacional; Agencia de Gestiod'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Molecular Biology-Centre for Genomic Regulation Systems Biology; ICREA(ICREA)	This research was supported by the European Research Council, InstitucioCatalana de Recerca i Estudis Avancats, Ministerio de Ciencia e Innovacion Plan Nacional, Agencia de Gestiod'Ajuts Universitaris i de Recerca, and the European Molecular Biology-Centre for Genomic Regulation Systems Biology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dichtel-Danjoy ML, 2004, TRENDS GENET, V20, P268, DOI 10.1016/j.tig.2004.03.010; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Waddington C., 1957, STRATEGY GENES; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]	34	67	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9035	10.1371/journal.pone.0009035	http://dx.doi.org/10.1371/journal.pone.0009035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140261	Green Published, gold			2022-12-25	WOS:000274474200021
J	Roux, O; Billen, J; Orivel, J; Dejean, A				Roux, Olivier; Billen, Johan; Orivel, Jerome; Dejean, Alain			An Overlooked Mandibular-Rubbing Behavior Used during Recruitment by the African Weaver Ant, Oecophylla longinoda	PLOS ONE			English	Article							FRUIT-FLIES DIPTERA; LATREILLE HYMENOPTERA; PREDATORY BEHAVIOR; FORMICIDAE; TEPHRITIDAE; PHEROMONES	In Oecophylla, an ant genus comprising two territorially dominant arboreal species, workers are known to (1) use anal spots to mark their territories, (2) drag their gaster along the substrate to deposit short-range recruitment trails, and (3) drag the extruded rectal gland along the substrate to deposit the trails used in long-range recruitment. Here we study an overlooked but important marking behavior in which O. longinoda workers first rub the underside of their mandibles onto the substrate, and then-in a surprising posture-tilt their head and also rub the upper side of their mandibles. We demonstrate that this behavior is used to recruit nestmates. Its frequency varies with the rate at which a new territory, a sugary food source, a prey item, or an alien ant are discovered. Microscopy analyses showed that both the upper side and the underside of the mandibles possess pores linked to secretory glands. So, by rubbing their mandibles onto the substrate, the workers probably spread a secretion from these glands that is involved in nestmate recruitment.	[Roux, Olivier; Dejean, Alain] CNRS, UMR, Kourou, France; [Billen, Johan] Univ Leuven, Inst Zool, Entomol Lab, Leuven, Belgium; [Orivel, Jerome] CNRS, UMR, Lab Evolut & Diversite Biol, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); KU Leuven; Centre National de la Recherche Scientifique (CNRS)	Roux, O (corresponding author), CNRS, UMR, Kourou, France.	oroux@cict.fr	Orivel, Jerome/C-4034-2011; Roux, Olivier/A-1181-2011; Roux, Olivier/I-5675-2016	Orivel, Jerome/0000-0002-5636-3228; Dejean, Alain/0000-0002-3561-2248; Roux, Olivier/0000-0001-5440-0219; Billen, Johan/0000-0002-2392-7293	French Centre National de la Recherche Scientifique [2ID]	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Support for this study was provided by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUGNON G, 1992, INSECT SOC, V39, P341, DOI 10.1007/BF01323954; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; BRADSHAW JWS, 1975, NATURE, V258, P230, DOI 10.1038/258230a0; BRADSHAW JWS, 1978, PHYSIOL ENTOMOL, P15; DEJEAN A, 1991, ETHOLOGY, V88, P89; Dejean A, 1996, OECOLOGIA, V106, P57, DOI 10.1007/BF00334407; DEJEAN A, 1990, WESTV STUD, P472; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2007, CR BIOL, V330, P701, DOI 10.1016/j.crvi.2007.06.005; HOLLDOBLER B, 1977, P NATL ACAD SCI USA, V74, P2072, DOI 10.1073/pnas.74.5.2072; HOLLDOBLER B, 1983, BIOTROPICA, V15, P241, DOI 10.2307/2387648; HOLLDOBLER B, 1978, BEHAV ECOL SOCIOBIOL, V4, P163, DOI 10.1007/BF00354978; HOLLDOBLER B, 1978, BEHAV ECOL SOCIOBIOL, V3, P19, DOI 10.1007/BF00300045; Holldobler B., 1990, pi; Kenne M, 2000, ENTOMOL EXP APPL, V94, P31, DOI 10.1023/A:1003900925341; Madi Y., 2006, ENTOMOTROPICA, V21, P117; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Offenberg J, 2007, INSECT SOC, V54, P248, DOI 10.1007/s00040-007-0938-5; Offenberg J, 2006, FUNCT ECOL, V20, P52, DOI 10.1111/j.1365-2435.2005.01059.x; Offenberg J, 2004, P ROY SOC B-BIOL SCI, V271, pS433, DOI 10.1098/rsbl.2004.0210; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Richard FJ, 2001, J INSECT BEHAV, V14, P271, DOI 10.1023/A:1007845929801; SCHOETERS E, 1994, ZOOMORPHOLOGY, V114, P125, DOI 10.1007/BF00396645; Van Mele P, 2008, AGR FOREST ENTOMOL, V10, P13, DOI 10.1111/j.1461-9563.2007.00350.x; Van Mele P, 2007, J ECON ENTOMOL, V100, P695, DOI 10.1603/0022-0493(2007)100[695:EOAAWA]2.0.CO;2; Van Mele P, 2009, PHYSIOL ENTOMOL, V34, P256, DOI 10.1111/j.1365-3032.2009.00685.x	26	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8957	10.1371/journal.pone.0008957	http://dx.doi.org/10.1371/journal.pone.0008957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126536	Green Submitted, Green Published, gold			2022-12-25	WOS:000274209700003
J	Langer, CCH; Ejsmont, RK; Schonbauer, C; Schnorrer, F; Tomancak, P				Langer, Christoph C. H.; Ejsmont, Radoslaw K.; Schoenbauer, Cornelia; Schnorrer, Frank; Tomancak, Pavel			In Vivo RNAi Rescue in Drosophila melanogaster with Genomic Transgenes from Drosophila pseudoobscura	PLOS ONE			English	Article							GENE; EXPRESSION; PROTEINS; ELEMENTS; DATABASE	Backgroud: Systematic, large-scale RNA interference (RNAi) approaches are very valuable to systematically investigate biological processes in cell culture or in tissues of organisms such as Drosophila. A notorious pitfall of all RNAi technologies are potential false positives caused by unspecific knock-down of genes other than the intended target gene. The ultimate proof for RNAi specificity is a rescue by a construct immune to RNAi, typically originating from a related species. Methodology/Principal Findings: We show that primary sequence divergence in areas targeted by Drosophila melanogaster RNAi hairpins in five non-melanogaster species is sufficient to identify orthologs for 81% of the genes that are predicted to be RNAi refractory. We use clones from a genomic fosmid library of Drosophila pseudoobscura to demonstrate the rescue of RNAi phenotypes in Drosophila melanogaster muscles. Four out of five fosmid clones we tested harbour cross-species functionality for the gene assayed, and three out of the four rescue a RNAi phenotype in Drosophila melanogaster. Conclusions/Significance: The Drosophila pseudoobscura fosmid library is designed for seamless cross-species transgenesis and can be readily used to demonstrate specificity of RNAi phenotypes in a systematic manner.	[Langer, Christoph C. H.; Schoenbauer, Cornelia; Schnorrer, Frank] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Ejsmont, Radoslaw K.; Tomancak, Pavel] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society; Max Planck Society	Langer, CCH (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	schnorrer@biochem.mpg.de; tomancak@mpi-cbg.de	Schnorrer, Frank/AIE-3578-2022; Tomancak, Pavel/C-2109-2009	Schnorrer, Frank/0000-0002-9518-7263; Tomancak, Pavel/0000-0002-2222-9370; Ejsmont, Radoslaw/0000-0001-7176-7848; Langer, Christoph C. H./0000-0001-8751-1564	Max-Planck Society; Human Frontier Science Program	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the Max-Planck Society and the Human Frontier Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2008, MOL BIOL CELL, V19, P4287, DOI 10.1091/mbc.E08-02-0182; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Burkart C, 2007, J MOL BIOL, V367, P953, DOI 10.1016/j.jmb.2007.01.059; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; EJSMONT RK, 2009, NAT METHODS; FESSLER LI, 1994, METHOD ENZYMOL, V245, P271; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; KONDO S, 2009, CROSS SPECIES RNAI R; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; MONTANEZ E, 2009, EMBO J; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Perrimon N, 2007, FLY, V1, P1; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; SAIDE JD, 1989, J CELL BIOL, V109, P2157, DOI 10.1083/jcb.109.5.2157; Sarov M, 2005, TRENDS BIOTECHNOL, V23, P446, DOI 10.1016/j.tibtech.2005.06.007; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schmid Andreas, 2008, V420, P239, DOI 10.1007/978-1-59745-583-1_14; SCHNORRER F, 2010, SYSTEMATIC GENETIC A; Schnorrer F, 2007, DEV CELL, V12, P751, DOI 10.1016/j.devcel.2007.02.017; Schulz JG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp450; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	45	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8928	10.1371/journal.pone.0008928	http://dx.doi.org/10.1371/journal.pone.0008928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126626	Green Published, gold			2022-12-25	WOS:000274138000007
J	Dong, J; Gao, YP; Liu, Y; Shi, JX; Feng, JN; Li, ZG; Pan, HP; Xue, YN; Liu, CA; Shen, BF; Shao, NS; Yang, G				Dong, Jie; Gao, Yaping; Liu, Yu; Shi, Jinxia; Feng, Jiannan; Li, Zhanguo; Pan, Heping; Xue, Yanning; Liu, Chuan; Shen, Beifen; Shao, Ningsheng; Yang, Guang			The Protective Antibodies Induced by a Novel Epitope of Human TNF-alpha Could Suppress the Development of Collagen-Induced Arthritis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; HUMAN-DISEASES; ANTAGONIST; ADALIMUMAB; INHIBITOR; BLOCKADE; EFFICACY; THERAPY; SAFETY	Tumor necrosis factor alpha (TNF-alpha) is a major inflammatory mediator that exhibits actions leading to tissue destruction and hampering recovery from damage. At present, two antibodies against human TNF-alpha (hTNF-alpha) are available, which are widely used for the clinic treatment of certain inflammatory diseases. This work was undertaken to identify a novel functional epitope of hTNF-alpha. We performed screening peptide library against anti-hTNF-alpha antibodies, ELISA and competitive ELISA to obtain the epitope of hTNF-alpha. The key residues of the epitope were identified by means of combinatorial alanine scanning and site-specific mutagenesis. The N terminus (80-91 aa) of hTNF-alpha proved to be a novel epitope (YG1). The two amino acids of YG1, proline and valine, were identified as the key residues, which were important for hTNF-alpha biological function. Furthermore, the function of the epitope was addressed on an animal model of collagen-induced arthritis (CIA). CIA could be suppressed in an animal model by prevaccination with the derivative peptides of YG1. The antibodies of YG1 could also inhibit the cytotoxicity of hTNF-alpha. These results demonstrate that YG1 is a novel epitope associated with the biological function of hTNF-alpha and the antibodies against YG1 can inhibit the development of CIA in animal model, so it would be a potential target of new therapeutic antibodies.	[Dong, Jie; Gao, Yaping; Liu, Yu; Feng, Jiannan; Pan, Heping; Xue, Yanning; Liu, Chuan; Shen, Beifen; Shao, Ningsheng; Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Shi, Jinxia; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China	Academy of Military Medical Sciences - China; Peking University	Dong, J (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	shaons@hotmail.com; yanggg@hotmail.com			Chinese National Key Program on Basic Research [2010CB529100]; National Natural Science Foundation of China [30700007, 30870093]; National High-Tech Research and Development Program [2006AA02Z132, 2006AA02Z323, 2006AA02A253]	Chinese National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by grants from the Chinese National Key Program on Basic Research (2010CB529100, http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (30700007, 30870093, http://www.nsfc.gov.cn/nsfc2009/index.htm) and the National High-Tech Research and Development Program (2006AA02Z132, 2006AA02Z323, 2006AA02A253, http://www.863.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKWILL FR, 1989, IMMUNOL TODAY, V10, P299, DOI 10.1016/0167-5699(89)90085-6; Bombardieri S, 2007, RHEUMATOLOGY, V46, P1191, DOI 10.1093/rheumatology/kem091; CHIARA B, 2009, AUTOIMMUN REV, V8, P260; Daniel T., 2008, PHARMACOL THERAPEUT, V117, P244; DIGIOVINE FS, 1988, ANN RHEUM DIS, V47, P768, DOI 10.1136/ard.47.9.768; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347; Fisher MC, 2009, NAT REV RHEUMATOL, V5, P288, DOI 10.1038/nrrheum.2009.51; Gibbons LJ, 2009, BIODRUGS, V23, P111, DOI 10.2165/00063030-200923020-00004; LARS K, 2009, LANCET, V373, P659; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Nanki T, 2004, J IMMUNOL, V173, P7010, DOI 10.4049/jimmunol.173.11.7010; Nishikawa M, 2003, ARTHRITIS RHEUM-US, V48, P2670, DOI 10.1002/art.11227; Reed C, 1997, PROTEIN ENG, V10, P1101, DOI 10.1093/protein/10.10.1101; ROBERTO C, 2009, AUTOIMMUN REV, V8, P274; SAXNE T, 1988, ARTHRITIS RHEUM, V31, P1041, DOI 10.1002/art.1780310816; Schiff MH, 2006, ANN RHEUM DIS, V65, P889, DOI 10.1136/ard.2005.043166; Setoguchi S, 2006, ARTHRITIS RHEUM-US, V54, P2757, DOI 10.1002/art.22056; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Waksman Y, 1996, CLIN EXP IMMUNOL, V103, P376; Wong M, 2008, CLIN IMMUNOL, V126, P121, DOI 10.1016/j.clim.2007.08.013	24	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8920	10.1371/journal.pone.0008920	http://dx.doi.org/10.1371/journal.pone.0008920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111721	Green Published, Green Submitted, gold			2022-12-25	WOS:000274114800022
J	Guerra, L; Albihn, A; Tronnersjo, S; Yan, QZ; Guidi, R; Stenerlow, B; Sterzenbach, T; Josenhans, C; Fox, JG; Schauer, DB; Thelestam, M; Larsson, LG; Henriksson, M; Frisan, T				Guerra, Lina; Albihn, Ami; Tronnersjo, Susanna; Yan, Qinzi; Guidi, Riccardo; Stenerlow, Bo; Sterzenbach, Torsten; Josenhans, Christine; Fox, James G.; Schauer, David B.; Thelestam, Monica; Larsson, Lars-Gunnar; Henriksson, Marie; Frisan, Teresa			Myc Is Required for Activation of the ATM-Dependent Checkpoints in Response to DNA Damage	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; C-MYC; INDUCED APOPTOSIS; TRANSCRIPTIONAL CONTROL; CANCER-CELLS; P53; ARREST; ALTERS; BAX; ONCOGENES	Background: The MYC protein controls cellular functions such as differentiation, proliferation, and apoptosis. In response to genotoxic agents, cells overexpressing MYC undergo apoptosis. However, the MYC-regulated effectors acting upstream of the mitochondrial apoptotic pathway are still unknown. Principal Findings: In this study, we demonstrate that expression of Myc is required to activate the Ataxia telangiectasia mutated (ATM)-dependent DNA damage checkpoint responses in rat cell lines exposed to ionizing radiation (IR) or the bacterial cytolethal distending toxin (CDT). Phosphorylation of the ATM kinase and its downstream effectors, such as histone H2AX, were impaired in the myc null cell line HO15.19, compared to the myc positive TGR-1 and HOmyc3 cells. Nuclear foci formation of the Nijmegen Breakage Syndrome (Nbs) 1 protein, essential for efficient ATM activation, was also reduced in absence of myc. Knock down of the endogenous levels of MYC by siRNA in the human cell line HCT116 resulted in decreased ATM and CHK2 phosphorylation in response to irradiation. Conversely, cell death induced by UV irradiation, known to activate the ATR-dependent checkpoint, was similar in all the cell lines, independently of the myc status. Conclusion: These data demonstrate that MYC contributes to the activation of the ATM-dependent checkpoint responses, leading to cell death in response to specific genotoxic stimuli.	[Guerra, Lina; Albihn, Ami; Tronnersjo, Susanna; Yan, Qinzi; Guidi, Riccardo; Thelestam, Monica; Larsson, Lars-Gunnar; Henriksson, Marie; Frisan, Teresa] Karolinska Inst, Dept Cell Biol, Stockholm, Sweden; [Guerra, Lina; Guidi, Riccardo; Thelestam, Monica; Frisan, Teresa] Karolinska Inst, Dept Mol Biol, Stockholm, Sweden; [Albihn, Ami; Tronnersjo, Susanna; Yan, Qinzi; Larsson, Lars-Gunnar; Henriksson, Marie] Karolinska Inst, Dept Microbiol, Stockholm, Sweden; [Albihn, Ami; Tronnersjo, Susanna; Yan, Qinzi; Larsson, Lars-Gunnar; Henriksson, Marie] Karolinska Inst, Dept Tumor Biol, S-10401 Stockholm, Sweden; [Stenerlow, Bo] Uppsala Univ, Rudbeck Lab, Div Biomed Radiat Sci, Uppsala, Sweden; [Sterzenbach, Torsten; Josenhans, Christine] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany; [Fox, James G.; Schauer, David B.] MIT, Div Comparat Med, Dept Biol Engn, Cambridge, MA 02139 USA; [Larsson, Lars-Gunnar] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Uppsala University; Hannover Medical School; Massachusetts Institute of Technology (MIT); Swedish University of Agricultural Sciences	Guerra, L (corresponding author), Karolinska Inst, Dept Cell Biol, Stockholm, Sweden.	Teresa.Frisan@ki.se	Henriksson, Marie Arsenian/F-5010-2015; Larsson, Lars-Gunnar/D-9747-2012; Frisan, Teresa/H-8444-2019	Frisan, Teresa/0000-0002-1209-0942; Arsenian Henriksson, Marie/0000-0001-6376-7792; Guidi, Riccardo/0000-0002-1033-0252	Swedish Research Council; Swedish Cancer Society; Ake Wiberg Foundation; Karolinska Institutet; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Ake Wiberg Foundation; Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work has been supported by the Swedish Research Council, the Swedish Cancer Society, the Ake Wiberg Foundation, and the Karolinska Institutet to TF, and by the Swedish Cancer Society and the Karolinska Institutet to MH and LGL. TF and MH are supported by the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2001, MOL CELL BIOL, V21, P4929, DOI 10.1128/MCB.21.15.4929-4937.2001; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Afanasyeva EA, 2007, INT J CANCER, V121, P2615, DOI 10.1002/ijc.22974; Albihn A, 2007, INT J CANCER, V121, P1821, DOI 10.1002/ijc.22866; Albihn A, 2006, J CELL BIOCHEM, V98, P1597, DOI 10.1002/jcb.20816; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Ge ZM, 2005, INFECT IMMUN, V73, P3559, DOI 10.1128/IAI.73.6.3559-3567.2005; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Juin P, 2002, MOL CELL BIOL, V22, P6158, DOI 10.1128/MCB.22.17.6158-6169.2002; Karlsson A, 2003, P NATL ACAD SCI USA, V100, P9974, DOI 10.1073/pnas.1732638100; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lax AJ, 2005, NAT REV MICROBIOL, V3, P343, DOI 10.1038/nrmicro1130; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Maclean KH, 2003, MOL CELL BIOL, V23, P7256, DOI 10.1128/MCB.23.20.7256-7270.2003; Maclean KH, 2007, MOL CANCER RES, V5, P705, DOI 10.1158/1541-7786.MCR-07-0058; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Ponzielli R, 2005, EUR J CANCER, V41, P2485, DOI 10.1016/j.ejca.2005.08.017; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Radford IR, 1999, INT J RADIAT BIOL, V75, P521, DOI 10.1080/095530099140168; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Sheen JH, 2003, BRIT J CANCER, V89, P1479, DOI 10.1038/sj.bjc.6601307; Sheen JH, 2002, MOL CELL BIOL, V22, P1819, DOI 10.1128/MCB.22.6.1819-1833.2002; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Soucie EL, 2001, MOL CELL BIOL, V21, P4725, DOI 10.1128/MCB.21.14.4725-4736.2001; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015	44	53	54	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8924	10.1371/journal.pone.0008924	http://dx.doi.org/10.1371/journal.pone.0008924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111719	Green Published, gold, Green Submitted			2022-12-25	WOS:000274114800025
J	Lei, K; Cushing, BS; Musatov, S; Ogawa, S; Kramer, KM				Lei, Kelly; Cushing, Bruce S.; Musatov, Sergei; Ogawa, Sonoko; Kramer, Kristin M.			Estrogen Receptor-alpha in the Bed Nucleus of the Stria Terminalis Regulates Social Affiliation in Male Prairie Voles (Microtus ochrogaster)	PLOS ONE			English	Article							PATERNAL BEHAVIOR; VENTROMEDIAL NUCLEUS; NEONATAL CASTRATION; NEURAL ACTIVATION; FOS EXPRESSION; VASOPRESSIN; FEMALE; AGGRESSION; AMYGDALA; TESTOSTERONE	Estrogen receptor alpha (ER alpha) typically masculinizes male behavior, while low levels of ER alpha in the medial amygdala (MeA) and the bed nucleus of the stria terminalis (BST) are associated with high levels of male prosocial behavior. In the males of the highly social prairie vole (Microtus ochrogaster), increasing ER alpha in the MeA inhibited the expression of spontaneous alloparental behavior and produced a preference for novel females. To test for the effects of increased ER alpha in the BST, a viral vector was used to enhance ER alpha expression in the BST of adult male prairie voles. Following treatment, adult males were tested for alloparental behavior with 1-3-day- old pups, and for heterosexual social preference and affiliation. Treatment did not affect alloparental behavior as 73% of ER alpha-BST males and 62.5% of control males were alloparental. Increasing ER alpha in the BST affected heterosexual affiliation, with ER alpha-BST males spending significantly less total time in side-by-side contact with females relative to time spent with control males. ER alpha-BST males did not show a preference for either the familiar or novel female. These findings differed significantly from those reported in ER alpha-MeA enhanced males, where ER alpha inhibited alloparental behavior and produced a preference for a novel female. The findings from this study suggest two things: first, that increased ER alpha in the BST decreases social affiliation and second, that altering ER alpha in different regions of the social neural circuit differentially impacts the expression of social behavior.	[Lei, Kelly; Kramer, Kristin M.] Univ Memphis, Dept Biol, Memphis, TN 38152 USA; [Cushing, Bruce S.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Cushing, Bruce S.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Musatov, Sergei] Rockefeller Univ, Neurobiol & Behav Lab, Neurologix Inc, New York, NY 10021 USA; [Ogawa, Sonoko] Univ Tsukuba, Kansei Behav & Brain Sci Grad Sch Comprehens Huma, Tsukuba, Ibaraki, Japan	University of Memphis; University System of Ohio; University of Akron; University System of Ohio; University of Akron; Rockefeller University; University of Tsukuba	Lei, K (corresponding author), Florida State Univ, Dept Psychol, Program Neurosci, Tallahassee, FL 32306 USA.	cbruce@uakron.edu			University of Memphis; National Institute of Mental Health [MH-01992]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001992] Funding Source: NIH RePORTER	University of Memphis; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by funds provided by the University of Memphis (KMK) and a grant from the National Institute of Mental Health MH-01992 (BSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bester-Meredith JK, 2001, HORM BEHAV, V40, P51, DOI 10.1006/hbeh.2001.1666; Bester-Meredith JK, 1999, HORM BEHAV, V36, P25, DOI 10.1006/hbeh.1999.1522; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Cooke BM, 2003, HORM BEHAV, V43, P336, DOI 10.1016/S0018-506X(02)00047-8; Curtis JT, 2003, PHYSIOL BEHAV, V80, P95, DOI 10.1016/S0031-9384(03)00226-9; Cushing BS, 2008, J NEUROSCI, V28, P10399, DOI 10.1523/JNEUROSCI.1928-08.2008; Cushing BS, 2006, J COMP NEUROL, V494, P595, DOI 10.1002/cne.20826; Cushing BS, 2005, NEUROSCI BIOBEHAV R, V29, P1089, DOI 10.1016/j.neubiorev.2005.04.001; Cushing BS, 2004, BRAIN RES, V1016, P247, DOI 10.1016/j.brainres.2004.05.010; Cushing BS, 2003, J NEUROENDOCRINOL, V15, P1021, DOI 10.1046/j.1365-2826.2003.01097.x; Cushing BS, 2003, BRAIN RES, V965, P203, DOI 10.1016/S0006-8993(02)04199-9; DeVries AC, 1996, P NATL ACAD SCI USA, V93, P11980, DOI 10.1073/pnas.93.21.11980; DeVries GJ, 1997, ANN NY ACAD SCI, V807, P273; EHERT G, 1993, NEUROREPORT, V11, P1247; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Frazier CRM, 2006, HORM BEHAV, V50, P699, DOI 10.1016/j.yhbeh.2006.06.035; Gobrogge KL, 2007, J COMP NEUROL, V502, P1109, DOI 10.1002/cne.21364; HNATCZUK OC, 1994, J NEUROENDOCRINOL, V6, P89, DOI 10.1111/j.1365-2826.1994.tb00558.x; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; KIRKPATRICK B, 1994, BEHAV NEUROSCI, V108, P501, DOI 10.1037/0735-7044.108.3.501; KIRKPATRICK B, 1994, BRAIN RES, V658, P112, DOI 10.1016/S0006-8993(09)90016-6; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Lonstein JS, 2002, HORM BEHAV, V41, P80, DOI 10.1006/hbeh.2001.1740; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5058, DOI 10.1210/en.139.12.5058; Patisaul HB, 2008, HORM BEHAV, V53, P580, DOI 10.1016/j.yhbeh.2008.01.008; Patisaul HB, 2009, BEHAV BRAIN RES, V196, P317, DOI 10.1016/j.bbr.2008.09.026; Pfaus JG, 1997, BRAIN RES BULL, V44, P397, DOI 10.1016/S0361-9230(97)00219-0; Rasia-Filho AA, 2000, J PSYCHIATR NEUROSCI, V25, P14; Rissman EF, 1999, BRAIN RES, V835, P80, DOI 10.1016/S0006-8993(99)01452-3; Roberts RL, 1998, ANIM BEHAV, V55, P1131, DOI 10.1006/anbe.1997.0659; Schultz KN, 2009, J NEUROSCI, V29, P1897, DOI 10.1523/JNEUROSCI.4647-08.2009; Trezza V, 2009, J NEUROSCI, V29, P1, DOI 10.1523/JNEUROSCI.5193-08.2009; WANG ZX, 1993, BRAIN RES, V631, P156, DOI 10.1016/0006-8993(93)91203-5; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; Wersinger SR, 1997, HORM BEHAV, V32, P176, DOI 10.1006/hbeh.1997.1419; YAHR P, 1994, PSYCHONEUROENDOCRINO, V19, P463, DOI 10.1016/0306-4530(94)90033-7; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	40	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8931	10.1371/journal.pone.0008931	http://dx.doi.org/10.1371/journal.pone.0008931			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111713	Green Published, gold, Green Submitted			2022-12-25	WOS:000274114800027
J	Groves, B; Abrahamsen, H; Clingan, H; Frantz, M; Mavor, L; Bailey, J; Ma, D				Groves, Benjamin; Abrahamsen, Hilde; Clingan, Heather; Frantz, Michael; Mavor, Lauren; Bailey, Jeffrey; Ma, Dzwokai			An Inhibitory Role of the G-Protein Regulator AGS3 in mTOR-Dependent Macroautophagy	PLOS ONE			English	Article							ALPHA-INTERACTING PROTEIN; HETEROTRIMERIC G-PROTEINS; BETA-GAMMA-SUBUNITS; TETRATRICOPEPTIDE REPEAT; AUTOPHAGOSOME FORMATION; MEDIATED INDUCTION; MAMMALIAN HOMOLOG; GOLGI MEMBRANES; HT-29 CELLS; GPR MOTIFS	Macroautophagy is a cellular process whereby the cell sequesters and recycles cytosolic constituents in a lysosome-dependent manner. It has also been implicated in a number of disorders, including cancer and neurodegeneration. Although a previous report that AGS3 over-expression promotes macroautophagy suggests a stimulatory role of AGS3 in this process, we have found that knock-down of AGS3, unexpectedly, also induces macroautophagy, indicating an inhibitory function of endogenous AGS3 in macroautophagy. Interestingly, AGS3 phosphorylation is decreased upon induction of mammalian target of rapamycin (mTOR)-dependent macroautophagy. Moreover, unlike wild-type AGS3, over-expression of an AGS3 mutant lacking this modification fails to enhance macroautophagic activity. These observations imply that AGS3 phosphorylation may participate in the modulation of macroautophagy.	[Groves, Benjamin; Clingan, Heather; Frantz, Michael; Mavor, Lauren; Bailey, Jeffrey; Ma, Dzwokai] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Groves, Benjamin; Bailey, Jeffrey; Ma, Dzwokai] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Abrahamsen, Hilde] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Abrahamsen, Hilde] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Oslo; University of Oslo	Groves, B (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	ma@lifesci.ucsb.edu	Abrahamsen, Hilde/E-5323-2010	/0000-0002-6129-2938	American Heart Association (AHA) [07651554]; National Alliance for Research on Schizophrenia and Depression (NARSAD)	American Heart Association (AHA)(American Heart Association); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD)	This work was supported in part by the American Heart Association (AHA) award (#07651554) and the National Alliance for Research on Schizophrenia and Depression (NARSAD) 2008 Young Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; BARR FA, 1991, FEBS LETT, V294, P239, DOI 10.1016/0014-5793(91)81438-E; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chen M, 2000, MOL CELL BIOL, V20, P7867, DOI 10.1128/MCB.20.21.7867-7880.2000; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DEALMEIDA JB, 1994, J CELL SCI, V107, P507; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lanier SM, 2004, BIOL CELL, V96, P369, DOI 10.1016/j.biolcel.2004.03.012; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Rani MRS, 2002, J BIOL CHEM, V277, P38456, DOI 10.1074/jbc.M203204200; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172	60	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8877	10.1371/journal.pone.0008877	http://dx.doi.org/10.1371/journal.pone.0008877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126274	gold, Green Published, Green Submitted			2022-12-25	WOS:000273896500006
J	Parmakelis, A; Moustaka, M; Poulakakis, N; Louis, C; Slotman, MA; Marshall, JC; Awono-Ambene, PH; Antonio-Nkondjio, C; Simard, F; Caccone, A; Powell, JR				Parmakelis, Aristeidis; Moustaka, Marina; Poulakakis, Nikolaos; Louis, Christos; Slotman, Michel A.; Marshall, Jonathon C.; Awono-Ambene, Parfait H.; Antonio-Nkondjio, Christophe; Simard, Frederic; Caccone, Adalgisa; Powell, Jeffrey R.			Anopheles Immune Genes and Amino Acid Sites Evolving Under the Effect of Positive Selection	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; GAMBIAE SPECIES COMPLEX; QUANTITATIVE TRAIT LOCI; PLASMODIUM-FALCIPARUM; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; MALARIA INFECTION; INDIVIDUAL SITES; RECOMBINATION; SYSTEM	Background: It has long been the goal of vector biology to generate genetic knowledge that can be used to "manipulate'' natural populations of vectors to eliminate or lessen disease burden. While long in coming, progress towards reaching this goal has been made. Aiming to increase our understanding regarding the interactions between Plasmodium and the Anopheles immune genes, we investigated the patterns of genetic diversity of four anti-Plasmodium genes in the Anopheles gambiae complex of species. Methodology/Principal Findings: Within a comparative phylogenetic and population genetics framework, the evolutionary history of four innate immunity genes within the An. gambiae complex (including the two most important human malaria vectors, An. gambiae and An. arabiensis) is reconstructed. The effect of natural selection in shaping the genes' diversity is examined. Introgression and retention of ancestral polymorphisms are relatively rare at all loci. Despite the potential confounding effects of these processes, we could identify sites that exhibited dN/dS ratios greater than 1. Conclusions/Significance: In two of the studied genes, CLIPB14 and FBN8, several sites indicated evolution under positive selection, with CLIPB14 exhibiting the most consistent evidence. Considering only the sites that were consistently identified by all methods, two sites in CLIPB14 are adaptively driven. However, the analysis inferring the lineage-specific evolution of each gene was not in favor of any of the Anopheles lineages evolving under the constraints imposed by positive selection. Nevertheless, the loci and the specific amino acids that were identified as evolving under strong evolutionary pressure merit further investigation for their involvement in the Anopheles defense against microbes in general.	[Parmakelis, Aristeidis; Moustaka, Marina] Univ Athens, Fac Biol, Dept Ecol & Taxon, Athens 11528, Greece; [Parmakelis, Aristeidis; Poulakakis, Nikolaos; Louis, Christos] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Parmakelis, Aristeidis; Poulakakis, Nikolaos; Marshall, Jonathon C.; Caccone, Adalgisa; Powell, Jeffrey R.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Louis, Christos] Fdn Res & Technol Heraklion, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Slotman, Michel A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Marshall, Jonathon C.] Weber State Univ, Dept Zool, Ogden, UT 84408 USA; [Awono-Ambene, Parfait H.; Antonio-Nkondjio, Christophe; Simard, Frederic] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Simard, Frederic] IRD, Bobo Dioulasso, Burkina Faso	National & Kapodistrian University of Athens; University of Crete; Yale University; Texas A&M University System; Texas A&M University College Station; Utah System of Higher Education; Weber State University; Institut de Recherche pour le Developpement (IRD)	Parmakelis, A (corresponding author), Univ Athens, Fac Biol, Dept Ecol & Taxon, Athens 11528, Greece.	aparmakel@biol.uoa.gr	SIMARD, Frederic/J-9489-2016; Poulakakis, Nikos/E-7848-2011; Caccone, Adalgisa/AAE-4238-2021; Louis, Christos/F-2527-2012; Parmakelis, Aristeidis/AAD-1162-2020; Marshall, Jonathon C./AGG-8101-2022; Frederic, SIMARD/AFV-5001-2022	SIMARD, Frederic/0000-0002-2871-5329; Caccone, Adalgisa/0000-0002-8949-9260; Parmakelis, Aristeidis/0000-0003-3092-4194; Frederic, SIMARD/0000-0002-2871-5329; Marshall, Jonathon/0000-0003-0955-4889; Antonio Nkondjio, Christophe/0000-0003-0073-1578	National Institutes of Health [RO1 A1 046018]; Marie Curie [MOIF-CT-2006-021357]; University of Athens	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie(European Commission); University of Athens	This research was supported by the National Institutes of Health grant RO1 A1 046018 to J.R.P. and A. C. A. P. was supported by a Marie Curie Outgoing International Fellowship ( Contract No. MOIF-CT-2006-021357) and a "Kapodistrias'' Research Grant from the Research Secretariat of the University of Athens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2003, GENETICS, V164, P1229; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; BESANSKY NJ, 2008, WHITE PAPER GENOME A; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; Cohuet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-227; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; FELDMANN AM, 1986, TROP GEOGR MED, V38, P317; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; KALENDAR R, 2007, FASTPCR PCR PRIMER P; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lehmann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004549; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 2001, HEREDITY, V87, P613, DOI 10.1046/j.1365-2540.2001.00965.x; McVean G, 2006, CURR OPIN GENET DEV, V16, P624, DOI 10.1016/j.gde.2006.09.004; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Obbard DJ, 2007, MOL ECOL, V16, P3497, DOI 10.1111/j.1365-294X.2007.03395.x; Obbard DJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-117; Obbard DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274; Parmakelis A, 2008, AM J TROP MED HYG, V78, P176, DOI 10.4269/ajtmh.2008.78.176; Parmakelis A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-79; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Simard F, 2007, INFECT GENET EVOL, V7, P285, DOI 10.1016/j.meegid.2006.11.004; Slotman MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000793; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; VERNICK KD, 1989, AM J TROP MED HYG, V40, P593, DOI 10.4269/ajtmh.1989.40.593; VERNICK KD, 1989, AM J TROP MED HYG, V40, P585, DOI 10.4269/ajtmh.1989.40.585; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Wang XG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-114; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zheng LB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-16; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	55	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8885	10.1371/journal.pone.0008885	http://dx.doi.org/10.1371/journal.pone.0008885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126662	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500009
J	Gomez-Varela, D; Kohl, T; Schmidt, M; Rubio, ME; Kawabe, H; Nehring, RB; Schafer, S; Stuhmer, W; Pardo, LA				Gomez-Varela, David; Kohl, Tobias; Schmidt, Manuela; Rubio, Maria E.; Kawabe, Hiroshi; Nehring, Ralf B.; Schaefer, Stephan; Stuehmer, Walter; Pardo, Luis A.			Characterization of Eag1 Channel Lateral Mobility in Rat Hippocampal Cultures by Single-Particle-Tracking with Quantum Dots	PLOS ONE			English	Article							SURFACE TRAFFICKING; AMPA RECEPTORS; ACTIN; CYTOSKELETON; ACTIVATION; DIFFUSION; DYNAMICS; EXPRESSION; FORM	Voltage-gated ion channels are main players involved in fast synaptic events. However, only slow intracellular mechanisms have so far been described for controlling their localization as real-time visualization of endogenous voltage-gated channels at high temporal and spatial resolution has not been achieved yet. Using a specific extracellular antibody and quantum dots we reveal and characterize lateral mobility as a faster mechanism to dynamically control the number of endogenous ether-a-go-go (Eag)1 ion channels inside synapses. We visualize Eag1 entering and leaving synapses by lateral diffusion in the plasma membrane of rat hippocampal neurons. Mathematical analysis of their trajectories revealed how the motion of Eag1 gets restricted when the channels diffuse into the synapse, suggesting molecular interactions between Eag1 and synaptic components. In contrast, Eag1 channels switch to Brownian movement when they exit synapses and diffuse into extrasynaptic membranes. Furthermore, we demonstrate that the mobility of Eag1 channels is specifically regulated inside synapses by actin filaments, microtubules and electrical activity. In summary, using single-particle-tracking techniques with quantum dots nanocrystals, our study shows for the first time the lateral diffusion of an endogenous voltage-gated ion channel in neurons. The location-dependent constraints imposed by cytoskeletal elements together with the regulatory role of electrical activity strongly suggest a pivotal role for the mobility of voltage-gated ion channels in synaptic activity.	[Gomez-Varela, David; Kohl, Tobias; Rubio, Maria E.; Stuehmer, Walter; Pardo, Luis A.] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Schmidt, Manuela] European Neurosci Inst, Gottingen, Germany; [Kawabe, Hiroshi] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Nehring, Ralf B.] Univ Texas Houston, Dept Neurosci, Houston, TX USA; [Nehring, Ralf B.] Univ Texas Houston, Dept Mol & Human Genet, Houston, TX USA; [Schaefer, Stephan] BIOTEC, Inst Biophys, Dresden, Germany; [Schmidt, Manuela; Stuehmer, Walter] Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, Gottingen, Germany	Max Planck Society; Max Planck Society; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Technische Universitat Dresden	Gomez-Varela, D (corresponding author), Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, Hermann Rein Str 3, D-37075 Gottingen, Germany.	dgomezvarela@ucsd.edu	Pardo, Luis/C-5066-2013; Kawabe, Hiroshi/U-7325-2018; Stuehmer, Walter/A-2176-2009	Pardo, Luis/0000-0003-1375-4349; Stuehmer, Walter/0000-0002-0642-7764; Schmidt, Manuela/0000-0003-1972-3519	Max-Planck-Society; Deutsche Forschungsgemeinschaft (DFG) Research Center for Molecular Physiology of the Brain (CMPB); Japan Society for the Promotion of Science; Mental Retardation and Developmental Disabilities Research Center (MRDDRC) Mouse Physiology Core [HD024064]; EFRE-Fonds; Alexander-von-Humboldt-Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG) Research Center for Molecular Physiology of the Brain (CMPB)(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mental Retardation and Developmental Disabilities Research Center (MRDDRC) Mouse Physiology Core; EFRE-Fonds; Alexander-von-Humboldt-Foundation(Alexander von Humboldt Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Max-Planck-Society (D. G. V., T. K., L. A. P. and W. S.), the Deutsche Forschungsgemeinschaft (DFG) Research Center for Molecular Physiology of the Brain (CMPB) (M. S. and W. S.), the Japan Society for the Promotion of Science (to H. K.), the Mental Retardation and Developmental Disabilities Research Center (MRDDRC) Mouse Physiology Core HD024064 (to R.B.N.), the EFRE-Fonds (to S. S.) and the Alexander-von-Humboldt-Foundation (to M. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bamji SX, 2005, NEURON, V47, P175, DOI 10.1016/j.neuron.2005.06.024; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Camacho J, 2000, PFLUG ARCH EUR J PHY, V441, P167, DOI 10.1007/s004240000420; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Clancy SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006330; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Jaskolski F, 2009, NEUROSCIENCE, V158, P19, DOI 10.1016/j.neuroscience.2008.01.075; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Mikasova L, 2008, P NATL ACAD SCI USA, V105, P18596, DOI 10.1073/pnas.0805959105; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; O'Malley D, 2005, FASEB J, V19, P1917, DOI 10.1096/fj.05-4166fje; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Savin T, 2005, BIOPHYS J, V88, P623, DOI 10.1529/biophysj.104.04245; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	41	35	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8858	10.1371/journal.pone.0008858	http://dx.doi.org/10.1371/journal.pone.0008858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111597	Green Published, gold			2022-12-25	WOS:000273896300010
J	Gesteira, TF; Coulson-Thomas, VJ; Taunay-Rodrigues, A; Oliveira, V; Thacker, BE; Juliano, MA; Pasqualini, R; Arap, W; Tersariol, ILS; Nader, HB; Esko, JD; Pinhal, MAS				Gesteira, Tarsis F.; Coulson-Thomas, Vivien J.; Taunay-Rodrigues, Alessandro; Oliveira, Vitor; Thacker, Bryan E.; Juliano, Maria A.; Pasqualini, Renata; Arap, Wadih; Tersariol, Ivarne L. S.; Nader, Helena B.; Esko, Jeffrey D.; Pinhal, Maria A. S.			Inhibitory Peptides of the Sulfotransferase Domain of the Heparan Sulfate Enzyme, N-Deacetylase-N-sulfotransferase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-DEACETYLASE/N-SULFOTRANSFERASE; PHAGE DISPLAY; GLYCOSAMINOGLYCAN BIOSYNTHESIS; MOLECULAR DIVERSITY; BINDING-SITE; LIBRARY; LIGAND; DISCOVERY; PROTEOGLYCANS; VASCULATURE	N-Deacetylase-N-sulfotransferase 1 (Ndst1) catalyzes the initial modification of heparan sulfate and heparin during their biosynthesis by removal of acetyl groups from subsets of N-acetylglucosamine units and subsequent sulfation of the resulting free amino groups. In this study, we used a phage display library to select peptides that interact with Ndst1, with the aim of finding inhibitors of the enzyme. The phage library consisted of cyclic random 10-mer peptides expressed in the phage capsid protein pIII. Selection was based on the ability of engineered phage to bind to recombinant murine Ndst1 (mNdst1) and displacement with heparin. Peptides that were enriched through multiple cycles of binding and disassociation displayed two specific sequences, CRGWRGEKIGNC and CNMQALSMPVTC. Both peptides inhibited mNdst1 activity in vitro, however, by distinct mechanisms. The peptide CRGWRGEKIGNC presents a chemokine-like repeat motif (BXX, where B represents a basic amino acid and X is a noncharged amino acid) and binds to heparan sulfate, thus blocking the binding of substrate to the enzyme. The peptide NMQALSMPVT inhibits mNdst1 activity by direct interaction with the enzyme near the active site. The discovery of inhibitory peptides in this way suggests a method for developing peptide inhibitors of heparan sulfate biosynthesis.	[Tersariol, Ivarne L. S.; Nader, Helena B.; Pinhal, Maria A. S.] Univ Fed Sao Paulo, Dept Bioquim, BR-04044020 Sao Paulo, Brazil; [Oliveira, Vitor; Juliano, Maria A.] Univ Fed Sao Paulo, Dept Biofis, BR-04044020 Sao Paulo, Brazil; [Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA; [Tersariol, Ivarne L. S.] Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, BR-05508000 Sao Paulo, Brazil; [Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Thacker, Bryan E.] Univ Calif San Diego, Biomed Sci Grad Program, San Diego, CA USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; UTMD Anderson Cancer Center; Universidade de Mogi das Cruzes; University of California System; University of California San Diego; University of California System; University of California San Diego	Pinhal, MAS (corresponding author), Univ Fed Sao Paulo, Dept Bioquim, Rua Tres Maio, BR-04044020 Sao Paulo, Brazil.	cidapinhal@gmail.com	Oliveira, Vitor/AAT-5981-2020; Pinhal, Maria Aparecida Silva/J-1797-2012; Oliveira, Vitor/L-3709-2013; Nader, Helena Bonciani/D-9253-2012; Complexos, INCT Fluidos/H-9172-2013; Dos Santos Tersariol, Ivarne Luis/G-4042-2012	Pinhal, Maria Aparecida Silva/0000-0003-4001-1663; Oliveira, Vitor/0000-0002-4662-1377; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; NADER, HELENA/0000-0002-7569-2166; Thacker, Bryan/0000-0003-0517-0810				Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Armstrong JI, 2000, ANGEW CHEM INT EDIT, V39, P1303, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1303::AID-ANIE1303>3.0.CO;2-0; Armstrong JI, 2001, ORG LETT, V3, P2657, DOI 10.1021/ol0162217; BAME KJ, 1991, J BIOL CHEM, V266, P10287; BAME KJ, 1991, J BIOL CHEM, V266, P12461; Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Berninsone P, 1998, J BIOL CHEM, V273, P25556, DOI 10.1074/jbc.273.40.25556; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Burritt JB, 1996, ANAL BIOCHEM, V238, P1, DOI 10.1006/abio.1996.0241; Burster T, 2007, BIOCHEM PHARMACOL, V74, P1514, DOI 10.1016/j.bcp.2007.07.037; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chapman E, 2002, J AM CHEM SOC, V124, P14524, DOI 10.1021/ja021086u; Conrad H. E., 1998, HEPARIN BINDING PROT; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fritz T A, 2001, Methods Mol Biol, V171, P317; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; Gorokhov A, 2000, BIOPHYS J, V79, P2909, DOI 10.1016/S0006-3495(00)76528-3; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hubbard SJ, 1993, NACCESS COMPUTER PRO; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; Jakobkiewicz-Banecka J, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-26; Jarvinen TAH, 2007, AM J PATHOL, V171, P702, DOI 10.2353/ajpath.2007.061251; Jenniskens GJ, 2003, FASEB J, V17, P878, DOI 10.1096/fj.02-0572fje; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Koike R, 2008, J MOL BIOL, V379, P397, DOI 10.1016/j.jmb.2008.04.019; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565; NADER HB, 1990, J BIOL CHEM, V265, P16807; PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Peletskaya EN, 1996, MOL DIVERS, V2, P13, DOI 10.1007/BF01718695; Roberts ALK, 2006, PEDIATR RES, V60, P309, DOI 10.1203/01.pdr.0000233037.00707.da; Ruoslahti E, 2000, ANNU REV IMMUNOL, V18, P813, DOI 10.1146/annurev.immunol.18.1.813; Sampaio L. O., 2006, INSIGHTS CARBOHYDRAT; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; Verdugo DE, 2001, J MED CHEM, V44, P2683, DOI 10.1021/jm010171u; Weber G., 1992, PROTEIN INTERACTIONS; Wei Z, 1999, J BIOL CHEM, V274, P1966, DOI 10.1074/jbc.274.4.1966; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9	56	26	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5338	5346		10.1074/jbc.M110.100719	http://dx.doi.org/10.1074/jbc.M110.100719			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	20129923	Green Published, hybrid			2022-12-25	WOS:000287230600042
J	Shimizu, S; Konishi, A; Nishida, Y; Mizuta, T; Nishina, H; Yamamoto, A; Tsujimoto, Y				Shimizu, S.; Konishi, A.; Nishida, Y.; Mizuta, T.; Nishina, H.; Yamamoto, A.; Tsujimoto, Y.			Involvement of JNK in the regulation of autophagic cell death	ONCOGENE			English	Article						JNK; autophagic cell death; Atg5	SIGNAL-TRANSDUCTION; PHOSPHORYLATION; ACTIVATION; APOPTOSIS; BAX; TRANSLOCATION; MITOCHONDRIA	Programmed cell death is a crucial process in the normal development and physiology of metazoans, and it can be divided into several categories that include type I death (apoptosis) and type II death (autophagic cell death). The Bcl-2 family proteins are well-characterized regulators of apoptosis, among which multidomain pro-apoptotic members (such as Bax and Bak) function as a mitochondrial gateway at which various apoptotic signals converge. Although embryonic fibroblasts from Bax/Bak double-knockout (DKO) mice are resistant to apoptosis, we have previously reported that these cells still die by autophagy in response to various death stimuli. In this study, we found that jun N-terminal kinase (JNK) was activated in etoposide-and staurosporine-treated, but not serum-starved, Bax/Bak DKO cells, and that autophagic cell death was suppressed by the addition of a JNK inhibitor and by a dominant-negative mutant of JNK. Studies with sek1(-/-)mkk7(-/-) cells revealed that disruption of JNK prevented the induction of autophagic cell death. Co-activation of JNK and autophagy induced autophagic cell death. Activation of JNK occurred downstream of the induction of autophagy, and was dependent on the autophagic process. These results indicate that JNK activation is crucial for the autophagic death of Bax/Bak DKO cells. Oncogene (2010) 29, 2070-2082; doi: 10.1038/onc.2009.487; published online 18 January 2010	[Shimizu, S.; Nishida, Y.; Mizuta, T.] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Bunkyo Ku, Tokyo 1035802, Japan; [Shimizu, S.; Nishida, Y.; Tsujimoto, Y.] Osaka Univ, Sch Med, Dept Med Genet, Suita, Osaka 565, Japan; [Konishi, A.] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Bunkyo Ku, Tokyo 1035802, Japan; [Nishina, H.] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, Tokyo 1035802, Japan; [Yamamoto, A.] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama, Japan	Tokyo Medical & Dental University (TMDU); Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Shimizu, S (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Bunkyo Ku, Yushima 1-5-45, Tokyo 1035802, Japan.	shimizu.pcb@mri.tmd.ac.jp; tsujimot@gene.med.osaka-u.ac.jp	Konishi, Akimitsu/J-4024-2019	Konishi, Akimitsu/0000-0002-3291-0821	National Institute of Biomedical Innovation (NIBIO); Japanese Ministry of Education, Science, Sports and Culture; Japanese Ministry of Health, Labor and Welfare; Uehara Memorial Foundation; Naito Foundation	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation)	We thank Dr N Mizushima for providing us with MEFs from Atg5 <SUP>/</SUP> and Atg5<SUP>+/+</SUP> mice and pCAGGS-GFP-LC3 plasmid. We also thank Drs R Davis and Y Gotoh for providing PCMV5-JNK1 APF plasmid and pCDNA3 MKK7-JNK1 WT plasmid, respectively. This study was partly supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); a grant for Scientific Research on Priority Areas, SORST of Japan Science and Technology Corp; a grant for the 21st Century COE Program; a grant for Creative Scientific Research from the Japanese Ministry of Education, Science, Sports and Culture; and a grant for Comprehensive Research on Aging and Health from the Japanese Ministry of Health, Labor and Welfare. This study was also supported by grants from the Uehara Memorial Foundation and the Naito Foundation.	Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Harris CA, 2001, J BIOL CHEM, V276, P37754; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; KLINONSKY DJ, 2005, CURR BIOL, V15, pR282; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Nishitai G, 2004, J BIOL CHEM, V279, P1621, DOI 10.1074/jbc.M310335200; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Park J, 1997, J BIOL CHEM, V272, P16725, DOI 10.1074/jbc.272.27.16725; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shimizu S, 1996, ONCOGENE, V12, P2251; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	28	132	135	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2010	29	14					2070	2082		10.1038/onc.2009.487	http://dx.doi.org/10.1038/onc.2009.487			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	579UX	20101227				2022-12-25	WOS:000276402800006
J	Lensink, MF; Govaerts, C; Ruysschaert, JM				Lensink, Marc F.; Govaerts, Cedric; Ruysschaert, Jean-Marie			Identification of Specific Lipid-binding Sites in Integral Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LACTOSE PERMEASE; ESCHERICHIA-COLI; TOPOLOGICAL ORGANIZATION; PHOSPHOLIPID-COMPOSITION; MULTIDRUG TRANSPORTER; ATOMIC CHARGES; PHOSPHATIDYLETHANOLAMINE; BILAYER; DATABASE	Protein-lipid interactions are increasingly recognized as central to the structure and function of membrane proteins. However, with the exception of simplified models, specific protein-lipid interactions are particularly difficult to highlight experimentally. Here, we used molecular dynamics simulations to identify a specific protein-lipid interaction in lactose permease, a prototypical model for transmembrane proteins. The interactions can be correlated with the functional dependence of the protein to specific lipid species. The technique is simple and widely applicable to other membrane proteins, and a variety of lipid matrices can be used.	[Lensink, Marc F.; Govaerts, Cedric; Ruysschaert, Jean-Marie] Univ Libre Bruxelles, B-1050 Brussels, Belgium	Universite Libre de Bruxelles	Lensink, MF (corresponding author), Univ Libre Bruxelles, Blvd Triomphe,CP 263, B-1050 Brussels, Belgium.	marc.lensink@ulb.ac.be	Lensink, Marc F/A-1678-2008	Lensink, Marc F/0000-0003-3957-9470	Region Wallonne of Belgium [515993]	Region Wallonne of Belgium	Supported by DGTRE Contract 515993 from the Region Wallonne of Belgium.	Aksimentiev Aleksei, 2008, V474, P181, DOI 10.1007/978-1-59745-480-3_11; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Carpenter EP, 2008, CURR OPIN STRUC BIOL, V18, P581, DOI 10.1016/j.sbi.2008.07.001; CHANDRASEKHAR J, 1984, J AM CHEM SOC, V106, P903, DOI 10.1021/ja00316a012; CHEN CC, 1984, J BIOL CHEM, V259, P150; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHIU SW, 1995, BIOPHYS J, V69, P1230, DOI 10.1016/S0006-3495(95)80005-6; Christopher NA, 1996, COMPUT CHEM, V20, P339, DOI 10.1016/0097-8485(95)00075-5; Deol SS, 2004, BIOPHYS J, V87, P3737, DOI 10.1529/biophysj.104.048397; DEVAUX PF, 1985, BIOCHIM BIOPHYS ACTA, V822, P63, DOI 10.1016/0304-4157(85)90004-8; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Dupradeau FY, 2008, NUCLEIC ACIDS RES, V36, pD360, DOI 10.1093/nar/gkm887; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guest MF, 2005, MOL PHYS, V103, P719, DOI 10.1080/00268970512331340592; Guvench Olgun, 2008, V443, P63, DOI 10.1007/978-1-59745-177-2_4; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lee AG, 2005, MOL BIOSYST, V1, P203, DOI 10.1039/b504527d; Lensink Marc F., 2008, V443, P161, DOI 10.1007/978-1-59745-177-2_9; Lensink MF, 2005, BIOPHYS J, V88, P939, DOI 10.1529/biophysj.104.052787; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lundstrom K, 2007, J CELL MOL MED, V11, P224, DOI 10.1111/j.1582-4934.2007.00028.x; Marrink SJ, 2002, BIOCHEMISTRY-US, V41, P5375, DOI 10.1021/bi015613i; Mazurkiewicz P, 2004, J BIOL CHEM, V279, P103, DOI 10.1074/jbc.M306579200; McAuley KE, 1999, P NATL ACAD SCI USA, V96, P14706, DOI 10.1073/pnas.96.26.14706; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mulliken R.S., 1995, J CHEM PHYS, V23, P1840; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Paila YD, 2009, BBA-BIOMEMBRANES, V1788, P295, DOI 10.1016/j.bbamem.2008.11.020; Powl AM, 2008, BIOCHEMISTRY-US, V47, P12175, DOI 10.1021/bi801352a; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; STARLING AP, 1995, BIOCHEM J, V310, P875, DOI 10.1042/bj3100875; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; Wakeham MC, 2001, BIOPHYS J, V80, P1395, DOI 10.1016/S0006-3495(01)76112-7; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P15525; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P530, DOI 10.1016/j.bbamem.2006.11.018; Yin Y, 2006, BIOPHYS J, V91, P3972, DOI 10.1529/biophysj.106.085993; Yuan CB, 2004, BIOPHYS J, V86, P3620, DOI 10.1529/biophysj.103.029678; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	63	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10519	10526		10.1074/jbc.M109.068890	http://dx.doi.org/10.1074/jbc.M109.068890			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139086	Green Published, hybrid			2022-12-25	WOS:000276264600038
J	Prieto-Echague, V; Gucwa, A; Craddock, BP; Brown, DA; Miller, WT				Prieto-Echaguee, Victoria; Gucwa, Azad; Craddock, Barbara P.; Brown, Deborah A.; Miller, W. Todd			Cancer-associated Mutations Activate the Nonreceptor Tyrosine Kinase Ack1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR STIMULATION; RECEPTOR SAM DOMAIN; C-SRC; CDC42-ASSOCIATED KINASE; EGF RECEPTOR; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; DOWN-REGULATION; PROTEIN; PHOSPHORYLATION	Ack1 is a nonreceptor tyrosine kinase that participates in tumorigenesis, cell survival, and migration. Relatively little is known about the mechanisms that regulate Ack1 activity. Recently, four somatic missense mutations of Ack1 were identified in cancer tissue samples, but the effects on Ack1 activity, and function have not been described. These mutations occur in the N-terminal region, the C-lobe of the kinase domain, and the SH3 domain. Here, we show that the cancer-associated mutations increase Ack1 autophosphorylation in mammalian cells without affecting localization and increase Ack1 activity in immune complex kinase assays. The cancer-associated mutations potentiate the ability of Ack1 to promote proliferation and migration, suggesting that point mutation is a mechanism for Ack1 deregulation. We propose that the C-terminal Mig6 homology region (MHR) (residues 802-990) participates in inhibitory intramolecular interactions. The isolated kinase domain of Ack1 interacts directly with the MHR, and the cancer-associated E346K mutation prevents binding. Likewise, mutation of a key hydrophobic residue in the MHR (Phe820) prevents the MHR-kinase interaction, activates Ack1, and increases cell migration. Thus, the cancer-associated mutation E346K appears to destabilize an autoinhibited conformation of Ack1, leading to constitutively high Ack1 activity.	[Prieto-Echaguee, Victoria; Craddock, Barbara P.; Miller, W. Todd] SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Gucwa, Azad; Brown, Deborah A.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Miller, WT (corresponding author), SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Basic Sci Tower T6, Stony Brook, NY 11794 USA.	todd.miller@stonybrook.edu		Prieto-Echague, Victoria/0000-0001-9924-9591	National Institutes of Health [CA122091]; NATIONAL CANCER INSTITUTE [R01CA122091, R01CA058530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA122091	Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Childress C, 2006, BIOCHEM J, V394, P693, DOI 10.1042/BJ20050576; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Hoehn GT, 1996, ONCOGENE, V12, P903; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Kato-Stankiewicz J, 2001, BIOCHEM BIOPH RES CO, V284, P470, DOI 10.1006/bbrc.2001.5004; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Linseman DA, 2001, J BIOL CHEM, V276, P5622, DOI 10.1074/jbc.M006812200; LIU XQ, 1993, ONCOGENE, V8, P1119; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Modzelewska K, 2006, J BIOL CHEM, V281, P37527, DOI 10.1074/jbc.M604342200; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nur-E-Kamal A, 2005, MOL CANCER RES, V3, P297, DOI 10.1158/1541-7786.MCR-04-0152; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Satoh T, 1996, FEBS LETT, V386, P230, DOI 10.1016/0014-5793(96)00449-8; Sem KP, 2002, MOL CELL BIOL, V22, P3685, DOI 10.1128/MCB.22.11.3685-3697.2002; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Yang WN, 2001, J BIOL CHEM, V276, P17468, DOI 10.1074/jbc.M010893200; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Yokoyama N, 2006, METHOD ENZYMOL, V406, P250, DOI 10.1016/S0076-6879(06)06018-6; Yokoyama N, 2005, J BIOL CHEM, V280, P42219, DOI 10.1074/jbc.M506996200; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	52	35	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10605	10615		10.1074/jbc.M109.060459	http://dx.doi.org/10.1074/jbc.M109.060459			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110370	Green Published, hybrid			2022-12-25	WOS:000276264600048
J	Stahmann, N; Woods, A; Spengler, K; Heslegrave, A; Bauer, R; Krause, S; Viollet, B; Carling, D; Heller, R				Stahmann, Nadine; Woods, Angela; Spengler, Katrin; Heslegrave, Amanda; Bauer, Reinhard; Krause, Siegfried; Viollet, Benoit; Carling, David; Heller, Regine			Activation of AMP-activated Protein Kinase by Vascular Endothelial Growth Factor Mediates Endothelial Angiogenesis Independently of Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SHEAR-STRESS; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; FACTOR RECEPTOR-2; UPSTREAM KINASE; NO SYNTHESIS; PKC-ALPHA; RAT-LIVER; IN-VIVO	AMP-activated protein kinase (AMPK) is a sensor of cellular energy state and a regulator of cellular homeostasis. In endothelial cells, AMPK is stimulated via the upstream kinases LKB1 and Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKK beta). Previously, AMPK has been reported to activate endothelial nitric-oxide synthase (eNOS). Using genetic and pharmacological approaches, we show that vascular endothelial growth factor (VEGF) stimulates AMPK in human and mice endothelial cells via CaMKK beta. VEGF-induced AMPK activation is potentiated under conditions of energy deprivation induced by 2-deoxyglucose. To investigate the role of AMPK in endothelial function, CaMKK beta, AMPK alpha 1, or AMPK alpha 2 was down-regulated by RNA interference, and studies in AMPK alpha 1(-/-) mice were performed. We demonstrate that AMPK does not mediate eNOS phosphorylation at serine residue 1177 or 633, NO-dependent cGMP generation, or Akt phosphorylation in response to VEGF. Using inhibitors of eNOS or soluble guanylyl cyclase and small interfering RNA against eNOS, we show that NO does not act upstream of AMPK. Taken together, these data indicate that VEGF-stimulated AMPK and eNOS pathways act independently of each other. However, acetyl-CoA carboxylase, a key enzyme in the regulation of fatty acid oxidation, was phosphorylated in response to VEGF in an AMPK alpha 1- and AMPK alpha 2-dependent manner. Our results show that AMPK alpha 1 plays an essential role in VEGF-induced angiogenesis in vitro (tube formation and sprouting from spheroids) and in vivo (Matrigel plug assay). In contrast, AMPK alpha 2 was not involved in VEGF-triggered sprouting. The data suggest that AMPK alpha 1 promotes VEGF-induced angiogenesis independently of eNOS, possibly by providing energy via inhibition of acetyl-CoA carboxylase.	[Stahmann, Nadine; Spengler, Katrin; Bauer, Reinhard; Krause, Siegfried; Heller, Regine] Univ Jena, Inst Mol Cell Biol, Ctr Mol Biomed, D-07745 Jena, Germany; [Woods, Angela; Heslegrave, Amanda; Carling, David] Univ London Imperial Coll Sci Technol & Med, Cellular Stress Grp, MRC Clin Sci Ctr, Hammersmith Hosp, London W12 0NN, England; [Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit] INSERM, U1016, F-75014 Paris, France	Friedrich Schiller University of Jena; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Heller, R (corresponding author), Univ Jena, Inst Mol Cell Biol, Ctr Mol Biomed, Hans Knoll Str 2, D-07745 Jena, Germany.	regine.heller@med.uni-jena.de	Viollet, Benoit/O-6927-2017; Heller, Regine/AAC-9353-2019; Carling, David/F-1943-2014; Viollet, Benoit/N-2397-2019	Viollet, Benoit/0000-0002-0121-0224; Carling, David/0000-0002-2316-1830; Viollet, Benoit/0000-0002-0121-0224; Heslegrave, Amanda/0000-0002-7290-6405; Spengler, Katrin/0000-0001-9611-7841	Deutsche Forchungsgemeinschaft [He2304-2/1]; Interdisziplinares Zentrum fur Klinische Forschung Jena; European Commission [LSHM-CT-2004-005272]; Medical Research Council UK; Medical Research Council [MC_U120027537] Funding Source: researchfish	Deutsche Forchungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung Jena; European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Deutsche Forchungsgemeinschaft (He2304-2/1) and the Interdisziplinares Zentrum fur Klinische Forschung Jena (to R. H.). Further support was obtained from the European Commission EXGENESIS Integrated Project Grant LSHM-CT-2004-005272 (to D. C. and B. V.) and the Medical Research Council UK (to D. C. and A. W.).	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Blanes MG, 2007, J BIOL CHEM, V282, P10660, DOI 10.1074/jbc.M609048200; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Boyle JG, 2008, J BIOL CHEM, V283, P11210, DOI 10.1074/jbc.M710048200; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; da Silva CG, 2006, CIRC RES, V98, pE39, DOI 10.1161/01.RES.0000215436.92414.1d; Dagher Z, 1999, BIOCHEM BIOPH RES CO, V265, P112, DOI 10.1006/bbrc.1999.1635; Dagher Z, 2001, CIRC RES, V88, P1276, DOI 10.1161/hh1201.092998; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Heller R, 2001, J BIOL CHEM, V276, P40, DOI 10.1074/jbc.M004392200; Heller R, 2008, CARDIOVASC RES, V80, P96, DOI 10.1093/cvr/cvn159; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Mount PF, 2008, ATHEROSCLEROSIS, V200, P28, DOI 10.1016/j.atherosclerosis.2007.12.003; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Mount PF, 2005, AM J PHYSIOL-RENAL, V289, pF1103, DOI 10.1152/ajprenal.00458.2004; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; Ruderman NB, 2003, BIOCHEM SOC T, V31, P202, DOI 10.1042/bst0310202; Schulz E, 2005, CIRCULATION, V111, P3473, DOI 10.1161/CIRCULATIONAHA.105.546812; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Sun L, 1998, J MED CHEM, V41, P2588, DOI 10.1021/jm980123i; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Thors B, 2004, FEBS LETT, V573, P175, DOI 10.1016/j.febslet.2004.07.078; Thors B, 2008, BBA-MOL CELL RES, V1783, P1893, DOI 10.1016/j.bbamcr.2008.07.003; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xu XB, 2008, ENDOCRINOLOGY, V149, P4183, DOI 10.1210/en.2008-0255; Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x; Zwetsloot KA, 2008, J PHYSIOL-LONDON, V586, P6021, DOI 10.1113/jphysiol.2008.159871	84	73	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10638	10652		10.1074/jbc.M110.108688	http://dx.doi.org/10.1074/jbc.M110.108688			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20129920	hybrid, Green Published			2022-12-25	WOS:000276264600051
J	Yu, SY; Zhao, DM; Jothi, R; Xue, HH				Yu, Shuyang; Zhao, Dong-Mei; Jothi, Raja; Xue, Hai-Hui			Critical Requirement of GABP alpha for Normal T Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GABP; ADULT HEMATOPOIETIC STEM; CHIP-SEQ DATA; BINDING-PROTEIN; LYMPHOCYTE DEVELOPMENT; GENE-EXPRESSION; NEUROMUSCULAR-JUNCTION; RECEPTOR EXPRESSION; CYCLE PROGRESSION; TARGET GENES	GA binding protein (GABP) consists of GABP alpha and GABP beta subunits. GABP alpha is a member of Ets family transcription factors and binds DNA via its conserved Ets domain, whereas GABP beta does not bind DNA but possesses transactivation activity. In T cells, GABP has been demonstrated to regulate the gene expression of interleukin-7 receptor alpha chain (IL-7R alpha) and postulated to be critical in T cell development. To directly investigate its function in early thymocyte development, we used GABP alpha conditional knock-out mice where the exons encoding the Ets DNA-binding domain are flanked with LoxP sites. Ablation of GABP alpha with the Lck-Cre transgene greatly diminished thymic cellularity, blocked thymocyte development at the double negative 3 (DN3) stage, and resulted in reduced expression of T cell receptor (TCR) beta chain in DN4 thymocytes. By chromatin immunoprecipitation, we demonstrated in DN thymocytes that GABP alpha is associated with transcription initiation sites of genes encoding key molecules in TCR rearrangements. Among these GABP-associated genes, knockdown of GABP alpha expression by RNA interference diminished expression of DNA ligase IV, Artemis, and Ku80 components in DNA-dependent protein kinase complex. Interestingly, forced expression of prearranged TCR but not IL-7R alpha can alleviate the DN3 block in GABP alpha-targeted mice. Our observations collectively indicate that in addition to regulating IL-7R alpha expression, GABP is critically required for TCR rearrangements and hence normal T cell development.	[Yu, Shuyang; Zhao, Dong-Mei; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Iowa City, IA 52246 USA; [Zhao, Dong-Mei] Univ Iowa, Dept Internal Med, Iowa City, IA 52246 USA; [Xue, Hai-Hui] Univ Iowa, Interdisciplinary Immunol Grad Program, Carver Coll Med, Iowa City, IA 52246 USA; [Jothi, Raja] NIEHS, NIH, Biostat Branch, Res Triangle Pk, NC 27709 USA	University of Iowa; University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Xue, HH (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52246 USA.	hai-hui-xue@uiowa.edu	Jothi, Raja/G-3780-2015	Xue, Hai-Hui/0000-0002-9163-7669; Jothi, Raja/0000-0002-4833-1090	National Institutes of Health [AI077504, HL095540]; NIEHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077504 and HL095540 (to H. -H. X.). This work was also supported by the Intramural Research Program of the NIEHS, National Institutes of Health (to R. J.).	Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Brabb T, 1997, EUR J IMMUNOL, V27, P136, DOI 10.1002/eji.1830270121; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Crook MF, 2008, FASEB J, V22, P225, DOI 10.1096/fj.07-8573com; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Garrett-Sinha LA, 2001, BLOOD, V97, P2908, DOI 10.1182/blood.V97.9.2908; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haring JS, 2008, J IMMUNOL, V180, P2855, DOI 10.4049/jimmunol.180.5.2855; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Jaworski A, 2007, MOL CELL BIOL, V27, P5040, DOI 10.1128/MCB.02228-06; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lacorazza HD, 2001, J IMMUNOL, V166, P3184, DOI 10.4049/jimmunol.166.5.3184; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lucas ME, 2009, J BIOL CHEM, V284, P14698, DOI 10.1074/jbc.M901104200; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; O'Leary DA, 2007, MOL CELL BIOL, V27, P3470, DOI 10.1128/MCB.00659-06; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Ravel-Chapuis A, 2007, EMBO J, V26, P1117, DOI 10.1038/sj.emboj.7601572; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Robey EA, 2004, CURR OPIN IMMUNOL, V16, P360, DOI 10.1016/j.coi.2004.03.009; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548	53	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10179	10188		10.1074/jbc.M109.088740	http://dx.doi.org/10.1074/jbc.M109.088740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139079	hybrid, Green Published			2022-12-25	WOS:000276264600002
J	Andrieu, C; Taieb, D; Baylot, V; Ettinger, S; Soubeyran, P; De-Thonel, A; Nelson, C; Garrido, C; So, A; Fazli, L; Bladou, F; Gleave, M; Iovanna, JL; Rocchi, P				Andrieu, C.; Taieb, D.; Baylot, V.; Ettinger, S.; Soubeyran, P.; De-Thonel, A.; Nelson, C.; Garrido, C.; So, A.; Fazli, L.; Bladou, F.; Gleave, M.; Iovanna, J. L.; Rocchi, P.			Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E	ONCOGENE			English	Article						prostate cancer; androgen independence; heat shock protein 27; eukaryotic translational initiation factor; ubiquitination	INITIATION-FACTOR 4E; INDEPENDENT PROGRESSION; PROTEASOMAL DEGRADATION; 4E-BINDING PROTEIN-1; LNCAP TUMORS; CYCLIN D1; TRANSLATION; GROWTH; HEAT-SHOCK-PROTEIN-27; APOPTOSIS	One strategy to improve therapies in advanced prostate cancer (PC) involves targeting genes that are activated by androgen withdrawal to delay the emergence of the androgen-independent (AI) phenotype. Heat shock protein 27 (Hsp27) expression becomes highly upregulated in PC cells after androgen withdrawal or chemotherapy, in which it functions as a cytoprotective chaperone to confer broadspectrum treatment resistance. The purpose of this study is to elucidate anti-apoptotic pathways regulated by Hsp27 that are activated during PC progression. Using two-hybrid experiment, we found that Hsp27 was having a major role in the protein translational initiation process. Furthermore, using complementary DNA (cDNA) microarray analysis, 4E binding protein 1 was identified as being proportionately and highly regulated by Hsp27. These data led us to analyze the protein synthesis initiation pathway, which is a prerequisite for cell growth and proliferation. Using northern and western blot analysis, we found that Hsp27 downregulation decreased eukaryotic translation initiation factor 4E (eIF4E) expression at the protein, but not mRNA, level. The cytoprotection afforded by Hsp27 overexpression was attenuated by eIF4E knockdown using specific eIF4E short interfering RNA (siRNA). Co-immunoprecipitation and co-immunofluorescence confirmed that Hsp27 colocalizes and interacts directly with eIF4E. Hsp27-eIF4E interaction decreases eIF4E ubiquitination and proteasomal degradation. By chaperoning eIF4E, Hsp27 seems to protect the protein synthesis initiation process to enhance cell survival during cell stress induced by castration or chemotherapy. Forced overexpression of eIF4E induces resistance to androgen-withdrawal and paclitaxel treatment in the prostate LNCaP cells in vitro. These findings identify Hsp27 as a modulator of eIF4E and establish a potential mechanism for the eIF4E-regulated apoptosis after androgen ablation and chemotherapy. Targeting Hsp27-eIF4E interaction may serve as a therapeutic target in advanced PC. Oncogene (2010) 29, 1883-1896; doi:10.1038/onc.2009.479; published online 18 January 2010	[Andrieu, C.; Taieb, D.; Baylot, V.; Soubeyran, P.; Iovanna, J. L.; Rocchi, P.] INSERM, Stress Cellulaire U624, F-13009 Marseille, France; [Andrieu, C.; Taieb, D.; Baylot, V.; Soubeyran, P.; Iovanna, J. L.; Rocchi, P.] Aix Marseille Univ, Marseille, France; [Ettinger, S.; Nelson, C.; So, A.; Fazli, L.; Gleave, M.] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC, Canada; [De-Thonel, A.; Garrido, C.] INSERM, U866, Fac Med, Dijon, France; [Bladou, F.] Hop St Marguerite, Serv Urol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of British Columbia; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Rocchi, P (corresponding author), INSERM, U624, Prostate Canc Res Project, Parc Sci & Technol Luminy,163 Ave Luminy, F-13009 Marseille, Provence, France.	palma.rocchi@inserm.fr	Baylot, Virginie/AAR-1416-2021; Soubeyran, Philippe/P-1758-2018; Andrieu, Claudia/O-4432-2017; Taieb, Pr. David/M-5219-2017; Garrido, Carolina/GWM-5557-2022; Baylot, Virginie/HCI-7158-2022; Iovanna, Juan/M-9805-2017; Rocchi, Palma/P-5455-2014; Garrido, carmen/G-1633-2018	Baylot, Virginie/0000-0003-1313-2857; Iovanna, Juan/0000-0003-1822-2237; Rocchi, Palma/0000-0002-4383-4684; Garrido, carmen/0000-0003-1368-1493; de Thonel, Aurelie/0000-0003-0405-0745; Soubeyran, Philippe/0000-0002-5876-3217	l'Institut National de la Sante et de la Recherche Medicale ( INSERM); l'Association pour la Recherche sur le Cancer (ARC); l'Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)	l'Institut National de la Sante et de la Recherche Medicale ( INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); l'Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); l'Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)	We thank Dr Valentina Evdokimova (British Columbia Cancer Agency, Canada) for her helpful advice on eIF4E experiments. We thank Dr Takayuki Murata (McGill University, Canada) for providing the pcDNA3.1 FLAG-tagged eIF4E vectors. We thank Virginia Yago and Paul Jugpal (Prostate Centre, Canada) for their excellent technical assistance in animal and laboratory experimentation. We thank Dr Jonathan Nowak (Inserm U624, France) for his excellent help in confocal microscopy. This work was supported from grants by l'Institut National de la Sante et de la Recherche Medicale (INSERM), l'Association pour la Recherche sur le Cancer (ARC) and l'Association pour la Recherche sur les Tumeurs de la Prostate (ARTP).	Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Arora S, 2005, CANCER RES, V65, P3806, DOI 10.1158/0008-5472.CAN-04-4036; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758; Cornford PA, 2000, CANCER RES, V60, P7099; Frankfurt OS, 1997, CLIN CANCER RES, V3, P465; Fusi A, 2004, TUMORI J, V90, P535, DOI 10.1177/030089160409000601; Gallagher Eva, 2006, Clin J Oncol Nurs, V10, P233, DOI 10.1188/06.CJON.233-240; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; GLEAVE ME, 1992, CANCER RES, V52, P1598; Gleave ME, 1999, UROLOGY, V54, P36, DOI 10.1016/S0090-4295(99)00453-7; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Heesom KJ, 2001, CURR BIOL, V11, P1374, DOI 10.1016/S0960-9822(01)00422-5; HOTTE SJ, 2009, J CLIN ONCOL S, V27, pS15; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kamada M, 2007, MOL CANCER THER, V6, P299, DOI 10.1158/1535-7163.MCT-06-0417; Kiyama S, 2003, CANCER RES, V63, P3575; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; Lucas A, 2006, J UROLOGY, V176, pS72, DOI 10.1016/j.juro.2006.06.077; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Meli M, 2006, J MED CHEM, V49, P7721, DOI 10.1021/jm060836y; Miller H, 2005, ARTERIOSCL THROM VAS, V25, pE10, DOI 10.1161/01.ATV.0000156536.89752.8e; Mitchell BS, 2003, NEW ENGL J MED, V348, P2597, DOI 10.1056/NEJMp030092; Miyake H, 2000, CANCER RES, V60, P170; Miyake H, 2000, CANCER RES, V60, P3058; Murata T, 2006, J BIOL CHEM, V281, P20788, DOI 10.1074/jbc.M600563200; Oridate N, 2005, CANCER BIOL THER, V4, P318, DOI 10.4161/cbt.4.3.1504; Othumpangat S, 2005, J BIOL CHEM, V280, P25162, DOI 10.1074/jbc.M414303200; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Rocchi P, 2004, ONCOGENE, V23, P9111, DOI 10.1038/sj.onc.1208154; Rocchi P, 2004, CANCER RES, V64, P6595, DOI 10.1158/0008-5472.CAN-03-3998; Rocchi P, 2006, BJU INT, V98, P1082, DOI 10.1111/j.1464-410X.2006.06425.x; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369	48	109	117	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	13					1883	1896		10.1038/onc.2009.479	http://dx.doi.org/10.1038/onc.2009.479			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	577CV	20101233				2022-12-25	WOS:000276199600002
J	Lauring, J; Cosgrove, DP; Fontana, S; Gustin, JP; Konishi, H; Abukhdeir, AM; Garay, JP; Mohseni, M; Wang, GM; Higgins, MJ; Gorkin, D; Reis, M; Vogelstein, B; Polyak, K; Cowherd, M; Buckhaults, PJ; Park, BH				Lauring, J.; Cosgrove, D. P.; Fontana, S.; Gustin, J. P.; Konishi, H.; Abukhdeir, A. M.; Garay, J. P.; Mohseni, M.; Wang, G. M.; Higgins, M. J.; Gorkin, D.; Reis, M.; Vogelstein, B.; Polyak, K.; Cowherd, M.; Buckhaults, P. J.; Park, B. H.			Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations	ONCOGENE			English	Article						Akt1; oncogene; knock in; gene targeting; breast epithelial cells	PLECKSTRIN HOMOLOGY DOMAIN; PTEN LOSS; PHOSPHOINOSITIDE 3-KINASE; HIGH-FREQUENCY; CANCER; ACTIVATION; CARCINOMA; GENE; CORRELATE; PATHWAY	An oncogenic mutation (G49A:E17K) in the AKT1 gene has been described recently in human breast, colon, and ovarian cancers. The low frequency of this mutation and perhaps other selective pressures have prevented the isolation of human cancer cell lines that harbor this mutation thereby limiting functional analysis. Here, we create a physiologic in vitro model to study the effects of this mutation by using somatic cell gene targeting using the nontumorigenic human breast epithelial cell line, MCF10A. Surprisingly, knock in of E17K into the AKT1 gene had minimal phenotypic consequences and importantly, did not recapitulate the biochemical and growth characteristics seen with somatic cell knock in of PIK3CA hotspot mutations. These results suggest that mutations in critical genes within the PI3-kinase (PI3K) pathway are not functionally equivalent, and that other cooperative genetic events may be necessary to achieve oncogenic PI3K pathway activation in cancers that contain the AKT1 E17K mutation. Oncogene (2010) 29, 2337-2345; doi:10.1038/onc.2009.516; published online 25 January 2010	[Lauring, J.; Cosgrove, D. P.; Fontana, S.; Gustin, J. P.; Konishi, H.; Abukhdeir, A. M.; Garay, J. P.; Mohseni, M.; Wang, G. M.; Higgins, M. J.; Gorkin, D.; Reis, M.; Vogelstein, B.; Park, B. H.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21231 USA; [Polyak, K.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Cowherd, M.; Buckhaults, P. J.] Univ S Carolina, Sch Med, Columbia, SC USA	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Lauring, J (corresponding author), Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Sch Med, 1650 Orleans St,Room 146, Baltimore, MD 21231 USA.	jlaurin1@jhmi.edu; bpark2@jhmi.edu	Reis, Marcelo Martins/H-9370-2012	Reis, Marcelo Martins/0000-0002-4706-1041; Abukhdeir, Abde/0000-0003-1172-5819; Higgins, Michaela Jane/0000-0002-9065-8652; Lauring, Josh/0000-0002-4312-704X; Konishi, Hiroyuki/0000-0003-1131-4905; Gorkin, David/0000-0003-4944-4107	Flight Attendant Medical Research Institute (FAMRI); V Foundation; Maryland Cigarette Restitution Fund; National Institutes of Health [CA88843, CA088843-08, T32 CA09071-27, CA109274]; trust of Ruby J Nelson in loving memory of Charlotte R Nelson; Avon Foundation; American Society of Clinical Oncology Foundation; Department of Defense [W81XWH-06-1-0325, BC083057]; FAMRI; Susan G Komen Foundation; Medical Scientist Training Program Fellowship; Mary Kay Ash Charitable Foundation; Stewart Trust Fund; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R37CA043460, T32CA009071, R55CA109274, P50CA088843, R01CA109274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute (FAMRI); V Foundation; Maryland Cigarette Restitution Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); trust of Ruby J Nelson in loving memory of Charlotte R Nelson; Avon Foundation; American Society of Clinical Oncology Foundation; Department of Defense(United States Department of Defense); FAMRI; Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); Medical Scientist Training Program Fellowship; Mary Kay Ash Charitable Foundation; Stewart Trust Fund; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JL receives support from the Flight Attendant Medical Research Institute (FAMRI), the V Foundation, and the Maryland Cigarette Restitution Fund, National Institutes of Health Grants CA88843, CA088843-08, The Susan G Komen for the Cure Career Catalyst Grant funded by the trust of Ruby J Nelson in loving memory of Charlotte R Nelson, and the Avon Foundation. DC receives support from National Institutes of Health Grant T32 CA09071-27 and a Young Investigator Award from the American Society of Clinical Oncology Foundation. JP Gustin is a recipient of a Department of Defense Breast Cancer Research Program Predoctoral Fellowship Award W81XWH-06-1-0325. JP Garay is a recipient of a Research Supplement to promote diversity in health-related research. HK is a recipient of a Young Clinical Scientist Award from FAMRI. AMA is supported by a Susan G Komen Foundation Postdoctoral Fellowship Award. GW is a recipient of a Medical Scientist Training Program Fellowship. MM is recipient of a Department of Defense Breast Cancer Predoctoral Training Award (BC083057). BHP acknowledges support from the Avon Foundation, Susan G Komen for the Cure, the Mary Kay Ash Charitable Foundation, the Stewart Trust Fund, National Institutes of Health Grants CA109274 and CA88843, FAMRI, and the Breast Cancer Research Foundation.	Abubaker J, 2007, LEUKEMIA, V21, P2368, DOI 10.1038/sj.leu.2404873; Abukhdeir AM, 2006, BREAST CANCER RES TR, V99, P23, DOI 10.1007/s10549-006-9177-0; Arena S, 2007, CANCER RES, V67, P8468, DOI 10.1158/0008-5472.CAN-07-1126; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cohen Y, 2010, GYNECOL ONCOL, V116, P88, DOI 10.1016/j.ygyno.2009.09.038; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Denley A, 2008, METHOD ENZYMOL, V438, P291, DOI 10.1016/S0076-6879(07)38020-8; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Hayes MP, 2006, CLIN CANCER RES, V12, P5932, DOI 10.1158/1078-0432.CCR-06-1375; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Konishi H, 2007, NAT PROTOC, V2, P2865, DOI 10.1038/nprot.2007.409; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Workman P, 2004, BIOCHEM SOC T, V32, P393, DOI 10.1042/BST0320393; Yoon DS, 2002, AM J PATHOL, V161, P391, DOI 10.1016/S0002-9440(10)64194-6	30	39	39	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	16					2337	2345		10.1038/onc.2009.516	http://dx.doi.org/10.1038/onc.2009.516			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20101210	Green Accepted			2022-12-25	WOS:000276951500003
J	Witte, CP; Keinath, N; Dubiella, U; Demouliere, R; Seal, A; Romeis, T				Witte, Claus-Peter; Keinath, Nana; Dubiella, Ullrich; Demouliere, Raphael; Seal, Anindita; Romeis, Tina			Tobacco Calcium-dependent Protein Kinases Are Differentially Phosphorylated in Vivo as Part of a Kinase Cascade That Regulates Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-LIKE DOMAIN; PLASMA-MEMBRANE; GUARD-CELLS; ARABIDOPSIS; CDPK; PLANT; AUTOPHOSPHORYLATION; ACTIVATION; IDENTIFICATION; LOCALIZATION	In vivo phosphorylation sites of the tobacco calcium-dependent protein kinases NtCDPK2 and NtCDPK3 were determined in response to biotic or abiotic stress. Stress-inducible phosphorylation was exclusively located in the variable N termini, where both kinases were phosphorylated differentially despite 91% overall sequence identity. In NtCDPK2, serine 40 and threonine 65 were phosphorylated within 2 min after stress. Whereas Thr(65) is subjected to intra-molecular in vivo autophosphorylation, Ser(40) represents a target for a regulatory upstream protein kinase, and correct NtCDPK2 membrane localization is required for Ser(40) phosphorylation. NtCDPK3 is phosphorylated at least at two sites in the N terminus by upstream kinase(s) upon stress stimulus, first at Ser(54), a site not present in NtCDPK2, and also at a second undetermined site not identical to Ser(40). Domain swap experiments established that differential phosphorylation of both kinases is exclusively determined by the respective N termini. A cell death-inducing response was only observed upon expression of a truncated variant lacking the junction and calcium-binding domain of NtCDPK2 (VK2). This response required protein kinase activity and was reduced when subcellular membrane localization was disturbed by a mutation in the myristoylation and palmitoylation site. Our data indicate that CDPKs are integrated in stress-dependent protein kinase signaling cascades, and regulation of CDPK function in response to in vivo stimulation is dependent on its membrane localization.	[Witte, Claus-Peter; Dubiella, Ullrich; Romeis, Tina] Free Univ Berlin, Inst Biol, Dept Plant Biochem, D-14195 Berlin, Germany; [Keinath, Nana; Demouliere, Raphael] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50935 Cologne, Germany; [Seal, Anindita] W Bengal Univ Technol, Dept Biotechnol, Kolkata 700064, W Bengal, India	Free University of Berlin; Max Planck Society; Maulana Abul Kalam Azad University of Technology	Romeis, T (corresponding author), Free Univ Berlin, Inst Biol, Dept Plant Biochem, Konigin Luise Str 12-16, D-14195 Berlin, Germany.	romeis@zedat.fu-berlin.de	Witte, Claus-Peter/L-1676-2017; Dubiella, Ullrich/AAF-6499-2019; Seal, Anindita/AAG-4466-2019	Witte, Claus-Peter/0000-0002-3617-7807; Seal, Anindita/0000-0001-7951-7595; Dubiella, Ullrich/0000-0001-9854-9795	European Molecular Biology Organization; Deutsche Forschungsgemeinschaft Research Consortia [SFB 635, SPP1212]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft Research Consortia(German Research Foundation (DFG))	This work was supported by a European Molecular Biology Organization long term fellowship (to C.-P. W.) and by Deutsche Forschungsgemeinschaft Research Consortia SFB 635 and SPP1212 (to T. R.).	Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Bohmer M, 2007, PLANT MOL BIOL, V65, P817, DOI 10.1007/s11103-007-9245-9; BOGRE L, 1988, PLANT SCI, V58, P135, DOI 10.1016/0168-9452(88)90001-5; Chandran V, 2006, J MOL BIOL, V357, P400, DOI 10.1016/j.jmb.2005.11.093; Chaudhuri S, 1999, PLANT PHYSIOL, V120, P859, DOI 10.1104/pp.120.3.859; Chehab EW, 2004, PLANT PHYSIOL, V135, P1430, DOI 10.1104/pp.103.035238; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Glinski M, 2003, RAPID COMMUN MASS SP, V17, P1579, DOI 10.1002/rcm.1093; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; HARMON AC, 2001, NEW PHYTOL, V151, P175, DOI DOI 10.1046/j.1469-8137.2001.00171.x; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hegeman AD, 2004, J AM SOC MASS SPECTR, V15, P647, DOI 10.1016/j.jasms.2003.12.019; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Lee JY, 1998, BIOCHEMISTRY-US, V37, P6801, DOI 10.1021/bi980062q; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Romeis T, 2000, PLANT CELL, V12, P803, DOI 10.1105/tpc.12.5.803; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Rutschmann F, 2002, PLANT PHYSIOL, V129, P156, DOI 10.1104/pp.000869; Siegel RS, 2009, PLANT J, V59, P207, DOI 10.1111/j.1365-313X.2009.03872.x; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; van Bentem SD, 2008, J PROTEOME RES, V7, P2458, DOI 10.1021/pr8000173; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Weljie AM, 2004, BIOCHEMISTRY-US, V43, P15131, DOI 10.1021/bi048751r; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Yoo BC, 1996, BIOCHEMISTRY-US, V35, P12029, DOI 10.1021/bi9606612; Yoon GM, 2006, PLANT CELL, V18, P867, DOI 10.1105/tpc.105.037135; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666	42	72	83	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9740	9748		10.1074/jbc.M109.052126	http://dx.doi.org/10.1074/jbc.M109.052126			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118232	hybrid, Green Published			2022-12-25	WOS:000276165900046
J	Kruger, C; Kappen, C				Kruger, Claudia; Kappen, Claudia			Expression of Cartilage Developmental Genes in Hoxc8-and Hoxd4-Transgenic Mice	PLOS ONE			English	Article							INDIAN-HEDGEHOG; NITRIC-OXIDE; CHONDROCYTE PROLIFERATION; TISSUE INHIBITOR; BONE-FORMATION; GROWTH; CHONDROGENESIS; DIFFERENTIATION; LIMB; OSTEOGENESIS	Hox genes encode transcription factors, which regulate skeletal patterning and chondrocyte differentiation during the development of cartilage, the precursor to mature bone. Overexpression of the homeobox transcription factors Hoxc8 and Hoxd4 causes severe cartilage defects due to delay in cartilage maturation. Matrix metalloproteinases (MMPs), bone morphogenetic proteins (BMPs) and fibroblastic growth factors (FGFs) are known to play important roles in skeletal development and endochondral bone formation and remodeling. In order to investigate whether these molecules are aberrantly expressed in Hoxc8- and/or Hoxd4-transgenic cartilage, we performed quantitative RT-PCR on chondrocytes from Hox-transgenic mice. Gene expression levels of Bmp4, Fgf8, Fgf10, Mmp9, Mmp13, Nos3, Timp3, Wnt3a and Wnt5a were altered in Hoxc8-transgenic chondrocytes, and Fgfr3, Ihh, Mmp8, and Wnt3a expression levels were altered in Hoxd4-transgenic chondrocytes, respectively. Notably, Wnt3a expression was elevated in Hoxc8- and reduced in Hoxd4-transgenic cartilage. These results suggest that both transcription factors affect cartilage maturation through different molecular mechanisms, and provide the basis for future studies into the role of these genes and possible interactions in pathogenesis of cartilage defects in Hoxc8- and Hoxd4-transgenic mice.	[Kruger, Claudia; Kappen, Claudia] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Kappen, Claudia] Univ Nebraska Med Ctr, Ctr Human Mol Genet, Munroe Meyer Inst Genet & Rehabil, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kruger, C (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Maternal Biol, Baton Rouge, LA 70803 USA.	Claudia.Kappen@pbrc.edu			University of Nebraska Medical Center [R21 DE14523]; Phillip Morris External Research Program; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC014523] Funding Source: NIH RePORTER	University of Nebraska Medical Center; Phillip Morris External Research Program; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded in part by R21 DE14523 (to Claudia Kappen), a Dean's indirect cost award from the University of Nebraska Medical Center, and a grant from the Phillip Morris External Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTE SS, 1994, DEV DYNAM, V200, P177, DOI 10.1002/aja.1002000302; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Burke D, 1998, TRENDS BIOCHEM SCI, V23, P59, DOI 10.1016/S0968-0004(97)01170-5; Chen L, 1999, J CLIN INVEST, V104, P1517, DOI 10.1172/JCI6690; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Church V, 2002, J CELL SCI, V115, P4809, DOI 10.1242/jcs.00152; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Cormier Stephania A, 2003, BMC Dev Biol, V3, P4, DOI 10.1186/1471-213X-3-4; Daumer KM, 2004, J CELL BIOCHEM, V93, P526, DOI 10.1002/jcb.20190; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Eames B. Frank, 2003, Birth Defects Research, V69, P93, DOI 10.1002/bdrc.10016; Ellsworth JL, 2002, OSTEOARTHR CARTILAGE, V10, P308, DOI 10.1053/joca.2002.0514; Evans DM, 1996, J BONE MINER RES, V11, P300; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gregg AR, 1998, AM J PHYSIOL-HEART C, V275, pH2319, DOI 10.1152/ajpheart.1998.275.6.H2319; GREGG AR, 1995, MAMM GENOME, V6, P152, DOI 10.1007/BF00303267; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Joronen K, 2000, HISTOCHEM CELL BIOL, V114, P157; Kappen C, 2004, GENESIS, V39, P155, DOI 10.1002/gene.20036; KAPPEN C, 2000, GENETIC MANIPULATION, P69; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; Kruger C, 2006, BIRTH DEFECTS RES A, V76, P216, DOI 10.1002/bdra.20245; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Lotz M, 1999, RHEUM DIS CLIN N AM, V25, P269, DOI 10.1016/S0889-857X(05)70067-3; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Ornitz DM, 2001, GENOME BIOL, V2; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Rundle CH, 1998, BBA-GENE STRUCT EXPR, V1398, P164, DOI 10.1016/S0167-4781(98)00046-3; Rundle CH, 1999, J EXP ZOOL, V283, P612, DOI 10.1002/(SICI)1097-010X(19990501)283:6<612::AID-JEZ14>3.3.CO;2-O; Sasano Y, 2002, J HISTOCHEM CYTOCHEM, V50, P325, DOI 10.1177/002215540205000304; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Teixeira CC, 2005, BONE, V37, P37, DOI 10.1016/j.bone.2005.03.010; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Turner CH, 1997, BONE, V21, P487, DOI 10.1016/S8756-3282(97)00202-0; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yueh YG, 1998, P NATL ACAD SCI USA, V95, P9956, DOI 10.1073/pnas.95.17.9956; Zhou J, 2007, BIOCHEM BIOPH RES CO, V363, P513, DOI 10.1016/j.bbrc.2007.08.198	58	22	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e8978	10.1371/journal.pone.0008978	http://dx.doi.org/10.1371/journal.pone.0008978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126390	Green Submitted, Green Published, gold			2022-12-25	WOS:000274207200002
J	Kim, SY; Dunn, IF; Firestein, R; Gupta, P; Wardwell, L; Repich, K; Schinzel, AC; Wittner, B; Silver, SJ; Root, DE; Boehm, JS; Ramaswamy, S; Lander, ES; Hahn, WC				Kim, So Young; Dunn, Ian F.; Firestein, Ron; Gupta, Piyush; Wardwell, Leslie; Repich, Kara; Schinzel, Anna C.; Wittner, Ben; Silver, Serena J.; Root, David E.; Boehm, Jesse S.; Ramaswamy, Sridhar; Lander, Eric S.; Hahn, William C.			CK1 epsilon Is Required for Breast Cancers Dependent on beta-Catenin Activity	PLOS ONE			English	Article							COLON-CANCER; WNT; EXPRESSION; ACTIVATION; GENE; INHIBITOR; PATHWAY; CELLS; IC261; CKI	Background: Aberrant beta-catenin signaling plays a key role in several cancer types, notably colon, liver and breast cancer. However approaches to modulate beta-catenin activity for therapeutic purposes have proven elusive to date. Methodology: To uncover genetic dependencies in breast cancer cells that harbor active beta-catenin signaling, we performed RNAi-based loss-of-function screens in breast cancer cell lines in which we had characterized beta-catenin activity. Here we identify CSNK1E, the gene encoding casein kinase 1 epsilon (CK1 epsilon) as required specifically for the proliferation of breast cancer cells with activated beta-catenin and confirm its role as a positive regulator of beta-catenin-driven transcription. Furthermore, we demonstrate that breast cancer cells that harbor activated beta-catenin activity exhibit enhanced sensitivity to pharmacological blockade of Wnt/beta-catenin signaling. We also find that expression of CK1e is able to promote oncogenic transformation of human cells in a beta-catenin-dependent manner. Conclusions/Significance: These studies identify CK1 epsilon as a critical contributor to activated beta-catenin signaling in cancer and suggest it may provide a potential therapeutic target for cancers that harbor active beta-catenin. More generally, these observations delineate an approach that can be used to identify druggable synthetic lethal interactions with signaling pathways that are frequently activated in cancer but are difficult to target with the currently available small molecule inhibitors.	[Kim, So Young; Dunn, Ian F.; Firestein, Ron; Wardwell, Leslie; Repich, Kara; Schinzel, Anna C.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wittner, Ben; Ramaswamy, Sridhar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Firestein, Ron] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kim, So Young; Schinzel, Anna C.; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kim, So Young; Firestein, Ron; Schinzel, Anna C.; Boehm, Jesse S.; Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Kim, So Young; Dunn, Ian F.; Firestein, Ron; Gupta, Piyush; Repich, Kara; Schinzel, Anna C.; Silver, Serena J.; Root, David E.; Boehm, Jesse S.; Ramaswamy, Sridhar; Lander, Eric S.; Hahn, William C.] Broad Inst, Cambridge, MA USA; [Wittner, Ben; Ramaswamy, Sridhar] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Ramaswamy, Sridhar] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University	Kim, SY (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	William_Hahn@dfci.harvard.edu		Boehm, Jesse/0000-0002-6795-6336	Department of Defense postdoctoral fellowship; National Institutes of Health (NIH) [K08 CA134836-01]; Mentored Clinical Scientist Award [P50 CA127003]; GI SPORE Career Development [R33 CA128625, R01 CA130988]; Department of Defense Idea Award [W81XWH-07-1-0408]; Dana-Farber Harvard Cancer Center SPORE in Breast Cancer [P50 CA89393]; NATIONAL CANCER INSTITUTE [P50CA127003, K08CA134836, K08CA100339, R33CA128625, R01CA130988, P50CA089393] Funding Source: NIH RePORTER	Department of Defense postdoctoral fellowship(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Clinical Scientist Award; GI SPORE Career Development; Department of Defense Idea Award(United States Department of Defense); Dana-Farber Harvard Cancer Center SPORE in Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Department of Defense postdoctoral fellowship (S.Y.K.), the Brain Science Foundation and Warren-Whitman-Richardson Foundation (I. D.), K08 CA134836-01 from National Institutes of Health (NIH): Mentored Clinical Scientist Award and P50 CA127003: GI SPORE Career Development Grant (R.F.), R33 CA128625 (W.C.H.), R01 CA130988 (W.C.H.), Department of Defense Idea Award W81XWH-07-1-0408 (W.C.H.), Dana-Farber Harvard Cancer Center SPORE in Breast Cancer P50 CA89393 (S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Badura L, 2007, J PHARMACOL EXP THER, V322, P730, DOI 10.1124/jpet.107.122846; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liefeld T, 2005, BIOINFORMATICS, V21, P3681, DOI 10.1093/bioinformatics/bti587; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu XH, 1996, CANCER RES, V56, P5125; Lo PK, 2006, CANCER BIOL THER, V5, P281, DOI 10.4161/cbt.5.3.2384; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Veeck J, 2008, CARCINOGENESIS, V29, P991, DOI 10.1093/carcin/bgn076; Yang WS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r92	38	62	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8979	10.1371/journal.pone.0008979	http://dx.doi.org/10.1371/journal.pone.0008979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126544	gold, Green Published, Green Submitted			2022-12-25	WOS:000274209700008
J	Loser, K; Brzoska, T; Oji, V; Auriemma, M; Voskort, M; Kupas, V; Klenner, L; Mensing, C; Hauschild, A; Beissert, S; Luger, TA				Loser, Karin; Brzoska, Thomas; Oji, Vinzenz; Auriemma, Matteo; Voskort, Maik; Kupas, Verena; Klenner, Lars; Mensing, Cornelius; Hauschild, Axel; Beissert, Stefan; Luger, Thomas A.			The Neuropeptide Alpha-Melanocyte-Stimulating Hormone Is Critically Involved in the Development of Cytotoxic CD8(+) T Cells in Mice and Humans	PLOS ONE			English	Article							HUMAN MELANOCORTIN-1 RECEPTOR; NF-KAPPA-B; CUTANEOUS MALIGNANT-MELANOMA; IN-VITRO; RED HAIR; SKIN-CANCER; INFLAMMATORY AGENTS; FUNCTION MUTATIONS; DENDRITIC CELLS; GENE VARIANTS	Background: The neuropeptide alpha-melanocyte-stimulating hormone is well known as a mediator of skin pigmentation. More recently, it has been shown that alpha-melanocyte-stimulating hormone also plays pivotal roles in energy homeostasis, sexual function, and inflammation or immunomodulation. Alpha-melanocyte-stimulating hormone exerts its antiinflammatory and immunomodulatory effects by binding to the melanocortin-1 receptor, and since T cells are important effectors during immune responses, we investigated the effects of alpha-melanocyte-stimulating hormone on T cell function. Methodology/Principal Findings: T cells were treated with alpha-melanocyte-stimulating hormone, and subsequently, their phenotype and function was analyzed in a contact allergy as well as a melanoma model. Furthermore, the relevance of alpha-melanocyte-stimulating hormone-mediated signaling for the induction of cytotoxicity was assessed in CD8(+) T cells from melanoma patients with functional and nonfunctional melanocortin-1 receptors. Here we demonstrate that the melanocortin-1 receptor is expressed by murine as well as human CD8(+) T cells, and we furthermore show that alpha-melanocyte-stimulating hormone/melanocortin-1 receptor-mediated signaling is critical for the induction of cytotoxicity in human and murine CD8(+) T cells. Upon adoptive transfer, alpha-melanocyte-stimulating hormone-treated murine CD8(+) T cells significantly reduced contact allergy responses in recipient mice. Additionally, the presented data indicate that alpha-melanocyte-stimulating hormone via signaling through a functional melanocortin-1 receptor augmented antitumoral immunity by up-regulating the expression of cytotoxic genes and enhancing the cytolytic activity in tumor-specific CD8(+) T cells. Conclusions/Significance: Together, these results point to an important role of alpha-melanocyte-stimulating hormone in MHC class I-restricted cytotoxicity. Therefore, treatment of contact allergies or skin cancer with alpha-melanocyte-stimulating hormone or other more stable agonists of melanocortin-1 receptor might ameliorate disease or improve antitumoral immune responses.	[Loser, Karin; Brzoska, Thomas; Oji, Vinzenz; Auriemma, Matteo; Voskort, Maik; Kupas, Verena; Klenner, Lars; Beissert, Stefan; Luger, Thomas A.] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Loser, Karin; Oji, Vinzenz; Beissert, Stefan] Univ Munster, Interdisciplinary Ctr Clin Res, D-4400 Munster, Germany; [Mensing, Cornelius; Hauschild, Axel] Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany	University of Munster; University of Munster; University of Kiel	Loser, K (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-4400 Munster, Germany.	loserk@uni-muenster.de	Hauschild, Axel/B-3185-2010	Oji, Vinzenz/0000-0003-1380-4828	Interdisciplinary Center of Clinical Research [Lo2/017/07]; German Cancer Society [107891]; German Research Association [Lo817/2-1]	Interdisciplinary Center of Clinical Research; German Cancer Society; German Research Association(German Research Foundation (DFG))	This study was supported by Interdisciplinary Center of Clinical Research grant Lo2/017/07 to KL and SB, German Cancer Society grant 107891 to KL and SB, and German Research Association grant Lo817/2-1 to KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mallek ZA, 2008, PHOTOCHEM PHOTOBIOL, V84, P501, DOI 10.1111/j.1751-1097.2008.00294.x; Adachi S, 1999, J IMMUNOL, V163, P3363; Andersen GN, 2001, CLIN EXP IMMUNOL, V126, P441, DOI 10.1046/j.1365-2249.2001.01604.x; Balkow S, 2009, EXP DERMATOL, V18, P78, DOI 10.1111/j.1600-0625.2008.00800.x; Barnetson R S, 1997, Australas J Dermatol, V38 Suppl 1, pS63; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Becher E, 1999, ANN NY ACAD SCI, V885, P188; Bellone M, 2000, J IMMUNOL, V165, P2651, DOI 10.4049/jimmunol.165.5.2651; Bhardwaj R, 1997, J IMMUNOL, V158, P3378; Botchkarev VA, 1999, ANN NY ACAD SCI, V885, P433; Box NF, 2001, J INVEST DERMATOL, V116, P224, DOI 10.1046/j.1523-1747.2001.01224.x; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Catania A, 1996, PEPTIDES, V17, P675, DOI 10.1016/0196-9781(96)00037-X; Cavani Andrea, 2008, V94, P93, DOI 10.1159/000154934; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; Cooper A, 2005, J IMMUNOL, V175, P4806, DOI 10.4049/jimmunol.175.7.4806; Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233, DOI 10.1002/jlb.67.2.233; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Elliott RJ, 2004, J INVEST DERMATOL, V122, P1010, DOI 10.1111/j.0022-202X.2004.22404.x; Eves P, 2003, BRIT J CANCER, V89, P2004, DOI 10.1038/sj.bjc.6601349; Fargnoli Maria Concetta, 2003, Hum Mutat, V21, P655, DOI 10.1002/humu.9150; GEHLSEN KR, 1992, PIGM CELL RES, V5, P219, DOI 10.1111/j.1600-0749.1992.tb00540.x; Grabbe S, 1996, J IMMUNOL, V156, P473; Gunzer M, 2001, J IMMUNOL METHODS, V258, P55, DOI 10.1016/S0022-1759(01)00466-5; Han D, 2007, GENE THER, V14, P383, DOI 10.1038/sj.gt.3302862; Hedley SJ, 2000, MELANOMA RES, V10, P323, DOI 10.1097/00008390-200008000-00003; High WA, 2005, J AM ACAD DERMATOL, V53, P89, DOI 10.1016/j.jaad.2005.03.006; Ichiyama T, 1999, J NEUROIMMUNOL, V99, P211, DOI 10.1016/S0165-5728(99)00122-8; Kalden DH, 1999, ANN NY ACAD SCI, V885, P254; KAMEYAMA K, 1990, INT J CANCER, V45, P1151, DOI 10.1002/ijc.2910450627; Kanetsky PA, 2004, CANCER EPIDEM BIOMAR, V13, P808; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Lin J, 2008, BRIT J DERMATOL, V159, P286, DOI 10.1111/j.1365-2133.2008.08682.x; Lipton JM, 1999, ANN NY ACAD SCI, V885, P173; Lipton JM, 1997, IMMUNOL TODAY, V18, P140, DOI 10.1016/S0167-5699(97)01009-8; LIPTON JM, 1994, ANN NY ACAD SCI, V741, P137, DOI 10.1111/j.1749-6632.1994.tb39654.x; Loser K, 2005, GENE THER, V12, P1294, DOI 10.1038/sj.gt.3302567; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; Luger TA, 2000, ANN NY ACAD SCI, V917, P232; Luger TA, 1996, J DERMATOL SCI, V13, P5, DOI 10.1016/0923-1811(95)00485-8; LUNEC J, 1992, MELANOMA RES, V2, P5, DOI 10.1097/00008390-199205000-00002; Maaser C, 2006, GUT, V55, P1415, DOI 10.1136/gut.2005.083634; Maaser C, 2006, ANN NY ACAD SCI, V1072, P123, DOI 10.1196/annals.1326.016; Makova K, 2005, PEPTIDES, V26, P1901, DOI 10.1016/j.peptides.2004.12.032; Manna SK, 1998, J IMMUNOL, V161, P2873; Melief C J, 1991, Semin Cancer Biol, V2, P347; Mossner R, 2007, ARCH DERMATOL RES, V298, P371, DOI 10.1007/s00403-006-0708-7; Morandini R, 1998, J CELL PHYSIOL, V175, P276, DOI 10.1002/(SICI)1097-4652(199806)175:3<276::AID-JCP5>3.0.CO;2-L; MORTON DL, 1971, PROG EXP TUMOR RES, V14, P25; MOUNTJOY KG, 1994, MOL CELL ENDOCRINOL, V102, pR7, DOI 10.1016/0303-7207(94)90113-9; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; NEUMANNANDERSEN G, 2005, SCAND J IMMUNOL, V61, P279; Nishida T, 2004, INT IMMUNOPHARMACOL, V4, P1059, DOI 10.1016/j.intimp.2004.04.011; Raap U, 2003, J IMMUNOL, V171, P353, DOI 10.4049/jimmunol.171.1.353; Rajora N, 1997, PEPTIDES, V18, P381, DOI 10.1016/S0196-9781(96)00345-2; Rees JL, 2000, PIGM CELL RES, V13, P135, DOI 10.1034/j.1600-0749.2000.130303.x; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x; Sanchez-Laorden BL, 2007, J BIOL CHEM, V282, P3241, DOI 10.1074/jbc.M606865200; Schioth HB, 1997, EUR J PHARMACOL, V319, P369, DOI 10.1016/S0014-2999(96)00959-4; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Scott MC, 2002, J CELL SCI, V115, P2349; STAR RA, 1995, P NATL ACAD SCI USA, V92, P8016, DOI 10.1073/pnas.92.17.8016; Straten PT, 1999, CANCER IMMUNOL IMMUN, V48, P386, DOI 10.1007/s002620050591; Sturm RA, 2002, MELANOMA RES, V12, P405, DOI 10.1097/00008390-200209000-00001; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Tenaud I, 2007, EXP DERMATOL, V16, P500, DOI 10.1111/j.1600-0625.2007.00552.x; Wikberg JES, 2000, PHARMACOL RES, V42, P393, DOI 10.1006/phrs.2000.0725; Wong TH, 2005, PEPTIDES, V26, P1965, DOI 10.1016/j.peptides.2004.11.021; Yoon SW, 2003, J BIOL CHEM, V278, P32914, DOI 10.1074/jbc.M302444200	73	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8958	10.1371/journal.pone.0008958	http://dx.doi.org/10.1371/journal.pone.0008958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126537	Green Published, gold, Green Submitted			2022-12-25	WOS:000274209700004
J	Cushion, MT; Linke, MJ; Ashbaugh, A; Sesterhenn, T; Collins, MS; Lynch, K; Brubaker, R; Walzer, PD				Cushion, Melanie T.; Linke, Michael J.; Ashbaugh, Alan; Sesterhenn, Tom; Collins, Margaret S.; Lynch, Keeley; Brubaker, Ronald; Walzer, Peter D.			Echinocandin Treatment of Pneumocystis Pneumonia in Rodent Models Depletes Cysts Leaving Trophic Burdens That Cannot Transmit the Infection	PLOS ONE			English	Article							CARINII-PNEUMONIA; JIROVECI PNEUMONIA; INFLAMMATORY RESPONSES; ASPERGILLUS-FUMIGATUS; CASPOFUNGIN; EFFICACY; THERAPY; MICE; TRIMETHOPRIM; MECHANISMS	Fungi in the genus Pneumocystis cause pneumonia (PCP) in hosts with debilitated immune systems and are emerging as comorbidity factors associated with chronic diseases such as COPD. Limited therapeutic choices and poor understanding of the life cycle are a result of the inability of these fungi to grow outside the mammalian lung. Within the alveolar lumen, Pneumocystis spp., appear to have a bi-phasic life cycle consisting of an asexual phase characterized by binary fission of trophic forms and a sexual cycle resulting in formation of cysts, but the life cycle stage that transmits the infection is not known. The cysts, but not the trophic forms, express beta -1,3-D-glucan synthetase and contain abundant beta -1,3-D-glucan. Here we show that therapeutic and prophylactic treatment of PCP with echinocandins, compounds which inhibit the synthesis of beta -1,3-D-glucan, depleted cysts in rodent models of PCP, while sparing the trophic forms which remained in significant numbers. Survival was enhanced in the echincandin treated mice, likely due to the decreased beta -1,3-D-glucan content in the lungs of treated mice and rats which coincided with reductions of cyst numbers, and dramatic remodeling of organism morphology. Strong evidence for the cyst as the agent of transmission was provided by the failure of anidulafungin-treated mice to transmit the infection. We show for the first time that withdrawal of anidulafungin treatment with continued immunosuppression permitted the repopulation of cyst forms. Treatment of PCP with an echinocandin alone will not likely result in eradication of infection and cessation of echinocandin treatment while the patient remains immunosuppressed could result in relapse. Importantly, the echinocandins provide novel and powerful chemical tools to probe the still poorly understood bi-phasic life cycle of this genus of fungal pathogens.	[Cushion, Melanie T.; Ashbaugh, Alan; Sesterhenn, Tom; Collins, Margaret S.; Lynch, Keeley; Walzer, Peter D.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Cushion, Melanie T.; Linke, Michael J.; Ashbaugh, Alan; Sesterhenn, Tom; Collins, Margaret S.; Lynch, Keeley; Walzer, Peter D.] Vet Adm Med Ctr, Cincinnati, OH 45220 USA; [Brubaker, Ronald] Christ Hosp, Dept Pathol, Cincinnati, OH 45219 USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Christ Hospital - Ohio	Cushion, MT (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA.	melanie.cushion@uc.edu		Cushion, Melanie T./0000-0001-6621-2784	National Institutes of Allergy and Infectious Diseases [NO1 AI75319]; Public Health Service Grant [R01 AI076104]; Medical Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076104, N01AI075319] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by Public Health Service Contract NO1 AI75319 from the National Institutes of Allergy and Infectious Diseases (to M. T. C. and P. D. W.); Public Health Service Grant R01 AI076104 (M. T. C.); Medical Research Service, Department of Veterans Affairs (M. T. C. and P. D. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JM, 2009, EUKARYOT CELL, V8, P446, DOI 10.1128/EC.00309-08; Beltz K, 2006, KLIN PADIATR, V218, P177, DOI 10.1055/s-2006-933433; Carmona EM, 2006, J IMMUNOL, V177, P459, DOI 10.4049/jimmunol.177.1.459; Collins MS, 2001, J EUKARYOT MICROBIOL, p178S; Cushion MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000423; Cushion MT, 2006, ANTIMICROB AGENTS CH, V50, P2337, DOI 10.1128/AAC.00126-06; Cushion MT, 2009, CURR MED CHEM, V16, P2514, DOI 10.2174/092986709788682038; Cushion MT, 2009, EUKARYOT CELL, V8, P197, DOI 10.1128/EC.00202-08; Evans SE, 2005, AM J RESP CELL MOL, V32, P490, DOI 10.1165/rcmb.2004-0300OC; Fisk DT, 2003, CLIN INFECT DIS, V36, P70, DOI 10.1086/344951; Hahn PY, 2003, J BIOL CHEM, V278, P2043, DOI 10.1074/jbc.M209715200; HEE SQ, 2003, BIOL MONITORING INTR, P78; Hof H, 2008, MYCOSES, V51, P1, DOI 10.1111/j.1439-0507.2008.01522.x; Hohl TM, 2008, J INFECT DIS, V198, P176, DOI 10.1086/589304; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Icenhour CR, 2002, EUKARYOT CELL, V1, P414, DOI 10.1128/EC.1.3.414-419.2002; Ito M, 2000, ANTIMICROB AGENTS CH, V44, P2259, DOI 10.1128/AAC.44.9.2259-2262.2000; Kamboj M, 2006, CLIN INFECT DIS, V43, pE92, DOI 10.1086/508282; Kanaani H, 2007, J AEROSOL SCI, V38, P83, DOI 10.1016/j.jaerosci.2006.10.003; Kauffman CA, 2008, SEMIN RESP CRIT CARE, V29, P211, DOI 10.1055/s-2008-1063859; Kaur N, 2007, DIGEST DIS SCI, V52, P1481, DOI 10.1007/s10620-006-9250-x; Komano Y, 2009, ARTHRIT RHEUM-ARTHR, V61, P305, DOI 10.1002/art.24283; KURTZ MB, 1994, ANTIMICROB AGENTS CH, V38, P1480, DOI 10.1128/AAC.38.7.1480; Lamaris GA, 2008, J INFECT DIS, V198, P186, DOI 10.1086/589305; Limper AH, 2003, J EUKARYOT MICROBIOL, V50, P646, DOI 10.1111/j.1550-7408.2003.tb00667.x; Linke M, 2005, MICROBES INFECT, V7, P748, DOI 10.1016/j.micinf.2005.01.011; Linke MJ, 2003, EMERG INFECT DIS, V9, P1613, DOI 10.3201/eid0912.030270; Mofenson Lynne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Morris A, 2008, COPD, V5, P43, DOI 10.1080/15412550701817656; Morris A, 2008, CLIN INFECT DIS, V46, P634, DOI 10.1086/526779; Patel Naimish, 2004, Treat Respir Med, V3, P381, DOI 10.2165/00151829-200403060-00005; Powles MA, 1998, ANTIMICROB AGENTS CH, V42, P1985, DOI 10.1128/AAC.42.8.1985; Qureshi MH, 2001, J IMMUNOL, V166, P5704, DOI 10.4049/jimmunol.166.9.5704; Radhi S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-118; Ruan SB, 2002, INFECT IMMUN, V70, P6107, DOI 10.1128/IAI.70.11.6107-6113.2002; Russian DA, 1998, DRUG RESIST UPDATE, V1, P16, DOI 10.1016/S1368-7646(98)80210-0; SCHMATZ DM, 1991, J PROTOZOOL, V38, pS151; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; Thompson MF, 2009, SCAND J INFECT DIS, P1; Utili R, 2007, TRANSPLANTATION, V84, P685, DOI 10.1097/01.tp.0000280546.91617.6c; Vassallo R, 2000, J IMMUNOL, V164, P3755, DOI 10.4049/jimmunol.164.7.3755; Vohra PK, 2004, BIOCHEM BIOPH RES CO, V319, P193, DOI 10.1016/j.bbrc.2004.04.154; WALZER PD, 1992, ANTIMICROB AGENTS CH, V36, P1935, DOI 10.1128/AAC.36.9.1935; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778; Waters L, 2007, EXPERT OPIN INV DRUG, V16, P899, DOI 10.1517/13543784.16.6.899; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227	48	100	112	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8524	10.1371/journal.pone.0008524	http://dx.doi.org/10.1371/journal.pone.0008524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126455	gold, Green Published, Green Submitted			2022-12-25	WOS:000274139100001
J	Abuya, TO; Fegan, G; Amin, AA; Akhwale, WS; Noor, AM; Snow, RW; Marsh, V				Abuya, Timothy O.; Fegan, Greg; Amin, Abdinasir A.; Akhwale, Willis S.; Noor, Abdisalan M.; Snow, Robert W.; Marsh, Vicki			Evaluating Different Dimensions of Programme Effectiveness for Private Medicine Retailer Malaria Control Interventions in Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; DEVELOPING-COUNTRIES; HOME TREATMENT; PUBLIC-HEALTH; RURAL KENYA; DRUG; MANAGEMENT; DISTRICTS; KNOWLEDGE; SERVICES	Background: Private medicine retailers (PMRs) are key partners in the home management of fevers in many settings. Current evidence on effectiveness for PMR interventions at scale is limited. This study presents evaluation findings of two different programs implemented at moderate scale targeting PMRs for malaria control in the Kisii and Kwale districts of Kenya. Key components of this evaluation were measurement of program performance, including coverage, PMR knowledge, practices, and utilization based on spatial analysis. Methodology/Principal Findings: The study utilized mixed quantitative methods including retail audits and surrogate client surveys based on post-intervention cross-sectional surveys in intervention and control areas and mapping of intervention outlets. There was a large and significant impact on PMR knowledge and practices of the program in Kisii, with 60.5% of trained PMRs selling amodiaquine medicines in adequate doses compared to 2.8% of untrained ones (OR; 53.5: 95% CI 6.7, 428.3), a program coverage of 69.7% targeted outlets, and a potential utilization of about 30,000 children under five. The evaluation in Kwale also indicates a significant impact with 18.8% and 2.3% intervention and control PMRs selling amodiaquine with correct advice, respectively (OR; 9.4: 95% CI 1.1, 83.7), a program coverage of 25.3% targeted outlets, and a potential utilization of about 48,000 children under five. A provisional benchmark of 7.5 km was a reasonable threshold distance for households to access PMR services. Conclusions/Significance: This evaluation show that PMR interventions operationalized in the district level settings are likely to impact PMR knowledge and practices and lead to increased coverage of appropriate treatment to target populations. There is value of evaluating different dimensions of public health programs, including quality, spatial access, and implementation practice. This approach strengthens the potential contribution of pragmatic study designs to evaluating public health programs in the real world.	[Abuya, Timothy O.; Fegan, Greg; Marsh, Vicki] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Kilifi, Kenya; [Fegan, Greg] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Amin, Abdinasir A.] Populat Serv Int, Malaria Control & Child Survival Dept, Nairobi, Kenya; [Akhwale, Willis S.] Minist Hlth, Div Vector Borne Dis, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Kenya Med Res Inst, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.; Marsh, Vicki] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; University of Oxford	Abuya, TO (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res, Kilifi, Kenya.	tabuya@kilifi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Abuya, Timothy/AAH-5479-2020; Snow, Robert William/AFR-1436-2022	Fegan, Greg W/0000-0002-2663-2765; Snow, Robert William/0000-0003-3725-6088; Marsh, Vicki/0000-0002-5178-4250; Huicho, Luis/0000-0002-5272-5885	Kenya Medical Research Institute (KEMRI); Wellcome Trust [084538, 079080, 081829]; World Health Organization Kenya Country Office	Kenya Medical Research Institute (KEMRI); Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization Kenya Country Office	Funding support for the surveys was provided by the Kenya Medical Research Institute (KEMRI), the Wellcome Trust, and the World Health Organization Kenya Country Office. T.O.A. is supported by the Wellcome Trust Strategic Award (#084538). R. W. S. is supported by the Wellcome Trust as Principal Research Fellow (#079080). A.M.N. is supported by the Wellcome Trust as a Research Training Fellow (#081829). This paper is published with the permission of the Director of KEMRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya T, 2009, AM J TROP MED HYG, V80, P905, DOI 10.4269/ajtmh.2009.80.905; Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; *AFF MED FAC MAL, 2007, TECHN PROP INCR ACC; Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x; AMIN AA, 2005, RANGE QUALITY COSTS; Black N, 1996, BRIT MED J, V312, P1215; *COGME, 1998, 10 COGME US DEP HHS; Gitonga CW, 2008, TROP MED INT HEALTH, V13, P487, DOI 10.1111/j.1365-3156.2008.02026.x; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Greer G, 2004, IMPROVING MANAGEMENT; Guagliardo MF, 2004, HEALTH PLACE, V10, P273, DOI 10.1016/j.healthplace.2003.01.001; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-157; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; *MERLIN ICIPE JOIN, MERL MAL CONTR W KEN; *MIN HLTH, 2006, DISTR LED MED RET TR; *MOH, 2001, NAT MAL STRAT 2001 2; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Ross L, 2005, J PUBLIC HEALTH, V27, P331, DOI 10.1093/pubmed/fdi058; SABOT O, 2008, DISTRIBUTION ARTEMIS, P27; SNOW R, MODELLING ANTIMALARI; Tawfik Y, 2006, TROP MED INT HEALTH, V11, P967, DOI 10.1111/j.1365-3156.2006.01622.x; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; WHO, 2004, SCAL HOM BAS MAN MAL; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; World Health Organization, 2005, WHOHTMMAL20051101	30	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8937	10.1371/journal.pone.0008937	http://dx.doi.org/10.1371/journal.pone.0008937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	550OR	20126620	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000274138000015
J	Matsumura, K; Opiekun, M; Oka, H; Vachani, A; Albelda, SM; Yamazaki, K; Beauchamp, GK				Matsumura, Koichi; Opiekun, Maryanne; Oka, Hiroaki; Vachani, Anil; Albelda, Steven M.; Yamazaki, Kunio; Beauchamp, Gary K.			Urinary Volatile Compounds as Biomarkers for Lung Cancer: A Proof of Principle Study Using Odor Signatures in Mouse Models of Lung Cancer	PLOS ONE			English	Article							ELECTRONIC NOSE; ORGANIC-COMPOUNDS; IN-VITRO; IDENTIFICATION; MICE; DISCRIMINATION; DIAGNOSIS; VECTOR; STAGE	A potential strategy for diagnosing lung cancer, the leading cause of cancer-related death, is to identify metabolic signatures (biomarkers) of the disease. Although data supports the hypothesis that volatile compounds can be detected in the breath of lung cancer patients by the sense of smell or through bioanalytical techniques, analysis of breath samples is cumbersome and technically challenging, thus limiting its applicability. The hypothesis explored here is that variations in small molecular weight volatile organic compounds ("odorants'') in urine could be used as biomarkers for lung cancer. To demonstrate the presence and chemical structures of volatile biomarkers, we studied mouse olfactory-guided behavior and metabolomics of volatile constituents of urine. Sensor mice could be trained to discriminate between odors of mice with and without experimental tumors demonstrating that volatile odorants are sufficient to identify tumor-bearing mice. Consistent with this result, chemical analyses of urinary volatiles demonstrated that the amounts of several compounds were dramatically different between tumor and control mice. Using principal component analysis and supervised machine-learning, we accurately discriminated between tumor and control groups, a result that was cross validated with novel test groups. Although there were shared differences between experimental and control animals in the two tumor models, we also found chemical differences between these models, demonstrating tumor-based specificity. The success of these studies provides a novel proof-of-principle demonstration of lung tumor diagnosis through urinary volatile odorants. This work should provide an impetus for similar searches for volatile diagnostic biomarkers in the urine of human lung cancer patients.	[Matsumura, Koichi; Opiekun, Maryanne; Yamazaki, Kunio; Beauchamp, Gary K.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Oka, Hiroaki] Panasonic Corp, Kyoto, Japan; [Vachani, Anil; Albelda, Steven M.] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; Panasonic; University of Pennsylvania	Matsumura, K (corresponding author), Univ Tokyo, Dept Integrated Biosci, Chiba, Japan.	beauchamp@monell.org			Panasonic Corporation	Panasonic Corporation	This study was supported by Panasonic Corporation. As indicated under the competing interest section, an employee of Panasonic, Dr. H. Oka, helped conceive the original idea and reviewed the manuscript. No other role in this research was played by Dr. Oka and Panasonic.	Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Belda-Iniesta C, 2007, CLIN TRANSL ONCOL, V9, P354; Bernabei M, 2008, SENSOR ACTUAT B-CHEM, V131, P1, DOI 10.1016/j.snb.2007.12.030; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Chen X, 2007, CANCER-AM CANCER SOC, V110, P835, DOI 10.1002/cncr.22844; Di Natale C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003139; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Gordon RT, 2008, J ALTERN COMPLEM MED, V14, P61, DOI 10.1089/acm.2006.6408; Gramolini AO, 2008, CLIN PHARMACOL THER, V83, P758, DOI 10.1038/clpt.2008.18; Greenberg AK, 2007, CURR OPIN PULM MED, V13, P249, DOI 10.1097/MCP.0b013e32819f8f06; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kodogiannis VS, 2008, IEEE T INF TECHNOL B, V12, P707, DOI 10.1109/TITB.2008.917928; Kwak J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003591; Lechner M, 2007, CURR MED CHEM, V14, P987, DOI 10.2174/092986707780362916; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Monahan E, 1993, LAB ANIMALS      JUN, P38; Montag S, 2001, P NATL ACAD SCI USA, V98, P9249, DOI 10.1073/pnas.161266398; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PERBELLINI L, 1986, ARCH TOXICOL, V58, P229, DOI 10.1007/BF00297111; Radhika V, 2007, NAT CHEM BIOL, V3, P325, DOI 10.1038/nchembio882; Ravenel JG, 2008, RADIOLOGY, V247, P400, DOI 10.1148/radiol.2472070868; Ravenel JG, 2008, AM J ROENTGENOL, V190, P755, DOI 10.2214/AJR.07.2899; Restrepo D, 2006, TRENDS NEUROSCI, V29, P604, DOI 10.1016/j.tins.2006.08.001; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; SONG G, 2009, LUNG CANC AOP WHAT I; Sponring A, 2009, ANTICANCER RES, V29, P419; Turner APF, 2004, NAT REV MICROBIOL, V2, P161, DOI 10.1038/nrmicro823; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wilderman MJ, 2005, CANCER RES, V65, P8379, DOI 10.1158/0008-5472.CAN-05-0920; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Willse A, 2005, ANAL CHEM, V77, P2348, DOI 10.1021/ac048711t; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; Yamazaki K, 2002, P NATL ACAD SCI USA, V99, P5612, DOI 10.1073/pnas.082093099; ZLATKIS A, 1981, CLIN CHEM, V27, P789	40	87	91	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8819	10.1371/journal.pone.0008819	http://dx.doi.org/10.1371/journal.pone.0008819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111698	Green Published, Green Submitted, gold			2022-12-25	WOS:000274114800005
J	Benard, A; Mercie, P; Alioum, A; Bonnet, F; Lazaro, E; Dupon, M; Neau, D; Dabis, F; Chene, G				Benard, Antoine; Mercie, Patrick; Alioum, Ahmadou; Bonnet, Fabrice; Lazaro, Estibaliz; Dupon, Michel; Neau, Didier; Dabis, Francois; Chene, Genevieve		GECSA	Bacterial Pneumonia among HIV-Infected Patients: Decreased Risk After Tobacco Smoking Cessation. ANRS CO3 Aquitaine Cohort, 2000-2007	PLOS ONE			English	Article							CIGARETTE-SMOKING; ANTIRETROVIRAL THERAPY; PNEUMOCOCCAL VACCINATION; CARDIOVASCULAR-DISEASE; IMPACT; IMMUNODEFICIENCY; PROGRESSION; MORBIDITY; MORTALITY; LEVEL	Background: Bacterial pneumonia is still a substantial cause of morbidity and mortality in HIV-infected patients in the era of combination Antiretroviral Therapy. The benefit of tobacco withdrawal on the risk of bacterial pneumonia has not been quantified in such populations, exposed to other important risk factors such as HIV-related immunodeficiency. Our objective was to estimate the effect of tobacco smoking withdrawal on the risk of bacterial pneumonia among HIV-infected individuals. Methodology/Principal Findings: Patients of the ANRS CO3 Aquitaine Cohort with >= two visits during 2000-2007 and without bacterial pneumonia at the first visit were included. Former smokers were patients who stopped smoking since >= one year. We used Cox proportional hazards models adjusted on CD4+ lymphocytes (CD4), gender, age, HIV transmission category, antiretroviral therapy, cotrimoxazole prophylaxis, statin treatment, viral load and previous AIDS diagnosis. 135 cases of bacterial pneumonia were reported in 3336 patients, yielding an incidence of 12 parts per thousand patient-years. The adjusted hazard of bacterial pneumonia was lower in former smokers (Hazard Ratio (HR): 0.48; P = 0.02) and never smokers (HR: 0.50; P = 0.01) compared to current smokers. It was higher in patients with,200 CD4 cells/mu L and in those with 200 to 349 CD4 cells/mL (HR: 2.98 and 1.98, respectively; both P, 0.01), but not in those with 350 to 499 CD4 cells/mu L (HR: 0.93; P = 0.79), compared to those with >= 500 CD4 cells/mu L. The interaction between CD4 cell count and tobacco smoking status was not statistically significant. Conclusions/Significance: Smoking cessation dramatically reduces the risk of bacterial pneumonia, whatever the level of immunodeficiency. Smoking cessation interventions should become a key element of the clinical management of HIV-infected individuals.	[Benard, Antoine; Mercie, Patrick; Alioum, Ahmadou; Bonnet, Fabrice; Neau, Didier; Dabis, Francois; Chene, Genevieve] INSERM, U897, CIC EC7, Bordeaux, France; [Benard, Antoine; Mercie, Patrick; Alioum, Ahmadou; Bonnet, Fabrice; Neau, Didier; Dabis, Francois; Chene, Genevieve] Univ Victor Segalen Bordeaux 2, ISPED, Bordeaux, France; [Benard, Antoine; Mercie, Patrick; Bonnet, Fabrice; Lazaro, Estibaliz; Dupon, Michel; Neau, Didier; Dabis, Francois; Chene, Genevieve] CHU Bordeaux, COREVIH Aquitaine, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Benard, A (corresponding author), INSERM, U897, CIC EC7, Bordeaux, France.	antoine.benard@isped.u-bordeaux2.fr	chene, genevieve/H-8665-2014; Alioum, Ahmadou/U-3789-2019; Bonnet, Fabrice/T-3254-2019; Benard, Antoine/N-4738-2015; DABIS, FRANCOIS/S-9298-2019	chene, genevieve/0000-0002-8368-6460; Benard, Antoine/0000-0003-2289-8096; DABIS, FRANCOIS/0000-0002-1614-8857; BREILH, Dominique/0000-0002-3783-2797	Agence Nationale de recherches sur le sida et les hepatites virales (ANRS, France); Conseil Regional d'Aquitaine	Agence Nationale de recherches sur le sida et les hepatites virales (ANRS, France)(ANRS); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	The Groupe d'Epidimiologie Clinique du SIDA en Aquitaine (GECSA) is supported by the Agence Nationale de recherches sur le sida et les hepatites virales (ANRS, France) through the Coordinated Action N7 and by the Conseil Regional d'Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Beck James M., 2001, American Journal of Respiratory and Critical Care Medicine, V164, P2120; Benard A, 2006, INT J TUBERC LUNG D, V10, P378; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Bouhnik AD, 2002, JAIDS-J ACQ IMM DEF, V31, pS149, DOI 10.1097/00126334-200212153-00013; Bruyand M, 2009, CLIN INFECT DIS, V49, P1109, DOI 10.1086/605594; Burns DN, 1996, J ACQ IMMUN DEF SYND, V13, P374, DOI 10.1097/00042560-199612010-00012; CLARKE JR, 1995, THORAX, V50, P567, DOI 10.1136/thx.50.5.567; Crothers K, 2005, J GEN INTERN MED, V20, P1142, DOI 10.1111/j.1525-1497.2005.0255.x; Dray-Spira R, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000255082.31728.52; Duval X, 2008, ANTIVIR THER, V13, P389; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gordin FM, 2008, AM J RESP CRIT CARE, V178, P630, DOI 10.1164/rccm.200804-617OC; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Le Moing V, 2006, HIV MED, V7, P261, DOI 10.1111/j.1468-1293.2006.00370.x; Lesprit P, 2007, AIDS, V21, P2425, DOI 10.1097/QAD.0b013e3282887e91; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; PITTET LA, 2009, AM J RESP CELL MOL B; Rodriguez-Barradas MC, 2008, CLIN INFECT DIS, V46, P1093, DOI 10.1086/529201; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sullivan JH, 2000, AM J RESP CRIT CARE, V162, P64, DOI 10.1164/ajrccm.162.1.9904101; Tetrault JM, 2007, ARCH INTERN MED, V167, P221, DOI 10.1001/archinte.167.3.221; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Twigg HL, 1996, CELL IMMUNOL, V170, P127, DOI 10.1006/cimm.1996.0142; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; Wewers MD, 1998, AM J RESP CRIT CARE, V158, P1543, DOI 10.1164/ajrccm.158.5.9802035	32	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8896	10.1371/journal.pone.0008896	http://dx.doi.org/10.1371/journal.pone.0008896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126646	Green Published, Green Submitted, gold			2022-12-25	WOS:000273896500018
J	Vallur, AC; Maizels, N				Vallur, Aarthy C.; Maizels, Nancy			Distinct Activities of Exonuclease 1 and Flap Endonuclease 1 at Telomeric G4 DNA	PLOS ONE			English	Article							WERNER-SYNDROME PROTEIN; REPEAT-CONTAINING RNA; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MAMMALIAN TELOMERES; SECONDARY STRUCTURE; GENOMIC STABILITY; REPLICATION FORK; MISMATCH REPAIR	Background: Exonuclease 1 (EXO1) and Flap endonuclease 1 (FEN1) are members of the RAD2 family of structure-specific nucleases. Genetic analysis has identified roles for EXO1 and FEN1 in replication, recombination, DNA repair and maintenance of telomeres. Telomeres are composed of G-rich repeats that readily form G4 DNA. We recently showed that human EXO1 and FEN1 exhibit distinct activities on G4 DNA substrates representative of intermediates in immunoglobulin class switch recombination. Methodology/Principal Findings: We have now compared activities of these enzymes on telomeric substrates bearing G4 DNA, identifying non-overlapping functions that provide mechanistic insight into the distinct telomeric phenotypes caused by their deficiencies. We show that hFEN1 but not hEXO1 cleaves substrates bearing telomeric G4 DNA 5'-flaps, consistent with the requirement for FEN1 in telomeric lagging strand replication. Both hEXO1 and hFEN1 are active on substrates bearing telomeric G4 DNA tails, resembling uncapped telomeres. Notably, hEXO1 but not hFEN1 is active on transcribed telomeric G-loops. Conclusion/Significance: Our results suggest that EXO1 may act at transcription-induced telomeric structures to promote telomere recombination while FEN1 has a dominant role in lagging strand replication at telomeres. Both enzymes can create ssDNA at uncapped telomere ends thereby contributing to recombination.	[Vallur, Aarthy C.; Maizels, Nancy] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Vallur, AC (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	maizels@u.washington.edu			NIH [R01 GM65988, PO1 CA77852]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01 GM65988 and PO1 CA77852 to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; Brosh RM, 2001, EMBO J, V20, P5791; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Duquette ML, 2007, CANCER RES, V67, P2586, DOI 10.1158/0008-5472.CAN-06-2419; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Guo ZG, 2008, MOL CELL BIOL, V28, P4310, DOI 10.1128/MCB.00200-08; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lopes J, 2002, EMBO J, V21, P3201, DOI 10.1093/emboj/cdf310; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Maleki S, 2002, CURR GENET, V41, P333, DOI 10.1007/s00294-002-0307-x; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Ng LJ, 2009, NUCLEIC ACIDS RES, V37, P1152, DOI 10.1093/nar/gkn1030; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Parenteau J, 2002, GENETICS, V162, P1583; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Perlot T, 2008, P NATL ACAD SCI USA, V105, P3843, DOI 10.1073/pnas.0712291105; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Saharia A, 2009, ONCOGENE, V28, P1162, DOI 10.1038/onc.2008.458; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sharma S, 2003, J BIOL CHEM, V278, P23487, DOI 10.1074/jbc.M212798200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2004, J BIOL CHEM, V279, P9847, DOI 10.1074/jbc.M309898200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Sun XM, 2003, DNA REPAIR, V2, P925, DOI 10.1016/S1568-7864(03)00093-4; Tishkoff DX, 1998, CANCER RES, V58, P5027; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tsolou A, 2007, DNA REPAIR, V6, P1607, DOI 10.1016/j.dnarep.2007.05.010; Vallur AC, 2008, P NATL ACAD SCI USA, V105, P16508, DOI 10.1073/pnas.0805327105; Wang WS, 2005, J BIOL CHEM, V280, P5391, DOI 10.1074/jbc.M412359200; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wilson DM, 1998, NUCLEIC ACIDS RES, V26, P3762, DOI 10.1093/nar/26.16.3762; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	65	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8908	10.1371/journal.pone.0008908	http://dx.doi.org/10.1371/journal.pone.0008908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126648	gold, Green Submitted, Green Published			2022-12-25	WOS:000273896500026
J	Sugawara, M; Resende, JM; Moraes, CM; Marquette, A; Chich, JF; Metz-Boutigue, MH; Bechinger, B				Sugawara, Masae; Resende, Jarbas M.; Moraes, Cleria Mendonca; Marquette, Arnaud; Chich, Jean-Francois; Metz-Boutigue, Marie-Helene; Bechinger, Burkhard			Membrane structure and interactions of human catestatin by multidimensional solution and solid-state NMR spectroscopy	FASEB JOURNAL			English	Article						cationic peptides; antimicrobial peptide; structure of membrane-associated peptide; oriented lipid bilayer; membrane topology; cell-penetrating peptide	CELL-PENETRATING PEPTIDES; CHROMOGRANIN-A FRAGMENT; O-GLYCOSYLATION SITES; ANTIMICROBIAL PEPTIDES; CATECHOLAMINE RELEASE; LIPID-MEMBRANES; PORE FORMATION; PROTEOLYTIC CLEAVAGE; ANTIBACTERIAL ACTION; SECONDARY STRUCTURE	Catestatin is a natural peptide of higher organisms including humans, with a wide variety of biological functions involved in catecholamine inhibition, cardiovascular regulation, control of blood pressure, inflammation, and innate immunity. It is derived from the natural processing of chromogranin A, induced in the skin after injury, and produced by chromaffin cells and neutrophils. With neutrophils, the peptide enters the cell by crossing the plasma membrane where it interacts with internal targets to induce calcium influx. Therefore, we investigated the membrane interactions and structure of several catestatin-derived peptides. Whereas fluorescence dye release experiments are indicative of membrane permeabilization, multidimensional solution NMR and circular dichroism spectroscopies show that catestatin adopts alpha-helical conformations between Ser-6 and Tyr-12 in the presence of dodecylphosphocholine micelles. Furthermore, proton-decoupled N-15 solid-state NMR spectroscopy of sequences labeled with N-15 and reconstituted into oriented lipid bilayers indicates that this domain is aligned in a strongly tilted to inplanar alignment. Proton-decoupled P-31 NMR spectra of the same samples are indicative of conformational and/or orientational heterogeneity at the level of the lipid bilayer head groups due to the presence of catestatin. The sequence and 3-dimensional structure of catestatin exhibit homologies with penetratin, which is suggestive that they both enter the cells by related mechanisms to target internal structures.-Sugawara, M., Resende, J. M., Moraes, C. M., Marquette, A., Chich, J.-F., Metz-Boutigue, M.-H., Bechinger, B. Membrane structure and interactions of human catestatin by multidimensional solution and solid-state NMR spectroscopy. FASEB J. 24, 1737-1146 (2010). www.fasebj.org	[Sugawara, Masae; Resende, Jarbas M.; Moraes, Cleria Mendonca; Marquette, Arnaud; Bechinger, Burkhard] Univ Strasbourg, CNRS, UMR 7177, Inst Chim, Strasbourg, France; [Resende, Jarbas M.] Univ Fed Minas Gerais, Dept Quim, Belo Horizonte, MG, Brazil; [Chich, Jean-Francois; Metz-Boutigue, Marie-Helene] Univ Strasbourg, INSERM, U575, Strasbourg, France; [Chich, Jean-Francois] INRA, Virol & Immunol Mol, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade Federal de Minas Gerais; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bechinger, B (corresponding author), Univ Strasbourg, Inst Le Bel, Fac Chim, 4 Rue Blaise Pascal, F-67070 Strasbourg, France.	bechinger@unistra.fr	Resende, Jarbas M/R-4519-2018	Resende, Jarbas/0000-0001-9827-7312; Mendonca de Moraes, Cleria/0000-0001-5602-9601	Institut National de la Sante et la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); University of Strasbourg; Centre National de la Recherche Scientifique (CNRS); Cordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimeno Cientifico e Technologico (CNPq); Vaincre la Mucoviscidose [TG0602]; RMN Grand-Est Network of the Ministry of Recherche; European Commission [MCRTN-33439]	Institut National de la Sante et la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); University of Strasbourg; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Cordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimeno Cientifico e Technologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Vaincre la Mucoviscidose; RMN Grand-Est Network of the Ministry of Recherche; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank Jesus Raya and Roland Graff for help with the solid-state and solution NMR spectrometers and Bernard Guerold (INSERM U575) for the peptide syntheses. This study was funded by the Institut National de la Sante et la Recherche Medicale (INSERM), Institut National de la Recherche Agronomique (INRA), the University of Strasbourg, and the Centre National de la Recherche Scientifique (CNRS). Furthermore, the CNRS, Cordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimeno Cientifico e Technologico (CNPq) are acknowledged for postdoctoral fellowships to M. S., C. M. M, and J.M.R., respectively. We thank Vaincre la Mucoviscidose (TG0602), the RMN Grand-Est Network of the Ministry of Recherche, and the European Commission under the 6th Framework Programme (Biocontrol, MCRTN-33439) for supporting the projects. We also thank the Brazilian-French program CAPES-COFECUB/EGIDE (487/05), which permitted several exchange visits to promote this work. The Institute for Supramolecular Chemistry of the University of Strasbourg (ISIS) is acknowledged for hosting the Bechinger Laboratory.	Alves ID, 2008, BBA-GEN SUBJECTS, V1780, P948, DOI 10.1016/j.bbagen.2008.04.004; Andronesi OC, 2004, J BIOMOL NMR, V30, P253, DOI 10.1007/s10858-004-3452-3; Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Balayssac S, 2006, BIOCHEMISTRY-US, V45, P1408, DOI 10.1021/bi0518390; BANKS P, 1965, BIOCHEM J, V97, pC40, DOI 10.1042/bj0970040C; Barany-Wallje E, 2004, FEBS LETT, V567, P265, DOI 10.1016/j.febslet.2004.04.079; Bechinger B, 1999, BIOPOLYMERS, V51, P174, DOI 10.1002/(SICI)1097-0282(1999)51:3<174::AID-BIP2>3.0.CO;2-7; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; BECHINGER B, 1991, J MAGN RESON, V95, P585, DOI 10.1016/0022-2364(91)90173-Q; Bechinger B., 2003, CONCEPT MAGN RESON A, V18A, P130; Bechinger B, 2009, CURR OPIN COLLOID IN, V14, P349, DOI 10.1016/j.cocis.2009.02.004; Biswas N, 2008, ENDOCRINOLOGY, V149, P749, DOI 10.1210/en.2007-0838; Biswas N, 2009, ENDOCRINOLOGY, V150, P3547, DOI 10.1210/en.2008-1613; Blois A, 2006, REGUL PEPTIDES, V135, P78, DOI 10.1016/j.regpep.2006.04.007; Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Davis JH, 1999, PROG NUCL MAG RES SP, V35, P1, DOI 10.1016/S0079-6565(99)00009-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s; Egger M, 2008, EUR J PHARMACOL, V598, P104, DOI 10.1016/j.ejphar.2008.09.016; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Ferrero E, 2004, FASEB J, V18, P554, DOI 10.1096/fj.03-0922fje; Gadroy P, 1998, J BIOL CHEM, V273, P34087, DOI 10.1074/jbc.273.51.34087; Galanth C, 2009, BIOCHEMISTRY-US, V48, P313, DOI 10.1021/bi802025a; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Hansen M, 2008, ADV DRUG DELIVER REV, V60, P572, DOI 10.1016/j.addr.2007.09.003; HEDIGER S, 1994, CHEM PHYS LETT, V223, P283, DOI 10.1016/0009-2614(94)00470-6; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Herbig ME, 2005, BIOPHYS J, V89, P4056, DOI 10.1529/biophysj.105.068692; Herrero CJ, 2002, J NEUROSCI, V22, P377, DOI 10.1523/JNEUROSCI.22-02-00377.2002; HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Jean-Francois F, 2007, EUR BIOPHYS J BIOPHY, V36, P1019, DOI 10.1007/s00249-007-0169-8; Jean-Francois F, 2009, FASEB J, V23, P3692, DOI 10.1096/fj.09-135574; Jean-Francois F, 2008, BIOPHYS J, V95, P5748, DOI 10.1529/biophysj.108.136655; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jung HJ, 2008, J MICROBIOL BIOTECHN, V18, P990; Kennedy BP, 1998, PEPTIDES, V19, P1241, DOI 10.1016/S0196-9781(98)00086-2; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruger PG, 2003, REGUL PEPTIDES, V114, P29, DOI 10.1016/S0167-0115(03)00069-7; Lamaziere A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001938; Lee JC, 2003, BIOCHEMISTRY-US, V42, P6938, DOI 10.1021/bi0300433; LENA C, 1993, TRENDS NEUROSCI, V16, P181, DOI 10.1016/0166-2236(93)90150-K; Lindberg M, 2001, FEBS LETT, V497, P39, DOI 10.1016/S0014-5793(01)02433-4; Lins L, 2008, BBA-BIOMEMBRANES, V1778, P1537, DOI 10.1016/j.bbamem.2008.04.006; Lugardon K, 2000, J BIOL CHEM, V275, P10745, DOI 10.1074/jbc.275.15.10745; Lugardon K, 2001, J BIOL CHEM, V276, P35875, DOI 10.1074/jbc.M104670200; Magzoub M, 2002, BBA-BIOMEMBRANES, V1563, P53, DOI 10.1016/S0005-2736(02)00373-5; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mason AJ, 2006, FASEB J, V20, P320, DOI 10.1096/fj.05-4293fje; METZBOUTIGUE MH, 1993, EUR J BIOCHEM, V217, P247, DOI 10.1111/j.1432-1033.1993.tb18240.x; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Preece NE, 2004, REGUL PEPTIDES, V118, P75, DOI 10.1016/j.regpep.2003.10.035; Radek KA, 2008, J INVEST DERMATOL, V128, P1525, DOI 10.1038/sj.jid.5701225; Ramamoorthy A, 2006, BBA-BIOMEMBRANES, V1758, P154, DOI 10.1016/j.bbamem.2006.02.014; Ramamoorthy A, 2010, BBA-BIOMEMBRANES, V1798, P223, DOI 10.1016/j.bbamem.2009.08.012; Ramamoorthy A, 2009, SOLID STATE NUCL MAG, V35, P201, DOI 10.1016/j.ssnmr.2009.03.003; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; Luque-Ortega JR, 2008, FASEB J, V22, P1817, DOI 10.1096/fj.07-096081; Salnikov ES, 2009, BIOPHYS J, V96, P86, DOI 10.1529/biophysj.108.136242; Salnikov ES, 2009, BIOCHIMIE, V91, P734, DOI 10.1016/j.biochi.2009.01.002; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; SIMON JP, 1989, BIOCHEM J, V262, P1; STRUB JM, 1995, EUR J BIOCHEM, V229, P356, DOI 10.1111/j.1432-1033.1995.0356k.x; Strub JM, 1997, J BIOL CHEM, V272, P11928, DOI 10.1074/jbc.272.18.11928; Tang M, 2007, J AM CHEM SOC, V129, P11438, DOI 10.1021/ja072511s; Thennarasu S, 2005, CHEM PHYS LIPIDS, V137, P38, DOI 10.1016/j.chemphyslip.2005.06.003; Tsigelny I, 1998, REGUL PEPTIDES, V77, P43, DOI 10.1016/S0167-0115(98)00040-8; Verly RM, 2009, BIOPHYS J, V96, P2194, DOI 10.1016/j.bpj.2008.11.063; Watts Anthony, 2004, Methods Mol Biol, V278, P403; Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n; Wi S, 2008, J PHYS CHEM B, V112, P11402, DOI 10.1021/jp801825k; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004501; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	82	37	39	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					1737	1746		10.1096/fj.09-142554	http://dx.doi.org/10.1096/fj.09-142554			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20103720	Green Submitted			2022-12-25	WOS:000278200000011
J	Cai, JL; Li, W; Su, HX; Qin, DJ; Yang, JY; Zhu, F; Xu, JY; He, WZ; Guo, XP; Labuda, K; Peterbauer, A; Wolbank, S; Zhong, M; Li, ZY; Wu, WT; So, KF; Redl, H; Zeng, LW; Esteban, MA; Pei, DQ				Cai, Jinglei; Li, Wen; Su, Huanxing; Qin, Dajiang; Yang, Jiayin; Zhu, Fan; Xu, Jianyong; He, Wenzhi; Guo, Xiangpeng; Labuda, Krystyna; Peterbauer, Anja; Wolbank, Susanne; Zhong, Mei; Li, Zhiyuan; Wu, Wutian; So, Kwok-Fai; Redl, Heinz; Zeng, Lingwen; Esteban, Miguel Angel; Pei, Duanqing			Generation of Human Induced Pluripotent Stem Cells from Umbilical Cord Matrix and Amniotic Membrane Mesenchymal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; DIRECTED DIFFERENTIATION; IPS CELLS; NEURONS; FIBROBLASTS; DERIVATION; INDUCTION	The umbilical cord and placenta are extra-embryonic tissues of particular interest for regenerative medicine. They share an early developmental origin and are a source of vast amounts of cells with multilineage differentiation potential that are poorly immunogenic and without controversy. Moreover, these cells are likely exempt from incorporated mutations when compared with juvenile or adult donor cells such as skin fibroblasts or keratinocytes. Here we report the efficient generation of induced pluripotent stem cells (iPSCs) from mesenchymal cells of the umbilical cord matrix (up to 0.4% of the cells became reprogrammed) and the placental amniotic membrane (up to 0.1%) using exogenous factors and a chemical mixture. iPSCs from these 2 tissues homogeneously showed human embryonic stem cell (hESC)-like characteristics including morphology, positive staining for alkaline phosphatase, normal karyotype, and expression of hESC-like markers including Nanog, Rex1, Oct4, TRA-1-60, TRA-1-80, SSEA-3, and SSEA-4. Selected clones also formed embryonic bodies and teratomas containing derivatives of the 3 germ layers, and could as well be readily differentiated into functional motor neurons. Among other things, our cell lines may prove useful for comparisons between iPSCs derived from multiple tissues regarding the extent of the epigenetic reprogramming, differentiation ability, stability of the resulting lineages, and the risk of associated abnormalities.	[Cai, Jinglei; Li, Wen; Qin, Dajiang; Yang, Jiayin; Zhu, Fan; Xu, Jianyong; He, Wenzhi; Guo, Xiangpeng; Li, Zhiyuan; Zeng, Lingwen; Esteban, Miguel Angel; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Cai, Jinglei; Li, Wen; Qin, Dajiang; Yang, Jiayin; Zhu, Fan; Xu, Jianyong; He, Wenzhi; Guo, Xiangpeng; Li, Zhiyuan; Zeng, Lingwen; Esteban, Miguel Angel; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Su, Huanxing; Wu, Wutian; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Labuda, Krystyna; Wolbank, Susanne; Redl, Heinz] Ludwig Boltzmann Inst Clin & Expt Traumatol, Austrian Cluster Tissue Regenerat, A-1200 Vienna, Austria; [Peterbauer, Anja] Red Cross Blood Transfus Serv Upper Austria, Austrian Cluster Tissue Regenerat, A-4020 Linz, Austria; [Zhong, Mei] Nanfang Hosp, Ctr Prenatal & Hereditary Dis Diag, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Hong Kong; Ludwig Boltzmann Institute; Southern Medical University - China	Esteban, MA (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	esteban@gibh.org; pei_duanqing@gibh.ac.cn	zhou, xingru/G-4442-2012; li, zhiyuan/HGD-9581-2022; Redl, Heinz/AAD-8157-2019; Su, Huanxing/X-3980-2019; Su, Huanxing/X-3954-2019; Gabriel, Christian/A-1689-2014	Su, Huanxing/0000-0002-0513-4943; Su, Huanxing/0000-0003-3254-825X; Gabriel, Christian/0000-0003-2043-9320; Wolbank, Susanne/0000-0002-1244-5854; So, Kwok-Fai/0000-0003-4039-4246	Chinese Academy of Sciences [KSCX2-YW-R-48, KSCX2-YW-R-244]; National Natural Science Foundation of China [30725012, 230725012, 90813033, 30630039]; Ministry of Science and Technology 973 Program [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902, 2010CB944800]; National High Technology Research and Development Program of China [2006AA02A103, 2007G-P034, 2007Z3-C7031]; Bureau of Science and Technology of Guangzhou Municipality [2006A50104002, 2008A1-E4011]; EFBIC (European Federation of Biotechnology)	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology 973 Program(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Bureau of Science and Technology of Guangzhou Municipality; EFBIC (European Federation of Biotechnology)	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences, Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams, Chinese Academy of Sciences (KSCX2-YW-R-48, KSCX2-YW-R-244), National Natural Science Foundation of China (30725012, 230725012, 90813033, 30630039), Ministry of Science and Technology 973 Program (2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902, 2010CB944800), National High Technology Research and Development Program of China (2006AA02A103, 2007G-P034, 2007Z3-C7031), Bureau of Science and Technology of Guangzhou Municipality (2006A50104002, 2008A1-E4011), and an EFBIC (European Federation of Biotechnology) RED travel grant.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Belmonte JCI, 2009, NAT REV GENET, V10, P878, DOI 10.1038/nrg2700; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Chamberlain SJ, 2008, NEUROGENETICS, V9, P227, DOI 10.1007/s10048-008-0147-z; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hollands P, 2009, STEM CELL REV REP, V5, P195, DOI 10.1007/s12015-009-9082-0; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Miki T, 2006, STEM CELL REV, V2, P133, DOI 10.1007/s12015-006-0020-0; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	49	138	167	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11227	11234		10.1074/jbc.M109.086389	http://dx.doi.org/10.1074/jbc.M109.086389			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139068	Green Published, hybrid			2022-12-25	WOS:000276286200028
J	Du, HN; Briggs, SD				Du, Hai-Ning; Briggs, Scott D.			A Nucleosome Surface Formed by Histone H4, H2A, and H3 Residues Is Needed for Proper Histone H3 Lys(36) Methylation, Histone Acetylation, and Repression of Cryptic Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; DOMAIN-CONTAINING GENE; SACCHAROMYCES-CEREVISIAE; BINDING MODULES; CORE PARTICLE; GENOME-WIDE; CHROMATIN; SET2; ELONGATION; LYSINE-36	Set2-mediated H3 Lys(36) methylation is a histone modification that has been demonstrated to function in transcriptional elongation by recruiting the Rpd3S histone deacetylase complex to repress intragenic cryptic transcription. Recently, we identified a trans-histone pathway in which the interaction between the N terminus of Set2 and histone H4 Lys(44) is needed to mediate trans-histone H3 Lys(36) di- and trimethylation. In the current study, we demonstrate that mutation of the lysine 44 residue in histone H4 or the Set2 mutant lacking the histone H4 interaction motif leads to intragenic cryptic transcripts, indicating that the Set2 and histone H4 interaction is important to repress intragenic cryptic transcription. We also determine that histone H2A residues (Leu(116) and Leu(117)), which are in close proximity to histone H4 Lys(44), are needed for proper trans-histone H3 Lys(36) methylation. Similar to H4 Lys(44) mutants, histone H2A Leu(116) and Leu(117) mutations exhibited decreased H3 Lys(36) di- and trimethylation, increased histone H4 acetylation, increased resistance to 6-azauracil, and cryptic transcription. Interestingly, the combined histone H4 Lys(44) and H2A mutations have more severe methylation defects and increased H4 acetylation levels. Furthermore, we identify that additional histone H2A and H3 core residues are also needed for H3 Lys(36) di- and trimethylation. Overall, our results show and suggest that multiple H4, H2A, and H3 residues contribute to and form a Set2 docking/recognition site on the nucleosomal surface so that proper Set2-mediated H3 Lys(36) di- and trimethylation, histone acetylation, and transcriptional elongation can occur.	[Briggs, Scott D.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Briggs, SD (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ, W Lafayette, IN 47907 USA.	sdbriggs@purdue.edu	du, hai-ning/AAE-5626-2022; Du, Hai-Ning/AAI-2020-2021	Du, Hai-Ning/0000-0001-8062-5411; Briggs, Scott D/0000-0003-2852-3594	National Institutes of Health [GM74183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM74183 (to S. D. B.).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HENSOLD JO, 1988, BLOOD, V71, P1153; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; KERPPOLA TK, 1991, FASEB J, V5, P2833, DOI 10.1096/fasebj.5.13.1916107; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Psathas JN, 2009, MOL CELL BIOL, V29, P6413, DOI 10.1128/MCB.00876-09; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; SWERDLOW PS, 1990, MOL CELL BIOL, V10, P4905, DOI 10.1128/MCB.10.9.4905; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; VAQUERO A, 2003, SCI AGING KNOWLEDGE, V14, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08	44	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11704	11713		10.1074/jbc.M109.085043	http://dx.doi.org/10.1074/jbc.M109.085043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139424	hybrid, Green Published			2022-12-25	WOS:000276286200074
J	Carracedo, S; Lu, N; Popova, SN; Jonsson, R; Eckes, B; Gullberg, D				Carracedo, Sergio; Lu, Ning; Popova, Svetlana N.; Jonsson, Roland; Eckes, Beate; Gullberg, Donald			The Fibroblast Integrin alpha 11 beta 1 Is Induced in a Mechanosensitive Manner Involving Activin A and Regulates Myofibroblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SMOOTH MUSCLE ACTIN; ACTIVATES LATENT TGF-BETA-1; EXTRACELLULAR-MATRIX; PERIODONTAL-LIGAMENT; COLLAGEN LATTICES; GENE-EXPRESSION; STEM-CELLS; RECEPTORS; ALPHA-2-BETA-1	Fibrotic tissue is characterized by an overabundance of myofibroblasts. Thus, understanding the factors that induce myofibroblast differentiation is paramount to preventing fibrotic healing. Previous studies have shown that mechanical stress derived from the integrin-mediated interaction between extracellular matrix and the cytoskeleton promotes myofibroblast differentiation. Integrin alpha 11 beta 1 is a collagen receptor on fibroblasts. To determine whether alpha 11 beta 1 can act as a mechanosensor to promote the myofibroblast phenotype, mouse embryonic fibroblasts and human corneal fibroblasts were utilized. We found that alpha 11 mRNA and protein levels were up-regulated in mouse embryonic fibroblasts grown in attached three-dimensional collagen gels and conversely down-regulated in cells grown in floating gels. alpha 11 up-regulation could be prevented by manually detaching the collagen gels or by cytochalasin-D-treatment. Furthermore, SB-431542, an inhibitor of signaling via ALK4, ALK5, and ALK7, prevented the up-regulation of alpha 11 and the concomitant phosphorylation of Smad3 under attached conditions. In attached gels, TGF-beta 1 was secreted in its inactive form but surprisingly not further activated, thus not influencing alpha 11 regulation. However, inhibition of activin A attenuated the up-regulation of alpha 11. To determine the role of alpha 11 in myofibroblast differentiation, human corneal fibroblasts were transfected with small interfering RNA to alpha 11, which decreased alpha-smooth muscle actin expression and myofibroblast differentiation. Our data suggest that alpha 11 beta 1 is regulated by cell/matrix stress involving activin A and Smad3 and that alpha 11 beta 1 regulates myofibroblast differentiation.	[Carracedo, Sergio; Lu, Ning; Popova, Svetlana N.; Gullberg, Donald] Univ Bergen, Gade Inst, Dept Biomed, N-5009 Bergen, Norway; [Jonsson, Roland] Univ Bergen, Gade Inst, Broegelmann Res Lab, N-5009 Bergen, Norway; [Eckes, Beate] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany	University of Bergen; University of Bergen; University of Cologne	Gullberg, D (corresponding author), Jonas Lies Vei 91, N-5009 Bergen, Norway.	donald.gullberg@biomed.uib.no	Gullberg, Donald/H-2495-2016	Gullberg, Donald/0000-0002-7245-4437	European Union [MEST-CT-2004-514483]; Strategic Research Program at Helse Bergen; German-Norwegian Deutsche Akademische Austauschdienst; Projektbezogenen Personenaustausch grant from the Research Council of Norway; Helse Vest, Kreftforeningen [PR 2007-0103]; Research Council of Norway [172330 V40]	European Union(European Commission); Strategic Research Program at Helse Bergen; German-Norwegian Deutsche Akademische Austauschdienst; Projektbezogenen Personenaustausch grant from the Research Council of Norway; Helse Vest, Kreftforeningen; Research Council of Norway(Research Council of Norway)	This work was supported by European Union Marie Curie Early Stage Training Contract MEST-CT-2004-514483 (to S. C.), the Strategic Research Program at Helse Bergen (to R. J.), a bilateral German-Norwegian Deutsche Akademische Austauschdienst, Program des Projektbezogenen Personenaustausch grant from the Research Council of Norway (to D. G.), Helse Vest, Kreftforeningen Grant PR 2007-0103 (to D. G.), and Research Council of Norway Grant 172330 V40 (to D. G.). org)	Abair TD, 2008, EXP CELL RES, V314, P3593, DOI 10.1016/j.yexcr.2008.08.014; ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Bystrom B, 2009, INVEST OPHTH VIS SCI, V50, P5044, DOI 10.1167/iovs.08-3261; Chipev Constantin C, 2002, BMC Dermatol, V2, P13, DOI 10.1186/1471-5945-2-13; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; CHIQUETEHRISMANN R, 1994, J CELL BIOL, V127, P2093, DOI 10.1083/jcb.127.6.2093; Cooke ME, 2000, J CELL SCI, V113, P2375; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; DELVOYE P, 1991, J INVEST DERMATOL, V97, P898, DOI 10.1111/1523-1747.ep12491651; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; deWinter JP, 1996, MOL CELL ENDOCRINOL, V116, P105, DOI 10.1016/0303-7207(95)03705-5; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; FEIJEN A, 1994, DEVELOPMENT, V120, P3621; Fluck M, 2003, BBA-MOL CELL RES, V1593, P239, DOI 10.1016/S0167-4889(02)00394-4; Fumagalli M, 2007, EXP DERMATOL, V16, P600, DOI 10.1111/j.1600-0625.2007.00571.x; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Gullberg D, 2009, MATRIX BIOL, V28, P383, DOI 10.1016/j.matbio.2009.09.008; HEINO J, 1989, J BIOL CHEM, V264, P380; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; LEHNERT SA, 1988, DEVELOPMENT, V104, P263; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu N, 2006, MATRIX BIOL, V25, P118, DOI 10.1016/j.matbio.2005.10.002; LU N, 2009, MATRIX BIOL IN PRESS; Lygoe KA, 2004, WOUND REPAIR REGEN, V12, P461, DOI 10.1111/j.1067-1927.2004.12402.x; Maier S, 2008, BBA-MOL CELL RES, V1783, P1150, DOI 10.1016/j.bbamcr.2008.01.013; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Ohga E, 1996, BIOCHEM BIOPH RES CO, V228, P391, DOI 10.1006/bbrc.1996.1672; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; Papetti M, 2003, INVEST OPHTH VIS SCI, V44, P4994, DOI 10.1167/iovs.03-0291; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patwari P, 2008, CIRC RES, V103, P234, DOI 10.1161/CIRCRESAHA.108.175331; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Pozzi M, 1998, J CELL BIOL, V142, P587; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Rodriguez A, 2009, J CELL MOL MED, V13, P3449, DOI 10.1111/j.1582-4934.2008.00638.x; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Shimizu A, 1998, GENES CELLS, V3, P125, DOI 10.1046/j.1365-2443.1998.00174.x; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Svendsen OS, 2009, ARTERIOSCL THROM VAS, V29, P1864, DOI 10.1161/ATVBAHA.109.194308; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Varas L, 2007, STEM CELLS DEV, V16, P965, DOI 10.1089/scd.2007.0049; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wipff PJ, 2009, J BODYW MOV THER, V13, P121, DOI 10.1016/j.jbmt.2008.04.031; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; You LT, 2002, INVEST OPHTH VIS SCI, V43, P72; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	83	94	97	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10434	10445		10.1074/jbc.M109.078766	http://dx.doi.org/10.1074/jbc.M109.078766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20129924	Green Published, hybrid			2022-12-25	WOS:000276264600029
J	del Valle-Perez, B; Martinez, VG; Lacasa-Salavert, C; Figueras, A; Shapiro, SS; Takafuta, T; Casanovas, O; Capella, G; Ventura, F; Vinals, F				del Valle-Perez, Beatriz; Gabriela Martinez, Vanesa; Lacasa-Salavert, Cristina; Figueras, Agnes; Shapiro, Sandor S.; Takafuta, Toshiro; Casanovas, Oriol; Capella, Gabriel; Ventura, Francesc; Vinals, Francesc			Filamin B Plays a Key Role in Vascular Endothelial Growth Factor-induced Endothelial Cell Motility through Its Interaction with Rac-1 and Vav-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MOLECULAR SCAFFOLD; ACTIN-FILAMENTS; MIGRATION; ACTIVATION; ANGIOGENESIS; MICE; PROTEIN; MALFORMATIONS; PERMEABILITY	Actin-binding proteins filamin A (FLNA) and B (FLNB) are expressed in endothelial cells and play an essential role during vascular development. In order to investigate their role in adult endothelial cell function, we initially confirmed their expression pattern in different adult mouse tissues and cultured cell lines and found that FLNB expression is concentrated mainly in endothelial cells, whereas FLNA is more ubiquitously expressed. Functionally, small interfering RNA knockdown of endogenous FLNB in human umbilical vein endothelial cells inhibited vascular endothelial growth factor (VEGF)-induced in vitro angiogenesis by decreasing endothelial cell migration capacity, whereas FLNA ablation did not alter these parameters. Moreover, FLNB-depleted cells increased their substrate adhesion with more focal adhesions. The molecular mechanism underlying this effect implicates modulation of small GTP-binding protein Rac-1 localization and activity, with altered activation of its downstream effectors p21 protein Cdc42/Rac-activated kinase (PAK)-4/5/6 and its activating guanine nucleotide exchange factor Vav-2. Moreover, our results suggest the existence of a signaling complex, including FLNB, Rac-1, and Vav-2, under basal conditions that would further interact with VEGFR2 and integrin alpha v beta 5 after VEGF stimulation. In conclusion, our results reveal a crucial role for FLNB in endothelial cell migration and in the angiogenic process in adult endothelial cells.	[del Valle-Perez, Beatriz; Gabriela Martinez, Vanesa; Lacasa-Salavert, Cristina; Figueras, Agnes; Casanovas, Oriol; Capella, Gabriel; Vinals, Francesc] Inst Catala Oncol IDIBELL, Lab Recerca Translac, E-08907 Barcelona, Spain; [del Valle-Perez, Beatriz; Lacasa-Salavert, Cristina; Ventura, Francesc; Vinals, Francesc] Univ Barcelona IDIBELL, Dept Ciencies Fisiol 2, Unitat Bioquim & Biol Mol, E-08907 Barcelona, Spain; [Shapiro, Sandor S.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA; [Takafuta, Toshiro] Nishi Kobe Med Ctr, Kobe, Hyogo 6512273, Japan	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Jefferson University; Kobe City Medical Center General Hospital	Vinals, F (corresponding author), Inst Catala Oncol IDIBELL, Lab Recerca Translac, Gran Via S-N KM 2,7, E-08907 Barcelona, Spain.	fvinyals@ico.scs.es	Ventura, Francesc/K-9700-2014; Viñals, Francesc/F-5928-2016; Vinals, Francesc/P-6278-2019; Capella, Gabriel/I-1879-2015; Ventura, Francesc/ABG-2285-2020; Casanovas, Oriol/L-5210-2014	Ventura, Francesc/0000-0001-9673-9405; Viñals, Francesc/0000-0002-9918-6751; Capella, Gabriel/0000-0002-4669-7320; Ventura, Francesc/0000-0001-9673-9405; Casanovas, Oriol/0000-0002-4298-3995	National Institutes of Health [HL-072439]; Ministerio de Ciencia y Tecnologia [SAF2004-01350, SAF2007-60955, RTICC RD2006-0092, BFU2008-02010]; Generalitat de Catalunya [2005SGR727, 2009SGR283]; National Hemophilia Foundation, Delaware Valley Chapter; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); National Hemophilia Foundation, Delaware Valley Chapter; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-072439 (to S. S. S. and T. T.). This work was also supported by Ministerio de Ciencia y Tecnologia Grants SAF2004-01350, SAF2007-60955, and RTICC RD2006-0092 (to F. Vinals) and BFU2008-02010 to (F. Ventura), Generalitat de Catalunya Grants 2005SGR727 and 2009SGR283 (to F. Vinals), and a grant from the National Hemophilia Foundation, Delaware Valley Chapter (to S. S. S.).	Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Farrington-Rock C, 2008, HUM MOL GENET, V17, P631, DOI 10.1093/hmg/ddm188; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gong Chunhong, 2004, Angiogenesis, V7, P313, DOI 10.1007/s10456-004-7960-2; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jeon YJ, 2008, MOL BIOL CELL, V19, P5116, DOI 10.1091/mbc.E08-06-0576; Kanters E, 2008, J BIOL CHEM, V283, P31830, DOI 10.1074/jbc.M804888200; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; LAEMMLI UK, 1970, NATURE, V227, P685; Lee JSY, 2003, HISTOL HISTOPATHOL, V18, P879, DOI 10.14670/HH-18.879; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; McKenzie FR, 1996, J BIOL CHEM, V271, P13476, DOI 10.1074/jbc.271.23.13476; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wang Q, 1997, J CELL PHYSIOL, V172, P171, DOI 10.1002/(SICI)1097-4652(199708)172:2<171::AID-JCP4>3.0.CO;2-L; Zhang WJ, 1998, J NEUROSCI, V18, P914; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	46	58	58	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10748	10760		10.1074/jbc.M109.062984	http://dx.doi.org/10.1074/jbc.M109.062984			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110358	hybrid, Green Published			2022-12-25	WOS:000276264600061
J	Harper, SL; Li, DH; Maksimova, Y; Gallagher, PG; Speicher, DW				Harper, Sandra L.; Li, Donghai; Maksimova, Yelena; Gallagher, Patrick G.; Speicher, David W.			A Fused alpha-beta "Mini-spectrin" Mimics the Intact Erythrocyte Spectrin Head-to-head Tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL SPECTRIN; DIMER SELF-ASSOCIATION; INITIATION SITE; CROSS-LINKING; MEMBRANE; ULTRACENTRIFUGATION; CYTOSKELETON; EQUILIBRIUM; PEPTIDES; SEGMENTS	Head-to-head assembly of two spectrin heterodimers to form an actin-cross-linking tetramer is a physiologically dynamic interaction that contributes to red cell membrane integrity. Recombinant beta-spectrin C-terminal and alpha-spectrin N-terminal peptides can form tetramer-like univalent complexes, but they cannot evaluate effects of the open-closed dimer interactions or lateral associations of the two-spectrin strands on tetramer formation. In this study we produced and characterized a fused "mini-spectrin dimer" containing the beta-spectrin C-terminal region linked to the alpha-spectrin N-terminal region. This fused mini-spectrin mimics structural and functional properties of intact, full-length dimers and tetramers, including lateral association of the alpha and beta subunits in the dimer and formation of a closed dimer. High performance liquid chromatography gel filtration analyses of this mini-spectrin provide the first direct non-imaging experimental evidence for open and closed spectrin dimers and show that dimer-tetramer-oligomer interconversion is slow at low temperatures and accelerated at 30 degrees C, analogous to full-length spectrin. This protein exhibits wild type dimer-tetramer dissociation constants of similar to 1 mu M at 30 degrees C, independent of initial oligomeric state. Conformational states of the mini-spectrin dimer were probed further using chemical crosslinking, which identified distinct groups of cross-links for "open" and "closed" dimers and confirmed the N-terminal region of alpha-spectrin remains highly flexible in the complex, exhibiting closely analogous structures to those observed for the isolated alpha-spectrin N-terminal using NMR (Park, S., Caffrey, M. S., Johnson, M. E., and Fung, L. W. (2003) J. Biol. Chem. 278, 21837-21844). This fusion protein should serve as a useful template for structural and functional studies of the divalent tetramer site.	[Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Li, Donghai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Maksimova, Yelena; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA	The Wistar Institute; Nanjing University; Yale University	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.org			National Institutes of Health [HL38794, HL65448]; Wistar Institute [CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448, R01HL038794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL38794 ( to D. W. S.) and HL65448 ( to P. G. G.). This work was also supported by institutional grant to the Wistar Institute Grant CA10815.	An XL, 2002, J BIOL CHEM, V277, P31796, DOI 10.1074/jbc.M204567200; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; DESILVA TM, 1992, BIOCHEMISTRY-US, V31, P10872, DOI 10.1021/bi00159a030; El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; HARPER S, 1998, CURRENT PROTOCOLS PR; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Lecomte MC, 1999, EUR BIOPHYS J BIOPHY, V28, P208, DOI 10.1007/s002490050201; Li DH, 2008, J BIOL CHEM, V283, P1553, DOI 10.1074/jbc.M706981200; Li DH, 2007, BIOCHEMISTRY-US, V46, P10585, DOI 10.1021/bi7007905; Long F, 2007, PROTEIN SCI, V16, P2519, DOI 10.1110/ps.073115307; LUCKOW EA, 1989, BIOCHEMISTRY-US, V28, P2348, DOI 10.1021/bi00431a055; Mehboob S, 2001, BIOCHEMISTRY-US, V40, P12457, DOI 10.1021/bi010984k; MORRIS M, 1989, BIOCHEMISTRY-US, V28, P8561, DOI 10.1021/bi00447a044; MORROW JS, 1981, J CELL BIOL, V88, P463, DOI 10.1083/jcb.88.2.463; OHANIAN V, 1984, BIOCHEMISTRY-US, V23, P4416, DOI 10.1021/bi00314a027; Park S, 2003, J BIOL CHEM, V278, P21837, DOI 10.1074/jbc.M300617200; RALSTON GB, 1978, J SUPRAMOL STR CELL, V8, P361, DOI 10.1002/jss.400080313; Sambrook J., 2001, MOL CLONING LAB MANU; SHAHBAKHTI F, 1986, BIOCHEMISTRY-US, V25, P5969, DOI 10.1021/bi00368a020; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; SPEICHER DW, 1993, J BIOL CHEM, V268, P4227; Speicher K D, 2000, J Biomol Tech, V11, P74; TSE WT, 1990, J CLIN INVEST, V86, P909, DOI 10.1172/JCI114792; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; Ursitti JA, 1996, J BIOL CHEM, V271, P6636, DOI 10.1074/jbc.271.12.6636; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003	32	13	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					11003	11012		10.1074/jbc.M109.083048	http://dx.doi.org/10.1074/jbc.M109.083048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139081	hybrid, Green Published			2022-12-25	WOS:000276264600084
J	Pewzner-Jung, Y; Park, H; Laviad, EL; Silva, LC; Lahiri, S; Stiban, J; Erez-Roman, R; Brugger, B; Sachsenheimer, T; Wieland, F; Prieto, M; Merrill, AH; Futerman, AH				Pewzner-Jung, Yael; Park, Hyejung; Laviad, Elad L.; Silva, Liana C.; Lahiri, Sujoy; Stiban, Johnny; Erez-Roman, Racheli; Bruegger, Britta; Sachsenheimer, Timo; Wieland, Felix; Prieto, Manuel; Merrill, Alfred H., Jr.; Futerman, Anthony H.			A Critical Role for Ceramide Synthase 2 in Liver Homeostasis I. ALTERATIONS IN LIPID METABOLIC PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; RAT-LIVER; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; SPHINGOID BASE; FAMILY-MEMBERS; SPHINGOLIPIDS; SPHINGANINE; GLUCOSYLCERAMIDE	Ceramide is an important lipid signaling molecule that plays critical roles in regulating cell behavior. Ceramide synthesis is surprisingly complex and is orchestrated by six mammalian ceramide synthases, each of which produces ceramides with restricted acyl chain lengths. We have generated a CerS2 null mouse and characterized the changes in the long chain base and sphingolipid composition of livers from these mice. Ceramide and downstream sphingolipids were devoid of very long (C22-C24) acyl chains, consistent with the substrate specificity of CerS2 toward acyl-CoAs. Unexpectedly, C16-ceramide levels were elevated, and as a result, total ceramide levels were unaltered; however, C16-ceramide synthesis in vitro was not increased. Levels of sphinganine were also significantly elevated, by up to 50-fold, reminiscent of the effect of the ceramide synthase inhibitor, fumonisin B1. With the exceptions of glucosylceramide synthase and neutral sphingomyelinase 2, none of the other enzymes tested in either the sphingolipid biosynthetic or degradative pathways were significantly changed. Total glycerophospholipid and cholesterol levels were unaltered, although there was a marked elevation in C18:1 and C18:2 fatty acids in phosphatidylethanolamine, concomitant with a reduction in C18:0 and C20:4 fatty acids. Finally, differences were observed in the biophysical properties of lipid extracts isolated from liver microsomes, with membranes from CerS2 null mice displaying higher membrane fluidity and showing morphological changes. Together, these results demonstrate novel modes of cross-talk and regulation between the various branches of lipid metabolic pathways upon inhibition of very long acyl chain ceramide synthesis.	[Pewzner-Jung, Yael; Laviad, Elad L.; Silva, Liana C.; Lahiri, Sujoy; Stiban, Johnny; Erez-Roman, Racheli; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Silva, Liana C.; Prieto, Manuel] Ctr Quim Fis Mol, Inst Super Tecn, P-1049001 Lisbon, Portugal; [Bruegger, Britta; Sachsenheimer, Timo; Wieland, Felix] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Universidade de Lisboa; Instituto Superior Tecnico; Ruprecht Karls University Heidelberg	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	Prieto, Manuel/N-4448-2013; Silva, Liana C./A-3025-2011; Stiban, Johnny/AAB-3468-2019; Pewzner, Faivish/I-6225-2017; Stiban, Johnny/AAC-1515-2019; iMed.ULisboa, InTraCellADD/B-4826-2014	Prieto, Manuel/0000-0003-3012-6598; Silva, Liana C./0000-0003-1311-0770; Pewzner, Faivish/0000-0002-7490-8121; Stiban, Johnny/0000-0002-3748-9976; Futerman, Anthony/0000-0003-0013-0115; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by Israel Science Foundation Grant 1404/07 and by The Minerva Foundation.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bjorkqvist YJE, 2009, BBA-BIOMEMBRANES, V1788, P1310, DOI 10.1016/j.bbamem.2009.02.019; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; COURCHAINE AJ, 1959, CLIN CHEM, V5, P609; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DEANA AD, 1990, BIOCHIM BIOPHYS ACTA, V1051, P199, DOI 10.1016/0167-4889(90)90194-I; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; FRIEDRICH G, 1993, METHOD ENZYMOL, V225, P681; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Kim DH, 2006, J TOXICOL ENV HEAL A, V69, P2071, DOI 10.1080/15287390600746215; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; MEIVARLEVY I, 1994, BIOCHEM J, V303, P377, DOI 10.1042/bj3030377; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2007, TRENDS BIOCHEM SCI, V32, P457, DOI 10.1016/j.tibs.2007.09.004; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pinto SN, 2008, BIOPHYS J, V95, P2867, DOI 10.1529/biophysj.108.129858; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Riley RT, 2006, TOXICOL SCI, V92, P335, DOI 10.1093/toxsci/kfj198; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Silva LC, 2009, BIOPHYS J, V96, P3210, DOI 10.1016/j.bpj.2008.12.3923; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; SULLARDS MC, 2001, SCI STKE, V86, pPL1; Tani M, 1999, J BIOCHEM-TOKYO, V125, P746; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; WANG E, 1991, J BIOL CHEM, V266, P14486; Yang J, 2003, ENVIRON POLLUT, V121, P345, DOI 10.1016/S0269-7491(02)00239-7	48	170	179	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10902	10910		10.1074/jbc.M109.077594	http://dx.doi.org/10.1074/jbc.M109.077594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110363	hybrid, Green Published			2022-12-25	WOS:000276264600075
J	Yang, YW; Petkova, A; Huang, K; Xu, B; Hua, QX; Ye, IJ; Chu, YC; Hu, SQ; Phillips, NB; Whittaker, J; Ismail-Beigi, F; Mackin, RB; Katsoyannis, PG; Tycko, R; Weiss, MA				Yang, Yanwu; Petkova, Aneta; Huang, Kun; Xu, Bin; Hua, Qing-xin; Ye, I-Ju; Chu, Ying-Chi; Hu, Shi-Quan; Phillips, Nelson B.; Whittaker, Jonathan; Ismail-Beigi, Faramarz; Mackin, Robert B.; Katsoyannis, Panayotis G.; Tycko, Robert; Weiss, Michael A.			An Achilles' Heel in an Amyloidogenic Protein and Its Repair INSULIN FIBRILLATION AND THERAPEUTIC DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTO-CROSS-LINKING; CHEMICAL-SHIFT INDEX; SOLID-STATE NMR; SECONDARY-STRUCTURE; AMINO-ACIDS; A-CHAIN; CRYSTAL-STRUCTURE; RECEPTOR-BINDING; ROTATING SOLIDS; LISPRO INSULIN	Insulin fibrillation provides a model for a broad class of amyloidogenic diseases. Conformational distortion of the native monomer leads to aggregation-coupled misfolding. Whereas beta-cells are protected from proteotoxicity by hexamer assembly, fibrillation limits the storage and use of insulin at elevated temperatures. Here, we have investigated conformational distortions of an engineered insulin monomer in relation to the structure of an insulin fibril. Anomalous (13)C NMR chemical shifts and rapid (15)N-detected (1)H-(2)H amide-proton exchange were observed in one of the three classical alpha-helices (residues A1-A8) of the hormone, suggesting a conformational equilibrium between locally folded and unfolded A-chain segments. Whereas hexamer assembly resolves these anomalies in accordance with its protective role, solid-state (13)C NMR studies suggest that the A-chain segment participates in a fibril-specific beta-sheet. Accordingly, we investigated whether helicogenic substitutions in the A1-A8 segment might delay fibrillation. Simultaneous substitution of three beta-branched residues (Ile(A2) -> Leu, Val(A3) -> Leu, and Thr(A8) -> His) yielded an analog with reduced thermodynamic stability but marked resistance to fibrillation. Whereas amide-proton exchange in the A1-A8 segment remained rapid, (13)C alpha chemical shifts exhibited a more helical pattern. This analog is essentially without activity, however, as Ile(A2) and Val(A3) define conserved receptor contacts. To obtain active analogs, substitutions were restricted to A8. These analogs exhibit high receptor-binding affinity; representative potency in a rodent model of diabetes mellitus was similar to wild-type insulin. Although (13)C alpha chemical shifts remain anomalous, significant protection from fibrillation is retained. Together, our studies define an "Achilles' heel" in a globular protein whose repair may enhance the stability of pharmaceutical formulations and broaden their therapeutic deployment in the developing world.	[Yang, Yanwu; Huang, Kun; Xu, Bin; Hua, Qing-xin; Ye, I-Ju; Hu, Shi-Quan; Phillips, Nelson B.; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Petkova, Aneta; Tycko, Robert] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Chu, Ying-Chi; Katsoyannis, Panayotis G.] NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA; [Mackin, Robert B.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Icahn School of Medicine at Mount Sinai; New York University; Creighton University	Yang, YW (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	yanwu.yang@case.edu; Michael.Weiss@case.edu	Huang, Kun/H-4427-2012	Xu, Bin/0000-0002-0490-9540	National Institutes of Health [DK52085, DK079233, DK04949, DK054662]; American Heart Association [0530067N]; American Diabetes Association; NIDDK, National Institutes of Health; Independent University of Bangladesh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Independent University of Bangladesh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52085 (to R. B. M.) and DK079233, DK04949, and DK054662 (to M. A. W.). This work was also supported by Grant 0530067N from the American Heart Association (to Y. Y.) and a grant from the American Diabetes Association (to N. B. P.). This paper is a contribution from the Cleveland Center for Membrane and Structural Biology. M. A. W. has equity in and consults to Thermalin Diabetes, Inc. (Cleveland, OH).; Solid-state NMR measurements were supported by the Intramural Research Program of the NIDDK, National Institutes of Health. We thank Drs. P. Carey, G. M. Clore, G. G. Dodson, R. Levy, D. F. Steiner, and B. Sykes for discussion; and we thank M. Choquette for technical assistance in generating the labeled DKP-proinsulin. M. A. W. thanks Drs. D. Jacobson (Case Western Reserve University Mandel School of Applied Social Sciences), M. R. Miah (Director, Southern Illinois University Carbondale School of Social Work), M. O. Rahman (Provost, Independent University of Bangladesh), and B. M. Chowdhury (Vice Chancellor, Independent University of Bangladesh) for sponsorship of a student-faculty trip to study poverty, micro-finance, and medical needs in the developing world.	Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; BADGER J, 1991, ACTA CRYSTALLOGR B, V47, P127, DOI 10.1107/S0108768190009570; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bennett AE, 1998, J CHEM PHYS, V108, P9463, DOI 10.1063/1.476420; BENTLEY G, 1978, J MOL BIOL, V126, P871, DOI 10.1016/0022-2836(78)90026-8; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Bode BW, 2002, DIABETES-METAB RES, V18, pS14, DOI 10.1002/dmrr.205; Bode BW, 2001, DIABETES CARE, V24, P69, DOI 10.2337/diacare.24.1.69; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, Pharm Biotechnol, V10, P343; BRANGE J, 1987, GALENICS INSULIN, P52; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11332, DOI 10.1073/pnas.90.23.11332; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demirdjian S, 1998, DIABETES CARE, V21, P867, DOI 10.2337/diacare.21.5.867; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Dong J, 2003, J MOL BIOL, V330, P431, DOI 10.1016/S0022-2836(03)00536-9; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Holleman F, 1997, NEW ENGL J MED, V337, P176, DOI 10.1056/NEJM199707173370307; Hong DP, 2005, BIOCHEMISTRY-US, V44, P16701, DOI 10.1021/bi051658y; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Ishii Y, 2001, J CHEM PHYS, V114, P8473, DOI 10.1063/1.1359445; Jacoby E, 1996, PROTEIN ENG, V9, P113, DOI 10.1093/protein/9.2.113; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Mackin RB, 2003, PROTEIN EXPRES PURIF, V27, P210, DOI 10.1016/S1046-5928(02)00643-5; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Mudaliar SR, 1999, DIABETES CARE, V22, P1501, DOI 10.2337/diacare.22.9.1501; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Nourse A, 1996, BIOL CHEM H-S, V377, P147; O'Donoghue SI, 2000, J BIOMOL NMR, V16, P93, DOI 10.1023/A:1008323819099; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; Radermecker RP, 2004, DIABETES-METAB RES, V20, P178, DOI 10.1002/dmrr.447; Renner R, 1999, DIABETES CARE, V22, P784, DOI 10.2337/diacare.22.5.784; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; WAUGH DAVID F., 1957, J CELL AND COMP PHYSIOL, V49, P145, DOI 10.1002/jcp.1030490415; Weiss MA, 2002, J MOL BIOL, V315, P103, DOI 10.1006/jmbi.2001.5224; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WOLLMER A, 1987, BIOL CHEM H-S, V368, P903, DOI 10.1515/bchm3.1987.368.2.903; Wolpert HA, 2002, BRIT MED J, V324, P1253, DOI 10.1136/bmj.324.7348.1253; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; YU NT, 1974, ARCH BIOCHEM BIOPHYS, V160, P614, DOI 10.1016/0003-9861(74)90438-X; Yunus, 1998, BANKER POOR MICROLEN; [No title captured]	88	37	43	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10806	10821		10.1074/jbc.M109.067850	http://dx.doi.org/10.1074/jbc.M109.067850			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20106984	hybrid, Green Published			2022-12-25	WOS:000276264600066
J	Garamszegi, N; Garamszegi, SP; Samavarchi-Tehrani, P; Walford, E; Schneiderbauer, MM; Wrana, JL; Scully, SP				Garamszegi, N.; Garamszegi, S. P.; Samavarchi-Tehrani, P.; Walford, E.; Schneiderbauer, M. M.; Wrana, J. L.; Scully, S. P.			Extracellular matrix-induced transforming growth factor-beta receptor signaling dynamics	ONCOGENE			English	Article						attachment-independent signaling; extracellular matrix; gene expressional plasticity; Smads; TGF-beta and integrin receptors	TGF-BETA; ARTICULAR CHONDROCYTES; II COLLAGEN; CELLS; TGF-BETA-1; ADHESION; SUPERFAMILY; SPECIFICITY; ACTIVATION; TRANSDUCTION	Matrix remodeling, degradation, inflammation and invasion liberate peptide fragments that can subsequently interact with cells in an attachment-independent manner. Such 'soluble' matrix components, including collagens, fibronectin and laminin, induced Smad activation (termed crosstalk signaling), which follows a similar chronological sequence and R-Smad specificity as induced by transforming growth factor (TGF)-beta 1. Smad4 nuclear translocation occurred in response to collagen binding, indicating downstream signal propagation. TGF-beta scavenging antibody affected only TGF-beta 1, but not crosstalk-induced responses. TGF-beta type II receptor mutation (DR26 Delta 25), which is deficient in TGF-beta type I receptor recruitment to the ligand, induced a heterotetramer signaling complex, and propagated Smad2 activation only through collagen induction and not TGF-beta signaling. Consequentially, TGF-beta ligand participation is not required for crosstalk signaling. This signaling requires a functional integrin beta 1 receptor as showed by RNA interference. Co-immunoprecipitation (co-IP) and fluorescent microscopy indicate the involvement of focal adhesion kinase (FAK) and Src activity in collagen-induced signal propagation, and suggest a membrane signaling complex formation that includes both TGF-beta receptors and integrins. The related gene expressional responses are distinct from that evoked by TGF-beta 1, supporting its separate function. This signaling mechanism expands and partially explains TGF-beta receptor dynamics and consequential signaling diversity-related gene expressional plasticity. Oncogene (2010) 29, 2368-2380; doi:10.1038/onc.2009.514; published online 25 January 2010	[Garamszegi, N.; Schneiderbauer, M. M.; Scully, S. P.] Univ Miami, Dept Orthopaed, Leonard M Miller Sch Med, Miami, FL 33136 USA; [Garamszegi, N.; Garamszegi, S. P.; Walford, E.; Scully, S. P.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Samavarchi-Tehrani, P.; Wrana, J. L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Miami; University of Miami; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Garamszegi, N (corresponding author), Univ Miami, Dept Orthopaed, Leonard M Miller Sch Med, Room 218,Papanicolau Bldg,Med Campus Locator M877, Miami, FL 33136 USA.	ngaramszegi@med.miami.edu	Wrana, Jeffrey/F-8857-2013		National Institutes of Health [CA-66088Y]; American Cancer Society [ACS 66105H]; Woman's Cancer Association [WCA 66461Y]; University of Miami Orthopaedics Department; Sylvester Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [S15CA066088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Woman's Cancer Association; University of Miami Orthopaedics Department; Sylvester Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Edward B Leof for the pSmad3-specific antibody, as well as for CCL 64 and R1B cells, Joan Massague for DR26 cells, Mary Goldring for C28 cells and Joel A Block for JJ012 cells. This work was supported by Grants CA-66088Y to SPS from National Institutes of Health, ACS 66105H to NG from the American Cancer Society and by the Woman's Cancer Association Madelon Ravlin Memorial Award WCA 66461Y to NG and SPS. Further support was provided by the University of Miami Orthopaedics Department, and the Sylvester Comprehensive Cancer Center.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BOYD FT, 1989, J BIOL CHEM, V264, P2272; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dumont N, 2002, DIFFERENTIATION, V70, P574, DOI 10.1046/j.1432-0436.2002.700910.x; Evans JG, 2006, EUR J CELL BIOL, V85, P145, DOI 10.1016/j.ejcb.2005.08.006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Franz CM, 2005, J CELL SCI, V118, P5315, DOI 10.1242/jcs.02653; GALERA P, 1992, EXP CELL RES, V200, P379, DOI 10.1016/0014-4827(92)90186-C; Garamszegi N, 2001, MOL BIOL CELL, V12, P2881, DOI 10.1091/mbc.12.9.2881; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; HILL D J, 1992, Progress in Growth Factor Research, V4, P45, DOI 10.1016/0955-2235(92)90004-2; Hoodless PA, 1998, CURR TOP MICROBIOL, V228, P235; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Jones J, 1996, ONCOGENE, V12, P119; Kracklauer Martin P, 2003, Mol Cancer, V2, P28, DOI 10.1186/1476-4598-2-28; LAIHO M, 1990, J BIOL CHEM, V265, P18518; LAIHO M, 1991, J BIOL CHEM, V266, P9108; LAIHO M, 1992, Critical Reviews in Oncogenesis, V3, P1; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Madan R, 2006, HUM PATHOL, V37, P9, DOI 10.1016/j.humpath.2005.09.024; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; PARSONS JT, 1994, J CELL SCI, P109; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Qi WN, 2003, J ORTHOPAED RES, V21, P282, DOI 10.1016/S0736-0266(02)00136-5; Qi WN, 1998, EXP CELL RES, V241, P142, DOI 10.1006/excr.1998.4032; Qi WN, 1997, J ORTHOPAED RES, V15, P483, DOI 10.1002/jor.1100150402; Qi WN, 2000, J ORTHOPAED RES, V18, P928, DOI 10.1002/jor.1100180612; Rechtman MM, 2009, J BIOL CHEM, V284, P7843, DOI 10.1074/jbc.M809215200; ROSIER RN, 1989, CONNECT TISSUE RES, V20, P295, DOI 10.3109/03008208909023900; Schneiderbauer MM, 2004, CELL SIGNAL, V16, P1133, DOI 10.1016/j.cellsig.2004.03.004; SEGARINI PR, 1990, ANN NY ACAD SCI, V593, P73, DOI 10.1111/j.1749-6632.1990.tb16101.x; Sheppard D, 2004, CURR OPIN CELL BIOL, V16, P552, DOI 10.1016/j.ceb.2004.06.017; SUZUKI F, 1992, ADV EXP MED BIOL, V324, P101; THORP BH, 1992, DEVELOPMENT, V114, P907; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	54	57	60	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2010	29	16					2368	2380		10.1038/onc.2009.514	http://dx.doi.org/10.1038/onc.2009.514			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	586YK	20101206				2022-12-25	WOS:000276951500006
J	Wang, J; Kim, J; Roh, M; Franco, OE; Hayward, SW; Wills, ML; Abdulkadir, SA				Wang, J.; Kim, J.; Roh, M.; Franco, O. E.; Hayward, S. W.; Wills, M. L.; Abdulkadir, S. A.			Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma	ONCOGENE			English	Article						Pim1; c-MYC; prostate cancer; mouse model; neuroendocrine	INDUCED NEUROENDOCRINE DIFFERENTIATION; UROGENITAL SINUS MESENCHYME; TRANSGENIC MOUSE MODEL; CANCER CELLS; INTRAEPITHELIAL NEOPLASIA; ONCOGENIC TRANSFORMATION; SIGNALING PATHWAY; MURINE PROSTATE; TUMOR-CELLS; PROTEIN	The oncogenic PIM1 kinase has been implicated as a cofactor for c-MYC in prostate carcinogenesis. In this study, we show that in human prostate tumors, coexpression of c-MYC and PIM1 is associated with higher Gleason grades. Using a tissue recombination model coupled with lentiviral-mediated gene transfer we find that Pim1 is weakly oncogenic in naive adult mouse prostatic epithelium. However, it cooperates dramatically with c-MYC to induce prostate cancer within 6-weeks. Importantly, c-MYC/Pim1 synergy is critically dependent on Pim1 kinase activity. c-MYC/Pim1 tumors showed increased levels of the active serine-62 (S62) phosphorylated form of c-MYC. Grafts expressing a phosphomimetic c-MYCS62D mutant had higher rates of proliferation than grafts expressing wild type c-MYC but did not form tumors like c-MYC/Pim1 grafts, indicating that Pim1 cooperativity with c-MYC in vivo involves additional mechanisms other than enhancement of c-MYC activity by S62 phosphorylation. c-MYC/Pim1-induced prostate carcinomas show evidence of neuroendocrine (NE) differentiation. Additional studies, including the identification of tumor cells coexpressing androgen receptor and NE cell markers synaptophysin and Ascl1 suggested that NE tumors arose from adenocarcinoma cells through transdifferentiation. These results directly show functional cooperativity between c-MYC and PIM1 in prostate tumorigenesis in vivo and support efforts for targeting PIM1 in prostate cancer. Oncogene (2010) 29, 2477-2487; doi:10.1038/onc.2010.10; published online 8 February 2010	[Kim, J.; Roh, M.; Wills, M. L.; Abdulkadir, S. A.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Wang, J.; Hayward, S. W.; Abdulkadir, S. A.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Franco, O. E.; Hayward, S. W.] Vanderbilt Univ, Med Ctr, Dept Urol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Abdulkadir, SA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, B33321A MCN,1161 21st Ave S, Nashville, TN 37232 USA.	sarki.abdulkadir@vanderbilt.edu	Hayward, Simon/A-1688-2011	Kim, Jongchan/0000-0002-9733-9881; Hayward, Simon/0000-0002-6059-6550	NIH [CA123484]; NATIONAL CANCER INSTITUTE [R01CA123484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Robert Matusik, Vito Quaranta, Fritz Parl and Susan Kasper for helpful discussions. This work was supported by NIH Grant CA123484 (SAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Abdulkadir SA, 2001, HUM PATHOL, V32, P935, DOI 10.1053/hupa.2001.27102; Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Cindolo L, 2007, UROL INT, V79, P287, DOI 10.1159/000109711; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Deeble PD, 2001, MOL CELL BIOL, V21, P8471, DOI 10.1128/MCB.21.24.8471-8482.2001; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; DISANTAGNESE PA, 1987, HUM PATHOL, V18, P849; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Garabedian EM, 1998, P NATL ACAD SCI USA, V95, P15382, DOI 10.1073/pnas.95.26.15382; Hansel DE, 2009, PROSTATE, V69, P603, DOI 10.1002/pros.20910; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Hu Y, 2004, P NATL ACAD SCI USA, V101, P5559, DOI 10.1073/pnas.0306988101; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kim J, 2002, CANCER RES, V62, P1549; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000542; Mirosevich J, 2006, PROSTATE, V66, P1013, DOI 10.1002/pros.20299; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Pinski J, 2006, PROSTATE, V66, P1136, DOI 10.1002/pros.20440; Roh M, 2005, J BIOL CHEM, V280, P40568, DOI 10.1074/jbc.M509369200; Roh M, 2003, CANCER RES, V63, P8079; Roh M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002572; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Sauer CG, 2006, PROSTATE, V66, P227, DOI 10.1002/pros.20338; Schmidt T, 1998, EMBO J, V17, P5349, DOI 10.1093/emboj/17.18.5349; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Vias M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-17; Wafa LA, 2007, HUM PATHOL, V38, P161, DOI 10.1016/j.humpath.2006.07.003; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Zhang XQ, 2003, ONCOGENE, V22, P6704, DOI 10.1038/sj.onc.1206764; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	45	102	111	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2010	29	17					2477	2487		10.1038/onc.2010.10	http://dx.doi.org/10.1038/onc.2010.10			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	589RB	20140016	Green Accepted			2022-12-25	WOS:000277169400003
J	Schulze, B; Mentzel, T; Jehle, AK; Mueller, K; Beeler, S; Boller, T; Felix, G; Chinchilla, D				Schulze, Birgit; Mentzel, Tobias; Jehle, Anna K.; Mueller, Katharina; Beeler, Seraina; Boller, Thomas; Felix, Georg; Chinchilla, Delphine			Rapid Heteromerization and Phosphorylation of Ligand-activated Plant Transmembrane Receptors and Their Associated Kinase BAK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; PROTEIN-PHOSPHORYLATION; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; ELICITOR; PERCEPTION; BRI1/BAK1; COMPLEX; BINDING; BRI1	In plants leucine-rich repeat receptor kinases (LRR-RKs) located at the plasma membrane play a pivotal role in the perception of extracellular signals. For two of these LRR-RKs, the brassinosteroid receptor BRI1 and the flagellin receptor FLS2, interaction with the LRR receptor-like kinase BAK1 (BRI1-associated receptor kinase 1) was shown to be required for signal transduction. Here we report that FLS2.BAK1 heteromerization occurs almost instantaneously after perception of the ligand, the flagellin-derived peptide flg22.Flg22 can induce formation of a stable FLS2.BAK1 complex in microsomal membrane preparations in vitro, and the kinase inhibitor K-252a does not prevent complex formation. A kinase dead version of BAK1 associates with FLS2 in a flg22-dependent manner but does not restore responsiveness to flg22 in cells of bak1 plants, demonstrating that kinase activity of BAK1 is essential for FLS2 signaling. Furthermore, using in vivo phospholabeling, we are able to detect de novo phosphorylation of both FLS2 and BAK1 within 15 s of stimulation with flg22. Similarly, brassinolide induces BAK1 phosphorylation within seconds. Other triggers of plant defense, such as bacterial EF-Tu and the endogenous AtPep1 likewise induce rapid formation of heterocomplexes consisting of de novo phosphorylated BAK1 and proteins representing the ligand-specific binding receptors EF-Tu receptor and Pep1 receptor 1, respectively. Thus, we propose that several LRR-RKs form tight complexes with BAK1 almost instantaneously after ligand binding and that the subsequent phosphorylation events are key initial steps in signal transduction.	[Schulze, Birgit; Mentzel, Tobias; Beeler, Seraina; Boller, Thomas; Chinchilla, Delphine] Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, CH-4056 Basel, Switzerland; [Jehle, Anna K.; Mueller, Katharina; Felix, Georg] Univ Tubingen, Inst Plant Biochem, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	University of Basel; Eberhard Karls University of Tubingen	Chinchilla, D (corresponding author), Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	delphine.chinchilla@unibas.ch	Boller, Thomas/G-3500-2012	Boller, Thomas/0000-0001-6768-7503; Witte, Anna Kristina/0000-0001-6471-0763				Ali GS, 2007, PLANT CELL PHYSIOL, V48, P1601, DOI 10.1093/pcp/pcm132; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1991, P NATL ACAD SCI USA, V88, P8831, DOI 10.1073/pnas.88.19.8831; FELIX G, 1994, P NATL ACAD SCI USA, V91, P952, DOI 10.1073/pnas.91.3.952; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kierszniowska S, 2009, MOL CELL PROTEOMICS, V8, P612, DOI 10.1074/mcp.M800346-MCP200; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Postel S, 2010, EUR J CELL BIOL, V89, P169, DOI 10.1016/j.ejcb.2009.11.001; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Ryan CA, 2007, CELL MICROBIOL, V9, P1902, DOI 10.1111/j.1462-5822.2007.00991.x; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Thuerig B, 2005, PHYSIOL MOL PLANT P, V67, P180, DOI 10.1016/j.pmpp.2006.01.002; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	46	302	319	3	89	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9444	9451		10.1074/jbc.M109.096842	http://dx.doi.org/10.1074/jbc.M109.096842			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20103591	hybrid, Green Published			2022-12-25	WOS:000276165900017
J	Ye, Y; Xiao, Y; Wang, W; Yearsley, K; Gao, JX; Shetuni, B; Barsky, SH				Ye, Y.; Xiao, Y.; Wang, W.; Yearsley, K.; Gao, J. X.; Shetuni, B.; Barsky, S. H.			ER alpha signaling through slug regulates E-cadherin and EMT	ONCOGENE			English	Article						ER alpha; slug; E-cadherin; EMT; ER alpha/N-CoR/HDAC1 corepressor complex	BREAST-CANCER CELLS; GLYCOGEN-SYNTHASE KINASE-3; ESTROGEN-RECEPTOR-ALPHA; EPITHELIAL-MESENCHYMAL TRANSITION; SEMIAUTOMATED IMAGING-SYSTEM; ENDOTHELIAL GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVITY; DOWN-REGULATION; BETA-CATENIN; EXPRESSION	The ER alpha signaling pathway is one of the most important and most studied pathways in human breast cancer, yet numerous questions still exist such as how hormonally responsive cancers progress to a more aggressive and hormonally independent phenotype. We have noted that human breast cancers exhibit a strong direct correlation between ER alpha and E-cadherin expression by immunohistochemistry, suggesting that ER alpha signaling might regulate E-cadherin and implying that this regulation might influence epithelial-mesenchymal transition (EMT) and tumor progression. To investigate this hypothesis and the mechanisms behind it, we studied the effects of ER alpha signaling in ER alpha-transfected ER alpha-negative breast carcinoma cell lines, the MDA-MB-468 and the MDA-MB-231 and the effects of ER alpha knockdown in naturally expressing ER alpha-positive lines, MCF-7 and T47D. When ER alpha was overexpressed in the ER alpha-negative lines, 17 beta-estradiol (E2) decreased slug and increased E-cadherin. Clones maximally exhibiting these changes grew more in clumps and became less invasive in Matrigel. When ER alpha was knocked down in the ER alpha-positive lines, slug increased, E-cadherin decreased, cells became spindly and exhibited increased Matrigel invasion. ER alpha signaling decreased slug expression by two different mechanisms: directly, by repression of slug transcription by the formation of a corepressor complex of ligand-activated ER alpha, HDAC inhibitor (HDAC1), and nuclear receptor corepressor (N-CoR) that bound the slug promoter in three half-site estrogen response elements (EREs); indirectly by phosphorylation and inactivation of GSK-3 beta through phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt). The GSK-3 beta inactivation, in turn, repressed slug expression and increased E-cadherin. In human breast cancer cases, there was a strong inverse correlation between slug and ER alpha and E-cadherin immunoreactivity. Our findings indicate that ER alpha signaling through slug regulates E-cadherin and EMT. Oncogene (2010) 29, 1451-1462; doi:10.1038/onc.2009.433; published online 18 January 2010	[Ye, Y.; Barsky, S. H.] Univ Nevada, Sch Med, Dept Pathol, Reno, NV 89557 USA; [Ye, Y.; Barsky, S. H.] Nevada Canc Inst, Dept Pathol, Las Vegas, NV USA; [Xiao, Y.; Wang, W.; Yearsley, K.; Gao, J. X.; Shetuni, B.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California San Diego; University System of Ohio; Ohio State University	Barsky, SH (corresponding author), Univ Nevada, Sch Med, Dept Pathol, 1 Manville Med Bldg, Reno, NV 89557 USA.	sbarsky@medicine.nevada.edu			Department of Defense Breast Cancer Research Program [W81XWH-06-1-0631]; Ohio State Strategic Initiative Grant Program; Donald A Senhauser Endowment	Department of Defense Breast Cancer Research Program(United States Department of Defense); Ohio State Strategic Initiative Grant Program; Donald A Senhauser Endowment	This study was supported by the Department of Defense Breast Cancer Research Program Grant W81XWH-06-1-0631, the Ohio State Strategic Initiative Grant Program and The Donald A Senhauser Endowment.	Alpaugh ML, 2002, AM J PATHOL, V161, P619, DOI 10.1016/S0002-9440(10)64217-4; Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Barsky SH, 2003, EXP MOL PATHOL, V74, P113, DOI 10.1016/S0014-4800(03)00011-X; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Cardona-Gomez P, 2004, MOL CELL NEUROSCI, V25, P363, DOI 10.1016/j.mcn.2003.10.008; Catalano A, 2004, J BIOL CHEM, V279, P46706, DOI 10.1074/jbc.M406696200; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; DEGROOT RP, 1993, ONCOGENE, V8, P841; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Grisouard J, 2007, MOL ENDOCRINOL, V21, P2427, DOI 10.1210/me.2007-0129; Hajra KM, 2002, CANCER RES, V62, P1613; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Hiraguri S, 1998, CANCER RES, V58, P1972; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hyder SM, 1996, CANCER RES, V56, P3954; Joshi AS, 2007, CYTOM PART A, V71A, P273, DOI 10.1002/cyto.a.20374; Kato S, 2000, GENES CELLS, V5, P593, DOI 10.1046/j.1365-2443.2000.00354.x; Keeton EK, 2005, MOL ENDOCRINOL, V19, P1543, DOI 10.1210/me.2004-0395; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Mendez P, 2006, ENDOCRINOLOGY, V147, P3027, DOI 10.1210/en.2005-1224; Moggs JG, 2005, J MOL ENDOCRINOL, V34, P535, DOI 10.1677/jme.1.01677; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; Natsugoe S, 2007, ONCOL REP, V17, P517; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Oesterreich S, 2003, CANCER RES, V63, P5203; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Sasaki CY, 2000, CANCER RES, V60, P7057; Sharangpani GM, 2007, J MICROSC-OXFORD, V226, P244, DOI 10.1111/j.1365-2818.2007.01772.x; Tomlinson JS, 2001, CANCER RES, V61, P5231; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Voss TC, 2005, MOL CELL ENDOCRINOL, V231, P33, DOI 10.1016/j.mce.2004.12.003; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yang S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-211; Ye Y, 2008, BIOCHEM J, V416, P179, DOI 10.1042/BJ20080328; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	54	143	155	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2010	29	10					1451	1462		10.1038/onc.2009.433	http://dx.doi.org/10.1038/onc.2009.433			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	566SD	20101232				2022-12-25	WOS:000275392400004
J	Ringkamp, M; Johanek, LM; Borzan, J; Hartke, TV; Wu, G; Pogatzki-Zahn, EM; Campbell, JN; Shim, B; Schepers, RJ; Meyer, RA				Ringkamp, Matthias; Johanek, Lisa M.; Borzan, Jasenka; Hartke, Timothy V.; Wu, Gang; Pogatzki-Zahn, Esther M.; Campbell, James N.; Shim, Beom; Schepers, Raf J.; Meyer, Richard A.			Conduction Properties Distinguish Unmyelinated Sympathetic Efferent Fibers and Unmyelinated Primary Afferent Fibers in the Monkey	PLOS ONE			English	Article							VELOCITY RECOVERY CYCLES; INNERVATING HUMAN SKIN; C-FIBERS; RAT; SODIUM; NOCICEPTORS; NERVE; INACTIVATION; HYPERALGESIA; MODALITY	Background: Different classes of unmyelinated nerve fibers appear to exhibit distinct conductive properties. We sought a criterion based on conduction properties for distinguishing sympathetic efferents and unmyelinated, primary afferents in peripheral nerves. Methodology/Principal Findings: In anesthetized monkey, centrifugal or centripetal recordings were made from single unmyelinated nerve fibers in the peroneal or sural nerve, and electrical stimuli were applied to either the sciatic nerve or the cutaneous nerve endings, respectively. In centrifugal recordings, electrical stimulation at the sympathetic chain and dorsal root was used to determine the fiber's origin. In centrifugal recordings, sympathetic fibers exhibited absolute speeding of conduction to a single pair of electrical stimuli separated by 50 ms; the second action potential was conducted faster (0.61 for all 0.16%) than the first unconditioned action potential. This was never observed in primary afferents. Following 2 Hz stimulation (3 min), activity-dependent slowing of conduction in the sympathetics (8.6 for all 0.5%) was greater than in one afferent group (6.7 for all 0.5%) but substantially less than in a second afferent group (29.4 for all 1.9%). In centripetal recordings, most mechanically-insensitive fibers also exhibited absolute speeding to twin pulse stimulation. The subset that did not show this absolute speeding was responsive to chemical stimuli (histamine, capsaicin) and likely consists of mechanically-insensitive afferents. During repetitive twin pulse stimulation, mechanosensitive afferents developed speeding, and speeding in sympathetic fibers increased. Conclusions/Significance: The presence of absolute speeding provides a criterion by which sympathetic efferents can be differentiated from primary afferents. The differences in conduction properties between sympathetics and afferents likely reflect differential expression of voltage-sensitive ion channels.	[Ringkamp, Matthias; Johanek, Lisa M.; Hartke, Timothy V.; Wu, Gang; Pogatzki-Zahn, Esther M.; Campbell, James N.; Shim, Beom; Schepers, Raf J.; Meyer, Richard A.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Borzan, Jasenka] Johns Hopkins Univ, Dept Anesthesiol, Sch Med, Baltimore, MD USA; [Meyer, Richard A.] Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Ringkamp, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	platelet@jhmi.edu		Shim, Beom/0000-0003-1318-7778	National Institutes of Health [NS-14447, NS-047399]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047399, R01NS014447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health (NS-14447 and NS-047399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMETT CJ, 1963, J PHYSIOL-LONDON, V165, P130, DOI 10.1113/jphysiol.1963.sp007047; BARRETT EF, 1982, J PHYSIOL-LONDON, V323, P117, DOI 10.1113/jphysiol.1982.sp014064; Bostock H, 2003, J PHYSIOL-LONDON, V553, P649, DOI 10.1113/jphysiol.2003.046342; CAMPBELL JN, 1983, J NEUROPHYSIOL, V49, P98, DOI 10.1152/jn.1983.49.1.98; Campero M, 2004, ACTA PHYSIOL SCAND, V182, P305, DOI 10.1111/j.1365-201X.2004.01357.x; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; DARIANSMITH I, 1979, J NEUROPHYSIOL, V42, P1297, DOI 10.1152/jn.1979.42.5.1297; De Col R, 2008, J PHYSIOL-LONDON, V586, P1089, DOI 10.1113/jphysiol.2007.145383; Gee MD, 1996, NEUROSCIENCE, V73, P667, DOI 10.1016/0306-4522(96)00070-X; George A, 2007, J PHYSIOL-LONDON, V578, P213, DOI 10.1113/jphysiol.2006.116129; Leffler A, 2007, J PHARMACOL EXP THER, V320, P354, DOI 10.1124/jpet.106.109025; Martinez-Pinna J, 2000, J PHYSIOL-LONDON, V527, P249, DOI 10.1111/j.1469-7793.2000.00249.x; MEYER RA, 1991, BRAIN RES, V561, P252, DOI 10.1016/0006-8993(91)91601-V; NAMER B, 2008, J NEUROPHYSIOL; Peng YB, 1999, J NEUROPHYSIOL, V82, P1164, DOI 10.1152/jn.1999.82.3.1164; RAYMOND SA, 1990, BRAIN RES, V526, P318, DOI 10.1016/0006-8993(90)91239-D; Ringkamp M, 1999, PAIN, V79, P143, DOI 10.1016/S0304-3959(98)00186-9; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; Schmelz M, 1997, J NEUROSCI, V17, P8003; Scroggs RS, 2008, J PHYSIOL-LONDON, V586, P923, DOI 10.1113/jphysiol.2008.150821; Serra J, 2004, J NEUROPHYSIOL, V91, P2770, DOI 10.1152/jn.00565.2003; Serra J, 1999, J PHYSIOL-LONDON, V515, P799, DOI 10.1111/j.1469-7793.1999.799ab.x; THALHAMMER JG, 1994, SOMATOSENS MOT RES, V11, P243, DOI 10.3109/08990229409051392; Weidner C, 1999, J NEUROSCI, V19, P10184; Weidner C, 2000, J PHYSIOL-LONDON, V527, P185, DOI 10.1111/j.1469-7793.2000.00185.x; Weidner C, 2002, J NEUROSCI, V22, P6704; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002	28	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9076	10.1371/journal.pone.0009076	http://dx.doi.org/10.1371/journal.pone.0009076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140089	gold, Green Published, Green Submitted			2022-12-25	WOS:000274442400014
J	Kabeer, BSA; Raman, B; Thomas, A; Perumal, V; Raja, A				Kabeer, Basirudeen Syed Ahamed; Raman, Balambal; Thomas, Aleyamma; Perumal, Venkatesan; Raja, Alamelu			Role of QuantiFERON-TB Gold, Interferon Gamma Inducible Protein-10 and Tuberculin Skin Test in Active Tuberculosis Diagnosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; WHOLE-BLOOD; RELEASE ASSAYS; IFN-GAMMA; PULMONARY TUBERCULOSIS; LATENT TUBERCULOSIS; PLEURAL EFFUSIONS; HIV; SENSITIVITY; DISEASE	Background: The measurement of Interferon gamma or Interferon gamma inducible protein (IP)-10 in antigen stimulated blood samples is suggested as an alternative method for latent tuberculosis (TB) diagnosis. Nonetheless, their role in active TB diagnosis, particularly in TB endemic settings is yet to be defined. In this study, the sensitivities and specificities of Interferon gamma release assay (IGRA), IP-10 assay and tuberculin skin test (TST) in detecting active TB cases were assessed in human immunodeficiency virus (HIV) sero-negative TB patients and healthy controls respectively. Methods/Principal Findings: A total of 177 adult TB patients and 100 healthy controls were included for this study. QuantiFERON-TB Gold In-tube (QFT-IT) method was used to analyze the sensitivity and specificity of IGRA. QFT-IT, IP-10 and TST yielded the diagnostic sensitivities of 90.6% (95%CI: 86.3%-94.9%), 92.5% (95%CI: 88.6%-96.4%) and 68.9% (95%CI: 60.6%-77.2%) and specificities of 55% (95%CI: 35.2%-54.8%), 48% (95%CI: 38.2%-57.8%) and 75.5% (95%CI: 66.8%84.2%), respectively. The extent of pulmonary involvement or presence of diabetes mellitus did not appear to influence the sensitivities of any of these tests. The combination of any of the two tests among QFT-IT, IP-10 and TST showed >98% sensitivity among smear negative cases and particularly the combination of IP-10, TST and smear microscopy showed 100% sensitivity, however, the specificity was decreased to 44.8%. Conclusions/Significance: QFT-IT and IP-10 were highly sensitive in detecting active TB cases. The combination with TST improved the sensitivity of QFT-IT and IP-10 significantly. Although the higher sensitivity of combination of QFT-IT/IP-10 and TST may be useful in active TB diagnosis, they are limited by their poor specificity due to the high prevalence of latent TB in our settings.	[Kabeer, Basirudeen Syed Ahamed; Raja, Alamelu] TB Res Ctr ICMR, Dept Immunol, Chennai, Tamil Nadu, India; [Raman, Balambal; Thomas, Aleyamma] TB Res Ctr ICMR, Dept Clin, Chennai, Tamil Nadu, India; [Perumal, Venkatesan] TB Res Ctr ICMR, Dept Stat, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Kabeer, BSA (corresponding author), TB Res Ctr ICMR, Dept Immunol, Chennai, Tamil Nadu, India.	alameluraja@gmail.com	Kabeer, Basirudeen Syed Ahamed/AAQ-7599-2020	Kabeer, Basirudeen Syed Ahamed/0000-0002-7287-1636	National Institutes of Health [AI064055]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI064055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project is financially supported by National Institutes of Health (R03) grant (AI064055). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Bartu V, 2008, J INT MED RES, V36, P434, DOI 10.1177/147323000803600307; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Dhillon NK, 2007, J IMMUNOL, V179, P2722, DOI 10.4049/jimmunol.179.5.2722; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Harada N, 2008, J INFECTION, V56, P348, DOI 10.1016/j.jinf.2008.02.011; Juffermans NP, 1999, INFECT IMMUN, V67, P4295, DOI 10.1128/IAI.67.8.4295-4297.1999; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Kabeer BSA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005718; Lagrange Philippe H, 2008, Open Respir Med J, V2, P52, DOI 10.2174/1874306400802010052; Lighter J, 2009, PEDIATRICS, V123, P30, DOI 10.1542/peds.2007-3618; Markowitz N, 1997, ANN INTERN MED, V126, P123, DOI 10.7326/0003-4819-126-2-199701150-00005; *MIN HLTH FAM WELF, 1998, REV NAT TUB CONTR PR; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; *NAT AIDS CONTR OR, 2007, OP GUID INT COUNS TE; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2006, INT J TUBERC LUNG D, V10, P942; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Palazzo R, 2008, CLIN VACCINE IMMUNOL, V15, P327, DOI 10.1128/CVI.00342-07; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Rajavelu P, 2005, FEMS IMMUNOL MED MIC, V45, P95, DOI 10.1016/j.femsim.2005.02.011; Ramachandran Geetha, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P251, DOI 10.1177/1545109707301344; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Samson KTR, 2006, CLIN EXP ALLERGY, V36, P475, DOI 10.1111/j.1365-2222.2006.02470.x; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Selvakumar N, 2006, INDIAN J MED RES, V124, P439; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; Steinbrook R, 2007, NEW ENGL J MED, V356, P1197, DOI 10.1056/NEJMp078011; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Tsukaguchi Katsuhiko, 2002, Kekkaku, V77, P409; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; WHO, 2008, GLOBAL TUBERCULOSIS; *WHO, 2008, GLOB TB DAT BAS TB C; Wu HP, 2007, RESP MED, V101, P48, DOI 10.1016/j.rmed.2006.04.016; Yamashiro S, 2005, CLIN EXP IMMUNOL, V139, P57, DOI 10.1111/j.1365-2249.2005.02677.x	45	81	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9051	10.1371/journal.pone.0009051	http://dx.doi.org/10.1371/journal.pone.0009051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140219	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000274474400010
J	Kram, YA; Mantey, S; Corbo, JC				Kram, Yoseph A.; Mantey, Stephanie; Corbo, Joseph C.			Avian Cone Photoreceptors Tile the Retina as Five Independent, Self-Organizing Mosaics	PLOS ONE			English	Article							CELL-REARRANGEMENT MODEL; MINIMAL-SPACING RULE; OIL DROPLETS; ZEBRAFISH RETINA; VORONOI TESSELLATIONS; GANGLION-CELLS; COLOR-VISION; SPECTRAL SENSITIVITIES; PATTERN-FORMATION; MAMMALIAN RETINA	The avian retina possesses one of the most sophisticated cone photoreceptor systems among vertebrates. Birds have five types of cones including four single cones, which support tetrachromatic color vision and a double cone, which is thought to mediate achromatic motion perception. Despite this richness, very little is known about the spatial organization of avian cones and its adaptive significance. Here we show that the five cone types of the chicken independently tile the retina as highly ordered mosaics with a characteristic spacing between cones of the same type. Measures of topological order indicate that double cones are more highly ordered than single cones, possibly reflecting their posited role in motion detection. Although cones show spacing interactions that are cell type-specific, all cone types use the same density-dependent yardstick to measure intercone distance. We propose a simple developmental model that can account for these observations. We also show that a single parameter, the global regularity index, defines the regularity of all five cone mosaics. Lastly, we demonstrate similar cone distributions in three additional avian species, suggesting that these patterning principles are universal among birds. Since regular photoreceptor spacing is critical for uniform sampling of visual space, the cone mosaics of the avian retina represent an elegant example of the emergence of adaptive global patterning secondary to simple local interactions between individual photoreceptors. Our results indicate that the evolutionary pressures that gave rise to the avian retina's various adaptations for enhanced color discrimination also acted to fine-tune its spatial sampling of color and luminance.	[Kram, Yoseph A.; Mantey, Stephanie; Corbo, Joseph C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Kram, YA (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	jcorbo@pathology.wustl.edu		Corbo, Joseph/0000-0002-9323-7140	National Eye Institute [R01EY018826]; Howard Hughes Medical Institute; Office of Undergraduate Research Hoopes Award; NATIONAL EYE INSTITUTE [R01EY018826] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Undergraduate Research Hoopes Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was funded by a grant from the National Eye Institute (R01EY018826). Additional financial support came from a Summer Undergraduate Research Fellowship from the Howard Hughes Medical Institute and the Office of Undergraduate Research Hoopes Award at Washington University and from an undergraduate summer research fellowship from the Honors Program at the University of Michigan Flint. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt Peter Kurt, 1996, Revista Brasileira de Biologia, V56, P199; Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; [Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Aste T., 2008, PURSUIT PERFECT PACK, V2nd; Bernardos RL, 2005, DEV BIOL, V278, P381, DOI 10.1016/j.ydbio.2004.11.018; BOSSOMAIER TRJ, 1985, VISION RES, V25, P145, DOI 10.1016/0042-6989(85)90089-6; BOWMAKER JK, 1977, VISION RES, V17, P755, DOI 10.1016/0042-6989(77)90117-1; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Campenhausen MV, 1998, J COMP PHYSIOL A, V183, P1; Cellerino A, 2000, EUR J NEUROSCI, V12, P613, DOI 10.1046/j.1460-9568.2000.00944.x; Collin SP, 2009, PHILOS T R SOC B, V364, P2925, DOI 10.1098/rstb.2009.0099; COOK JE, 1992, J COMP NEUROL, V318, P355, DOI 10.1002/cne.903180402; Cook JE, 1996, VISUAL NEUROSCI, V13, P15, DOI 10.1017/S0952523800007094; Cook JE, 2000, TRENDS NEUROSCI, V23, P26, DOI 10.1016/S0166-2236(99)01487-3; CURCIO CA, 1992, VISUAL NEUROSCI, V9, P169, DOI 10.1017/S0952523800009639; Daudet N, 2009, DEV BIOL, V326, P86, DOI 10.1016/j.ydbio.2008.10.033; DUNN RF, 1966, J ULTRA MOL STRUCT R, V16, P672, DOI 10.1016/S0022-5320(66)80013-8; Eglen SJ, 2008, VISUAL NEUROSCI, V25, P209, DOI 10.1017/S0952523808080176; Eglen SJ, 2006, MATH MED BIOL, V23, P79, DOI 10.1093/imammb/dql003; ENGSTROM KJELL, 1963, ACTA ZOOL, V44, P179; FRENCH AS, 1977, BIOL CYBERN, V27, P229, DOI 10.1007/BF00344144; Galli-Resta L, 1999, EUR J NEUROSCI, V11, P1461, DOI 10.1046/j.1460-9568.1999.00555.x; GERVOIS A, 1992, J PHYS A-MATH GEN, V25, P6169, DOI 10.1088/0305-4470/25/23/014; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; GOLDSMITH TH, 1984, VISION RES, V24, P1661, DOI 10.1016/0042-6989(84)90324-9; GRANER F, 2001, PHYS REV E, V63; Hart NS, 2005, J COMP PHYSIOL A, V191, P381, DOI 10.1007/s00359-004-0595-3; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; LEMAITRE J, 1993, PHILOS MAG B, V67, P347, DOI 10.1080/13642819308220137; Lopez R, 2005, J NEUROSCI RES, V79, P401, DOI 10.1002/jnr.20360; LYALL AH, 1957, Q J MICROSC SCI, V98, P189; MAIER EJ, 1993, J COMP PHYSIOL A, V172, P295, DOI 10.1007/BF00216611; Manning JR, 2009, VISUAL NEUROSCI, V26, P5, DOI 10.1017/S095252380808084X; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Mochizuki A, 2002, J THEOR BIOL, V215, P345, DOI 10.1006/jtbi.2001.2508; MORRIS VB, 1970, J COMP NEUROL, V140, P359, DOI 10.1002/cne.901400308; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Osorio D, 2005, P ROY SOC B-BIOL SCI, V272, P1745, DOI 10.1098/rspb.2005.3156; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; Quilliet C, 2008, PHIL MAG LETT, V88, P651, DOI 10.1080/09500830802334249; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Raven MA, 2003, J COMP NEUROL, V461, P123, DOI 10.1002/cne.10693; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Sadoc J. F., 1999, FOAMS EMULSIONS; Schliecker G, 2002, ADV PHYS, V51, P1319, DOI 10.1080/00018730210140814; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Shamim KM, 1997, VISUAL NEUROSCI, V14, P811, DOI 10.1017/S095252380001155X; SHAPIRO MB, 1985, J AM STAT ASSOC, V80, P803, DOI 10.2307/2288535; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Stenkamp DL, 2001, J COMP NEUROL, V431, P363, DOI 10.1002/1096-9861(20010319)431:4<363::AID-CNE1076>3.0.CO;2-7; SZETO K, 2002, PHYS REV LETT, V88, P3; Teixeira PIC, 2002, EUR PHYS J E, V9, P161, DOI 10.1140/epje/i2002-10070-8; Tohya S, 1999, J THEOR BIOL, V200, P231, DOI 10.1006/jtbi.1999.0990; Tohya S, 2003, J THEOR BIOL, V221, P289, DOI 10.1006/jtbi.2003.3192; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 2003, P ROY SOC B-BIOL SCI, V270, P1255, DOI 10.1098/rspb.2003.2381; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; WEAIRE D, 1984, CONTEMP PHYS, V25, P59, DOI 10.1080/00107518408210979; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; YELLOTT JI, 1982, VISION RES, V22, P1205, DOI 10.1016/0042-6989(82)90086-4; YELLOTT JI, 1983, SCIENCE, V221, P382, DOI 10.1126/science.6867716; YOUNG SR, 1984, VISION RES, V24, P129, DOI 10.1016/0042-6989(84)90098-1; Zhu HX, 2001, PHILOS MAG A, V81, P2765, DOI 10.1080/01418610010032364	73	111	113	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8992	10.1371/journal.pone.0008992	http://dx.doi.org/10.1371/journal.pone.0008992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126550	Green Published, Green Submitted, gold			2022-12-25	WOS:000274209700018
J	Bitton, DA; Smith, DL; Connolly, Y; Scutt, PJ; Miller, CJ				Bitton, Danny A.; Smith, Duncan L.; Connolly, Yvonne; Scutt, Paul J.; Miller, Crispin J.			An Integrated Mass-Spectrometry Pipeline Identifies Novel Protein Coding-Regions in the Human Genome	PLOS ONE			English	Article							FALSE DISCOVERY RATES; TILING ARRAYS; GENE; ANNOTATION; SEARCH; DATABASES; PEPTIDES; SEQUENCE; MODEL; PROTEOMICS	Background: Most protein mass spectrometry (MS) experiments rely on searches against a database of known or predicted proteins, limiting their ability as a gene discovery tool. Results: Using a search against an in silico translation of the entire human genome, combined with a series of annotation filters, we identified 346 putative novel peptides [False Discovery Rate (FDR), <5%] in a MS dataset derived from two human breast epithelial cell lines. A subset of these were then successfully validated by a different MS technique. Two of these correspond to novel isoforms of Heterogeneous Ribonuclear Proteins, while the rest correspond to novel loci. Conclusions: MS technology can be used for ab initio gene discovery in human data, which, since it is based on different underlying assumptions, identifies protein-coding genes not found by other techniques. As MS technology continues to evolve, such approaches will become increasingly powerful.	[Bitton, Danny A.; Scutt, Paul J.; Miller, Crispin J.] Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Appl Computat Biol & Bioinformat Grp, Manchester, Lancs, England; [Smith, Duncan L.; Connolly, Yvonne] Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Biol Mass Spectrometry Facil, Manchester, Lancs, England	Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Bitton, DA (corresponding author), Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Appl Computat Biol & Bioinformat Grp, Manchester, Lancs, England.	cmiller@picr.man.ac.uk		Miller, Crispin/0000-0003-4341-1283	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This project was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Choudhary JS, 2001, PROTEOMICS, V1, P651, DOI 10.1002/1615-9861(200104)1:5<651::AID-PROT651>3.0.CO;2-N; Choudhary JS, 2001, TRENDS BIOTECHNOL, V19, pS17, DOI 10.1016/S0167-7799(01)01795-4; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; DeLano WL, 2002, PYMOL USERS MANUAL; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fermin D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r35; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guigo R, 2003, P NATL ACAD SCI USA, V100, P1140, DOI 10.1073/pnas.0337561100; Guigo R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s2; Gupta N, 2007, GENOME RES, V17, P1362, DOI 10.1101/gr.6427907; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Halasz G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r59; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JIRI P, 2008, PROTEOMICS, V8, P1744; Jones AR, 2009, PROTEOMICS, V9, P1220, DOI 10.1002/pmic.200800473; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kerlavage A, 2002, NUCLEIC ACIDS RES, V30, P129, DOI 10.1093/nar/30.1.129; Kuster B, 2001, PROTEOMICS, V1, P641; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Menon R, 2009, CANCER RES, V69, P300, DOI 10.1158/0008-5472.CAN-08-2145; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Okoniewski MJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r79; Okoniewski MJ, 2007, BIOTECHNIQUES, V42, P181, DOI 10.2144/000112315; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RYO Y, 2006, GENOME INFORM, V17, P88; Schadt EE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r73; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P924, DOI 10.1074/mcp.M400193-MCP200; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016; Yates JR, 1997, J PROTEIN CHEM, V16, P495	58	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8949	10.1371/journal.pone.0008949	http://dx.doi.org/10.1371/journal.pone.0008949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126623	gold, Green Published, Green Submitted			2022-12-25	WOS:000274138000024
J	Laird, RM; Hayes, SM				Laird, Renee M.; Hayes, Sandra M.			Roles of the Src Tyrosine Kinases Lck and Fyn in Regulating gamma delta TCR Signal Strength	PLOS ONE			English	Article							T-CELL-RECEPTOR; ALPHA-BETA; INTERLEUKIN-7 RECEPTOR; FAMILY KINASES; DEFICIENT MICE; LYMPHOCYTE DEVELOPMENT; ENRICHED MICRODOMAINS; THYMOCYTE DEVELOPMENT; ANTIGEN RECEPTOR; INTERFERON-GAMMA	Lck and Fyn, members of the Src family of tyrosine kinases, are key components of the alpha beta TCR-coupled signaling pathway. While it is generally accepted that both Lck and Fyn positively regulate signal transduction by the alpha beta TCR, recent studies have shown that Lck and Fyn have distinct functions in this signaling pathway, with Lck being a positive regulator and Fyn being a negative regulator of alpha beta TCR signal transduction. To determine whether Lck and Fyn also differentially regulate gamma delta TCR signal transduction, we analyzed gamma delta T cell development and function in mice with reduced Lck or Fyn expression levels. We found that reducing Lck or Fyn levels altered the strength of the gamma delta TCR signaling response, with low levels of Lck weakening gamma delta TCR signal strength and low levels of Fyn augmenting gamma delta TCR signal strength. These alterations in gamma delta TCR signal strength had profound effects not only on alpha beta/gamma delta lineage choice, but also on gamma delta thymocyte maturation and gamma delta T cell effector function. These results indicate that the cellular levels of Lck and Fyn play a role in regulating the strength of the gamma delta TCR signaling response at different stages in the life of the gamma delta T cell.	[Laird, Renee M.; Hayes, Sandra M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Laird, RM (corresponding author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY USA.	HayesSa@upstate.edu			Hendricks Fund	Hendricks Fund	This work was supported in part by the Hendricks Fund for Medical Research awarded to S. M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; BRDICKA T, J EXP MED, V191, P1591; BRUNO S, 1992, CELL PROLIFERAT, V25, P31, DOI 10.1111/j.1365-2184.1992.tb01435.x; Buckland J, 2000, EUR J IMMUNOL, V30, P8, DOI 10.1002/1521-4141(200001)30:1<8::AID-IMMU8>3.3.CO;2-#; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Filby A, 2007, J IMMUNOL, V179, P4635, DOI 10.4049/jimmunol.179.7.4635; GERDES J, 1984, J IMMUNOL, V133, P1710; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; KAWAI K, 1995, J EXP MED, V181, P345, DOI 10.1084/jem.181.1.345; Kim K, 1998, J IMMUNOL, V160, P5735; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Laird RM, 2009, MOL IMMUNOL, V46, P2429, DOI 10.1016/j.molimm.2009.03.029; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Mamchak AA, 2008, J IMMUNOL, V181, P5374, DOI 10.4049/jimmunol.181.8.5374; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; Page ST, 1997, EUR J IMMUNOL, V27, P554, DOI 10.1002/eji.1830270229; PAGE TH, 1995, EUR J IMMUNOL, V25, P2956, DOI 10.1002/eji.1830251036; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; PENNINGER J, 1993, SCIENCE, V260, P358, DOI 10.1126/science.8469988; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; SIM GK, 1995, J IMMUNOL, V154, P5821; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357; Trobridge PA, 2001, EUR J IMMUNOL, V31, P3567, DOI 10.1002/1521-4141(200112)31:12<3567::AID-IMMU3567>3.0.CO;2-M; Utting O, 1998, J IMMUNOL, V160, P5410; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VENKITARAMAN AR, 1992, P NATL ACAD SCI USA, V89, P12083, DOI 10.1073/pnas.89.24.12083; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	56	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8899	10.1371/journal.pone.0008899	http://dx.doi.org/10.1371/journal.pone.0008899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126650	Green Published, gold, Green Submitted			2022-12-25	WOS:000273896500019
J	Rapanelli, M; Lew, SE; Frick, LR; Zanutto, BS				Rapanelli, Maximiliano; Eduardo Lew, Sergio; Romina Frick, Luciana; Silvano Zanutto, Bonifacio			Plasticity in the Rat Prefrontal Cortex: Linking Gene Expression and an Operant Learning with a Computational Theory	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; SYNAPTIC CONSOLIDATION; PROTEIN EXPRESSION; NEURONAL-ACTIVITY; MESSENGER-RNA; SYNAPSIN-I; DOPAMINE; BRAIN; STRIATUM	The plasticity in the medial Prefrontal Cortex (mPFC) of rodents or lateral prefrontal cortex in non human primates (IPFC), plays a key role neural circuits involved in learning and memory. Several genes, like brain-derived neurotrophic factor (BDNF), cAMP response element binding (CREB), Synapsin I, Calcium/calmodulin-dependent protein kinase II (CamKII), activity-regulated cytoskeleton-associated protein (Arc), c-jun and c-fos have been related to plasticity processes. We analysed differential expression of related plasticity genes and immediate early genes in the mPFC of rats during learning an operant conditioning task. Incompletely and completely trained animals were studied because of the distinct events predicted by our computational model at different learning stages. During learning an operant conditioning task, we measured changes in the mRNA levels by Real-Time RT-PCR during learning; expression of these markers associated to plasticity was incremented while learning and such increments began to decline when the task was learned. The plasticity changes in the IPFC during learning predicted by the model matched up with those of the representative gene BDNF. Herein, we showed for the first time that plasticity in the mPFC in rats during learning of an operant conditioning is higher while learning than when the task is learned, using an integrative approach of a computational model and gene expression.	[Rapanelli, Maximiliano; Romina Frick, Luciana; Silvano Zanutto, Bonifacio] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Biol Comportamiento, RA-1033 Buenos Aires, DF, Argentina; [Eduardo Lew, Sergio; Silvano Zanutto, Bonifacio] Univ Buenos Aires, Inst Ingn Biomed, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Rapanelli, M (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Lab Biol Comportamiento, RA-1033 Buenos Aires, DF, Argentina.	rapanelli@dna.uba.ar	rapanelli, maximiliano/P-3141-2016; Lew, Sergio/AAE-7122-2022	rapanelli, maximiliano/0000-0001-7329-2364; Lew, Sergio/0000-0001-7700-6687	Agencia Nacional de Promocion Cientifica y Tecnotogica [PICT 2006 2485]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5876]; Universidad de Buenos Aires (UBACyT); Sigma Xi [G200803150637]	Agencia Nacional de Promocion Cientifica y Tecnotogica; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBACyT)(University of Buenos Aires); Sigma Xi	This study was funded by Agencia Nacional de Promocion Cientifica y Tecnotogica (PICT 2006 2485), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 5876), Universidad de Buenos Aires (UBACyT) and Sigma Xi (G200803150637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.0406960101; Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Bertaina-Anglade V, 2000, EUR J NEUROSCI, V12, P3803, DOI 10.1046/j.1460-9568.2000.00258.x; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; de Wit S, 2009, J NEUROSCI, V29, P11330, DOI 10.1523/JNEUROSCI.1639-09.2009; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Gaiddon C, 1996, J NEUROCHEM, V66, P2279; GARRIS PA, 1994, J NEUROSCI, V14, P442; Gomez-Pinilla F, 2001, BRAIN RES, V904, P13, DOI 10.1016/S0006-8993(01)02394-0; Gonon F, 1997, J NEUROSCI, V17, P5972; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Kennerley SW, 2009, J NEUROSCI, V29, P3259, DOI 10.1523/JNEUROSCI.5353-08.2009; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Kwon B, 2008, BRAIN RES, V1207, P128, DOI 10.1016/j.brainres.2008.01.072; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Lew SE, 2008, NEUROCOMPUTING, V71, P2782, DOI 10.1016/j.neucom.2007.09.010; Lew SE, 2001, IEEE IJCNN, P331, DOI 10.1109/IJCNN.2001.939041; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Morimoto K, 1998, BRAIN RES, V783, P57, DOI 10.1016/S0006-8993(97)01154-2; Murray KD, 2003, NEUROSCIENCE, V122, P407, DOI 10.1016/j.neuroscience.2003.07.015; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Petrides M, 2000, J NEUROSCI, V20, P7496; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rapanelli M, 2009, NEUROSCIENCE, V163, P1031, DOI 10.1016/j.neuroscience.2009.07.037; Romanelli P, 2007, BEHAV BRAIN RES, V184, P91, DOI 10.1016/j.bbr.2007.06.021; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Soule J, 2006, BIOCHEM SOC T, V34, P600, DOI 10.1042/BST0340600; Svarnik OE, 2005, NEUROSCIENCE, V136, P33, DOI 10.1016/j.neuroscience.2005.07.038; Teather LA, 2005, NEUROBIOL LEARN MEM, V84, P75, DOI 10.1016/j.nlm.2005.03.006; Tseng KY, 2006, SYNAPSE, V59, P412, DOI 10.1002/syn.20255; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; ZANUTTO BS, 2007, PLOS COMPUT BIOL, V3	46	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8656	10.1371/journal.pone.0008656	http://dx.doi.org/10.1371/journal.pone.0008656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XB	20111591	Green Submitted, Green Published, gold			2022-12-25	WOS:000278099200001
J	Chung, B; Verdier, F; Matak, P; Deschemin, JC; Mayeux, P; Vaulont, S				Chung, Bomee; Verdier, Frederique; Matak, Pavle; Deschemin, Jean-Christophe; Mayeux, Patrick; Vaulont, Sophie			Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone	FASEB JOURNAL			English	Article						hepatocyte; erythroblasts; inflammation	HEREDITARY HEMOCHROMATOSIS PROTEIN; TRANSFERRIN RECEPTOR 2; GENE-EXPRESSION; MICE; INFLAMMATION; ANEMIA; HFE; CYTOKINE; CELLS; BMP6	Erythropoietic activity is known to affect iron homeostasis through regulation of the liver iron regulatory hormone hepcidin. To identify new factors secreted by the erythroblasts that could influence hepcidin synthesis, we set up a coculture model. HuH7 hepatoma cells cocultured with primary human erythroblasts or erythroleukemic UT7 cells presented a 20-to 35-fold increase of hepcidin gene expression. This induction was fully blunted in the presence of a neutralizing oncostatin M antibody, demonstrating that this cytokine, belonging to the IL-6 family of cytokines, was responsible for increased levels of hepcidin expression. We further demonstrated that recombinant oncostatin M induced a dramatic transcriptional increase of hepcidin in HuH7 cells through specific activation of the STAT pathway. Hepcidin induction by oncostatin M was also observed in hepatocytes in primary culture and is believed to be cell specific since no induction was found in isolated bone marrow cells, macrophagic, stromal, and lymphoma-derived cell lines, nor in erythroblasts. Finally, we show that oncostatin M administration in vivo increases hepcidin expression and leads to significantly decreased serum iron levels. This work identifies a new potent inducer of hepcidin expression in the liver and supports a role for modulators of oncostatin M signaling pathway in treating iron disorders.-Chung, B., Verdier, F., Matak, P., Deschemin, J.-C., Mayeux, P., Vaulont, S. Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone. FASEB J. 24, 2093-2103 (2010). www.fasebj.org	[Vaulont, Sophie] Univ Paris 05, Inst Cochin, Fac Med Cochin Port Royal, CNRS,UMR 8104, F-75014 Paris, France; [Chung, Bomee; Verdier, Frederique; Matak, Pavle; Deschemin, Jean-Christophe; Mayeux, Patrick; Vaulont, Sophie] INSERM, U567, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Vaulont, S (corresponding author), Univ Paris 05, Inst Cochin, Fac Med Cochin Port Royal, CNRS,UMR 8104, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	sophie.vaulont@inserm.fr	Verdier, Frédérique/P-1512-2017; Vaulont, Sophie/O-6732-2017	Deschemin, Jean-Christophe/0000-0002-1256-8459	Agence Nationale de la Recherche, EU [LSHM-CT-2006-037296]; Association pour la Recherche sur le Cancer [1145]	Agence Nationale de la Recherche, EU(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	The authors greatly thank Yael Zermati, all the members of the hepcidin team, and Hugues Gascan for fruitful discussions. This work was supported by funding from the Agence Nationale de la Recherche, EU contract LSHM-CT-2006-037296, and Association pour la Recherche sur le Cancer grant 1145.	Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Chen SH, 2004, CYTOKINE GROWTH F R, V15, P379, DOI 10.1016/j.cytogfr.2004.06.002; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Demirag MD, 2009, INTERNAL MED, V48, P421, DOI 10.2169/internalmedicine.48.1578; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Freyssinier JM, 1999, BRIT J HAEMATOL, V106, P912; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Ichihara M, 1997, BLOOD, V90, P165; Inamura J, 2005, HEPATOL RES, V33, P198, DOI 10.1016/j.hepres.2005.08.005; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kamiya A, 2001, FEBS LETT, V492, P90, DOI 10.1016/S0014-5793(01)02140-8; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kanda J, 2009, INT J HEMATOL, V90, P545, DOI 10.1007/s12185-009-0443-x; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2009, BLOOD, V114, P2515, DOI 10.1182/blood-2009-02-206771; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; Koening CL, 2009, BLOOD, V114, P1913, DOI 10.1182/blood-2009-03-209577; Lee MS, 2005, HUM VACCINES, V1, P6, DOI 10.4161/hv.1.1.1424; Liu HY, 2009, INT J MOL MED, V23, P161, DOI 10.3892/ijmm_00000113; Lou DQ, 2005, HEPATOLOGY, V41, P1056, DOI 10.1002/hep.20663; Matak P, 2009, HAEMATOL-HEMATOL J, V94, P773, DOI 10.3324/haematol.2008.003400; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Plater-Zyberk C, 2001, ARTHRITIS RHEUM, V44, P2697, DOI 10.1002/1529-0131(200111)44:11<2697::AID-ART450>3.0.CO;2-#; Ramey G, 2007, FEBS LETT, V581, P1053, DOI 10.1016/j.febslet.2007.02.002; Ramey G, 2009, HAEMATOL-HEMATOL J, V94, P765, DOI 10.3324/haematol.2008.003541; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Vaulont S, 2005, J CLIN INVEST, V115, P2079, DOI 10.1172/JCI25642; Verdier F, 2000, J BIOL CHEM, V275, P18375, DOI 10.1074/jbc.275.24.18375; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wrighting DM, 2008, CURR TOP DEV BIOL, V82, P141, DOI 10.1016/S0070-2153(07)00006-3; WRIGHTING DM, 2006, BLOOD, V103, P10289; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	61	35	36	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2010	24	6					2093	2103		10.1096/fj.09-152561	http://dx.doi.org/10.1096/fj.09-152561			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	603HR	20124431	Bronze			2022-12-25	WOS:000278200000042
J	Jackson, HM; Kawahara, T; Nisimoto, Y; Smith, SME; Lambeth, JD				Jackson, Heather M.; Kawahara, Tsukasa; Nisimoto, Yukio; Smith, Susan M. E.; Lambeth, J. David			Nox4 B-loop Creates an Interface between the Transmembrane and Dehydrogenase Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERATING NADPH OXIDASE; NAD(P)H OXIDASE; SUPEROXIDE GENERATION; FLAVOCYTOCHROME; IDENTIFICATION; ACTIVATION; P47(PHOX); PROTEINS; CLONING; SUBUNIT	By targeting redox-sensitive amino acids in signaling proteins, the NADPH oxidase (Nox) family of enzymes link reactive oxygen species to physiological processes. We previously analyzed the sequences of 107 Nox enzymes and identified conserved regions that are predicted to have important functions in Nox structure or activation. One such region is the cytosolic B-loop, which in Nox1-4 contains a conserved polybasic region. Previous studies of Nox2 showed that certain basic residues in the B-loop are important for activity and translocation of p47(phox)/p67(phox), suggesting this region participates in subunit assembly. However, conservation of this region in Nox4, which does not require p47(phox)/p67(phox), suggested an additional role for the B-loop in Nox function. Here, we show by mutation of Nox4 B-loop residues that this region is important for Nox4 activity. Fluorescence polarization detected binding between Nox4 B-loop peptide and dehydrogenase domain (K-d = 58 +/- 12 nM). This interaction was weakened with Nox4 R96E B-loop corresponding to a mutation that also markedly decreases the activity of holo-Nox4. Truncations of the dehydrogenase domain localize the B-loop-binding site to the N-terminal half of the NADPH-binding subdomain. Similarly, the Nox2 B-loop bound to the Nox2 dehydrogenase domain, and both the Nox2 and Nox4 interactions were dependent on the polybasic region of the B-loop. These data indicate that the B-loop is critical for Nox4 function; we propose that the B-loop, by binding to the dehydrogenase domain, provides the interface between the transmembrane and dehydrogenase domains of Nox enzymes.	[Jackson, Heather M.; Kawahara, Tsukasa; Nisimoto, Yukio; Smith, Susan M. E.; Lambeth, J. David] Emory Univ, Sch Med, Dept Pathol & Expt Med, Atlanta, GA 30322 USA	Emory University	Lambeth, JD (corresponding author), Emory Univ, Sch Med, Dept Pathol & Expt Med, 148 Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	noxdoc@mac.com			National Institutes of Health [CA105116, CA084138]; American Heart Association [0815088E]; NATIONAL CANCER INSTITUTE [R56CA105116, R01CA084138, R01CA105116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105116 and CA084138. This work was also supported by American Heart Association Grant 0815088E.	ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 1999, J BIOL CHEM, V274, P10451, DOI 10.1074/jbc.274.15.10451; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; CHEN ZW, 1994, SCIENCE, V266, P430, DOI 10.1126/science.7939681; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; DELEO FR, 1995, P NATL ACAD SCI USA, V92, P7110, DOI 10.1073/pnas.92.15.7110; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Ebisu K, 2001, J BIOL CHEM, V276, P24498, DOI 10.1074/jbc.M101122200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Goyal P, 2005, BIOCHEM BIOPH RES CO, V329, P32, DOI 10.1016/j.bbrc.2005.01.089; GUNNER MR, 1991, P NATL ACAD SCI USA, V88, P9151, DOI 10.1073/pnas.88.20.9151; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hwang JN, 2005, AM J PHYSIOL-CELL PH, V288, pC899, DOI 10.1152/ajpcell.00474.2004; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; Jameson DM, 1999, METHODS, V19, P222, DOI 10.1006/meth.1999.0853; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; MOORE GR, 1986, P NATL ACAD SCI USA, V83, P4998, DOI 10.1073/pnas.83.14.4998; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; Park MY, 1997, BIOCHEM BIOPH RES CO, V234, P531, DOI 10.1006/bbrc.1997.6672; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09	54	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10281	10290		10.1074/jbc.M109.084939	http://dx.doi.org/10.1074/jbc.M109.084939			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139414	Green Published, hybrid			2022-12-25	WOS:000276264600012
J	Takabe, K; Kim, RH; Allegood, JC; Mitra, P; Ramachandran, S; Nagahashi, M; Harikumar, KB; Hait, NC; Milstien, S; Spiegel, S				Takabe, Kazuaki; Kim, Roger H.; Allegood, Jeremy C.; Mitra, Poulami; Ramachandran, Subramaniam; Nagahashi, Masayuki; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Milstien, Sheldon; Spiegel, Sarah			Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; G-PROTEIN; PLASMA-MEMBRANE; SPHINGOLIPID METABOLISM; MCF-7 CELLS; STEM-CELLS; ESTROGEN; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; RECEPTOR	Sphingosine 1-phosphate (S1P), a potent sphingolipid mediator produced by sphingosine kinase isoenzymes (SphK1 and SphK2), regulates diverse cellular processes important for breast cancer progression acting in an autocrine and/or paracrine manner. Here we show that SphK1, but not SphK2, increased S1P export from MCF-7 cells. Whereas for both estradiol (E-2) and epidermal growth factor-activated SphK1 and production of S1P, only E-2 stimulated rapid release of S1P and dihydro-S1P from MCF-7 cells. E-2-induced S1P and dihydro-S1P export required estrogen receptor-alpha, not GPR30, and was suppressed either by pharmacological inhibitors or gene silencing of ABCC1(multidrug resistant protein 1) or ABCG2(breast cancer resistance protein). Inhibiting these transporters also blocked E2-induced activation of ERK1/2, indicating that E-2 activates ERK via downstream signaling of S1P. Taken together, our findings suggest that E-2-induced export of S1P mediated by ABCC1 and ABCG2 transporters and consequent activation of S1P receptors may contribute to nongenomic signaling of E-2 important for breast cancer pathophysiology.	[Allegood, Jeremy C.; Mitra, Poulami; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; [Takabe, Kazuaki; Kim, Roger H.; Ramachandran, Subramaniam; Nagahashi, Masayuki] Virginia Commonwealth Univ, Dept Surg, Sch Med, Div Surg Oncol, Richmond, VA 23298 USA; [Takabe, Kazuaki; Kim, Roger H.; Allegood, Jeremy C.; Mitra, Poulami; Ramachandran, Subramaniam; Nagahashi, Masayuki; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Ramachandran, Subramaniam/B-8247-2013; Harikumar, Kuzhuvelil/AAC-2407-2020; Nagahashi, Masayuki/AAB-4202-2020; Kim, Roger/I-2838-2019	Harikumar, Kuzhuvelil/0000-0002-1763-4179; Kim, Roger/0000-0003-0718-7376; Takabe, Kazuaki/0000-0002-6435-4241	National Institutes of Health [R37GM043880, R01CA61774]; Virginia Commonwealth University [BIRCWH K12HD055881]; Susan G. Komen for the Cure Career Catalyst [KG090510]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD055881] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; Susan G. Komen for the Cure Career Catalyst(Susan G. Komen Breast Cancer Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37GM043880 and R01CA61774 (to S. S.), Virginia Commonwealth University Grant BIRCWH K12HD055881, and Susan G. Komen for the Cure Career Catalyst Research Grant KG090510 (to K. T.).	Bergelin N, 2009, ENDOCRINOLOGY, V150, P2055, DOI 10.1210/en.2008-0625; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Doll F, 2007, ENDOCR-RELAT CANCER, V14, P325, DOI 10.1677/ERC-06-0050; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; French KJ, 2003, CANCER RES, V63, P5962; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kleuser B, 2008, MOL PHARMACOL, V74, P1533, DOI 10.1124/mol.108.046854; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Mitra P, 2007, METHOD ENZYMOL, V434, P257, DOI 10.1016/S0076-6879(07)34014-7; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Nieuwenhuis B, 2009, J MOL MED, V87, P645, DOI 10.1007/s00109-009-0468-x; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Shida D, 2008, CANCER RES, V68, P6569, DOI 10.1158/0008-5472.CAN-08-0411; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; THU R, 2005, NEW ENGL J MED, V353, P2747; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Visram H, 2006, CANCER BIOL THER, V5, P1677, DOI 10.4161/cbt.5.12.3378	54	194	203	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10477	10486		10.1074/jbc.M109.064162	http://dx.doi.org/10.1074/jbc.M109.064162			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110355	Green Published, hybrid			2022-12-25	WOS:000276264600034
J	Thien, CBF; Dagger, SA; Steer, JH; Koentgen, F; Jansen, ES; Scott, CL; Langdon, WY				Thien, Christine B. F.; Dagger, Samantha A.; Steer, James H.; Koentgen, Frank; Jansen, Elisa S.; Scott, Clare L.; Langdon, Wallace Y.			c-Cbl Promotes T Cell Receptor-induced Thymocyte Apoptosis by Activating the Phosphatidylinositol 3-Kinase/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER BIM; NEGATIVE SELECTION; TYROSINE PHOSPHORYLATION; AUTOREACTIVE THYMOCYTES; OF-FUNCTION; KINASE; DOMAIN; INHIBITORS; ZAP-70; LIGASE	The ability of thymocytes to assess T cell receptor (TCR) signaling strength and initiate the appropriate downstream response is crucial for determining their fate. We have previously shown that a c-Cbl RING finger mutant knock-in mouse, in which the E3 ubiquitin ligase activity of c-Cbl is inactivated, is highly sensitive to TCR-induced death signals that cause thymic deletion. This high intensity signal involves the enhanced tyrosine phosphorylation of the mutant c-Cbl protein promoting a marked increase in the activation of Akt. Here we show that this high intensity signal in c-Cbl RING finger mutant thymocytes also promotes the enhanced induction of two mediators of TCR-directed thymocyte apoptosis, Nur77 and the pro-apoptotic Bcl-2 family member, Bim. In contrast, a knock-in mouse harboring a mutation at Tyr-737, the site in c-Cbl that activates phosphatidylinositol 3-kinase, shows reduced TCR-mediated responses including suppression of Akt activation, a reduced induction of Nur77 and Bim, and greater resistance to thymocyte death. These findings identify tyrosine-phosphorylated c-Cbl as a critical sensor of TCR signal strength that regulates the engagement of death-promoting signals.	[Thien, Christine B. F.; Dagger, Samantha A.; Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA 6009, Australia; [Steer, James H.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA 6009, Australia; [Koentgen, Frank] Ozgene Pty Ltd, Bentley, WA 6102, Australia; [Jansen, Elisa S.; Scott, Clare L.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Western Australia; University of Western Australia; Walter & Eliza Hall Institute	Langdon, WY (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA 6009, Australia.	wally.langdon@uwa.edu.au	Thien, Christine/GQP-0424-2022	Thien, Christine/0000-0003-3884-5546	National Health and Medical Research Council (NHMRC) [458539]; Department of Health, Western Australia; NHMRC [406675, 303112]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Department of Health, Western Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) (Canberra) Grant 458539, an infrastructure grant from the Medical and Health Research Infrastructure Fund, Department of Health, Western Australia, and NHMRC Fellowships 406675 (to C. L. S.) and 303112 ( to W.Y.L.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Andoniou CE, 1996, ONCOGENE, V12, P1981; ANDONIOU CE, 1996, THESIS U W AUSTR; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; CALNAN BJ, 1995, IMMUNITY, V3, P273; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Grossmann AH, 2004, FEBS LETT, V577, P555, DOI 10.1016/j.febslet.2004.10.054; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gustin SE, 2006, J IMMUNOL, V177, P5980, DOI 10.4049/jimmunol.177.9.5980; Harris TE, 1996, BIOCHEM BIOPH RES CO, V227, P672, DOI 10.1006/bbrc.1996.1567; Huang F, 2006, IMMUNITY, V25, P571, DOI 10.1016/j.immuni.2006.08.021; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Maltzman JS, 2005, J EXP MED, V202, P893, DOI 10.1084/jem.20051128; Molero JC, 2006, DIABETES, V55, P3411, DOI 10.2337/db06-0955; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Ohashi PS, 2003, CURR OPIN IMMUNOL, V15, P668, DOI 10.1016/j.coi.2003.09.013; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Siggs OM, 2006, CURR OPIN IMMUNOL, V18, P175, DOI 10.1016/j.coi.2006.01.001; Sohn SJ, 2007, CURR OPIN IMMUNOL, V19, P510, DOI 10.1016/j.coi.2007.06.001; Strasser A, 2008, IMMUNOL CELL BIOL, V86, P57, DOI 10.1038/sj.icb.7100141; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Thien CBF, 2003, J EXP MED, V197, P503, DOI 10.1084/jem.20021498; Thien CBF, 1999, J IMMUNOL, V162, P7133; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	43	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10969	10981		10.1074/jbc.M109.094920	http://dx.doi.org/10.1074/jbc.M109.094920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133944	Green Published, hybrid			2022-12-25	WOS:000276264600081
J	Graham, JF; Agarwal, S; Kurian, D; Kirby, L; Pinheiro, TJT; Gill, AC				Graham, James F.; Agarwal, Sonya; Kurian, Dominic; Kirby, Louise; Pinheiro, Teresa J. T.; Gill, Andrew C.			Low Density Subcellular Fractions Enhance Disease-specific Prion Protein Misfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE CONVERSION; IN-VITRO; LIPID-MEMBRANES; RECOMBINANT PRP; INFECTIOUS PRIONS; HEPARAN-SULFATE; SCRAPIE; PROPAGATION; STRAINS; AMPLIFICATION	The production of prion particles in vitro by amplification with or without exogenous seed typically results in infectivity titers less than those associated with PrPSc isolated ex vivo and highlights the potential role of co-factors that can catalyze disease-specific prion protein misfolding in vivo. We used a cell-free conversion assay previously shown to replicate many aspects of transmissible spongiform encephalopathy disease to investigate the cellular location of disease-specific co-factors using fractions derived from gradient centrifugation of a scrapie-susceptible cell line. Fractions from the low density region of the gradient doubled the efficiency of conversion of recombinant PrP. These fractions contain plasma membrane and cytoplasmic proteins, and conversion enhancement can be achieved using PrPSc derived from two different strains of mouse-passaged scrapie as seed. Equivalent fractions from a second scrapie-susceptible cell line also stimulate conversion. We also show that subcellular fractions enhancing disease-specific prion protein conversion prevent in vitro fibrillization of recombinant prion protein, suggesting the existence of separate, competing mechanisms of disease-specific and nonspecific misfolding in vivo.	[Graham, James F.; Agarwal, Sonya; Kirby, Louise; Gill, Andrew C.] Univ Edinburgh, Neuropathogenesis Div, Roslin Inst, Easter Bush Vet Ctr, Roslin EH25 9RG, Midlothian, Scotland; [Graham, James F.; Agarwal, Sonya; Kirby, Louise; Gill, Andrew C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Vet Ctr, Roslin EH25 9RG, Midlothian, Scotland; [Pinheiro, Teresa J. T.] Univ Warwick, Sch Biol Sci, Coventry CV4 7AL, W Midlands, England; [Kurian, Dominic] Inst Anim Hlth, Newbury RG20 7NN, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Warwick; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Gill, AC (corresponding author), Univ Edinburgh, Neuropathogenesis Div, Roslin Inst, Easter Bush Vet Ctr, Alexander Robertson Bldg, Roslin EH25 9RG, Midlothian, Scotland.	andrew.gill@roslin.ed.ac.uk	Gill, Andrew C/A-5219-2009; Gill, ANdrew/GRO-1248-2022	Gill, Andrew C/0000-0001-5201-9473; Kurian, Dominic/0000-0002-5924-665X	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Department for Environment, Food, and Rural Affairs; BBSRC [BBS/E/A/00001663, BBS/E/D/05241338] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/A/00001663, BBS/E/D/05241338] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a doctoral training account from the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom.; Supported through an Institute Strategic Programme Grant from the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom.; Supported by the Department for Environment, Food, and Rural Affairs.	Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Breydo Leonid, 2008, V459, P105, DOI 10.1007/978-1-59745-234-2_8; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Fasano C, 2006, J MOL NEUROSCI, V29, P195, DOI 10.1385/JMN:29:3:195; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Hachiya NS, 2005, NEUROSCI LETT, V374, P98, DOI 10.1016/j.neulet.2004.10.044; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Kirby L, 2003, J GEN VIROL, V84, P1013, DOI 10.1099/vir.0.18903-0; Kirby L, 2004, TECHNIQUES PRION RES; Kirby L, 2006, J GEN VIROL, V87, P3747, DOI 10.1099/vir.0.82086-0; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Makarava Natallia, 2008, V459, P131, DOI 10.1007/978-1-59745-234-2_10; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ritchie MA, 2002, J AM SOC MASS SPECTR, V13, P1065, DOI 10.1016/S1044-0305(02)00421-X; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Summers DW, 2009, PRION, V3, P59, DOI 10.4161/pri.3.2.9062; Supattapone Surachai, 2008, V459, P117, DOI 10.1007/978-1-59745-234-2_9; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Weissmann C, 2009, FOLIA NEUROPATHOL, V47, P104; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377	45	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9868	9880		10.1074/jbc.M109.093484	http://dx.doi.org/10.1074/jbc.M109.093484			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106973	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000276165900058
J	Low, DHP; Frecer, V; Le Saux, A; Srinivasan, GA; Ho, B; Chen, JZ; Ding, JL				Low, Diana Hooi Ping; Frecer, Vladimir; Le Saux, Agnes; Srinivasan, Ganesh Anand; Ho, Bow; Chen, Jianzhu; Ding, Jeak Ling			Molecular Interfaces of the Galactose-binding Protein Tectonin Domains in Host-Pathogen Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; CRYSTAL-STRUCTURE; INNATE IMMUNITY; RECOGNITION RECEPTORS; HYDROGEN-EXCHANGE; LECTIN; DOCKING; HADDOCK; CLONING; PLASMA	beta-Propeller proteins function in catalysis, protein-protein interaction, cell cycle regulation, and innate immunity. The galactose-binding protein (GBP) from the plasma of the horseshoe crab, Carcinoscorpius rotundicauda, is a beta-propeller protein that functions in antimicrobial defense. Studies have shown that upon binding to Gram-negative bacterial lipopolysaccharide (LPS), GBP interacts with C-reactive protein (CRP) to form a pathogen-recognition complex, which helps to eliminate invading microbes. However, the molecular basis of interactions between GBP and LPS and how it interplays with CRP remain largely unknown. By homology modeling, we showed that GBP contains six beta-propeller/Tectonin domains. Ligand docking indicated that Tectonin domains 6 to 1 likely contain the LPS binding sites. Protein-protein interaction studies demonstrated that Tectonin domain 4 interacts most strongly with CRP. Hydrogen-deuterium exchange mass spectrometry mapped distinct sites of GBP that interact with LPS and with CRP, consistent with in silico predictions. Furthermore, infection condition (lowered Ca2+ level) increases GBP-CRP affinity by 1000-fold. Resupplementing the system with a physiological level of Ca2+ did not reverse the protein-protein affinity to the basal state, suggesting that the infection-induced complex had undergone irreversible conformational change. We propose that GBP serves as a bridging molecule, participating in molecular interactions, GBP-LPS and GBP-CRP, to form a stable pathogen-recognition complex. The interaction interfaces in these two partners suggest that Tectonin domains can differentiate self/nonself, crucial to frontline defense against infection. In addition, GBP shares architectural and functional homologies to a human protein, hTectonin, suggesting its evolutionarily conservation for similar to 500 million years, from horseshoe crab to human.	[Low, Diana Hooi Ping; Le Saux, Agnes; Srinivasan, Ganesh Anand; Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Low, Diana Hooi Ping; Chen, Jianzhu; Ding, Jeak Ling] Singapore Massachusetts Inst Technol Alliance, Singapore 117576, Singapore; [Ho, Bow] Natl Univ Singapore, Dept Microbiol, Singapore 117543, Singapore; [Frecer, Vladimir] Lab Mol Biostruct & Nanomat Modeling, I-34149 Trieste, Italy; [Frecer, Vladimir] Slovak Acad Sci, Canc Res Inst, Bratislava 83391, Slovakia; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA 02142 USA	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Slovak Academy of Sciences; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsdjl@nus.edu.sg	Frecer, Vladimir/AAY-3030-2021; Ding, Jeak/H-8057-2012	Low, Diana/0000-0002-6054-8524	Singapore-MIT Alliance, Computational and Systems Biology; AcRF [T208B3109]	Singapore-MIT Alliance, Computational and Systems Biology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); AcRF	This work was supported by grants from the Singapore-MIT Alliance, Computational and Systems Biology and the AcRF (T208B3109, MoE).	Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Blackwell JM, 2000, MICROBES INFECT, V2, P317, DOI 10.1016/S1286-4579(00)00295-1; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen SC, 2001, J BIOL CHEM, V276, P9631, DOI 10.1074/jbc.M008414200; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Daiyasu H, 2008, J BIOCHEM, V144, P467, DOI 10.1093/jb/mvn095; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Frecer V, 2000, EUR J BIOCHEM, V267, P837, DOI 10.1046/j.1432-1327.2000.01069.x; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Hubbard S, 1996, NACCESS VERSION 2 1; Huh CG, 1998, J BIOL CHEM, V273, P6565, DOI 10.1074/jbc.273.11.6565; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; Kawai F, 1999, J IND MICROBIOL BIOT, V23, P400, DOI 10.1038/sj.jim.2900730; Le Saux A, 2008, J MOL BIOL, V377, P902, DOI 10.1016/j.jmb.2008.01.045; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li Y, 2007, EUR J IMMUNOL, V37, P3477, DOI 10.1002/eji.200737078; Low DHP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006260; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; Naberezhnykh GA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P432, DOI 10.1134/S0006297908040081; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Ng PML, 2004, J ENDOTOXIN RES, V10, P163, DOI 10.1179/096805104225004833; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Petsko G., 2004, PROTEIN STRUCTURE FU; Rakotobe D, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-32; Ramadan MAM, 2002, ACTA CRYSTALLOGR D, V58, P992, DOI 10.1107/S0907444902005693; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Schroder HC, 2003, J BIOL CHEM, V278, P32810, DOI 10.1074/jbc.M304116200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200; Yadid I, 2007, J MOL BIOL, V365, P10, DOI 10.1016/j.jmb.2006.09.055; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	38	17	19	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9898	9907		10.1074/jbc.M109.059774	http://dx.doi.org/10.1074/jbc.M109.059774			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118243	hybrid, Green Published			2022-12-25	WOS:000276165900060
J	Ma, YH; Chen, L; Wright, GM; Pillai, SR; Chellappan, SP; Cress, WD				Ma, Yihong; Chen, Lu; Wright, Gabriela M.; Pillai, Smitha R.; Chellappan, Srikumar P.; Cress, W. Douglas			CDKN1C Negatively Regulates RNA Polymerase II C-terminal Domain Phosphorylation in an E2F1-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; TRANSCRIPTION FACTOR TFIIH; INDUCED APOPTOSIS; PHYSICAL INTERACTION; INHIBITOR P57(KIP2); POTENTIAL MEDIATOR; TUMOR-SUPPRESSOR; UP-REGULATION; E2F ACTIVITY; P-TEFB	CDKN1C is a cyclin-dependent kinase inhibitor and is a candidate tumor suppressor gene. We previously found that the CDKN1C protein represses E2F1-driven transcription in an apparent negative feedback loop. Herein, we explore the mechanism by which CDKN1C represses transcription. We find that adenoviral-mediated overexpression of CDKN1C leads to a dramatic reduction in phosphorylation of the RNA polymerase II (pol II) C-terminal domain (CTD). RNA interference studies demonstrate that this activity is not an artifact of CDKN1C over-expression, because endogenous CDKN1C mediates an inhibition of RNA pol II CTD phosphorylation in HeLa cells upon treatment with dexamethasone. Surprisingly, we find that CDKN1C-mediated repression of RNA pol II phosphorylation is E2F1-dependent, suggesting that E2F1 may direct CDKN1C to chromatin. Chromatin immunoprecipitation assays demonstrate that CDKN1C is associated with E2F1-regulated promoters in vivo and that this association can dramatically reduce the level of RNA pol II CTD phosphorylation at both Ser-2 and Ser-5 of the C-terminal domain repeat. In addition, we show that CDKN1C interacts with both CDK7 and CDK9 (putative RNA pol II CTD kinases) and that CDKN1C blocks their ability to phosphorylate a glutathione S-transferase-CTD fusion protein in vitro. E2F1 and CDKN1C are found to form stable complexes both in vivo and in vitro. Molecular studies demonstrate that the E2F1-CDKN1C interaction is mediated by two E2F domains. A central E2F1 domain interacts directly with CDKN1C, whereas a C-terminal E2F1 domain interacts with CDKN1C via interaction with Rb. The results presented in this report highlight a novel mechanism of tumor suppression by CDKN1C.	[Ma, Yihong; Chen, Lu; Wright, Gabriela M.; Pillai, Smitha R.; Chellappan, Srikumar P.; Cress, W. Douglas] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Cress, WD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.	douglas.cress@moffitt.org		Pillai, Smitha/0000-0001-9718-5010	National Institutes of Health [CA90489, CA119997]; Florida Department of Health [08BB-05]; Moffitt Research Institute; NATIONAL CANCER INSTITUTE [R01CA090489, P50CA119997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; Moffitt Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA90489 and CA119997 from NCI. This work was also supported by the Florida Department of Health (Grant 08BB-05) and by the Moffitt Research Institute.	Afshari CA, 1996, CELL GROWTH DIFFER, V7, P979; Alheim K, 2003, J MOL ENDOCRINOL, V30, P359, DOI 10.1677/jme.0.0300359; Amini S, 2002, ONCOGENE, V21, P5797, DOI 10.1038/sj.onc.1205754; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Cress WD, 1996, MOL CELL BIOL, V16, P2119; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; CRESS WD, 1994, J VIROL, V68, P4212, DOI 10.1128/JVI.68.7.4213-4219.1994; De Falco G, 2000, ONCOGENE, V19, P373, DOI 10.1038/sj.onc.1203305; DeGregori J, 2006, CURR MOL MED, V6, P739; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Eymin B, 2001, ONCOGENE, V20, P1033, DOI 10.1038/sj.onc.1204220; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; HARPER JW, 1993, CELL, V75, P805; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; Johnson DG, 2006, CURR MOL MED, V6, P731; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kaldis P, 1998, MOL BIOL CELL, V9, P2545, DOI 10.1091/mbc.9.9.2545; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Ko LJ, 1997, MOL CELL BIOL, V17, P7220, DOI 10.1128/MCB.17.12.7220; Lee DK, 2000, J BIOL CHEM, V275, P9308, DOI 10.1074/jbc.275.13.9308; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; Ma Y, 2007, ONCOGENE, V26, P3532, DOI 10.1038/sj.onc.1210143; Ma YH, 2004, CANCER BIOL THER, V3, P1262, DOI 10.4161/cbt.3.12.1239; Ma YH, 2003, J BIOL CHEM, V278, P16770, DOI 10.1074/jbc.M212702200; Ma YH, 2003, MOL CANCER THER, V2, P73; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Mason SL, 2002, ONCOGENE, V21, P4220, DOI 10.1038/sj.onc.1205524; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Misra RN, 2004, J MED CHEM, V47, P1719, DOI 10.1021/jm0305568; Morris DP, 1997, METHODS, V12, P264, DOI 10.1006/meth.1997.0478; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Rickert P, 1996, ONCOGENE, V12, P2631; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Samuelsson MKR, 1999, MOL ENDOCRINOL, V13, P1811, DOI 10.1210/me.13.11.1811; Schneider E, 1998, ONCOGENE, V17, P2733, DOI 10.1038/sj.onc.1202504; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Simone C, 2002, ONCOGENE, V21, P4158, DOI 10.1038/sj.onc.1205511; Stewart MC, 2004, J BONE MINER RES, V19, P123, DOI 10.1359/JBMR.0301209; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vandel L, 1999, EMBO J, V18, P4280, DOI 10.1093/emboj/18.15.4280; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Yang XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005011; Zeng HW, 2009, J NUTR, V139, P1613, DOI 10.3945/jn.109.110320; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814	61	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9813	9822		10.1074/jbc.M109.091496	http://dx.doi.org/10.1074/jbc.M109.091496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106982	hybrid, Green Published			2022-12-25	WOS:000276165900053
J	Popp, D; Xu, WJ; Narita, A; Brzoska, AJ; Skurray, RA; Firth, N; Goshdastider, U; Maeda, Y; Robinson, RC; Schumacher, MA				Popp, David; Xu, Weijun; Narita, Akihiro; Brzoska, Anthony J.; Skurray, Ronald A.; Firth, Neville; Goshdastider, Umesh; Maeda, Yuichiro; Robinson, Robert C.; Schumacher, Maria A.			Structure and Filament Dynamics of the pSK41 Actin-like ParM Protein IMPLICATIONS FOR PLASMID DNA SEGREGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-THURINGIENSIS; CRYSTAL-STRUCTURE; F-ACTIN; INSTABILITY; HOMOLOG; PARTITION; POLYMERIZATION; CYTOSKELETON; COMPLEX; SYSTEM	Type II plasmid partition systems utilize ParM NTPases in coordination with a centromere-binding protein called ParR to mediate accurate DNA segregation, a process critical for plasmid retention. The Staphylococcus aureus pSK41 plasmid is a medically important plasmid that confers resistance to multiple antibiotics, disinfectants, and antiseptics. In the first step of partition, the pSK41 ParR binds its DNA centromere to form a superhelical partition complex that recruits ParM, which then mediates plasmid separation. pSK41 ParM is homologous to R1 ParM, a known actin homologue, suggesting that it may also form filaments to drive partition. To gain insight into the partition function of ParM, we examined its ability to form filaments and determined the crystal structure of apoParM to 1.95 angstrom. The structure shows that pSK41 ParM belongs to the actin/Hsp70 superfamily. Unexpectedly, however, pSK41 ParM shows the strongest structural homology to the archaeal actin-like protein Thermoplasma acidophilum Ta0583, rather than its functional homologue, R1 ParM. Consistent with this divergence, we find that regions shown to be involved in R1 ParM filament formation are not important in formation of pSK41 ParM polymers. These data are also consonant with our finding that pSK41 ParM forms 1-start 10/4 helices very different from the 37/17 symmetry of R1 ParM. The polymerization kinetics of pSK41 ParM also differed from that of R1 ParM. These results indicate that type II NTPases utilize different polymeric structures to drive plasmid segregation.	[Popp, David; Narita, Akihiro; Maeda, Yuichiro] Japan Sci & Technol Corp, Harima Inst Spring, ERATO Actin Filament Dynam Project, RIKEN, Sayo, Hyogo 6795148, Japan; [Popp, David; Robinson, Robert C.] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Xu, Weijun; Schumacher, Maria A.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Brzoska, Anthony J.; Skurray, Ronald A.; Firth, Neville] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Narita, Akihiro; Goshdastider, Umesh; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Narita, Akihiro; Goshdastider, Umesh; Maeda, Yuichiro] Nagoya Univ, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Japan Science & Technology Agency (JST); RIKEN; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Texas System; UTMD Anderson Cancer Center; University of Sydney; Nagoya University; Nagoya University	Popp, D (corresponding author), Japan Sci & Technol Corp, Harima Inst Spring, ERATO Actin Filament Dynam Project, RIKEN, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	dpopp@imcb.A-star.edu.sg; maschuma@mdanderson.org	Robinson, Robert/G-9702-2011; Ghoshdastider, Umesh/O-5327-2015	Robinson, Robert/0000-0001-6367-6903; Firth, Neville/0000-0002-5791-7691; Ghoshdastider, Umesh/0000-0003-4471-9394	National Institutes of Health [R01 AI080687]; Australian Research Council Discovery [DP0346013]; National Health and Medical Research Council of Australia Project [571028]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council Discovery(Australian Research Council); National Health and Medical Research Council of Australia Project(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI080687 (to M. A. S.), Australian Research Council Discovery Grant DP0346013 (to N. F. and R. A. S.), and National Health and Medical Research Council of Australia Project Grant 571028 (to N. F., M. A. S., and R. A. S.).	Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; DeLano W, 2002, PYMOL 0 99; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Firth N., 2006, GRAM POSITIVE PATHOG, P413; Funnell BE, 2005, PLASMID, V53, P119, DOI 10.1016/j.plasmid.2004.12.009; Galkin VE, 2009, STRUCTURE, V17, P1253, DOI 10.1016/j.str.2009.07.008; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Hara F, 2007, J BACTERIOL, V189, P2039, DOI 10.1128/JB.01454-06; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holmes K C, 1965, Methods Biochem Anal, V13, P113, DOI 10.1002/9780470110317.ch4; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Popp D, 2008, BIOPOLYMERS, V89, P711, DOI 10.1002/bip.20999; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Roeben A, 2006, J MOL BIOL, V358, P145, DOI 10.1016/j.jmb.2006.01.096; Rommelaere H, 2003, STRUCTURE, V11, P1279, DOI 10.1016/j.str.2003.09.002; Sablin EP, 2002, P NATL ACAD SCI USA, V99, P10945, DOI 10.1073/pnas.152329899; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Simpson AE, 2003, J BACTERIOL, V185, P2143, DOI 10.1128/JB.185.7.2143-2152.2003; Tang M, 2007, J BACTERIOL, V189, P8053, DOI 10.1128/JB.00908-07; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025	55	37	38	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10130	10140		10.1074/jbc.M109.071613	http://dx.doi.org/10.1074/jbc.M109.071613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106979	hybrid, Green Published			2022-12-25	WOS:000276165900080
J	Rienstra, H; Katta, K; Celie, JWAM; van Goor, H; Navis, G; van den Born, J; Hillebrands, JL				Rienstra, Heleen; Katta, Kirankumar; Celie, Johanna W. A. M.; van Goor, Harry; Navis, Gerjan; van den Born, Jacob; Hillebrands, Jan-Luuk			Differential Expression of Proteoglycans in Tissue Remodeling and Lymphangiogenesis after Experimental Renal Transplantation in Rats	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MUSCLE-CELL PROLIFERATION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; EPITHELIAL-MESENCHYMAL TRANSITION; GLOMERULAR EXTRACELLULAR-MATRIX; INTERTUBULAR CAPILLARY CHANGES; BASEMENT-MEMBRANE; L-SELECTIN; LYMPHATIC NEOANGIOGENESIS; DIABETIC-NEPHROPATHY	Background: Chronic transplant dysfunction explains the majority of late renal allograft loss and is accompanied by extensive tissue remodeling leading to transplant vasculopathy, glomerulosclerosis and interstitial fibrosis. Matrix proteoglycans mediate cell-cell and cell-matrix interactions and play key roles in tissue remodeling. The aim of this study was to characterize differential heparan sulfate proteoglycan and chondroitin sulfate proteoglycan expression in transplant vasculopathy, glomerulosclerosis and interstitial fibrosis in renal allografts with chronic transplant dysfunction. Methods: Renal allografts were transplanted in the Dark Agouti-to-Wistar Furth rat strain combination. Dark Agouti-to-Dark Agouti isografts and non-transplanted Dark Agouti kidneys served as controls. Allograft and isograft recipients were sacrificed 66 and 81 days (mean) after transplantation, respectively. Heparan sulfate proteoglycan (collXVIII, perlecan and agrin) and chondroitin sulfate proteoglycan (versican) expression, as well as CD31 and LYVE-1 (vascular and lymphatic endothelium, respectively) expression were (semi-) quantitatively analyzed using immunofluorescence. Findings: Arteries with transplant vasculopathy and sclerotic glomeruli in allografts displayed pronounced neo-expression of collXVIII and perlecan. In contrast, in interstitial fibrosis expression of the chondroitin sulfate proteoglycan versican dominated. In the cortical tubular basement membranes in both iso-and allografts, induction of collXVIII was detected. Allografts presented extensive lymphangiogenesis (p<0.01 compared to isografts and non-transplanted controls), which was associated with induced perlecan expression underneath the lymphatic endothelium (p<0.05 and p<0.01 compared to isografts and non-transplanted controls, respectively). Both the magnitude of lymphangiogenesis and perlecan expression correlated with severity of interstitial fibrosis and impaired graft function. Interpretation: Our results reveal that changes in the extent of expression and the type of proteoglycans being expressed are tightly associated with tissue remodeling after renal transplantation. Therefore, proteoglycans might be potential targets for clinical intervention in renal chronic transplant dysfunction.	[Rienstra, Heleen] Univ Groningen, Dept Cell Biol, Univ Med Ctr Groningen, Immunol Sect, Groningen, Netherlands; [Katta, Kirankumar; Navis, Gerjan; van den Born, Jacob] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Div Nephrol, Groningen, Netherlands; [Celie, Johanna W. A. M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Div Pathol, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Groningen	Rienstra, H (corresponding author), Univ Groningen, Dept Cell Biol, Univ Med Ctr Groningen, Immunol Sect, Groningen, Netherlands.	j.l.hillebrands@path.umcg.nl	van+Goor, Harry/AAS-7712-2020	van Goor, Harry/0000-0002-6670-1577; Hillebrands, Jan-Luuk/0000-0003-3135-3274	Dutch Kidney Foundation [C03.6015]; University Medical Center Groningen	Dutch Kidney Foundation; University Medical Center Groningen	This study was supported by a Career Stimulation Program Grant from the Dutch Kidney Foundation (C03.6015, J.-L.H. and H. R.) and the University Medical Center Groningen (K. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2005, TRANSPLANTATION, V79, P672, DOI 10.1097/01.TP.0000155961.57664.DB; Aresu L, 2007, VIRCHOWS ARCH, V451, P937, DOI 10.1007/s00428-007-0482-8; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bellini MH, 2007, NEPHROLOGY, V12, P459, DOI 10.1111/j.1440-1797.2007.00850.x; Bingley JA, 1998, J VASC SURG, V28, P308, DOI 10.1016/S0741-5214(98)70167-3; Bjornson A, 2005, AM J PHYSIOL-RENAL, V288, pF748, DOI 10.1152/ajprenal.00202.2004; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; Celie JWAM, 2008, AM J PHYSIOL-RENAL, V294, pF253, DOI 10.1152/ajprenal.00429.2007; Celie JWAM, 2007, AM J PATHOL, V170, P1865, DOI 10.2353/ajpath.2007.070061; Celie JWAM, 2009, FRONT BIOSCI-LANDMRK, V14, P4932, DOI 10.2741/3578; Celie JWAM, 2005, J BIOL CHEM, V280, P26965, DOI 10.1074/jbc.M502188200; Celie JWAM, 2005, J IMMUNOL METHODS, V298, P155, DOI 10.1016/j.jim.2005.01.009; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; Colvin RB, 2004, J AM SOC NEPHROL, V15, P827, DOI 10.1097/01.ASN.0000117895.24143.87; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Farb A, 2004, CIRCULATION, V110, P940, DOI 10.1161/01.CIR.0000139337.56084.30; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Hillebrands JL, 2003, ARTERIOSCL THROM VAS, V23, P380, DOI 10.1161/01.ATV.0000059337.60393.64; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393, DOI 10.1177/002215540305101101; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kawashima H, 1999, INT IMMUNOL, V11, P393, DOI 10.1093/intimm/11.3.393; Kawashima H, 2003, J BIOL CHEM, V278, P13069, DOI 10.1074/jbc.M212244200; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kinsella MG, 2004, ATHEROSCLEROSIS, V175, P51, DOI 10.1016/j.atherosclerosis.2004.01.045; Kinsella MG, 2003, ARTERIOSCL THROM VAS, V23, P608, DOI 10.1161/01.ATV.0000063109.94810.EE; Kouwenhoven EA, 2000, TRANSPL INT, V13, P385; Kunter U, 2003, TRANSPLANTATION, V75, P3, DOI 10.1097/00007890-200301150-00002; Labropoulou VT, 2006, HISTOPATHOLOGY, V49, P582, DOI 10.1111/j.1365-2559.2006.02558.x; Lavin PJ, 2008, CURR OPIN NEPHROL HY, V17, P386, DOI 10.1097/MNH.0b013e32830464f4; Lin H, 1996, J HEART LUNG TRANSPL, V15, P1233; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Maciel TT, 2008, J NEPHROL, V21, P753; Malek P, 1968, Lymphology, V1, P4; MAZZUCCO G, 1994, ULTRASTRUCT PATHOL, V18, P533, DOI 10.3109/01913129409021895; MONGA G, 1992, MODERN PATHOL, V5, P125; Netelenbos T, 2003, J LEUKOCYTE BIOL, V74, P1035, DOI 10.1189/jlb.1202593; OToole JJ, 1996, P NATL ACAD SCI USA, V93, P7369, DOI 10.1073/pnas.93.14.7369; PAUL LC, 1984, KIDNEY INT, V25, P771, DOI 10.1038/ki.1984.89; Raats CJI, 1998, J BIOL CHEM, V273, P17832, DOI 10.1074/jbc.273.28.17832; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Rienstra H, 2009, AM J TRANSPLANT, V9, P463, DOI 10.1111/j.1600-6143.2008.02534.x; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rutkowski JM, 2006, AM J PHYSIOL-HEART C, V291, pH1402, DOI 10.1152/ajpheart.00038.2006; Sakamoto I, 2009, KIDNEY INT, V75, P828, DOI 10.1038/ki.2008.661; Sakko AJ, 2001, CANCER RES, V61, P926; Segev A, 2004, CARDIOVASC RES, V63, P603, DOI 10.1016/j.cardiores.2004.03.028; Sephel GC, 1996, MATRIX BIOL, V15, P263, DOI 10.1016/S0945-053X(96)90117-1; Shimizu A, 2000, CLIN TRANSPLANT, V14, P6, DOI 10.1034/j.1399-0012.2000.0140s3006.x; Sinniah R, 1999, ULTRASTRUCT PATHOL, V23, P359, DOI 10.1080/019131299281329; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Stoessel A, 2008, AM J PHYSIOL-RENAL, V295, pF717, DOI 10.1152/ajprenal.00071.2008; Stuht S, 2007, AM J TRANSPLANT, V7, P377, DOI 10.1111/j.1600-6143.2006.01638.x; Suzuki T, 2001, AM J PATHOL, V158, P75, DOI 10.1016/S0002-9440(10)63946-6; Talusan P, 2005, MOL CELL PROTEOMICS, V4, P1350, DOI 10.1074/mcp.M500088-MCP200; TAMSMA JT, 1994, DIABETOLOGIA, V37, P313, DOI 10.1007/BF00398060; Thaunat O, 2006, TRENDS IMMUNOL, V27, P441, DOI 10.1016/j.it.2006.08.003; Tran PK, 2007, ATHEROSCLEROSIS, V190, P264, DOI 10.1016/j.atherosclerosis.2006.03.010; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; van den Born J, 2006, J BIOL CHEM, V281, P29606, DOI 10.1074/jbc.M601552200; van Goor H, 2009, KIDNEY INT, V75, P767, DOI 10.1038/ki.2009.45; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; vandenBorn J, 1996, J BIOL CHEM, V271, P22802, DOI 10.1074/jbc.271.37.22802; Waanders F, 2009, AM J PHYSIOL-RENAL, V296, pF1072, DOI 10.1152/ajprenal.90643.2008; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Yang YX, 2001, PEDIATR NEPHROL, V16, P429, DOI 10.1007/s004670100563	75	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9095	10.1371/journal.pone.0009095	http://dx.doi.org/10.1371/journal.pone.0009095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140097	Green Published, Green Submitted, gold			2022-12-25	WOS:000274442400025
J	Donlin, MJ; Cannon, NA; Aurora, R; Li, J; Wahed, AS; Di Bisceglie, AM; Tavis, JE				Donlin, Maureen J.; Cannon, Nathan A.; Aurora, Rajeev; Li, Jia; Wahed, Abdus S.; Di Bisceglie, Adrian M.; Tavis, John E.		Virahep C Study Grp	Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; OPEN-READING FRAME; PEGINTERFERON ALPHA-2B; PLUS RIBAVIRIN; IL28B; SUBSTITUTIONS; DIVERSITY; EVOLUTION; IMMUNITY; PROTEIN	Background: Hepatitis C virus (HCV) has six major genotypes, and patients infected with genotype 1 respond less well to interferon-based therapy than other genotypes. African American patients respond to interferon a-based therapy at about half the rate of Caucasian Americans. The effect of HCV's genetic variation on treatment outcome in both racial groups is poorly understood. Methodology: We determined the near full-length pre-therapy consensus sequences from 94 patients infected with HCV genotype 1a or 1b undergoing treatment with peginterferon alpha-2a and ribavirin through the Virahep-C study. The sequences were stratified by genotype, race and treatment outcome to identify HCV genetic differences associated with treatment efficacy. Principal Findings: HCV sequences from patients who achieved sustained viral response were more diverse than sequences from non-responders. These inter-patient diversity differences were found primarily in the NS5A gene in genotype 1a and in core and NS2 in genotype 1b. These differences could not be explained by host selection pressures. Genotype 1b but not 1a African American patients had viral genetic differences that correlated with treatment outcome. Conclusions & Significance: Higher inter-patient viral genetic diversity correlated with successful treatment, implying that there are HCV genotype 1 strains with intrinsic differences in sensitivity to therapy. Core, NS3 and NS5A have interferonsuppressive activities detectable through in vitro assays, and hence these activities also appear to function in human patients. Both preferential infection with relatively resistant HCV variants and host-specific factors appear to contribute to the unusually poor response to therapy in African American patients.	[Donlin, Maureen J.; Cannon, Nathan A.; Aurora, Rajeev; Tavis, John E.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Li, Jia; Wahed, Abdus S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, St Louis, MO USA; [Donlin, Maureen J.; Di Bisceglie, Adrian M.; Tavis, John E.] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA	Saint Louis University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint Louis University; Saint Louis University	Donlin, MJ (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	tavisje@slu.edu	Donlin, Maureen J./M-4709-2019	Donlin, Maureen/0000-0001-7312-079X; Wahed, Abdus/0000-0001-6911-7221; Aurora, Rajeev/0000-0002-6609-6055	National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute;  [U01 DK60345]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060345] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Virahep-C was funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute with further support under a Cooperative Research and Development Agreement with Roche Laboratories, Inc. Funding for this viral genetics project was through U01 DK60345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Cannon NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002123; Combet Christophe, 2004, Appl Bioinformatics, V3, P237, DOI 10.2165/00822942-200403040-00005; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Dentzer TG, 2009, J VIROL, V83, P12702, DOI 10.1128/JVI.01184-09; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Jeffers LJ, 2004, HEPATOLOGY, V39, P1702, DOI 10.1002/hep.20212; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jopling CL, 2006, COLD SPRING HARB SYM, V71, P369, DOI 10.1101/sqb.2006.71.022; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Reddy KR, 1999, HEPATOLOGY, V30, P787, DOI 10.1002/hep.510300319; Rosen HR, 2007, HEPATOLOGY, V46, P350, DOI 10.1002/hep.21714; Saito T, 2008, HEPATOL RES, V38, P115, DOI 10.1111/j.1872-034X.2007.00283.x; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Strait BJ, 1996, BIOPHYS J, V71, P148, DOI 10.1016/S0006-3495(96)79210-X; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Walewski JL, 2002, RNA, V8, P557, DOI 10.1017/S1355838202029023; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Yan T, 2005, NUCLEIC ACIDS RES, V33, pW262, DOI 10.1093/nar/gki368; Yao E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-88; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403; Yusim Karina, 2005, Appl Bioinformatics, V4, P217, DOI 10.2165/00822942-200504040-00002; Zhou DH, 2007, J VIROL METHODS, V141, P220, DOI 10.1016/j.jviromet.2006.12.002	41	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9032	10.1371/journal.pone.0009032	http://dx.doi.org/10.1371/journal.pone.0009032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140258	Green Accepted, Green Published, gold			2022-12-25	WOS:000274474200018
J	Drotz, MK; Brodin, T; Nilsson, AN				Drotz, Marcus K.; Brodin, Tomas; Nilsson, Anders N.			Multiple Origins of Elytral Reticulation Modifications in the West Palearctic Agabus bipustulatus Complex (Coleoptera, Dytiscidae)	PLOS ONE			English	Article							DIVING BEETLES COLEOPTERA; GENE FLOW; ULTRAVIOLET-RADIATION; SYMPATRIC SPECIATION; PHYLOGENY; DIMORPHISM; HYPOTHESIS; EVOLUTION; SELECTION; PATTERNS	The Agabus bipustulatus complex includes one of Europe's most widely distributed and common diving beetles. This complex, which is known for its large morphological variation, has a complex demographic and altitudinal variation in elytral reticulation. The various depth of the reticulation imprint, both in smaller and larger meshes, results in both mat and shiny individuals, as well as intermediate forms. The West Palearctic lowland is inhabited by a sexually dimorphic form, with shiny males and mat females. In mountain regions, shiny individuals of both sexes are found intermixed with mat individuals or in pure populations in central and southern areas, whereas pure populations of mat individuals are exclusively found in the northern region at high altitude. Sexual selection is proposed as a driving force in shaping this variation. However, the occurrence of different types of reticulation in both sexes and disjunct geographical distribution patterns suggest an additional function of the reticulation. Here we investigate the phylogeographical history, genetic structure and reticulation variation of several named forms within the Agabus bipustulatus complex including A. nevadensis. The molecular analyses recognised several well-supported clades within the complex. Several of the named forms had two or more independent origins. Few south European populations were uniform in reticulation patterns, and the males were found to display large variation. Reticulation diversity and population genetic variability were clearly correlated to altitude, but no genetic differences were detected among populations with mixed or homogenous forms. Observed reduction in secondary reticulation in female and increased variance in male at high altitude in South Europe may be explained by the occurrence of an additional selective force, beside sexual selection. The combined effect of these selective processes is here demonstrated in an extreme case to generate isolation barriers between populations at high altitudes. Here we discuss this selective force in relation to thermal selection.	[Drotz, Marcus K.] Lake Vanern Museum Nat & Cultural Hist, Lidkoping, Sweden; [Brodin, Tomas; Nilsson, Anders N.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Umea University	Drotz, MK (corresponding author), Lake Vanern Museum Nat & Cultural Hist, Lidkoping, Sweden.	Marcus.Drotz@lidkoping.se		Brodin, Tomas/0000-0003-1086-7567	Nilsson-Ehle foundation	Nilsson-Ehle foundation	This research project was partially sponsored by Nilsson-Ehle foundation (material and analysis costs) within the Kungl. Fysiografiska Sallskapet (http://www.fysiografen.se/default.asp) and Lidkoping municipality (salary cost for main author). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1999, PHYLOGEOGRAPHY HIST; BALFOURBROWNE F, 1950, BRIT WATER BEETLES, V2, P394; Barton NH, 2001, DISPERSAL, P330; Berger J, 2005, THEATER HEUTE, P36; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bergsten J, 2001, BIOL J LINN SOC, V73, P221, DOI 10.1006/bijl.2001.0540; Bergsten J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000522; Bilton DT, 2008, BIOL J LINN SOC, V94, P685, DOI 10.1111/j.1095-8312.2008.01029.x; Bolnick DI, 2003, EVOLUTION, V57, P2433, DOI 10.1554/02-595; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Crow JF, 2003, GENETICS, V164, P1; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Drotz MK, 2001, BIOL J LINN SOC, V73, P11, DOI 10.1006/bijl.2001.0491; DROTZ MK, THESIS U UMEA UMEA; Falkenstrom G, 1940, ARK ZOOL, V32, P1; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Franciscolo M.E., 1974, Bollettino Mus Civ Stor nat Verona, VNo. 1, P345; FRANCISCOLO ME, 1979, FAUNA ITALIA, V14, P11; FRESNEDA J, 1988, REV ESPANOLA ENTOMOL, V64, P17; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Grahame JW, 2006, EVOLUTION, V60, P268; Gross J, 2004, ENVIRON ENTOMOL, V33, P799, DOI 10.1603/0046-225X-33.4.799; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HOUSTON KJ, 1979, J AUST ENTOMOL SOC, V18, P45; HOWE JW, 2008, PLYMOUTH STUDENT SCI, V1, P56; KHALAF KT, 1980, FLA ENTOMOL, V63, P307, DOI 10.2307/3494627; Kirkpatrick M, 2004, P ROY SOC B-BIOL SCI, V271, P687, DOI 10.1098/rspb.2003.2645; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Knowles LL, 2007, EVOLUTION, V61, P477, DOI 10.1111/j.1558-5646.2007.00043.x; Laurion I, 2000, LIMNOL OCEANOGR, V45, P1274, DOI 10.4319/lo.2000.45.6.1274; Lehuraux Leon., 1931, NOMADISME COLONISATI; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LINDBERG H, 1939, COMMENTATIONES BIOL, V7, P1; Mikhailov Y.E., 2001, Pirineos, V156, P57; Miller KB, 2003, BIOL J LINN SOC, V79, P359, DOI 10.1046/j.1095-8312.2003.00195.x; Nilsson A.N., 2001, DYTISCIDAE COLEOPTER, V3; Nilsson Anders N., 1995, Fauna Entomologica Scandinavica, V32, P1; Nixon K, 1999, WINCLADA VER 0 9 99M; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Nosil P, 2005, EVOLUTION, V59, P705; Parker G.A., 1979, P123; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; POPE RD, 1977, BIOL J LINN SOC, V9, P331, DOI 10.1111/j.1095-8312.1977.tb00275.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ribera I, 2004, MOL PHYLOGENET EVOL, V30, P545, DOI 10.1016/S1055-7903(03)00224-0; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schmucki DA, 2002, OPT ENG, V41, P3090, DOI 10.1117/1.1516820; Sen N. S., 1993, VERHANDLUNGEN NATURF, V16, P73; SHARP D, 1882, SCI T ROYAL DUBLIN S, V2, P17; SHAW CR, 1970, BIOCHEM GENET, V4, P297, DOI 10.1007/BF00485780; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Via S, 2002, AM NAT, V159, pS1, DOI 10.1086/338368; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zimmermann A., 1934, Koleopterologische Rundschau, V20, P138; ZIMMERMANN A, 1919, ARCH NATURGESCH, V83, P107; ZIMMERMANN A, 1920, COLEOPTERORUM CATALO	69	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9034	10.1371/journal.pone.0009034	http://dx.doi.org/10.1371/journal.pone.0009034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140264	gold, Green Published, Green Submitted			2022-12-25	WOS:000274474200020
J	Metzgar, D; Myers, CA; Russell, KL; Faix, D; Blair, PJ; Brown, J; Vo, S; Swayne, DE; Thomas, C; Stenger, DA; Lin, B; Malanoski, AP; Wang, Z; Blaney, KM; Long, NC; Schnur, JM; Saad, MD; Borsuk, LA; Lichanska, AM; Lorence, MC; Weslowski, B; Schafer, KO; Tibbetts, C				Metzgar, David; Myers, Christopher A.; Russell, Kevin L.; Faix, Dennis; Blair, Patrick J.; Brown, Jason; Vo, Scott; Swayne, David E.; Thomas, Colleen; Stenger, David A.; Lin, Baochuan; Malanoski, Anthony P.; Wang, Zheng; Blaney, Kate M.; Long, Nina C.; Schnur, Joel M.; Saad, Magdi D.; Borsuk, Lisa A.; Lichanska, Agnieszka M.; Lorence, Matthew C.; Weslowski, Brian; Schafer, Klaus O.; Tibbetts, Clark			Single Assay for Simultaneous Detection and Differential Identification of Human and Avian Influenza Virus Types, Subtypes, and Emergent Variants	PLOS ONE			English	Article							RESEQUENCING DNA MICROARRAYS; PATHOGEN IDENTIFICATION; BACTERIAL PNEUMONIA; PANDEMIC INFLUENZA; BROAD-SPECTRUM; HEMAGGLUTININ; SURVEILLANCE; TOOL	For more than four decades the cause of most type A influenza virus infections of humans has been attributed to only two viral subtypes, A/H1N1 or A/H3N2. In contrast, avian and other vertebrate species are a reservoir of type A influenza virus genome diversity, hosting strains representing at least 120 of 144 combinations of 16 viral hemagglutinin and 9 viral neuraminidase subtypes. Viral genome segment reassortments and mutations emerging within this reservoir may spawn new influenza virus strains as imminent epidemic or pandemic threats to human health and poultry production. Traditional methods to detect and differentiate influenza virus subtypes are either time-consuming and labor-intensive (culture-based) or remarkably insensitive (antibody-based). Molecular diagnostic assays based upon reverse transcriptase-polymerase chain reaction (RT-PCR) have short assay cycle time, and high analytical sensitivity and specificity. However, none of these diagnostic tests determine viral gene nucleotide sequences to distinguish strains and variants of a detected pathogen from one specimen to the next. Decision-quality, strain-and variant-specific pathogen gene sequence information may be critical for public health, infection control, surveillance, epidemiology, or medical/veterinary treatment planning. The Resequencing Pathogen Microarray (RPM-Flu) is a robust, highly multiplexed and target gene sequencing-based alternative to both traditional culture-or biomarker-based diagnostic tests. RPM-Flu is a single, simultaneous differential diagnostic assay for all subtype combinations of type A influenza viruses and for 30 other viral and bacterial pathogens that may cause influenza-like illness. These other pathogen targets of RPM-Flu may co-infect and compound the morbidity and/or mortality of patients with influenza. The informative specificity of a single RPM-Flu test represents specimen-specific viral gene sequences as determinants of virus type, A/HN subtype, virulence, host-range, and resistance to antiviral agents.	[Metzgar, David; Myers, Christopher A.; Russell, Kevin L.; Faix, Dennis; Blair, Patrick J.; Brown, Jason; Vo, Scott] USN, Dept Resp Dis Res, Hlth Res Ctr, San Diego, CA 92152 USA; [Russell, Kevin L.] US Dept Def Global Emerging Infect Surveillance &, Div Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA; [Swayne, David E.; Thomas, Colleen; Blaney, Kate M.] ARS, SE Poultry Res Lab, USDA, Athens, GA USA; [Stenger, David A.; Lin, Baochuan; Malanoski, Anthony P.; Wang, Zheng; Long, Nina C.; Schnur, Joel M.] USN, Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Schnur, Joel M.] George Mason Univ, Manassas, VA USA; [Saad, Magdi D.] Naval Med Res Unit 3, Cairo, Egypt; [Borsuk, Lisa A.; Lichanska, Agnieszka M.; Lorence, Matthew C.; Weslowski, Brian; Schafer, Klaus O.; Tibbetts, Clark] TessArae LLC, Potomac Falls, VA USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; United States Department of Agriculture (USDA); United States Department of Defense; United States Navy; Naval Research Laboratory; George Mason University; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3)	Metzgar, D (corresponding author), USN, Dept Resp Dis Res, Hlth Res Ctr, San Diego, CA 92152 USA.	clark.tibbetts@tessarae.com	Swayne, David/AAP-7166-2020; Malanoski, Anthony P/C-7814-2011; Saad, Magdi/H-5561-2013; Stitt, Alan/A-9842-2009; Lin, Baochuan/A-8390-2009; Malanoski, Anthony/P-6975-2019	Malanoski, Anthony P/0000-0001-6192-888X; Saad, Magdi/0000-0003-2111-8115; Stitt, Alan/0000-0002-8647-9918; Lin, Baochuan/0000-0002-9484-0785; Malanoski, Anthony/0000-0001-6192-888X; Swayne, David/0000-0001-7472-1992	TessArae [NCRADA-NRL-06-406]; United States Navy to TessArae [N00244-07-C-0037]; Department of Defense; Division of the Armed Forces Health Surveillance Center, Silver Spring, Maryland	TessArae; United States Navy to TessArae; Department of Defense(United States Department of Defense); Division of the Armed Forces Health Surveillance Center, Silver Spring, Maryland	No grant funding supported this effort. TessArae and the Naval Research Laboratory worked together under a Cooperative Research and Development Agreement (NCRADA-NRL-06-406), with financial resources contributed from TessArae. TessArae and the Naval Health Research Center worked together under a research services contract (N00244-07-C-0037) from the United States Navy to TessArae. Partial funding for this respiratory disease surveillance initiative was provided by the Department of Defense, Global Emerging Infections Surveillance and Response System (GEIS), a Division of the Armed Forces Health Surveillance Center, Silver Spring, Maryland. TessArae and the Department of Agriculture, Agricultural Research Service, Southeast Poultry Research Laboratory (SEPRL) cooperated under a no-cost cooperative agreement under which SEPRL provided samples (as their respective costs assumed) for testing and TessArae performed the testing (as their respective costs assumed). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUSTIN FJ, 1990, J GEN VIROL, V71, P2471, DOI 10.1099/0022-1317-71-10-2471; Brammer L., 2008, Morbidity and Mortality Weekly Report, V57, P1329; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dawson ED, 2006, ANAL CHEM, V78, P7610, DOI 10.1021/ac061739f; Freed NE, 2007, MOL CELL PROBE, V21, P103, DOI 10.1016/j.mcp.2006.08.007; Gingeras TR, 1998, GENOME RES, V8, P435, DOI 10.1101/gr.8.5.435; Gupta RK, 2008, EMERG INFECT DIS, V14, P1187, DOI 10.3201/eid1408.070751; Harvey R, 2004, J VIROL, V78, P502, DOI 10.1128/JVI.78.1.502-507.2004; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Kamps BS, 2006, INFLUENZA REPORT; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; Lin B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000419; Lin BC, 2009, J CLIN MICROBIOL, V47, P988, DOI 10.1128/JCM.01346-08; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Malanoski AP, 2006, NUCLEIC ACIDS RES, V34, P5300, DOI 10.1093/nar/gkl565; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; *WHO, 2009, INFL A H1N1 VIR RES; *WHO, 2009, CUM NUMB CONF HUM CA; World Health Organization, 2002, WHO MAN AN INFL DIAG	27	25	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e8995	10.1371/journal.pone.0008995	http://dx.doi.org/10.1371/journal.pone.0008995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140251	Green Published, gold, Green Submitted			2022-12-25	WOS:000274474200003
J	Duncan, CDS; Weeks, KM				Duncan, Caia D. S.; Weeks, Kevin M.			The Mrs1 Splicing Factor Binds the bI3 Group I Intron at Each of Two Tetraloop-Receptor Motifs	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MITOCHONDRIAL INTRONS; TERTIARY INTERACTIONS; SHAPE CHEMISTRY; RNA; PROTEIN; RIBOZYME; DOMAIN; SITE; ARCHITECTURE	Most large ribozymes require protein cofactors in order to function efficiently. The yeast mitochondrial bI3 group I intron requires two proteins for efficient splicing, Mrs1 and the bI3 maturase. Mrs1 has evolved from DNA junction resolvases to function as an RNA cofactor for at least two group I introns; however, the RNA binding site and the mechanism by which Mrs1 facilitates splicing were unknown. Here we use high-throughput RNA structure analysis to show that Mrs1 binds a ubiquitous RNA tertiary structure motif, the GNRA tetraloop-receptor interaction, at two sites in the bI3 RNA. Mrs1 also interacts at similar tetraloop-receptor elements, as well as other structures, in the self-folding Azoarcus group I intron and in the RNase P enzyme. Thus, Mrs1 recognizes general features found in the tetraloop-receptor motif. Identification of the two Mrs1 binding sites now makes it possible to create a model of the complete six-component bI3 ribonucleoprotein. All protein cofactors bind at the periphery of the RNA such that every long-range RNA tertiary interaction is stabilized by protein binding, involving either Mrs1 or the bI3 maturase. This work emphasizes the strong evolutionary pressure to bolster RNA tertiary structure with RNA-binding interactions as seen in the ribosome, spliceosome, and other large RNA machines.	[Duncan, Caia D. S.; Weeks, Kevin M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Duncan, CDS (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA.	weeks@unc.edu		Duncan, Caia/0000-0001-8564-964X	National Institutes of Health (NIH) [GM056222, GM064803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056222, R01GM064803] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM056222 (bI3 ribonucleoprotein) and GM064803 (methods development) to K. M. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; Bassi GS, 2003, BIOCHEMISTRY-US, V42, P9980, DOI 10.1021/bi0346906; Bassi GS, 2002, P NATL ACAD SCI USA, V99, P128, DOI 10.1073/pnas.012579299; Bifano AL, 2008, J MOL BIOL, V383, P667, DOI 10.1016/j.jmb.2008.08.070; BOUSQUET I, 1990, CURR GENET, V18, P117, DOI 10.1007/BF00312599; Caprara MG, 2007, RNA, V13, P211, DOI 10.1261/rna.307907; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Duncan CDS, 2008, BIOCHEMISTRY-US, V47, P8504, DOI 10.1021/bi800207b; Gesteland R., 2006, RNA WORLD, V3rd edn. Cold Spring Harbor; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; JAEGER L, 1994, J MOL BIOL, V236, P1271, DOI 10.1016/0022-2836(94)90055-8; Kaspar BJ, 2008, NUCLEIC ACIDS RES, V36, P2958, DOI 10.1093/nar/gkn045; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Longo A, 2005, NAT STRUCT MOL BIOL, V12, P779, DOI 10.1038/nsmb976; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Mitra S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn267; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Paukstelis PJ, 2005, MOL CELL, V17, P417, DOI 10.1016/j.molcel.2004.12.026; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; Shcherbakova I, 2008, NAT PROTOC, V3, P288, DOI 10.1038/nprot.2007.533; Tanner MA, 1996, RNA, V2, P74; Tullius TD, 2005, CURR OPIN CHEM BIOL, V9, P127, DOI 10.1016/j.cbpa.2005.02.009; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008; Vicens Q, 2008, RNA, V14, P2013, DOI 10.1261/rna.1027208; Wardleworth BN, 2000, J BIOL CHEM, V275, P23725, DOI 10.1074/jbc.M002612200; Webb AE, 2001, J MOL BIOL, V309, P1087, DOI 10.1006/jmbi.2001.4714; Weeks KM, 1997, CURR OPIN STRUC BIOL, V7, P336, DOI 10.1016/S0959-440X(97)80048-6; WEEKS KM, 1995, CELL, V82, P221, DOI 10.1016/0092-8674(95)90309-7; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Woodson SA, 2005, CURR OPIN STRUC BIOL, V15, P324, DOI 10.1016/j.sbi.2005.05.007; Zhang Xu-hong, 2008, Asian Journal of Ecotoxicology, V3, P9; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8983	10.1371/journal.pone.0008983	http://dx.doi.org/10.1371/journal.pone.0008983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126554	Green Published, gold, Green Submitted			2022-12-25	WOS:000274209700011
J	Zani, BG; Indolfi, L; Edelman, ER				Zani, Brett G.; Indolfi, Laura; Edelman, Elazer R.			Tubular Bridges for Bronchial Epithelial Cell Migration and Communication	PLOS ONE			English	Article							DROSOPHILA TRACHEAL SYSTEM; HEPATOCYTE GROWTH-FACTOR; INTERCELLULAR BRIDGES; TUNNELING NANOTUBES; AIRWAY EPITHELIUM; OXIDATIVE STRESS; GENE-EXPRESSION; PROLIFERATION; CYTONEMES; LUNG	Background: Biological processes from embryogenesis to tumorigenesis rely on the coordinated coalescence of cells and synchronized cell-to-cell communication. Intercellular signaling enables cell masses to communicate through endocrine pathways at a distance or by direct contact over shorter dimensions. Cellular bridges, the longest direct connections between cells, facilitate transfer of cellular signals and components over hundreds of microns in vitro and in vivo. Methodology/Principal Findings: Using various cellular imaging techniques on human tissue cultures, we identified two types of tubular, bronchial epithelial (EP) connections, up to a millimeter in length, designated EP bridges. Structurally distinct from other cellular connections, the first type of EP bridge may mediate transport of cellular material between cells, while the second type of EP bridge is functionally distinct from all other cellular connections by mediating migration of epithelial cells between EP masses. Morphological and biochemical interactions with other cell types differentially regulated the nuclear factor-kappa B and cyclooxygenase inflammatory pathways, resulting in increased levels of inflammatory molecules that impeded EP bridge formation. Pharmacologic inhibition of these inflammatory pathways caused increased morphological and mobility changes stimulating the biogenesis of EP bridges, in part through the upregulation of reactive oxygen species pathways. Conclusions/Significance: EP bridge formation appears to be a normal response of EP physiology in vitro, which is differentially inhibited by inflammatory cellular pathways depending upon the morphological and biochemical interactions between EP cells and other cell types. These tubular EP conduits may represent an ultra long-range form of direct intercellular communication and a completely new mechanism of tissue-mediated cell migration.	[Zani, Brett G.; Indolfi, Laura; Edelman, Elazer R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Indolfi, Laura] Univ Naples Federico 2, Italian Inst Technol, Interdisciplinary Res Ctr Biomat CRIB, Naples, Italy; [Edelman, Elazer R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Istituto Italiano di Tecnologia - IIT; University of Naples Federico II; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zani, BG (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	zani@mit.edu		Edelman, Elazer/0000-0002-7832-7156	NIH [R01 GM 49039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM 49039 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chen F, 2003, CANCER RES, V63, P7689; Chen F, 2006, J BIOL CHEM, V281, P37142, DOI 10.1074/jbc.M603631200; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Chung S, 2008, J CELL SCI, V121, P3501, DOI 10.1242/jcs.037887; Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Hartney JM, 2006, AM J PHYSIOL-LUNG C, V290, pL105, DOI 10.1152/ajplung.00221.2005; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Lu YB, 2005, J IMMUNOL, V175, P5423, DOI 10.4049/jimmunol.175.8.5423; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; ONFELT B, 2005, SCI STKE, pPE55; Pan TL, 2001, AM J RESP CELL MOL, V25, P353, DOI 10.1165/ajrcmb.25.3.4004; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; RUGENDORFF A, 1994, ROUX ARCH DEV BIOL, V203, P266, DOI 10.1007/BF00360522; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Rustom A, 2009, ANN NY ACAD SCI, V1178, P129, DOI 10.1111/j.1749-6632.2009.04997.x; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; SCHUGER L, 1990, DEVELOPMENT, V110, P1091; Schwarz MA, 2004, AM J RESP CELL MOL, V30, P784, DOI 10.1165/rcmb.2003-0145OC; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; WOLFF JR, 1972, ANGIOLOGICA, V9, P11; Woodruff RI, 1998, DEV BIOL, V200, P82, DOI 10.1006/dbio.1998.8948; Zahner G, 2006, FEBS LETT, V580, P2523, DOI 10.1016/j.febslet.2006.03.063	43	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8930	10.1371/journal.pone.0008930	http://dx.doi.org/10.1371/journal.pone.0008930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126618	Green Published, gold, Green Submitted			2022-12-25	WOS:000274138000009
J	Peedicayil, A; Vierkant, RA; Hartmann, LC; Fridley, BL; Fredericksen, ZS; White, KL; Elliott, EA; Phelan, CM; Tsai, YY; Berchuck, A; Iversen, ES; Couch, FJ; Peethamabaran, P; Larson, MC; Kalli, KR; Kosel, ML; Shridhar, V; Rider, DN; Liebow, M; Cunningham, JM; Schildkraut, JM; Sellers, TA; Goode, EL				Peedicayil, Abraham; Vierkant, Robert A.; Hartmann, Lynn C.; Fridley, Brooke L.; Fredericksen, Zachary S.; White, Kristin L.; Elliott, Elaine A.; Phelan, Catherine M.; Tsai, Ya-Yu; Berchuck, Andrew; Iversen, Edwin S., Jr.; Couch, Fergus J.; Peethamabaran, Prema; Larson, Melissa C.; Kalli, Kimberly R.; Kosel, Matthew L.; Shridhar, Vijayalakshmi; Rider, David N.; Liebow, Mark; Cunningham, Julie M.; Schildkraut, Joellen M.; Sellers, Thomas A.; Goode, Ellen L.			Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated Genes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SUSCEPTIBILITY; EXPRESSION; ACETYLATION; PERFORMANCE; SET; DNA	Background: We previously identified a panel of genes associated with outcome of ovarian cancer. The purpose of the current study was to assess whether variants in these genes correlated with ovarian cancer risk. Methods and Findings: Women with and without invasive ovarian cancer (749 cases, 1,041 controls) were genotyped at 136 single nucleotide polymorphisms (SNPs) within 13 candidate genes. Risk was estimated for each SNP and for overall variation within each gene. At the gene-level, variation within MSL1 (male-specific lethal-1 homolog) was associated with risk of serous cancer (p = 0.03); haplotypes within PRPF31 (PRP31 pre-mRNA processing factor 31 homolog) were associated with risk of invasive disease (p = 0.03). MSL1 rs7211770 was associated with decreased risk of serous disease (OR 0.81, 95% CI 0.66-0.98; p = 0.03). SNPs in MFSD7, BTN3A3, ZNF200, PTPRS, and CCND1A were inversely associated with risk (p < 0.05), and there was increased risk at HEXIM1 rs1053578 (p = 0.04, OR 1.40, 95% CI 1.02-1.91). Conclusions: Tumor studies can reveal novel genes worthy of follow-up for cancer susceptibility. Here, we found that inherited markers in the gene encoding MSL1, part of a complex that modifies the histone H4, may decrease risk of invasive serous ovarian cancer.	[Peedicayil, Abraham; Vierkant, Robert A.; Hartmann, Lynn C.; Fridley, Brooke L.; Fredericksen, Zachary S.; White, Kristin L.; Elliott, Elaine A.; Couch, Fergus J.; Peethamabaran, Prema; Larson, Melissa C.; Kalli, Kimberly R.; Kosel, Matthew L.; Shridhar, Vijayalakshmi; Rider, David N.; Liebow, Mark; Cunningham, Julie M.; Goode, Ellen L.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Phelan, Catherine M.; Tsai, Ya-Yu; Sellers, Thomas A.] H Lee Moffitt Canc Res Inst, Tampa, FL USA; [Berchuck, Andrew; Iversen, Edwin S., Jr.; Schildkraut, Joellen M.] Duke Univ, Durham, NC USA	Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute; Duke University	Peedicayil, A (corresponding author), Mayo Clin, Coll Med, Rochester, MN 55905 USA.	egoode@mayo.edu	Vierkant, Robert/AAP-4927-2020; Fridley, Brooke L/D-8315-2015	Vierkant, Robert/0000-0001-6242-5221; Fridley, Brooke L/0000-0001-7739-7956; Peedicayil, Abraham/0000-0002-9318-566X	National Cancer Institute [R01 CA122443, R01 CA88868]; Ovarian Cancer Research Fund; Fred C. and Katherine B. Andersen Foundation; NATIONAL CANCER INSTITUTE [R01CA122443, R01CA088868] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund; Fred C. and Katherine B. Andersen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute [R01 CA122443, R01 CA88868], the Ovarian Cancer Research Fund, and the Fred C. and Katherine B. Andersen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Cooper GM., 2007, CELL MOL APPROACH; Cunningham JM, 2008, CANCER EPIDEM BIOMAR, V17, P1781, DOI 10.1158/1055-9965.EPI-07-2849; De Smet F, 2005, CLIN CANCER RES, V11, P7958, DOI 10.1158/1078-0432.CCR-05-1216; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gayther SA, 2007, CANCER RES, V67, P3027, DOI 10.1158/0008-5472.CAN-06-3261; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; LI Y, 2006, AM J HUM GENET S, V79, P416; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pearce CL, 2008, BRIT J CANCER, V98, P282, DOI 10.1038/sj.bjc.6604170; Pharoah PDP, 2002, BEST PRACT RES CL OB, V16, P449, DOI 10.1053/beog.2002.0296; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramus SJ, 2007, HUM MUTAT, V28, P1207, DOI 10.1002/humu.20599; Ramus SJ, 2008, INT J CANCER, V123, P380, DOI 10.1002/ijc.23448; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schildkraut JM, 2009, CANCER RES, V69, P2349, DOI 10.1158/0008-5472.CAN-08-2902; Sellers TA, 2005, CANCER EPIDEM BIOMAR, V14, P2536, DOI 10.1158/1055-9965.EPI-05-0142; Sellers TA, 2008, CANCER EPIDEM BIOMAR, V17, P397, DOI 10.1158/1055-9965.EPI-07-0565; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X	33	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8884	10.1371/journal.pone.0008884	http://dx.doi.org/10.1371/journal.pone.0008884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111712	Green Submitted, Green Published, gold			2022-12-25	WOS:000274114800009
J	Huang, V; Qin, Y; Wang, J; Wang, XL; Place, RF; Lin, GT; Lue, TF; Li, LC				Huang, Vera; Qin, Yi; Wang, Ji; Wang, Xiaoling; Place, Robert F.; Lin, Guiting; Lue, Tom F.; Li, Long-Cheng			RNAa Is Conserved in Mammalian Cells	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; NONHUMAN-PRIMATES; P53 RESTORATION; EXPRESSION; ACTIVATION; APOPTOSIS; DELIVERY; BINDING; DNA	Background: RNA activation (RNAa) is a newly discovered mechanism of gene activation triggered by small double-stranded RNAs termed 'small activating RNAs' (saRNAs). Thus far, RNAa has only been demonstrated in human cells and is unclear whether it is conserved in other mammals. Methodology/Principal Findings: In the present study, we evaluated RNAa in cells derived from four mammalian species including nonhuman primates (African green monkey and chimpanzee), mouse, and rat. Previously, we identified saRNAs leading to the activation of E-cadherin, p21, and VEGF in human cells. As the targeted sequences are highly conserved in primates, transfection of each human saRNA into African green monkey (COS1) and chimpanzee (WES) cells also resulted in induction of the intended gene. Additional saRNAs targeting clinically relevant genes including p53, PAR4, WT1, RB1, p27, NKX3-1, VDR, IL2, and pS2 were also designed and transfected into COS1 and WES cells. Of the nine genes, p53, PAR4, WT1, and NKX3-1 were induced by their corresponding saRNAs. We further extended our analysis of RNAa into rodent cell types. We identified two saRNAs that induced the expression of mouse Cyclin B1 in NIH/3T3 and TRAMP C1 cells, which led to increased phosphorylation of histone H3, a downstream marker for chromosome condensation and entry into mitosis. We also identified two saRNAs that activated the expression of CXCR4 in primary rat adipose-derived stem cells. Conclusions/Significance: This study demonstrates that RNAa exists in mammalian species other than human. Our findings also suggest that nonhuman primate disease models may have clinical applicability for validating RNAa-based drugs.	[Huang, Vera; Qin, Yi; Wang, Ji; Wang, Xiaoling; Place, Robert F.; Li, Long-Cheng] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Huang, Vera; Qin, Yi; Wang, Ji; Wang, Xiaoling; Place, Robert F.; Lin, Guiting; Lue, Tom F.; Li, Long-Cheng] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Huang, V (corresponding author), Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA.	lilc@urology.ucsf.edu	Wang, Ji/I-5795-2012; Li, Long-Cheng/D-8078-2017	Li, Long-Cheng/0000-0002-3971-6335; Huang, Vera/0000-0003-1882-9522	National Institutes of Health [1R21CA131774-02, 1R01GM090293-0109]; Department of Defense [W81XWH-08-1-0260]; NATIONAL CANCER INSTITUTE [R21CA131774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (1R21CA131774-02 and 1R01GM090293-0109) and Department of Defense (W81XWH-08-1-0260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Blagbrough IS, 2009, PHARM RES-DORDR, V26, P1, DOI 10.1007/s11095-008-9646-8; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Foster BA, 1997, CANCER RES, V57, P3325; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; Kumari SR, 1998, CANCER RES, V58, P5075; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; LIN G, 2009, STEM C IN PRESS 0226; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Perez AL, 2009, MUSCLE NERVE, V40, P562, DOI 10.1002/mus.21317; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Querbes W, 2009, OLIGONUCLEOTIDES, V19, P23, DOI 10.1089/oli.2008.0165; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Turunen MP, 2009, CIRC RES, V105, P604, DOI 10.1161/CIRCRESAHA.109.200774; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	26	139	167	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8848	10.1371/journal.pone.0008848	http://dx.doi.org/10.1371/journal.pone.0008848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107511	gold, Green Submitted, Green Published			2022-12-25	WOS:000273896100013
J	Fanarraga, ML; Bellido, J; Jaen, C; Villegas, JC; Zabala, JC				Lopez Fanarraga, Monica; Bellido, Javier; Jaen, Cristina; Carlos Villegas, Juan; Carlos Zabala, Juan			TBCD Links Centriologenesis, Spindle Microtubule Dynamics, and Midbody Abscission in Human Cells	PLOS ONE			English	Article							FOLDING COFACTOR D; GAMMA-TUBULIN; BETA-TUBULIN; FISSION YEAST; PROTEIN; CENTROSOME; CENTRIOLE; CILIOGENESIS; CYCLE; IDENTIFICATION	Microtubule-organizing centers recruit alpha- and beta-tubulin polypeptides for microtubule nucleation. Tubulin synthesis is complex, requiring five specific cofactors, designated tubulin cofactors (TBCs) A-E, which contribute to various aspects of microtubule dynamics in vivo. Here, we show that tubulin cofactor D (TBCD) is concentrated at the centrosome and midbody, where it participates in centriologenesis, spindle organization, and cell abscission. TBCD exhibits a cell-cycle-specific pattern, localizing on the daughter centriole at G1 and on procentrioles by S, and disappearing from older centrioles at telophase as the protein is recruited to the midbody. Our data show that TBCD overexpression results in microtubule release from the centrosome and G1 arrest, whereas its depletion produces mitotic aberrations and incomplete microtubule retraction at the midbody during cytokinesis. TBCD is recruited to the centriole replication site at the onset of the centrosome duplication cycle. A role in centriologenesis is further supported in differentiating ciliated cells, where TBCD is organized into "centriolar rosettes". These data suggest that TBCD participates in both canonical and de novo centriolar assembly pathways.	[Lopez Fanarraga, Monica; Bellido, Javier; Jaen, Cristina; Carlos Zabala, Juan] Univ Cantabria, Dept Biol Mol, Marques de Valdecilla Fac Med, Inst Formac & Invest, E-39005 Santander, Spain	Universidad de Cantabria	Fanarraga, ML (corresponding author), Univ Cantabria, Dept Biol Mol, Marques de Valdecilla Fac Med, Inst Formac & Invest, E-39005 Santander, Spain.	zabalajc@unican.es	Fanarraga, Monica/AAE-5804-2019; Zabala, Juan Carlos/K-5163-2014; Fanarraga, Mónica L./M-6177-2014	Fanarraga, Monica/0000-0003-4754-311X; Zabala, Juan Carlos/0000-0003-2679-5473; Fanarraga, Mónica L./0000-0003-4754-311X; VILLEGAS, JUAN CARLOS/0000-0003-3293-8653	Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D;  [BFU2007-64882]	Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D; 	This study was funded by BFU2007-64882 and Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D (http://ciencia.micinn.fecyt.es/ciencia/jsp/plantilla.jsp?area=consolider&id=51) and the Instituto de Formacion e Investigacion Marques de Valdecilla (http://www.fmdv.org/index2.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzi KC, 2002, MOL CELL BIOL, V22, P138, DOI 10.1128/MCB.22.1.138-147.2002; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Archer JE, 1998, MOL CELL BIOL, V18, P1757, DOI 10.1128/MCB.18.3.1757; ARCHER JE, 1995, CELL, V82, P425, DOI 10.1016/0092-8674(95)90431-X; AVILA J, 2008, CURRENT PROTOCOLS CE; Bartolini F, 2005, J CELL SCI, V118, P1197, DOI 10.1242/jcs.01719; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; Doxsey SJ, 2005, MOL CELL, V20, P170, DOI 10.1016/j.molcel.2005.10.010; Fanarraga ML, 1999, CELL MOTIL CYTOSKEL, V43, P243, DOI 10.1002/(SICI)1097-0169(1999)43:3<243::AID-CM7>3.0.CO;2-0; Fedyanina OS, 2006, CURR GENET, V50, P281, DOI 10.1007/s00294-006-0095-9; Fedyanina OS, 2009, YEAST, V26, P235, DOI 10.1002/yea.1663; Hagiwara H, 2004, INT REV CYTOL, V234, P101, DOI 10.1016/S0074-7696(04)34003-9; Hirata D, 1998, EMBO J, V17, P658, DOI 10.1093/emboj/17.3.658; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Keller CE, 2005, TRENDS CELL BIOL, V15, P570; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kortazar D, 2007, EXP CELL RES, V313, P425, DOI 10.1016/j.yexcr.2006.09.002; Kortazar D, 2006, PROTEIN EXPRES PURIF, V49, P196, DOI 10.1016/j.pep.2006.03.005; LAJOIEMAZENC I, 1994, J CELL SCI, V107, P2825; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Martin L, 2000, FEBS LETT, V470, P93, DOI 10.1016/S0014-5793(00)01293-X; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2005, J CELL SCI, V118, P1105, DOI 10.1242/jcs.02284; SHU HB, 1995, J CELL SCI, V108, P2955; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Steinborn K, 2002, GENE DEV, V16, P959, DOI 10.1101/gad.221702; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Szymanski D, 2002, CURR BIOL, V12, pR767, DOI 10.1016/S0960-9822(02)01288-5; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; ZABALA JC, 1992, CELL MOTIL CYTOSKEL, V23, P222, DOI 10.1002/cm.970230306	45	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8846	10.1371/journal.pone.0008846	http://dx.doi.org/10.1371/journal.pone.0008846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107510	Green Published, gold			2022-12-25	WOS:000273896100011
J	Prasanna, SJ; Gopalakrishnan, D; Shankar, SR; Vasandan, AB				Prasanna, S. Jyothi; Gopalakrishnan, Divya; Shankar, Shilpa Rani; Vasandan, Anoop Babu			Pro-Inflammatory Cytokines, IFN gamma and TNF alpha, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially	PLOS ONE			English	Article							PROLIFERATION IN-VITRO; NECROSIS-FACTOR-ALPHA; STROMAL CELLS; LIFE-SPAN; IMMUNOGENICITY; FETAL; TRANSPLANTATION; REJECTION; RESPONSES; SUPPRESSION	Background: Wharton's jelly derived stem cells (WJMSCs) are gaining attention as a possible clinical alternative to bone marrow derived mesenchymal stem cells (BMMSCs) owing to better accessibility, higher expansion potential and low immunogenicity. Usage of allogenic mesenchymal stem cells (MSC) could be permissible in vivo only if they retain their immune properties in an inflammatory setting. Thus the focus of this study is to understand and compare the immune properties of BMMSCs and WJMSCs primed with key pro-inflammatory cytokines, Interferon-gamma (IFN gamma) and Tumor Necrosis Factor-alpha (TNF alpha). Methodology/Principal Findings: Initially the effect of priming on MSC mediated suppression of alloantigen and mitogen induced lymphoproliferation was evaluated in vitro. Treatment with IFN gamma or TNF alpha, did not ablate the immune-suppression caused by both the MSCs. Extent of immune-suppression was more with WJMSCs than BMMSCs in both the cases. Surprisingly, priming BMMSCs enhanced suppression of mitogen driven lymphoproliferation only; whereas IFN gamma primed WJMSCs were better suppressors of MLRs. Further, kinetic analysis of cytokine profiles in co-cultures of primed/unprimed MSCs and Phytohematoagglutinin (PHA) activated lymphocytes was evaluated. Results indicated a decrease in levels of pro-inflammatory cytokines. Interestingly, a change in kinetics and thresholds of Interleukin-2 (IL-2) secretion was observed only with BMMSCs. Analysis of activation markers on PHA-stimulated lymphocytes indicated different expression patterns in co-cultures of primed/unprimed WJMSCs and BMMSCs. Strikingly, co-culture with WJMSCs resulted in an early activation of a negative co-stimulatory molecule, CTLA4, which was not evident with BMMSCs. A screen for immune suppressive factors in primed/unprimed WJMSCs and BMMSCs indicated inherent differences in IFN gamma inducible Indoleamine 2, 3-dioxygenase (IDO) activity, Hepatocyte growth factor (HGF) and Prostaglandin E-2 (PGE2) levels which could possibly influence the mechanism of immune-modulation. Conclusion/Significance: This study demonstrates that inflammation affects the immune properties of MSCs distinctly. Importantly different tissue derived MSCs could utilize unique mechanisms of immune-modulation.	[Prasanna, S. Jyothi; Gopalakrishnan, Divya; Shankar, Shilpa Rani; Vasandan, Anoop Babu] Manipal Univ, Manipal Inst Regenerat Med, Constituent Inst, Bangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Prasanna, SJ (corresponding author), Manipal Univ, Manipal Inst Regenerat Med, Constituent Inst, Bangalore, Karnataka, India.	jyothi.prasanna@manipal.edu			Department of Biotechnology, India [BT/PR7091/MED/14/941/2006]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by grant BT/PR7091/MED/14/941/2006 obtained from Department of Biotechnology, India (dbtindia.nic.in). The funders have no role in the study design, data analysis and collection, decision to publish or preparation of the manuscript.	Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; CARTER A, 1990, BRIT J HAEMATOL, V74, P424, DOI 10.1111/j.1365-2141.1990.tb06330.x; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chan WK, 2008, EXP HEMATOL, V36, P1545, DOI 10.1016/j.exphem.2008.06.008; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Clarkson MR, 2005, TRANSPLANTATION, V80, P555, DOI 10.1097/01.tp.0000168432.60022.99; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Fang LB, 2006, TRANSPLANTATION, V82, P1370, DOI 10.1097/01.tp.0000232450.62408.f9; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gotherstrom C, 2004, AM J OBSTET GYNECOL, V190, P239, DOI 10.1016/j.ajog.2003.07.022; Gotherstrom C, 2003, BONE MARROW TRANSPL, V32, P265, DOI 10.1038/sj.bmt.1704111; Gotherstrom C, 2005, HAEMATOLOGICA, V90, P1017; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; JOHANNISSON A, 1995, CYTOMETRY, V19, P343, DOI 10.1002/cyto.990190409; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Kadam SS, 2009, IN VITRO CELL DEV-AN, V45, P23, DOI 10.1007/s11626-008-9155-4; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Krampera M, 2006, CURR OPIN PHARMACOL, V6, P435, DOI 10.1016/j.coph.2006.02.008; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Magatti M, 2008, STEM CELLS, V26, P182, DOI 10.1634/stemcells.2007-0491; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; ROTH MD, 1994, J EXP MED, V179, P857, DOI 10.1084/jem.179.3.857; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Sundin M, 2007, HAEMATOLOGICA, V92, P1208, DOI 10.3324/haematol.11446; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Xuan Min, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P433; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; YOO KH, 2009, CELL IMMUNOL; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190	63	399	423	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9016	10.1371/journal.pone.0009016	http://dx.doi.org/10.1371/journal.pone.0009016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	21152066	Green Submitted, gold, Green Published			2022-12-25	WOS:000274207200013
J	Huang, HR; Xie, CQ; Sun, X; Ritchie, RP; Zhang, JF; Chen, YE				Huang, Huarong; Xie, Changqing; Sun, Xuan; Ritchie, Raquel P.; Zhang, Jifeng; Chen, Y. Eugene			miR-10a Contributes to Retinoid Acid-induced Smooth Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; NF-KAPPA-B; SERUM RESPONSE FACTOR; NEOINTIMAL LESION FORMATION; HISTONE DEACETYLASES; GENE-EXPRESSION; MYELOID-LEUKEMIA; DOWN-REGULATION; MICRORNA; GROWTH	MicroRNAs (miRs) have been reported to play a critical role in muscle differentiation and function. The purpose of this study is to determine the role of miRs during smooth muscle cell (SMC) differentiation from embryonic stem cells (ESCs). MicroRNA profiling showed that miR-10a expression is steadily increased during in vitro differentiation of mouse ESCs into SMCs. Loss-of-function approaches using miR-10a inhibitors uncovered that miR-10a is a critical mediator for SMC lineage determination in our retinoic acid-induced ESC/SMC differentiation system. In addition, we have documented for the first time that histone deacetylase 4 is a novel target of miR-10a and mediates miR-10a function during ESC/SMC differentiation. To determine the molecular mechanism through which retinoic acid induced miR-10a expression, a consensus NF-kappa B element was identified in the miR-10a gene promoter by bioinformatics analysis, and chromatin immunoprecipitation assay confirmed that NF-kappa B could bind to this element. Finally, inhibition of NF-kappa B nuclear translocation repressed miR-10a expression and decreased SMC differentiation from ESCs. Our data demonstrate for the first time that miR-10a is a novel regulator in SMC differentiation from ESCs. These studies suggest that miR-10a may play important roles in vascular biology and have implications for the diagnosis and treatment of vascular diseases.	[Huang, Huarong; Xie, Changqing; Sun, Xuan; Ritchie, Raquel P.; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Dept Internal Med, Med Ctr, Ann Arbor, MI 48109 USA; [Sun, Xuan] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410078, Hunan, Peoples R China	University of Michigan System; University of Michigan; Central South University	Chen, YE (corresponding author), 1150 W Med Ctr Dr,MSRB 3,7301E, Ann Arbor, MI 48109 USA.	echenum@umich.edu		Striepen, Boris/0000-0002-7426-432X	National Institutes of Health [HL092421, HL068878, HL89544]; American Heart Association [0825837G, 09SDG2260023, 0835237N, 0840025N]; American Heart Association National Scientific Development [09SDG2260023, 0835237N, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, R21HL092421, R01HL068878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Heart Association National Scientific Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092421, HL068878, and HL89544 (to Y.E.C.).; Supported by American Heart Association Postdoctoral Fellowship 0825837G.; Supported by American Heart Association National Scientific Development Grant 09SDG2260023.; Supported by a National Institutes of Health Research Supplement to Promote Diversity.; Supported by American Heart Association National Scientific Development Grant 0835237N.; An American Heart Association established investigator (Grant 0840025N).	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NARAYANAN R, 1993, MOL CELL BIOL, V13, P3802, DOI 10.1128/MCB.13.6.3802; Neppl RL, 2009, CELL STEM CELL, V5, P130, DOI 10.1016/j.stem.2009.07.004; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Sinha Sanjay, 2009, V482, P345, DOI 10.1007/978-1-59745-060-7_22; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Walsh K, 2001, Z Kardiol, V90 Suppl 3, P12; Widera D, 2006, INT J DEV NEUROSCI, V24, P91, DOI 10.1016/j.ijdevneu.2005.11.017; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xie CQ, 2007, ARTERIOSCL THROM VAS, V27, pE311, DOI 10.1161/ATVBAHA.107.154260; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056	55	118	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9383	9389		10.1074/jbc.M109.095612	http://dx.doi.org/10.1074/jbc.M109.095612			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118242	Green Published, hybrid			2022-12-25	WOS:000276165900010
